drug_index,disease_index,drug_name,disease_name,path_type,original_relation,nodes,score
14014,33675.0,Flunisolide,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Flunisolide']",0.5
14014,35565.0,Flunisolide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Flunisolide']",0.5
14014,37888.0,Flunisolide,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Flunisolide']",0.5
14017,33575.0,Fluorometholone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Fluorometholone']",0.5
14017,33581.0,Fluorometholone,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Fluorometholone']",0.5
14017,83830.0,Fluorometholone,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Fluorometholone']",0.5
14018,30813.0,Beclomethasone dipropionate,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Beclomethasone dipropionate']",0.5
14018,33675.0,Beclomethasone dipropionate,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Beclomethasone dipropionate']",0.5
14018,35565.0,Beclomethasone dipropionate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Beclomethasone dipropionate']",0.5
14018,37811.0,Beclomethasone dipropionate,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Beclomethasone dipropionate']",0.5
14018,37888.0,Beclomethasone dipropionate,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Beclomethasone dipropionate']",0.5
14018,83830.0,Beclomethasone dipropionate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Beclomethasone dipropionate']",0.5
14019,27219.0,Betamethasone,hypogonadotropic hypogonadism with or without anosmia,disease-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'CYP19A1', 'Betamethasone']",0.5
14019,27249.0,Betamethasone,isolated growth hormone deficiency,disease-protein-drug,contraindication,"['isolated growth hormone deficiency', 'CYP19A1', 'Betamethasone']",0.5
14019,27452.0,Betamethasone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Betamethasone']",0.5
14019,27741.0,Betamethasone,pituitary deficiency due to empty sella turcica syndrome,disease-protein-drug,contraindication,"['pituitary deficiency due to empty sella turcica syndrome', 'CYP19A1', 'Betamethasone']",0.5
14019,28005.0,Betamethasone,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,off-label use,"['developmental and epileptic encephalopathy', 'Hepatomegaly', 'ALB', 'Betamethasone']",0.5
14019,28158.0,Betamethasone,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ABCB1', 'Betamethasone']",0.5
14019,28158.0,Betamethasone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Betamethasone']",0.5
14019,28158.0,Betamethasone,inflammatory bowel disease,disease-phenotype-protein-drug,indication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Betamethasone']",0.5
14019,28407.0,Betamethasone,hypogonadotropic hypogonadism,disease-protein-drug,contraindication,"['hypogonadotropic hypogonadism', 'CYP19A1', 'Betamethasone']",0.5
14019,28478.0,Betamethasone,autoimmune disease,disease-exposure-bioprocess-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Betamethasone']",0.5
14019,28478.0,Betamethasone,autoimmune disease,disease-exposure-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'CYP1B1', 'Betamethasone']",0.5
14019,28754.0,Betamethasone,autosomal recessive infantile hypercalcemia,disease-phenotype-protein-drug,contraindication,"['autosomal recessive infantile hypercalcemia', 'Vomiting', 'ABCB1', 'Betamethasone']",0.5
14019,29078.0,Betamethasone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Betamethasone']",0.5
14019,29078.0,Betamethasone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,29078.0,Betamethasone,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,29186.0,Betamethasone,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,contraindication,"['carbamoyl phosphate synthetase I deficiency disease', 'Vomiting', 'ABCB1', 'Betamethasone']",0.5
14019,29614.0,Betamethasone,osteoporosis,disease-protein-drug,contraindication,"['osteoporosis', 'CYP19A1', 'Betamethasone']",0.5
14019,29614.0,Betamethasone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,29614.0,Betamethasone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Betamethasone']",0.5
14019,29832.0,Betamethasone,hyperargininemia,disease-phenotype-protein-drug,contraindication,"['hyperargininemia', 'Hepatomegaly', 'ALB', 'Betamethasone']",0.5
14019,29854.0,Betamethasone,hereditary angioedema,disease-phenotype-protein-drug,indication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Betamethasone']",0.5
14019,29993.0,Betamethasone,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'ALB', 'Betamethasone']",0.5
14019,30494.0,Betamethasone,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,off-label use,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Betamethasone']",0.5
14019,30511.0,Betamethasone,anti-glomerular basement membrane disease,disease-phenotype-protein-drug,off-label use,"['anti-glomerular basement membrane disease', 'Proteinuria', 'ALB', 'Betamethasone']",0.5
14019,30813.0,Betamethasone,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Vomiting', 'ABCB1', 'Betamethasone']",0.5
14019,30892.0,Betamethasone,newborn respiratory distress syndrome,disease-protein-drug,off-label use,"['newborn respiratory distress syndrome', 'ALB', 'Betamethasone']",0.5
14019,30990.0,Betamethasone,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'ALB', 'Betamethasone']",0.5
14019,31511.0,Betamethasone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Betamethasone']",0.5
14019,31714.0,Betamethasone,short stature due to growth hormone qualitative anomaly,disease-protein-drug,contraindication,"['short stature due to growth hormone qualitative anomaly', 'CYP19A1', 'Betamethasone']",0.5
14019,32099.0,Betamethasone,granulomatosis with polyangiitis,disease-phenotype-protein-drug,off-label use,"['granulomatosis with polyangiitis', 'Proteinuria', 'ALB', 'Betamethasone']",0.5
14019,32132.0,Betamethasone,citrullinemia,disease-phenotype-protein-drug,contraindication,"['citrullinemia', 'Hepatomegaly', 'ALB', 'Betamethasone']",0.5
14019,32217.0,Betamethasone,hypopituitarism,disease-protein-drug,contraindication,"['hypopituitarism', 'CYP19A1', 'Betamethasone']",0.5
14019,32337.0,Betamethasone,"combined pituitary hormone deficiencies, genetic form",disease-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'CYP19A1', 'Betamethasone']",0.5
14019,32563.0,Betamethasone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Betamethasone']",0.5
14019,32584.0,Betamethasone,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,indication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Betamethasone']",0.5
14019,32746.0,Betamethasone,Stevens-Johnson syndrome,disease-protein-drug,indication,"['Stevens-Johnson syndrome', 'ALB', 'Betamethasone']",0.5
14019,32746.0,Betamethasone,Stevens-Johnson syndrome,disease-phenotype-protein-drug,indication,"['Stevens-Johnson syndrome', 'Thrombocytopenia', 'ALB', 'Betamethasone']",0.5
14019,32815.0,Betamethasone,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Betamethasone']",0.5
14019,32905.0,Betamethasone,Sheehan syndrome,disease-protein-drug,contraindication,"['Sheehan syndrome', 'CYP19A1', 'Betamethasone']",0.5
14019,32905.0,Betamethasone,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Betamethasone']",0.5
14019,32967.0,Betamethasone,sarcoidosis,disease-phenotype-protein-drug,indication,"['sarcoidosis', 'Hepatomegaly', 'ALB', 'Betamethasone']",0.5
14019,33077.0,Betamethasone,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,33077.0,Betamethasone,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'ALB', 'Betamethasone']",0.5
14019,33166.0,Betamethasone,isolated congenital growth hormone deficiency,disease-protein-drug,contraindication,"['isolated congenital growth hormone deficiency', 'CYP19A1', 'Betamethasone']",0.5
14019,33232.0,Betamethasone,X-linked intellectual disability with isolated growth hormone deficiency,disease-protein-drug,contraindication,"['X-linked intellectual disability with isolated growth hormone deficiency', 'CYP19A1', 'Betamethasone']",0.5
14019,33453.0,Betamethasone,Kallmann syndrome,disease-protein-drug,contraindication,"['Kallmann syndrome', 'CYP19A1', 'Betamethasone']",0.5
14019,33534.0,Betamethasone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Betamethasone']",0.5
14019,33575.0,Betamethasone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Betamethasone']",0.5
14019,33575.0,Betamethasone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,33575.0,Betamethasone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Betamethasone']",0.5
14019,33577.0,Betamethasone,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Betamethasone']",0.5
14019,33577.0,Betamethasone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,33577.0,Betamethasone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,33621.0,Betamethasone,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Betamethasone']",0.5
14019,33621.0,Betamethasone,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Betamethasone']",0.5
14019,33621.0,Betamethasone,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,33649.0,Betamethasone,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Betamethasone']",0.5
14019,33649.0,Betamethasone,exanthem (disease),disease-exposure-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'CYP1B1', 'Betamethasone']",0.5
14019,33675.0,Betamethasone,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Betamethasone']",0.5
14019,33675.0,Betamethasone,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,33679.0,Betamethasone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Betamethasone']",0.5
14019,35641.0,Betamethasone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Betamethasone']",0.5
14019,35650.0,Betamethasone,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Betamethasone']",0.5
14019,35650.0,Betamethasone,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Cadmium', 'ALB', 'Betamethasone']",0.5
14019,35669.0,Betamethasone,heart disease,disease-exposure-bioprocess-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Betamethasone']",0.5
14019,35669.0,Betamethasone,heart disease,disease-exposure-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,35823.0,Betamethasone,eye disease,disease-exposure-bioprocess-gene-drug,indication,"['eye disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,35823.0,Betamethasone,eye disease,disease-exposure-gene-drug,indication,"['eye disease', 'Particulate Matter', 'CYP1B1', 'Betamethasone']",0.5
14019,35915.0,Betamethasone,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Betamethasone']",0.5
14019,35915.0,Betamethasone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,36035.0,Betamethasone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Betamethasone']",0.5
14019,36129.0,Betamethasone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,36129.0,Betamethasone,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,36241.0,Betamethasone,hepatitis,disease-protein-drug,off-label use,"['hepatitis', 'ALB', 'Betamethasone']",0.5
14019,36432.0,Betamethasone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Betamethasone']",0.5
14019,36469.0,Betamethasone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Betamethasone']",0.5
14019,36644.0,Betamethasone,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,37285.0,Betamethasone,thymus gland disease,disease-protein-drug,contraindication,"['thymus gland disease', 'CYP19A1', 'Betamethasone']",0.5
14019,37617.0,Betamethasone,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Betamethasone']",0.5
14019,37617.0,Betamethasone,chronic obstructive pulmonary disease,disease-exposure-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,37722.0,Betamethasone,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,37722.0,Betamethasone,multiple sclerosis,disease-exposure-gene-drug,indication,"['multiple sclerosis', 'Lead', 'ALB', 'Betamethasone']",0.5
14019,37765.0,Betamethasone,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Betamethasone']",0.5
14019,37770.0,Betamethasone,contact dermatitis,disease-protein-drug,indication,"['contact dermatitis', 'CYP1B1', 'Betamethasone']",0.5
14019,37830.0,Betamethasone,bronchitis,disease-exposure-bioprocess-gene-drug,off-label use,"['bronchitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Betamethasone']",0.5
14019,37830.0,Betamethasone,bronchitis,disease-exposure-gene-drug,off-label use,"['bronchitis', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,37888.0,Betamethasone,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Betamethasone']",0.5
14019,37888.0,Betamethasone,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Betamethasone']",0.5
14019,37888.0,Betamethasone,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'CYP1B1', 'Betamethasone']",0.5
14019,37888.0,Betamethasone,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Betamethasone']",0.5
14019,38085.0,Betamethasone,acquired pituitary hormone deficiency,disease-protein-drug,contraindication,"['acquired pituitary hormone deficiency', 'CYP19A1', 'Betamethasone']",0.5
14019,38179.0,Betamethasone,congenital hypogonadotropic hypogonadism,disease-protein-drug,contraindication,"['congenital hypogonadotropic hypogonadism', 'CYP19A1', 'Betamethasone']",0.5
14019,38508.0,Betamethasone,non-acquired pituitary hormone deficiency,disease-protein-drug,contraindication,"['non-acquired pituitary hormone deficiency', 'CYP19A1', 'Betamethasone']",0.5
14019,39025.0,Betamethasone,non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations,disease-protein-drug,contraindication,"['non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations', 'CYP19A1', 'Betamethasone']",0.5
14019,39202.0,Betamethasone,non-acquired combined pituitary hormone deficiency,disease-protein-drug,contraindication,"['non-acquired combined pituitary hormone deficiency', 'CYP19A1', 'Betamethasone']",0.5
14019,39203.0,Betamethasone,pituitary deficiency,disease-protein-drug,contraindication,"['pituitary deficiency', 'CYP19A1', 'Betamethasone']",0.5
14019,39539.0,Betamethasone,pituitary hormone defiency from vascular origin,disease-protein-drug,contraindication,"['pituitary hormone defiency from vascular origin', 'CYP19A1', 'Betamethasone']",0.5
14019,39540.0,Betamethasone,angioedema,disease-protein-drug,indication,"['angioedema', 'ALB', 'Betamethasone']",0.5
14019,39798.0,Betamethasone,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Betamethasone']",0.5
14019,39798.0,Betamethasone,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'CYP1B1', 'Betamethasone']",0.5
14019,39872.0,Betamethasone,acute respiratory distress syndrome,disease-protein-drug,off-label use,"['acute respiratory distress syndrome', 'ALB', 'Betamethasone']",0.5
14019,83765.0,Betamethasone,hypogonadotropic hypogonadism-frontoparietal alopecia syndrome,disease-protein-drug,contraindication,"['hypogonadotropic hypogonadism-frontoparietal alopecia syndrome', 'CYP19A1', 'Betamethasone']",0.5
14019,83766.0,Betamethasone,short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,disease-protein-drug,contraindication,"['short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia', 'CYP19A1', 'Betamethasone']",0.5
14019,83776.0,Betamethasone,postmenopausal osteoporosis,disease-protein-drug,contraindication,"['postmenopausal osteoporosis', 'CYP19A1', 'Betamethasone']",0.5
14019,83777.0,Betamethasone,occupational dermatitis,disease-protein-drug,indication,"['occupational dermatitis', 'CYP1B1', 'Betamethasone']",0.5
14019,83778.0,Betamethasone,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Betamethasone']",0.5
14019,83778.0,Betamethasone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,83779.0,Betamethasone,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Betamethasone']",0.5
14019,83779.0,Betamethasone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Betamethasone']",0.5
14019,83789.0,Betamethasone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Betamethasone']",0.5
14019,83791.0,Betamethasone,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Betamethasone']",0.5
14020,27326.0,Fluticasone propionate,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR3C1', 'Fluticasone propionate']",0.5
14020,27326.0,Fluticasone propionate,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'PGR', 'Fluticasone propionate']",0.5
14020,29614.0,Fluticasone propionate,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Fluticasone propionate']",0.5
14020,30813.0,Fluticasone propionate,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Fluticasone propionate']",0.5
14020,32905.0,Fluticasone propionate,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Fluticasone propionate']",0.5
14020,33575.0,Fluticasone propionate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Fluticasone propionate']",0.5
14020,33575.0,Fluticasone propionate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Fluticasone propionate']",0.5
14020,33577.0,Fluticasone propionate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Fluticasone propionate']",0.5
14020,33577.0,Fluticasone propionate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Fluticasone propionate']",0.5
14020,33577.0,Fluticasone propionate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Fluticasone propionate']",0.5
14020,33649.0,Fluticasone propionate,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Fluticasone propionate']",0.5
14020,33679.0,Fluticasone propionate,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Fluticasone propionate']",0.5
14020,35565.0,Fluticasone propionate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Fluticasone propionate']",0.5
14020,35641.0,Fluticasone propionate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Fluticasone propionate']",0.5
14020,35897.0,Fluticasone propionate,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Fluticasone propionate']",0.5
14020,36034.0,Fluticasone propionate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Fluticasone propionate']",0.5
14020,36035.0,Fluticasone propionate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Fluticasone propionate']",0.5
14020,36129.0,Fluticasone propionate,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Fluticasone propionate']",0.5
14020,36187.0,Fluticasone propionate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Fluticasone propionate']",0.5
14020,36187.0,Fluticasone propionate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Fluticasone propionate']",0.5
14020,39696.0,Fluticasone propionate,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary tuberculosis', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR3C1', 'Fluticasone propionate']",0.5
14020,39696.0,Fluticasone propionate,pulmonary tuberculosis,disease-exposure-gene-drug,contraindication,"['pulmonary tuberculosis', 'Arsenic', 'PGR', 'Fluticasone propionate']",0.5
14020,39798.0,Fluticasone propionate,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Fluticasone propionate']",0.5
14020,39798.0,Fluticasone propionate,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'PGR', 'Fluticasone propionate']",0.5
14020,83830.0,Fluticasone propionate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Fluticasone propionate']",0.5
14021,33649.0,Fluocinolone acetonide,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Ozone', 'regulation of inflammatory response', 'ANXA1', 'Fluocinolone acetonide']",0.5
14021,36129.0,Fluocinolone acetonide,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Fluocinolone acetonide']",0.5
14021,39798.0,Fluocinolone acetonide,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Fluocinolone acetonide']",0.5
14023,27219.0,Triamcinolone,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'PTGS2', 'Triamcinolone']",0.5
14023,27366.0,Triamcinolone,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Triamcinolone']",0.5
14023,27452.0,Triamcinolone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Premature birth', 'PTGS2', 'Triamcinolone']",0.5
14023,27741.0,Triamcinolone,pituitary deficiency due to empty sella turcica syndrome,disease-phenotype-protein-drug,contraindication,"['pituitary deficiency due to empty sella turcica syndrome', 'Seizure', 'PTGS2', 'Triamcinolone']",0.5
14023,27925.0,Triamcinolone,keloid formation,disease-protein-drug,indication,"['keloid formation', 'ALB', 'Triamcinolone']",0.5
14023,28005.0,Triamcinolone,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,off-label use,"['developmental and epileptic encephalopathy', 'Seizure', 'PTGS2', 'Triamcinolone']",0.5
14023,28478.0,Triamcinolone,autoimmune disease,disease-exposure-bioprocess-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Triamcinolone']",0.5
14023,29078.0,Triamcinolone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS2', 'Triamcinolone']",0.5
14023,29078.0,Triamcinolone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Triamcinolone']",0.5
14023,29078.0,Triamcinolone,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'BCHE', 'Triamcinolone']",0.5
14023,29078.0,Triamcinolone,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Triamcinolone']",0.5
14023,29078.0,Triamcinolone,rheumatoid arthritis,disease-exposure-molfunc-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,29182.0,Triamcinolone,systemic lupus erythematosus (disease),disease-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'PTGS2', 'Triamcinolone']",0.5
14023,29182.0,Triamcinolone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Triamcinolone']",0.5
14023,29182.0,Triamcinolone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Triamcinolone']",0.5
14023,29186.0,Triamcinolone,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,contraindication,"['carbamoyl phosphate synthetase I deficiency disease', 'Seizure', 'PTGS2', 'Triamcinolone']",0.5
14023,29614.0,Triamcinolone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'bone mineralization', 'PTGS2', 'Triamcinolone']",0.5
14023,29614.0,Triamcinolone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Triamcinolone']",0.5
14023,29832.0,Triamcinolone,hyperargininemia,disease-phenotype-protein-drug,contraindication,"['hyperargininemia', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5
14023,29993.0,Triamcinolone,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5
14023,30494.0,Triamcinolone,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,off-label use,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Triamcinolone']",0.5
14023,30494.0,Triamcinolone,plasma cell myeloma,disease-exposure-gene-drug,off-label use,"['plasma cell myeloma', 'glyphosate', 'BCHE', 'Triamcinolone']",0.5
14023,30494.0,Triamcinolone,plasma cell myeloma,disease-exposure-molfunc-gene-drug,off-label use,"['plasma cell myeloma', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,30511.0,Triamcinolone,anti-glomerular basement membrane disease,disease-phenotype-protein-drug,off-label use,"['anti-glomerular basement membrane disease', 'Fever', 'PTGS2', 'Triamcinolone']",0.5
14023,30654.0,Triamcinolone,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'PTGS2', 'Triamcinolone']",0.5
14023,30813.0,Triamcinolone,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Seizure', 'PTGS2', 'Triamcinolone']",0.5
14023,30892.0,Triamcinolone,newborn respiratory distress syndrome,disease-protein-drug,off-label use,"['newborn respiratory distress syndrome', 'ALB', 'Triamcinolone']",0.5
14023,30892.0,Triamcinolone,newborn respiratory distress syndrome,disease-phenotype-protein-drug,off-label use,"['newborn respiratory distress syndrome', 'Tachycardia', 'BCHE', 'Triamcinolone']",0.5
14023,30990.0,Triamcinolone,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5
14023,31511.0,Triamcinolone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Triamcinolone']",0.5
14023,31723.0,Triamcinolone,autoimmune hemolytic anemia,disease-phenotype-protein-drug,indication,"['autoimmune hemolytic anemia', 'Tachycardia', 'BCHE', 'Triamcinolone']",0.5
14023,32099.0,Triamcinolone,granulomatosis with polyangiitis,disease-exposure-bioprocess-gene-drug,off-label use,"['granulomatosis with polyangiitis', 'Dust', 'regulation of blood pressure', 'PTGS2', 'Triamcinolone']",0.5
14023,32099.0,Triamcinolone,granulomatosis with polyangiitis,disease-phenotype-protein-drug,off-label use,"['granulomatosis with polyangiitis', 'Arrhythmia', 'PTGS2', 'Triamcinolone']",0.5
14023,32123.0,Triamcinolone,Takayasu arteritis,disease-phenotype-protein-drug,off-label use,"['Takayasu arteritis', 'Fever', 'PTGS2', 'Triamcinolone']",0.5
14023,32132.0,Triamcinolone,citrullinemia,disease-phenotype-protein-drug,contraindication,"['citrullinemia', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5
14023,32325.0,Triamcinolone,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5
14023,32337.0,Triamcinolone,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'Seizure', 'PTGS2', 'Triamcinolone']",0.5
14023,32505.0,Triamcinolone,tuberculosis,disease-phenotype-protein-drug,contraindication,"['tuberculosis', 'Fever', 'PTGS2', 'Triamcinolone']",0.5
14023,32563.0,Triamcinolone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Triamcinolone']",0.5
14023,32584.0,Triamcinolone,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,indication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Premature birth', 'PTGS2', 'Triamcinolone']",0.5
14023,32746.0,Triamcinolone,Stevens-Johnson syndrome,disease-protein-drug,indication,"['Stevens-Johnson syndrome', 'ALB', 'Triamcinolone']",0.5
14023,32746.0,Triamcinolone,Stevens-Johnson syndrome,disease-phenotype-protein-drug,indication,"['Stevens-Johnson syndrome', 'Thrombocytopenia', 'ALB', 'Triamcinolone']",0.5
14023,32807.0,Triamcinolone,rheumatic fever,disease-phenotype-protein-drug,off-label use,"['rheumatic fever', 'Fever', 'PTGS2', 'Triamcinolone']",0.5
14023,32967.0,Triamcinolone,sarcoidosis,disease-phenotype-protein-drug,indication,"['sarcoidosis', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5
14023,32980.0,Triamcinolone,hereditary hemorrhagic telangiectasia,disease-phenotype-protein-drug,contraindication,"['hereditary hemorrhagic telangiectasia', 'Seizure', 'PTGS2', 'Triamcinolone']",0.5
14023,32986.0,Triamcinolone,polyarteritis nodosa,disease-phenotype-protein-drug,off-label use,"['polyarteritis nodosa', 'Fever', 'PTGS2', 'Triamcinolone']",0.5
14023,33077.0,Triamcinolone,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'inflammatory response', 'PTGS2', 'Triamcinolone']",0.5
14023,33077.0,Triamcinolone,Hodgkins lymphoma,disease-exposure-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'PTGS2', 'Triamcinolone']",0.5
14023,33077.0,Triamcinolone,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'ALB', 'Triamcinolone']",0.5
14023,33077.0,Triamcinolone,Hodgkins lymphoma,disease-exposure-molfunc-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,33206.0,Triamcinolone,eosinophilic pneumonia,disease-phenotype-protein-drug,indication,"['eosinophilic pneumonia', 'Fever', 'PTGS2', 'Triamcinolone']",0.5
14023,33410.0,Triamcinolone,dermatitis herpetiformis,disease-phenotype-protein-drug,indication,"['dermatitis herpetiformis', 'Edema', 'PTGS2', 'Triamcinolone']",0.5
14023,33453.0,Triamcinolone,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Seizure', 'PTGS2', 'Triamcinolone']",0.5
14023,33534.0,Triamcinolone,pediatric systemic lupus erythematosus,disease-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'PTGS2', 'Triamcinolone']",0.5
14023,33534.0,Triamcinolone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Triamcinolone']",0.5
14023,33575.0,Triamcinolone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS2', 'Triamcinolone']",0.5
14023,33575.0,Triamcinolone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS2', 'Triamcinolone']",0.5
14023,33575.0,Triamcinolone,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,33577.0,Triamcinolone,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Triamcinolone']",0.5
14023,33577.0,Triamcinolone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS2', 'Triamcinolone']",0.5
14023,33577.0,Triamcinolone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS2', 'Triamcinolone']",0.5
14023,33577.0,Triamcinolone,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,33621.0,Triamcinolone,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Triamcinolone']",0.5
14023,33621.0,Triamcinolone,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'PTGS2', 'Triamcinolone']",0.5
14023,33621.0,Triamcinolone,acute lymphoblastic leukemia (disease),disease-exposure-molfunc-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Insecticides', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,33649.0,Triamcinolone,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Ozone', 'regulation of inflammatory response', 'PTGS2', 'Triamcinolone']",0.5
14023,33654.0,Triamcinolone,uveitis,disease-protein-drug,indication,"['uveitis', 'ALB', 'Triamcinolone']",0.5
14023,33679.0,Triamcinolone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Triamcinolone']",0.5
14023,35565.0,Triamcinolone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Triamcinolone']",0.5
14023,35565.0,Triamcinolone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Triamcinolone']",0.5
14023,35641.0,Triamcinolone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Triamcinolone']",0.5
14023,35650.0,Triamcinolone,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Benzene', 'inflammatory response', 'PTGS2', 'Triamcinolone']",0.5
14023,35650.0,Triamcinolone,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Benzene', 'PTGS2', 'Triamcinolone']",0.5
14023,35650.0,Triamcinolone,non-Hodgkin lymphoma,disease-exposure-molfunc-gene-drug,indication,"['non-Hodgkin lymphoma', 'beta-hexachlorocyclohexane', 'acetylcholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,35669.0,Triamcinolone,heart disease,disease-exposure-bioprocess-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Triamcinolone']",0.5
14023,35669.0,Triamcinolone,heart disease,disease-exposure-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'PTGS2', 'Triamcinolone']",0.5
14023,35669.0,Triamcinolone,heart disease,disease-exposure-molfunc-gene-drug,off-label use,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,35823.0,Triamcinolone,eye disease,disease-exposure-bioprocess-gene-drug,indication,"['eye disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Triamcinolone']",0.5
14023,35823.0,Triamcinolone,eye disease,disease-exposure-gene-drug,indication,"['eye disease', 'Pesticides', 'BCHE', 'Triamcinolone']",0.5
14023,35823.0,Triamcinolone,eye disease,disease-exposure-molfunc-gene-drug,indication,"['eye disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,35915.0,Triamcinolone,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Triamcinolone']",0.5
14023,35915.0,Triamcinolone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Triamcinolone']",0.5
14023,35970.0,Triamcinolone,lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['lymphoma', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Triamcinolone']",0.5
14023,36026.0,Triamcinolone,open-angle glaucoma,disease-protein-drug,contraindication,"['open-angle glaucoma', 'PTGS2', 'Triamcinolone']",0.5
14023,36035.0,Triamcinolone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Triamcinolone']",0.5
14023,36129.0,Triamcinolone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'regulation of blood pressure', 'PTGS2', 'Triamcinolone']",0.5
14023,36129.0,Triamcinolone,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Air Pollutants', 'PTGS2', 'Triamcinolone']",0.5
14023,36241.0,Triamcinolone,hepatitis,disease-protein-drug,off-label use,"['hepatitis', 'ALB', 'Triamcinolone']",0.5
14023,36432.0,Triamcinolone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Triamcinolone']",0.5
14023,36469.0,Triamcinolone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Triamcinolone']",0.5
14023,36469.0,Triamcinolone,hypothyroidism,disease-exposure-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'BCHE', 'Triamcinolone']",0.5
14023,36469.0,Triamcinolone,hypothyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,36584.0,Triamcinolone,iris disease,disease-protein-drug,indication,"['iris disease', 'ALB', 'Triamcinolone']",0.5
14023,36644.0,Triamcinolone,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Triamcinolone']",0.5
14023,36644.0,Triamcinolone,skin disease,disease-exposure-gene-drug,indication,"['skin disease', 'Pesticides', 'BCHE', 'Triamcinolone']",0.5
14023,36644.0,Triamcinolone,skin disease,disease-exposure-molfunc-gene-drug,indication,"['skin disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,37608.0,Triamcinolone,ciliary body disease,disease-protein-drug,indication,"['ciliary body disease', 'ALB', 'Triamcinolone']",0.5
14023,37617.0,Triamcinolone,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Triamcinolone']",0.5
14023,37617.0,Triamcinolone,chronic obstructive pulmonary disease,disease-exposure-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'PTGS2', 'Triamcinolone']",0.5
14023,37617.0,Triamcinolone,chronic obstructive pulmonary disease,disease-exposure-molfunc-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Triamcinolone']",0.5
14023,37722.0,Triamcinolone,multiple sclerosis,disease-protein-drug,indication,"['multiple sclerosis', 'BCHE', 'Triamcinolone']",0.5
14023,37722.0,Triamcinolone,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'regulation of blood pressure', 'PTGS2', 'Triamcinolone']",0.5
14023,37722.0,Triamcinolone,multiple sclerosis,disease-exposure-gene-drug,indication,"['multiple sclerosis', 'Lead', 'ALB', 'Triamcinolone']",0.5
14023,37765.0,Triamcinolone,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Triamcinolone']",0.5
14023,37830.0,Triamcinolone,bronchitis,disease-exposure-bioprocess-gene-drug,off-label use,"['bronchitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Triamcinolone']",0.5
14023,37830.0,Triamcinolone,bronchitis,disease-exposure-gene-drug,off-label use,"['bronchitis', 'Air Pollutants', 'PTGS2', 'Triamcinolone']",0.5
14023,39245.0,Triamcinolone,panuveitis (disease),disease-protein-drug,indication,"['panuveitis (disease)', 'ALB', 'Triamcinolone']",0.5
14023,39540.0,Triamcinolone,angioedema,disease-protein-drug,indication,"['angioedema', 'ALB', 'Triamcinolone']",0.5
14023,39540.0,Triamcinolone,angioedema,disease-phenotype-protein-drug,indication,"['angioedema', 'Edema', 'PTGS2', 'Triamcinolone']",0.5
14023,39821.0,Triamcinolone,keloid,disease-protein-drug,indication,"['keloid', 'ALB', 'Triamcinolone']",0.5
14023,39872.0,Triamcinolone,acute respiratory distress syndrome,disease-protein-drug,off-label use,"['acute respiratory distress syndrome', 'ALB', 'Triamcinolone']",0.5
14023,83764.0,Triamcinolone,hyperglycemia,disease-protein-drug,contraindication,"['hyperglycemia', 'PTGS2', 'Triamcinolone']",0.5
14023,83764.0,Triamcinolone,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'regulation of blood pressure', 'PTGS2', 'Triamcinolone']",0.5
14023,83778.0,Triamcinolone,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Triamcinolone']",0.5
14023,83778.0,Triamcinolone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Triamcinolone']",0.5
14023,83779.0,Triamcinolone,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Triamcinolone']",0.5
14023,83779.0,Triamcinolone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Triamcinolone']",0.5
14023,83789.0,Triamcinolone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Triamcinolone']",0.5
14023,83791.0,Triamcinolone,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Triamcinolone']",0.5
14023,83830.0,Triamcinolone,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Triamcinolone']",0.5
14024,27249.0,Prednisone,isolated growth hormone deficiency,disease-phenotype-protein-drug,contraindication,"['isolated growth hormone deficiency', 'Truncal obesity', 'HSD11B1', 'Prednisone']",0.5
14024,27452.0,Prednisone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Prednisone']",0.5
14024,27648.0,Prednisone,familial glucocorticoid deficiency,disease-phenotype-protein-drug,indication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Prednisone']",0.5
14024,28005.0,Prednisone,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,off-label use,"['developmental and epileptic encephalopathy', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5
14024,28158.0,Prednisone,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ABCB1', 'Prednisone']",0.5
14024,28158.0,Prednisone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Prednisone']",0.5
14024,28158.0,Prednisone,inflammatory bowel disease,disease-phenotype-protein-drug,indication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Prednisone']",0.5
14024,28478.0,Prednisone,autoimmune disease,disease-exposure-bioprocess-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednisone']",0.5
14024,28478.0,Prednisone,autoimmune disease,disease-exposure-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'CYP1B1', 'Prednisone']",0.5
14024,28830.0,Prednisone,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Prednisone']",0.5
14024,29078.0,Prednisone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Prednisone']",0.5
14024,29078.0,Prednisone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,29078.0,Prednisone,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'CYP1B1', 'Prednisone']",0.5
14024,29113.0,Prednisone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'HSD11B1', 'Prednisone']",0.5
14024,29186.0,Prednisone,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,contraindication,"['carbamoyl phosphate synthetase I deficiency disease', 'Vomiting', 'ABCB1', 'Prednisone']",0.5
14024,29614.0,Prednisone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,29614.0,Prednisone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Prednisone']",0.5
14024,29832.0,Prednisone,hyperargininemia,disease-phenotype-protein-drug,contraindication,"['hyperargininemia', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5
14024,29854.0,Prednisone,hereditary angioedema,disease-phenotype-protein-drug,indication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Prednisone']",0.5
14024,29993.0,Prednisone,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5
14024,30494.0,Prednisone,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,off-label use,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Prednisone']",0.5
14024,30511.0,Prednisone,anti-glomerular basement membrane disease,disease-phenotype-protein-drug,off-label use,"['anti-glomerular basement membrane disease', 'Proteinuria', 'ALB', 'Prednisone']",0.5
14024,30813.0,Prednisone,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Vomiting', 'ABCB1', 'Prednisone']",0.5
14024,30990.0,Prednisone,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5
14024,31511.0,Prednisone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Prednisone']",0.5
14024,32099.0,Prednisone,granulomatosis with polyangiitis,disease-phenotype-protein-drug,off-label use,"['granulomatosis with polyangiitis', 'Proteinuria', 'ALB', 'Prednisone']",0.5
14024,32132.0,Prednisone,citrullinemia,disease-phenotype-protein-drug,contraindication,"['citrullinemia', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5
14024,32325.0,Prednisone,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5
14024,32563.0,Prednisone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Prednisone']",0.5
14024,32584.0,Prednisone,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,indication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Prednisone']",0.5
14024,32746.0,Prednisone,Stevens-Johnson syndrome,disease-protein-drug,indication,"['Stevens-Johnson syndrome', 'ALB', 'Prednisone']",0.5
14024,32746.0,Prednisone,Stevens-Johnson syndrome,disease-phenotype-protein-drug,indication,"['Stevens-Johnson syndrome', 'Thrombocytopenia', 'ALB', 'Prednisone']",0.5
14024,32815.0,Prednisone,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Prednisone']",0.5
14024,32905.0,Prednisone,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Prednisone']",0.5
14024,32967.0,Prednisone,sarcoidosis,disease-phenotype-protein-drug,indication,"['sarcoidosis', 'Hepatomegaly', 'ALB', 'Prednisone']",0.5
14024,33575.0,Prednisone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisone']",0.5
14024,33575.0,Prednisone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'CYP1B1', 'Prednisone']",0.5
14024,33577.0,Prednisone,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Prednisone']",0.5
14024,33577.0,Prednisone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,33577.0,Prednisone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'CYP1B1', 'Prednisone']",0.5
14024,33621.0,Prednisone,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Prednisone']",0.5
14024,33621.0,Prednisone,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisone']",0.5
14024,33621.0,Prednisone,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'CYP1B1', 'Prednisone']",0.5
14024,33679.0,Prednisone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Prednisone']",0.5
14024,35641.0,Prednisone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Prednisone']",0.5
14024,35650.0,Prednisone,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Prednisone']",0.5
14024,35650.0,Prednisone,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Cadmium', 'ALB', 'Prednisone']",0.5
14024,35669.0,Prednisone,heart disease,disease-exposure-bioprocess-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisone']",0.5
14024,35669.0,Prednisone,heart disease,disease-exposure-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'CYP1B1', 'Prednisone']",0.5
14024,35884.0,Prednisone,diffuse large B-cell lymphoma,disease-protein-drug,indication,"['diffuse large B-cell lymphoma', 'ABCB1', 'Prednisone']",0.5
14024,35915.0,Prednisone,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Prednisone']",0.5
14024,35915.0,Prednisone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,36035.0,Prednisone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Prednisone']",0.5
14024,36129.0,Prednisone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,36129.0,Prednisone,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Air Pollutants', 'CYP1B1', 'Prednisone']",0.5
14024,36425.0,Prednisone,primary central nervous system lymphoma,disease-protein-drug,indication,"['primary central nervous system lymphoma', 'ABCB1', 'Prednisone']",0.5
14024,36432.0,Prednisone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Prednisone']",0.5
14024,36469.0,Prednisone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Prednisone']",0.5
14024,36644.0,Prednisone,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,37617.0,Prednisone,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisone']",0.5
14024,37617.0,Prednisone,chronic obstructive pulmonary disease,disease-exposure-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'CYP1B1', 'Prednisone']",0.5
14024,37722.0,Prednisone,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,37722.0,Prednisone,multiple sclerosis,disease-exposure-gene-drug,indication,"['multiple sclerosis', 'Lead', 'ALB', 'Prednisone']",0.5
14024,37765.0,Prednisone,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Prednisone']",0.5
14024,37770.0,Prednisone,contact dermatitis,disease-protein-drug,indication,"['contact dermatitis', 'CYP1B1', 'Prednisone']",0.5
14024,37888.0,Prednisone,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Prednisone']",0.5
14024,37888.0,Prednisone,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednisone']",0.5
14024,37888.0,Prednisone,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'CYP1B1', 'Prednisone']",0.5
14024,37888.0,Prednisone,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Prednisone']",0.5
14024,39540.0,Prednisone,angioedema,disease-protein-drug,indication,"['angioedema', 'ALB', 'Prednisone']",0.5
14024,83764.0,Prednisone,hyperglycemia,disease-protein-drug,contraindication,"['hyperglycemia', 'HSD11B1', 'Prednisone']",0.5
14024,83777.0,Prednisone,occupational dermatitis,disease-protein-drug,indication,"['occupational dermatitis', 'CYP1B1', 'Prednisone']",0.5
14024,83778.0,Prednisone,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Prednisone']",0.5
14024,83778.0,Prednisone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,83779.0,Prednisone,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Prednisone']",0.5
14024,83779.0,Prednisone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Prednisone']",0.5
14024,83789.0,Prednisone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Prednisone']",0.5
14024,83791.0,Prednisone,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Prednisone']",0.5
14024,84154.0,Prednisone,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,indication,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Prednisone']",0.5
14024,84155.0,Prednisone,Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly,disease-protein-drug,indication,"['Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly', 'ABCB1', 'Prednisone']",0.5
14024,84156.0,Prednisone,plasmablastic lymphoma,disease-protein-drug,indication,"['plasmablastic lymphoma', 'ABCB1', 'Prednisone']",0.5
14024,84157.0,Prednisone,diffuse large B-cell lymphoma of the central nervous system,disease-protein-drug,indication,"['diffuse large B-cell lymphoma of the central nervous system', 'ABCB1', 'Prednisone']",0.5
14024,84158.0,Prednisone,T-cell/histiocyte rich large B cell lymphoma,disease-protein-drug,indication,"['T-cell/histiocyte rich large B cell lymphoma', 'ABCB1', 'Prednisone']",0.5
14024,84159.0,Prednisone,ALK-positive large B-cell lymphoma,disease-protein-drug,indication,"['ALK-positive large B-cell lymphoma', 'ABCB1', 'Prednisone']",0.5
14024,84160.0,Prednisone,primary mediastinal large B-cell lymphoma,disease-protein-drug,indication,"['primary mediastinal large B-cell lymphoma', 'ABCB1', 'Prednisone']",0.5
14024,84161.0,Prednisone,intravascular large B-cell lymphoma,disease-protein-drug,indication,"['intravascular large B-cell lymphoma', 'ABCB1', 'Prednisone']",0.5
14025,30813.0,Mitotane,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Mitotane']",0.5
14025,35565.0,Mitotane,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Mitotane']",0.5
14025,35565.0,Mitotane,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Mitotane']",0.5
14026,33649.0,Flumethasone,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Flumethasone']",0.5
14026,36129.0,Flumethasone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Flumethasone']",0.5
14028,27249.0,Hydrocortisone,isolated growth hormone deficiency,disease-phenotype-protein-drug,contraindication,"['isolated growth hormone deficiency', 'Truncal obesity', 'HSD11B1', 'Hydrocortisone']",0.5
14028,28478.0,Hydrocortisone,autoimmune disease,disease-exposure-bioprocess-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'ANXA1', 'Hydrocortisone']",0.5
14028,28478.0,Hydrocortisone,autoimmune disease,disease-exposure-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'CYP1B1', 'Hydrocortisone']",0.5
14028,28830.0,Hydrocortisone,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Hydrocortisone']",0.5
14028,29078.0,Hydrocortisone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Hydrocortisone']",0.5
14028,29078.0,Hydrocortisone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Hydrocortisone']",0.5
14028,29078.0,Hydrocortisone,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'CYP1B1', 'Hydrocortisone']",0.5
14028,29113.0,Hydrocortisone,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'HSD11B2', 'Hydrocortisone']",0.5
14028,29113.0,Hydrocortisone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'HSD11B1', 'Hydrocortisone']",0.5
14028,29182.0,Hydrocortisone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'ANXA1', 'Hydrocortisone']",0.5
14028,29182.0,Hydrocortisone,systemic lupus erythematosus (disease),disease-exposure-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Hydrocortisone']",0.5
14028,29229.0,Hydrocortisone,glaucoma,disease-protein-drug,contraindication,"['glaucoma', 'CYP1B1', 'Hydrocortisone']",0.5
14028,29614.0,Hydrocortisone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'HSD11B2', 'Hydrocortisone']",0.5
14028,29614.0,Hydrocortisone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SHBG', 'Hydrocortisone']",0.5
14028,29993.0,Hydrocortisone,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'CYP1B1', 'Hydrocortisone']",0.5
14028,30990.0,Hydrocortisone,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'CYP1B1', 'Hydrocortisone']",0.5
14028,32584.0,Hydrocortisone,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,indication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Hydrocortisone']",0.5
14028,32815.0,Hydrocortisone,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Hydrocortisone']",0.5
14028,32905.0,Hydrocortisone,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Hydrocortisone']",0.5
14028,32967.0,Hydrocortisone,sarcoidosis,disease-phenotype-protein-drug,indication,"['sarcoidosis', 'Hepatomegaly', 'CYP1B1', 'Hydrocortisone']",0.5
14028,33077.0,Hydrocortisone,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'inflammatory response', 'ANXA1', 'Hydrocortisone']",0.5
14028,33077.0,Hydrocortisone,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'CYP1B1', 'Hydrocortisone']",0.5
14028,33575.0,Hydrocortisone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Hydrocortisone']",0.5
14028,33575.0,Hydrocortisone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone']",0.5
14028,33575.0,Hydrocortisone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'CYP1B1', 'Hydrocortisone']",0.5
14028,33577.0,Hydrocortisone,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Hydrocortisone']",0.5
14028,33577.0,Hydrocortisone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone']",0.5
14028,33577.0,Hydrocortisone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'CYP1B1', 'Hydrocortisone']",0.5
14028,33581.0,Hydrocortisone,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Hydrocortisone']",0.5
14028,33581.0,Hydrocortisone,conjunctivitis (disease),disease-exposure-gene-drug,contraindication,"['conjunctivitis (disease)', 'Particulate Matter', 'CYP1B1', 'Hydrocortisone']",0.5
14028,33621.0,Hydrocortisone,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Hydrocortisone']",0.5
14028,33621.0,Hydrocortisone,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Hydrocortisone']",0.5
14028,33621.0,Hydrocortisone,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'CYP1B1', 'Hydrocortisone']",0.5
14028,33649.0,Hydrocortisone,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Ozone', 'regulation of inflammatory response', 'ANXA1', 'Hydrocortisone']",0.5
14028,33649.0,Hydrocortisone,exanthem (disease),disease-exposure-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'CYP1B1', 'Hydrocortisone']",0.5
14028,33675.0,Hydrocortisone,asthma,disease-protein-drug,indication,"['asthma', 'HSD11B2', 'Hydrocortisone']",0.5
14028,33675.0,Hydrocortisone,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Hydrocortisone']",0.5
14028,33675.0,Hydrocortisone,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Hydrocortisone']",0.5
14028,33679.0,Hydrocortisone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Hydrocortisone']",0.5
14028,35565.0,Hydrocortisone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'CYP11B1', 'Hydrocortisone']",0.5
14028,35641.0,Hydrocortisone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Hydrocortisone']",0.5
14028,35650.0,Hydrocortisone,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Benzene', 'inflammatory response', 'ANXA1', 'Hydrocortisone']",0.5
14028,35650.0,Hydrocortisone,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Polychlorinated Biphenyls', 'SHBG', 'Hydrocortisone']",0.5
14028,35764.0,Hydrocortisone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone']",0.5
14028,35823.0,Hydrocortisone,eye disease,disease-exposure-bioprocess-gene-drug,indication,"['eye disease', 'perfluorooctane sulfonic acid', 'immune response', 'CYP11B1', 'Hydrocortisone']",0.5
14028,35823.0,Hydrocortisone,eye disease,disease-exposure-gene-drug,indication,"['eye disease', 'Polychlorinated Biphenyls', 'SHBG', 'Hydrocortisone']",0.5
14028,35915.0,Hydrocortisone,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Hydrocortisone']",0.5
14028,35915.0,Hydrocortisone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Hydrocortisone']",0.5
14028,35970.0,Hydrocortisone,lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['lymphoma', 'Tetrachlorodibenzodioxin', 'testosterone biosynthetic process', 'SRD5A2', 'Hydrocortisone']",0.5
14028,36034.0,Hydrocortisone,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Hydrocortisone']",0.5
14028,36035.0,Hydrocortisone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Hydrocortisone']",0.5
14028,36080.0,Hydrocortisone,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of blood pressure', 'CYP11B1', 'Hydrocortisone']",0.5
14028,36080.0,Hydrocortisone,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'CYP1B1', 'Hydrocortisone']",0.5
14028,36129.0,Hydrocortisone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone']",0.5
14028,36129.0,Hydrocortisone,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Air Pollutants', 'CYP1B1', 'Hydrocortisone']",0.5
14028,36469.0,Hydrocortisone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Hydrocortisone']",0.5
14028,37722.0,Hydrocortisone,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone']",0.5
14028,37765.0,Hydrocortisone,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'HSD11B2', 'Hydrocortisone']",0.5
14028,37770.0,Hydrocortisone,contact dermatitis,disease-protein-drug,indication,"['contact dermatitis', 'CYP1B1', 'Hydrocortisone']",0.5
14028,37785.0,Hydrocortisone,ulcerative colitis (disease),disease-protein-drug,indication,"['ulcerative colitis (disease)', 'ABCB1', 'Hydrocortisone']",0.5
14028,37785.0,Hydrocortisone,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,indication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Hydrocortisone']",0.5
14028,37888.0,Hydrocortisone,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Hydrocortisone']",0.5
14028,37888.0,Hydrocortisone,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'CYP1B1', 'Hydrocortisone']",0.5
14028,39773.0,Hydrocortisone,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'HSD11B2', 'Hydrocortisone']",0.5
14028,39798.0,Hydrocortisone,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Hydrocortisone']",0.5
14028,39798.0,Hydrocortisone,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'CYP1B1', 'Hydrocortisone']",0.5
14028,83754.0,Hydrocortisone,common wart,disease-exposure-bioprocess-gene-drug,contraindication,"['common wart', 'Zinc', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone']",0.5
14028,83764.0,Hydrocortisone,hyperglycemia,disease-protein-drug,contraindication,"['hyperglycemia', 'HSD11B1', 'Hydrocortisone']",0.5
14028,83764.0,Hydrocortisone,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'regulation of blood pressure', 'CYP11B1', 'Hydrocortisone']",0.5
14028,83777.0,Hydrocortisone,occupational dermatitis,disease-protein-drug,indication,"['occupational dermatitis', 'CYP1B1', 'Hydrocortisone']",0.5
14028,83778.0,Hydrocortisone,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Hydrocortisone']",0.5
14028,83778.0,Hydrocortisone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Hydrocortisone']",0.5
14028,83779.0,Hydrocortisone,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Hydrocortisone']",0.5
14028,83779.0,Hydrocortisone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Hydrocortisone']",0.5
14028,83781.0,Hydrocortisone,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'HSD11B2', 'Hydrocortisone']",0.5
14028,83830.0,Hydrocortisone,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Hydrocortisone']",0.5
14029,33649.0,Flurandrenolide,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Flurandrenolide']",0.5
14029,36129.0,Flurandrenolide,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Flurandrenolide']",0.5
14029,39798.0,Flurandrenolide,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Flurandrenolide']",0.5
14030,27286.0,Prednisolone,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,27292.0,Prednisolone,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,27452.0,Prednisolone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Prednisolone']",0.5
14030,27648.0,Prednisolone,familial glucocorticoid deficiency,disease-phenotype-protein-drug,indication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Prednisolone']",0.5
14030,28005.0,Prednisolone,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,off-label use,"['developmental and epileptic encephalopathy', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,28158.0,Prednisolone,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ABCB1', 'Prednisolone']",0.5
14030,28158.0,Prednisolone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,28158.0,Prednisolone,inflammatory bowel disease,disease-phenotype-protein-drug,indication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Prednisolone']",0.5
14030,28478.0,Prednisolone,autoimmune disease,disease-exposure-bioprocess-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednisolone']",0.5
14030,28764.0,Prednisolone,Sjogren syndrome,disease-phenotype-protein-drug,indication,"['Sjogren syndrome', 'Thrombocytopenia', 'ALB', 'Prednisolone']",0.5
14030,28830.0,Prednisolone,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Prednisolone']",0.5
14030,29078.0,Prednisolone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Prednisolone']",0.5
14030,29078.0,Prednisolone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,29182.0,Prednisolone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednisolone']",0.5
14030,29182.0,Prednisolone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Prednisolone']",0.5
14030,29186.0,Prednisolone,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,contraindication,"['carbamoyl phosphate synthetase I deficiency disease', 'Vomiting', 'ABCB1', 'Prednisolone']",0.5
14030,29614.0,Prednisolone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,29614.0,Prednisolone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Prednisolone']",0.5
14030,29832.0,Prednisolone,hyperargininemia,disease-phenotype-protein-drug,contraindication,"['hyperargininemia', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,29854.0,Prednisolone,hereditary angioedema,disease-phenotype-protein-drug,indication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Prednisolone']",0.5
14030,29993.0,Prednisolone,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,30494.0,Prednisolone,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,off-label use,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,30511.0,Prednisolone,anti-glomerular basement membrane disease,disease-phenotype-protein-drug,off-label use,"['anti-glomerular basement membrane disease', 'Proteinuria', 'ALB', 'Prednisolone']",0.5
14030,30813.0,Prednisolone,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Vomiting', 'ABCB1', 'Prednisolone']",0.5
14030,30892.0,Prednisolone,newborn respiratory distress syndrome,disease-protein-drug,off-label use,"['newborn respiratory distress syndrome', 'ALB', 'Prednisolone']",0.5
14030,30990.0,Prednisolone,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,32099.0,Prednisolone,granulomatosis with polyangiitis,disease-phenotype-protein-drug,off-label use,"['granulomatosis with polyangiitis', 'Proteinuria', 'ALB', 'Prednisolone']",0.5
14030,32132.0,Prednisolone,citrullinemia,disease-phenotype-protein-drug,contraindication,"['citrullinemia', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,32325.0,Prednisolone,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,32563.0,Prednisolone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Prednisolone']",0.5
14030,32746.0,Prednisolone,Stevens-Johnson syndrome,disease-protein-drug,indication,"['Stevens-Johnson syndrome', 'ALB', 'Prednisolone']",0.5
14030,32746.0,Prednisolone,Stevens-Johnson syndrome,disease-phenotype-protein-drug,indication,"['Stevens-Johnson syndrome', 'Thrombocytopenia', 'ALB', 'Prednisolone']",0.5
14030,32905.0,Prednisolone,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Prednisolone']",0.5
14030,32967.0,Prednisolone,sarcoidosis,disease-phenotype-protein-drug,indication,"['sarcoidosis', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,33077.0,Prednisolone,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,33077.0,Prednisolone,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'ALB', 'Prednisolone']",0.5
14030,33534.0,Prednisolone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Prednisolone']",0.5
14030,33575.0,Prednisolone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisolone']",0.5
14030,33575.0,Prednisolone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Prednisolone']",0.5
14030,33577.0,Prednisolone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,33577.0,Prednisolone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Prednisolone']",0.5
14030,33581.0,Prednisolone,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednisolone']",0.5
14030,33621.0,Prednisolone,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Prednisolone']",0.5
14030,33621.0,Prednisolone,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisolone']",0.5
14030,33649.0,Prednisolone,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednisolone']",0.5
14030,33654.0,Prednisolone,uveitis,disease-protein-drug,indication,"['uveitis', 'ALB', 'Prednisolone']",0.5
14030,33675.0,Prednisolone,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisolone']",0.5
14030,33679.0,Prednisolone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Prednisolone']",0.5
14030,35641.0,Prednisolone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Prednisolone']",0.5
14030,35650.0,Prednisolone,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Prednisolone']",0.5
14030,35650.0,Prednisolone,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Cadmium', 'ALB', 'Prednisolone']",0.5
14030,35669.0,Prednisolone,heart disease,disease-exposure-bioprocess-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisolone']",0.5
14030,35823.0,Prednisolone,eye disease,disease-exposure-bioprocess-gene-drug,indication,"['eye disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,35915.0,Prednisolone,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Prednisolone']",0.5
14030,35915.0,Prednisolone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,35916.0,Prednisolone,dry eye syndrome,disease-exposure-bioprocess-gene-drug,indication,"['dry eye syndrome', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,35916.0,Prednisolone,dry eye syndrome,disease-exposure-gene-drug,indication,"['dry eye syndrome', 'Lead', 'ALB', 'Prednisolone']",0.5
14030,36091.0,Prednisolone,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Prednisolone']",0.5
14030,36129.0,Prednisolone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,36129.0,Prednisolone,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Lead', 'ALB', 'Prednisolone']",0.5
14030,36241.0,Prednisolone,hepatitis,disease-protein-drug,off-label use,"['hepatitis', 'ALB', 'Prednisolone']",0.5
14030,36432.0,Prednisolone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Prednisolone']",0.5
14030,36469.0,Prednisolone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,36584.0,Prednisolone,iris disease,disease-protein-drug,indication,"['iris disease', 'ALB', 'Prednisolone']",0.5
14030,36644.0,Prednisolone,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,37608.0,Prednisolone,ciliary body disease,disease-protein-drug,indication,"['ciliary body disease', 'ALB', 'Prednisolone']",0.5
14030,37617.0,Prednisolone,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisolone']",0.5
14030,37722.0,Prednisolone,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,37722.0,Prednisolone,multiple sclerosis,disease-exposure-gene-drug,indication,"['multiple sclerosis', 'Lead', 'ALB', 'Prednisolone']",0.5
14030,37765.0,Prednisolone,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Prednisolone']",0.5
14030,37830.0,Prednisolone,bronchitis,disease-exposure-bioprocess-gene-drug,off-label use,"['bronchitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisolone']",0.5
14030,37888.0,Prednisolone,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Prednisolone']",0.5
14030,37888.0,Prednisolone,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednisolone']",0.5
14030,37888.0,Prednisolone,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Prednisolone']",0.5
14030,39245.0,Prednisolone,panuveitis (disease),disease-protein-drug,indication,"['panuveitis (disease)', 'ALB', 'Prednisolone']",0.5
14030,39540.0,Prednisolone,angioedema,disease-protein-drug,indication,"['angioedema', 'ALB', 'Prednisolone']",0.5
14030,39872.0,Prednisolone,acute respiratory distress syndrome,disease-protein-drug,off-label use,"['acute respiratory distress syndrome', 'ALB', 'Prednisolone']",0.5
14030,83778.0,Prednisolone,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Prednisolone']",0.5
14030,83778.0,Prednisolone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,83779.0,Prednisolone,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Prednisolone']",0.5
14030,83779.0,Prednisolone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Prednisolone']",0.5
14030,83789.0,Prednisolone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Prednisolone']",0.5
14030,83791.0,Prednisolone,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Prednisolone']",0.5
14030,83830.0,Prednisolone,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Prednisolone']",0.5
14032,36129.0,Clobetasol propionate,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Clobetasol propionate']",0.5
14032,36129.0,Clobetasol propionate,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Lead', 'ALB', 'Clobetasol propionate']",0.5
14032,39798.0,Clobetasol propionate,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Clobetasol propionate']",0.5
14032,39798.0,Clobetasol propionate,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'ALB', 'Clobetasol propionate']",0.5
14033,33575.0,Fluocinonide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Fluocinonide']",0.5
14033,33649.0,Fluocinonide,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Fluocinonide']",0.5
14033,36129.0,Fluocinonide,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Fluocinonide']",0.5
14034,29186.0,Budesonide,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,contraindication,"['carbamoyl phosphate synthetase I deficiency disease', 'Vomiting', 'ABCB1', 'Budesonide']",0.5
14034,29229.0,Budesonide,glaucoma,disease-protein-drug,contraindication,"['glaucoma', 'CYP1B1', 'Budesonide']",0.5
14034,29614.0,Budesonide,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Budesonide']",0.5
14034,29614.0,Budesonide,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Budesonide']",0.5
14034,29832.0,Budesonide,hyperargininemia,disease-phenotype-protein-drug,contraindication,"['hyperargininemia', 'Hepatomegaly', 'ALB', 'Budesonide']",0.5
14034,32132.0,Budesonide,citrullinemia,disease-phenotype-protein-drug,contraindication,"['citrullinemia', 'Hepatomegaly', 'ALB', 'Budesonide']",0.5
14034,32905.0,Budesonide,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Budesonide']",0.5
14034,33575.0,Budesonide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ANXA1', 'Budesonide']",0.5
14034,33575.0,Budesonide,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'CYP1B1', 'Budesonide']",0.5
14034,33577.0,Budesonide,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Budesonide']",0.5
14034,33577.0,Budesonide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Budesonide']",0.5
14034,33577.0,Budesonide,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'CYP1B1', 'Budesonide']",0.5
14034,33679.0,Budesonide,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Budesonide']",0.5
14034,35565.0,Budesonide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Budesonide']",0.5
14034,35565.0,Budesonide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Budesonide']",0.5
14034,35641.0,Budesonide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Budesonide']",0.5
14034,35915.0,Budesonide,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Budesonide']",0.5
14034,35915.0,Budesonide,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Budesonide']",0.5
14034,36035.0,Budesonide,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Budesonide']",0.5
14034,36432.0,Budesonide,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Budesonide']",0.5
14034,36469.0,Budesonide,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Budesonide']",0.5
14034,37765.0,Budesonide,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Budesonide']",0.5
14034,37888.0,Budesonide,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Budesonide']",0.5
14034,37888.0,Budesonide,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Budesonide']",0.5
14034,37888.0,Budesonide,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'CYP1B1', 'Budesonide']",0.5
14034,37888.0,Budesonide,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Budesonide']",0.5
14034,39696.0,Budesonide,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Budesonide']",0.5
14034,39696.0,Budesonide,pulmonary tuberculosis,disease-exposure-gene-drug,contraindication,"['pulmonary tuberculosis', 'Air Pollutants', 'CYP1B1', 'Budesonide']",0.5
14034,83778.0,Budesonide,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Budesonide']",0.5
14034,83778.0,Budesonide,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Budesonide']",0.5
14034,83779.0,Budesonide,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Budesonide']",0.5
14034,83779.0,Budesonide,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Budesonide']",0.5
14034,83791.0,Budesonide,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Budesonide']",0.5
14034,83830.0,Budesonide,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Budesonide']",0.5
14036,29614.0,Ciclesonide,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol biosynthetic process', 'CES1', 'Ciclesonide']",0.5
14036,33675.0,Ciclesonide,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Ciclesonide']",0.5
14036,37888.0,Ciclesonide,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Ciclesonide']",0.5
14036,83830.0,Ciclesonide,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Ciclesonide']",0.5
14038,30813.0,Fluticasone furoate,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Fluticasone furoate']",0.5
14038,33675.0,Fluticasone furoate,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Fluticasone furoate']",0.5
14038,33675.0,Fluticasone furoate,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Arsenic', 'PGR', 'Fluticasone furoate']",0.5
14038,37888.0,Fluticasone furoate,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Fluticasone furoate']",0.5
14038,39696.0,Fluticasone furoate,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary tuberculosis', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR3C1', 'Fluticasone furoate']",0.5
14038,39696.0,Fluticasone furoate,pulmonary tuberculosis,disease-exposure-gene-drug,contraindication,"['pulmonary tuberculosis', 'Arsenic', 'PGR', 'Fluticasone furoate']",0.5
14038,83830.0,Fluticasone furoate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Fluticasone furoate']",0.5
14042,28158.0,Hydrocortisone acetate,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,28158.0,Hydrocortisone acetate,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Hydrocortisone acetate']",0.5
14042,28158.0,Hydrocortisone acetate,inflammatory bowel disease,disease-phenotype-protein-drug,indication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,28478.0,Hydrocortisone acetate,autoimmune disease,disease-exposure-bioprocess-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'ANXA1', 'Hydrocortisone acetate']",0.5
14042,28830.0,Hydrocortisone acetate,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,29078.0,Hydrocortisone acetate,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,29078.0,Hydrocortisone acetate,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,29113.0,Hydrocortisone acetate,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'HSD11B2', 'Hydrocortisone acetate']",0.5
14042,29182.0,Hydrocortisone acetate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'ANXA1', 'Hydrocortisone acetate']",0.5
14042,29614.0,Hydrocortisone acetate,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'HSD11B2', 'Hydrocortisone acetate']",0.5
14042,29614.0,Hydrocortisone acetate,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,29854.0,Hydrocortisone acetate,hereditary angioedema,disease-phenotype-protein-drug,indication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,30654.0,Hydrocortisone acetate,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Hydrocortisone acetate']",0.5
14042,30813.0,Hydrocortisone acetate,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Vomiting', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,32815.0,Hydrocortisone acetate,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,32905.0,Hydrocortisone acetate,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,33077.0,Hydrocortisone acetate,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'inflammatory response', 'ANXA1', 'Hydrocortisone acetate']",0.5
14042,33534.0,Hydrocortisone acetate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Vomiting', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,33575.0,Hydrocortisone acetate,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,33575.0,Hydrocortisone acetate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,33575.0,Hydrocortisone acetate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,33577.0,Hydrocortisone acetate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Hydrocortisone acetate']",0.5
14042,33577.0,Hydrocortisone acetate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,33577.0,Hydrocortisone acetate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,33581.0,Hydrocortisone acetate,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Hydrocortisone acetate']",0.5
14042,33621.0,Hydrocortisone acetate,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,33621.0,Hydrocortisone acetate,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Hydrocortisone acetate']",0.5
14042,33649.0,Hydrocortisone acetate,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Ozone', 'regulation of inflammatory response', 'ANXA1', 'Hydrocortisone acetate']",0.5
14042,33675.0,Hydrocortisone acetate,asthma,disease-protein-drug,indication,"['asthma', 'HSD11B2', 'Hydrocortisone acetate']",0.5
14042,33675.0,Hydrocortisone acetate,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Hydrocortisone acetate']",0.5
14042,33675.0,Hydrocortisone acetate,asthma,disease-exposure-gene-drug,indication,"['asthma', 'bisphenol A', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,33679.0,Hydrocortisone acetate,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Hydrocortisone acetate']",0.5
14042,35565.0,Hydrocortisone acetate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,35641.0,Hydrocortisone acetate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Hydrocortisone acetate']",0.5
14042,35650.0,Hydrocortisone acetate,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Benzene', 'inflammatory response', 'ANXA1', 'Hydrocortisone acetate']",0.5
14042,35650.0,Hydrocortisone acetate,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Polychlorinated Biphenyls', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,35764.0,Hydrocortisone acetate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,35823.0,Hydrocortisone acetate,eye disease,disease-exposure-bioprocess-gene-drug,indication,"['eye disease', 'perfluorooctane sulfonic acid', 'immune response', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,35823.0,Hydrocortisone acetate,eye disease,disease-exposure-gene-drug,indication,"['eye disease', 'Polychlorinated Biphenyls', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,35915.0,Hydrocortisone acetate,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Hydrocortisone acetate']",0.5
14042,35915.0,Hydrocortisone acetate,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,36034.0,Hydrocortisone acetate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Hydrocortisone acetate']",0.5
14042,36035.0,Hydrocortisone acetate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Hydrocortisone acetate']",0.5
14042,36080.0,Hydrocortisone acetate,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of blood pressure', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,36129.0,Hydrocortisone acetate,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,36129.0,Hydrocortisone acetate,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Phthalic Acids', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,36469.0,Hydrocortisone acetate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Hydrocortisone acetate']",0.5
14042,37722.0,Hydrocortisone acetate,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,37765.0,Hydrocortisone acetate,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'HSD11B2', 'Hydrocortisone acetate']",0.5
14042,37888.0,Hydrocortisone acetate,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Hydrocortisone acetate']",0.5
14042,39773.0,Hydrocortisone acetate,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'HSD11B2', 'Hydrocortisone acetate']",0.5
14042,39798.0,Hydrocortisone acetate,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Hydrocortisone acetate']",0.5
14042,39798.0,Hydrocortisone acetate,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'bisphenol A', 'SHBG', 'Hydrocortisone acetate']",0.5
14042,83764.0,Hydrocortisone acetate,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'regulation of blood pressure', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,83769.0,Hydrocortisone acetate,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Hydrocortisone acetate']",0.5
14042,83778.0,Hydrocortisone acetate,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Hydrocortisone acetate']",0.5
14042,83778.0,Hydrocortisone acetate,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,83779.0,Hydrocortisone acetate,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Hydrocortisone acetate']",0.5
14042,83779.0,Hydrocortisone acetate,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP11B1', 'Hydrocortisone acetate']",0.5
14042,83781.0,Hydrocortisone acetate,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'HSD11B2', 'Hydrocortisone acetate']",0.5
14042,83790.0,Hydrocortisone acetate,gout,disease-protein-drug,indication,"['gout', 'ABCG2', 'Hydrocortisone acetate']",0.5
14042,83830.0,Hydrocortisone acetate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Hydrocortisone acetate']",0.5
14050,27286.0,Prednisolone acetate,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ALB', 'Prednisolone acetate']",0.5
14050,27292.0,Prednisolone acetate,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'ALB', 'Prednisolone acetate']",0.5
14050,33575.0,Prednisolone acetate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednisolone acetate']",0.5
14050,33575.0,Prednisolone acetate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Prednisolone acetate']",0.5
14050,33581.0,Prednisolone acetate,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednisolone acetate']",0.5
14050,33654.0,Prednisolone acetate,uveitis,disease-protein-drug,indication,"['uveitis', 'ALB', 'Prednisolone acetate']",0.5
14050,36584.0,Prednisolone acetate,iris disease,disease-protein-drug,indication,"['iris disease', 'ALB', 'Prednisolone acetate']",0.5
14050,37608.0,Prednisolone acetate,ciliary body disease,disease-protein-drug,indication,"['ciliary body disease', 'ALB', 'Prednisolone acetate']",0.5
14050,39245.0,Prednisolone acetate,panuveitis (disease),disease-protein-drug,indication,"['panuveitis (disease)', 'ALB', 'Prednisolone acetate']",0.5
14050,83830.0,Prednisolone acetate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Prednisolone acetate']",0.5
14052,28158.0,Vitamin A,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'developmental growth', 'STRA6', 'Vitamin A']",0.5
14052,28921.0,Vitamin A,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Hepatomegaly', 'ALB', 'Vitamin A']",0.5
14052,29946.0,Vitamin A,primary hyperoxaluria,disease-phenotype-protein-drug,contraindication,"['primary hyperoxaluria', 'Pain', 'ALB', 'Vitamin A']",0.5
14052,31502.0,Vitamin A,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Hepatomegaly', 'ALB', 'Vitamin A']",0.5
14052,31820.0,Vitamin A,abetalipoproteinemia,disease-phenotype-protein-drug,off-label use,"['abetalipoproteinemia', 'Hepatomegaly', 'ALB', 'Vitamin A']",0.5
14052,32967.0,Vitamin A,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'ALB', 'Vitamin A']",0.5
14052,35565.0,Vitamin A,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'STRA6', 'Vitamin A']",0.5
14052,35565.0,Vitamin A,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Vitamin A']",0.5
14052,35764.0,Vitamin A,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Vitamin A']",0.5
14052,35764.0,Vitamin A,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'RBP4', 'Vitamin A']",0.5
14052,35764.0,Vitamin A,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Vitamin A']",0.5
14052,37785.0,Vitamin A,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'developmental growth', 'STRA6', 'Vitamin A']",0.5
14052,84142.0,Vitamin A,vitamin A deficiency (disease),disease-protein-drug,indication,"['vitamin A deficiency (disease)', 'LRAT', 'Vitamin A']",0.5
14054,28900.0,Vitamin E,familial isolated deficiency of vitamin E,disease-protein-drug,indication,"['familial isolated deficiency of vitamin E', 'TTPA', 'Vitamin E']",0.5
14054,28900.0,Vitamin E,familial isolated deficiency of vitamin E,disease-phenotype-protein-drug,indication,"['familial isolated deficiency of vitamin E', 'Skeletal muscle atrophy', 'TTPA', 'Vitamin E']",0.5
14054,31033.0,Vitamin E,benign recurrent intrahepatic cholestasis,disease-protein-drug,indication,"['benign recurrent intrahepatic cholestasis', 'NQO1', 'Vitamin E']",0.5
14054,31033.0,Vitamin E,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,indication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'NR1I2', 'Vitamin E']",0.5
14054,32629.0,Vitamin E,familial intrahepatic cholestasis,disease-protein-drug,indication,"['familial intrahepatic cholestasis', 'NQO1', 'Vitamin E']",0.5
14054,32629.0,Vitamin E,familial intrahepatic cholestasis,disease-phenotype-protein-drug,indication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'NR1I2', 'Vitamin E']",0.5
14054,38059.0,Vitamin E,cholestasis,disease-protein-drug,indication,"['cholestasis', 'NQO1', 'Vitamin E']",0.5
14058,28017.0,Diethylstilbestrol,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Diethylstilbestrol']",0.5
14058,29061.0,Diethylstilbestrol,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'CYP19A1', 'Diethylstilbestrol']",0.5
14058,29113.0,Diethylstilbestrol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Diethylstilbestrol']",0.5
14058,29220.0,Diethylstilbestrol,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'NR1I2', 'Diethylstilbestrol']",0.5
14058,29646.0,Diethylstilbestrol,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,29646.0,Diethylstilbestrol,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,29646.0,Diethylstilbestrol,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Toluene', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,29646.0,Diethylstilbestrol,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'NR1I2', 'Diethylstilbestrol']",0.5
14058,30827.0,Diethylstilbestrol,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'ESR2', 'Diethylstilbestrol']",0.5
14058,31395.0,Diethylstilbestrol,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Diethylstilbestrol']",0.5
14058,31477.0,Diethylstilbestrol,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Diethylstilbestrol']",0.5
14058,31596.0,Diethylstilbestrol,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,31732.0,Diethylstilbestrol,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'COMT', 'Diethylstilbestrol']",0.5
14058,32617.0,Diethylstilbestrol,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Diethylstilbestrol']",0.5
14058,32719.0,Diethylstilbestrol,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Hearing impairment', 'ESRRB', 'Diethylstilbestrol']",0.5
14058,33534.0,Diethylstilbestrol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Vomiting', 'ABCB1', 'Diethylstilbestrol']",0.5
14058,33575.0,Diethylstilbestrol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Diethylstilbestrol']",0.5
14058,33575.0,Diethylstilbestrol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,33575.0,Diethylstilbestrol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'SHBG', 'Diethylstilbestrol']",0.5
14058,33575.0,Diethylstilbestrol,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Diethylstilbestrol']",0.5
14058,33577.0,Diethylstilbestrol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Diethylstilbestrol']",0.5
14058,33577.0,Diethylstilbestrol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'SHBG', 'Diethylstilbestrol']",0.5
14058,33593.0,Diethylstilbestrol,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,33593.0,Diethylstilbestrol,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Organophosphorus Compounds', 'developmental process', 'COMT', 'Diethylstilbestrol']",0.5
14058,33593.0,Diethylstilbestrol,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Diethylstilbestrol']",0.5
14058,33598.0,Diethylstilbestrol,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Diethylstilbestrol']",0.5
14058,33598.0,Diethylstilbestrol,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,33675.0,Diethylstilbestrol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,33675.0,Diethylstilbestrol,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'bisphenol A', 'SHBG', 'Diethylstilbestrol']",0.5
14058,33680.0,Diethylstilbestrol,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'CYP19A1', 'Diethylstilbestrol']",0.5
14058,33680.0,Diethylstilbestrol,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Diethylstilbestrol']",0.5
14058,33680.0,Diethylstilbestrol,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Diethylstilbestrol']",0.5
14058,33695.0,Diethylstilbestrol,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Diethylstilbestrol']",0.5
14058,33699.0,Diethylstilbestrol,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,35565.0,Diethylstilbestrol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Diethylstilbestrol']",0.5
14058,35641.0,Diethylstilbestrol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Diethylstilbestrol']",0.5
14058,35669.0,Diethylstilbestrol,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,35669.0,Diethylstilbestrol,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'SHBG', 'Diethylstilbestrol']",0.5
14058,35738.0,Diethylstilbestrol,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR2', 'Diethylstilbestrol']",0.5
14058,35739.0,Diethylstilbestrol,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR2', 'Diethylstilbestrol']",0.5
14058,35761.0,Diethylstilbestrol,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,35761.0,Diethylstilbestrol,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'SHBG', 'Diethylstilbestrol']",0.5
14058,35764.0,Diethylstilbestrol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Diethylstilbestrol']",0.5
14058,35901.0,Diethylstilbestrol,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,35901.0,Diethylstilbestrol,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'CYP19A1', 'Diethylstilbestrol']",0.5
14058,35909.0,Diethylstilbestrol,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Diethylstilbestrol']",0.5
14058,35958.0,Diethylstilbestrol,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Diethylstilbestrol']",0.5
14058,35963.0,Diethylstilbestrol,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,35966.0,Diethylstilbestrol,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,35966.0,Diethylstilbestrol,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Diethylstilbestrol']",0.5
14058,35966.0,Diethylstilbestrol,prostate cancer,disease-exposure-gene-drug,contraindication,"['prostate cancer', 'Pesticides', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,36187.0,Diethylstilbestrol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR2', 'Diethylstilbestrol']",0.5
14058,36187.0,Diethylstilbestrol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,36187.0,Diethylstilbestrol,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'SHBG', 'Diethylstilbestrol']",0.5
14058,36469.0,Diethylstilbestrol,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Diethylstilbestrol']",0.5
14058,36527.0,Diethylstilbestrol,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Diethylstilbestrol']",0.5
14058,36634.0,Diethylstilbestrol,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,36634.0,Diethylstilbestrol,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Diethylstilbestrol']",0.5
14058,36634.0,Diethylstilbestrol,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Toluene', 'CYP2E1', 'Diethylstilbestrol']",0.5
14058,36792.0,Diethylstilbestrol,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,36794.0,Diethylstilbestrol,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37038.0,Diethylstilbestrol,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR2', 'Diethylstilbestrol']",0.5
14058,37047.0,Diethylstilbestrol,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37082.0,Diethylstilbestrol,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37150.0,Diethylstilbestrol,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37152.0,Diethylstilbestrol,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37180.0,Diethylstilbestrol,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37180.0,Diethylstilbestrol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,37180.0,Diethylstilbestrol,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'bisphenol A', 'SHBG', 'Diethylstilbestrol']",0.5
14058,37423.0,Diethylstilbestrol,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37466.0,Diethylstilbestrol,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37573.0,Diethylstilbestrol,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,37659.0,Diethylstilbestrol,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Diethylstilbestrol']",0.5
14058,37768.0,Diethylstilbestrol,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Diethylstilbestrol']",0.5
14058,37967.0,Diethylstilbestrol,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,39603.0,Diethylstilbestrol,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Diethylstilbestrol']",0.5
14058,39615.0,Diethylstilbestrol,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83816.0,Diethylstilbestrol,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83817.0,Diethylstilbestrol,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83818.0,Diethylstilbestrol,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83819.0,Diethylstilbestrol,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83820.0,Diethylstilbestrol,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83821.0,Diethylstilbestrol,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83822.0,Diethylstilbestrol,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83823.0,Diethylstilbestrol,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Diethylstilbestrol']",0.5
14058,83824.0,Diethylstilbestrol,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Diethylstilbestrol']",0.5
14059,27648.0,Liothyronine,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Liothyronine']",0.5
14059,29614.0,Liothyronine,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Liothyronine']",0.5
14059,29614.0,Liothyronine,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SERPINA7', 'Liothyronine']",0.5
14059,30813.0,Liothyronine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Liothyronine']",0.5
14059,31714.0,Liothyronine,short stature due to growth hormone qualitative anomaly,disease-phenotype-protein-drug,contraindication,"['short stature due to growth hormone qualitative anomaly', 'Growth delay', 'THRA', 'Liothyronine']",0.5
14059,32217.0,Liothyronine,hypopituitarism,disease-phenotype-protein-drug,contraindication,"['hypopituitarism', 'Growth delay', 'THRA', 'Liothyronine']",0.5
14059,32337.0,Liothyronine,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'Growth delay', 'THRA', 'Liothyronine']",0.5
14059,32584.0,Liothyronine,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Liothyronine']",0.5
14059,32622.0,Liothyronine,thyroid gland undifferentiated (anaplastic) carcinoma,disease-phenotype-protein-drug,indication,"['thyroid gland undifferentiated (anaplastic) carcinoma', 'Pain', 'ALB', 'Liothyronine']",0.5
14059,32719.0,Liothyronine,congenital hypothyroidism,disease-phenotype-protein-drug,indication,"['congenital hypothyroidism', 'Growth delay', 'THRA', 'Liothyronine']",0.5
14059,32905.0,Liothyronine,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Liothyronine']",0.5
14059,33296.0,Liothyronine,familial papillary or follicular thyroid carcinoma,disease-phenotype-protein-drug,indication,"['familial papillary or follicular thyroid carcinoma', 'Pain', 'ALB', 'Liothyronine']",0.5
14059,33575.0,Liothyronine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Liothyronine']",0.5
14059,33575.0,Liothyronine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Liothyronine']",0.5
14059,33577.0,Liothyronine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'SLCO4C1', 'Liothyronine']",0.5
14059,33577.0,Liothyronine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Liothyronine']",0.5
14059,35669.0,Liothyronine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Liothyronine']",0.5
14059,35761.0,Liothyronine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Liothyronine']",0.5
14059,35761.0,Liothyronine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Liothyronine']",0.5
14059,36034.0,Liothyronine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Liothyronine']",0.5
14059,36187.0,Liothyronine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Liothyronine']",0.5
14059,36187.0,Liothyronine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Liothyronine']",0.5
14059,36252.0,Liothyronine,thyroid gland disease,disease-exposure-bioprocess-gene-drug,indication,"['thyroid gland disease', 'Particulate Matter', 'regulation of gene expression', 'SLC10A1', 'Liothyronine']",0.5
14059,36252.0,Liothyronine,thyroid gland disease,disease-exposure-gene-drug,indication,"['thyroid gland disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Liothyronine']",0.5
14059,36469.0,Liothyronine,hypothyroidism,disease-exposure-bioprocess-gene-drug,indication,"['hypothyroidism', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Liothyronine']",0.5
14059,36944.0,Liothyronine,thyroid cancer,disease-exposure-bioprocess-gene-drug,indication,"['thyroid cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'SLCO4C1', 'Liothyronine']",0.5
14059,37180.0,Liothyronine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Liothyronine']",0.5
14059,37180.0,Liothyronine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Liothyronine']",0.5
14060,27648.0,Levothyroxine,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Levothyroxine']",0.5
14060,29614.0,Levothyroxine,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'thyroid hormone metabolic process', 'SLC16A2', 'Levothyroxine']",0.5
14060,29614.0,Levothyroxine,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SERPINA7', 'Levothyroxine']",0.5
14060,30813.0,Levothyroxine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Levothyroxine']",0.5
14060,31714.0,Levothyroxine,short stature due to growth hormone qualitative anomaly,disease-phenotype-protein-drug,contraindication,"['short stature due to growth hormone qualitative anomaly', 'Growth delay', 'THRA', 'Levothyroxine']",0.5
14060,32217.0,Levothyroxine,hypopituitarism,disease-phenotype-protein-drug,contraindication,"['hypopituitarism', 'Growth delay', 'THRA', 'Levothyroxine']",0.5
14060,32337.0,Levothyroxine,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'Growth delay', 'THRA', 'Levothyroxine']",0.5
14060,32584.0,Levothyroxine,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Levothyroxine']",0.5
14060,32622.0,Levothyroxine,thyroid gland undifferentiated (anaplastic) carcinoma,disease-phenotype-protein-drug,indication,"['thyroid gland undifferentiated (anaplastic) carcinoma', 'Pain', 'ALB', 'Levothyroxine']",0.5
14060,32719.0,Levothyroxine,congenital hypothyroidism,disease-phenotype-protein-drug,indication,"['congenital hypothyroidism', 'Growth delay', 'THRA', 'Levothyroxine']",0.5
14060,32905.0,Levothyroxine,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Levothyroxine']",0.5
14060,33296.0,Levothyroxine,familial papillary or follicular thyroid carcinoma,disease-phenotype-protein-drug,indication,"['familial papillary or follicular thyroid carcinoma', 'Pain', 'ALB', 'Levothyroxine']",0.5
14060,33575.0,Levothyroxine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Levothyroxine']",0.5
14060,33575.0,Levothyroxine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Levothyroxine']",0.5
14060,33577.0,Levothyroxine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'thyroid hormone metabolic process', 'SLC16A2', 'Levothyroxine']",0.5
14060,33577.0,Levothyroxine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Levothyroxine']",0.5
14060,35669.0,Levothyroxine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Levothyroxine']",0.5
14060,35761.0,Levothyroxine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Levothyroxine']",0.5
14060,35761.0,Levothyroxine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Levothyroxine']",0.5
14060,35958.0,Levothyroxine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ITGB3', 'Levothyroxine']",0.5
14060,36034.0,Levothyroxine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Levothyroxine']",0.5
14060,36187.0,Levothyroxine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Levothyroxine']",0.5
14060,36187.0,Levothyroxine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Levothyroxine']",0.5
14060,36252.0,Levothyroxine,thyroid gland disease,disease-exposure-bioprocess-gene-drug,indication,"['thyroid gland disease', 'Particulate Matter', 'platelet activation', 'ITGB3', 'Levothyroxine']",0.5
14060,36252.0,Levothyroxine,thyroid gland disease,disease-exposure-gene-drug,indication,"['thyroid gland disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Levothyroxine']",0.5
14060,36469.0,Levothyroxine,hypothyroidism,disease-exposure-bioprocess-gene-drug,indication,"['hypothyroidism', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Levothyroxine']",0.5
14060,36944.0,Levothyroxine,thyroid cancer,disease-exposure-bioprocess-gene-drug,indication,"['thyroid cancer', 'perfluorooctanoic acid', 'thyroid hormone metabolic process', 'SLC16A2', 'Levothyroxine']",0.5
14060,37180.0,Levothyroxine,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ITGB3', 'Levothyroxine']",0.5
14060,37180.0,Levothyroxine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'THRA', 'Levothyroxine']",0.5
14060,37180.0,Levothyroxine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Levothyroxine']",0.5
14060,83823.0,Levothyroxine,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ITGB3', 'Levothyroxine']",0.5
14060,83824.0,Levothyroxine,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ITGB3', 'Levothyroxine']",0.5
14061,27366.0,Diclofenac,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Diclofenac']",0.5
14061,27494.0,Diclofenac,cystoid macular edema,disease-phenotype-protein-drug,off-label use,"['cystoid macular edema', 'Edema', 'PTGS2', 'Diclofenac']",0.5
14061,28158.0,Diclofenac,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Diclofenac']",0.5
14061,28158.0,Diclofenac,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Diclofenac']",0.5
14061,28158.0,Diclofenac,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Diclofenac']",0.5
14061,30035.0,Diclofenac,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Diclofenac']",0.5
14061,33575.0,Diclofenac,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Diclofenac']",0.5
14061,33575.0,Diclofenac,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Diclofenac']",0.5
14061,33575.0,Diclofenac,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Diclofenac']",0.5
14061,33577.0,Diclofenac,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Diclofenac']",0.5
14061,33577.0,Diclofenac,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Diclofenac']",0.5
14061,33632.0,Diclofenac,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Diclofenac']",0.5
14061,33632.0,Diclofenac,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Diclofenac']",0.5
14061,33675.0,Diclofenac,asthma,disease-protein-drug,contraindication,"['asthma', 'ALOX5', 'Diclofenac']",0.5
14061,33675.0,Diclofenac,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Diclofenac']",0.5
14061,33675.0,Diclofenac,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'PTGS1', 'Diclofenac']",0.5
14061,35565.0,Diclofenac,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Diclofenac']",0.5
14061,35565.0,Diclofenac,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Diclofenac']",0.5
14061,35669.0,Diclofenac,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Diclofenac']",0.5
14061,35669.0,Diclofenac,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Diclofenac']",0.5
14061,35761.0,Diclofenac,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Diclofenac']",0.5
14061,35761.0,Diclofenac,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Diclofenac']",0.5
14061,35909.0,Diclofenac,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Diclofenac']",0.5
14061,35909.0,Diclofenac,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Diclofenac']",0.5
14061,36432.0,Diclofenac,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Diclofenac']",0.5
14061,36544.0,Diclofenac,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP2E1', 'Diclofenac']",0.5
14061,36544.0,Diclofenac,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Diclofenac']",0.5
14061,36644.0,Diclofenac,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Mustard Gas', 'regulation of gene expression', 'CYP1A2', 'Diclofenac']",0.5
14061,36644.0,Diclofenac,skin disease,disease-exposure-gene-drug,indication,"['skin disease', 'Pesticides', 'CYP2E1', 'Diclofenac']",0.5
14061,37180.0,Diclofenac,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Diclofenac']",0.5
14061,37180.0,Diclofenac,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Diclofenac']",0.5
14061,39773.0,Diclofenac,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ALOX5', 'Diclofenac']",0.5
14061,83781.0,Diclofenac,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ALOX5', 'Diclofenac']",0.5
14061,83961.0,Diclofenac,duodenal ulcer (disease),disease-protein-drug,contraindication,"['duodenal ulcer (disease)', 'PTGS2', 'Diclofenac']",0.5
14062,29078.0,Diflunisal,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Diflunisal']",0.5
14062,29078.0,Diflunisal,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Diflunisal']",0.5
14062,29078.0,Diflunisal,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Diflunisal']",0.5
14062,29078.0,Diflunisal,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Diflunisal']",0.5
14062,33577.0,Diflunisal,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Diflunisal']",0.5
14062,33577.0,Diflunisal,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Diflunisal']",0.5
14062,35565.0,Diflunisal,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Diflunisal']",0.5
14062,35565.0,Diflunisal,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Diflunisal']",0.5
14062,35669.0,Diflunisal,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Diflunisal']",0.5
14062,35669.0,Diflunisal,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Diflunisal']",0.5
14062,35761.0,Diflunisal,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Diflunisal']",0.5
14062,35761.0,Diflunisal,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Diflunisal']",0.5
14062,35764.0,Diflunisal,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Diflunisal']",0.5
14062,35764.0,Diflunisal,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Diflunisal']",0.5
14062,35764.0,Diflunisal,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Diflunisal']",0.5
14062,37180.0,Diflunisal,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Diflunisal']",0.5
14062,37180.0,Diflunisal,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Diflunisal']",0.5
14063,35623.0,Dimethyl sulfoxide,benign urinary system neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['benign urinary system neoplasm', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dimethyl sulfoxide']",0.5
14063,35764.0,Dimethyl sulfoxide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Dimethyl sulfoxide']",0.5
14106,33577.0,Hydroxocobalamin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CUBN', 'Hydroxocobalamin']",0.5
14106,39044.0,Hydroxocobalamin,methylmalonic acidemia,disease-protein-drug,off-label use,"['methylmalonic acidemia', 'MMUT', 'Hydroxocobalamin']",0.5
14108,37659.0,Ubidecarenone,heart failure,disease-exposure-bioprocess-gene-drug,indication,"['heart failure', 'Air Pollutants', 'memory', 'VLDLR', 'Ubidecarenone']",0.5
14112,28208.0,Etretinate,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'RARA', 'Etretinate']",0.5
14112,28208.0,Etretinate,type 2 diabetes mellitus,disease-exposure-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Cadmium', 'RARA', 'Etretinate']",0.5
14112,33575.0,Etretinate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'RARA', 'Etretinate']",0.5
14112,33575.0,Etretinate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'RARA', 'Etretinate']",0.5
14112,33575.0,Etretinate,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Etretinate']",0.5
14112,33695.0,Etretinate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'RXRA', 'Etretinate']",0.5
14112,33695.0,Etretinate,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'RARA', 'Etretinate']",0.5
14112,35565.0,Etretinate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'RXRA', 'Etretinate']",0.5
14112,35565.0,Etretinate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'RARA', 'Etretinate']",0.5
14112,36544.0,Etretinate,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'RXRA', 'Etretinate']",0.5
14113,29361.0,Tamibarotene,acute promyelocytic leukemia,disease-protein-drug,indication,"['acute promyelocytic leukemia', 'RARA', 'Tamibarotene']",0.5
14115,30035.0,Bismuth subsalicylate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'TF', 'Bismuth subsalicylate']",0.5
14115,33575.0,Bismuth subsalicylate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'TF', 'Bismuth subsalicylate']",0.5
14115,33575.0,Bismuth subsalicylate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Bismuth subsalicylate']",0.5
14115,35565.0,Bismuth subsalicylate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Bismuth subsalicylate']",0.5
14115,35641.0,Bismuth subsalicylate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Bismuth subsalicylate']",0.5
14115,35764.0,Bismuth subsalicylate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Bismuth subsalicylate']",0.5
14115,35764.0,Bismuth subsalicylate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Bismuth subsalicylate']",0.5
14115,35764.0,Bismuth subsalicylate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Bismuth subsalicylate']",0.5
14127,28158.0,Octreotide,inflammatory bowel disease,disease-protein-drug,off-label use,"['inflammatory bowel disease', 'ABCB1', 'Octreotide']",0.5
14127,28158.0,Octreotide,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,off-label use,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Octreotide']",0.5
14127,28158.0,Octreotide,inflammatory bowel disease,disease-phenotype-protein-drug,off-label use,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Octreotide']",0.5
14127,32272.0,Octreotide,pancreatic insulin-producing neuroendocrine tumor,disease-phenotype-protein-drug,off-label use,"['pancreatic insulin-producing neuroendocrine tumor', 'Seizure', 'ABCC2', 'Octreotide']",0.5
14127,33575.0,Octreotide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Octreotide']",0.5
14127,33575.0,Octreotide,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Octreotide']",0.5
14127,35565.0,Octreotide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Octreotide']",0.5
14127,35565.0,Octreotide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Octreotide']",0.5
14127,36469.0,Octreotide,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Octreotide']",0.5
14127,37765.0,Octreotide,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Octreotide']",0.5
14128,27591.0,Ascorbic acid,myotonia congenita,disease-phenotype-protein-drug,contraindication,"['myotonia congenita', 'Myotonia', 'SLC2A1', 'Ascorbic acid']",0.5
14128,28042.0,Ascorbic acid,hyperkalemic periodic paralysis,disease-phenotype-protein-drug,contraindication,"['hyperkalemic periodic paralysis', 'Respiratory insufficiency', 'SLC23A1', 'Ascorbic acid']",0.5
14128,28921.0,Ascorbic acid,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Hepatomegaly', 'ALB', 'Ascorbic acid']",0.5
14128,29078.0,Ascorbic acid,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,contraindication,"['rheumatoid arthritis', 'Pesticides', 'visual learning', 'DBH', 'Ascorbic acid']",0.5
14128,29078.0,Ascorbic acid,rheumatoid arthritis,disease-exposure-gene-drug,contraindication,"['rheumatoid arthritis', 'Air Pollutants', 'TXNRD1', 'Ascorbic acid']",0.5
14128,29113.0,Ascorbic acid,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'SLC2A4', 'Ascorbic acid']",0.5
14128,29182.0,Ascorbic acid,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'OGFOD1', 'Ascorbic acid']",0.5
14128,29182.0,Ascorbic acid,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Ascorbic acid']",0.5
14128,29946.0,Ascorbic acid,primary hyperoxaluria,disease-phenotype-protein-drug,contraindication,"['primary hyperoxaluria', 'Pain', 'ALB', 'Ascorbic acid']",0.5
14128,31502.0,Ascorbic acid,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Hepatomegaly', 'ALB', 'Ascorbic acid']",0.5
14128,32967.0,Ascorbic acid,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'ALB', 'Ascorbic acid']",0.5
14128,33534.0,Ascorbic acid,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Ascorbic acid']",0.5
14128,33575.0,Ascorbic acid,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'PAM', 'Ascorbic acid']",0.5
14128,33575.0,Ascorbic acid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'SLC23A2', 'Ascorbic acid']",0.5
14128,33575.0,Ascorbic acid,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'SLC2A4', 'Ascorbic acid']",0.5
14128,33577.0,Ascorbic acid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'SLC2A4', 'Ascorbic acid']",0.5
14128,33577.0,Ascorbic acid,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'TXNRD1', 'Ascorbic acid']",0.5
14128,33635.0,Ascorbic acid,leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['leukemia (disease)', 'Cobalt', 'glucose homeostasis', 'SLC2A4', 'Ascorbic acid']",0.5
14128,33635.0,Ascorbic acid,leukemia (disease),disease-exposure-gene-drug,contraindication,"['leukemia (disease)', 'Cadmium', 'ALB', 'Ascorbic acid']",0.5
14128,33675.0,Ascorbic acid,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'glucose homeostasis', 'SLC2A4', 'Ascorbic acid']",0.5
14128,33675.0,Ascorbic acid,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'TXNRD1', 'Ascorbic acid']",0.5
14128,35565.0,Ascorbic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'DBH', 'Ascorbic acid']",0.5
14128,35565.0,Ascorbic acid,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'SLC2A4', 'Ascorbic acid']",0.5
14128,35641.0,Ascorbic acid,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'PAM', 'Ascorbic acid']",0.5
14128,35641.0,Ascorbic acid,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DBH', 'Ascorbic acid']",0.5
14128,35764.0,Ascorbic acid,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Ascorbic acid']",0.5
14128,35764.0,Ascorbic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'SLC2A4', 'Ascorbic acid']",0.5
14128,35764.0,Ascorbic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Mercury', 'TXNRD1', 'Ascorbic acid']",0.5
14128,37722.0,Ascorbic acid,multiple sclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['multiple sclerosis', 'Mercury', 'glucose homeostasis', 'SLC2A4', 'Ascorbic acid']",0.5
14128,37722.0,Ascorbic acid,multiple sclerosis,disease-exposure-gene-drug,contraindication,"['multiple sclerosis', 'Mercury', 'TXNRD1', 'Ascorbic acid']",0.5
14128,37785.0,Ascorbic acid,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'PAM', 'Ascorbic acid']",0.5
14128,37805.0,Ascorbic acid,HIV infectious disease,disease-protein-drug,contraindication,"['HIV infectious disease', 'ALB', 'Ascorbic acid']",0.5
14128,37888.0,Ascorbic acid,allergic rhinitis,disease-protein-drug,contraindication,"['allergic rhinitis', 'ALB', 'Ascorbic acid']",0.5
14128,37888.0,Ascorbic acid,allergic rhinitis,disease-exposure-bioprocess-gene-drug,contraindication,"['allergic rhinitis', 'Nitrogen Dioxide', 'glucose homeostasis', 'SLC2A4', 'Ascorbic acid']",0.5
14128,37888.0,Ascorbic acid,allergic rhinitis,disease-exposure-gene-drug,contraindication,"['allergic rhinitis', 'Air Pollutants', 'TXNRD1', 'Ascorbic acid']",0.5
14128,37888.0,Ascorbic acid,allergic rhinitis,disease-phenotype-protein-drug,contraindication,"['allergic rhinitis', 'Allergy', 'ALB', 'Ascorbic acid']",0.5
14128,83791.0,Ascorbic acid,vasomotor rhinitis,disease-protein-drug,contraindication,"['vasomotor rhinitis', 'ALB', 'Ascorbic acid']",0.5
14128,83967.0,Ascorbic acid,dental fluorosis,disease-exposure-gene-drug,contraindication,"['dental fluorosis', 'Fluorides', 'ALB', 'Ascorbic acid']",0.5
14129,28869.0,Lutein,macular degeneration,disease-exposure-bioprocess-gene-drug,indication,"['macular degeneration', 'Lead', 'transport', 'ALB', 'Lutein']",0.5
14129,28869.0,Lutein,macular degeneration,disease-exposure-gene-drug,indication,"['macular degeneration', 'Lead', 'ALB', 'Lutein']",0.5
14129,35916.0,Lutein,dry eye syndrome,disease-exposure-bioprocess-gene-drug,indication,"['dry eye syndrome', 'Lead', 'transport', 'ALB', 'Lutein']",0.5
14129,35916.0,Lutein,dry eye syndrome,disease-exposure-gene-drug,indication,"['dry eye syndrome', 'Lead', 'ALB', 'Lutein']",0.5
14131,28158.0,Icosapent,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'PPARA', 'Icosapent']",0.5
14131,28158.0,Icosapent,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'TRPV1', 'Icosapent']",0.5
14131,28249.0,Icosapent,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'PPARD', 'Icosapent']",0.5
14131,29113.0,Icosapent,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'PPARG', 'Icosapent']",0.5
14131,30612.0,Icosapent,Leber hereditary optic neuropathy,disease-phenotype-protein-drug,contraindication,"['Leber hereditary optic neuropathy', 'Arrhythmia', 'PTGS2', 'Icosapent']",0.5
14131,31502.0,Icosapent,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Increased body weight', 'PPARD', 'Icosapent']",0.5
14131,33575.0,Icosapent,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'PPARA', 'Icosapent']",0.5
14131,33575.0,Icosapent,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'PPARD', 'Icosapent']",0.5
14131,33575.0,Icosapent,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Icosapent']",0.5
14131,33695.0,Icosapent,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['hypertriglyceridemia (disease)', 'Mercury', 'glucose homeostasis', 'FFAR1', 'Icosapent']",0.5
14131,33695.0,Icosapent,hypertriglyceridemia (disease),disease-exposure-gene-drug,off-label use,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Icosapent']",0.5
14131,37785.0,Icosapent,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'regulation of gene expression', 'SLC8A1', 'Icosapent']",0.5
14131,38242.0,Icosapent,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'PPARD', 'Icosapent']",0.5
14132,27933.0,Pyridoxine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Pyridoxine']",0.5
14132,27933.0,Pyridoxine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'DNA methylation', 'CYP1A1', 'Pyridoxine']",0.5
14132,27933.0,Pyridoxine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Pyridoxine']",0.5
14132,27933.0,Pyridoxine,anxiety disorder,disease-exposure-molfunc-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'alkaline phosphatase activity', 'ALPL', 'Pyridoxine']",0.5
14132,28313.0,Pyridoxine,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Pyridoxine']",0.5
14132,28478.0,Pyridoxine,autoimmune disease,disease-exposure-bioprocess-gene-drug,contraindication,"['autoimmune disease', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Pyridoxine']",0.5
14132,29182.0,Pyridoxine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Pyridoxine']",0.5
14132,29182.0,Pyridoxine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Pyridoxine']",0.5
14132,30813.0,Pyridoxine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'ALPL', 'Pyridoxine']",0.5
14132,31502.0,Pyridoxine,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Hepatomegaly', 'CYP1A1', 'Pyridoxine']",0.5
14132,32384.0,Pyridoxine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ALPL', 'Pyridoxine']",0.5
14132,32928.0,Pyridoxine,acute liver failure,disease-protein-drug,contraindication,"['acute liver failure', 'ALB', 'Pyridoxine']",0.5
14132,32928.0,Pyridoxine,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Thrombocytopenia', 'ALB', 'Pyridoxine']",0.5
14132,33534.0,Pyridoxine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Pyridoxine']",0.5
14132,33575.0,Pyridoxine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Pyridoxine']",0.5
14132,33575.0,Pyridoxine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Pyridoxine']",0.5
14132,33575.0,Pyridoxine,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'alkaline phosphatase activity', 'ALPL', 'Pyridoxine']",0.5
14132,33594.0,Pyridoxine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'DNA methylation', 'CYP1A1', 'Pyridoxine']",0.5
14132,33594.0,Pyridoxine,diarrheal disease,disease-exposure-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'CYP1A1', 'Pyridoxine']",0.5
14132,33594.0,Pyridoxine,diarrheal disease,disease-exposure-molfunc-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'alkaline phosphatase activity', 'ALPL', 'Pyridoxine']",0.5
14132,35565.0,Pyridoxine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'DNA methylation', 'CYP1A1', 'Pyridoxine']",0.5
14132,35565.0,Pyridoxine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Pyridoxine']",0.5
14132,35751.0,Pyridoxine,peripheral nervous system disease,disease-exposure-gene-drug,contraindication,"['peripheral nervous system disease', 'Agent Orange', 'CYP1A1', 'Pyridoxine']",0.5
14132,35764.0,Pyridoxine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Pyridoxine']",0.5
14132,35764.0,Pyridoxine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'DNA methylation', 'CYP1A1', 'Pyridoxine']",0.5
14132,35764.0,Pyridoxine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Pyridoxine']",0.5
14132,35764.0,Pyridoxine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'alkaline phosphatase activity', 'ALPL', 'Pyridoxine']",0.5
14132,36241.0,Pyridoxine,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Pyridoxine']",0.5
14132,37703.0,Pyridoxine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Pyridoxine']",0.5
14132,37785.0,Pyridoxine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'DNA methylation', 'CYP1A1', 'Pyridoxine']",0.5
14132,83760.0,Pyridoxine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Pyridoxine']",0.5
14133,33577.0,Torasemide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Torasemide']",0.5
14133,33577.0,Torasemide,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Torasemide']",0.5
14133,33695.0,Torasemide,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Torasemide']",0.5
14133,33695.0,Torasemide,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Torasemide']",0.5
14133,36432.0,Torasemide,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ALB', 'Torasemide']",0.5
14133,37765.0,Torasemide,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Torasemide']",0.5
14133,83802.0,Torasemide,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Torasemide']",0.5
14134,27933.0,Nelfinavir,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Nelfinavir']",0.5
14134,27933.0,Nelfinavir,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Nelfinavir']",0.5
14134,27933.0,Nelfinavir,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Nelfinavir']",0.5
14134,33575.0,Nelfinavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Nelfinavir']",0.5
14134,33575.0,Nelfinavir,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Nelfinavir']",0.5
14134,33594.0,Nelfinavir,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Nelfinavir']",0.5
14134,35565.0,Nelfinavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Nelfinavir']",0.5
14134,35565.0,Nelfinavir,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Nelfinavir']",0.5
14134,37703.0,Nelfinavir,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Nelfinavir']",0.5
14134,37805.0,Nelfinavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Nelfinavir']",0.5
14134,83760.0,Nelfinavir,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Nelfinavir']",0.5
14135,27626.0,Lovastatin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Lovastatin']",0.5
14135,30035.0,Lovastatin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Lovastatin']",0.5
14135,33575.0,Lovastatin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Lovastatin']",0.5
14135,33575.0,Lovastatin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Lovastatin']",0.5
14135,33598.0,Lovastatin,stroke disorder,disease-protein-drug,off-label use,"['stroke disorder', 'ALB', 'Lovastatin']",0.5
14135,33598.0,Lovastatin,stroke disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['stroke disorder', 'Pesticides', 'visual learning', 'HMGCR', 'Lovastatin']",0.5
14135,33598.0,Lovastatin,stroke disorder,disease-exposure-gene-drug,off-label use,"['stroke disorder', 'Cadmium', 'ALB', 'Lovastatin']",0.5
14135,33605.0,Lovastatin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Lovastatin']",0.5
14135,33612.0,Lovastatin,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Lovastatin']",0.5
14135,33695.0,Lovastatin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'HMGCR', 'Lovastatin']",0.5
14135,33695.0,Lovastatin,hypertriglyceridemia (disease),disease-exposure-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Lovastatin']",0.5
14135,35565.0,Lovastatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Lovastatin']",0.5
14135,35565.0,Lovastatin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Lovastatin']",0.5
14135,35909.0,Lovastatin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Lovastatin']",0.5
14135,35953.0,Lovastatin,atherosclerosis,disease-exposure-bioprocess-gene-drug,indication,"['atherosclerosis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Lovastatin']",0.5
14135,35953.0,Lovastatin,atherosclerosis,disease-exposure-gene-drug,indication,"['atherosclerosis', 'Lead', 'ALB', 'Lovastatin']",0.5
14135,36187.0,Lovastatin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Lovastatin']",0.5
14135,36187.0,Lovastatin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Lovastatin']",0.5
14135,37180.0,Lovastatin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Lovastatin']",0.5
14135,37180.0,Lovastatin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Lovastatin']",0.5
14135,83898.0,Lovastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Lovastatin']",0.5
14136,30669.0,Enflurane,Becker muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['Becker muscular dystrophy', 'Arrhythmia', 'CACNA1C', 'Enflurane']",0.5
14136,32149.0,Enflurane,Duchenne muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['Duchenne muscular dystrophy', 'Respiratory insufficiency', 'CACNA1S', 'Enflurane']",0.5
14136,33459.0,Enflurane,malignant hyperthermia of anesthesia,disease-protein-drug,contraindication,"['malignant hyperthermia of anesthesia', 'CACNA1S', 'Enflurane']",0.5
14136,35641.0,Enflurane,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CACNA2D2', 'Enflurane']",0.5
14136,35641.0,Enflurane,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Enflurane']",0.5
14136,83838.0,Enflurane,exercise-induced malignant hyperthermia,disease-protein-drug,contraindication,"['exercise-induced malignant hyperthermia', 'CACNA1S', 'Enflurane']",0.5
14137,27286.0,Butabarbital,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ALB', 'Butabarbital']",0.5
14137,27292.0,Butabarbital,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Areflexia', 'CHRNB2', 'Butabarbital']",0.5
14137,27626.0,Butabarbital,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Butabarbital']",0.5
14137,27933.0,Butabarbital,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Butabarbital']",0.5
14137,27933.0,Butabarbital,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'DNA repair', 'CHRNA4', 'Butabarbital']",0.5
14137,27933.0,Butabarbital,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,28052.0,Butabarbital,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'ALB', 'Butabarbital']",0.5
14137,28249.0,Butabarbital,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'GABRB3', 'Butabarbital']",0.5
14137,30035.0,Butabarbital,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRNB4', 'Butabarbital']",0.5
14137,31618.0,Butabarbital,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CHRNB4', 'Butabarbital']",0.5
14137,31650.0,Butabarbital,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRNB4', 'Butabarbital']",0.5
14137,32033.0,Butabarbital,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Butabarbital']",0.5
14137,32313.0,Butabarbital,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRNB4', 'Butabarbital']",0.5
14137,32977.0,Butabarbital,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CHRNB4', 'Butabarbital']",0.5
14137,33577.0,Butabarbital,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'CHRNB2', 'Butabarbital']",0.5
14137,33577.0,Butabarbital,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,33598.0,Butabarbital,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Butabarbital']",0.5
14137,33598.0,Butabarbital,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,33598.0,Butabarbital,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,33632.0,Butabarbital,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GABRA5', 'Butabarbital']",0.5
14137,33632.0,Butabarbital,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Butabarbital']",0.5
14137,33675.0,Butabarbital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,33678.0,Butabarbital,glomerulonephritis,disease-protein-drug,contraindication,"['glomerulonephritis', 'ALB', 'Butabarbital']",0.5
14137,35565.0,Butabarbital,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,35565.0,Butabarbital,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,35641.0,Butabarbital,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Butabarbital']",0.5
14137,35641.0,Butabarbital,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Butabarbital']",0.5
14137,35669.0,Butabarbital,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,35761.0,Butabarbital,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Butabarbital']",0.5
14137,35761.0,Butabarbital,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,35764.0,Butabarbital,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Butabarbital']",0.5
14137,35764.0,Butabarbital,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNB2', 'Butabarbital']",0.5
14137,35764.0,Butabarbital,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,35909.0,Butabarbital,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,35915.0,Butabarbital,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'GRIA1', 'Butabarbital']",0.5
14137,35915.0,Butabarbital,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'CHRNB2', 'Butabarbital']",0.5
14137,35953.0,Butabarbital,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,35953.0,Butabarbital,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Lead', 'ALB', 'Butabarbital']",0.5
14137,36034.0,Butabarbital,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'CHRNA7', 'Butabarbital']",0.5
14137,36080.0,Butabarbital,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,36136.0,Butabarbital,autonomic nervous system disease,disease-protein-drug,contraindication,"['autonomic nervous system disease', 'CHRNA3', 'Butabarbital']",0.5
14137,36187.0,Butabarbital,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,36187.0,Butabarbital,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,36266.0,Butabarbital,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRG2', 'Butabarbital']",0.5
14137,36274.0,Butabarbital,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,36274.0,Butabarbital,pyloric stenosis (disease),disease-exposure-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,36693.0,Butabarbital,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'GRIA4', 'Butabarbital']",0.5
14137,36693.0,Butabarbital,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Butabarbital']",0.5
14137,37180.0,Butabarbital,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,37180.0,Butabarbital,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Butabarbital']",0.5
14137,37617.0,Butabarbital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butabarbital']",0.5
14137,37703.0,Butabarbital,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Butabarbital']",0.5
14137,38242.0,Butabarbital,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'GABRB3', 'Butabarbital']",0.5
14137,38242.0,Butabarbital,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Butabarbital']",0.5
14137,83760.0,Butabarbital,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CHRNA6', 'Butabarbital']",0.5
14137,83778.0,Butabarbital,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'GRIA1', 'Butabarbital']",0.5
14137,83778.0,Butabarbital,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'CHRNB2', 'Butabarbital']",0.5
14137,83779.0,Butabarbital,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'GRIA1', 'Butabarbital']",0.5
14137,83779.0,Butabarbital,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'CHRNB2', 'Butabarbital']",0.5
14137,83805.0,Butabarbital,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRG2', 'Butabarbital']",0.5
14138,32299.0,Nevirapine,toxic epidermal necrolysis,disease-protein-drug,contraindication,"['toxic epidermal necrolysis', 'ALB', 'Nevirapine']",0.5
14138,32299.0,Nevirapine,toxic epidermal necrolysis,disease-phenotype-protein-drug,contraindication,"['toxic epidermal necrolysis', 'Elevated hepatic transaminase', 'CYP1A2', 'Nevirapine']",0.5
14138,32746.0,Nevirapine,Stevens-Johnson syndrome,disease-protein-drug,contraindication,"['Stevens-Johnson syndrome', 'ALB', 'Nevirapine']",0.5
14138,32746.0,Nevirapine,Stevens-Johnson syndrome,disease-phenotype-protein-drug,contraindication,"['Stevens-Johnson syndrome', 'Thrombocytopenia', 'ALB', 'Nevirapine']",0.5
14138,33295.0,Nevirapine,Lyell syndrome,disease-protein-drug,contraindication,"['Lyell syndrome', 'ALB', 'Nevirapine']",0.5
14138,33295.0,Nevirapine,Lyell syndrome,disease-phenotype-protein-drug,contraindication,"['Lyell syndrome', 'Thrombocytopenia', 'ALB', 'Nevirapine']",0.5
14138,33649.0,Nevirapine,exanthem (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['exanthem (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Nevirapine']",0.5
14138,35565.0,Nevirapine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Nevirapine']",0.5
14138,35565.0,Nevirapine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Nevirapine']",0.5
14138,36544.0,Nevirapine,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP2A6', 'Nevirapine']",0.5
14138,36544.0,Nevirapine,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Nevirapine']",0.5
14138,37743.0,Nevirapine,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP2A6', 'Nevirapine']",0.5
14138,37805.0,Nevirapine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Nevirapine']",0.5
14139,28158.0,Benzatropine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Benzatropine']",0.5
14139,28547.0,Benzatropine,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'SLC6A3', 'Benzatropine']",0.5
14139,28547.0,Benzatropine,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Benzatropine']",0.5
14139,28547.0,Benzatropine,Parkinson disease,disease-exposure-gene-drug,indication,"['Parkinson disease', 'Lead', 'ALB', 'Benzatropine']",0.5
14139,28801.0,Benzatropine,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'SLC6A3', 'Benzatropine']",0.5
14139,28801.0,Benzatropine,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5
14139,28974.0,Benzatropine,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'SLC6A3', 'Benzatropine']",0.5
14139,28974.0,Benzatropine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5
14139,30093.0,Benzatropine,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'SLC6A3', 'Benzatropine']",0.5
14139,31408.0,Benzatropine,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'SLC6A3', 'Benzatropine']",0.5
14139,31408.0,Benzatropine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5
14139,31650.0,Benzatropine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5
14139,32468.0,Benzatropine,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5
14139,32759.0,Benzatropine,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'SLC6A3', 'Benzatropine']",0.5
14139,32974.0,Benzatropine,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'SLC6A3', 'Benzatropine']",0.5
14139,32974.0,Benzatropine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Seizure', 'SLC6A2', 'Benzatropine']",0.5
14139,32999.0,Benzatropine,shigellosis,disease-phenotype-protein-drug,contraindication,"['shigellosis', 'Thrombocytopenia', 'ALB', 'Benzatropine']",0.5
14139,33241.0,Benzatropine,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'SLC6A3', 'Benzatropine']",0.5
14139,33577.0,Benzatropine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Benzatropine']",0.5
14139,33577.0,Benzatropine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Benzatropine']",0.5
14139,33594.0,Benzatropine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'memory', 'SLC6A4', 'Benzatropine']",0.5
14139,33605.0,Benzatropine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Benzatropine']",0.5
14139,35565.0,Benzatropine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Benzatropine']",0.5
14139,35565.0,Benzatropine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Benzatropine']",0.5
14139,35764.0,Benzatropine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Benzatropine']",0.5
14139,35764.0,Benzatropine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'SLC6A4', 'Benzatropine']",0.5
14139,35764.0,Benzatropine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Benzatropine']",0.5
14139,36034.0,Benzatropine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Benzatropine']",0.5
14139,36187.0,Benzatropine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Benzatropine']",0.5
14139,36187.0,Benzatropine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Benzatropine']",0.5
14139,37617.0,Benzatropine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Benzatropine']",0.5
14139,37785.0,Benzatropine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Benzatropine']",0.5
14140,27326.0,Ziprasidone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Ziprasidone']",0.5
14140,27326.0,Ziprasidone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Ziprasidone']",0.5
14140,27645.0,Ziprasidone,torsion dystonia,disease-phenotype-protein-drug,contraindication,"['torsion dystonia', 'Action tremor', 'CHRM4', 'Ziprasidone']",0.5
14140,27655.0,Ziprasidone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'HTR1B', 'Ziprasidone']",0.5
14140,27740.0,Ziprasidone,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Ziprasidone']",0.5
14140,28149.0,Ziprasidone,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Ziprasidone']",0.5
14140,28313.0,Ziprasidone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Ziprasidone']",0.5
14140,28313.0,Ziprasidone,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Ziprasidone']",0.5
14140,28396.0,Ziprasidone,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Ziprasidone']",0.5
14140,28651.0,Ziprasidone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2A', 'Ziprasidone']",0.5
14140,28780.0,Ziprasidone,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Ziprasidone']",0.5
14140,28780.0,Ziprasidone,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,28780.0,Ziprasidone,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Ziprasidone']",0.5
14140,29113.0,Ziprasidone,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Ziprasidone']",0.5
14140,29494.0,Ziprasidone,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Ziprasidone']",0.5
14140,30324.0,Ziprasidone,blepharospasm,disease-protein-drug,contraindication,"['blepharospasm', 'DRD5', 'Ziprasidone']",0.5
14140,30879.0,Ziprasidone,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'HTR1B', 'Ziprasidone']",0.5
14140,31393.0,Ziprasidone,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Ziprasidone']",0.5
14140,31393.0,Ziprasidone,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Ziprasidone']",0.5
14140,31393.0,Ziprasidone,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,33449.0,Ziprasidone,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Ziprasidone']",0.5
14140,33454.0,Ziprasidone,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Ziprasidone']",0.5
14140,33575.0,Ziprasidone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Ziprasidone']",0.5
14140,33575.0,Ziprasidone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,33593.0,Ziprasidone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2A', 'Ziprasidone']",0.5
14140,33593.0,Ziprasidone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Ziprasidone']",0.5
14140,33593.0,Ziprasidone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,33593.0,Ziprasidone,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Ziprasidone']",0.5
14140,35641.0,Ziprasidone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Ziprasidone']",0.5
14140,35641.0,Ziprasidone,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Ziprasidone']",0.5
14140,35764.0,Ziprasidone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Ziprasidone']",0.5
14140,35764.0,Ziprasidone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Ziprasidone']",0.5
14140,35764.0,Ziprasidone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,35909.0,Ziprasidone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Ziprasidone']",0.5
14140,36104.0,Ziprasidone,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Ziprasidone']",0.5
14140,36187.0,Ziprasidone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ziprasidone']",0.5
14140,36187.0,Ziprasidone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,36229.0,Ziprasidone,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Ziprasidone']",0.5
14140,36432.0,Ziprasidone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRA2C', 'Ziprasidone']",0.5
14140,37180.0,Ziprasidone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ziprasidone']",0.5
14140,37180.0,Ziprasidone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,37659.0,Ziprasidone,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ADRA2C', 'Ziprasidone']",0.5
14140,37659.0,Ziprasidone,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ziprasidone']",0.5
14140,37659.0,Ziprasidone,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,37786.0,Ziprasidone,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ziprasidone']",0.5
14140,37786.0,Ziprasidone,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Ziprasidone']",0.5
14140,38003.0,Ziprasidone,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD3', 'Ziprasidone']",0.5
14140,38242.0,Ziprasidone,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'HTR5A', 'Ziprasidone']",0.5
14140,38242.0,Ziprasidone,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Ziprasidone']",0.5
14140,38928.0,Ziprasidone,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Ziprasidone']",0.5
14140,39531.0,Ziprasidone,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Ziprasidone']",0.5
14140,83751.0,Ziprasidone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Ziprasidone']",0.5
14140,83752.0,Ziprasidone,focal hand dystonia,disease-protein-drug,contraindication,"['focal hand dystonia', 'DRD5', 'Ziprasidone']",0.5
14140,83763.0,Ziprasidone,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'DRD5', 'Ziprasidone']",0.5
14140,83764.0,Ziprasidone,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Ziprasidone']",0.5
14140,83998.0,Ziprasidone,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Ziprasidone']",0.5
14141,27326.0,Phenytoin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CACNA1C', 'Phenytoin']",0.5
14141,27326.0,Phenytoin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenytoin']",0.5
14141,27326.0,Phenytoin,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Sudden cardiac death', 'CACNA1C', 'Phenytoin']",0.5
14141,27626.0,Phenytoin,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'CYP11B1', 'Phenytoin']",0.5
14141,27626.0,Phenytoin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Phenytoin']",0.5
14141,27655.0,Phenytoin,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Phenytoin']",0.5
14141,27655.0,Phenytoin,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Syncope', 'CACNA1C', 'Phenytoin']",0.5
14141,27664.0,Phenytoin,idiopathic aplastic anemia,disease-phenotype-protein-drug,contraindication,"['idiopathic aplastic anemia', 'Thrombocytopenia', 'ALB', 'Phenytoin']",0.5
14141,27933.0,Phenytoin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Phenytoin']",0.5
14141,27933.0,Phenytoin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'CYP11B1', 'Phenytoin']",0.5
14141,27933.0,Phenytoin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Phenytoin']",0.5
14141,27933.0,Phenytoin,anxiety disorder,disease-exposure-molfunc-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Phenytoin']",0.5
14141,29182.0,Phenytoin,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'COMT', 'Phenytoin']",0.5
14141,29182.0,Phenytoin,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Phenytoin']",0.5
14141,29352.0,Phenytoin,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Phenytoin']",0.5
14141,29494.0,Phenytoin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NR1I2', 'Phenytoin']",0.5
14141,29525.0,Phenytoin,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Syncope', 'CACNA1C', 'Phenytoin']",0.5
14141,29865.0,Phenytoin,Lennox-Gastaut syndrome,disease-protein-drug,indication,"['Lennox-Gastaut syndrome', 'SCN1A', 'Phenytoin']",0.5
14141,29865.0,Phenytoin,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Mental deterioration', 'CACNA1C', 'Phenytoin']",0.5
14141,30035.0,Phenytoin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Phenytoin']",0.5
14141,30184.0,Phenytoin,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'NR1I2', 'Phenytoin']",0.5
14141,30879.0,Phenytoin,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'ABCC2', 'Phenytoin']",0.5
14141,31618.0,Phenytoin,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Respiratory insufficiency', 'CACNA1S', 'Phenytoin']",0.5
14141,32313.0,Phenytoin,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'ABCC2', 'Phenytoin']",0.5
14141,32456.0,Phenytoin,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'SCN1A', 'Phenytoin']",0.5
14141,32456.0,Phenytoin,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'ABCC2', 'Phenytoin']",0.5
14141,32977.0,Phenytoin,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Phenytoin']",0.5
14141,32977.0,Phenytoin,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ABCC2', 'Phenytoin']",0.5
14141,33534.0,Phenytoin,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Phenytoin']",0.5
14141,33575.0,Phenytoin,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Phenytoin']",0.5
14141,33575.0,Phenytoin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Phenytoin']",0.5
14141,33575.0,Phenytoin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Phenytoin']",0.5
14141,33575.0,Phenytoin,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Tobacco Smoke Pollution', 'superoxide dismutase activity', 'NQO1', 'Phenytoin']",0.5
14141,33605.0,Phenytoin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Phenytoin']",0.5
14141,33632.0,Phenytoin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Phenytoin']",0.5
14141,33632.0,Phenytoin,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Phenytoin']",0.5
14141,35565.0,Phenytoin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Phenytoin']",0.5
14141,35565.0,Phenytoin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Phenytoin']",0.5
14141,35641.0,Phenytoin,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Phenytoin']",0.5
14141,35764.0,Phenytoin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Phenytoin']",0.5
14141,35764.0,Phenytoin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Phenytoin']",0.5
14141,35764.0,Phenytoin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Phenytoin']",0.5
14141,36080.0,Phenytoin,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'CACNA1S', 'Phenytoin']",0.5
14141,36080.0,Phenytoin,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'COMT', 'Phenytoin']",0.5
14141,36080.0,Phenytoin,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Soot', 'NQO1', 'Phenytoin']",0.5
14141,36104.0,Phenytoin,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Phenytoin']",0.5
14141,36229.0,Phenytoin,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Phenytoin']",0.5
14141,36252.0,Phenytoin,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'methylation', 'COMT', 'Phenytoin']",0.5
14141,36252.0,Phenytoin,thyroid gland disease,disease-exposure-gene-drug,contraindication,"['thyroid gland disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Phenytoin']",0.5
14141,36252.0,Phenytoin,thyroid gland disease,disease-exposure-molfunc-gene-drug,contraindication,"['thyroid gland disease', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Phenytoin']",0.5
14141,36266.0,Phenytoin,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRG2', 'Phenytoin']",0.5
14141,36693.0,Phenytoin,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Phenytoin']",0.5
14141,36743.0,Phenytoin,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'ABCC2', 'Phenytoin']",0.5
14141,37180.0,Phenytoin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenytoin']",0.5
14141,37180.0,Phenytoin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Phenytoin']",0.5
14141,37180.0,Phenytoin,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Phenytoin']",0.5
14141,37703.0,Phenytoin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CACNA1C', 'Phenytoin']",0.5
14141,38242.0,Phenytoin,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'GABRB3', 'Phenytoin']",0.5
14141,38958.0,Phenytoin,sick sinus syndrome,disease-protein-drug,contraindication,"['sick sinus syndrome', 'SCN1B', 'Phenytoin']",0.5
14141,39815.0,Phenytoin,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'ABCC2', 'Phenytoin']",0.5
14141,83751.0,Phenytoin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'SCN5A', 'Phenytoin']",0.5
14141,83760.0,Phenytoin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CACNA1C', 'Phenytoin']",0.5
14141,83761.0,Phenytoin,epilepsy with generalized tonic-clonic seizures,disease-protein-drug,indication,"['epilepsy with generalized tonic-clonic seizures', 'CYP2D6', 'Phenytoin']",0.5
14141,83764.0,Phenytoin,hyperglycemia,disease-protein-drug,contraindication,"['hyperglycemia', 'NQO1', 'Phenytoin']",0.5
14141,83764.0,Phenytoin,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'regulation of blood pressure', 'CYP11B1', 'Phenytoin']",0.5
14141,83805.0,Phenytoin,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRG2', 'Phenytoin']",0.5
14141,83906.0,Phenytoin,status epilepticus,disease-protein-drug,indication,"['status epilepticus', 'SCN8A', 'Phenytoin']",0.5
14141,83928.0,Phenytoin,partial motor epilepsy,disease-protein-drug,indication,"['partial motor epilepsy', 'ABCC2', 'Phenytoin']",0.5
14142,27503.0,Metoprolol,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,off-label use,"['catecholaminergic polymorphic ventricular tachycardia', 'Bradycardia', 'CYP2D6', 'Metoprolol']",0.5
14142,27933.0,Metoprolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Metoprolol']",0.5
14142,27933.0,Metoprolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Metoprolol']",0.5
14142,27933.0,Metoprolol,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Metoprolol']",0.5
14142,29113.0,Metoprolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Metoprolol']",0.5
14142,29182.0,Metoprolol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Metoprolol']",0.5
14142,29182.0,Metoprolol,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Metoprolol']",0.5
14142,31122.0,Metoprolol,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'ALB', 'Metoprolol']",0.5
14142,31493.0,Metoprolol,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Metoprolol']",0.5
14142,33534.0,Metoprolol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Metoprolol']",0.5
14142,33575.0,Metoprolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Metoprolol']",0.5
14142,33575.0,Metoprolol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Metoprolol']",0.5
14142,33605.0,Metoprolol,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Metoprolol']",0.5
14142,33618.0,Metoprolol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Metoprolol']",0.5
14142,33675.0,Metoprolol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Metoprolol']",0.5
14142,33675.0,Metoprolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Metoprolol']",0.5
14142,33679.0,Metoprolol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Metoprolol']",0.5
14142,35565.0,Metoprolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Metoprolol']",0.5
14142,35565.0,Metoprolol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Metoprolol']",0.5
14142,36034.0,Metoprolol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,off-label use,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Metoprolol']",0.5
14142,37180.0,Metoprolol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,indication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Metoprolol']",0.5
14142,37180.0,Metoprolol,myocardial infarction (disease),disease-exposure-gene-drug,indication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Metoprolol']",0.5
14142,37703.0,Metoprolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Metoprolol']",0.5
14142,39798.0,Metoprolol,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Metoprolol']",0.5
14142,39798.0,Metoprolol,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'ALB', 'Metoprolol']",0.5
14142,83760.0,Metoprolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Metoprolol']",0.5
14142,83802.0,Metoprolol,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Metoprolol']",0.5
14143,29118.0,Dicoumarol,acquired polycythemia vera,disease-phenotype-protein-drug,contraindication,"['acquired polycythemia vera', 'Hepatomegaly', 'ALB', 'Dicoumarol']",0.5
14143,31033.0,Dicoumarol,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'NQO1', 'Dicoumarol']",0.5
14143,31033.0,Dicoumarol,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'ALB', 'Dicoumarol']",0.5
14143,32563.0,Dicoumarol,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,contraindication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Dicoumarol']",0.5
14143,32629.0,Dicoumarol,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'NQO1', 'Dicoumarol']",0.5
14143,32629.0,Dicoumarol,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'ALB', 'Dicoumarol']",0.5
14143,33025.0,Dicoumarol,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'ALB', 'Dicoumarol']",0.5
14143,33577.0,Dicoumarol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'visual perception', 'CRYZ', 'Dicoumarol']",0.5
14143,33577.0,Dicoumarol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Dicoumarol']",0.5
14143,33632.0,Dicoumarol,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'urea metabolic process', 'CYP2C9', 'Dicoumarol']",0.5
14143,33632.0,Dicoumarol,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Dicoumarol']",0.5
14143,35565.0,Dicoumarol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Dicoumarol']",0.5
14143,35565.0,Dicoumarol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Dicoumarol']",0.5
14143,35766.0,Dicoumarol,thrombotic disease,disease-exposure-bioprocess-gene-drug,indication,"['thrombotic disease', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Dicoumarol']",0.5
14143,35854.0,Dicoumarol,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Dicoumarol']",0.5
14143,35909.0,Dicoumarol,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Dicoumarol']",0.5
14143,35915.0,Dicoumarol,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Dicoumarol']",0.5
14143,36034.0,Dicoumarol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'visual perception', 'CRYZ', 'Dicoumarol']",0.5
14143,36432.0,Dicoumarol,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Dicoumarol']",0.5
14143,36469.0,Dicoumarol,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'visual perception', 'CRYZ', 'Dicoumarol']",0.5
14143,37180.0,Dicoumarol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,indication,"['myocardial infarction (disease)', 'Air Pollutants', 'response to oxidative stress', 'NQO1', 'Dicoumarol']",0.5
14143,37180.0,Dicoumarol,myocardial infarction (disease),disease-exposure-gene-drug,indication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Dicoumarol']",0.5
14143,37180.0,Dicoumarol,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,indication,"['myocardial infarction (disease)', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Dicoumarol']",0.5
14143,38059.0,Dicoumarol,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'NQO1', 'Dicoumarol']",0.5
14143,83778.0,Dicoumarol,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Dicoumarol']",0.5
14143,83779.0,Dicoumarol,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Dicoumarol']",0.5
14143,83942.0,Dicoumarol,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'response to oxidative stress', 'NQO1', 'Dicoumarol']",0.5
14144,27933.0,Topiramate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Topiramate']",0.5
14144,27933.0,Topiramate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'SCN10A', 'Topiramate']",0.5
14144,27933.0,Topiramate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Topiramate']",0.5
14144,29865.0,Topiramate,Lennox-Gastaut syndrome,disease-protein-drug,indication,"['Lennox-Gastaut syndrome', 'SCN1A', 'Topiramate']",0.5
14144,29865.0,Topiramate,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Mental deterioration', 'CACNA1C', 'Topiramate']",0.5
14144,30035.0,Topiramate,substance abuse/dependence,disease-protein-drug,off-label use,"['substance abuse/dependence', 'ABCB1', 'Topiramate']",0.5
14144,32456.0,Topiramate,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'SCN1A', 'Topiramate']",0.5
14144,32456.0,Topiramate,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'CACNA1E', 'Topiramate']",0.5
14144,33594.0,Topiramate,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of heart rate', 'SCN10A', 'Topiramate']",0.5
14144,35565.0,Topiramate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'PRKAG1', 'Topiramate']",0.5
14144,35565.0,Topiramate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Topiramate']",0.5
14144,35764.0,Topiramate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Topiramate']",0.5
14144,35764.0,Topiramate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'PRKAA1', 'Topiramate']",0.5
14144,35764.0,Topiramate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Topiramate']",0.5
14144,36743.0,Topiramate,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'GRIK1', 'Topiramate']",0.5
14144,37703.0,Topiramate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CACNA1C', 'Topiramate']",0.5
14144,83760.0,Topiramate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CACNA1C', 'Topiramate']",0.5
14145,35552.0,Cefmetazole,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'innate immune response', 'SLC15A2', 'Cefmetazole']",0.5
14146,35565.0,Argatroban,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Argatroban']",0.5
14146,35565.0,Argatroban,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Argatroban']",0.5
14147,83995.0,Conjugated estrogens,psychologic dyspareunia,disease-protein-drug,indication,"['psychologic dyspareunia', 'SHBG', 'Conjugated estrogens']",0.5
14148,27476.0,Atomoxetine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'memory', 'SLC6A4', 'Atomoxetine']",0.5
14148,28052.0,Atomoxetine,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'ALB', 'Atomoxetine']",0.5
14148,28249.0,Atomoxetine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Atomoxetine']",0.5
14148,28396.0,Atomoxetine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Atomoxetine']",0.5
14148,29525.0,Atomoxetine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Atomoxetine']",0.5
14148,31122.0,Atomoxetine,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'ALB', 'Atomoxetine']",0.5
14148,31524.0,Atomoxetine,postural orthostatic tachycardia syndrome,disease-protein-drug,contraindication,"['postural orthostatic tachycardia syndrome', 'SLC6A2', 'Atomoxetine']",0.5
14148,33577.0,Atomoxetine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Atomoxetine']",0.5
14148,33577.0,Atomoxetine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'GRIN2B', 'Atomoxetine']",0.5
14148,33598.0,Atomoxetine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Atomoxetine']",0.5
14148,33598.0,Atomoxetine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Atomoxetine']",0.5
14148,33598.0,Atomoxetine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Atomoxetine']",0.5
14148,33605.0,Atomoxetine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Atomoxetine']",0.5
14148,35565.0,Atomoxetine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'FCGR1A', 'Atomoxetine']",0.5
14148,35565.0,Atomoxetine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Atomoxetine']",0.5
14148,35641.0,Atomoxetine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Atomoxetine']",0.5
14148,35641.0,Atomoxetine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Atomoxetine']",0.5
14148,35909.0,Atomoxetine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'SLC6A4', 'Atomoxetine']",0.5
14148,35915.0,Atomoxetine,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'GRIN1', 'Atomoxetine']",0.5
14148,35915.0,Atomoxetine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Atomoxetine']",0.5
14148,36187.0,Atomoxetine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Atomoxetine']",0.5
14148,36187.0,Atomoxetine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'GRIN2B', 'Atomoxetine']",0.5
14148,37180.0,Atomoxetine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Atomoxetine']",0.5
14148,37180.0,Atomoxetine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'bisphenol A', 'GRIN2B', 'Atomoxetine']",0.5
14148,38242.0,Atomoxetine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Atomoxetine']",0.5
14148,38242.0,Atomoxetine,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Atomoxetine']",0.5
14148,83778.0,Atomoxetine,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'GRIN1', 'Atomoxetine']",0.5
14148,83778.0,Atomoxetine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Atomoxetine']",0.5
14148,83779.0,Atomoxetine,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'GRIN1', 'Atomoxetine']",0.5
14148,83779.0,Atomoxetine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Atomoxetine']",0.5
14148,84036.0,Atomoxetine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'inflammatory response', 'ORM1', 'Atomoxetine']",0.5
14148,84036.0,Atomoxetine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Cadmium', 'ALB', 'Atomoxetine']",0.5
14149,27933.0,Etonogestrel,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Etonogestrel']",0.5
14149,27933.0,Etonogestrel,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,27933.0,Etonogestrel,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,29182.0,Etonogestrel,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Etonogestrel']",0.5
14149,29182.0,Etonogestrel,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Etonogestrel']",0.5
14149,29646.0,Etonogestrel,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,29646.0,Etonogestrel,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,29646.0,Etonogestrel,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'ALB', 'Etonogestrel']",0.5
14149,30827.0,Etonogestrel,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Etonogestrel']",0.5
14149,31393.0,Etonogestrel,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'SHBG', 'Etonogestrel']",0.5
14149,31393.0,Etonogestrel,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,31393.0,Etonogestrel,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Etonogestrel']",0.5
14149,31477.0,Etonogestrel,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Etonogestrel']",0.5
14149,32395.0,Etonogestrel,toxic shock syndrome,disease-phenotype-protein-drug,contraindication,"['toxic shock syndrome', 'Thrombocytopenia', 'ALB', 'Etonogestrel']",0.5
14149,32617.0,Etonogestrel,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'CYP3A4', 'Etonogestrel']",0.5
14149,33534.0,Etonogestrel,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Etonogestrel']",0.5
14149,33575.0,Etonogestrel,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Etonogestrel']",0.5
14149,33575.0,Etonogestrel,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,33575.0,Etonogestrel,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,33577.0,Etonogestrel,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,33577.0,Etonogestrel,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,33593.0,Etonogestrel,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,33593.0,Etonogestrel,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Etonogestrel']",0.5
14149,33598.0,Etonogestrel,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Etonogestrel']",0.5
14149,33598.0,Etonogestrel,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,33598.0,Etonogestrel,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'SHBG', 'Etonogestrel']",0.5
14149,33675.0,Etonogestrel,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,33675.0,Etonogestrel,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,33695.0,Etonogestrel,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,33695.0,Etonogestrel,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Etonogestrel']",0.5
14149,35565.0,Etonogestrel,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,35565.0,Etonogestrel,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Etonogestrel']",0.5
14149,35641.0,Etonogestrel,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Etonogestrel']",0.5
14149,35738.0,Etonogestrel,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Etonogestrel']",0.5
14149,35739.0,Etonogestrel,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'PGR', 'Etonogestrel']",0.5
14149,35764.0,Etonogestrel,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Etonogestrel']",0.5
14149,35764.0,Etonogestrel,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,35764.0,Etonogestrel,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,35909.0,Etonogestrel,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,36187.0,Etonogestrel,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,36187.0,Etonogestrel,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,36634.0,Etonogestrel,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,36634.0,Etonogestrel,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,37038.0,Etonogestrel,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Etonogestrel']",0.5
14149,37180.0,Etonogestrel,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,37180.0,Etonogestrel,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'PGR', 'Etonogestrel']",0.5
14149,37573.0,Etonogestrel,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Etonogestrel']",0.5
14149,37703.0,Etonogestrel,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Etonogestrel']",0.5
14149,38928.0,Etonogestrel,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'SHBG', 'Etonogestrel']",0.5
14149,83760.0,Etonogestrel,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Etonogestrel']",0.5
14150,27326.0,Morphine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'LY96', 'Morphine']",0.5
14150,27648.0,Morphine,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Morphine']",0.5
14150,27655.0,Morphine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'OPRM1', 'Morphine']",0.5
14150,27933.0,Morphine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Morphine']",0.5
14150,27933.0,Morphine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'LY96', 'Morphine']",0.5
14150,27933.0,Morphine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Morphine']",0.5
14150,28149.0,Morphine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Morphine']",0.5
14150,28158.0,Morphine,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Morphine']",0.5
14150,28158.0,Morphine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,28158.0,Morphine,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Morphine']",0.5
14150,30035.0,Morphine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Morphine']",0.5
14150,31072.0,Morphine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Morphine']",0.5
14150,31493.0,Morphine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Morphine']",0.5
14150,31618.0,Morphine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Respiratory insufficiency', 'OPRM1', 'Morphine']",0.5
14150,31650.0,Morphine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'OPRM1', 'Morphine']",0.5
14150,32313.0,Morphine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'OPRM1', 'Morphine']",0.5
14150,32384.0,Morphine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Morphine']",0.5
14150,32584.0,Morphine,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Morphine']",0.5
14150,32719.0,Morphine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Morphine']",0.5
14150,33577.0,Morphine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,33577.0,Morphine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Morphine']",0.5
14150,33594.0,Morphine,diarrheal disease,disease-exposure-bioprocess-gene-drug,indication,"['diarrheal disease', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'LY96', 'Morphine']",0.5
14150,33605.0,Morphine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Morphine']",0.5
14150,33675.0,Morphine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'LY96', 'Morphine']",0.5
14150,35565.0,Morphine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Morphine']",0.5
14150,35565.0,Morphine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Morphine']",0.5
14150,35641.0,Morphine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Morphine']",0.5
14150,35764.0,Morphine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Morphine']",0.5
14150,35764.0,Morphine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,35764.0,Morphine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Morphine']",0.5
14150,35909.0,Morphine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,35915.0,Morphine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,36034.0,Morphine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,36080.0,Morphine,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Morphine']",0.5
14150,36080.0,Morphine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'LY96', 'Morphine']",0.5
14150,36187.0,Morphine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'LY96', 'Morphine']",0.5
14150,36187.0,Morphine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Morphine']",0.5
14150,36274.0,Morphine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'LY96', 'Morphine']",0.5
14150,36274.0,Morphine,pyloric stenosis (disease),disease-exposure-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'ALB', 'Morphine']",0.5
14150,36469.0,Morphine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,36693.0,Morphine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Morphine']",0.5
14150,37617.0,Morphine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'LY96', 'Morphine']",0.5
14150,37703.0,Morphine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'OPRM1', 'Morphine']",0.5
14150,83749.0,Morphine,drug-induced dyskinesia,disease-protein-drug,contraindication,"['drug-induced dyskinesia', 'OPRM1', 'Morphine']",0.5
14150,83751.0,Morphine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Morphine']",0.5
14150,83760.0,Morphine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'OPRM1', 'Morphine']",0.5
14150,83778.0,Morphine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,83779.0,Morphine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Morphine']",0.5
14150,83910.0,Morphine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Morphine']",0.5
14151,27933.0,Desogestrel,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Desogestrel']",0.5
14151,27933.0,Desogestrel,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,27933.0,Desogestrel,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PGR', 'Desogestrel']",0.5
14151,29061.0,Desogestrel,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'PGR', 'Desogestrel']",0.5
14151,29182.0,Desogestrel,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Desogestrel']",0.5
14151,29182.0,Desogestrel,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Desogestrel']",0.5
14151,29220.0,Desogestrel,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'ALB', 'Desogestrel']",0.5
14151,29646.0,Desogestrel,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ESR1', 'Desogestrel']",0.5
14151,29646.0,Desogestrel,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,29646.0,Desogestrel,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'PGR', 'Desogestrel']",0.5
14151,29646.0,Desogestrel,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'ALB', 'Desogestrel']",0.5
14151,30827.0,Desogestrel,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Desogestrel']",0.5
14151,31107.0,Desogestrel,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,31477.0,Desogestrel,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Desogestrel']",0.5
14151,31477.0,Desogestrel,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Desogestrel']",0.5
14151,31596.0,Desogestrel,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Desogestrel']",0.5
14151,32617.0,Desogestrel,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ESR1', 'Desogestrel']",0.5
14151,33534.0,Desogestrel,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Desogestrel']",0.5
14151,33575.0,Desogestrel,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Desogestrel']",0.5
14151,33575.0,Desogestrel,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,33575.0,Desogestrel,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Desogestrel']",0.5
14151,33577.0,Desogestrel,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Desogestrel']",0.5
14151,33577.0,Desogestrel,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Desogestrel']",0.5
14151,33593.0,Desogestrel,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Desogestrel']",0.5
14151,33593.0,Desogestrel,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Desogestrel']",0.5
14151,33593.0,Desogestrel,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Desogestrel']",0.5
14151,33598.0,Desogestrel,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Desogestrel']",0.5
14151,33598.0,Desogestrel,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Desogestrel']",0.5
14151,33598.0,Desogestrel,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'SHBG', 'Desogestrel']",0.5
14151,33675.0,Desogestrel,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,33675.0,Desogestrel,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'PGR', 'Desogestrel']",0.5
14151,33680.0,Desogestrel,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'PGR', 'Desogestrel']",0.5
14151,33680.0,Desogestrel,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Desogestrel']",0.5
14151,33680.0,Desogestrel,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Desogestrel']",0.5
14151,33695.0,Desogestrel,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Desogestrel']",0.5
14151,33695.0,Desogestrel,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Desogestrel']",0.5
14151,33699.0,Desogestrel,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,35565.0,Desogestrel,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Desogestrel']",0.5
14151,35565.0,Desogestrel,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Desogestrel']",0.5
14151,35641.0,Desogestrel,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Desogestrel']",0.5
14151,35738.0,Desogestrel,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Desogestrel']",0.5
14151,35739.0,Desogestrel,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Desogestrel']",0.5
14151,35901.0,Desogestrel,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Desogestrel']",0.5
14151,35901.0,Desogestrel,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Desogestrel']",0.5
14151,35909.0,Desogestrel,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Desogestrel']",0.5
14151,35958.0,Desogestrel,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Desogestrel']",0.5
14151,36187.0,Desogestrel,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Desogestrel']",0.5
14151,36187.0,Desogestrel,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,36187.0,Desogestrel,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Desogestrel']",0.5
14151,36469.0,Desogestrel,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Desogestrel']",0.5
14151,36527.0,Desogestrel,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Desogestrel']",0.5
14151,36634.0,Desogestrel,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ESR1', 'Desogestrel']",0.5
14151,36634.0,Desogestrel,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Desogestrel']",0.5
14151,36634.0,Desogestrel,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'PGR', 'Desogestrel']",0.5
14151,36792.0,Desogestrel,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Desogestrel']",0.5
14151,36794.0,Desogestrel,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Desogestrel']",0.5
14151,37038.0,Desogestrel,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Desogestrel']",0.5
14151,37047.0,Desogestrel,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Desogestrel']",0.5
14151,37082.0,Desogestrel,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Desogestrel']",0.5
14151,37150.0,Desogestrel,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Desogestrel']",0.5
14151,37152.0,Desogestrel,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Desogestrel']",0.5
14151,37180.0,Desogestrel,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Desogestrel']",0.5
14151,37180.0,Desogestrel,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,37180.0,Desogestrel,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'PGR', 'Desogestrel']",0.5
14151,37423.0,Desogestrel,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Desogestrel']",0.5
14151,37466.0,Desogestrel,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Desogestrel']",0.5
14151,37573.0,Desogestrel,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Desogestrel']",0.5
14151,37703.0,Desogestrel,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Desogestrel']",0.5
14151,37768.0,Desogestrel,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Desogestrel']",0.5
14151,37967.0,Desogestrel,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Desogestrel']",0.5
14151,39603.0,Desogestrel,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Desogestrel']",0.5
14151,39615.0,Desogestrel,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Desogestrel']",0.5
14151,83760.0,Desogestrel,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Desogestrel']",0.5
14151,83816.0,Desogestrel,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Desogestrel']",0.5
14151,83817.0,Desogestrel,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Desogestrel']",0.5
14151,83818.0,Desogestrel,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Desogestrel']",0.5
14151,83819.0,Desogestrel,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Desogestrel']",0.5
14151,83820.0,Desogestrel,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Desogestrel']",0.5
14151,83821.0,Desogestrel,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Desogestrel']",0.5
14151,83822.0,Desogestrel,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Desogestrel']",0.5
14151,83823.0,Desogestrel,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Desogestrel']",0.5
14151,83824.0,Desogestrel,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Desogestrel']",0.5
14152,27933.0,Chlorthalidone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Chlorthalidone']",0.5
14152,27933.0,Chlorthalidone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Lead', 'transport', 'ALB', 'Chlorthalidone']",0.5
14152,27933.0,Chlorthalidone,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,28208.0,Chlorthalidone,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Chlorthalidone']",0.5
14152,28208.0,Chlorthalidone,type 2 diabetes mellitus,disease-exposure-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,28552.0,Chlorthalidone,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Chlorthalidone']",0.5
14152,29182.0,Chlorthalidone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Chlorthalidone']",0.5
14152,29182.0,Chlorthalidone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Chlorthalidone']",0.5
14152,31493.0,Chlorthalidone,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Chlorthalidone']",0.5
14152,33534.0,Chlorthalidone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Chlorthalidone']",0.5
14152,33575.0,Chlorthalidone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Chlorthalidone']",0.5
14152,33575.0,Chlorthalidone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,33577.0,Chlorthalidone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Chlorthalidone']",0.5
14152,33577.0,Chlorthalidone,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,33675.0,Chlorthalidone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Benzo(a)pyrene', 'heme biosynthetic process', 'ALB', 'Chlorthalidone']",0.5
14152,35641.0,Chlorthalidone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Chlorthalidone']",0.5
14152,35764.0,Chlorthalidone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Chlorthalidone']",0.5
14152,35764.0,Chlorthalidone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Chlorthalidone']",0.5
14152,35764.0,Chlorthalidone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,35909.0,Chlorthalidone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Chlorthalidone']",0.5
14152,35916.0,Chlorthalidone,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Lead', 'transport', 'ALB', 'Chlorthalidone']",0.5
14152,35916.0,Chlorthalidone,dry eye syndrome,disease-exposure-gene-drug,contraindication,"['dry eye syndrome', 'Lead', 'ALB', 'Chlorthalidone']",0.5
14152,36040.0,Chlorthalidone,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'ALB', 'Chlorthalidone']",0.5
14152,36040.0,Chlorthalidone,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Lead', 'transport', 'ALB', 'Chlorthalidone']",0.5
14152,36040.0,Chlorthalidone,chronic kidney disease,disease-exposure-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,36187.0,Chlorthalidone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'transport', 'ALB', 'Chlorthalidone']",0.5
14152,36187.0,Chlorthalidone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,36432.0,Chlorthalidone,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ALB', 'Chlorthalidone']",0.5
14152,37180.0,Chlorthalidone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Lead', 'transport', 'ALB', 'Chlorthalidone']",0.5
14152,37180.0,Chlorthalidone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,37703.0,Chlorthalidone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Chlorthalidone']",0.5
14152,83760.0,Chlorthalidone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Chlorthalidone']",0.5
14152,83923.0,Chlorthalidone,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'ALB', 'Chlorthalidone']",0.5
14152,83923.0,Chlorthalidone,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Chlorthalidone']",0.5
14152,83923.0,Chlorthalidone,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Cadmium', 'ALB', 'Chlorthalidone']",0.5
14152,83924.0,Chlorthalidone,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'ALB', 'Chlorthalidone']",0.5
14153,27626.0,Valproic acid,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Valproic acid']",0.5
14153,27933.0,Valproic acid,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Valproic acid']",0.5
14153,27933.0,Valproic acid,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'positive regulation of heart rate', 'SCN3B', 'Valproic acid']",0.5
14153,27933.0,Valproic acid,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PPARG', 'Valproic acid']",0.5
14153,28249.0,Valproic acid,major affective disorder,disease-protein-drug,off-label use,"['major affective disorder', 'PPARD', 'Valproic acid']",0.5
14153,29186.0,Valproic acid,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,contraindication,"['carbamoyl phosphate synthetase I deficiency disease', 'Ataxia', 'SCN8A', 'Valproic acid']",0.5
14153,29832.0,Valproic acid,hyperargininemia,disease-phenotype-protein-drug,contraindication,"['hyperargininemia', 'Hepatomegaly', 'ALB', 'Valproic acid']",0.5
14153,31493.0,Valproic acid,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Valproic acid']",0.5
14153,32132.0,Valproic acid,citrullinemia,disease-phenotype-protein-drug,contraindication,"['citrullinemia', 'Hepatomegaly', 'ALB', 'Valproic acid']",0.5
14153,32977.0,Valproic acid,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Valproic acid']",0.5
14153,32977.0,Valproic acid,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Pruritus', 'SCN9A', 'Valproic acid']",0.5
14153,33125.0,Valproic acid,early myoclonic encephalopathy,disease-protein-drug,off-label use,"['early myoclonic encephalopathy', 'SCN1B', 'Valproic acid']",0.5
14153,35565.0,Valproic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Valproic acid']",0.5
14153,35565.0,Valproic acid,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Valproic acid']",0.5
14153,35641.0,Valproic acid,epilepsy,disease-protein-drug,off-label use,"['epilepsy', 'SCN9A', 'Valproic acid']",0.5
14153,35764.0,Valproic acid,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Valproic acid']",0.5
14153,35764.0,Valproic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'HDAC9', 'Valproic acid']",0.5
14153,35764.0,Valproic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PPARG', 'Valproic acid']",0.5
14153,36063.0,Valproic acid,cognitive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cognitive disorder', 'Pesticides', 'cholesterol metabolic process', 'PPARD', 'Valproic acid']",0.5
14153,36743.0,Valproic acid,partial epilepsy,disease-protein-drug,off-label use,"['partial epilepsy', 'SCN3A', 'Valproic acid']",0.5
14153,37703.0,Valproic acid,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'HDAC2', 'Valproic acid']",0.5
14153,38242.0,Valproic acid,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'PPARD', 'Valproic acid']",0.5
14153,83760.0,Valproic acid,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Valproic acid']",0.5
14153,83763.0,Valproic acid,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'SCN2A', 'Valproic acid']",0.5
14154,28017.0,Acetaminophen,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Acetaminophen']",0.5
14154,35565.0,Acetaminophen,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Acetaminophen']",0.5
14154,35565.0,Acetaminophen,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Acetaminophen']",0.5
14154,37765.0,Acetaminophen,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Acetaminophen']",0.5
14154,83791.0,Acetaminophen,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Acetaminophen']",0.5
14155,31116.0,Gefitinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Gefitinib']",0.5
14155,33688.0,Gefitinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Gefitinib']",0.5
14155,35471.0,Gefitinib,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'inflammatory response', 'ORM1', 'Gefitinib']",0.5
14155,35565.0,Gefitinib,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Gefitinib']",0.5
14155,35565.0,Gefitinib,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Gefitinib']",0.5
14156,27326.0,Amitriptyline,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Amitriptyline']",0.5
14156,27326.0,Amitriptyline,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Amitriptyline']",0.5
14156,27326.0,Amitriptyline,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'HTR1A', 'Amitriptyline']",0.5
14156,27626.0,Amitriptyline,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'OPRD1', 'Amitriptyline']",0.5
14156,27626.0,Amitriptyline,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Amitriptyline']",0.5
14156,27655.0,Amitriptyline,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Amitriptyline']",0.5
14156,27655.0,Amitriptyline,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'HTR1B', 'Amitriptyline']",0.5
14156,27933.0,Amitriptyline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Amitriptyline']",0.5
14156,27933.0,Amitriptyline,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Amitriptyline']",0.5
14156,27933.0,Amitriptyline,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,28149.0,Amitriptyline,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Amitriptyline']",0.5
14156,28396.0,Amitriptyline,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Amitriptyline']",0.5
14156,28547.0,Amitriptyline,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Amitriptyline']",0.5
14156,28547.0,Amitriptyline,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Amitriptyline']",0.5
14156,28547.0,Amitriptyline,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Lead', 'ALB', 'Amitriptyline']",0.5
14156,28547.0,Amitriptyline,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Amitriptyline']",0.5
14156,28651.0,Amitriptyline,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'NTRK2', 'Amitriptyline']",0.5
14156,28780.0,Amitriptyline,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Amitriptyline']",0.5
14156,28780.0,Amitriptyline,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Amitriptyline']",0.5
14156,28780.0,Amitriptyline,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,28780.0,Amitriptyline,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Amitriptyline']",0.5
14156,29175.0,Amitriptyline,thyrotoxicosis,disease-phenotype-protein-drug,contraindication,"['thyrotoxicosis', 'Polyphagia', 'NTRK2', 'Amitriptyline']",0.5
14156,29525.0,Amitriptyline,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Amitriptyline']",0.5
14156,29637.0,Amitriptyline,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'HTR1B', 'Amitriptyline']",0.5
14156,30035.0,Amitriptyline,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Amitriptyline']",0.5
14156,31393.0,Amitriptyline,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Amitriptyline']",0.5
14156,31393.0,Amitriptyline,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Amitriptyline']",0.5
14156,31393.0,Amitriptyline,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,31524.0,Amitriptyline,postural orthostatic tachycardia syndrome,disease-protein-drug,contraindication,"['postural orthostatic tachycardia syndrome', 'SLC6A2', 'Amitriptyline']",0.5
14156,31618.0,Amitriptyline,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Respiratory insufficiency', 'OPRM1', 'Amitriptyline']",0.5
14156,32313.0,Amitriptyline,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'HTR1B', 'Amitriptyline']",0.5
14156,32977.0,Amitriptyline,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Amitriptyline']",0.5
14156,32977.0,Amitriptyline,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Fever', 'HTR1A', 'Amitriptyline']",0.5
14156,33454.0,Amitriptyline,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Amitriptyline']",0.5
14156,33593.0,Amitriptyline,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'NTRK2', 'Amitriptyline']",0.5
14156,33593.0,Amitriptyline,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Amitriptyline']",0.5
14156,33593.0,Amitriptyline,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,33593.0,Amitriptyline,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Amitriptyline']",0.5
14156,33632.0,Amitriptyline,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'UGT2B10', 'Amitriptyline']",0.5
14156,33632.0,Amitriptyline,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Amitriptyline']",0.5
14156,35565.0,Amitriptyline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Amitriptyline']",0.5
14156,35565.0,Amitriptyline,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,35641.0,Amitriptyline,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Amitriptyline']",0.5
14156,35641.0,Amitriptyline,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Amitriptyline']",0.5
14156,35764.0,Amitriptyline,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Amitriptyline']",0.5
14156,35764.0,Amitriptyline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Amitriptyline']",0.5
14156,35764.0,Amitriptyline,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,35833.0,Amitriptyline,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Amitriptyline']",0.5
14156,35915.0,Amitriptyline,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'HTR1B', 'Amitriptyline']",0.5
14156,35915.0,Amitriptyline,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Amitriptyline']",0.5
14156,36034.0,Amitriptyline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'NTRK1', 'Amitriptyline']",0.5
14156,36104.0,Amitriptyline,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Amitriptyline']",0.5
14156,36187.0,Amitriptyline,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Amitriptyline']",0.5
14156,36187.0,Amitriptyline,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,36229.0,Amitriptyline,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Amitriptyline']",0.5
14156,36693.0,Amitriptyline,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Amitriptyline']",0.5
14156,36693.0,Amitriptyline,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Amitriptyline']",0.5
14156,37180.0,Amitriptyline,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Amitriptyline']",0.5
14156,37180.0,Amitriptyline,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,37703.0,Amitriptyline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'HTR1B', 'Amitriptyline']",0.5
14156,37706.0,Amitriptyline,parkinsonian disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['parkinsonian disorder', 'Dust', 'immune response', 'OPRD1', 'Amitriptyline']",0.5
14156,37786.0,Amitriptyline,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Amitriptyline']",0.5
14156,37786.0,Amitriptyline,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Amitriptyline']",0.5
14156,38003.0,Amitriptyline,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'CYP2D6', 'Amitriptyline']",0.5
14156,38928.0,Amitriptyline,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Amitriptyline']",0.5
14156,83751.0,Amitriptyline,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Amitriptyline']",0.5
14156,83760.0,Amitriptyline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'HTR1B', 'Amitriptyline']",0.5
14156,83763.0,Amitriptyline,manic bipolar affective disorder,disease-protein-drug,contraindication,"['manic bipolar affective disorder', 'SLC6A4', 'Amitriptyline']",0.5
14156,83764.0,Amitriptyline,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Amitriptyline']",0.5
14156,83778.0,Amitriptyline,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'HTR1B', 'Amitriptyline']",0.5
14156,83778.0,Amitriptyline,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Amitriptyline']",0.5
14156,83779.0,Amitriptyline,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'HTR1B', 'Amitriptyline']",0.5
14156,83779.0,Amitriptyline,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Amitriptyline']",0.5
14156,83903.0,Amitriptyline,post-traumatic stress disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['post-traumatic stress disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Amitriptyline']",0.5
14156,83998.0,Amitriptyline,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'OPRM1', 'Amitriptyline']",0.5
14157,28158.0,Hydromorphone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'UGT2B7', 'Hydromorphone']",0.5
14157,29525.0,Hydromorphone,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Hydromorphone']",0.5
14157,30035.0,Hydromorphone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Hydromorphone']",0.5
14157,30813.0,Hydromorphone,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Hydromorphone']",0.5
14157,31072.0,Hydromorphone,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Hydromorphone']",0.5
14157,32384.0,Hydromorphone,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Hydromorphone']",0.5
14157,32719.0,Hydromorphone,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Hydromorphone']",0.5
14157,33605.0,Hydromorphone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Hydromorphone']",0.5
14157,33677.0,Hydromorphone,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Hydromorphone']",0.5
14157,35565.0,Hydromorphone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Hydromorphone']",0.5
14157,35565.0,Hydromorphone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Hydromorphone']",0.5
14157,35641.0,Hydromorphone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Hydromorphone']",0.5
14157,35764.0,Hydromorphone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Hydromorphone']",0.5
14157,35764.0,Hydromorphone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Hydromorphone']",0.5
14157,35764.0,Hydromorphone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Hydromorphone']",0.5
14157,35897.0,Hydromorphone,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Hydromorphone']",0.5
14157,36080.0,Hydromorphone,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Hydromorphone']",0.5
14157,36469.0,Hydromorphone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'UGT2B7', 'Hydromorphone']",0.5
14157,36492.0,Hydromorphone,brain cancer,disease-protein-drug,contraindication,"['brain cancer', 'CYP2C9', 'Hydromorphone']",0.5
14157,36492.0,Hydromorphone,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Hydromorphone']",0.5
14157,36492.0,Hydromorphone,brain cancer,disease-exposure-gene-drug,contraindication,"['brain cancer', 'Lead', 'ALB', 'Hydromorphone']",0.5
14157,36693.0,Hydromorphone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Hydromorphone']",0.5
14157,37785.0,Hydromorphone,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Hydromorphone']",0.5
14157,83910.0,Hydromorphone,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Hydromorphone']",0.5
14158,27366.0,Indomethacin,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Indomethacin']",0.5
14158,27626.0,Indomethacin,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'PTGDR2', 'Indomethacin']",0.5
14158,27626.0,Indomethacin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Indomethacin']",0.5
14158,27629.0,Indomethacin,Bartter disease,disease-phenotype-protein-drug,off-label use,"['Bartter disease', 'Fever', 'PTGS2', 'Indomethacin']",0.5
14158,27933.0,Indomethacin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Indomethacin']",0.5
14158,27933.0,Indomethacin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Indomethacin']",0.5
14158,27933.0,Indomethacin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PTGS2', 'Indomethacin']",0.5
14158,28158.0,Indomethacin,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Indomethacin']",0.5
14158,28158.0,Indomethacin,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'UGT2B7', 'Indomethacin']",0.5
14158,28158.0,Indomethacin,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Indomethacin']",0.5
14158,28419.0,Indomethacin,Liddle syndrome,disease-phenotype-protein-drug,off-label use,"['Liddle syndrome', 'Arrhythmia', 'PTGS2', 'Indomethacin']",0.5
14158,28547.0,Indomethacin,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Indomethacin']",0.5
14158,28547.0,Indomethacin,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Indomethacin']",0.5
14158,28547.0,Indomethacin,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,28547.0,Indomethacin,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Nausea', 'ABCB1', 'Indomethacin']",0.5
14158,28849.0,Indomethacin,colorectal cancer,disease-protein-drug,contraindication,"['colorectal cancer', 'ABCB1', 'Indomethacin']",0.5
14158,28861.0,Indomethacin,patent ductus arteriosus,disease-exposure-bioprocess-gene-drug,indication,"['patent ductus arteriosus', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Indomethacin']",0.5
14158,28861.0,Indomethacin,patent ductus arteriosus,disease-exposure-gene-drug,indication,"['patent ductus arteriosus', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,29273.0,Indomethacin,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'PPARG', 'Indomethacin']",0.5
14158,32446.0,Indomethacin,nephrogenic diabetes insipidus,disease-phenotype-protein-drug,off-label use,"['nephrogenic diabetes insipidus', 'Fever', 'PTGS2', 'Indomethacin']",0.5
14158,33306.0,Indomethacin,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Thrombocytopenia', 'ALB', 'Indomethacin']",0.5
14158,33577.0,Indomethacin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Indomethacin']",0.5
14158,33577.0,Indomethacin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,33609.0,Indomethacin,osteoarthritis,disease-protein-drug,indication,"['osteoarthritis', 'PPARG', 'Indomethacin']",0.5
14158,33675.0,Indomethacin,asthma,disease-protein-drug,contraindication,"['asthma', 'PTGDR2', 'Indomethacin']",0.5
14158,33675.0,Indomethacin,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Indomethacin']",0.5
14158,33675.0,Indomethacin,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,35565.0,Indomethacin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Indomethacin']",0.5
14158,35565.0,Indomethacin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Indomethacin']",0.5
14158,35641.0,Indomethacin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Indomethacin']",0.5
14158,35669.0,Indomethacin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Indomethacin']",0.5
14158,35669.0,Indomethacin,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,35761.0,Indomethacin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Indomethacin']",0.5
14158,35761.0,Indomethacin,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,35764.0,Indomethacin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Indomethacin']",0.5
14158,35764.0,Indomethacin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Indomethacin']",0.5
14158,35764.0,Indomethacin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Indomethacin']",0.5
14158,36209.0,Indomethacin,arthropathy,disease-protein-drug,indication,"['arthropathy', 'PPARG', 'Indomethacin']",0.5
14158,36223.0,Indomethacin,malignant colon neoplasm,disease-protein-drug,contraindication,"['malignant colon neoplasm', 'PTGS2', 'Indomethacin']",0.5
14158,36432.0,Indomethacin,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Indomethacin']",0.5
14158,36581.0,Indomethacin,colonic neoplasm,disease-protein-drug,contraindication,"['colonic neoplasm', 'PTGS2', 'Indomethacin']",0.5
14158,36581.0,Indomethacin,colonic neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['colonic neoplasm', 'Asbestos', 'inflammatory response', 'PTGS2', 'Indomethacin']",0.5
14158,37144.0,Indomethacin,squamous cell carcinoma of colon,disease-protein-drug,contraindication,"['squamous cell carcinoma of colon', 'PTGS2', 'Indomethacin']",0.5
14158,37180.0,Indomethacin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Indomethacin']",0.5
14158,37180.0,Indomethacin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,37564.0,Indomethacin,gastric ulcer (disease),disease-protein-drug,contraindication,"['gastric ulcer (disease)', 'PTGS1', 'Indomethacin']",0.5
14158,37659.0,Indomethacin,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Indomethacin']",0.5
14158,37659.0,Indomethacin,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Indomethacin']",0.5
14158,37659.0,Indomethacin,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,37703.0,Indomethacin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Indomethacin']",0.5
14158,37706.0,Indomethacin,parkinsonian disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['parkinsonian disorder', 'Dust', 'regulation of blood pressure', 'PTGS1', 'Indomethacin']",0.5
14158,37785.0,Indomethacin,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Indomethacin']",0.5
14158,37785.0,Indomethacin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'regulation of gene expression', 'SLC10A1', 'Indomethacin']",0.5
14158,39773.0,Indomethacin,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'PTGDR2', 'Indomethacin']",0.5
14158,83760.0,Indomethacin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Indomethacin']",0.5
14158,83781.0,Indomethacin,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'PTGDR2', 'Indomethacin']",0.5
14158,83942.0,Indomethacin,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Indomethacin']",0.5
14158,83942.0,Indomethacin,intracerebral hemorrhage,disease-exposure-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'PTGS1', 'Indomethacin']",0.5
14158,83961.0,Indomethacin,duodenal ulcer (disease),disease-protein-drug,contraindication,"['duodenal ulcer (disease)', 'PTGS2', 'Indomethacin']",0.5
14159,27655.0,Ipratropium,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'CHRM1', 'Ipratropium']",0.5
14159,29113.0,Ipratropium,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Ipratropium']",0.5
14159,29525.0,Ipratropium,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Ipratropium']",0.5
14159,33575.0,Ipratropium,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Ipratropium']",0.5
14159,33575.0,Ipratropium,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Ipratropium']",0.5
14159,33577.0,Ipratropium,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Ipratropium']",0.5
14159,33577.0,Ipratropium,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Ipratropium']",0.5
14159,33675.0,Ipratropium,asthma,disease-exposure-bioprocess-gene-drug,off-label use,"['asthma', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ipratropium']",0.5
14159,35641.0,Ipratropium,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Ipratropium']",0.5
14159,35897.0,Ipratropium,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'cognition', 'CHRM1', 'Ipratropium']",0.5
14159,36034.0,Ipratropium,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Ipratropium']",0.5
14159,36187.0,Ipratropium,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ipratropium']",0.5
14159,36187.0,Ipratropium,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Ipratropium']",0.5
14159,37617.0,Ipratropium,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,indication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ipratropium']",0.5
14159,37786.0,Ipratropium,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ipratropium']",0.5
14159,37786.0,Ipratropium,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Ipratropium']",0.5
14159,37830.0,Ipratropium,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ipratropium']",0.5
14159,37888.0,Ipratropium,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Ipratropium']",0.5
14159,37888.0,Ipratropium,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cognition', 'CHRM1', 'Ipratropium']",0.5
14159,37888.0,Ipratropium,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Ipratropium']",0.5
14159,83791.0,Ipratropium,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Ipratropium']",0.5
14160,27326.0,Methadone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Methadone']",0.5
14160,27326.0,Methadone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Methadone']",0.5
14160,27655.0,Methadone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'OPRM1', 'Methadone']",0.5
14160,28158.0,Methadone,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Methadone']",0.5
14160,28158.0,Methadone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Methadone']",0.5
14160,28158.0,Methadone,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Methadone']",0.5
14160,30035.0,Methadone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Methadone']",0.5
14160,31072.0,Methadone,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Methadone']",0.5
14160,31732.0,Methadone,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'CHRNA7', 'Methadone']",0.5
14160,32719.0,Methadone,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Hypothermia', 'CHRNB2', 'Methadone']",0.5
14160,33605.0,Methadone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Methadone']",0.5
14160,33675.0,Methadone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Methadone']",0.5
14160,33675.0,Methadone,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'bisphenol A', 'GRIN2B', 'Methadone']",0.5
14160,35565.0,Methadone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Methadone']",0.5
14160,35565.0,Methadone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Methadone']",0.5
14160,35641.0,Methadone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Methadone']",0.5
14160,35641.0,Methadone,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Methadone']",0.5
14160,35764.0,Methadone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Methadone']",0.5
14160,35764.0,Methadone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNB2', 'Methadone']",0.5
14160,35764.0,Methadone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Methadone']",0.5
14160,36080.0,Methadone,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Methadone']",0.5
14160,36080.0,Methadone,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Methadone']",0.5
14160,36469.0,Methadone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'GRIN2B', 'Methadone']",0.5
14160,36693.0,Methadone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Methadone']",0.5
14160,36693.0,Methadone,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Methadone']",0.5
14160,83751.0,Methadone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Methadone']",0.5
14161,27740.0,Olanzapine,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Olanzapine']",0.5
14161,27933.0,Olanzapine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Olanzapine']",0.5
14161,27933.0,Olanzapine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Olanzapine']",0.5
14161,27933.0,Olanzapine,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,28149.0,Olanzapine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Olanzapine']",0.5
14161,28249.0,Olanzapine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'DRD5', 'Olanzapine']",0.5
14161,28313.0,Olanzapine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Olanzapine']",0.5
14161,28313.0,Olanzapine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Olanzapine']",0.5
14161,28375.0,Olanzapine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Olanzapine']",0.5
14161,28396.0,Olanzapine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Olanzapine']",0.5
14161,28456.0,Olanzapine,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'HTR1B', 'Olanzapine']",0.5
14161,28651.0,Olanzapine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ADRB1', 'Olanzapine']",0.5
14161,28780.0,Olanzapine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Olanzapine']",0.5
14161,28780.0,Olanzapine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Olanzapine']",0.5
14161,28780.0,Olanzapine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,28780.0,Olanzapine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Olanzapine']",0.5
14161,29113.0,Olanzapine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Olanzapine']",0.5
14161,29113.0,Olanzapine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Olanzapine']",0.5
14161,29352.0,Olanzapine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Olanzapine']",0.5
14161,29494.0,Olanzapine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Olanzapine']",0.5
14161,29637.0,Olanzapine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Olanzapine']",0.5
14161,29637.0,Olanzapine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'HTR1B', 'Olanzapine']",0.5
14161,30184.0,Olanzapine,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Olanzapine']",0.5
14161,30879.0,Olanzapine,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'HTR1B', 'Olanzapine']",0.5
14161,31393.0,Olanzapine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Olanzapine']",0.5
14161,31393.0,Olanzapine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'inflammatory response', 'HRH1', 'Olanzapine']",0.5
14161,31393.0,Olanzapine,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,33091.0,Olanzapine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Tachycardia', 'DRD2', 'Olanzapine']",0.5
14161,33449.0,Olanzapine,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Olanzapine']",0.5
14161,33454.0,Olanzapine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Olanzapine']",0.5
14161,33575.0,Olanzapine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Olanzapine']",0.5
14161,33575.0,Olanzapine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Olanzapine']",0.5
14161,33575.0,Olanzapine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,33593.0,Olanzapine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ADRB1', 'Olanzapine']",0.5
14161,33593.0,Olanzapine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Organophosphorus Compounds', 'learning or memory', 'DRD3', 'Olanzapine']",0.5
14161,33593.0,Olanzapine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,33593.0,Olanzapine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Olanzapine']",0.5
14161,33598.0,Olanzapine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Olanzapine']",0.5
14161,33598.0,Olanzapine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'CHRM1', 'Olanzapine']",0.5
14161,33598.0,Olanzapine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,33605.0,Olanzapine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HTR1D', 'Olanzapine']",0.5
14161,33658.0,Olanzapine,hyperlipidemia,disease-protein-drug,contraindication,"['hyperlipidemia', 'ADRB3', 'Olanzapine']",0.5
14161,33695.0,Olanzapine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'regulation of heart rate', 'DRD2', 'Olanzapine']",0.5
14161,33695.0,Olanzapine,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,35565.0,Olanzapine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Olanzapine']",0.5
14161,35565.0,Olanzapine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,35641.0,Olanzapine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Olanzapine']",0.5
14161,35641.0,Olanzapine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Olanzapine']",0.5
14161,35909.0,Olanzapine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Olanzapine']",0.5
14161,36104.0,Olanzapine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Olanzapine']",0.5
14161,36187.0,Olanzapine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Olanzapine']",0.5
14161,36187.0,Olanzapine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Olanzapine']",0.5
14161,36187.0,Olanzapine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,36229.0,Olanzapine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Olanzapine']",0.5
14161,36312.0,Olanzapine,transient ischemic attack (disease),disease-protein-drug,contraindication,"['transient ischemic attack (disease)', 'ALB', 'Olanzapine']",0.5
14161,36312.0,Olanzapine,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Olanzapine']",0.5
14161,36432.0,Olanzapine,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRB1', 'Olanzapine']",0.5
14161,37180.0,Olanzapine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Olanzapine']",0.5
14161,37180.0,Olanzapine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,37565.0,Olanzapine,delirium,disease-protein-drug,contraindication,"['delirium', 'DRD3', 'Olanzapine']",0.5
14161,37659.0,Olanzapine,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ADRB1', 'Olanzapine']",0.5
14161,37659.0,Olanzapine,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Olanzapine']",0.5
14161,37659.0,Olanzapine,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,37747.0,Olanzapine,physiological sexual disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['physiological sexual disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Olanzapine']",0.5
14161,37764.0,Olanzapine,familial hyperlipidemia,disease-protein-drug,contraindication,"['familial hyperlipidemia', 'ADRB3', 'Olanzapine']",0.5
14161,37765.0,Olanzapine,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ADRA1A', 'Olanzapine']",0.5
14161,37786.0,Olanzapine,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB1', 'Olanzapine']",0.5
14161,37786.0,Olanzapine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Olanzapine']",0.5
14161,37786.0,Olanzapine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Olanzapine']",0.5
14161,38242.0,Olanzapine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'DRD5', 'Olanzapine']",0.5
14161,38242.0,Olanzapine,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Olanzapine']",0.5
14161,38928.0,Olanzapine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Olanzapine']",0.5
14161,38957.0,Olanzapine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'HTR1B', 'Olanzapine']",0.5
14161,38957.0,Olanzapine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Olanzapine']",0.5
14161,39081.0,Olanzapine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Olanzapine']",0.5
14161,39531.0,Olanzapine,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Olanzapine']",0.5
14161,83763.0,Olanzapine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'DRD5', 'Olanzapine']",0.5
14161,83764.0,Olanzapine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'learning or memory', 'DRD3', 'Olanzapine']",0.5
14161,83840.0,Olanzapine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Olanzapine']",0.5
14161,83841.0,Olanzapine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'HTR1B', 'Olanzapine']",0.5
14161,83842.0,Olanzapine,anorexia nervosa,disease-protein-drug,contraindication,"['anorexia nervosa', 'HTR2A', 'Olanzapine']",0.5
14161,83998.0,Olanzapine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Olanzapine']",0.5
14161,84023.0,Olanzapine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Olanzapine']",0.5
14162,27933.0,Atenolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Atenolol']",0.5
14162,27933.0,Atenolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Atenolol']",0.5
14162,27933.0,Atenolol,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Atenolol']",0.5
14162,28208.0,Atenolol,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Atenolol']",0.5
14162,28208.0,Atenolol,type 2 diabetes mellitus,disease-exposure-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Cadmium', 'ALB', 'Atenolol']",0.5
14162,28208.0,Atenolol,type 2 diabetes mellitus,disease-phenotype-protein-drug,contraindication,"['type 2 diabetes mellitus', 'Insulin resistance', 'ADRB2', 'Atenolol']",0.5
14162,28552.0,Atenolol,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Atenolol']",0.5
14162,29113.0,Atenolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Atenolol']",0.5
14162,31493.0,Atenolol,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Atenolol']",0.5
14162,33534.0,Atenolol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Atenolol']",0.5
14162,33575.0,Atenolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Atenolol']",0.5
14162,33575.0,Atenolol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Atenolol']",0.5
14162,33577.0,Atenolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Atenolol']",0.5
14162,33577.0,Atenolol,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Atenolol']",0.5
14162,33618.0,Atenolol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Atenolol']",0.5
14162,33675.0,Atenolol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Atenolol']",0.5
14162,33675.0,Atenolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Atenolol']",0.5
14162,33679.0,Atenolol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Atenolol']",0.5
14162,36034.0,Atenolol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,off-label use,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Atenolol']",0.5
14162,37180.0,Atenolol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,indication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Atenolol']",0.5
14162,37180.0,Atenolol,myocardial infarction (disease),disease-exposure-gene-drug,indication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Atenolol']",0.5
14162,37703.0,Atenolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Atenolol']",0.5
14162,39773.0,Atenolol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ADRB2', 'Atenolol']",0.5
14162,83760.0,Atenolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Atenolol']",0.5
14162,83781.0,Atenolol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ADRB2', 'Atenolol']",0.5
14162,83802.0,Atenolol,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Atenolol']",0.5
14163,27503.0,Diltiazem,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Syncope', 'CACNA1C', 'Diltiazem']",0.5
14163,28052.0,Diltiazem,hypertrophic cardiomyopathy,disease-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'CACNA1C', 'Diltiazem']",0.5
14163,28052.0,Diltiazem,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'ALB', 'Diltiazem']",0.5
14163,28231.0,Diltiazem,supravalvular aortic stenosis (disease),disease-phenotype-protein-drug,contraindication,"['supravalvular aortic stenosis (disease)', 'Arrhythmia', 'CACNA1C', 'Diltiazem']",0.5
14163,28441.0,Diltiazem,hereditary angioedema with C1Inh deficiency,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema with C1Inh deficiency', 'Vomiting', 'ABCB1', 'Diltiazem']",0.5
14163,29854.0,Diltiazem,hereditary angioedema,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Diltiazem']",0.5
14163,33025.0,Diltiazem,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'ALB', 'Diltiazem']",0.5
14163,33577.0,Diltiazem,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Diltiazem']",0.5
14163,33577.0,Diltiazem,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Diltiazem']",0.5
14163,33577.0,Diltiazem,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Diltiazem']",0.5
14163,33605.0,Diltiazem,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Diltiazem']",0.5
14163,33618.0,Diltiazem,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'CYP2C19', 'Diltiazem']",0.5
14163,33618.0,Diltiazem,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'platelet degranulation', 'ORM1', 'Diltiazem']",0.5
14163,35565.0,Diltiazem,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Diltiazem']",0.5
14163,35565.0,Diltiazem,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Diltiazem']",0.5
14163,35764.0,Diltiazem,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Diltiazem']",0.5
14163,35764.0,Diltiazem,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Diltiazem']",0.5
14163,35764.0,Diltiazem,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Diltiazem']",0.5
14163,35854.0,Diltiazem,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Diltiazem']",0.5
14163,36035.0,Diltiazem,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Diltiazem']",0.5
14163,36104.0,Diltiazem,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Diltiazem']",0.5
14163,36229.0,Diltiazem,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Diltiazem']",0.5
14164,27933.0,Alprazolam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Alprazolam']",0.5
14164,27933.0,Alprazolam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Alprazolam']",0.5
14164,27933.0,Alprazolam,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Alprazolam']",0.5
14164,30035.0,Alprazolam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Alprazolam']",0.5
14164,31618.0,Alprazolam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Alprazolam']",0.5
14164,32033.0,Alprazolam,insomnia (disease),disease-protein-drug,off-label use,"['insomnia (disease)', 'GABRB3', 'Alprazolam']",0.5
14164,33593.0,Alprazolam,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'inflammatory response', 'ORM1', 'Alprazolam']",0.5
14164,33593.0,Alprazolam,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Alprazolam']",0.5
14164,35565.0,Alprazolam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Alprazolam']",0.5
14164,35565.0,Alprazolam,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Alprazolam']",0.5
14164,35764.0,Alprazolam,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Alprazolam']",0.5
14164,35764.0,Alprazolam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Alprazolam']",0.5
14164,35764.0,Alprazolam,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Alprazolam']",0.5
14164,37703.0,Alprazolam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Alprazolam']",0.5
14164,83760.0,Alprazolam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Alprazolam']",0.5
14165,27292.0,Rosiglitazone,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'CYP1A2', 'Rosiglitazone']",0.5
14165,29614.0,Rosiglitazone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'PPARD', 'Rosiglitazone']",0.5
14165,29614.0,Rosiglitazone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Rosiglitazone']",0.5
14165,30035.0,Rosiglitazone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2D6', 'Rosiglitazone']",0.5
14165,32905.0,Rosiglitazone,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Bradycardia', 'CYP2D6', 'Rosiglitazone']",0.5
14165,33453.0,Rosiglitazone,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Tremor', 'CYP2D6', 'Rosiglitazone']",0.5
14165,33598.0,Rosiglitazone,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Rosiglitazone']",0.5
14165,33598.0,Rosiglitazone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'PPARD', 'Rosiglitazone']",0.5
14165,33598.0,Rosiglitazone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS1', 'Rosiglitazone']",0.5
14165,35565.0,Rosiglitazone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Rosiglitazone']",0.5
14165,35565.0,Rosiglitazone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Rosiglitazone']",0.5
14165,35764.0,Rosiglitazone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Rosiglitazone']",0.5
14165,35764.0,Rosiglitazone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Rosiglitazone']",0.5
14165,35764.0,Rosiglitazone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PPARG', 'Rosiglitazone']",0.5
14165,35909.0,Rosiglitazone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Rosiglitazone']",0.5
14165,35909.0,Rosiglitazone,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Rosiglitazone']",0.5
14165,36187.0,Rosiglitazone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'RXRG', 'Rosiglitazone']",0.5
14165,36187.0,Rosiglitazone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARD', 'Rosiglitazone']",0.5
14165,36187.0,Rosiglitazone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Rosiglitazone']",0.5
14165,36544.0,Rosiglitazone,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP2A6', 'Rosiglitazone']",0.5
14165,36544.0,Rosiglitazone,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Rosiglitazone']",0.5
14165,37180.0,Rosiglitazone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARD', 'Rosiglitazone']",0.5
14165,37180.0,Rosiglitazone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Rosiglitazone']",0.5
14165,37786.0,Rosiglitazone,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'RXRG', 'Rosiglitazone']",0.5
14165,37786.0,Rosiglitazone,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARD', 'Rosiglitazone']",0.5
14165,37786.0,Rosiglitazone,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'PTGS1', 'Rosiglitazone']",0.5
14165,83885.0,Rosiglitazone,hypoglycemia,disease-protein-drug,contraindication,"['hypoglycemia', 'PPARA', 'Rosiglitazone']",0.5
14166,28208.0,Acetohexamide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Acetohexamide']",0.5
14166,28208.0,Acetohexamide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Cadmium', 'ALB', 'Acetohexamide']",0.5
14166,33575.0,Acetohexamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Acetohexamide']",0.5
14166,33575.0,Acetohexamide,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Acetohexamide']",0.5
14167,32999.0,Ampicillin,shigellosis,disease-phenotype-protein-drug,indication,"['shigellosis', 'Thrombocytopenia', 'ALB', 'Ampicillin']",0.5
14167,33193.0,Ampicillin,plague,disease-phenotype-protein-drug,off-label use,"['plague', 'Hepatomegaly', 'ALB', 'Ampicillin']",0.5
14167,33306.0,Ampicillin,necrotizing enterocolitis,disease-phenotype-protein-drug,off-label use,"['necrotizing enterocolitis', 'Thrombocytopenia', 'ALB', 'Ampicillin']",0.5
14167,33474.0,Ampicillin,typhoid fever,disease-phenotype-protein-drug,indication,"['typhoid fever', 'Hepatomegaly', 'ALB', 'Ampicillin']",0.5
14167,33594.0,Ampicillin,diarrheal disease,disease-exposure-bioprocess-gene-drug,indication,"['diarrheal disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Ampicillin']",0.5
14167,35764.0,Ampicillin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Ampicillin']",0.5
14167,35764.0,Ampicillin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'SLC16A1', 'Ampicillin']",0.5
14167,35764.0,Ampicillin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Ampicillin']",0.5
14167,83845.0,Ampicillin,viral meningitis,disease-protein-drug,indication,"['viral meningitis', 'ALB', 'Ampicillin']",0.5
14168,27629.0,Spironolactone,Bartter disease,disease-protein-drug,indication,"['Bartter disease', 'CYP11B1', 'Spironolactone']",0.5
14168,27629.0,Spironolactone,Bartter disease,disease-phenotype-protein-drug,indication,"['Bartter disease', 'Seizure', 'ABCC2', 'Spironolactone']",0.5
14168,29113.0,Spironolactone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Spironolactone']",0.5
14168,29182.0,Spironolactone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'CYP11B1', 'Spironolactone']",0.5
14168,29182.0,Spironolactone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Spironolactone']",0.5
14168,30756.0,Spironolactone,polycystic ovary syndrome,disease-protein-drug,off-label use,"['polycystic ovary syndrome', 'SRD5A1', 'Spironolactone']",0.5
14168,30756.0,Spironolactone,polycystic ovary syndrome,disease-phenotype-protein-drug,off-label use,"['polycystic ovary syndrome', 'Oligomenorrhea', 'CYP17A1', 'Spironolactone']",0.5
14168,33534.0,Spironolactone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Spironolactone']",0.5
14168,33575.0,Spironolactone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Spironolactone']",0.5
14168,33575.0,Spironolactone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Spironolactone']",0.5
14168,33575.0,Spironolactone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'CACNA2D1', 'Spironolactone']",0.5
14168,33575.0,Spironolactone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Spironolactone']",0.5
14168,33577.0,Spironolactone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Spironolactone']",0.5
14168,33577.0,Spironolactone,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'CACNA2D1', 'Spironolactone']",0.5
14168,35764.0,Spironolactone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Spironolactone']",0.5
14168,35764.0,Spironolactone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Spironolactone']",0.5
14168,35764.0,Spironolactone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Spironolactone']",0.5
14168,36432.0,Spironolactone,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'NR3C2', 'Spironolactone']",0.5
14168,39275.0,Spironolactone,primary aldosteronism,disease-protein-drug,indication,"['primary aldosteronism', 'CYP11B1', 'Spironolactone']",0.5
14168,39276.0,Spironolactone,hyperaldosteronism,disease-protein-drug,indication,"['hyperaldosteronism', 'CYP11B1', 'Spironolactone']",0.5
14168,83802.0,Spironolactone,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Spironolactone']",0.5
14168,84246.0,Spironolactone,Waterhouse-Friderichsen syndrome,disease-protein-drug,indication,"['Waterhouse-Friderichsen syndrome', 'CYP11B1', 'Spironolactone']",0.5
14170,28849.0,Trifluridine,colorectal cancer,disease-protein-drug,indication,"['colorectal cancer', 'TYMP', 'Trifluridine']",0.5
14170,36223.0,Trifluridine,malignant colon neoplasm,disease-protein-drug,indication,"['malignant colon neoplasm', 'TYMP', 'Trifluridine']",0.5
14170,36581.0,Trifluridine,colonic neoplasm,disease-protein-drug,indication,"['colonic neoplasm', 'TYMP', 'Trifluridine']",0.5
14170,37144.0,Trifluridine,squamous cell carcinoma of colon,disease-protein-drug,indication,"['squamous cell carcinoma of colon', 'TYMP', 'Trifluridine']",0.5
14171,27476.0,Meperidine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cognition', 'CHRM1', 'Meperidine']",0.5
14171,27648.0,Meperidine,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Meperidine']",0.5
14171,28921.0,Meperidine,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Hepatomegaly', 'ALB', 'Meperidine']",0.5
14171,29352.0,Meperidine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Meperidine']",0.5
14171,30035.0,Meperidine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Meperidine']",0.5
14171,30184.0,Meperidine,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Meperidine']",0.5
14171,30374.0,Meperidine,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'CYP1A2', 'Meperidine']",0.5
14171,30664.0,Meperidine,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,contraindication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'GRIN2D', 'Meperidine']",0.5
14171,30813.0,Meperidine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Meperidine']",0.5
14171,31122.0,Meperidine,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'ALB', 'Meperidine']",0.5
14171,31618.0,Meperidine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Respiratory insufficiency', 'OPRM1', 'Meperidine']",0.5
14171,31732.0,Meperidine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'SLC6A3', 'Meperidine']",0.5
14171,32313.0,Meperidine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'OPRM1', 'Meperidine']",0.5
14171,32384.0,Meperidine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Meperidine']",0.5
14171,32584.0,Meperidine,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Meperidine']",0.5
14171,32719.0,Meperidine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Meperidine']",0.5
14171,33454.0,Meperidine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Meperidine']",0.5
14171,33605.0,Meperidine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Meperidine']",0.5
14171,33675.0,Meperidine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Meperidine']",0.5
14171,33675.0,Meperidine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'bisphenol A', 'GRIN2B', 'Meperidine']",0.5
14171,35565.0,Meperidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Meperidine']",0.5
14171,35565.0,Meperidine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Meperidine']",0.5
14171,35641.0,Meperidine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Meperidine']",0.5
14171,35641.0,Meperidine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Meperidine']",0.5
14171,35669.0,Meperidine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Meperidine']",0.5
14171,35669.0,Meperidine,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'GRIN2B', 'Meperidine']",0.5
14171,35761.0,Meperidine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'ORM1', 'Meperidine']",0.5
14171,35761.0,Meperidine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'GRIN2B', 'Meperidine']",0.5
14171,36080.0,Meperidine,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Meperidine']",0.5
14171,36080.0,Meperidine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Meperidine']",0.5
14171,36104.0,Meperidine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Meperidine']",0.5
14171,36229.0,Meperidine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Meperidine']",0.5
14171,36274.0,Meperidine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Meperidine']",0.5
14171,36274.0,Meperidine,pyloric stenosis (disease),disease-exposure-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'ALB', 'Meperidine']",0.5
14171,36469.0,Meperidine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'GRIN2B', 'Meperidine']",0.5
14171,36478.0,Meperidine,nervous system disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['nervous system disorder', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP3A4', 'Meperidine']",0.5
14171,36693.0,Meperidine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Meperidine']",0.5
14171,36693.0,Meperidine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Meperidine']",0.5
14171,37617.0,Meperidine,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A2', 'Meperidine']",0.5
14171,37617.0,Meperidine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Meperidine']",0.5
14171,38003.0,Meperidine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'CYP2D6', 'Meperidine']",0.5
14171,39531.0,Meperidine,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Meperidine']",0.5
14171,83910.0,Meperidine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Meperidine']",0.5
14172,35552.0,Cefalotin,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'innate immune response', 'SLC15A2', 'Cefalotin']",0.5
14173,27626.0,Imipramine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Imipramine']",0.5
14173,27921.0,Imipramine,attention deficit-hyperactivity disorder,disease-protein-drug,off-label use,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Imipramine']",0.5
14173,27933.0,Imipramine,anxiety disorder,disease-protein-drug,off-label use,"['anxiety disorder', 'ABCB1', 'Imipramine']",0.5
14173,27933.0,Imipramine,anxiety disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR7', 'Imipramine']",0.5
14173,27933.0,Imipramine,anxiety disorder,disease-exposure-gene-drug,off-label use,"['anxiety disorder', 'Cadmium', 'ALB', 'Imipramine']",0.5
14173,28249.0,Imipramine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'DRD5', 'Imipramine']",0.5
14173,28313.0,Imipramine,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'CYP2E1', 'Imipramine']",0.5
14173,28313.0,Imipramine,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'social behavior', 'SLC6A4', 'Imipramine']",0.5
14173,28391.0,Imipramine,narcolepsy,disease-exposure-bioprocess-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Imipramine']",0.5
14173,28391.0,Imipramine,narcolepsy,disease-exposure-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'CYP2E1', 'Imipramine']",0.5
14173,29525.0,Imipramine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'KCND3', 'Imipramine']",0.5
14173,30035.0,Imipramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Imipramine']",0.5
14173,30664.0,Imipramine,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,off-label use,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'ADRA1B', 'Imipramine']",0.5
14173,33598.0,Imipramine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Imipramine']",0.5
14173,33598.0,Imipramine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Imipramine']",0.5
14173,33598.0,Imipramine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Imipramine']",0.5
14173,35565.0,Imipramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Imipramine']",0.5
14173,35565.0,Imipramine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Imipramine']",0.5
14173,35641.0,Imipramine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'KCNH1', 'Imipramine']",0.5
14173,35641.0,Imipramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Imipramine']",0.5
14173,35669.0,Imipramine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Imipramine']",0.5
14173,35669.0,Imipramine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Imipramine']",0.5
14173,35761.0,Imipramine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Imipramine']",0.5
14173,35761.0,Imipramine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Imipramine']",0.5
14173,35764.0,Imipramine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Imipramine']",0.5
14173,35764.0,Imipramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'DRD2', 'Imipramine']",0.5
14173,35764.0,Imipramine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Imipramine']",0.5
14173,35909.0,Imipramine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Imipramine']",0.5
14173,36034.0,Imipramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Imipramine']",0.5
14173,36104.0,Imipramine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Imipramine']",0.5
14173,36187.0,Imipramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Imipramine']",0.5
14173,36187.0,Imipramine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Imipramine']",0.5
14173,36229.0,Imipramine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Imipramine']",0.5
14173,37703.0,Imipramine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A4', 'Imipramine']",0.5
14173,38242.0,Imipramine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'DRD5', 'Imipramine']",0.5
14173,38242.0,Imipramine,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Imipramine']",0.5
14173,83760.0,Imipramine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Imipramine']",0.5
14173,84019.0,Imipramine,anxiety,disease-protein-drug,off-label use,"['anxiety', 'SLC6A4', 'Imipramine']",0.5
14173,84036.0,Imipramine,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'SLC6A3', 'Imipramine']",0.5
14173,84036.0,Imipramine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'inflammatory response', 'HRH1', 'Imipramine']",0.5
14173,84036.0,Imipramine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Cadmium', 'ALB', 'Imipramine']",0.5
14174,27933.0,Acitretin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Acitretin']",0.5
14174,27933.0,Acitretin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'RXRA', 'Acitretin']",0.5
14174,27933.0,Acitretin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Acitretin']",0.5
14174,31072.0,Acitretin,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Acitretin']",0.5
14174,31493.0,Acitretin,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Acitretin']",0.5
14174,33575.0,Acitretin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'RARA', 'Acitretin']",0.5
14174,33575.0,Acitretin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Acitretin']",0.5
14174,33593.0,Acitretin,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'female pregnancy', 'RARA', 'Acitretin']",0.5
14174,33593.0,Acitretin,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Acitretin']",0.5
14174,33695.0,Acitretin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'RXRA', 'Acitretin']",0.5
14174,33695.0,Acitretin,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Acitretin']",0.5
14174,36544.0,Acitretin,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ALB', 'Acitretin']",0.5
14174,36544.0,Acitretin,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'RXRA', 'Acitretin']",0.5
14174,37703.0,Acitretin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Acitretin']",0.5
14174,83760.0,Acitretin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Acitretin']",0.5
14175,27366.0,Nabumetone,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Nabumetone']",0.5
14175,29078.0,Nabumetone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'MPO', 'Nabumetone']",0.5
14175,29078.0,Nabumetone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Nabumetone']",0.5
14175,29078.0,Nabumetone,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Nabumetone']",0.5
14175,29078.0,Nabumetone,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Nabumetone']",0.5
14175,29273.0,Nabumetone,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'AKR1C2', 'Nabumetone']",0.5
14175,30035.0,Nabumetone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PTGS2', 'Nabumetone']",0.5
14175,32325.0,Nabumetone,juvenile idiopathic arthritis,disease-phenotype-protein-drug,off-label use,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Nabumetone']",0.5
14175,33577.0,Nabumetone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'AKR1C1', 'Nabumetone']",0.5
14175,33577.0,Nabumetone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Nabumetone']",0.5
14175,33609.0,Nabumetone,osteoarthritis,disease-protein-drug,indication,"['osteoarthritis', 'AKR1C2', 'Nabumetone']",0.5
14175,35565.0,Nabumetone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Nabumetone']",0.5
14175,35565.0,Nabumetone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Nabumetone']",0.5
14175,35669.0,Nabumetone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Nabumetone']",0.5
14175,35669.0,Nabumetone,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Nabumetone']",0.5
14175,35761.0,Nabumetone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'MPO', 'Nabumetone']",0.5
14175,35761.0,Nabumetone,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Nabumetone']",0.5
14175,35764.0,Nabumetone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Nabumetone']",0.5
14175,35764.0,Nabumetone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'AKR1C1', 'Nabumetone']",0.5
14175,35764.0,Nabumetone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Nabumetone']",0.5
14175,36209.0,Nabumetone,arthropathy,disease-protein-drug,indication,"['arthropathy', 'AKR1C2', 'Nabumetone']",0.5
14175,37180.0,Nabumetone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Nabumetone']",0.5
14175,37180.0,Nabumetone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Nabumetone']",0.5
14176,27933.0,Fluoxetine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Fluoxetine']",0.5
14176,27933.0,Fluoxetine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Fluoxetine']",0.5
14176,27933.0,Fluoxetine,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,28149.0,Fluoxetine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Fluoxetine']",0.5
14176,28249.0,Fluoxetine,major affective disorder,disease-protein-drug,off-label use,"['major affective disorder', 'CHRNA2', 'Fluoxetine']",0.5
14176,28391.0,Fluoxetine,narcolepsy,disease-exposure-bioprocess-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Fluoxetine']",0.5
14176,28396.0,Fluoxetine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Fluoxetine']",0.5
14176,28456.0,Fluoxetine,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'CHRNB4', 'Fluoxetine']",0.5
14176,28651.0,Fluoxetine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2C', 'Fluoxetine']",0.5
14176,28780.0,Fluoxetine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Fluoxetine']",0.5
14176,28780.0,Fluoxetine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Fluoxetine']",0.5
14176,28780.0,Fluoxetine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,28780.0,Fluoxetine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'CHRNB4', 'Fluoxetine']",0.5
14176,28899.0,Fluoxetine,obsessive-compulsive disorder,disease-protein-drug,indication,"['obsessive-compulsive disorder', 'SLC6A4', 'Fluoxetine']",0.5
14176,28899.0,Fluoxetine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,indication,"['obsessive-compulsive disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Fluoxetine']",0.5
14176,29352.0,Fluoxetine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Fluoxetine']",0.5
14176,29494.0,Fluoxetine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Fluoxetine']",0.5
14176,29525.0,Fluoxetine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'KCNH2', 'Fluoxetine']",0.5
14176,29637.0,Fluoxetine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'CHRNB4', 'Fluoxetine']",0.5
14176,30184.0,Fluoxetine,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Fluoxetine']",0.5
14176,30879.0,Fluoxetine,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'CHRNB4', 'Fluoxetine']",0.5
14176,31393.0,Fluoxetine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Fluoxetine']",0.5
14176,31393.0,Fluoxetine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'inflammatory response', 'ORM1', 'Fluoxetine']",0.5
14176,31393.0,Fluoxetine,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,33091.0,Fluoxetine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Nausea', 'ABCB1', 'Fluoxetine']",0.5
14176,33454.0,Fluoxetine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Fluoxetine']",0.5
14176,33575.0,Fluoxetine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Fluoxetine']",0.5
14176,33575.0,Fluoxetine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Fluoxetine']",0.5
14176,33575.0,Fluoxetine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,33593.0,Fluoxetine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2C', 'Fluoxetine']",0.5
14176,33593.0,Fluoxetine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Organophosphorus Compounds', 'social behavior', 'SLC6A4', 'Fluoxetine']",0.5
14176,33593.0,Fluoxetine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,33593.0,Fluoxetine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Fluoxetine']",0.5
14176,33598.0,Fluoxetine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Fluoxetine']",0.5
14176,33598.0,Fluoxetine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Fluoxetine']",0.5
14176,33598.0,Fluoxetine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,33605.0,Fluoxetine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Fluoxetine']",0.5
14176,33695.0,Fluoxetine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'memory', 'SLC6A4', 'Fluoxetine']",0.5
14176,33695.0,Fluoxetine,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,35565.0,Fluoxetine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Fluoxetine']",0.5
14176,35565.0,Fluoxetine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,35641.0,Fluoxetine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CHRNB4', 'Fluoxetine']",0.5
14176,35909.0,Fluoxetine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Fluoxetine']",0.5
14176,36104.0,Fluoxetine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Fluoxetine']",0.5
14176,36187.0,Fluoxetine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fluoxetine']",0.5
14176,36187.0,Fluoxetine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,36229.0,Fluoxetine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Fluoxetine']",0.5
14176,36312.0,Fluoxetine,transient ischemic attack (disease),disease-protein-drug,contraindication,"['transient ischemic attack (disease)', 'ALB', 'Fluoxetine']",0.5
14176,36312.0,Fluoxetine,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Fluoxetine']",0.5
14176,36432.0,Fluoxetine,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Fluoxetine']",0.5
14176,37180.0,Fluoxetine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fluoxetine']",0.5
14176,37180.0,Fluoxetine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,37659.0,Fluoxetine,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Fluoxetine']",0.5
14176,37659.0,Fluoxetine,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fluoxetine']",0.5
14176,37659.0,Fluoxetine,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,37703.0,Fluoxetine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A4', 'Fluoxetine']",0.5
14176,37747.0,Fluoxetine,physiological sexual disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['physiological sexual disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Fluoxetine']",0.5
14176,37765.0,Fluoxetine,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Fluoxetine']",0.5
14176,37786.0,Fluoxetine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fluoxetine']",0.5
14176,37786.0,Fluoxetine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Fluoxetine']",0.5
14176,38242.0,Fluoxetine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'CHRNA2', 'Fluoxetine']",0.5
14176,38928.0,Fluoxetine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Fluoxetine']",0.5
14176,38957.0,Fluoxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Fluoxetine']",0.5
14176,38957.0,Fluoxetine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Fluoxetine']",0.5
14176,39531.0,Fluoxetine,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Fluoxetine']",0.5
14176,83760.0,Fluoxetine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Fluoxetine']",0.5
14176,83764.0,Fluoxetine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'social behavior', 'SLC6A4', 'Fluoxetine']",0.5
14176,83840.0,Fluoxetine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Fluoxetine']",0.5
14176,83841.0,Fluoxetine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Fluoxetine']",0.5
14176,84226.0,Fluoxetine,postpartum depression,disease-protein-drug,off-label use,"['postpartum depression', 'SLC6A4', 'Fluoxetine']",0.5
14177,27933.0,Duloxetine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Duloxetine']",0.5
14177,27933.0,Duloxetine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Duloxetine']",0.5
14177,27933.0,Duloxetine,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Cadmium', 'ALB', 'Duloxetine']",0.5
14177,28149.0,Duloxetine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Duloxetine']",0.5
14177,28249.0,Duloxetine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Duloxetine']",0.5
14177,30035.0,Duloxetine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Duloxetine']",0.5
14177,31524.0,Duloxetine,postural orthostatic tachycardia syndrome,disease-protein-drug,contraindication,"['postural orthostatic tachycardia syndrome', 'SLC6A2', 'Duloxetine']",0.5
14177,33091.0,Duloxetine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Nausea', 'ABCB1', 'Duloxetine']",0.5
14177,33454.0,Duloxetine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Duloxetine']",0.5
14177,33577.0,Duloxetine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Duloxetine']",0.5
14177,33577.0,Duloxetine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Duloxetine']",0.5
14177,35565.0,Duloxetine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Duloxetine']",0.5
14177,35565.0,Duloxetine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Duloxetine']",0.5
14177,35641.0,Duloxetine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Duloxetine']",0.5
14177,36241.0,Duloxetine,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Duloxetine']",0.5
14177,36242.0,Duloxetine,fatty liver disease,disease-protein-drug,contraindication,"['fatty liver disease', 'CYP1A2', 'Duloxetine']",0.5
14177,36242.0,Duloxetine,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'SLC6A3', 'Duloxetine']",0.5
14177,36242.0,Duloxetine,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Cadmium', 'ALB', 'Duloxetine']",0.5
14177,37765.0,Duloxetine,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Duloxetine']",0.5
14177,38242.0,Duloxetine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Duloxetine']",0.5
14177,38957.0,Duloxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Duloxetine']",0.5
14177,38957.0,Duloxetine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Duloxetine']",0.5
14177,83764.0,Duloxetine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'social behavior', 'SLC6A4', 'Duloxetine']",0.5
14177,83840.0,Duloxetine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Duloxetine']",0.5
14177,83841.0,Duloxetine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Duloxetine']",0.5
14178,27326.0,Chlorpromazine,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CALM1', 'Chlorpromazine']",0.5
14178,27326.0,Chlorpromazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Chlorpromazine']",0.5
14178,27326.0,Chlorpromazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Chlorpromazine']",0.5
14178,27326.0,Chlorpromazine,long QT syndrome,disease-exposure-molfunc-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Chlorpromazine']",0.5
14178,27626.0,Chlorpromazine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Chlorpromazine']",0.5
14178,27655.0,Chlorpromazine,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Chlorpromazine']",0.5
14178,27655.0,Chlorpromazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Chlorpromazine']",0.5
14178,27843.0,Chlorpromazine,acute intermittent porphyria,disease-phenotype-protein-drug,indication,"['acute intermittent porphyria', 'Tachycardia', 'DRD2', 'Chlorpromazine']",0.5
14178,28313.0,Chlorpromazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'CYP2E1', 'Chlorpromazine']",0.5
14178,28313.0,Chlorpromazine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Chlorpromazine']",0.5
14178,28375.0,Chlorpromazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Chlorpromazine']",0.5
14178,28396.0,Chlorpromazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Chlorpromazine']",0.5
14178,28547.0,Chlorpromazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'CYP2E1', 'Chlorpromazine']",0.5
14178,28547.0,Chlorpromazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Chlorpromazine']",0.5
14178,28547.0,Chlorpromazine,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Chlorpyrifos', 'BCHE', 'Chlorpromazine']",0.5
14178,28547.0,Chlorpromazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Chlorpromazine']",0.5
14178,28547.0,Chlorpromazine,Parkinson disease,disease-exposure-molfunc-gene-drug,contraindication,"['Parkinson disease', 'Organophosphates', 'cholinesterase activity', 'BCHE', 'Chlorpromazine']",0.5
14178,28651.0,Chlorpromazine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'CYP2E1', 'Chlorpromazine']",0.5
14178,28780.0,Chlorpromazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CALM1', 'Chlorpromazine']",0.5
14178,28780.0,Chlorpromazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Chlorpromazine']",0.5
14178,28780.0,Chlorpromazine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP2E1', 'Chlorpromazine']",0.5
14178,28780.0,Chlorpromazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Chlorpromazine']",0.5
14178,28780.0,Chlorpromazine,Alzheimer disease,disease-exposure-molfunc-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Chlorpromazine']",0.5
14178,29525.0,Chlorpromazine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'KCNH2', 'Chlorpromazine']",0.5
14178,29637.0,Chlorpromazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Chlorpromazine']",0.5
14178,29637.0,Chlorpromazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD1', 'Chlorpromazine']",0.5
14178,30035.0,Chlorpromazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Chlorpromazine']",0.5
14178,30324.0,Chlorpromazine,blepharospasm,disease-protein-drug,contraindication,"['blepharospasm', 'DRD5', 'Chlorpromazine']",0.5
14178,31393.0,Chlorpromazine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Chlorpromazine']",0.5
14178,31393.0,Chlorpromazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Chlorpromazine']",0.5
14178,31393.0,Chlorpromazine,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Chlorpromazine']",0.5
14178,31393.0,Chlorpromazine,metabolic syndrome X,disease-exposure-molfunc-gene-drug,contraindication,"['metabolic syndrome X', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Chlorpromazine']",0.5
14178,33454.0,Chlorpromazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Chlorpromazine']",0.5
14178,33593.0,Chlorpromazine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'CYP2E1', 'Chlorpromazine']",0.5
14178,33593.0,Chlorpromazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Chlorpromazine']",0.5
14178,33593.0,Chlorpromazine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Chlorpromazine']",0.5
14178,33593.0,Chlorpromazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CALM1', 'Chlorpromazine']",0.5
14178,33593.0,Chlorpromazine,obesity disorder,disease-exposure-molfunc-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'acetylcholinesterase activity', 'BCHE', 'Chlorpromazine']",0.5
14178,33632.0,Chlorpromazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'choline metabolic process', 'BCHE', 'Chlorpromazine']",0.5
14178,33632.0,Chlorpromazine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Chlorpromazine']",0.5
14178,35565.0,Chlorpromazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Chlorpromazine']",0.5
14178,35565.0,Chlorpromazine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Chlorpromazine']",0.5
14178,35641.0,Chlorpromazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Chlorpromazine']",0.5
14178,35641.0,Chlorpromazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Chlorpromazine']",0.5
14178,35915.0,Chlorpromazine,mental disorder,disease-protein-drug,indication,"['mental disorder', 'DRD5', 'Chlorpromazine']",0.5
14178,35915.0,Chlorpromazine,mental disorder,disease-exposure-bioprocess-gene-drug,indication,"['mental disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Chlorpromazine']",0.5
14178,36104.0,Chlorpromazine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Chlorpromazine']",0.5
14178,36187.0,Chlorpromazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Chlorpromazine']",0.5
14178,36187.0,Chlorpromazine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Chlorpromazine']",0.5
14178,36187.0,Chlorpromazine,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Chlorpromazine']",0.5
14178,36229.0,Chlorpromazine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Chlorpromazine']",0.5
14178,37180.0,Chlorpromazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Chlorpromazine']",0.5
14178,37180.0,Chlorpromazine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Chlorpromazine']",0.5
14178,37180.0,Chlorpromazine,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Chlorpromazine']",0.5
14178,37706.0,Chlorpromazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Chlorpromazine']",0.5
14178,37786.0,Chlorpromazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Chlorpromazine']",0.5
14178,37786.0,Chlorpromazine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Chlorpromazine']",0.5
14178,37786.0,Chlorpromazine,myocardial ischemia,disease-exposure-molfunc-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Chlorpromazine']",0.5
14178,38003.0,Chlorpromazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD3', 'Chlorpromazine']",0.5
14178,38928.0,Chlorpromazine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Chlorpromazine']",0.5
14178,39081.0,Chlorpromazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Chlorpromazine']",0.5
14178,83751.0,Chlorpromazine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Chlorpromazine']",0.5
14178,83752.0,Chlorpromazine,focal hand dystonia,disease-protein-drug,contraindication,"['focal hand dystonia', 'DRD5', 'Chlorpromazine']",0.5
14178,83763.0,Chlorpromazine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'DRD5', 'Chlorpromazine']",0.5
14178,83764.0,Chlorpromazine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Chlorpromazine']",0.5
14178,83778.0,Chlorpromazine,schizophreniform disorder,disease-protein-drug,indication,"['schizophreniform disorder', 'DRD5', 'Chlorpromazine']",0.5
14178,83778.0,Chlorpromazine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Chlorpromazine']",0.5
14178,83779.0,Chlorpromazine,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'DRD5', 'Chlorpromazine']",0.5
14178,83779.0,Chlorpromazine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Chlorpromazine']",0.5
14178,83998.0,Chlorpromazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Chlorpromazine']",0.5
14178,84023.0,Chlorpromazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Chlorpromazine']",0.5
14179,33577.0,Raloxifene,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Raloxifene']",0.5
14179,33577.0,Raloxifene,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Raloxifene']",0.5
14179,33598.0,Raloxifene,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Raloxifene']",0.5
14179,33598.0,Raloxifene,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Raloxifene']",0.5
14179,33598.0,Raloxifene,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Raloxifene']",0.5
14179,33695.0,Raloxifene,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Raloxifene']",0.5
14179,33695.0,Raloxifene,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Raloxifene']",0.5
14179,33699.0,Raloxifene,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Raloxifene']",0.5
14179,35565.0,Raloxifene,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'SERPINB9', 'Raloxifene']",0.5
14179,35565.0,Raloxifene,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Raloxifene']",0.5
14179,35909.0,Raloxifene,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Raloxifene']",0.5
14179,36187.0,Raloxifene,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR2', 'Raloxifene']",0.5
14179,36187.0,Raloxifene,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Raloxifene']",0.5
14179,36187.0,Raloxifene,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Raloxifene']",0.5
14179,36312.0,Raloxifene,transient ischemic attack (disease),disease-protein-drug,contraindication,"['transient ischemic attack (disease)', 'ALB', 'Raloxifene']",0.5
14179,36312.0,Raloxifene,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Raloxifene']",0.5
14179,83776.0,Raloxifene,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'CYP19A1', 'Raloxifene']",0.5
14180,27933.0,Buspirone,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Buspirone']",0.5
14180,27933.0,Buspirone,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'DRD2', 'Buspirone']",0.5
14180,27933.0,Buspirone,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Cadmium', 'ALB', 'Buspirone']",0.5
14180,39531.0,Buspirone,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Buspirone']",0.5
14181,28651.0,Zidovudine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A2', 'Zidovudine']",0.5
14181,31493.0,Zidovudine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Zidovudine']",0.5
14181,33593.0,Zidovudine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A2', 'Zidovudine']",0.5
14181,33593.0,Zidovudine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'telomere maintenance', 'TERT', 'Zidovudine']",0.5
14181,33593.0,Zidovudine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Zidovudine']",0.5
14181,33632.0,Zidovudine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Zidovudine']",0.5
14181,33632.0,Zidovudine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Zidovudine']",0.5
14181,33695.0,Zidovudine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Zidovudine']",0.5
14181,33695.0,Zidovudine,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Zidovudine']",0.5
14181,35565.0,Zidovudine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Zidovudine']",0.5
14181,35565.0,Zidovudine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Zidovudine']",0.5
14181,35764.0,Zidovudine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Zidovudine']",0.5
14181,35764.0,Zidovudine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Zidovudine']",0.5
14181,35764.0,Zidovudine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Zidovudine']",0.5
14181,36104.0,Zidovudine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Zidovudine']",0.5
14181,36229.0,Zidovudine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Zidovudine']",0.5
14181,36242.0,Zidovudine,fatty liver disease,disease-protein-drug,contraindication,"['fatty liver disease', 'SLC22A8', 'Zidovudine']",0.5
14181,36242.0,Zidovudine,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Zidovudine']",0.5
14181,36242.0,Zidovudine,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Cadmium', 'ALB', 'Zidovudine']",0.5
14181,37805.0,Zidovudine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Zidovudine']",0.5
14181,84131.0,Zidovudine,non-alcoholic steatohepatitis,disease-protein-drug,contraindication,"['non-alcoholic steatohepatitis', 'SLC22A8', 'Zidovudine']",0.5
14182,27361.0,Oxycodone,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'OPRM1', 'Oxycodone']",0.5
14182,27581.0,Oxycodone,von Willebrand disease,disease-phenotype-protein-drug,contraindication,"['von Willebrand disease', 'Thrombocytopenia', 'ALB', 'Oxycodone']",0.5
14182,28158.0,Oxycodone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Oxycodone']",0.5
14182,28473.0,Oxycodone,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Oxycodone']",0.5
14182,29525.0,Oxycodone,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Oxycodone']",0.5
14182,30035.0,Oxycodone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Oxycodone']",0.5
14182,30813.0,Oxycodone,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Oxycodone']",0.5
14182,32384.0,Oxycodone,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Oxycodone']",0.5
14182,33440.0,Oxycodone,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Thrombocytopenia', 'ALB', 'Oxycodone']",0.5
14182,33577.0,Oxycodone,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Oxycodone']",0.5
14182,33577.0,Oxycodone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Oxycodone']",0.5
14182,33577.0,Oxycodone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Oxycodone']",0.5
14182,33594.0,Oxycodone,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Oxycodone']",0.5
14182,33605.0,Oxycodone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Oxycodone']",0.5
14182,33632.0,Oxycodone,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Oxycodone']",0.5
14182,33632.0,Oxycodone,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Oxycodone']",0.5
14182,33677.0,Oxycodone,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Oxycodone']",0.5
14182,35565.0,Oxycodone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Oxycodone']",0.5
14182,35565.0,Oxycodone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Oxycodone']",0.5
14182,35641.0,Oxycodone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Oxycodone']",0.5
14182,35764.0,Oxycodone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Oxycodone']",0.5
14182,35764.0,Oxycodone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Oxycodone']",0.5
14182,35764.0,Oxycodone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Oxycodone']",0.5
14182,35897.0,Oxycodone,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Oxycodone']",0.5
14182,36035.0,Oxycodone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Oxycodone']",0.5
14182,36080.0,Oxycodone,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Oxycodone']",0.5
14182,36080.0,Oxycodone,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'ORM1', 'Oxycodone']",0.5
14182,36469.0,Oxycodone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Oxycodone']",0.5
14182,36492.0,Oxycodone,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Oxycodone']",0.5
14182,36492.0,Oxycodone,brain cancer,disease-exposure-gene-drug,contraindication,"['brain cancer', 'Lead', 'ALB', 'Oxycodone']",0.5
14182,36693.0,Oxycodone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Oxycodone']",0.5
14182,37180.0,Oxycodone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Oxycodone']",0.5
14182,37180.0,Oxycodone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Oxycodone']",0.5
14182,37785.0,Oxycodone,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Oxycodone']",0.5
14182,38575.0,Oxycodone,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Oxycodone']",0.5
14182,39531.0,Oxycodone,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Oxycodone']",0.5
14182,83910.0,Oxycodone,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Oxycodone']",0.5
14182,83911.0,Oxycodone,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Oxycodone']",0.5
14183,27366.0,Tolmetin,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Tolmetin']",0.5
14183,29078.0,Tolmetin,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'MPO', 'Tolmetin']",0.5
14183,29078.0,Tolmetin,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Tolmetin']",0.5
14183,29078.0,Tolmetin,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Tolmetin']",0.5
14183,29078.0,Tolmetin,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Tolmetin']",0.5
14183,32325.0,Tolmetin,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Tolmetin']",0.5
14183,33577.0,Tolmetin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Tolmetin']",0.5
14183,33577.0,Tolmetin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Tolmetin']",0.5
14183,35565.0,Tolmetin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Tolmetin']",0.5
14183,35565.0,Tolmetin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Tolmetin']",0.5
14183,35669.0,Tolmetin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Tolmetin']",0.5
14183,35669.0,Tolmetin,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Tolmetin']",0.5
14183,35761.0,Tolmetin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'MPO', 'Tolmetin']",0.5
14183,35761.0,Tolmetin,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Tolmetin']",0.5
14183,35764.0,Tolmetin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Tolmetin']",0.5
14183,35764.0,Tolmetin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Tolmetin']",0.5
14183,35764.0,Tolmetin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Tolmetin']",0.5
14183,37180.0,Tolmetin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Tolmetin']",0.5
14183,37180.0,Tolmetin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Tolmetin']",0.5
14184,27326.0,Ritonavir,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ritonavir']",0.5
14184,27326.0,Ritonavir,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Ritonavir']",0.5
14184,27361.0,Ritonavir,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'ABCC2', 'Ritonavir']",0.5
14184,27476.0,Ritonavir,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Ritonavir']",0.5
14184,27476.0,Ritonavir,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Ritonavir']",0.5
14184,27655.0,Ritonavir,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Ritonavir']",0.5
14184,28052.0,Ritonavir,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'NR1I2', 'Ritonavir']",0.5
14184,31493.0,Ritonavir,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Ritonavir']",0.5
14184,33575.0,Ritonavir,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Ritonavir']",0.5
14184,33575.0,Ritonavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Ritonavir']",0.5
14184,33575.0,Ritonavir,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Ritonavir']",0.5
14184,33695.0,Ritonavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Ritonavir']",0.5
14184,33695.0,Ritonavir,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Ritonavir']",0.5
14184,35565.0,Ritonavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Ritonavir']",0.5
14184,35565.0,Ritonavir,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Ritonavir']",0.5
14184,36187.0,Ritonavir,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ritonavir']",0.5
14184,36187.0,Ritonavir,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Ritonavir']",0.5
14184,36645.0,Ritonavir,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Ritonavir']",0.5
14184,37743.0,Ritonavir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Ritonavir']",0.5
14184,37765.0,Ritonavir,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Ritonavir']",0.5
14184,37786.0,Ritonavir,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Ritonavir']",0.5
14184,37786.0,Ritonavir,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Ritonavir']",0.5
14184,37805.0,Ritonavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Ritonavir']",0.5
14184,38312.0,Ritonavir,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Ritonavir']",0.5
14184,83751.0,Ritonavir,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Ritonavir']",0.5
14184,83790.0,Ritonavir,gout,disease-protein-drug,contraindication,"['gout', 'ABCG2', 'Ritonavir']",0.5
14184,83802.0,Ritonavir,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Ritonavir']",0.5
14184,83802.0,Ritonavir,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Ritonavir']",0.5
14185,35764.0,Vancomycin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Vancomycin']",0.5
14185,35764.0,Vancomycin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Vancomycin']",0.5
14185,35764.0,Vancomycin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Vancomycin']",0.5
14186,31477.0,Cisplatin,ovarian cancer,disease-protein-drug,indication,"['ovarian cancer', 'ATP7B', 'Cisplatin']",0.5
14186,31477.0,Cisplatin,ovarian cancer,disease-exposure-bioprocess-gene-drug,indication,"['ovarian cancer', 'Cadmium', 'regulation of blood pressure', 'PTGS2', 'Cisplatin']",0.5
14186,31477.0,Cisplatin,ovarian cancer,disease-exposure-gene-drug,indication,"['ovarian cancer', 'Cadmium', 'ALB', 'Cisplatin']",0.5
14186,32617.0,Cisplatin,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'PTGS2', 'Cisplatin']",0.5
14186,36527.0,Cisplatin,yolk sac tumor,disease-protein-drug,indication,"['yolk sac tumor', 'ATP7B', 'Cisplatin']",0.5
14186,36792.0,Cisplatin,ovarian mucinous adenocarcinoma,disease-protein-drug,indication,"['ovarian mucinous adenocarcinoma', 'ATP7B', 'Cisplatin']",0.5
14186,36794.0,Cisplatin,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'ATP7B', 'Cisplatin']",0.5
14186,37047.0,Cisplatin,immature ovarian teratoma,disease-protein-drug,indication,"['immature ovarian teratoma', 'ATP7B', 'Cisplatin']",0.5
14186,37082.0,Cisplatin,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5
14186,37150.0,Cisplatin,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5
14186,37152.0,Cisplatin,familial ovarian cancer,disease-protein-drug,indication,"['familial ovarian cancer', 'ATP7B', 'Cisplatin']",0.5
14186,37423.0,Cisplatin,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'ATP7B', 'Cisplatin']",0.5
14186,37466.0,Cisplatin,ovarian small cell carcinoma,disease-protein-drug,indication,"['ovarian small cell carcinoma', 'ATP7B', 'Cisplatin']",0.5
14186,37967.0,Cisplatin,ovarian endometrioid adenocarcinoma,disease-protein-drug,indication,"['ovarian endometrioid adenocarcinoma', 'ATP7B', 'Cisplatin']",0.5
14186,39603.0,Cisplatin,malignant sex cord stromal tumor of ovary,disease-protein-drug,indication,"['malignant sex cord stromal tumor of ovary', 'ATP7B', 'Cisplatin']",0.5
14186,39615.0,Cisplatin,borderline epithelial tumor of ovary,disease-protein-drug,indication,"['borderline epithelial tumor of ovary', 'ATP7B', 'Cisplatin']",0.5
14186,83816.0,Cisplatin,ovarian carcinosarcoma,disease-protein-drug,indication,"['ovarian carcinosarcoma', 'ATP7B', 'Cisplatin']",0.5
14186,83817.0,Cisplatin,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary site-specific ovarian cancer syndrome', 'ATP7B', 'Cisplatin']",0.5
14186,83818.0,Cisplatin,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'ATP7B', 'Cisplatin']",0.5
14186,83819.0,Cisplatin,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5
14186,83820.0,Cisplatin,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5
14186,83821.0,Cisplatin,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ATP7B', 'Cisplatin']",0.5
14186,83822.0,Cisplatin,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,indication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ATP7B', 'Cisplatin']",0.5
14187,27476.0,Erlotinib,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'UGT1A1', 'Erlotinib']",0.5
14187,27476.0,Erlotinib,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Erlotinib']",0.5
14187,27626.0,Erlotinib,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Erlotinib']",0.5
14187,29646.0,Erlotinib,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ABCB1', 'Erlotinib']",0.5
14187,29646.0,Erlotinib,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Erlotinib']",0.5
14187,29646.0,Erlotinib,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'CYP1B1', 'Erlotinib']",0.5
14187,29646.0,Erlotinib,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'NR1I2', 'Erlotinib']",0.5
14187,30892.0,Erlotinib,newborn respiratory distress syndrome,disease-protein-drug,contraindication,"['newborn respiratory distress syndrome', 'ALB', 'Erlotinib']",0.5
14187,30892.0,Erlotinib,newborn respiratory distress syndrome,disease-phenotype-protein-drug,contraindication,"['newborn respiratory distress syndrome', 'Bradycardia', 'CYP1A1', 'Erlotinib']",0.5
14187,31116.0,Erlotinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Erlotinib']",0.5
14187,33063.0,Erlotinib,adult acute respiratory distress syndrome,disease-protein-drug,contraindication,"['adult acute respiratory distress syndrome', 'ALB', 'Erlotinib']",0.5
14187,33063.0,Erlotinib,adult acute respiratory distress syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['adult acute respiratory distress syndrome', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Erlotinib']",0.5
14187,33063.0,Erlotinib,adult acute respiratory distress syndrome,disease-exposure-gene-drug,contraindication,"['adult acute respiratory distress syndrome', 'Air Pollutants', 'CYP1B1', 'Erlotinib']",0.5
14187,33440.0,Erlotinib,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Thrombocytopenia', 'ALB', 'Erlotinib']",0.5
14187,33598.0,Erlotinib,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Erlotinib']",0.5
14187,33598.0,Erlotinib,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Erlotinib']",0.5
14187,33598.0,Erlotinib,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Erlotinib']",0.5
14187,33688.0,Erlotinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Erlotinib']",0.5
14187,35471.0,Erlotinib,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'inflammatory response', 'ORM1', 'Erlotinib']",0.5
14187,35565.0,Erlotinib,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Erlotinib']",0.5
14187,35565.0,Erlotinib,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Erlotinib']",0.5
14187,35764.0,Erlotinib,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Erlotinib']",0.5
14187,35764.0,Erlotinib,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Erlotinib']",0.5
14187,35764.0,Erlotinib,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Erlotinib']",0.5
14187,35909.0,Erlotinib,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Erlotinib']",0.5
14187,35909.0,Erlotinib,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Erlotinib']",0.5
14187,36187.0,Erlotinib,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Erlotinib']",0.5
14187,36187.0,Erlotinib,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CYP1B1', 'Erlotinib']",0.5
14187,36634.0,Erlotinib,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ABCB1', 'Erlotinib']",0.5
14187,36634.0,Erlotinib,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Erlotinib']",0.5
14187,36634.0,Erlotinib,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Air Pollutants', 'CYP1B1', 'Erlotinib']",0.5
14187,36645.0,Erlotinib,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'UGT1A1', 'Erlotinib']",0.5
14187,37180.0,Erlotinib,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Erlotinib']",0.5
14187,37180.0,Erlotinib,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Erlotinib']",0.5
14187,37786.0,Erlotinib,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Erlotinib']",0.5
14187,37786.0,Erlotinib,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Agent Orange', 'CYP1A1', 'Erlotinib']",0.5
14187,38312.0,Erlotinib,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'UGT1A1', 'Erlotinib']",0.5
14187,39872.0,Erlotinib,acute respiratory distress syndrome,disease-protein-drug,contraindication,"['acute respiratory distress syndrome', 'ALB', 'Erlotinib']",0.5
14188,27326.0,Ciprofloxacin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Ciprofloxacin']",0.5
14188,27326.0,Ciprofloxacin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ciprofloxacin']",0.5
14188,27655.0,Ciprofloxacin,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Ciprofloxacin']",0.5
14188,32710.0,Ciprofloxacin,inhalational anthrax,disease-phenotype-protein-drug,off-label use,"['inhalational anthrax', 'Vomiting', 'ABCB1', 'Ciprofloxacin']",0.5
14188,32729.0,Ciprofloxacin,botulism,disease-phenotype-protein-drug,indication,"['botulism', 'Arrhythmia', 'KCNH2', 'Ciprofloxacin']",0.5
14188,32999.0,Ciprofloxacin,shigellosis,disease-phenotype-protein-drug,indication,"['shigellosis', 'Thrombocytopenia', 'ALB', 'Ciprofloxacin']",0.5
14188,33314.0,Ciprofloxacin,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Ciprofloxacin']",0.5
14188,33594.0,Ciprofloxacin,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ciprofloxacin']",0.5
14188,35641.0,Ciprofloxacin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Ciprofloxacin']",0.5
14188,35764.0,Ciprofloxacin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Ciprofloxacin']",0.5
14188,35764.0,Ciprofloxacin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Ciprofloxacin']",0.5
14188,35764.0,Ciprofloxacin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Ciprofloxacin']",0.5
14188,83751.0,Ciprofloxacin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Ciprofloxacin']",0.5
14189,27326.0,Nortriptyline,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Nortriptyline']",0.5
14189,27326.0,Nortriptyline,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Nortriptyline']",0.5
14189,27655.0,Nortriptyline,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ADRA1B', 'Nortriptyline']",0.5
14189,27921.0,Nortriptyline,attention deficit-hyperactivity disorder,disease-protein-drug,off-label use,"['attention deficit-hyperactivity disorder', 'DRD2', 'Nortriptyline']",0.5
14189,27933.0,Nortriptyline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Nortriptyline']",0.5
14189,27933.0,Nortriptyline,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Nortriptyline']",0.5
14189,27933.0,Nortriptyline,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Cadmium', 'ALB', 'Nortriptyline']",0.5
14189,30035.0,Nortriptyline,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Nortriptyline']",0.5
14189,33598.0,Nortriptyline,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Nortriptyline']",0.5
14189,33598.0,Nortriptyline,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Nortriptyline']",0.5
14189,33598.0,Nortriptyline,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Nortriptyline']",0.5
14189,35641.0,Nortriptyline,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Nortriptyline']",0.5
14189,35641.0,Nortriptyline,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Nortriptyline']",0.5
14189,35909.0,Nortriptyline,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Nortriptyline']",0.5
14189,36034.0,Nortriptyline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Nortriptyline']",0.5
14189,37180.0,Nortriptyline,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Nortriptyline']",0.5
14189,37180.0,Nortriptyline,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Nortriptyline']",0.5
14189,37703.0,Nortriptyline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'ADRB1', 'Nortriptyline']",0.5
14189,39531.0,Nortriptyline,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Nortriptyline']",0.5
14189,83751.0,Nortriptyline,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Nortriptyline']",0.5
14189,83760.0,Nortriptyline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'ADRB1', 'Nortriptyline']",0.5
14189,83763.0,Nortriptyline,manic bipolar affective disorder,disease-protein-drug,contraindication,"['manic bipolar affective disorder', 'SLC6A4', 'Nortriptyline']",0.5
14189,84036.0,Nortriptyline,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'DRD2', 'Nortriptyline']",0.5
14189,84036.0,Nortriptyline,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Nortriptyline']",0.5
14189,84036.0,Nortriptyline,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Cadmium', 'ALB', 'Nortriptyline']",0.5
14190,27626.0,Fluorouracil,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'MTHFR', 'Fluorouracil']",0.5
14190,28849.0,Fluorouracil,colorectal cancer,disease-protein-drug,indication,"['colorectal cancer', 'MTHFR', 'Fluorouracil']",0.5
14190,29402.0,Fluorouracil,esophageal cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['esophageal cancer', 'Vehicle Emissions', 'methylation', 'TYMS', 'Fluorouracil']",0.5
14190,29945.0,Fluorouracil,gastric cancer,disease-protein-drug,indication,"['gastric cancer', 'TYMP', 'Fluorouracil']",0.5
14190,31107.0,Fluorouracil,cervical cancer,disease-protein-drug,off-label use,"['cervical cancer', 'MTHFR', 'Fluorouracil']",0.5
14190,31107.0,Fluorouracil,cervical cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['cervical cancer', 'Vehicle Emissions', 'methylation', 'TYMS', 'Fluorouracil']",0.5
14190,31257.0,Fluorouracil,dihydropyrimidine dehydrogenase deficiency,disease-protein-drug,contraindication,"['dihydropyrimidine dehydrogenase deficiency', 'DPYD', 'Fluorouracil']",0.5
14190,31257.0,Fluorouracil,dihydropyrimidine dehydrogenase deficiency,disease-phenotype-protein-drug,contraindication,"['dihydropyrimidine dehydrogenase deficiency', 'Delayed speech and language development', 'DPYD', 'Fluorouracil']",0.5
14190,31380.0,Fluorouracil,diffuse gastric adenocarcinoma,disease-protein-drug,indication,"['diffuse gastric adenocarcinoma', 'TYMP', 'Fluorouracil']",0.5
14190,31756.0,Fluorouracil,urinary bladder cancer,disease-protein-drug,off-label use,"['urinary bladder cancer', 'TYMP', 'Fluorouracil']",0.5
14190,31756.0,Fluorouracil,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder cancer', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Fluorouracil']",0.5
14190,31756.0,Fluorouracil,urinary bladder cancer,disease-exposure-gene-drug,off-label use,"['urinary bladder cancer', 'Pesticides', 'MTHFR', 'Fluorouracil']",0.5
14190,33104.0,Fluorouracil,carcinoid syndrome,disease-phenotype-protein-drug,off-label use,"['carcinoid syndrome', 'Elevated hepatic transaminase', 'MTHFR', 'Fluorouracil']",0.5
14190,33464.0,Fluorouracil,urinary bladder small cell neuroendocrine carcinoma,disease-protein-drug,off-label use,"['urinary bladder small cell neuroendocrine carcinoma', 'TYMP', 'Fluorouracil']",0.5
14190,33594.0,Fluorouracil,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Fluorouracil']",0.5
14190,33642.0,Fluorouracil,urinary bladder carcinoma,disease-protein-drug,off-label use,"['urinary bladder carcinoma', 'TYMP', 'Fluorouracil']",0.5
14190,33642.0,Fluorouracil,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Fluorouracil']",0.5
14190,33642.0,Fluorouracil,urinary bladder carcinoma,disease-exposure-gene-drug,off-label use,"['urinary bladder carcinoma', 'Pesticides', 'MTHFR', 'Fluorouracil']",0.5
14190,35565.0,Fluorouracil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Fluorouracil']",0.5
14190,35565.0,Fluorouracil,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Fluorouracil']",0.5
14190,35624.0,Fluorouracil,urinary bladder neoplasm,disease-protein-drug,off-label use,"['urinary bladder neoplasm', 'TYMP', 'Fluorouracil']",0.5
14190,35624.0,Fluorouracil,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Fluorouracil']",0.5
14190,35624.0,Fluorouracil,urinary bladder neoplasm,disease-exposure-gene-drug,off-label use,"['urinary bladder neoplasm', 'Pesticides', 'MTHFR', 'Fluorouracil']",0.5
14190,35764.0,Fluorouracil,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Fluorouracil']",0.5
14190,35764.0,Fluorouracil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Fluorouracil']",0.5
14190,35764.0,Fluorouracil,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Fluorouracil']",0.5
14190,35771.0,Fluorouracil,breast neoplasm,disease-protein-drug,off-label use,"['breast neoplasm', 'MTHFR', 'Fluorouracil']",0.5
14190,35771.0,Fluorouracil,breast neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['breast neoplasm', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Fluorouracil']",0.5
14190,35771.0,Fluorouracil,breast neoplasm,disease-exposure-gene-drug,off-label use,"['breast neoplasm', 'beta-hexachlorocyclohexane', 'SERPINA7', 'Fluorouracil']",0.5
14190,36000.0,Fluorouracil,gastric neoplasm,disease-protein-drug,indication,"['gastric neoplasm', 'TYMP', 'Fluorouracil']",0.5
14190,36000.0,Fluorouracil,gastric neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['gastric neoplasm', 'Lead', 'urea metabolic process', 'CYP2C9', 'Fluorouracil']",0.5
14190,36000.0,Fluorouracil,gastric neoplasm,disease-exposure-gene-drug,indication,"['gastric neoplasm', 'Lead', 'ALB', 'Fluorouracil']",0.5
14190,36050.0,Fluorouracil,head and neck cancer,disease-protein-drug,off-label use,"['head and neck cancer', 'TYMS', 'Fluorouracil']",0.5
14190,36104.0,Fluorouracil,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'MTHFR', 'Fluorouracil']",0.5
14190,36223.0,Fluorouracil,malignant colon neoplasm,disease-protein-drug,indication,"['malignant colon neoplasm', 'TYMP', 'Fluorouracil']",0.5
14190,36229.0,Fluorouracil,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'MTHFR', 'Fluorouracil']",0.5
14190,36301.0,Fluorouracil,leukopenia,disease-protein-drug,contraindication,"['leukopenia', 'MTHFR', 'Fluorouracil']",0.5
14190,36581.0,Fluorouracil,colonic neoplasm,disease-protein-drug,indication,"['colonic neoplasm', 'TYMP', 'Fluorouracil']",0.5
14190,36644.0,Fluorouracil,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Mustard Gas', 'regulation of gene expression', 'CYP1A2', 'Fluorouracil']",0.5
14190,36644.0,Fluorouracil,skin disease,disease-exposure-gene-drug,indication,"['skin disease', 'Pesticides', 'MTHFR', 'Fluorouracil']",0.5
14190,37144.0,Fluorouracil,squamous cell carcinoma of colon,disease-protein-drug,indication,"['squamous cell carcinoma of colon', 'TYMP', 'Fluorouracil']",0.5
14190,37273.0,Fluorouracil,gastric carcinoma,disease-protein-drug,indication,"['gastric carcinoma', 'TYMP', 'Fluorouracil']",0.5
14190,37334.0,Fluorouracil,breast carcinoma,disease-protein-drug,off-label use,"['breast carcinoma', 'MTHFR', 'Fluorouracil']",0.5
14190,83865.0,Fluorouracil,upper aerodigestive tract neoplasm,disease-protein-drug,off-label use,"['upper aerodigestive tract neoplasm', 'TYMS', 'Fluorouracil']",0.5
14190,83866.0,Fluorouracil,non-papillary transitional cell carcinoma of the bladder,disease-protein-drug,off-label use,"['non-papillary transitional cell carcinoma of the bladder', 'TYMP', 'Fluorouracil']",0.5
14190,83899.0,Fluorouracil,gastric linitis plastica,disease-protein-drug,indication,"['gastric linitis plastica', 'TYMP', 'Fluorouracil']",0.5
14191,27366.0,Piroxicam,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Piroxicam']",0.5
14191,29078.0,Piroxicam,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Piroxicam']",0.5
14191,29078.0,Piroxicam,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Piroxicam']",0.5
14191,29078.0,Piroxicam,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Piroxicam']",0.5
14191,29078.0,Piroxicam,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Piroxicam']",0.5
14191,30035.0,Piroxicam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PTGS2', 'Piroxicam']",0.5
14191,32325.0,Piroxicam,juvenile idiopathic arthritis,disease-phenotype-protein-drug,off-label use,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Piroxicam']",0.5
14191,32928.0,Piroxicam,acute liver failure,disease-protein-drug,contraindication,"['acute liver failure', 'ALB', 'Piroxicam']",0.5
14191,32928.0,Piroxicam,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Thrombocytopenia', 'ALB', 'Piroxicam']",0.5
14191,33577.0,Piroxicam,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Piroxicam']",0.5
14191,33577.0,Piroxicam,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Piroxicam']",0.5
14191,33598.0,Piroxicam,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Piroxicam']",0.5
14191,33598.0,Piroxicam,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Piroxicam']",0.5
14191,33598.0,Piroxicam,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS1', 'Piroxicam']",0.5
14191,33632.0,Piroxicam,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'PTGS1', 'Piroxicam']",0.5
14191,33632.0,Piroxicam,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Piroxicam']",0.5
14191,35565.0,Piroxicam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Piroxicam']",0.5
14191,35565.0,Piroxicam,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Piroxicam']",0.5
14191,35669.0,Piroxicam,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Piroxicam']",0.5
14191,35669.0,Piroxicam,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Piroxicam']",0.5
14191,35761.0,Piroxicam,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Piroxicam']",0.5
14191,35761.0,Piroxicam,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Piroxicam']",0.5
14191,35764.0,Piroxicam,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Piroxicam']",0.5
14191,35764.0,Piroxicam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Piroxicam']",0.5
14191,35764.0,Piroxicam,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Piroxicam']",0.5
14191,35766.0,Piroxicam,thrombotic disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombotic disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Piroxicam']",0.5
14191,35909.0,Piroxicam,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'PTGS2', 'Piroxicam']",0.5
14191,35909.0,Piroxicam,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Piroxicam']",0.5
14191,36241.0,Piroxicam,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Piroxicam']",0.5
14191,36432.0,Piroxicam,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Piroxicam']",0.5
14191,36544.0,Piroxicam,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ALB', 'Piroxicam']",0.5
14191,36544.0,Piroxicam,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Piroxicam']",0.5
14191,37180.0,Piroxicam,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Piroxicam']",0.5
14191,37180.0,Piroxicam,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Piroxicam']",0.5
14192,27626.0,Lamotrigine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'OPRK1', 'Lamotrigine']",0.5
14192,27626.0,Lamotrigine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Lamotrigine']",0.5
14192,27664.0,Lamotrigine,idiopathic aplastic anemia,disease-phenotype-protein-drug,contraindication,"['idiopathic aplastic anemia', 'Thrombocytopenia', 'ALB', 'Lamotrigine']",0.5
14192,27933.0,Lamotrigine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Lamotrigine']",0.5
14192,27933.0,Lamotrigine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'transmission of nerve impulse', 'DRD5', 'Lamotrigine']",0.5
14192,27933.0,Lamotrigine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Lamotrigine']",0.5
14192,29865.0,Lamotrigine,Lennox-Gastaut syndrome,disease-protein-drug,indication,"['Lennox-Gastaut syndrome', 'SCN1A', 'Lamotrigine']",0.5
14192,29865.0,Lamotrigine,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Focal-onset seizure', 'DRD1', 'Lamotrigine']",0.5
14192,32456.0,Lamotrigine,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'SCN1A', 'Lamotrigine']",0.5
14192,32456.0,Lamotrigine,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'DRD1', 'Lamotrigine']",0.5
14192,35565.0,Lamotrigine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'ADORA1', 'Lamotrigine']",0.5
14192,35565.0,Lamotrigine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Lamotrigine']",0.5
14192,35641.0,Lamotrigine,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Lamotrigine']",0.5
14192,35641.0,Lamotrigine,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Lamotrigine']",0.5
14192,36104.0,Lamotrigine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Lamotrigine']",0.5
14192,36229.0,Lamotrigine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Lamotrigine']",0.5
14192,36743.0,Lamotrigine,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'DRD1', 'Lamotrigine']",0.5
14192,37703.0,Lamotrigine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Lamotrigine']",0.5
14192,38242.0,Lamotrigine,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'DRD5', 'Lamotrigine']",0.5
14192,38242.0,Lamotrigine,bipolar disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Lamotrigine']",0.5
14192,39815.0,Lamotrigine,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'DRD1', 'Lamotrigine']",0.5
14192,83760.0,Lamotrigine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Lamotrigine']",0.5
14192,83907.0,Lamotrigine,pancytopenia,disease-protein-drug,contraindication,"['pancytopenia', 'DHFR', 'Lamotrigine']",0.5
14193,28714.0,Hydroxyzine,cystic fibrosis,disease-phenotype-protein-drug,contraindication,"['cystic fibrosis', 'Hepatomegaly', 'ALB', 'Hydroxyzine']",0.5
14193,29525.0,Hydroxyzine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'KCNH2', 'Hydroxyzine']",0.5
14193,29709.0,Hydroxyzine,"dermatitis, atopic",disease-phenotype-protein-drug,indication,"['dermatitis, atopic', 'Pruritus', 'HRH1', 'Hydroxyzine']",0.5
14193,30035.0,Hydroxyzine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Hydroxyzine']",0.5
14193,32719.0,Hydroxyzine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'KCNH2', 'Hydroxyzine']",0.5
14193,33575.0,Hydroxyzine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Hydroxyzine']",0.5
14193,33575.0,Hydroxyzine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Hydroxyzine']",0.5
14193,33577.0,Hydroxyzine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Hydroxyzine']",0.5
14193,33577.0,Hydroxyzine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Hydroxyzine']",0.5
14193,33577.0,Hydroxyzine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Hydroxyzine']",0.5
14193,33683.0,Hydroxyzine,urticaria (disease),disease-protein-drug,indication,"['urticaria (disease)', 'ALB', 'Hydroxyzine']",0.5
14193,35565.0,Hydroxyzine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Hydroxyzine']",0.5
14193,35565.0,Hydroxyzine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Hydroxyzine']",0.5
14193,35641.0,Hydroxyzine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Hydroxyzine']",0.5
14193,35641.0,Hydroxyzine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Hydroxyzine']",0.5
14193,35669.0,Hydroxyzine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Hydroxyzine']",0.5
14193,35761.0,Hydroxyzine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Hydroxyzine']",0.5
14193,35761.0,Hydroxyzine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Hydroxyzine']",0.5
14193,35915.0,Hydroxyzine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyzine']",0.5
14193,36034.0,Hydroxyzine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Hydroxyzine']",0.5
14193,36035.0,Hydroxyzine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Hydroxyzine']",0.5
14193,36091.0,Hydroxyzine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Hydroxyzine']",0.5
14193,36129.0,Hydroxyzine,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'memory', 'HRH1', 'Hydroxyzine']",0.5
14193,36129.0,Hydroxyzine,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Lead', 'ALB', 'Hydroxyzine']",0.5
14193,36187.0,Hydroxyzine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Hydroxyzine']",0.5
14193,36187.0,Hydroxyzine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Hydroxyzine']",0.5
14193,36236.0,Hydroxyzine,cor pulmonale,disease-exposure-bioprocess-gene-drug,contraindication,"['cor pulmonale', 'Ozone', 'regulation of heart rate by cardiac conduction', 'KCNH2', 'Hydroxyzine']",0.5
14193,36469.0,Hydroxyzine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Hydroxyzine']",0.5
14193,37180.0,Hydroxyzine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Hydroxyzine']",0.5
14193,37180.0,Hydroxyzine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Hydroxyzine']",0.5
14193,37786.0,Hydroxyzine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Hydroxyzine']",0.5
14193,37786.0,Hydroxyzine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Hydroxyzine']",0.5
14193,37888.0,Hydroxyzine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Hydroxyzine']",0.5
14193,37888.0,Hydroxyzine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Hydroxyzine']",0.5
14193,37888.0,Hydroxyzine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Hydroxyzine']",0.5
14193,39540.0,Hydroxyzine,angioedema,disease-protein-drug,indication,"['angioedema', 'ALB', 'Hydroxyzine']",0.5
14193,83778.0,Hydroxyzine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyzine']",0.5
14193,83779.0,Hydroxyzine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyzine']",0.5
14193,83791.0,Hydroxyzine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Hydroxyzine']",0.5
14194,27626.0,Methotrexate,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'SLCO4C1', 'Methotrexate']",0.5
14194,27626.0,Methotrexate,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'MTHFR', 'Methotrexate']",0.5
14194,28158.0,Methotrexate,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'MTHFR', 'Methotrexate']",0.5
14194,28158.0,Methotrexate,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'developmental growth', 'TYMS', 'Methotrexate']",0.5
14194,28158.0,Methotrexate,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Methotrexate']",0.5
14194,28520.0,Methotrexate,myeloid leukemia,disease-exposure-bioprocess-gene-drug,off-label use,"['myeloid leukemia', 'Pesticides', 'spermatogenesis', 'SLCO4C1', 'Methotrexate']",0.5
14194,28520.0,Methotrexate,myeloid leukemia,disease-exposure-gene-drug,off-label use,"['myeloid leukemia', 'Pesticides', 'MTHFR', 'Methotrexate']",0.5
14194,28830.0,Methotrexate,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'MTHFR', 'Methotrexate']",0.5
14194,29078.0,Methotrexate,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'MTHFR', 'Methotrexate']",0.5
14194,29078.0,Methotrexate,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'spermatogenesis', 'SLCO4C1', 'Methotrexate']",0.5
14194,29078.0,Methotrexate,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'MTHFR', 'Methotrexate']",0.5
14194,29182.0,Methotrexate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'TYMS', 'Methotrexate']",0.5
14194,29182.0,Methotrexate,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,off-label use,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'MTHFR', 'Methotrexate']",0.5
14194,29361.0,Methotrexate,acute promyelocytic leukemia,disease-phenotype-protein-drug,off-label use,"['acute promyelocytic leukemia', 'Thrombocytopenia', 'MTHFR', 'Methotrexate']",0.5
14194,30035.0,Methotrexate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MTHFR', 'Methotrexate']",0.5
14194,30075.0,Methotrexate,Burkitt lymphoma,disease-protein-drug,indication,"['Burkitt lymphoma', 'MTHFR', 'Methotrexate']",0.5
14194,30075.0,Methotrexate,Burkitt lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Burkitt lymphoma', 'Pesticides', 'spermatogenesis', 'SLCO4C1', 'Methotrexate']",0.5
14194,30075.0,Methotrexate,Burkitt lymphoma,disease-exposure-gene-drug,indication,"['Burkitt lymphoma', 'Pesticides', 'MTHFR', 'Methotrexate']",0.5
14194,30447.0,Methotrexate,"lymphoma, non-Hodgkin, familial",disease-protein-drug,indication,"['lymphoma, non-Hodgkin, familial', 'MTHFR', 'Methotrexate']",0.5
14194,30654.0,Methotrexate,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'MTHFR', 'Methotrexate']",0.5
14194,30990.0,Methotrexate,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'ABCC3', 'Methotrexate']",0.5
14194,31116.0,Methotrexate,lung cancer,disease-protein-drug,indication,"['lung cancer', 'MTHFR', 'Methotrexate']",0.5
14194,31481.0,Methotrexate,bone osteosarcoma,disease-protein-drug,indication,"['bone osteosarcoma', 'CYP3A4', 'Methotrexate']",0.5
14194,31481.0,Methotrexate,bone osteosarcoma,disease-phenotype-protein-drug,indication,"['bone osteosarcoma', 'Pain', 'ALB', 'Methotrexate']",0.5
14194,31756.0,Methotrexate,urinary bladder cancer,disease-protein-drug,off-label use,"['urinary bladder cancer', 'MTHFR', 'Methotrexate']",0.5
14194,31756.0,Methotrexate,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder cancer', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Methotrexate']",0.5
14194,31756.0,Methotrexate,urinary bladder cancer,disease-exposure-gene-drug,off-label use,"['urinary bladder cancer', 'Pesticides', 'MTHFR', 'Methotrexate']",0.5
14194,32325.0,Methotrexate,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ABCC3', 'Methotrexate']",0.5
14194,32531.0,Methotrexate,mantle cell lymphoma,disease-protein-drug,indication,"['mantle cell lymphoma', 'MTHFR', 'Methotrexate']",0.5
14194,32978.0,Methotrexate,polymyositis,disease-phenotype-protein-drug,off-label use,"['polymyositis', 'Hepatomegaly', 'ABCC3', 'Methotrexate']",0.5
14194,33464.0,Methotrexate,urinary bladder small cell neuroendocrine carcinoma,disease-protein-drug,off-label use,"['urinary bladder small cell neuroendocrine carcinoma', 'MTHFR', 'Methotrexate']",0.5
14194,33534.0,Methotrexate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,off-label use,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'MTHFR', 'Methotrexate']",0.5
14194,33621.0,Methotrexate,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'MTHFR', 'Methotrexate']",0.5
14194,33621.0,Methotrexate,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Methotrexate']",0.5
14194,33621.0,Methotrexate,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Pesticides', 'MTHFR', 'Methotrexate']",0.5
14194,33623.0,Methotrexate,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'MTHFR', 'Methotrexate']",0.5
14194,33632.0,Methotrexate,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'MTHFR', 'Methotrexate']",0.5
14194,33632.0,Methotrexate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Methotrexate']",0.5
14194,33632.0,Methotrexate,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Methotrexate']",0.5
14194,33642.0,Methotrexate,urinary bladder carcinoma,disease-protein-drug,off-label use,"['urinary bladder carcinoma', 'MTHFR', 'Methotrexate']",0.5
14194,33642.0,Methotrexate,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Methotrexate']",0.5
14194,33642.0,Methotrexate,urinary bladder carcinoma,disease-exposure-gene-drug,off-label use,"['urinary bladder carcinoma', 'Pesticides', 'MTHFR', 'Methotrexate']",0.5
14194,35471.0,Methotrexate,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'inflammatory response', 'ABCC2', 'Methotrexate']",0.5
14194,35565.0,Methotrexate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SLCO4C1', 'Methotrexate']",0.5
14194,35565.0,Methotrexate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Methotrexate']",0.5
14194,35624.0,Methotrexate,urinary bladder neoplasm,disease-protein-drug,off-label use,"['urinary bladder neoplasm', 'MTHFR', 'Methotrexate']",0.5
14194,35624.0,Methotrexate,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Methotrexate']",0.5
14194,35624.0,Methotrexate,urinary bladder neoplasm,disease-exposure-gene-drug,off-label use,"['urinary bladder neoplasm', 'Pesticides', 'MTHFR', 'Methotrexate']",0.5
14194,35650.0,Methotrexate,non-Hodgkin lymphoma,disease-protein-drug,indication,"['non-Hodgkin lymphoma', 'MTHFR', 'Methotrexate']",0.5
14194,35650.0,Methotrexate,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Methotrexate']",0.5
14194,35650.0,Methotrexate,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Cadmium', 'ALB', 'Methotrexate']",0.5
14194,35651.0,Methotrexate,B-cell neoplasm,disease-protein-drug,indication,"['B-cell neoplasm', 'MTHFR', 'Methotrexate']",0.5
14194,35764.0,Methotrexate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Methotrexate']",0.5
14194,35764.0,Methotrexate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'SLC16A1', 'Methotrexate']",0.5
14194,35764.0,Methotrexate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Methotrexate']",0.5
14194,35970.0,Methotrexate,lymphoma,disease-protein-drug,indication,"['lymphoma', 'MTHFR', 'Methotrexate']",0.5
14194,35970.0,Methotrexate,lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['lymphoma', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Methotrexate']",0.5
14194,36050.0,Methotrexate,head and neck cancer,disease-protein-drug,indication,"['head and neck cancer', 'TYMS', 'Methotrexate']",0.5
14194,36301.0,Methotrexate,leukopenia,disease-protein-drug,contraindication,"['leukopenia', 'MTHFR', 'Methotrexate']",0.5
14194,36458.0,Methotrexate,Langerhans cell histiocytosis,disease-protein-drug,indication,"['Langerhans cell histiocytosis', 'MTHFR', 'Methotrexate']",0.5
14194,36812.0,Methotrexate,lung neoplasm,disease-protein-drug,indication,"['lung neoplasm', 'MTHFR', 'Methotrexate']",0.5
14194,36812.0,Methotrexate,lung neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['lung neoplasm', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Methotrexate']",0.5
14194,36812.0,Methotrexate,lung neoplasm,disease-exposure-gene-drug,indication,"['lung neoplasm', 'Cadmium', 'ALB', 'Methotrexate']",0.5
14194,37785.0,Methotrexate,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Methotrexate']",0.5
14194,37785.0,Methotrexate,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Methotrexate']",0.5
14194,83769.0,Methotrexate,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Methotrexate']",0.5
14194,83796.0,Methotrexate,lymphosarcoma,disease-protein-drug,indication,"['lymphosarcoma', 'MTHFR', 'Methotrexate']",0.5
14194,83865.0,Methotrexate,upper aerodigestive tract neoplasm,disease-protein-drug,indication,"['upper aerodigestive tract neoplasm', 'TYMS', 'Methotrexate']",0.5
14194,83866.0,Methotrexate,non-papillary transitional cell carcinoma of the bladder,disease-protein-drug,off-label use,"['non-papillary transitional cell carcinoma of the bladder', 'MTHFR', 'Methotrexate']",0.5
14195,35764.0,Cephalexin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Cephalexin']",0.5
14195,35764.0,Cephalexin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Cephalexin']",0.5
14195,35764.0,Cephalexin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Cephalexin']",0.5
14196,27933.0,Propranolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Propranolol']",0.5
14196,27933.0,Propranolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1B', 'Propranolol']",0.5
14196,27933.0,Propranolol,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Propranolol']",0.5
14196,28052.0,Propranolol,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,indication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'CYP1A1', 'Propranolol']",0.5
14196,29113.0,Propranolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Propranolol']",0.5
14196,29182.0,Propranolol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Propranolol']",0.5
14196,29182.0,Propranolol,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Propranolol']",0.5
14196,29587.0,Propranolol,hereditary neurocutaneous angioma,disease-phenotype-protein-drug,indication,"['hereditary neurocutaneous angioma', 'Seizure', 'HTR1B', 'Propranolol']",0.5
14196,30820.0,Propranolol,tufted angioma (disease),disease-phenotype-protein-drug,indication,"['tufted angioma (disease)', 'Pain', 'HTR1A', 'Propranolol']",0.5
14196,31493.0,Propranolol,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Propranolol']",0.5
14196,31650.0,Propranolol,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'HTR1B', 'Propranolol']",0.5
14196,32222.0,Propranolol,congenital hemangioma,disease-phenotype-protein-drug,indication,"['congenital hemangioma', 'Thrombocytopenia', 'ALB', 'Propranolol']",0.5
14196,32241.0,Propranolol,laryngotracheal angioma,disease-phenotype-protein-drug,indication,"['laryngotracheal angioma', 'Apnea', 'HTR1A', 'Propranolol']",0.5
14196,33398.0,Propranolol,retinal capillary malformation,disease-phenotype-protein-drug,indication,"['retinal capillary malformation', 'Pain', 'HTR1A', 'Propranolol']",0.5
14196,33534.0,Propranolol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Propranolol']",0.5
14196,33575.0,Propranolol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Propranolol']",0.5
14196,33575.0,Propranolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Propranolol']",0.5
14196,33575.0,Propranolol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Propranolol']",0.5
14196,33577.0,Propranolol,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Propranolol']",0.5
14196,33577.0,Propranolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Propranolol']",0.5
14196,33577.0,Propranolol,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Propranolol']",0.5
14196,33618.0,Propranolol,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'CYP2C19', 'Propranolol']",0.5
14196,33618.0,Propranolol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Propranolol']",0.5
14196,33679.0,Propranolol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Propranolol']",0.5
14196,35565.0,Propranolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Propranolol']",0.5
14196,35565.0,Propranolol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Propranolol']",0.5
14196,35764.0,Propranolol,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Propranolol']",0.5
14196,35764.0,Propranolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Propranolol']",0.5
14196,35764.0,Propranolol,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Propranolol']",0.5
14196,35897.0,Propranolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Propranolol']",0.5
14196,36034.0,Propranolol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,off-label use,"['hyperthyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Propranolol']",0.5
14196,36035.0,Propranolol,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Propranolol']",0.5
14196,36266.0,Propranolol,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'MAOA', 'Propranolol']",0.5
14196,37703.0,Propranolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'HTR1B', 'Propranolol']",0.5
14196,37830.0,Propranolol,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Propranolol']",0.5
14196,37830.0,Propranolol,bronchitis,disease-exposure-gene-drug,contraindication,"['bronchitis', 'Tobacco Smoke Pollution', 'CYP1A1', 'Propranolol']",0.5
14196,83760.0,Propranolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'HTR1B', 'Propranolol']",0.5
14196,83802.0,Propranolol,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Propranolol']",0.5
14196,83805.0,Propranolol,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'MAOA', 'Propranolol']",0.5
14197,29078.0,Fenoprofen,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Fenoprofen']",0.5
14197,29078.0,Fenoprofen,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Fenoprofen']",0.5
14197,29078.0,Fenoprofen,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Fenoprofen']",0.5
14197,29078.0,Fenoprofen,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Fenoprofen']",0.5
14197,29273.0,Fenoprofen,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'PPARG', 'Fenoprofen']",0.5
14197,30035.0,Fenoprofen,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PTGS2', 'Fenoprofen']",0.5
14197,33577.0,Fenoprofen,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'PPARG', 'Fenoprofen']",0.5
14197,33577.0,Fenoprofen,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Fenoprofen']",0.5
14197,33598.0,Fenoprofen,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Fenoprofen']",0.5
14197,33598.0,Fenoprofen,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Fenoprofen']",0.5
14197,33598.0,Fenoprofen,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS1', 'Fenoprofen']",0.5
14197,33609.0,Fenoprofen,osteoarthritis,disease-protein-drug,indication,"['osteoarthritis', 'PPARG', 'Fenoprofen']",0.5
14197,33632.0,Fenoprofen,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'PPARG', 'Fenoprofen']",0.5
14197,33632.0,Fenoprofen,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Fenoprofen']",0.5
14197,35669.0,Fenoprofen,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Fenoprofen']",0.5
14197,35669.0,Fenoprofen,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Fenoprofen']",0.5
14197,35761.0,Fenoprofen,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Fenoprofen']",0.5
14197,35761.0,Fenoprofen,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Fenoprofen']",0.5
14197,35764.0,Fenoprofen,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Fenoprofen']",0.5
14197,35764.0,Fenoprofen,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'PPARG', 'Fenoprofen']",0.5
14197,35764.0,Fenoprofen,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Fenoprofen']",0.5
14197,35766.0,Fenoprofen,thrombotic disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombotic disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Fenoprofen']",0.5
14197,35909.0,Fenoprofen,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'PPARA', 'Fenoprofen']",0.5
14197,35909.0,Fenoprofen,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Fenoprofen']",0.5
14197,36209.0,Fenoprofen,arthropathy,disease-protein-drug,indication,"['arthropathy', 'PPARG', 'Fenoprofen']",0.5
14197,36432.0,Fenoprofen,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Fenoprofen']",0.5
14197,36544.0,Fenoprofen,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ALB', 'Fenoprofen']",0.5
14197,36544.0,Fenoprofen,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Fenoprofen']",0.5
14197,37180.0,Fenoprofen,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Fenoprofen']",0.5
14197,37180.0,Fenoprofen,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Fenoprofen']",0.5
14198,27933.0,Clonidine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Clonidine']",0.5
14198,27933.0,Clonidine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Clonidine']",0.5
14198,27933.0,Clonidine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Clonidine']",0.5
14198,28208.0,Clonidine,type 2 diabetes mellitus,disease-protein-drug,contraindication,"['type 2 diabetes mellitus', 'SLC22A3', 'Clonidine']",0.5
14198,28208.0,Clonidine,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,28208.0,Clonidine,type 2 diabetes mellitus,disease-exposure-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Agent Orange', 'CYP1A1', 'Clonidine']",0.5
14198,29182.0,Clonidine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Clonidine']",0.5
14198,29182.0,Clonidine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Clonidine']",0.5
14198,29525.0,Clonidine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Clonidine']",0.5
14198,31493.0,Clonidine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Clonidine']",0.5
14198,33534.0,Clonidine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Clonidine']",0.5
14198,33575.0,Clonidine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Clonidine']",0.5
14198,33575.0,Clonidine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,33575.0,Clonidine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Clonidine']",0.5
14198,33577.0,Clonidine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Clonidine']",0.5
14198,33577.0,Clonidine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,33577.0,Clonidine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Clonidine']",0.5
14198,33594.0,Clonidine,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Clonidine']",0.5
14198,33594.0,Clonidine,diarrheal disease,disease-exposure-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'CYP1A1', 'Clonidine']",0.5
14198,33605.0,Clonidine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Clonidine']",0.5
14198,35909.0,Clonidine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Clonidine']",0.5
14198,35916.0,Clonidine,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,35916.0,Clonidine,dry eye syndrome,disease-exposure-gene-drug,contraindication,"['dry eye syndrome', 'Lead', 'ALB', 'Clonidine']",0.5
14198,36035.0,Clonidine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Clonidine']",0.5
14198,36040.0,Clonidine,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'ALB', 'Clonidine']",0.5
14198,36040.0,Clonidine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,36040.0,Clonidine,chronic kidney disease,disease-exposure-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'ALB', 'Clonidine']",0.5
14198,36080.0,Clonidine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Clonidine']",0.5
14198,36187.0,Clonidine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,36187.0,Clonidine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Clonidine']",0.5
14198,37180.0,Clonidine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,37180.0,Clonidine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'CYP1A1', 'Clonidine']",0.5
14198,37703.0,Clonidine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Clonidine']",0.5
14198,37786.0,Clonidine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,37786.0,Clonidine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Agent Orange', 'CYP1A1', 'Clonidine']",0.5
14198,83760.0,Clonidine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Clonidine']",0.5
14198,83802.0,Clonidine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Clonidine']",0.5
14198,83923.0,Clonidine,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'ALB', 'Clonidine']",0.5
14198,83923.0,Clonidine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Clonidine']",0.5
14198,83923.0,Clonidine,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Cadmium', 'ALB', 'Clonidine']",0.5
14198,83924.0,Clonidine,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'ALB', 'Clonidine']",0.5
14198,84036.0,Clonidine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Clonidine']",0.5
14198,84036.0,Clonidine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Cadmium', 'ALB', 'Clonidine']",0.5
14199,27286.0,Sulfamethizole,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ALB', 'Sulfamethizole']",0.5
14199,27292.0,Sulfamethizole,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'ALB', 'Sulfamethizole']",0.5
14199,28208.0,Sulfamethizole,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Sulfamethizole']",0.5
14199,28208.0,Sulfamethizole,type 2 diabetes mellitus,disease-exposure-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Cadmium', 'ALB', 'Sulfamethizole']",0.5
14199,28552.0,Sulfamethizole,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Sulfamethizole']",0.5
14199,32999.0,Sulfamethizole,shigellosis,disease-phenotype-protein-drug,indication,"['shigellosis', 'Thrombocytopenia', 'ALB', 'Sulfamethizole']",0.5
14199,33575.0,Sulfamethizole,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Sulfamethizole']",0.5
14199,33575.0,Sulfamethizole,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Sulfamethizole']",0.5
14199,33678.0,Sulfamethizole,glomerulonephritis,disease-protein-drug,contraindication,"['glomerulonephritis', 'ALB', 'Sulfamethizole']",0.5
14199,35565.0,Sulfamethizole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Sulfamethizole']",0.5
14199,35565.0,Sulfamethizole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Sulfamethizole']",0.5
14199,35764.0,Sulfamethizole,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Sulfamethizole']",0.5
14199,35764.0,Sulfamethizole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Sulfamethizole']",0.5
14199,35764.0,Sulfamethizole,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Sulfamethizole']",0.5
14200,28441.0,Enalapril,hereditary angioedema with C1Inh deficiency,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema with C1Inh deficiency', 'Vomiting', 'ABCB1', 'Enalapril']",0.5
14200,29854.0,Enalapril,hereditary angioedema,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Enalapril']",0.5
14200,33577.0,Enalapril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Enalapril']",0.5
14200,33577.0,Enalapril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Enalapril']",0.5
14200,36432.0,Enalapril,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ALB', 'Enalapril']",0.5
14200,37659.0,Enalapril,heart failure,disease-protein-drug,indication,"['heart failure', 'ALB', 'Enalapril']",0.5
14200,37659.0,Enalapril,heart failure,disease-exposure-bioprocess-gene-drug,indication,"['heart failure', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Enalapril']",0.5
14200,37659.0,Enalapril,heart failure,disease-exposure-gene-drug,indication,"['heart failure', 'Cadmium', 'ALB', 'Enalapril']",0.5
14200,39540.0,Enalapril,angioedema,disease-protein-drug,contraindication,"['angioedema', 'ALB', 'Enalapril']",0.5
14201,27286.0,Oxytetracycline,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ALB', 'Oxytetracycline']",0.5
14201,27292.0,Oxytetracycline,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'ALB', 'Oxytetracycline']",0.5
14201,27700.0,Oxytetracycline,sclerosing cholangitis,disease-phenotype-protein-drug,off-label use,"['sclerosing cholangitis', 'Hepatomegaly', 'ALB', 'Oxytetracycline']",0.5
14201,32932.0,Oxytetracycline,brucellosis,disease-phenotype-protein-drug,indication,"['brucellosis', 'Hepatomegaly', 'ALB', 'Oxytetracycline']",0.5
14201,32949.0,Oxytetracycline,relapsing fever,disease-phenotype-protein-drug,indication,"['relapsing fever', 'Thrombocytopenia', 'ALB', 'Oxytetracycline']",0.5
14201,32959.0,Oxytetracycline,Q fever,disease-phenotype-protein-drug,indication,"['Q fever', 'Hepatomegaly', 'ALB', 'Oxytetracycline']",0.5
14201,33193.0,Oxytetracycline,plague,disease-phenotype-protein-drug,off-label use,"['plague', 'Hepatomegaly', 'ALB', 'Oxytetracycline']",0.5
14201,33314.0,Oxytetracycline,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Oxytetracycline']",0.5
14201,33332.0,Oxytetracycline,tularemia,disease-phenotype-protein-drug,off-label use,"['tularemia', 'Thrombocytopenia', 'ALB', 'Oxytetracycline']",0.5
14201,33618.0,Oxytetracycline,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Oxytetracycline']",0.5
14201,33678.0,Oxytetracycline,glomerulonephritis,disease-protein-drug,contraindication,"['glomerulonephritis', 'ALB', 'Oxytetracycline']",0.5
14201,35552.0,Oxytetracycline,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Oxytetracycline']",0.5
14201,35565.0,Oxytetracycline,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Oxytetracycline']",0.5
14201,35764.0,Oxytetracycline,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Oxytetracycline']",0.5
14201,35764.0,Oxytetracycline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Oxytetracycline']",0.5
14201,35764.0,Oxytetracycline,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Oxytetracycline']",0.5
14201,37830.0,Oxytetracycline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Oxytetracycline']",0.5
14202,27933.0,Labetalol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Labetalol']",0.5
14202,27933.0,Labetalol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Labetalol']",0.5
14202,27933.0,Labetalol,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Labetalol']",0.5
14202,29113.0,Labetalol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Labetalol']",0.5
14202,29182.0,Labetalol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Labetalol']",0.5
14202,29182.0,Labetalol,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Labetalol']",0.5
14202,31493.0,Labetalol,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Labetalol']",0.5
14202,33534.0,Labetalol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Labetalol']",0.5
14202,33575.0,Labetalol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Labetalol']",0.5
14202,33575.0,Labetalol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Labetalol']",0.5
14202,33577.0,Labetalol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Labetalol']",0.5
14202,33577.0,Labetalol,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Labetalol']",0.5
14202,33605.0,Labetalol,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Labetalol']",0.5
14202,33679.0,Labetalol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Labetalol']",0.5
14202,35565.0,Labetalol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Labetalol']",0.5
14202,35565.0,Labetalol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Labetalol']",0.5
14202,35764.0,Labetalol,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Labetalol']",0.5
14202,35764.0,Labetalol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Labetalol']",0.5
14202,35764.0,Labetalol,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Labetalol']",0.5
14202,35897.0,Labetalol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Labetalol']",0.5
14202,37703.0,Labetalol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Labetalol']",0.5
14202,38020.0,Labetalol,neonatal jaundice,disease-protein-drug,contraindication,"['neonatal jaundice', 'UGT1A1', 'Labetalol']",0.5
14202,39531.0,Labetalol,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Labetalol']",0.5
14202,83760.0,Labetalol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Labetalol']",0.5
14202,83802.0,Labetalol,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Labetalol']",0.5
14203,27933.0,Medroxyprogesterone acetate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Medroxyprogesterone acetate']",0.5
14203,27933.0,Medroxyprogesterone acetate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,27933.0,Medroxyprogesterone acetate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,28017.0,Medroxyprogesterone acetate,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Medroxyprogesterone acetate']",0.5
14203,28651.0,Medroxyprogesterone acetate,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,29061.0,Medroxyprogesterone acetate,endometriosis of uterus,disease-protein-drug,indication,"['endometriosis of uterus', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,29182.0,Medroxyprogesterone acetate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,29182.0,Medroxyprogesterone acetate,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,29220.0,Medroxyprogesterone acetate,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,29614.0,Medroxyprogesterone acetate,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Medroxyprogesterone acetate']",0.5
14203,29614.0,Medroxyprogesterone acetate,osteoporosis,disease-exposure-gene-drug,indication,"['osteoporosis', 'Cadmium', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,29908.0,Medroxyprogesterone acetate,familial male-limited precocious puberty,disease-phenotype-protein-drug,off-label use,"['familial male-limited precocious puberty', 'Male infertility', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,30035.0,Medroxyprogesterone acetate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Medroxyprogesterone acetate']",0.5
14203,30756.0,Medroxyprogesterone acetate,polycystic ovary syndrome,disease-protein-drug,off-label use,"['polycystic ovary syndrome', 'HSD3B2', 'Medroxyprogesterone acetate']",0.5
14203,30827.0,Medroxyprogesterone acetate,endometrial cancer,disease-protein-drug,indication,"['endometrial cancer', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,31477.0,Medroxyprogesterone acetate,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,31477.0,Medroxyprogesterone acetate,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,31596.0,Medroxyprogesterone acetate,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,31732.0,Medroxyprogesterone acetate,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'GABRA5', 'Medroxyprogesterone acetate']",0.5
14203,32617.0,Medroxyprogesterone acetate,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Medroxyprogesterone acetate']",0.5
14203,33534.0,Medroxyprogesterone acetate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,33575.0,Medroxyprogesterone acetate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,33575.0,Medroxyprogesterone acetate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,33577.0,Medroxyprogesterone acetate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Medroxyprogesterone acetate']",0.5
14203,33577.0,Medroxyprogesterone acetate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,33593.0,Medroxyprogesterone acetate,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,33593.0,Medroxyprogesterone acetate,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,33593.0,Medroxyprogesterone acetate,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,33598.0,Medroxyprogesterone acetate,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,33598.0,Medroxyprogesterone acetate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Medroxyprogesterone acetate']",0.5
14203,33598.0,Medroxyprogesterone acetate,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Arsenic', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,33675.0,Medroxyprogesterone acetate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,33675.0,Medroxyprogesterone acetate,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,33680.0,Medroxyprogesterone acetate,endometriosis (disease),disease-protein-drug,indication,"['endometriosis (disease)', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,33680.0,Medroxyprogesterone acetate,endometriosis (disease),disease-exposure-bioprocess-gene-drug,indication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,33695.0,Medroxyprogesterone acetate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Medroxyprogesterone acetate']",0.5
14203,33695.0,Medroxyprogesterone acetate,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,33699.0,Medroxyprogesterone acetate,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,35565.0,Medroxyprogesterone acetate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Medroxyprogesterone acetate']",0.5
14203,35565.0,Medroxyprogesterone acetate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,35641.0,Medroxyprogesterone acetate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Medroxyprogesterone acetate']",0.5
14203,35738.0,Medroxyprogesterone acetate,endometrial carcinoma (disease),disease-protein-drug,indication,"['endometrial carcinoma (disease)', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,35739.0,Medroxyprogesterone acetate,uterine corpus cancer,disease-protein-drug,indication,"['uterine corpus cancer', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,35764.0,Medroxyprogesterone acetate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Medroxyprogesterone acetate']",0.5
14203,35764.0,Medroxyprogesterone acetate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Medroxyprogesterone acetate']",0.5
14203,35764.0,Medroxyprogesterone acetate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,35901.0,Medroxyprogesterone acetate,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,35909.0,Medroxyprogesterone acetate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Medroxyprogesterone acetate']",0.5
14203,35958.0,Medroxyprogesterone acetate,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,36187.0,Medroxyprogesterone acetate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,36187.0,Medroxyprogesterone acetate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,36187.0,Medroxyprogesterone acetate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,36469.0,Medroxyprogesterone acetate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Medroxyprogesterone acetate']",0.5
14203,36527.0,Medroxyprogesterone acetate,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,36792.0,Medroxyprogesterone acetate,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,36794.0,Medroxyprogesterone acetate,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37038.0,Medroxyprogesterone acetate,endometrium neoplasm,disease-protein-drug,indication,"['endometrium neoplasm', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,37047.0,Medroxyprogesterone acetate,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37082.0,Medroxyprogesterone acetate,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37150.0,Medroxyprogesterone acetate,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37152.0,Medroxyprogesterone acetate,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37180.0,Medroxyprogesterone acetate,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37180.0,Medroxyprogesterone acetate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37180.0,Medroxyprogesterone acetate,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'PGR', 'Medroxyprogesterone acetate']",0.5
14203,37423.0,Medroxyprogesterone acetate,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37466.0,Medroxyprogesterone acetate,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37573.0,Medroxyprogesterone acetate,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37703.0,Medroxyprogesterone acetate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Medroxyprogesterone acetate']",0.5
14203,37768.0,Medroxyprogesterone acetate,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,37967.0,Medroxyprogesterone acetate,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,39603.0,Medroxyprogesterone acetate,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,39615.0,Medroxyprogesterone acetate,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83760.0,Medroxyprogesterone acetate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Medroxyprogesterone acetate']",0.5
14203,83816.0,Medroxyprogesterone acetate,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83817.0,Medroxyprogesterone acetate,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83818.0,Medroxyprogesterone acetate,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83819.0,Medroxyprogesterone acetate,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83820.0,Medroxyprogesterone acetate,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83821.0,Medroxyprogesterone acetate,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83822.0,Medroxyprogesterone acetate,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83823.0,Medroxyprogesterone acetate,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14203,83824.0,Medroxyprogesterone acetate,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Medroxyprogesterone acetate']",0.5
14204,27366.0,Sulindac,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Sulindac']",0.5
14204,29078.0,Sulindac,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Sulindac']",0.5
14204,29078.0,Sulindac,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'PPARD', 'Sulindac']",0.5
14204,29078.0,Sulindac,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'CYP1A1', 'Sulindac']",0.5
14204,29078.0,Sulindac,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Sulindac']",0.5
14204,29182.0,Sulindac,systemic lupus erythematosus (disease),disease-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'PTGS2', 'Sulindac']",0.5
14204,29182.0,Sulindac,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'PPARD', 'Sulindac']",0.5
14204,29182.0,Sulindac,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Sulindac']",0.5
14204,30035.0,Sulindac,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PTGS2', 'Sulindac']",0.5
14204,33025.0,Sulindac,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'CYP1A1', 'Sulindac']",0.5
14204,33534.0,Sulindac,pediatric systemic lupus erythematosus,disease-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'PTGS2', 'Sulindac']",0.5
14204,33534.0,Sulindac,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Sulindac']",0.5
14204,33577.0,Sulindac,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'adipose tissue development', 'PPARD', 'Sulindac']",0.5
14204,33577.0,Sulindac,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Sulindac']",0.5
14204,33632.0,Sulindac,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'PPARD', 'Sulindac']",0.5
14204,33632.0,Sulindac,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Sulindac']",0.5
14204,35565.0,Sulindac,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'PTGDR2', 'Sulindac']",0.5
14204,35565.0,Sulindac,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Sulindac']",0.5
14204,35669.0,Sulindac,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARD', 'Sulindac']",0.5
14204,35669.0,Sulindac,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Sulindac']",0.5
14204,35761.0,Sulindac,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose metabolic process', 'PPARD', 'Sulindac']",0.5
14204,35761.0,Sulindac,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Sulindac']",0.5
14204,35764.0,Sulindac,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Sulindac']",0.5
14204,35764.0,Sulindac,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'adipose tissue development', 'PPARD', 'Sulindac']",0.5
14204,35764.0,Sulindac,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Sulindac']",0.5
14204,35854.0,Sulindac,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Sulindac']",0.5
14204,36432.0,Sulindac,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Sulindac']",0.5
14204,37180.0,Sulindac,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARD', 'Sulindac']",0.5
14204,37180.0,Sulindac,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Sulindac']",0.5
14205,28082.0,Nafcillin,chronic Epstein-Barr virus infection syndrome,disease-phenotype-protein-drug,contraindication,"['chronic Epstein-Barr virus infection syndrome', 'Splenomegaly', 'CYP1A2', 'Nafcillin']",0.5
14205,35764.0,Nafcillin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Nafcillin']",0.5
14205,35764.0,Nafcillin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Nafcillin']",0.5
14205,35764.0,Nafcillin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Nafcillin']",0.5
14206,27286.0,Chloroquine,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'CYP2D6', 'Chloroquine']",0.5
14206,27292.0,Chloroquine,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'CYP1A1', 'Chloroquine']",0.5
14206,29078.0,Chloroquine,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Chloroquine']",0.5
14206,29078.0,Chloroquine,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cognition', 'TNF', 'Chloroquine']",0.5
14206,29078.0,Chloroquine,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'TNF', 'Chloroquine']",0.5
14206,29078.0,Chloroquine,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'TNF', 'Chloroquine']",0.5
14206,29078.0,Chloroquine,rheumatoid arthritis,disease-exposure-molfunc-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'glutathione transferase activity', 'GSTA2', 'Chloroquine']",0.5
14206,29182.0,Chloroquine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Chloroquine']",0.5
14206,29182.0,Chloroquine,systemic lupus erythematosus (disease),disease-exposure-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'TNF', 'Chloroquine']",0.5
14206,29182.0,Chloroquine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Chloroquine']",0.5
14206,30035.0,Chloroquine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Chloroquine']",0.5
14206,32325.0,Chloroquine,juvenile idiopathic arthritis,disease-phenotype-protein-drug,off-label use,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'CYP1A1', 'Chloroquine']",0.5
14206,32977.0,Chloroquine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Fever', 'TNF', 'Chloroquine']",0.5
14206,33128.0,Chloroquine,malaria,disease-protein-drug,indication,"['malaria', 'TNF', 'Chloroquine']",0.5
14206,33128.0,Chloroquine,malaria,disease-phenotype-protein-drug,indication,"['malaria', 'Fever', 'TNF', 'Chloroquine']",0.5
14206,33179.0,Chloroquine,porphyria cutanea tarda,disease-phenotype-protein-drug,off-label use,"['porphyria cutanea tarda', 'Edema', 'TNF', 'Chloroquine']",0.5
14206,33534.0,Chloroquine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Chloroquine']",0.5
14206,33623.0,Chloroquine,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'TNF', 'Chloroquine']",0.5
14206,33632.0,Chloroquine,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'TNF', 'Chloroquine']",0.5
14206,33632.0,Chloroquine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Chloroquine']",0.5
14206,33632.0,Chloroquine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Chloroquine']",0.5
14206,35565.0,Chloroquine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'TNF', 'Chloroquine']",0.5
14206,35565.0,Chloroquine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Chloroquine']",0.5
14206,35641.0,Chloroquine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Chloroquine']",0.5
14206,35823.0,Chloroquine,eye disease,disease-exposure-bioprocess-gene-drug,contraindication,"['eye disease', 'perfluorooctane sulfonic acid', 'cognition', 'TNF', 'Chloroquine']",0.5
14206,35823.0,Chloroquine,eye disease,disease-exposure-gene-drug,contraindication,"['eye disease', 'Pesticides', 'TNF', 'Chloroquine']",0.5
14206,35823.0,Chloroquine,eye disease,disease-exposure-molfunc-gene-drug,contraindication,"['eye disease', 'Pesticides', 'glutathione transferase activity', 'GSTA2', 'Chloroquine']",0.5
14206,36104.0,Chloroquine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Chloroquine']",0.5
14206,36229.0,Chloroquine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Chloroquine']",0.5
14206,36260.0,Chloroquine,retinal disease,disease-exposure-gene-drug,contraindication,"['retinal disease', 'Agent Orange', 'CYP1A1', 'Chloroquine']",0.5
14206,38024.0,Chloroquine,psoriasis,disease-protein-drug,contraindication,"['psoriasis', 'TNF', 'Chloroquine']",0.5
14206,39728.0,Chloroquine,parapsoriasis,disease-protein-drug,contraindication,"['parapsoriasis', 'TNF', 'Chloroquine']",0.5
14207,27476.0,Imatinib,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Imatinib']",0.5
14207,27626.0,Imatinib,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'KIT', 'Imatinib']",0.5
14207,27626.0,Imatinib,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Imatinib']",0.5
14207,28414.0,Imatinib,idiopathic hypereosinophilic syndrome,disease-protein-drug,indication,"['idiopathic hypereosinophilic syndrome', 'PDGFRA', 'Imatinib']",0.5
14207,28414.0,Imatinib,idiopathic hypereosinophilic syndrome,disease-phenotype-protein-drug,indication,"['idiopathic hypereosinophilic syndrome', 'Hepatomegaly', 'ALB', 'Imatinib']",0.5
14207,28542.0,Imatinib,mastocytosis,disease-protein-drug,indication,"['mastocytosis', 'KIT', 'Imatinib']",0.5
14207,28542.0,Imatinib,mastocytosis,disease-phenotype-protein-drug,indication,"['mastocytosis', 'Hepatomegaly', 'ALB', 'Imatinib']",0.5
14207,28651.0,Imatinib,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A2', 'Imatinib']",0.5
14207,33089.0,Imatinib,dermatofibrosarcoma protuberans,disease-phenotype-protein-drug,indication,"['dermatofibrosarcoma protuberans', 'Erythema', 'PTGS1', 'Imatinib']",0.5
14207,33575.0,Imatinib,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Imatinib']",0.5
14207,33575.0,Imatinib,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABL1', 'Imatinib']",0.5
14207,33575.0,Imatinib,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Imatinib']",0.5
14207,33577.0,Imatinib,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Imatinib']",0.5
14207,33577.0,Imatinib,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Imatinib']",0.5
14207,33577.0,Imatinib,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Imatinib']",0.5
14207,33593.0,Imatinib,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A2', 'Imatinib']",0.5
14207,33593.0,Imatinib,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Organophosphorus Compounds', 'learning or memory', 'NTRK1', 'Imatinib']",0.5
14207,33593.0,Imatinib,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Imatinib']",0.5
14207,33593.0,Imatinib,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CYP2D6', 'Imatinib']",0.5
14207,33632.0,Imatinib,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Imatinib']",0.5
14207,33632.0,Imatinib,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Imatinib']",0.5
14207,35565.0,Imatinib,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'KIT', 'Imatinib']",0.5
14207,35565.0,Imatinib,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Imatinib']",0.5
14207,35764.0,Imatinib,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Imatinib']",0.5
14207,35764.0,Imatinib,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Imatinib']",0.5
14207,35764.0,Imatinib,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Imatinib']",0.5
14207,36035.0,Imatinib,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Imatinib']",0.5
14207,36104.0,Imatinib,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Imatinib']",0.5
14207,36187.0,Imatinib,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Imatinib']",0.5
14207,36187.0,Imatinib,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Imatinib']",0.5
14207,36229.0,Imatinib,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Imatinib']",0.5
14207,36432.0,Imatinib,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'PDGFRA', 'Imatinib']",0.5
14207,37613.0,Imatinib,hypereosinophilic syndrome,disease-protein-drug,indication,"['hypereosinophilic syndrome', 'PDGFRA', 'Imatinib']",0.5
14207,37659.0,Imatinib,heart failure,disease-protein-drug,contraindication,"['heart failure', 'PDGFRA', 'Imatinib']",0.5
14207,37659.0,Imatinib,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Imatinib']",0.5
14207,37659.0,Imatinib,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'PTGS1', 'Imatinib']",0.5
14207,39498.0,Imatinib,systemic mastocytosis,disease-protein-drug,indication,"['systemic mastocytosis', 'KIT', 'Imatinib']",0.5
14207,39531.0,Imatinib,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Imatinib']",0.5
14207,84261.0,Imatinib,"blast phase chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['blast phase chronic myelogenous leukemia, BCR-ABL1 positive', 'BCR', 'Imatinib']",0.5
14207,84304.0,Imatinib,chronic eosinophilic leukemia,disease-protein-drug,indication,"['chronic eosinophilic leukemia', 'PDGFRA', 'Imatinib']",0.5
14207,84305.0,Imatinib,"chronic eosinophilic leukemia, not otherwise specified",disease-protein-drug,indication,"['chronic eosinophilic leukemia, not otherwise specified', 'PDGFRA', 'Imatinib']",0.5
14208,27219.0,Testosterone,hypogonadotropic hypogonadism with or without anosmia,disease-protein-drug,indication,"['hypogonadotropic hypogonadism with or without anosmia', 'CYP19A1', 'Testosterone']",0.5
14208,27219.0,Testosterone,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,indication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CYP11A1', 'Testosterone']",0.5
14208,27249.0,Testosterone,isolated growth hormone deficiency,disease-protein-drug,indication,"['isolated growth hormone deficiency', 'CYP19A1', 'Testosterone']",0.5
14208,27522.0,Testosterone,Noonan syndrome,disease-phenotype-protein-drug,off-label use,"['Noonan syndrome', 'Hepatomegaly', 'CYP1A1', 'Testosterone']",0.5
14208,27609.0,Testosterone,Prader-Willi syndrome,disease-phenotype-protein-drug,off-label use,"['Prader-Willi syndrome', 'Adrenal insufficiency', 'CYP11A1', 'Testosterone']",0.5
14208,27741.0,Testosterone,pituitary deficiency due to empty sella turcica syndrome,disease-protein-drug,indication,"['pituitary deficiency due to empty sella turcica syndrome', 'CYP19A1', 'Testosterone']",0.5
14208,27741.0,Testosterone,pituitary deficiency due to empty sella turcica syndrome,disease-phenotype-protein-drug,indication,"['pituitary deficiency due to empty sella turcica syndrome', 'Seizure', 'CYP11A1', 'Testosterone']",0.5
14208,28407.0,Testosterone,hypogonadotropic hypogonadism,disease-protein-drug,indication,"['hypogonadotropic hypogonadism', 'CYP19A1', 'Testosterone']",0.5
14208,29061.0,Testosterone,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'MAOA', 'Testosterone']",0.5
14208,29113.0,Testosterone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Testosterone']",0.5
14208,29182.0,Testosterone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Testosterone']",0.5
14208,29182.0,Testosterone,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Testosterone']",0.5
14208,29182.0,Testosterone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Testosterone']",0.5
14208,29220.0,Testosterone,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'CYP1A1', 'Testosterone']",0.5
14208,29646.0,Testosterone,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'CYP1A1', 'Testosterone']",0.5
14208,29646.0,Testosterone,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,29646.0,Testosterone,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,29646.0,Testosterone,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'CYP1A1', 'Testosterone']",0.5
14208,30073.0,Testosterone,cryptorchidism (disease),disease-exposure-bioprocess-gene-drug,indication,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'spermatogenesis', 'AR', 'Testosterone']",0.5
14208,30073.0,Testosterone,cryptorchidism (disease),disease-exposure-gene-drug,indication,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'CYP1A1', 'Testosterone']",0.5
14208,30827.0,Testosterone,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'CYP11A1', 'Testosterone']",0.5
14208,31395.0,Testosterone,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Testosterone']",0.5
14208,31395.0,Testosterone,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Testosterone']",0.5
14208,31477.0,Testosterone,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Testosterone']",0.5
14208,31477.0,Testosterone,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'DNA methylation', 'CYP1A1', 'Testosterone']",0.5
14208,31477.0,Testosterone,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Testosterone']",0.5
14208,31596.0,Testosterone,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Testosterone']",0.5
14208,31618.0,Testosterone,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CYP11A1', 'Testosterone']",0.5
14208,31630.0,Testosterone,androgen insensitivity syndrome,disease-protein-drug,indication,"['androgen insensitivity syndrome', 'AR', 'Testosterone']",0.5
14208,31630.0,Testosterone,androgen insensitivity syndrome,disease-phenotype-protein-drug,indication,"['androgen insensitivity syndrome', 'Male infertility', 'CYP1A1', 'Testosterone']",0.5
14208,31714.0,Testosterone,short stature due to growth hormone qualitative anomaly,disease-protein-drug,indication,"['short stature due to growth hormone qualitative anomaly', 'CYP19A1', 'Testosterone']",0.5
14208,32217.0,Testosterone,hypopituitarism,disease-protein-drug,indication,"['hypopituitarism', 'CYP19A1', 'Testosterone']",0.5
14208,32313.0,Testosterone,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CYP11A1', 'Testosterone']",0.5
14208,32337.0,Testosterone,"combined pituitary hormone deficiencies, genetic form",disease-protein-drug,indication,"['combined pituitary hormone deficiencies, genetic form', 'CYP19A1', 'Testosterone']",0.5
14208,32337.0,Testosterone,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,indication,"['combined pituitary hormone deficiencies, genetic form', 'Seizure', 'CYP11A1', 'Testosterone']",0.5
14208,32518.0,Testosterone,trisomy 13,disease-phenotype-protein-drug,indication,"['trisomy 13', 'Seizure', 'CYP11A1', 'Testosterone']",0.5
14208,32617.0,Testosterone,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'CYP1A1', 'Testosterone']",0.5
14208,32899.0,Testosterone,pituitary deficiency due to Rathke's pouch cysts,disease-protein-drug,indication,"[""pituitary deficiency due to Rathke's pouch cysts"", 'CYP19A1', 'Testosterone']",0.5
14208,33166.0,Testosterone,isolated congenital growth hormone deficiency,disease-protein-drug,indication,"['isolated congenital growth hormone deficiency', 'CYP19A1', 'Testosterone']",0.5
14208,33232.0,Testosterone,X-linked intellectual disability with isolated growth hormone deficiency,disease-protein-drug,indication,"['X-linked intellectual disability with isolated growth hormone deficiency', 'CYP19A1', 'Testosterone']",0.5
14208,33453.0,Testosterone,Kallmann syndrome,disease-protein-drug,indication,"['Kallmann syndrome', 'CYP19A1', 'Testosterone']",0.5
14208,33453.0,Testosterone,Kallmann syndrome,disease-phenotype-protein-drug,indication,"['Kallmann syndrome', 'Seizure', 'CYP11A1', 'Testosterone']",0.5
14208,33534.0,Testosterone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Testosterone']",0.5
14208,33575.0,Testosterone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Testosterone']",0.5
14208,33575.0,Testosterone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,33575.0,Testosterone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Testosterone']",0.5
14208,33575.0,Testosterone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Testosterone']",0.5
14208,33577.0,Testosterone,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Testosterone']",0.5
14208,33577.0,Testosterone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone']",0.5
14208,33577.0,Testosterone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Testosterone']",0.5
14208,33593.0,Testosterone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Testosterone']",0.5
14208,33593.0,Testosterone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'DNA methylation', 'CYP1A1', 'Testosterone']",0.5
14208,33593.0,Testosterone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Testosterone']",0.5
14208,33598.0,Testosterone,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Testosterone']",0.5
14208,33598.0,Testosterone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Testosterone']",0.5
14208,33598.0,Testosterone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Testosterone']",0.5
14208,33603.0,Testosterone,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'ESR1', 'Testosterone']",0.5
14208,33675.0,Testosterone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,33675.0,Testosterone,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,33680.0,Testosterone,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'MAOA', 'Testosterone']",0.5
14208,33680.0,Testosterone,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Testosterone']",0.5
14208,33680.0,Testosterone,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Testosterone']",0.5
14208,33695.0,Testosterone,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone']",0.5
14208,33695.0,Testosterone,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Testosterone']",0.5
14208,33699.0,Testosterone,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,33699.0,Testosterone,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,35565.0,Testosterone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Testosterone']",0.5
14208,35565.0,Testosterone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Testosterone']",0.5
14208,35641.0,Testosterone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Testosterone']",0.5
14208,35669.0,Testosterone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,35669.0,Testosterone,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,35738.0,Testosterone,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'CYP11A1', 'Testosterone']",0.5
14208,35739.0,Testosterone,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'CYP11A1', 'Testosterone']",0.5
14208,35761.0,Testosterone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,35761.0,Testosterone,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,35764.0,Testosterone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Testosterone']",0.5
14208,35764.0,Testosterone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone']",0.5
14208,35764.0,Testosterone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Testosterone']",0.5
14208,35901.0,Testosterone,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Testosterone']",0.5
14208,35901.0,Testosterone,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'CYP19A1', 'Testosterone']",0.5
14208,35909.0,Testosterone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Testosterone']",0.5
14208,35909.0,Testosterone,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,35953.0,Testosterone,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'ESR1', 'Testosterone']",0.5
14208,35953.0,Testosterone,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Diethylhexyl Phthalate', 'Leydig cell differentiation', 'AR', 'Testosterone']",0.5
14208,35953.0,Testosterone,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,35958.0,Testosterone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'NR3C2', 'Testosterone']",0.5
14208,35963.0,Testosterone,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP2C19', 'Testosterone']",0.5
14208,35966.0,Testosterone,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP2C19', 'Testosterone']",0.5
14208,35966.0,Testosterone,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Testosterone']",0.5
14208,35966.0,Testosterone,prostate cancer,disease-exposure-gene-drug,contraindication,"['prostate cancer', 'Agent Orange', 'CYP1A1', 'Testosterone']",0.5
14208,36035.0,Testosterone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Testosterone']",0.5
14208,36187.0,Testosterone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Testosterone']",0.5
14208,36187.0,Testosterone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,36187.0,Testosterone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,36432.0,Testosterone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'NR3C2', 'Testosterone']",0.5
14208,36453.0,Testosterone,hypogonadism,disease-protein-drug,indication,"['hypogonadism', 'CYP19A1', 'Testosterone']",0.5
14208,36469.0,Testosterone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Testosterone']",0.5
14208,36527.0,Testosterone,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Testosterone']",0.5
14208,36634.0,Testosterone,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'CYP1A1', 'Testosterone']",0.5
14208,36634.0,Testosterone,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Testosterone']",0.5
14208,36634.0,Testosterone,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,36792.0,Testosterone,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Testosterone']",0.5
14208,36794.0,Testosterone,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Testosterone']",0.5
14208,37038.0,Testosterone,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'CYP11A1', 'Testosterone']",0.5
14208,37047.0,Testosterone,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Testosterone']",0.5
14208,37082.0,Testosterone,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Testosterone']",0.5
14208,37150.0,Testosterone,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Testosterone']",0.5
14208,37152.0,Testosterone,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Testosterone']",0.5
14208,37180.0,Testosterone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'NR3C2', 'Testosterone']",0.5
14208,37180.0,Testosterone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,37180.0,Testosterone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,37285.0,Testosterone,thymus gland disease,disease-protein-drug,indication,"['thymus gland disease', 'CYP19A1', 'Testosterone']",0.5
14208,37423.0,Testosterone,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Testosterone']",0.5
14208,37466.0,Testosterone,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Testosterone']",0.5
14208,37573.0,Testosterone,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,37573.0,Testosterone,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,37659.0,Testosterone,heart failure,disease-protein-drug,contraindication,"['heart failure', 'NR3C2', 'Testosterone']",0.5
14208,37659.0,Testosterone,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone']",0.5
14208,37659.0,Testosterone,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'CYP1B1', 'Testosterone']",0.5
14208,37768.0,Testosterone,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Testosterone']",0.5
14208,37967.0,Testosterone,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Testosterone']",0.5
14208,38085.0,Testosterone,acquired pituitary hormone deficiency,disease-protein-drug,indication,"['acquired pituitary hormone deficiency', 'CYP19A1', 'Testosterone']",0.5
14208,38179.0,Testosterone,congenital hypogonadotropic hypogonadism,disease-protein-drug,indication,"['congenital hypogonadotropic hypogonadism', 'CYP19A1', 'Testosterone']",0.5
14208,38508.0,Testosterone,non-acquired pituitary hormone deficiency,disease-protein-drug,indication,"['non-acquired pituitary hormone deficiency', 'CYP19A1', 'Testosterone']",0.5
14208,39025.0,Testosterone,non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations,disease-protein-drug,indication,"['non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations', 'CYP19A1', 'Testosterone']",0.5
14208,39202.0,Testosterone,non-acquired combined pituitary hormone deficiency,disease-protein-drug,indication,"['non-acquired combined pituitary hormone deficiency', 'CYP19A1', 'Testosterone']",0.5
14208,39203.0,Testosterone,pituitary deficiency,disease-protein-drug,indication,"['pituitary deficiency', 'CYP19A1', 'Testosterone']",0.5
14208,39539.0,Testosterone,pituitary hormone defiency from vascular origin,disease-protein-drug,indication,"['pituitary hormone defiency from vascular origin', 'CYP19A1', 'Testosterone']",0.5
14208,39603.0,Testosterone,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Testosterone']",0.5
14208,39615.0,Testosterone,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Testosterone']",0.5
14208,83765.0,Testosterone,hypogonadotropic hypogonadism-frontoparietal alopecia syndrome,disease-protein-drug,indication,"['hypogonadotropic hypogonadism-frontoparietal alopecia syndrome', 'CYP19A1', 'Testosterone']",0.5
14208,83766.0,Testosterone,short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,disease-protein-drug,indication,"['short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia', 'CYP19A1', 'Testosterone']",0.5
14208,83816.0,Testosterone,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Testosterone']",0.5
14208,83817.0,Testosterone,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Testosterone']",0.5
14208,83818.0,Testosterone,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Testosterone']",0.5
14208,83819.0,Testosterone,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Testosterone']",0.5
14208,83820.0,Testosterone,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Testosterone']",0.5
14208,83821.0,Testosterone,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Testosterone']",0.5
14208,83822.0,Testosterone,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Testosterone']",0.5
14208,83823.0,Testosterone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'NR3C2', 'Testosterone']",0.5
14208,83824.0,Testosterone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'NR3C2', 'Testosterone']",0.5
14208,84094.0,Testosterone,premature menopause,disease-protein-drug,indication,"['premature menopause', 'CYP2C19', 'Testosterone']",0.5
14209,27577.0,Efavirenz,Fanconi renotubular syndrome,disease-phenotype-protein-drug,contraindication,"['Fanconi renotubular syndrome', 'Proteinuria', 'ALB', 'Efavirenz']",0.5
14209,27933.0,Efavirenz,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Efavirenz']",0.5
14209,27933.0,Efavirenz,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Efavirenz']",0.5
14209,27933.0,Efavirenz,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Efavirenz']",0.5
14209,28651.0,Efavirenz,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A1', 'Efavirenz']",0.5
14209,33593.0,Efavirenz,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A1', 'Efavirenz']",0.5
14209,33593.0,Efavirenz,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Efavirenz']",0.5
14209,33593.0,Efavirenz,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Efavirenz']",0.5
14209,33593.0,Efavirenz,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CYP2D6', 'Efavirenz']",0.5
14209,33695.0,Efavirenz,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Efavirenz']",0.5
14209,33695.0,Efavirenz,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Efavirenz']",0.5
14209,35565.0,Efavirenz,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Efavirenz']",0.5
14209,35565.0,Efavirenz,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Efavirenz']",0.5
14209,35641.0,Efavirenz,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Efavirenz']",0.5
14209,35764.0,Efavirenz,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Efavirenz']",0.5
14209,35764.0,Efavirenz,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Efavirenz']",0.5
14209,35764.0,Efavirenz,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Efavirenz']",0.5
14209,36242.0,Efavirenz,fatty liver disease,disease-protein-drug,contraindication,"['fatty liver disease', 'CYP1A2', 'Efavirenz']",0.5
14209,36242.0,Efavirenz,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Efavirenz']",0.5
14209,36242.0,Efavirenz,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Cadmium', 'ALB', 'Efavirenz']",0.5
14209,37703.0,Efavirenz,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Efavirenz']",0.5
14209,37743.0,Efavirenz,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Efavirenz']",0.5
14209,37805.0,Efavirenz,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Efavirenz']",0.5
14209,83760.0,Efavirenz,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Efavirenz']",0.5
14209,84131.0,Efavirenz,non-alcoholic steatohepatitis,disease-protein-drug,contraindication,"['non-alcoholic steatohepatitis', 'CYP1A2', 'Efavirenz']",0.5
14210,31493.0,Stavudine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Stavudine']",0.5
14210,33575.0,Stavudine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Stavudine']",0.5
14210,33575.0,Stavudine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Stavudine']",0.5
14210,33593.0,Stavudine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Stavudine']",0.5
14210,33593.0,Stavudine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Stavudine']",0.5
14210,35565.0,Stavudine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Stavudine']",0.5
14210,35764.0,Stavudine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Stavudine']",0.5
14210,35764.0,Stavudine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Stavudine']",0.5
14210,35764.0,Stavudine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Stavudine']",0.5
14210,36242.0,Stavudine,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Lead', 'transport', 'ALB', 'Stavudine']",0.5
14210,36242.0,Stavudine,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Cadmium', 'ALB', 'Stavudine']",0.5
14210,37805.0,Stavudine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Stavudine']",0.5
14211,27746.0,Estrone,intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['intrahepatic cholestasis', 'Elevated hepatic transaminase', 'CYP1A2', 'Estrone']",0.5
14211,27933.0,Estrone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Estrone']",0.5
14211,27933.0,Estrone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of systemic arterial blood pressure', 'AR', 'Estrone']",0.5
14211,27933.0,Estrone,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Estrone']",0.5
14211,28017.0,Estrone,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Estrone']",0.5
14211,28651.0,Estrone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'CYP2E1', 'Estrone']",0.5
14211,29061.0,Estrone,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'CYP19A1', 'Estrone']",0.5
14211,29113.0,Estrone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Estrone']",0.5
14211,29182.0,Estrone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Estrone']",0.5
14211,29182.0,Estrone,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Estrone']",0.5
14211,29182.0,Estrone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Estrone']",0.5
14211,29220.0,Estrone,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'CYP1A1', 'Estrone']",0.5
14211,29646.0,Estrone,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'CYP2E1', 'Estrone']",0.5
14211,29646.0,Estrone,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Estrone']",0.5
14211,29646.0,Estrone,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'CYP1B1', 'Estrone']",0.5
14211,29646.0,Estrone,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'CYP1A1', 'Estrone']",0.5
14211,30714.0,Estrone,"cholestasis, intrahepatic, of pregnancy",disease-phenotype-protein-drug,contraindication,"['cholestasis, intrahepatic, of pregnancy', 'Elevated hepatic transaminase', 'CYP1A2', 'Estrone']",0.5
14211,30756.0,Estrone,polycystic ovary syndrome,disease-protein-drug,off-label use,"['polycystic ovary syndrome', 'CYP19A1', 'Estrone']",0.5
14211,30827.0,Estrone,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'ESR2', 'Estrone']",0.5
14211,31107.0,Estrone,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Vehicle Emissions', 'methylation', 'CYP1A2', 'Estrone']",0.5
14211,31107.0,Estrone,cervical cancer,disease-exposure-gene-drug,contraindication,"['cervical cancer', 'Air Pollutants', 'CYP1B1', 'Estrone']",0.5
14211,31477.0,Estrone,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Estrone']",0.5
14211,31477.0,Estrone,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'DNA methylation', 'CYP1A1', 'Estrone']",0.5
14211,31477.0,Estrone,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Estrone']",0.5
14211,31596.0,Estrone,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Estrone']",0.5
14211,32617.0,Estrone,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Estrone']",0.5
14211,32977.0,Estrone,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Estrone']",0.5
14211,33575.0,Estrone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Estrone']",0.5
14211,33575.0,Estrone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Estrone']",0.5
14211,33575.0,Estrone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Estrone']",0.5
14211,33575.0,Estrone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Estrone']",0.5
14211,33593.0,Estrone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'CYP2E1', 'Estrone']",0.5
14211,33593.0,Estrone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'DNA methylation', 'CYP1A1', 'Estrone']",0.5
14211,33593.0,Estrone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Estrone']",0.5
14211,33598.0,Estrone,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Estrone']",0.5
14211,33598.0,Estrone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Estrone']",0.5
14211,33598.0,Estrone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Estrone']",0.5
14211,33675.0,Estrone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Estrone']",0.5
14211,33675.0,Estrone,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Estrone']",0.5
14211,33680.0,Estrone,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'CYP19A1', 'Estrone']",0.5
14211,33680.0,Estrone,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Estrone']",0.5
14211,33680.0,Estrone,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Estrone']",0.5
14211,33695.0,Estrone,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estrone']",0.5
14211,33695.0,Estrone,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Estrone']",0.5
14211,33699.0,Estrone,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Estrone']",0.5
14211,33699.0,Estrone,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'CYP1B1', 'Estrone']",0.5
14211,35565.0,Estrone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Estrone']",0.5
14211,35565.0,Estrone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Estrone']",0.5
14211,35641.0,Estrone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Estrone']",0.5
14211,35670.0,Estrone,heart valve disease,disease-exposure-gene-drug,contraindication,"['heart valve disease', 'Agent Orange', 'CYP1A1', 'Estrone']",0.5
14211,35738.0,Estrone,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR2', 'Estrone']",0.5
14211,35739.0,Estrone,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR2', 'Estrone']",0.5
14211,35901.0,Estrone,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Estrone']",0.5
14211,35901.0,Estrone,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'CYP19A1', 'Estrone']",0.5
14211,35909.0,Estrone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Estrone']",0.5
14211,35909.0,Estrone,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Estrone']",0.5
14211,35958.0,Estrone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Estrone']",0.5
14211,36035.0,Estrone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Estrone']",0.5
14211,36187.0,Estrone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR2', 'Estrone']",0.5
14211,36187.0,Estrone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Estrone']",0.5
14211,36187.0,Estrone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CYP1B1', 'Estrone']",0.5
14211,36469.0,Estrone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Estrone']",0.5
14211,36527.0,Estrone,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Estrone']",0.5
14211,36634.0,Estrone,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'CYP2E1', 'Estrone']",0.5
14211,36634.0,Estrone,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Estrone']",0.5
14211,36634.0,Estrone,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Toluene', 'CYP2E1', 'Estrone']",0.5
14211,36792.0,Estrone,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Estrone']",0.5
14211,36794.0,Estrone,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Estrone']",0.5
14211,37038.0,Estrone,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR2', 'Estrone']",0.5
14211,37047.0,Estrone,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Estrone']",0.5
14211,37082.0,Estrone,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Estrone']",0.5
14211,37150.0,Estrone,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Estrone']",0.5
14211,37152.0,Estrone,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Estrone']",0.5
14211,37180.0,Estrone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Estrone']",0.5
14211,37180.0,Estrone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Estrone']",0.5
14211,37180.0,Estrone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Estrone']",0.5
14211,37423.0,Estrone,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Estrone']",0.5
14211,37466.0,Estrone,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Estrone']",0.5
14211,37573.0,Estrone,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Estrone']",0.5
14211,37573.0,Estrone,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'CYP1B1', 'Estrone']",0.5
14211,37703.0,Estrone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Estrone']",0.5
14211,37768.0,Estrone,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Estrone']",0.5
14211,37967.0,Estrone,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Estrone']",0.5
14211,39603.0,Estrone,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Estrone']",0.5
14211,39615.0,Estrone,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Estrone']",0.5
14211,83760.0,Estrone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Estrone']",0.5
14211,83816.0,Estrone,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Estrone']",0.5
14211,83817.0,Estrone,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Estrone']",0.5
14211,83818.0,Estrone,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Estrone']",0.5
14211,83819.0,Estrone,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Estrone']",0.5
14211,83820.0,Estrone,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Estrone']",0.5
14211,83821.0,Estrone,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Estrone']",0.5
14211,83822.0,Estrone,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Estrone']",0.5
14211,83823.0,Estrone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Estrone']",0.5
14211,83824.0,Estrone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Estrone']",0.5
14212,27503.0,Verapamil,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Syncope', 'CACNA1C', 'Verapamil']",0.5
14212,28052.0,Verapamil,hypertrophic cardiomyopathy,disease-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'CACNA1C', 'Verapamil']",0.5
14212,28052.0,Verapamil,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'ABCC3', 'Verapamil']",0.5
14212,28231.0,Verapamil,supravalvular aortic stenosis (disease),disease-phenotype-protein-drug,contraindication,"['supravalvular aortic stenosis (disease)', 'Arrhythmia', 'CACNA1C', 'Verapamil']",0.5
14212,28441.0,Verapamil,hereditary angioedema with C1Inh deficiency,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema with C1Inh deficiency', 'Vomiting', 'ABCB1', 'Verapamil']",0.5
14212,28540.0,Verapamil,Wolff-Parkinson-white syndrome (disease),disease-phenotype-protein-drug,contraindication,"['Wolff-Parkinson-white syndrome (disease)', 'Sudden cardiac death', 'CACNA1C', 'Verapamil']",0.5
14212,29854.0,Verapamil,hereditary angioedema,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Verapamil']",0.5
14212,30669.0,Verapamil,Becker muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['Becker muscular dystrophy', 'Elevated hepatic transaminase', 'CYP1A2', 'Verapamil']",0.5
14212,31650.0,Verapamil,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ADRA1B', 'Verapamil']",0.5
14212,32149.0,Verapamil,Duchenne muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['Duchenne muscular dystrophy', 'Arrhythmia', 'CACNA1C', 'Verapamil']",0.5
14212,33025.0,Verapamil,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'ABCC3', 'Verapamil']",0.5
14212,33577.0,Verapamil,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Verapamil']",0.5
14212,33577.0,Verapamil,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Verapamil']",0.5
14212,33577.0,Verapamil,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Verapamil']",0.5
14212,33605.0,Verapamil,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Verapamil']",0.5
14212,33618.0,Verapamil,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'CYP2C19', 'Verapamil']",0.5
14212,33618.0,Verapamil,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Verapamil']",0.5
14212,35565.0,Verapamil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Verapamil']",0.5
14212,35565.0,Verapamil,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Verapamil']",0.5
14212,35764.0,Verapamil,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Verapamil']",0.5
14212,35764.0,Verapamil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'SLC6A4', 'Verapamil']",0.5
14212,35764.0,Verapamil,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Verapamil']",0.5
14212,35854.0,Verapamil,bone disease,disease-exposure-bioprocess-gene-drug,contraindication,"['bone disease', 'Fluorides', 'methylation', 'CYP1A2', 'Verapamil']",0.5
14212,35854.0,Verapamil,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Verapamil']",0.5
14212,36035.0,Verapamil,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Verapamil']",0.5
14212,36104.0,Verapamil,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Verapamil']",0.5
14212,36229.0,Verapamil,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Verapamil']",0.5
14212,37659.0,Verapamil,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Verapamil']",0.5
14212,37659.0,Verapamil,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Verapamil']",0.5
14212,37659.0,Verapamil,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Verapamil']",0.5
14212,39540.0,Verapamil,angioedema,disease-protein-drug,contraindication,"['angioedema', 'ALB', 'Verapamil']",0.5
14212,83803.0,Verapamil,diastolic heart failure,disease-protein-drug,off-label use,"['diastolic heart failure', 'ADRA1D', 'Verapamil']",0.5
14213,27626.0,Tamoxifen,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'thyroid hormone metabolic process', 'SULT2A1', 'Tamoxifen']",0.5
14213,27626.0,Tamoxifen,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Tamoxifen']",0.5
14213,30827.0,Tamoxifen,endometrial cancer,disease-protein-drug,off-label use,"['endometrial cancer', 'ESR2', 'Tamoxifen']",0.5
14213,31477.0,Tamoxifen,ovarian cancer,disease-protein-drug,off-label use,"['ovarian cancer', 'ESR1', 'Tamoxifen']",0.5
14213,31477.0,Tamoxifen,ovarian cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['ovarian cancer', 'Cadmium', 'inflammatory response', 'PRKCZ', 'Tamoxifen']",0.5
14213,31477.0,Tamoxifen,ovarian cancer,disease-exposure-gene-drug,off-label use,"['ovarian cancer', 'Cadmium', 'ALB', 'Tamoxifen']",0.5
14213,32617.0,Tamoxifen,hereditary breast ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Tamoxifen']",0.5
14213,33598.0,Tamoxifen,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Tamoxifen']",0.5
14213,33598.0,Tamoxifen,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Tamoxifen']",0.5
14213,33598.0,Tamoxifen,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Tamoxifen']",0.5
14213,33699.0,Tamoxifen,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Tamoxifen']",0.5
14213,33699.0,Tamoxifen,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'CYP1B1', 'Tamoxifen']",0.5
14213,35738.0,Tamoxifen,endometrial carcinoma (disease),disease-protein-drug,off-label use,"['endometrial carcinoma (disease)', 'ESR2', 'Tamoxifen']",0.5
14213,35739.0,Tamoxifen,uterine corpus cancer,disease-protein-drug,off-label use,"['uterine corpus cancer', 'ESR2', 'Tamoxifen']",0.5
14213,35909.0,Tamoxifen,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Tamoxifen']",0.5
14213,35909.0,Tamoxifen,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Tamoxifen']",0.5
14213,36527.0,Tamoxifen,yolk sac tumor,disease-protein-drug,off-label use,"['yolk sac tumor', 'ESR1', 'Tamoxifen']",0.5
14213,36792.0,Tamoxifen,ovarian mucinous adenocarcinoma,disease-protein-drug,off-label use,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Tamoxifen']",0.5
14213,36794.0,Tamoxifen,ovarian adenocarcinoma,disease-protein-drug,off-label use,"['ovarian adenocarcinoma', 'ESR1', 'Tamoxifen']",0.5
14213,37038.0,Tamoxifen,endometrium neoplasm,disease-protein-drug,off-label use,"['endometrium neoplasm', 'ESR2', 'Tamoxifen']",0.5
14213,37047.0,Tamoxifen,immature ovarian teratoma,disease-protein-drug,off-label use,"['immature ovarian teratoma', 'ESR1', 'Tamoxifen']",0.5
14213,37082.0,Tamoxifen,malignant germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant germ cell tumor of ovary', 'ESR1', 'Tamoxifen']",0.5
14213,37150.0,Tamoxifen,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Tamoxifen']",0.5
14213,37152.0,Tamoxifen,familial ovarian cancer,disease-protein-drug,off-label use,"['familial ovarian cancer', 'ESR1', 'Tamoxifen']",0.5
14213,37423.0,Tamoxifen,ovarian clear cell adenocarcinoma,disease-protein-drug,off-label use,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Tamoxifen']",0.5
14213,37466.0,Tamoxifen,ovarian small cell carcinoma,disease-protein-drug,off-label use,"['ovarian small cell carcinoma', 'ESR1', 'Tamoxifen']",0.5
14213,37967.0,Tamoxifen,ovarian endometrioid adenocarcinoma,disease-protein-drug,off-label use,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Tamoxifen']",0.5
14213,39603.0,Tamoxifen,malignant sex cord stromal tumor of ovary,disease-protein-drug,off-label use,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Tamoxifen']",0.5
14213,39615.0,Tamoxifen,borderline epithelial tumor of ovary,disease-protein-drug,off-label use,"['borderline epithelial tumor of ovary', 'ESR1', 'Tamoxifen']",0.5
14213,83816.0,Tamoxifen,ovarian carcinosarcoma,disease-protein-drug,off-label use,"['ovarian carcinosarcoma', 'ESR1', 'Tamoxifen']",0.5
14213,83817.0,Tamoxifen,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Tamoxifen']",0.5
14213,83818.0,Tamoxifen,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,off-label use,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Tamoxifen']",0.5
14213,83819.0,Tamoxifen,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Tamoxifen']",0.5
14213,83820.0,Tamoxifen,maligant granulosa cell tumor of ovary,disease-protein-drug,off-label use,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Tamoxifen']",0.5
14213,83821.0,Tamoxifen,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,off-label use,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Tamoxifen']",0.5
14213,83822.0,Tamoxifen,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,off-label use,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Tamoxifen']",0.5
14215,29182.0,Losartan,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'AGTR1', 'Losartan']",0.5
14215,29182.0,Losartan,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Losartan']",0.5
14215,31493.0,Losartan,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Losartan']",0.5
14215,33534.0,Losartan,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Losartan']",0.5
14215,33575.0,Losartan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'AGTR1', 'Losartan']",0.5
14215,33575.0,Losartan,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Losartan']",0.5
14215,33577.0,Losartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Losartan']",0.5
14215,33577.0,Losartan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Losartan']",0.5
14215,33577.0,Losartan,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Losartan']",0.5
14215,33605.0,Losartan,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Losartan']",0.5
14215,33618.0,Losartan,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'CYP2C19', 'Losartan']",0.5
14215,33618.0,Losartan,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'AGTR1', 'Losartan']",0.5
14215,35565.0,Losartan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Losartan']",0.5
14215,35565.0,Losartan,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Losartan']",0.5
14215,36035.0,Losartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Losartan']",0.5
14215,36286.0,Losartan,diabetic nephropathy,disease-protein-drug,indication,"['diabetic nephropathy', 'ALB', 'Losartan']",0.5
14215,38020.0,Losartan,neonatal jaundice,disease-protein-drug,contraindication,"['neonatal jaundice', 'UGT1A1', 'Losartan']",0.5
14215,83790.0,Losartan,gout,disease-protein-drug,contraindication,"['gout', 'SLC2A9', 'Losartan']",0.5
14215,83802.0,Losartan,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'SLC2A9', 'Losartan']",0.5
14215,83802.0,Losartan,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Losartan']",0.5
14216,29118.0,Warfarin,acquired polycythemia vera,disease-phenotype-protein-drug,contraindication,"['acquired polycythemia vera', 'Hepatomegaly', 'NR1I2', 'Warfarin']",0.5
14216,31033.0,Warfarin,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'CYP1A2', 'Warfarin']",0.5
14216,31033.0,Warfarin,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'NR1I2', 'Warfarin']",0.5
14216,32563.0,Warfarin,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,contraindication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Warfarin']",0.5
14216,32629.0,Warfarin,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'CYP1A2', 'Warfarin']",0.5
14216,32629.0,Warfarin,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'NR1I2', 'Warfarin']",0.5
14216,32719.0,Warfarin,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Prolonged neonatal jaundice', 'NR1I2', 'Warfarin']",0.5
14216,33025.0,Warfarin,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'NR1I2', 'Warfarin']",0.5
14216,33577.0,Warfarin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Warfarin']",0.5
14216,33577.0,Warfarin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Warfarin']",0.5
14216,33632.0,Warfarin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Warfarin']",0.5
14216,33632.0,Warfarin,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Warfarin']",0.5
14216,33699.0,Warfarin,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,indication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Warfarin']",0.5
14216,35565.0,Warfarin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Warfarin']",0.5
14216,35565.0,Warfarin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Warfarin']",0.5
14216,35766.0,Warfarin,thrombotic disease,disease-exposure-bioprocess-gene-drug,indication,"['thrombotic disease', 'Particulate Matter', 'methylation', 'CYP1A2', 'Warfarin']",0.5
14216,35854.0,Warfarin,bone disease,disease-exposure-bioprocess-gene-drug,contraindication,"['bone disease', 'Fluorides', 'methylation', 'CYP1A2', 'Warfarin']",0.5
14216,35854.0,Warfarin,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Warfarin']",0.5
14216,35909.0,Warfarin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Warfarin']",0.5
14216,35915.0,Warfarin,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Warfarin']",0.5
14216,36034.0,Warfarin,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Warfarin']",0.5
14216,36432.0,Warfarin,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Warfarin']",0.5
14216,36469.0,Warfarin,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Warfarin']",0.5
14216,38059.0,Warfarin,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'CYP1A2', 'Warfarin']",0.5
14216,39531.0,Warfarin,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Warfarin']",0.5
14216,83778.0,Warfarin,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Warfarin']",0.5
14216,83779.0,Warfarin,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Warfarin']",0.5
14216,83942.0,Warfarin,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Warfarin']",0.5
14217,29182.0,Furosemide,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Furosemide']",0.5
14217,29182.0,Furosemide,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Furosemide']",0.5
14217,31493.0,Furosemide,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Furosemide']",0.5
14217,33534.0,Furosemide,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Furosemide']",0.5
14217,33575.0,Furosemide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Furosemide']",0.5
14217,33575.0,Furosemide,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Furosemide']",0.5
14217,33605.0,Furosemide,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Furosemide']",0.5
14217,36432.0,Furosemide,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ALB', 'Furosemide']",0.5
14217,37180.0,Furosemide,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Furosemide']",0.5
14217,37180.0,Furosemide,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Furosemide']",0.5
14217,83802.0,Furosemide,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'female pregnancy', 'ABCC2', 'Furosemide']",0.5
14217,83802.0,Furosemide,obsolete hyperuricemia (disease),disease-exposure-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Furosemide']",0.5
14218,31493.0,Lamivudine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Lamivudine']",0.5
14218,33593.0,Lamivudine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A3', 'Lamivudine']",0.5
14218,33593.0,Lamivudine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'cellular response to oxidative stress', 'NME2', 'Lamivudine']",0.5
14218,33593.0,Lamivudine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Lamivudine']",0.5
14218,33632.0,Lamivudine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'response to oxidative stress', 'ABCC2', 'Lamivudine']",0.5
14218,33632.0,Lamivudine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Lamivudine']",0.5
14218,33695.0,Lamivudine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'cellular response to oxidative stress', 'NME2', 'Lamivudine']",0.5
14218,33695.0,Lamivudine,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Lamivudine']",0.5
14218,35565.0,Lamivudine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'female pregnancy', 'ABCC2', 'Lamivudine']",0.5
14218,35565.0,Lamivudine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Lamivudine']",0.5
14218,35764.0,Lamivudine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Lamivudine']",0.5
14218,35764.0,Lamivudine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cellular response to oxidative stress', 'NME2', 'Lamivudine']",0.5
14218,35764.0,Lamivudine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Lamivudine']",0.5
14218,36104.0,Lamivudine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Lamivudine']",0.5
14218,36229.0,Lamivudine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Lamivudine']",0.5
14218,36242.0,Lamivudine,fatty liver disease,disease-protein-drug,contraindication,"['fatty liver disease', 'ABCC2', 'Lamivudine']",0.5
14218,36242.0,Lamivudine,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Polychlorinated Biphenyls', 'female pregnancy', 'ABCC2', 'Lamivudine']",0.5
14218,36242.0,Lamivudine,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Cadmium', 'ALB', 'Lamivudine']",0.5
14218,37805.0,Lamivudine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Lamivudine']",0.5
14218,84131.0,Lamivudine,non-alcoholic steatohepatitis,disease-protein-drug,contraindication,"['non-alcoholic steatohepatitis', 'ABCC2', 'Lamivudine']",0.5
14219,30035.0,Flurbiprofen,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PTGS2', 'Flurbiprofen']",0.5
14219,33577.0,Flurbiprofen,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Flurbiprofen']",0.5
14219,33577.0,Flurbiprofen,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Flurbiprofen']",0.5
14219,35565.0,Flurbiprofen,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Flurbiprofen']",0.5
14219,35565.0,Flurbiprofen,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Flurbiprofen']",0.5
14219,35669.0,Flurbiprofen,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Flurbiprofen']",0.5
14219,35669.0,Flurbiprofen,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Flurbiprofen']",0.5
14219,35761.0,Flurbiprofen,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Flurbiprofen']",0.5
14219,35761.0,Flurbiprofen,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Flurbiprofen']",0.5
14219,35764.0,Flurbiprofen,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Flurbiprofen']",0.5
14219,35764.0,Flurbiprofen,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Flurbiprofen']",0.5
14219,35764.0,Flurbiprofen,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Flurbiprofen']",0.5
14219,37180.0,Flurbiprofen,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Flurbiprofen']",0.5
14219,37180.0,Flurbiprofen,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Flurbiprofen']",0.5
14220,27326.0,Apomorphine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Apomorphine']",0.5
14220,27326.0,Apomorphine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Apomorphine']",0.5
14220,27655.0,Apomorphine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'HTR1B', 'Apomorphine']",0.5
14220,28396.0,Apomorphine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'HTR1A', 'Apomorphine']",0.5
14220,28547.0,Apomorphine,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD1', 'Apomorphine']",0.5
14220,28547.0,Apomorphine,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Apomorphine']",0.5
14220,28547.0,Apomorphine,Parkinson disease,disease-exposure-gene-drug,indication,"['Parkinson disease', 'Lead', 'ALB', 'Apomorphine']",0.5
14220,28547.0,Apomorphine,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'HTR1A', 'Apomorphine']",0.5
14220,28801.0,Apomorphine,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD1', 'Apomorphine']",0.5
14220,28801.0,Apomorphine,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'HTR1A', 'Apomorphine']",0.5
14220,30035.0,Apomorphine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'DRD2', 'Apomorphine']",0.5
14220,30093.0,Apomorphine,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DRD1', 'Apomorphine']",0.5
14220,30093.0,Apomorphine,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'HTR1A', 'Apomorphine']",0.5
14220,31408.0,Apomorphine,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DRD1', 'Apomorphine']",0.5
14220,31408.0,Apomorphine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'HTR1A', 'Apomorphine']",0.5
14220,32759.0,Apomorphine,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DRD1', 'Apomorphine']",0.5
14220,32759.0,Apomorphine,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'HTR1A', 'Apomorphine']",0.5
14220,32974.0,Apomorphine,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DRD1', 'Apomorphine']",0.5
14220,32974.0,Apomorphine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'HTR1A', 'Apomorphine']",0.5
14220,33241.0,Apomorphine,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DRD1', 'Apomorphine']",0.5
14220,33241.0,Apomorphine,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'HTR1A', 'Apomorphine']",0.5
14220,35565.0,Apomorphine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'thyroid hormone metabolic process', 'SULT1B1', 'Apomorphine']",0.5
14220,35565.0,Apomorphine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Apomorphine']",0.5
14220,35909.0,Apomorphine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'thyroid hormone metabolic process', 'SULT1B1', 'Apomorphine']",0.5
14220,35915.0,Apomorphine,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'HTR1B', 'Apomorphine']",0.5
14220,35915.0,Apomorphine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Apomorphine']",0.5
14220,36187.0,Apomorphine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'SULT1A1', 'Apomorphine']",0.5
14220,36187.0,Apomorphine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Apomorphine']",0.5
14220,36187.0,Apomorphine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Apomorphine']",0.5
14220,83749.0,Apomorphine,drug-induced dyskinesia,disease-protein-drug,contraindication,"['drug-induced dyskinesia', 'DRD3', 'Apomorphine']",0.5
14220,83751.0,Apomorphine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Apomorphine']",0.5
14220,83778.0,Apomorphine,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'HTR1B', 'Apomorphine']",0.5
14220,83778.0,Apomorphine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Apomorphine']",0.5
14220,83779.0,Apomorphine,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'HTR1B', 'Apomorphine']",0.5
14220,83779.0,Apomorphine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Apomorphine']",0.5
14221,27746.0,Norethisterone,intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['intrahepatic cholestasis', 'Elevated hepatic transaminase', 'CYP1A2', 'Norethisterone']",0.5
14221,27933.0,Norethisterone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Norethisterone']",0.5
14221,27933.0,Norethisterone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of systemic arterial blood pressure', 'AR', 'Norethisterone']",0.5
14221,27933.0,Norethisterone,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,28017.0,Norethisterone,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Norethisterone']",0.5
14221,29061.0,Norethisterone,endometriosis of uterus,disease-protein-drug,indication,"['endometriosis of uterus', 'SRD5A1', 'Norethisterone']",0.5
14221,29182.0,Norethisterone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Norethisterone']",0.5
14221,29182.0,Norethisterone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Norethisterone']",0.5
14221,29220.0,Norethisterone,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'ALB', 'Norethisterone']",0.5
14221,29614.0,Norethisterone,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Norethisterone']",0.5
14221,29614.0,Norethisterone,osteoporosis,disease-exposure-gene-drug,indication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SHBG', 'Norethisterone']",0.5
14221,29646.0,Norethisterone,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ABCB1', 'Norethisterone']",0.5
14221,29646.0,Norethisterone,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norethisterone']",0.5
14221,29646.0,Norethisterone,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,29646.0,Norethisterone,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'ALB', 'Norethisterone']",0.5
14221,30714.0,Norethisterone,"cholestasis, intrahepatic, of pregnancy",disease-phenotype-protein-drug,contraindication,"['cholestasis, intrahepatic, of pregnancy', 'Elevated hepatic transaminase', 'CYP1A2', 'Norethisterone']",0.5
14221,30756.0,Norethisterone,polycystic ovary syndrome,disease-protein-drug,off-label use,"['polycystic ovary syndrome', 'SRD5A1', 'Norethisterone']",0.5
14221,30827.0,Norethisterone,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Norethisterone']",0.5
14221,31107.0,Norethisterone,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Vehicle Emissions', 'methylation', 'CYP1A2', 'Norethisterone']",0.5
14221,31477.0,Norethisterone,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Norethisterone']",0.5
14221,32617.0,Norethisterone,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Norethisterone']",0.5
14221,32977.0,Norethisterone,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Norethisterone']",0.5
14221,33534.0,Norethisterone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Norethisterone']",0.5
14221,33575.0,Norethisterone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Norethisterone']",0.5
14221,33575.0,Norethisterone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norethisterone']",0.5
14221,33575.0,Norethisterone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,33575.0,Norethisterone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Norethisterone']",0.5
14221,33577.0,Norethisterone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Norethisterone']",0.5
14221,33577.0,Norethisterone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,33593.0,Norethisterone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'testosterone biosynthetic process', 'SRD5A2', 'Norethisterone']",0.5
14221,33593.0,Norethisterone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Norethisterone']",0.5
14221,33598.0,Norethisterone,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Norethisterone']",0.5
14221,33598.0,Norethisterone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Norethisterone']",0.5
14221,33598.0,Norethisterone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'SHBG', 'Norethisterone']",0.5
14221,33675.0,Norethisterone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norethisterone']",0.5
14221,33675.0,Norethisterone,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,33680.0,Norethisterone,endometriosis (disease),disease-protein-drug,indication,"['endometriosis (disease)', 'SRD5A1', 'Norethisterone']",0.5
14221,33680.0,Norethisterone,endometriosis (disease),disease-exposure-bioprocess-gene-drug,indication,"['endometriosis (disease)', 'bisphenol A', 'testosterone biosynthetic process', 'SRD5A2', 'Norethisterone']",0.5
14221,33680.0,Norethisterone,endometriosis (disease),disease-exposure-gene-drug,indication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Norethisterone']",0.5
14221,33695.0,Norethisterone,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Norethisterone']",0.5
14221,33695.0,Norethisterone,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Norethisterone']",0.5
14221,33699.0,Norethisterone,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norethisterone']",0.5
14221,35565.0,Norethisterone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Norethisterone']",0.5
14221,35565.0,Norethisterone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Norethisterone']",0.5
14221,35641.0,Norethisterone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Norethisterone']",0.5
14221,35738.0,Norethisterone,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Norethisterone']",0.5
14221,35739.0,Norethisterone,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'SRD5A2', 'Norethisterone']",0.5
14221,35764.0,Norethisterone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Norethisterone']",0.5
14221,35764.0,Norethisterone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Norethisterone']",0.5
14221,35764.0,Norethisterone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,35901.0,Norethisterone,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Norethisterone']",0.5
14221,35909.0,Norethisterone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Norethisterone']",0.5
14221,36043.0,Norethisterone,primary ovarian failure,disease-protein-drug,indication,"['primary ovarian failure', 'CYP2C19', 'Norethisterone']",0.5
14221,36187.0,Norethisterone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norethisterone']",0.5
14221,36187.0,Norethisterone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,36469.0,Norethisterone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Norethisterone']",0.5
14221,36634.0,Norethisterone,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ABCB1', 'Norethisterone']",0.5
14221,36634.0,Norethisterone,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Norethisterone']",0.5
14221,36634.0,Norethisterone,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,37038.0,Norethisterone,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Norethisterone']",0.5
14221,37180.0,Norethisterone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norethisterone']",0.5
14221,37180.0,Norethisterone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'PGR', 'Norethisterone']",0.5
14221,37573.0,Norethisterone,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norethisterone']",0.5
14221,37703.0,Norethisterone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'SRD5A1', 'Norethisterone']",0.5
14221,83760.0,Norethisterone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'SRD5A1', 'Norethisterone']",0.5
14222,32905.0,Nateglinide,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Bradycardia', 'CYP2D6', 'Nateglinide']",0.5
14222,33453.0,Nateglinide,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Tremor', 'CYP2D6', 'Nateglinide']",0.5
14222,33575.0,Nateglinide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Nateglinide']",0.5
14222,33575.0,Nateglinide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Nateglinide']",0.5
14222,33575.0,Nateglinide,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Nateglinide']",0.5
14222,35565.0,Nateglinide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'ABCC8', 'Nateglinide']",0.5
14222,35565.0,Nateglinide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Nateglinide']",0.5
14223,27740.0,Risperidone,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Risperidone']",0.5
14223,28149.0,Risperidone,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Risperidone']",0.5
14223,28313.0,Risperidone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Risperidone']",0.5
14223,28313.0,Risperidone,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Risperidone']",0.5
14223,28375.0,Risperidone,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Risperidone']",0.5
14223,28396.0,Risperidone,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Risperidone']",0.5
14223,28547.0,Risperidone,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Risperidone']",0.5
14223,28547.0,Risperidone,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Risperidone']",0.5
14223,28547.0,Risperidone,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Lead', 'ALB', 'Risperidone']",0.5
14223,28547.0,Risperidone,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Risperidone']",0.5
14223,28651.0,Risperidone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2A', 'Risperidone']",0.5
14223,28780.0,Risperidone,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Risperidone']",0.5
14223,28780.0,Risperidone,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'HRH1', 'Risperidone']",0.5
14223,28780.0,Risperidone,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,28780.0,Risperidone,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Risperidone']",0.5
14223,29352.0,Risperidone,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Risperidone']",0.5
14223,29494.0,Risperidone,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Risperidone']",0.5
14223,29637.0,Risperidone,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Risperidone']",0.5
14223,29637.0,Risperidone,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD1', 'Risperidone']",0.5
14223,30035.0,Risperidone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Risperidone']",0.5
14223,30184.0,Risperidone,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Risperidone']",0.5
14223,30879.0,Risperidone,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'DRD1', 'Risperidone']",0.5
14223,31393.0,Risperidone,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Risperidone']",0.5
14223,31393.0,Risperidone,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'inflammatory response', 'HRH1', 'Risperidone']",0.5
14223,31393.0,Risperidone,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,31912.0,Risperidone,autism susceptibility 1,disease-protein-drug,indication,"['autism susceptibility 1', 'HTR1D', 'Risperidone']",0.5
14223,31912.0,Risperidone,autism susceptibility 1,disease-phenotype-protein-drug,indication,"['autism susceptibility 1', 'Seizure', 'DRD1', 'Risperidone']",0.5
14223,33449.0,Risperidone,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Risperidone']",0.5
14223,33454.0,Risperidone,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Risperidone']",0.5
14223,33575.0,Risperidone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Risperidone']",0.5
14223,33575.0,Risperidone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,33593.0,Risperidone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2A', 'Risperidone']",0.5
14223,33593.0,Risperidone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'inflammatory response', 'HRH1', 'Risperidone']",0.5
14223,33593.0,Risperidone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,33593.0,Risperidone,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Risperidone']",0.5
14223,33598.0,Risperidone,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Risperidone']",0.5
14223,33598.0,Risperidone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'visual learning', 'HRH1', 'Risperidone']",0.5
14223,33598.0,Risperidone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,33605.0,Risperidone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HTR1D', 'Risperidone']",0.5
14223,35565.0,Risperidone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Risperidone']",0.5
14223,35565.0,Risperidone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,35641.0,Risperidone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Risperidone']",0.5
14223,35641.0,Risperidone,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Risperidone']",0.5
14223,35669.0,Risperidone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Risperidone']",0.5
14223,35761.0,Risperidone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Risperidone']",0.5
14223,35761.0,Risperidone,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,35909.0,Risperidone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'HRH1', 'Risperidone']",0.5
14223,36104.0,Risperidone,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Risperidone']",0.5
14223,36187.0,Risperidone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Risperidone']",0.5
14223,36187.0,Risperidone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,36229.0,Risperidone,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Risperidone']",0.5
14223,36693.0,Risperidone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'DRD2', 'Risperidone']",0.5
14223,36693.0,Risperidone,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Risperidone']",0.5
14223,37180.0,Risperidone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Risperidone']",0.5
14223,37180.0,Risperidone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,37706.0,Risperidone,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Risperidone']",0.5
14223,37717.0,Risperidone,autism spectrum disorder,disease-protein-drug,indication,"['autism spectrum disorder', 'HTR1D', 'Risperidone']",0.5
14223,37786.0,Risperidone,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Risperidone']",0.5
14223,37786.0,Risperidone,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Risperidone']",0.5
14223,38242.0,Risperidone,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'DRD2', 'Risperidone']",0.5
14223,38242.0,Risperidone,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Risperidone']",0.5
14223,38928.0,Risperidone,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Risperidone']",0.5
14223,39081.0,Risperidone,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Risperidone']",0.5
14223,39531.0,Risperidone,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Risperidone']",0.5
14223,83763.0,Risperidone,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'HTR2A', 'Risperidone']",0.5
14223,83998.0,Risperidone,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Risperidone']",0.5
14223,84023.0,Risperidone,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Risperidone']",0.5
14223,84310.0,Risperidone,autism (disease),disease-protein-drug,indication,"['autism (disease)', 'HTR1D', 'Risperidone']",0.5
14223,84310.0,Risperidone,autism (disease),disease-exposure-bioprocess-gene-drug,indication,"['autism (disease)', 'Mercury', 'regulation of heart rate', 'DRD2', 'Risperidone']",0.5
14223,84310.0,Risperidone,autism (disease),disease-exposure-gene-drug,indication,"['autism (disease)', 'Lead', 'ALB', 'Risperidone']",0.5
14224,36274.0,Meclizine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'HRH1', 'Meclizine']",0.5
14224,36274.0,Meclizine,pyloric stenosis (disease),disease-exposure-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'ALB', 'Meclizine']",0.5
14226,27933.0,Zileuton,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Zileuton']",0.5
14226,27933.0,Zileuton,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Zileuton']",0.5
14226,27933.0,Zileuton,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Zileuton']",0.5
14226,35565.0,Zileuton,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Zileuton']",0.5
14226,35565.0,Zileuton,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Zileuton']",0.5
14226,37703.0,Zileuton,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Zileuton']",0.5
14226,39773.0,Zileuton,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ALOX5', 'Zileuton']",0.5
14226,83760.0,Zileuton,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Zileuton']",0.5
14226,83781.0,Zileuton,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ALOX5', 'Zileuton']",0.5
14227,27366.0,Etodolac,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Etodolac']",0.5
14227,29078.0,Etodolac,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Etodolac']",0.5
14227,29078.0,Etodolac,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Etodolac']",0.5
14227,29078.0,Etodolac,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Etodolac']",0.5
14227,29078.0,Etodolac,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Etodolac']",0.5
14227,33577.0,Etodolac,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Etodolac']",0.5
14227,33577.0,Etodolac,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Etodolac']",0.5
14227,35565.0,Etodolac,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Etodolac']",0.5
14227,35565.0,Etodolac,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Etodolac']",0.5
14227,35669.0,Etodolac,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Etodolac']",0.5
14227,35669.0,Etodolac,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Etodolac']",0.5
14227,35761.0,Etodolac,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Etodolac']",0.5
14227,35761.0,Etodolac,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Etodolac']",0.5
14227,35764.0,Etodolac,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Etodolac']",0.5
14227,35764.0,Etodolac,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Etodolac']",0.5
14227,35764.0,Etodolac,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Etodolac']",0.5
14227,37180.0,Etodolac,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Etodolac']",0.5
14227,37180.0,Etodolac,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Etodolac']",0.5
14228,33605.0,Isoflurane,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIA1', 'Isoflurane']",0.5
14228,35565.0,Isoflurane,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Isoflurane']",0.5
14228,35565.0,Isoflurane,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Isoflurane']",0.5
14229,27933.0,Tretinoin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Tretinoin']",0.5
14229,27933.0,Tretinoin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'CRABP2', 'Tretinoin']",0.5
14229,27933.0,Tretinoin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Tretinoin']",0.5
14229,27933.0,Tretinoin,anxiety disorder,disease-exposure-molfunc-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'glutathione transferase activity', 'HPGDS', 'Tretinoin']",0.5
14229,28158.0,Tretinoin,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Tretinoin']",0.5
14229,28158.0,Tretinoin,inflammatory bowel disease,disease-exposure-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'CYP1A1', 'Tretinoin']",0.5
14229,28651.0,Tretinoin,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'CYP26B1', 'Tretinoin']",0.5
14229,28764.0,Tretinoin,Sjogren syndrome,disease-phenotype-protein-drug,contraindication,"['Sjogren syndrome', 'Thrombocytopenia', 'ALB', 'Tretinoin']",0.5
14229,29352.0,Tretinoin,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Tretinoin']",0.5
14229,29361.0,Tretinoin,acute promyelocytic leukemia,disease-protein-drug,indication,"['acute promyelocytic leukemia', 'RARA', 'Tretinoin']",0.5
14229,29361.0,Tretinoin,acute promyelocytic leukemia,disease-phenotype-protein-drug,indication,"['acute promyelocytic leukemia', 'Thrombocytopenia', 'ALB', 'Tretinoin']",0.5
14229,29494.0,Tretinoin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A1', 'Tretinoin']",0.5
14229,29614.0,Tretinoin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'RARA', 'Tretinoin']",0.5
14229,29614.0,Tretinoin,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Tretinoin']",0.5
14229,30035.0,Tretinoin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2B6', 'Tretinoin']",0.5
14229,30184.0,Tretinoin,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A1', 'Tretinoin']",0.5
14229,30990.0,Tretinoin,mycosis fungoides and variants,disease-phenotype-protein-drug,contraindication,"['mycosis fungoides and variants', 'Hepatomegaly', 'CYP1A1', 'Tretinoin']",0.5
14229,31072.0,Tretinoin,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CYP1A1', 'Tretinoin']",0.5
14229,31493.0,Tretinoin,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Tretinoin']",0.5
14229,33025.0,Tretinoin,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'CYP1A1', 'Tretinoin']",0.5
14229,33575.0,Tretinoin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'PDK4', 'Tretinoin']",0.5
14229,33575.0,Tretinoin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Tretinoin']",0.5
14229,33575.0,Tretinoin,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'glutathione transferase activity', 'HPGDS', 'Tretinoin']",0.5
14229,33593.0,Tretinoin,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'CYP26B1', 'Tretinoin']",0.5
14229,33593.0,Tretinoin,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'PDK4', 'Tretinoin']",0.5
14229,33593.0,Tretinoin,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Tretinoin']",0.5
14229,33695.0,Tretinoin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'glucose homeostasis', 'PDK4', 'Tretinoin']",0.5
14229,33695.0,Tretinoin,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Tretinoin']",0.5
14229,33695.0,Tretinoin,hypertriglyceridemia (disease),disease-exposure-molfunc-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Metals, Heavy', 'glutathione transferase activity', 'HPGDS', 'Tretinoin']",0.5
14229,35565.0,Tretinoin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'CYP26B1', 'Tretinoin']",0.5
14229,35565.0,Tretinoin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Tretinoin']",0.5
14229,35669.0,Tretinoin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'blood vessel development', 'ALDH1A2', 'Tretinoin']",0.5
14229,35669.0,Tretinoin,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Arsenic', 'CYP1A1', 'Tretinoin']",0.5
14229,35669.0,Tretinoin,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Metals, Heavy', 'glutathione transferase activity', 'HPGDS', 'Tretinoin']",0.5
14229,35761.0,Tretinoin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose metabolic process', 'PDK4', 'Tretinoin']",0.5
14229,35761.0,Tretinoin,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'CYP1A1', 'Tretinoin']",0.5
14229,35761.0,Tretinoin,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'glutathione transferase activity', 'HPGDS', 'Tretinoin']",0.5
14229,35764.0,Tretinoin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Tretinoin']",0.5
14229,35764.0,Tretinoin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'PDK4', 'Tretinoin']",0.5
14229,35764.0,Tretinoin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Tretinoin']",0.5
14229,35854.0,Tretinoin,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Tretinoin']",0.5
14229,35915.0,Tretinoin,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Tretinoin']",0.5
14229,35916.0,Tretinoin,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Mercury', 'glucose homeostasis', 'PDK4', 'Tretinoin']",0.5
14229,35916.0,Tretinoin,dry eye syndrome,disease-exposure-gene-drug,contraindication,"['dry eye syndrome', 'Lead', 'ALB', 'Tretinoin']",0.5
14229,36129.0,Tretinoin,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Mercury', 'glucose homeostasis', 'PDK4', 'Tretinoin']",0.5
14229,36129.0,Tretinoin,atopic eczema,disease-exposure-gene-drug,contraindication,"['atopic eczema', 'Lead', 'ALB', 'Tretinoin']",0.5
14229,36241.0,Tretinoin,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Tretinoin']",0.5
14229,36432.0,Tretinoin,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Tretinoin']",0.5
14229,37180.0,Tretinoin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'blood vessel development', 'ALDH1A2', 'Tretinoin']",0.5
14229,37180.0,Tretinoin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'CYP1A1', 'Tretinoin']",0.5
14229,37180.0,Tretinoin,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'glutathione transferase activity', 'HPGDS', 'Tretinoin']",0.5
14229,37703.0,Tretinoin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Tretinoin']",0.5
14229,37785.0,Tretinoin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'spermatogenesis', 'CYP26B1', 'Tretinoin']",0.5
14229,39798.0,Tretinoin,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'blood vessel development', 'ALDH1A2', 'Tretinoin']",0.5
14229,39798.0,Tretinoin,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'CYP1A1', 'Tretinoin']",0.5
14229,83760.0,Tretinoin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Tretinoin']",0.5
14229,83778.0,Tretinoin,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Tretinoin']",0.5
14229,83779.0,Tretinoin,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Tretinoin']",0.5
14230,27286.0,Tetracycline,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5
14230,27292.0,Tetracycline,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5
14230,27700.0,Tetracycline,sclerosing cholangitis,disease-exposure-bioprocess-gene-drug,off-label use,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Tetracycline']",0.5
14230,27700.0,Tetracycline,sclerosing cholangitis,disease-phenotype-protein-drug,off-label use,"['sclerosing cholangitis', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5
14230,32932.0,Tetracycline,brucellosis,disease-phenotype-protein-drug,indication,"['brucellosis', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5
14230,32949.0,Tetracycline,relapsing fever,disease-phenotype-protein-drug,indication,"['relapsing fever', 'Thrombocytopenia', 'ALB', 'Tetracycline']",0.5
14230,32959.0,Tetracycline,Q fever,disease-phenotype-protein-drug,indication,"['Q fever', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5
14230,33128.0,Tetracycline,malaria,disease-phenotype-protein-drug,off-label use,"['malaria', 'Thrombocytopenia', 'ALB', 'Tetracycline']",0.5
14230,33193.0,Tetracycline,plague,disease-phenotype-protein-drug,off-label use,"['plague', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5
14230,33314.0,Tetracycline,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Tetracycline']",0.5
14230,33332.0,Tetracycline,tularemia,disease-phenotype-protein-drug,off-label use,"['tularemia', 'Thrombocytopenia', 'ALB', 'Tetracycline']",0.5
14230,33575.0,Tetracycline,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'innate immune response', 'PADI4', 'Tetracycline']",0.5
14230,33575.0,Tetracycline,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Tetracycline']",0.5
14230,33618.0,Tetracycline,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Tetracycline']",0.5
14230,33678.0,Tetracycline,glomerulonephritis,disease-protein-drug,contraindication,"['glomerulonephritis', 'ALB', 'Tetracycline']",0.5
14230,35552.0,Tetracycline,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'innate immune response', 'PADI4', 'Tetracycline']",0.5
14230,35565.0,Tetracycline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Tetracycline']",0.5
14230,35565.0,Tetracycline,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Tetracycline']",0.5
14230,35641.0,Tetracycline,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Tetracycline']",0.5
14230,35764.0,Tetracycline,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Tetracycline']",0.5
14230,35764.0,Tetracycline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Tetracycline']",0.5
14230,35764.0,Tetracycline,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Tetracycline']",0.5
14230,37830.0,Tetracycline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Nicotine', 'stem cell population maintenance', 'PADI4', 'Tetracycline']",0.5
14231,27476.0,Irinotecan,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Irinotecan']",0.5
14231,27476.0,Irinotecan,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Irinotecan']",0.5
14231,27626.0,Irinotecan,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Irinotecan']",0.5
14231,29173.0,Irinotecan,small cell lung carcinoma,disease-protein-drug,off-label use,"['small cell lung carcinoma', 'UGT1A1', 'Irinotecan']",0.5
14231,29173.0,Irinotecan,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'response to folic acid', 'BCHE', 'Irinotecan']",0.5
14231,29173.0,Irinotecan,small cell lung carcinoma,disease-exposure-molfunc-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Irinotecan']",0.5
14231,31116.0,Irinotecan,lung cancer,disease-protein-drug,off-label use,"['lung cancer', 'ABCB1', 'Irinotecan']",0.5
14231,31493.0,Irinotecan,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Irinotecan']",0.5
14231,33594.0,Irinotecan,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Irinotecan']",0.5
14231,33594.0,Irinotecan,diarrheal disease,disease-exposure-molfunc-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Irinotecan']",0.5
14231,33632.0,Irinotecan,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'choline metabolic process', 'BCHE', 'Irinotecan']",0.5
14231,33632.0,Irinotecan,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Irinotecan']",0.5
14231,33688.0,Irinotecan,non-small cell lung carcinoma (disease),disease-protein-drug,off-label use,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Irinotecan']",0.5
14231,35565.0,Irinotecan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CES1', 'Irinotecan']",0.5
14231,35565.0,Irinotecan,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Irinotecan']",0.5
14231,35764.0,Irinotecan,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Irinotecan']",0.5
14231,35764.0,Irinotecan,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Irinotecan']",0.5
14231,35764.0,Irinotecan,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Irinotecan']",0.5
14231,35764.0,Irinotecan,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Irinotecan']",0.5
14231,36104.0,Irinotecan,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Irinotecan']",0.5
14231,36229.0,Irinotecan,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Irinotecan']",0.5
14231,36645.0,Irinotecan,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Irinotecan']",0.5
14231,36983.0,Irinotecan,astrocytoma (excluding glioblastoma),disease-exposure-bioprocess-gene-drug,off-label use,"['astrocytoma (excluding glioblastoma)', 'Lead', 'choline metabolic process', 'BCHE', 'Irinotecan']",0.5
14231,36983.0,Irinotecan,astrocytoma (excluding glioblastoma),disease-exposure-gene-drug,off-label use,"['astrocytoma (excluding glioblastoma)', 'Lead', 'ALB', 'Irinotecan']",0.5
14231,38312.0,Irinotecan,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'ABCC2', 'Irinotecan']",0.5
14232,36091.0,Olopatadine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Olopatadine']",0.5
14232,37888.0,Olopatadine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Olopatadine']",0.5
14232,37888.0,Olopatadine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cognition', 'HRH3', 'Olopatadine']",0.5
14232,37888.0,Olopatadine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Olopatadine']",0.5
14232,83791.0,Olopatadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Olopatadine']",0.5
14233,27933.0,Hydroflumethiazide,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Hydroflumethiazide']",0.5
14233,27933.0,Hydroflumethiazide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'ATP1A1', 'Hydroflumethiazide']",0.5
14233,27933.0,Hydroflumethiazide,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Hydroflumethiazide']",0.5
14233,28158.0,Hydroflumethiazide,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'regulation of blood pressure', 'ATP1A1', 'Hydroflumethiazide']",0.5
14233,33577.0,Hydroflumethiazide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ATP1A1', 'Hydroflumethiazide']",0.5
14233,33577.0,Hydroflumethiazide,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Hydroflumethiazide']",0.5
14233,35641.0,Hydroflumethiazide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Hydroflumethiazide']",0.5
14233,35764.0,Hydroflumethiazide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Hydroflumethiazide']",0.5
14233,35764.0,Hydroflumethiazide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ATP1A1', 'Hydroflumethiazide']",0.5
14233,35764.0,Hydroflumethiazide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Hydroflumethiazide']",0.5
14233,36432.0,Hydroflumethiazide,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ALB', 'Hydroflumethiazide']",0.5
14233,37703.0,Hydroflumethiazide,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Hydroflumethiazide']",0.5
14233,83760.0,Hydroflumethiazide,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Hydroflumethiazide']",0.5
14234,27933.0,Oxcarbazepine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Oxcarbazepine']",0.5
14234,27933.0,Oxcarbazepine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'positive regulation of heart rate', 'SCN3B', 'Oxcarbazepine']",0.5
14234,27933.0,Oxcarbazepine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Oxcarbazepine']",0.5
14234,36743.0,Oxcarbazepine,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'SCN3A', 'Oxcarbazepine']",0.5
14234,37703.0,Oxcarbazepine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Oxcarbazepine']",0.5
14234,83760.0,Oxcarbazepine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Oxcarbazepine']",0.5
14234,83928.0,Oxcarbazepine,partial motor epilepsy,disease-protein-drug,indication,"['partial motor epilepsy', 'SCN3A', 'Oxcarbazepine']",0.5
14235,27746.0,Estradiol,intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['intrahepatic cholestasis', 'Elevated hepatic transaminase', 'CYP1A2', 'Estradiol']",0.5
14235,27933.0,Estradiol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Estradiol']",0.5
14235,27933.0,Estradiol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Estradiol']",0.5
14235,27933.0,Estradiol,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Estradiol']",0.5
14235,28017.0,Estradiol,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Estradiol']",0.5
14235,28651.0,Estradiol,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A3', 'Estradiol']",0.5
14235,29061.0,Estradiol,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'ESR2', 'Estradiol']",0.5
14235,29182.0,Estradiol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Estradiol']",0.5
14235,29182.0,Estradiol,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Estradiol']",0.5
14235,29182.0,Estradiol,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Estradiol']",0.5
14235,29220.0,Estradiol,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'NR1I2', 'Estradiol']",0.5
14235,29614.0,Estradiol,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'COMT', 'Estradiol']",0.5
14235,29614.0,Estradiol,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SHBG', 'Estradiol']",0.5
14235,29646.0,Estradiol,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ABCB1', 'Estradiol']",0.5
14235,29646.0,Estradiol,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol']",0.5
14235,29646.0,Estradiol,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,29646.0,Estradiol,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'NR1I2', 'Estradiol']",0.5
14235,30035.0,Estradiol,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Estradiol']",0.5
14235,30714.0,Estradiol,"cholestasis, intrahepatic, of pregnancy",disease-phenotype-protein-drug,contraindication,"['cholestasis, intrahepatic, of pregnancy', 'Elevated hepatic transaminase', 'CYP1A2', 'Estradiol']",0.5
14235,30813.0,Estradiol,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'CHRNA4', 'Estradiol']",0.5
14235,30827.0,Estradiol,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'ESR2', 'Estradiol']",0.5
14235,31107.0,Estradiol,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Vehicle Emissions', 'methylation', 'COMT', 'Estradiol']",0.5
14235,31107.0,Estradiol,cervical cancer,disease-exposure-gene-drug,contraindication,"['cervical cancer', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,31393.0,Estradiol,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'NR1I2', 'Estradiol']",0.5
14235,31393.0,Estradiol,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol']",0.5
14235,31393.0,Estradiol,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Estradiol']",0.5
14235,31395.0,Estradiol,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Estradiol']",0.5
14235,31477.0,Estradiol,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Estradiol']",0.5
14235,31477.0,Estradiol,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'cognition', 'CHRNA4', 'Estradiol']",0.5
14235,31477.0,Estradiol,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Estradiol']",0.5
14235,31596.0,Estradiol,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Estradiol']",0.5
14235,31732.0,Estradiol,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'COMT', 'Estradiol']",0.5
14235,32313.0,Estradiol,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRNA4', 'Estradiol']",0.5
14235,32395.0,Estradiol,toxic shock syndrome,disease-phenotype-protein-drug,contraindication,"['toxic shock syndrome', 'Thrombocytopenia', 'ALB', 'Estradiol']",0.5
14235,32617.0,Estradiol,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Estradiol']",0.5
14235,32719.0,Estradiol,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'ESR2', 'Estradiol']",0.5
14235,32977.0,Estradiol,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Estradiol']",0.5
14235,32977.0,Estradiol,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CHRNA4', 'Estradiol']",0.5
14235,33534.0,Estradiol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Estradiol']",0.5
14235,33575.0,Estradiol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Estradiol']",0.5
14235,33575.0,Estradiol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol']",0.5
14235,33575.0,Estradiol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Estradiol']",0.5
14235,33577.0,Estradiol,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Estradiol']",0.5
14235,33577.0,Estradiol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol']",0.5
14235,33577.0,Estradiol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Estradiol']",0.5
14235,33593.0,Estradiol,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A3', 'Estradiol']",0.5
14235,33593.0,Estradiol,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Organophosphorus Compounds', 'developmental process', 'COMT', 'Estradiol']",0.5
14235,33593.0,Estradiol,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Estradiol']",0.5
14235,33598.0,Estradiol,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Estradiol']",0.5
14235,33598.0,Estradiol,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'CHRNA4', 'Estradiol']",0.5
14235,33598.0,Estradiol,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Estradiol']",0.5
14235,33675.0,Estradiol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol']",0.5
14235,33675.0,Estradiol,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,33680.0,Estradiol,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'ESR2', 'Estradiol']",0.5
14235,33680.0,Estradiol,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR2', 'Estradiol']",0.5
14235,33680.0,Estradiol,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Estradiol']",0.5
14235,33695.0,Estradiol,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol']",0.5
14235,33695.0,Estradiol,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Estradiol']",0.5
14235,33699.0,Estradiol,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol']",0.5
14235,33699.0,Estradiol,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,35565.0,Estradiol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Estradiol']",0.5
14235,35565.0,Estradiol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Estradiol']",0.5
14235,35641.0,Estradiol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Estradiol']",0.5
14235,35669.0,Estradiol,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Estradiol']",0.5
14235,35669.0,Estradiol,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol']",0.5
14235,35669.0,Estradiol,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,35670.0,Estradiol,heart valve disease,disease-exposure-gene-drug,contraindication,"['heart valve disease', 'Agent Orange', 'CYP1A1', 'Estradiol']",0.5
14235,35738.0,Estradiol,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR2', 'Estradiol']",0.5
14235,35739.0,Estradiol,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR2', 'Estradiol']",0.5
14235,35761.0,Estradiol,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol']",0.5
14235,35761.0,Estradiol,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,35764.0,Estradiol,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Estradiol']",0.5
14235,35764.0,Estradiol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol']",0.5
14235,35764.0,Estradiol,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Estradiol']",0.5
14235,35901.0,Estradiol,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Estradiol']",0.5
14235,35901.0,Estradiol,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Estradiol']",0.5
14235,35909.0,Estradiol,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRNA4', 'Estradiol']",0.5
14235,35909.0,Estradiol,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,35958.0,Estradiol,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Estradiol']",0.5
14235,35963.0,Estradiol,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP2C19', 'Estradiol']",0.5
14235,35966.0,Estradiol,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP2C19', 'Estradiol']",0.5
14235,35966.0,Estradiol,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol']",0.5
14235,35966.0,Estradiol,prostate cancer,disease-exposure-gene-drug,contraindication,"['prostate cancer', 'Agent Orange', 'CYP1A1', 'Estradiol']",0.5
14235,36035.0,Estradiol,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Estradiol']",0.5
14235,36043.0,Estradiol,primary ovarian failure,disease-protein-drug,indication,"['primary ovarian failure', 'CYP2C19', 'Estradiol']",0.5
14235,36187.0,Estradiol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR2', 'Estradiol']",0.5
14235,36187.0,Estradiol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol']",0.5
14235,36187.0,Estradiol,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,36432.0,Estradiol,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Estradiol']",0.5
14235,36469.0,Estradiol,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Estradiol']",0.5
14235,36527.0,Estradiol,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Estradiol']",0.5
14235,36634.0,Estradiol,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ABCB1', 'Estradiol']",0.5
14235,36634.0,Estradiol,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'cognition', 'CHRNA4', 'Estradiol']",0.5
14235,36634.0,Estradiol,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,36792.0,Estradiol,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Estradiol']",0.5
14235,36794.0,Estradiol,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Estradiol']",0.5
14235,37038.0,Estradiol,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR2', 'Estradiol']",0.5
14235,37047.0,Estradiol,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Estradiol']",0.5
14235,37082.0,Estradiol,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Estradiol']",0.5
14235,37150.0,Estradiol,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Estradiol']",0.5
14235,37152.0,Estradiol,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Estradiol']",0.5
14235,37180.0,Estradiol,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Estradiol']",0.5
14235,37180.0,Estradiol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol']",0.5
14235,37180.0,Estradiol,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,37423.0,Estradiol,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Estradiol']",0.5
14235,37466.0,Estradiol,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Estradiol']",0.5
14235,37573.0,Estradiol,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol']",0.5
14235,37573.0,Estradiol,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,37659.0,Estradiol,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Estradiol']",0.5
14235,37659.0,Estradiol,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol']",0.5
14235,37659.0,Estradiol,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'CYP1B1', 'Estradiol']",0.5
14235,37703.0,Estradiol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Estradiol']",0.5
14235,37768.0,Estradiol,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Estradiol']",0.5
14235,37967.0,Estradiol,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Estradiol']",0.5
14235,38928.0,Estradiol,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'NR1I2', 'Estradiol']",0.5
14235,39603.0,Estradiol,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Estradiol']",0.5
14235,39615.0,Estradiol,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Estradiol']",0.5
14235,83760.0,Estradiol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Estradiol']",0.5
14235,83764.0,Estradiol,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'developmental process', 'COMT', 'Estradiol']",0.5
14235,83816.0,Estradiol,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Estradiol']",0.5
14235,83817.0,Estradiol,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Estradiol']",0.5
14235,83818.0,Estradiol,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Estradiol']",0.5
14235,83819.0,Estradiol,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Estradiol']",0.5
14235,83820.0,Estradiol,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Estradiol']",0.5
14235,83821.0,Estradiol,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Estradiol']",0.5
14235,83822.0,Estradiol,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Estradiol']",0.5
14235,83823.0,Estradiol,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Estradiol']",0.5
14235,83824.0,Estradiol,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Estradiol']",0.5
14236,33577.0,Mefenamic acid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Mefenamic acid']",0.5
14236,33577.0,Mefenamic acid,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Mefenamic acid']",0.5
14236,35565.0,Mefenamic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Mefenamic acid']",0.5
14236,35565.0,Mefenamic acid,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Mefenamic acid']",0.5
14236,35669.0,Mefenamic acid,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Mefenamic acid']",0.5
14236,35669.0,Mefenamic acid,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Mefenamic acid']",0.5
14236,35761.0,Mefenamic acid,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Mefenamic acid']",0.5
14236,35761.0,Mefenamic acid,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Mefenamic acid']",0.5
14236,35764.0,Mefenamic acid,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Mefenamic acid']",0.5
14236,35764.0,Mefenamic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Mefenamic acid']",0.5
14236,35764.0,Mefenamic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Mefenamic acid']",0.5
14236,37180.0,Mefenamic acid,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Mefenamic acid']",0.5
14236,37180.0,Mefenamic acid,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Mefenamic acid']",0.5
14237,28651.0,Acyclovir,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SUCLA2', 'Acyclovir']",0.5
14237,32886.0,Acyclovir,typical hemolytic-uremic syndrome,disease-protein-drug,contraindication,"['typical hemolytic-uremic syndrome', 'ALB', 'Acyclovir']",0.5
14237,32886.0,Acyclovir,typical hemolytic-uremic syndrome,disease-phenotype-protein-drug,contraindication,"['typical hemolytic-uremic syndrome', 'Thrombocytopenia', 'ALB', 'Acyclovir']",0.5
14237,33440.0,Acyclovir,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Thrombocytopenia', 'ALB', 'Acyclovir']",0.5
14237,33575.0,Acyclovir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'PCK1', 'Acyclovir']",0.5
14237,33575.0,Acyclovir,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Acyclovir']",0.5
14237,33577.0,Acyclovir,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'PCK1', 'Acyclovir']",0.5
14237,33577.0,Acyclovir,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Acyclovir']",0.5
14237,33593.0,Acyclovir,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SUCLA2', 'Acyclovir']",0.5
14237,33593.0,Acyclovir,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'PCK1', 'Acyclovir']",0.5
14237,33593.0,Acyclovir,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Acyclovir']",0.5
14237,33598.0,Acyclovir,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Acyclovir']",0.5
14237,33598.0,Acyclovir,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'glucose homeostasis', 'PCK1', 'Acyclovir']",0.5
14237,33598.0,Acyclovir,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Acyclovir']",0.5
14237,35764.0,Acyclovir,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Acyclovir']",0.5
14237,35764.0,Acyclovir,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'PCK1', 'Acyclovir']",0.5
14237,35764.0,Acyclovir,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Acyclovir']",0.5
14237,35909.0,Acyclovir,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'NME1', 'Acyclovir']",0.5
14237,35958.0,Acyclovir,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'CKB', 'Acyclovir']",0.5
14237,37180.0,Acyclovir,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'CKB', 'Acyclovir']",0.5
14237,37180.0,Acyclovir,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'PCK1', 'Acyclovir']",0.5
14237,37180.0,Acyclovir,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Acyclovir']",0.5
14237,39020.0,Acyclovir,hemolytic-uremic syndrome,disease-protein-drug,contraindication,"['hemolytic-uremic syndrome', 'ALB', 'Acyclovir']",0.5
14237,39798.0,Acyclovir,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'glucose homeostasis', 'PCK1', 'Acyclovir']",0.5
14237,39798.0,Acyclovir,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'ALB', 'Acyclovir']",0.5
14237,83764.0,Acyclovir,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'PCK1', 'Acyclovir']",0.5
14237,83823.0,Acyclovir,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'CKB', 'Acyclovir']",0.5
14237,83824.0,Acyclovir,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'CKB', 'Acyclovir']",0.5
14238,27366.0,Naproxen,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Naproxen']",0.5
14238,28017.0,Naproxen,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Naproxen']",0.5
14238,28651.0,Naproxen,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'PTGS2', 'Naproxen']",0.5
14238,29078.0,Naproxen,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Naproxen']",0.5
14238,29078.0,Naproxen,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Naproxen']",0.5
14238,29078.0,Naproxen,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,29078.0,Naproxen,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Naproxen']",0.5
14238,29614.0,Naproxen,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'bone mineralization', 'PTGS2', 'Naproxen']",0.5
14238,29614.0,Naproxen,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Naproxen']",0.5
14238,30035.0,Naproxen,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Naproxen']",0.5
14238,31395.0,Naproxen,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Naproxen']",0.5
14238,32325.0,Naproxen,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Naproxen']",0.5
14238,33091.0,Naproxen,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Fever', 'PTGS2', 'Naproxen']",0.5
14238,33302.0,Naproxen,familial or sporadic hemiplegic migraine,disease-phenotype-protein-drug,contraindication,"['familial or sporadic hemiplegic migraine', 'Focal sensory seizure', 'ABCB1', 'Naproxen']",0.5
14238,33575.0,Naproxen,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Naproxen']",0.5
14238,33575.0,Naproxen,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Naproxen']",0.5
14238,33575.0,Naproxen,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,33577.0,Naproxen,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Naproxen']",0.5
14238,33577.0,Naproxen,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,33593.0,Naproxen,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'PTGS2', 'Naproxen']",0.5
14238,33593.0,Naproxen,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'regulation of blood pressure', 'PTGS1', 'Naproxen']",0.5
14238,33593.0,Naproxen,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Naproxen']",0.5
14238,33598.0,Naproxen,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Naproxen']",0.5
14238,33598.0,Naproxen,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Naproxen']",0.5
14238,33598.0,Naproxen,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,33603.0,Naproxen,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'PTGS2', 'Naproxen']",0.5
14238,35565.0,Naproxen,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Naproxen']",0.5
14238,35565.0,Naproxen,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Naproxen']",0.5
14238,35641.0,Naproxen,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Naproxen']",0.5
14238,35669.0,Naproxen,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Naproxen']",0.5
14238,35669.0,Naproxen,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,35761.0,Naproxen,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Naproxen']",0.5
14238,35761.0,Naproxen,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,35764.0,Naproxen,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Naproxen']",0.5
14238,35764.0,Naproxen,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Naproxen']",0.5
14238,35764.0,Naproxen,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Naproxen']",0.5
14238,35909.0,Naproxen,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Naproxen']",0.5
14238,35909.0,Naproxen,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,35953.0,Naproxen,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'PTGS2', 'Naproxen']",0.5
14238,35953.0,Naproxen,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Naproxen']",0.5
14238,35953.0,Naproxen,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,36034.0,Naproxen,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Naproxen']",0.5
14238,36187.0,Naproxen,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PTGS2', 'Naproxen']",0.5
14238,36187.0,Naproxen,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Naproxen']",0.5
14238,36187.0,Naproxen,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,36312.0,Naproxen,transient ischemic attack (disease),disease-protein-drug,contraindication,"['transient ischemic attack (disease)', 'PTGS2', 'Naproxen']",0.5
14238,36312.0,Naproxen,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Naproxen']",0.5
14238,36432.0,Naproxen,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Naproxen']",0.5
14238,37180.0,Naproxen,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Naproxen']",0.5
14238,37180.0,Naproxen,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,37718.0,Naproxen,brain ischemia,disease-protein-drug,contraindication,"['brain ischemia', 'PTGS2', 'Naproxen']",0.5
14238,37718.0,Naproxen,brain ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Naproxen']",0.5
14238,37718.0,Naproxen,brain ischemia,disease-exposure-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,37786.0,Naproxen,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Naproxen']",0.5
14238,37786.0,Naproxen,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14238,38044.0,Naproxen,coronary atherosclerosis,disease-protein-drug,contraindication,"['coronary atherosclerosis', 'PTGS2', 'Naproxen']",0.5
14238,39798.0,Naproxen,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Naproxen']",0.5
14238,39798.0,Naproxen,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'PTGS1', 'Naproxen']",0.5
14239,33605.0,Alfentanil,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Alfentanil']",0.5
14239,35565.0,Alfentanil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Alfentanil']",0.5
14239,35565.0,Alfentanil,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Alfentanil']",0.5
14239,35764.0,Alfentanil,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Alfentanil']",0.5
14239,35764.0,Alfentanil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Alfentanil']",0.5
14239,35764.0,Alfentanil,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Alfentanil']",0.5
14240,33575.0,Indapamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Indapamide']",0.5
14240,33575.0,Indapamide,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Indapamide']",0.5
14240,35565.0,Indapamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Indapamide']",0.5
14240,35565.0,Indapamide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Indapamide']",0.5
14240,36432.0,Indapamide,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ALB', 'Indapamide']",0.5
14240,83802.0,Indapamide,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Indapamide']",0.5
14241,27326.0,Fentanyl,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fentanyl']",0.5
14241,27655.0,Fentanyl,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'OPRM1', 'Fentanyl']",0.5
14241,27933.0,Fentanyl,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Fentanyl']",0.5
14241,27933.0,Fentanyl,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fentanyl']",0.5
14241,27933.0,Fentanyl,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Fentanyl']",0.5
14241,28017.0,Fentanyl,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Fentanyl']",0.5
14241,28149.0,Fentanyl,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Fentanyl']",0.5
14241,28158.0,Fentanyl,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Fentanyl']",0.5
14241,28158.0,Fentanyl,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Fentanyl']",0.5
14241,28158.0,Fentanyl,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Fentanyl']",0.5
14241,30035.0,Fentanyl,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Fentanyl']",0.5
14241,31072.0,Fentanyl,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Fentanyl']",0.5
14241,31122.0,Fentanyl,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'ALB', 'Fentanyl']",0.5
14241,31493.0,Fentanyl,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Fentanyl']",0.5
14241,31650.0,Fentanyl,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'OPRM1', 'Fentanyl']",0.5
14241,33454.0,Fentanyl,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Fentanyl']",0.5
14241,33577.0,Fentanyl,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Fentanyl']",0.5
14241,33577.0,Fentanyl,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Fentanyl']",0.5
14241,33605.0,Fentanyl,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Fentanyl']",0.5
14241,33675.0,Fentanyl,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fentanyl']",0.5
14241,35565.0,Fentanyl,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Fentanyl']",0.5
14241,35565.0,Fentanyl,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Fentanyl']",0.5
14241,35669.0,Fentanyl,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fentanyl']",0.5
14241,35761.0,Fentanyl,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'ORM1', 'Fentanyl']",0.5
14241,35761.0,Fentanyl,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Fentanyl']",0.5
14241,35764.0,Fentanyl,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Fentanyl']",0.5
14241,35764.0,Fentanyl,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Fentanyl']",0.5
14241,35764.0,Fentanyl,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Fentanyl']",0.5
14241,36080.0,Fentanyl,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Fentanyl']",0.5
14241,36080.0,Fentanyl,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'ORM1', 'Fentanyl']",0.5
14241,36693.0,Fentanyl,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Fentanyl']",0.5
14241,37617.0,Fentanyl,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fentanyl']",0.5
14241,37703.0,Fentanyl,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'OPRM1', 'Fentanyl']",0.5
14241,39531.0,Fentanyl,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Fentanyl']",0.5
14241,83751.0,Fentanyl,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Fentanyl']",0.5
14241,83760.0,Fentanyl,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'OPRM1', 'Fentanyl']",0.5
14242,27366.0,Meloxicam,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Meloxicam']",0.5
14242,29078.0,Meloxicam,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCC4', 'Meloxicam']",0.5
14242,29078.0,Meloxicam,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Meloxicam']",0.5
14242,29078.0,Meloxicam,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Meloxicam']",0.5
14242,29078.0,Meloxicam,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Meloxicam']",0.5
14242,30035.0,Meloxicam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PTGS2', 'Meloxicam']",0.5
14242,33575.0,Meloxicam,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Meloxicam']",0.5
14242,33575.0,Meloxicam,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Meloxicam']",0.5
14242,33577.0,Meloxicam,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Meloxicam']",0.5
14242,33577.0,Meloxicam,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Meloxicam']",0.5
14242,33598.0,Meloxicam,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Meloxicam']",0.5
14242,33598.0,Meloxicam,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Meloxicam']",0.5
14242,33598.0,Meloxicam,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS1', 'Meloxicam']",0.5
14242,33632.0,Meloxicam,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Meloxicam']",0.5
14242,33632.0,Meloxicam,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Meloxicam']",0.5
14242,35669.0,Meloxicam,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Meloxicam']",0.5
14242,35669.0,Meloxicam,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Meloxicam']",0.5
14242,35761.0,Meloxicam,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Meloxicam']",0.5
14242,35761.0,Meloxicam,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Meloxicam']",0.5
14242,35764.0,Meloxicam,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Meloxicam']",0.5
14242,35764.0,Meloxicam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Meloxicam']",0.5
14242,35764.0,Meloxicam,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Meloxicam']",0.5
14242,35909.0,Meloxicam,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'PTGS2', 'Meloxicam']",0.5
14242,35909.0,Meloxicam,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Meloxicam']",0.5
14242,36432.0,Meloxicam,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Meloxicam']",0.5
14242,37180.0,Meloxicam,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Meloxicam']",0.5
14242,37180.0,Meloxicam,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Meloxicam']",0.5
14244,33605.0,Propofol,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Propofol']",0.5
14244,35641.0,Propofol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Propofol']",0.5
14244,36080.0,Propofol,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Propofol']",0.5
14244,36080.0,Propofol,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'CYP1B1', 'Propofol']",0.5
14245,27933.0,Diazepam,anxiety disorder,disease-protein-drug,off-label use,"['anxiety disorder', 'ABCB1', 'Diazepam']",0.5
14245,27933.0,Diazepam,anxiety disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Diazepam']",0.5
14245,27933.0,Diazepam,anxiety disorder,disease-exposure-gene-drug,off-label use,"['anxiety disorder', 'Cadmium', 'ALB', 'Diazepam']",0.5
14245,30035.0,Diazepam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Diazepam']",0.5
14245,30715.0,Diazepam,Wernicke-Korsakoff syndrome,disease-phenotype-protein-drug,indication,"['Wernicke-Korsakoff syndrome', 'Memory impairment', 'GABRA5', 'Diazepam']",0.5
14245,31618.0,Diazepam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Diazepam']",0.5
14245,31650.0,Diazepam,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'GABRA5', 'Diazepam']",0.5
14245,32313.0,Diazepam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Diazepam']",0.5
14245,35565.0,Diazepam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Diazepam']",0.5
14245,35565.0,Diazepam,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Diazepam']",0.5
14245,35641.0,Diazepam,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Diazepam']",0.5
14245,35833.0,Diazepam,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Diazepam']",0.5
14245,35833.0,Diazepam,lung disease,disease-exposure-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'PTGS1', 'Diazepam']",0.5
14245,36080.0,Diazepam,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of blood pressure', 'PTGS1', 'Diazepam']",0.5
14245,36080.0,Diazepam,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'PTGS1', 'Diazepam']",0.5
14245,37703.0,Diazepam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Diazepam']",0.5
14245,83760.0,Diazepam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Diazepam']",0.5
14246,27933.0,Oxazepam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Oxazepam']",0.5
14246,27933.0,Oxazepam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Lead', 'lipid metabolic process', 'UGT2B7', 'Oxazepam']",0.5
14246,27933.0,Oxazepam,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Oxazepam']",0.5
14246,30035.0,Oxazepam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Oxazepam']",0.5
14246,31618.0,Oxazepam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Oxazepam']",0.5
14246,32313.0,Oxazepam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Oxazepam']",0.5
14246,32977.0,Oxazepam,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GABRA5', 'Oxazepam']",0.5
14246,33605.0,Oxazepam,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Oxazepam']",0.5
14246,35565.0,Oxazepam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'brain development', 'GABRA5', 'Oxazepam']",0.5
14246,35565.0,Oxazepam,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Oxazepam']",0.5
14246,35764.0,Oxazepam,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Oxazepam']",0.5
14246,35764.0,Oxazepam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'lipid metabolic process', 'UGT2B7', 'Oxazepam']",0.5
14246,35764.0,Oxazepam,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Oxazepam']",0.5
14246,35833.0,Oxazepam,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'UGT2B7', 'Oxazepam']",0.5
14246,37703.0,Oxazepam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Oxazepam']",0.5
14246,83760.0,Oxazepam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Oxazepam']",0.5
14247,33594.0,Clofazimine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'innate immune response', 'PPARG', 'Clofazimine']",0.5
14247,33594.0,Clofazimine,diarrheal disease,disease-exposure-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'PPARG', 'Clofazimine']",0.5
14247,35565.0,Clofazimine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Clofazimine']",0.5
14247,35565.0,Clofazimine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Clofazimine']",0.5
14247,35749.0,Clofazimine,digestive system disease,disease-exposure-bioprocess-gene-drug,contraindication,"['digestive system disease', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP3A4', 'Clofazimine']",0.5
14248,27421.0,Cysteamine,nephropathic cystinosis,disease-phenotype-protein-drug,indication,"['nephropathic cystinosis', 'Hepatomegaly', 'ALB', 'Cysteamine']",0.5
14248,27933.0,Cysteamine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Cysteamine']",0.5
14248,27933.0,Cysteamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'response to oxidative stress', 'MPO', 'Cysteamine']",0.5
14248,27933.0,Cysteamine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Cysteamine']",0.5
14248,31072.0,Cysteamine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Cysteamine']",0.5
14248,32469.0,Cysteamine,cystinosis,disease-phenotype-protein-drug,indication,"['cystinosis', 'Proteinuria', 'ALB', 'Cysteamine']",0.5
14248,35565.0,Cysteamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'response to oxidative stress', 'MPO', 'Cysteamine']",0.5
14248,35565.0,Cysteamine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Cysteamine']",0.5
14248,35641.0,Cysteamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Cysteamine']",0.5
14248,36644.0,Cysteamine,skin disease,disease-exposure-bioprocess-gene-drug,contraindication,"['skin disease', 'Arsenic', 'response to oxidative stress', 'MPO', 'Cysteamine']",0.5
14248,37703.0,Cysteamine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Cysteamine']",0.5
14248,83760.0,Cysteamine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Cysteamine']",0.5
14249,27503.0,Pseudoephedrine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'FOS', 'Pseudoephedrine']",0.5
14249,28158.0,Pseudoephedrine,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'TNF', 'Pseudoephedrine']",0.5
14249,28158.0,Pseudoephedrine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,28158.0,Pseudoephedrine,inflammatory bowel disease,disease-exposure-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'TNF', 'Pseudoephedrine']",0.5
14249,28714.0,Pseudoephedrine,cystic fibrosis,disease-phenotype-protein-drug,contraindication,"['cystic fibrosis', 'Hepatomegaly', 'ALB', 'Pseudoephedrine']",0.5
14249,29113.0,Pseudoephedrine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'TNF', 'Pseudoephedrine']",0.5
14249,29113.0,Pseudoephedrine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'TNF', 'Pseudoephedrine']",0.5
14249,30035.0,Pseudoephedrine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'FOS', 'Pseudoephedrine']",0.5
14249,30374.0,Pseudoephedrine,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'TNF', 'Pseudoephedrine']",0.5
14249,30813.0,Pseudoephedrine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'FOS', 'Pseudoephedrine']",0.5
14249,31072.0,Pseudoephedrine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'TNF', 'Pseudoephedrine']",0.5
14249,31493.0,Pseudoephedrine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Pseudoephedrine']",0.5
14249,31650.0,Pseudoephedrine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'FOS', 'Pseudoephedrine']",0.5
14249,31732.0,Pseudoephedrine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'SLC6A3', 'Pseudoephedrine']",0.5
14249,32384.0,Pseudoephedrine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'FOS', 'Pseudoephedrine']",0.5
14249,32584.0,Pseudoephedrine,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Premature birth', 'TNF', 'Pseudoephedrine']",0.5
14249,32719.0,Pseudoephedrine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Hypothermia', 'TNF', 'Pseudoephedrine']",0.5
14249,33342.0,Pseudoephedrine,congenital diaphragmatic hernia,disease-phenotype-protein-drug,contraindication,"['congenital diaphragmatic hernia', 'Hypoxemia', 'ATF4', 'Pseudoephedrine']",0.5
14249,33575.0,Pseudoephedrine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'NFKB1', 'Pseudoephedrine']",0.5
14249,33575.0,Pseudoephedrine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,33575.0,Pseudoephedrine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'NFKB1', 'Pseudoephedrine']",0.5
14249,33577.0,Pseudoephedrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,33577.0,Pseudoephedrine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'TNF', 'Pseudoephedrine']",0.5
14249,33598.0,Pseudoephedrine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'TNF', 'Pseudoephedrine']",0.5
14249,33598.0,Pseudoephedrine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,33598.0,Pseudoephedrine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'TNF', 'Pseudoephedrine']",0.5
14249,33603.0,Pseudoephedrine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'TNF', 'Pseudoephedrine']",0.5
14249,33605.0,Pseudoephedrine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'TNF', 'Pseudoephedrine']",0.5
14249,33623.0,Pseudoephedrine,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'TNF', 'Pseudoephedrine']",0.5
14249,33632.0,Pseudoephedrine,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'TNF', 'Pseudoephedrine']",0.5
14249,33632.0,Pseudoephedrine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,33632.0,Pseudoephedrine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Pseudoephedrine']",0.5
14249,33675.0,Pseudoephedrine,asthma,disease-protein-drug,contraindication,"['asthma', 'TNF', 'Pseudoephedrine']",0.5
14249,33675.0,Pseudoephedrine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,33675.0,Pseudoephedrine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,35565.0,Pseudoephedrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,35565.0,Pseudoephedrine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'NFKB1', 'Pseudoephedrine']",0.5
14249,35641.0,Pseudoephedrine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'FOS', 'Pseudoephedrine']",0.5
14249,35669.0,Pseudoephedrine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'TNF', 'Pseudoephedrine']",0.5
14249,35669.0,Pseudoephedrine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,35669.0,Pseudoephedrine,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,35761.0,Pseudoephedrine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,35761.0,Pseudoephedrine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,35764.0,Pseudoephedrine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Pseudoephedrine']",0.5
14249,35764.0,Pseudoephedrine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,35764.0,Pseudoephedrine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Pseudoephedrine']",0.5
14249,35897.0,Pseudoephedrine,pulmonary emphysema,disease-protein-drug,contraindication,"['pulmonary emphysema', 'TNF', 'Pseudoephedrine']",0.5
14249,35897.0,Pseudoephedrine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,35897.0,Pseudoephedrine,pulmonary emphysema,disease-exposure-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'IL2', 'Pseudoephedrine']",0.5
14249,35909.0,Pseudoephedrine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Pseudoephedrine']",0.5
14249,35909.0,Pseudoephedrine,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,35953.0,Pseudoephedrine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'TNF', 'Pseudoephedrine']",0.5
14249,35953.0,Pseudoephedrine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,35953.0,Pseudoephedrine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,35958.0,Pseudoephedrine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'TNF', 'Pseudoephedrine']",0.5
14249,36034.0,Pseudoephedrine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'TNF', 'Pseudoephedrine']",0.5
14249,36080.0,Pseudoephedrine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,36080.0,Pseudoephedrine,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Soot', 'TNF', 'Pseudoephedrine']",0.5
14249,36091.0,Pseudoephedrine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'TNF', 'Pseudoephedrine']",0.5
14249,36187.0,Pseudoephedrine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Pseudoephedrine']",0.5
14249,36187.0,Pseudoephedrine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,36187.0,Pseudoephedrine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,36236.0,Pseudoephedrine,cor pulmonale,disease-exposure-bioprocess-gene-drug,contraindication,"['cor pulmonale', 'Ozone', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,36274.0,Pseudoephedrine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,36274.0,Pseudoephedrine,pyloric stenosis (disease),disease-exposure-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'ALB', 'Pseudoephedrine']",0.5
14249,36432.0,Pseudoephedrine,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRB1', 'Pseudoephedrine']",0.5
14249,36469.0,Pseudoephedrine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'cognition', 'TNF', 'Pseudoephedrine']",0.5
14249,36469.0,Pseudoephedrine,hypothyroidism,disease-exposure-gene-drug,contraindication,"['hypothyroidism', 'Insecticides', 'IL2', 'Pseudoephedrine']",0.5
14249,36492.0,Pseudoephedrine,brain cancer,disease-protein-drug,contraindication,"['brain cancer', 'IL2', 'Pseudoephedrine']",0.5
14249,36492.0,Pseudoephedrine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,36492.0,Pseudoephedrine,brain cancer,disease-exposure-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'TNF', 'Pseudoephedrine']",0.5
14249,36693.0,Pseudoephedrine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC6A4', 'Pseudoephedrine']",0.5
14249,37180.0,Pseudoephedrine,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'TNF', 'Pseudoephedrine']",0.5
14249,37180.0,Pseudoephedrine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,37180.0,Pseudoephedrine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,37405.0,Pseudoephedrine,nodular fasciitis,disease-protein-drug,contraindication,"['nodular fasciitis', 'TNF', 'Pseudoephedrine']",0.5
14249,37564.0,Pseudoephedrine,gastric ulcer (disease),disease-protein-drug,contraindication,"['gastric ulcer (disease)', 'TNF', 'Pseudoephedrine']",0.5
14249,37617.0,Pseudoephedrine,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'TNF', 'Pseudoephedrine']",0.5
14249,37617.0,Pseudoephedrine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,37617.0,Pseudoephedrine,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,37785.0,Pseudoephedrine,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'TNF', 'Pseudoephedrine']",0.5
14249,37785.0,Pseudoephedrine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Pseudoephedrine']",0.5
14249,37811.0,Pseudoephedrine,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,37811.0,Pseudoephedrine,rhinitis,disease-exposure-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'IL2', 'Pseudoephedrine']",0.5
14249,37888.0,Pseudoephedrine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Pseudoephedrine']",0.5
14249,37888.0,Pseudoephedrine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'gene expression', 'IL2', 'Pseudoephedrine']",0.5
14249,37888.0,Pseudoephedrine,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'IL2', 'Pseudoephedrine']",0.5
14249,37888.0,Pseudoephedrine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'TNF', 'Pseudoephedrine']",0.5
14249,39609.0,Pseudoephedrine,pharyngitis,disease-exposure-bioprocess-gene-drug,indication,"['pharyngitis', 'urea formaldehyde foam', 'T cell differentiation', 'IL2', 'Pseudoephedrine']",0.5
14249,83791.0,Pseudoephedrine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Pseudoephedrine']",0.5
14249,83823.0,Pseudoephedrine,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'TNF', 'Pseudoephedrine']",0.5
14249,83824.0,Pseudoephedrine,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'TNF', 'Pseudoephedrine']",0.5
14249,83910.0,Pseudoephedrine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'SLC6A3', 'Pseudoephedrine']",0.5
14250,29182.0,Terbinafine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Terbinafine']",0.5
14250,29182.0,Terbinafine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Terbinafine']",0.5
14250,30035.0,Terbinafine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2D6', 'Terbinafine']",0.5
14250,33534.0,Terbinafine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Terbinafine']",0.5
14250,35565.0,Terbinafine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Terbinafine']",0.5
14250,35565.0,Terbinafine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Terbinafine']",0.5
14250,35764.0,Terbinafine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Terbinafine']",0.5
14250,35764.0,Terbinafine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Terbinafine']",0.5
14250,35764.0,Terbinafine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Terbinafine']",0.5
14251,27326.0,Tacrolimus,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Tacrolimus']",0.5
14251,27452.0,Tacrolimus,Diamond-Blackfan anemia,disease-phenotype-protein-drug,contraindication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Tacrolimus']",0.5
14251,27460.0,Tacrolimus,WT limb-blood syndrome,disease-phenotype-protein-drug,contraindication,"['WT limb-blood syndrome', 'Thrombocytopenia', 'ALB', 'Tacrolimus']",0.5
14251,27664.0,Tacrolimus,idiopathic aplastic anemia,disease-phenotype-protein-drug,contraindication,"['idiopathic aplastic anemia', 'Thrombocytopenia', 'ALB', 'Tacrolimus']",0.5
14251,30222.0,Tacrolimus,congenital amegakaryocytic thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['congenital amegakaryocytic thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Tacrolimus']",0.5
14251,30543.0,Tacrolimus,Shwachman-Diamond syndrome,disease-phenotype-protein-drug,contraindication,"['Shwachman-Diamond syndrome', 'Hepatomegaly', 'ALB', 'Tacrolimus']",0.5
14251,31313.0,Tacrolimus,pancytopenia-developmental delay syndrome,disease-phenotype-protein-drug,contraindication,"['pancytopenia-developmental delay syndrome', 'Thrombocytopenia', 'ALB', 'Tacrolimus']",0.5
14251,31519.0,Tacrolimus,ataxia-pancytopenia syndrome,disease-phenotype-protein-drug,contraindication,"['ataxia-pancytopenia syndrome', 'Thrombocytopenia', 'ALB', 'Tacrolimus']",0.5
14251,32319.0,Tacrolimus,Fanconi anemia,disease-phenotype-protein-drug,contraindication,"['Fanconi anemia', 'Thrombocytopenia', 'ALB', 'Tacrolimus']",0.5
14251,32562.0,Tacrolimus,Hoyeraal-Hreidarsson syndrome,disease-phenotype-protein-drug,contraindication,"['Hoyeraal-Hreidarsson syndrome', 'Thrombocytopenia', 'ALB', 'Tacrolimus']",0.5
14251,33575.0,Tacrolimus,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Tacrolimus']",0.5
14251,33575.0,Tacrolimus,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Tacrolimus']",0.5
14251,33577.0,Tacrolimus,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Tacrolimus']",0.5
14251,33577.0,Tacrolimus,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCA5', 'Tacrolimus']",0.5
14251,33577.0,Tacrolimus,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Tacrolimus']",0.5
14251,35641.0,Tacrolimus,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Tacrolimus']",0.5
14251,35692.0,Tacrolimus,intellectual disability,disease-exposure-bioprocess-gene-drug,contraindication,"['intellectual disability', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Tacrolimus']",0.5
14251,35757.0,Tacrolimus,learning disability,disease-exposure-bioprocess-gene-drug,contraindication,"['learning disability', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Tacrolimus']",0.5
14251,35757.0,Tacrolimus,learning disability,disease-exposure-gene-drug,contraindication,"['learning disability', 'Cadmium', 'ALB', 'Tacrolimus']",0.5
14251,35764.0,Tacrolimus,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Tacrolimus']",0.5
14251,35764.0,Tacrolimus,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCA5', 'Tacrolimus']",0.5
14251,35764.0,Tacrolimus,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Tacrolimus']",0.5
14251,36035.0,Tacrolimus,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Tacrolimus']",0.5
14251,36129.0,Tacrolimus,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol homeostasis', 'ABCA5', 'Tacrolimus']",0.5
14251,36129.0,Tacrolimus,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Lead', 'ALB', 'Tacrolimus']",0.5
14251,36425.0,Tacrolimus,primary central nervous system lymphoma,disease-protein-drug,contraindication,"['primary central nervous system lymphoma', 'ABCB1', 'Tacrolimus']",0.5
14251,39531.0,Tacrolimus,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Tacrolimus']",0.5
14251,83751.0,Tacrolimus,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Tacrolimus']",0.5
14254,27577.0,Emtricitabine,Fanconi renotubular syndrome,disease-phenotype-protein-drug,contraindication,"['Fanconi renotubular syndrome', 'Proteinuria', 'ALB', 'Emtricitabine']",0.5
14254,27933.0,Emtricitabine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Emtricitabine']",0.5
14254,27933.0,Emtricitabine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Lead', 'transport', 'ALB', 'Emtricitabine']",0.5
14254,27933.0,Emtricitabine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Emtricitabine']",0.5
14254,33593.0,Emtricitabine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Emtricitabine']",0.5
14254,33593.0,Emtricitabine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Emtricitabine']",0.5
14254,33695.0,Emtricitabine,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Emtricitabine']",0.5
14254,35565.0,Emtricitabine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Emtricitabine']",0.5
14254,35641.0,Emtricitabine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Emtricitabine']",0.5
14254,35764.0,Emtricitabine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Emtricitabine']",0.5
14254,35764.0,Emtricitabine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Emtricitabine']",0.5
14254,35764.0,Emtricitabine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Emtricitabine']",0.5
14254,36242.0,Emtricitabine,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Lead', 'transport', 'ALB', 'Emtricitabine']",0.5
14254,36242.0,Emtricitabine,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Cadmium', 'ALB', 'Emtricitabine']",0.5
14254,37703.0,Emtricitabine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Emtricitabine']",0.5
14254,37805.0,Emtricitabine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Emtricitabine']",0.5
14254,83760.0,Emtricitabine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Emtricitabine']",0.5
14255,29182.0,Quinapril,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Quinapril']",0.5
14255,29182.0,Quinapril,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'ACE', 'Quinapril']",0.5
14255,29182.0,Quinapril,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Quinapril']",0.5
14255,31493.0,Quinapril,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Quinapril']",0.5
14255,33025.0,Quinapril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'ALB', 'Quinapril']",0.5
14255,33534.0,Quinapril,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Quinapril']",0.5
14255,33575.0,Quinapril,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Quinapril']",0.5
14255,33575.0,Quinapril,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Quinapril']",0.5
14255,33577.0,Quinapril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Quinapril']",0.5
14255,33577.0,Quinapril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Quinapril']",0.5
14255,33605.0,Quinapril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ACE', 'Quinapril']",0.5
14255,33618.0,Quinapril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Quinapril']",0.5
14255,33618.0,Quinapril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Quinapril']",0.5
14255,33618.0,Quinapril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Quinapril']",0.5
14255,35565.0,Quinapril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Quinapril']",0.5
14255,35565.0,Quinapril,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Quinapril']",0.5
14255,35764.0,Quinapril,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Quinapril']",0.5
14255,35764.0,Quinapril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Quinapril']",0.5
14255,35764.0,Quinapril,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Quinapril']",0.5
14255,35854.0,Quinapril,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Quinapril']",0.5
14255,36187.0,Quinapril,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ACE', 'Quinapril']",0.5
14255,36187.0,Quinapril,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Quinapril']",0.5
14255,36187.0,Quinapril,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Quinapril']",0.5
14255,36286.0,Quinapril,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'ACE', 'Quinapril']",0.5
14255,37786.0,Quinapril,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Quinapril']",0.5
14255,37786.0,Quinapril,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Quinapril']",0.5
14255,39540.0,Quinapril,angioedema,disease-protein-drug,contraindication,"['angioedema', 'ALB', 'Quinapril']",0.5
14255,83802.0,Quinapril,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Quinapril']",0.5
14256,30035.0,Didanosine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC29A1', 'Didanosine']",0.5
14256,31493.0,Didanosine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Didanosine']",0.5
14256,32967.0,Didanosine,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'ALB', 'Didanosine']",0.5
14256,33575.0,Didanosine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'immune response', 'PNP', 'Didanosine']",0.5
14256,33575.0,Didanosine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PNP', 'Didanosine']",0.5
14256,33577.0,Didanosine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'immune response', 'PNP', 'Didanosine']",0.5
14256,33577.0,Didanosine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PNP', 'Didanosine']",0.5
14256,33593.0,Didanosine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'SLC29A1', 'Didanosine']",0.5
14256,33593.0,Didanosine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Didanosine']",0.5
14256,33594.0,Didanosine,diarrheal disease,disease-exposure-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'PNP', 'Didanosine']",0.5
14256,33695.0,Didanosine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'immune response', 'PNP', 'Didanosine']",0.5
14256,33695.0,Didanosine,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Didanosine']",0.5
14256,35565.0,Didanosine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'PNP', 'Didanosine']",0.5
14256,35565.0,Didanosine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Didanosine']",0.5
14256,35764.0,Didanosine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Didanosine']",0.5
14256,35764.0,Didanosine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'PNP', 'Didanosine']",0.5
14256,35764.0,Didanosine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PNP', 'Didanosine']",0.5
14256,36187.0,Didanosine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'transport', 'ALB', 'Didanosine']",0.5
14256,36187.0,Didanosine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PNP', 'Didanosine']",0.5
14256,36242.0,Didanosine,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'immune response', 'PNP', 'Didanosine']",0.5
14256,36242.0,Didanosine,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Arsenic', 'PNP', 'Didanosine']",0.5
14256,37805.0,Didanosine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Didanosine']",0.5
14256,83802.0,Didanosine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'immune response', 'PNP', 'Didanosine']",0.5
14257,27647.0,Etacrynic acid,hypoparathyroidism,disease-phenotype-protein-drug,contraindication,"['hypoparathyroidism', 'Seizure', 'ATP1A1', 'Etacrynic acid']",0.5
14257,28396.0,Etacrynic acid,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Stridor', 'GSTP1', 'Etacrynic acid']",0.5
14257,31493.0,Etacrynic acid,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Etacrynic acid']",0.5
14257,33577.0,Etacrynic acid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ATP1A1', 'Etacrynic acid']",0.5
14257,33577.0,Etacrynic acid,hypertensive disorder,disease-exposure-gene-drug,off-label use,"['hypertensive disorder', 'Arsenic', 'GSTP1', 'Etacrynic acid']",0.5
14257,33577.0,Etacrynic acid,hypertensive disorder,disease-exposure-molfunc-gene-drug,off-label use,"['hypertensive disorder', 'Metals, Heavy', 'glutathione transferase activity', 'GSTA2', 'Etacrynic acid']",0.5
14257,33605.0,Etacrynic acid,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Etacrynic acid']",0.5
14257,36432.0,Etacrynic acid,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ALB', 'Etacrynic acid']",0.5
14257,37765.0,Etacrynic acid,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Etacrynic acid']",0.5
14257,83764.0,Etacrynic acid,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'regulation of blood pressure', 'ATP1A1', 'Etacrynic acid']",0.5
14257,83802.0,Etacrynic acid,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctanoic acid', 'mammary gland development', 'LEF1', 'Etacrynic acid']",0.5
14258,27326.0,Quinidine,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'SCN5A', 'Quinidine']",0.5
14258,27326.0,Quinidine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Quinidine']",0.5
14258,27326.0,Quinidine,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Quinidine']",0.5
14258,27326.0,Quinidine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Quinidine']",0.5
14258,27626.0,Quinidine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Quinidine']",0.5
14258,27655.0,Quinidine,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Quinidine']",0.5
14258,27655.0,Quinidine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Quinidine']",0.5
14258,28103.0,Quinidine,progressive familial heart block,disease-protein-drug,contraindication,"['progressive familial heart block', 'SCN5A', 'Quinidine']",0.5
14258,28103.0,Quinidine,progressive familial heart block,disease-phenotype-protein-drug,contraindication,"['progressive familial heart block', 'Arrhythmia', 'SLC22A5', 'Quinidine']",0.5
14258,31650.0,Quinidine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ABCC2', 'Quinidine']",0.5
14258,33128.0,Quinidine,malaria,disease-phenotype-protein-drug,indication,"['malaria', 'Thrombocytopenia', 'ALB', 'Quinidine']",0.5
14258,33605.0,Quinidine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Quinidine']",0.5
14258,33618.0,Quinidine,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'SCN5A', 'Quinidine']",0.5
14258,33618.0,Quinidine,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Quinidine']",0.5
14258,35565.0,Quinidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Quinidine']",0.5
14258,35565.0,Quinidine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Quinidine']",0.5
14258,35764.0,Quinidine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Quinidine']",0.5
14258,35764.0,Quinidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Quinidine']",0.5
14258,35764.0,Quinidine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Quinidine']",0.5
14258,35897.0,Quinidine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Quinidine']",0.5
14258,37659.0,Quinidine,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Quinidine']",0.5
14258,37659.0,Quinidine,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Quinidine']",0.5
14258,37659.0,Quinidine,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Quinidine']",0.5
14258,83751.0,Quinidine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'SCN5A', 'Quinidine']",0.5
14259,28208.0,Repaglinide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Repaglinide']",0.5
14259,28208.0,Repaglinide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose homeostasis', 'PPARG', 'Repaglinide']",0.5
14259,28208.0,Repaglinide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'PPARG', 'Repaglinide']",0.5
14259,28208.0,Repaglinide,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'PPARG', 'Repaglinide']",0.5
14259,33575.0,Repaglinide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Repaglinide']",0.5
14259,33575.0,Repaglinide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'PPARG', 'Repaglinide']",0.5
14259,33575.0,Repaglinide,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PPARG', 'Repaglinide']",0.5
14259,35565.0,Repaglinide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Repaglinide']",0.5
14259,35565.0,Repaglinide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Repaglinide']",0.5
14259,35764.0,Repaglinide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Repaglinide']",0.5
14259,35764.0,Repaglinide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Repaglinide']",0.5
14259,35764.0,Repaglinide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PPARG', 'Repaglinide']",0.5
14259,37180.0,Repaglinide,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Repaglinide']",0.5
14259,37180.0,Repaglinide,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PPARG', 'Repaglinide']",0.5
14260,36034.0,Cyclobenzaprine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Cyclobenzaprine']",0.5
14261,35565.0,Metacycline,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Metacycline']",0.5
14261,35764.0,Metacycline,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Metacycline']",0.5
14261,35764.0,Metacycline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Metacycline']",0.5
14261,35764.0,Metacycline,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Metacycline']",0.5
14262,28158.0,Salicylic acid,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,off-label use,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'SLC16A1', 'Salicylic acid']",0.5
14262,29078.0,Salicylic acid,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Salicylic acid']",0.5
14262,29078.0,Salicylic acid,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Salicylic acid']",0.5
14262,29078.0,Salicylic acid,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Salicylic acid']",0.5
14262,29078.0,Salicylic acid,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Salicylic acid']",0.5
14262,29273.0,Salicylic acid,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'AKR1C1', 'Salicylic acid']",0.5
14262,31176.0,Salicylic acid,palmoplantar keratoderma,disease-phenotype-protein-drug,indication,"['palmoplantar keratoderma', 'Erythema', 'PTGS1', 'Salicylic acid']",0.5
14262,32325.0,Salicylic acid,juvenile idiopathic arthritis,disease-phenotype-protein-drug,off-label use,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Salicylic acid']",0.5
14262,32807.0,Salicylic acid,rheumatic fever,disease-phenotype-protein-drug,off-label use,"['rheumatic fever', 'Fever', 'PTGS2', 'Salicylic acid']",0.5
14262,36209.0,Salicylic acid,arthropathy,disease-protein-drug,indication,"['arthropathy', 'AKR1C1', 'Salicylic acid']",0.5
14262,37785.0,Salicylic acid,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'AKR1C1', 'Salicylic acid']",0.5
14262,37888.0,Salicylic acid,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Salicylic acid']",0.5
14262,37888.0,Salicylic acid,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'PTGS2', 'Salicylic acid']",0.5
14262,37888.0,Salicylic acid,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Air Pollutants', 'PTGS1', 'Salicylic acid']",0.5
14262,37888.0,Salicylic acid,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Salicylic acid']",0.5
14262,83791.0,Salicylic acid,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Salicylic acid']",0.5
14263,27326.0,Salmeterol,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Salmeterol']",0.5
14263,29113.0,Salmeterol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Salmeterol']",0.5
14263,29614.0,Salmeterol,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Salmeterol']",0.5
14263,29614.0,Salmeterol,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Salmeterol']",0.5
14263,33453.0,Salmeterol,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Tremor', 'ADRB2', 'Salmeterol']",0.5
14263,33575.0,Salmeterol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Salmeterol']",0.5
14263,33575.0,Salmeterol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Salmeterol']",0.5
14263,33575.0,Salmeterol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Salmeterol']",0.5
14263,33577.0,Salmeterol,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Salmeterol']",0.5
14263,33577.0,Salmeterol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Salmeterol']",0.5
14263,33577.0,Salmeterol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Salmeterol']",0.5
14263,33679.0,Salmeterol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Salmeterol']",0.5
14263,35641.0,Salmeterol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Salmeterol']",0.5
14263,35897.0,Salmeterol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Salmeterol']",0.5
14263,36034.0,Salmeterol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Salmeterol']",0.5
14263,36035.0,Salmeterol,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Salmeterol']",0.5
14263,36187.0,Salmeterol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Salmeterol']",0.5
14263,36187.0,Salmeterol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Salmeterol']",0.5
14263,36187.0,Salmeterol,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Salmeterol']",0.5
14263,39773.0,Salmeterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Salmeterol']",0.5
14263,83781.0,Salmeterol,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Salmeterol']",0.5
14264,37805.0,Zalcitabine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Zalcitabine']",0.5
14265,35766.0,Phenprocoumon,thrombotic disease,disease-exposure-bioprocess-gene-drug,indication,"['thrombotic disease', 'Particulate Matter', 'platelet degranulation', 'ORM1', 'Phenprocoumon']",0.5
14265,37180.0,Phenprocoumon,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,indication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Phenprocoumon']",0.5
14265,37180.0,Phenprocoumon,myocardial infarction (disease),disease-exposure-gene-drug,indication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Phenprocoumon']",0.5
14266,33575.0,Fexofenadine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Fexofenadine']",0.5
14266,33575.0,Fexofenadine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Fexofenadine']",0.5
14266,33577.0,Fexofenadine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Fexofenadine']",0.5
14266,33577.0,Fexofenadine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Fexofenadine']",0.5
14266,33683.0,Fexofenadine,urticaria (disease),disease-protein-drug,off-label use,"['urticaria (disease)', 'ALB', 'Fexofenadine']",0.5
14266,35764.0,Fexofenadine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Fexofenadine']",0.5
14266,35764.0,Fexofenadine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Fexofenadine']",0.5
14266,35764.0,Fexofenadine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Fexofenadine']",0.5
14266,35953.0,Fexofenadine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Fexofenadine']",0.5
14266,35953.0,Fexofenadine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fexofenadine']",0.5
14266,35953.0,Fexofenadine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Lead', 'ALB', 'Fexofenadine']",0.5
14266,36034.0,Fexofenadine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Fexofenadine']",0.5
14266,36091.0,Fexofenadine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Fexofenadine']",0.5
14266,36187.0,Fexofenadine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Fexofenadine']",0.5
14266,36187.0,Fexofenadine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Fexofenadine']",0.5
14266,37888.0,Fexofenadine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Fexofenadine']",0.5
14266,37888.0,Fexofenadine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Fexofenadine']",0.5
14266,37888.0,Fexofenadine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Fexofenadine']",0.5
14266,39540.0,Fexofenadine,angioedema,disease-protein-drug,off-label use,"['angioedema', 'ALB', 'Fexofenadine']",0.5
14266,83791.0,Fexofenadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Fexofenadine']",0.5
14267,30035.0,Isoniazid,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Isoniazid']",0.5
14267,32928.0,Isoniazid,acute liver failure,disease-protein-drug,contraindication,"['acute liver failure', 'ALB', 'Isoniazid']",0.5
14267,32928.0,Isoniazid,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Thrombocytopenia', 'ALB', 'Isoniazid']",0.5
14267,32977.0,Isoniazid,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Isoniazid']",0.5
14267,33575.0,Isoniazid,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Isoniazid']",0.5
14267,33575.0,Isoniazid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Isoniazid']",0.5
14267,33575.0,Isoniazid,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Isoniazid']",0.5
14267,35565.0,Isoniazid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Isoniazid']",0.5
14267,35565.0,Isoniazid,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Isoniazid']",0.5
14267,36241.0,Isoniazid,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Isoniazid']",0.5
14267,39696.0,Isoniazid,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Isoniazid']",0.5
14268,27746.0,Norgestimate,intrahepatic cholestasis,disease-protein-drug,contraindication,"['intrahepatic cholestasis', 'ABCC2', 'Norgestimate']",0.5
14268,27933.0,Norgestimate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Norgestimate']",0.5
14268,27933.0,Norgestimate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of systemic arterial blood pressure', 'AR', 'Norgestimate']",0.5
14268,27933.0,Norgestimate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PGR', 'Norgestimate']",0.5
14268,28017.0,Norgestimate,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Norgestimate']",0.5
14268,28651.0,Norgestimate,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ESR1', 'Norgestimate']",0.5
14268,29061.0,Norgestimate,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'PGR', 'Norgestimate']",0.5
14268,29182.0,Norgestimate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Norgestimate']",0.5
14268,29182.0,Norgestimate,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Norgestimate']",0.5
14268,29220.0,Norgestimate,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'ALB', 'Norgestimate']",0.5
14268,29646.0,Norgestimate,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ABCB1', 'Norgestimate']",0.5
14268,29646.0,Norgestimate,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norgestimate']",0.5
14268,29646.0,Norgestimate,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'PGR', 'Norgestimate']",0.5
14268,29646.0,Norgestimate,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'ALB', 'Norgestimate']",0.5
14268,30714.0,Norgestimate,"cholestasis, intrahepatic, of pregnancy",disease-protein-drug,contraindication,"['cholestasis, intrahepatic, of pregnancy', 'ABCC2', 'Norgestimate']",0.5
14268,30827.0,Norgestimate,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Norgestimate']",0.5
14268,31107.0,Norgestimate,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Vehicle Emissions', 'inflammatory response', 'ABCC2', 'Norgestimate']",0.5
14268,31477.0,Norgestimate,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Norgestimate']",0.5
14268,31477.0,Norgestimate,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'inflammatory response', 'ABCC2', 'Norgestimate']",0.5
14268,31477.0,Norgestimate,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Norgestimate']",0.5
14268,31596.0,Norgestimate,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Norgestimate']",0.5
14268,32617.0,Norgestimate,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Norgestimate']",0.5
14268,32977.0,Norgestimate,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ABCC2', 'Norgestimate']",0.5
14268,33534.0,Norgestimate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Norgestimate']",0.5
14268,33575.0,Norgestimate,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Norgestimate']",0.5
14268,33575.0,Norgestimate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Norgestimate']",0.5
14268,33575.0,Norgestimate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Norgestimate']",0.5
14268,33575.0,Norgestimate,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Norgestimate']",0.5
14268,33577.0,Norgestimate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Norgestimate']",0.5
14268,33577.0,Norgestimate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Norgestimate']",0.5
14268,33593.0,Norgestimate,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Norgestimate']",0.5
14268,33593.0,Norgestimate,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'spermatogenesis', 'AR', 'Norgestimate']",0.5
14268,33593.0,Norgestimate,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Norgestimate']",0.5
14268,33598.0,Norgestimate,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Norgestimate']",0.5
14268,33598.0,Norgestimate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Norgestimate']",0.5
14268,33598.0,Norgestimate,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'SHBG', 'Norgestimate']",0.5
14268,33680.0,Norgestimate,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'PGR', 'Norgestimate']",0.5
14268,33680.0,Norgestimate,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Norgestimate']",0.5
14268,33680.0,Norgestimate,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Norgestimate']",0.5
14268,33695.0,Norgestimate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Norgestimate']",0.5
14268,33695.0,Norgestimate,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Norgestimate']",0.5
14268,33699.0,Norgestimate,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norgestimate']",0.5
14268,35565.0,Norgestimate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Norgestimate']",0.5
14268,35565.0,Norgestimate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Norgestimate']",0.5
14268,35641.0,Norgestimate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Norgestimate']",0.5
14268,35738.0,Norgestimate,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Norgestimate']",0.5
14268,35739.0,Norgestimate,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Norgestimate']",0.5
14268,35764.0,Norgestimate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Norgestimate']",0.5
14268,35764.0,Norgestimate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Norgestimate']",0.5
14268,35764.0,Norgestimate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Norgestimate']",0.5
14268,35901.0,Norgestimate,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Norgestimate']",0.5
14268,35901.0,Norgestimate,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Norgestimate']",0.5
14268,35909.0,Norgestimate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Norgestimate']",0.5
14268,35958.0,Norgestimate,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Norgestimate']",0.5
14268,36187.0,Norgestimate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Norgestimate']",0.5
14268,36187.0,Norgestimate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norgestimate']",0.5
14268,36187.0,Norgestimate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Norgestimate']",0.5
14268,36469.0,Norgestimate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Norgestimate']",0.5
14268,36527.0,Norgestimate,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Norgestimate']",0.5
14268,36634.0,Norgestimate,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ABCB1', 'Norgestimate']",0.5
14268,36634.0,Norgestimate,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Norgestimate']",0.5
14268,36634.0,Norgestimate,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'PGR', 'Norgestimate']",0.5
14268,36792.0,Norgestimate,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Norgestimate']",0.5
14268,36794.0,Norgestimate,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Norgestimate']",0.5
14268,37038.0,Norgestimate,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Norgestimate']",0.5
14268,37047.0,Norgestimate,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Norgestimate']",0.5
14268,37082.0,Norgestimate,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Norgestimate']",0.5
14268,37150.0,Norgestimate,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Norgestimate']",0.5
14268,37152.0,Norgestimate,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Norgestimate']",0.5
14268,37180.0,Norgestimate,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Norgestimate']",0.5
14268,37180.0,Norgestimate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norgestimate']",0.5
14268,37180.0,Norgestimate,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'PGR', 'Norgestimate']",0.5
14268,37423.0,Norgestimate,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Norgestimate']",0.5
14268,37466.0,Norgestimate,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Norgestimate']",0.5
14268,37573.0,Norgestimate,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norgestimate']",0.5
14268,37703.0,Norgestimate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Norgestimate']",0.5
14268,37768.0,Norgestimate,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Norgestimate']",0.5
14268,37967.0,Norgestimate,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Norgestimate']",0.5
14268,39603.0,Norgestimate,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Norgestimate']",0.5
14268,39615.0,Norgestimate,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Norgestimate']",0.5
14268,83760.0,Norgestimate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Norgestimate']",0.5
14268,83816.0,Norgestimate,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Norgestimate']",0.5
14268,83817.0,Norgestimate,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Norgestimate']",0.5
14268,83818.0,Norgestimate,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Norgestimate']",0.5
14268,83819.0,Norgestimate,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Norgestimate']",0.5
14268,83820.0,Norgestimate,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Norgestimate']",0.5
14268,83821.0,Norgestimate,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Norgestimate']",0.5
14268,83822.0,Norgestimate,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Norgestimate']",0.5
14268,83823.0,Norgestimate,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Norgestimate']",0.5
14268,83824.0,Norgestimate,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Norgestimate']",0.5
14269,27452.0,Methylprednisolone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Methylprednisolone']",0.5
14269,27648.0,Methylprednisolone,familial glucocorticoid deficiency,disease-phenotype-protein-drug,indication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Methylprednisolone']",0.5
14269,28005.0,Methylprednisolone,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,off-label use,"['developmental and epileptic encephalopathy', 'Hepatomegaly', 'ALB', 'Methylprednisolone']",0.5
14269,28158.0,Methylprednisolone,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ABCB1', 'Methylprednisolone']",0.5
14269,28158.0,Methylprednisolone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Methylprednisolone']",0.5
14269,28158.0,Methylprednisolone,inflammatory bowel disease,disease-phenotype-protein-drug,indication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Methylprednisolone']",0.5
14269,28478.0,Methylprednisolone,autoimmune disease,disease-exposure-bioprocess-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'ANXA1', 'Methylprednisolone']",0.5
14269,28478.0,Methylprednisolone,autoimmune disease,disease-exposure-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'CYP1B1', 'Methylprednisolone']",0.5
14269,28830.0,Methylprednisolone,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Methylprednisolone']",0.5
14269,29078.0,Methylprednisolone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Methylprednisolone']",0.5
14269,29078.0,Methylprednisolone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,29078.0,Methylprednisolone,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'CYP1B1', 'Methylprednisolone']",0.5
14269,29182.0,Methylprednisolone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'ANXA1', 'Methylprednisolone']",0.5
14269,29182.0,Methylprednisolone,systemic lupus erythematosus (disease),disease-exposure-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Methylprednisolone']",0.5
14269,29182.0,Methylprednisolone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Methylprednisolone']",0.5
14269,29186.0,Methylprednisolone,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,contraindication,"['carbamoyl phosphate synthetase I deficiency disease', 'Vomiting', 'ABCB1', 'Methylprednisolone']",0.5
14269,29614.0,Methylprednisolone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,29614.0,Methylprednisolone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Methylprednisolone']",0.5
14269,29832.0,Methylprednisolone,hyperargininemia,disease-phenotype-protein-drug,contraindication,"['hyperargininemia', 'Hepatomegaly', 'ALB', 'Methylprednisolone']",0.5
14269,29854.0,Methylprednisolone,hereditary angioedema,disease-phenotype-protein-drug,indication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Methylprednisolone']",0.5
14269,29993.0,Methylprednisolone,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'ALB', 'Methylprednisolone']",0.5
14269,30494.0,Methylprednisolone,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,off-label use,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Methylprednisolone']",0.5
14269,30511.0,Methylprednisolone,anti-glomerular basement membrane disease,disease-phenotype-protein-drug,off-label use,"['anti-glomerular basement membrane disease', 'Proteinuria', 'ALB', 'Methylprednisolone']",0.5
14269,30892.0,Methylprednisolone,newborn respiratory distress syndrome,disease-protein-drug,off-label use,"['newborn respiratory distress syndrome', 'ALB', 'Methylprednisolone']",0.5
14269,30990.0,Methylprednisolone,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'ALB', 'Methylprednisolone']",0.5
14269,31511.0,Methylprednisolone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Methylprednisolone']",0.5
14269,32099.0,Methylprednisolone,granulomatosis with polyangiitis,disease-exposure-bioprocess-gene-drug,off-label use,"['granulomatosis with polyangiitis', 'Dust', 'neutrophil homeostasis', 'ANXA1', 'Methylprednisolone']",0.5
14269,32099.0,Methylprednisolone,granulomatosis with polyangiitis,disease-phenotype-protein-drug,off-label use,"['granulomatosis with polyangiitis', 'Proteinuria', 'ALB', 'Methylprednisolone']",0.5
14269,32132.0,Methylprednisolone,citrullinemia,disease-phenotype-protein-drug,contraindication,"['citrullinemia', 'Hepatomegaly', 'ALB', 'Methylprednisolone']",0.5
14269,32325.0,Methylprednisolone,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Methylprednisolone']",0.5
14269,32563.0,Methylprednisolone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Methylprednisolone']",0.5
14269,32584.0,Methylprednisolone,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,indication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Methylprednisolone']",0.5
14269,32746.0,Methylprednisolone,Stevens-Johnson syndrome,disease-protein-drug,indication,"['Stevens-Johnson syndrome', 'ALB', 'Methylprednisolone']",0.5
14269,32746.0,Methylprednisolone,Stevens-Johnson syndrome,disease-phenotype-protein-drug,indication,"['Stevens-Johnson syndrome', 'Thrombocytopenia', 'ALB', 'Methylprednisolone']",0.5
14269,32815.0,Methylprednisolone,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Methylprednisolone']",0.5
14269,32905.0,Methylprednisolone,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Methylprednisolone']",0.5
14269,33534.0,Methylprednisolone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Methylprednisolone']",0.5
14269,33575.0,Methylprednisolone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ANXA1', 'Methylprednisolone']",0.5
14269,33575.0,Methylprednisolone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'CYP1B1', 'Methylprednisolone']",0.5
14269,33621.0,Methylprednisolone,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Methylprednisolone']",0.5
14269,33621.0,Methylprednisolone,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Methylprednisolone']",0.5
14269,33621.0,Methylprednisolone,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'CYP1B1', 'Methylprednisolone']",0.5
14269,33675.0,Methylprednisolone,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Methylprednisolone']",0.5
14269,33675.0,Methylprednisolone,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Methylprednisolone']",0.5
14269,33679.0,Methylprednisolone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Methylprednisolone']",0.5
14269,35641.0,Methylprednisolone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Methylprednisolone']",0.5
14269,35650.0,Methylprednisolone,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Benzene', 'inflammatory response', 'ANXA1', 'Methylprednisolone']",0.5
14269,35650.0,Methylprednisolone,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Cadmium', 'ALB', 'Methylprednisolone']",0.5
14269,35669.0,Methylprednisolone,heart disease,disease-exposure-bioprocess-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Methylprednisolone']",0.5
14269,35669.0,Methylprednisolone,heart disease,disease-exposure-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'CYP1B1', 'Methylprednisolone']",0.5
14269,35823.0,Methylprednisolone,eye disease,disease-exposure-bioprocess-gene-drug,indication,"['eye disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,35823.0,Methylprednisolone,eye disease,disease-exposure-gene-drug,indication,"['eye disease', 'Particulate Matter', 'CYP1B1', 'Methylprednisolone']",0.5
14269,35915.0,Methylprednisolone,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Methylprednisolone']",0.5
14269,35915.0,Methylprednisolone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,36035.0,Methylprednisolone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Methylprednisolone']",0.5
14269,36129.0,Methylprednisolone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,36129.0,Methylprednisolone,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Air Pollutants', 'CYP1B1', 'Methylprednisolone']",0.5
14269,36241.0,Methylprednisolone,hepatitis,disease-protein-drug,off-label use,"['hepatitis', 'ALB', 'Methylprednisolone']",0.5
14269,36432.0,Methylprednisolone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Methylprednisolone']",0.5
14269,36469.0,Methylprednisolone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Methylprednisolone']",0.5
14269,36644.0,Methylprednisolone,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,37617.0,Methylprednisolone,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Methylprednisolone']",0.5
14269,37617.0,Methylprednisolone,chronic obstructive pulmonary disease,disease-exposure-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'CYP1B1', 'Methylprednisolone']",0.5
14269,37722.0,Methylprednisolone,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,37722.0,Methylprednisolone,multiple sclerosis,disease-exposure-gene-drug,indication,"['multiple sclerosis', 'Lead', 'ALB', 'Methylprednisolone']",0.5
14269,37765.0,Methylprednisolone,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Methylprednisolone']",0.5
14269,37770.0,Methylprednisolone,contact dermatitis,disease-protein-drug,indication,"['contact dermatitis', 'CYP1B1', 'Methylprednisolone']",0.5
14269,37830.0,Methylprednisolone,bronchitis,disease-exposure-bioprocess-gene-drug,off-label use,"['bronchitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Methylprednisolone']",0.5
14269,37830.0,Methylprednisolone,bronchitis,disease-exposure-gene-drug,off-label use,"['bronchitis', 'Air Pollutants', 'CYP1B1', 'Methylprednisolone']",0.5
14269,37888.0,Methylprednisolone,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Methylprednisolone']",0.5
14269,37888.0,Methylprednisolone,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Methylprednisolone']",0.5
14269,37888.0,Methylprednisolone,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'CYP1B1', 'Methylprednisolone']",0.5
14269,37888.0,Methylprednisolone,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Methylprednisolone']",0.5
14269,39872.0,Methylprednisolone,acute respiratory distress syndrome,disease-protein-drug,off-label use,"['acute respiratory distress syndrome', 'ALB', 'Methylprednisolone']",0.5
14269,83777.0,Methylprednisolone,occupational dermatitis,disease-protein-drug,indication,"['occupational dermatitis', 'CYP1B1', 'Methylprednisolone']",0.5
14269,83778.0,Methylprednisolone,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Methylprednisolone']",0.5
14269,83778.0,Methylprednisolone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,83779.0,Methylprednisolone,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Methylprednisolone']",0.5
14269,83779.0,Methylprednisolone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Methylprednisolone']",0.5
14269,83789.0,Methylprednisolone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Methylprednisolone']",0.5
14269,83791.0,Methylprednisolone,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Methylprednisolone']",0.5
14270,27746.0,Ethinylestradiol,intrahepatic cholestasis,disease-protein-drug,contraindication,"['intrahepatic cholestasis', 'ABCB11', 'Ethinylestradiol']",0.5
14270,27746.0,Ethinylestradiol,intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['intrahepatic cholestasis', 'Elevated hepatic transaminase', 'SULT1E1', 'Ethinylestradiol']",0.5
14270,27933.0,Ethinylestradiol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Ethinylestradiol']",0.5
14270,27933.0,Ethinylestradiol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ethinylestradiol']",0.5
14270,27933.0,Ethinylestradiol,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'SHBG', 'Ethinylestradiol']",0.5
14270,28651.0,Ethinylestradiol,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'NR1I2', 'Ethinylestradiol']",0.5
14270,29182.0,Ethinylestradiol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'COMT', 'Ethinylestradiol']",0.5
14270,29182.0,Ethinylestradiol,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Ethinylestradiol']",0.5
14270,29220.0,Ethinylestradiol,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'NR1I2', 'Ethinylestradiol']",0.5
14270,29614.0,Ethinylestradiol,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Ethinylestradiol']",0.5
14270,29614.0,Ethinylestradiol,osteoporosis,disease-exposure-gene-drug,indication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SHBG', 'Ethinylestradiol']",0.5
14270,29646.0,Ethinylestradiol,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ABCB1', 'Ethinylestradiol']",0.5
14270,29646.0,Ethinylestradiol,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Ethinylestradiol']",0.5
14270,29646.0,Ethinylestradiol,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'NR1I2', 'Ethinylestradiol']",0.5
14270,30714.0,Ethinylestradiol,"cholestasis, intrahepatic, of pregnancy",disease-protein-drug,contraindication,"['cholestasis, intrahepatic, of pregnancy', 'ABCB11', 'Ethinylestradiol']",0.5
14270,30714.0,Ethinylestradiol,"cholestasis, intrahepatic, of pregnancy",disease-phenotype-protein-drug,contraindication,"['cholestasis, intrahepatic, of pregnancy', 'Pruritus', 'ABCB11', 'Ethinylestradiol']",0.5
14270,30813.0,Ethinylestradiol,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'ABCC2', 'Ethinylestradiol']",0.5
14270,30827.0,Ethinylestradiol,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'ESR1', 'Ethinylestradiol']",0.5
14270,31107.0,Ethinylestradiol,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Vehicle Emissions', 'methylation', 'COMT', 'Ethinylestradiol']",0.5
14270,31477.0,Ethinylestradiol,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Ethinylestradiol']",0.5
14270,31477.0,Ethinylestradiol,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'inflammatory response', 'ABCC2', 'Ethinylestradiol']",0.5
14270,31477.0,Ethinylestradiol,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Ethinylestradiol']",0.5
14270,31596.0,Ethinylestradiol,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,31732.0,Ethinylestradiol,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'COMT', 'Ethinylestradiol']",0.5
14270,32617.0,Ethinylestradiol,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Ethinylestradiol']",0.5
14270,32719.0,Ethinylestradiol,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Prolonged neonatal jaundice', 'NR1I2', 'Ethinylestradiol']",0.5
14270,32977.0,Ethinylestradiol,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Ethinylestradiol']",0.5
14270,32977.0,Ethinylestradiol,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ABCC2', 'Ethinylestradiol']",0.5
14270,33534.0,Ethinylestradiol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Ethinylestradiol']",0.5
14270,33575.0,Ethinylestradiol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Ethinylestradiol']",0.5
14270,33575.0,Ethinylestradiol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Ethinylestradiol']",0.5
14270,33575.0,Ethinylestradiol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'SHBG', 'Ethinylestradiol']",0.5
14270,33577.0,Ethinylestradiol,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Ethinylestradiol']",0.5
14270,33577.0,Ethinylestradiol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Ethinylestradiol']",0.5
14270,33577.0,Ethinylestradiol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'SHBG', 'Ethinylestradiol']",0.5
14270,33593.0,Ethinylestradiol,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'NR1I2', 'Ethinylestradiol']",0.5
14270,33593.0,Ethinylestradiol,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Organophosphorus Compounds', 'developmental process', 'COMT', 'Ethinylestradiol']",0.5
14270,33593.0,Ethinylestradiol,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Ethinylestradiol']",0.5
14270,33598.0,Ethinylestradiol,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Ethinylestradiol']",0.5
14270,33598.0,Ethinylestradiol,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Ethinylestradiol']",0.5
14270,33598.0,Ethinylestradiol,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'SHBG', 'Ethinylestradiol']",0.5
14270,33675.0,Ethinylestradiol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Ethinylestradiol']",0.5
14270,33675.0,Ethinylestradiol,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'bisphenol A', 'SHBG', 'Ethinylestradiol']",0.5
14270,33680.0,Ethinylestradiol,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Ethinylestradiol']",0.5
14270,33680.0,Ethinylestradiol,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Ethinylestradiol']",0.5
14270,33695.0,Ethinylestradiol,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Ethinylestradiol']",0.5
14270,33695.0,Ethinylestradiol,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Ethinylestradiol']",0.5
14270,33699.0,Ethinylestradiol,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Ethinylestradiol']",0.5
14270,35565.0,Ethinylestradiol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Ethinylestradiol']",0.5
14270,35565.0,Ethinylestradiol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Ethinylestradiol']",0.5
14270,35641.0,Ethinylestradiol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Ethinylestradiol']",0.5
14270,35738.0,Ethinylestradiol,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR1', 'Ethinylestradiol']",0.5
14270,35739.0,Ethinylestradiol,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Ethinylestradiol']",0.5
14270,35764.0,Ethinylestradiol,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Ethinylestradiol']",0.5
14270,35764.0,Ethinylestradiol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Ethinylestradiol']",0.5
14270,35764.0,Ethinylestradiol,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Ethinylestradiol']",0.5
14270,35901.0,Ethinylestradiol,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,35901.0,Ethinylestradiol,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Ethinylestradiol']",0.5
14270,35909.0,Ethinylestradiol,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Ethinylestradiol']",0.5
14270,35958.0,Ethinylestradiol,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Ethinylestradiol']",0.5
14270,35963.0,Ethinylestradiol,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP2C19', 'Ethinylestradiol']",0.5
14270,35966.0,Ethinylestradiol,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP2C19', 'Ethinylestradiol']",0.5
14270,35966.0,Ethinylestradiol,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Ethinylestradiol']",0.5
14270,36035.0,Ethinylestradiol,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Ethinylestradiol']",0.5
14270,36187.0,Ethinylestradiol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Ethinylestradiol']",0.5
14270,36187.0,Ethinylestradiol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Ethinylestradiol']",0.5
14270,36187.0,Ethinylestradiol,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'SHBG', 'Ethinylestradiol']",0.5
14270,36432.0,Ethinylestradiol,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Ethinylestradiol']",0.5
14270,36469.0,Ethinylestradiol,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Ethinylestradiol']",0.5
14270,36527.0,Ethinylestradiol,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Ethinylestradiol']",0.5
14270,36634.0,Ethinylestradiol,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ABCB1', 'Ethinylestradiol']",0.5
14270,36634.0,Ethinylestradiol,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Ethinylestradiol']",0.5
14270,36792.0,Ethinylestradiol,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,36794.0,Ethinylestradiol,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,37038.0,Ethinylestradiol,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR1', 'Ethinylestradiol']",0.5
14270,37047.0,Ethinylestradiol,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,37082.0,Ethinylestradiol,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Ethinylestradiol']",0.5
14270,37150.0,Ethinylestradiol,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Ethinylestradiol']",0.5
14270,37152.0,Ethinylestradiol,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Ethinylestradiol']",0.5
14270,37180.0,Ethinylestradiol,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Ethinylestradiol']",0.5
14270,37180.0,Ethinylestradiol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Ethinylestradiol']",0.5
14270,37180.0,Ethinylestradiol,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'bisphenol A', 'SHBG', 'Ethinylestradiol']",0.5
14270,37423.0,Ethinylestradiol,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,37466.0,Ethinylestradiol,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,37573.0,Ethinylestradiol,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Ethinylestradiol']",0.5
14270,37659.0,Ethinylestradiol,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Ethinylestradiol']",0.5
14270,37659.0,Ethinylestradiol,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Ethinylestradiol']",0.5
14270,37659.0,Ethinylestradiol,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Ethinylestradiol']",0.5
14270,37703.0,Ethinylestradiol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Ethinylestradiol']",0.5
14270,37768.0,Ethinylestradiol,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Ethinylestradiol']",0.5
14270,37967.0,Ethinylestradiol,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,39603.0,Ethinylestradiol,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Ethinylestradiol']",0.5
14270,39615.0,Ethinylestradiol,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Ethinylestradiol']",0.5
14270,83760.0,Ethinylestradiol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Ethinylestradiol']",0.5
14270,83764.0,Ethinylestradiol,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'developmental process', 'COMT', 'Ethinylestradiol']",0.5
14270,83816.0,Ethinylestradiol,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Ethinylestradiol']",0.5
14270,83817.0,Ethinylestradiol,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Ethinylestradiol']",0.5
14270,83818.0,Ethinylestradiol,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Ethinylestradiol']",0.5
14270,83819.0,Ethinylestradiol,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Ethinylestradiol']",0.5
14270,83820.0,Ethinylestradiol,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Ethinylestradiol']",0.5
14270,83821.0,Ethinylestradiol,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Ethinylestradiol']",0.5
14270,83822.0,Ethinylestradiol,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Ethinylestradiol']",0.5
14270,83823.0,Ethinylestradiol,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Ethinylestradiol']",0.5
14270,83824.0,Ethinylestradiol,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Ethinylestradiol']",0.5
14271,27933.0,Isotretinoin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Isotretinoin']",0.5
14271,27933.0,Isotretinoin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,27933.0,Isotretinoin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,28158.0,Isotretinoin,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,28764.0,Isotretinoin,Sjogren syndrome,disease-phenotype-protein-drug,contraindication,"['Sjogren syndrome', 'Thrombocytopenia', 'ALB', 'Isotretinoin']",0.5
14271,29182.0,Isotretinoin,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Isotretinoin']",0.5
14271,29182.0,Isotretinoin,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Isotretinoin']",0.5
14271,29352.0,Isotretinoin,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Isotretinoin']",0.5
14271,29494.0,Isotretinoin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Isotretinoin']",0.5
14271,29614.0,Isotretinoin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'RARA', 'Isotretinoin']",0.5
14271,29614.0,Isotretinoin,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,30184.0,Isotretinoin,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Isotretinoin']",0.5
14271,31072.0,Isotretinoin,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Isotretinoin']",0.5
14271,33025.0,Isotretinoin,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'ALB', 'Isotretinoin']",0.5
14271,33534.0,Isotretinoin,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Isotretinoin']",0.5
14271,33575.0,Isotretinoin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'RARA', 'Isotretinoin']",0.5
14271,33575.0,Isotretinoin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,33593.0,Isotretinoin,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'female pregnancy', 'RARA', 'Isotretinoin']",0.5
14271,33593.0,Isotretinoin,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,33695.0,Isotretinoin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,33695.0,Isotretinoin,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,35565.0,Isotretinoin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,35565.0,Isotretinoin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,35669.0,Isotretinoin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'RARA', 'Isotretinoin']",0.5
14271,35761.0,Isotretinoin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'RARA', 'Isotretinoin']",0.5
14271,35761.0,Isotretinoin,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,35764.0,Isotretinoin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Isotretinoin']",0.5
14271,35764.0,Isotretinoin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,35764.0,Isotretinoin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,35854.0,Isotretinoin,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Isotretinoin']",0.5
14271,35915.0,Isotretinoin,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,35916.0,Isotretinoin,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,35916.0,Isotretinoin,dry eye syndrome,disease-exposure-gene-drug,contraindication,"['dry eye syndrome', 'Lead', 'ALB', 'Isotretinoin']",0.5
14271,36187.0,Isotretinoin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'RARA', 'Isotretinoin']",0.5
14271,36187.0,Isotretinoin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,36241.0,Isotretinoin,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Isotretinoin']",0.5
14271,37703.0,Isotretinoin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Isotretinoin']",0.5
14271,37786.0,Isotretinoin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'RARA', 'Isotretinoin']",0.5
14271,37786.0,Isotretinoin,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Isotretinoin']",0.5
14271,39540.0,Isotretinoin,angioedema,disease-protein-drug,contraindication,"['angioedema', 'ALB', 'Isotretinoin']",0.5
14271,83760.0,Isotretinoin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Isotretinoin']",0.5
14271,83778.0,Isotretinoin,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,83779.0,Isotretinoin,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14271,83802.0,Isotretinoin,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Isotretinoin']",0.5
14272,27326.0,Formoterol,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Formoterol']",0.5
14272,27326.0,Formoterol,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Formoterol']",0.5
14272,29113.0,Formoterol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Formoterol']",0.5
14272,29525.0,Formoterol,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Formoterol']",0.5
14272,29614.0,Formoterol,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Formoterol']",0.5
14272,29614.0,Formoterol,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Formoterol']",0.5
14272,32905.0,Formoterol,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Bradycardia', 'CYP2D6', 'Formoterol']",0.5
14272,33453.0,Formoterol,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Tremor', 'CYP2D6', 'Formoterol']",0.5
14272,33575.0,Formoterol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Formoterol']",0.5
14272,33575.0,Formoterol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Formoterol']",0.5
14272,33575.0,Formoterol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Formoterol']",0.5
14272,33577.0,Formoterol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Formoterol']",0.5
14272,33577.0,Formoterol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Formoterol']",0.5
14272,33679.0,Formoterol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Formoterol']",0.5
14272,35565.0,Formoterol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Formoterol']",0.5
14272,35565.0,Formoterol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Formoterol']",0.5
14272,35641.0,Formoterol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Formoterol']",0.5
14272,35897.0,Formoterol,pulmonary emphysema,disease-protein-drug,indication,"['pulmonary emphysema', 'CYP2A6', 'Formoterol']",0.5
14272,35897.0,Formoterol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Formoterol']",0.5
14272,36034.0,Formoterol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'UGT2B7', 'Formoterol']",0.5
14272,36187.0,Formoterol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Formoterol']",0.5
14272,36187.0,Formoterol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Formoterol']",0.5
14272,36187.0,Formoterol,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Formoterol']",0.5
14272,39773.0,Formoterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Formoterol']",0.5
14272,83781.0,Formoterol,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Formoterol']",0.5
14273,27626.0,Azathioprine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ITPA', 'Azathioprine']",0.5
14273,28158.0,Azathioprine,inflammatory bowel disease,disease-protein-drug,off-label use,"['inflammatory bowel disease', 'ABCB1', 'Azathioprine']",0.5
14273,28158.0,Azathioprine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,off-label use,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'RAC1', 'Azathioprine']",0.5
14273,28158.0,Azathioprine,inflammatory bowel disease,disease-phenotype-protein-drug,off-label use,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Azathioprine']",0.5
14273,29078.0,Azathioprine,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Azathioprine']",0.5
14273,29078.0,Azathioprine,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP1A2', 'Azathioprine']",0.5
14273,29078.0,Azathioprine,rheumatoid arthritis,disease-exposure-molfunc-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'glutathione transferase activity', 'GSTA2', 'Azathioprine']",0.5
14273,29182.0,Azathioprine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'RAC1', 'Azathioprine']",0.5
14273,29182.0,Azathioprine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,off-label use,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ITPA', 'Azathioprine']",0.5
14273,31493.0,Azathioprine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Azathioprine']",0.5
14273,31637.0,Azathioprine,Budd-Chiari syndrome,disease-phenotype-protein-drug,contraindication,"['Budd-Chiari syndrome', 'Hepatomegaly', 'ALB', 'Azathioprine']",0.5
14273,32978.0,Azathioprine,polymyositis,disease-phenotype-protein-drug,off-label use,"['polymyositis', 'Hepatomegaly', 'ALB', 'Azathioprine']",0.5
14273,33348.0,Azathioprine,autoimmune hepatitis,disease-phenotype-protein-drug,off-label use,"['autoimmune hepatitis', 'Elevated hepatic transaminase', 'RAC1', 'Azathioprine']",0.5
14273,33534.0,Azathioprine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,off-label use,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ITPA', 'Azathioprine']",0.5
14273,36425.0,Azathioprine,primary central nervous system lymphoma,disease-protein-drug,contraindication,"['primary central nervous system lymphoma', 'ABCB1', 'Azathioprine']",0.5
14273,37785.0,Azathioprine,ulcerative colitis (disease),disease-protein-drug,off-label use,"['ulcerative colitis (disease)', 'ABCB1', 'Azathioprine']",0.5
14273,37785.0,Azathioprine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Azathioprine']",0.5
14274,27626.0,Auranofin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Auranofin']",0.5
14274,29078.0,Auranofin,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'inflammatory response', 'IKBKB', 'Auranofin']",0.5
14274,30061.0,Auranofin,Felty syndrome,disease-phenotype-protein-drug,off-label use,"['Felty syndrome', 'Hepatomegaly', 'ALB', 'Auranofin']",0.5
14274,32325.0,Auranofin,juvenile idiopathic arthritis,disease-phenotype-protein-drug,off-label use,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Auranofin']",0.5
14274,33306.0,Auranofin,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Thrombocytopenia', 'ALB', 'Auranofin']",0.5
14274,33575.0,Auranofin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PRDX5', 'Auranofin']",0.5
14274,33575.0,Auranofin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Auranofin']",0.5
14274,33577.0,Auranofin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'inflammatory response', 'IKBKB', 'Auranofin']",0.5
14274,33577.0,Auranofin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Auranofin']",0.5
14274,33649.0,Auranofin,exanthem (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'PRDX5', 'Auranofin']",0.5
14274,33683.0,Auranofin,urticaria (disease),disease-protein-drug,contraindication,"['urticaria (disease)', 'ALB', 'Auranofin']",0.5
14274,35471.0,Auranofin,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'cellular response to oxidative stress', 'PRDX5', 'Auranofin']",0.5
14274,35565.0,Auranofin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'cellular response to oxidative stress', 'PRDX5', 'Auranofin']",0.5
14274,35565.0,Auranofin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Auranofin']",0.5
14274,35764.0,Auranofin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Auranofin']",0.5
14274,35764.0,Auranofin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cellular response to oxidative stress', 'PRDX5', 'Auranofin']",0.5
14274,35764.0,Auranofin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Auranofin']",0.5
14274,35916.0,Auranofin,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Lead', 'response to oxidative stress', 'PRDX5', 'Auranofin']",0.5
14274,35916.0,Auranofin,dry eye syndrome,disease-exposure-gene-drug,contraindication,"['dry eye syndrome', 'Lead', 'ALB', 'Auranofin']",0.5
14274,36129.0,Auranofin,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Air Pollutants', 'inflammatory response', 'IKBKB', 'Auranofin']",0.5
14274,36129.0,Auranofin,atopic eczema,disease-exposure-gene-drug,contraindication,"['atopic eczema', 'Lead', 'ALB', 'Auranofin']",0.5
14274,36241.0,Auranofin,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Auranofin']",0.5
14274,39540.0,Auranofin,angioedema,disease-protein-drug,contraindication,"['angioedema', 'ALB', 'Auranofin']",0.5
14275,27286.0,Doxorubicin,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'CYP2D6', 'Doxorubicin']",0.5
14275,27292.0,Doxorubicin,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'NOS3', 'Doxorubicin']",0.5
14275,27476.0,Doxorubicin,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Doxorubicin']",0.5
14275,27476.0,Doxorubicin,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Doxorubicin']",0.5
14275,27626.0,Doxorubicin,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,27626.0,Doxorubicin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Doxorubicin']",0.5
14275,28052.0,Doxorubicin,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'NOS3', 'Doxorubicin']",0.5
14275,28103.0,Doxorubicin,progressive familial heart block,disease-phenotype-protein-drug,contraindication,"['progressive familial heart block', 'Bradycardia', 'CYP2D6', 'Doxorubicin']",0.5
14275,28520.0,Doxorubicin,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'NQO1', 'Doxorubicin']",0.5
14275,28520.0,Doxorubicin,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,28520.0,Doxorubicin,myeloid leukemia,disease-exposure-molfunc-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Doxorubicin']",0.5
14275,28830.0,Doxorubicin,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'NQO1', 'Doxorubicin']",0.5
14275,29173.0,Doxorubicin,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['small cell lung carcinoma', 'Arsenic', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,29646.0,Doxorubicin,hepatocellular carcinoma,disease-protein-drug,off-label use,"['hepatocellular carcinoma', 'ABCB1', 'Doxorubicin']",0.5
14275,29646.0,Doxorubicin,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of blood pressure', 'NOS3', 'Doxorubicin']",0.5
14275,29646.0,Doxorubicin,hepatocellular carcinoma,disease-exposure-gene-drug,off-label use,"['hepatocellular carcinoma', 'Air Pollutants', 'NOS2', 'Doxorubicin']",0.5
14275,29646.0,Doxorubicin,hepatocellular carcinoma,disease-phenotype-protein-drug,off-label use,"['hepatocellular carcinoma', 'Hepatomegaly', 'NOS3', 'Doxorubicin']",0.5
14275,30075.0,Doxorubicin,Burkitt lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Burkitt lymphoma', 'Pesticides', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,30075.0,Doxorubicin,Burkitt lymphoma,disease-exposure-molfunc-gene-drug,indication,"['Burkitt lymphoma', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Doxorubicin']",0.5
14275,30494.0,Doxorubicin,plasma cell myeloma,disease-protein-drug,indication,"['plasma cell myeloma', 'NQO1', 'Doxorubicin']",0.5
14275,30494.0,Doxorubicin,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,30827.0,Doxorubicin,endometrial cancer,disease-protein-drug,off-label use,"['endometrial cancer', 'AKR1C3', 'Doxorubicin']",0.5
14275,31116.0,Doxorubicin,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Doxorubicin']",0.5
14275,31481.0,Doxorubicin,bone osteosarcoma,disease-protein-drug,indication,"['bone osteosarcoma', 'CYP3A4', 'Doxorubicin']",0.5
14275,31481.0,Doxorubicin,bone osteosarcoma,disease-phenotype-protein-drug,indication,"['bone osteosarcoma', 'Pain', 'ALB', 'Doxorubicin']",0.5
14275,32531.0,Doxorubicin,mantle cell lymphoma,disease-phenotype-protein-drug,indication,"['mantle cell lymphoma', 'Fever', 'NOS1', 'Doxorubicin']",0.5
14275,32589.0,Doxorubicin,Kaposi's sarcoma (disease),disease-phenotype-protein-drug,indication,"[""Kaposi's sarcoma (disease)"", 'Fever', 'NOS1', 'Doxorubicin']",0.5
14275,32617.0,Doxorubicin,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Doxorubicin']",0.5
14275,32622.0,Doxorubicin,thyroid gland undifferentiated (anaplastic) carcinoma,disease-phenotype-protein-drug,indication,"['thyroid gland undifferentiated (anaplastic) carcinoma', 'Pain', 'ALB', 'Doxorubicin']",0.5
14275,33077.0,Doxorubicin,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'inflammatory response', 'NOS2', 'Doxorubicin']",0.5
14275,33077.0,Doxorubicin,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'NOS3', 'Doxorubicin']",0.5
14275,33077.0,Doxorubicin,Hodgkins lymphoma,disease-exposure-molfunc-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Doxorubicin']",0.5
14275,33104.0,Doxorubicin,carcinoid syndrome,disease-phenotype-protein-drug,off-label use,"['carcinoid syndrome', 'Elevated hepatic transaminase', 'NQO1', 'Doxorubicin']",0.5
14275,33158.0,Doxorubicin,kidney Wilms tumor,disease-phenotype-protein-drug,indication,"['kidney Wilms tumor', 'Fever', 'NOS1', 'Doxorubicin']",0.5
14275,33294.0,Doxorubicin,follicular lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['follicular lymphoma', 'Polychlorinated Biphenyls', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,33294.0,Doxorubicin,follicular lymphoma,disease-phenotype-protein-drug,indication,"['follicular lymphoma', 'Fever', 'NOS1', 'Doxorubicin']",0.5
14275,33621.0,Doxorubicin,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Doxorubicin']",0.5
14275,33621.0,Doxorubicin,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'regulation of blood pressure', 'NOS3', 'Doxorubicin']",0.5
14275,33621.0,Doxorubicin,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'NOS2', 'Doxorubicin']",0.5
14275,33621.0,Doxorubicin,acute lymphoblastic leukemia (disease),disease-exposure-molfunc-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Doxorubicin']",0.5
14275,33632.0,Doxorubicin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Doxorubicin']",0.5
14275,33632.0,Doxorubicin,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Doxorubicin']",0.5
14275,35565.0,Doxorubicin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,35565.0,Doxorubicin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Doxorubicin']",0.5
14275,35650.0,Doxorubicin,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', ""2,2',3,3',4,4',5-heptachlorobiphenyl"", 'cognition', 'CBR3', 'Doxorubicin']",0.5
14275,35650.0,Doxorubicin,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Cadmium', 'ALB', 'Doxorubicin']",0.5
14275,35650.0,Doxorubicin,non-Hodgkin lymphoma,disease-exposure-molfunc-gene-drug,indication,"['non-Hodgkin lymphoma', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Doxorubicin']",0.5
14275,35669.0,Doxorubicin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'NOS3', 'Doxorubicin']",0.5
14275,35669.0,Doxorubicin,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'NOS2', 'Doxorubicin']",0.5
14275,35738.0,Doxorubicin,endometrial carcinoma (disease),disease-protein-drug,off-label use,"['endometrial carcinoma (disease)', 'AKR1C3', 'Doxorubicin']",0.5
14275,35739.0,Doxorubicin,uterine corpus cancer,disease-protein-drug,off-label use,"['uterine corpus cancer', 'AKR1C3', 'Doxorubicin']",0.5
14275,35761.0,Doxorubicin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose metabolic process', 'AKR1A1', 'Doxorubicin']",0.5
14275,35761.0,Doxorubicin,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'NOS2', 'Doxorubicin']",0.5
14275,35761.0,Doxorubicin,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Doxorubicin']",0.5
14275,35771.0,Doxorubicin,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'ABCB1', 'Doxorubicin']",0.5
14275,35771.0,Doxorubicin,breast neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['breast neoplasm', 'Cobalt', 'glucose metabolic process', 'AKR1A1', 'Doxorubicin']",0.5
14275,35771.0,Doxorubicin,breast neoplasm,disease-exposure-gene-drug,indication,"['breast neoplasm', 'Air Pollutants', 'NOS2', 'Doxorubicin']",0.5
14275,35771.0,Doxorubicin,breast neoplasm,disease-exposure-molfunc-gene-drug,indication,"['breast neoplasm', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Doxorubicin']",0.5
14275,35884.0,Doxorubicin,diffuse large B-cell lymphoma,disease-protein-drug,indication,"['diffuse large B-cell lymphoma', 'ABCB1', 'Doxorubicin']",0.5
14275,35884.0,Doxorubicin,diffuse large B-cell lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['diffuse large B-cell lymphoma', 'Polychlorinated Biphenyls', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,35970.0,Doxorubicin,lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['lymphoma', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,36104.0,Doxorubicin,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Doxorubicin']",0.5
14275,36229.0,Doxorubicin,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Doxorubicin']",0.5
14275,36425.0,Doxorubicin,primary central nervous system lymphoma,disease-protein-drug,indication,"['primary central nervous system lymphoma', 'ABCB1', 'Doxorubicin']",0.5
14275,36432.0,Doxorubicin,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Doxorubicin']",0.5
14275,36527.0,Doxorubicin,yolk sac tumor,disease-protein-drug,indication,"['yolk sac tumor', 'CYP1B1', 'Doxorubicin']",0.5
14275,36634.0,Doxorubicin,liver cancer,disease-protein-drug,off-label use,"['liver cancer', 'ABCB1', 'Doxorubicin']",0.5
14275,36634.0,Doxorubicin,liver cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['liver cancer', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Doxorubicin']",0.5
14275,36634.0,Doxorubicin,liver cancer,disease-exposure-gene-drug,off-label use,"['liver cancer', 'Air Pollutants', 'NOS2', 'Doxorubicin']",0.5
14275,36645.0,Doxorubicin,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Doxorubicin']",0.5
14275,36792.0,Doxorubicin,ovarian mucinous adenocarcinoma,disease-protein-drug,indication,"['ovarian mucinous adenocarcinoma', 'CYP1B1', 'Doxorubicin']",0.5
14275,36794.0,Doxorubicin,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'CYP1B1', 'Doxorubicin']",0.5
14275,36812.0,Doxorubicin,lung neoplasm,disease-protein-drug,indication,"['lung neoplasm', 'NOS2', 'Doxorubicin']",0.5
14275,36812.0,Doxorubicin,lung neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['lung neoplasm', 'Coke', 'visual perception', 'ABCC6', 'Doxorubicin']",0.5
14275,36812.0,Doxorubicin,lung neoplasm,disease-exposure-gene-drug,indication,"['lung neoplasm', 'Air Pollutants', 'NOS2', 'Doxorubicin']",0.5
14275,36812.0,Doxorubicin,lung neoplasm,disease-exposure-molfunc-gene-drug,indication,"['lung neoplasm', 'Pesticides', 'superoxide dismutase activity', 'NQO1', 'Doxorubicin']",0.5
14275,36944.0,Doxorubicin,thyroid cancer,disease-exposure-bioprocess-gene-drug,indication,"['thyroid cancer', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Doxorubicin']",0.5
14275,37038.0,Doxorubicin,endometrium neoplasm,disease-protein-drug,off-label use,"['endometrium neoplasm', 'AKR1C3', 'Doxorubicin']",0.5
14275,37047.0,Doxorubicin,immature ovarian teratoma,disease-protein-drug,indication,"['immature ovarian teratoma', 'CYP1B1', 'Doxorubicin']",0.5
14275,37082.0,Doxorubicin,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5
14275,37150.0,Doxorubicin,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5
14275,37152.0,Doxorubicin,familial ovarian cancer,disease-protein-drug,indication,"['familial ovarian cancer', 'CYP1B1', 'Doxorubicin']",0.5
14275,37334.0,Doxorubicin,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'ABCB1', 'Doxorubicin']",0.5
14275,37423.0,Doxorubicin,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'CYP1B1', 'Doxorubicin']",0.5
14275,37466.0,Doxorubicin,ovarian small cell carcinoma,disease-protein-drug,indication,"['ovarian small cell carcinoma', 'CYP1B1', 'Doxorubicin']",0.5
14275,37659.0,Doxorubicin,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Doxorubicin']",0.5
14275,37659.0,Doxorubicin,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of blood pressure', 'NOS3', 'Doxorubicin']",0.5
14275,37659.0,Doxorubicin,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'NOS2', 'Doxorubicin']",0.5
14275,37967.0,Doxorubicin,ovarian endometrioid adenocarcinoma,disease-protein-drug,indication,"['ovarian endometrioid adenocarcinoma', 'CYP1B1', 'Doxorubicin']",0.5
14275,38312.0,Doxorubicin,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'ABCC2', 'Doxorubicin']",0.5
14275,39603.0,Doxorubicin,malignant sex cord stromal tumor of ovary,disease-protein-drug,indication,"['malignant sex cord stromal tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5
14275,39615.0,Doxorubicin,borderline epithelial tumor of ovary,disease-protein-drug,indication,"['borderline epithelial tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5
14275,83769.0,Doxorubicin,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Doxorubicin']",0.5
14275,83802.0,Doxorubicin,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Doxorubicin']",0.5
14275,83802.0,Doxorubicin,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SLC22A16', 'Doxorubicin']",0.5
14275,83816.0,Doxorubicin,ovarian carcinosarcoma,disease-protein-drug,indication,"['ovarian carcinosarcoma', 'CYP1B1', 'Doxorubicin']",0.5
14275,83817.0,Doxorubicin,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary site-specific ovarian cancer syndrome', 'CYP1B1', 'Doxorubicin']",0.5
14275,83818.0,Doxorubicin,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'CYP1B1', 'Doxorubicin']",0.5
14275,83819.0,Doxorubicin,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant dysgerminomatous germ cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5
14275,83820.0,Doxorubicin,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5
14275,83821.0,Doxorubicin,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'CYP1B1', 'Doxorubicin']",0.5
14275,83822.0,Doxorubicin,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,indication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'CYP1B1', 'Doxorubicin']",0.5
14275,84154.0,Doxorubicin,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,indication,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Doxorubicin']",0.5
14275,84155.0,Doxorubicin,Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly,disease-protein-drug,indication,"['Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly', 'ABCB1', 'Doxorubicin']",0.5
14275,84156.0,Doxorubicin,plasmablastic lymphoma,disease-protein-drug,indication,"['plasmablastic lymphoma', 'ABCB1', 'Doxorubicin']",0.5
14275,84157.0,Doxorubicin,diffuse large B-cell lymphoma of the central nervous system,disease-protein-drug,indication,"['diffuse large B-cell lymphoma of the central nervous system', 'ABCB1', 'Doxorubicin']",0.5
14275,84158.0,Doxorubicin,T-cell/histiocyte rich large B cell lymphoma,disease-protein-drug,indication,"['T-cell/histiocyte rich large B cell lymphoma', 'ABCB1', 'Doxorubicin']",0.5
14275,84159.0,Doxorubicin,ALK-positive large B-cell lymphoma,disease-protein-drug,indication,"['ALK-positive large B-cell lymphoma', 'ABCB1', 'Doxorubicin']",0.5
14275,84160.0,Doxorubicin,primary mediastinal large B-cell lymphoma,disease-protein-drug,indication,"['primary mediastinal large B-cell lymphoma', 'ABCB1', 'Doxorubicin']",0.5
14275,84161.0,Doxorubicin,intravascular large B-cell lymphoma,disease-protein-drug,indication,"['intravascular large B-cell lymphoma', 'ABCB1', 'Doxorubicin']",0.5
14276,27933.0,Hydrochlorothiazide,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Hydrochlorothiazide']",0.5
14276,27933.0,Hydrochlorothiazide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Lead', 'transport', 'ALB', 'Hydrochlorothiazide']",0.5
14276,27933.0,Hydrochlorothiazide,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,28052.0,Hydrochlorothiazide,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'ALB', 'Hydrochlorothiazide']",0.5
14276,28547.0,Hydrochlorothiazide,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Lead', 'transport', 'ALB', 'Hydrochlorothiazide']",0.5
14276,28547.0,Hydrochlorothiazide,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Lead', 'ALB', 'Hydrochlorothiazide']",0.5
14276,28552.0,Hydrochlorothiazide,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Hydrochlorothiazide']",0.5
14276,29182.0,Hydrochlorothiazide,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Hydrochlorothiazide']",0.5
14276,29182.0,Hydrochlorothiazide,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Hydrochlorothiazide']",0.5
14276,31033.0,Hydrochlorothiazide,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'ALB', 'Hydrochlorothiazide']",0.5
14276,31072.0,Hydrochlorothiazide,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Hydrochlorothiazide']",0.5
14276,31122.0,Hydrochlorothiazide,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'ALB', 'Hydrochlorothiazide']",0.5
14276,31493.0,Hydrochlorothiazide,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Hydrochlorothiazide']",0.5
14276,32629.0,Hydrochlorothiazide,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'ALB', 'Hydrochlorothiazide']",0.5
14276,32928.0,Hydrochlorothiazide,acute liver failure,disease-protein-drug,contraindication,"['acute liver failure', 'ALB', 'Hydrochlorothiazide']",0.5
14276,32928.0,Hydrochlorothiazide,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Thrombocytopenia', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33025.0,Hydrochlorothiazide,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33534.0,Hydrochlorothiazide,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33575.0,Hydrochlorothiazide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33575.0,Hydrochlorothiazide,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33577.0,Hydrochlorothiazide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33577.0,Hydrochlorothiazide,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33598.0,Hydrochlorothiazide,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33598.0,Hydrochlorothiazide,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33598.0,Hydrochlorothiazide,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33605.0,Hydrochlorothiazide,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33632.0,Hydrochlorothiazide,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'transport', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33632.0,Hydrochlorothiazide,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Hydrochlorothiazide']",0.5
14276,33675.0,Hydrochlorothiazide,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Benzo(a)pyrene', 'heme biosynthetic process', 'ALB', 'Hydrochlorothiazide']",0.5
14276,35565.0,Hydrochlorothiazide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,35641.0,Hydrochlorothiazide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Hydrochlorothiazide']",0.5
14276,35764.0,Hydrochlorothiazide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Hydrochlorothiazide']",0.5
14276,35764.0,Hydrochlorothiazide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Hydrochlorothiazide']",0.5
14276,35764.0,Hydrochlorothiazide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,35854.0,Hydrochlorothiazide,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Hydrochlorothiazide']",0.5
14276,35897.0,Hydrochlorothiazide,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Hydrochlorothiazide']",0.5
14276,35909.0,Hydrochlorothiazide,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Hydrochlorothiazide']",0.5
14276,36187.0,Hydrochlorothiazide,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'transport', 'ALB', 'Hydrochlorothiazide']",0.5
14276,36187.0,Hydrochlorothiazide,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,36241.0,Hydrochlorothiazide,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Hydrochlorothiazide']",0.5
14276,36286.0,Hydrochlorothiazide,diabetic nephropathy,disease-protein-drug,contraindication,"['diabetic nephropathy', 'ALB', 'Hydrochlorothiazide']",0.5
14276,36432.0,Hydrochlorothiazide,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Hydrochlorothiazide']",0.5
14276,37659.0,Hydrochlorothiazide,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Hydrochlorothiazide']",0.5
14276,37659.0,Hydrochlorothiazide,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,37703.0,Hydrochlorothiazide,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Hydrochlorothiazide']",0.5
14276,37765.0,Hydrochlorothiazide,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Hydrochlorothiazide']",0.5
14276,37786.0,Hydrochlorothiazide,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Lead', 'transport', 'ALB', 'Hydrochlorothiazide']",0.5
14276,37786.0,Hydrochlorothiazide,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,37830.0,Hydrochlorothiazide,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Hydrochlorothiazide']",0.5
14276,39540.0,Hydrochlorothiazide,angioedema,disease-protein-drug,contraindication,"['angioedema', 'ALB', 'Hydrochlorothiazide']",0.5
14276,39798.0,Hydrochlorothiazide,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'ALB', 'Hydrochlorothiazide']",0.5
14276,83760.0,Hydrochlorothiazide,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Hydrochlorothiazide']",0.5
14277,27476.0,Letrozole,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Letrozole']",0.5
14277,29614.0,Letrozole,osteoporosis,disease-protein-drug,contraindication,"['osteoporosis', 'CYP19A1', 'Letrozole']",0.5
14277,29614.0,Letrozole,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Letrozole']",0.5
14277,29614.0,Letrozole,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Letrozole']",0.5
14277,31477.0,Letrozole,ovarian cancer,disease-exposure-gene-drug,off-label use,"['ovarian cancer', 'Cadmium', 'ALB', 'Letrozole']",0.5
14277,32617.0,Letrozole,hereditary breast ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Letrozole']",0.5
14277,35909.0,Letrozole,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Letrozole']",0.5
14277,37765.0,Letrozole,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Letrozole']",0.5
14277,83776.0,Letrozole,postmenopausal osteoporosis,disease-protein-drug,contraindication,"['postmenopausal osteoporosis', 'CYP19A1', 'Letrozole']",0.5
14278,27366.0,Ketoprofen,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Ketoprofen']",0.5
14278,29078.0,Ketoprofen,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCC4', 'Ketoprofen']",0.5
14278,29078.0,Ketoprofen,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Ketoprofen']",0.5
14278,29078.0,Ketoprofen,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Ketoprofen']",0.5
14278,29078.0,Ketoprofen,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Ketoprofen']",0.5
14278,33577.0,Ketoprofen,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Ketoprofen']",0.5
14278,33577.0,Ketoprofen,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Ketoprofen']",0.5
14278,35669.0,Ketoprofen,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketoprofen']",0.5
14278,35669.0,Ketoprofen,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Ketoprofen']",0.5
14278,35761.0,Ketoprofen,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Ketoprofen']",0.5
14278,35761.0,Ketoprofen,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Ketoprofen']",0.5
14278,35764.0,Ketoprofen,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Ketoprofen']",0.5
14278,35764.0,Ketoprofen,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Ketoprofen']",0.5
14278,35764.0,Ketoprofen,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Ketoprofen']",0.5
14278,37180.0,Ketoprofen,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketoprofen']",0.5
14278,37180.0,Ketoprofen,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Ketoprofen']",0.5
14279,27286.0,Sulfamethoxazole,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ALB', 'Sulfamethoxazole']",0.5
14279,27626.0,Sulfamethoxazole,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Sulfamethoxazole']",0.5
14279,32932.0,Sulfamethoxazole,brucellosis,disease-phenotype-protein-drug,off-label use,"['brucellosis', 'Hepatomegaly', 'ALB', 'Sulfamethoxazole']",0.5
14279,32977.0,Sulfamethoxazole,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Pruritus', 'ABCB11', 'Sulfamethoxazole']",0.5
14279,32999.0,Sulfamethoxazole,shigellosis,disease-phenotype-protein-drug,indication,"['shigellosis', 'Thrombocytopenia', 'ALB', 'Sulfamethoxazole']",0.5
14279,33314.0,Sulfamethoxazole,leptospirosis,disease-phenotype-protein-drug,off-label use,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Sulfamethoxazole']",0.5
14279,33359.0,Sulfamethoxazole,Whipple disease,disease-phenotype-protein-drug,off-label use,"['Whipple disease', 'Hepatomegaly', 'ALB', 'Sulfamethoxazole']",0.5
14279,33474.0,Sulfamethoxazole,typhoid fever,disease-phenotype-protein-drug,off-label use,"['typhoid fever', 'Hepatomegaly', 'ALB', 'Sulfamethoxazole']",0.5
14279,33678.0,Sulfamethoxazole,glomerulonephritis,disease-protein-drug,contraindication,"['glomerulonephritis', 'ALB', 'Sulfamethoxazole']",0.5
14279,35565.0,Sulfamethoxazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Sulfamethoxazole']",0.5
14279,35565.0,Sulfamethoxazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Sulfamethoxazole']",0.5
14279,35764.0,Sulfamethoxazole,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Sulfamethoxazole']",0.5
14279,35764.0,Sulfamethoxazole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Sulfamethoxazole']",0.5
14279,35764.0,Sulfamethoxazole,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Sulfamethoxazole']",0.5
14280,27219.0,Glyburide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'ABCC2', 'Glyburide']",0.5
14280,27292.0,Glyburide,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'ABCC3', 'Glyburide']",0.5
14280,27648.0,Glyburide,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Glyburide']",0.5
14280,27741.0,Glyburide,pituitary deficiency due to empty sella turcica syndrome,disease-phenotype-protein-drug,contraindication,"['pituitary deficiency due to empty sella turcica syndrome', 'Seizure', 'ABCC2', 'Glyburide']",0.5
14280,28208.0,Glyburide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'KCNJ11', 'Glyburide']",0.5
14280,28208.0,Glyburide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose metabolic process', 'KCNJ11', 'Glyburide']",0.5
14280,28208.0,Glyburide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Cadmium', 'ALB', 'Glyburide']",0.5
14280,28208.0,Glyburide,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'KCNJ11', 'Glyburide']",0.5
14280,30035.0,Glyburide,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Glyburide']",0.5
14280,30813.0,Glyburide,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'ABCC2', 'Glyburide']",0.5
14280,32337.0,Glyburide,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'Seizure', 'ABCC2', 'Glyburide']",0.5
14280,32384.0,Glyburide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ABCC2', 'Glyburide']",0.5
14280,32584.0,Glyburide,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Glyburide']",0.5
14280,32905.0,Glyburide,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Glyburide']",0.5
14280,33453.0,Glyburide,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Seizure', 'ABCC2', 'Glyburide']",0.5
14280,33575.0,Glyburide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'KCNJ11', 'Glyburide']",0.5
14280,33575.0,Glyburide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'KCNJ11', 'Glyburide']",0.5
14280,33575.0,Glyburide,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Glyburide']",0.5
14280,35565.0,Glyburide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CFTR', 'Glyburide']",0.5
14280,35565.0,Glyburide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Glyburide']",0.5
14280,35764.0,Glyburide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Glyburide']",0.5
14280,35764.0,Glyburide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCA1', 'Glyburide']",0.5
14280,35764.0,Glyburide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Glyburide']",0.5
14280,37180.0,Glyburide,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Glyburide']",0.5
14280,37180.0,Glyburide,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Glyburide']",0.5
14281,27655.0,Ketoconazole,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Ketoconazole']",0.5
14281,30813.0,Ketoconazole,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Hyperkalemia', 'CYP17A1', 'Ketoconazole']",0.5
14281,32651.0,Ketoconazole,coccidioidomycosis,disease-phenotype-protein-drug,indication,"['coccidioidomycosis', 'Pruritus', 'ABCB11', 'Ketoconazole']",0.5
14281,32764.0,Ketoconazole,chromomycosis,disease-phenotype-protein-drug,indication,"['chromomycosis', 'Pruritus', 'ABCB11', 'Ketoconazole']",0.5
14281,35565.0,Ketoconazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Ketoconazole']",0.5
14281,35565.0,Ketoconazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Ketoconazole']",0.5
14281,39798.0,Ketoconazole,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Ketoconazole']",0.5
14281,39798.0,Ketoconazole,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'CYP1B1', 'Ketoconazole']",0.5
14281,83751.0,Ketoconazole,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Ketoconazole']",0.5
14282,29182.0,Irbesartan,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'PTGS1', 'Irbesartan']",0.5
14282,29182.0,Irbesartan,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Irbesartan']",0.5
14282,31493.0,Irbesartan,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Irbesartan']",0.5
14282,33534.0,Irbesartan,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Irbesartan']",0.5
14282,33575.0,Irbesartan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Irbesartan']",0.5
14282,33575.0,Irbesartan,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Irbesartan']",0.5
14282,33577.0,Irbesartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Irbesartan']",0.5
14282,33577.0,Irbesartan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Irbesartan']",0.5
14282,33577.0,Irbesartan,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Irbesartan']",0.5
14282,33605.0,Irbesartan,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Irbesartan']",0.5
14282,33612.0,Irbesartan,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Irbesartan']",0.5
14282,33618.0,Irbesartan,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'PTGS1', 'Irbesartan']",0.5
14282,33618.0,Irbesartan,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Air Pollutants', 'PTGS1', 'Irbesartan']",0.5
14282,36035.0,Irbesartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Irbesartan']",0.5
14282,36286.0,Irbesartan,diabetic nephropathy,disease-protein-drug,indication,"['diabetic nephropathy', 'ALB', 'Irbesartan']",0.5
14282,39540.0,Irbesartan,angioedema,disease-protein-drug,contraindication,"['angioedema', 'ALB', 'Irbesartan']",0.5
14282,83802.0,Irbesartan,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Irbesartan']",0.5
14283,27626.0,Probenecid,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Probenecid']",0.5
14283,27664.0,Probenecid,idiopathic aplastic anemia,disease-phenotype-protein-drug,contraindication,"['idiopathic aplastic anemia', 'Thrombocytopenia', 'ALB', 'Probenecid']",0.5
14283,29352.0,Probenecid,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Probenecid']",0.5
14283,29494.0,Probenecid,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ABCC3', 'Probenecid']",0.5
14283,30184.0,Probenecid,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ABCC3', 'Probenecid']",0.5
14283,30879.0,Probenecid,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'ABCC2', 'Probenecid']",0.5
14283,33594.0,Probenecid,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'SLC10A1', 'Probenecid']",0.5
14283,33612.0,Probenecid,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Probenecid']",0.5
14283,35764.0,Probenecid,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Probenecid']",0.5
14283,35764.0,Probenecid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'SLC16A1', 'Probenecid']",0.5
14283,35764.0,Probenecid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Probenecid']",0.5
14283,36104.0,Probenecid,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Probenecid']",0.5
14283,36229.0,Probenecid,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Probenecid']",0.5
14283,83790.0,Probenecid,gout,disease-protein-drug,indication,"['gout', 'SLC2A9', 'Probenecid']",0.5
14283,83802.0,Probenecid,obsolete hyperuricemia (disease),disease-protein-drug,indication,"['obsolete hyperuricemia (disease)', 'SLC2A9', 'Probenecid']",0.5
14283,83802.0,Probenecid,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Probenecid']",0.5
14284,27626.0,Fenofibrate,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Fenofibrate']",0.5
14284,28745.0,Fenofibrate,dermatomyositis,disease-phenotype-protein-drug,contraindication,"['dermatomyositis', 'Pruritus', 'ABCB11', 'Fenofibrate']",0.5
14284,29352.0,Fenofibrate,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Fenofibrate']",0.5
14284,29494.0,Fenofibrate,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NR1I2', 'Fenofibrate']",0.5
14284,29955.0,Fenofibrate,Reynolds syndrome,disease-protein-drug,contraindication,"['Reynolds syndrome', 'ALB', 'Fenofibrate']",0.5
14284,29955.0,Fenofibrate,Reynolds syndrome,disease-phenotype-protein-drug,contraindication,"['Reynolds syndrome', 'Hepatomegaly', 'NR1I2', 'Fenofibrate']",0.5
14284,31144.0,Fenofibrate,primary biliary cholangitis,disease-protein-drug,contraindication,"['primary biliary cholangitis', 'ALB', 'Fenofibrate']",0.5
14284,31144.0,Fenofibrate,primary biliary cholangitis,disease-phenotype-protein-drug,contraindication,"['primary biliary cholangitis', 'Pruritus', 'ABCB11', 'Fenofibrate']",0.5
14284,31493.0,Fenofibrate,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Fenofibrate']",0.5
14284,33612.0,Fenofibrate,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Fenofibrate']",0.5
14284,33632.0,Fenofibrate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'urea metabolic process', 'CYP2C9', 'Fenofibrate']",0.5
14284,33632.0,Fenofibrate,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Fenofibrate']",0.5
14284,33658.0,Fenofibrate,hyperlipidemia,disease-protein-drug,indication,"['hyperlipidemia', 'PPARA', 'Fenofibrate']",0.5
14284,33695.0,Fenofibrate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Fenofibrate']",0.5
14284,33695.0,Fenofibrate,hypertriglyceridemia (disease),disease-exposure-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Fenofibrate']",0.5
14284,35565.0,Fenofibrate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CES1', 'Fenofibrate']",0.5
14284,35565.0,Fenofibrate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Fenofibrate']",0.5
14284,37764.0,Fenofibrate,familial hyperlipidemia,disease-protein-drug,indication,"['familial hyperlipidemia', 'PPARA', 'Fenofibrate']",0.5
14285,39696.0,Gatifloxacin,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,off-label use,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Gatifloxacin']",0.5
14286,27626.0,Rifampicin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Rifampicin']",0.5
14286,27664.0,Rifampicin,idiopathic aplastic anemia,disease-phenotype-protein-drug,contraindication,"['idiopathic aplastic anemia', 'Thrombocytopenia', 'ALB', 'Rifampicin']",0.5
14286,27933.0,Rifampicin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Rifampicin']",0.5
14286,27933.0,Rifampicin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Rifampicin']",0.5
14286,27933.0,Rifampicin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Rifampicin']",0.5
14286,30035.0,Rifampicin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Rifampicin']",0.5
14286,32710.0,Rifampicin,inhalational anthrax,disease-phenotype-protein-drug,off-label use,"['inhalational anthrax', 'Vomiting', 'ABCB1', 'Rifampicin']",0.5
14286,32928.0,Rifampicin,acute liver failure,disease-protein-drug,contraindication,"['acute liver failure', 'ALB', 'Rifampicin']",0.5
14286,32928.0,Rifampicin,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Thrombocytopenia', 'ALB', 'Rifampicin']",0.5
14286,32977.0,Rifampicin,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Rifampicin']",0.5
14286,32977.0,Rifampicin,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ABCC2', 'Rifampicin']",0.5
14286,33575.0,Rifampicin,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Rifampicin']",0.5
14286,33575.0,Rifampicin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Rifampicin']",0.5
14286,33575.0,Rifampicin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Rifampicin']",0.5
14286,33632.0,Rifampicin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Rifampicin']",0.5
14286,33632.0,Rifampicin,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Rifampicin']",0.5
14286,35565.0,Rifampicin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Rifampicin']",0.5
14286,35565.0,Rifampicin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Rifampicin']",0.5
14286,36104.0,Rifampicin,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Rifampicin']",0.5
14286,36229.0,Rifampicin,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Rifampicin']",0.5
14286,36241.0,Rifampicin,hepatitis,disease-protein-drug,contraindication,"['hepatitis', 'ALB', 'Rifampicin']",0.5
14286,37703.0,Rifampicin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Rifampicin']",0.5
14286,39531.0,Rifampicin,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Rifampicin']",0.5
14286,39696.0,Rifampicin,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Rifampicin']",0.5
14286,83760.0,Rifampicin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Rifampicin']",0.5
14287,27626.0,Ibuprofen,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Ibuprofen']",0.5
14287,27648.0,Ibuprofen,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Ibuprofen']",0.5
14287,27933.0,Ibuprofen,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Ibuprofen']",0.5
14287,27933.0,Ibuprofen,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Ibuprofen']",0.5
14287,27933.0,Ibuprofen,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PTGS2', 'Ibuprofen']",0.5
14287,28158.0,Ibuprofen,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Ibuprofen']",0.5
14287,28158.0,Ibuprofen,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Ibuprofen']",0.5
14287,28158.0,Ibuprofen,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Ibuprofen']",0.5
14287,28861.0,Ibuprofen,patent ductus arteriosus,disease-exposure-bioprocess-gene-drug,indication,"['patent ductus arteriosus', 'Particulate Matter', 'reactive oxygen species metabolic process', 'BCL2', 'Ibuprofen']",0.5
14287,28861.0,Ibuprofen,patent ductus arteriosus,disease-exposure-gene-drug,indication,"['patent ductus arteriosus', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,28899.0,Ibuprofen,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Ibuprofen']",0.5
14287,29078.0,Ibuprofen,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Ibuprofen']",0.5
14287,29078.0,Ibuprofen,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Ibuprofen']",0.5
14287,29078.0,Ibuprofen,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,29078.0,Ibuprofen,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Ibuprofen']",0.5
14287,29113.0,Ibuprofen,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'PPARG', 'Ibuprofen']",0.5
14287,29182.0,Ibuprofen,systemic lupus erythematosus (disease),disease-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'PTGS2', 'Ibuprofen']",0.5
14287,29182.0,Ibuprofen,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'reactive oxygen species metabolic process', 'BCL2', 'Ibuprofen']",0.5
14287,29182.0,Ibuprofen,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Ibuprofen']",0.5
14287,29273.0,Ibuprofen,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'PPARG', 'Ibuprofen']",0.5
14287,29525.0,Ibuprofen,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'PTGS2', 'Ibuprofen']",0.5
14287,30035.0,Ibuprofen,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Ibuprofen']",0.5
14287,30612.0,Ibuprofen,Leber hereditary optic neuropathy,disease-phenotype-protein-drug,contraindication,"['Leber hereditary optic neuropathy', 'Arrhythmia', 'PTGS2', 'Ibuprofen']",0.5
14287,30813.0,Ibuprofen,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'PTGS2', 'Ibuprofen']",0.5
14287,31072.0,Ibuprofen,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Ibuprofen']",0.5
14287,31395.0,Ibuprofen,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Ibuprofen']",0.5
14287,31732.0,Ibuprofen,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'BCL2', 'Ibuprofen']",0.5
14287,32384.0,Ibuprofen,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'PTGS2', 'Ibuprofen']",0.5
14287,32584.0,Ibuprofen,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Premature birth', 'PTGS2', 'Ibuprofen']",0.5
14287,32719.0,Ibuprofen,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'PTGS2', 'Ibuprofen']",0.5
14287,33306.0,Ibuprofen,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Thrombocytopenia', 'ALB', 'Ibuprofen']",0.5
14287,33534.0,Ibuprofen,pediatric systemic lupus erythematosus,disease-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'PTGS2', 'Ibuprofen']",0.5
14287,33534.0,Ibuprofen,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Ibuprofen']",0.5
14287,33575.0,Ibuprofen,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'PPARA', 'Ibuprofen']",0.5
14287,33575.0,Ibuprofen,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Ibuprofen']",0.5
14287,33575.0,Ibuprofen,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,33577.0,Ibuprofen,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'PPARG', 'Ibuprofen']",0.5
14287,33577.0,Ibuprofen,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,33598.0,Ibuprofen,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Ibuprofen']",0.5
14287,33598.0,Ibuprofen,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Ibuprofen']",0.5
14287,33598.0,Ibuprofen,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,33603.0,Ibuprofen,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'PTGS2', 'Ibuprofen']",0.5
14287,33605.0,Ibuprofen,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Ibuprofen']",0.5
14287,33609.0,Ibuprofen,osteoarthritis,disease-protein-drug,indication,"['osteoarthritis', 'PPARG', 'Ibuprofen']",0.5
14287,33632.0,Ibuprofen,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Ibuprofen']",0.5
14287,33632.0,Ibuprofen,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Ibuprofen']",0.5
14287,35565.0,Ibuprofen,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'BCL2', 'Ibuprofen']",0.5
14287,35565.0,Ibuprofen,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Ibuprofen']",0.5
14287,35641.0,Ibuprofen,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Ibuprofen']",0.5
14287,35764.0,Ibuprofen,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Ibuprofen']",0.5
14287,35764.0,Ibuprofen,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'PPARG', 'Ibuprofen']",0.5
14287,35764.0,Ibuprofen,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Ibuprofen']",0.5
14287,35897.0,Ibuprofen,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'reactive oxygen species metabolic process', 'BCL2', 'Ibuprofen']",0.5
14287,35909.0,Ibuprofen,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'BCL2', 'Ibuprofen']",0.5
14287,35909.0,Ibuprofen,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,35953.0,Ibuprofen,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'PTGS2', 'Ibuprofen']",0.5
14287,35953.0,Ibuprofen,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'diisobutyl phthalate', 'renal system process', 'BCL2', 'Ibuprofen']",0.5
14287,35953.0,Ibuprofen,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Diethylhexyl Phthalate', 'PPARG', 'Ibuprofen']",0.5
14287,35958.0,Ibuprofen,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'BCL2', 'Ibuprofen']",0.5
14287,36034.0,Ibuprofen,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Ibuprofen']",0.5
14287,36080.0,Ibuprofen,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of blood pressure', 'PTGS1', 'Ibuprofen']",0.5
14287,36080.0,Ibuprofen,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,36187.0,Ibuprofen,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PTGS2', 'Ibuprofen']",0.5
14287,36187.0,Ibuprofen,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Ibuprofen']",0.5
14287,36187.0,Ibuprofen,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,36209.0,Ibuprofen,arthropathy,disease-protein-drug,indication,"['arthropathy', 'PPARG', 'Ibuprofen']",0.5
14287,36236.0,Ibuprofen,cor pulmonale,disease-exposure-bioprocess-gene-drug,contraindication,"['cor pulmonale', 'Ozone', 'regulation of inflammatory response', 'PTGS2', 'Ibuprofen']",0.5
14287,36469.0,Ibuprofen,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Ibuprofen']",0.5
14287,36492.0,Ibuprofen,brain cancer,disease-protein-drug,contraindication,"['brain cancer', 'CYP2C9', 'Ibuprofen']",0.5
14287,36492.0,Ibuprofen,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Ibuprofen']",0.5
14287,36492.0,Ibuprofen,brain cancer,disease-exposure-gene-drug,contraindication,"['brain cancer', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,36693.0,Ibuprofen,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CFTR', 'Ibuprofen']",0.5
14287,37180.0,Ibuprofen,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'BCL2', 'Ibuprofen']",0.5
14287,37180.0,Ibuprofen,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Ibuprofen']",0.5
14287,37180.0,Ibuprofen,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,37617.0,Ibuprofen,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Ibuprofen']",0.5
14287,37617.0,Ibuprofen,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,37785.0,Ibuprofen,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Ibuprofen']",0.5
14287,37785.0,Ibuprofen,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'regulation of gene expression', 'BCL2', 'Ibuprofen']",0.5
14287,37786.0,Ibuprofen,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Ibuprofen']",0.5
14287,37786.0,Ibuprofen,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'PTGS1', 'Ibuprofen']",0.5
14287,38044.0,Ibuprofen,coronary atherosclerosis,disease-protein-drug,contraindication,"['coronary atherosclerosis', 'PTGS2', 'Ibuprofen']",0.5
14287,83823.0,Ibuprofen,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'BCL2', 'Ibuprofen']",0.5
14287,83824.0,Ibuprofen,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'BCL2', 'Ibuprofen']",0.5
14287,83875.0,Ibuprofen,bladder neck obstruction,disease-protein-drug,contraindication,"['bladder neck obstruction', 'PTGS2', 'Ibuprofen']",0.5
14288,32228.0,Benzylpenicillin,foodborne botulism,disease-phenotype-protein-drug,indication,"['foodborne botulism', 'Arrhythmia', 'SLC22A5', 'Benzylpenicillin']",0.5
14288,32729.0,Benzylpenicillin,botulism,disease-phenotype-protein-drug,indication,"['botulism', 'Arrhythmia', 'SLC22A5', 'Benzylpenicillin']",0.5
14288,32949.0,Benzylpenicillin,relapsing fever,disease-phenotype-protein-drug,off-label use,"['relapsing fever', 'Thrombocytopenia', 'ALB', 'Benzylpenicillin']",0.5
14288,32950.0,Benzylpenicillin,Lyme disease,disease-phenotype-protein-drug,off-label use,"['Lyme disease', 'Arrhythmia', 'SLC22A5', 'Benzylpenicillin']",0.5
14288,33314.0,Benzylpenicillin,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Benzylpenicillin']",0.5
14288,35764.0,Benzylpenicillin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Benzylpenicillin']",0.5
14288,35764.0,Benzylpenicillin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Benzylpenicillin']",0.5
14288,35764.0,Benzylpenicillin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Benzylpenicillin']",0.5
14288,35831.0,Benzylpenicillin,respiratory tract infectious disease,disease-exposure-bioprocess-gene-drug,indication,"['respiratory tract infectious disease', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Benzylpenicillin']",0.5
14290,28547.0,Echothiophate,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'BCHE', 'Echothiophate']",0.5
14290,28547.0,Echothiophate,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Lead', 'choline metabolic process', 'BCHE', 'Echothiophate']",0.5
14290,28547.0,Echothiophate,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Chlorpyrifos', 'BCHE', 'Echothiophate']",0.5
14290,28547.0,Echothiophate,Parkinson disease,disease-exposure-molfunc-gene-drug,contraindication,"['Parkinson disease', 'Organophosphates', 'cholinesterase activity', 'BCHE', 'Echothiophate']",0.5
14290,33577.0,Echothiophate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'response to folic acid', 'BCHE', 'Echothiophate']",0.5
14290,33577.0,Echothiophate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Echothiophate']",0.5
14290,33577.0,Echothiophate,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Echothiophate']",0.5
14290,33594.0,Echothiophate,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Echothiophate']",0.5
14290,33594.0,Echothiophate,diarrheal disease,disease-exposure-molfunc-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Echothiophate']",0.5
14290,33605.0,Echothiophate,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Echothiophate']",0.5
14290,33654.0,Echothiophate,uveitis,disease-protein-drug,contraindication,"['uveitis', 'ALB', 'Echothiophate']",0.5
14290,33675.0,Echothiophate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'response to folic acid', 'BCHE', 'Echothiophate']",0.5
14290,33675.0,Echothiophate,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'glyphosate', 'BCHE', 'Echothiophate']",0.5
14290,33675.0,Echothiophate,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Echothiophate']",0.5
14290,35641.0,Echothiophate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Echothiophate']",0.5
14290,36584.0,Echothiophate,iris disease,disease-protein-drug,contraindication,"['iris disease', 'ALB', 'Echothiophate']",0.5
14290,37608.0,Echothiophate,ciliary body disease,disease-protein-drug,contraindication,"['ciliary body disease', 'ALB', 'Echothiophate']",0.5
14290,39245.0,Echothiophate,panuveitis (disease),disease-protein-drug,contraindication,"['panuveitis (disease)', 'ALB', 'Echothiophate']",0.5
14291,27326.0,Amoxicillin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'innate immune response', 'SLC15A2', 'Amoxicillin']",0.5
14291,27700.0,Amoxicillin,sclerosing cholangitis,disease-phenotype-protein-drug,off-label use,"['sclerosing cholangitis', 'Hepatomegaly', 'ALB', 'Amoxicillin']",0.5
14291,29614.0,Amoxicillin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Amoxicillin']",0.5
14291,29614.0,Amoxicillin,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Amoxicillin']",0.5
14291,31033.0,Amoxicillin,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'ALB', 'Amoxicillin']",0.5
14291,32629.0,Amoxicillin,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'ALB', 'Amoxicillin']",0.5
14291,33314.0,Amoxicillin,leptospirosis,disease-phenotype-protein-drug,off-label use,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Amoxicillin']",0.5
14291,33474.0,Amoxicillin,typhoid fever,disease-phenotype-protein-drug,off-label use,"['typhoid fever', 'Hepatomegaly', 'ALB', 'Amoxicillin']",0.5
14291,35565.0,Amoxicillin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Amoxicillin']",0.5
14291,35764.0,Amoxicillin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Amoxicillin']",0.5
14291,35764.0,Amoxicillin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Amoxicillin']",0.5
14291,35764.0,Amoxicillin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Amoxicillin']",0.5
14292,28158.0,Oxybutynin,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Oxybutynin']",0.5
14292,31650.0,Oxybutynin,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Oxybutynin']",0.5
14292,33577.0,Oxybutynin,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Oxybutynin']",0.5
14292,33577.0,Oxybutynin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Oxybutynin']",0.5
14292,33577.0,Oxybutynin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Oxybutynin']",0.5
14292,35565.0,Oxybutynin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Oxybutynin']",0.5
14292,35565.0,Oxybutynin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Oxybutynin']",0.5
14292,35764.0,Oxybutynin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Oxybutynin']",0.5
14292,35764.0,Oxybutynin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Oxybutynin']",0.5
14292,35764.0,Oxybutynin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Oxybutynin']",0.5
14292,36034.0,Oxybutynin,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Oxybutynin']",0.5
14292,36035.0,Oxybutynin,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Oxybutynin']",0.5
14292,36187.0,Oxybutynin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Oxybutynin']",0.5
14292,36187.0,Oxybutynin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Oxybutynin']",0.5
14292,37785.0,Oxybutynin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Oxybutynin']",0.5
14292,39622.0,Oxybutynin,cauda equina syndrome,disease-protein-drug,indication,"['cauda equina syndrome', 'CHRM2', 'Oxybutynin']",0.5
14292,84212.0,Oxybutynin,obsolete neurogenic bladder (disease),disease-protein-drug,indication,"['obsolete neurogenic bladder (disease)', 'CHRM2', 'Oxybutynin']",0.5
14293,27292.0,Glipizide,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'ALB', 'Glipizide']",0.5
14293,28208.0,Glipizide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Glipizide']",0.5
14293,28208.0,Glipizide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose homeostasis', 'PPARG', 'Glipizide']",0.5
14293,28208.0,Glipizide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'PPARG', 'Glipizide']",0.5
14293,28208.0,Glipizide,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'PPARG', 'Glipizide']",0.5
14293,33575.0,Glipizide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Glipizide']",0.5
14293,33575.0,Glipizide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'PPARG', 'Glipizide']",0.5
14293,33575.0,Glipizide,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PPARG', 'Glipizide']",0.5
14293,35565.0,Glipizide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Glipizide']",0.5
14293,35565.0,Glipizide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Glipizide']",0.5
14293,35764.0,Glipizide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Glipizide']",0.5
14293,35764.0,Glipizide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Glipizide']",0.5
14293,35764.0,Glipizide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PPARG', 'Glipizide']",0.5
14293,37180.0,Glipizide,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Glipizide']",0.5
14293,37180.0,Glipizide,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PPARG', 'Glipizide']",0.5
14294,27933.0,Clonazepam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Clonazepam']",0.5
14294,27933.0,Clonazepam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR1I2', 'Clonazepam']",0.5
14294,27933.0,Clonazepam,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Clonazepam']",0.5
14294,30035.0,Clonazepam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Clonazepam']",0.5
14294,31618.0,Clonazepam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Clonazepam']",0.5
14294,32313.0,Clonazepam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Clonazepam']",0.5
14294,32456.0,Clonazepam,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'GABRB3', 'Clonazepam']",0.5
14294,32456.0,Clonazepam,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'GABRA5', 'Clonazepam']",0.5
14294,32977.0,Clonazepam,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GABRA5', 'Clonazepam']",0.5
14294,33115.0,Clonazepam,absence epilepsy,disease-protein-drug,indication,"['absence epilepsy', 'GABRG2', 'Clonazepam']",0.5
14294,33125.0,Clonazepam,early myoclonic encephalopathy,disease-protein-drug,indication,"['early myoclonic encephalopathy', 'GABRG2', 'Clonazepam']",0.5
14294,35565.0,Clonazepam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Clonazepam']",0.5
14294,35565.0,Clonazepam,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Clonazepam']",0.5
14294,35764.0,Clonazepam,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Clonazepam']",0.5
14294,35764.0,Clonazepam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Clonazepam']",0.5
14294,35764.0,Clonazepam,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Clonazepam']",0.5
14294,36080.0,Clonazepam,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Clonazepam']",0.5
14294,37703.0,Clonazepam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Clonazepam']",0.5
14294,39815.0,Clonazepam,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'GABRA5', 'Clonazepam']",0.5
14294,83760.0,Clonazepam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Clonazepam']",0.5
14295,33683.0,Promethazine,urticaria (disease),disease-protein-drug,indication,"['urticaria (disease)', 'ALB', 'Promethazine']",0.5
14295,36091.0,Promethazine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Promethazine']",0.5
14295,37888.0,Promethazine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Promethazine']",0.5
14295,37888.0,Promethazine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cognition', 'CHRM1', 'Promethazine']",0.5
14295,37888.0,Promethazine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Promethazine']",0.5
14295,83791.0,Promethazine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Promethazine']",0.5
14296,27476.0,Atazanavir,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'UGT1A1', 'Atazanavir']",0.5
14296,27476.0,Atazanavir,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Atazanavir']",0.5
14296,33575.0,Atazanavir,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Atazanavir']",0.5
14296,33575.0,Atazanavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Atazanavir']",0.5
14296,33575.0,Atazanavir,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Atazanavir']",0.5
14296,35565.0,Atazanavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Atazanavir']",0.5
14296,35565.0,Atazanavir,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Atazanavir']",0.5
14296,36645.0,Atazanavir,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'UGT1A1', 'Atazanavir']",0.5
14296,37743.0,Atazanavir,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Atazanavir']",0.5
14296,37805.0,Atazanavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Atazanavir']",0.5
14296,38312.0,Atazanavir,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Atazanavir']",0.5
14296,39531.0,Atazanavir,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Atazanavir']",0.5
14297,29220.0,Atorvastatin,hyperlipoproteinemia,disease-phenotype-protein-drug,indication,"['hyperlipoproteinemia', 'Hepatomegaly', 'NR1I3', 'Atorvastatin']",0.5
14297,30035.0,Atorvastatin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Atorvastatin']",0.5
14297,33598.0,Atorvastatin,stroke disorder,disease-protein-drug,indication,"['stroke disorder', 'ALB', 'Atorvastatin']",0.5
14297,33598.0,Atorvastatin,stroke disorder,disease-exposure-bioprocess-gene-drug,indication,"['stroke disorder', 'Pesticides', 'visual learning', 'HMGCR', 'Atorvastatin']",0.5
14297,33598.0,Atorvastatin,stroke disorder,disease-exposure-gene-drug,indication,"['stroke disorder', 'Air Pollutants', 'AHR', 'Atorvastatin']",0.5
14297,33603.0,Atorvastatin,arteriosclerosis disorder,disease-protein-drug,indication,"['arteriosclerosis disorder', 'AHR', 'Atorvastatin']",0.5
14297,33605.0,Atorvastatin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Atorvastatin']",0.5
14297,33612.0,Atorvastatin,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Atorvastatin']",0.5
14297,33695.0,Atorvastatin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'HMGCR', 'Atorvastatin']",0.5
14297,33695.0,Atorvastatin,hypertriglyceridemia (disease),disease-exposure-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Atorvastatin']",0.5
14297,35565.0,Atorvastatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'AHR', 'Atorvastatin']",0.5
14297,35565.0,Atorvastatin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Atorvastatin']",0.5
14297,35764.0,Atorvastatin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Atorvastatin']",0.5
14297,35764.0,Atorvastatin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'HMGCR', 'Atorvastatin']",0.5
14297,35764.0,Atorvastatin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'AHR', 'Atorvastatin']",0.5
14297,35909.0,Atorvastatin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'AHR', 'Atorvastatin']",0.5
14297,35909.0,Atorvastatin,cerebrovascular disorder,disease-exposure-gene-drug,indication,"['cerebrovascular disorder', 'Air Pollutants', 'AHR', 'Atorvastatin']",0.5
14297,35953.0,Atorvastatin,atherosclerosis,disease-protein-drug,indication,"['atherosclerosis', 'AHR', 'Atorvastatin']",0.5
14297,35953.0,Atorvastatin,atherosclerosis,disease-exposure-bioprocess-gene-drug,indication,"['atherosclerosis', 'Air Pollutants', 'blood vessel development', 'AHR', 'Atorvastatin']",0.5
14297,35953.0,Atorvastatin,atherosclerosis,disease-exposure-gene-drug,indication,"['atherosclerosis', 'Air Pollutants', 'AHR', 'Atorvastatin']",0.5
14297,36469.0,Atorvastatin,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Atorvastatin']",0.5
14297,83898.0,Atorvastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Atorvastatin']",0.5
14298,29220.0,Rosuvastatin,hyperlipoproteinemia,disease-phenotype-protein-drug,indication,"['hyperlipoproteinemia', 'Hepatomegaly', 'ALB', 'Rosuvastatin']",0.5
14298,30035.0,Rosuvastatin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCC4', 'Rosuvastatin']",0.5
14298,33598.0,Rosuvastatin,stroke disorder,disease-protein-drug,indication,"['stroke disorder', 'ALB', 'Rosuvastatin']",0.5
14298,33598.0,Rosuvastatin,stroke disorder,disease-exposure-bioprocess-gene-drug,indication,"['stroke disorder', 'Pesticides', 'visual learning', 'HMGCR', 'Rosuvastatin']",0.5
14298,33598.0,Rosuvastatin,stroke disorder,disease-exposure-gene-drug,indication,"['stroke disorder', 'Arsenic', 'SLC7A11', 'Rosuvastatin']",0.5
14298,33695.0,Rosuvastatin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'HMGCR', 'Rosuvastatin']",0.5
14298,33695.0,Rosuvastatin,hypertriglyceridemia (disease),disease-exposure-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Rosuvastatin']",0.5
14298,35565.0,Rosuvastatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Rosuvastatin']",0.5
14298,35565.0,Rosuvastatin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Rosuvastatin']",0.5
14298,35909.0,Rosuvastatin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'SLC10A1', 'Rosuvastatin']",0.5
14298,35953.0,Rosuvastatin,atherosclerosis,disease-exposure-bioprocess-gene-drug,indication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Rosuvastatin']",0.5
14298,35953.0,Rosuvastatin,atherosclerosis,disease-exposure-gene-drug,indication,"['atherosclerosis', 'Arsenic', 'SLC7A11', 'Rosuvastatin']",0.5
14298,36469.0,Rosuvastatin,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2C9', 'Rosuvastatin']",0.5
14298,37175.0,Rosuvastatin,proteinuria,disease-exposure-bioprocess-gene-drug,contraindication,"['proteinuria', 'Cadmium', 'cellular response to oxidative stress', 'SLC7A11', 'Rosuvastatin']",0.5
14298,37175.0,Rosuvastatin,proteinuria,disease-exposure-gene-drug,contraindication,"['proteinuria', 'Cadmium', 'ALB', 'Rosuvastatin']",0.5
14298,83898.0,Rosuvastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Rosuvastatin']",0.5
14299,27933.0,Sertraline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Sertraline']",0.5
14299,27933.0,Sertraline,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Sertraline']",0.5
14299,27933.0,Sertraline,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Cadmium', 'ALB', 'Sertraline']",0.5
14299,28249.0,Sertraline,major affective disorder,disease-protein-drug,off-label use,"['major affective disorder', 'MAOB', 'Sertraline']",0.5
14299,28456.0,Sertraline,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'SLC6A2', 'Sertraline']",0.5
14299,28899.0,Sertraline,obsessive-compulsive disorder,disease-protein-drug,indication,"['obsessive-compulsive disorder', 'SLC6A4', 'Sertraline']",0.5
14299,28899.0,Sertraline,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,indication,"['obsessive-compulsive disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Sertraline']",0.5
14299,33091.0,Sertraline,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Nausea', 'ABCB1', 'Sertraline']",0.5
14299,33454.0,Sertraline,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Sertraline']",0.5
14299,35565.0,Sertraline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A4', 'Sertraline']",0.5
14299,35565.0,Sertraline,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Sertraline']",0.5
14299,35641.0,Sertraline,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Sertraline']",0.5
14299,36105.0,Sertraline,phobic disorder,disease-protein-drug,indication,"['phobic disorder', 'SLC6A3', 'Sertraline']",0.5
14299,37703.0,Sertraline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOB', 'Sertraline']",0.5
14299,38242.0,Sertraline,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'MAOB', 'Sertraline']",0.5
14299,83760.0,Sertraline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'MAOB', 'Sertraline']",0.5
14299,83841.0,Sertraline,endogenous depression,disease-protein-drug,off-label use,"['endogenous depression', 'MAOB', 'Sertraline']",0.5
14300,35565.0,Miconazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CYP51A1', 'Miconazole']",0.5
14300,35565.0,Miconazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Miconazole']",0.5
14301,32977.0,Nifedipine,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Nifedipine']",0.5
14301,32977.0,Nifedipine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ABCC2', 'Nifedipine']",0.5
14301,33577.0,Nifedipine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Nifedipine']",0.5
14301,33577.0,Nifedipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Nifedipine']",0.5
14301,33577.0,Nifedipine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Nifedipine']",0.5
14301,33605.0,Nifedipine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Nifedipine']",0.5
14301,35565.0,Nifedipine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Nifedipine']",0.5
14301,35565.0,Nifedipine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Nifedipine']",0.5
14301,35764.0,Nifedipine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Nifedipine']",0.5
14301,35764.0,Nifedipine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Nifedipine']",0.5
14301,35764.0,Nifedipine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Nifedipine']",0.5
14301,35958.0,Nifedipine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'CACNA1H', 'Nifedipine']",0.5
14301,36035.0,Nifedipine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Nifedipine']",0.5
14301,36274.0,Nifedipine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'ORM1', 'Nifedipine']",0.5
14301,36274.0,Nifedipine,pyloric stenosis (disease),disease-exposure-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'ALB', 'Nifedipine']",0.5
14301,37180.0,Nifedipine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Nifedipine']",0.5
14301,37180.0,Nifedipine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'CYP1A1', 'Nifedipine']",0.5
14301,37659.0,Nifedipine,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Nifedipine']",0.5
14301,37659.0,Nifedipine,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Nifedipine']",0.5
14301,37659.0,Nifedipine,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Nifedipine']",0.5
14301,37765.0,Nifedipine,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Nifedipine']",0.5
14302,27326.0,Amiodarone,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CACNA1C', 'Amiodarone']",0.5
14302,27326.0,Amiodarone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Amiodarone']",0.5
14302,27326.0,Amiodarone,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Amiodarone']",0.5
14302,27326.0,Amiodarone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Sudden cardiac death', 'CACNA1C', 'Amiodarone']",0.5
14302,27655.0,Amiodarone,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Amiodarone']",0.5
14302,27655.0,Amiodarone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Syncope', 'CACNA1C', 'Amiodarone']",0.5
14302,32719.0,Amiodarone,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Hearing impairment', 'CACNA1D', 'Amiodarone']",0.5
14302,33206.0,Amiodarone,eosinophilic pneumonia,disease-phenotype-protein-drug,contraindication,"['eosinophilic pneumonia', 'Respiratory insufficiency', 'CACNA1S', 'Amiodarone']",0.5
14302,33618.0,Amiodarone,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'CYP2C19', 'Amiodarone']",0.5
14302,33618.0,Amiodarone,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Amiodarone']",0.5
14302,33618.0,Amiodarone,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Air Pollutants', 'PPARG', 'Amiodarone']",0.5
14302,33679.0,Amiodarone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Amiodarone']",0.5
14302,35565.0,Amiodarone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Amiodarone']",0.5
14302,35565.0,Amiodarone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Amiodarone']",0.5
14302,35751.0,Amiodarone,peripheral nervous system disease,disease-exposure-gene-drug,contraindication,"['peripheral nervous system disease', 'Agent Orange', 'CYP1A1', 'Amiodarone']",0.5
14302,36034.0,Amiodarone,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'visual perception', 'CACNA1F', 'Amiodarone']",0.5
14302,36469.0,Amiodarone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'visual perception', 'CACNA1F', 'Amiodarone']",0.5
14302,36544.0,Amiodarone,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ABCB1', 'Amiodarone']",0.5
14302,36544.0,Amiodarone,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Amiodarone']",0.5
14302,38958.0,Amiodarone,sick sinus syndrome,disease-protein-drug,contraindication,"['sick sinus syndrome', 'CACNB2', 'Amiodarone']",0.5
14302,39880.0,Amiodarone,ventricular fibrillation (disease),disease-protein-drug,indication,"['ventricular fibrillation (disease)', 'KCNH2', 'Amiodarone']",0.5
14302,83751.0,Amiodarone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Amiodarone']",0.5
14303,28208.0,Gliclazide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Gliclazide']",0.5
14303,28208.0,Gliclazide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Gliclazide']",0.5
14303,28208.0,Gliclazide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Cadmium', 'ALB', 'Gliclazide']",0.5
14304,28208.0,Tolbutamide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Tolbutamide']",0.5
14304,28208.0,Tolbutamide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Tolbutamide']",0.5
14304,28208.0,Tolbutamide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Cadmium', 'ALB', 'Tolbutamide']",0.5
14304,35565.0,Tolbutamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'ABCC8', 'Tolbutamide']",0.5
14304,35565.0,Tolbutamide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Tolbutamide']",0.5
14304,35764.0,Tolbutamide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Tolbutamide']",0.5
14304,35764.0,Tolbutamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'ABCC8', 'Tolbutamide']",0.5
14304,35764.0,Tolbutamide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Tolbutamide']",0.5
14305,31395.0,Dutasteride,benign prostatic hyperplasia (disease),disease-protein-drug,indication,"['benign prostatic hyperplasia (disease)', 'SRD5A2', 'Dutasteride']",0.5
14305,31395.0,Dutasteride,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,indication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'testosterone biosynthetic process', 'SRD5A2', 'Dutasteride']",0.5
14305,35565.0,Dutasteride,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'inflammatory response', 'ORM1', 'Dutasteride']",0.5
14305,35565.0,Dutasteride,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Dutasteride']",0.5
14306,27292.0,Pioglitazone,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'CYP1A1', 'Pioglitazone']",0.5
14306,28208.0,Pioglitazone,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'PPARG', 'Pioglitazone']",0.5
14306,28208.0,Pioglitazone,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose homeostasis', 'PPARG', 'Pioglitazone']",0.5
14306,28208.0,Pioglitazone,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Agent Orange', 'CYP1A1', 'Pioglitazone']",0.5
14306,28208.0,Pioglitazone,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'PPARG', 'Pioglitazone']",0.5
14306,30035.0,Pioglitazone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Pioglitazone']",0.5
14306,31756.0,Pioglitazone,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder cancer', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'PPARG', 'Pioglitazone']",0.5
14306,31756.0,Pioglitazone,urinary bladder cancer,disease-exposure-gene-drug,contraindication,"['urinary bladder cancer', 'Pesticides', 'CYP1A1', 'Pioglitazone']",0.5
14306,32905.0,Pioglitazone,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Bradycardia', 'CYP1A1', 'Pioglitazone']",0.5
14306,33575.0,Pioglitazone,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'PPARG', 'Pioglitazone']",0.5
14306,33575.0,Pioglitazone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'PPARG', 'Pioglitazone']",0.5
14306,33575.0,Pioglitazone,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Pioglitazone']",0.5
14306,33642.0,Pioglitazone,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'PPARG', 'Pioglitazone']",0.5
14306,33642.0,Pioglitazone,urinary bladder carcinoma,disease-exposure-gene-drug,contraindication,"['urinary bladder carcinoma', 'Pesticides', 'CYP1A1', 'Pioglitazone']",0.5
14306,35565.0,Pioglitazone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Pioglitazone']",0.5
14306,35565.0,Pioglitazone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Pioglitazone']",0.5
14306,35624.0,Pioglitazone,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'PPARG', 'Pioglitazone']",0.5
14306,35624.0,Pioglitazone,urinary bladder neoplasm,disease-exposure-gene-drug,contraindication,"['urinary bladder neoplasm', 'Pesticides', 'CYP1A1', 'Pioglitazone']",0.5
14306,35764.0,Pioglitazone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Pioglitazone']",0.5
14306,35764.0,Pioglitazone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'PPARG', 'Pioglitazone']",0.5
14306,35764.0,Pioglitazone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Pioglitazone']",0.5
14306,36432.0,Pioglitazone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Pioglitazone']",0.5
14306,37180.0,Pioglitazone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Pioglitazone']",0.5
14306,37180.0,Pioglitazone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PPARG', 'Pioglitazone']",0.5
14307,33632.0,Tiludronic acid,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'gene expression', 'TCIRG1', 'Tiludronic acid']",0.5
14307,33632.0,Tiludronic acid,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Tiludronic acid']",0.5
14307,35764.0,Tiludronic acid,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Tiludronic acid']",0.5
14307,35764.0,Tiludronic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'gene expression', 'TCIRG1', 'Tiludronic acid']",0.5
14307,35764.0,Tiludronic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTPRE', 'Tiludronic acid']",0.5
14308,29113.0,Carvedilol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Carvedilol']",0.5
14308,33575.0,Carvedilol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Carvedilol']",0.5
14308,33575.0,Carvedilol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Carvedilol']",0.5
14308,33575.0,Carvedilol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Carvedilol']",0.5
14308,33577.0,Carvedilol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Carvedilol']",0.5
14308,33577.0,Carvedilol,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Carvedilol']",0.5
14308,33605.0,Carvedilol,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Carvedilol']",0.5
14308,33618.0,Carvedilol,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'SELE', 'Carvedilol']",0.5
14308,33618.0,Carvedilol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Carvedilol']",0.5
14308,33618.0,Carvedilol,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'VCAM1', 'Carvedilol']",0.5
14308,33675.0,Carvedilol,asthma,disease-protein-drug,contraindication,"['asthma', 'VEGFA', 'Carvedilol']",0.5
14308,33675.0,Carvedilol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of blood pressure', 'NPPB', 'Carvedilol']",0.5
14308,33675.0,Carvedilol,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'VCAM1', 'Carvedilol']",0.5
14308,35897.0,Carvedilol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Carvedilol']",0.5
14308,35897.0,Carvedilol,pulmonary emphysema,disease-exposure-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'VCAM1', 'Carvedilol']",0.5
14308,36035.0,Carvedilol,hypertension,disease-protein-drug,indication,"['hypertension', 'VEGFA', 'Carvedilol']",0.5
14308,37830.0,Carvedilol,bronchitis,disease-protein-drug,contraindication,"['bronchitis', 'VEGFA', 'Carvedilol']",0.5
14308,37830.0,Carvedilol,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'regulation of blood pressure', 'NPPB', 'Carvedilol']",0.5
14308,37830.0,Carvedilol,bronchitis,disease-exposure-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'VCAM1', 'Carvedilol']",0.5
14308,39531.0,Carvedilol,liver failure,disease-protein-drug,contraindication,"['liver failure', 'VEGFA', 'Carvedilol']",0.5
14308,39773.0,Carvedilol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'VEGFA', 'Carvedilol']",0.5
14308,39798.0,Carvedilol,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'regulation of blood pressure', 'NPPB', 'Carvedilol']",0.5
14308,39798.0,Carvedilol,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'VCAM1', 'Carvedilol']",0.5
14308,83781.0,Carvedilol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'VEGFA', 'Carvedilol']",0.5
14308,83803.0,Carvedilol,diastolic heart failure,disease-protein-drug,off-label use,"['diastolic heart failure', 'ADRA1D', 'Carvedilol']",0.5
14309,27326.0,Levofloxacin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Levofloxacin']",0.5
14309,27626.0,Levofloxacin,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'SLCO4C1', 'Levofloxacin']",0.5
14309,27626.0,Levofloxacin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Levofloxacin']",0.5
14309,29352.0,Levofloxacin,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Levofloxacin']",0.5
14309,29494.0,Levofloxacin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Levofloxacin']",0.5
14309,30184.0,Levofloxacin,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Levofloxacin']",0.5
14309,33575.0,Levofloxacin,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Levofloxacin']",0.5
14309,33575.0,Levofloxacin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Levofloxacin']",0.5
14309,33575.0,Levofloxacin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Levofloxacin']",0.5
14309,33594.0,Levofloxacin,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Levofloxacin']",0.5
14309,33632.0,Levofloxacin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'urea metabolic process', 'CYP2C9', 'Levofloxacin']",0.5
14309,33632.0,Levofloxacin,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Levofloxacin']",0.5
14309,35565.0,Levofloxacin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SLCO4C1', 'Levofloxacin']",0.5
14309,35565.0,Levofloxacin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Levofloxacin']",0.5
14309,35641.0,Levofloxacin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Levofloxacin']",0.5
14309,36104.0,Levofloxacin,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Levofloxacin']",0.5
14309,36187.0,Levofloxacin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Levofloxacin']",0.5
14309,36187.0,Levofloxacin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Levofloxacin']",0.5
14309,36229.0,Levofloxacin,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Levofloxacin']",0.5
14309,36544.0,Levofloxacin,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ABCB1', 'Levofloxacin']",0.5
14309,36544.0,Levofloxacin,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SLCO4C1', 'Levofloxacin']",0.5
14309,37786.0,Levofloxacin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Levofloxacin']",0.5
14309,37786.0,Levofloxacin,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Levofloxacin']",0.5
14309,39696.0,Levofloxacin,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,off-label use,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Levofloxacin']",0.5
14310,27326.0,Doxepin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Doxepin']",0.5
14310,27326.0,Doxepin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Doxepin']",0.5
14310,27326.0,Doxepin,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'HTR1A', 'Doxepin']",0.5
14310,27655.0,Doxepin,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Doxepin']",0.5
14310,27655.0,Doxepin,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ADRA1B', 'Doxepin']",0.5
14310,27933.0,Doxepin,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Doxepin']",0.5
14310,27933.0,Doxepin,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR2B', 'Doxepin']",0.5
14310,27933.0,Doxepin,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Cadmium', 'ALB', 'Doxepin']",0.5
14310,28149.0,Doxepin,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Doxepin']",0.5
14310,28396.0,Doxepin,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Doxepin']",0.5
14310,29525.0,Doxepin,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'KCNH2', 'Doxepin']",0.5
14310,29709.0,Doxepin,"dermatitis, atopic",disease-phenotype-protein-drug,indication,"['dermatitis, atopic', 'Pruritus', 'HRH1', 'Doxepin']",0.5
14310,30035.0,Doxepin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Doxepin']",0.5
14310,31524.0,Doxepin,postural orthostatic tachycardia syndrome,disease-protein-drug,contraindication,"['postural orthostatic tachycardia syndrome', 'SLC6A2', 'Doxepin']",0.5
14310,31618.0,Doxepin,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'ADRA1B', 'Doxepin']",0.5
14310,32313.0,Doxepin,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'ADRA1B', 'Doxepin']",0.5
14310,33664.0,Doxepin,sleep apnea syndrome,disease-phenotype-protein-drug,contraindication,"['sleep apnea syndrome', 'Apnea', 'HTR1A', 'Doxepin']",0.5
14310,35641.0,Doxepin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Doxepin']",0.5
14310,35641.0,Doxepin,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Doxepin']",0.5
14310,36034.0,Doxepin,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Doxepin']",0.5
14310,36129.0,Doxepin,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'memory', 'SLC6A4', 'Doxepin']",0.5
14310,36129.0,Doxepin,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Lead', 'ALB', 'Doxepin']",0.5
14310,37703.0,Doxepin,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A4', 'Doxepin']",0.5
14310,38242.0,Doxepin,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'SLC6A2', 'Doxepin']",0.5
14310,38242.0,Doxepin,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Doxepin']",0.5
14310,39531.0,Doxepin,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Doxepin']",0.5
14310,83751.0,Doxepin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Doxepin']",0.5
14310,83760.0,Doxepin,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Doxepin']",0.5
14310,83763.0,Doxepin,manic bipolar affective disorder,disease-protein-drug,contraindication,"['manic bipolar affective disorder', 'SLC6A4', 'Doxepin']",0.5
14310,84019.0,Doxepin,anxiety,disease-protein-drug,indication,"['anxiety', 'SLC6A4', 'Doxepin']",0.5
14311,27700.0,Cloxacillin,sclerosing cholangitis,disease-phenotype-protein-drug,off-label use,"['sclerosing cholangitis', 'Hepatomegaly', 'ALB', 'Cloxacillin']",0.5
14311,35764.0,Cloxacillin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Cloxacillin']",0.5
14311,35764.0,Cloxacillin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Cloxacillin']",0.5
14311,35764.0,Cloxacillin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Cloxacillin']",0.5
14312,31072.0,Halothane,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Halothane']",0.5
14312,33605.0,Halothane,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Halothane']",0.5
14312,35565.0,Halothane,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ATP2B4', 'Halothane']",0.5
14312,35565.0,Halothane,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Halothane']",0.5
14313,27326.0,Arsenic trioxide,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of transcription, DNA-templated', 'PML', 'Arsenic trioxide']",0.5
14313,27326.0,Arsenic trioxide,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'TXNRD1', 'Arsenic trioxide']",0.5
14313,27655.0,Arsenic trioxide,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Arsenic trioxide']",0.5
14313,28502.0,Arsenic trioxide,myelomonocytic leukemia,disease-phenotype-protein-drug,indication,"['myelomonocytic leukemia', 'Thrombocytopenia', 'ALB', 'Arsenic trioxide']",0.5
14313,29361.0,Arsenic trioxide,acute promyelocytic leukemia,disease-protein-drug,indication,"['acute promyelocytic leukemia', 'PML', 'Arsenic trioxide']",0.5
14313,29361.0,Arsenic trioxide,acute promyelocytic leukemia,disease-phenotype-protein-drug,indication,"['acute promyelocytic leukemia', 'Thrombocytopenia', 'ALB', 'Arsenic trioxide']",0.5
14313,35565.0,Arsenic trioxide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Arsenic trioxide']",0.5
14313,35565.0,Arsenic trioxide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Arsenic trioxide']",0.5
14313,35764.0,Arsenic trioxide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Arsenic trioxide']",0.5
14313,35764.0,Arsenic trioxide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'AKT1', 'Arsenic trioxide']",0.5
14313,35764.0,Arsenic trioxide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Mercury', 'TXNRD1', 'Arsenic trioxide']",0.5
14313,83751.0,Arsenic trioxide,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Arsenic trioxide']",0.5
14314,27326.0,Naloxone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Naloxone']",0.5
14314,27648.0,Naloxone,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Naloxone']",0.5
14314,27655.0,Naloxone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'OPRM1', 'Naloxone']",0.5
14314,28149.0,Naloxone,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Naloxone']",0.5
14314,28158.0,Naloxone,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Naloxone']",0.5
14314,28158.0,Naloxone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Naloxone']",0.5
14314,28158.0,Naloxone,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Naloxone']",0.5
14314,29525.0,Naloxone,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Naloxone']",0.5
14314,30035.0,Naloxone,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'ABCB1', 'Naloxone']",0.5
14314,30813.0,Naloxone,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Naloxone']",0.5
14314,31072.0,Naloxone,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Naloxone']",0.5
14314,32384.0,Naloxone,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Naloxone']",0.5
14314,32584.0,Naloxone,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Naloxone']",0.5
14314,32719.0,Naloxone,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Hearing impairment', 'TLR4', 'Naloxone']",0.5
14314,33605.0,Naloxone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Naloxone']",0.5
14314,33677.0,Naloxone,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Naloxone']",0.5
14314,35565.0,Naloxone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CES1', 'Naloxone']",0.5
14314,35565.0,Naloxone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Naloxone']",0.5
14314,35641.0,Naloxone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Naloxone']",0.5
14314,35641.0,Naloxone,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'CREB1', 'Naloxone']",0.5
14314,35764.0,Naloxone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Naloxone']",0.5
14314,35764.0,Naloxone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Naloxone']",0.5
14314,35764.0,Naloxone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Naloxone']",0.5
14314,35897.0,Naloxone,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Naloxone']",0.5
14314,36080.0,Naloxone,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Naloxone']",0.5
14314,36080.0,Naloxone,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cholesterol biosynthetic process', 'CES1', 'Naloxone']",0.5
14314,36080.0,Naloxone,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'TLR4', 'Naloxone']",0.5
14314,36236.0,Naloxone,cor pulmonale,disease-exposure-bioprocess-gene-drug,contraindication,"['cor pulmonale', 'Ozone', 'regulation of inflammatory response', 'ESR1', 'Naloxone']",0.5
14314,36469.0,Naloxone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'CREB1', 'Naloxone']",0.5
14314,36492.0,Naloxone,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'visual learning', 'CREB1', 'Naloxone']",0.5
14314,36492.0,Naloxone,brain cancer,disease-exposure-gene-drug,contraindication,"['brain cancer', 'Air Pollutants', 'TLR4', 'Naloxone']",0.5
14314,36693.0,Naloxone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Naloxone']",0.5
14314,36693.0,Naloxone,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'CREB1', 'Naloxone']",0.5
14314,37617.0,Naloxone,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'TLR4', 'Naloxone']",0.5
14314,37617.0,Naloxone,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'TLR4', 'Naloxone']",0.5
14314,37743.0,Naloxone,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Naloxone']",0.5
14314,37753.0,Naloxone,opiate dependence,disease-protein-drug,indication,"['opiate dependence', 'CREB1', 'Naloxone']",0.5
14314,37785.0,Naloxone,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Naloxone']",0.5
14314,37785.0,Naloxone,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'CREB1', 'Naloxone']",0.5
14314,83751.0,Naloxone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Naloxone']",0.5
14314,83910.0,Naloxone,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Naloxone']",0.5
14314,84242.0,Naloxone,morphine dependence,disease-protein-drug,indication,"['morphine dependence', 'OPRM1', 'Naloxone']",0.5
14315,31072.0,Desflurane,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Desflurane']",0.5
14315,31650.0,Desflurane,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'GABRA5', 'Desflurane']",0.5
14315,35565.0,Desflurane,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ATP2B4', 'Desflurane']",0.5
14315,35565.0,Desflurane,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Desflurane']",0.5
14315,36187.0,Desflurane,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ATP2B1', 'Desflurane']",0.5
14315,36187.0,Desflurane,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'ATP2B1', 'Desflurane']",0.5
14315,36187.0,Desflurane,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'MT-ND1', 'Desflurane']",0.5
14315,37765.0,Desflurane,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Desflurane']",0.5
14316,35565.0,Flecainide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Flecainide']",0.5
14316,35565.0,Flecainide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Flecainide']",0.5
14316,35764.0,Flecainide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Flecainide']",0.5
14316,35764.0,Flecainide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN5A', 'Flecainide']",0.5
14316,35764.0,Flecainide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Flecainide']",0.5
14316,38396.0,Flecainide,familial sick sinus syndrome,disease-protein-drug,contraindication,"['familial sick sinus syndrome', 'SCN5A', 'Flecainide']",0.5
14316,38958.0,Flecainide,sick sinus syndrome,disease-protein-drug,contraindication,"['sick sinus syndrome', 'SCN5A', 'Flecainide']",0.5
14317,27286.0,Captopril,galactosemia,disease-phenotype-protein-drug,off-label use,"['galactosemia', 'Hepatomegaly', 'ALB', 'Captopril']",0.5
14317,27292.0,Captopril,glycogen storage disease,disease-protein-drug,off-label use,"['glycogen storage disease', 'ACE', 'Captopril']",0.5
14317,27292.0,Captopril,glycogen storage disease,disease-phenotype-protein-drug,off-label use,"['glycogen storage disease', 'Splenomegaly', 'BDKRB1', 'Captopril']",0.5
14317,28052.0,Captopril,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'ALB', 'Captopril']",0.5
14317,28231.0,Captopril,supravalvular aortic stenosis (disease),disease-phenotype-protein-drug,contraindication,"['supravalvular aortic stenosis (disease)', 'Arrhythmia', 'ACE', 'Captopril']",0.5
14317,28441.0,Captopril,hereditary angioedema with C1Inh deficiency,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema with C1Inh deficiency', 'Vomiting', 'ABCB1', 'Captopril']",0.5
14317,29182.0,Captopril,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MMP2', 'Captopril']",0.5
14317,29182.0,Captopril,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'ACE', 'Captopril']",0.5
14317,29182.0,Captopril,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Captopril']",0.5
14317,29854.0,Captopril,hereditary angioedema,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Captopril']",0.5
14317,31493.0,Captopril,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Captopril']",0.5
14317,33025.0,Captopril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'ALB', 'Captopril']",0.5
14317,33534.0,Captopril,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Captopril']",0.5
14317,33605.0,Captopril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ACE', 'Captopril']",0.5
14317,33618.0,Captopril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Captopril']",0.5
14317,33618.0,Captopril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MMP2', 'Captopril']",0.5
14317,33618.0,Captopril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Captopril']",0.5
14317,35565.0,Captopril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Captopril']",0.5
14317,35565.0,Captopril,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Captopril']",0.5
14317,35764.0,Captopril,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Captopril']",0.5
14317,35764.0,Captopril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ACE', 'Captopril']",0.5
14317,35764.0,Captopril,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'MMP2', 'Captopril']",0.5
14317,35854.0,Captopril,bone disease,disease-exposure-gene-drug,contraindication,"['bone disease', 'Fluorides', 'ALB', 'Captopril']",0.5
14317,36104.0,Captopril,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Captopril']",0.5
14317,36229.0,Captopril,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Captopril']",0.5
14317,36286.0,Captopril,diabetic nephropathy,disease-protein-drug,indication,"['diabetic nephropathy', 'MMP9', 'Captopril']",0.5
14317,39540.0,Captopril,angioedema,disease-protein-drug,contraindication,"['angioedema', 'ALB', 'Captopril']",0.5
14317,83802.0,Captopril,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Captopril']",0.5
14318,33193.0,Ceftriaxone,plague,disease-phenotype-protein-drug,off-label use,"['plague', 'Hepatomegaly', 'ALB', 'Ceftriaxone']",0.5
14318,33314.0,Ceftriaxone,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'ALB', 'Ceftriaxone']",0.5
14318,35565.0,Ceftriaxone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Ceftriaxone']",0.5
14318,83845.0,Ceftriaxone,viral meningitis,disease-protein-drug,indication,"['viral meningitis', 'ALB', 'Ceftriaxone']",0.5
14319,27326.0,Saquinavir,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Saquinavir']",0.5
14319,27326.0,Saquinavir,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Saquinavir']",0.5
14319,27361.0,Saquinavir,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'ABCC2', 'Saquinavir']",0.5
14319,27655.0,Saquinavir,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Saquinavir']",0.5
14319,30035.0,Saquinavir,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Saquinavir']",0.5
14319,33575.0,Saquinavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Saquinavir']",0.5
14319,33575.0,Saquinavir,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Saquinavir']",0.5
14319,33695.0,Saquinavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Saquinavir']",0.5
14319,33695.0,Saquinavir,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Saquinavir']",0.5
14319,35565.0,Saquinavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Saquinavir']",0.5
14319,35565.0,Saquinavir,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Saquinavir']",0.5
14319,37743.0,Saquinavir,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Saquinavir']",0.5
14319,37765.0,Saquinavir,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Saquinavir']",0.5
14319,37805.0,Saquinavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Saquinavir']",0.5
14319,39531.0,Saquinavir,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Saquinavir']",0.5
14319,83751.0,Saquinavir,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Saquinavir']",0.5
14320,27219.0,Dexamethasone,hypogonadotropic hypogonadism with or without anosmia,disease-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'NR0B1', 'Dexamethasone']",0.5
14320,27219.0,Dexamethasone,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Oligomenorrhea', 'CYP17A1', 'Dexamethasone']",0.5
14320,27249.0,Dexamethasone,isolated growth hormone deficiency,disease-protein-drug,contraindication,"['isolated growth hormone deficiency', 'CYP17A1', 'Dexamethasone']",0.5
14320,27249.0,Dexamethasone,isolated growth hormone deficiency,disease-phenotype-protein-drug,contraindication,"['isolated growth hormone deficiency', 'Truncal obesity', 'HSD11B1', 'Dexamethasone']",0.5
14320,27452.0,Dexamethasone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5
14320,27648.0,Dexamethasone,familial glucocorticoid deficiency,disease-phenotype-protein-drug,indication,"['familial glucocorticoid deficiency', 'Hyperkalemia', 'CYP17A1', 'Dexamethasone']",0.5
14320,27741.0,Dexamethasone,pituitary deficiency due to empty sella turcica syndrome,disease-protein-drug,contraindication,"['pituitary deficiency due to empty sella turcica syndrome', 'CYP17A1', 'Dexamethasone']",0.5
14320,27741.0,Dexamethasone,pituitary deficiency due to empty sella turcica syndrome,disease-phenotype-protein-drug,contraindication,"['pituitary deficiency due to empty sella turcica syndrome', 'Oligomenorrhea', 'CYP17A1', 'Dexamethasone']",0.5
14320,27878.0,Dexamethasone,X-linked adrenal hypoplasia congenita,disease-protein-drug,indication,"['X-linked adrenal hypoplasia congenita', 'NR0B1', 'Dexamethasone']",0.5
14320,27925.0,Dexamethasone,keloid formation,disease-protein-drug,indication,"['keloid formation', 'ALB', 'Dexamethasone']",0.5
14320,28005.0,Dexamethasone,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,off-label use,"['developmental and epileptic encephalopathy', 'Decreased liver function', 'NOS2', 'Dexamethasone']",0.5
14320,28158.0,Dexamethasone,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ABCB1', 'Dexamethasone']",0.5
14320,28158.0,Dexamethasone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Dexamethasone']",0.5
14320,28158.0,Dexamethasone,inflammatory bowel disease,disease-exposure-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'CYP1A1', 'Dexamethasone']",0.5
14320,28158.0,Dexamethasone,inflammatory bowel disease,disease-phenotype-protein-drug,indication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Dexamethasone']",0.5
14320,28407.0,Dexamethasone,hypogonadotropic hypogonadism,disease-protein-drug,contraindication,"['hypogonadotropic hypogonadism', 'NR0B1', 'Dexamethasone']",0.5
14320,28830.0,Dexamethasone,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'CYP2E1', 'Dexamethasone']",0.5
14320,29078.0,Dexamethasone,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Dexamethasone']",0.5
14320,29078.0,Dexamethasone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'spermatogenesis', 'NR0B1', 'Dexamethasone']",0.5
14320,29078.0,Dexamethasone,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'CYP2E1', 'Dexamethasone']",0.5
14320,29113.0,Dexamethasone,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'HSD11B2', 'Dexamethasone']",0.5
14320,29113.0,Dexamethasone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'HSD11B1', 'Dexamethasone']",0.5
14320,29182.0,Dexamethasone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Dexamethasone']",0.5
14320,29182.0,Dexamethasone,systemic lupus erythematosus (disease),disease-exposure-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'NOS2', 'Dexamethasone']",0.5
14320,29182.0,Dexamethasone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5
14320,29186.0,Dexamethasone,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,contraindication,"['carbamoyl phosphate synthetase I deficiency disease', 'Cerebral edema', 'NOS2', 'Dexamethasone']",0.5
14320,29614.0,Dexamethasone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Dexamethasone']",0.5
14320,29614.0,Dexamethasone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'ALB', 'Dexamethasone']",0.5
14320,29715.0,Dexamethasone,chondrocalcinosis,disease-phenotype-protein-drug,indication,"['chondrocalcinosis', 'Seizure', 'ABCC2', 'Dexamethasone']",0.5
14320,29832.0,Dexamethasone,hyperargininemia,disease-phenotype-protein-drug,contraindication,"['hyperargininemia', 'Hepatomegaly', 'NR1I2', 'Dexamethasone']",0.5
14320,29854.0,Dexamethasone,hereditary angioedema,disease-phenotype-protein-drug,indication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Dexamethasone']",0.5
14320,29993.0,Dexamethasone,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'NR1I2', 'Dexamethasone']",0.5
14320,30447.0,Dexamethasone,"lymphoma, non-Hodgkin, familial",disease-protein-drug,indication,"['lymphoma, non-Hodgkin, familial', 'CYP2E1', 'Dexamethasone']",0.5
14320,30511.0,Dexamethasone,anti-glomerular basement membrane disease,disease-protein-drug,off-label use,"['anti-glomerular basement membrane disease', 'NOS2', 'Dexamethasone']",0.5
14320,30511.0,Dexamethasone,anti-glomerular basement membrane disease,disease-phenotype-protein-drug,off-label use,"['anti-glomerular basement membrane disease', 'Proteinuria', 'ALB', 'Dexamethasone']",0.5
14320,30654.0,Dexamethasone,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Dexamethasone']",0.5
14320,30813.0,Dexamethasone,Addison disease,disease-protein-drug,indication,"['Addison disease', 'NR0B1', 'Dexamethasone']",0.5
14320,30813.0,Dexamethasone,Addison disease,disease-phenotype-protein-drug,indication,"['Addison disease', 'Hyperkalemia', 'CYP17A1', 'Dexamethasone']",0.5
14320,30892.0,Dexamethasone,newborn respiratory distress syndrome,disease-protein-drug,off-label use,"['newborn respiratory distress syndrome', 'ALB', 'Dexamethasone']",0.5
14320,30892.0,Dexamethasone,newborn respiratory distress syndrome,disease-phenotype-protein-drug,off-label use,"['newborn respiratory distress syndrome', 'Bradycardia', 'CYP1A1', 'Dexamethasone']",0.5
14320,30990.0,Dexamethasone,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'NR1I2', 'Dexamethasone']",0.5
14320,31511.0,Dexamethasone,autoimmune thrombocytopenic,disease-phenotype-protein-drug,indication,"['autoimmune thrombocytopenic', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5
14320,31650.0,Dexamethasone,myasthenia gravis,disease-phenotype-protein-drug,off-label use,"['myasthenia gravis', 'Seizure', 'ABCC2', 'Dexamethasone']",0.5
14320,31714.0,Dexamethasone,short stature due to growth hormone qualitative anomaly,disease-protein-drug,contraindication,"['short stature due to growth hormone qualitative anomaly', 'CYP17A1', 'Dexamethasone']",0.5
14320,32099.0,Dexamethasone,granulomatosis with polyangiitis,disease-protein-drug,off-label use,"['granulomatosis with polyangiitis', 'NOS2', 'Dexamethasone']",0.5
14320,32099.0,Dexamethasone,granulomatosis with polyangiitis,disease-exposure-bioprocess-gene-drug,off-label use,"['granulomatosis with polyangiitis', 'Dust', 'neutrophil homeostasis', 'ANXA1', 'Dexamethasone']",0.5
14320,32099.0,Dexamethasone,granulomatosis with polyangiitis,disease-phenotype-protein-drug,off-label use,"['granulomatosis with polyangiitis', 'Proteinuria', 'ALB', 'Dexamethasone']",0.5
14320,32123.0,Dexamethasone,Takayasu arteritis,disease-protein-drug,off-label use,"['Takayasu arteritis', 'NOS2', 'Dexamethasone']",0.5
14320,32123.0,Dexamethasone,Takayasu arteritis,disease-phenotype-protein-drug,off-label use,"['Takayasu arteritis', 'Seizure', 'ABCC2', 'Dexamethasone']",0.5
14320,32132.0,Dexamethasone,citrullinemia,disease-phenotype-protein-drug,contraindication,"['citrullinemia', 'Hepatomegaly', 'NR1I2', 'Dexamethasone']",0.5
14320,32217.0,Dexamethasone,hypopituitarism,disease-protein-drug,contraindication,"['hypopituitarism', 'CYP17A1', 'Dexamethasone']",0.5
14320,32337.0,Dexamethasone,"combined pituitary hormone deficiencies, genetic form",disease-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'CYP17A1', 'Dexamethasone']",0.5
14320,32337.0,Dexamethasone,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'Seizure', 'ABCC2', 'Dexamethasone']",0.5
14320,32384.0,Dexamethasone,adrenal insufficiency,disease-phenotype-protein-drug,indication,"['adrenal insufficiency', 'Hyperkalemia', 'CYP17A1', 'Dexamethasone']",0.5
14320,32531.0,Dexamethasone,mantle cell lymphoma,disease-protein-drug,indication,"['mantle cell lymphoma', 'CYP2E1', 'Dexamethasone']",0.5
14320,32563.0,Dexamethasone,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,indication,"['heparin-induced thrombocytopenia (disease)', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5
14320,32719.0,Dexamethasone,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Hypothermia', 'NOS2', 'Dexamethasone']",0.5
14320,32746.0,Dexamethasone,Stevens-Johnson syndrome,disease-protein-drug,indication,"['Stevens-Johnson syndrome', 'ALB', 'Dexamethasone']",0.5
14320,32746.0,Dexamethasone,Stevens-Johnson syndrome,disease-phenotype-protein-drug,indication,"['Stevens-Johnson syndrome', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5
14320,32815.0,Dexamethasone,Trichinellosis,disease-phenotype-protein-drug,indication,"['Trichinellosis', 'Nausea', 'ABCB1', 'Dexamethasone']",0.5
14320,32899.0,Dexamethasone,pituitary deficiency due to Rathke's pouch cysts,disease-protein-drug,contraindication,"[""pituitary deficiency due to Rathke's pouch cysts"", 'CYP17A1', 'Dexamethasone']",0.5
14320,32905.0,Dexamethasone,Sheehan syndrome,disease-protein-drug,contraindication,"['Sheehan syndrome', 'CYP17A1', 'Dexamethasone']",0.5
14320,32905.0,Dexamethasone,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Oligomenorrhea', 'CYP17A1', 'Dexamethasone']",0.5
14320,32967.0,Dexamethasone,sarcoidosis,disease-phenotype-protein-drug,indication,"['sarcoidosis', 'Hepatomegaly', 'NR1I2', 'Dexamethasone']",0.5
14320,32980.0,Dexamethasone,hereditary hemorrhagic telangiectasia,disease-phenotype-protein-drug,contraindication,"['hereditary hemorrhagic telangiectasia', 'Seizure', 'ABCC2', 'Dexamethasone']",0.5
14320,32986.0,Dexamethasone,polyarteritis nodosa,disease-protein-drug,off-label use,"['polyarteritis nodosa', 'NOS2', 'Dexamethasone']",0.5
14320,33077.0,Dexamethasone,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'inflammatory response', 'ANXA1', 'Dexamethasone']",0.5
14320,33077.0,Dexamethasone,Hodgkins lymphoma,disease-exposure-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'CYP2E1', 'Dexamethasone']",0.5
14320,33077.0,Dexamethasone,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'NR1I2', 'Dexamethasone']",0.5
14320,33166.0,Dexamethasone,isolated congenital growth hormone deficiency,disease-protein-drug,contraindication,"['isolated congenital growth hormone deficiency', 'CYP17A1', 'Dexamethasone']",0.5
14320,33232.0,Dexamethasone,X-linked intellectual disability with isolated growth hormone deficiency,disease-protein-drug,contraindication,"['X-linked intellectual disability with isolated growth hormone deficiency', 'CYP17A1', 'Dexamethasone']",0.5
14320,33294.0,Dexamethasone,follicular lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['follicular lymphoma', 'Polychlorinated Biphenyls', 'spermatogenesis', 'NR0B1', 'Dexamethasone']",0.5
14320,33410.0,Dexamethasone,dermatitis herpetiformis,disease-phenotype-protein-drug,indication,"['dermatitis herpetiformis', 'Pruritus', 'ABCB11', 'Dexamethasone']",0.5
14320,33453.0,Dexamethasone,Kallmann syndrome,disease-protein-drug,contraindication,"['Kallmann syndrome', 'CYP17A1', 'Dexamethasone']",0.5
14320,33453.0,Dexamethasone,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Seizure', 'ABCC2', 'Dexamethasone']",0.5
14320,33534.0,Dexamethasone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Dexamethasone']",0.5
14320,33575.0,Dexamethasone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'NOS2', 'Dexamethasone']",0.5
14320,33575.0,Dexamethasone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Dexamethasone']",0.5
14320,33575.0,Dexamethasone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Dexamethasone']",0.5
14320,33577.0,Dexamethasone,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Dexamethasone']",0.5
14320,33577.0,Dexamethasone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Dexamethasone']",0.5
14320,33577.0,Dexamethasone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Dexamethasone']",0.5
14320,33581.0,Dexamethasone,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Dexamethasone']",0.5
14320,33581.0,Dexamethasone,conjunctivitis (disease),disease-exposure-gene-drug,contraindication,"['conjunctivitis (disease)', 'Soot', 'NOS2', 'Dexamethasone']",0.5
14320,33621.0,Dexamethasone,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'CYP2E1', 'Dexamethasone']",0.5
14320,33621.0,Dexamethasone,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR0B1', 'Dexamethasone']",0.5
14320,33621.0,Dexamethasone,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'NOS2', 'Dexamethasone']",0.5
14320,33649.0,Dexamethasone,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Ozone', 'regulation of inflammatory response', 'ANXA1', 'Dexamethasone']",0.5
14320,33649.0,Dexamethasone,exanthem (disease),disease-exposure-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'NOS2', 'Dexamethasone']",0.5
14320,33654.0,Dexamethasone,uveitis,disease-protein-drug,indication,"['uveitis', 'ALB', 'Dexamethasone']",0.5
14320,33675.0,Dexamethasone,asthma,disease-protein-drug,indication,"['asthma', 'HSD11B2', 'Dexamethasone']",0.5
14320,33675.0,Dexamethasone,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR0B1', 'Dexamethasone']",0.5
14320,33675.0,Dexamethasone,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Air Pollutants', 'NOS2', 'Dexamethasone']",0.5
14320,33679.0,Dexamethasone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Dexamethasone']",0.5
14320,35510.0,Dexamethasone,adrenogenital syndrome,disease-protein-drug,indication,"['adrenogenital syndrome', 'CYP17A1', 'Dexamethasone']",0.5
14320,35641.0,Dexamethasone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Dexamethasone']",0.5
14320,35650.0,Dexamethasone,non-Hodgkin lymphoma,disease-protein-drug,indication,"['non-Hodgkin lymphoma', 'CYP2E1', 'Dexamethasone']",0.5
14320,35650.0,Dexamethasone,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', ""2,2',3,3',4,4',5-heptachlorobiphenyl"", 'triglyceride metabolic process', 'CYP2E1', 'Dexamethasone']",0.5
14320,35650.0,Dexamethasone,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Cadmium', 'ALB', 'Dexamethasone']",0.5
14320,35651.0,Dexamethasone,B-cell neoplasm,disease-protein-drug,indication,"['B-cell neoplasm', 'CYP2E1', 'Dexamethasone']",0.5
14320,35669.0,Dexamethasone,heart disease,disease-exposure-bioprocess-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR0B1', 'Dexamethasone']",0.5
14320,35669.0,Dexamethasone,heart disease,disease-exposure-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'NOS2', 'Dexamethasone']",0.5
14320,35823.0,Dexamethasone,eye disease,disease-exposure-bioprocess-gene-drug,indication,"['eye disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'NR0B1', 'Dexamethasone']",0.5
14320,35823.0,Dexamethasone,eye disease,disease-exposure-gene-drug,indication,"['eye disease', 'Pesticides', 'CYP2E1', 'Dexamethasone']",0.5
14320,35884.0,Dexamethasone,diffuse large B-cell lymphoma,disease-protein-drug,indication,"['diffuse large B-cell lymphoma', 'CYP2E1', 'Dexamethasone']",0.5
14320,35884.0,Dexamethasone,diffuse large B-cell lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['diffuse large B-cell lymphoma', 'Polychlorinated Biphenyls', 'spermatogenesis', 'NR0B1', 'Dexamethasone']",0.5
14320,35915.0,Dexamethasone,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Dexamethasone']",0.5
14320,35915.0,Dexamethasone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP11B1', 'Dexamethasone']",0.5
14320,35970.0,Dexamethasone,lymphoma,disease-protein-drug,indication,"['lymphoma', 'CYP2E1', 'Dexamethasone']",0.5
14320,35970.0,Dexamethasone,lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['lymphoma', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'NR0B1', 'Dexamethasone']",0.5
14320,35970.0,Dexamethasone,lymphoma,disease-exposure-gene-drug,indication,"['lymphoma', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Dexamethasone']",0.5
14320,36035.0,Dexamethasone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Dexamethasone']",0.5
14320,36091.0,Dexamethasone,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'CYP1A1', 'Dexamethasone']",0.5
14320,36129.0,Dexamethasone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Dexamethasone']",0.5
14320,36129.0,Dexamethasone,atopic eczema,disease-exposure-gene-drug,indication,"['atopic eczema', 'Air Pollutants', 'NOS2', 'Dexamethasone']",0.5
14320,36425.0,Dexamethasone,primary central nervous system lymphoma,disease-protein-drug,indication,"['primary central nervous system lymphoma', 'ABCB1', 'Dexamethasone']",0.5
14320,36432.0,Dexamethasone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Dexamethasone']",0.5
14320,36458.0,Dexamethasone,Langerhans cell histiocytosis,disease-protein-drug,indication,"['Langerhans cell histiocytosis', 'CYP2E1', 'Dexamethasone']",0.5
14320,36469.0,Dexamethasone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Dexamethasone']",0.5
14320,36469.0,Dexamethasone,hypothyroidism,disease-exposure-gene-drug,contraindication,"['hypothyroidism', 'Nitrates', 'NOS2', 'Dexamethasone']",0.5
14320,36584.0,Dexamethasone,iris disease,disease-protein-drug,indication,"['iris disease', 'ALB', 'Dexamethasone']",0.5
14320,36644.0,Dexamethasone,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'spermatogenesis', 'NR0B1', 'Dexamethasone']",0.5
14320,36644.0,Dexamethasone,skin disease,disease-exposure-gene-drug,indication,"['skin disease', 'Pesticides', 'CYP2E1', 'Dexamethasone']",0.5
14320,37285.0,Dexamethasone,thymus gland disease,disease-protein-drug,contraindication,"['thymus gland disease', 'CYP17A1', 'Dexamethasone']",0.5
14320,37608.0,Dexamethasone,ciliary body disease,disease-protein-drug,indication,"['ciliary body disease', 'ALB', 'Dexamethasone']",0.5
14320,37722.0,Dexamethasone,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Dexamethasone']",0.5
14320,37722.0,Dexamethasone,multiple sclerosis,disease-exposure-gene-drug,indication,"['multiple sclerosis', 'Tobacco Smoke Pollution', 'CYP1A1', 'Dexamethasone']",0.5
14320,37765.0,Dexamethasone,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Dexamethasone']",0.5
14320,37770.0,Dexamethasone,contact dermatitis,disease-protein-drug,indication,"['contact dermatitis', 'CYP1A1', 'Dexamethasone']",0.5
14320,37888.0,Dexamethasone,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Dexamethasone']",0.5
14320,37888.0,Dexamethasone,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ANXA1', 'Dexamethasone']",0.5
14320,37888.0,Dexamethasone,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'NOS2', 'Dexamethasone']",0.5
14320,37888.0,Dexamethasone,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'CYP1A1', 'Dexamethasone']",0.5
14320,38024.0,Dexamethasone,psoriasis,disease-protein-drug,indication,"['psoriasis', 'NOS2', 'Dexamethasone']",0.5
14320,38085.0,Dexamethasone,acquired pituitary hormone deficiency,disease-protein-drug,contraindication,"['acquired pituitary hormone deficiency', 'CYP17A1', 'Dexamethasone']",0.5
14320,38179.0,Dexamethasone,congenital hypogonadotropic hypogonadism,disease-protein-drug,contraindication,"['congenital hypogonadotropic hypogonadism', 'CYP17A1', 'Dexamethasone']",0.5
14320,38508.0,Dexamethasone,non-acquired pituitary hormone deficiency,disease-protein-drug,contraindication,"['non-acquired pituitary hormone deficiency', 'CYP17A1', 'Dexamethasone']",0.5
14320,38513.0,Dexamethasone,congenital adrenal hyperplasia,disease-protein-drug,indication,"['congenital adrenal hyperplasia', 'CYP17A1', 'Dexamethasone']",0.5
14320,39025.0,Dexamethasone,non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations,disease-protein-drug,contraindication,"['non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations', 'CYP17A1', 'Dexamethasone']",0.5
14320,39202.0,Dexamethasone,non-acquired combined pituitary hormone deficiency,disease-protein-drug,contraindication,"['non-acquired combined pituitary hormone deficiency', 'CYP17A1', 'Dexamethasone']",0.5
14320,39203.0,Dexamethasone,pituitary deficiency,disease-protein-drug,contraindication,"['pituitary deficiency', 'CYP17A1', 'Dexamethasone']",0.5
14320,39245.0,Dexamethasone,panuveitis (disease),disease-protein-drug,indication,"['panuveitis (disease)', 'ALB', 'Dexamethasone']",0.5
14320,39524.0,Dexamethasone,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'NOS2', 'Dexamethasone']",0.5
14320,39539.0,Dexamethasone,pituitary hormone defiency from vascular origin,disease-protein-drug,contraindication,"['pituitary hormone defiency from vascular origin', 'CYP17A1', 'Dexamethasone']",0.5
14320,39540.0,Dexamethasone,angioedema,disease-protein-drug,indication,"['angioedema', 'ALB', 'Dexamethasone']",0.5
14320,39728.0,Dexamethasone,parapsoriasis,disease-protein-drug,indication,"['parapsoriasis', 'NOS2', 'Dexamethasone']",0.5
14320,39773.0,Dexamethasone,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'HSD11B2', 'Dexamethasone']",0.5
14320,39798.0,Dexamethasone,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR0B1', 'Dexamethasone']",0.5
14320,39798.0,Dexamethasone,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'NOS2', 'Dexamethasone']",0.5
14320,39821.0,Dexamethasone,keloid,disease-protein-drug,indication,"['keloid', 'ALB', 'Dexamethasone']",0.5
14320,39872.0,Dexamethasone,acute respiratory distress syndrome,disease-protein-drug,off-label use,"['acute respiratory distress syndrome', 'ALB', 'Dexamethasone']",0.5
14320,83764.0,Dexamethasone,hyperglycemia,disease-protein-drug,contraindication,"['hyperglycemia', 'HSD11B1', 'Dexamethasone']",0.5
14320,83764.0,Dexamethasone,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'regulation of blood pressure', 'CYP11B1', 'Dexamethasone']",0.5
14320,83765.0,Dexamethasone,hypogonadotropic hypogonadism-frontoparietal alopecia syndrome,disease-protein-drug,contraindication,"['hypogonadotropic hypogonadism-frontoparietal alopecia syndrome', 'CYP17A1', 'Dexamethasone']",0.5
14320,83766.0,Dexamethasone,short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,disease-protein-drug,contraindication,"['short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia', 'CYP17A1', 'Dexamethasone']",0.5
14320,83769.0,Dexamethasone,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Dexamethasone']",0.5
14320,83777.0,Dexamethasone,occupational dermatitis,disease-protein-drug,indication,"['occupational dermatitis', 'CYP1A1', 'Dexamethasone']",0.5
14320,83778.0,Dexamethasone,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Dexamethasone']",0.5
14320,83778.0,Dexamethasone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP11B1', 'Dexamethasone']",0.5
14320,83779.0,Dexamethasone,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Dexamethasone']",0.5
14320,83779.0,Dexamethasone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP11B1', 'Dexamethasone']",0.5
14320,83781.0,Dexamethasone,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'HSD11B2', 'Dexamethasone']",0.5
14320,83789.0,Dexamethasone,serum sickness,disease-protein-drug,indication,"['serum sickness', 'ALB', 'Dexamethasone']",0.5
14320,83790.0,Dexamethasone,gout,disease-protein-drug,indication,"['gout', 'ABCG2', 'Dexamethasone']",0.5
14320,83791.0,Dexamethasone,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Dexamethasone']",0.5
14320,83796.0,Dexamethasone,lymphosarcoma,disease-protein-drug,indication,"['lymphosarcoma', 'CYP2E1', 'Dexamethasone']",0.5
14320,83830.0,Dexamethasone,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Dexamethasone']",0.5
14320,84154.0,Dexamethasone,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,indication,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Dexamethasone']",0.5
14320,84155.0,Dexamethasone,Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly,disease-protein-drug,indication,"['Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly', 'ABCB1', 'Dexamethasone']",0.5
14320,84156.0,Dexamethasone,plasmablastic lymphoma,disease-protein-drug,indication,"['plasmablastic lymphoma', 'ABCB1', 'Dexamethasone']",0.5
14320,84157.0,Dexamethasone,diffuse large B-cell lymphoma of the central nervous system,disease-protein-drug,indication,"['diffuse large B-cell lymphoma of the central nervous system', 'ABCB1', 'Dexamethasone']",0.5
14320,84158.0,Dexamethasone,T-cell/histiocyte rich large B cell lymphoma,disease-protein-drug,indication,"['T-cell/histiocyte rich large B cell lymphoma', 'ABCB1', 'Dexamethasone']",0.5
14320,84159.0,Dexamethasone,ALK-positive large B-cell lymphoma,disease-protein-drug,indication,"['ALK-positive large B-cell lymphoma', 'ABCB1', 'Dexamethasone']",0.5
14320,84160.0,Dexamethasone,primary mediastinal large B-cell lymphoma,disease-protein-drug,indication,"['primary mediastinal large B-cell lymphoma', 'ABCB1', 'Dexamethasone']",0.5
14320,84161.0,Dexamethasone,intravascular large B-cell lymphoma,disease-protein-drug,indication,"['intravascular large B-cell lymphoma', 'ABCB1', 'Dexamethasone']",0.5
14321,27933.0,Levodopa,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'DRD5', 'Levodopa']",0.5
14321,27933.0,Levodopa,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'transmission of nerve impulse', 'DRD5', 'Levodopa']",0.5
14321,27933.0,Levodopa,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Levodopa']",0.5
14321,28396.0,Levodopa,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Neurodegeneration', 'DDC', 'Levodopa']",0.5
14321,28801.0,Levodopa,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD1', 'Levodopa']",0.5
14321,28801.0,Levodopa,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Seizure', 'DRD1', 'Levodopa']",0.5
14321,28974.0,Levodopa,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DRD1', 'Levodopa']",0.5
14321,28974.0,Levodopa,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Seizure', 'DRD1', 'Levodopa']",0.5
14321,30093.0,Levodopa,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DRD1', 'Levodopa']",0.5
14321,31033.0,Levodopa,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'ALB', 'Levodopa']",0.5
14321,32468.0,Levodopa,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Oculogyric crisis', 'DDC', 'Levodopa']",0.5
14321,32629.0,Levodopa,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'ALB', 'Levodopa']",0.5
14321,32759.0,Levodopa,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DRD1', 'Levodopa']",0.5
14321,32974.0,Levodopa,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DRD1', 'Levodopa']",0.5
14321,32974.0,Levodopa,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Seizure', 'DRD1', 'Levodopa']",0.5
14321,33241.0,Levodopa,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DRD1', 'Levodopa']",0.5
14321,33575.0,Levodopa,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of heart rate', 'DRD2', 'Levodopa']",0.5
14321,33575.0,Levodopa,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Levodopa']",0.5
14321,33594.0,Levodopa,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'pigmentation', 'DRD2', 'Levodopa']",0.5
14321,33653.0,Levodopa,melanoma,disease-exposure-bioprocess-gene-drug,contraindication,"['melanoma', 'mancozeb', 'social behavior', 'DRD3', 'Levodopa']",0.5
14321,35565.0,Levodopa,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'thyroid-stimulating hormone secretion', 'SLC16A10', 'Levodopa']",0.5
14321,35565.0,Levodopa,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Levodopa']",0.5
14321,35641.0,Levodopa,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD1', 'Levodopa']",0.5
14321,35641.0,Levodopa,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Levodopa']",0.5
14321,35764.0,Levodopa,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Levodopa']",0.5
14321,35764.0,Levodopa,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'DRD2', 'Levodopa']",0.5
14321,35764.0,Levodopa,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Levodopa']",0.5
14321,35833.0,Levodopa,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'regulation of heart rate', 'DRD2', 'Levodopa']",0.5
14321,35833.0,Levodopa,lung disease,disease-exposure-gene-drug,contraindication,"['lung disease', 'Tobacco Smoke Pollution', 'SLC7A8', 'Levodopa']",0.5
14321,35915.0,Levodopa,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'DRD5', 'Levodopa']",0.5
14321,35915.0,Levodopa,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Levodopa']",0.5
14321,37180.0,Levodopa,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of heart rate', 'DRD2', 'Levodopa']",0.5
14321,37180.0,Levodopa,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Levodopa']",0.5
14321,37703.0,Levodopa,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'DRD5', 'Levodopa']",0.5
14321,37706.0,Levodopa,parkinsonian disorder,disease-protein-drug,indication,"['parkinsonian disorder', 'DDC', 'Levodopa']",0.5
14321,83749.0,Levodopa,drug-induced dyskinesia,disease-protein-drug,contraindication,"['drug-induced dyskinesia', 'DRD3', 'Levodopa']",0.5
14321,83760.0,Levodopa,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'DRD5', 'Levodopa']",0.5
14321,83778.0,Levodopa,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'DRD5', 'Levodopa']",0.5
14321,83778.0,Levodopa,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Levodopa']",0.5
14321,83779.0,Levodopa,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'DRD5', 'Levodopa']",0.5
14321,83779.0,Levodopa,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Levodopa']",0.5
14322,31072.0,Sevoflurane,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Sevoflurane']",0.5
14322,33605.0,Sevoflurane,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIA1', 'Sevoflurane']",0.5
14322,35565.0,Sevoflurane,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Sevoflurane']",0.5
14322,35565.0,Sevoflurane,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Sevoflurane']",0.5
14322,35641.0,Sevoflurane,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Sevoflurane']",0.5
14322,35764.0,Sevoflurane,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Sevoflurane']",0.5
14322,35764.0,Sevoflurane,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'visual perception', 'GLRA1', 'Sevoflurane']",0.5
14322,35764.0,Sevoflurane,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Sevoflurane']",0.5
14322,37175.0,Sevoflurane,proteinuria,disease-exposure-bioprocess-gene-drug,contraindication,"['proteinuria', 'Cadmium', 'visual perception', 'GLRA1', 'Sevoflurane']",0.5
14322,37175.0,Sevoflurane,proteinuria,disease-exposure-gene-drug,contraindication,"['proteinuria', 'Cadmium', 'ALB', 'Sevoflurane']",0.5
14323,27740.0,Aripiprazole,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Aripiprazole']",0.5
14323,28149.0,Aripiprazole,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'OPRD1', 'Aripiprazole']",0.5
14323,28313.0,Aripiprazole,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HTR5A', 'Aripiprazole']",0.5
14323,28313.0,Aripiprazole,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Aripiprazole']",0.5
14323,28396.0,Aripiprazole,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Aripiprazole']",0.5
14323,28473.0,Aripiprazole,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Aripiprazole']",0.5
14323,28651.0,Aripiprazole,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ADRB1', 'Aripiprazole']",0.5
14323,28780.0,Aripiprazole,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Aripiprazole']",0.5
14323,28780.0,Aripiprazole,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Aripiprazole']",0.5
14323,28780.0,Aripiprazole,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Cadmium', 'ALB', 'Aripiprazole']",0.5
14323,28780.0,Aripiprazole,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Aripiprazole']",0.5
14323,29113.0,Aripiprazole,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Aripiprazole']",0.5
14323,29113.0,Aripiprazole,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Aripiprazole']",0.5
14323,29352.0,Aripiprazole,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Aripiprazole']",0.5
14323,29494.0,Aripiprazole,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Aripiprazole']",0.5
14323,29525.0,Aripiprazole,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Aripiprazole']",0.5
14323,30879.0,Aripiprazole,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'HTR1B', 'Aripiprazole']",0.5
14323,31393.0,Aripiprazole,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Aripiprazole']",0.5
14323,31393.0,Aripiprazole,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Aripiprazole']",0.5
14323,31393.0,Aripiprazole,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'ALB', 'Aripiprazole']",0.5
14323,31912.0,Aripiprazole,autism susceptibility 1,disease-protein-drug,indication,"['autism susceptibility 1', 'HTR5A', 'Aripiprazole']",0.5
14323,31912.0,Aripiprazole,autism susceptibility 1,disease-phenotype-protein-drug,indication,"['autism susceptibility 1', 'Seizure', 'HTR1B', 'Aripiprazole']",0.5
14323,33449.0,Aripiprazole,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Aripiprazole']",0.5
14323,33454.0,Aripiprazole,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Aripiprazole']",0.5
14323,33575.0,Aripiprazole,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Aripiprazole']",0.5
14323,33575.0,Aripiprazole,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'GRIN2B', 'Aripiprazole']",0.5
14323,33593.0,Aripiprazole,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ADRB1', 'Aripiprazole']",0.5
14323,33593.0,Aripiprazole,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Aripiprazole']",0.5
14323,33593.0,Aripiprazole,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'GRIN2B', 'Aripiprazole']",0.5
14323,33593.0,Aripiprazole,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Aripiprazole']",0.5
14323,33605.0,Aripiprazole,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HTR1D', 'Aripiprazole']",0.5
14323,33658.0,Aripiprazole,hyperlipidemia,disease-protein-drug,contraindication,"['hyperlipidemia', 'ADRB2', 'Aripiprazole']",0.5
14323,35641.0,Aripiprazole,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Aripiprazole']",0.5
14323,35641.0,Aripiprazole,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Aripiprazole']",0.5
14323,35909.0,Aripiprazole,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Aripiprazole']",0.5
14323,36187.0,Aripiprazole,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Aripiprazole']",0.5
14323,36187.0,Aripiprazole,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'HRH3', 'Aripiprazole']",0.5
14323,36187.0,Aripiprazole,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'GRIN2B', 'Aripiprazole']",0.5
14323,37180.0,Aripiprazole,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'HRH3', 'Aripiprazole']",0.5
14323,37180.0,Aripiprazole,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'bisphenol A', 'GRIN2B', 'Aripiprazole']",0.5
14323,37717.0,Aripiprazole,autism spectrum disorder,disease-protein-drug,indication,"['autism spectrum disorder', 'HTR5A', 'Aripiprazole']",0.5
14323,37764.0,Aripiprazole,familial hyperlipidemia,disease-protein-drug,contraindication,"['familial hyperlipidemia', 'ADRB2', 'Aripiprazole']",0.5
14323,37786.0,Aripiprazole,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB1', 'Aripiprazole']",0.5
14323,37786.0,Aripiprazole,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'HRH3', 'Aripiprazole']",0.5
14323,37786.0,Aripiprazole,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Aripiprazole']",0.5
14323,38242.0,Aripiprazole,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'HTR5A', 'Aripiprazole']",0.5
14323,38242.0,Aripiprazole,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Aripiprazole']",0.5
14323,38575.0,Aripiprazole,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Aripiprazole']",0.5
14323,38928.0,Aripiprazole,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Aripiprazole']",0.5
14323,83763.0,Aripiprazole,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'SLC6A4', 'Aripiprazole']",0.5
14323,83764.0,Aripiprazole,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Aripiprazole']",0.5
14323,83911.0,Aripiprazole,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Aripiprazole']",0.5
14323,83960.0,Aripiprazole,Alzheimer disease without neurofibrillary tangles,disease-protein-drug,contraindication,"['Alzheimer disease without neurofibrillary tangles', 'CYP2D6', 'Aripiprazole']",0.5
14323,83998.0,Aripiprazole,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Aripiprazole']",0.5
14323,84310.0,Aripiprazole,autism (disease),disease-protein-drug,indication,"['autism (disease)', 'HTR5A', 'Aripiprazole']",0.5
14323,84310.0,Aripiprazole,autism (disease),disease-exposure-bioprocess-gene-drug,indication,"['autism (disease)', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Aripiprazole']",0.5
14323,84310.0,Aripiprazole,autism (disease),disease-exposure-gene-drug,indication,"['autism (disease)', 'Lead', 'ALB', 'Aripiprazole']",0.5
14324,27626.0,Gemfibrozil,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Gemfibrozil']",0.5
14324,29955.0,Gemfibrozil,Reynolds syndrome,disease-protein-drug,contraindication,"['Reynolds syndrome', 'ALB', 'Gemfibrozil']",0.5
14324,29955.0,Gemfibrozil,Reynolds syndrome,disease-phenotype-protein-drug,contraindication,"['Reynolds syndrome', 'Hepatomegaly', 'ALB', 'Gemfibrozil']",0.5
14324,31144.0,Gemfibrozil,primary biliary cholangitis,disease-protein-drug,contraindication,"['primary biliary cholangitis', 'ALB', 'Gemfibrozil']",0.5
14324,33632.0,Gemfibrozil,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Gemfibrozil']",0.5
14324,33632.0,Gemfibrozil,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Gemfibrozil']",0.5
14324,33695.0,Gemfibrozil,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Gemfibrozil']",0.5
14324,33695.0,Gemfibrozil,hypertriglyceridemia (disease),disease-exposure-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Gemfibrozil']",0.5
14324,35565.0,Gemfibrozil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Gemfibrozil']",0.5
14324,35565.0,Gemfibrozil,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Gemfibrozil']",0.5
14325,27933.0,Clomipramine,anxiety disorder,disease-protein-drug,off-label use,"['anxiety disorder', 'ABCB1', 'Clomipramine']",0.5
14325,27933.0,Clomipramine,anxiety disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR2B', 'Clomipramine']",0.5
14325,27933.0,Clomipramine,anxiety disorder,disease-exposure-gene-drug,off-label use,"['anxiety disorder', 'Arsenic', 'GSTP1', 'Clomipramine']",0.5
14325,27933.0,Clomipramine,anxiety disorder,disease-exposure-molfunc-gene-drug,off-label use,"['anxiety disorder', 'Pesticides', 'glutathione transferase activity', 'GSTP1', 'Clomipramine']",0.5
14325,28391.0,Clomipramine,narcolepsy,disease-exposure-bioprocess-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Clomipramine']",0.5
14325,28391.0,Clomipramine,narcolepsy,disease-exposure-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'GSTP1', 'Clomipramine']",0.5
14325,28391.0,Clomipramine,narcolepsy,disease-exposure-molfunc-gene-drug,off-label use,"['narcolepsy', 'Metals, Heavy', 'glutathione transferase activity', 'GSTP1', 'Clomipramine']",0.5
14325,28899.0,Clomipramine,obsessive-compulsive disorder,disease-protein-drug,indication,"['obsessive-compulsive disorder', 'HTR2A', 'Clomipramine']",0.5
14325,28899.0,Clomipramine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,indication,"['obsessive-compulsive disorder', 'Nicotine', 'vasoconstriction', 'HTR2B', 'Clomipramine']",0.5
14325,30035.0,Clomipramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Clomipramine']",0.5
14325,31122.0,Clomipramine,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'ALB', 'Clomipramine']",0.5
14325,33188.0,Clomipramine,neuroblastoma,disease-protein-drug,contraindication,"['neuroblastoma', 'ABCB1', 'Clomipramine']",0.5
14325,33459.0,Clomipramine,malignant hyperthermia of anesthesia,disease-phenotype-protein-drug,contraindication,"['malignant hyperthermia of anesthesia', 'Fever', 'HTR2A', 'Clomipramine']",0.5
14325,35565.0,Clomipramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Clomipramine']",0.5
14325,35565.0,Clomipramine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Clomipramine']",0.5
14325,35641.0,Clomipramine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Clomipramine']",0.5
14325,36034.0,Clomipramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Clomipramine']",0.5
14325,37703.0,Clomipramine,neurotic disorder,disease-protein-drug,off-label use,"['neurotic disorder', 'SLC6A4', 'Clomipramine']",0.5
14325,83760.0,Clomipramine,dysthymic disorder,disease-protein-drug,off-label use,"['dysthymic disorder', 'SLC6A4', 'Clomipramine']",0.5
14325,83763.0,Clomipramine,manic bipolar affective disorder,disease-protein-drug,contraindication,"['manic bipolar affective disorder', 'SLC6A4', 'Clomipramine']",0.5
14325,84019.0,Clomipramine,anxiety,disease-protein-drug,off-label use,"['anxiety', 'SLC6A4', 'Clomipramine']",0.5
14326,33575.0,Darunavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Darunavir']",0.5
14326,33575.0,Darunavir,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Darunavir']",0.5
14326,33695.0,Darunavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Darunavir']",0.5
14326,33695.0,Darunavir,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Darunavir']",0.5
14326,35565.0,Darunavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Darunavir']",0.5
14326,35565.0,Darunavir,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Darunavir']",0.5
14326,37743.0,Darunavir,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Darunavir']",0.5
14326,37765.0,Darunavir,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Darunavir']",0.5
14326,37805.0,Darunavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Darunavir']",0.5
14326,39531.0,Darunavir,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Darunavir']",0.5
14327,27933.0,Hydralazine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Hydralazine']",0.5
14327,27933.0,Hydralazine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'HIF1A', 'Hydralazine']",0.5
14327,27933.0,Hydralazine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Hydralazine']",0.5
14327,28052.0,Hydralazine,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'ALB', 'Hydralazine']",0.5
14327,28158.0,Hydralazine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Hydralazine']",0.5
14327,29182.0,Hydralazine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'HIF1A', 'Hydralazine']",0.5
14327,29182.0,Hydralazine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Hydralazine']",0.5
14327,31072.0,Hydralazine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Hydralazine']",0.5
14327,31493.0,Hydralazine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Hydralazine']",0.5
14327,33534.0,Hydralazine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Hydralazine']",0.5
14327,33575.0,Hydralazine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'AOC3', 'Hydralazine']",0.5
14327,33575.0,Hydralazine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Hydralazine']",0.5
14327,33577.0,Hydralazine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Hydralazine']",0.5
14327,33577.0,Hydralazine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Hydralazine']",0.5
14327,33598.0,Hydralazine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Hydralazine']",0.5
14327,33598.0,Hydralazine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'hemoglobin biosynthetic process', 'HIF1A', 'Hydralazine']",0.5
14327,33598.0,Hydralazine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Hydralazine']",0.5
14327,33605.0,Hydralazine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Hydralazine']",0.5
14327,33632.0,Hydralazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Hydralazine']",0.5
14327,33632.0,Hydralazine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Hydralazine']",0.5
14327,35641.0,Hydralazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Hydralazine']",0.5
14327,35641.0,Hydralazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HIF1A', 'Hydralazine']",0.5
14327,35764.0,Hydralazine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Hydralazine']",0.5
14327,35764.0,Hydralazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Hydralazine']",0.5
14327,35764.0,Hydralazine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Hydralazine']",0.5
14327,35909.0,Hydralazine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'HIF1A', 'Hydralazine']",0.5
14327,36034.0,Hydralazine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Hydralazine']",0.5
14327,36187.0,Hydralazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'hemoglobin biosynthetic process', 'HIF1A', 'Hydralazine']",0.5
14327,36187.0,Hydralazine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Hydralazine']",0.5
14327,37180.0,Hydralazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'hemoglobin biosynthetic process', 'HIF1A', 'Hydralazine']",0.5
14327,37180.0,Hydralazine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Hydralazine']",0.5
14327,37703.0,Hydralazine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Hydralazine']",0.5
14327,37785.0,Hydralazine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'HIF1A', 'Hydralazine']",0.5
14327,83760.0,Hydralazine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Hydralazine']",0.5
14327,83802.0,Hydralazine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'HIF1A', 'Hydralazine']",0.5
14327,83942.0,Hydralazine,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'hemoglobin biosynthetic process', 'HIF1A', 'Hydralazine']",0.5
14328,31493.0,Exenatide,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Exenatide']",0.5
14328,33577.0,Exenatide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Exenatide']",0.5
14328,33577.0,Exenatide,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Exenatide']",0.5
14328,36040.0,Exenatide,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'ALB', 'Exenatide']",0.5
14328,36040.0,Exenatide,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Lead', 'psychomotor behavior', 'DPP4', 'Exenatide']",0.5
14328,36040.0,Exenatide,chronic kidney disease,disease-exposure-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'ALB', 'Exenatide']",0.5
14328,83923.0,Exenatide,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'ALB', 'Exenatide']",0.5
14328,83923.0,Exenatide,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Exenatide']",0.5
14328,83923.0,Exenatide,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Cadmium', 'ALB', 'Exenatide']",0.5
14328,83924.0,Exenatide,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'ALB', 'Exenatide']",0.5
14329,29113.0,Insulin detemir,diabetic ketoacidosis,disease-phenotype-protein-drug,indication,"['diabetic ketoacidosis', 'Insulin resistance', 'INSR', 'Insulin detemir']",0.5
14330,27326.0,Fosphenytoin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'SCN5A', 'Fosphenytoin']",0.5
14330,27326.0,Fosphenytoin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Fosphenytoin']",0.5
14330,27626.0,Fosphenytoin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Fosphenytoin']",0.5
14330,27655.0,Fosphenytoin,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'SCN5A', 'Fosphenytoin']",0.5
14330,29182.0,Fosphenytoin,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Fosphenytoin']",0.5
14330,29182.0,Fosphenytoin,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Fosphenytoin']",0.5
14330,29352.0,Fosphenytoin,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Fosphenytoin']",0.5
14330,29494.0,Fosphenytoin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Fosphenytoin']",0.5
14330,30035.0,Fosphenytoin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2B6', 'Fosphenytoin']",0.5
14330,33534.0,Fosphenytoin,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Fosphenytoin']",0.5
14330,33605.0,Fosphenytoin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Fosphenytoin']",0.5
14330,35565.0,Fosphenytoin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Fosphenytoin']",0.5
14330,35565.0,Fosphenytoin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Fosphenytoin']",0.5
14330,35641.0,Fosphenytoin,epilepsy,disease-protein-drug,indication,"['epilepsy', 'ALB', 'Fosphenytoin']",0.5
14330,35764.0,Fosphenytoin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Fosphenytoin']",0.5
14330,35764.0,Fosphenytoin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN5A', 'Fosphenytoin']",0.5
14330,35764.0,Fosphenytoin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Fosphenytoin']",0.5
14330,83751.0,Fosphenytoin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'SCN5A', 'Fosphenytoin']",0.5
14331,27933.0,Polythiazide,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Polythiazide']",0.5
14331,27933.0,Polythiazide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Lead', 'transport', 'ALB', 'Polythiazide']",0.5
14331,27933.0,Polythiazide,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Polythiazide']",0.5
14331,33577.0,Polythiazide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Polythiazide']",0.5
14331,33577.0,Polythiazide,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Polythiazide']",0.5
14331,35641.0,Polythiazide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Polythiazide']",0.5
14331,35764.0,Polythiazide,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Polythiazide']",0.5
14331,35764.0,Polythiazide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Polythiazide']",0.5
14331,35764.0,Polythiazide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Polythiazide']",0.5
14331,36040.0,Polythiazide,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'ALB', 'Polythiazide']",0.5
14331,36040.0,Polythiazide,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Lead', 'transport', 'ALB', 'Polythiazide']",0.5
14331,36040.0,Polythiazide,chronic kidney disease,disease-exposure-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'ALB', 'Polythiazide']",0.5
14331,37703.0,Polythiazide,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Polythiazide']",0.5
14331,83760.0,Polythiazide,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Polythiazide']",0.5
14331,83923.0,Polythiazide,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'ALB', 'Polythiazide']",0.5
14331,83923.0,Polythiazide,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Polythiazide']",0.5
14331,83923.0,Polythiazide,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Cadmium', 'ALB', 'Polythiazide']",0.5
14331,83924.0,Polythiazide,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'ALB', 'Polythiazide']",0.5
14332,27700.0,Cefazolin,sclerosing cholangitis,disease-exposure-bioprocess-gene-drug,indication,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'gene expression', 'IL2', 'Cefazolin']",0.5
14332,27700.0,Cefazolin,sclerosing cholangitis,disease-phenotype-protein-drug,indication,"['sclerosing cholangitis', 'Hepatomegaly', 'ALB', 'Cefazolin']",0.5
14332,32393.0,Cefazolin,staphylococcal pneumonia,disease-phenotype-protein-drug,indication,"['staphylococcal pneumonia', 'Fever', 'IL2', 'Cefazolin']",0.5
14333,35552.0,Cefonicid,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Cefonicid']",0.5
14334,35565.0,Cefoperazone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Cefoperazone']",0.5
14335,35565.0,Cefotetan,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Cefotetan']",0.5
14335,35764.0,Cefotetan,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Cefotetan']",0.5
14335,35764.0,Cefotetan,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Cefotetan']",0.5
14335,35764.0,Cefotetan,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Cefotetan']",0.5
14336,27503.0,Ephedrine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'SLC6A2', 'Ephedrine']",0.5
14336,27626.0,Ephedrine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Ephedrine']",0.5
14336,28714.0,Ephedrine,cystic fibrosis,disease-phenotype-protein-drug,contraindication,"['cystic fibrosis', 'Hepatomegaly', 'ALB', 'Ephedrine']",0.5
14336,29113.0,Ephedrine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Ephedrine']",0.5
14336,30035.0,Ephedrine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Ephedrine']",0.5
14336,30274.0,Ephedrine,HELLP syndrome,disease-phenotype-protein-drug,contraindication,"['HELLP syndrome', 'Thrombocytopenia', 'ALB', 'Ephedrine']",0.5
14336,30491.0,Ephedrine,obstructive sleep apnea syndrome,disease-protein-drug,contraindication,"['obstructive sleep apnea syndrome', 'BCHE', 'Ephedrine']",0.5
14336,30813.0,Ephedrine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'SLC6A2', 'Ephedrine']",0.5
14336,31072.0,Ephedrine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'ALB', 'Ephedrine']",0.5
14336,31493.0,Ephedrine,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Ephedrine']",0.5
14336,31618.0,Ephedrine,congenital central hypoventilation syndrome,disease-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'BCHE', 'Ephedrine']",0.5
14336,31618.0,Ephedrine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'SLC6A2', 'Ephedrine']",0.5
14336,31650.0,Ephedrine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'SLC6A2', 'Ephedrine']",0.5
14336,31732.0,Ephedrine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'ACHE', 'Ephedrine']",0.5
14336,32313.0,Ephedrine,Haddad syndrome,disease-protein-drug,contraindication,"['Haddad syndrome', 'BCHE', 'Ephedrine']",0.5
14336,32313.0,Ephedrine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'SLC6A2', 'Ephedrine']",0.5
14336,32384.0,Ephedrine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC6A2', 'Ephedrine']",0.5
14336,32737.0,Ephedrine,hypocomplementemic urticarial vasculitis,disease-phenotype-protein-drug,contraindication,"['hypocomplementemic urticarial vasculitis', 'Hepatomegaly', 'ALB', 'Ephedrine']",0.5
14336,32977.0,Ephedrine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'SLC6A2', 'Ephedrine']",0.5
14336,33575.0,Ephedrine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,33575.0,Ephedrine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,33575.0,Ephedrine,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,33577.0,Ephedrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,33577.0,Ephedrine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,33577.0,Ephedrine,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,33598.0,Ephedrine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Ephedrine']",0.5
14336,33598.0,Ephedrine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,33598.0,Ephedrine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'BCHE', 'Ephedrine']",0.5
14336,33598.0,Ephedrine,stroke disorder,disease-exposure-molfunc-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,33605.0,Ephedrine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Ephedrine']",0.5
14336,33623.0,Ephedrine,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'ACHE', 'Ephedrine']",0.5
14336,33632.0,Ephedrine,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'ACHE', 'Ephedrine']",0.5
14336,33632.0,Ephedrine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'choline metabolic process', 'BCHE', 'Ephedrine']",0.5
14336,33632.0,Ephedrine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Ephedrine']",0.5
14336,33664.0,Ephedrine,sleep apnea syndrome,disease-protein-drug,contraindication,"['sleep apnea syndrome', 'BCHE', 'Ephedrine']",0.5
14336,33664.0,Ephedrine,sleep apnea syndrome,disease-phenotype-protein-drug,contraindication,"['sleep apnea syndrome', 'Apnea', 'BCHE', 'Ephedrine']",0.5
14336,33675.0,Ephedrine,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Ephedrine']",0.5
14336,33675.0,Ephedrine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,33675.0,Ephedrine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'glyphosate', 'BCHE', 'Ephedrine']",0.5
14336,33675.0,Ephedrine,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,35565.0,Ephedrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'bone resorption', 'ADRB2', 'Ephedrine']",0.5
14336,35565.0,Ephedrine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,35641.0,Ephedrine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Ephedrine']",0.5
14336,35669.0,Ephedrine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,35669.0,Ephedrine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,35761.0,Ephedrine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,35761.0,Ephedrine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,35761.0,Ephedrine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,35764.0,Ephedrine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Ephedrine']",0.5
14336,35764.0,Ephedrine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,35764.0,Ephedrine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,35764.0,Ephedrine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,35897.0,Ephedrine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Ephedrine']",0.5
14336,35909.0,Ephedrine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Ephedrine']",0.5
14336,35953.0,Ephedrine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,35953.0,Ephedrine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Lead', 'ALB', 'Ephedrine']",0.5
14336,35953.0,Ephedrine,atherosclerosis,disease-exposure-molfunc-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,36034.0,Ephedrine,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Ephedrine']",0.5
14336,36034.0,Ephedrine,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,36091.0,Ephedrine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'ALB', 'Ephedrine']",0.5
14336,36187.0,Ephedrine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Ephedrine']",0.5
14336,36187.0,Ephedrine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,36187.0,Ephedrine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,36187.0,Ephedrine,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,36252.0,Ephedrine,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Ephedrine']",0.5
14336,36252.0,Ephedrine,thyroid gland disease,disease-exposure-gene-drug,contraindication,"['thyroid gland disease', 'Pesticides', 'BCHE', 'Ephedrine']",0.5
14336,36252.0,Ephedrine,thyroid gland disease,disease-exposure-molfunc-gene-drug,contraindication,"['thyroid gland disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,36274.0,Ephedrine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'bone resorption', 'ADRB2', 'Ephedrine']",0.5
14336,36274.0,Ephedrine,pyloric stenosis (disease),disease-exposure-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,36432.0,Ephedrine,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRB1', 'Ephedrine']",0.5
14336,36469.0,Ephedrine,hypothyroidism,disease-exposure-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'BCHE', 'Ephedrine']",0.5
14336,36469.0,Ephedrine,hypothyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,36492.0,Ephedrine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Lead', 'choline metabolic process', 'BCHE', 'Ephedrine']",0.5
14336,36492.0,Ephedrine,brain cancer,disease-exposure-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'BCHE', 'Ephedrine']",0.5
14336,36492.0,Ephedrine,brain cancer,disease-exposure-molfunc-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,37180.0,Ephedrine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,37180.0,Ephedrine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,37180.0,Ephedrine,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,37617.0,Ephedrine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,37617.0,Ephedrine,chronic obstructive pulmonary disease,disease-exposure-molfunc-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,37703.0,Ephedrine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Ephedrine']",0.5
14336,37786.0,Ephedrine,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB1', 'Ephedrine']",0.5
14336,37786.0,Ephedrine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'response to folic acid', 'BCHE', 'Ephedrine']",0.5
14336,37786.0,Ephedrine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Ephedrine']",0.5
14336,37786.0,Ephedrine,myocardial ischemia,disease-exposure-molfunc-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,37811.0,Ephedrine,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Ephedrine']",0.5
14336,37811.0,Ephedrine,rhinitis,disease-exposure-gene-drug,indication,"['rhinitis', 'glyphosate', 'BCHE', 'Ephedrine']",0.5
14336,37811.0,Ephedrine,rhinitis,disease-exposure-molfunc-gene-drug,indication,"['rhinitis', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Ephedrine']",0.5
14336,37830.0,Ephedrine,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Ephedrine']",0.5
14336,37888.0,Ephedrine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'ALB', 'Ephedrine']",0.5
14336,37888.0,Ephedrine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Ephedrine']",0.5
14336,37888.0,Ephedrine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Ephedrine']",0.5
14336,83760.0,Ephedrine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Ephedrine']",0.5
14336,83791.0,Ephedrine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'ALB', 'Ephedrine']",0.5
14338,27626.0,Colchicine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Colchicine']",0.5
14338,27664.0,Colchicine,idiopathic aplastic anemia,disease-phenotype-protein-drug,contraindication,"['idiopathic aplastic anemia', 'Thrombocytopenia', 'ALB', 'Colchicine']",0.5
14338,29352.0,Colchicine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Colchicine']",0.5
14338,29494.0,Colchicine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Colchicine']",0.5
14338,30184.0,Colchicine,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Colchicine']",0.5
14338,30773.0,Colchicine,autosomal recessive familial Mediterranean fever,disease-phenotype-protein-drug,indication,"['autosomal recessive familial Mediterranean fever', 'Hepatomegaly', 'ALB', 'Colchicine']",0.5
14338,32202.0,Colchicine,familial Mediterranean fever,disease-phenotype-protein-drug,indication,"['familial Mediterranean fever', 'Proteinuria', 'ALB', 'Colchicine']",0.5
14338,33594.0,Colchicine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Colchicine']",0.5
14338,33612.0,Colchicine,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Colchicine']",0.5
14338,36104.0,Colchicine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Colchicine']",0.5
14338,36229.0,Colchicine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Colchicine']",0.5
14340,27361.0,Magnesium salicylate,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'PTGS2', 'Magnesium salicylate']",0.5
14340,27626.0,Magnesium salicylate,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Magnesium salicylate']",0.5
14340,27933.0,Magnesium salicylate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Magnesium salicylate']",0.5
14340,27933.0,Magnesium salicylate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,27933.0,Magnesium salicylate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PTGS2', 'Magnesium salicylate']",0.5
14340,28374.0,Magnesium salicylate,gastroesophageal reflux disease,disease-protein-drug,contraindication,"['gastroesophageal reflux disease', 'PTGS2', 'Magnesium salicylate']",0.5
14340,28899.0,Magnesium salicylate,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,29078.0,Magnesium salicylate,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Magnesium salicylate']",0.5
14340,29078.0,Magnesium salicylate,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,29078.0,Magnesium salicylate,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Magnesium salicylate']",0.5
14340,29078.0,Magnesium salicylate,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Magnesium salicylate']",0.5
14340,29525.0,Magnesium salicylate,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'PTGS2', 'Magnesium salicylate']",0.5
14340,30035.0,Magnesium salicylate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PTGS2', 'Magnesium salicylate']",0.5
14340,31395.0,Magnesium salicylate,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Magnesium salicylate']",0.5
14340,32325.0,Magnesium salicylate,juvenile idiopathic arthritis,disease-phenotype-protein-drug,off-label use,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Magnesium salicylate']",0.5
14340,32807.0,Magnesium salicylate,rheumatic fever,disease-phenotype-protein-drug,off-label use,"['rheumatic fever', 'Fever', 'PTGS2', 'Magnesium salicylate']",0.5
14340,33306.0,Magnesium salicylate,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Thrombocytopenia', 'ALB', 'Magnesium salicylate']",0.5
14340,33440.0,Magnesium salicylate,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Thrombocytopenia', 'ALB', 'Magnesium salicylate']",0.5
14340,33575.0,Magnesium salicylate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Magnesium salicylate']",0.5
14340,33575.0,Magnesium salicylate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Magnesium salicylate']",0.5
14340,33577.0,Magnesium salicylate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,33577.0,Magnesium salicylate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Magnesium salicylate']",0.5
14340,33632.0,Magnesium salicylate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,33632.0,Magnesium salicylate,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Magnesium salicylate']",0.5
14340,33714.0,Magnesium salicylate,esophagitis (disease),disease-protein-drug,contraindication,"['esophagitis (disease)', 'PTGS2', 'Magnesium salicylate']",0.5
14340,35565.0,Magnesium salicylate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Magnesium salicylate']",0.5
14340,35565.0,Magnesium salicylate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Magnesium salicylate']",0.5
14340,35641.0,Magnesium salicylate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Magnesium salicylate']",0.5
14340,35669.0,Magnesium salicylate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,35669.0,Magnesium salicylate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Magnesium salicylate']",0.5
14340,35761.0,Magnesium salicylate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Magnesium salicylate']",0.5
14340,35761.0,Magnesium salicylate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Magnesium salicylate']",0.5
14340,35764.0,Magnesium salicylate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Magnesium salicylate']",0.5
14340,35764.0,Magnesium salicylate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,35764.0,Magnesium salicylate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Magnesium salicylate']",0.5
14340,36034.0,Magnesium salicylate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Magnesium salicylate']",0.5
14340,36040.0,Magnesium salicylate,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'PTGS1', 'Magnesium salicylate']",0.5
14340,36040.0,Magnesium salicylate,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,36040.0,Magnesium salicylate,chronic kidney disease,disease-exposure-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'ALB', 'Magnesium salicylate']",0.5
14340,36187.0,Magnesium salicylate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PTGS2', 'Magnesium salicylate']",0.5
14340,36187.0,Magnesium salicylate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,36187.0,Magnesium salicylate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Magnesium salicylate']",0.5
14340,37786.0,Magnesium salicylate,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Magnesium salicylate']",0.5
14340,37786.0,Magnesium salicylate,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'PTGS1', 'Magnesium salicylate']",0.5
14340,83875.0,Magnesium salicylate,bladder neck obstruction,disease-protein-drug,contraindication,"['bladder neck obstruction', 'PTGS2', 'Magnesium salicylate']",0.5
14340,83878.0,Magnesium salicylate,peptic esophagitis,disease-protein-drug,contraindication,"['peptic esophagitis', 'PTGS2', 'Magnesium salicylate']",0.5
14340,83923.0,Magnesium salicylate,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'PTGS1', 'Magnesium salicylate']",0.5
14340,83923.0,Magnesium salicylate,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Magnesium salicylate']",0.5
14340,83923.0,Magnesium salicylate,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Cadmium', 'ALB', 'Magnesium salicylate']",0.5
14340,83924.0,Magnesium salicylate,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'PTGS1', 'Magnesium salicylate']",0.5
14341,33699.0,Acenocoumarol,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,indication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Acenocoumarol']",0.5
14342,29113.0,Testosterone propionate,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Testosterone propionate']",0.5
14342,30073.0,Testosterone propionate,cryptorchidism (disease),disease-exposure-bioprocess-gene-drug,indication,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'spermatogenesis', 'AR', 'Testosterone propionate']",0.5
14342,31395.0,Testosterone propionate,benign prostatic hyperplasia (disease),disease-protein-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'SRD5A2', 'Testosterone propionate']",0.5
14342,31395.0,Testosterone propionate,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Testosterone propionate']",0.5
14342,32518.0,Testosterone propionate,trisomy 13,disease-phenotype-protein-drug,indication,"['trisomy 13', 'Intrauterine growth retardation', 'COMT', 'Testosterone propionate']",0.5
14342,33575.0,Testosterone propionate,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Testosterone propionate']",0.5
14342,33575.0,Testosterone propionate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone propionate']",0.5
14342,33575.0,Testosterone propionate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'SHBG', 'Testosterone propionate']",0.5
14342,33575.0,Testosterone propionate,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Testosterone propionate']",0.5
14342,35565.0,Testosterone propionate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Testosterone propionate']",0.5
14342,35565.0,Testosterone propionate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Testosterone propionate']",0.5
14342,35669.0,Testosterone propionate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone propionate']",0.5
14342,35669.0,Testosterone propionate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'SHBG', 'Testosterone propionate']",0.5
14342,35761.0,Testosterone propionate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone propionate']",0.5
14342,35761.0,Testosterone propionate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'SHBG', 'Testosterone propionate']",0.5
14342,35764.0,Testosterone propionate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Testosterone propionate']",0.5
14342,35764.0,Testosterone propionate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Testosterone propionate']",0.5
14342,35764.0,Testosterone propionate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Testosterone propionate']",0.5
14342,35963.0,Testosterone propionate,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'SRD5A2', 'Testosterone propionate']",0.5
14342,35966.0,Testosterone propionate,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'SRD5A2', 'Testosterone propionate']",0.5
14342,35966.0,Testosterone propionate,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Testosterone propionate']",0.5
14342,36432.0,Testosterone propionate,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Testosterone propionate']",0.5
14342,36688.0,Testosterone propionate,prostate neoplasm,disease-protein-drug,contraindication,"['prostate neoplasm', 'SRD5A2', 'Testosterone propionate']",0.5
14342,84094.0,Testosterone propionate,premature menopause,disease-protein-drug,indication,"['premature menopause', 'AR', 'Testosterone propionate']",0.5
14343,35565.0,Sulfamerazine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Sulfamerazine']",0.5
14343,35764.0,Sulfamerazine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Sulfamerazine']",0.5
14343,35764.0,Sulfamerazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Sulfamerazine']",0.5
14343,35764.0,Sulfamerazine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Sulfamerazine']",0.5
14344,35565.0,Sulfamethazine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Sulfamethazine']",0.5
14344,35764.0,Sulfamethazine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Sulfamethazine']",0.5
14344,35764.0,Sulfamethazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Sulfamethazine']",0.5
14344,35764.0,Sulfamethazine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Sulfamethazine']",0.5
14346,27326.0,Lopinavir,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Lopinavir']",0.5
14346,27326.0,Lopinavir,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Lopinavir']",0.5
14346,27476.0,Lopinavir,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Lopinavir']",0.5
14346,28052.0,Lopinavir,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'ALB', 'Lopinavir']",0.5
14346,31493.0,Lopinavir,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Lopinavir']",0.5
14346,33575.0,Lopinavir,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Lopinavir']",0.5
14346,33575.0,Lopinavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Lopinavir']",0.5
14346,33575.0,Lopinavir,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Lopinavir']",0.5
14346,33695.0,Lopinavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Lopinavir']",0.5
14346,33695.0,Lopinavir,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Lopinavir']",0.5
14346,35565.0,Lopinavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Lopinavir']",0.5
14346,35565.0,Lopinavir,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Lopinavir']",0.5
14346,36187.0,Lopinavir,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Lopinavir']",0.5
14346,36187.0,Lopinavir,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Lopinavir']",0.5
14346,37743.0,Lopinavir,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Lopinavir']",0.5
14346,37765.0,Lopinavir,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Lopinavir']",0.5
14346,37786.0,Lopinavir,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Lopinavir']",0.5
14346,37786.0,Lopinavir,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Lopinavir']",0.5
14346,37805.0,Lopinavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Lopinavir']",0.5
14346,38312.0,Lopinavir,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Lopinavir']",0.5
14346,83751.0,Lopinavir,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Lopinavir']",0.5
14347,27286.0,Hydroxychloroquine,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'CYP2D6', 'Hydroxychloroquine']",0.5
14347,27292.0,Hydroxychloroquine,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Hepatomegaly', 'ALB', 'Hydroxychloroquine']",0.5
14347,29078.0,Hydroxychloroquine,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Hydroxychloroquine']",0.5
14347,29078.0,Hydroxychloroquine,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxychloroquine']",0.5
14347,29182.0,Hydroxychloroquine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ACE2', 'Hydroxychloroquine']",0.5
14347,29182.0,Hydroxychloroquine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Hydroxychloroquine']",0.5
14347,30035.0,Hydroxychloroquine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Hydroxychloroquine']",0.5
14347,32325.0,Hydroxychloroquine,juvenile idiopathic arthritis,disease-phenotype-protein-drug,off-label use,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Hydroxychloroquine']",0.5
14347,33534.0,Hydroxychloroquine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Hydroxychloroquine']",0.5
14347,33632.0,Hydroxychloroquine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Hydroxychloroquine']",0.5
14347,33632.0,Hydroxychloroquine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Hydroxychloroquine']",0.5
14347,35565.0,Hydroxychloroquine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'TLR7', 'Hydroxychloroquine']",0.5
14347,35565.0,Hydroxychloroquine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Hydroxychloroquine']",0.5
14347,35823.0,Hydroxychloroquine,eye disease,disease-exposure-bioprocess-gene-drug,contraindication,"['eye disease', 'perfluorooctane sulfonic acid', 'immune response', 'TLR7', 'Hydroxychloroquine']",0.5
14347,36104.0,Hydroxychloroquine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Hydroxychloroquine']",0.5
14347,36229.0,Hydroxychloroquine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Hydroxychloroquine']",0.5
14351,27740.0,Thiothixene,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR2A', 'Thiothixene']",0.5
14351,28313.0,Thiothixene,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Thiothixene']",0.5
14351,28313.0,Thiothixene,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP1A2', 'Thiothixene']",0.5
14351,28547.0,Thiothixene,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'DRD1', 'Thiothixene']",0.5
14351,28547.0,Thiothixene,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'memory', 'HTR2A', 'Thiothixene']",0.5
14351,28547.0,Thiothixene,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Lead', 'ALB', 'Thiothixene']",0.5
14351,28547.0,Thiothixene,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Thiothixene']",0.5
14351,28780.0,Thiothixene,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Thiothixene']",0.5
14351,28780.0,Thiothixene,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'DRD2', 'Thiothixene']",0.5
14351,28780.0,Thiothixene,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Cadmium', 'ALB', 'Thiothixene']",0.5
14351,28780.0,Thiothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Thiothixene']",0.5
14351,29352.0,Thiothixene,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Thiothixene']",0.5
14351,29494.0,Thiothixene,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Thiothixene']",0.5
14351,30184.0,Thiothixene,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Thiothixene']",0.5
14351,30715.0,Thiothixene,Wernicke-Korsakoff syndrome,disease-phenotype-protein-drug,contraindication,"['Wernicke-Korsakoff syndrome', 'Memory impairment', 'DRD2', 'Thiothixene']",0.5
14351,30879.0,Thiothixene,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'DRD1', 'Thiothixene']",0.5
14351,33449.0,Thiothixene,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR2A', 'Thiothixene']",0.5
14351,33454.0,Thiothixene,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Thiothixene']",0.5
14351,35641.0,Thiothixene,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD1', 'Thiothixene']",0.5
14351,35641.0,Thiothixene,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Thiothixene']",0.5
14351,35669.0,Thiothixene,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'HTR2A', 'Thiothixene']",0.5
14351,35761.0,Thiothixene,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'memory', 'HTR2A', 'Thiothixene']",0.5
14351,35761.0,Thiothixene,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Thiothixene']",0.5
14351,37706.0,Thiothixene,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Thiothixene']",0.5
14351,83998.0,Thiothixene,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Thiothixene']",0.5
14352,83790.0,Topiroxostat,gout,disease-protein-drug,indication,"['gout', 'ABCG2', 'Topiroxostat']",0.5
14352,83802.0,Topiroxostat,obsolete hyperuricemia (disease),disease-protein-drug,indication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Topiroxostat']",0.5
14352,83802.0,Topiroxostat,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Topiroxostat']",0.5
14359,28921.0,Quercetin,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Hepatomegaly', 'NR1I2', 'Quercetin']",0.5
14359,29946.0,Quercetin,primary hyperoxaluria,disease-phenotype-protein-drug,contraindication,"['primary hyperoxaluria', 'Elevated hepatic transaminase', 'AHR', 'Quercetin']",0.5
14359,31502.0,Quercetin,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Increased body weight', 'AHR', 'Quercetin']",0.5
14359,35764.0,Quercetin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Quercetin']",0.5
14359,35764.0,Quercetin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'SLC16A1', 'Quercetin']",0.5
14359,35764.0,Quercetin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'AHR', 'Quercetin']",0.5
14368,27326.0,Dronedarone,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CACNA1C', 'Dronedarone']",0.5
14368,27326.0,Dronedarone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'SLC8A1', 'Dronedarone']",0.5
14368,27326.0,Dronedarone,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'KCNQ1', 'Dronedarone']",0.5
14368,27326.0,Dronedarone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Sudden cardiac death', 'CACNA1C', 'Dronedarone']",0.5
14368,27655.0,Dronedarone,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNQ1', 'Dronedarone']",0.5
14368,27655.0,Dronedarone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Syncope', 'CACNA1C', 'Dronedarone']",0.5
14368,33618.0,Dronedarone,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'KCND3', 'Dronedarone']",0.5
14368,33618.0,Dronedarone,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'gene expression', 'KCNQ1', 'Dronedarone']",0.5
14368,38396.0,Dronedarone,familial sick sinus syndrome,disease-protein-drug,contraindication,"['familial sick sinus syndrome', 'SCN5A', 'Dronedarone']",0.5
14368,38958.0,Dronedarone,sick sinus syndrome,disease-protein-drug,contraindication,"['sick sinus syndrome', 'CACNB2', 'Dronedarone']",0.5
14368,83751.0,Dronedarone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'SCN5A', 'Dronedarone']",0.5
14369,29113.0,Nebivolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Nebivolol']",0.5
14369,33575.0,Nebivolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Nebivolol']",0.5
14369,33575.0,Nebivolol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Nebivolol']",0.5
14369,33577.0,Nebivolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Nebivolol']",0.5
14369,33577.0,Nebivolol,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Nebivolol']",0.5
14369,33618.0,Nebivolol,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'CYP2C19', 'Nebivolol']",0.5
14369,33618.0,Nebivolol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Nebivolol']",0.5
14369,35565.0,Nebivolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Nebivolol']",0.5
14369,35565.0,Nebivolol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Nebivolol']",0.5
14369,39798.0,Nebivolol,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Nebivolol']",0.5
14369,39798.0,Nebivolol,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'ALB', 'Nebivolol']",0.5
14373,27326.0,Vandetanib,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'response to cobalamin', 'EGFR', 'Vandetanib']",0.5
14373,30749.0,Vandetanib,thyroid gland carcinoma,disease-protein-drug,indication,"['thyroid gland carcinoma', 'RET', 'Vandetanib']",0.5
14373,30749.0,Vandetanib,thyroid gland carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['thyroid gland carcinoma', 'perfluorooctanoic acid', 'lactation', 'VEGFA', 'Vandetanib']",0.5
14373,31732.0,Vandetanib,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'VEGFA', 'Vandetanib']",0.5
14373,33577.0,Vandetanib,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Vandetanib']",0.5
14373,33577.0,Vandetanib,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Nitrogen Dioxide', 'VEGFA', 'Vandetanib']",0.5
14373,36035.0,Vandetanib,hypertension,disease-protein-drug,contraindication,"['hypertension', 'VEGFA', 'Vandetanib']",0.5
14373,36312.0,Vandetanib,transient ischemic attack (disease),disease-protein-drug,contraindication,"['transient ischemic attack (disease)', 'ALB', 'Vandetanib']",0.5
14373,36312.0,Vandetanib,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'VEGFA', 'Vandetanib']",0.5
14373,36432.0,Vandetanib,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Vandetanib']",0.5
14373,36469.0,Vandetanib,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'EGFR', 'Vandetanib']",0.5
14373,37659.0,Vandetanib,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Vandetanib']",0.5
14373,37659.0,Vandetanib,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Vandetanib']",0.5
14373,37659.0,Vandetanib,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Nitrogen Dioxide', 'VEGFA', 'Vandetanib']",0.5
14373,37718.0,Vandetanib,brain ischemia,disease-protein-drug,contraindication,"['brain ischemia', 'ALB', 'Vandetanib']",0.5
14373,37718.0,Vandetanib,brain ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Vandetanib']",0.5
14373,83751.0,Vandetanib,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Vandetanib']",0.5
14374,27626.0,Iodine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Iodine']",0.5
14374,29894.0,Iodine,Hashimoto thyroiditis,disease-protein-drug,contraindication,"['Hashimoto thyroiditis', 'TG', 'Iodine']",0.5
14374,31732.0,Iodine,myxedema,disease-protein-drug,contraindication,"['myxedema', 'TPO', 'Iodine']",0.5
14374,32719.0,Iodine,congenital hypothyroidism,disease-protein-drug,contraindication,"['congenital hypothyroidism', 'TPO', 'Iodine']",0.5
14374,32719.0,Iodine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Hearing impairment', 'SLC26A4', 'Iodine']",0.5
14374,32737.0,Iodine,hypocomplementemic urticarial vasculitis,disease-phenotype-protein-drug,contraindication,"['hypocomplementemic urticarial vasculitis', 'Hepatomegaly', 'ALB', 'Iodine']",0.5
14374,35565.0,Iodine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'response to oxidative stress', 'TPO', 'Iodine']",0.5
14374,35565.0,Iodine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Iodine']",0.5
14374,35641.0,Iodine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Iodine']",0.5
14374,35764.0,Iodine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Iodine']",0.5
14374,35764.0,Iodine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to oxidative stress', 'TPO', 'Iodine']",0.5
14374,35764.0,Iodine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Iodine']",0.5
14374,36080.0,Iodine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'response to oxidative stress', 'TPO', 'Iodine']",0.5
14374,36080.0,Iodine,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'TPO', 'Iodine']",0.5
14374,36469.0,Iodine,hypothyroidism,disease-protein-drug,contraindication,"['hypothyroidism', 'TPO', 'Iodine']",0.5
14374,37830.0,Iodine,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'response to oxidative stress', 'TPO', 'Iodine']",0.5
14374,37830.0,Iodine,bronchitis,disease-exposure-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'TPO', 'Iodine']",0.5
14374,39696.0,Iodine,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary tuberculosis', 'Arsenic', 'response to oxidative stress', 'TPO', 'Iodine']",0.5
14374,39696.0,Iodine,pulmonary tuberculosis,disease-exposure-gene-drug,contraindication,"['pulmonary tuberculosis', 'Air Pollutants', 'TPO', 'Iodine']",0.5
14375,33632.0,Telaprevir,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Telaprevir']",0.5
14375,33632.0,Telaprevir,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Telaprevir']",0.5
14375,37743.0,Telaprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Telaprevir']",0.5
14378,27933.0,Rufinamide,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ALB', 'Rufinamide']",0.5
14378,27933.0,Rufinamide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Rufinamide']",0.5
14378,27933.0,Rufinamide,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Rufinamide']",0.5
14378,35565.0,Rufinamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'GRM5', 'Rufinamide']",0.5
14378,35565.0,Rufinamide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Rufinamide']",0.5
14378,37703.0,Rufinamide,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Rufinamide']",0.5
14378,83760.0,Rufinamide,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Rufinamide']",0.5
14379,33440.0,Prasugrel,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Thrombocytopenia', 'ALB', 'Prasugrel']",0.5
14379,33598.0,Prasugrel,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Prasugrel']",0.5
14379,33598.0,Prasugrel,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Prasugrel']",0.5
14379,33598.0,Prasugrel,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Prasugrel']",0.5
14379,33605.0,Prasugrel,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Prasugrel']",0.5
14379,35909.0,Prasugrel,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Prasugrel']",0.5
14379,36312.0,Prasugrel,transient ischemic attack (disease),disease-protein-drug,contraindication,"['transient ischemic attack (disease)', 'ALB', 'Prasugrel']",0.5
14379,36312.0,Prasugrel,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'platelet activation', 'P2RY12', 'Prasugrel']",0.5
14380,27655.0,Asenapine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'HTR1B', 'Asenapine']",0.5
14380,27740.0,Asenapine,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Asenapine']",0.5
14380,28313.0,Asenapine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HTR5A', 'Asenapine']",0.5
14380,28313.0,Asenapine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Asenapine']",0.5
14380,28375.0,Asenapine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Asenapine']",0.5
14380,28396.0,Asenapine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Asenapine']",0.5
14380,28473.0,Asenapine,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Asenapine']",0.5
14380,28651.0,Asenapine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ADRB1', 'Asenapine']",0.5
14380,28780.0,Asenapine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Asenapine']",0.5
14380,28780.0,Asenapine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'DRD3', 'Asenapine']",0.5
14380,28780.0,Asenapine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Cadmium', 'ALB', 'Asenapine']",0.5
14380,28780.0,Asenapine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Asenapine']",0.5
14380,29113.0,Asenapine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Asenapine']",0.5
14380,29352.0,Asenapine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ALB', 'Asenapine']",0.5
14380,29494.0,Asenapine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'ALB', 'Asenapine']",0.5
14380,29637.0,Asenapine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Asenapine']",0.5
14380,29637.0,Asenapine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'HTR1B', 'Asenapine']",0.5
14380,30184.0,Asenapine,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'ALB', 'Asenapine']",0.5
14380,30879.0,Asenapine,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'HTR1B', 'Asenapine']",0.5
14380,33449.0,Asenapine,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Asenapine']",0.5
14380,33454.0,Asenapine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'ALB', 'Asenapine']",0.5
14380,33575.0,Asenapine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Asenapine']",0.5
14380,33575.0,Asenapine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Asenapine']",0.5
14380,33575.0,Asenapine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Asenapine']",0.5
14380,33593.0,Asenapine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ADRB1', 'Asenapine']",0.5
14380,33593.0,Asenapine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Asenapine']",0.5
14380,33593.0,Asenapine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Asenapine']",0.5
14380,33593.0,Asenapine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Asenapine']",0.5
14380,33598.0,Asenapine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Asenapine']",0.5
14380,33598.0,Asenapine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'visual learning', 'DRD3', 'Asenapine']",0.5
14380,33598.0,Asenapine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Cadmium', 'ALB', 'Asenapine']",0.5
14380,33679.0,Asenapine,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Asenapine']",0.5
14380,35641.0,Asenapine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Asenapine']",0.5
14380,35641.0,Asenapine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Asenapine']",0.5
14380,35909.0,Asenapine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Asenapine']",0.5
14380,36187.0,Asenapine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Asenapine']",0.5
14380,36187.0,Asenapine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Asenapine']",0.5
14380,36187.0,Asenapine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Asenapine']",0.5
14380,36312.0,Asenapine,transient ischemic attack (disease),disease-protein-drug,contraindication,"['transient ischemic attack (disease)', 'ALB', 'Asenapine']",0.5
14380,36312.0,Asenapine,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Asenapine']",0.5
14380,37180.0,Asenapine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Asenapine']",0.5
14380,37180.0,Asenapine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Asenapine']",0.5
14380,37786.0,Asenapine,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB1', 'Asenapine']",0.5
14380,37786.0,Asenapine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Asenapine']",0.5
14380,37786.0,Asenapine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'ALB', 'Asenapine']",0.5
14380,38242.0,Asenapine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'HTR5A', 'Asenapine']",0.5
14380,38242.0,Asenapine,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Asenapine']",0.5
14380,38575.0,Asenapine,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Asenapine']",0.5
14380,39081.0,Asenapine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Asenapine']",0.5
14380,39531.0,Asenapine,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Asenapine']",0.5
14380,83751.0,Asenapine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Asenapine']",0.5
14380,83763.0,Asenapine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'HTR2A', 'Asenapine']",0.5
14380,83764.0,Asenapine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Asenapine']",0.5
14380,83911.0,Asenapine,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Asenapine']",0.5
14380,83960.0,Asenapine,Alzheimer disease without neurofibrillary tangles,disease-protein-drug,contraindication,"['Alzheimer disease without neurofibrillary tangles', 'CYP2D6', 'Asenapine']",0.5
14380,83998.0,Asenapine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Asenapine']",0.5
14380,84023.0,Asenapine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Asenapine']",0.5
14381,29709.0,Levocetirizine,"dermatitis, atopic",disease-phenotype-protein-drug,off-label use,"['dermatitis, atopic', 'Pruritus', 'HRH1', 'Levocetirizine']",0.5
14381,33683.0,Levocetirizine,urticaria (disease),disease-protein-drug,off-label use,"['urticaria (disease)', 'ALB', 'Levocetirizine']",0.5
14381,35764.0,Levocetirizine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Levocetirizine']",0.5
14381,35764.0,Levocetirizine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Levocetirizine']",0.5
14381,35764.0,Levocetirizine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Levocetirizine']",0.5
14381,36040.0,Levocetirizine,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'ALB', 'Levocetirizine']",0.5
14381,36040.0,Levocetirizine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'memory', 'HRH1', 'Levocetirizine']",0.5
14381,36040.0,Levocetirizine,chronic kidney disease,disease-exposure-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'ALB', 'Levocetirizine']",0.5
14381,36129.0,Levocetirizine,atopic eczema,disease-exposure-bioprocess-gene-drug,off-label use,"['atopic eczema', 'Mercury', 'memory', 'HRH1', 'Levocetirizine']",0.5
14381,36129.0,Levocetirizine,atopic eczema,disease-exposure-gene-drug,off-label use,"['atopic eczema', 'Lead', 'ALB', 'Levocetirizine']",0.5
14381,37888.0,Levocetirizine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Levocetirizine']",0.5
14381,37888.0,Levocetirizine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Levocetirizine']",0.5
14381,37888.0,Levocetirizine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'ALB', 'Levocetirizine']",0.5
14381,39540.0,Levocetirizine,angioedema,disease-protein-drug,off-label use,"['angioedema', 'ALB', 'Levocetirizine']",0.5
14381,83791.0,Levocetirizine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Levocetirizine']",0.5
14381,83923.0,Levocetirizine,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'ALB', 'Levocetirizine']",0.5
14381,83923.0,Levocetirizine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Levocetirizine']",0.5
14381,83923.0,Levocetirizine,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Cadmium', 'ALB', 'Levocetirizine']",0.5
14381,83924.0,Levocetirizine,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'ALB', 'Levocetirizine']",0.5
14382,37743.0,Simeprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Simeprevir']",0.5
14383,27452.0,Oxymetholone,Diamond-Blackfan anemia,disease-phenotype-protein-drug,indication,"['Diamond-Blackfan anemia', 'Respiratory distress', 'NPPB', 'Oxymetholone']",0.5
14383,27664.0,Oxymetholone,idiopathic aplastic anemia,disease-phenotype-protein-drug,indication,"['idiopathic aplastic anemia', 'Thrombocytopenia', 'ALB', 'Oxymetholone']",0.5
14383,29113.0,Oxymetholone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Oxymetholone']",0.5
14383,31395.0,Oxymetholone,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Oxymetholone']",0.5
14383,33575.0,Oxymetholone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Oxymetholone']",0.5
14383,33575.0,Oxymetholone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Oxymetholone']",0.5
14383,33575.0,Oxymetholone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'SHBG', 'Oxymetholone']",0.5
14383,33575.0,Oxymetholone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Oxymetholone']",0.5
14383,33603.0,Oxymetholone,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'NPPB', 'Oxymetholone']",0.5
14383,35565.0,Oxymetholone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Oxymetholone']",0.5
14383,35565.0,Oxymetholone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Oxymetholone']",0.5
14383,35669.0,Oxymetholone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Oxymetholone']",0.5
14383,35669.0,Oxymetholone,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'SHBG', 'Oxymetholone']",0.5
14383,35761.0,Oxymetholone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Oxymetholone']",0.5
14383,35761.0,Oxymetholone,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'SHBG', 'Oxymetholone']",0.5
14383,35764.0,Oxymetholone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Oxymetholone']",0.5
14383,35764.0,Oxymetholone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'NPPB', 'Oxymetholone']",0.5
14383,35764.0,Oxymetholone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Oxymetholone']",0.5
14383,35953.0,Oxymetholone,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'NPPB', 'Oxymetholone']",0.5
14383,35953.0,Oxymetholone,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Diethylhexyl Phthalate', 'Leydig cell differentiation', 'AR', 'Oxymetholone']",0.5
14383,35953.0,Oxymetholone,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'bisphenol A', 'SHBG', 'Oxymetholone']",0.5
14383,35963.0,Oxymetholone,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'SHBG', 'Oxymetholone']",0.5
14383,35966.0,Oxymetholone,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'SHBG', 'Oxymetholone']",0.5
14383,35966.0,Oxymetholone,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Oxymetholone']",0.5
14383,36187.0,Oxymetholone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'NPPB', 'Oxymetholone']",0.5
14383,36187.0,Oxymetholone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Oxymetholone']",0.5
14383,36187.0,Oxymetholone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'SHBG', 'Oxymetholone']",0.5
14383,36432.0,Oxymetholone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'NPPB', 'Oxymetholone']",0.5
14384,28158.0,Prucalopride,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Prucalopride']",0.5
14384,28158.0,Prucalopride,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Prucalopride']",0.5
14384,28158.0,Prucalopride,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Prucalopride']",0.5
14384,37785.0,Prucalopride,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Prucalopride']",0.5
14384,37785.0,Prucalopride,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Prucalopride']",0.5
14385,28208.0,Liraglutide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'GLP1R', 'Liraglutide']",0.5
14385,28208.0,Liraglutide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Liraglutide']",0.5
14385,28208.0,Liraglutide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Arsenic', 'MME', 'Liraglutide']",0.5
14385,31493.0,Liraglutide,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Liraglutide']",0.5
14385,33575.0,Liraglutide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'GLP1R', 'Liraglutide']",0.5
14385,33575.0,Liraglutide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Liraglutide']",0.5
14385,33575.0,Liraglutide,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Arsenic', 'MME', 'Liraglutide']",0.5
14385,36252.0,Liraglutide,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Liraglutide']",0.5
14387,27522.0,Methyltestosterone,Noonan syndrome,disease-phenotype-protein-drug,off-label use,"['Noonan syndrome', 'Hepatomegaly', 'ALB', 'Methyltestosterone']",0.5
14387,28651.0,Methyltestosterone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ESR1', 'Methyltestosterone']",0.5
14387,29061.0,Methyltestosterone,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'CYP19A1', 'Methyltestosterone']",0.5
14387,29113.0,Methyltestosterone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Methyltestosterone']",0.5
14387,29182.0,Methyltestosterone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Methyltestosterone']",0.5
14387,29182.0,Methyltestosterone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Methyltestosterone']",0.5
14387,29220.0,Methyltestosterone,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'ALB', 'Methyltestosterone']",0.5
14387,29646.0,Methyltestosterone,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'AR', 'Methyltestosterone']",0.5
14387,29646.0,Methyltestosterone,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Methyltestosterone']",0.5
14387,29646.0,Methyltestosterone,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'ALB', 'Methyltestosterone']",0.5
14387,30073.0,Methyltestosterone,cryptorchidism (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'spermatogenesis', 'AR', 'Methyltestosterone']",0.5
14387,30827.0,Methyltestosterone,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'ESR1', 'Methyltestosterone']",0.5
14387,31477.0,Methyltestosterone,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Methyltestosterone']",0.5
14387,31477.0,Methyltestosterone,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Methyltestosterone']",0.5
14387,31596.0,Methyltestosterone,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Methyltestosterone']",0.5
14387,31630.0,Methyltestosterone,androgen insensitivity syndrome,disease-protein-drug,indication,"['androgen insensitivity syndrome', 'AR', 'Methyltestosterone']",0.5
14387,31630.0,Methyltestosterone,androgen insensitivity syndrome,disease-phenotype-protein-drug,indication,"['androgen insensitivity syndrome', 'Male infertility', 'AR', 'Methyltestosterone']",0.5
14387,32617.0,Methyltestosterone,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'AR', 'Methyltestosterone']",0.5
14387,33534.0,Methyltestosterone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Methyltestosterone']",0.5
14387,33575.0,Methyltestosterone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Methyltestosterone']",0.5
14387,33575.0,Methyltestosterone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Methyltestosterone']",0.5
14387,33575.0,Methyltestosterone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'SHBG', 'Methyltestosterone']",0.5
14387,33575.0,Methyltestosterone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Methyltestosterone']",0.5
14387,33577.0,Methyltestosterone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Methyltestosterone']",0.5
14387,33577.0,Methyltestosterone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'SHBG', 'Methyltestosterone']",0.5
14387,33593.0,Methyltestosterone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Methyltestosterone']",0.5
14387,33593.0,Methyltestosterone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'spermatogenesis', 'AR', 'Methyltestosterone']",0.5
14387,33593.0,Methyltestosterone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Methyltestosterone']",0.5
14387,33598.0,Methyltestosterone,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Methyltestosterone']",0.5
14387,33598.0,Methyltestosterone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Methyltestosterone']",0.5
14387,33598.0,Methyltestosterone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'SHBG', 'Methyltestosterone']",0.5
14387,33675.0,Methyltestosterone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Methyltestosterone']",0.5
14387,33675.0,Methyltestosterone,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'bisphenol A', 'SHBG', 'Methyltestosterone']",0.5
14387,33680.0,Methyltestosterone,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'CYP19A1', 'Methyltestosterone']",0.5
14387,33680.0,Methyltestosterone,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Methyltestosterone']",0.5
14387,33680.0,Methyltestosterone,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Methyltestosterone']",0.5
14387,33695.0,Methyltestosterone,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Methyltestosterone']",0.5
14387,33695.0,Methyltestosterone,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Methyltestosterone']",0.5
14387,33699.0,Methyltestosterone,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Methyltestosterone']",0.5
14387,35565.0,Methyltestosterone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Methyltestosterone']",0.5
14387,35565.0,Methyltestosterone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Methyltestosterone']",0.5
14387,35641.0,Methyltestosterone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Methyltestosterone']",0.5
14387,35738.0,Methyltestosterone,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR1', 'Methyltestosterone']",0.5
14387,35739.0,Methyltestosterone,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Methyltestosterone']",0.5
14387,35764.0,Methyltestosterone,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Methyltestosterone']",0.5
14387,35764.0,Methyltestosterone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Methyltestosterone']",0.5
14387,35764.0,Methyltestosterone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Methyltestosterone']",0.5
14387,35901.0,Methyltestosterone,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Methyltestosterone']",0.5
14387,35901.0,Methyltestosterone,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'CYP19A1', 'Methyltestosterone']",0.5
14387,35909.0,Methyltestosterone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Methyltestosterone']",0.5
14387,35958.0,Methyltestosterone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Methyltestosterone']",0.5
14387,35963.0,Methyltestosterone,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'SHBG', 'Methyltestosterone']",0.5
14387,35966.0,Methyltestosterone,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'SHBG', 'Methyltestosterone']",0.5
14387,35966.0,Methyltestosterone,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Methyltestosterone']",0.5
14387,36187.0,Methyltestosterone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Methyltestosterone']",0.5
14387,36187.0,Methyltestosterone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Methyltestosterone']",0.5
14387,36187.0,Methyltestosterone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'SHBG', 'Methyltestosterone']",0.5
14387,36432.0,Methyltestosterone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Methyltestosterone']",0.5
14387,36469.0,Methyltestosterone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Methyltestosterone']",0.5
14387,36527.0,Methyltestosterone,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Methyltestosterone']",0.5
14387,36634.0,Methyltestosterone,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'AR', 'Methyltestosterone']",0.5
14387,36634.0,Methyltestosterone,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Methyltestosterone']",0.5
14387,36792.0,Methyltestosterone,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Methyltestosterone']",0.5
14387,36794.0,Methyltestosterone,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Methyltestosterone']",0.5
14387,37038.0,Methyltestosterone,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR1', 'Methyltestosterone']",0.5
14387,37047.0,Methyltestosterone,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Methyltestosterone']",0.5
14387,37082.0,Methyltestosterone,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Methyltestosterone']",0.5
14387,37150.0,Methyltestosterone,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Methyltestosterone']",0.5
14387,37152.0,Methyltestosterone,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Methyltestosterone']",0.5
14387,37180.0,Methyltestosterone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Methyltestosterone']",0.5
14387,37180.0,Methyltestosterone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Methyltestosterone']",0.5
14387,37180.0,Methyltestosterone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'bisphenol A', 'SHBG', 'Methyltestosterone']",0.5
14387,37423.0,Methyltestosterone,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Methyltestosterone']",0.5
14387,37466.0,Methyltestosterone,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Methyltestosterone']",0.5
14387,37573.0,Methyltestosterone,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Methyltestosterone']",0.5
14387,37659.0,Methyltestosterone,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ALB', 'Methyltestosterone']",0.5
14387,37659.0,Methyltestosterone,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Methyltestosterone']",0.5
14387,37659.0,Methyltestosterone,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Cadmium', 'ALB', 'Methyltestosterone']",0.5
14387,37768.0,Methyltestosterone,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Methyltestosterone']",0.5
14387,37967.0,Methyltestosterone,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Methyltestosterone']",0.5
14387,39603.0,Methyltestosterone,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Methyltestosterone']",0.5
14387,39615.0,Methyltestosterone,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Methyltestosterone']",0.5
14387,83816.0,Methyltestosterone,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Methyltestosterone']",0.5
14387,83817.0,Methyltestosterone,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Methyltestosterone']",0.5
14387,83818.0,Methyltestosterone,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Methyltestosterone']",0.5
14387,83819.0,Methyltestosterone,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Methyltestosterone']",0.5
14387,83820.0,Methyltestosterone,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Methyltestosterone']",0.5
14387,83821.0,Methyltestosterone,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Methyltestosterone']",0.5
14387,83822.0,Methyltestosterone,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Methyltestosterone']",0.5
14387,83823.0,Methyltestosterone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Methyltestosterone']",0.5
14387,83824.0,Methyltestosterone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Methyltestosterone']",0.5
14387,84094.0,Methyltestosterone,premature menopause,disease-protein-drug,indication,"['premature menopause', 'AR', 'Methyltestosterone']",0.5
14388,33605.0,Fospropofol,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Fospropofol']",0.5
14389,28374.0,Mangafodipir,gastroesophageal reflux disease,disease-protein-drug,contraindication,"['gastroesophageal reflux disease', 'SOD2', 'Mangafodipir']",0.5
14389,28478.0,Mangafodipir,autoimmune disease,disease-exposure-bioprocess-gene-drug,contraindication,"['autoimmune disease', 'Particulate Matter', 'regulation of blood pressure', 'SOD2', 'Mangafodipir']",0.5
14389,28478.0,Mangafodipir,autoimmune disease,disease-exposure-gene-drug,contraindication,"['autoimmune disease', 'Particulate Matter', 'SOD2', 'Mangafodipir']",0.5
14389,33714.0,Mangafodipir,esophagitis (disease),disease-protein-drug,contraindication,"['esophagitis (disease)', 'SOD2', 'Mangafodipir']",0.5
14389,35565.0,Mangafodipir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'regulation of blood pressure', 'SOD2', 'Mangafodipir']",0.5
14389,35565.0,Mangafodipir,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Mangafodipir']",0.5
14389,35764.0,Mangafodipir,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Mangafodipir']",0.5
14389,35764.0,Mangafodipir,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'SOD2', 'Mangafodipir']",0.5
14389,35764.0,Mangafodipir,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Mangafodipir']",0.5
14389,83878.0,Mangafodipir,peptic esophagitis,disease-protein-drug,contraindication,"['peptic esophagitis', 'SOD2', 'Mangafodipir']",0.5
14390,29078.0,Azapropazone,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Azapropazone']",0.5
14399,35565.0,Ticagrelor,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Ticagrelor']",0.5
14399,35565.0,Ticagrelor,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Ticagrelor']",0.5
14399,39798.0,Ticagrelor,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,indication,"['peripheral arterial disease', 'Air Pollutants', 'platelet aggregation', 'P2RY12', 'Ticagrelor']",0.5
14399,39798.0,Ticagrelor,peripheral arterial disease,disease-exposure-gene-drug,indication,"['peripheral arterial disease', 'Cadmium', 'ALB', 'Ticagrelor']",0.5
14400,28714.0,Ivacaftor,cystic fibrosis,disease-protein-drug,indication,"['cystic fibrosis', 'CFTR', 'Ivacaftor']",0.5
14400,28714.0,Ivacaftor,cystic fibrosis,disease-phenotype-protein-drug,indication,"['cystic fibrosis', 'Male infertility', 'CFTR', 'Ivacaftor']",0.5
14401,36240.0,Vismodegib,carcinoma,disease-protein-drug,indication,"['carcinoma', 'ABCB1', 'Vismodegib']",0.5
14401,37009.0,Vismodegib,sweat gland cancer,disease-protein-drug,indication,"['sweat gland cancer', 'SMO', 'Vismodegib']",0.5
14401,37166.0,Vismodegib,sebaceous adenocarcinoma,disease-protein-drug,indication,"['sebaceous adenocarcinoma', 'SMO', 'Vismodegib']",0.5
14401,37738.0,Vismodegib,basal cell carcinoma,disease-protein-drug,indication,"['basal cell carcinoma', 'SMO', 'Vismodegib']",0.5
14401,37738.0,Vismodegib,basal cell carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['basal cell carcinoma', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Vismodegib']",0.5
14402,33605.0,Pitavastatin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Pitavastatin']",0.5
14402,33612.0,Pitavastatin,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Pitavastatin']",0.5
14402,35565.0,Pitavastatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Pitavastatin']",0.5
14402,35565.0,Pitavastatin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Pitavastatin']",0.5
14402,36469.0,Pitavastatin,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'UGT2B7', 'Pitavastatin']",0.5
14402,83898.0,Pitavastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Pitavastatin']",0.5
14403,27326.0,Rilpivirine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR1I2', 'Rilpivirine']",0.5
14403,27326.0,Rilpivirine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Rilpivirine']",0.5
14403,27577.0,Rilpivirine,Fanconi renotubular syndrome,disease-phenotype-protein-drug,contraindication,"['Fanconi renotubular syndrome', 'Proteinuria', 'ALB', 'Rilpivirine']",0.5
14403,28651.0,Rilpivirine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'NR1I2', 'Rilpivirine']",0.5
14403,33593.0,Rilpivirine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'NR1I2', 'Rilpivirine']",0.5
14403,33593.0,Rilpivirine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Rilpivirine']",0.5
14403,33593.0,Rilpivirine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Rilpivirine']",0.5
14403,33593.0,Rilpivirine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CYP2D6', 'Rilpivirine']",0.5
14403,33625.0,Rilpivirine,hypophosphatemia (disease),disease-protein-drug,contraindication,"['hypophosphatemia (disease)', 'NR1I2', 'Rilpivirine']",0.5
14403,35565.0,Rilpivirine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Rilpivirine']",0.5
14403,35565.0,Rilpivirine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Rilpivirine']",0.5
14403,35764.0,Rilpivirine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Rilpivirine']",0.5
14403,35764.0,Rilpivirine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Rilpivirine']",0.5
14403,35764.0,Rilpivirine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Rilpivirine']",0.5
14403,36242.0,Rilpivirine,fatty liver disease,disease-protein-drug,contraindication,"['fatty liver disease', 'NR1I2', 'Rilpivirine']",0.5
14403,36242.0,Rilpivirine,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Rilpivirine']",0.5
14403,36242.0,Rilpivirine,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Cadmium', 'ALB', 'Rilpivirine']",0.5
14403,37805.0,Rilpivirine,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Rilpivirine']",0.5
14403,83751.0,Rilpivirine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Rilpivirine']",0.5
14403,84131.0,Rilpivirine,non-alcoholic steatohepatitis,disease-protein-drug,contraindication,"['non-alcoholic steatohepatitis', 'NR1I2', 'Rilpivirine']",0.5
14405,27326.0,Vemurafenib,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Vemurafenib']",0.5
14405,27326.0,Vemurafenib,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Vemurafenib']",0.5
14405,27476.0,Vemurafenib,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Vemurafenib']",0.5
14405,33654.0,Vemurafenib,uveitis,disease-protein-drug,contraindication,"['uveitis', 'ALB', 'Vemurafenib']",0.5
14405,36584.0,Vemurafenib,iris disease,disease-protein-drug,contraindication,"['iris disease', 'ALB', 'Vemurafenib']",0.5
14405,37608.0,Vemurafenib,ciliary body disease,disease-protein-drug,contraindication,"['ciliary body disease', 'ALB', 'Vemurafenib']",0.5
14405,39245.0,Vemurafenib,panuveitis (disease),disease-protein-drug,contraindication,"['panuveitis (disease)', 'ALB', 'Vemurafenib']",0.5
14405,83751.0,Vemurafenib,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Vemurafenib']",0.5
14406,33577.0,Mirabegron,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Mirabegron']",0.5
14406,33577.0,Mirabegron,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Mirabegron']",0.5
14406,33577.0,Mirabegron,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Mirabegron']",0.5
14407,29078.0,Tofacitinib,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'TYK2', 'Tofacitinib']",0.5
14407,29078.0,Tofacitinib,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Tofacitinib']",0.5
14408,30826.0,Enzalutamide,familial prostate carcinoma,disease-protein-drug,indication,"['familial prostate carcinoma', 'CYP2C19', 'Enzalutamide']",0.5
14408,35963.0,Enzalutamide,prostate carcinoma,disease-protein-drug,indication,"['prostate carcinoma', 'CYP2C19', 'Enzalutamide']",0.5
14408,35966.0,Enzalutamide,prostate cancer,disease-protein-drug,indication,"['prostate cancer', 'CYP2C19', 'Enzalutamide']",0.5
14408,35966.0,Enzalutamide,prostate cancer,disease-exposure-bioprocess-gene-drug,indication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Enzalutamide']",0.5
14411,30654.0,Ibrutinib,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'BTK', 'Ibrutinib']",0.5
14411,32213.0,Ibrutinib,Waldenstrom macroglobulinemia,disease-phenotype-protein-drug,indication,"['Waldenstrom macroglobulinemia', 'Hepatomegaly', 'ALB', 'Ibrutinib']",0.5
14411,32520.0,Ibrutinib,graft versus host disease,disease-phenotype-protein-drug,indication,"['graft versus host disease', 'Pain', 'ALB', 'Ibrutinib']",0.5
14411,83868.0,Ibrutinib,Richter syndrome,disease-protein-drug,indication,"['Richter syndrome', 'BTK', 'Ibrutinib']",0.5
14413,31116.0,Nintedanib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Nintedanib']",0.5
14413,33688.0,Nintedanib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Nintedanib']",0.5
14419,29273.0,Dexibuprofen,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'PPARG', 'Dexibuprofen']",0.5
14419,32325.0,Dexibuprofen,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'ALB', 'Dexibuprofen']",0.5
14419,33609.0,Dexibuprofen,osteoarthritis,disease-protein-drug,indication,"['osteoarthritis', 'PPARG', 'Dexibuprofen']",0.5
14419,36209.0,Dexibuprofen,arthropathy,disease-protein-drug,indication,"['arthropathy', 'PPARG', 'Dexibuprofen']",0.5
14420,28313.0,Blonanserin,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Blonanserin']",0.5
14420,28313.0,Blonanserin,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Blonanserin']",0.5
14421,33577.0,Aranidipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Aranidipine']",0.5
14421,33577.0,Aranidipine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Aranidipine']",0.5
14424,27286.0,Methylene blue,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'CYP2D6', 'Methylene blue']",0.5
14424,27292.0,Methylene blue,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'CYP1A2', 'Methylene blue']",0.5
14424,27361.0,Methylene blue,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'NOS1', 'Methylene blue']",0.5
14424,29113.0,Methylene blue,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'NOS1', 'Methylene blue']",0.5
14424,31271.0,Methylene blue,achalasia (disease),disease-protein-drug,contraindication,"['achalasia (disease)', 'NOS1', 'Methylene blue']",0.5
14424,31650.0,Methylene blue,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'NOS1', 'Methylene blue']",0.5
14424,32841.0,Methylene blue,idiopathic achalasia,disease-protein-drug,contraindication,"['idiopathic achalasia', 'NOS1', 'Methylene blue']",0.5
14424,33342.0,Methylene blue,congenital diaphragmatic hernia,disease-phenotype-protein-drug,contraindication,"['congenital diaphragmatic hernia', 'Hypoxemia', 'NOS1', 'Methylene blue']",0.5
14424,33440.0,Methylene blue,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Thrombocytopenia', 'ALB', 'Methylene blue']",0.5
14424,33575.0,Methylene blue,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Methylene blue']",0.5
14424,33575.0,Methylene blue,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'NOS1', 'Methylene blue']",0.5
14424,33575.0,Methylene blue,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Methylene blue']",0.5
14424,33577.0,Methylene blue,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Methylene blue']",0.5
14424,33577.0,Methylene blue,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Methylene blue']",0.5
14424,33577.0,Methylene blue,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Methylene blue']",0.5
14424,33632.0,Methylene blue,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Methylene blue']",0.5
14424,33632.0,Methylene blue,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'ALB', 'Methylene blue']",0.5
14424,35565.0,Methylene blue,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Methylene blue']",0.5
14424,35565.0,Methylene blue,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Methylene blue']",0.5
14424,35669.0,Methylene blue,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'NOS1', 'Methylene blue']",0.5
14424,35761.0,Methylene blue,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'NOS1', 'Methylene blue']",0.5
14424,35761.0,Methylene blue,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Methylene blue']",0.5
14424,35764.0,Methylene blue,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Methylene blue']",0.5
14424,35764.0,Methylene blue,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Methylene blue']",0.5
14424,35764.0,Methylene blue,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Methylene blue']",0.5
14424,36034.0,Methylene blue,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Methylene blue']",0.5
14424,36035.0,Methylene blue,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Methylene blue']",0.5
14424,36187.0,Methylene blue,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'NOS1', 'Methylene blue']",0.5
14424,36187.0,Methylene blue,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Methylene blue']",0.5
14424,36274.0,Methylene blue,pyloric stenosis (disease),disease-exposure-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'ALB', 'Methylene blue']",0.5
14424,36432.0,Methylene blue,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Methylene blue']",0.5
14424,37765.0,Methylene blue,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ALB', 'Methylene blue']",0.5
14424,38462.0,Methylene blue,sulfhemoglobinemia,disease-protein-drug,indication,"['sulfhemoglobinemia', 'CYP1A2', 'Methylene blue']",0.5
14424,39480.0,Methylene blue,methemoglobinemia,disease-protein-drug,indication,"['methemoglobinemia', 'CYP1A2', 'Methylene blue']",0.5
14424,83873.0,Methylene blue,megaesophagus,disease-protein-drug,contraindication,"['megaesophagus', 'NOS1', 'Methylene blue']",0.5
14427,28714.0,Lumacaftor,cystic fibrosis,disease-protein-drug,indication,"['cystic fibrosis', 'CFTR', 'Lumacaftor']",0.5
14427,28714.0,Lumacaftor,cystic fibrosis,disease-phenotype-protein-drug,indication,"['cystic fibrosis', 'Male infertility', 'CFTR', 'Lumacaftor']",0.5
14428,37805.0,Tenofovir alafenamide,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Tenofovir alafenamide']",0.5
14429,28921.0,Iopodic acid,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Hepatomegaly', 'ALB', 'Iopodic acid']",0.5
14429,31122.0,Iopodic acid,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'ALB', 'Iopodic acid']",0.5
14429,33675.0,Iopodic acid,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Benzo(a)pyrene', 'heme biosynthetic process', 'ALB', 'Iopodic acid']",0.5
14429,35764.0,Iopodic acid,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Iopodic acid']",0.5
14429,35764.0,Iopodic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'thyroid hormone metabolic process', 'DIO3', 'Iopodic acid']",0.5
14429,35764.0,Iopodic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Iopodic acid']",0.5
14434,36129.0,Hydroquinone,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Mercury', 'visual perception', 'TYR', 'Hydroquinone']",0.5
14434,36129.0,Hydroquinone,atopic eczema,disease-exposure-gene-drug,contraindication,"['atopic eczema', 'Lead', 'ALB', 'Hydroquinone']",0.5
14434,39798.0,Hydroquinone,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'pigmentation', 'TYR', 'Hydroquinone']",0.5
14434,39798.0,Hydroquinone,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'ALB', 'Hydroquinone']",0.5
14435,33575.0,Insulin degludec,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'CYP1A2', 'Insulin degludec']",0.5
14435,33575.0,Insulin degludec,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'IGF1R', 'Insulin degludec']",0.5
14435,33575.0,Insulin degludec,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Insulin degludec']",0.5
14439,29525.0,Butamben,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Syncope', 'CACNA1C', 'Butamben']",0.5
14439,35641.0,Butamben,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CACNA2D2', 'Butamben']",0.5
14439,36080.0,Butamben,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'CACNA1S', 'Butamben']",0.5
14439,36080.0,Butamben,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'ORM1', 'Butamben']",0.5
14439,36080.0,Butamben,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'CACNA2D1', 'Butamben']",0.5
14443,37743.0,Grazoprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Grazoprevir']",0.5
14447,28391.0,Pitolisant,narcolepsy,disease-exposure-bioprocess-gene-drug,indication,"['narcolepsy', 'Pesticides', 'cognition', 'HRH3', 'Pitolisant']",0.5
14447,30664.0,Pitolisant,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Memory impairment', 'HRH3', 'Pitolisant']",0.5
14449,27275.0,Selumetinib,neurofibromatosis,disease-protein-drug,indication,"['neurofibromatosis', 'MAP2K2', 'Selumetinib']",0.5
14451,33594.0,Rifamycin,diarrheal disease,disease-exposure-bioprocess-gene-drug,indication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Rifamycin']",0.5
14452,28547.0,Istradefylline,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'ABCB1', 'Istradefylline']",0.5
14452,28547.0,Istradefylline,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Istradefylline']",0.5
14452,28547.0,Istradefylline,Parkinson disease,disease-exposure-gene-drug,indication,"['Parkinson disease', 'Lead', 'ALB', 'Istradefylline']",0.5
14452,28547.0,Istradefylline,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'ADORA2A', 'Istradefylline']",0.5
14452,28974.0,Istradefylline,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'ABCB1', 'Istradefylline']",0.5
14452,28974.0,Istradefylline,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'ADORA2A', 'Istradefylline']",0.5
14452,30093.0,Istradefylline,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'ABCB1', 'Istradefylline']",0.5
14452,30093.0,Istradefylline,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'ADORA2A', 'Istradefylline']",0.5
14452,32759.0,Istradefylline,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'ABCB1', 'Istradefylline']",0.5
14452,32759.0,Istradefylline,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'ADORA2A', 'Istradefylline']",0.5
14452,32974.0,Istradefylline,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'ABCB1', 'Istradefylline']",0.5
14452,32974.0,Istradefylline,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'ADORA2A', 'Istradefylline']",0.5
14452,33241.0,Istradefylline,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'ABCB1', 'Istradefylline']",0.5
14452,33241.0,Istradefylline,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'ADORA2A', 'Istradefylline']",0.5
14454,32504.0,Nifurtimox,Chagas disease,disease-phenotype-protein-drug,indication,"['Chagas disease', 'Hepatomegaly', 'ALB', 'Nifurtimox']",0.5
14455,33575.0,Ertugliflozin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Copper', 'lipid metabolic process', 'UGT2B7', 'Ertugliflozin']",0.5
14455,33575.0,Ertugliflozin,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Ertugliflozin']",0.5
14458,37617.0,Revefenacin,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,indication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Revefenacin']",0.5
14461,28520.0,Glasdegib,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Glasdegib']",0.5
14463,28520.0,Gilteritinib,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'FLT3', 'Gilteritinib']",0.5
14463,28520.0,Gilteritinib,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'spermatogenesis', 'AXL', 'Gilteritinib']",0.5
14463,37714.0,Gilteritinib,unclassified acute myeloid leukemia,disease-protein-drug,indication,"['unclassified acute myeloid leukemia', 'FLT3', 'Gilteritinib']",0.5
14463,38274.0,Gilteritinib,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'FLT3', 'Gilteritinib']",0.5
14463,39124.0,Gilteritinib,therapy related acute myeloid leukemia and myelodysplastic syndrome,disease-protein-drug,indication,"['therapy related acute myeloid leukemia and myelodysplastic syndrome', 'FLT3', 'Gilteritinib']",0.5
14463,83852.0,Gilteritinib,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'FLT3', 'Gilteritinib']",0.5
14463,83853.0,Gilteritinib,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'FLT3', 'Gilteritinib']",0.5
14463,83854.0,Gilteritinib,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'FLT3', 'Gilteritinib']",0.5
14463,83855.0,Gilteritinib,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'FLT3', 'Gilteritinib']",0.5
14463,83856.0,Gilteritinib,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'FLT3', 'Gilteritinib']",0.5
14463,83857.0,Gilteritinib,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'FLT3', 'Gilteritinib']",0.5
14463,83858.0,Gilteritinib,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'FLT3', 'Gilteritinib']",0.5
14463,83859.0,Gilteritinib,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'FLT3', 'Gilteritinib']",0.5
14463,83860.0,Gilteritinib,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'FLT3', 'Gilteritinib']",0.5
14463,83861.0,Gilteritinib,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'FLT3', 'Gilteritinib']",0.5
14463,83862.0,Gilteritinib,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'FLT3', 'Gilteritinib']",0.5
14466,37766.0,Favipiravir,influenza,disease-protein-drug,indication,"['influenza', 'SLC22A8', 'Favipiravir']",0.5
14466,84255.0,Favipiravir,"influenza, severe, susceptibility to",disease-protein-drug,indication,"['influenza, severe, susceptibility to', 'SLC22A8', 'Favipiravir']",0.5
14476,28017.0,Testosterone cypionate,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Testosterone cypionate']",0.5
14476,28651.0,Testosterone cypionate,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A3', 'Testosterone cypionate']",0.5
14476,29061.0,Testosterone cypionate,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'SRD5A1', 'Testosterone cypionate']",0.5
14476,29113.0,Testosterone cypionate,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Testosterone cypionate']",0.5
14476,29182.0,Testosterone cypionate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,29182.0,Testosterone cypionate,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Testosterone cypionate']",0.5
14476,29220.0,Testosterone cypionate,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,30073.0,Testosterone cypionate,cryptorchidism (disease),disease-exposure-bioprocess-gene-drug,indication,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'spermatogenesis', 'AR', 'Testosterone cypionate']",0.5
14476,30073.0,Testosterone cypionate,cryptorchidism (disease),disease-exposure-gene-drug,indication,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,30827.0,Testosterone cypionate,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'CYP11A1', 'Testosterone cypionate']",0.5
14476,31395.0,Testosterone cypionate,benign prostatic hyperplasia (disease),disease-protein-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'SRD5A2', 'Testosterone cypionate']",0.5
14476,31395.0,Testosterone cypionate,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Testosterone cypionate']",0.5
14476,31395.0,Testosterone cypionate,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,31477.0,Testosterone cypionate,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Testosterone cypionate']",0.5
14476,31477.0,Testosterone cypionate,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'DNA methylation', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,31477.0,Testosterone cypionate,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Testosterone cypionate']",0.5
14476,31596.0,Testosterone cypionate,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,31618.0,Testosterone cypionate,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CYP11A1', 'Testosterone cypionate']",0.5
14476,31630.0,Testosterone cypionate,androgen insensitivity syndrome,disease-protein-drug,indication,"['androgen insensitivity syndrome', 'AR', 'Testosterone cypionate']",0.5
14476,31630.0,Testosterone cypionate,androgen insensitivity syndrome,disease-phenotype-protein-drug,indication,"['androgen insensitivity syndrome', 'Male infertility', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,32313.0,Testosterone cypionate,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CYP11A1', 'Testosterone cypionate']",0.5
14476,32518.0,Testosterone cypionate,trisomy 13,disease-phenotype-protein-drug,indication,"['trisomy 13', 'Seizure', 'CYP11A1', 'Testosterone cypionate']",0.5
14476,32617.0,Testosterone cypionate,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Testosterone cypionate']",0.5
14476,33534.0,Testosterone cypionate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Testosterone cypionate']",0.5
14476,33575.0,Testosterone cypionate,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Testosterone cypionate']",0.5
14476,33575.0,Testosterone cypionate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone cypionate']",0.5
14476,33575.0,Testosterone cypionate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,33575.0,Testosterone cypionate,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Testosterone cypionate']",0.5
14476,33577.0,Testosterone cypionate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Testosterone cypionate']",0.5
14476,33577.0,Testosterone cypionate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone cypionate']",0.5
14476,33577.0,Testosterone cypionate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,33593.0,Testosterone cypionate,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A3', 'Testosterone cypionate']",0.5
14476,33593.0,Testosterone cypionate,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'DNA methylation', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,33593.0,Testosterone cypionate,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Testosterone cypionate']",0.5
14476,33598.0,Testosterone cypionate,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Testosterone cypionate']",0.5
14476,33598.0,Testosterone cypionate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Testosterone cypionate']",0.5
14476,33598.0,Testosterone cypionate,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,33675.0,Testosterone cypionate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone cypionate']",0.5
14476,33675.0,Testosterone cypionate,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,33695.0,Testosterone cypionate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone cypionate']",0.5
14476,33695.0,Testosterone cypionate,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Testosterone cypionate']",0.5
14476,33699.0,Testosterone cypionate,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone cypionate']",0.5
14476,35565.0,Testosterone cypionate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Testosterone cypionate']",0.5
14476,35565.0,Testosterone cypionate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,35641.0,Testosterone cypionate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Testosterone cypionate']",0.5
14476,35669.0,Testosterone cypionate,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Testosterone cypionate']",0.5
14476,35669.0,Testosterone cypionate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone cypionate']",0.5
14476,35669.0,Testosterone cypionate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Arsenic', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,35738.0,Testosterone cypionate,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'CYP11A1', 'Testosterone cypionate']",0.5
14476,35739.0,Testosterone cypionate,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'SRD5A2', 'Testosterone cypionate']",0.5
14476,35761.0,Testosterone cypionate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone cypionate']",0.5
14476,35761.0,Testosterone cypionate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,35764.0,Testosterone cypionate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Testosterone cypionate']",0.5
14476,35764.0,Testosterone cypionate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone cypionate']",0.5
14476,35764.0,Testosterone cypionate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,35901.0,Testosterone cypionate,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,35901.0,Testosterone cypionate,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'CYP19A1', 'Testosterone cypionate']",0.5
14476,35909.0,Testosterone cypionate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Testosterone cypionate']",0.5
14476,35958.0,Testosterone cypionate,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'NR3C2', 'Testosterone cypionate']",0.5
14476,35963.0,Testosterone cypionate,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP2C19', 'Testosterone cypionate']",0.5
14476,35966.0,Testosterone cypionate,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP2C19', 'Testosterone cypionate']",0.5
14476,35966.0,Testosterone cypionate,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Testosterone cypionate']",0.5
14476,35966.0,Testosterone cypionate,prostate cancer,disease-exposure-gene-drug,contraindication,"['prostate cancer', 'Agent Orange', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,36035.0,Testosterone cypionate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Testosterone cypionate']",0.5
14476,36187.0,Testosterone cypionate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Testosterone cypionate']",0.5
14476,36187.0,Testosterone cypionate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone cypionate']",0.5
14476,36187.0,Testosterone cypionate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,36432.0,Testosterone cypionate,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'NR3C2', 'Testosterone cypionate']",0.5
14476,36469.0,Testosterone cypionate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,36527.0,Testosterone cypionate,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Testosterone cypionate']",0.5
14476,36688.0,Testosterone cypionate,prostate neoplasm,disease-protein-drug,contraindication,"['prostate neoplasm', 'SRD5A2', 'Testosterone cypionate']",0.5
14476,36792.0,Testosterone cypionate,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,36794.0,Testosterone cypionate,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,37038.0,Testosterone cypionate,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'CYP11A1', 'Testosterone cypionate']",0.5
14476,37047.0,Testosterone cypionate,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,37082.0,Testosterone cypionate,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Testosterone cypionate']",0.5
14476,37150.0,Testosterone cypionate,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Testosterone cypionate']",0.5
14476,37152.0,Testosterone cypionate,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Testosterone cypionate']",0.5
14476,37180.0,Testosterone cypionate,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'NR3C2', 'Testosterone cypionate']",0.5
14476,37180.0,Testosterone cypionate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone cypionate']",0.5
14476,37180.0,Testosterone cypionate,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,37423.0,Testosterone cypionate,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,37466.0,Testosterone cypionate,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,37573.0,Testosterone cypionate,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone cypionate']",0.5
14476,37573.0,Testosterone cypionate,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Tobacco Smoke Pollution', 'CYP1A1', 'Testosterone cypionate']",0.5
14476,37768.0,Testosterone cypionate,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Testosterone cypionate']",0.5
14476,37967.0,Testosterone cypionate,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,39603.0,Testosterone cypionate,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Testosterone cypionate']",0.5
14476,39615.0,Testosterone cypionate,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Testosterone cypionate']",0.5
14476,83816.0,Testosterone cypionate,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Testosterone cypionate']",0.5
14476,83817.0,Testosterone cypionate,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Testosterone cypionate']",0.5
14476,83818.0,Testosterone cypionate,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Testosterone cypionate']",0.5
14476,83819.0,Testosterone cypionate,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Testosterone cypionate']",0.5
14476,83820.0,Testosterone cypionate,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Testosterone cypionate']",0.5
14476,83821.0,Testosterone cypionate,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Testosterone cypionate']",0.5
14476,83822.0,Testosterone cypionate,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Testosterone cypionate']",0.5
14476,83823.0,Testosterone cypionate,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'NR3C2', 'Testosterone cypionate']",0.5
14476,83824.0,Testosterone cypionate,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'NR3C2', 'Testosterone cypionate']",0.5
14476,84094.0,Testosterone cypionate,premature menopause,disease-protein-drug,indication,"['premature menopause', 'CYP2C19', 'Testosterone cypionate']",0.5
14477,28017.0,Testosterone enanthate,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Testosterone enanthate']",0.5
14477,28651.0,Testosterone enanthate,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A3', 'Testosterone enanthate']",0.5
14477,29061.0,Testosterone enanthate,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'SRD5A1', 'Testosterone enanthate']",0.5
14477,29182.0,Testosterone enanthate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,29182.0,Testosterone enanthate,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Testosterone enanthate']",0.5
14477,29220.0,Testosterone enanthate,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,30073.0,Testosterone enanthate,cryptorchidism (disease),disease-exposure-bioprocess-gene-drug,indication,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'spermatogenesis', 'AR', 'Testosterone enanthate']",0.5
14477,30073.0,Testosterone enanthate,cryptorchidism (disease),disease-exposure-gene-drug,indication,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,30827.0,Testosterone enanthate,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'CYP11A1', 'Testosterone enanthate']",0.5
14477,31395.0,Testosterone enanthate,benign prostatic hyperplasia (disease),disease-protein-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'SRD5A2', 'Testosterone enanthate']",0.5
14477,31395.0,Testosterone enanthate,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Testosterone enanthate']",0.5
14477,31395.0,Testosterone enanthate,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,31477.0,Testosterone enanthate,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Testosterone enanthate']",0.5
14477,31477.0,Testosterone enanthate,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'DNA methylation', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,31477.0,Testosterone enanthate,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Testosterone enanthate']",0.5
14477,31596.0,Testosterone enanthate,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,31618.0,Testosterone enanthate,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CYP11A1', 'Testosterone enanthate']",0.5
14477,31630.0,Testosterone enanthate,androgen insensitivity syndrome,disease-protein-drug,indication,"['androgen insensitivity syndrome', 'AR', 'Testosterone enanthate']",0.5
14477,31630.0,Testosterone enanthate,androgen insensitivity syndrome,disease-phenotype-protein-drug,indication,"['androgen insensitivity syndrome', 'Male infertility', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,32313.0,Testosterone enanthate,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CYP11A1', 'Testosterone enanthate']",0.5
14477,32518.0,Testosterone enanthate,trisomy 13,disease-phenotype-protein-drug,indication,"['trisomy 13', 'Seizure', 'CYP11A1', 'Testosterone enanthate']",0.5
14477,32617.0,Testosterone enanthate,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Testosterone enanthate']",0.5
14477,33534.0,Testosterone enanthate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Testosterone enanthate']",0.5
14477,33575.0,Testosterone enanthate,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Testosterone enanthate']",0.5
14477,33575.0,Testosterone enanthate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone enanthate']",0.5
14477,33575.0,Testosterone enanthate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,33575.0,Testosterone enanthate,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Testosterone enanthate']",0.5
14477,33577.0,Testosterone enanthate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Testosterone enanthate']",0.5
14477,33577.0,Testosterone enanthate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone enanthate']",0.5
14477,33577.0,Testosterone enanthate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,33593.0,Testosterone enanthate,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A3', 'Testosterone enanthate']",0.5
14477,33593.0,Testosterone enanthate,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'DNA methylation', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,33593.0,Testosterone enanthate,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Testosterone enanthate']",0.5
14477,33598.0,Testosterone enanthate,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Testosterone enanthate']",0.5
14477,33598.0,Testosterone enanthate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Testosterone enanthate']",0.5
14477,33598.0,Testosterone enanthate,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,33675.0,Testosterone enanthate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone enanthate']",0.5
14477,33675.0,Testosterone enanthate,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,33680.0,Testosterone enanthate,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'SRD5A1', 'Testosterone enanthate']",0.5
14477,33680.0,Testosterone enanthate,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'testosterone biosynthetic process', 'SRD5A2', 'Testosterone enanthate']",0.5
14477,33680.0,Testosterone enanthate,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Testosterone enanthate']",0.5
14477,33695.0,Testosterone enanthate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone enanthate']",0.5
14477,33695.0,Testosterone enanthate,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Testosterone enanthate']",0.5
14477,33699.0,Testosterone enanthate,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone enanthate']",0.5
14477,35565.0,Testosterone enanthate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Testosterone enanthate']",0.5
14477,35565.0,Testosterone enanthate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,35641.0,Testosterone enanthate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Testosterone enanthate']",0.5
14477,35669.0,Testosterone enanthate,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Testosterone enanthate']",0.5
14477,35669.0,Testosterone enanthate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone enanthate']",0.5
14477,35669.0,Testosterone enanthate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Arsenic', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,35738.0,Testosterone enanthate,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'CYP11A1', 'Testosterone enanthate']",0.5
14477,35739.0,Testosterone enanthate,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'SRD5A2', 'Testosterone enanthate']",0.5
14477,35761.0,Testosterone enanthate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone enanthate']",0.5
14477,35761.0,Testosterone enanthate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,35764.0,Testosterone enanthate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Testosterone enanthate']",0.5
14477,35764.0,Testosterone enanthate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Testosterone enanthate']",0.5
14477,35764.0,Testosterone enanthate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,35901.0,Testosterone enanthate,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,35901.0,Testosterone enanthate,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'CYP19A1', 'Testosterone enanthate']",0.5
14477,35909.0,Testosterone enanthate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Testosterone enanthate']",0.5
14477,35958.0,Testosterone enanthate,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'NR3C2', 'Testosterone enanthate']",0.5
14477,35963.0,Testosterone enanthate,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP2C19', 'Testosterone enanthate']",0.5
14477,35966.0,Testosterone enanthate,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP2C19', 'Testosterone enanthate']",0.5
14477,35966.0,Testosterone enanthate,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Testosterone enanthate']",0.5
14477,35966.0,Testosterone enanthate,prostate cancer,disease-exposure-gene-drug,contraindication,"['prostate cancer', 'Agent Orange', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,36035.0,Testosterone enanthate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Testosterone enanthate']",0.5
14477,36187.0,Testosterone enanthate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Testosterone enanthate']",0.5
14477,36187.0,Testosterone enanthate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone enanthate']",0.5
14477,36187.0,Testosterone enanthate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,36432.0,Testosterone enanthate,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'NR3C2', 'Testosterone enanthate']",0.5
14477,36469.0,Testosterone enanthate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,36527.0,Testosterone enanthate,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Testosterone enanthate']",0.5
14477,36688.0,Testosterone enanthate,prostate neoplasm,disease-protein-drug,contraindication,"['prostate neoplasm', 'SRD5A2', 'Testosterone enanthate']",0.5
14477,36792.0,Testosterone enanthate,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,36794.0,Testosterone enanthate,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,37038.0,Testosterone enanthate,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'CYP11A1', 'Testosterone enanthate']",0.5
14477,37047.0,Testosterone enanthate,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,37082.0,Testosterone enanthate,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Testosterone enanthate']",0.5
14477,37150.0,Testosterone enanthate,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Testosterone enanthate']",0.5
14477,37152.0,Testosterone enanthate,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Testosterone enanthate']",0.5
14477,37180.0,Testosterone enanthate,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'NR3C2', 'Testosterone enanthate']",0.5
14477,37180.0,Testosterone enanthate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone enanthate']",0.5
14477,37180.0,Testosterone enanthate,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,37423.0,Testosterone enanthate,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,37466.0,Testosterone enanthate,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,37573.0,Testosterone enanthate,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Testosterone enanthate']",0.5
14477,37573.0,Testosterone enanthate,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Tobacco Smoke Pollution', 'CYP1A1', 'Testosterone enanthate']",0.5
14477,37768.0,Testosterone enanthate,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Testosterone enanthate']",0.5
14477,37967.0,Testosterone enanthate,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,39603.0,Testosterone enanthate,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Testosterone enanthate']",0.5
14477,39615.0,Testosterone enanthate,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Testosterone enanthate']",0.5
14477,83816.0,Testosterone enanthate,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Testosterone enanthate']",0.5
14477,83817.0,Testosterone enanthate,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Testosterone enanthate']",0.5
14477,83818.0,Testosterone enanthate,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Testosterone enanthate']",0.5
14477,83819.0,Testosterone enanthate,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Testosterone enanthate']",0.5
14477,83820.0,Testosterone enanthate,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Testosterone enanthate']",0.5
14477,83821.0,Testosterone enanthate,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Testosterone enanthate']",0.5
14477,83822.0,Testosterone enanthate,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Testosterone enanthate']",0.5
14477,83823.0,Testosterone enanthate,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'NR3C2', 'Testosterone enanthate']",0.5
14477,83824.0,Testosterone enanthate,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'NR3C2', 'Testosterone enanthate']",0.5
14477,84094.0,Testosterone enanthate,premature menopause,disease-protein-drug,indication,"['premature menopause', 'CYP2C19', 'Testosterone enanthate']",0.5
14478,27219.0,Testosterone undecanoate,hypogonadotropic hypogonadism with or without anosmia,disease-protein-drug,indication,"['hypogonadotropic hypogonadism with or without anosmia', 'CYP19A1', 'Testosterone undecanoate']",0.5
14478,27219.0,Testosterone undecanoate,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,indication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'CYP11A1', 'Testosterone undecanoate']",0.5
14478,28407.0,Testosterone undecanoate,hypogonadotropic hypogonadism,disease-protein-drug,indication,"['hypogonadotropic hypogonadism', 'CYP19A1', 'Testosterone undecanoate']",0.5
14478,36043.0,Testosterone undecanoate,primary ovarian failure,disease-protein-drug,indication,"['primary ovarian failure', 'CYP2C19', 'Testosterone undecanoate']",0.5
14478,36453.0,Testosterone undecanoate,hypogonadism,disease-protein-drug,indication,"['hypogonadism', 'CYP19A1', 'Testosterone undecanoate']",0.5
14481,27933.0,Estradiol cypionate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Estradiol cypionate']",0.5
14481,27933.0,Estradiol cypionate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Estradiol cypionate']",0.5
14481,27933.0,Estradiol cypionate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,28017.0,Estradiol cypionate,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Estradiol cypionate']",0.5
14481,28651.0,Estradiol cypionate,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A3', 'Estradiol cypionate']",0.5
14481,29061.0,Estradiol cypionate,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'HSD17B2', 'Estradiol cypionate']",0.5
14481,29182.0,Estradiol cypionate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,29182.0,Estradiol cypionate,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,29182.0,Estradiol cypionate,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Estradiol cypionate']",0.5
14481,29614.0,Estradiol cypionate,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cognition', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,29614.0,Estradiol cypionate,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SHBG', 'Estradiol cypionate']",0.5
14481,30035.0,Estradiol cypionate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Estradiol cypionate']",0.5
14481,31395.0,Estradiol cypionate,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,31477.0,Estradiol cypionate,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Estradiol cypionate']",0.5
14481,31477.0,Estradiol cypionate,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'cognition', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,31477.0,Estradiol cypionate,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Estradiol cypionate']",0.5
14481,31596.0,Estradiol cypionate,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,31618.0,Estradiol cypionate,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,32313.0,Estradiol cypionate,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,32719.0,Estradiol cypionate,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'ESR2', 'Estradiol cypionate']",0.5
14481,33534.0,Estradiol cypionate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Estradiol cypionate']",0.5
14481,33575.0,Estradiol cypionate,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Estradiol cypionate']",0.5
14481,33575.0,Estradiol cypionate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,33575.0,Estradiol cypionate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,33577.0,Estradiol cypionate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Estradiol cypionate']",0.5
14481,33577.0,Estradiol cypionate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol cypionate']",0.5
14481,33577.0,Estradiol cypionate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,33593.0,Estradiol cypionate,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A3', 'Estradiol cypionate']",0.5
14481,33593.0,Estradiol cypionate,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'DNA methylation', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,33593.0,Estradiol cypionate,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Estradiol cypionate']",0.5
14481,33598.0,Estradiol cypionate,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Estradiol cypionate']",0.5
14481,33598.0,Estradiol cypionate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,33598.0,Estradiol cypionate,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,33675.0,Estradiol cypionate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol cypionate']",0.5
14481,33675.0,Estradiol cypionate,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,33680.0,Estradiol cypionate,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'HSD17B2', 'Estradiol cypionate']",0.5
14481,33680.0,Estradiol cypionate,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR2', 'Estradiol cypionate']",0.5
14481,33680.0,Estradiol cypionate,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Estradiol cypionate']",0.5
14481,33695.0,Estradiol cypionate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol cypionate']",0.5
14481,33695.0,Estradiol cypionate,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Estradiol cypionate']",0.5
14481,33699.0,Estradiol cypionate,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol cypionate']",0.5
14481,33699.0,Estradiol cypionate,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,35565.0,Estradiol cypionate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,35565.0,Estradiol cypionate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,35641.0,Estradiol cypionate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Estradiol cypionate']",0.5
14481,35669.0,Estradiol cypionate,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Estradiol cypionate']",0.5
14481,35669.0,Estradiol cypionate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol cypionate']",0.5
14481,35669.0,Estradiol cypionate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,35739.0,Estradiol cypionate,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'HSD17B2', 'Estradiol cypionate']",0.5
14481,35761.0,Estradiol cypionate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,35761.0,Estradiol cypionate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,35764.0,Estradiol cypionate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Estradiol cypionate']",0.5
14481,35764.0,Estradiol cypionate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol cypionate']",0.5
14481,35764.0,Estradiol cypionate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,35901.0,Estradiol cypionate,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,35901.0,Estradiol cypionate,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Estradiol cypionate']",0.5
14481,35909.0,Estradiol cypionate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,35909.0,Estradiol cypionate,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,35958.0,Estradiol cypionate,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Estradiol cypionate']",0.5
14481,35963.0,Estradiol cypionate,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP2C19', 'Estradiol cypionate']",0.5
14481,35966.0,Estradiol cypionate,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP2C19', 'Estradiol cypionate']",0.5
14481,35966.0,Estradiol cypionate,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol cypionate']",0.5
14481,35966.0,Estradiol cypionate,prostate cancer,disease-exposure-gene-drug,contraindication,"['prostate cancer', 'Agent Orange', 'CYP1A1', 'Estradiol cypionate']",0.5
14481,36035.0,Estradiol cypionate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Estradiol cypionate']",0.5
14481,36043.0,Estradiol cypionate,primary ovarian failure,disease-protein-drug,indication,"['primary ovarian failure', 'CYP2C19', 'Estradiol cypionate']",0.5
14481,36187.0,Estradiol cypionate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR2', 'Estradiol cypionate']",0.5
14481,36187.0,Estradiol cypionate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol cypionate']",0.5
14481,36187.0,Estradiol cypionate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,36432.0,Estradiol cypionate,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Estradiol cypionate']",0.5
14481,36469.0,Estradiol cypionate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Estradiol cypionate']",0.5
14481,36527.0,Estradiol cypionate,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Estradiol cypionate']",0.5
14481,36792.0,Estradiol cypionate,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,36794.0,Estradiol cypionate,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,37038.0,Estradiol cypionate,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'HSD17B2', 'Estradiol cypionate']",0.5
14481,37047.0,Estradiol cypionate,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,37082.0,Estradiol cypionate,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Estradiol cypionate']",0.5
14481,37150.0,Estradiol cypionate,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Estradiol cypionate']",0.5
14481,37152.0,Estradiol cypionate,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Estradiol cypionate']",0.5
14481,37180.0,Estradiol cypionate,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Estradiol cypionate']",0.5
14481,37180.0,Estradiol cypionate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol cypionate']",0.5
14481,37180.0,Estradiol cypionate,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,37423.0,Estradiol cypionate,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,37466.0,Estradiol cypionate,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,37573.0,Estradiol cypionate,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol cypionate']",0.5
14481,37573.0,Estradiol cypionate,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol cypionate']",0.5
14481,37703.0,Estradiol cypionate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Estradiol cypionate']",0.5
14481,37768.0,Estradiol cypionate,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Estradiol cypionate']",0.5
14481,37967.0,Estradiol cypionate,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,39603.0,Estradiol cypionate,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Estradiol cypionate']",0.5
14481,39615.0,Estradiol cypionate,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Estradiol cypionate']",0.5
14481,83760.0,Estradiol cypionate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Estradiol cypionate']",0.5
14481,83816.0,Estradiol cypionate,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Estradiol cypionate']",0.5
14481,83817.0,Estradiol cypionate,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Estradiol cypionate']",0.5
14481,83818.0,Estradiol cypionate,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Estradiol cypionate']",0.5
14481,83819.0,Estradiol cypionate,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Estradiol cypionate']",0.5
14481,83820.0,Estradiol cypionate,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Estradiol cypionate']",0.5
14481,83821.0,Estradiol cypionate,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Estradiol cypionate']",0.5
14481,83822.0,Estradiol cypionate,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Estradiol cypionate']",0.5
14481,83823.0,Estradiol cypionate,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Estradiol cypionate']",0.5
14481,83824.0,Estradiol cypionate,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Estradiol cypionate']",0.5
14483,27933.0,Estradiol valerate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Estradiol valerate']",0.5
14483,27933.0,Estradiol valerate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Estradiol valerate']",0.5
14483,27933.0,Estradiol valerate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Estradiol valerate']",0.5
14483,28017.0,Estradiol valerate,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Estradiol valerate']",0.5
14483,28651.0,Estradiol valerate,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A3', 'Estradiol valerate']",0.5
14483,29061.0,Estradiol valerate,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'HSD17B2', 'Estradiol valerate']",0.5
14483,29182.0,Estradiol valerate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Estradiol valerate']",0.5
14483,29182.0,Estradiol valerate,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Estradiol valerate']",0.5
14483,29182.0,Estradiol valerate,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Estradiol valerate']",0.5
14483,29220.0,Estradiol valerate,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'NR1I2', 'Estradiol valerate']",0.5
14483,30827.0,Estradiol valerate,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'HSD17B2', 'Estradiol valerate']",0.5
14483,31395.0,Estradiol valerate,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Estradiol valerate']",0.5
14483,31477.0,Estradiol valerate,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Estradiol valerate']",0.5
14483,31477.0,Estradiol valerate,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'cognition', 'CHRNA4', 'Estradiol valerate']",0.5
14483,31477.0,Estradiol valerate,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Estradiol valerate']",0.5
14483,31596.0,Estradiol valerate,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Estradiol valerate']",0.5
14483,31618.0,Estradiol valerate,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CHRNA4', 'Estradiol valerate']",0.5
14483,32313.0,Estradiol valerate,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRNA4', 'Estradiol valerate']",0.5
14483,32617.0,Estradiol valerate,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Estradiol valerate']",0.5
14483,32719.0,Estradiol valerate,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'ESR2', 'Estradiol valerate']",0.5
14483,33534.0,Estradiol valerate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Estradiol valerate']",0.5
14483,33575.0,Estradiol valerate,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Estradiol valerate']",0.5
14483,33575.0,Estradiol valerate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol valerate']",0.5
14483,33575.0,Estradiol valerate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Estradiol valerate']",0.5
14483,33577.0,Estradiol valerate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Estradiol valerate']",0.5
14483,33577.0,Estradiol valerate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol valerate']",0.5
14483,33577.0,Estradiol valerate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Estradiol valerate']",0.5
14483,33593.0,Estradiol valerate,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A3', 'Estradiol valerate']",0.5
14483,33593.0,Estradiol valerate,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'DNA methylation', 'CYP1A1', 'Estradiol valerate']",0.5
14483,33593.0,Estradiol valerate,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Estradiol valerate']",0.5
14483,33598.0,Estradiol valerate,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Estradiol valerate']",0.5
14483,33598.0,Estradiol valerate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'CHRNA4', 'Estradiol valerate']",0.5
14483,33598.0,Estradiol valerate,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Estradiol valerate']",0.5
14483,33675.0,Estradiol valerate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol valerate']",0.5
14483,33675.0,Estradiol valerate,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Estradiol valerate']",0.5
14483,33680.0,Estradiol valerate,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'HSD17B2', 'Estradiol valerate']",0.5
14483,33680.0,Estradiol valerate,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR2', 'Estradiol valerate']",0.5
14483,33680.0,Estradiol valerate,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Estradiol valerate']",0.5
14483,33695.0,Estradiol valerate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol valerate']",0.5
14483,33695.0,Estradiol valerate,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Estradiol valerate']",0.5
14483,33699.0,Estradiol valerate,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol valerate']",0.5
14483,33699.0,Estradiol valerate,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol valerate']",0.5
14483,35565.0,Estradiol valerate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Estradiol valerate']",0.5
14483,35565.0,Estradiol valerate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Estradiol valerate']",0.5
14483,35641.0,Estradiol valerate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Estradiol valerate']",0.5
14483,35669.0,Estradiol valerate,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Estradiol valerate']",0.5
14483,35669.0,Estradiol valerate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol valerate']",0.5
14483,35669.0,Estradiol valerate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'CYP1B1', 'Estradiol valerate']",0.5
14483,35738.0,Estradiol valerate,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'HSD17B2', 'Estradiol valerate']",0.5
14483,35739.0,Estradiol valerate,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'HSD17B2', 'Estradiol valerate']",0.5
14483,35761.0,Estradiol valerate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol valerate']",0.5
14483,35761.0,Estradiol valerate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'CYP1B1', 'Estradiol valerate']",0.5
14483,35764.0,Estradiol valerate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Estradiol valerate']",0.5
14483,35764.0,Estradiol valerate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Estradiol valerate']",0.5
14483,35764.0,Estradiol valerate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Estradiol valerate']",0.5
14483,35901.0,Estradiol valerate,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Estradiol valerate']",0.5
14483,35901.0,Estradiol valerate,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Estradiol valerate']",0.5
14483,35909.0,Estradiol valerate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRNA4', 'Estradiol valerate']",0.5
14483,35909.0,Estradiol valerate,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Estradiol valerate']",0.5
14483,35958.0,Estradiol valerate,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Estradiol valerate']",0.5
14483,35963.0,Estradiol valerate,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP2C19', 'Estradiol valerate']",0.5
14483,35966.0,Estradiol valerate,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP2C19', 'Estradiol valerate']",0.5
14483,35966.0,Estradiol valerate,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Estradiol valerate']",0.5
14483,35966.0,Estradiol valerate,prostate cancer,disease-exposure-gene-drug,contraindication,"['prostate cancer', 'Agent Orange', 'CYP1A1', 'Estradiol valerate']",0.5
14483,36035.0,Estradiol valerate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Estradiol valerate']",0.5
14483,36043.0,Estradiol valerate,primary ovarian failure,disease-protein-drug,indication,"['primary ovarian failure', 'CYP2C19', 'Estradiol valerate']",0.5
14483,36187.0,Estradiol valerate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR2', 'Estradiol valerate']",0.5
14483,36187.0,Estradiol valerate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol valerate']",0.5
14483,36187.0,Estradiol valerate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CYP1B1', 'Estradiol valerate']",0.5
14483,36432.0,Estradiol valerate,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ALB', 'Estradiol valerate']",0.5
14483,36469.0,Estradiol valerate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Atrazine', 'positive regulation of thyroid hormone generation', 'SLCO1C1', 'Estradiol valerate']",0.5
14483,36527.0,Estradiol valerate,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Estradiol valerate']",0.5
14483,36792.0,Estradiol valerate,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Estradiol valerate']",0.5
14483,36794.0,Estradiol valerate,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Estradiol valerate']",0.5
14483,37038.0,Estradiol valerate,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'HSD17B2', 'Estradiol valerate']",0.5
14483,37047.0,Estradiol valerate,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Estradiol valerate']",0.5
14483,37082.0,Estradiol valerate,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Estradiol valerate']",0.5
14483,37150.0,Estradiol valerate,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Estradiol valerate']",0.5
14483,37152.0,Estradiol valerate,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Estradiol valerate']",0.5
14483,37180.0,Estradiol valerate,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Estradiol valerate']",0.5
14483,37180.0,Estradiol valerate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol valerate']",0.5
14483,37180.0,Estradiol valerate,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol valerate']",0.5
14483,37423.0,Estradiol valerate,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Estradiol valerate']",0.5
14483,37466.0,Estradiol valerate,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Estradiol valerate']",0.5
14483,37573.0,Estradiol valerate,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Estradiol valerate']",0.5
14483,37573.0,Estradiol valerate,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'CYP1B1', 'Estradiol valerate']",0.5
14483,37703.0,Estradiol valerate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Estradiol valerate']",0.5
14483,37768.0,Estradiol valerate,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Estradiol valerate']",0.5
14483,37967.0,Estradiol valerate,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Estradiol valerate']",0.5
14483,39603.0,Estradiol valerate,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Estradiol valerate']",0.5
14483,39615.0,Estradiol valerate,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Estradiol valerate']",0.5
14483,83760.0,Estradiol valerate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Estradiol valerate']",0.5
14483,83816.0,Estradiol valerate,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Estradiol valerate']",0.5
14483,83817.0,Estradiol valerate,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Estradiol valerate']",0.5
14483,83818.0,Estradiol valerate,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Estradiol valerate']",0.5
14483,83819.0,Estradiol valerate,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Estradiol valerate']",0.5
14483,83820.0,Estradiol valerate,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Estradiol valerate']",0.5
14483,83821.0,Estradiol valerate,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Estradiol valerate']",0.5
14483,83822.0,Estradiol valerate,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Estradiol valerate']",0.5
14483,83823.0,Estradiol valerate,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Estradiol valerate']",0.5
14483,83824.0,Estradiol valerate,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Estradiol valerate']",0.5
14484,27326.0,Tenofovir,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cellular response to oxidative stress', 'NME2', 'Tenofovir']",0.5
14484,27577.0,Tenofovir,Fanconi renotubular syndrome,disease-phenotype-protein-drug,contraindication,"['Fanconi renotubular syndrome', 'Proteinuria', 'ALB', 'Tenofovir']",0.5
14484,27933.0,Tenofovir,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Tenofovir']",0.5
14484,27933.0,Tenofovir,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cellular response to oxidative stress', 'NME2', 'Tenofovir']",0.5
14484,27933.0,Tenofovir,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Cadmium', 'ALB', 'Tenofovir']",0.5
14484,33593.0,Tenofovir,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'cellular response to oxidative stress', 'NME2', 'Tenofovir']",0.5
14484,33593.0,Tenofovir,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Tenofovir']",0.5
14484,33695.0,Tenofovir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Tenofovir']",0.5
14484,33695.0,Tenofovir,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Tenofovir']",0.5
14484,35565.0,Tenofovir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Tenofovir']",0.5
14484,35565.0,Tenofovir,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Tenofovir']",0.5
14484,35641.0,Tenofovir,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Tenofovir']",0.5
14484,35764.0,Tenofovir,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Tenofovir']",0.5
14484,35764.0,Tenofovir,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Tenofovir']",0.5
14484,35764.0,Tenofovir,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Tenofovir']",0.5
14484,36242.0,Tenofovir,fatty liver disease,disease-protein-drug,contraindication,"['fatty liver disease', 'SLC22A8', 'Tenofovir']",0.5
14484,36242.0,Tenofovir,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Tenofovir']",0.5
14484,36242.0,Tenofovir,fatty liver disease,disease-exposure-gene-drug,contraindication,"['fatty liver disease', 'Cadmium', 'ALB', 'Tenofovir']",0.5
14484,37703.0,Tenofovir,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Tenofovir']",0.5
14484,37743.0,Tenofovir,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Tenofovir']",0.5
14484,37805.0,Tenofovir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'ALB', 'Tenofovir']",0.5
14484,83751.0,Tenofovir,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Tenofovir']",0.5
14484,83760.0,Tenofovir,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Tenofovir']",0.5
14484,84131.0,Tenofovir,non-alcoholic steatohepatitis,disease-protein-drug,contraindication,"['non-alcoholic steatohepatitis', 'SLC22A8', 'Tenofovir']",0.5
14485,28313.0,Aripiprazole lauroxil,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD5', 'Aripiprazole lauroxil']",0.5
14485,28313.0,Aripiprazole lauroxil,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Aripiprazole lauroxil']",0.5
14488,35764.0,Aluminium phosphate,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Aluminium phosphate']",0.5
14488,35764.0,Aluminium phosphate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ATP1A1', 'Aluminium phosphate']",0.5
14488,35764.0,Aluminium phosphate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Aluminium phosphate']",0.5
14490,27286.0,Zinc chloride,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'ALB', 'Zinc chloride']",0.5
14490,27292.0,Zinc chloride,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Delayed puberty', 'IGFALS', 'Zinc chloride']",0.5
14490,29305.0,Zinc chloride,methemoglobinemia due to deficiency of methemoglobin reductase,disease-phenotype-protein-drug,contraindication,"['methemoglobinemia due to deficiency of methemoglobin reductase', 'Cyanosis', 'HBB', 'Zinc chloride']",0.5
14490,31168.0,Zinc chloride,pyruvate dehydrogenase E3 deficiency,disease-phenotype-protein-drug,contraindication,"['pyruvate dehydrogenase E3 deficiency', 'Hepatomegaly', 'ALB', 'Zinc chloride']",0.5
14490,31502.0,Zinc chloride,Wilson disease,disease-protein-drug,contraindication,"['Wilson disease', 'A2M', 'Zinc chloride']",0.5
14490,31502.0,Zinc chloride,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Increased body weight', 'APP', 'Zinc chloride']",0.5
14490,31937.0,Zinc chloride,acrodermatitis enteropathica,disease-protein-drug,off-label use,"['acrodermatitis enteropathica', 'SLC39A4', 'Zinc chloride']",0.5
14490,31937.0,Zinc chloride,acrodermatitis enteropathica,disease-phenotype-protein-drug,off-label use,"['acrodermatitis enteropathica', 'Hepatomegaly', 'ALB', 'Zinc chloride']",0.5
14490,36214.0,Zinc chloride,iron metabolism disease,disease-protein-drug,contraindication,"['iron metabolism disease', 'A2M', 'Zinc chloride']",0.5
14490,38462.0,Zinc chloride,sulfhemoglobinemia,disease-protein-drug,contraindication,"['sulfhemoglobinemia', 'HBB', 'Zinc chloride']",0.5
14490,38641.0,Zinc chloride,hereditary hemochromatosis,disease-protein-drug,contraindication,"['hereditary hemochromatosis', 'A2M', 'Zinc chloride']",0.5
14490,39480.0,Zinc chloride,methemoglobinemia,disease-protein-drug,contraindication,"['methemoglobinemia', 'HBB', 'Zinc chloride']",0.5
14493,30494.0,Dexamethasone acetate,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'NR0B1', 'Dexamethasone acetate']",0.5
14493,30494.0,Dexamethasone acetate,plasma cell myeloma,disease-exposure-gene-drug,indication,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Dexamethasone acetate']",0.5
14499,28714.0,Elexacaftor,cystic fibrosis,disease-protein-drug,indication,"['cystic fibrosis', 'CFTR', 'Elexacaftor']",0.5
14499,28714.0,Elexacaftor,cystic fibrosis,disease-phenotype-protein-drug,indication,"['cystic fibrosis', 'Male infertility', 'CFTR', 'Elexacaftor']",0.5
14503,33621.0,Pegaspargase,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Halogenated Diphenyl Ethers', 'SERPINA7', 'Pegaspargase']",0.5
14504,27476.0,Floxuridine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'developmental growth', 'TYMS', 'Floxuridine']",0.5
14504,27476.0,Floxuridine,Gilbert syndrome,disease-exposure-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Floxuridine']",0.5
14504,33623.0,Floxuridine,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'TYMS', 'Floxuridine']",0.5
14504,33632.0,Floxuridine,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'TYMS', 'Floxuridine']",0.5
14504,33632.0,Floxuridine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'urea metabolic process', 'CYP2C9', 'Floxuridine']",0.5
14504,35565.0,Floxuridine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Floxuridine']",0.5
14504,35565.0,Floxuridine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Floxuridine']",0.5
14504,35764.0,Floxuridine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Floxuridine']",0.5
14504,36187.0,Floxuridine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'response to folic acid', 'TYMS', 'Floxuridine']",0.5
14504,36634.0,Floxuridine,liver cancer,disease-protein-drug,indication,"['liver cancer', 'TYMS', 'Floxuridine']",0.5
14504,36634.0,Floxuridine,liver cancer,disease-exposure-bioprocess-gene-drug,indication,"['liver cancer', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Floxuridine']",0.5
14504,37786.0,Floxuridine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'response to folic acid', 'TYMS', 'Floxuridine']",0.5
14506,33695.0,Niacin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'glucose homeostasis', 'SLC16A1', 'Niacin']",0.5
14507,33658.0,Clofibrate,hyperlipidemia,disease-protein-drug,indication,"['hyperlipidemia', 'PPARA', 'Clofibrate']",0.5
14507,37764.0,Clofibrate,familial hyperlipidemia,disease-protein-drug,indication,"['familial hyperlipidemia', 'PPARA', 'Clofibrate']",0.5
14508,27933.0,Ethotoin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'SCN5A', 'Ethotoin']",0.5
14508,27933.0,Ethotoin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Polychlorinated Biphenyls', 'SERPINA7', 'Ethotoin']",0.5
14508,29182.0,Ethotoin,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of heart rate', 'SCN5A', 'Ethotoin']",0.5
14508,35565.0,Ethotoin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Ethotoin']",0.5
14509,27366.0,Meclofenamic acid,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Meclofenamic acid']",0.5
14509,29078.0,Meclofenamic acid,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ALOX5', 'Meclofenamic acid']",0.5
14509,29078.0,Meclofenamic acid,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'lipid oxidation', 'ALOX5', 'Meclofenamic acid']",0.5
14509,29078.0,Meclofenamic acid,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Meclofenamic acid']",0.5
14509,29078.0,Meclofenamic acid,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Meclofenamic acid']",0.5
14509,30035.0,Meclofenamic acid,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PTGS2', 'Meclofenamic acid']",0.5
14509,33577.0,Meclofenamic acid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ALOX5', 'Meclofenamic acid']",0.5
14509,33577.0,Meclofenamic acid,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Meclofenamic acid']",0.5
14509,33632.0,Meclofenamic acid,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'PTGS1', 'Meclofenamic acid']",0.5
14509,33632.0,Meclofenamic acid,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Meclofenamic acid']",0.5
14509,35565.0,Meclofenamic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Meclofenamic acid']",0.5
14509,35565.0,Meclofenamic acid,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Meclofenamic acid']",0.5
14509,35669.0,Meclofenamic acid,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Meclofenamic acid']",0.5
14509,35669.0,Meclofenamic acid,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Meclofenamic acid']",0.5
14509,35761.0,Meclofenamic acid,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Meclofenamic acid']",0.5
14509,35761.0,Meclofenamic acid,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Meclofenamic acid']",0.5
14509,35764.0,Meclofenamic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ALOX5', 'Meclofenamic acid']",0.5
14509,35764.0,Meclofenamic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Meclofenamic acid']",0.5
14509,37180.0,Meclofenamic acid,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Meclofenamic acid']",0.5
14509,37180.0,Meclofenamic acid,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Meclofenamic acid']",0.5
14510,27361.0,Heparin,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'FGF2', 'Heparin']",0.5
14510,27626.0,Heparin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'PF4', 'Heparin']",0.5
14510,28158.0,Heparin,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'SELP', 'Heparin']",0.5
14510,29614.0,Heparin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'bone mineralization', 'FGFR2', 'Heparin']",0.5
14510,29614.0,Heparin,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SERPINA7', 'Heparin']",0.5
14510,30094.0,Heparin,antithrombin III deficiency,disease-protein-drug,contraindication,"['antithrombin III deficiency', 'SERPINC1', 'Heparin']",0.5
14510,32563.0,Heparin,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,contraindication,"['heparin-induced thrombocytopenia (disease)', 'Venous thrombosis', 'SERPINC1', 'Heparin']",0.5
14510,33699.0,Heparin,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,indication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'PF4', 'Heparin']",0.5
14510,33699.0,Heparin,pulmonary embolism (disease),disease-exposure-gene-drug,indication,"['pulmonary embolism (disease)', 'Air Pollutants', 'SELP', 'Heparin']",0.5
14510,35849.0,Heparin,disseminated intravascular coagulation,disease-protein-drug,indication,"['disseminated intravascular coagulation', 'SERPINC1', 'Heparin']",0.5
14510,37180.0,Heparin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'PF4', 'Heparin']",0.5
14510,37180.0,Heparin,myocardial infarction (disease),disease-exposure-gene-drug,off-label use,"['myocardial infarction (disease)', 'Air Pollutants', 'SELP', 'Heparin']",0.5
14510,37785.0,Heparin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'SERPINC1', 'Heparin']",0.5
14510,39484.0,Heparin,purpura fulminans,disease-protein-drug,indication,"['purpura fulminans', 'SERPINC1', 'Heparin']",0.5
14510,83812.0,Heparin,acute coronary syndrome,disease-protein-drug,off-label use,"['acute coronary syndrome', 'SERPINC1', 'Heparin']",0.5
14510,83942.0,Heparin,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'PF4', 'Heparin']",0.5
14510,83942.0,Heparin,intracerebral hemorrhage,disease-exposure-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'SELP', 'Heparin']",0.5
14511,33459.0,Dantrolene,malignant hyperthermia of anesthesia,disease-protein-drug,indication,"['malignant hyperthermia of anesthesia', 'RYR1', 'Dantrolene']",0.5
14511,35565.0,Dantrolene,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Dantrolene']",0.5
14511,83838.0,Dantrolene,exercise-induced malignant hyperthermia,disease-protein-drug,indication,"['exercise-induced malignant hyperthermia', 'RYR1', 'Dantrolene']",0.5
14514,33621.0,Asparaginase Erwinia chrysanthemi,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Halogenated Diphenyl Ethers', 'SERPINA7', 'Asparaginase Erwinia chrysanthemi']",0.5
14516,29945.0,Tegafur,gastric cancer,disease-protein-drug,indication,"['gastric cancer', 'CYP2A6', 'Tegafur']",0.5
14516,31380.0,Tegafur,diffuse gastric adenocarcinoma,disease-protein-drug,indication,"['diffuse gastric adenocarcinoma', 'CYP2A6', 'Tegafur']",0.5
14516,36000.0,Tegafur,gastric neoplasm,disease-protein-drug,indication,"['gastric neoplasm', 'CYP2A6', 'Tegafur']",0.5
14516,37273.0,Tegafur,gastric carcinoma,disease-protein-drug,indication,"['gastric carcinoma', 'CYP2A6', 'Tegafur']",0.5
14516,83899.0,Tegafur,gastric linitis plastica,disease-protein-drug,indication,"['gastric linitis plastica', 'CYP2A6', 'Tegafur']",0.5
14520,35565.0,Allantoin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'SERPINA7', 'Allantoin']",0.5
14527,27522.0,Fluoxymesterone,Noonan syndrome,disease-phenotype-protein-drug,indication,"['Noonan syndrome', 'Male infertility', 'AR', 'Fluoxymesterone']",0.5
14527,28651.0,Fluoxymesterone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ESR1', 'Fluoxymesterone']",0.5
14527,29061.0,Fluoxymesterone,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'NR3C1', 'Fluoxymesterone']",0.5
14527,29113.0,Fluoxymesterone,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'HSD11B2', 'Fluoxymesterone']",0.5
14527,29113.0,Fluoxymesterone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Fluoxymesterone']",0.5
14527,29182.0,Fluoxymesterone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Fluoxymesterone']",0.5
14527,30073.0,Fluoxymesterone,cryptorchidism (disease),disease-exposure-bioprocess-gene-drug,indication,"['cryptorchidism (disease)', 'Dichlorodiphenyl Dichloroethylene', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,31395.0,Fluoxymesterone,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,31477.0,Fluoxymesterone,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Fluoxymesterone']",0.5
14527,31596.0,Fluoxymesterone,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,31630.0,Fluoxymesterone,androgen insensitivity syndrome,disease-protein-drug,indication,"['androgen insensitivity syndrome', 'AR', 'Fluoxymesterone']",0.5
14527,31630.0,Fluoxymesterone,androgen insensitivity syndrome,disease-phenotype-protein-drug,indication,"['androgen insensitivity syndrome', 'Male infertility', 'AR', 'Fluoxymesterone']",0.5
14527,32617.0,Fluoxymesterone,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'AR', 'Fluoxymesterone']",0.5
14527,33575.0,Fluoxymesterone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Fluoxymesterone']",0.5
14527,33575.0,Fluoxymesterone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluoxymesterone']",0.5
14527,33575.0,Fluoxymesterone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'SHBG', 'Fluoxymesterone']",0.5
14527,33575.0,Fluoxymesterone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Fluoxymesterone']",0.5
14527,33577.0,Fluoxymesterone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,33577.0,Fluoxymesterone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'SHBG', 'Fluoxymesterone']",0.5
14527,33593.0,Fluoxymesterone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Fluoxymesterone']",0.5
14527,33593.0,Fluoxymesterone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,33593.0,Fluoxymesterone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Fluoxymesterone']",0.5
14527,33598.0,Fluoxymesterone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,33598.0,Fluoxymesterone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'SHBG', 'Fluoxymesterone']",0.5
14527,33632.0,Fluoxymesterone,anemia (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['anemia (disease)', 'Lead', 'regulation of systemic arterial blood pressure', 'AR', 'Fluoxymesterone']",0.5
14527,33675.0,Fluoxymesterone,asthma,disease-protein-drug,contraindication,"['asthma', 'HSD11B2', 'Fluoxymesterone']",0.5
14527,33675.0,Fluoxymesterone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluoxymesterone']",0.5
14527,33675.0,Fluoxymesterone,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'bisphenol A', 'SHBG', 'Fluoxymesterone']",0.5
14527,33680.0,Fluoxymesterone,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'NR3C1', 'Fluoxymesterone']",0.5
14527,33680.0,Fluoxymesterone,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,33680.0,Fluoxymesterone,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Fluoxymesterone']",0.5
14527,33699.0,Fluoxymesterone,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluoxymesterone']",0.5
14527,35565.0,Fluoxymesterone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,35739.0,Fluoxymesterone,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Fluoxymesterone']",0.5
14527,35764.0,Fluoxymesterone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Fluoxymesterone']",0.5
14527,35901.0,Fluoxymesterone,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,35901.0,Fluoxymesterone,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Fluoxymesterone']",0.5
14527,35909.0,Fluoxymesterone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,35958.0,Fluoxymesterone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'HSD11B2', 'Fluoxymesterone']",0.5
14527,35963.0,Fluoxymesterone,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'SHBG', 'Fluoxymesterone']",0.5
14527,35966.0,Fluoxymesterone,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'SHBG', 'Fluoxymesterone']",0.5
14527,35966.0,Fluoxymesterone,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Fluoxymesterone']",0.5
14527,36187.0,Fluoxymesterone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Fluoxymesterone']",0.5
14527,36187.0,Fluoxymesterone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluoxymesterone']",0.5
14527,36187.0,Fluoxymesterone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'SHBG', 'Fluoxymesterone']",0.5
14527,36527.0,Fluoxymesterone,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Fluoxymesterone']",0.5
14527,36792.0,Fluoxymesterone,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,36794.0,Fluoxymesterone,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,37038.0,Fluoxymesterone,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR1', 'Fluoxymesterone']",0.5
14527,37047.0,Fluoxymesterone,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,37082.0,Fluoxymesterone,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Fluoxymesterone']",0.5
14527,37150.0,Fluoxymesterone,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Fluoxymesterone']",0.5
14527,37152.0,Fluoxymesterone,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Fluoxymesterone']",0.5
14527,37180.0,Fluoxymesterone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'HSD11B2', 'Fluoxymesterone']",0.5
14527,37180.0,Fluoxymesterone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluoxymesterone']",0.5
14527,37180.0,Fluoxymesterone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'bisphenol A', 'SHBG', 'Fluoxymesterone']",0.5
14527,37423.0,Fluoxymesterone,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,37466.0,Fluoxymesterone,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,37573.0,Fluoxymesterone,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluoxymesterone']",0.5
14527,37659.0,Fluoxymesterone,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluoxymesterone']",0.5
14527,37768.0,Fluoxymesterone,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Fluoxymesterone']",0.5
14527,37967.0,Fluoxymesterone,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,39603.0,Fluoxymesterone,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Fluoxymesterone']",0.5
14527,39615.0,Fluoxymesterone,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Fluoxymesterone']",0.5
14527,39773.0,Fluoxymesterone,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'HSD11B2', 'Fluoxymesterone']",0.5
14527,83781.0,Fluoxymesterone,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'HSD11B2', 'Fluoxymesterone']",0.5
14527,83816.0,Fluoxymesterone,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Fluoxymesterone']",0.5
14527,83817.0,Fluoxymesterone,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Fluoxymesterone']",0.5
14527,83818.0,Fluoxymesterone,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Fluoxymesterone']",0.5
14527,83819.0,Fluoxymesterone,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Fluoxymesterone']",0.5
14527,83820.0,Fluoxymesterone,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Fluoxymesterone']",0.5
14527,83821.0,Fluoxymesterone,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Fluoxymesterone']",0.5
14527,83822.0,Fluoxymesterone,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Fluoxymesterone']",0.5
14527,83823.0,Fluoxymesterone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'HSD11B2', 'Fluoxymesterone']",0.5
14527,83824.0,Fluoxymesterone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'HSD11B2', 'Fluoxymesterone']",0.5
14527,84094.0,Fluoxymesterone,premature menopause,disease-protein-drug,indication,"['premature menopause', 'AR', 'Fluoxymesterone']",0.5
14528,29061.0,Danazol,endometriosis of uterus,disease-protein-drug,indication,"['endometriosis of uterus', 'CYP19A1', 'Danazol']",0.5
14528,29908.0,Danazol,familial male-limited precocious puberty,disease-phenotype-protein-drug,off-label use,"['familial male-limited precocious puberty', 'Male infertility', 'AR', 'Danazol']",0.5
14528,31745.0,Danazol,aromatase excess syndrome,disease-protein-drug,off-label use,"['aromatase excess syndrome', 'CYP19A1', 'Danazol']",0.5
14528,35565.0,Danazol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Danazol']",0.5
14528,35764.0,Danazol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Danazol']",0.5
14528,35764.0,Danazol,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Danazol']",0.5
14528,37768.0,Danazol,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Danazol']",0.5
14530,29113.0,Stanolone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Stanolone']",0.5
14530,29646.0,Stanolone,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ABCB1', 'Stanolone']",0.5
14530,29646.0,Stanolone,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanolone']",0.5
14530,31395.0,Stanolone,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Stanolone']",0.5
14530,32635.0,Stanolone,monosomy X,disease-phenotype-protein-drug,off-label use,"['monosomy X', 'Female infertility', 'CYP17A1', 'Stanolone']",0.5
14530,32829.0,Stanolone,Turner syndrome,disease-phenotype-protein-drug,off-label use,"['Turner syndrome', 'Female infertility', 'CYP17A1', 'Stanolone']",0.5
14530,33575.0,Stanolone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Stanolone']",0.5
14530,33575.0,Stanolone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanolone']",0.5
14530,33575.0,Stanolone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'SHBG', 'Stanolone']",0.5
14530,33575.0,Stanolone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Stanolone']",0.5
14530,33603.0,Stanolone,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'ESR1', 'Stanolone']",0.5
14530,35565.0,Stanolone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Stanolone']",0.5
14530,35669.0,Stanolone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanolone']",0.5
14530,35669.0,Stanolone,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'SHBG', 'Stanolone']",0.5
14530,35761.0,Stanolone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanolone']",0.5
14530,35761.0,Stanolone,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'SHBG', 'Stanolone']",0.5
14530,35764.0,Stanolone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP11A1', 'Stanolone']",0.5
14530,35953.0,Stanolone,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'ESR1', 'Stanolone']",0.5
14530,35953.0,Stanolone,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Diethylhexyl Phthalate', 'Leydig cell differentiation', 'AR', 'Stanolone']",0.5
14530,35953.0,Stanolone,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'bisphenol A', 'SHBG', 'Stanolone']",0.5
14530,35958.0,Stanolone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'NR3C2', 'Stanolone']",0.5
14530,35963.0,Stanolone,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'SHBG', 'Stanolone']",0.5
14530,35966.0,Stanolone,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'SHBG', 'Stanolone']",0.5
14530,35966.0,Stanolone,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Stanolone']",0.5
14530,36187.0,Stanolone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Stanolone']",0.5
14530,36187.0,Stanolone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanolone']",0.5
14530,36187.0,Stanolone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'SHBG', 'Stanolone']",0.5
14530,36432.0,Stanolone,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'NR3C2', 'Stanolone']",0.5
14530,36634.0,Stanolone,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ABCB1', 'Stanolone']",0.5
14530,36634.0,Stanolone,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Stanolone']",0.5
14530,37180.0,Stanolone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'NR3C2', 'Stanolone']",0.5
14530,37180.0,Stanolone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanolone']",0.5
14530,37180.0,Stanolone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'bisphenol A', 'SHBG', 'Stanolone']",0.5
14530,37659.0,Stanolone,heart failure,disease-protein-drug,contraindication,"['heart failure', 'NR3C2', 'Stanolone']",0.5
14530,37659.0,Stanolone,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanolone']",0.5
14530,83823.0,Stanolone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'NR3C2', 'Stanolone']",0.5
14530,83824.0,Stanolone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'NR3C2', 'Stanolone']",0.5
14537,27655.0,Ranolazine,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'SCN4B', 'Ranolazine']",0.5
14537,27655.0,Ranolazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Syncope', 'CACNA1C', 'Ranolazine']",0.5
14537,35764.0,Ranolazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Ranolazine']",0.5
14537,37765.0,Ranolazine,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ADRA1A', 'Ranolazine']",0.5
14537,83751.0,Ranolazine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'SCN5A', 'Ranolazine']",0.5
14538,27326.0,Disopyramide,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'SCN5A', 'Disopyramide']",0.5
14538,27326.0,Disopyramide,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Disopyramide']",0.5
14538,27326.0,Disopyramide,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CHRM2', 'Disopyramide']",0.5
14538,28052.0,Disopyramide,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'CYP1A2', 'Disopyramide']",0.5
14538,31650.0,Disopyramide,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Disopyramide']",0.5
14538,33618.0,Disopyramide,atrial fibrillation (disease),disease-protein-drug,contraindication,"['atrial fibrillation (disease)', 'KCND3', 'Disopyramide']",0.5
14538,33618.0,Disopyramide,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Disopyramide']",0.5
14538,35565.0,Disopyramide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Disopyramide']",0.5
14538,35764.0,Disopyramide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN5A', 'Disopyramide']",0.5
14538,37769.0,Disopyramide,ventricular tachycardia,disease-protein-drug,off-label use,"['ventricular tachycardia', 'SCN5A', 'Disopyramide']",0.5
14539,30664.0,Prazosin,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,contraindication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'ADRA1B', 'Prazosin']",0.5
14539,36040.0,Prazosin,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Prazosin']",0.5
14539,83923.0,Prazosin,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'platelet activation', 'ADRA2B', 'Prazosin']",0.5
14540,27933.0,Amoxapine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'GABRB3', 'Amoxapine']",0.5
14540,27933.0,Amoxapine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1B', 'Amoxapine']",0.5
14540,28249.0,Amoxapine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'GABRB3', 'Amoxapine']",0.5
14540,28313.0,Amoxapine,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'GABRB3', 'Amoxapine']",0.5
14540,28313.0,Amoxapine,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Amoxapine']",0.5
14540,30035.0,Amoxapine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Amoxapine']",0.5
14540,33454.0,Amoxapine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Amoxapine']",0.5
14540,35565.0,Amoxapine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Amoxapine']",0.5
14540,35641.0,Amoxapine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Amoxapine']",0.5
14540,35641.0,Amoxapine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Amoxapine']",0.5
14540,35669.0,Amoxapine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Amoxapine']",0.5
14540,35761.0,Amoxapine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Amoxapine']",0.5
14540,35764.0,Amoxapine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Amoxapine']",0.5
14540,36034.0,Amoxapine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'DRD3', 'Amoxapine']",0.5
14540,37703.0,Amoxapine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'HTR1B', 'Amoxapine']",0.5
14540,38242.0,Amoxapine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'GABRB3', 'Amoxapine']",0.5
14540,38242.0,Amoxapine,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Amoxapine']",0.5
14540,83760.0,Amoxapine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'HTR1B', 'Amoxapine']",0.5
14540,83998.0,Amoxapine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Amoxapine']",0.5
14541,28396.0,Tamsulosin,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Tamsulosin']",0.5
14541,35565.0,Tamsulosin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Tamsulosin']",0.5
14542,27933.0,Maprotiline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'SLC6A2', 'Maprotiline']",0.5
14542,27933.0,Maprotiline,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR7', 'Maprotiline']",0.5
14542,30035.0,Maprotiline,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Maprotiline']",0.5
14542,33598.0,Maprotiline,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'CHRM1', 'Maprotiline']",0.5
14542,35565.0,Maprotiline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Maprotiline']",0.5
14542,35641.0,Maprotiline,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADRA1B', 'Maprotiline']",0.5
14542,35641.0,Maprotiline,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Maprotiline']",0.5
14542,35669.0,Maprotiline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Maprotiline']",0.5
14542,35761.0,Maprotiline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Maprotiline']",0.5
14542,35909.0,Maprotiline,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Maprotiline']",0.5
14542,36034.0,Maprotiline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Maprotiline']",0.5
14542,37180.0,Maprotiline,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Maprotiline']",0.5
14542,37703.0,Maprotiline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A2', 'Maprotiline']",0.5
14542,38242.0,Maprotiline,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Maprotiline']",0.5
14542,38242.0,Maprotiline,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Maprotiline']",0.5
14542,83760.0,Maprotiline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A2', 'Maprotiline']",0.5
14543,27326.0,Desipramine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Desipramine']",0.5
14543,27326.0,Desipramine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Desipramine']",0.5
14543,27655.0,Desipramine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ADRA1B', 'Desipramine']",0.5
14543,27921.0,Desipramine,attention deficit-hyperactivity disorder,disease-protein-drug,off-label use,"['attention deficit-hyperactivity disorder', 'DRD2', 'Desipramine']",0.5
14543,27933.0,Desipramine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Desipramine']",0.5
14543,27933.0,Desipramine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Desipramine']",0.5
14543,27933.0,Desipramine,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Desipramine']",0.5
14543,28249.0,Desipramine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Desipramine']",0.5
14543,28313.0,Desipramine,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'CYP2E1', 'Desipramine']",0.5
14543,28313.0,Desipramine,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'social behavior', 'SLC6A4', 'Desipramine']",0.5
14543,28391.0,Desipramine,narcolepsy,disease-exposure-bioprocess-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Desipramine']",0.5
14543,28391.0,Desipramine,narcolepsy,disease-exposure-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'CYP2E1', 'Desipramine']",0.5
14543,29525.0,Desipramine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Desipramine']",0.5
14543,30035.0,Desipramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Desipramine']",0.5
14543,33598.0,Desipramine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Desipramine']",0.5
14543,33598.0,Desipramine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Desipramine']",0.5
14543,35565.0,Desipramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Desipramine']",0.5
14543,35641.0,Desipramine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Desipramine']",0.5
14543,35641.0,Desipramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Desipramine']",0.5
14543,35764.0,Desipramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Desipramine']",0.5
14543,35909.0,Desipramine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Desipramine']",0.5
14543,36034.0,Desipramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Desipramine']",0.5
14543,37703.0,Desipramine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'ADRB1', 'Desipramine']",0.5
14543,38242.0,Desipramine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Desipramine']",0.5
14543,38242.0,Desipramine,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Desipramine']",0.5
14543,83751.0,Desipramine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Desipramine']",0.5
14543,83760.0,Desipramine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'ADRB1', 'Desipramine']",0.5
14543,84019.0,Desipramine,anxiety,disease-protein-drug,off-label use,"['anxiety', 'SLC6A4', 'Desipramine']",0.5
14543,84036.0,Desipramine,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'DRD2', 'Desipramine']",0.5
14543,84036.0,Desipramine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Desipramine']",0.5
14543,84036.0,Desipramine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Pesticides', 'CYP2E1', 'Desipramine']",0.5
14544,27921.0,Bupropion,attention deficit-hyperactivity disorder,disease-protein-drug,off-label use,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Bupropion']",0.5
14544,27933.0,Bupropion,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'SLC6A2', 'Bupropion']",0.5
14544,27933.0,Bupropion,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Bupropion']",0.5
14544,27933.0,Bupropion,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Bupropion']",0.5
14544,28249.0,Bupropion,major affective disorder,disease-protein-drug,indication,"['major affective disorder', 'SLC6A2', 'Bupropion']",0.5
14544,28651.0,Bupropion,monogenic obesity,disease-protein-drug,indication,"['monogenic obesity', 'CYP2E1', 'Bupropion']",0.5
14544,30035.0,Bupropion,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Bupropion']",0.5
14544,33577.0,Bupropion,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Bupropion']",0.5
14544,33593.0,Bupropion,obesity disorder,disease-protein-drug,indication,"['obesity disorder', 'CYP2E1', 'Bupropion']",0.5
14544,33593.0,Bupropion,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Cadmium', 'inflammatory response', 'ORM1', 'Bupropion']",0.5
14544,33593.0,Bupropion,obesity disorder,disease-phenotype-protein-drug,indication,"['obesity disorder', 'Increased body weight', 'CYP2D6', 'Bupropion']",0.5
14544,35565.0,Bupropion,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Bupropion']",0.5
14544,35641.0,Bupropion,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Bupropion']",0.5
14544,35764.0,Bupropion,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Bupropion']",0.5
14544,35915.0,Bupropion,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Bupropion']",0.5
14544,37180.0,Bupropion,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Bupropion']",0.5
14544,37180.0,Bupropion,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'CYP2E1', 'Bupropion']",0.5
14544,37703.0,Bupropion,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A2', 'Bupropion']",0.5
14544,38242.0,Bupropion,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'SLC6A2', 'Bupropion']",0.5
14544,38957.0,Bupropion,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'CYP2C9', 'Bupropion']",0.5
14544,38957.0,Bupropion,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'platelet degranulation', 'ORM1', 'Bupropion']",0.5
14544,39531.0,Bupropion,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Bupropion']",0.5
14544,83760.0,Bupropion,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A2', 'Bupropion']",0.5
14544,83778.0,Bupropion,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Bupropion']",0.5
14544,83779.0,Bupropion,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Bupropion']",0.5
14544,83840.0,Bupropion,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'SLC6A2', 'Bupropion']",0.5
14544,83841.0,Bupropion,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'CYP2C9', 'Bupropion']",0.5
14544,84036.0,Bupropion,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'SLC6A3', 'Bupropion']",0.5
14544,84036.0,Bupropion,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'inflammatory response', 'ORM1', 'Bupropion']",0.5
14544,84036.0,Bupropion,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Pesticides', 'CYP2E1', 'Bupropion']",0.5
14544,84229.0,Bupropion,nicotine dependence,disease-protein-drug,indication,"['nicotine dependence', 'CHRNA3', 'Bupropion']",0.5
14544,84242.0,Bupropion,morphine dependence,disease-protein-drug,contraindication,"['morphine dependence', 'CHRNA3', 'Bupropion']",0.5
14545,28158.0,Clindamycin,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Clindamycin']",0.5
14545,28158.0,Clindamycin,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Clindamycin']",0.5
14545,28158.0,Clindamycin,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Clindamycin']",0.5
14545,32710.0,Clindamycin,inhalational anthrax,disease-phenotype-protein-drug,off-label use,"['inhalational anthrax', 'Vomiting', 'ABCB1', 'Clindamycin']",0.5
14545,36129.0,Clindamycin,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Clindamycin']",0.5
14545,37785.0,Clindamycin,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Clindamycin']",0.5
14545,37785.0,Clindamycin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Clindamycin']",0.5
14545,39531.0,Clindamycin,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Clindamycin']",0.5
14546,27645.0,Metoclopramide,torsion dystonia,disease-phenotype-protein-drug,contraindication,"['torsion dystonia', 'Action tremor', 'CYP2D6', 'Metoclopramide']",0.5
14546,27933.0,Metoclopramide,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Metoclopramide']",0.5
14546,27933.0,Metoclopramide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'DRD2', 'Metoclopramide']",0.5
14546,28547.0,Metoclopramide,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Metoclopramide']",0.5
14546,28547.0,Metoclopramide,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Metoclopramide']",0.5
14546,28547.0,Metoclopramide,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Metoclopramide']",0.5
14546,31122.0,Metoclopramide,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Tachycardia', 'DRD2', 'Metoclopramide']",0.5
14546,31168.0,Metoclopramide,pyruvate dehydrogenase E3 deficiency,disease-phenotype-protein-drug,contraindication,"['pyruvate dehydrogenase E3 deficiency', 'Hepatomegaly', 'CYP1A2', 'Metoclopramide']",0.5
14546,32977.0,Metoclopramide,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Metoclopramide']",0.5
14546,32977.0,Metoclopramide,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'DRD2', 'Metoclopramide']",0.5
14546,33454.0,Metoclopramide,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Metoclopramide']",0.5
14546,33577.0,Metoclopramide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'DRD2', 'Metoclopramide']",0.5
14546,35641.0,Metoclopramide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Metoclopramide']",0.5
14546,35641.0,Metoclopramide,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Metoclopramide']",0.5
14546,37703.0,Metoclopramide,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Metoclopramide']",0.5
14546,37706.0,Metoclopramide,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Metoclopramide']",0.5
14546,37765.0,Metoclopramide,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'CYP1A2', 'Metoclopramide']",0.5
14546,83760.0,Metoclopramide,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Metoclopramide']",0.5
14546,83998.0,Metoclopramide,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Metoclopramide']",0.5
14547,27933.0,Penbutolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'HTR1B', 'Penbutolol']",0.5
14547,27933.0,Penbutolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1B', 'Penbutolol']",0.5
14547,29113.0,Penbutolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Penbutolol']",0.5
14547,31650.0,Penbutolol,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'HTR1B', 'Penbutolol']",0.5
14547,33575.0,Penbutolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Penbutolol']",0.5
14547,33577.0,Penbutolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Penbutolol']",0.5
14547,35565.0,Penbutolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Penbutolol']",0.5
14547,35764.0,Penbutolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Penbutolol']",0.5
14547,35897.0,Penbutolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Penbutolol']",0.5
14547,36432.0,Penbutolol,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRB1', 'Penbutolol']",0.5
14547,37659.0,Penbutolol,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ADRB1', 'Penbutolol']",0.5
14547,37659.0,Penbutolol,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Penbutolol']",0.5
14547,37703.0,Penbutolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'HTR1B', 'Penbutolol']",0.5
14547,83760.0,Penbutolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'HTR1B', 'Penbutolol']",0.5
14551,28208.0,Canagliflozin,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Canagliflozin']",0.5
14554,30816.0,Mecasermin,Laron syndrome,disease-phenotype-protein-drug,indication,"['Laron syndrome', 'Delayed puberty', 'IGFALS', 'Mecasermin']",0.5
14557,27361.0,Turoctocog alfa pegol,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F9', 'Turoctocog alfa pegol']",0.5
14557,27361.0,Turoctocog alfa pegol,hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Thromboembolism', 'PROC', 'Turoctocog alfa pegol']",0.5
14557,32354.0,Turoctocog alfa pegol,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F9', 'Turoctocog alfa pegol']",0.5
14558,30813.0,Etomidate,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Cyanosis', 'ADRA2B', 'Etomidate']",0.5
14559,27285.0,Calcitriol,hereditary hypophosphatemic rickets,disease-protein-drug,off-label use,"['hereditary hypophosphatemic rickets', 'VDR', 'Calcitriol']",0.5
14559,27285.0,Calcitriol,hereditary hypophosphatemic rickets,disease-phenotype-protein-drug,off-label use,"['hereditary hypophosphatemic rickets', 'Hypercalciuria', 'CYP24A1', 'Calcitriol']",0.5
14559,32967.0,Calcitriol,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hypercalciuria', 'CYP24A1', 'Calcitriol']",0.5
14559,33626.0,Calcitriol,rickets (disease),disease-protein-drug,off-label use,"['rickets (disease)', 'VDR', 'Calcitriol']",0.5
14559,33656.0,Calcitriol,hypercalcemia disease,disease-protein-drug,indication,"['hypercalcemia disease', 'CYP24A1', 'Calcitriol']",0.5
14559,33656.0,Calcitriol,hypercalcemia disease,disease-phenotype-protein-drug,indication,"['hypercalcemia disease', 'Infantile hypercalcemia', 'CYP24A1', 'Calcitriol']",0.5
14559,35583.0,Calcitriol,phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'CYP24A1', 'Calcitriol']",0.5
14559,35764.0,Calcitriol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Calcitriol']",0.5
14559,37171.0,Calcitriol,nephrolithiasis,disease-protein-drug,contraindication,"['nephrolithiasis', 'CYP24A1', 'Calcitriol']",0.5
14559,38682.0,Calcitriol,nephrocalcinosis,disease-protein-drug,indication,"['nephrocalcinosis', 'CYP24A1', 'Calcitriol']",0.5
14559,39444.0,Calcitriol,osteomalacia (disease),disease-protein-drug,off-label use,"['osteomalacia (disease)', 'VDR', 'Calcitriol']",0.5
14559,83831.0,Calcitriol,acute urate nephropathy,disease-protein-drug,contraindication,"['acute urate nephropathy', 'CYP24A1', 'Calcitriol']",0.5
14559,83952.0,Calcitriol,obsolete vitamin D deficiency,disease-protein-drug,off-label use,"['obsolete vitamin D deficiency', 'VDR', 'Calcitriol']",0.5
14560,27647.0,Ergocalciferol,hypoparathyroidism,disease-phenotype-protein-drug,indication,"['hypoparathyroidism', 'Seizure', 'CYP27A1', 'Ergocalciferol']",0.5
14560,28900.0,Ergocalciferol,familial isolated deficiency of vitamin E,disease-phenotype-protein-drug,contraindication,"['familial isolated deficiency of vitamin E', 'Mental deterioration', 'CACNA1C', 'Ergocalciferol']",0.5
14560,28921.0,Ergocalciferol,sickle cell anemia,disease-protein-drug,contraindication,"['sickle cell anemia', 'CACNA1C', 'Ergocalciferol']",0.5
14560,28921.0,Ergocalciferol,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Pain', 'CACNA2D1', 'Ergocalciferol']",0.5
14560,29614.0,Ergocalciferol,osteoporosis,disease-protein-drug,indication,"['osteoporosis', 'CYP24A1', 'Ergocalciferol']",0.5
14560,29614.0,Ergocalciferol,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'bone mineralization', 'CYP27B1', 'Ergocalciferol']",0.5
14560,29946.0,Ergocalciferol,primary hyperoxaluria,disease-phenotype-protein-drug,contraindication,"['primary hyperoxaluria', 'Hypercalciuria', 'CYP24A1', 'Ergocalciferol']",0.5
14560,30827.0,Ergocalciferol,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'CYP11A1', 'Ergocalciferol']",0.5
14560,31107.0,Ergocalciferol,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Vehicle Emissions', 'regulation of heart contraction', 'CACNA1H', 'Ergocalciferol']",0.5
14560,31107.0,Ergocalciferol,cervical cancer,disease-exposure-gene-drug,contraindication,"['cervical cancer', 'Air Pollutants', 'CACNA2D1', 'Ergocalciferol']",0.5
14560,31502.0,Ergocalciferol,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Hypercalciuria', 'CYP24A1', 'Ergocalciferol']",0.5
14560,33575.0,Ergocalciferol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'VDR', 'Ergocalciferol']",0.5
14560,33575.0,Ergocalciferol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'CACNA2D1', 'Ergocalciferol']",0.5
14560,33577.0,Ergocalciferol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'visual perception', 'CACNA1F', 'Ergocalciferol']",0.5
14560,33577.0,Ergocalciferol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'CACNA2D1', 'Ergocalciferol']",0.5
14560,33594.0,Ergocalciferol,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cortisol metabolic process', 'CYP11A1', 'Ergocalciferol']",0.5
14560,33618.0,Ergocalciferol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of heart contraction', 'CACNA1H', 'Ergocalciferol']",0.5
14560,33618.0,Ergocalciferol,atrial fibrillation (disease),disease-exposure-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Air Pollutants', 'CACNA2D1', 'Ergocalciferol']",0.5
14560,33626.0,Ergocalciferol,rickets (disease),disease-protein-drug,indication,"['rickets (disease)', 'VDR', 'Ergocalciferol']",0.5
14560,33656.0,Ergocalciferol,hypercalcemia disease,disease-protein-drug,contraindication,"['hypercalcemia disease', 'CYP24A1', 'Ergocalciferol']",0.5
14560,33656.0,Ergocalciferol,hypercalcemia disease,disease-phenotype-protein-drug,contraindication,"['hypercalcemia disease', 'Infantile hypercalcemia', 'CYP24A1', 'Ergocalciferol']",0.5
14560,35565.0,Ergocalciferol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP27A1', 'Ergocalciferol']",0.5
14560,35583.0,Ergocalciferol,phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'CYP24A1', 'Ergocalciferol']",0.5
14560,35764.0,Ergocalciferol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'visual perception', 'CACNA1F', 'Ergocalciferol']",0.5
14560,35963.0,Ergocalciferol,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'VDR', 'Ergocalciferol']",0.5
14560,35966.0,Ergocalciferol,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'VDR', 'Ergocalciferol']",0.5
14560,35966.0,Ergocalciferol,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Chlorpyrifos', 'visual perception', 'CACNA1F', 'Ergocalciferol']",0.5
14560,37038.0,Ergocalciferol,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'CYP11A1', 'Ergocalciferol']",0.5
14560,37171.0,Ergocalciferol,nephrolithiasis,disease-protein-drug,contraindication,"['nephrolithiasis', 'CYP24A1', 'Ergocalciferol']",0.5
14560,38682.0,Ergocalciferol,nephrocalcinosis,disease-protein-drug,contraindication,"['nephrocalcinosis', 'CYP24A1', 'Ergocalciferol']",0.5
14560,39444.0,Ergocalciferol,osteomalacia (disease),disease-protein-drug,indication,"['osteomalacia (disease)', 'VDR', 'Ergocalciferol']",0.5
14560,83776.0,Ergocalciferol,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'CYP24A1', 'Ergocalciferol']",0.5
14560,83813.0,Ergocalciferol,hereditary persistence of fetal hemoglobin,disease-protein-drug,contraindication,"['hereditary persistence of fetal hemoglobin', 'CACNA1C', 'Ergocalciferol']",0.5
14560,83831.0,Ergocalciferol,acute urate nephropathy,disease-protein-drug,contraindication,"['acute urate nephropathy', 'CYP24A1', 'Ergocalciferol']",0.5
14560,83952.0,Ergocalciferol,obsolete vitamin D deficiency,disease-protein-drug,indication,"['obsolete vitamin D deficiency', 'VDR', 'Ergocalciferol']",0.5
14561,27647.0,Cholecalciferol,hypoparathyroidism,disease-phenotype-protein-drug,indication,"['hypoparathyroidism', 'Seizure', 'CYP27A1', 'Cholecalciferol']",0.5
14561,28921.0,Cholecalciferol,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Hepatomegaly', 'CYP1A1', 'Cholecalciferol']",0.5
14561,29614.0,Cholecalciferol,osteoporosis,disease-protein-drug,indication,"['osteoporosis', 'VDR', 'Cholecalciferol']",0.5
14561,29614.0,Cholecalciferol,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP27A1', 'Cholecalciferol']",0.5
14561,30827.0,Cholecalciferol,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'CYP11A1', 'Cholecalciferol']",0.5
14561,31107.0,Cholecalciferol,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Vehicle Emissions', 'DNA methylation', 'CYP1A1', 'Cholecalciferol']",0.5
14561,31502.0,Cholecalciferol,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Hepatomegaly', 'CYP1A1', 'Cholecalciferol']",0.5
14561,32967.0,Cholecalciferol,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'CYP1A1', 'Cholecalciferol']",0.5
14561,33575.0,Cholecalciferol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'VDR', 'Cholecalciferol']",0.5
14561,33575.0,Cholecalciferol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Cholecalciferol']",0.5
14561,33577.0,Cholecalciferol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP27A1', 'Cholecalciferol']",0.5
14561,33577.0,Cholecalciferol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Cholecalciferol']",0.5
14561,33594.0,Cholecalciferol,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cortisol metabolic process', 'CYP11A1', 'Cholecalciferol']",0.5
14561,33594.0,Cholecalciferol,diarrheal disease,disease-exposure-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'CYP1A1', 'Cholecalciferol']",0.5
14561,33618.0,Cholecalciferol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Cholecalciferol']",0.5
14561,33626.0,Cholecalciferol,rickets (disease),disease-protein-drug,indication,"['rickets (disease)', 'VDR', 'Cholecalciferol']",0.5
14561,35565.0,Cholecalciferol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP27A1', 'Cholecalciferol']",0.5
14561,35565.0,Cholecalciferol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Cholecalciferol']",0.5
14561,35764.0,Cholecalciferol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP27A1', 'Cholecalciferol']",0.5
14561,35764.0,Cholecalciferol,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Cholecalciferol']",0.5
14561,35963.0,Cholecalciferol,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'CYP1A1', 'Cholecalciferol']",0.5
14561,35966.0,Cholecalciferol,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'CYP1A1', 'Cholecalciferol']",0.5
14561,35966.0,Cholecalciferol,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Cholecalciferol']",0.5
14561,35966.0,Cholecalciferol,prostate cancer,disease-exposure-gene-drug,contraindication,"['prostate cancer', 'Agent Orange', 'CYP1A1', 'Cholecalciferol']",0.5
14561,37038.0,Cholecalciferol,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'CYP11A1', 'Cholecalciferol']",0.5
14561,39444.0,Cholecalciferol,osteomalacia (disease),disease-protein-drug,indication,"['osteomalacia (disease)', 'VDR', 'Cholecalciferol']",0.5
14561,83776.0,Cholecalciferol,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'VDR', 'Cholecalciferol']",0.5
14561,83952.0,Cholecalciferol,obsolete vitamin D deficiency,disease-protein-drug,indication,"['obsolete vitamin D deficiency', 'VDR', 'Cholecalciferol']",0.5
14574,28158.0,Sulfinpyrazone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Sulfinpyrazone']",0.5
14574,35764.0,Sulfinpyrazone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Sulfinpyrazone']",0.5
14574,83802.0,Sulfinpyrazone,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Sulfinpyrazone']",0.5
14578,27700.0,Cholic Acid,sclerosing cholangitis,disease-exposure-bioprocess-gene-drug,contraindication,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'FABP6', 'Cholic Acid']",0.5
14578,27700.0,Cholic Acid,sclerosing cholangitis,disease-phenotype-protein-drug,contraindication,"['sclerosing cholangitis', 'Hepatomegaly', 'ABCC3', 'Cholic Acid']",0.5
14578,29955.0,Cholic Acid,Reynolds syndrome,disease-protein-drug,contraindication,"['Reynolds syndrome', 'ABCC2', 'Cholic Acid']",0.5
14578,29955.0,Cholic Acid,Reynolds syndrome,disease-phenotype-protein-drug,contraindication,"['Reynolds syndrome', 'Hepatomegaly', 'ABCC3', 'Cholic Acid']",0.5
14578,31033.0,Cholic Acid,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'ABCC2', 'Cholic Acid']",0.5
14578,31033.0,Cholic Acid,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'ABCC3', 'Cholic Acid']",0.5
14578,31144.0,Cholic Acid,primary biliary cholangitis,disease-protein-drug,contraindication,"['primary biliary cholangitis', 'ABCC2', 'Cholic Acid']",0.5
14578,31144.0,Cholic Acid,primary biliary cholangitis,disease-phenotype-protein-drug,contraindication,"['primary biliary cholangitis', 'Pruritus', 'ABCB11', 'Cholic Acid']",0.5
14578,31541.0,Cholic Acid,cerebrotendinous xanthomatosis,disease-phenotype-protein-drug,indication,"['cerebrotendinous xanthomatosis', 'Seizure', 'ABCC2', 'Cholic Acid']",0.5
14578,32629.0,Cholic Acid,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'ABCC2', 'Cholic Acid']",0.5
14578,32629.0,Cholic Acid,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'ABCC3', 'Cholic Acid']",0.5
14578,33677.0,Cholic Acid,constipation disorder,disease-protein-drug,indication,"['constipation disorder', 'GPBAR1', 'Cholic Acid']",0.5
14578,35565.0,Cholic Acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Cholic Acid']",0.5
14578,38059.0,Cholic Acid,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'ABCC2', 'Cholic Acid']",0.5
14579,33575.0,Nitazoxanide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Polychlorinated Biphenyls', 'female pregnancy', 'SLC19A1', 'Nitazoxanide']",0.5
14579,35565.0,Nitazoxanide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'female pregnancy', 'SLC19A1', 'Nitazoxanide']",0.5
14581,29525.0,Cocaine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Cocaine']",0.5
14581,35641.0,Cocaine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SCN9A', 'Cocaine']",0.5
14581,36034.0,Cocaine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Cocaine']",0.5
14581,36034.0,Cocaine,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Cocaine']",0.5
14581,36034.0,Cocaine,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Cocaine']",0.5
14582,27933.0,Nadolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Nadolol']",0.5
14582,27933.0,Nadolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Nadolol']",0.5
14582,29113.0,Nadolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Nadolol']",0.5
14582,29182.0,Nadolol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'POU2F1', 'Nadolol']",0.5
14582,33534.0,Nadolol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Vomiting', 'ABCB1', 'Nadolol']",0.5
14582,33575.0,Nadolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Nadolol']",0.5
14582,33577.0,Nadolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Nadolol']",0.5
14582,33679.0,Nadolol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Nadolol']",0.5
14582,35565.0,Nadolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'bone resorption', 'ADRB2', 'Nadolol']",0.5
14582,35764.0,Nadolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Nadolol']",0.5
14582,35897.0,Nadolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'POU2F1', 'Nadolol']",0.5
14582,36432.0,Nadolol,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRB1', 'Nadolol']",0.5
14582,37659.0,Nadolol,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ADRB1', 'Nadolol']",0.5
14582,37659.0,Nadolol,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Nadolol']",0.5
14582,37703.0,Nadolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Nadolol']",0.5
14582,83760.0,Nadolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Nadolol']",0.5
14583,27326.0,Solifenacin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Solifenacin']",0.5
14583,27326.0,Solifenacin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Solifenacin']",0.5
14583,27326.0,Solifenacin,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Solifenacin']",0.5
14583,27326.0,Solifenacin,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Solifenacin']",0.5
14583,27655.0,Solifenacin,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'CHRM1', 'Solifenacin']",0.5
14583,35565.0,Solifenacin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Solifenacin']",0.5
14583,35565.0,Solifenacin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Solifenacin']",0.5
14583,39531.0,Solifenacin,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Solifenacin']",0.5
14583,83751.0,Solifenacin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Solifenacin']",0.5
14585,33575.0,Ammonia,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Lead', 'homocysteine metabolic process', 'CPS1', 'Ammonia']",0.5
14588,33632.0,Isosorbide mononitrate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Petroleum', 'respiratory system process', 'ADH5', 'Isosorbide mononitrate']",0.5
14588,36034.0,Isosorbide mononitrate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Petroleum', 'respiratory system process', 'ADH5', 'Isosorbide mononitrate']",0.5
14588,37180.0,Isosorbide mononitrate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'respiratory system process', 'ADH5', 'Isosorbide mononitrate']",0.5
14588,37180.0,Isosorbide mononitrate,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'glutathione transferase activity', 'GSTM1', 'Isosorbide mononitrate']",0.5
14588,83942.0,Isosorbide mononitrate,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'respiratory system process', 'ADH5', 'Isosorbide mononitrate']",0.5
14589,33575.0,Polyethylene glycol 400,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'ENPP1', 'Polyethylene glycol 400']",0.5
14589,33575.0,Polyethylene glycol 400,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'oxylipin biosynthetic process', 'CYP4A11', 'Polyethylene glycol 400']",0.5
14589,33577.0,Polyethylene glycol 400,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'immune response', 'ENPP1', 'Polyethylene glycol 400']",0.5
14589,33581.0,Polyethylene glycol 400,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'respiratory system process', 'ADH5', 'Polyethylene glycol 400']",0.5
14589,35641.0,Polyethylene glycol 400,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Polyethylene glycol 400']",0.5
14589,35669.0,Polyethylene glycol 400,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'oxylipin biosynthetic process', 'CYP4A11', 'Polyethylene glycol 400']",0.5
14589,35761.0,Polyethylene glycol 400,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'oxylipin biosynthetic process', 'CYP4A11', 'Polyethylene glycol 400']",0.5
14589,35764.0,Polyethylene glycol 400,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'ENPP1', 'Polyethylene glycol 400']",0.5
14589,35916.0,Polyethylene glycol 400,dry eye syndrome,disease-exposure-bioprocess-gene-drug,indication,"['dry eye syndrome', 'Mercury', 'immune response', 'ENPP1', 'Polyethylene glycol 400']",0.5
14589,36034.0,Polyethylene glycol 400,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Petroleum', 'respiratory system process', 'ADH5', 'Polyethylene glycol 400']",0.5
14590,33598.0,Ozanimod,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Ozanimod']",0.5
14590,35909.0,Ozanimod,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'respiratory system process', 'ADH5', 'Ozanimod']",0.5
14590,36312.0,Ozanimod,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'S1PR1', 'Ozanimod']",0.5
14590,37180.0,Ozanimod,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'respiratory system process', 'ADH5', 'Ozanimod']",0.5
14590,37659.0,Ozanimod,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'respiratory system process', 'ADH5', 'Ozanimod']",0.5
14590,37722.0,Ozanimod,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'cholesterol homeostasis', 'AKR1C1', 'Ozanimod']",0.5
14591,31918.0,Glycine,phenylketonuria,disease-phenotype-protein-drug,contraindication,"['phenylketonuria', 'Seizure', 'GLDC', 'Glycine']",0.5
14591,35669.0,Glycine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'hemoglobin biosynthetic process', 'ALAS2', 'Glycine']",0.5
14591,35669.0,Glycine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'transaminase activity', 'AGXT', 'Glycine']",0.5
14591,35761.0,Glycine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'GSS', 'Glycine']",0.5
14591,35761.0,Glycine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'transaminase activity', 'AGXT', 'Glycine']",0.5
14591,35764.0,Glycine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'GRIN2A', 'Glycine']",0.5
14591,35764.0,Glycine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'transaminase activity', 'AGXT', 'Glycine']",0.5
14591,36040.0,Glycine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'memory', 'GRIN2A', 'Glycine']",0.5
14591,37811.0,Glycine,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'hemoglobin biosynthetic process', 'ALAS2', 'Glycine']",0.5
14591,37888.0,Glycine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'methylation', 'GNMT', 'Glycine']",0.5
14591,83923.0,Glycine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'methylation', 'GNMT', 'Glycine']",0.5
14594,27361.0,Albutrepenonacog alfa,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F8', 'Albutrepenonacog alfa']",0.5
14594,32354.0,Albutrepenonacog alfa,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F8', 'Albutrepenonacog alfa']",0.5
14595,27361.0,Desmopressin,hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Seizure', 'PTGS2', 'Desmopressin']",0.5
14595,33577.0,Desmopressin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Desmopressin']",0.5
14595,33577.0,Desmopressin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Desmopressin']",0.5
14595,35831.0,Desmopressin,respiratory tract infectious disease,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory tract infectious disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Desmopressin']",0.5
14595,35831.0,Desmopressin,respiratory tract infectious disease,disease-exposure-gene-drug,contraindication,"['respiratory tract infectious disease', 'Air Pollutants', 'PTGS1', 'Desmopressin']",0.5
14595,36187.0,Desmopressin,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PTGS2', 'Desmopressin']",0.5
14595,36187.0,Desmopressin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Desmopressin']",0.5
14595,36187.0,Desmopressin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Desmopressin']",0.5
14595,37888.0,Desmopressin,allergic rhinitis,disease-exposure-bioprocess-gene-drug,contraindication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'PTGS2', 'Desmopressin']",0.5
14595,37888.0,Desmopressin,allergic rhinitis,disease-exposure-gene-drug,contraindication,"['allergic rhinitis', 'Air Pollutants', 'PTGS1', 'Desmopressin']",0.5
14596,28017.0,Eletriptan,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Eletriptan']",0.5
14596,33091.0,Eletriptan,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Fever', 'HTR1A', 'Eletriptan']",0.5
14596,33302.0,Eletriptan,familial or sporadic hemiplegic migraine,disease-phenotype-protein-drug,contraindication,"['familial or sporadic hemiplegic migraine', 'Coma', 'CYP2D6', 'Eletriptan']",0.5
14596,33575.0,Eletriptan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Eletriptan']",0.5
14596,33575.0,Eletriptan,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Eletriptan']",0.5
14596,33577.0,Eletriptan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Eletriptan']",0.5
14596,33577.0,Eletriptan,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Eletriptan']",0.5
14596,33593.0,Eletriptan,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'regulation of blood pressure', 'PTGS1', 'Eletriptan']",0.5
14596,33593.0,Eletriptan,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CYP2D6', 'Eletriptan']",0.5
14596,35565.0,Eletriptan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Eletriptan']",0.5
14596,35909.0,Eletriptan,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Eletriptan']",0.5
14596,35909.0,Eletriptan,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Eletriptan']",0.5
14596,36187.0,Eletriptan,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Eletriptan']",0.5
14596,36187.0,Eletriptan,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Eletriptan']",0.5
14596,36312.0,Eletriptan,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'regulation of blood pressure', 'PTGS1', 'Eletriptan']",0.5
14596,37180.0,Eletriptan,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Eletriptan']",0.5
14596,37180.0,Eletriptan,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Eletriptan']",0.5
14596,37718.0,Eletriptan,brain ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Eletriptan']",0.5
14596,37718.0,Eletriptan,brain ischemia,disease-exposure-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'PTGS1', 'Eletriptan']",0.5
14596,37786.0,Eletriptan,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Eletriptan']",0.5
14596,37786.0,Eletriptan,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'PTGS1', 'Eletriptan']",0.5
14596,39798.0,Eletriptan,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Eletriptan']",0.5
14596,39798.0,Eletriptan,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'PTGS1', 'Eletriptan']",0.5
14597,27286.0,Dapsone,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PTGS2', 'Dapsone']",0.5
14597,27292.0,Dapsone,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Arrhythmia', 'PTGS2', 'Dapsone']",0.5
14597,29182.0,Dapsone,systemic lupus erythematosus (disease),disease-protein-drug,off-label use,"['systemic lupus erythematosus (disease)', 'PTGS2', 'Dapsone']",0.5
14597,29182.0,Dapsone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Dapsone']",0.5
14597,29182.0,Dapsone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,off-label use,"['systemic lupus erythematosus (disease)', 'Seizure', 'PTGS2', 'Dapsone']",0.5
14597,31168.0,Dapsone,pyruvate dehydrogenase E3 deficiency,disease-phenotype-protein-drug,contraindication,"['pyruvate dehydrogenase E3 deficiency', 'Seizure', 'PTGS2', 'Dapsone']",0.5
14597,32522.0,Dapsone,subcorneal pustular dermatosis,disease-phenotype-protein-drug,off-label use,"['subcorneal pustular dermatosis', 'Erythema', 'PTGS1', 'Dapsone']",0.5
14597,33194.0,Dapsone,bullous pemphigoid,disease-phenotype-protein-drug,off-label use,"['bullous pemphigoid', 'Erythema', 'PTGS1', 'Dapsone']",0.5
14597,33210.0,Dapsone,pneumocystosis,disease-phenotype-protein-drug,off-label use,"['pneumocystosis', 'Fever', 'PTGS2', 'Dapsone']",0.5
14597,33410.0,Dapsone,dermatitis herpetiformis,disease-phenotype-protein-drug,indication,"['dermatitis herpetiformis', 'Erythema', 'PTGS1', 'Dapsone']",0.5
14597,33494.0,Dapsone,pyoderma gangrenosum,disease-phenotype-protein-drug,off-label use,"['pyoderma gangrenosum', 'Fever', 'PTGS2', 'Dapsone']",0.5
14597,33534.0,Dapsone,pediatric systemic lupus erythematosus,disease-protein-drug,off-label use,"['pediatric systemic lupus erythematosus', 'PTGS2', 'Dapsone']",0.5
14597,33534.0,Dapsone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,off-label use,"['pediatric systemic lupus erythematosus', 'Fever', 'PTGS2', 'Dapsone']",0.5
14597,33632.0,Dapsone,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Dapsone']",0.5
14597,33632.0,Dapsone,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Dapsone']",0.5
14597,35565.0,Dapsone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Dapsone']",0.5
14598,27933.0,Dronabinol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Dronabinol']",0.5
14598,27933.0,Dronabinol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Dronabinol']",0.5
14598,28313.0,Dronabinol,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'ABCB1', 'Dronabinol']",0.5
14598,28313.0,Dronabinol,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Dronabinol']",0.5
14598,28313.0,Dronabinol,schizophrenia,disease-exposure-gene-drug,contraindication,"['schizophrenia', 'Air Pollutants', 'PTGS1', 'Dronabinol']",0.5
14598,30035.0,Dronabinol,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Dronabinol']",0.5
14598,33577.0,Dronabinol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'CNR1', 'Dronabinol']",0.5
14598,33577.0,Dronabinol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Dronabinol']",0.5
14598,33605.0,Dronabinol,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'CNR1', 'Dronabinol']",0.5
14598,35641.0,Dronabinol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Dronabinol']",0.5
14598,36693.0,Dronabinol,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CNR1', 'Dronabinol']",0.5
14598,37703.0,Dronabinol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Dronabinol']",0.5
14598,38242.0,Dronabinol,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'CNR2', 'Dronabinol']",0.5
14598,83760.0,Dronabinol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Dronabinol']",0.5
14599,27933.0,Montelukast,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C9', 'Montelukast']",0.5
14599,27933.0,Montelukast,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'respiratory gaseous exchange by respiratory system', 'CYSLTR1', 'Montelukast']",0.5
14599,37888.0,Montelukast,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ALOX5', 'Montelukast']",0.5
14599,37888.0,Montelukast,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Air Pollutants', 'PTGS1', 'Montelukast']",0.5
14599,39773.0,Montelukast,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ALOX5', 'Montelukast']",0.5
14599,83781.0,Montelukast,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ALOX5', 'Montelukast']",0.5
14600,29078.0,Rofecoxib,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCC4', 'Rofecoxib']",0.5
14600,29078.0,Rofecoxib,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Rofecoxib']",0.5
14600,29078.0,Rofecoxib,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Rofecoxib']",0.5
14600,29078.0,Rofecoxib,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Rofecoxib']",0.5
14600,32325.0,Rofecoxib,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Hepatomegaly', 'CYP1A2', 'Rofecoxib']",0.5
14601,27933.0,Zafirlukast,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Zafirlukast']",0.5
14601,27933.0,Zafirlukast,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'respiratory gaseous exchange by respiratory system', 'CYSLTR1', 'Zafirlukast']",0.5
14601,27933.0,Zafirlukast,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Zafirlukast']",0.5
14601,33675.0,Zafirlukast,asthma,disease-protein-drug,indication,"['asthma', 'PTGS1', 'Zafirlukast']",0.5
14601,33675.0,Zafirlukast,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Zafirlukast']",0.5
14601,33675.0,Zafirlukast,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Air Pollutants', 'PTGS1', 'Zafirlukast']",0.5
14601,35565.0,Zafirlukast,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Zafirlukast']",0.5
14601,37703.0,Zafirlukast,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Zafirlukast']",0.5
14601,37765.0,Zafirlukast,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'CYP1A2', 'Zafirlukast']",0.5
14601,83760.0,Zafirlukast,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Zafirlukast']",0.5
14602,27326.0,Voriconazole,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Voriconazole']",0.5
14602,35565.0,Voriconazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Voriconazole']",0.5
14602,83751.0,Voriconazole,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Voriconazole']",0.5
14603,28208.0,Chlorpropamide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Chlorpropamide']",0.5
14603,28208.0,Chlorpropamide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Chlorpropamide']",0.5
14603,28208.0,Chlorpropamide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'PTGS1', 'Chlorpropamide']",0.5
14603,33575.0,Chlorpropamide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Chlorpropamide']",0.5
14603,33575.0,Chlorpropamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Chlorpropamide']",0.5
14603,33575.0,Chlorpropamide,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Chlorpropamide']",0.5
14603,35565.0,Chlorpropamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'ABCC8', 'Chlorpropamide']",0.5
14603,35669.0,Chlorpropamide,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Chlorpropamide']",0.5
14603,35669.0,Chlorpropamide,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Chlorpropamide']",0.5
14603,35761.0,Chlorpropamide,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Chlorpropamide']",0.5
14603,35761.0,Chlorpropamide,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Chlorpropamide']",0.5
14604,28520.0,Etoposide,myeloid leukemia,disease-protein-drug,off-label use,"['myeloid leukemia', 'TOP2B', 'Etoposide']",0.5
14604,28520.0,Etoposide,myeloid leukemia,disease-exposure-bioprocess-gene-drug,off-label use,"['myeloid leukemia', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Etoposide']",0.5
14604,28520.0,Etoposide,myeloid leukemia,disease-exposure-gene-drug,off-label use,"['myeloid leukemia', 'Pesticides', 'CYP2E1', 'Etoposide']",0.5
14604,28520.0,Etoposide,myeloid leukemia,disease-exposure-molfunc-gene-drug,off-label use,"['myeloid leukemia', 'Pesticides', 'glutathione transferase activity', 'GSTP1', 'Etoposide']",0.5
14604,29173.0,Etoposide,small cell lung carcinoma,disease-protein-drug,indication,"['small cell lung carcinoma', 'UGT1A1', 'Etoposide']",0.5
14604,29173.0,Etoposide,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['small cell lung carcinoma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Etoposide']",0.5
14604,29173.0,Etoposide,small cell lung carcinoma,disease-exposure-gene-drug,indication,"['small cell lung carcinoma', 'Arsenic', 'PTGS2', 'Etoposide']",0.5
14604,29993.0,Etoposide,classic Hodgkin lymphoma,disease-protein-drug,off-label use,"['classic Hodgkin lymphoma', 'UGT1A1', 'Etoposide']",0.5
14604,29993.0,Etoposide,classic Hodgkin lymphoma,disease-phenotype-protein-drug,off-label use,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'ABCC3', 'Etoposide']",0.5
14604,30075.0,Etoposide,Burkitt lymphoma,disease-protein-drug,off-label use,"['Burkitt lymphoma', 'CYP2E1', 'Etoposide']",0.5
14604,30075.0,Etoposide,Burkitt lymphoma,disease-exposure-bioprocess-gene-drug,off-label use,"['Burkitt lymphoma', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Etoposide']",0.5
14604,30075.0,Etoposide,Burkitt lymphoma,disease-exposure-gene-drug,off-label use,"['Burkitt lymphoma', 'Pesticides', 'CYP2E1', 'Etoposide']",0.5
14604,30075.0,Etoposide,Burkitt lymphoma,disease-exposure-molfunc-gene-drug,off-label use,"['Burkitt lymphoma', 'Pesticides', 'glutathione transferase activity', 'GSTP1', 'Etoposide']",0.5
14604,30494.0,Etoposide,plasma cell myeloma,disease-protein-drug,off-label use,"['plasma cell myeloma', 'GSTT1', 'Etoposide']",0.5
14604,30494.0,Etoposide,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,off-label use,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Etoposide']",0.5
14604,30494.0,Etoposide,plasma cell myeloma,disease-phenotype-protein-drug,off-label use,"['plasma cell myeloma', 'Splenomegaly', 'CYP1A2', 'Etoposide']",0.5
14604,31116.0,Etoposide,lung cancer,disease-protein-drug,off-label use,"['lung cancer', 'CYP2E1', 'Etoposide']",0.5
14604,31477.0,Etoposide,ovarian cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['ovarian cancer', 'Cadmium', 'regulation of blood pressure', 'PTGS1', 'Etoposide']",0.5
14604,31481.0,Etoposide,bone osteosarcoma,disease-protein-drug,off-label use,"['bone osteosarcoma', 'CYP3A4', 'Etoposide']",0.5
14604,31481.0,Etoposide,bone osteosarcoma,disease-phenotype-protein-drug,off-label use,"['bone osteosarcoma', 'Fever', 'PTGS2', 'Etoposide']",0.5
14604,32589.0,Etoposide,Kaposi's sarcoma (disease),disease-phenotype-protein-drug,off-label use,"[""Kaposi's sarcoma (disease)"", 'Fever', 'PTGS2', 'Etoposide']",0.5
14604,32617.0,Etoposide,hereditary breast ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Etoposide']",0.5
14604,33077.0,Etoposide,Hodgkins lymphoma,disease-protein-drug,off-label use,"['Hodgkins lymphoma', 'UGT1A1', 'Etoposide']",0.5
14604,33077.0,Etoposide,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,off-label use,"['Hodgkins lymphoma', 'Benzene', 'methylation', 'CYP1A2', 'Etoposide']",0.5
14604,33077.0,Etoposide,Hodgkins lymphoma,disease-exposure-gene-drug,off-label use,"['Hodgkins lymphoma', 'Benzene', 'PTGS2', 'Etoposide']",0.5
14604,33077.0,Etoposide,Hodgkins lymphoma,disease-phenotype-protein-drug,off-label use,"['Hodgkins lymphoma', 'Hepatomegaly', 'ABCC3', 'Etoposide']",0.5
14604,33077.0,Etoposide,Hodgkins lymphoma,disease-exposure-molfunc-gene-drug,off-label use,"['Hodgkins lymphoma', 'Pesticides', 'glutathione transferase activity', 'GSTP1', 'Etoposide']",0.5
14604,33188.0,Etoposide,neuroblastoma,disease-protein-drug,off-label use,"['neuroblastoma', 'ABCB1', 'Etoposide']",0.5
14604,33632.0,Etoposide,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Etoposide']",0.5
14604,33632.0,Etoposide,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Etoposide']",0.5
14604,33688.0,Etoposide,non-small cell lung carcinoma (disease),disease-protein-drug,off-label use,"['non-small cell lung carcinoma (disease)', 'CYP2E1', 'Etoposide']",0.5
14604,35471.0,Etoposide,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'cellular response to oxidative stress', 'GSTP1', 'Etoposide']",0.5
14604,35616.0,Etoposide,testicular cancer,disease-exposure-bioprocess-gene-drug,indication,"['testicular cancer', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Etoposide']",0.5
14604,35884.0,Etoposide,diffuse large B-cell lymphoma,disease-protein-drug,off-label use,"['diffuse large B-cell lymphoma', 'CYP2E1', 'Etoposide']",0.5
14604,35884.0,Etoposide,diffuse large B-cell lymphoma,disease-exposure-bioprocess-gene-drug,off-label use,"['diffuse large B-cell lymphoma', 'Polychlorinated Biphenyls', 'methylation', 'CYP1A2', 'Etoposide']",0.5
14604,36104.0,Etoposide,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Etoposide']",0.5
14604,36229.0,Etoposide,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Etoposide']",0.5
14604,36425.0,Etoposide,primary central nervous system lymphoma,disease-protein-drug,off-label use,"['primary central nervous system lymphoma', 'ABCB1', 'Etoposide']",0.5
14604,36544.0,Etoposide,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP2E1', 'Etoposide']",0.5
14604,36544.0,Etoposide,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Etoposide']",0.5
14604,83792.0,Etoposide,obsolete Hodgkin's granuloma,disease-protein-drug,off-label use,"[""obsolete Hodgkin's granuloma"", 'UGT1A1', 'Etoposide']",0.5
14604,83793.0,Etoposide,Hodgkin's paragranuloma,disease-protein-drug,off-label use,"[""Hodgkin's paragranuloma"", 'UGT1A1', 'Etoposide']",0.5
14604,83794.0,Etoposide,"classic Hodgkin lymphoma, lymphocyte-rich type",disease-protein-drug,off-label use,"['classic Hodgkin lymphoma, lymphocyte-rich type', 'UGT1A1', 'Etoposide']",0.5
14604,84154.0,Etoposide,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,off-label use,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Etoposide']",0.5
14604,84155.0,Etoposide,Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly,disease-protein-drug,off-label use,"['Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly', 'ABCB1', 'Etoposide']",0.5
14604,84156.0,Etoposide,plasmablastic lymphoma,disease-protein-drug,off-label use,"['plasmablastic lymphoma', 'ABCB1', 'Etoposide']",0.5
14604,84157.0,Etoposide,diffuse large B-cell lymphoma of the central nervous system,disease-protein-drug,off-label use,"['diffuse large B-cell lymphoma of the central nervous system', 'ABCB1', 'Etoposide']",0.5
14604,84158.0,Etoposide,T-cell/histiocyte rich large B cell lymphoma,disease-protein-drug,off-label use,"['T-cell/histiocyte rich large B cell lymphoma', 'ABCB1', 'Etoposide']",0.5
14604,84159.0,Etoposide,ALK-positive large B-cell lymphoma,disease-protein-drug,off-label use,"['ALK-positive large B-cell lymphoma', 'ABCB1', 'Etoposide']",0.5
14604,84160.0,Etoposide,primary mediastinal large B-cell lymphoma,disease-protein-drug,off-label use,"['primary mediastinal large B-cell lymphoma', 'ABCB1', 'Etoposide']",0.5
14604,84161.0,Etoposide,intravascular large B-cell lymphoma,disease-protein-drug,off-label use,"['intravascular large B-cell lymphoma', 'ABCB1', 'Etoposide']",0.5
14605,29182.0,Candesartan cilexetil,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'PTGS1', 'Candesartan cilexetil']",0.5
14605,33534.0,Candesartan cilexetil,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'AGTR1', 'Candesartan cilexetil']",0.5
14605,33575.0,Candesartan cilexetil,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Candesartan cilexetil']",0.5
14605,33575.0,Candesartan cilexetil,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Candesartan cilexetil']",0.5
14605,33577.0,Candesartan cilexetil,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Candesartan cilexetil']",0.5
14605,33577.0,Candesartan cilexetil,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Candesartan cilexetil']",0.5
14605,33577.0,Candesartan cilexetil,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Candesartan cilexetil']",0.5
14605,33618.0,Candesartan cilexetil,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'PTGS1', 'Candesartan cilexetil']",0.5
14605,33618.0,Candesartan cilexetil,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Air Pollutants', 'PTGS1', 'Candesartan cilexetil']",0.5
14605,35565.0,Candesartan cilexetil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Candesartan cilexetil']",0.5
14605,36035.0,Candesartan cilexetil,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Candesartan cilexetil']",0.5
14605,83802.0,Candesartan cilexetil,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Candesartan cilexetil']",0.5
14606,28396.0,Thalidomide,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Skeletal muscle atrophy', 'TNF', 'Thalidomide']",0.5
14606,30494.0,Thalidomide,plasma cell myeloma,disease-protein-drug,indication,"['plasma cell myeloma', 'CRBN', 'Thalidomide']",0.5
14606,30494.0,Thalidomide,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Thalidomide']",0.5
14606,30494.0,Thalidomide,plasma cell myeloma,disease-exposure-gene-drug,indication,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Thalidomide']",0.5
14606,32520.0,Thalidomide,graft versus host disease,disease-phenotype-protein-drug,off-label use,"['graft versus host disease', 'Erythema', 'PTGS1', 'Thalidomide']",0.5
14606,33699.0,Thalidomide,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Thalidomide']",0.5
14606,33699.0,Thalidomide,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'TNF', 'Thalidomide']",0.5
14606,35641.0,Thalidomide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'PTGS2', 'Thalidomide']",0.5
14606,35751.0,Thalidomide,peripheral nervous system disease,disease-exposure-gene-drug,contraindication,"['peripheral nervous system disease', 'Agent Orange', 'CYP1A1', 'Thalidomide']",0.5
14607,37888.0,Diphenhydramine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Diphenhydramine']",0.5
14607,37888.0,Diphenhydramine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Diphenhydramine']",0.5
14607,37888.0,Diphenhydramine,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Air Pollutants', 'PTGS1', 'Diphenhydramine']",0.5
14607,83791.0,Diphenhydramine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Diphenhydramine']",0.5
14608,27476.0,Ifosfamide,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Ifosfamide']",0.5
14608,29173.0,Ifosfamide,small cell lung carcinoma,disease-protein-drug,off-label use,"['small cell lung carcinoma', 'CYP2A6', 'Ifosfamide']",0.5
14608,29173.0,Ifosfamide,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR1I2', 'Ifosfamide']",0.5
14608,30075.0,Ifosfamide,Burkitt lymphoma,disease-exposure-bioprocess-gene-drug,off-label use,"['Burkitt lymphoma', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Ifosfamide']",0.5
14608,31116.0,Ifosfamide,lung cancer,disease-protein-drug,off-label use,"['lung cancer', 'CYP2A6', 'Ifosfamide']",0.5
14608,31481.0,Ifosfamide,bone osteosarcoma,disease-protein-drug,off-label use,"['bone osteosarcoma', 'NR1I2', 'Ifosfamide']",0.5
14608,33632.0,Ifosfamide,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Ifosfamide']",0.5
14608,33632.0,Ifosfamide,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Ifosfamide']",0.5
14608,35565.0,Ifosfamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Ifosfamide']",0.5
14608,35764.0,Ifosfamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Ifosfamide']",0.5
14609,27933.0,Zopiclone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRA3', 'Zopiclone']",0.5
14609,27933.0,Zopiclone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Zopiclone']",0.5
14609,27933.0,Zopiclone,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Zopiclone']",0.5
14609,37703.0,Zopiclone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRA3', 'Zopiclone']",0.5
14609,83760.0,Zopiclone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRA3', 'Zopiclone']",0.5
14610,27933.0,Ketamine,anxiety disorder,disease-protein-drug,off-label use,"['anxiety disorder', 'SLC6A2', 'Ketamine']",0.5
14610,27933.0,Ketamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Ketamine']",0.5
14610,27933.0,Ketamine,anxiety disorder,disease-exposure-gene-drug,off-label use,"['anxiety disorder', 'Insecticides', 'BCHE', 'Ketamine']",0.5
14610,27933.0,Ketamine,anxiety disorder,disease-exposure-molfunc-gene-drug,off-label use,"['anxiety disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ketamine']",0.5
14610,30035.0,Ketamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Ketamine']",0.5
14610,31072.0,Ketamine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Ketamine']",0.5
14610,33577.0,Ketamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Ketamine']",0.5
14610,33577.0,Ketamine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Ketamine']",0.5
14610,33577.0,Ketamine,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ketamine']",0.5
14610,33598.0,Ketamine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'CHRM1', 'Ketamine']",0.5
14610,33598.0,Ketamine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'BCHE', 'Ketamine']",0.5
14610,33598.0,Ketamine,stroke disorder,disease-exposure-molfunc-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Ketamine']",0.5
14610,35909.0,Ketamine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Ketamine']",0.5
14610,35909.0,Ketamine,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Ketamine']",0.5
14610,36034.0,Ketamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Ketamine']",0.5
14610,36034.0,Ketamine,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Ketamine']",0.5
14610,36034.0,Ketamine,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Ketamine']",0.5
14610,36080.0,Ketamine,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Ketamine']",0.5
14610,36080.0,Ketamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of blood pressure', 'PTGS1', 'Ketamine']",0.5
14610,36080.0,Ketamine,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'PTGS1', 'Ketamine']",0.5
14610,36187.0,Ketamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketamine']",0.5
14610,36187.0,Ketamine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Ketamine']",0.5
14610,36187.0,Ketamine,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ketamine']",0.5
14610,37180.0,Ketamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketamine']",0.5
14610,37180.0,Ketamine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Ketamine']",0.5
14610,37180.0,Ketamine,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ketamine']",0.5
14610,37565.0,Ketamine,delirium,disease-protein-drug,contraindication,"['delirium', 'DRD2', 'Ketamine']",0.5
14610,37786.0,Ketamine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketamine']",0.5
14610,37786.0,Ketamine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'PTGS1', 'Ketamine']",0.5
14610,37786.0,Ketamine,myocardial ischemia,disease-exposure-molfunc-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ketamine']",0.5
14610,38957.0,Ketamine,major depressive disorder,disease-protein-drug,off-label use,"['major depressive disorder', 'HTR1B', 'Ketamine']",0.5
14610,38957.0,Ketamine,major depressive disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['major depressive disorder', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Ketamine']",0.5
14610,83840.0,Ketamine,unipolar depression,disease-protein-drug,off-label use,"['unipolar depression', 'SLC6A2', 'Ketamine']",0.5
14610,83841.0,Ketamine,endogenous depression,disease-protein-drug,off-label use,"['endogenous depression', 'HTR1B', 'Ketamine']",0.5
14612,32617.0,Trabectedin,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'CYP3A4', 'Trabectedin']",0.5
14619,27361.0,"Antihemophilic factor, human recombinant",hemophilia,disease-protein-drug,indication,"['hemophilia', 'F9', 'Antihemophilic factor, human recombinant']",0.5
14619,27361.0,"Antihemophilic factor, human recombinant",hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Thromboembolism', 'PROC', 'Antihemophilic factor, human recombinant']",0.5
14621,27361.0,Lonoctocog alfa,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F9', 'Lonoctocog alfa']",0.5
14621,27361.0,Lonoctocog alfa,hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Thromboembolism', 'PROC', 'Lonoctocog alfa']",0.5
14621,32354.0,Lonoctocog alfa,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F9', 'Lonoctocog alfa']",0.5
14622,32354.0,Moroctocog alfa,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F9', 'Moroctocog alfa']",0.5
14623,29182.0,Prasterone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Prasterone']",0.5
14623,29182.0,Prasterone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,indication,"['systemic lupus erythematosus (disease)', 'Seizure', 'SIGMAR1', 'Prasterone']",0.5
14623,33534.0,Prasterone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,indication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'PPARA', 'Prasterone']",0.5
14623,83995.0,Prasterone,psychologic dyspareunia,disease-protein-drug,indication,"['psychologic dyspareunia', 'CYP17A1', 'Prasterone']",0.5
14628,33621.0,Tioguanine,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['acute lymphoblastic leukemia (disease)', 'Particulate Matter', 'platelet degranulation', 'ABCC4', 'Tioguanine']",0.5
14628,83802.0,Tioguanine,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'HPRT1', 'Tioguanine']",0.5
14629,27933.0,Tryptophan,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'TDO2', 'Tryptophan']",0.5
14629,27933.0,Tryptophan,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'thyroid hormone metabolic process', 'SLC16A2', 'Tryptophan']",0.5
14629,28313.0,Tryptophan,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'TDO2', 'Tryptophan']",0.5
14629,28478.0,Tryptophan,autoimmune disease,disease-exposure-bioprocess-gene-drug,contraindication,"['autoimmune disease', 'Particulate Matter', 'platelet degranulation', 'TPH1', 'Tryptophan']",0.5
14629,29182.0,Tryptophan,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'platelet degranulation', 'TPH1', 'Tryptophan']",0.5
14629,33534.0,Tryptophan,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Fever', 'TPH2', 'Tryptophan']",0.5
14629,37703.0,Tryptophan,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'TPH2', 'Tryptophan']",0.5
14629,83760.0,Tryptophan,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'TPH2', 'Tryptophan']",0.5
14633,28313.0,Lumateperone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Lumateperone']",0.5
14633,28313.0,Lumateperone,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'SLC6A4', 'Lumateperone']",0.5
14634,37659.0,Nitric Oxide,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Nitric Oxide']",0.5
14634,38462.0,Nitric Oxide,sulfhemoglobinemia,disease-protein-drug,contraindication,"['sulfhemoglobinemia', 'CYP1A2', 'Nitric Oxide']",0.5
14634,39480.0,Nitric Oxide,methemoglobinemia,disease-protein-drug,contraindication,"['methemoglobinemia', 'CYP1A2', 'Nitric Oxide']",0.5
14635,28052.0,Nitroglycerin,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Cardiomegaly', 'NPR1', 'Nitroglycerin']",0.5
14635,33632.0,Nitroglycerin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'NPR1', 'Nitroglycerin']",0.5
14635,37180.0,Nitroglycerin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'NPR1', 'Nitroglycerin']",0.5
14635,83942.0,Nitroglycerin,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'regulation of blood pressure', 'NPR1', 'Nitroglycerin']",0.5
14636,33632.0,Amyl Nitrite,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'NPR1', 'Amyl Nitrite']",0.5
14636,83942.0,Amyl Nitrite,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'regulation of blood pressure', 'NPR1', 'Amyl Nitrite']",0.5
14638,30374.0,Benzyl alcohol,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,31395.0,Benzyl alcohol,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,33575.0,Benzyl alcohol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Benzyl alcohol']",0.5
14638,33575.0,Benzyl alcohol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,33575.0,Benzyl alcohol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,35953.0,Benzyl alcohol,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Benzyl alcohol']",0.5
14638,35953.0,Benzyl alcohol,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,36034.0,Benzyl alcohol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,36187.0,Benzyl alcohol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,36187.0,Benzyl alcohol,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,37617.0,Benzyl alcohol,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,37617.0,Benzyl alcohol,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,37617.0,Benzyl alcohol,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'CYP1A1', 'Benzyl alcohol']",0.5
14638,37770.0,Benzyl alcohol,contact dermatitis,disease-protein-drug,contraindication,"['contact dermatitis', 'ALDH2', 'Benzyl alcohol']",0.5
14638,83777.0,Benzyl alcohol,occupational dermatitis,disease-protein-drug,contraindication,"['occupational dermatitis', 'ALDH2', 'Benzyl alcohol']",0.5
14640,27476.0,Propylthiouracil,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'memory', 'DBH', 'Propylthiouracil']",0.5
14640,29494.0,Propylthiouracil,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A1', 'Propylthiouracil']",0.5
14640,30184.0,Propylthiouracil,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A1', 'Propylthiouracil']",0.5
14640,31732.0,Propylthiouracil,myxedema,disease-protein-drug,contraindication,"['myxedema', 'TPO', 'Propylthiouracil']",0.5
14640,32719.0,Propylthiouracil,congenital hypothyroidism,disease-protein-drug,contraindication,"['congenital hypothyroidism', 'TPO', 'Propylthiouracil']",0.5
14640,36034.0,Propylthiouracil,hyperthyroidism,disease-exposure-bioprocess-gene-drug,indication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'DBH', 'Propylthiouracil']",0.5
14640,36469.0,Propylthiouracil,hypothyroidism,disease-protein-drug,contraindication,"['hypothyroidism', 'TPO', 'Propylthiouracil']",0.5
14640,36469.0,Propylthiouracil,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'DBH', 'Propylthiouracil']",0.5
14640,36544.0,Propylthiouracil,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'memory', 'DBH', 'Propylthiouracil']",0.5
14641,31122.0,Dopamine,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'MAOB', 'Dopamine']",0.5
14641,31122.0,Dopamine,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'SOD1', 'Dopamine']",0.5
14641,33605.0,Dopamine,hypotensive disorder,disease-protein-drug,indication,"['hypotensive disorder', 'MAOB', 'Dopamine']",0.5
14641,35735.0,Dopamine,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'MAOB', 'Dopamine']",0.5
14641,35894.0,Dopamine,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'MAOB', 'Dopamine']",0.5
14641,35895.0,Dopamine,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'MAOB', 'Dopamine']",0.5
14641,36149.0,Dopamine,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'MAOB', 'Dopamine']",0.5
14641,36860.0,Dopamine,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'MAOB', 'Dopamine']",0.5
14641,37919.0,Dopamine,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'MAOB', 'Dopamine']",0.5
14643,27361.0,Capsaicin,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'GLUL', 'Capsaicin']",0.5
14643,28374.0,Capsaicin,gastroesophageal reflux disease,disease-protein-drug,contraindication,"['gastroesophageal reflux disease', 'PTGS2', 'Capsaicin']",0.5
14643,28374.0,Capsaicin,gastroesophageal reflux disease,disease-phenotype-protein-drug,contraindication,"['gastroesophageal reflux disease', 'Gastroesophageal reflux', 'TRPV1', 'Capsaicin']",0.5
14643,29525.0,Capsaicin,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'PTGS2', 'Capsaicin']",0.5
14643,33440.0,Capsaicin,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Fever', 'PTGS2', 'Capsaicin']",0.5
14643,33575.0,Capsaicin,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Capsaicin']",0.5
14643,33575.0,Capsaicin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'MPO', 'Capsaicin']",0.5
14643,33575.0,Capsaicin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS2', 'Capsaicin']",0.5
14643,33575.0,Capsaicin,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,33577.0,Capsaicin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'DBH', 'Capsaicin']",0.5
14643,33577.0,Capsaicin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS2', 'Capsaicin']",0.5
14643,33577.0,Capsaicin,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,33598.0,Capsaicin,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Capsaicin']",0.5
14643,33598.0,Capsaicin,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Capsaicin']",0.5
14643,33598.0,Capsaicin,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Capsaicin']",0.5
14643,33598.0,Capsaicin,stroke disorder,disease-exposure-molfunc-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,33632.0,Capsaicin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'choline metabolic process', 'BCHE', 'Capsaicin']",0.5
14643,33632.0,Capsaicin,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS2', 'Capsaicin']",0.5
14643,33714.0,Capsaicin,esophagitis (disease),disease-protein-drug,contraindication,"['esophagitis (disease)', 'PTGS2', 'Capsaicin']",0.5
14643,35565.0,Capsaicin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Capsaicin']",0.5
14643,35641.0,Capsaicin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'PTGS2', 'Capsaicin']",0.5
14643,35641.0,Capsaicin,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DBH', 'Capsaicin']",0.5
14643,35669.0,Capsaicin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PHB2', 'Capsaicin']",0.5
14643,35669.0,Capsaicin,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS2', 'Capsaicin']",0.5
14643,35669.0,Capsaicin,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,35761.0,Capsaicin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'MPO', 'Capsaicin']",0.5
14643,35761.0,Capsaicin,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS2', 'Capsaicin']",0.5
14643,35761.0,Capsaicin,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,35764.0,Capsaicin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'DBH', 'Capsaicin']",0.5
14643,35764.0,Capsaicin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Capsaicin']",0.5
14643,35764.0,Capsaicin,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,35909.0,Capsaicin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Capsaicin']",0.5
14643,35909.0,Capsaicin,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS2', 'Capsaicin']",0.5
14643,36034.0,Capsaicin,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Capsaicin']",0.5
14643,36034.0,Capsaicin,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Capsaicin']",0.5
14643,36034.0,Capsaicin,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,36080.0,Capsaicin,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Capsaicin']",0.5
14643,36080.0,Capsaicin,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'PTGS2', 'Capsaicin']",0.5
14643,36644.0,Capsaicin,skin disease,disease-exposure-bioprocess-gene-drug,contraindication,"['skin disease', 'Mustard Gas', 'regulation of gene expression', 'CYP1A2', 'Capsaicin']",0.5
14643,36644.0,Capsaicin,skin disease,disease-exposure-gene-drug,contraindication,"['skin disease', 'Pesticides', 'CYP2E1', 'Capsaicin']",0.5
14643,36644.0,Capsaicin,skin disease,disease-exposure-molfunc-gene-drug,contraindication,"['skin disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,37180.0,Capsaicin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PHB2', 'Capsaicin']",0.5
14643,37180.0,Capsaicin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS2', 'Capsaicin']",0.5
14643,37180.0,Capsaicin,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Capsaicin']",0.5
14643,83878.0,Capsaicin,peptic esophagitis,disease-protein-drug,contraindication,"['peptic esophagitis', 'PTGS2', 'Capsaicin']",0.5
14644,27933.0,Sodium oxybate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Lead', 'glutamate metabolic process', 'ALDH5A1', 'Sodium oxybate']",0.5
14644,28588.0,Sodium oxybate,succinic semialdehyde dehydrogenase deficiency,disease-protein-drug,contraindication,"['succinic semialdehyde dehydrogenase deficiency', 'ALDH5A1', 'Sodium oxybate']",0.5
14644,33577.0,Sodium oxybate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Lead', 'glutamate metabolic process', 'ALDH5A1', 'Sodium oxybate']",0.5
14645,31918.0,Methionine,phenylketonuria,disease-phenotype-protein-drug,contraindication,"['phenylketonuria', 'Seizure', 'MTHFR', 'Methionine']",0.5
14645,32967.0,Methionine,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Thrombocytopenia', 'MTHFR', 'Methionine']",0.5
14645,33575.0,Methionine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'MAT1A', 'Methionine']",0.5
14645,33575.0,Methionine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'MSRB2', 'Methionine']",0.5
14645,33575.0,Methionine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'MTHFR', 'Methionine']",0.5
14645,33577.0,Methionine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'DNA methylation', 'MTRR', 'Methionine']",0.5
14645,35669.0,Methionine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'DNA methylation', 'MTRR', 'Methionine']",0.5
14645,35761.0,Methionine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'MSRB2', 'Methionine']",0.5
14645,35761.0,Methionine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'MTHFR', 'Methionine']",0.5
14645,35764.0,Methionine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'selenium compound metabolic process', 'MAT1A', 'Methionine']",0.5
14645,36040.0,Methionine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'perfluorooctanoic acid', 'DNA methylation', 'MTRR', 'Methionine']",0.5
14645,83923.0,Methionine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cell population proliferation', 'GLUL', 'Methionine']",0.5
14646,37785.0,Succinic acid,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'adipose tissue development', 'OXCT1', 'Succinic acid']",0.5
14650,33632.0,Dabigatran etexilate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'UGT2B7', 'Dabigatran etexilate']",0.5
14650,83942.0,Dabigatran etexilate,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'memory', 'NQO2', 'Dabigatran etexilate']",0.5
14655,36644.0,Masoprocol,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'lipid oxidation', 'ALOX5', 'Masoprocol']",0.5
14656,28005.0,Cannabidiol,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,indication,"['developmental and epileptic encephalopathy', 'Intrauterine growth retardation', 'SOD1', 'Cannabidiol']",0.5
14656,29865.0,Cannabidiol,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Focal-onset seizure', 'OPRM1', 'Cannabidiol']",0.5
14656,32456.0,Cannabidiol,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'OPRM1', 'Cannabidiol']",0.5
14658,33695.0,Omega-3 fatty acids,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'glucose homeostasis', 'ALOX5', 'Omega-3 fatty acids']",0.5
14662,33675.0,Ribavirin,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'perfluorooctanoic acid', 'lactation', 'SLC29A1', 'Ribavirin']",0.5
14662,36187.0,Ribavirin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'perfluorooctanoic acid', 'lactation', 'SLC29A1', 'Ribavirin']",0.5
14662,37786.0,Ribavirin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'perfluorooctanoic acid', 'lactation', 'SLC29A1', 'Ribavirin']",0.5
14662,39884.0,Ribavirin,respiratory syncytial virus infectious disease,disease-exposure-bioprocess-gene-drug,indication,"['respiratory syncytial virus infectious disease', 'perfluorooctanoic acid', 'lactation', 'SLC29A1', 'Ribavirin']",0.5
14663,28520.0,Aldesleukin,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Aldesleukin']",0.5
14663,28520.0,Aldesleukin,myeloid leukemia,disease-exposure-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'CYP2E1', 'Aldesleukin']",0.5
14664,31918.0,Sapropterin,phenylketonuria,disease-protein-drug,indication,"['phenylketonuria', 'PAH', 'Sapropterin']",0.5
14664,31918.0,Sapropterin,phenylketonuria,disease-phenotype-protein-drug,indication,"['phenylketonuria', 'Intrauterine growth retardation', 'NOS3', 'Sapropterin']",0.5
14664,38741.0,Sapropterin,disorder of phenylalanine metabolism,disease-protein-drug,indication,"['disorder of phenylalanine metabolism', 'PAH', 'Sapropterin']",0.5
14667,29614.0,Risedronic acid,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'bone mineralization', 'PTGS2', 'Risedronic acid']",0.5
14667,32967.0,Risedronic acid,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Fever', 'PTGS2', 'Risedronic acid']",0.5
14667,35764.0,Risedronic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS2', 'Risedronic acid']",0.5
14667,35764.0,Risedronic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Risedronic acid']",0.5
14668,33577.0,Bumetanide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS2', 'Bumetanide']",0.5
14668,33577.0,Bumetanide,hypertensive disorder,disease-exposure-gene-drug,off-label use,"['hypertensive disorder', 'Air Pollutants', 'PTGS2', 'Bumetanide']",0.5
14668,35565.0,Bumetanide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Bumetanide']",0.5
14668,36432.0,Bumetanide,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'PTGS2', 'Bumetanide']",0.5
14668,83802.0,Bumetanide,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Bumetanide']",0.5
14669,29078.0,Bromfenac,rheumatoid arthritis,disease-protein-drug,contraindication,"['rheumatoid arthritis', 'PTGS1', 'Bromfenac']",0.5
14669,29078.0,Bromfenac,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,contraindication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Bromfenac']",0.5
14669,29078.0,Bromfenac,rheumatoid arthritis,disease-exposure-gene-drug,contraindication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Bromfenac']",0.5
14669,29078.0,Bromfenac,rheumatoid arthritis,disease-phenotype-protein-drug,contraindication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Bromfenac']",0.5
14669,33575.0,Bromfenac,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Bromfenac']",0.5
14669,33575.0,Bromfenac,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Bromfenac']",0.5
14670,27933.0,Drospirenone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'PTGS2', 'Drospirenone']",0.5
14670,27933.0,Drospirenone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of systemic arterial blood pressure', 'AR', 'Drospirenone']",0.5
14670,27933.0,Drospirenone,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PTGS2', 'Drospirenone']",0.5
14670,28651.0,Drospirenone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'PTGS2', 'Drospirenone']",0.5
14670,29061.0,Drospirenone,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'NR3C2', 'Drospirenone']",0.5
14670,29113.0,Drospirenone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Drospirenone']",0.5
14670,29182.0,Drospirenone,systemic lupus erythematosus (disease),disease-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'PTGS2', 'Drospirenone']",0.5
14670,29182.0,Drospirenone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Drospirenone']",0.5
14670,29182.0,Drospirenone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'PTGS2', 'Drospirenone']",0.5
14670,29220.0,Drospirenone,hyperlipoproteinemia,disease-protein-drug,contraindication,"['hyperlipoproteinemia', 'PON1', 'Drospirenone']",0.5
14670,30813.0,Drospirenone,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'PTGS2', 'Drospirenone']",0.5
14670,30827.0,Drospirenone,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Drospirenone']",0.5
14670,32617.0,Drospirenone,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'PTGS2', 'Drospirenone']",0.5
14670,32719.0,Drospirenone,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'PTGS2', 'Drospirenone']",0.5
14670,32977.0,Drospirenone,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Fever', 'PTGS2', 'Drospirenone']",0.5
14670,33534.0,Drospirenone,pediatric systemic lupus erythematosus,disease-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'PTGS2', 'Drospirenone']",0.5
14670,33534.0,Drospirenone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Fever', 'PTGS2', 'Drospirenone']",0.5
14670,33575.0,Drospirenone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS2', 'Drospirenone']",0.5
14670,33575.0,Drospirenone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS2', 'Drospirenone']",0.5
14670,33575.0,Drospirenone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Drospirenone']",0.5
14670,33577.0,Drospirenone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS2', 'Drospirenone']",0.5
14670,33577.0,Drospirenone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'PON1', 'Drospirenone']",0.5
14670,33593.0,Drospirenone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'PTGS2', 'Drospirenone']",0.5
14670,33593.0,Drospirenone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'regulation of blood pressure', 'PTGS2', 'Drospirenone']",0.5
14670,33593.0,Drospirenone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Lead', 'PON1', 'Drospirenone']",0.5
14670,33598.0,Drospirenone,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Drospirenone']",0.5
14670,33598.0,Drospirenone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Drospirenone']",0.5
14670,33598.0,Drospirenone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS2', 'Drospirenone']",0.5
14670,33675.0,Drospirenone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Drospirenone']",0.5
14670,33675.0,Drospirenone,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'PTGS2', 'Drospirenone']",0.5
14670,33680.0,Drospirenone,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'NR3C2', 'Drospirenone']",0.5
14670,33680.0,Drospirenone,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'regulation of blood pressure', 'PTGS2', 'Drospirenone']",0.5
14670,33680.0,Drospirenone,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'monobutyl phthalate', 'PTGS2', 'Drospirenone']",0.5
14670,33695.0,Drospirenone,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'regulation of blood pressure', 'PTGS2', 'Drospirenone']",0.5
14670,33695.0,Drospirenone,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'PON1', 'Drospirenone']",0.5
14670,33699.0,Drospirenone,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Drospirenone']",0.5
14670,33699.0,Drospirenone,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'PTGS2', 'Drospirenone']",0.5
14670,35565.0,Drospirenone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Drospirenone']",0.5
14670,35641.0,Drospirenone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'PTGS2', 'Drospirenone']",0.5
14670,35738.0,Drospirenone,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Drospirenone']",0.5
14670,35739.0,Drospirenone,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'PGR', 'Drospirenone']",0.5
14670,35764.0,Drospirenone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS2', 'Drospirenone']",0.5
14670,35764.0,Drospirenone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Mercury', 'PON1', 'Drospirenone']",0.5
14670,35901.0,Drospirenone,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'PTGS2', 'Drospirenone']",0.5
14670,35909.0,Drospirenone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Drospirenone']",0.5
14670,35909.0,Drospirenone,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS2', 'Drospirenone']",0.5
14670,35958.0,Drospirenone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'NR3C2', 'Drospirenone']",0.5
14670,36187.0,Drospirenone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PTGS2', 'Drospirenone']",0.5
14670,36187.0,Drospirenone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Drospirenone']",0.5
14670,36187.0,Drospirenone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS2', 'Drospirenone']",0.5
14670,36469.0,Drospirenone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Drospirenone']",0.5
14670,37038.0,Drospirenone,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Drospirenone']",0.5
14670,37180.0,Drospirenone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'NR3C2', 'Drospirenone']",0.5
14670,37180.0,Drospirenone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Drospirenone']",0.5
14670,37180.0,Drospirenone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS2', 'Drospirenone']",0.5
14670,37573.0,Drospirenone,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Drospirenone']",0.5
14670,37573.0,Drospirenone,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'PTGS2', 'Drospirenone']",0.5
14670,37703.0,Drospirenone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'NR3C2', 'Drospirenone']",0.5
14670,37764.0,Drospirenone,familial hyperlipidemia,disease-protein-drug,contraindication,"['familial hyperlipidemia', 'PON1', 'Drospirenone']",0.5
14670,83760.0,Drospirenone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'NR3C2', 'Drospirenone']",0.5
14670,83823.0,Drospirenone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'NR3C2', 'Drospirenone']",0.5
14670,83824.0,Drospirenone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'NR3C2', 'Drospirenone']",0.5
14677,36026.0,Tafluprost,open-angle glaucoma,disease-protein-drug,indication,"['open-angle glaucoma', 'PTGS2', 'Tafluprost']",0.5
14678,28158.0,Folic acid,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'MTHFR', 'Folic acid']",0.5
14678,28158.0,Folic acid,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'FOLR2', 'Folic acid']",0.5
14678,28249.0,Folic acid,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'MTHFR', 'Folic acid']",0.5
14678,28921.0,Folic acid,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Hepatomegaly', 'ABCC3', 'Folic acid']",0.5
14678,29946.0,Folic acid,primary hyperoxaluria,disease-phenotype-protein-drug,contraindication,"['primary hyperoxaluria', 'Elevated hepatic transaminase', 'MTHFR', 'Folic acid']",0.5
14678,31502.0,Folic acid,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Hepatomegaly', 'ABCC3', 'Folic acid']",0.5
14678,32967.0,Folic acid,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'ABCC3', 'Folic acid']",0.5
14678,33575.0,Folic acid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'FOLR2', 'Folic acid']",0.5
14678,33575.0,Folic acid,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'MTHFR', 'Folic acid']",0.5
14678,33594.0,Folic acid,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'response to folic acid', 'MTHFR', 'Folic acid']",0.5
14678,35764.0,Folic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to folic acid', 'MTHFR', 'Folic acid']",0.5
14678,38242.0,Folic acid,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'MTHFR', 'Folic acid']",0.5
14680,31502.0,Zinc acetate,Wilson disease,disease-protein-drug,indication,"['Wilson disease', 'A2M', 'Zinc acetate']",0.5
14680,31502.0,Zinc acetate,Wilson disease,disease-phenotype-protein-drug,indication,"['Wilson disease', 'Increased body weight', 'APP', 'Zinc acetate']",0.5
14680,32977.0,Zinc acetate,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Paresthesia', 'INS', 'Zinc acetate']",0.5
14680,33649.0,Zinc acetate,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Ozone', 'heart contraction', 'SOD1', 'Zinc acetate']",0.5
14680,33649.0,Zinc acetate,exanthem (disease),disease-exposure-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'TP53', 'Zinc acetate']",0.5
14680,36214.0,Zinc acetate,iron metabolism disease,disease-protein-drug,indication,"['iron metabolism disease', 'A2M', 'Zinc acetate']",0.5
14680,36924.0,Zinc acetate,dermatitis,disease-protein-drug,indication,"['dermatitis', 'PARP1', 'Zinc acetate']",0.5
14680,37627.0,Zinc acetate,hemorrhoid,disease-protein-drug,indication,"['hemorrhoid', 'PON1', 'Zinc acetate']",0.5
14680,38641.0,Zinc acetate,hereditary hemochromatosis,disease-protein-drug,indication,"['hereditary hemochromatosis', 'A2M', 'Zinc acetate']",0.5
14681,33575.0,Ademetionine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'MAT1A', 'Ademetionine']",0.5
14681,33575.0,Ademetionine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'selenium compound metabolic process', 'MAT1A', 'Ademetionine']",0.5
14681,33575.0,Ademetionine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'AS3MT', 'Ademetionine']",0.5
14681,33577.0,Ademetionine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'triglyceride metabolic process', 'CYP2E1', 'Ademetionine']",0.5
14681,33577.0,Ademetionine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'AS3MT', 'Ademetionine']",0.5
14682,35565.0,Trimetrexate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'female pregnancy', 'SLC19A1', 'Trimetrexate']",0.5
14685,27933.0,Progesterone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Progesterone']",0.5
14685,27933.0,Progesterone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of systemic arterial blood pressure', 'AR', 'Progesterone']",0.5
14685,27933.0,Progesterone,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Progesterone']",0.5
14685,28017.0,Progesterone,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Progesterone']",0.5
14685,28651.0,Progesterone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A3', 'Progesterone']",0.5
14685,29061.0,Progesterone,endometriosis of uterus,disease-protein-drug,indication,"['endometriosis of uterus', 'NR3C2', 'Progesterone']",0.5
14685,29113.0,Progesterone,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Progesterone']",0.5
14685,29182.0,Progesterone,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Progesterone']",0.5
14685,29182.0,Progesterone,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Progesterone']",0.5
14685,29182.0,Progesterone,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'OPRK1', 'Progesterone']",0.5
14685,29614.0,Progesterone,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Progesterone']",0.5
14685,29614.0,Progesterone,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SHBG', 'Progesterone']",0.5
14685,29646.0,Progesterone,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ABCB1', 'Progesterone']",0.5
14685,29646.0,Progesterone,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Progesterone']",0.5
14685,29646.0,Progesterone,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'CYP1B1', 'Progesterone']",0.5
14685,29646.0,Progesterone,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'CYP1A1', 'Progesterone']",0.5
14685,29908.0,Progesterone,familial male-limited precocious puberty,disease-phenotype-protein-drug,off-label use,"['familial male-limited precocious puberty', 'Male infertility', 'CYP17A1', 'Progesterone']",0.5
14685,30035.0,Progesterone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Progesterone']",0.5
14685,30756.0,Progesterone,polycystic ovary syndrome,disease-phenotype-protein-drug,off-label use,"['polycystic ovary syndrome', 'Oligomenorrhea', 'CYP17A1', 'Progesterone']",0.5
14685,30827.0,Progesterone,endometrial cancer,disease-protein-drug,indication,"['endometrial cancer', 'PGR', 'Progesterone']",0.5
14685,31477.0,Progesterone,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Progesterone']",0.5
14685,31477.0,Progesterone,ovarian cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'inflammatory response', 'ORM1', 'Progesterone']",0.5
14685,31596.0,Progesterone,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Progesterone']",0.5
14685,32617.0,Progesterone,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Progesterone']",0.5
14685,32719.0,Progesterone,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Progesterone']",0.5
14685,32977.0,Progesterone,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'OPRK1', 'Progesterone']",0.5
14685,32990.0,Progesterone,precocious puberty,disease-phenotype-protein-drug,off-label use,"['precocious puberty', 'Increased body weight', 'CYP2D6', 'Progesterone']",0.5
14685,33512.0,Progesterone,preeclampsia,disease-exposure-bioprocess-gene-drug,contraindication,"['preeclampsia', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Progesterone']",0.5
14685,33512.0,Progesterone,preeclampsia,disease-exposure-gene-drug,contraindication,"['preeclampsia', 'Pesticides', 'CYP1A1', 'Progesterone']",0.5
14685,33534.0,Progesterone,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'OPRK1', 'Progesterone']",0.5
14685,33575.0,Progesterone,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Progesterone']",0.5
14685,33575.0,Progesterone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Progesterone']",0.5
14685,33575.0,Progesterone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Progesterone']",0.5
14685,33575.0,Progesterone,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Progesterone']",0.5
14685,33577.0,Progesterone,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Progesterone']",0.5
14685,33577.0,Progesterone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Progesterone']",0.5
14685,33577.0,Progesterone,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Progesterone']",0.5
14685,33593.0,Progesterone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A3', 'Progesterone']",0.5
14685,33593.0,Progesterone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'DNA methylation', 'CYP1A1', 'Progesterone']",0.5
14685,33593.0,Progesterone,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Progesterone']",0.5
14685,33593.0,Progesterone,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CYP2D6', 'Progesterone']",0.5
14685,33598.0,Progesterone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Progesterone']",0.5
14685,33598.0,Progesterone,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Progesterone']",0.5
14685,33675.0,Progesterone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Progesterone']",0.5
14685,33675.0,Progesterone,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Progesterone']",0.5
14685,33680.0,Progesterone,endometriosis (disease),disease-protein-drug,indication,"['endometriosis (disease)', 'NR3C2', 'Progesterone']",0.5
14685,33680.0,Progesterone,endometriosis (disease),disease-exposure-bioprocess-gene-drug,indication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Progesterone']",0.5
14685,33680.0,Progesterone,endometriosis (disease),disease-exposure-gene-drug,indication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Progesterone']",0.5
14685,33695.0,Progesterone,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Progesterone']",0.5
14685,33699.0,Progesterone,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Progesterone']",0.5
14685,33699.0,Progesterone,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'CYP1B1', 'Progesterone']",0.5
14685,35565.0,Progesterone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Progesterone']",0.5
14685,35565.0,Progesterone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Progesterone']",0.5
14685,35641.0,Progesterone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Progesterone']",0.5
14685,35738.0,Progesterone,endometrial carcinoma (disease),disease-protein-drug,indication,"['endometrial carcinoma (disease)', 'PGR', 'Progesterone']",0.5
14685,35739.0,Progesterone,uterine corpus cancer,disease-protein-drug,indication,"['uterine corpus cancer', 'ESR2', 'Progesterone']",0.5
14685,35764.0,Progesterone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Progesterone']",0.5
14685,35764.0,Progesterone,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Progesterone']",0.5
14685,35901.0,Progesterone,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Progesterone']",0.5
14685,35901.0,Progesterone,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Progesterone']",0.5
14685,35909.0,Progesterone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Progesterone']",0.5
14685,35909.0,Progesterone,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Progesterone']",0.5
14685,35958.0,Progesterone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'NR3C2', 'Progesterone']",0.5
14685,36035.0,Progesterone,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Progesterone']",0.5
14685,36187.0,Progesterone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR2', 'Progesterone']",0.5
14685,36187.0,Progesterone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Progesterone']",0.5
14685,36187.0,Progesterone,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CYP1B1', 'Progesterone']",0.5
14685,36469.0,Progesterone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Progesterone']",0.5
14685,36527.0,Progesterone,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Progesterone']",0.5
14685,36634.0,Progesterone,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ABCB1', 'Progesterone']",0.5
14685,36634.0,Progesterone,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Progesterone']",0.5
14685,36634.0,Progesterone,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Air Pollutants', 'CYP1B1', 'Progesterone']",0.5
14685,36792.0,Progesterone,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Progesterone']",0.5
14685,36794.0,Progesterone,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Progesterone']",0.5
14685,37038.0,Progesterone,endometrium neoplasm,disease-protein-drug,indication,"['endometrium neoplasm', 'PGR', 'Progesterone']",0.5
14685,37047.0,Progesterone,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Progesterone']",0.5
14685,37082.0,Progesterone,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Progesterone']",0.5
14685,37150.0,Progesterone,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Progesterone']",0.5
14685,37152.0,Progesterone,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Progesterone']",0.5
14685,37180.0,Progesterone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'NR3C2', 'Progesterone']",0.5
14685,37180.0,Progesterone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Progesterone']",0.5
14685,37180.0,Progesterone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Progesterone']",0.5
14685,37423.0,Progesterone,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Progesterone']",0.5
14685,37466.0,Progesterone,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Progesterone']",0.5
14685,37573.0,Progesterone,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Progesterone']",0.5
14685,37573.0,Progesterone,dementia (disease),disease-exposure-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'CYP1B1', 'Progesterone']",0.5
14685,37703.0,Progesterone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Progesterone']",0.5
14685,37768.0,Progesterone,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Progesterone']",0.5
14685,37967.0,Progesterone,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Progesterone']",0.5
14685,39531.0,Progesterone,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Progesterone']",0.5
14685,39603.0,Progesterone,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Progesterone']",0.5
14685,39615.0,Progesterone,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Progesterone']",0.5
14685,83760.0,Progesterone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Progesterone']",0.5
14685,83816.0,Progesterone,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Progesterone']",0.5
14685,83817.0,Progesterone,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Progesterone']",0.5
14685,83818.0,Progesterone,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Progesterone']",0.5
14685,83819.0,Progesterone,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Progesterone']",0.5
14685,83820.0,Progesterone,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Progesterone']",0.5
14685,83821.0,Progesterone,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Progesterone']",0.5
14685,83822.0,Progesterone,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Progesterone']",0.5
14685,83823.0,Progesterone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'NR3C2', 'Progesterone']",0.5
14685,83824.0,Progesterone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'NR3C2', 'Progesterone']",0.5
14685,84172.0,Progesterone,glucose intolerance,disease-exposure-bioprocess-gene-drug,contraindication,"['glucose intolerance', 'Zinc', 'inflammatory response', 'ORM1', 'Progesterone']",0.5
14685,84172.0,Progesterone,glucose intolerance,disease-exposure-gene-drug,contraindication,"['glucose intolerance', 'Arsenic', 'CYP1A1', 'Progesterone']",0.5
14685,84173.0,Progesterone,prediabetes syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['prediabetes syndrome', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Progesterone']",0.5
14686,27933.0,Clomifene,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Clomifene']",0.5
14686,27933.0,Clomifene,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Clomifene']",0.5
14686,27933.0,Clomifene,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'SHBG', 'Clomifene']",0.5
14686,29505.0,Clomifene,male infertility due to large-headed multiflagellar polyploid spermatozoa,disease-phenotype-protein-drug,off-label use,"['male infertility due to large-headed multiflagellar polyploid spermatozoa', 'Male infertility', 'CYP17A1', 'Clomifene']",0.5
14686,29924.0,Clomifene,ovarian hyperstimulation syndrome,disease-phenotype-protein-drug,contraindication,"['ovarian hyperstimulation syndrome', 'Nausea', 'ABCB1', 'Clomifene']",0.5
14686,30756.0,Clomifene,polycystic ovary syndrome,disease-phenotype-protein-drug,contraindication,"['polycystic ovary syndrome', 'Oligomenorrhea', 'CYP17A1', 'Clomifene']",0.5
14686,30813.0,Clomifene,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Hyperkalemia', 'CYP17A1', 'Clomifene']",0.5
14686,30827.0,Clomifene,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'ESR1', 'Clomifene']",0.5
14686,32384.0,Clomifene,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Hyperkalemia', 'CYP17A1', 'Clomifene']",0.5
14686,33560.0,Clomifene,ovarian cyst (disease),disease-protein-drug,contraindication,"['ovarian cyst (disease)', 'CYP17A1', 'Clomifene']",0.5
14686,33680.0,Clomifene,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Clomifene']",0.5
14686,33680.0,Clomifene,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Clomifene']",0.5
14686,35738.0,Clomifene,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR1', 'Clomifene']",0.5
14686,35739.0,Clomifene,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Clomifene']",0.5
14686,36414.0,Clomifene,male infertility,disease-exposure-bioprocess-gene-drug,off-label use,"['male infertility', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Clomifene']",0.5
14686,36414.0,Clomifene,male infertility,disease-exposure-gene-drug,off-label use,"['male infertility', 'bisphenol A', 'SHBG', 'Clomifene']",0.5
14686,37038.0,Clomifene,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR1', 'Clomifene']",0.5
14686,37703.0,Clomifene,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Clomifene']",0.5
14686,38512.0,Clomifene,female infertility,disease-protein-drug,indication,"['female infertility', 'CYP17A1', 'Clomifene']",0.5
14686,38512.0,Clomifene,female infertility,disease-exposure-gene-drug,indication,"['female infertility', 'Phthalic Acids', 'SHBG', 'Clomifene']",0.5
14686,83760.0,Clomifene,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Clomifene']",0.5
14691,29182.0,Amiloride,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'gene expression', 'SCNN1B', 'Amiloride']",0.5
14691,33534.0,Amiloride,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'SCNN1A', 'Amiloride']",0.5
14691,33575.0,Amiloride,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'gene expression', 'SCNN1B', 'Amiloride']",0.5
14691,33575.0,Amiloride,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PLAU', 'Amiloride']",0.5
14691,35565.0,Amiloride,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'gene expression', 'SCNN1B', 'Amiloride']",0.5
14691,35764.0,Amiloride,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'gene expression', 'SCNN1B', 'Amiloride']",0.5
14691,35764.0,Amiloride,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PLAU', 'Amiloride']",0.5
14691,36432.0,Amiloride,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'SLC9A1', 'Amiloride']",0.5
14691,83802.0,Amiloride,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'gene expression', 'SCNN1B', 'Amiloride']",0.5
14696,32503.0,Pentamidine,human African trypanosomiasis,disease-phenotype-protein-drug,indication,"['human African trypanosomiasis', 'Tremor', 'CYP2D6', 'Pentamidine']",0.5
14696,33316.0,Pentamidine,leishmaniasis,disease-phenotype-protein-drug,off-label use,"['leishmaniasis', 'Hepatomegaly', 'CYP1A1', 'Pentamidine']",0.5
14696,33575.0,Pentamidine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'oxylipin biosynthetic process', 'CYP4A11', 'Pentamidine']",0.5
14696,33575.0,Pentamidine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Pentamidine']",0.5
14696,33632.0,Pentamidine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'oxylipin biosynthetic process', 'CYP4A11', 'Pentamidine']",0.5
14696,33675.0,Pentamidine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'oxylipin biosynthetic process', 'CYP4A11', 'Pentamidine']",0.5
14696,33675.0,Pentamidine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'CYP1A1', 'Pentamidine']",0.5
14696,35565.0,Pentamidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Pentamidine']",0.5
14696,35565.0,Pentamidine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Pentamidine']",0.5
14696,35764.0,Pentamidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Pentamidine']",0.5
14696,35764.0,Pentamidine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Pentamidine']",0.5
14696,36035.0,Pentamidine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Pentamidine']",0.5
14698,35565.0,Pyrantel,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Pyrantel']",0.5
14701,27326.0,Mefloquine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of transcription, DNA-templated', 'ADORA2A', 'Mefloquine']",0.5
14701,27326.0,Mefloquine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'BCHE', 'Mefloquine']",0.5
14701,27326.0,Mefloquine,long QT syndrome,disease-exposure-molfunc-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Mefloquine']",0.5
14701,27933.0,Mefloquine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Mefloquine']",0.5
14701,27933.0,Mefloquine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'ADORA2A', 'Mefloquine']",0.5
14701,27933.0,Mefloquine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Insecticides', 'BCHE', 'Mefloquine']",0.5
14701,27933.0,Mefloquine,anxiety disorder,disease-exposure-molfunc-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Mefloquine']",0.5
14701,28313.0,Mefloquine,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'ABCB1', 'Mefloquine']",0.5
14701,28313.0,Mefloquine,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Mefloquine']",0.5
14701,35565.0,Mefloquine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Mefloquine']",0.5
14701,35641.0,Mefloquine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Mefloquine']",0.5
14701,35915.0,Mefloquine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Mefloquine']",0.5
14701,37703.0,Mefloquine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Mefloquine']",0.5
14701,83760.0,Mefloquine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Mefloquine']",0.5
14701,83778.0,Mefloquine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Mefloquine']",0.5
14701,83779.0,Mefloquine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Mefloquine']",0.5
14702,32875.0,Ranitidine,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Ranitidine']",0.5
14702,32977.0,Ranitidine,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Ranitidine']",0.5
14702,32977.0,Ranitidine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ACHE', 'Ranitidine']",0.5
14702,35565.0,Ranitidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Ranitidine']",0.5
14702,35764.0,Ranitidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Ranitidine']",0.5
14702,35764.0,Ranitidine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'ACHE', 'Ranitidine']",0.5
14702,36000.0,Ranitidine,gastric neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['gastric neoplasm', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Ranitidine']",0.5
14704,32967.0,Calcifediol,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hypercalciuria', 'CYP24A1', 'Calcifediol']",0.5
14704,33626.0,Calcifediol,rickets (disease),disease-protein-drug,indication,"['rickets (disease)', 'VDR', 'Calcifediol']",0.5
14704,35583.0,Calcifediol,phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'CYP24A1', 'Calcifediol']",0.5
14704,35764.0,Calcifediol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'calcium ion homeostasis', 'CYP27B1', 'Calcifediol']",0.5
14704,37171.0,Calcifediol,nephrolithiasis,disease-protein-drug,contraindication,"['nephrolithiasis', 'CYP24A1', 'Calcifediol']",0.5
14704,38682.0,Calcifediol,nephrocalcinosis,disease-protein-drug,contraindication,"['nephrocalcinosis', 'CYP24A1', 'Calcifediol']",0.5
14704,83831.0,Calcifediol,acute urate nephropathy,disease-protein-drug,contraindication,"['acute urate nephropathy', 'CYP24A1', 'Calcifediol']",0.5
14704,83952.0,Calcifediol,obsolete vitamin D deficiency,disease-protein-drug,off-label use,"['obsolete vitamin D deficiency', 'VDR', 'Calcifediol']",0.5
14706,29820.0,Cyanocobalamin,pernicious anemia,disease-protein-drug,indication,"['pernicious anemia', 'CBLIF', 'Cyanocobalamin']",0.5
14706,37603.0,Cyanocobalamin,homocystinuria (disease),disease-protein-drug,off-label use,"['homocystinuria (disease)', 'MTRR', 'Cyanocobalamin']",0.5
14706,39044.0,Cyanocobalamin,methylmalonic acidemia,disease-protein-drug,off-label use,"['methylmalonic acidemia', 'MMUT', 'Cyanocobalamin']",0.5
14707,28158.0,Ferrous sulfate anhydrous,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'HAMP', 'Ferrous sulfate anhydrous']",0.5
14707,31502.0,Ferrous sulfate anhydrous,Wilson disease,disease-protein-drug,contraindication,"['Wilson disease', 'TFR2', 'Ferrous sulfate anhydrous']",0.5
14707,33622.0,Ferrous sulfate anhydrous,microcytic anemia,disease-protein-drug,indication,"['microcytic anemia', 'TFRC', 'Ferrous sulfate anhydrous']",0.5
14707,36172.0,Ferrous sulfate anhydrous,hemosiderosis,disease-protein-drug,contraindication,"['hemosiderosis', 'TFR2', 'Ferrous sulfate anhydrous']",0.5
14707,36214.0,Ferrous sulfate anhydrous,iron metabolism disease,disease-protein-drug,contraindication,"['iron metabolism disease', 'TFR2', 'Ferrous sulfate anhydrous']",0.5
14707,36315.0,Ferrous sulfate anhydrous,deficiency anemia,disease-protein-drug,indication,"['deficiency anemia', 'TFRC', 'Ferrous sulfate anhydrous']",0.5
14707,38641.0,Ferrous sulfate anhydrous,hereditary hemochromatosis,disease-protein-drug,contraindication,"['hereditary hemochromatosis', 'TFR2', 'Ferrous sulfate anhydrous']",0.5
14707,83813.0,Ferrous sulfate anhydrous,hereditary persistence of fetal hemoglobin,disease-protein-drug,contraindication,"['hereditary persistence of fetal hemoglobin', 'TFR2', 'Ferrous sulfate anhydrous']",0.5
14707,84087.0,Ferrous sulfate anhydrous,iron deficiency anemia,disease-protein-drug,indication,"['iron deficiency anemia', 'TFRC', 'Ferrous sulfate anhydrous']",0.5
14709,27933.0,Gabapentin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of ventricular cardiac muscle cell membrane repolarization', 'CACNA2D1', 'Gabapentin']",0.5
14709,27933.0,Gabapentin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'KCNQ5', 'Gabapentin']",0.5
14709,35764.0,Gabapentin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of glomerular filtration', 'ADORA1', 'Gabapentin']",0.5
14710,27647.0,Doxercalciferol,hypoparathyroidism,disease-phenotype-protein-drug,contraindication,"['hypoparathyroidism', 'Seizure', 'CYP27A1', 'Doxercalciferol']",0.5
14710,35565.0,Doxercalciferol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP27A1', 'Doxercalciferol']",0.5
14711,27700.0,Chenodeoxycholic acid,sclerosing cholangitis,disease-exposure-bioprocess-gene-drug,contraindication,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Chenodeoxycholic acid']",0.5
14711,27700.0,Chenodeoxycholic acid,sclerosing cholangitis,disease-phenotype-protein-drug,contraindication,"['sclerosing cholangitis', 'Hepatomegaly', 'NR1I2', 'Chenodeoxycholic acid']",0.5
14711,29955.0,Chenodeoxycholic acid,Reynolds syndrome,disease-phenotype-protein-drug,contraindication,"['Reynolds syndrome', 'Hepatomegaly', 'NR1I2', 'Chenodeoxycholic acid']",0.5
14711,31033.0,Chenodeoxycholic acid,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'CYP27A1', 'Chenodeoxycholic acid']",0.5
14711,31033.0,Chenodeoxycholic acid,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'NR1I2', 'Chenodeoxycholic acid']",0.5
14711,32629.0,Chenodeoxycholic acid,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'CYP27A1', 'Chenodeoxycholic acid']",0.5
14711,32629.0,Chenodeoxycholic acid,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'NR1I2', 'Chenodeoxycholic acid']",0.5
14711,33594.0,Chenodeoxycholic acid,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR1I2', 'Chenodeoxycholic acid']",0.5
14711,35565.0,Chenodeoxycholic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP27A1', 'Chenodeoxycholic acid']",0.5
14711,38059.0,Chenodeoxycholic acid,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'CYP27A1', 'Chenodeoxycholic acid']",0.5
14713,27626.0,Decitabine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'DNMT3A', 'Decitabine']",0.5
14713,28520.0,Decitabine,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'DNMT3A', 'Decitabine']",0.5
14713,28520.0,Decitabine,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'spermatogenesis', 'DNMT3A', 'Decitabine']",0.5
14713,33575.0,Decitabine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'DNA methylation', 'DNMT3A', 'Decitabine']",0.5
14713,35565.0,Decitabine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'DNA methylation involved in embryo development', 'DNMT3A', 'Decitabine']",0.5
14713,35764.0,Decitabine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'DNA methylation involved in embryo development', 'DNMT3A', 'Decitabine']",0.5
14713,37714.0,Decitabine,unclassified acute myeloid leukemia,disease-protein-drug,indication,"['unclassified acute myeloid leukemia', 'DNMT3A', 'Decitabine']",0.5
14713,38274.0,Decitabine,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'DNMT3A', 'Decitabine']",0.5
14713,39124.0,Decitabine,therapy related acute myeloid leukemia and myelodysplastic syndrome,disease-protein-drug,indication,"['therapy related acute myeloid leukemia and myelodysplastic syndrome', 'DNMT3A', 'Decitabine']",0.5
14713,83852.0,Decitabine,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'DNMT3A', 'Decitabine']",0.5
14713,83853.0,Decitabine,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'DNMT3A', 'Decitabine']",0.5
14713,83854.0,Decitabine,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'DNMT3A', 'Decitabine']",0.5
14713,83855.0,Decitabine,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'DNMT3A', 'Decitabine']",0.5
14713,83856.0,Decitabine,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'DNMT3A', 'Decitabine']",0.5
14713,83857.0,Decitabine,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'DNMT3A', 'Decitabine']",0.5
14713,83858.0,Decitabine,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'DNMT3A', 'Decitabine']",0.5
14713,83859.0,Decitabine,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'DNMT3A', 'Decitabine']",0.5
14713,83860.0,Decitabine,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'DNMT3A', 'Decitabine']",0.5
14713,83861.0,Decitabine,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'DNMT3A', 'Decitabine']",0.5
14713,83862.0,Decitabine,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'DNMT3A', 'Decitabine']",0.5
14715,30075.0,Coenzyme M,Burkitt lymphoma,disease-exposure-gene-drug,off-label use,"['Burkitt lymphoma', 'Pesticides', 'GSR', 'Coenzyme M']",0.5
14715,30075.0,Coenzyme M,Burkitt lymphoma,disease-exposure-molfunc-gene-drug,off-label use,"['Burkitt lymphoma', 'Pesticides', 'glutathione-disulfide reductase (NADPH) activity', 'GSR', 'Coenzyme M']",0.5
14715,33623.0,Coenzyme M,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'GSR', 'Coenzyme M']",0.5
14715,33632.0,Coenzyme M,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'GSR', 'Coenzyme M']",0.5
14715,35565.0,Coenzyme M,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'cellular response to oxidative stress', 'GSR', 'Coenzyme M']",0.5
14715,35764.0,Coenzyme M,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cellular response to oxidative stress', 'GSR', 'Coenzyme M']",0.5
14719,35764.0,Epirubicin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'rhythmic process', 'TOP2A', 'Epirubicin']",0.5
14719,35771.0,Epirubicin,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'TOP2A', 'Epirubicin']",0.5
14719,35771.0,Epirubicin,breast neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['breast neoplasm', 'Air Pollutants', 'cellular response to DNA damage stimulus', 'TOP2A', 'Epirubicin']",0.5
14719,36000.0,Epirubicin,gastric neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['gastric neoplasm', 'Lead', 'lipid metabolic process', 'UGT2B7', 'Epirubicin']",0.5
14719,37180.0,Epirubicin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cellular response to DNA damage stimulus', 'TOP2A', 'Epirubicin']",0.5
14719,37334.0,Epirubicin,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'TOP2A', 'Epirubicin']",0.5
14721,33593.0,Orlistat,obesity disorder,disease-protein-drug,indication,"['obesity disorder', 'FASN', 'Orlistat']",0.5
14721,33593.0,Orlistat,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'triglyceride metabolic process', 'LIPF', 'Orlistat']",0.5
14721,36544.0,Orlistat,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'FASN', 'Orlistat']",0.5
14721,36544.0,Orlistat,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Orlistat']",0.5
14725,29186.0,Glycerol phenylbutyrate,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,indication,"['carbamoyl phosphate synthetase I deficiency disease', 'Coma', 'CYP2D6', 'Glycerol phenylbutyrate']",0.5
14725,30829.0,Glycerol phenylbutyrate,argininosuccinic aciduria,disease-phenotype-protein-drug,indication,"['argininosuccinic aciduria', 'Coma', 'CYP2D6', 'Glycerol phenylbutyrate']",0.5
14725,32132.0,Glycerol phenylbutyrate,citrullinemia,disease-phenotype-protein-drug,indication,"['citrullinemia', 'Tremor', 'CYP2D6', 'Glycerol phenylbutyrate']",0.5
14726,27933.0,Melatonin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Melatonin']",0.5
14726,27933.0,Melatonin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'CALM1', 'Melatonin']",0.5
14726,27933.0,Melatonin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Melatonin']",0.5
14726,28313.0,Melatonin,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'MTNR1A', 'Melatonin']",0.5
14726,28313.0,Melatonin,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Melatonin']",0.5
14726,28313.0,Melatonin,schizophrenia,disease-exposure-gene-drug,contraindication,"['schizophrenia', 'Air Pollutants', 'CYP1B1', 'Melatonin']",0.5
14726,28478.0,Melatonin,autoimmune disease,disease-exposure-bioprocess-gene-drug,contraindication,"['autoimmune disease', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Melatonin']",0.5
14726,28478.0,Melatonin,autoimmune disease,disease-exposure-gene-drug,contraindication,"['autoimmune disease', 'Particulate Matter', 'CYP1B1', 'Melatonin']",0.5
14726,29182.0,Melatonin,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Melatonin']",0.5
14726,29182.0,Melatonin,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'CYP1B1', 'Melatonin']",0.5
14726,30035.0,Melatonin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CALM1', 'Melatonin']",0.5
14726,32967.0,Melatonin,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'CYP1A1', 'Melatonin']",0.5
14726,35565.0,Melatonin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'CALR', 'Melatonin']",0.5
14726,35565.0,Melatonin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Melatonin']",0.5
14726,35764.0,Melatonin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'MTNR1B', 'Melatonin']",0.5
14726,35764.0,Melatonin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Melatonin']",0.5
14726,37703.0,Melatonin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ASMT', 'Melatonin']",0.5
14726,83760.0,Melatonin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ASMT', 'Melatonin']",0.5
14727,33632.0,Pralatrexate,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'TYMS', 'Pralatrexate']",0.5
14727,33632.0,Pralatrexate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'FPGS', 'Pralatrexate']",0.5
14729,28426.0,Cimetidine,multiple endocrine neoplasia,disease-phenotype-protein-drug,indication,"['multiple endocrine neoplasia', 'Vomiting', 'ABCB1', 'Cimetidine']",0.5
14729,28542.0,Cimetidine,mastocytosis,disease-phenotype-protein-drug,indication,"['mastocytosis', 'Hepatomegaly', 'CYP1A2', 'Cimetidine']",0.5
14729,32875.0,Cimetidine,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Cimetidine']",0.5
14729,35565.0,Cimetidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Cimetidine']",0.5
14729,36000.0,Cimetidine,gastric neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['gastric neoplasm', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Cimetidine']",0.5
14731,33577.0,Mibefradil,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Mibefradil']",0.5
14731,33577.0,Mibefradil,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'CYP11B1', 'Mibefradil']",0.5
14731,35565.0,Mibefradil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Mibefradil']",0.5
14731,36035.0,Mibefradil,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Mibefradil']",0.5
14731,38396.0,Mibefradil,familial sick sinus syndrome,disease-protein-drug,contraindication,"['familial sick sinus syndrome', 'CACNA1D', 'Mibefradil']",0.5
14731,38958.0,Mibefradil,sick sinus syndrome,disease-protein-drug,contraindication,"['sick sinus syndrome', 'CACNB2', 'Mibefradil']",0.5
14733,27933.0,Levomefolic acid,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'MTR', 'Levomefolic acid']",0.5
14733,27933.0,Levomefolic acid,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'methylation', 'MTR', 'Levomefolic acid']",0.5
14733,29182.0,Levomefolic acid,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'MTR', 'Levomefolic acid']",0.5
14733,29182.0,Levomefolic acid,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'MTR', 'Levomefolic acid']",0.5
14733,30813.0,Levomefolic acid,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'MTR', 'Levomefolic acid']",0.5
14733,32617.0,Levomefolic acid,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'MTR', 'Levomefolic acid']",0.5
14733,32977.0,Levomefolic acid,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'MTR', 'Levomefolic acid']",0.5
14733,33534.0,Levomefolic acid,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'MTR', 'Levomefolic acid']",0.5
14733,33575.0,Levomefolic acid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'methylation', 'MTR', 'Levomefolic acid']",0.5
14733,33577.0,Levomefolic acid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'female pregnancy', 'SLC19A1', 'Levomefolic acid']",0.5
14733,33593.0,Levomefolic acid,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'female pregnancy', 'SLC19A1', 'Levomefolic acid']",0.5
14733,33598.0,Levomefolic acid,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'methylation', 'MTR', 'Levomefolic acid']",0.5
14733,33675.0,Levomefolic acid,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'methylation', 'MTR', 'Levomefolic acid']",0.5
14733,35565.0,Levomefolic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'female pregnancy', 'SLC19A1', 'Levomefolic acid']",0.5
14733,35764.0,Levomefolic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'methylation', 'MTR', 'Levomefolic acid']",0.5
14733,35909.0,Levomefolic acid,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'female pregnancy', 'SLC19A1', 'Levomefolic acid']",0.5
14733,36187.0,Levomefolic acid,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'methylation', 'MTR', 'Levomefolic acid']",0.5
14733,37573.0,Levomefolic acid,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Soot', 'methylation', 'MTR', 'Levomefolic acid']",0.5
14733,37703.0,Levomefolic acid,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'MTR', 'Levomefolic acid']",0.5
14733,83760.0,Levomefolic acid,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'MTR', 'Levomefolic acid']",0.5
14735,37703.0,Brexanolone,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'GABRB3', 'Brexanolone']",0.5
14736,28849.0,Oxaliplatin,colorectal cancer,disease-protein-drug,off-label use,"['colorectal cancer', 'ATP7A', 'Oxaliplatin']",0.5
14736,35471.0,Oxaliplatin,pulmonary fibrosis,disease-protein-drug,contraindication,"['pulmonary fibrosis', 'SOD1', 'Oxaliplatin']",0.5
14736,35471.0,Oxaliplatin,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'cellular response to oxidative stress', 'SOD1', 'Oxaliplatin']",0.5
14736,35565.0,Oxaliplatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SOD1', 'Oxaliplatin']",0.5
14736,35616.0,Oxaliplatin,testicular cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['testicular cancer', 'perfluorooctanoic acid', 'lactation', 'ATP7A', 'Oxaliplatin']",0.5
14736,35764.0,Oxaliplatin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'SOD1', 'Oxaliplatin']",0.5
14736,35764.0,Oxaliplatin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'SOD1', 'Oxaliplatin']",0.5
14736,35764.0,Oxaliplatin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'GSTP1', 'Oxaliplatin']",0.5
14736,36223.0,Oxaliplatin,malignant colon neoplasm,disease-protein-drug,off-label use,"['malignant colon neoplasm', 'ATP7A', 'Oxaliplatin']",0.5
14736,36527.0,Oxaliplatin,yolk sac tumor,disease-protein-drug,off-label use,"['yolk sac tumor', 'ATP7B', 'Oxaliplatin']",0.5
14736,36581.0,Oxaliplatin,colonic neoplasm,disease-protein-drug,off-label use,"['colonic neoplasm', 'ATP7A', 'Oxaliplatin']",0.5
14736,36581.0,Oxaliplatin,colonic neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['colonic neoplasm', 'Asbestos', 'cellular response to oxidative stress', 'SOD1', 'Oxaliplatin']",0.5
14736,37144.0,Oxaliplatin,squamous cell carcinoma of colon,disease-protein-drug,off-label use,"['squamous cell carcinoma of colon', 'ATP7A', 'Oxaliplatin']",0.5
14736,84056.0,Oxaliplatin,postinflammatory pulmonary fibrosis,disease-protein-drug,contraindication,"['postinflammatory pulmonary fibrosis', 'SOD1', 'Oxaliplatin']",0.5
14737,27626.0,Carboplatin,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'SOD1', 'Carboplatin']",0.5
14737,27626.0,Carboplatin,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'XDH', 'Carboplatin']",0.5
14737,28520.0,Carboplatin,myeloid leukemia,disease-protein-drug,off-label use,"['myeloid leukemia', 'NQO1', 'Carboplatin']",0.5
14737,28520.0,Carboplatin,myeloid leukemia,disease-exposure-bioprocess-gene-drug,off-label use,"['myeloid leukemia', 'Pesticides', 'spermatogenesis', 'SOD1', 'Carboplatin']",0.5
14737,28520.0,Carboplatin,myeloid leukemia,disease-exposure-gene-drug,off-label use,"['myeloid leukemia', 'Pesticides', 'GSTP1', 'Carboplatin']",0.5
14737,28520.0,Carboplatin,myeloid leukemia,disease-exposure-molfunc-gene-drug,off-label use,"['myeloid leukemia', 'Pesticides', 'glutathione transferase activity', 'GSTM1', 'Carboplatin']",0.5
14737,29173.0,Carboplatin,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'regulation of gene expression', 'ATP7A', 'Carboplatin']",0.5
14737,29173.0,Carboplatin,small cell lung carcinoma,disease-exposure-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'GSTP1', 'Carboplatin']",0.5
14737,31107.0,Carboplatin,cervical cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['cervical cancer', 'Vehicle Emissions', 'regulation of blood pressure', 'SOD1', 'Carboplatin']",0.5
14737,31107.0,Carboplatin,cervical cancer,disease-exposure-gene-drug,off-label use,"['cervical cancer', 'Air Pollutants', 'SOD1', 'Carboplatin']",0.5
14737,31116.0,Carboplatin,lung cancer,disease-protein-drug,off-label use,"['lung cancer', 'GSTT1', 'Carboplatin']",0.5
14737,31477.0,Carboplatin,ovarian cancer,disease-protein-drug,indication,"['ovarian cancer', 'ATP7B', 'Carboplatin']",0.5
14737,31477.0,Carboplatin,ovarian cancer,disease-exposure-bioprocess-gene-drug,indication,"['ovarian cancer', 'Cadmium', 'regulation of blood pressure', 'SOD1', 'Carboplatin']",0.5
14737,31756.0,Carboplatin,urinary bladder cancer,disease-protein-drug,off-label use,"['urinary bladder cancer', 'MT1A', 'Carboplatin']",0.5
14737,31756.0,Carboplatin,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder cancer', 'perfluorooctanoic acid', 'lactation', 'ATP7A', 'Carboplatin']",0.5
14737,31756.0,Carboplatin,urinary bladder cancer,disease-exposure-gene-drug,off-label use,"['urinary bladder cancer', 'Pesticides', 'GSTP1', 'Carboplatin']",0.5
14737,31756.0,Carboplatin,urinary bladder cancer,disease-exposure-molfunc-gene-drug,off-label use,"['urinary bladder cancer', 'Pesticides', 'glutathione transferase activity', 'GSTM1', 'Carboplatin']",0.5
14737,33464.0,Carboplatin,urinary bladder small cell neuroendocrine carcinoma,disease-protein-drug,off-label use,"['urinary bladder small cell neuroendocrine carcinoma', 'MT1A', 'Carboplatin']",0.5
14737,33623.0,Carboplatin,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'ATP7A', 'Carboplatin']",0.5
14737,33632.0,Carboplatin,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'ATP7A', 'Carboplatin']",0.5
14737,33632.0,Carboplatin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'SOD1', 'Carboplatin']",0.5
14737,33632.0,Carboplatin,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'SOD1', 'Carboplatin']",0.5
14737,33642.0,Carboplatin,urinary bladder carcinoma,disease-protein-drug,off-label use,"['urinary bladder carcinoma', 'MT1A', 'Carboplatin']",0.5
14737,33642.0,Carboplatin,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'lactation', 'ATP7A', 'Carboplatin']",0.5
14737,33642.0,Carboplatin,urinary bladder carcinoma,disease-exposure-gene-drug,off-label use,"['urinary bladder carcinoma', 'Pesticides', 'GSTP1', 'Carboplatin']",0.5
14737,33642.0,Carboplatin,urinary bladder carcinoma,disease-exposure-molfunc-gene-drug,off-label use,"['urinary bladder carcinoma', 'Pesticides', 'glutathione transferase activity', 'GSTM1', 'Carboplatin']",0.5
14737,33688.0,Carboplatin,non-small cell lung carcinoma (disease),disease-protein-drug,off-label use,"['non-small cell lung carcinoma (disease)', 'NQO1', 'Carboplatin']",0.5
14737,35565.0,Carboplatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SOD1', 'Carboplatin']",0.5
14737,35616.0,Carboplatin,testicular cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['testicular cancer', 'perfluorooctanoic acid', 'lactation', 'ATP7A', 'Carboplatin']",0.5
14737,35624.0,Carboplatin,urinary bladder neoplasm,disease-protein-drug,off-label use,"['urinary bladder neoplasm', 'MT1A', 'Carboplatin']",0.5
14737,35624.0,Carboplatin,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'lactation', 'ATP7A', 'Carboplatin']",0.5
14737,35624.0,Carboplatin,urinary bladder neoplasm,disease-exposure-gene-drug,off-label use,"['urinary bladder neoplasm', 'Pesticides', 'GSTP1', 'Carboplatin']",0.5
14737,35624.0,Carboplatin,urinary bladder neoplasm,disease-exposure-molfunc-gene-drug,off-label use,"['urinary bladder neoplasm', 'Pesticides', 'glutathione transferase activity', 'GSTM1', 'Carboplatin']",0.5
14737,35764.0,Carboplatin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'SOD1', 'Carboplatin']",0.5
14737,35764.0,Carboplatin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'SOD1', 'Carboplatin']",0.5
14737,35764.0,Carboplatin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'GSTP1', 'Carboplatin']",0.5
14737,35771.0,Carboplatin,breast neoplasm,disease-protein-drug,off-label use,"['breast neoplasm', 'ATP7B', 'Carboplatin']",0.5
14737,35771.0,Carboplatin,breast neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['breast neoplasm', 'Air Pollutants', 'blood vessel development', 'ATP7A', 'Carboplatin']",0.5
14737,35771.0,Carboplatin,breast neoplasm,disease-exposure-gene-drug,off-label use,"['breast neoplasm', 'Air Pollutants', 'SOD1', 'Carboplatin']",0.5
14737,35771.0,Carboplatin,breast neoplasm,disease-exposure-molfunc-gene-drug,off-label use,"['breast neoplasm', 'Pesticides', 'glutathione transferase activity', 'GSTM1', 'Carboplatin']",0.5
14737,36527.0,Carboplatin,yolk sac tumor,disease-protein-drug,off-label use,"['yolk sac tumor', 'ATP7B', 'Carboplatin']",0.5
14737,36792.0,Carboplatin,ovarian mucinous adenocarcinoma,disease-protein-drug,indication,"['ovarian mucinous adenocarcinoma', 'ATP7B', 'Carboplatin']",0.5
14737,36794.0,Carboplatin,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'ATP7B', 'Carboplatin']",0.5
14737,37047.0,Carboplatin,immature ovarian teratoma,disease-protein-drug,indication,"['immature ovarian teratoma', 'ATP7B', 'Carboplatin']",0.5
14737,37082.0,Carboplatin,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5
14737,37150.0,Carboplatin,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5
14737,37152.0,Carboplatin,familial ovarian cancer,disease-protein-drug,indication,"['familial ovarian cancer', 'ATP7B', 'Carboplatin']",0.5
14737,37334.0,Carboplatin,breast carcinoma,disease-protein-drug,off-label use,"['breast carcinoma', 'ATP7B', 'Carboplatin']",0.5
14737,37423.0,Carboplatin,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'ATP7B', 'Carboplatin']",0.5
14737,37466.0,Carboplatin,ovarian small cell carcinoma,disease-protein-drug,indication,"['ovarian small cell carcinoma', 'ATP7B', 'Carboplatin']",0.5
14737,37967.0,Carboplatin,ovarian endometrioid adenocarcinoma,disease-protein-drug,indication,"['ovarian endometrioid adenocarcinoma', 'ATP7B', 'Carboplatin']",0.5
14737,39603.0,Carboplatin,malignant sex cord stromal tumor of ovary,disease-protein-drug,indication,"['malignant sex cord stromal tumor of ovary', 'ATP7B', 'Carboplatin']",0.5
14737,39615.0,Carboplatin,borderline epithelial tumor of ovary,disease-protein-drug,indication,"['borderline epithelial tumor of ovary', 'ATP7B', 'Carboplatin']",0.5
14737,83816.0,Carboplatin,ovarian carcinosarcoma,disease-protein-drug,indication,"['ovarian carcinosarcoma', 'ATP7B', 'Carboplatin']",0.5
14737,83817.0,Carboplatin,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary site-specific ovarian cancer syndrome', 'ATP7B', 'Carboplatin']",0.5
14737,83818.0,Carboplatin,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'ATP7B', 'Carboplatin']",0.5
14737,83819.0,Carboplatin,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5
14737,83820.0,Carboplatin,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5
14737,83821.0,Carboplatin,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ATP7B', 'Carboplatin']",0.5
14737,83822.0,Carboplatin,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,indication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ATP7B', 'Carboplatin']",0.5
14737,83866.0,Carboplatin,non-papillary transitional cell carcinoma of the bladder,disease-protein-drug,off-label use,"['non-papillary transitional cell carcinoma of the bladder', 'MT1A', 'Carboplatin']",0.5
14738,32319.0,Busulfan,Fanconi anemia,disease-phenotype-protein-drug,contraindication,"['Fanconi anemia', 'Abnormality of chromosome stability', 'GSTM1', 'Busulfan']",0.5
14738,33632.0,Busulfan,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Busulfan']",0.5
14738,35471.0,Busulfan,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'cellular response to oxidative stress', 'GSTP1', 'Busulfan']",0.5
14738,83802.0,Busulfan,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Busulfan']",0.5
14740,29993.0,Chlorambucil,classic Hodgkin lymphoma,disease-protein-drug,indication,"['classic Hodgkin lymphoma', 'GSTP1', 'Chlorambucil']",0.5
14740,35471.0,Chlorambucil,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'cellular response to oxidative stress', 'GSTP1', 'Chlorambucil']",0.5
14740,36544.0,Chlorambucil,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'GSTP1', 'Chlorambucil']",0.5
14740,83792.0,Chlorambucil,obsolete Hodgkin's granuloma,disease-protein-drug,indication,"[""obsolete Hodgkin's granuloma"", 'GSTP1', 'Chlorambucil']",0.5
14740,83793.0,Chlorambucil,Hodgkin's paragranuloma,disease-protein-drug,indication,"[""Hodgkin's paragranuloma"", 'GSTP1', 'Chlorambucil']",0.5
14740,83794.0,Chlorambucil,"classic Hodgkin lymphoma, lymphocyte-rich type",disease-protein-drug,indication,"['classic Hodgkin lymphoma, lymphocyte-rich type', 'GSTP1', 'Chlorambucil']",0.5
14751,27933.0,Zinc sulfate,anxiety disorder,disease-exposure-molfunc-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Zinc sulfate']",0.5
14751,33575.0,Zinc sulfate,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Zinc sulfate']",0.5
14751,33577.0,Zinc sulfate,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Zinc sulfate']",0.5
14751,33594.0,Zinc sulfate,diarrheal disease,disease-exposure-molfunc-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Zinc sulfate']",0.5
14751,35669.0,Zinc sulfate,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Zinc sulfate']",0.5
14751,35761.0,Zinc sulfate,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Zinc sulfate']",0.5
14751,35764.0,Zinc sulfate,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Zinc sulfate']",0.5
14751,37604.0,Zinc sulfate,erectile dysfunction (disease),disease-exposure-molfunc-gene-drug,off-label use,"['erectile dysfunction (disease)', 'bisphenol A', 'alkaline phosphatase activity', 'ALPG', 'Zinc sulfate']",0.5
14754,83830.0,Loteprednol etabonate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Loteprednol etabonate']",0.5
14758,27476.0,Capecitabine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'developmental growth', 'TYMS', 'Capecitabine']",0.5
14758,31257.0,Capecitabine,dihydropyrimidine dehydrogenase deficiency,disease-protein-drug,contraindication,"['dihydropyrimidine dehydrogenase deficiency', 'DPYD', 'Capecitabine']",0.5
14758,31257.0,Capecitabine,dihydropyrimidine dehydrogenase deficiency,disease-phenotype-protein-drug,contraindication,"['dihydropyrimidine dehydrogenase deficiency', 'Delayed speech and language development', 'DPYD', 'Capecitabine']",0.5
14758,31380.0,Capecitabine,diffuse gastric adenocarcinoma,disease-protein-drug,indication,"['diffuse gastric adenocarcinoma', 'TYMP', 'Capecitabine']",0.5
14758,31477.0,Capecitabine,ovarian cancer,disease-protein-drug,off-label use,"['ovarian cancer', 'TYMS', 'Capecitabine']",0.5
14758,32617.0,Capecitabine,hereditary breast ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary breast ovarian cancer syndrome', 'CDA', 'Capecitabine']",0.5
14758,33623.0,Capecitabine,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'TYMS', 'Capecitabine']",0.5
14758,33632.0,Capecitabine,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'TYMS', 'Capecitabine']",0.5
14758,33632.0,Capecitabine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'urea metabolic process', 'CYP2C9', 'Capecitabine']",0.5
14758,35565.0,Capecitabine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CES1', 'Capecitabine']",0.5
14758,36000.0,Capecitabine,gastric neoplasm,disease-protein-drug,indication,"['gastric neoplasm', 'TYMP', 'Capecitabine']",0.5
14758,36000.0,Capecitabine,gastric neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['gastric neoplasm', 'Lead', 'urea metabolic process', 'CYP2C9', 'Capecitabine']",0.5
14758,36104.0,Capecitabine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'DPYD', 'Capecitabine']",0.5
14758,36187.0,Capecitabine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'response to folic acid', 'TYMS', 'Capecitabine']",0.5
14758,36229.0,Capecitabine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'DPYD', 'Capecitabine']",0.5
14758,36527.0,Capecitabine,yolk sac tumor,disease-protein-drug,off-label use,"['yolk sac tumor', 'TYMS', 'Capecitabine']",0.5
14758,36792.0,Capecitabine,ovarian mucinous adenocarcinoma,disease-protein-drug,off-label use,"['ovarian mucinous adenocarcinoma', 'TYMS', 'Capecitabine']",0.5
14758,36794.0,Capecitabine,ovarian adenocarcinoma,disease-protein-drug,off-label use,"['ovarian adenocarcinoma', 'TYMS', 'Capecitabine']",0.5
14758,37047.0,Capecitabine,immature ovarian teratoma,disease-protein-drug,off-label use,"['immature ovarian teratoma', 'TYMS', 'Capecitabine']",0.5
14758,37082.0,Capecitabine,malignant germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant germ cell tumor of ovary', 'TYMS', 'Capecitabine']",0.5
14758,37150.0,Capecitabine,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'TYMS', 'Capecitabine']",0.5
14758,37152.0,Capecitabine,familial ovarian cancer,disease-protein-drug,off-label use,"['familial ovarian cancer', 'TYMS', 'Capecitabine']",0.5
14758,37273.0,Capecitabine,gastric carcinoma,disease-protein-drug,indication,"['gastric carcinoma', 'TYMP', 'Capecitabine']",0.5
14758,37423.0,Capecitabine,ovarian clear cell adenocarcinoma,disease-protein-drug,off-label use,"['ovarian clear cell adenocarcinoma', 'TYMS', 'Capecitabine']",0.5
14758,37466.0,Capecitabine,ovarian small cell carcinoma,disease-protein-drug,off-label use,"['ovarian small cell carcinoma', 'TYMS', 'Capecitabine']",0.5
14758,37967.0,Capecitabine,ovarian endometrioid adenocarcinoma,disease-protein-drug,off-label use,"['ovarian endometrioid adenocarcinoma', 'TYMS', 'Capecitabine']",0.5
14758,39603.0,Capecitabine,malignant sex cord stromal tumor of ovary,disease-protein-drug,off-label use,"['malignant sex cord stromal tumor of ovary', 'TYMS', 'Capecitabine']",0.5
14758,39615.0,Capecitabine,borderline epithelial tumor of ovary,disease-protein-drug,off-label use,"['borderline epithelial tumor of ovary', 'TYMS', 'Capecitabine']",0.5
14758,83816.0,Capecitabine,ovarian carcinosarcoma,disease-protein-drug,off-label use,"['ovarian carcinosarcoma', 'TYMS', 'Capecitabine']",0.5
14758,83817.0,Capecitabine,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary site-specific ovarian cancer syndrome', 'TYMS', 'Capecitabine']",0.5
14758,83818.0,Capecitabine,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,off-label use,"['primary non-gestational choriocarcinoma of ovary', 'TYMS', 'Capecitabine']",0.5
14758,83819.0,Capecitabine,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant dysgerminomatous germ cell tumor of ovary', 'TYMS', 'Capecitabine']",0.5
14758,83820.0,Capecitabine,maligant granulosa cell tumor of ovary,disease-protein-drug,off-label use,"['maligant granulosa cell tumor of ovary', 'TYMS', 'Capecitabine']",0.5
14758,83821.0,Capecitabine,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,off-label use,"['malignant Sertoli-Leydig cell tumor of ovary', 'TYMS', 'Capecitabine']",0.5
14758,83822.0,Capecitabine,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,off-label use,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'TYMS', 'Capecitabine']",0.5
14758,83899.0,Capecitabine,gastric linitis plastica,disease-protein-drug,indication,"['gastric linitis plastica', 'TYMP', 'Capecitabine']",0.5
14762,27933.0,Bendroflumethiazide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'methylation', 'TPMT', 'Bendroflumethiazide']",0.5
14762,29182.0,Bendroflumethiazide,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'TPMT', 'Bendroflumethiazide']",0.5
14762,33575.0,Bendroflumethiazide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'methylation', 'TPMT', 'Bendroflumethiazide']",0.5
14762,33577.0,Bendroflumethiazide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Arsenic', 'methylation', 'TPMT', 'Bendroflumethiazide']",0.5
14762,35764.0,Bendroflumethiazide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'methylation', 'TPMT', 'Bendroflumethiazide']",0.5
14762,35897.0,Bendroflumethiazide,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'methylation', 'TPMT', 'Bendroflumethiazide']",0.5
14763,27933.0,Trichlormethiazide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'ATP1A1', 'Trichlormethiazide']",0.5
14763,28158.0,Trichlormethiazide,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'regulation of blood pressure', 'ATP1A1', 'Trichlormethiazide']",0.5
14763,33577.0,Trichlormethiazide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ATP1A1', 'Trichlormethiazide']",0.5
14763,35764.0,Trichlormethiazide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ATP1A1', 'Trichlormethiazide']",0.5
14764,27476.0,Mercaptopurine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorooctanoic acid', 'lactation', 'SLC29A1', 'Mercaptopurine']",0.5
14764,27626.0,Mercaptopurine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'XDH', 'Mercaptopurine']",0.5
14764,29118.0,Mercaptopurine,acquired polycythemia vera,disease-phenotype-protein-drug,off-label use,"['acquired polycythemia vera', 'Thrombocytopenia', 'XDH', 'Mercaptopurine']",0.5
14764,29361.0,Mercaptopurine,acute promyelocytic leukemia,disease-phenotype-protein-drug,indication,"['acute promyelocytic leukemia', 'Thrombocytopenia', 'XDH', 'Mercaptopurine']",0.5
14764,33621.0,Mercaptopurine,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Benzene', 'methylation', 'TPMT', 'Mercaptopurine']",0.5
14764,35565.0,Mercaptopurine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'lactation', 'SLC29A1', 'Mercaptopurine']",0.5
14764,35764.0,Mercaptopurine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'methylation', 'TPMT', 'Mercaptopurine']",0.5
14764,36104.0,Mercaptopurine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'TPMT', 'Mercaptopurine']",0.5
14764,36229.0,Mercaptopurine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'TPMT', 'Mercaptopurine']",0.5
14764,36301.0,Mercaptopurine,leukopenia,disease-protein-drug,contraindication,"['leukopenia', 'TPMT', 'Mercaptopurine']",0.5
14764,37785.0,Mercaptopurine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'SLC29A1', 'Mercaptopurine']",0.5
14768,28158.0,Dalteparin,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'SELP', 'Dalteparin']",0.5
14768,29614.0,Dalteparin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorooctanoic acid', 'lactation', 'SERPINC1', 'Dalteparin']",0.5
14768,29614.0,Dalteparin,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Particulate Matter', 'SELP', 'Dalteparin']",0.5
14768,30094.0,Dalteparin,antithrombin III deficiency,disease-protein-drug,contraindication,"['antithrombin III deficiency', 'SERPINC1', 'Dalteparin']",0.5
14768,32296.0,Dalteparin,acquired purpura fulminans,disease-protein-drug,indication,"['acquired purpura fulminans', 'SERPINC1', 'Dalteparin']",0.5
14768,32563.0,Dalteparin,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,contraindication,"['heparin-induced thrombocytopenia (disease)', 'Venous thrombosis', 'TFPI', 'Dalteparin']",0.5
14768,33699.0,Dalteparin,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,indication,"['pulmonary embolism (disease)', 'Air Pollutants', 'inflammatory response', 'SELP', 'Dalteparin']",0.5
14768,33699.0,Dalteparin,pulmonary embolism (disease),disease-exposure-gene-drug,indication,"['pulmonary embolism (disease)', 'Air Pollutants', 'SELP', 'Dalteparin']",0.5
14768,35849.0,Dalteparin,disseminated intravascular coagulation,disease-protein-drug,indication,"['disseminated intravascular coagulation', 'SERPINC1', 'Dalteparin']",0.5
14768,36325.0,Dalteparin,diabetic retinopathy,disease-protein-drug,contraindication,"['diabetic retinopathy', 'VEGFA', 'Dalteparin']",0.5
14768,37180.0,Dalteparin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'SELP', 'Dalteparin']",0.5
14768,37180.0,Dalteparin,myocardial infarction (disease),disease-exposure-gene-drug,off-label use,"['myocardial infarction (disease)', 'Air Pollutants', 'SELP', 'Dalteparin']",0.5
14768,37785.0,Dalteparin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'SERPINC1', 'Dalteparin']",0.5
14768,39484.0,Dalteparin,purpura fulminans,disease-protein-drug,indication,"['purpura fulminans', 'SERPINC1', 'Dalteparin']",0.5
14768,39531.0,Dalteparin,liver failure,disease-protein-drug,contraindication,"['liver failure', 'VEGFA', 'Dalteparin']",0.5
14768,83812.0,Dalteparin,acute coronary syndrome,disease-protein-drug,off-label use,"['acute coronary syndrome', 'SERPINC1', 'Dalteparin']",0.5
14768,83940.0,Dalteparin,diabetic cataract,disease-protein-drug,contraindication,"['diabetic cataract', 'VEGFA', 'Dalteparin']",0.5
14768,83942.0,Dalteparin,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'inflammatory response', 'SELP', 'Dalteparin']",0.5
14768,83942.0,Dalteparin,intracerebral hemorrhage,disease-exposure-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'SELP', 'Dalteparin']",0.5
14771,31033.0,Ticlopidine,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'CYP1A2', 'Ticlopidine']",0.5
14771,31033.0,Ticlopidine,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'CYP1A2', 'Ticlopidine']",0.5
14771,32629.0,Ticlopidine,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'CYP1A2', 'Ticlopidine']",0.5
14771,32629.0,Ticlopidine,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'CYP1A2', 'Ticlopidine']",0.5
14771,33440.0,Ticlopidine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Coma', 'CYP2D6', 'Ticlopidine']",0.5
14771,33635.0,Ticlopidine,leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['leukemia (disease)', 'Benzene', 'methylation', 'CYP1A2', 'Ticlopidine']",0.5
14771,33635.0,Ticlopidine,leukemia (disease),disease-exposure-gene-drug,contraindication,"['leukemia (disease)', 'Pesticides', 'CYP2E1', 'Ticlopidine']",0.5
14771,38059.0,Ticlopidine,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'CYP1A2', 'Ticlopidine']",0.5
14771,83942.0,Ticlopidine,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'response to oxidative stress', 'MPO', 'Ticlopidine']",0.5
14772,27286.0,Aminosalicylic acid,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PTGS2', 'Aminosalicylic acid']",0.5
14772,27292.0,Aminosalicylic acid,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Arrhythmia', 'PTGS2', 'Aminosalicylic acid']",0.5
14772,28158.0,Aminosalicylic acid,inflammatory bowel disease,disease-protein-drug,off-label use,"['inflammatory bowel disease', 'MPO', 'Aminosalicylic acid']",0.5
14772,28158.0,Aminosalicylic acid,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,off-label use,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'regulation of blood pressure', 'PTGS2', 'Aminosalicylic acid']",0.5
14772,35565.0,Aminosalicylic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'CHUK', 'Aminosalicylic acid']",0.5
14772,35764.0,Aminosalicylic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ALOX5', 'Aminosalicylic acid']",0.5
14772,35764.0,Aminosalicylic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Aminosalicylic acid']",0.5
14772,36252.0,Aminosalicylic acid,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'ALOX5', 'Aminosalicylic acid']",0.5
14772,37564.0,Aminosalicylic acid,gastric ulcer (disease),disease-protein-drug,contraindication,"['gastric ulcer (disease)', 'PTGS2', 'Aminosalicylic acid']",0.5
14772,37785.0,Aminosalicylic acid,ulcerative colitis (disease),disease-protein-drug,off-label use,"['ulcerative colitis (disease)', 'MPO', 'Aminosalicylic acid']",0.5
14772,37785.0,Aminosalicylic acid,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'PTGS2', 'Aminosalicylic acid']",0.5
14772,39696.0,Aminosalicylic acid,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'ALOX5', 'Aminosalicylic acid']",0.5
14772,39696.0,Aminosalicylic acid,pulmonary tuberculosis,disease-exposure-gene-drug,indication,"['pulmonary tuberculosis', 'Arsenic', 'PTGS2', 'Aminosalicylic acid']",0.5
14772,83961.0,Aminosalicylic acid,duodenal ulcer (disease),disease-protein-drug,contraindication,"['duodenal ulcer (disease)', 'PTGS2', 'Aminosalicylic acid']",0.5
14773,35552.0,Cefaclor,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'innate immune response', 'SLC15A2', 'Cefaclor']",0.5
14773,35831.0,Cefaclor,respiratory tract infectious disease,disease-exposure-bioprocess-gene-drug,indication,"['respiratory tract infectious disease', 'Air Pollutants', 'response to oxidative stress', 'MPO', 'Cefaclor']",0.5
14774,29614.0,Enoxaparin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorooctanoic acid', 'lactation', 'SERPINC1', 'Enoxaparin']",0.5
14774,30094.0,Enoxaparin,antithrombin III deficiency,disease-protein-drug,contraindication,"['antithrombin III deficiency', 'SERPINC1', 'Enoxaparin']",0.5
14774,32296.0,Enoxaparin,acquired purpura fulminans,disease-protein-drug,indication,"['acquired purpura fulminans', 'SERPINC1', 'Enoxaparin']",0.5
14774,32563.0,Enoxaparin,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,contraindication,"['heparin-induced thrombocytopenia (disease)', 'Venous thrombosis', 'SERPINC1', 'Enoxaparin']",0.5
14774,33699.0,Enoxaparin,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,indication,"['pulmonary embolism (disease)', 'Air Pollutants', 'response to oxidative stress', 'MPO', 'Enoxaparin']",0.5
14774,35849.0,Enoxaparin,disseminated intravascular coagulation,disease-protein-drug,indication,"['disseminated intravascular coagulation', 'SERPINC1', 'Enoxaparin']",0.5
14774,37180.0,Enoxaparin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['myocardial infarction (disease)', 'Air Pollutants', 'response to oxidative stress', 'MPO', 'Enoxaparin']",0.5
14774,37785.0,Enoxaparin,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'MPO', 'Enoxaparin']",0.5
14774,37785.0,Enoxaparin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'SERPINC1', 'Enoxaparin']",0.5
14774,39484.0,Enoxaparin,purpura fulminans,disease-protein-drug,indication,"['purpura fulminans', 'SERPINC1', 'Enoxaparin']",0.5
14774,83812.0,Enoxaparin,acute coronary syndrome,disease-protein-drug,off-label use,"['acute coronary syndrome', 'SERPINC1', 'Enoxaparin']",0.5
14774,83942.0,Enoxaparin,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'response to oxidative stress', 'MPO', 'Enoxaparin']",0.5
14775,27829.0,Calcipotriol,idiopathic inherited hypercalciuria,disease-phenotype-protein-drug,contraindication,"['idiopathic inherited hypercalciuria', 'Hypercalciuria', 'CYP24A1', 'Calcipotriol']",0.5
14775,27830.0,Calcipotriol,familial hypocalciuric hypercalcemia,disease-phenotype-protein-drug,contraindication,"['familial hypocalciuric hypercalcemia', 'Hypercalciuria', 'CYP24A1', 'Calcipotriol']",0.5
14775,28754.0,Calcipotriol,autosomal recessive infantile hypercalcemia,disease-protein-drug,contraindication,"['autosomal recessive infantile hypercalcemia', 'CYP24A1', 'Calcipotriol']",0.5
14775,28754.0,Calcipotriol,autosomal recessive infantile hypercalcemia,disease-phenotype-protein-drug,contraindication,"['autosomal recessive infantile hypercalcemia', 'Hypercalciuria', 'CYP24A1', 'Calcipotriol']",0.5
14775,33656.0,Calcipotriol,hypercalcemia disease,disease-protein-drug,contraindication,"['hypercalcemia disease', 'CYP24A1', 'Calcipotriol']",0.5
14775,33656.0,Calcipotriol,hypercalcemia disease,disease-phenotype-protein-drug,contraindication,"['hypercalcemia disease', 'Infantile hypercalcemia', 'CYP24A1', 'Calcipotriol']",0.5
14775,35583.0,Calcipotriol,phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'CYP24A1', 'Calcipotriol']",0.5
14775,38682.0,Calcipotriol,nephrocalcinosis,disease-protein-drug,contraindication,"['nephrocalcinosis', 'CYP24A1', 'Calcipotriol']",0.5
14775,39798.0,Calcipotriol,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'VDR', 'Calcipotriol']",0.5
14779,35565.0,Tiopronin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'response to oxidative stress', 'MPO', 'Tiopronin']",0.5
14779,35764.0,Tiopronin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to oxidative stress', 'MPO', 'Tiopronin']",0.5
14779,37175.0,Tiopronin,proteinuria,disease-exposure-bioprocess-gene-drug,contraindication,"['proteinuria', 'Cadmium', 'response to oxidative stress', 'MPO', 'Tiopronin']",0.5
14780,28520.0,Cytarabine,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'triglyceride metabolic process', 'SLC22A4', 'Cytarabine']",0.5
14780,30075.0,Cytarabine,Burkitt lymphoma,disease-exposure-bioprocess-gene-drug,off-label use,"['Burkitt lymphoma', 'Pesticides', 'triglyceride metabolic process', 'SLC22A4', 'Cytarabine']",0.5
14780,30654.0,Cytarabine,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'POLB', 'Cytarabine']",0.5
14780,33063.0,Cytarabine,adult acute respiratory distress syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['adult acute respiratory distress syndrome', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Cytarabine']",0.5
14780,33594.0,Cytarabine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'DNA repair', 'POLB', 'Cytarabine']",0.5
14780,33621.0,Cytarabine,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'inflammatory response', 'POLB', 'Cytarabine']",0.5
14780,33632.0,Cytarabine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Cytarabine']",0.5
14780,35565.0,Cytarabine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Cytarabine']",0.5
14780,35764.0,Cytarabine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Cytarabine']",0.5
14780,35884.0,Cytarabine,diffuse large B-cell lymphoma,disease-exposure-bioprocess-gene-drug,off-label use,"['diffuse large B-cell lymphoma', 'Polychlorinated Biphenyls', 'triglyceride metabolic process', 'SLC22A4', 'Cytarabine']",0.5
14780,83802.0,Cytarabine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Cytarabine']",0.5
14782,28555.0,Biotin,biotinidase deficiency,disease-phenotype-protein-drug,off-label use,"['biotinidase deficiency', 'Hepatomegaly', 'CYP1B1', 'Biotin']",0.5
14782,28786.0,Biotin,holocarboxylase synthetase deficiency,disease-protein-drug,off-label use,"['holocarboxylase synthetase deficiency', 'HLCS', 'Biotin']",0.5
14782,28786.0,Biotin,holocarboxylase synthetase deficiency,disease-phenotype-protein-drug,off-label use,"['holocarboxylase synthetase deficiency', 'Seizure', 'SLC5A6', 'Biotin']",0.5
14782,29070.0,Biotin,propionic acidemia,disease-protein-drug,off-label use,"['propionic acidemia', 'PCCB', 'Biotin']",0.5
14782,29070.0,Biotin,propionic acidemia,disease-phenotype-protein-drug,off-label use,"['propionic acidemia', 'Hepatomegaly', 'CYP1B1', 'Biotin']",0.5
14782,32967.0,Biotin,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'CYP1B1', 'Biotin']",0.5
14782,35764.0,Biotin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'tissue homeostasis', 'ACACA', 'Biotin']",0.5
14783,27326.0,Caffeine,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Caffeine']",0.5
14783,27326.0,Caffeine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'PIK3CA', 'Caffeine']",0.5
14783,27326.0,Caffeine,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Caffeine']",0.5
14783,27326.0,Caffeine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'ADORA1', 'Caffeine']",0.5
14783,27361.0,Caffeine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'ADORA2A', 'Caffeine']",0.5
14783,27648.0,Caffeine,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Weight loss', 'ADORA2A', 'Caffeine']",0.5
14783,27655.0,Caffeine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ADORA2A', 'Caffeine']",0.5
14783,27933.0,Caffeine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ADORA2A', 'Caffeine']",0.5
14783,27933.0,Caffeine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'telomere maintenance', 'ATM', 'Caffeine']",0.5
14783,27933.0,Caffeine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Caffeine']",0.5
14783,28158.0,Caffeine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'PDE3A', 'Caffeine']",0.5
14783,28158.0,Caffeine,inflammatory bowel disease,disease-exposure-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'CYP1A1', 'Caffeine']",0.5
14783,28158.0,Caffeine,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Weight loss', 'ADORA2A', 'Caffeine']",0.5
14783,28396.0,Caffeine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'ADORA2A', 'Caffeine']",0.5
14783,28473.0,Caffeine,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Caffeine']",0.5
14783,28651.0,Caffeine,monogenic obesity,disease-protein-drug,off-label use,"['monogenic obesity', 'CYP2E1', 'Caffeine']",0.5
14783,28780.0,Caffeine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Caffeine']",0.5
14783,28780.0,Caffeine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,28780.0,Caffeine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP2E1', 'Caffeine']",0.5
14783,28780.0,Caffeine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ADORA2A', 'Caffeine']",0.5
14783,28899.0,Caffeine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Nicotine', 'telomere maintenance', 'ATM', 'Caffeine']",0.5
14783,28899.0,Caffeine,obsessive-compulsive disorder,disease-exposure-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Tobacco Smoke Pollution', 'CYP1A1', 'Caffeine']",0.5
14783,29113.0,Caffeine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'ITPR3', 'Caffeine']",0.5
14783,29175.0,Caffeine,thyrotoxicosis,disease-phenotype-protein-drug,contraindication,"['thyrotoxicosis', 'Weight loss', 'ADORA2A', 'Caffeine']",0.5
14783,29229.0,Caffeine,glaucoma,disease-protein-drug,contraindication,"['glaucoma', 'CYP1B1', 'Caffeine']",0.5
14783,30035.0,Caffeine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Caffeine']",0.5
14783,30374.0,Caffeine,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'CYP1A1', 'Caffeine']",0.5
14783,30612.0,Caffeine,Leber hereditary optic neuropathy,disease-phenotype-protein-drug,contraindication,"['Leber hereditary optic neuropathy', 'Postural tremor', 'ADORA2A', 'Caffeine']",0.5
14783,30813.0,Caffeine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Weight loss', 'ADORA2A', 'Caffeine']",0.5
14783,31072.0,Caffeine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CYP1A1', 'Caffeine']",0.5
14783,31395.0,Caffeine,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Caffeine']",0.5
14783,31618.0,Caffeine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'ADORA2A', 'Caffeine']",0.5
14783,31650.0,Caffeine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ADORA2A', 'Caffeine']",0.5
14783,32033.0,Caffeine,insomnia (disease),disease-protein-drug,contraindication,"['insomnia (disease)', 'ADORA2A', 'Caffeine']",0.5
14783,32313.0,Caffeine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'ADORA2A', 'Caffeine']",0.5
14783,32384.0,Caffeine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Weight loss', 'ADORA2A', 'Caffeine']",0.5
14783,32797.0,Caffeine,IgG4-related retroperitoneal fibrosis,disease-phenotype-protein-drug,contraindication,"['IgG4-related retroperitoneal fibrosis', 'Weight loss', 'ADORA2A', 'Caffeine']",0.5
14783,32841.0,Caffeine,idiopathic achalasia,disease-phenotype-protein-drug,contraindication,"['idiopathic achalasia', 'Weight loss', 'ADORA2A', 'Caffeine']",0.5
14783,32977.0,Caffeine,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Caffeine']",0.5
14783,32977.0,Caffeine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ADORA2A', 'Caffeine']",0.5
14783,33306.0,Caffeine,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'ADORA1', 'Caffeine']",0.5
14783,33440.0,Caffeine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Coma', 'CYP2D6', 'Caffeine']",0.5
14783,33575.0,Caffeine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Caffeine']",0.5
14783,33575.0,Caffeine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'PIK3CA', 'Caffeine']",0.5
14783,33575.0,Caffeine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Caffeine']",0.5
14783,33577.0,Caffeine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'adipose tissue development', 'PIK3CA', 'Caffeine']",0.5
14783,33577.0,Caffeine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Caffeine']",0.5
14783,33593.0,Caffeine,obesity disorder,disease-protein-drug,off-label use,"['obesity disorder', 'CYP2E1', 'Caffeine']",0.5
14783,33593.0,Caffeine,obesity disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['obesity disorder', 'Cobalt', 'metabolic process', 'PDE11A', 'Caffeine']",0.5
14783,33593.0,Caffeine,obesity disorder,disease-exposure-gene-drug,off-label use,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'CYP1A1', 'Caffeine']",0.5
14783,33593.0,Caffeine,obesity disorder,disease-phenotype-protein-drug,off-label use,"['obesity disorder', 'Increased body weight', 'PIK3CA', 'Caffeine']",0.5
14783,33594.0,Caffeine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'PIK3CA', 'Caffeine']",0.5
14783,33594.0,Caffeine,diarrheal disease,disease-exposure-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'CYP1A1', 'Caffeine']",0.5
14783,33605.0,Caffeine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADORA1', 'Caffeine']",0.5
14783,33632.0,Caffeine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'PDE3A', 'Caffeine']",0.5
14783,33632.0,Caffeine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,33675.0,Caffeine,asthma,disease-protein-drug,contraindication,"['asthma', 'PDE4D', 'Caffeine']",0.5
14783,33675.0,Caffeine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,33675.0,Caffeine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,35471.0,Caffeine,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'inflammatory response', 'ADORA2A', 'Caffeine']",0.5
14783,35565.0,Caffeine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,35565.0,Caffeine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Caffeine']",0.5
14783,35641.0,Caffeine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADORA2A', 'Caffeine']",0.5
14783,35669.0,Caffeine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,35669.0,Caffeine,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,35761.0,Caffeine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose metabolic process', 'PIK3CA', 'Caffeine']",0.5
14783,35761.0,Caffeine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,35764.0,Caffeine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'adipose tissue development', 'PIK3CA', 'Caffeine']",0.5
14783,35764.0,Caffeine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Caffeine']",0.5
14783,35897.0,Caffeine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Caffeine']",0.5
14783,35897.0,Caffeine,pulmonary emphysema,disease-exposure-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'CYP1B1', 'Caffeine']",0.5
14783,35953.0,Caffeine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Caffeine']",0.5
14783,35953.0,Caffeine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,35958.0,Caffeine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'PDE3A', 'Caffeine']",0.5
14783,36034.0,Caffeine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Diazinon', 'telomere maintenance', 'ATM', 'Caffeine']",0.5
14783,36040.0,Caffeine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'adipose tissue development', 'PIK3CA', 'Caffeine']",0.5
14783,36080.0,Caffeine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Caffeine']",0.5
14783,36080.0,Caffeine,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,36187.0,Caffeine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PDE4B', 'Caffeine']",0.5
14783,36187.0,Caffeine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,36187.0,Caffeine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,36266.0,Caffeine,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'PRKDC', 'Caffeine']",0.5
14783,36274.0,Caffeine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'fatty acid homeostasis', 'ADORA1', 'Caffeine']",0.5
14783,36312.0,Caffeine,transient ischemic attack (disease),disease-protein-drug,contraindication,"['transient ischemic attack (disease)', 'ADORA1', 'Caffeine']",0.5
14783,36312.0,Caffeine,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Caffeine']",0.5
14783,36312.0,Caffeine,transient ischemic attack (disease),disease-exposure-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'CYP1B1', 'Caffeine']",0.5
14783,36469.0,Caffeine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Diazinon', 'telomere maintenance', 'ATM', 'Caffeine']",0.5
14783,36492.0,Caffeine,brain cancer,disease-protein-drug,contraindication,"['brain cancer', 'CYP2C9', 'Caffeine']",0.5
14783,36492.0,Caffeine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,36492.0,Caffeine,brain cancer,disease-exposure-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'CYP2E1', 'Caffeine']",0.5
14783,36693.0,Caffeine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'PDE1C', 'Caffeine']",0.5
14783,37180.0,Caffeine,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'PDE3A', 'Caffeine']",0.5
14783,37180.0,Caffeine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,37180.0,Caffeine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,37617.0,Caffeine,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A1', 'Caffeine']",0.5
14783,37617.0,Caffeine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,37617.0,Caffeine,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,37703.0,Caffeine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'PDE4A', 'Caffeine']",0.5
14783,37718.0,Caffeine,brain ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['brain ischemia', 'urea formaldehyde foam', 'T cell differentiation', 'PIK3CD', 'Caffeine']",0.5
14783,37718.0,Caffeine,brain ischemia,disease-exposure-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,37785.0,Caffeine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,37786.0,Caffeine,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'PDE4B', 'Caffeine']",0.5
14783,37786.0,Caffeine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,37786.0,Caffeine,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Agent Orange', 'CYP1A1', 'Caffeine']",0.5
14783,37888.0,Caffeine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'PIK3CD', 'Caffeine']",0.5
14783,37888.0,Caffeine,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'ADORA2B', 'Caffeine']",0.5
14783,37888.0,Caffeine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'CYP1A1', 'Caffeine']",0.5
14783,38513.0,Caffeine,congenital adrenal hyperplasia,disease-protein-drug,contraindication,"['congenital adrenal hyperplasia', 'PDE8B', 'Caffeine']",0.5
14783,38575.0,Caffeine,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Caffeine']",0.5
14783,39609.0,Caffeine,pharyngitis,disease-exposure-bioprocess-gene-drug,indication,"['pharyngitis', 'urea formaldehyde foam', 'T cell differentiation', 'PIK3CD', 'Caffeine']",0.5
14783,39798.0,Caffeine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Caffeine']",0.5
14783,39798.0,Caffeine,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'ADORA2B', 'Caffeine']",0.5
14783,83760.0,Caffeine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'PDE4A', 'Caffeine']",0.5
14783,83790.0,Caffeine,gout,disease-protein-drug,contraindication,"['gout', 'ABCG2', 'Caffeine']",0.5
14783,83805.0,Caffeine,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'PRKDC', 'Caffeine']",0.5
14783,83823.0,Caffeine,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'PDE3A', 'Caffeine']",0.5
14783,83824.0,Caffeine,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'PDE3A', 'Caffeine']",0.5
14783,83910.0,Caffeine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'ADORA2A', 'Caffeine']",0.5
14783,83911.0,Caffeine,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Caffeine']",0.5
14783,83923.0,Caffeine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Caffeine']",0.5
14783,83923.0,Caffeine,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'CYP1B1', 'Caffeine']",0.5
14784,27933.0,Theophylline,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'HDAC2', 'Theophylline']",0.5
14784,27933.0,Theophylline,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'positive regulation of heart rate', 'ADA', 'Theophylline']",0.5
14784,27933.0,Theophylline,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Theophylline']",0.5
14784,28714.0,Theophylline,cystic fibrosis,disease-phenotype-protein-drug,contraindication,"['cystic fibrosis', 'Male infertility', 'CYP1A1', 'Theophylline']",0.5
14784,29175.0,Theophylline,thyrotoxicosis,disease-phenotype-protein-drug,contraindication,"['thyrotoxicosis', 'Weight loss', 'ADORA2A', 'Theophylline']",0.5
14784,30035.0,Theophylline,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Theophylline']",0.5
14784,31395.0,Theophylline,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Theophylline']",0.5
14784,31618.0,Theophylline,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'ADORA2A', 'Theophylline']",0.5
14784,32313.0,Theophylline,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'ADORA2A', 'Theophylline']",0.5
14784,32737.0,Theophylline,hypocomplementemic urticarial vasculitis,disease-phenotype-protein-drug,contraindication,"['hypocomplementemic urticarial vasculitis', 'Hepatomegaly', 'CYP1A1', 'Theophylline']",0.5
14784,32977.0,Theophylline,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Theophylline']",0.5
14784,32977.0,Theophylline,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ADORA2A', 'Theophylline']",0.5
14784,33575.0,Theophylline,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Theophylline']",0.5
14784,33575.0,Theophylline,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'triglyceride homeostasis', 'ADORA1', 'Theophylline']",0.5
14784,33575.0,Theophylline,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Theophylline']",0.5
14784,33577.0,Theophylline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of glomerular filtration', 'ADORA1', 'Theophylline']",0.5
14784,33577.0,Theophylline,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Theophylline']",0.5
14784,33603.0,Theophylline,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'PARP1', 'Theophylline']",0.5
14784,33623.0,Theophylline,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'PARP1', 'Theophylline']",0.5
14784,33632.0,Theophylline,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'PARP1', 'Theophylline']",0.5
14784,33632.0,Theophylline,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'PDE3A', 'Theophylline']",0.5
14784,33632.0,Theophylline,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,33675.0,Theophylline,asthma,disease-protein-drug,indication,"['asthma', 'PARP1', 'Theophylline']",0.5
14784,33675.0,Theophylline,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Theophylline']",0.5
14784,33675.0,Theophylline,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,35565.0,Theophylline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'ADORA1', 'Theophylline']",0.5
14784,35565.0,Theophylline,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Theophylline']",0.5
14784,35641.0,Theophylline,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADORA2A', 'Theophylline']",0.5
14784,35669.0,Theophylline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Theophylline']",0.5
14784,35669.0,Theophylline,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,35761.0,Theophylline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'triglyceride homeostasis', 'ADORA1', 'Theophylline']",0.5
14784,35761.0,Theophylline,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,35764.0,Theophylline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of glomerular filtration', 'ADORA1', 'Theophylline']",0.5
14784,35764.0,Theophylline,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Theophylline']",0.5
14784,35833.0,Theophylline,lung disease,disease-exposure-bioprocess-gene-drug,indication,"['lung disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Theophylline']",0.5
14784,35833.0,Theophylline,lung disease,disease-exposure-gene-drug,indication,"['lung disease', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,35897.0,Theophylline,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Theophylline']",0.5
14784,35897.0,Theophylline,pulmonary emphysema,disease-exposure-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'CYP1B1', 'Theophylline']",0.5
14784,35915.0,Theophylline,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cognition', 'ADORA1', 'Theophylline']",0.5
14784,35953.0,Theophylline,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'PARP1', 'Theophylline']",0.5
14784,35953.0,Theophylline,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Theophylline']",0.5
14784,35953.0,Theophylline,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,35958.0,Theophylline,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'PDE3A', 'Theophylline']",0.5
14784,36034.0,Theophylline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Diazinon', 'telomere maintenance', 'PARP1', 'Theophylline']",0.5
14784,36187.0,Theophylline,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PDE4B', 'Theophylline']",0.5
14784,36187.0,Theophylline,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Theophylline']",0.5
14784,36187.0,Theophylline,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,36252.0,Theophylline,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Theophylline']",0.5
14784,36252.0,Theophylline,thyroid gland disease,disease-exposure-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'CYP1B1', 'Theophylline']",0.5
14784,36469.0,Theophylline,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Diazinon', 'telomere maintenance', 'PARP1', 'Theophylline']",0.5
14784,36693.0,Theophylline,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Theophylline']",0.5
14784,37180.0,Theophylline,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'PDE3A', 'Theophylline']",0.5
14784,37180.0,Theophylline,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Theophylline']",0.5
14784,37180.0,Theophylline,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,37703.0,Theophylline,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'HDAC2', 'Theophylline']",0.5
14784,37786.0,Theophylline,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'PDE4B', 'Theophylline']",0.5
14784,37786.0,Theophylline,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Theophylline']",0.5
14784,37786.0,Theophylline,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Agent Orange', 'CYP1A1', 'Theophylline']",0.5
14784,37830.0,Theophylline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Theophylline']",0.5
14784,37830.0,Theophylline,bronchitis,disease-exposure-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'ADORA2B', 'Theophylline']",0.5
14784,39773.0,Theophylline,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'PARP1', 'Theophylline']",0.5
14784,83760.0,Theophylline,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'PDE4A', 'Theophylline']",0.5
14784,83778.0,Theophylline,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cognition', 'ADORA1', 'Theophylline']",0.5
14784,83779.0,Theophylline,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cognition', 'ADORA1', 'Theophylline']",0.5
14784,83781.0,Theophylline,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'PARP1', 'Theophylline']",0.5
14784,83823.0,Theophylline,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'PDE3A', 'Theophylline']",0.5
14784,83824.0,Theophylline,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'PDE3A', 'Theophylline']",0.5
14785,29614.0,Omeprazole,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Omeprazole']",0.5
14785,29614.0,Omeprazole,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Particulate Matter', 'CYP1B1', 'Omeprazole']",0.5
14785,32875.0,Omeprazole,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Omeprazole']",0.5
14785,35565.0,Omeprazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'AHR', 'Omeprazole']",0.5
14785,35565.0,Omeprazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Omeprazole']",0.5
14786,27326.0,Lansoprazole,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Lansoprazole']",0.5
14786,27326.0,Lansoprazole,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,27326.0,Lansoprazole,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Lansoprazole']",0.5
14786,27326.0,Lansoprazole,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Lansoprazole']",0.5
14786,27503.0,Lansoprazole,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Bradycardia', 'CYP1A1', 'Lansoprazole']",0.5
14786,28082.0,Lansoprazole,chronic Epstein-Barr virus infection syndrome,disease-phenotype-protein-drug,contraindication,"['chronic Epstein-Barr virus infection syndrome', 'Splenomegaly', 'MAPT', 'Lansoprazole']",0.5
14786,29614.0,Lansoprazole,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,29614.0,Lansoprazole,osteoporosis,disease-exposure-gene-drug,contraindication,"['osteoporosis', 'Particulate Matter', 'CYP1B1', 'Lansoprazole']",0.5
14786,30035.0,Lansoprazole,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Lansoprazole']",0.5
14786,31033.0,Lansoprazole,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'CYP1A1', 'Lansoprazole']",0.5
14786,32629.0,Lansoprazole,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'CYP1A1', 'Lansoprazole']",0.5
14786,32875.0,Lansoprazole,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Weight loss', 'MAPT', 'Lansoprazole']",0.5
14786,33577.0,Lansoprazole,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,33577.0,Lansoprazole,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Lansoprazole']",0.5
14786,33598.0,Lansoprazole,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Lansoprazole']",0.5
14786,33598.0,Lansoprazole,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Lansoprazole']",0.5
14786,33632.0,Lansoprazole,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Lansoprazole']",0.5
14786,33632.0,Lansoprazole,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'CYP1B1', 'Lansoprazole']",0.5
14786,35565.0,Lansoprazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,35565.0,Lansoprazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Lansoprazole']",0.5
14786,35669.0,Lansoprazole,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Lansoprazole']",0.5
14786,35669.0,Lansoprazole,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,35669.0,Lansoprazole,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'CYP1B1', 'Lansoprazole']",0.5
14786,35761.0,Lansoprazole,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,35761.0,Lansoprazole,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'CYP1B1', 'Lansoprazole']",0.5
14786,35764.0,Lansoprazole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,35764.0,Lansoprazole,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Lansoprazole']",0.5
14786,35909.0,Lansoprazole,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,35909.0,Lansoprazole,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CYP1B1', 'Lansoprazole']",0.5
14786,37180.0,Lansoprazole,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'memory', 'MAPT', 'Lansoprazole']",0.5
14786,37180.0,Lansoprazole,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Lansoprazole']",0.5
14786,83751.0,Lansoprazole,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Lansoprazole']",0.5
14787,27286.0,Flutamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'NR1I2', 'Flutamide']",0.5
14787,27292.0,Flutamide,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'AHR', 'Flutamide']",0.5
14787,27476.0,Flutamide,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Flutamide']",0.5
14787,31168.0,Flutamide,pyruvate dehydrogenase E3 deficiency,disease-phenotype-protein-drug,contraindication,"['pyruvate dehydrogenase E3 deficiency', 'Hepatomegaly', 'NR1I2', 'Flutamide']",0.5
14787,35565.0,Flutamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Flutamide']",0.5
14787,35565.0,Flutamide,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Flutamide']",0.5
14787,35963.0,Flutamide,prostate carcinoma,disease-protein-drug,indication,"['prostate carcinoma', 'CYP2C19', 'Flutamide']",0.5
14787,35966.0,Flutamide,prostate cancer,disease-protein-drug,indication,"['prostate cancer', 'CYP2C19', 'Flutamide']",0.5
14787,35966.0,Flutamide,prostate cancer,disease-exposure-bioprocess-gene-drug,indication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Flutamide']",0.5
14787,35966.0,Flutamide,prostate cancer,disease-exposure-gene-drug,indication,"['prostate cancer', 'Agent Orange', 'CYP1A1', 'Flutamide']",0.5
14787,38462.0,Flutamide,sulfhemoglobinemia,disease-protein-drug,contraindication,"['sulfhemoglobinemia', 'CYP1A2', 'Flutamide']",0.5
14787,39480.0,Flutamide,methemoglobinemia,disease-protein-drug,contraindication,"['methemoglobinemia', 'CYP1A2', 'Flutamide']",0.5
14789,27503.0,Daunorubicin,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'ABCC2', 'Daunorubicin']",0.5
14789,28052.0,Daunorubicin,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'CYP1A1', 'Daunorubicin']",0.5
14789,28830.0,Daunorubicin,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Daunorubicin']",0.5
14789,29352.0,Daunorubicin,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'XDH', 'Daunorubicin']",0.5
14789,29361.0,Daunorubicin,acute promyelocytic leukemia,disease-phenotype-protein-drug,indication,"['acute promyelocytic leukemia', 'Thrombocytopenia', 'XDH', 'Daunorubicin']",0.5
14789,29494.0,Daunorubicin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A1', 'Daunorubicin']",0.5
14789,29863.0,Daunorubicin,monocytic leukemia,disease-protein-drug,indication,"['monocytic leukemia', 'TOP2B', 'Daunorubicin']",0.5
14789,30184.0,Daunorubicin,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A1', 'Daunorubicin']",0.5
14789,30654.0,Daunorubicin,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Daunorubicin']",0.5
14789,30879.0,Daunorubicin,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'ABCC2', 'Daunorubicin']",0.5
14789,33188.0,Daunorubicin,neuroblastoma,disease-protein-drug,off-label use,"['neuroblastoma', 'ABCB1', 'Daunorubicin']",0.5
14789,33621.0,Daunorubicin,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Daunorubicin']",0.5
14789,33621.0,Daunorubicin,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Daunorubicin']",0.5
14789,33621.0,Daunorubicin,acute lymphoblastic leukemia (disease),disease-exposure-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'CYP1B1', 'Daunorubicin']",0.5
14789,35565.0,Daunorubicin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Daunorubicin']",0.5
14789,35565.0,Daunorubicin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Daunorubicin']",0.5
14789,35641.0,Daunorubicin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Daunorubicin']",0.5
14789,35764.0,Daunorubicin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Daunorubicin']",0.5
14789,35764.0,Daunorubicin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Daunorubicin']",0.5
14789,36104.0,Daunorubicin,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Daunorubicin']",0.5
14789,36229.0,Daunorubicin,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Daunorubicin']",0.5
14789,83769.0,Daunorubicin,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Daunorubicin']",0.5
14789,83802.0,Daunorubicin,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Daunorubicin']",0.5
14789,83802.0,Daunorubicin,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Daunorubicin']",0.5
14790,27292.0,Primaquine,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'CYP1A2', 'Primaquine']",0.5
14790,31168.0,Primaquine,pyruvate dehydrogenase E3 deficiency,disease-phenotype-protein-drug,contraindication,"['pyruvate dehydrogenase E3 deficiency', 'Hepatomegaly', 'CYP1A1', 'Primaquine']",0.5
14790,36104.0,Primaquine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Primaquine']",0.5
14790,36229.0,Primaquine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Primaquine']",0.5
14791,28520.0,Mitoxantrone,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Mitoxantrone']",0.5
14791,28520.0,Mitoxantrone,myeloid leukemia,disease-exposure-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'CYP2E1', 'Mitoxantrone']",0.5
14791,33294.0,Mitoxantrone,follicular lymphoma,disease-exposure-bioprocess-gene-drug,off-label use,"['follicular lymphoma', 'Polychlorinated Biphenyls', 'triglyceride metabolic process', 'CYP2E1', 'Mitoxantrone']",0.5
14791,33632.0,Mitoxantrone,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Mitoxantrone']",0.5
14791,33632.0,Mitoxantrone,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'CYP1B1', 'Mitoxantrone']",0.5
14791,35565.0,Mitoxantrone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Mitoxantrone']",0.5
14791,35641.0,Mitoxantrone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Mitoxantrone']",0.5
14791,36104.0,Mitoxantrone,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Mitoxantrone']",0.5
14791,36229.0,Mitoxantrone,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Mitoxantrone']",0.5
14791,37659.0,Mitoxantrone,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'cellular response to DNA damage stimulus', 'TOP2A', 'Mitoxantrone']",0.5
14791,37659.0,Mitoxantrone,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'CYP1B1', 'Mitoxantrone']",0.5
14792,27476.0,Paclitaxel,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Paclitaxel']",0.5
14792,27476.0,Paclitaxel,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Paclitaxel']",0.5
14792,27933.0,Paclitaxel,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Paclitaxel']",0.5
14792,27933.0,Paclitaxel,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,27933.0,Paclitaxel,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'BCL2', 'Paclitaxel']",0.5
14792,29173.0,Paclitaxel,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,29173.0,Paclitaxel,small cell lung carcinoma,disease-exposure-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'BCL2', 'Paclitaxel']",0.5
14792,29402.0,Paclitaxel,esophageal cancer,disease-protein-drug,off-label use,"['esophageal cancer', 'ABCB1', 'Paclitaxel']",0.5
14792,29402.0,Paclitaxel,esophageal cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['esophageal cancer', 'Vehicle Emissions', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,31107.0,Paclitaxel,cervical cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['cervical cancer', 'Vehicle Emissions', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,31107.0,Paclitaxel,cervical cancer,disease-exposure-gene-drug,off-label use,"['cervical cancer', 'Air Pollutants', 'CYP1B1', 'Paclitaxel']",0.5
14792,31116.0,Paclitaxel,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Paclitaxel']",0.5
14792,31122.0,Paclitaxel,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Cerebral hemorrhage', 'BCL2', 'Paclitaxel']",0.5
14792,31650.0,Paclitaxel,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ABCC2', 'Paclitaxel']",0.5
14792,31756.0,Paclitaxel,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder cancer', 'perfluorooctanoic acid', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,31756.0,Paclitaxel,urinary bladder cancer,disease-exposure-gene-drug,off-label use,"['urinary bladder cancer', 'Arsenic', 'BCL2', 'Paclitaxel']",0.5
14792,32307.0,Paclitaxel,desmoplastic small round cell tumor,disease-phenotype-protein-drug,indication,"['desmoplastic small round cell tumor', 'Hepatomegaly', 'NR1I2', 'Paclitaxel']",0.5
14792,32589.0,Paclitaxel,Kaposi's sarcoma (disease),disease-protein-drug,indication,"[""Kaposi's sarcoma (disease)"", 'BCL2', 'Paclitaxel']",0.5
14792,32589.0,Paclitaxel,Kaposi's sarcoma (disease),disease-phenotype-protein-drug,indication,"[""Kaposi's sarcoma (disease)"", 'Weight loss', 'MAPT', 'Paclitaxel']",0.5
14792,32617.0,Paclitaxel,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Paclitaxel']",0.5
14792,33575.0,Paclitaxel,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'BCL2', 'Paclitaxel']",0.5
14792,33575.0,Paclitaxel,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Paclitaxel']",0.5
14792,33575.0,Paclitaxel,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'CYP1B1', 'Paclitaxel']",0.5
14792,33575.0,Paclitaxel,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Paclitaxel']",0.5
14792,33577.0,Paclitaxel,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Paclitaxel']",0.5
14792,33577.0,Paclitaxel,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Paclitaxel']",0.5
14792,33577.0,Paclitaxel,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'CYP1B1', 'Paclitaxel']",0.5
14792,33632.0,Paclitaxel,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Paclitaxel']",0.5
14792,33632.0,Paclitaxel,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'CYP1B1', 'Paclitaxel']",0.5
14792,33642.0,Paclitaxel,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,33642.0,Paclitaxel,urinary bladder carcinoma,disease-exposure-gene-drug,off-label use,"['urinary bladder carcinoma', 'Arsenic', 'BCL2', 'Paclitaxel']",0.5
14792,33675.0,Paclitaxel,asthma,disease-protein-drug,contraindication,"['asthma', 'BCL2', 'Paclitaxel']",0.5
14792,33675.0,Paclitaxel,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Paclitaxel']",0.5
14792,33675.0,Paclitaxel,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'CYP1B1', 'Paclitaxel']",0.5
14792,33688.0,Paclitaxel,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Paclitaxel']",0.5
14792,35565.0,Paclitaxel,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,35616.0,Paclitaxel,testicular cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['testicular cancer', 'perfluorooctanoic acid', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,35624.0,Paclitaxel,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'regulation of gene expression', 'BCL2', 'Paclitaxel']",0.5
14792,35624.0,Paclitaxel,urinary bladder neoplasm,disease-exposure-gene-drug,off-label use,"['urinary bladder neoplasm', 'Arsenic', 'BCL2', 'Paclitaxel']",0.5
14792,35764.0,Paclitaxel,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Paclitaxel']",0.5
14792,35764.0,Paclitaxel,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'BCL2', 'Paclitaxel']",0.5
14792,35771.0,Paclitaxel,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'ABCB1', 'Paclitaxel']",0.5
14792,35771.0,Paclitaxel,breast neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['breast neoplasm', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Paclitaxel']",0.5
14792,35771.0,Paclitaxel,breast neoplasm,disease-exposure-gene-drug,indication,"['breast neoplasm', 'Air Pollutants', 'CYP1B1', 'Paclitaxel']",0.5
14792,35897.0,Paclitaxel,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'reactive oxygen species metabolic process', 'BCL2', 'Paclitaxel']",0.5
14792,35897.0,Paclitaxel,pulmonary emphysema,disease-exposure-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'CYP1B1', 'Paclitaxel']",0.5
14792,35958.0,Paclitaxel,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'BCL2', 'Paclitaxel']",0.5
14792,36035.0,Paclitaxel,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Paclitaxel']",0.5
14792,36050.0,Paclitaxel,head and neck cancer,disease-protein-drug,off-label use,"['head and neck cancer', 'BCL2', 'Paclitaxel']",0.5
14792,36104.0,Paclitaxel,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Paclitaxel']",0.5
14792,36229.0,Paclitaxel,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Paclitaxel']",0.5
14792,36527.0,Paclitaxel,yolk sac tumor,disease-protein-drug,off-label use,"['yolk sac tumor', 'CYP1B1', 'Paclitaxel']",0.5
14792,36645.0,Paclitaxel,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Paclitaxel']",0.5
14792,36792.0,Paclitaxel,ovarian mucinous adenocarcinoma,disease-protein-drug,indication,"['ovarian mucinous adenocarcinoma', 'CYP1B1', 'Paclitaxel']",0.5
14792,36794.0,Paclitaxel,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'CYP1B1', 'Paclitaxel']",0.5
14792,37047.0,Paclitaxel,immature ovarian teratoma,disease-protein-drug,indication,"['immature ovarian teratoma', 'CYP1B1', 'Paclitaxel']",0.5
14792,37082.0,Paclitaxel,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5
14792,37150.0,Paclitaxel,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5
14792,37152.0,Paclitaxel,familial ovarian cancer,disease-protein-drug,indication,"['familial ovarian cancer', 'CYP1B1', 'Paclitaxel']",0.5
14792,37180.0,Paclitaxel,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'BCL2', 'Paclitaxel']",0.5
14792,37180.0,Paclitaxel,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Paclitaxel']",0.5
14792,37180.0,Paclitaxel,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CYP1B1', 'Paclitaxel']",0.5
14792,37334.0,Paclitaxel,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'ABCB1', 'Paclitaxel']",0.5
14792,37423.0,Paclitaxel,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'CYP1B1', 'Paclitaxel']",0.5
14792,37466.0,Paclitaxel,ovarian small cell carcinoma,disease-protein-drug,indication,"['ovarian small cell carcinoma', 'CYP1B1', 'Paclitaxel']",0.5
14792,37703.0,Paclitaxel,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Paclitaxel']",0.5
14792,37967.0,Paclitaxel,ovarian endometrioid adenocarcinoma,disease-protein-drug,indication,"['ovarian endometrioid adenocarcinoma', 'CYP1B1', 'Paclitaxel']",0.5
14792,38312.0,Paclitaxel,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Paclitaxel']",0.5
14792,39603.0,Paclitaxel,malignant sex cord stromal tumor of ovary,disease-protein-drug,indication,"['malignant sex cord stromal tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5
14792,39615.0,Paclitaxel,borderline epithelial tumor of ovary,disease-protein-drug,indication,"['borderline epithelial tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5
14792,39773.0,Paclitaxel,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'BCL2', 'Paclitaxel']",0.5
14792,83760.0,Paclitaxel,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Paclitaxel']",0.5
14792,83781.0,Paclitaxel,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'BCL2', 'Paclitaxel']",0.5
14792,83816.0,Paclitaxel,ovarian carcinosarcoma,disease-protein-drug,indication,"['ovarian carcinosarcoma', 'CYP1B1', 'Paclitaxel']",0.5
14792,83817.0,Paclitaxel,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary site-specific ovarian cancer syndrome', 'CYP1B1', 'Paclitaxel']",0.5
14792,83818.0,Paclitaxel,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'CYP1B1', 'Paclitaxel']",0.5
14792,83819.0,Paclitaxel,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant dysgerminomatous germ cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5
14792,83820.0,Paclitaxel,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5
14792,83821.0,Paclitaxel,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'CYP1B1', 'Paclitaxel']",0.5
14792,83822.0,Paclitaxel,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,indication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'CYP1B1', 'Paclitaxel']",0.5
14792,83823.0,Paclitaxel,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'BCL2', 'Paclitaxel']",0.5
14792,83824.0,Paclitaxel,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'BCL2', 'Paclitaxel']",0.5
14792,83865.0,Paclitaxel,upper aerodigestive tract neoplasm,disease-protein-drug,off-label use,"['upper aerodigestive tract neoplasm', 'BCL2', 'Paclitaxel']",0.5
14793,27476.0,Docetaxel,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Docetaxel']",0.5
14793,27476.0,Docetaxel,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Docetaxel']",0.5
14793,29173.0,Docetaxel,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'regulation of gene expression', 'BCL2', 'Docetaxel']",0.5
14793,29173.0,Docetaxel,small cell lung carcinoma,disease-exposure-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'BCL2', 'Docetaxel']",0.5
14793,29402.0,Docetaxel,esophageal cancer,disease-protein-drug,off-label use,"['esophageal cancer', 'ABCB1', 'Docetaxel']",0.5
14793,29402.0,Docetaxel,esophageal cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['esophageal cancer', 'Vehicle Emissions', 'regulation of gene expression', 'BCL2', 'Docetaxel']",0.5
14793,30826.0,Docetaxel,familial prostate carcinoma,disease-protein-drug,indication,"['familial prostate carcinoma', 'BCL2', 'Docetaxel']",0.5
14793,31116.0,Docetaxel,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Docetaxel']",0.5
14793,31477.0,Docetaxel,ovarian cancer,disease-protein-drug,off-label use,"['ovarian cancer', 'CYP1B1', 'Docetaxel']",0.5
14793,31477.0,Docetaxel,ovarian cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['ovarian cancer', 'Cadmium', 'inflammatory response', 'ABCC2', 'Docetaxel']",0.5
14793,32617.0,Docetaxel,hereditary breast ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Docetaxel']",0.5
14793,32924.0,Docetaxel,carcinoma of esophagus,disease-protein-drug,off-label use,"['carcinoma of esophagus', 'ABCB1', 'Docetaxel']",0.5
14793,32924.0,Docetaxel,carcinoma of esophagus,disease-phenotype-protein-drug,off-label use,"['carcinoma of esophagus', 'Weight loss', 'MAPT', 'Docetaxel']",0.5
14793,33594.0,Docetaxel,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'BCL2', 'Docetaxel']",0.5
14793,33594.0,Docetaxel,diarrheal disease,disease-exposure-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'BCL2', 'Docetaxel']",0.5
14793,33632.0,Docetaxel,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Docetaxel']",0.5
14793,33632.0,Docetaxel,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'CYP1B1', 'Docetaxel']",0.5
14793,35565.0,Docetaxel,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'BCL2', 'Docetaxel']",0.5
14793,35771.0,Docetaxel,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'ABCB1', 'Docetaxel']",0.5
14793,35771.0,Docetaxel,breast neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['breast neoplasm', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Docetaxel']",0.5
14793,35771.0,Docetaxel,breast neoplasm,disease-exposure-gene-drug,indication,"['breast neoplasm', 'Air Pollutants', 'CYP1B1', 'Docetaxel']",0.5
14793,35963.0,Docetaxel,prostate carcinoma,disease-protein-drug,indication,"['prostate carcinoma', 'BCL2', 'Docetaxel']",0.5
14793,35966.0,Docetaxel,prostate cancer,disease-protein-drug,indication,"['prostate cancer', 'BCL2', 'Docetaxel']",0.5
14793,35966.0,Docetaxel,prostate cancer,disease-exposure-bioprocess-gene-drug,indication,"['prostate cancer', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Docetaxel']",0.5
14793,36000.0,Docetaxel,gastric neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['gastric neoplasm', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Docetaxel']",0.5
14793,36000.0,Docetaxel,gastric neoplasm,disease-exposure-gene-drug,indication,"['gastric neoplasm', 'Air Pollutants', 'CYP1B1', 'Docetaxel']",0.5
14793,36050.0,Docetaxel,head and neck cancer,disease-protein-drug,indication,"['head and neck cancer', 'BCL2', 'Docetaxel']",0.5
14793,36104.0,Docetaxel,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Docetaxel']",0.5
14793,36229.0,Docetaxel,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Docetaxel']",0.5
14793,36527.0,Docetaxel,yolk sac tumor,disease-protein-drug,off-label use,"['yolk sac tumor', 'CYP1B1', 'Docetaxel']",0.5
14793,36645.0,Docetaxel,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Docetaxel']",0.5
14793,36792.0,Docetaxel,ovarian mucinous adenocarcinoma,disease-protein-drug,off-label use,"['ovarian mucinous adenocarcinoma', 'CYP1B1', 'Docetaxel']",0.5
14793,36794.0,Docetaxel,ovarian adenocarcinoma,disease-protein-drug,off-label use,"['ovarian adenocarcinoma', 'CYP1B1', 'Docetaxel']",0.5
14793,37047.0,Docetaxel,immature ovarian teratoma,disease-protein-drug,off-label use,"['immature ovarian teratoma', 'CYP1B1', 'Docetaxel']",0.5
14793,37082.0,Docetaxel,malignant germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant germ cell tumor of ovary', 'CYP1B1', 'Docetaxel']",0.5
14793,37150.0,Docetaxel,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'CYP1B1', 'Docetaxel']",0.5
14793,37152.0,Docetaxel,familial ovarian cancer,disease-protein-drug,off-label use,"['familial ovarian cancer', 'CYP1B1', 'Docetaxel']",0.5
14793,37334.0,Docetaxel,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'ABCB1', 'Docetaxel']",0.5
14793,37423.0,Docetaxel,ovarian clear cell adenocarcinoma,disease-protein-drug,off-label use,"['ovarian clear cell adenocarcinoma', 'CYP1B1', 'Docetaxel']",0.5
14793,37466.0,Docetaxel,ovarian small cell carcinoma,disease-protein-drug,off-label use,"['ovarian small cell carcinoma', 'CYP1B1', 'Docetaxel']",0.5
14793,37967.0,Docetaxel,ovarian endometrioid adenocarcinoma,disease-protein-drug,off-label use,"['ovarian endometrioid adenocarcinoma', 'CYP1B1', 'Docetaxel']",0.5
14793,38312.0,Docetaxel,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Docetaxel']",0.5
14793,39603.0,Docetaxel,malignant sex cord stromal tumor of ovary,disease-protein-drug,off-label use,"['malignant sex cord stromal tumor of ovary', 'CYP1B1', 'Docetaxel']",0.5
14793,39615.0,Docetaxel,borderline epithelial tumor of ovary,disease-protein-drug,off-label use,"['borderline epithelial tumor of ovary', 'CYP1B1', 'Docetaxel']",0.5
14793,83816.0,Docetaxel,ovarian carcinosarcoma,disease-protein-drug,off-label use,"['ovarian carcinosarcoma', 'CYP1B1', 'Docetaxel']",0.5
14793,83817.0,Docetaxel,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary site-specific ovarian cancer syndrome', 'CYP1B1', 'Docetaxel']",0.5
14793,83818.0,Docetaxel,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,off-label use,"['primary non-gestational choriocarcinoma of ovary', 'CYP1B1', 'Docetaxel']",0.5
14793,83819.0,Docetaxel,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,off-label use,"['malignant dysgerminomatous germ cell tumor of ovary', 'CYP1B1', 'Docetaxel']",0.5
14793,83820.0,Docetaxel,maligant granulosa cell tumor of ovary,disease-protein-drug,off-label use,"['maligant granulosa cell tumor of ovary', 'CYP1B1', 'Docetaxel']",0.5
14793,83821.0,Docetaxel,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,off-label use,"['malignant Sertoli-Leydig cell tumor of ovary', 'CYP1B1', 'Docetaxel']",0.5
14793,83822.0,Docetaxel,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,off-label use,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'CYP1B1', 'Docetaxel']",0.5
14793,83865.0,Docetaxel,upper aerodigestive tract neoplasm,disease-protein-drug,indication,"['upper aerodigestive tract neoplasm', 'BCL2', 'Docetaxel']",0.5
14794,27326.0,Dasatinib,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Dasatinib']",0.5
14794,27326.0,Dasatinib,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Dasatinib']",0.5
14794,27326.0,Dasatinib,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Dasatinib']",0.5
14794,27326.0,Dasatinib,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Dasatinib']",0.5
14794,27626.0,Dasatinib,thrombocytopenia,disease-protein-drug,contraindication,"['thrombocytopenia', 'SRC', 'Dasatinib']",0.5
14794,27626.0,Dasatinib,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'KIT', 'Dasatinib']",0.5
14794,33632.0,Dasatinib,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Dasatinib']",0.5
14794,33632.0,Dasatinib,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'HSPA8', 'Dasatinib']",0.5
14794,35565.0,Dasatinib,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'KIT', 'Dasatinib']",0.5
14794,35565.0,Dasatinib,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Dasatinib']",0.5
14794,36104.0,Dasatinib,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Dasatinib']",0.5
14794,36229.0,Dasatinib,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Dasatinib']",0.5
14794,37180.0,Dasatinib,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'HSPA8', 'Dasatinib']",0.5
14794,37180.0,Dasatinib,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'HSPA8', 'Dasatinib']",0.5
14794,37659.0,Dasatinib,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'HSPA8', 'Dasatinib']",0.5
14794,37659.0,Dasatinib,heart failure,disease-exposure-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'HSPA8', 'Dasatinib']",0.5
14794,83751.0,Dasatinib,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Dasatinib']",0.5
14794,83942.0,Dasatinib,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'HSPA8', 'Dasatinib']",0.5
14794,83942.0,Dasatinib,intracerebral hemorrhage,disease-exposure-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'HSPA8', 'Dasatinib']",0.5
14794,84261.0,Dasatinib,"blast phase chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['blast phase chronic myelogenous leukemia, BCR-ABL1 positive', 'BCR', 'Dasatinib']",0.5
14797,35764.0,Imipenem,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'inflammatory response', 'DPEP1', 'Imipenem']",0.5
14797,36209.0,Imipenem,arthropathy,disease-protein-drug,indication,"['arthropathy', 'DPEP1', 'Imipenem']",0.5
14799,28208.0,Insulin human,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'PCSK2', 'Insulin human']",0.5
14799,28208.0,Insulin human,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose homeostasis', 'IGF1R', 'Insulin human']",0.5
14799,28208.0,Insulin human,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'INSR', 'Insulin human']",0.5
14799,29113.0,Insulin human,diabetic ketoacidosis,disease-phenotype-protein-drug,indication,"['diabetic ketoacidosis', 'Insulin resistance', 'INSR', 'Insulin human']",0.5
14799,33575.0,Insulin human,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'PCSK2', 'Insulin human']",0.5
14799,33575.0,Insulin human,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'IGF1R', 'Insulin human']",0.5
14800,28651.0,Norelgestromin,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'STS', 'Norelgestromin']",0.5
14800,29113.0,Norelgestromin,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'STS', 'Norelgestromin']",0.5
14800,29182.0,Norelgestromin,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Norelgestromin']",0.5
14800,29182.0,Norelgestromin,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ALB', 'Norelgestromin']",0.5
14800,29220.0,Norelgestromin,hyperlipoproteinemia,disease-phenotype-protein-drug,contraindication,"['hyperlipoproteinemia', 'Hepatomegaly', 'ALB', 'Norelgestromin']",0.5
14800,29646.0,Norelgestromin,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'AR', 'Norelgestromin']",0.5
14800,29646.0,Norelgestromin,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norelgestromin']",0.5
14800,29646.0,Norelgestromin,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,29646.0,Norelgestromin,hepatocellular carcinoma,disease-phenotype-protein-drug,contraindication,"['hepatocellular carcinoma', 'Hepatomegaly', 'ALB', 'Norelgestromin']",0.5
14800,30827.0,Norelgestromin,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Norelgestromin']",0.5
14800,31477.0,Norelgestromin,ovarian cancer,disease-exposure-gene-drug,contraindication,"['ovarian cancer', 'Cadmium', 'ALB', 'Norelgestromin']",0.5
14800,32617.0,Norelgestromin,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'AR', 'Norelgestromin']",0.5
14800,33534.0,Norelgestromin,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ALB', 'Norelgestromin']",0.5
14800,33575.0,Norelgestromin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norelgestromin']",0.5
14800,33575.0,Norelgestromin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,33575.0,Norelgestromin,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Norelgestromin']",0.5
14800,33577.0,Norelgestromin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Norelgestromin']",0.5
14800,33577.0,Norelgestromin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,33593.0,Norelgestromin,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'STS', 'Norelgestromin']",0.5
14800,33593.0,Norelgestromin,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'spermatogenesis', 'AR', 'Norelgestromin']",0.5
14800,33593.0,Norelgestromin,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'ALB', 'Norelgestromin']",0.5
14800,33593.0,Norelgestromin,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'STS', 'Norelgestromin']",0.5
14800,33598.0,Norelgestromin,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ALB', 'Norelgestromin']",0.5
14800,33598.0,Norelgestromin,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Norelgestromin']",0.5
14800,33598.0,Norelgestromin,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,33675.0,Norelgestromin,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norelgestromin']",0.5
14800,33675.0,Norelgestromin,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,33695.0,Norelgestromin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Norelgestromin']",0.5
14800,33695.0,Norelgestromin,hypertriglyceridemia (disease),disease-exposure-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'ALB', 'Norelgestromin']",0.5
14800,33699.0,Norelgestromin,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norelgestromin']",0.5
14800,35565.0,Norelgestromin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Norelgestromin']",0.5
14800,35565.0,Norelgestromin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Norelgestromin']",0.5
14800,35641.0,Norelgestromin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Norelgestromin']",0.5
14800,35738.0,Norelgestromin,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Norelgestromin']",0.5
14800,35739.0,Norelgestromin,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'PGR', 'Norelgestromin']",0.5
14800,35764.0,Norelgestromin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Norelgestromin']",0.5
14800,35764.0,Norelgestromin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Norelgestromin']",0.5
14800,35764.0,Norelgestromin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,35909.0,Norelgestromin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Norelgestromin']",0.5
14800,36187.0,Norelgestromin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norelgestromin']",0.5
14800,36187.0,Norelgestromin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,36634.0,Norelgestromin,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'AR', 'Norelgestromin']",0.5
14800,36634.0,Norelgestromin,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Norelgestromin']",0.5
14800,36634.0,Norelgestromin,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,37038.0,Norelgestromin,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Norelgestromin']",0.5
14800,37180.0,Norelgestromin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norelgestromin']",0.5
14800,37180.0,Norelgestromin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'PGR', 'Norelgestromin']",0.5
14800,37573.0,Norelgestromin,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Norelgestromin']",0.5
14800,37703.0,Norelgestromin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ALB', 'Norelgestromin']",0.5
14800,83760.0,Norelgestromin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ALB', 'Norelgestromin']",0.5
14802,31116.0,Pemetrexed,lung cancer,disease-protein-drug,indication,"['lung cancer', 'GART', 'Pemetrexed']",0.5
14802,33623.0,Pemetrexed,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'TYMS', 'Pemetrexed']",0.5
14802,33632.0,Pemetrexed,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'TYMS', 'Pemetrexed']",0.5
14802,35764.0,Pemetrexed,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to folic acid', 'TYMS', 'Pemetrexed']",0.5
14806,27933.0,Entacapone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'COMT', 'Entacapone']",0.5
14806,27933.0,Entacapone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'methylation', 'COMT', 'Entacapone']",0.5
14806,28396.0,Entacapone,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Entacapone']",0.5
14806,28547.0,Entacapone,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'CYP2D6', 'Entacapone']",0.5
14806,28547.0,Entacapone,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Organophosphorus Compounds', 'developmental process', 'COMT', 'Entacapone']",0.5
14806,28547.0,Entacapone,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Entacapone']",0.5
14806,28801.0,Entacapone,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'CYP2D6', 'Entacapone']",0.5
14806,28801.0,Entacapone,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CYP2D6', 'Entacapone']",0.5
14806,28974.0,Entacapone,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'CYP2D6', 'Entacapone']",0.5
14806,28974.0,Entacapone,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CYP2D6', 'Entacapone']",0.5
14806,31408.0,Entacapone,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'CYP2D6', 'Entacapone']",0.5
14806,31408.0,Entacapone,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CYP2D6', 'Entacapone']",0.5
14806,32759.0,Entacapone,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'CYP2D6', 'Entacapone']",0.5
14806,32759.0,Entacapone,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CYP2D6', 'Entacapone']",0.5
14806,32974.0,Entacapone,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'CYP2D6', 'Entacapone']",0.5
14806,32974.0,Entacapone,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CYP2D6', 'Entacapone']",0.5
14806,33241.0,Entacapone,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'CYP2D6', 'Entacapone']",0.5
14806,33241.0,Entacapone,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CYP2D6', 'Entacapone']",0.5
14806,33575.0,Entacapone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'methylation', 'COMT', 'Entacapone']",0.5
14806,33594.0,Entacapone,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'methylation', 'COMT', 'Entacapone']",0.5
14806,33653.0,Entacapone,melanoma,disease-exposure-bioprocess-gene-drug,contraindication,"['melanoma', 'Arsenic', 'methylation', 'COMT', 'Entacapone']",0.5
14806,35565.0,Entacapone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Entacapone']",0.5
14806,35764.0,Entacapone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Entacapone']",0.5
14806,35833.0,Entacapone,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Tobacco Smoke Pollution', 'cholesterol metabolic process', 'CYP2D6', 'Entacapone']",0.5
14806,35915.0,Entacapone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Entacapone']",0.5
14806,37180.0,Entacapone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'methylation', 'COMT', 'Entacapone']",0.5
14806,37703.0,Entacapone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'COMT', 'Entacapone']",0.5
14806,83760.0,Entacapone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'COMT', 'Entacapone']",0.5
14806,83778.0,Entacapone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Entacapone']",0.5
14806,83779.0,Entacapone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Entacapone']",0.5
14807,27559.0,Epinephrine,dilated cardiomyopathy,disease-protein-drug,contraindication,"['dilated cardiomyopathy', 'ADRB1', 'Epinephrine']",0.5
14807,27559.0,Epinephrine,dilated cardiomyopathy,disease-exposure-bioprocess-gene-drug,contraindication,"['dilated cardiomyopathy', 'bisphenol A', 'glucose metabolic process', 'TNF', 'Epinephrine']",0.5
14807,27559.0,Epinephrine,dilated cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['dilated cardiomyopathy', 'Pulmonary arterial hypertension', 'TNF', 'Epinephrine']",0.5
14807,28547.0,Epinephrine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'MAOB', 'Epinephrine']",0.5
14807,28547.0,Epinephrine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Epinephrine']",0.5
14807,28547.0,Epinephrine,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,28547.0,Epinephrine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'ADRB2', 'Epinephrine']",0.5
14807,29113.0,Epinephrine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'TNF', 'Epinephrine']",0.5
14807,29113.0,Epinephrine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'TNF', 'Epinephrine']",0.5
14807,31650.0,Epinephrine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ADRA1B', 'Epinephrine']",0.5
14807,32712.0,Epinephrine,histiocytoid cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['histiocytoid cardiomyopathy', 'Pulmonary edema', 'TNF', 'Epinephrine']",0.5
14807,33575.0,Epinephrine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'TNF', 'Epinephrine']",0.5
14807,33575.0,Epinephrine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'TNF', 'Epinephrine']",0.5
14807,33575.0,Epinephrine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,33577.0,Epinephrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Epinephrine']",0.5
14807,33577.0,Epinephrine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'TNF', 'Epinephrine']",0.5
14807,33605.0,Epinephrine,hypotensive disorder,disease-protein-drug,indication,"['hypotensive disorder', 'MAOB', 'Epinephrine']",0.5
14807,33618.0,Epinephrine,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'methylation', 'COMT', 'Epinephrine']",0.5
14807,33618.0,Epinephrine,atrial fibrillation (disease),disease-exposure-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'TNF', 'Epinephrine']",0.5
14807,33675.0,Epinephrine,asthma,disease-protein-drug,indication,"['asthma', 'TNF', 'Epinephrine']",0.5
14807,33675.0,Epinephrine,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Epinephrine']",0.5
14807,33675.0,Epinephrine,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,33679.0,Epinephrine,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Epinephrine']",0.5
14807,35565.0,Epinephrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'TNF', 'Epinephrine']",0.5
14807,35641.0,Epinephrine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADRA1B', 'Epinephrine']",0.5
14807,35669.0,Epinephrine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'TNF', 'Epinephrine']",0.5
14807,35669.0,Epinephrine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Epinephrine']",0.5
14807,35669.0,Epinephrine,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,35761.0,Epinephrine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose metabolic process', 'TNF', 'Epinephrine']",0.5
14807,35761.0,Epinephrine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,35764.0,Epinephrine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Epinephrine']",0.5
14807,35766.0,Epinephrine,thrombotic disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombotic disease', 'Particulate Matter', 'methylation', 'COMT', 'Epinephrine']",0.5
14807,35766.0,Epinephrine,thrombotic disease,disease-exposure-gene-drug,contraindication,"['thrombotic disease', 'Particulate Matter', 'TNF', 'Epinephrine']",0.5
14807,35897.0,Epinephrine,pulmonary emphysema,disease-protein-drug,indication,"['pulmonary emphysema', 'TNF', 'Epinephrine']",0.5
14807,35897.0,Epinephrine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'methylation', 'COMT', 'Epinephrine']",0.5
14807,35897.0,Epinephrine,pulmonary emphysema,disease-exposure-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'TNF', 'Epinephrine']",0.5
14807,35958.0,Epinephrine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'TNF', 'Epinephrine']",0.5
14807,36034.0,Epinephrine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'TNF', 'Epinephrine']",0.5
14807,36080.0,Epinephrine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'COMT', 'Epinephrine']",0.5
14807,36080.0,Epinephrine,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Soot', 'TNF', 'Epinephrine']",0.5
14807,36187.0,Epinephrine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Epinephrine']",0.5
14807,36187.0,Epinephrine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Epinephrine']",0.5
14807,36187.0,Epinephrine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,37180.0,Epinephrine,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'TNF', 'Epinephrine']",0.5
14807,37180.0,Epinephrine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Epinephrine']",0.5
14807,37180.0,Epinephrine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,37706.0,Epinephrine,parkinsonian disorder,disease-exposure-gene-drug,contraindication,"['parkinsonian disorder', 'Dust', 'TNF', 'Epinephrine']",0.5
14807,37830.0,Epinephrine,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Epinephrine']",0.5
14807,37830.0,Epinephrine,bronchitis,disease-exposure-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,39493.0,Epinephrine,bronchiectasis,disease-protein-drug,indication,"['bronchiectasis', 'TNF', 'Epinephrine']",0.5
14807,39773.0,Epinephrine,allergic asthma,disease-protein-drug,off-label use,"['allergic asthma', 'TNF', 'Epinephrine']",0.5
14807,39798.0,Epinephrine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Epinephrine']",0.5
14807,39798.0,Epinephrine,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'TNF', 'Epinephrine']",0.5
14807,83781.0,Epinephrine,intrinsic asthma,disease-protein-drug,off-label use,"['intrinsic asthma', 'TNF', 'Epinephrine']",0.5
14807,83823.0,Epinephrine,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'TNF', 'Epinephrine']",0.5
14807,83824.0,Epinephrine,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'TNF', 'Epinephrine']",0.5
14807,84058.0,Epinephrine,cardiac arrest,disease-protein-drug,off-label use,"['cardiac arrest', 'TNF', 'Epinephrine']",0.5
14808,28052.0,Dobutamine,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Cardiomegaly', 'ADRA1B', 'Dobutamine']",0.5
14808,33577.0,Dobutamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'female pregnancy', 'COMT', 'Dobutamine']",0.5
14808,33618.0,Dobutamine,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'methylation', 'COMT', 'Dobutamine']",0.5
14808,33679.0,Dobutamine,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Dobutamine']",0.5
14808,35958.0,Dobutamine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Dobutamine']",0.5
14808,37180.0,Dobutamine,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Dobutamine']",0.5
14808,37180.0,Dobutamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Dobutamine']",0.5
14808,83823.0,Dobutamine,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Dobutamine']",0.5
14808,83824.0,Dobutamine,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Dobutamine']",0.5
14809,27933.0,Methyldopa,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ADRA2A', 'Methyldopa']",0.5
14809,27933.0,Methyldopa,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of cytokine production', 'ADRA2A', 'Methyldopa']",0.5
14809,28547.0,Methyldopa,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'DDC', 'Methyldopa']",0.5
14809,28547.0,Methyldopa,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Methyldopa']",0.5
14809,29182.0,Methyldopa,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'COMT', 'Methyldopa']",0.5
14809,31122.0,Methyldopa,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'DDC', 'Methyldopa']",0.5
14809,33577.0,Methyldopa,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Methyldopa']",0.5
14809,33632.0,Methyldopa,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Methyldopa']",0.5
14809,33695.0,Methyldopa,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Methyldopa']",0.5
14809,35565.0,Methyldopa,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'female pregnancy', 'COMT', 'Methyldopa']",0.5
14809,35735.0,Methyldopa,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'DDC', 'Methyldopa']",0.5
14809,35764.0,Methyldopa,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Methyldopa']",0.5
14809,35894.0,Methyldopa,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'DDC', 'Methyldopa']",0.5
14809,35895.0,Methyldopa,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'DDC', 'Methyldopa']",0.5
14809,36149.0,Methyldopa,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'DDC', 'Methyldopa']",0.5
14809,36860.0,Methyldopa,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'DDC', 'Methyldopa']",0.5
14809,37703.0,Methyldopa,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRA2A', 'Methyldopa']",0.5
14809,37706.0,Methyldopa,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DDC', 'Methyldopa']",0.5
14809,37919.0,Methyldopa,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'DDC', 'Methyldopa']",0.5
14809,83760.0,Methyldopa,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRA2A', 'Methyldopa']",0.5
14809,83802.0,Methyldopa,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'female pregnancy', 'COMT', 'Methyldopa']",0.5
14810,35764.0,Micafungin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'methylation', 'COMT', 'Micafungin']",0.5
14811,35669.0,Nylidrin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'methylation', 'COMT', 'Nylidrin']",0.5
14811,35671.0,Nylidrin,vascular disease,disease-exposure-bioprocess-gene-drug,indication,"['vascular disease', 'Arsenic', 'methylation', 'COMT', 'Nylidrin']",0.5
14811,35761.0,Nylidrin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'methylation', 'COMT', 'Nylidrin']",0.5
14811,36034.0,Nylidrin,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Nylidrin']",0.5
14811,37180.0,Nylidrin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'methylation', 'COMT', 'Nylidrin']",0.5
14813,28208.0,Troglitazone,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'PPARA', 'Troglitazone']",0.5
14813,28208.0,Troglitazone,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose metabolic process', 'PPARD', 'Troglitazone']",0.5
14813,28208.0,Troglitazone,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Agent Orange', 'CYP1A1', 'Troglitazone']",0.5
14813,28208.0,Troglitazone,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'PPARG', 'Troglitazone']",0.5
14813,33575.0,Troglitazone,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'PPARA', 'Troglitazone']",0.5
14813,33575.0,Troglitazone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'PPARD', 'Troglitazone']",0.5
14813,33575.0,Troglitazone,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Troglitazone']",0.5
14813,33575.0,Troglitazone,diabetes mellitus (disease),disease-phenotype-protein-drug,indication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Troglitazone']",0.5
14813,33575.0,Troglitazone,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,indication,"['diabetes mellitus (disease)', 'Pesticides', 'glutathione transferase activity', 'GSTP1', 'Troglitazone']",0.5
14814,29061.0,Chlorotrianisene,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'CYP19A1', 'Chlorotrianisene']",0.5
14814,29182.0,Chlorotrianisene,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Chlorotrianisene']",0.5
14814,30827.0,Chlorotrianisene,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'ESR1', 'Chlorotrianisene']",0.5
14814,31477.0,Chlorotrianisene,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Chlorotrianisene']",0.5
14814,31596.0,Chlorotrianisene,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,32617.0,Chlorotrianisene,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ESR1', 'Chlorotrianisene']",0.5
14814,33575.0,Chlorotrianisene,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Chlorotrianisene']",0.5
14814,33575.0,Chlorotrianisene,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Chlorotrianisene']",0.5
14814,33593.0,Chlorotrianisene,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Chlorotrianisene']",0.5
14814,33593.0,Chlorotrianisene,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Chlorotrianisene']",0.5
14814,33593.0,Chlorotrianisene,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'mono-benzyl phthalate', 'CYP19A1', 'Chlorotrianisene']",0.5
14814,33598.0,Chlorotrianisene,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Chlorotrianisene']",0.5
14814,33675.0,Chlorotrianisene,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Chlorotrianisene']",0.5
14814,33680.0,Chlorotrianisene,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'CYP19A1', 'Chlorotrianisene']",0.5
14814,33680.0,Chlorotrianisene,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Chlorotrianisene']",0.5
14814,33680.0,Chlorotrianisene,endometriosis (disease),disease-exposure-gene-drug,contraindication,"['endometriosis (disease)', 'monobutyl phthalate', 'CYP19A1', 'Chlorotrianisene']",0.5
14814,33699.0,Chlorotrianisene,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Chlorotrianisene']",0.5
14814,35738.0,Chlorotrianisene,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR1', 'Chlorotrianisene']",0.5
14814,35739.0,Chlorotrianisene,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Chlorotrianisene']",0.5
14814,35901.0,Chlorotrianisene,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,35901.0,Chlorotrianisene,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'CYP19A1', 'Chlorotrianisene']",0.5
14814,35909.0,Chlorotrianisene,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Chlorotrianisene']",0.5
14814,35958.0,Chlorotrianisene,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Chlorotrianisene']",0.5
14814,36187.0,Chlorotrianisene,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Chlorotrianisene']",0.5
14814,36187.0,Chlorotrianisene,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Chlorotrianisene']",0.5
14814,36527.0,Chlorotrianisene,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Chlorotrianisene']",0.5
14814,36792.0,Chlorotrianisene,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,36794.0,Chlorotrianisene,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,37038.0,Chlorotrianisene,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR1', 'Chlorotrianisene']",0.5
14814,37047.0,Chlorotrianisene,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,37082.0,Chlorotrianisene,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Chlorotrianisene']",0.5
14814,37150.0,Chlorotrianisene,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Chlorotrianisene']",0.5
14814,37152.0,Chlorotrianisene,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Chlorotrianisene']",0.5
14814,37180.0,Chlorotrianisene,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Chlorotrianisene']",0.5
14814,37180.0,Chlorotrianisene,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Chlorotrianisene']",0.5
14814,37423.0,Chlorotrianisene,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,37466.0,Chlorotrianisene,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,37573.0,Chlorotrianisene,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Chlorotrianisene']",0.5
14814,37768.0,Chlorotrianisene,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Chlorotrianisene']",0.5
14814,37967.0,Chlorotrianisene,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,39603.0,Chlorotrianisene,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Chlorotrianisene']",0.5
14814,39615.0,Chlorotrianisene,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Chlorotrianisene']",0.5
14814,83816.0,Chlorotrianisene,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Chlorotrianisene']",0.5
14814,83817.0,Chlorotrianisene,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Chlorotrianisene']",0.5
14814,83818.0,Chlorotrianisene,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Chlorotrianisene']",0.5
14814,83819.0,Chlorotrianisene,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Chlorotrianisene']",0.5
14814,83820.0,Chlorotrianisene,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Chlorotrianisene']",0.5
14814,83821.0,Chlorotrianisene,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Chlorotrianisene']",0.5
14814,83822.0,Chlorotrianisene,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Chlorotrianisene']",0.5
14814,83823.0,Chlorotrianisene,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Chlorotrianisene']",0.5
14814,83824.0,Chlorotrianisene,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Chlorotrianisene']",0.5
14816,35764.0,Edetic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'placenta development', 'ADA', 'Edetic acid']",0.5
14816,39696.0,Edetic acid,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary tuberculosis', 'Arsenic', 'placenta development', 'ADA', 'Edetic acid']",0.5
14827,33577.0,Oxytocin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'OXT', 'Oxytocin']",0.5
14827,84223.0,Oxytocin,asphyxia neonatorum,disease-protein-drug,contraindication,"['asphyxia neonatorum', 'OXT', 'Oxytocin']",0.5
14828,27933.0,Cycloserine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'DDC', 'Cycloserine']",0.5
14829,28313.0,Flupentixol,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Flupentixol']",0.5
14829,28313.0,Flupentixol,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cognition', 'CHRM1', 'Flupentixol']",0.5
14830,28396.0,Amantadine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Neurodegeneration', 'DDC', 'Amantadine']",0.5
14830,28445.0,Amantadine,Creutzfeldt Jacob disease,disease-protein-drug,off-label use,"['Creutzfeldt Jacob disease', 'MAOB', 'Amantadine']",0.5
14830,28445.0,Amantadine,Creutzfeldt Jacob disease,disease-phenotype-protein-drug,off-label use,"['Creutzfeldt Jacob disease', 'Seizure', 'CHRNA3', 'Amantadine']",0.5
14830,28547.0,Amantadine,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'MAOB', 'Amantadine']",0.5
14830,28547.0,Amantadine,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Amantadine']",0.5
14830,28547.0,Amantadine,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Limb dystonia', 'CHRNA4', 'Amantadine']",0.5
14830,28801.0,Amantadine,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'MAOB', 'Amantadine']",0.5
14830,28801.0,Amantadine,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Seizure', 'CHRNA3', 'Amantadine']",0.5
14830,28974.0,Amantadine,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'MAOB', 'Amantadine']",0.5
14830,28974.0,Amantadine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Seizure', 'CHRNA3', 'Amantadine']",0.5
14830,30035.0,Amantadine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Amantadine']",0.5
14830,30093.0,Amantadine,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'MAOB', 'Amantadine']",0.5
14830,31408.0,Amantadine,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'MAOB', 'Amantadine']",0.5
14830,31408.0,Amantadine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Seizure', 'CHRNA3', 'Amantadine']",0.5
14830,32468.0,Amantadine,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Oculogyric crisis', 'DDC', 'Amantadine']",0.5
14830,32477.0,Amantadine,Creutzfeldt-Jakob disease,disease-phenotype-protein-drug,off-label use,"['Creutzfeldt-Jakob disease', 'Memory impairment', 'DRD2', 'Amantadine']",0.5
14830,32759.0,Amantadine,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'MAOB', 'Amantadine']",0.5
14830,32974.0,Amantadine,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'MAOB', 'Amantadine']",0.5
14830,32974.0,Amantadine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Seizure', 'CHRNA3', 'Amantadine']",0.5
14830,33241.0,Amantadine,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'MAOB', 'Amantadine']",0.5
14830,33653.0,Amantadine,melanoma,disease-exposure-bioprocess-gene-drug,contraindication,"['melanoma', 'Arsenic', 'DNA repair', 'CHRNA4', 'Amantadine']",0.5
14830,35641.0,Amantadine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CHRNA3', 'Amantadine']",0.5
14830,35641.0,Amantadine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Amantadine']",0.5
14830,35764.0,Amantadine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'DRD2', 'Amantadine']",0.5
14830,35915.0,Amantadine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cognition', 'CHRNA4', 'Amantadine']",0.5
14830,36129.0,Amantadine,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Mercury', 'regulation of heart rate', 'DRD2', 'Amantadine']",0.5
14830,36693.0,Amantadine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'DRD2', 'Amantadine']",0.5
14830,36693.0,Amantadine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Amantadine']",0.5
14830,37706.0,Amantadine,parkinsonian disorder,disease-protein-drug,indication,"['parkinsonian disorder', 'DDC', 'Amantadine']",0.5
14830,38003.0,Amantadine,basal ganglia disease,disease-protein-drug,indication,"['basal ganglia disease', 'DRD2', 'Amantadine']",0.5
14830,83778.0,Amantadine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cognition', 'CHRNA4', 'Amantadine']",0.5
14830,83779.0,Amantadine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cognition', 'CHRNA4', 'Amantadine']",0.5
14831,28547.0,Droxidopa,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DDC', 'Droxidopa']",0.5
14831,28547.0,Droxidopa,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Droxidopa']",0.5
14831,28547.0,Droxidopa,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5
14831,28974.0,Droxidopa,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DDC', 'Droxidopa']",0.5
14831,28974.0,Droxidopa,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5
14831,30093.0,Droxidopa,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DDC', 'Droxidopa']",0.5
14831,30093.0,Droxidopa,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'ADRB2', 'Droxidopa']",0.5
14831,31408.0,Droxidopa,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DDC', 'Droxidopa']",0.5
14831,31408.0,Droxidopa,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5
14831,32759.0,Droxidopa,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DDC', 'Droxidopa']",0.5
14831,32759.0,Droxidopa,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'ADRB2', 'Droxidopa']",0.5
14831,32974.0,Droxidopa,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DDC', 'Droxidopa']",0.5
14831,32974.0,Droxidopa,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5
14831,33241.0,Droxidopa,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DDC', 'Droxidopa']",0.5
14831,33241.0,Droxidopa,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'ADRB2', 'Droxidopa']",0.5
14833,27361.0,Riboflavin,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'MTHFR', 'Riboflavin']",0.5
14833,27933.0,Riboflavin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'MTHFR', 'Riboflavin']",0.5
14833,27933.0,Riboflavin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'response to folic acid', 'MTHFR', 'Riboflavin']",0.5
14833,27933.0,Riboflavin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'MTHFR', 'Riboflavin']",0.5
14833,30653.0,Riboflavin,multiple acyl-CoA dehydrogenase deficiency,disease-phenotype-protein-drug,off-label use,"['multiple acyl-CoA dehydrogenase deficiency', 'Elevated hepatic transaminase', 'MTHFR', 'Riboflavin']",0.5
14833,31033.0,Riboflavin,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Elevated hepatic transaminase', 'MTHFR', 'Riboflavin']",0.5
14833,31606.0,Riboflavin,glutaryl-CoA dehydrogenase deficiency,disease-phenotype-protein-drug,off-label use,"['glutaryl-CoA dehydrogenase deficiency', 'Seizure', 'MTHFR', 'Riboflavin']",0.5
14833,33306.0,Riboflavin,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Thrombocytopenia', 'MTHFR', 'Riboflavin']",0.5
14833,33577.0,Riboflavin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'response to folic acid', 'MTHFR', 'Riboflavin']",0.5
14833,33605.0,Riboflavin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'MAOA', 'Riboflavin']",0.5
14833,35764.0,Riboflavin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to folic acid', 'MTHFR', 'Riboflavin']",0.5
14833,36187.0,Riboflavin,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'MTHFR', 'Riboflavin']",0.5
14833,36187.0,Riboflavin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'response to folic acid', 'MTHFR', 'Riboflavin']",0.5
14833,37180.0,Riboflavin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'response to folic acid', 'MTHFR', 'Riboflavin']",0.5
14833,37180.0,Riboflavin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'MTHFR', 'Riboflavin']",0.5
14833,37786.0,Riboflavin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'response to folic acid', 'MTHFR', 'Riboflavin']",0.5
14835,29182.0,Benazepril,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Benazepril']",0.5
14835,29182.0,Benazepril,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'ACE', 'Benazepril']",0.5
14835,29182.0,Benazepril,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'MTHFR', 'Benazepril']",0.5
14835,33025.0,Benazepril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Seizure', 'MTHFR', 'Benazepril']",0.5
14835,33534.0,Benazepril,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'MTHFR', 'Benazepril']",0.5
14835,33575.0,Benazepril,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Benazepril']",0.5
14835,33575.0,Benazepril,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Particulate Matter', 'ACE', 'Benazepril']",0.5
14835,33577.0,Benazepril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Benazepril']",0.5
14835,33577.0,Benazepril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Benazepril']",0.5
14835,33605.0,Benazepril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ACE', 'Benazepril']",0.5
14835,33618.0,Benazepril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Benazepril']",0.5
14835,33618.0,Benazepril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Benazepril']",0.5
14835,33618.0,Benazepril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Benazepril']",0.5
14835,35565.0,Benazepril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Benazepril']",0.5
14835,35764.0,Benazepril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ACE', 'Benazepril']",0.5
14835,36104.0,Benazepril,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'MTHFR', 'Benazepril']",0.5
14835,36229.0,Benazepril,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'MTHFR', 'Benazepril']",0.5
14835,36286.0,Benazepril,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'ACE', 'Benazepril']",0.5
14835,83802.0,Benazepril,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Benazepril']",0.5
14836,29182.0,Ramipril,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Ramipril']",0.5
14836,29182.0,Ramipril,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'ACE', 'Ramipril']",0.5
14836,29182.0,Ramipril,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'BCHE', 'Ramipril']",0.5
14836,33025.0,Ramipril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Splenomegaly', 'BDKRB1', 'Ramipril']",0.5
14836,33027.0,Ramipril,scleroderma (disease),disease-phenotype-protein-drug,contraindication,"['scleroderma (disease)', 'Pain', 'BDKRB1', 'Ramipril']",0.5
14836,33225.0,Ramipril,systemic sclerosis,disease-phenotype-protein-drug,contraindication,"['systemic sclerosis', 'Albuminuria', 'ACE', 'Ramipril']",0.5
14836,33228.0,Ramipril,localized scleroderma,disease-phenotype-protein-drug,contraindication,"['localized scleroderma', 'Arrhythmia', 'ACE', 'Ramipril']",0.5
14836,33534.0,Ramipril,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'BCHE', 'Ramipril']",0.5
14836,33577.0,Ramipril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Ramipril']",0.5
14836,33577.0,Ramipril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Ramipril']",0.5
14836,33577.0,Ramipril,hypertensive disorder,disease-exposure-molfunc-gene-drug,indication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ramipril']",0.5
14836,33598.0,Ramipril,stroke disorder,disease-protein-drug,indication,"['stroke disorder', 'ACE', 'Ramipril']",0.5
14836,33598.0,Ramipril,stroke disorder,disease-exposure-bioprocess-gene-drug,indication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'ACE', 'Ramipril']",0.5
14836,33598.0,Ramipril,stroke disorder,disease-exposure-gene-drug,indication,"['stroke disorder', 'Pesticides', 'BCHE', 'Ramipril']",0.5
14836,33598.0,Ramipril,stroke disorder,disease-exposure-molfunc-gene-drug,indication,"['stroke disorder', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Ramipril']",0.5
14836,33605.0,Ramipril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ACE', 'Ramipril']",0.5
14836,33618.0,Ramipril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Ramipril']",0.5
14836,33618.0,Ramipril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Ramipril']",0.5
14836,33618.0,Ramipril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Ramipril']",0.5
14836,35565.0,Ramipril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Ramipril']",0.5
14836,35764.0,Ramipril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ACE', 'Ramipril']",0.5
14836,35764.0,Ramipril,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ramipril']",0.5
14836,35909.0,Ramipril,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'ACE', 'Ramipril']",0.5
14836,35909.0,Ramipril,cerebrovascular disorder,disease-exposure-gene-drug,indication,"['cerebrovascular disorder', 'Particulate Matter', 'ACE', 'Ramipril']",0.5
14836,36286.0,Ramipril,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'ACE', 'Ramipril']",0.5
14838,27315.0,Succinylcholine,limb-girdle muscular dystrophy,disease-protein-drug,contraindication,"['limb-girdle muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,27315.0,Succinylcholine,limb-girdle muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['limb-girdle muscular dystrophy', 'Seizure', 'BCHE', 'Succinylcholine']",0.5
14838,27375.0,Succinylcholine,tibial muscular dystrophy,disease-protein-drug,contraindication,"['tibial muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,27548.0,Succinylcholine,oculopharyngeal muscular dystrophy,disease-protein-drug,contraindication,"['oculopharyngeal muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,27586.0,Succinylcholine,progressive scapulohumeroperoneal distal myopathy,disease-protein-drug,contraindication,"['progressive scapulohumeroperoneal distal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,27674.0,Succinylcholine,Emery-Dreifuss muscular dystrophy,disease-protein-drug,contraindication,"['Emery-Dreifuss muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,27677.0,Succinylcholine,Miyoshi muscular dystrophy,disease-protein-drug,contraindication,"['Miyoshi muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,27678.0,Succinylcholine,Finnish upper limb-onset distal myopathy,disease-protein-drug,contraindication,"['Finnish upper limb-onset distal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,27707.0,Succinylcholine,distal myopathy with posterior leg and anterior hand involvement,disease-protein-drug,contraindication,"['distal myopathy with posterior leg and anterior hand involvement', 'BCHE', 'Succinylcholine']",0.5
14838,27709.0,Succinylcholine,MYH7-related skeletal myopathy,disease-protein-drug,contraindication,"['MYH7-related skeletal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,27733.0,Succinylcholine,adult-onset distal myopathy due to VCP mutation,disease-protein-drug,contraindication,"['adult-onset distal myopathy due to VCP mutation', 'BCHE', 'Succinylcholine']",0.5
14838,27733.0,Succinylcholine,adult-onset distal myopathy due to VCP mutation,disease-phenotype-protein-drug,contraindication,"['adult-onset distal myopathy due to VCP mutation', 'Fasciculations', 'BCHE', 'Succinylcholine']",0.5
14838,27735.0,Succinylcholine,X-linked Emery-Dreifuss muscular dystrophy,disease-protein-drug,contraindication,"['X-linked Emery-Dreifuss muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,27737.0,Succinylcholine,autosomal recessive Emery-Dreifuss muscular dystrophy,disease-protein-drug,contraindication,"['autosomal recessive Emery-Dreifuss muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,27738.0,Succinylcholine,autosomal dominant Emery-Dreifuss muscular dystrophy,disease-protein-drug,contraindication,"['autosomal dominant Emery-Dreifuss muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,27738.0,Succinylcholine,autosomal dominant Emery-Dreifuss muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['autosomal dominant Emery-Dreifuss muscular dystrophy', 'Bradycardia', 'CHRM2', 'Succinylcholine']",0.5
14838,27762.0,Succinylcholine,myofibrillar myopathy,disease-protein-drug,contraindication,"['myofibrillar myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,27762.0,Succinylcholine,myofibrillar myopathy,disease-phenotype-protein-drug,contraindication,"['myofibrillar myopathy', 'Bradycardia', 'CHRM2', 'Succinylcholine']",0.5
14838,27805.0,Succinylcholine,"distal myopathy, Welander type",disease-protein-drug,contraindication,"['distal myopathy, Welander type', 'BCHE', 'Succinylcholine']",0.5
14838,28595.0,Succinylcholine,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a",disease-protein-drug,contraindication,"['muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a', 'BCHE', 'Succinylcholine']",0.5
14838,28595.0,Succinylcholine,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a",disease-phenotype-protein-drug,contraindication,"['muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a', 'Seizure', 'BCHE', 'Succinylcholine']",0.5
14838,29368.0,Succinylcholine,limb-girdle muscular dystrophy due to POMK deficiency,disease-protein-drug,contraindication,"['limb-girdle muscular dystrophy due to POMK deficiency', 'BCHE', 'Succinylcholine']",0.5
14838,29517.0,Succinylcholine,MYH7-related late-onset scapuloperoneal muscular dystrophy,disease-protein-drug,contraindication,"['MYH7-related late-onset scapuloperoneal muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,30056.0,Succinylcholine,butyrylcholinesterase deficiency,disease-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'BCHE', 'Succinylcholine']",0.5
14838,30056.0,Succinylcholine,butyrylcholinesterase deficiency,disease-phenotype-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'Apnea', 'BCHE', 'Succinylcholine']",0.5
14838,30168.0,Succinylcholine,hereditary proximal myopathy with early respiratory failure,disease-protein-drug,contraindication,"['hereditary proximal myopathy with early respiratory failure', 'BCHE', 'Succinylcholine']",0.5
14838,30310.0,Succinylcholine,autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6),disease-protein-drug,contraindication,"['autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6)', 'BCHE', 'Succinylcholine']",0.5
14838,30345.0,Succinylcholine,Bethlem myopathy,disease-protein-drug,contraindication,"['Bethlem myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,30563.0,Succinylcholine,facioscapulohumeral muscular dystrophy,disease-protein-drug,contraindication,"['facioscapulohumeral muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,30563.0,Succinylcholine,facioscapulohumeral muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['facioscapulohumeral muscular dystrophy', 'Seizure', 'BCHE', 'Succinylcholine']",0.5
14838,30669.0,Succinylcholine,Becker muscular dystrophy,disease-protein-drug,contraindication,"['Becker muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,31123.0,Succinylcholine,oculogastrointestinal muscular dystrophy,disease-protein-drug,contraindication,"['oculogastrointestinal muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,31181.0,Succinylcholine,muscular dystrophy,disease-protein-drug,contraindication,"['muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,31262.0,Succinylcholine,X-linked scapuloperoneal muscular dystrophy,disease-protein-drug,contraindication,"['X-linked scapuloperoneal muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,31522.0,Succinylcholine,oculopharyngodistal myopathy,disease-protein-drug,contraindication,"['oculopharyngodistal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,31650.0,Succinylcholine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Succinylcholine']",0.5
14838,31732.0,Succinylcholine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'CHRM1', 'Succinylcholine']",0.5
14838,31818.0,Succinylcholine,X-linked myopathy with postural muscle atrophy,disease-protein-drug,contraindication,"['X-linked myopathy with postural muscle atrophy', 'BCHE', 'Succinylcholine']",0.5
14838,32149.0,Succinylcholine,Duchenne muscular dystrophy,disease-protein-drug,contraindication,"['Duchenne muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,32408.0,Succinylcholine,Duchenne and Becker muscular dystrophy,disease-protein-drug,contraindication,"['Duchenne and Becker muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,32448.0,Succinylcholine,KLHL9-related early-onset distal myopathy,disease-protein-drug,contraindication,"['KLHL9-related early-onset distal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,32689.0,Succinylcholine,nebulin-related early-onset distal myopathy,disease-protein-drug,contraindication,"['nebulin-related early-onset distal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,33487.0,Succinylcholine,intellectual disability-hyperkinetic movement-truncal ataxia syndrome,disease-protein-drug,contraindication,"['intellectual disability-hyperkinetic movement-truncal ataxia syndrome', 'BCHE', 'Succinylcholine']",0.5
14838,33487.0,Succinylcholine,intellectual disability-hyperkinetic movement-truncal ataxia syndrome,disease-phenotype-protein-drug,contraindication,"['intellectual disability-hyperkinetic movement-truncal ataxia syndrome', 'Seizure', 'BCHE', 'Succinylcholine']",0.5
14838,33632.0,Succinylcholine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'choline metabolic process', 'BCHE', 'Succinylcholine']",0.5
14838,35669.0,Succinylcholine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Succinylcholine']",0.5
14838,35669.0,Succinylcholine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Succinylcholine']",0.5
14838,35761.0,Succinylcholine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Succinylcholine']",0.5
14838,35761.0,Succinylcholine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'BCHE', 'Succinylcholine']",0.5
14838,35761.0,Succinylcholine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Succinylcholine']",0.5
14838,36166.0,Succinylcholine,progressive muscular dystrophy,disease-protein-drug,contraindication,"['progressive muscular dystrophy', 'BCHE', 'Succinylcholine']",0.5
14838,36469.0,Succinylcholine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Succinylcholine']",0.5
14838,36469.0,Succinylcholine,hypothyroidism,disease-exposure-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'BCHE', 'Succinylcholine']",0.5
14838,36469.0,Succinylcholine,hypothyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Succinylcholine']",0.5
14838,38381.0,Succinylcholine,distal myopathy,disease-protein-drug,contraindication,"['distal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,38704.0,Succinylcholine,autosomal recessive distal myopathy,disease-protein-drug,contraindication,"['autosomal recessive distal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,38865.0,Succinylcholine,autosomal dominant distal myopathy,disease-protein-drug,contraindication,"['autosomal dominant distal myopathy', 'BCHE', 'Succinylcholine']",0.5
14838,84272.0,Succinylcholine,obsolete autosomal dominant limb-girdle muscular dystrophy type 1C,disease-protein-drug,contraindication,"['obsolete autosomal dominant limb-girdle muscular dystrophy type 1C', 'BCHE', 'Succinylcholine']",0.5
14838,84273.0,Succinylcholine,symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers,disease-protein-drug,contraindication,"['symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers', 'BCHE', 'Succinylcholine']",0.5
14838,84274.0,Succinylcholine,autosomal dominant limb-girdle muscular dystrophy type 1E (DES),disease-protein-drug,contraindication,"['autosomal dominant limb-girdle muscular dystrophy type 1E (DES)', 'BCHE', 'Succinylcholine']",0.5
14839,28313.0,Sulpiride,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Sulpiride']",0.5
14839,28313.0,Sulpiride,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Sulpiride']",0.5
14840,28158.0,Profenamine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Profenamine']",0.5
14840,31650.0,Profenamine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Profenamine']",0.5
14840,33594.0,Profenamine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Profenamine']",0.5
14840,33594.0,Profenamine,diarrheal disease,disease-exposure-molfunc-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Profenamine']",0.5
14840,35565.0,Profenamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Profenamine']",0.5
14840,35764.0,Profenamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Profenamine']",0.5
14840,35764.0,Profenamine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Profenamine']",0.5
14840,36034.0,Profenamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Profenamine']",0.5
14840,36034.0,Profenamine,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Profenamine']",0.5
14840,36034.0,Profenamine,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Profenamine']",0.5
14840,36187.0,Profenamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Profenamine']",0.5
14840,36187.0,Profenamine,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Profenamine']",0.5
14840,37617.0,Profenamine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Profenamine']",0.5
14840,37617.0,Profenamine,chronic obstructive pulmonary disease,disease-exposure-molfunc-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Profenamine']",0.5
14840,37785.0,Profenamine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Profenamine']",0.5
14841,27326.0,Triflupromazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Triflupromazine']",0.5
14841,27326.0,Triflupromazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Triflupromazine']",0.5
14841,27326.0,Triflupromazine,long QT syndrome,disease-exposure-molfunc-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Triflupromazine']",0.5
14841,27655.0,Triflupromazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Triflupromazine']",0.5
14841,28149.0,Triflupromazine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Triflupromazine']",0.5
14841,28375.0,Triflupromazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Triflupromazine']",0.5
14841,28547.0,Triflupromazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Triflupromazine']",0.5
14841,28547.0,Triflupromazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,28547.0,Triflupromazine,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Chlorpyrifos', 'BCHE', 'Triflupromazine']",0.5
14841,28547.0,Triflupromazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Nausea', 'ABCB1', 'Triflupromazine']",0.5
14841,28547.0,Triflupromazine,Parkinson disease,disease-exposure-molfunc-gene-drug,contraindication,"['Parkinson disease', 'Organophosphates', 'cholinesterase activity', 'BCHE', 'Triflupromazine']",0.5
14841,28651.0,Triflupromazine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'BCHE', 'Triflupromazine']",0.5
14841,28780.0,Triflupromazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'BCHE', 'Triflupromazine']",0.5
14841,28780.0,Triflupromazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,28780.0,Triflupromazine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'BCHE', 'Triflupromazine']",0.5
14841,28780.0,Triflupromazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Triflupromazine']",0.5
14841,28780.0,Triflupromazine,Alzheimer disease,disease-exposure-molfunc-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Triflupromazine']",0.5
14841,29637.0,Triflupromazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Triflupromazine']",0.5
14841,29637.0,Triflupromazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD1', 'Triflupromazine']",0.5
14841,30035.0,Triflupromazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Triflupromazine']",0.5
14841,31393.0,Triflupromazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Cadmium', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,31393.0,Triflupromazine,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Pesticides', 'BCHE', 'Triflupromazine']",0.5
14841,31393.0,Triflupromazine,metabolic syndrome X,disease-exposure-molfunc-gene-drug,contraindication,"['metabolic syndrome X', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Triflupromazine']",0.5
14841,33454.0,Triflupromazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Triflupromazine']",0.5
14841,33593.0,Triflupromazine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'BCHE', 'Triflupromazine']",0.5
14841,33593.0,Triflupromazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'behavior', 'HTR2B', 'Triflupromazine']",0.5
14841,33593.0,Triflupromazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'DRD2', 'Triflupromazine']",0.5
14841,33593.0,Triflupromazine,obesity disorder,disease-exposure-molfunc-gene-drug,contraindication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'acetylcholinesterase activity', 'BCHE', 'Triflupromazine']",0.5
14841,33632.0,Triflupromazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'choline metabolic process', 'BCHE', 'Triflupromazine']",0.5
14841,35565.0,Triflupromazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,35641.0,Triflupromazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Triflupromazine']",0.5
14841,35641.0,Triflupromazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Triflupromazine']",0.5
14841,35915.0,Triflupromazine,mental disorder,disease-exposure-bioprocess-gene-drug,indication,"['mental disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,36104.0,Triflupromazine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Triflupromazine']",0.5
14841,36187.0,Triflupromazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,36187.0,Triflupromazine,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Triflupromazine']",0.5
14841,36229.0,Triflupromazine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Triflupromazine']",0.5
14841,37180.0,Triflupromazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,37180.0,Triflupromazine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Chlorpyrifos', 'BCHE', 'Triflupromazine']",0.5
14841,37180.0,Triflupromazine,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Triflupromazine']",0.5
14841,37706.0,Triflupromazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Triflupromazine']",0.5
14841,37786.0,Triflupromazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,37786.0,Triflupromazine,myocardial ischemia,disease-exposure-molfunc-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Triflupromazine']",0.5
14841,38003.0,Triflupromazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD2', 'Triflupromazine']",0.5
14841,83778.0,Triflupromazine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizophreniform disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,83779.0,Triflupromazine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizoaffective disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Triflupromazine']",0.5
14841,83998.0,Triflupromazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Triflupromazine']",0.5
14841,84023.0,Triflupromazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Triflupromazine']",0.5
14842,29525.0,Cinchocaine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Cinchocaine']",0.5
14842,30056.0,Cinchocaine,butyrylcholinesterase deficiency,disease-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'BCHE', 'Cinchocaine']",0.5
14842,30056.0,Cinchocaine,butyrylcholinesterase deficiency,disease-phenotype-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'Apnea', 'BCHE', 'Cinchocaine']",0.5
14842,31650.0,Cinchocaine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Cinchocaine']",0.5
14842,35565.0,Cinchocaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'learning', 'BCHE', 'Cinchocaine']",0.5
14842,35641.0,Cinchocaine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'BCHE', 'Cinchocaine']",0.5
14842,35669.0,Cinchocaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Cinchocaine']",0.5
14842,35669.0,Cinchocaine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cinchocaine']",0.5
14842,35761.0,Cinchocaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Cinchocaine']",0.5
14842,35761.0,Cinchocaine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'BCHE', 'Cinchocaine']",0.5
14842,35761.0,Cinchocaine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cinchocaine']",0.5
14842,35764.0,Cinchocaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Cinchocaine']",0.5
14842,35764.0,Cinchocaine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cinchocaine']",0.5
14842,36080.0,Cinchocaine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of heart rate', 'SCN10A', 'Cinchocaine']",0.5
14843,28426.0,Nizatidine,multiple endocrine neoplasia,disease-phenotype-protein-drug,off-label use,"['multiple endocrine neoplasia', 'Vomiting', 'ABCB1', 'Nizatidine']",0.5
14843,32875.0,Nizatidine,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,off-label use,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Nizatidine']",0.5
14843,35565.0,Nizatidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'HRH2', 'Nizatidine']",0.5
14843,36000.0,Nizatidine,gastric neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['gastric neoplasm', 'Lead', 'choline metabolic process', 'BCHE', 'Nizatidine']",0.5
14845,27326.0,Procaine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'DNA methylation involved in embryo development', 'DNMT3A', 'Procaine']",0.5
14845,27326.0,Procaine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'BCHE', 'Procaine']",0.5
14845,27326.0,Procaine,long QT syndrome,disease-exposure-molfunc-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Procaine']",0.5
14845,27626.0,Procaine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'DNMT3A', 'Procaine']",0.5
14845,27626.0,Procaine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ASPG', 'Procaine']",0.5
14845,27655.0,Procaine,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'SCN10A', 'Procaine']",0.5
14845,27655.0,Procaine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'SLC6A2', 'Procaine']",0.5
14845,27740.0,Procaine,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'ASPG', 'Procaine']",0.5
14845,28103.0,Procaine,progressive familial heart block,disease-phenotype-protein-drug,contraindication,"['progressive familial heart block', 'Sudden death', 'SCN10A', 'Procaine']",0.5
14845,29182.0,Procaine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Procaine']",0.5
14845,29182.0,Procaine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Thrombocytopenia', 'ASPG', 'Procaine']",0.5
14845,29352.0,Procaine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Thrombocytopenia', 'ASPG', 'Procaine']",0.5
14845,29494.0,Procaine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Thrombocytopenia', 'ASPG', 'Procaine']",0.5
14845,30056.0,Procaine,butyrylcholinesterase deficiency,disease-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'BCHE', 'Procaine']",0.5
14845,30056.0,Procaine,butyrylcholinesterase deficiency,disease-phenotype-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'Apnea', 'BCHE', 'Procaine']",0.5
14845,30879.0,Procaine,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'SLC6A2', 'Procaine']",0.5
14845,31650.0,Procaine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Hearing impairment', 'DNMT1', 'Procaine']",0.5
14845,33449.0,Procaine,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'ASPG', 'Procaine']",0.5
14845,33534.0,Procaine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Thrombocytopenia', 'ASPG', 'Procaine']",0.5
14845,33605.0,Procaine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'MAOB', 'Procaine']",0.5
14845,35565.0,Procaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'DNA methylation involved in embryo development', 'DNMT3A', 'Procaine']",0.5
14845,35669.0,Procaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Procaine']",0.5
14845,35669.0,Procaine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Procaine']",0.5
14845,35761.0,Procaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Procaine']",0.5
14845,35761.0,Procaine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'BCHE', 'Procaine']",0.5
14845,35761.0,Procaine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Procaine']",0.5
14845,35764.0,Procaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Procaine']",0.5
14845,35764.0,Procaine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Procaine']",0.5
14846,33025.0,Perindopril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Seizure', 'BCHE', 'Perindopril']",0.5
14846,33577.0,Perindopril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Perindopril']",0.5
14846,33577.0,Perindopril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Perindopril']",0.5
14846,33577.0,Perindopril,hypertensive disorder,disease-exposure-molfunc-gene-drug,indication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Perindopril']",0.5
14846,33605.0,Perindopril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ACE', 'Perindopril']",0.5
14846,33618.0,Perindopril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Perindopril']",0.5
14846,33618.0,Perindopril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Perindopril']",0.5
14846,33618.0,Perindopril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Perindopril']",0.5
14846,35565.0,Perindopril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Perindopril']",0.5
14846,35764.0,Perindopril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ACE', 'Perindopril']",0.5
14846,35764.0,Perindopril,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Perindopril']",0.5
14846,36286.0,Perindopril,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'ACE', 'Perindopril']",0.5
14848,28764.0,Terbutaline,Sjogren syndrome,disease-phenotype-protein-drug,off-label use,"['Sjogren syndrome', 'Seizure', 'BCHE', 'Terbutaline']",0.5
14848,29113.0,Terbutaline,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Terbutaline']",0.5
14848,33575.0,Terbutaline,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'response to folic acid', 'BCHE', 'Terbutaline']",0.5
14848,33575.0,Terbutaline,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Chlorpyrifos', 'BCHE', 'Terbutaline']",0.5
14848,33575.0,Terbutaline,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Terbutaline']",0.5
14848,33577.0,Terbutaline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'response to folic acid', 'BCHE', 'Terbutaline']",0.5
14848,33577.0,Terbutaline,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Terbutaline']",0.5
14848,33675.0,Terbutaline,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Terbutaline']",0.5
14848,33675.0,Terbutaline,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Arsenic', 'response to folic acid', 'BCHE', 'Terbutaline']",0.5
14848,33675.0,Terbutaline,asthma,disease-exposure-gene-drug,indication,"['asthma', 'glyphosate', 'BCHE', 'Terbutaline']",0.5
14848,33675.0,Terbutaline,asthma,disease-exposure-molfunc-gene-drug,indication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Terbutaline']",0.5
14848,33679.0,Terbutaline,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Terbutaline']",0.5
14848,35641.0,Terbutaline,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'BCHE', 'Terbutaline']",0.5
14848,35897.0,Terbutaline,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Terbutaline']",0.5
14848,35916.0,Terbutaline,dry eye syndrome,disease-exposure-bioprocess-gene-drug,indication,"['dry eye syndrome', 'Lead', 'choline metabolic process', 'BCHE', 'Terbutaline']",0.5
14848,36034.0,Terbutaline,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Terbutaline']",0.5
14848,36034.0,Terbutaline,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Terbutaline']",0.5
14848,36187.0,Terbutaline,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Terbutaline']",0.5
14848,36187.0,Terbutaline,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Terbutaline']",0.5
14848,36187.0,Terbutaline,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Terbutaline']",0.5
14848,37786.0,Terbutaline,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB1', 'Terbutaline']",0.5
14848,37786.0,Terbutaline,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'response to folic acid', 'BCHE', 'Terbutaline']",0.5
14848,37786.0,Terbutaline,myocardial ischemia,disease-exposure-molfunc-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Terbutaline']",0.5
14848,37830.0,Terbutaline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Terbutaline']",0.5
14848,39773.0,Terbutaline,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Terbutaline']",0.5
14848,83781.0,Terbutaline,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Terbutaline']",0.5
14849,30879.0,Mechlorethamine,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'BCHE', 'Mechlorethamine']",0.5
14849,33077.0,Mechlorethamine,Hodgkins lymphoma,disease-exposure-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'BCHE', 'Mechlorethamine']",0.5
14849,33077.0,Mechlorethamine,Hodgkins lymphoma,disease-exposure-molfunc-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Mechlorethamine']",0.5
14849,33632.0,Mechlorethamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'choline metabolic process', 'BCHE', 'Mechlorethamine']",0.5
14849,35650.0,Mechlorethamine,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'glyphosate', 'BCHE', 'Mechlorethamine']",0.5
14849,35650.0,Mechlorethamine,non-Hodgkin lymphoma,disease-exposure-molfunc-gene-drug,indication,"['non-Hodgkin lymphoma', 'beta-hexachlorocyclohexane', 'acetylcholinesterase activity', 'BCHE', 'Mechlorethamine']",0.5
14849,36812.0,Mechlorethamine,lung neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['lung neoplasm', 'Arsenic', 'response to folic acid', 'BCHE', 'Mechlorethamine']",0.5
14849,36812.0,Mechlorethamine,lung neoplasm,disease-exposure-gene-drug,indication,"['lung neoplasm', 'Chlorpyrifos', 'BCHE', 'Mechlorethamine']",0.5
14849,36812.0,Mechlorethamine,lung neoplasm,disease-exposure-molfunc-gene-drug,indication,"['lung neoplasm', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Mechlorethamine']",0.5
14851,33575.0,Cyclopentolate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Cyclopentolate']",0.5
14851,33575.0,Cyclopentolate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Chlorpyrifos', 'BCHE', 'Cyclopentolate']",0.5
14851,33575.0,Cyclopentolate,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cyclopentolate']",0.5
14851,33577.0,Cyclopentolate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Cyclopentolate']",0.5
14851,33577.0,Cyclopentolate,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cyclopentolate']",0.5
14851,35669.0,Cyclopentolate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Cyclopentolate']",0.5
14851,35669.0,Cyclopentolate,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cyclopentolate']",0.5
14851,35761.0,Cyclopentolate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Cyclopentolate']",0.5
14851,35761.0,Cyclopentolate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'BCHE', 'Cyclopentolate']",0.5
14851,35761.0,Cyclopentolate,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cyclopentolate']",0.5
14851,35953.0,Cyclopentolate,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'cognition', 'CHRM1', 'Cyclopentolate']",0.5
14851,35953.0,Cyclopentolate,atherosclerosis,disease-exposure-molfunc-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cyclopentolate']",0.5
14851,36034.0,Cyclopentolate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Cyclopentolate']",0.5
14851,36034.0,Cyclopentolate,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Cyclopentolate']",0.5
14851,36034.0,Cyclopentolate,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Cyclopentolate']",0.5
14851,36187.0,Cyclopentolate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Cyclopentolate']",0.5
14851,36187.0,Cyclopentolate,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Cyclopentolate']",0.5
14852,27326.0,Procainamide,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'SCN5A', 'Procainamide']",0.5
14852,27326.0,Procainamide,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'DNA methylation involved in embryo development', 'DNMT1', 'Procainamide']",0.5
14852,27326.0,Procainamide,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'BCHE', 'Procainamide']",0.5
14852,27326.0,Procainamide,long QT syndrome,disease-exposure-molfunc-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Procainamide']",0.5
14852,27655.0,Procainamide,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Procainamide']",0.5
14852,27655.0,Procainamide,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'BCHE', 'Procainamide']",0.5
14852,28103.0,Procainamide,progressive familial heart block,disease-protein-drug,contraindication,"['progressive familial heart block', 'SCN5A', 'Procainamide']",0.5
14852,28103.0,Procainamide,progressive familial heart block,disease-phenotype-protein-drug,contraindication,"['progressive familial heart block', 'Arrhythmia', 'SLC22A5', 'Procainamide']",0.5
14852,29182.0,Procainamide,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of heart rate', 'SCN5A', 'Procainamide']",0.5
14852,29182.0,Procainamide,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'BCHE', 'Procainamide']",0.5
14852,29494.0,Procainamide,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'DNMT1', 'Procainamide']",0.5
14852,30879.0,Procainamide,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'BCHE', 'Procainamide']",0.5
14852,31650.0,Procainamide,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Hearing impairment', 'DNMT1', 'Procainamide']",0.5
14852,33534.0,Procainamide,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'BCHE', 'Procainamide']",0.5
14852,35565.0,Procainamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'DNA methylation involved in embryo development', 'DNMT1', 'Procainamide']",0.5
14852,35764.0,Procainamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN5A', 'Procainamide']",0.5
14852,35764.0,Procainamide,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Procainamide']",0.5
14852,83751.0,Procainamide,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'SCN5A', 'Procainamide']",0.5
14852,84197.0,Procainamide,obsolete bundle branch block,disease-protein-drug,contraindication,"['obsolete bundle branch block', 'SCN5A', 'Procainamide']",0.5
14854,28547.0,Ambenonium,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'BCHE', 'Ambenonium']",0.5
14854,28547.0,Ambenonium,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Lead', 'choline metabolic process', 'BCHE', 'Ambenonium']",0.5
14854,28547.0,Ambenonium,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Chlorpyrifos', 'BCHE', 'Ambenonium']",0.5
14854,28547.0,Ambenonium,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'ACHE', 'Ambenonium']",0.5
14854,28547.0,Ambenonium,Parkinson disease,disease-exposure-molfunc-gene-drug,contraindication,"['Parkinson disease', 'Organophosphates', 'cholinesterase activity', 'BCHE', 'Ambenonium']",0.5
14854,31650.0,Ambenonium,myasthenia gravis,disease-phenotype-protein-drug,indication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Ambenonium']",0.5
14854,33675.0,Ambenonium,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'response to folic acid', 'BCHE', 'Ambenonium']",0.5
14854,33675.0,Ambenonium,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'glyphosate', 'BCHE', 'Ambenonium']",0.5
14854,33675.0,Ambenonium,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Ambenonium']",0.5
14856,30056.0,Chloroprocaine,butyrylcholinesterase deficiency,disease-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'BCHE', 'Chloroprocaine']",0.5
14856,30056.0,Chloroprocaine,butyrylcholinesterase deficiency,disease-phenotype-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'Apnea', 'BCHE', 'Chloroprocaine']",0.5
14856,31650.0,Chloroprocaine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Chloroprocaine']",0.5
14856,35565.0,Chloroprocaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Chloroprocaine']",0.5
14856,35669.0,Chloroprocaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Chloroprocaine']",0.5
14856,35669.0,Chloroprocaine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Chloroprocaine']",0.5
14856,35761.0,Chloroprocaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Chloroprocaine']",0.5
14856,35761.0,Chloroprocaine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'BCHE', 'Chloroprocaine']",0.5
14856,35761.0,Chloroprocaine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Chloroprocaine']",0.5
14856,35764.0,Chloroprocaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Chloroprocaine']",0.5
14856,35764.0,Chloroprocaine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Chloroprocaine']",0.5
14861,28610.0,Neostigmine,Mowat-Wilson syndrome,disease-phenotype-protein-drug,contraindication,"['Mowat-Wilson syndrome', 'Seizure', 'BCHE', 'Neostigmine']",0.5
14861,29014.0,Neostigmine,Hirschsprung disease-ganglioneuroblastoma syndrome,disease-phenotype-protein-drug,contraindication,"['Hirschsprung disease-ganglioneuroblastoma syndrome', 'Seizure', 'BCHE', 'Neostigmine']",0.5
14861,31650.0,Neostigmine,myasthenia gravis,disease-phenotype-protein-drug,indication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Neostigmine']",0.5
14861,32708.0,Neostigmine,Mowat-Wilson syndrome due to a ZEB2 point mutation,disease-phenotype-protein-drug,contraindication,"['Mowat-Wilson syndrome due to a ZEB2 point mutation', 'Focal-onset seizure', 'BCHE', 'Neostigmine']",0.5
14861,32714.0,Neostigmine,Mowat-Wilson syndrome due to monosomy 2q22,disease-phenotype-protein-drug,contraindication,"['Mowat-Wilson syndrome due to monosomy 2q22', 'Focal-onset seizure', 'BCHE', 'Neostigmine']",0.5
14861,33675.0,Neostigmine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'response to folic acid', 'BCHE', 'Neostigmine']",0.5
14861,33675.0,Neostigmine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'glyphosate', 'BCHE', 'Neostigmine']",0.5
14861,33675.0,Neostigmine,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Neostigmine']",0.5
14861,35641.0,Neostigmine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'BCHE', 'Neostigmine']",0.5
14861,36034.0,Neostigmine,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Neostigmine']",0.5
14861,36034.0,Neostigmine,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Neostigmine']",0.5
14868,31756.0,Thiotepa,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,indication,"['urinary bladder cancer', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Thiotepa']",0.5
14868,31756.0,Thiotepa,urinary bladder cancer,disease-exposure-gene-drug,indication,"['urinary bladder cancer', 'Pesticides', 'BCHE', 'Thiotepa']",0.5
14868,31756.0,Thiotepa,urinary bladder cancer,disease-exposure-molfunc-gene-drug,indication,"['urinary bladder cancer', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Thiotepa']",0.5
14868,32617.0,Thiotepa,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'BCHE', 'Thiotepa']",0.5
14868,33077.0,Thiotepa,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Thiotepa']",0.5
14868,33077.0,Thiotepa,Hodgkins lymphoma,disease-exposure-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'BCHE', 'Thiotepa']",0.5
14868,33077.0,Thiotepa,Hodgkins lymphoma,disease-exposure-molfunc-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Thiotepa']",0.5
14868,33642.0,Thiotepa,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Thiotepa']",0.5
14868,33642.0,Thiotepa,urinary bladder carcinoma,disease-exposure-gene-drug,indication,"['urinary bladder carcinoma', 'Pesticides', 'BCHE', 'Thiotepa']",0.5
14868,33642.0,Thiotepa,urinary bladder carcinoma,disease-exposure-molfunc-gene-drug,indication,"['urinary bladder carcinoma', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Thiotepa']",0.5
14868,35565.0,Thiotepa,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Thiotepa']",0.5
14868,35624.0,Thiotepa,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Thiotepa']",0.5
14868,35624.0,Thiotepa,urinary bladder neoplasm,disease-exposure-gene-drug,indication,"['urinary bladder neoplasm', 'Pesticides', 'BCHE', 'Thiotepa']",0.5
14868,35624.0,Thiotepa,urinary bladder neoplasm,disease-exposure-molfunc-gene-drug,indication,"['urinary bladder neoplasm', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Thiotepa']",0.5
14868,35650.0,Thiotepa,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Thiotepa']",0.5
14868,35650.0,Thiotepa,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'glyphosate', 'BCHE', 'Thiotepa']",0.5
14868,35650.0,Thiotepa,non-Hodgkin lymphoma,disease-exposure-molfunc-gene-drug,indication,"['non-Hodgkin lymphoma', 'beta-hexachlorocyclohexane', 'acetylcholinesterase activity', 'BCHE', 'Thiotepa']",0.5
14868,35764.0,Thiotepa,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Thiotepa']",0.5
14868,35764.0,Thiotepa,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Thiotepa']",0.5
14869,33577.0,Clevidipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'visual perception', 'CACNA1F', 'Clevidipine']",0.5
14869,33577.0,Clevidipine,hypertensive disorder,disease-exposure-molfunc-gene-drug,indication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Clevidipine']",0.5
14869,33695.0,Clevidipine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'visual perception', 'CACNA1F', 'Clevidipine']",0.5
14869,37659.0,Clevidipine,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of heart rate by cardiac conduction', 'CACNA1C', 'Clevidipine']",0.5
14874,37604.0,Moxisylyte,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,indication,"['erectile dysfunction (disease)', 'Arsenic', 'response to folic acid', 'BCHE', 'Moxisylyte']",0.5
14874,37604.0,Moxisylyte,erectile dysfunction (disease),disease-exposure-molfunc-gene-drug,indication,"['erectile dysfunction (disease)', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Moxisylyte']",0.5
14875,32617.0,Tretamine,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'BCHE', 'Tretamine']",0.5
14875,33632.0,Tretamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'choline metabolic process', 'BCHE', 'Tretamine']",0.5
14880,28552.0,Nicotine,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'locomotory behavior', 'CHRNA3', 'Nicotine']",0.5
14880,28552.0,Nicotine,type 1 diabetes mellitus,disease-exposure-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'CYP1A1', 'Nicotine']",0.5
14880,30035.0,Nicotine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Nicotine']",0.5
14880,31122.0,Nicotine,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'MAOB', 'Nicotine']",0.5
14880,33575.0,Nicotine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Nicotine']",0.5
14880,33575.0,Nicotine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Nicotine']",0.5
14880,33575.0,Nicotine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Nicotine']",0.5
14880,33575.0,Nicotine,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'CYP19A1', 'Nicotine']",0.5
14880,33605.0,Nicotine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'MAOB', 'Nicotine']",0.5
14880,35565.0,Nicotine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Nicotine']",0.5
14880,35565.0,Nicotine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Nicotine']",0.5
14880,35735.0,Nicotine,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'MAOB', 'Nicotine']",0.5
14880,35894.0,Nicotine,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'MAOB', 'Nicotine']",0.5
14880,35895.0,Nicotine,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'MAOB', 'Nicotine']",0.5
14880,36034.0,Nicotine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'CHRNA7', 'Nicotine']",0.5
14880,36149.0,Nicotine,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'MAOB', 'Nicotine']",0.5
14880,36187.0,Nicotine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Nicotine']",0.5
14880,36187.0,Nicotine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Nicotine']",0.5
14880,36860.0,Nicotine,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'MAOB', 'Nicotine']",0.5
14880,37180.0,Nicotine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRNA4', 'Nicotine']",0.5
14880,37180.0,Nicotine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'CYP1A1', 'Nicotine']",0.5
14880,37919.0,Nicotine,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'MAOB', 'Nicotine']",0.5
14880,83764.0,Nicotine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'learning or memory', 'CHRNA7', 'Nicotine']",0.5
14880,84229.0,Nicotine,nicotine dependence,disease-protein-drug,indication,"['nicotine dependence', 'CYP2A6', 'Nicotine']",0.5
14881,27286.0,Phenylephrine,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CYP1A2', 'Phenylephrine']",0.5
14881,27292.0,Phenylephrine,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'CYP1A2', 'Phenylephrine']",0.5
14881,27361.0,Phenylephrine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,27476.0,Phenylephrine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,27503.0,Phenylephrine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,27933.0,Phenylephrine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'MAOB', 'Phenylephrine']",0.5
14881,27933.0,Phenylephrine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,28158.0,Phenylephrine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,28473.0,Phenylephrine,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'MAOB', 'Phenylephrine']",0.5
14881,28780.0,Phenylephrine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'MAOB', 'Phenylephrine']",0.5
14881,28780.0,Phenylephrine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,28780.0,Phenylephrine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,28899.0,Phenylephrine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Tobacco Smoke Pollution', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,30035.0,Phenylephrine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Phenylephrine']",0.5
14881,30374.0,Phenylephrine,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'CYP1A2', 'Phenylephrine']",0.5
14881,30664.0,Phenylephrine,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,contraindication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'ADRA1B', 'Phenylephrine']",0.5
14881,30813.0,Phenylephrine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,31618.0,Phenylephrine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,31650.0,Phenylephrine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,32313.0,Phenylephrine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,32384.0,Phenylephrine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,32737.0,Phenylephrine,hypocomplementemic urticarial vasculitis,disease-phenotype-protein-drug,contraindication,"['hypocomplementemic urticarial vasculitis', 'Hepatomegaly', 'CYP1A2', 'Phenylephrine']",0.5
14881,32977.0,Phenylephrine,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Phenylephrine']",0.5
14881,32977.0,Phenylephrine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,33440.0,Phenylephrine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Seizure', 'ADRA1B', 'Phenylephrine']",0.5
14881,33454.0,Phenylephrine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Elevated hepatic transaminase', 'CYP1A2', 'Phenylephrine']",0.5
14881,33575.0,Phenylephrine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Phenylephrine']",0.5
14881,33575.0,Phenylephrine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,33577.0,Phenylephrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,33605.0,Phenylephrine,hypotensive disorder,disease-protein-drug,off-label use,"['hypotensive disorder', 'MAOB', 'Phenylephrine']",0.5
14881,33675.0,Phenylephrine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,35565.0,Phenylephrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,35641.0,Phenylephrine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADRA1B', 'Phenylephrine']",0.5
14881,35669.0,Phenylephrine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,35761.0,Phenylephrine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,35764.0,Phenylephrine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,35897.0,Phenylephrine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'methylation', 'CYP1A2', 'Phenylephrine']",0.5
14881,35915.0,Phenylephrine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,35953.0,Phenylephrine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Phenylephrine']",0.5
14881,36034.0,Phenylephrine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,36080.0,Phenylephrine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Phenylephrine']",0.5
14881,36187.0,Phenylephrine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,36252.0,Phenylephrine,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'methylation', 'CYP1A2', 'Phenylephrine']",0.5
14881,36469.0,Phenylephrine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,36478.0,Phenylephrine,nervous system disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['nervous system disorder', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,36492.0,Phenylephrine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,37180.0,Phenylephrine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,37617.0,Phenylephrine,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A2', 'Phenylephrine']",0.5
14881,37617.0,Phenylephrine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,37785.0,Phenylephrine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,37786.0,Phenylephrine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,37811.0,Phenylephrine,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Phenylephrine']",0.5
14881,37830.0,Phenylephrine,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants, Occupational', 'regulation of gene expression', 'CYP1A2', 'Phenylephrine']",0.5
14881,37888.0,Phenylephrine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Phenylephrine']",0.5
14881,38575.0,Phenylephrine,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'MAOB', 'Phenylephrine']",0.5
14881,83778.0,Phenylephrine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,83779.0,Phenylephrine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP1A2', 'Phenylephrine']",0.5
14881,83911.0,Phenylephrine,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'MAOB', 'Phenylephrine']",0.5
14882,31122.0,Linezolid,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'MAOB', 'Linezolid']",0.5
14882,33577.0,Linezolid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Linezolid']",0.5
14882,35735.0,Linezolid,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'MAOB', 'Linezolid']",0.5
14882,35894.0,Linezolid,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'MAOB', 'Linezolid']",0.5
14882,35895.0,Linezolid,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'MAOB', 'Linezolid']",0.5
14882,36149.0,Linezolid,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'MAOB', 'Linezolid']",0.5
14882,36860.0,Linezolid,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'MAOB', 'Linezolid']",0.5
14882,37919.0,Linezolid,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'MAOB', 'Linezolid']",0.5
14884,28249.0,Phenelzine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'MAOB', 'Phenelzine']",0.5
14884,28313.0,Phenelzine,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'MAOB', 'Phenelzine']",0.5
14884,28313.0,Phenelzine,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Phenelzine']",0.5
14884,28396.0,Phenelzine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Phenelzine']",0.5
14884,30035.0,Phenelzine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Phenelzine']",0.5
14884,31122.0,Phenelzine,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'MAOB', 'Phenelzine']",0.5
14884,33575.0,Phenelzine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'AOC3', 'Phenelzine']",0.5
14884,33575.0,Phenelzine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'GPT', 'Phenelzine']",0.5
14884,33575.0,Phenelzine,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Trihalomethanes', 'L-alanine:2-oxoglutarate aminotransferase activity', 'GPT2', 'Phenelzine']",0.5
14884,33577.0,Phenelzine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Phenelzine']",0.5
14884,33577.0,Phenelzine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Phenelzine']",0.5
14884,33577.0,Phenelzine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'GPT', 'Phenelzine']",0.5
14884,33577.0,Phenelzine,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'L-alanine:2-oxoglutarate aminotransferase activity', 'GPT2', 'Phenelzine']",0.5
14884,35565.0,Phenelzine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Phenelzine']",0.5
14884,35565.0,Phenelzine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'GPT', 'Phenelzine']",0.5
14884,35565.0,Phenelzine,liver disease,disease-exposure-molfunc-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'L-alanine:2-oxoglutarate aminotransferase activity', 'GPT2', 'Phenelzine']",0.5
14884,35641.0,Phenelzine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABAT', 'Phenelzine']",0.5
14884,35669.0,Phenelzine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'AOC3', 'Phenelzine']",0.5
14884,35735.0,Phenelzine,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'MAOB', 'Phenelzine']",0.5
14884,35761.0,Phenelzine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'AOC3', 'Phenelzine']",0.5
14884,35761.0,Phenelzine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'GPT', 'Phenelzine']",0.5
14884,35764.0,Phenelzine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Phenelzine']",0.5
14884,35764.0,Phenelzine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'GPT', 'Phenelzine']",0.5
14884,35894.0,Phenelzine,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'MAOB', 'Phenelzine']",0.5
14884,35895.0,Phenelzine,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'MAOB', 'Phenelzine']",0.5
14884,35909.0,Phenelzine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'triglyceride metabolic process', 'CYP2E1', 'Phenelzine']",0.5
14884,35909.0,Phenelzine,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'GPT', 'Phenelzine']",0.5
14884,35909.0,Phenelzine,cerebrovascular disorder,disease-exposure-molfunc-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'L-alanine:2-oxoglutarate aminotransferase activity', 'GPT2', 'Phenelzine']",0.5
14884,36034.0,Phenelzine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Phenelzine']",0.5
14884,36035.0,Phenelzine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Phenelzine']",0.5
14884,36149.0,Phenelzine,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'MAOB', 'Phenelzine']",0.5
14884,36187.0,Phenelzine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'AOC3', 'Phenelzine']",0.5
14884,36187.0,Phenelzine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'GPT', 'Phenelzine']",0.5
14884,36187.0,Phenelzine,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'perfluorooctanoic acid', 'L-alanine:2-oxoglutarate aminotransferase activity', 'GPT2', 'Phenelzine']",0.5
14884,36860.0,Phenelzine,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'MAOB', 'Phenelzine']",0.5
14884,37703.0,Phenelzine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOB', 'Phenelzine']",0.5
14884,37919.0,Phenelzine,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'MAOB', 'Phenelzine']",0.5
14884,38242.0,Phenelzine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'MAOB', 'Phenelzine']",0.5
14884,83760.0,Phenelzine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'MAOB', 'Phenelzine']",0.5
14885,27933.0,Moclobemide,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Moclobemide']",0.5
14885,27933.0,Moclobemide,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Moclobemide']",0.5
14885,37703.0,Moclobemide,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOB', 'Moclobemide']",0.5
14885,83760.0,Moclobemide,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'MAOB', 'Moclobemide']",0.5
14893,27933.0,Iproniazid,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Iproniazid']",0.5
14893,27933.0,Iproniazid,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Iproniazid']",0.5
14893,37703.0,Iproniazid,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOB', 'Iproniazid']",0.5
14893,83760.0,Iproniazid,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'MAOB', 'Iproniazid']",0.5
14897,28017.0,Zolmitriptan,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Zolmitriptan']",0.5
14897,33302.0,Zolmitriptan,familial or sporadic hemiplegic migraine,disease-phenotype-protein-drug,contraindication,"['familial or sporadic hemiplegic migraine', 'Focal sensory seizure', 'ABCB1', 'Zolmitriptan']",0.5
14897,33577.0,Zolmitriptan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HTR2A', 'Zolmitriptan']",0.5
14897,33598.0,Zolmitriptan,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP1A2', 'Zolmitriptan']",0.5
14897,35565.0,Zolmitriptan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Zolmitriptan']",0.5
14897,35764.0,Zolmitriptan,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HTR2A', 'Zolmitriptan']",0.5
14897,35909.0,Zolmitriptan,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Zolmitriptan']",0.5
14897,36187.0,Zolmitriptan,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'memory', 'HTR2A', 'Zolmitriptan']",0.5
14897,36312.0,Zolmitriptan,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Zolmitriptan']",0.5
14897,37180.0,Zolmitriptan,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'memory', 'HTR2A', 'Zolmitriptan']",0.5
14897,37718.0,Zolmitriptan,brain ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'memory', 'HTR2A', 'Zolmitriptan']",0.5
14897,37768.0,Zolmitriptan,migraine disorder,disease-protein-drug,indication,"['migraine disorder', 'HTR2A', 'Zolmitriptan']",0.5
14897,37786.0,Zolmitriptan,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'memory', 'HTR2A', 'Zolmitriptan']",0.5
14897,39798.0,Zolmitriptan,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'memory', 'HTR2A', 'Zolmitriptan']",0.5
14898,27361.0,Phenylpropanolamine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'DRD1', 'Phenylpropanolamine']",0.5
14898,27933.0,Phenylpropanolamine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,27933.0,Phenylpropanolamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'transmission of nerve impulse', 'DRD1', 'Phenylpropanolamine']",0.5
14898,28651.0,Phenylpropanolamine,monogenic obesity,disease-protein-drug,off-label use,"['monogenic obesity', 'ADRB1', 'Phenylpropanolamine']",0.5
14898,28780.0,Phenylpropanolamine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'DRD1', 'Phenylpropanolamine']",0.5
14898,28780.0,Phenylpropanolamine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Phenylpropanolamine']",0.5
14898,28899.0,Phenylpropanolamine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Nicotine', 'transmission of nerve impulse', 'DRD1', 'Phenylpropanolamine']",0.5
14898,30035.0,Phenylpropanolamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,30813.0,Phenylpropanolamine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Cyanosis', 'ADRA2B', 'Phenylpropanolamine']",0.5
14898,31502.0,Phenylpropanolamine,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Tremor', 'ADRB2', 'Phenylpropanolamine']",0.5
14898,32384.0,Phenylpropanolamine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'DRD1', 'Phenylpropanolamine']",0.5
14898,33440.0,Phenylpropanolamine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Seizure', 'DRD1', 'Phenylpropanolamine']",0.5
14898,33593.0,Phenylpropanolamine,obesity disorder,disease-protein-drug,off-label use,"['obesity disorder', 'ADRB1', 'Phenylpropanolamine']",0.5
14898,33593.0,Phenylpropanolamine,obesity disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,33605.0,Phenylpropanolamine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,35565.0,Phenylpropanolamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'female pregnancy', 'ADRA2B', 'Phenylpropanolamine']",0.5
14898,35641.0,Phenylpropanolamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD1', 'Phenylpropanolamine']",0.5
14898,35641.0,Phenylpropanolamine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD1', 'Phenylpropanolamine']",0.5
14898,35764.0,Phenylpropanolamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,35897.0,Phenylpropanolamine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Phenylpropanolamine']",0.5
14898,35953.0,Phenylpropanolamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,36080.0,Phenylpropanolamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'positive regulation of blood pressure', 'ADRA2B', 'Phenylpropanolamine']",0.5
14898,36187.0,Phenylpropanolamine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Phenylpropanolamine']",0.5
14898,36187.0,Phenylpropanolamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,36492.0,Phenylpropanolamine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'visual learning', 'DRD1', 'Phenylpropanolamine']",0.5
14898,36693.0,Phenylpropanolamine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'DRD1', 'Phenylpropanolamine']",0.5
14898,37180.0,Phenylpropanolamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,37617.0,Phenylpropanolamine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,37785.0,Phenylpropanolamine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'female pregnancy', 'ADRA2B', 'Phenylpropanolamine']",0.5
14898,37786.0,Phenylpropanolamine,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB1', 'Phenylpropanolamine']",0.5
14898,37786.0,Phenylpropanolamine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phenylpropanolamine']",0.5
14898,37811.0,Phenylpropanolamine,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phenylpropanolamine']",0.5
14899,28017.0,Sumatriptan,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Sumatriptan']",0.5
14899,30035.0,Sumatriptan,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Sumatriptan']",0.5
14899,33091.0,Sumatriptan,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Fever', 'HTR1A', 'Sumatriptan']",0.5
14899,33302.0,Sumatriptan,familial or sporadic hemiplegic migraine,disease-phenotype-protein-drug,contraindication,"['familial or sporadic hemiplegic migraine', 'Focal sensory seizure', 'ABCB1', 'Sumatriptan']",0.5
14899,33575.0,Sumatriptan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14899,33577.0,Sumatriptan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Sumatriptan']",0.5
14899,33593.0,Sumatriptan,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14899,33598.0,Sumatriptan,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Sumatriptan']",0.5
14899,35565.0,Sumatriptan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14899,35641.0,Sumatriptan,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Sumatriptan']",0.5
14899,35669.0,Sumatriptan,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Sumatriptan']",0.5
14899,35761.0,Sumatriptan,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14899,35764.0,Sumatriptan,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14899,35909.0,Sumatriptan,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Sumatriptan']",0.5
14899,36187.0,Sumatriptan,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14899,36312.0,Sumatriptan,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Sumatriptan']",0.5
14899,37180.0,Sumatriptan,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14899,37786.0,Sumatriptan,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14899,39798.0,Sumatriptan,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Sumatriptan']",0.5
14900,28651.0,Almotriptan,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'CYP2E1', 'Almotriptan']",0.5
14900,33091.0,Almotriptan,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Tremor', 'CYP2D6', 'Almotriptan']",0.5
14900,33302.0,Almotriptan,familial or sporadic hemiplegic migraine,disease-phenotype-protein-drug,contraindication,"['familial or sporadic hemiplegic migraine', 'Coma', 'CYP2D6', 'Almotriptan']",0.5
14900,33575.0,Almotriptan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Almotriptan']",0.5
14900,33575.0,Almotriptan,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'CYP2E1', 'Almotriptan']",0.5
14900,33577.0,Almotriptan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Almotriptan']",0.5
14900,33593.0,Almotriptan,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'CYP2E1', 'Almotriptan']",0.5
14900,33593.0,Almotriptan,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'bone remodeling', 'HTR1B', 'Almotriptan']",0.5
14900,33593.0,Almotriptan,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CYP2D6', 'Almotriptan']",0.5
14900,33598.0,Almotriptan,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Almotriptan']",0.5
14900,33598.0,Almotriptan,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Almotriptan']",0.5
14900,35565.0,Almotriptan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Almotriptan']",0.5
14900,35909.0,Almotriptan,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'triglyceride metabolic process', 'CYP2E1', 'Almotriptan']",0.5
14900,36187.0,Almotriptan,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Almotriptan']",0.5
14900,36312.0,Almotriptan,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Almotriptan']",0.5
14900,37180.0,Almotriptan,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Almotriptan']",0.5
14900,37180.0,Almotriptan,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'CYP2E1', 'Almotriptan']",0.5
14900,37786.0,Almotriptan,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Almotriptan']",0.5
14900,39798.0,Almotriptan,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Almotriptan']",0.5
14901,33575.0,Naratriptan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'bone remodeling', 'HTR1B', 'Naratriptan']",0.5
14901,33577.0,Naratriptan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Naratriptan']",0.5
14901,33593.0,Naratriptan,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'bone remodeling', 'HTR1B', 'Naratriptan']",0.5
14901,33598.0,Naratriptan,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Naratriptan']",0.5
14901,35909.0,Naratriptan,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Naratriptan']",0.5
14901,36187.0,Naratriptan,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Naratriptan']",0.5
14901,36312.0,Naratriptan,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Naratriptan']",0.5
14901,37180.0,Naratriptan,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'bone remodeling', 'HTR1B', 'Naratriptan']",0.5
14901,37786.0,Naratriptan,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'bone remodeling', 'HTR1B', 'Naratriptan']",0.5
14901,39798.0,Naratriptan,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Naratriptan']",0.5
14902,33577.0,Rizatriptan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Rizatriptan']",0.5
14902,33598.0,Rizatriptan,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Rizatriptan']",0.5
14902,35565.0,Rizatriptan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Rizatriptan']",0.5
14902,35909.0,Rizatriptan,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Rizatriptan']",0.5
14902,36040.0,Rizatriptan,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Rizatriptan']",0.5
14902,36187.0,Rizatriptan,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Rizatriptan']",0.5
14902,37180.0,Rizatriptan,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'bone remodeling', 'HTR1B', 'Rizatriptan']",0.5
14902,37786.0,Rizatriptan,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'bone remodeling', 'HTR1B', 'Rizatriptan']",0.5
14902,39798.0,Rizatriptan,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'bone remodeling', 'HTR1B', 'Rizatriptan']",0.5
14902,83923.0,Rizatriptan,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Rizatriptan']",0.5
14904,28547.0,Safinamide,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'MAOB', 'Safinamide']",0.5
14904,28547.0,Safinamide,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Safinamide']",0.5
14904,28547.0,Safinamide,Parkinson disease,disease-exposure-gene-drug,indication,"['Parkinson disease', 'Pesticides', 'CYP2E1', 'Safinamide']",0.5
14904,28547.0,Safinamide,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Safinamide']",0.5
14904,28974.0,Safinamide,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'MAOB', 'Safinamide']",0.5
14904,28974.0,Safinamide,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CYP2D6', 'Safinamide']",0.5
14904,31408.0,Safinamide,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'MAOB', 'Safinamide']",0.5
14904,31408.0,Safinamide,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CYP2D6', 'Safinamide']",0.5
14904,32759.0,Safinamide,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'MAOB', 'Safinamide']",0.5
14904,32759.0,Safinamide,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CYP2D6', 'Safinamide']",0.5
14904,32974.0,Safinamide,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'MAOB', 'Safinamide']",0.5
14904,32974.0,Safinamide,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CYP2D6', 'Safinamide']",0.5
14904,33241.0,Safinamide,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'MAOB', 'Safinamide']",0.5
14904,33241.0,Safinamide,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CYP2D6', 'Safinamide']",0.5
14905,27933.0,Pirlindole,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ADRA2A', 'Pirlindole']",0.5
14905,27933.0,Pirlindole,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Arsenic', 'positive regulation of cytokine production', 'ADRA2A', 'Pirlindole']",0.5
14905,37703.0,Pirlindole,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOA', 'Pirlindole']",0.5
14905,83760.0,Pirlindole,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'MAOA', 'Pirlindole']",0.5
14906,27933.0,Toloxatone,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOA', 'Toloxatone']",0.5
14906,27933.0,Toloxatone,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Toloxatone']",0.5
14906,37703.0,Toloxatone,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'MAOA', 'Toloxatone']",0.5
14906,83760.0,Toloxatone,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'MAOA', 'Toloxatone']",0.5
14908,28017.0,Ubrogepant,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Ubrogepant']",0.5
14909,33575.0,Nitrofural,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'XDH', 'Nitrofural']",0.5
14909,36544.0,Nitrofural,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Nitrofural']",0.5
14910,32928.0,Pyrazinamide,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Thrombocytopenia', 'XDH', 'Pyrazinamide']",0.5
14910,33575.0,Pyrazinamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'XDH', 'Pyrazinamide']",0.5
14910,35565.0,Pyrazinamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Pyrazinamide']",0.5
14910,83790.0,Pyrazinamide,gout,disease-protein-drug,contraindication,"['gout', 'XDH', 'Pyrazinamide']",0.5
14911,35565.0,Allopurinol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Allopurinol']",0.5
14911,83790.0,Allopurinol,gout,disease-protein-drug,indication,"['gout', 'ABCG2', 'Allopurinol']",0.5
14911,83802.0,Allopurinol,obsolete hyperuricemia (disease),disease-protein-drug,indication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Allopurinol']",0.5
14911,83802.0,Allopurinol,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['obsolete hyperuricemia (disease)', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Allopurinol']",0.5
14913,27626.0,Trifluoperazine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'XDH', 'Trifluoperazine']",0.5
14913,28149.0,Trifluoperazine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Trifluoperazine']",0.5
14913,28313.0,Trifluoperazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Trifluoperazine']",0.5
14913,28313.0,Trifluoperazine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP1A2', 'Trifluoperazine']",0.5
14913,28396.0,Trifluoperazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Neurodegeneration', 'XDH', 'Trifluoperazine']",0.5
14913,28780.0,Trifluoperazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CALM1', 'Trifluoperazine']",0.5
14913,28780.0,Trifluoperazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'DRD2', 'Trifluoperazine']",0.5
14913,28780.0,Trifluoperazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD2', 'Trifluoperazine']",0.5
14913,33454.0,Trifluoperazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Thrombocytopenia', 'XDH', 'Trifluoperazine']",0.5
14913,33632.0,Trifluoperazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'positive regulation of multicellular organism growth', 'DRD2', 'Trifluoperazine']",0.5
14913,35565.0,Trifluoperazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Trifluoperazine']",0.5
14913,35641.0,Trifluoperazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Trifluoperazine']",0.5
14913,35641.0,Trifluoperazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Trifluoperazine']",0.5
14913,36104.0,Trifluoperazine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Trifluoperazine']",0.5
14913,36229.0,Trifluoperazine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Trifluoperazine']",0.5
14913,36242.0,Trifluoperazine,fatty liver disease,disease-protein-drug,contraindication,"['fatty liver disease', 'CYP1A2', 'Trifluoperazine']",0.5
14913,36242.0,Trifluoperazine,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'DRD2', 'Trifluoperazine']",0.5
14913,37765.0,Trifluoperazine,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'ADRA1A', 'Trifluoperazine']",0.5
14913,83998.0,Trifluoperazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Trifluoperazine']",0.5
14914,27626.0,Procarbazine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'XDH', 'Procarbazine']",0.5
14914,29118.0,Procarbazine,acquired polycythemia vera,disease-phenotype-protein-drug,off-label use,"['acquired polycythemia vera', 'Thrombocytopenia', 'XDH', 'Procarbazine']",0.5
14914,30035.0,Procarbazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Procarbazine']",0.5
14914,35565.0,Procarbazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Procarbazine']",0.5
14918,33605.0,Adenosine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADORA1', 'Adenosine']",0.5
14918,33675.0,Adenosine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'ADORA1', 'Adenosine']",0.5
14918,33675.0,Adenosine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'ADORA2B', 'Adenosine']",0.5
14918,35897.0,Adenosine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'apoptotic process', 'ADORA2A', 'Adenosine']",0.5
14918,36080.0,Adenosine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'ADORA1', 'Adenosine']",0.5
14918,36080.0,Adenosine,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'ADORA2B', 'Adenosine']",0.5
14918,36187.0,Adenosine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Adenosine']",0.5
14918,36187.0,Adenosine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'ADORA2B', 'Adenosine']",0.5
14918,37617.0,Adenosine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Adenosine']",0.5
14918,37617.0,Adenosine,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'ADORA2B', 'Adenosine']",0.5
14919,33632.0,Nelarabine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'negative regulation of inflammatory response', 'ADA', 'Nelarabine']",0.5
14919,35757.0,Nelarabine,learning disability,disease-exposure-bioprocess-gene-drug,contraindication,"['learning disability', 'Arsenic', 'DNA repair', 'POLA1', 'Nelarabine']",0.5
14921,33594.0,Aspartic acid,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'gene expression', 'SLC1A1', 'Aspartic acid']",0.5
14921,35764.0,Aspartic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'gene expression', 'SLC1A1', 'Aspartic acid']",0.5
14921,35764.0,Aspartic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'GOT1', 'Aspartic acid']",0.5
14924,29113.0,Diazoxide,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'KCNJ11', 'Diazoxide']",0.5
14924,29113.0,Diazoxide,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'KCNJ11', 'Diazoxide']",0.5
14924,30471.0,Diazoxide,"hyperinsulinemic hypoglycemia, familial",disease-protein-drug,indication,"['hyperinsulinemic hypoglycemia, familial', 'KCNJ11', 'Diazoxide']",0.5
14924,32272.0,Diazoxide,pancreatic insulin-producing neuroendocrine tumor,disease-phenotype-protein-drug,indication,"['pancreatic insulin-producing neuroendocrine tumor', 'Increased body weight', 'KCNMA1', 'Diazoxide']",0.5
14924,33575.0,Diazoxide,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'KCNJ11', 'Diazoxide']",0.5
14924,33575.0,Diazoxide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'KCNJ11', 'Diazoxide']",0.5
14924,35565.0,Diazoxide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'regulation of blood pressure', 'ATP1A1', 'Diazoxide']",0.5
14924,35764.0,Diazoxide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ATP1A1', 'Diazoxide']",0.5
14924,35909.0,Diazoxide,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'regulation of blood pressure', 'ATP1A1', 'Diazoxide']",0.5
14924,36187.0,Diazoxide,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ATP1A1', 'Diazoxide']",0.5
14924,36187.0,Diazoxide,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'ATP1A1', 'Diazoxide']",0.5
14924,38720.0,Diazoxide,hyperinsulinemic hypoglycemia,disease-protein-drug,indication,"['hyperinsulinemic hypoglycemia', 'KCNJ11', 'Diazoxide']",0.5
14924,38889.0,Diazoxide,congenital isolated hyperinsulinism,disease-protein-drug,indication,"['congenital isolated hyperinsulinism', 'KCNJ11', 'Diazoxide']",0.5
14924,83764.0,Diazoxide,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'regulation of blood pressure', 'ATP1A1', 'Diazoxide']",0.5
14926,35583.0,Paricalcitol,phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'CYP24A1', 'Paricalcitol']",0.5
14926,38682.0,Paricalcitol,nephrocalcinosis,disease-protein-drug,contraindication,"['nephrocalcinosis', 'CYP24A1', 'Paricalcitol']",0.5
14932,35669.0,Proline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'platelet aggregation', 'PPIA', 'Proline']",0.5
14932,35761.0,Proline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'platelet aggregation', 'PPIA', 'Proline']",0.5
14932,35764.0,Proline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cellular response to oxidative stress', 'PYCR1', 'Proline']",0.5
14932,36040.0,Proline,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'cellular response to oxidative stress', 'PYCR1', 'Proline']",0.5
14932,83923.0,Proline,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'platelet activation', 'PPIA', 'Proline']",0.5
14934,27476.0,Cyclosporine,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Cyclosporine']",0.5
14934,27476.0,Cyclosporine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Cyclosporine']",0.5
14934,28764.0,Cyclosporine,Sjogren syndrome,disease-phenotype-protein-drug,indication,"['Sjogren syndrome', 'Seizure', 'ABCC2', 'Cyclosporine']",0.5
14934,29078.0,Cyclosporine,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Cyclosporine']",0.5
14934,29078.0,Cyclosporine,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Cyclosporine']",0.5
14934,31072.0,Cyclosporine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'ABCB1', 'Cyclosporine']",0.5
14934,32520.0,Cyclosporine,graft versus host disease,disease-phenotype-protein-drug,off-label use,"['graft versus host disease', 'Vomiting', 'ABCB1', 'Cyclosporine']",0.5
14934,33440.0,Cyclosporine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Coma', 'CYP2D6', 'Cyclosporine']",0.5
14934,33577.0,Cyclosporine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Cyclosporine']",0.5
14934,33577.0,Cyclosporine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Cyclosporine']",0.5
14934,33581.0,Cyclosporine,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'regulation of gene expression', 'SLC10A1', 'Cyclosporine']",0.5
14934,33672.0,Cyclosporine,neoplasm (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['neoplasm (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Cyclosporine']",0.5
14934,33695.0,Cyclosporine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Cyclosporine']",0.5
14934,35565.0,Cyclosporine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Cyclosporine']",0.5
14934,35641.0,Cyclosporine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Cyclosporine']",0.5
14934,35764.0,Cyclosporine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Cyclosporine']",0.5
14934,35916.0,Cyclosporine,dry eye syndrome,disease-exposure-bioprocess-gene-drug,indication,"['dry eye syndrome', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Cyclosporine']",0.5
14934,36035.0,Cyclosporine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Cyclosporine']",0.5
14934,36425.0,Cyclosporine,primary central nervous system lymphoma,disease-protein-drug,contraindication,"['primary central nervous system lymphoma', 'ABCB1', 'Cyclosporine']",0.5
14934,36645.0,Cyclosporine,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Cyclosporine']",0.5
14934,38312.0,Cyclosporine,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Cyclosporine']",0.5
14934,83802.0,Cyclosporine,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Cyclosporine']",0.5
14934,83802.0,Cyclosporine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'SLC10A1', 'Cyclosporine']",0.5
14935,27326.0,Fluconazole,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Fluconazole']",0.5
14935,35565.0,Fluconazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Fluconazole']",0.5
14935,35764.0,Fluconazole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Fluconazole']",0.5
14936,27326.0,Erythromycin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Erythromycin']",0.5
14936,27326.0,Erythromycin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of ventricular cardiac muscle cell membrane repolarization', 'KCNH2', 'Erythromycin']",0.5
14936,27655.0,Erythromycin,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Erythromycin']",0.5
14936,27655.0,Erythromycin,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Erythromycin']",0.5
14936,31650.0,Erythromycin,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ABCC2', 'Erythromycin']",0.5
14936,32710.0,Erythromycin,inhalational anthrax,disease-phenotype-protein-drug,off-label use,"['inhalational anthrax', 'Vomiting', 'ABCB1', 'Erythromycin']",0.5
14936,32729.0,Erythromycin,botulism,disease-phenotype-protein-drug,off-label use,"['botulism', 'Arrhythmia', 'KCNH2', 'Erythromycin']",0.5
14936,32949.0,Erythromycin,relapsing fever,disease-phenotype-protein-drug,off-label use,"['relapsing fever', 'Vomiting', 'ABCB1', 'Erythromycin']",0.5
14936,32950.0,Erythromycin,Lyme disease,disease-phenotype-protein-drug,off-label use,"['Lyme disease', 'Arrhythmia', 'KCNH2', 'Erythromycin']",0.5
14936,32977.0,Erythromycin,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ABCC2', 'Erythromycin']",0.5
14936,33297.0,Erythromycin,listeriosis,disease-phenotype-protein-drug,indication,"['listeriosis', 'Nausea', 'ABCB1', 'Erythromycin']",0.5
14936,33314.0,Erythromycin,leptospirosis,disease-phenotype-protein-drug,off-label use,"['leptospirosis', 'Arrhythmia', 'KCNH2', 'Erythromycin']",0.5
14936,35565.0,Erythromycin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Erythromycin']",0.5
14936,35764.0,Erythromycin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Erythromycin']",0.5
14936,83751.0,Erythromycin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Erythromycin']",0.5
14937,28052.0,Sildenafil,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Cardiomegaly', 'CYP2E1', 'Sildenafil']",0.5
14937,28921.0,Sildenafil,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Cardiomegaly', 'CYP2E1', 'Sildenafil']",0.5
14937,30494.0,Sildenafil,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,contraindication,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Sildenafil']",0.5
14937,33598.0,Sildenafil,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Sildenafil']",0.5
14937,33598.0,Sildenafil,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Sildenafil']",0.5
14937,33635.0,Sildenafil,leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['leukemia (disease)', 'Cadmium', 'visual perception', 'PDE6H', 'Sildenafil']",0.5
14937,33635.0,Sildenafil,leukemia (disease),disease-exposure-gene-drug,contraindication,"['leukemia (disease)', 'Pesticides', 'CYP2E1', 'Sildenafil']",0.5
14937,35909.0,Sildenafil,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'triglyceride metabolic process', 'CYP2E1', 'Sildenafil']",0.5
14937,37180.0,Sildenafil,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Sildenafil']",0.5
14937,37180.0,Sildenafil,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'CYP2E1', 'Sildenafil']",0.5
14937,37604.0,Sildenafil,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,indication,"['erectile dysfunction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Sildenafil']",0.5
14937,83995.0,Sildenafil,psychologic dyspareunia,disease-protein-drug,indication,"['psychologic dyspareunia', 'CYP2D6', 'Sildenafil']",0.5
14937,83996.0,Sildenafil,premature ejaculation (disease),disease-protein-drug,indication,"['premature ejaculation (disease)', 'CYP2D6', 'Sildenafil']",0.5
14938,27933.0,Reserpine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Reserpine']",0.5
14938,27933.0,Reserpine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'response to oxidative stress', 'ABCC2', 'Reserpine']",0.5
14938,28158.0,Reserpine,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Reserpine']",0.5
14938,28158.0,Reserpine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'ABCC2', 'Reserpine']",0.5
14938,28158.0,Reserpine,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Reserpine']",0.5
14938,28208.0,Reserpine,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Reserpine']",0.5
14938,29182.0,Reserpine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'BIRC5', 'Reserpine']",0.5
14938,29182.0,Reserpine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'ABCC2', 'Reserpine']",0.5
14938,31072.0,Reserpine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'ABCB1', 'Reserpine']",0.5
14938,33534.0,Reserpine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'ABCC2', 'Reserpine']",0.5
14938,33575.0,Reserpine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Reserpine']",0.5
14938,33577.0,Reserpine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Reserpine']",0.5
14938,33577.0,Reserpine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Reserpine']",0.5
14938,33598.0,Reserpine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'BIRC5', 'Reserpine']",0.5
14938,33695.0,Reserpine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Reserpine']",0.5
14938,35565.0,Reserpine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Reserpine']",0.5
14938,35641.0,Reserpine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Reserpine']",0.5
14938,35764.0,Reserpine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Reserpine']",0.5
14938,35909.0,Reserpine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Reserpine']",0.5
14938,35915.0,Reserpine,mental disorder,disease-exposure-bioprocess-gene-drug,indication,"['mental disorder', 'Asbestos', 'inflammatory response', 'ABCC2', 'Reserpine']",0.5
14938,36035.0,Reserpine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Reserpine']",0.5
14938,36187.0,Reserpine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'BIRC5', 'Reserpine']",0.5
14938,37703.0,Reserpine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'SLC18A1', 'Reserpine']",0.5
14938,37785.0,Reserpine,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Reserpine']",0.5
14938,37785.0,Reserpine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Reserpine']",0.5
14938,83760.0,Reserpine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'SLC18A1', 'Reserpine']",0.5
14938,83778.0,Reserpine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizophreniform disorder', 'Asbestos', 'inflammatory response', 'ABCC2', 'Reserpine']",0.5
14938,83779.0,Reserpine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizoaffective disorder', 'Asbestos', 'inflammatory response', 'ABCC2', 'Reserpine']",0.5
14938,83802.0,Reserpine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Reserpine']",0.5
14939,27361.0,Indinavir,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'ABCC2', 'Indinavir']",0.5
14939,27476.0,Indinavir,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Indinavir']",0.5
14939,27476.0,Indinavir,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Indinavir']",0.5
14939,33575.0,Indinavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Indinavir']",0.5
14939,33695.0,Indinavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Indinavir']",0.5
14939,35565.0,Indinavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Indinavir']",0.5
14939,36645.0,Indinavir,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Indinavir']",0.5
14939,38312.0,Indinavir,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'ABCC2', 'Indinavir']",0.5
14940,27559.0,Lidocaine,dilated cardiomyopathy,disease-protein-drug,contraindication,"['dilated cardiomyopathy', 'EGFR', 'Lidocaine']",0.5
14940,27559.0,Lidocaine,dilated cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['dilated cardiomyopathy', 'Sudden death', 'SCN10A', 'Lidocaine']",0.5
14940,27669.0,Lidocaine,familial dilated cardiomyopathy,disease-protein-drug,contraindication,"['familial dilated cardiomyopathy', 'SCN5A', 'Lidocaine']",0.5
14940,27669.0,Lidocaine,familial dilated cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['familial dilated cardiomyopathy', 'Arrhythmia', 'SLC22A5', 'Lidocaine']",0.5
14940,28547.0,Lidocaine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Lidocaine']",0.5
14940,28547.0,Lidocaine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Lidocaine']",0.5
14940,28547.0,Lidocaine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Lidocaine']",0.5
14940,29113.0,Lidocaine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'EGFR', 'Lidocaine']",0.5
14940,29525.0,Lidocaine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Lidocaine']",0.5
14940,29614.0,Lidocaine,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Lidocaine']",0.5
14940,29617.0,Lidocaine,atrioventricular dissociation (disease),disease-protein-drug,contraindication,"['atrioventricular dissociation (disease)', 'SCN10A', 'Lidocaine']",0.5
14940,29709.0,Lidocaine,"dermatitis, atopic",disease-phenotype-protein-drug,contraindication,"['dermatitis, atopic', 'Pruritus', 'SCN9A', 'Lidocaine']",0.5
14940,30035.0,Lidocaine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Lidocaine']",0.5
14940,30813.0,Lidocaine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Lidocaine']",0.5
14940,32712.0,Lidocaine,histiocytoid cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['histiocytoid cardiomyopathy', 'Hepatomegaly', 'CYP1A2', 'Lidocaine']",0.5
14940,32719.0,Lidocaine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'SLC22A5', 'Lidocaine']",0.5
14940,33440.0,Lidocaine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Arrhythmia', 'SLC22A5', 'Lidocaine']",0.5
14940,33575.0,Lidocaine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'EGFR', 'Lidocaine']",0.5
14940,33575.0,Lidocaine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ORM1', 'Lidocaine']",0.5
14940,33577.0,Lidocaine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Lidocaine']",0.5
14940,33577.0,Lidocaine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Lidocaine']",0.5
14940,33586.0,Lidocaine,atrioventricular block (disease),disease-protein-drug,contraindication,"['atrioventricular block (disease)', 'SCN5A', 'Lidocaine']",0.5
14940,33618.0,Lidocaine,atrial fibrillation (disease),disease-protein-drug,contraindication,"['atrial fibrillation (disease)', 'SCN10A', 'Lidocaine']",0.5
14940,33618.0,Lidocaine,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Lidocaine']",0.5
14940,33632.0,Lidocaine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Lidocaine']",0.5
14940,35565.0,Lidocaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Lidocaine']",0.5
14940,35641.0,Lidocaine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Lidocaine']",0.5
14940,35641.0,Lidocaine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'learning or memory', 'EGFR', 'Lidocaine']",0.5
14940,35669.0,Lidocaine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A5', 'Lidocaine']",0.5
14940,35669.0,Lidocaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Lidocaine']",0.5
14940,35761.0,Lidocaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'ORM1', 'Lidocaine']",0.5
14940,35764.0,Lidocaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Lidocaine']",0.5
14940,35915.0,Lidocaine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Lidocaine']",0.5
14940,36034.0,Lidocaine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'EGFR', 'Lidocaine']",0.5
14940,36035.0,Lidocaine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Lidocaine']",0.5
14940,36080.0,Lidocaine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Lidocaine']",0.5
14940,36129.0,Lidocaine,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Lidocaine']",0.5
14940,36187.0,Lidocaine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Lidocaine']",0.5
14940,36469.0,Lidocaine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'EGFR', 'Lidocaine']",0.5
14940,36644.0,Lidocaine,skin disease,disease-exposure-bioprocess-gene-drug,contraindication,"['skin disease', 'Mustard Gas', 'regulation of gene expression', 'CYP1A2', 'Lidocaine']",0.5
14940,36924.0,Lidocaine,dermatitis,disease-protein-drug,indication,"['dermatitis', 'EGFR', 'Lidocaine']",0.5
14940,37180.0,Lidocaine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Lidocaine']",0.5
14940,37765.0,Lidocaine,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'CYP1A2', 'Lidocaine']",0.5
14940,39531.0,Lidocaine,liver failure,disease-protein-drug,contraindication,"['liver failure', 'ORM1', 'Lidocaine']",0.5
14940,39798.0,Lidocaine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Lidocaine']",0.5
14940,83778.0,Lidocaine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Lidocaine']",0.5
14940,83779.0,Lidocaine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Lidocaine']",0.5
14940,83945.0,Lidocaine,obsolete heart block,disease-protein-drug,contraindication,"['obsolete heart block', 'SCN10A', 'Lidocaine']",0.5
14940,83995.0,Lidocaine,psychologic dyspareunia,disease-protein-drug,indication,"['psychologic dyspareunia', 'CYP2D6', 'Lidocaine']",0.5
14940,83996.0,Lidocaine,premature ejaculation (disease),disease-protein-drug,indication,"['premature ejaculation (disease)', 'CYP2D6', 'Lidocaine']",0.5
14940,84192.0,Lidocaine,postherpetic neuralgia,disease-protein-drug,indication,"['postherpetic neuralgia', 'SCN9A', 'Lidocaine']",0.5
14941,28208.0,Amcinonide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Zinc', 'inflammatory response', 'ANXA1', 'Amcinonide']",0.5
14941,28552.0,Amcinonide,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'insulin secretion', 'ANXA1', 'Amcinonide']",0.5
14941,33575.0,Amcinonide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'ANXA1', 'Amcinonide']",0.5
14941,36129.0,Amcinonide,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Amcinonide']",0.5
14941,39798.0,Amcinonide,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Amcinonide']",0.5
14942,29113.0,Terfenadine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Terfenadine']",0.5
14942,33575.0,Terfenadine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Terfenadine']",0.5
14942,33577.0,Terfenadine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Terfenadine']",0.5
14942,33577.0,Terfenadine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Terfenadine']",0.5
14942,33603.0,Terfenadine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Terfenadine']",0.5
14942,35953.0,Terfenadine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Terfenadine']",0.5
14942,35953.0,Terfenadine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'cognition', 'CHRM1', 'Terfenadine']",0.5
14942,36034.0,Terfenadine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Terfenadine']",0.5
14942,36035.0,Terfenadine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Terfenadine']",0.5
14942,36187.0,Terfenadine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Terfenadine']",0.5
14942,83791.0,Terfenadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Terfenadine']",0.5
14943,27933.0,Levonorgestrel,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'AR', 'Levonorgestrel']",0.5
14943,27933.0,Levonorgestrel,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,27933.0,Levonorgestrel,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PGR', 'Levonorgestrel']",0.5
14943,28651.0,Levonorgestrel,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ESR1', 'Levonorgestrel']",0.5
14943,29061.0,Levonorgestrel,endometriosis of uterus,disease-protein-drug,off-label use,"['endometriosis of uterus', 'SRD5A1', 'Levonorgestrel']",0.5
14943,29113.0,Levonorgestrel,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Levonorgestrel']",0.5
14943,29182.0,Levonorgestrel,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Levonorgestrel']",0.5
14943,29614.0,Levonorgestrel,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Levonorgestrel']",0.5
14943,29614.0,Levonorgestrel,osteoporosis,disease-exposure-gene-drug,indication,"['osteoporosis', 'Polychlorinated Biphenyls', 'SHBG', 'Levonorgestrel']",0.5
14943,29646.0,Levonorgestrel,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'AR', 'Levonorgestrel']",0.5
14943,29646.0,Levonorgestrel,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,29646.0,Levonorgestrel,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'PGR', 'Levonorgestrel']",0.5
14943,30756.0,Levonorgestrel,polycystic ovary syndrome,disease-protein-drug,off-label use,"['polycystic ovary syndrome', 'SRD5A1', 'Levonorgestrel']",0.5
14943,30827.0,Levonorgestrel,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Levonorgestrel']",0.5
14943,31107.0,Levonorgestrel,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,31477.0,Levonorgestrel,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Levonorgestrel']",0.5
14943,31596.0,Levonorgestrel,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Levonorgestrel']",0.5
14943,32617.0,Levonorgestrel,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'AR', 'Levonorgestrel']",0.5
14943,33575.0,Levonorgestrel,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SHBG', 'Levonorgestrel']",0.5
14943,33575.0,Levonorgestrel,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,33575.0,Levonorgestrel,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Levonorgestrel']",0.5
14943,33575.0,Levonorgestrel,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Levonorgestrel']",0.5
14943,33577.0,Levonorgestrel,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Levonorgestrel']",0.5
14943,33577.0,Levonorgestrel,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Levonorgestrel']",0.5
14943,33577.0,Levonorgestrel,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Levonorgestrel']",0.5
14943,33593.0,Levonorgestrel,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Levonorgestrel']",0.5
14943,33593.0,Levonorgestrel,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'spermatogenesis', 'AR', 'Levonorgestrel']",0.5
14943,33593.0,Levonorgestrel,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'SHBG', 'Levonorgestrel']",0.5
14943,33598.0,Levonorgestrel,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Levonorgestrel']",0.5
14943,33598.0,Levonorgestrel,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'SHBG', 'Levonorgestrel']",0.5
14943,33632.0,Levonorgestrel,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,33635.0,Levonorgestrel,leukemia (disease),disease-protein-drug,contraindication,"['leukemia (disease)', 'AR', 'Levonorgestrel']",0.5
14943,33635.0,Levonorgestrel,leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['leukemia (disease)', 'Pesticides', 'spermatogenesis', 'AR', 'Levonorgestrel']",0.5
14943,33675.0,Levonorgestrel,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,33675.0,Levonorgestrel,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'PGR', 'Levonorgestrel']",0.5
14943,33680.0,Levonorgestrel,endometriosis (disease),disease-protein-drug,off-label use,"['endometriosis (disease)', 'SRD5A1', 'Levonorgestrel']",0.5
14943,33680.0,Levonorgestrel,endometriosis (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Levonorgestrel']",0.5
14943,33680.0,Levonorgestrel,endometriosis (disease),disease-exposure-gene-drug,off-label use,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Levonorgestrel']",0.5
14943,33695.0,Levonorgestrel,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Levonorgestrel']",0.5
14943,33699.0,Levonorgestrel,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,35565.0,Levonorgestrel,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Levonorgestrel']",0.5
14943,35738.0,Levonorgestrel,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Levonorgestrel']",0.5
14943,35739.0,Levonorgestrel,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Levonorgestrel']",0.5
14943,35764.0,Levonorgestrel,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Levonorgestrel']",0.5
14943,35764.0,Levonorgestrel,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Levonorgestrel']",0.5
14943,35901.0,Levonorgestrel,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Levonorgestrel']",0.5
14943,35901.0,Levonorgestrel,leiomyoma,disease-exposure-gene-drug,contraindication,"['leiomyoma', 'monobutyl phthalate', 'SHBG', 'Levonorgestrel']",0.5
14943,35909.0,Levonorgestrel,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Levonorgestrel']",0.5
14943,35958.0,Levonorgestrel,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Levonorgestrel']",0.5
14943,36035.0,Levonorgestrel,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Levonorgestrel']",0.5
14943,36187.0,Levonorgestrel,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Levonorgestrel']",0.5
14943,36187.0,Levonorgestrel,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,36187.0,Levonorgestrel,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Levonorgestrel']",0.5
14943,36469.0,Levonorgestrel,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Levonorgestrel']",0.5
14943,36527.0,Levonorgestrel,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Levonorgestrel']",0.5
14943,36634.0,Levonorgestrel,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'AR', 'Levonorgestrel']",0.5
14943,36634.0,Levonorgestrel,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Levonorgestrel']",0.5
14943,36634.0,Levonorgestrel,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'PGR', 'Levonorgestrel']",0.5
14943,36792.0,Levonorgestrel,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Levonorgestrel']",0.5
14943,36794.0,Levonorgestrel,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Levonorgestrel']",0.5
14943,37038.0,Levonorgestrel,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Levonorgestrel']",0.5
14943,37047.0,Levonorgestrel,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Levonorgestrel']",0.5
14943,37082.0,Levonorgestrel,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Levonorgestrel']",0.5
14943,37150.0,Levonorgestrel,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Levonorgestrel']",0.5
14943,37152.0,Levonorgestrel,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Levonorgestrel']",0.5
14943,37423.0,Levonorgestrel,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Levonorgestrel']",0.5
14943,37466.0,Levonorgestrel,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Levonorgestrel']",0.5
14943,37573.0,Levonorgestrel,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Levonorgestrel']",0.5
14943,37703.0,Levonorgestrel,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'SRD5A1', 'Levonorgestrel']",0.5
14943,37768.0,Levonorgestrel,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Levonorgestrel']",0.5
14943,37967.0,Levonorgestrel,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Levonorgestrel']",0.5
14943,39603.0,Levonorgestrel,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Levonorgestrel']",0.5
14943,39615.0,Levonorgestrel,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Levonorgestrel']",0.5
14943,83760.0,Levonorgestrel,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'SRD5A1', 'Levonorgestrel']",0.5
14943,83816.0,Levonorgestrel,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Levonorgestrel']",0.5
14943,83817.0,Levonorgestrel,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Levonorgestrel']",0.5
14943,83818.0,Levonorgestrel,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Levonorgestrel']",0.5
14943,83819.0,Levonorgestrel,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Levonorgestrel']",0.5
14943,83820.0,Levonorgestrel,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Levonorgestrel']",0.5
14943,83821.0,Levonorgestrel,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Levonorgestrel']",0.5
14943,83822.0,Levonorgestrel,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Levonorgestrel']",0.5
14943,83823.0,Levonorgestrel,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Levonorgestrel']",0.5
14943,83824.0,Levonorgestrel,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Levonorgestrel']",0.5
14944,28208.0,Amlodipine,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Amlodipine']",0.5
14944,28208.0,Amlodipine,type 2 diabetes mellitus,disease-exposure-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Agent Orange', 'CYP1A1', 'Amlodipine']",0.5
14944,28441.0,Amlodipine,hereditary angioedema with C1Inh deficiency,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema with C1Inh deficiency', 'Vomiting', 'ABCB1', 'Amlodipine']",0.5
14944,29182.0,Amlodipine,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Amlodipine']",0.5
14944,29182.0,Amlodipine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'CACNA1B', 'Amlodipine']",0.5
14944,29854.0,Amlodipine,hereditary angioedema,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Amlodipine']",0.5
14944,30035.0,Amlodipine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Amlodipine']",0.5
14944,31033.0,Amlodipine,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'CYP1A1', 'Amlodipine']",0.5
14944,32629.0,Amlodipine,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'CYP1A1', 'Amlodipine']",0.5
14944,32719.0,Amlodipine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'CACNA1C', 'Amlodipine']",0.5
14944,33025.0,Amlodipine,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Hepatomegaly', 'CYP1A1', 'Amlodipine']",0.5
14944,33534.0,Amlodipine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'CACNA1B', 'Amlodipine']",0.5
14944,33575.0,Amlodipine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Amlodipine']",0.5
14944,33575.0,Amlodipine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Amlodipine']",0.5
14944,33577.0,Amlodipine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Amlodipine']",0.5
14944,33577.0,Amlodipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Amlodipine']",0.5
14944,33577.0,Amlodipine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Amlodipine']",0.5
14944,33612.0,Amlodipine,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Amlodipine']",0.5
14944,35565.0,Amlodipine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Amlodipine']",0.5
14944,35565.0,Amlodipine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Amlodipine']",0.5
14944,35764.0,Amlodipine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Amlodipine']",0.5
14944,35764.0,Amlodipine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Amlodipine']",0.5
14944,35909.0,Amlodipine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Amlodipine']",0.5
14944,36035.0,Amlodipine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Amlodipine']",0.5
14944,36104.0,Amlodipine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Amlodipine']",0.5
14944,36229.0,Amlodipine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Amlodipine']",0.5
14944,36469.0,Amlodipine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'DDT', 'DNA methylation', 'CYP1A1', 'Amlodipine']",0.5
14944,83802.0,Amlodipine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Amlodipine']",0.5
14945,27626.0,Sorafenib,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'KIT', 'Sorafenib']",0.5
14945,27933.0,Sorafenib,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Sorafenib']",0.5
14945,27933.0,Sorafenib,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'stem cell population maintenance', 'KIT', 'Sorafenib']",0.5
14945,28640.0,Sorafenib,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'FLT4', 'Sorafenib']",0.5
14945,29646.0,Sorafenib,hepatocellular carcinoma,disease-protein-drug,indication,"['hepatocellular carcinoma', 'ABCB1', 'Sorafenib']",0.5
14945,29646.0,Sorafenib,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['hepatocellular carcinoma', 'Air Pollutants', 'respiratory system process', 'FLT4', 'Sorafenib']",0.5
14945,29646.0,Sorafenib,hepatocellular carcinoma,disease-phenotype-protein-drug,indication,"['hepatocellular carcinoma', 'Hepatomegaly', 'CYP1A2', 'Sorafenib']",0.5
14945,30749.0,Sorafenib,thyroid gland carcinoma,disease-protein-drug,indication,"['thyroid gland carcinoma', 'FLT1', 'Sorafenib']",0.5
14945,30749.0,Sorafenib,thyroid gland carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['thyroid gland carcinoma', 'perfluorooctanoic acid', 'respiratory system process', 'FLT4', 'Sorafenib']",0.5
14945,32621.0,Sorafenib,pediatric hepatocellular carcinoma,disease-protein-drug,indication,"['pediatric hepatocellular carcinoma', 'ABCB1', 'Sorafenib']",0.5
14945,32621.0,Sorafenib,pediatric hepatocellular carcinoma,disease-phenotype-protein-drug,indication,"['pediatric hepatocellular carcinoma', 'Hepatomegaly', 'CYP1A2', 'Sorafenib']",0.5
14945,33577.0,Sorafenib,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Sorafenib']",0.5
14945,33577.0,Sorafenib,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Sorafenib']",0.5
14945,33625.0,Sorafenib,hypophosphatemia (disease),disease-protein-drug,contraindication,"['hypophosphatemia (disease)', 'FGFR1', 'Sorafenib']",0.5
14945,33632.0,Sorafenib,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Petroleum', 'respiratory system process', 'FLT4', 'Sorafenib']",0.5
14945,33643.0,Sorafenib,renal cell carcinoma (disease),disease-protein-drug,indication,"['renal cell carcinoma (disease)', 'FLT4', 'Sorafenib']",0.5
14945,33643.0,Sorafenib,renal cell carcinoma (disease),disease-exposure-bioprocess-gene-drug,indication,"['renal cell carcinoma (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Sorafenib']",0.5
14945,36035.0,Sorafenib,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Sorafenib']",0.5
14945,36104.0,Sorafenib,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Sorafenib']",0.5
14945,36187.0,Sorafenib,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'RALBP1', 'Sorafenib']",0.5
14945,36187.0,Sorafenib,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'respiratory system process', 'FLT4', 'Sorafenib']",0.5
14945,36229.0,Sorafenib,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Sorafenib']",0.5
14945,36634.0,Sorafenib,liver cancer,disease-protein-drug,indication,"['liver cancer', 'ABCB1', 'Sorafenib']",0.5
14945,36634.0,Sorafenib,liver cancer,disease-exposure-bioprocess-gene-drug,indication,"['liver cancer', 'perfluorooctanoic acid', 'respiratory system process', 'FLT4', 'Sorafenib']",0.5
14945,36935.0,Sorafenib,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'FLT1', 'Sorafenib']",0.5
14945,36937.0,Sorafenib,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'FLT4', 'Sorafenib']",0.5
14945,36999.0,Sorafenib,adenocarcinoma of liver and intrahepatic biliary tract,disease-protein-drug,indication,"['adenocarcinoma of liver and intrahepatic biliary tract', 'ABCB1', 'Sorafenib']",0.5
14945,37115.0,Sorafenib,squamous cell carcinoma of liver and intrahepatic biliary tract,disease-protein-drug,indication,"['squamous cell carcinoma of liver and intrahepatic biliary tract', 'ABCB1', 'Sorafenib']",0.5
14945,37180.0,Sorafenib,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'respiratory system process', 'FLT4', 'Sorafenib']",0.5
14945,37703.0,Sorafenib,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Sorafenib']",0.5
14945,37786.0,Sorafenib,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'RALBP1', 'Sorafenib']",0.5
14945,37786.0,Sorafenib,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'respiratory system process', 'FLT4', 'Sorafenib']",0.5
14945,83760.0,Sorafenib,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Sorafenib']",0.5
14945,83869.0,Sorafenib,fibrolamellar hepatocellular carcinoma,disease-protein-drug,indication,"['fibrolamellar hepatocellular carcinoma', 'ABCB1', 'Sorafenib']",0.5
14945,83870.0,Sorafenib,undifferentiated carcinoma of liver and intrahepatic biliary tract,disease-protein-drug,indication,"['undifferentiated carcinoma of liver and intrahepatic biliary tract', 'ABCB1', 'Sorafenib']",0.5
14946,33577.0,Nisoldipine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Nisoldipine']",0.5
14946,33577.0,Nisoldipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'visual perception', 'CACNB2', 'Nisoldipine']",0.5
14946,33577.0,Nisoldipine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'CACNA2D1', 'Nisoldipine']",0.5
14946,35953.0,Nisoldipine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'regulation of heart rate by cardiac conduction', 'CACNA1C', 'Nisoldipine']",0.5
14946,35953.0,Nisoldipine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'CACNA2D1', 'Nisoldipine']",0.5
14946,36035.0,Nisoldipine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Nisoldipine']",0.5
14946,36187.0,Nisoldipine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of heart rate by cardiac conduction', 'CACNA1C', 'Nisoldipine']",0.5
14946,36187.0,Nisoldipine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CACNA2D1', 'Nisoldipine']",0.5
14947,33612.0,Cerivastatin,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Cerivastatin']",0.5
14947,35565.0,Cerivastatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Cerivastatin']",0.5
14947,35764.0,Cerivastatin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'HMGCR', 'Cerivastatin']",0.5
14947,83898.0,Cerivastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Cerivastatin']",0.5
14948,30654.0,Teniposide,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Teniposide']",0.5
14948,33188.0,Teniposide,neuroblastoma,disease-protein-drug,off-label use,"['neuroblastoma', 'TOP2A', 'Teniposide']",0.5
14948,33621.0,Teniposide,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'cellular response to DNA damage stimulus', 'TOP2A', 'Teniposide']",0.5
14948,35565.0,Teniposide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Teniposide']",0.5
14948,35764.0,Teniposide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'visual perception', 'ABCC6', 'Teniposide']",0.5
14948,83769.0,Teniposide,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Teniposide']",0.5
14949,33632.0,Chloramphenicol,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Chloramphenicol']",0.5
14949,35565.0,Chloramphenicol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Chloramphenicol']",0.5
14949,35764.0,Chloramphenicol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Chloramphenicol']",0.5
14950,31395.0,Loratadine,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Loratadine']",0.5
14950,33575.0,Loratadine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Loratadine']",0.5
14950,33575.0,Loratadine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Loratadine']",0.5
14950,33575.0,Loratadine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Loratadine']",0.5
14950,33603.0,Loratadine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Loratadine']",0.5
14950,35565.0,Loratadine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Loratadine']",0.5
14950,35565.0,Loratadine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Loratadine']",0.5
14950,35764.0,Loratadine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Loratadine']",0.5
14950,35764.0,Loratadine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Loratadine']",0.5
14950,35953.0,Loratadine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Loratadine']",0.5
14950,35953.0,Loratadine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Loratadine']",0.5
14950,35953.0,Loratadine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'CYP1A1', 'Loratadine']",0.5
14950,36034.0,Loratadine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Loratadine']",0.5
14950,36035.0,Loratadine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Loratadine']",0.5
14950,36091.0,Loratadine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'CYP1A1', 'Loratadine']",0.5
14950,36187.0,Loratadine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Loratadine']",0.5
14950,36187.0,Loratadine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Loratadine']",0.5
14950,37888.0,Loratadine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Loratadine']",0.5
14950,37888.0,Loratadine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Loratadine']",0.5
14950,37888.0,Loratadine,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Loratadine']",0.5
14950,37888.0,Loratadine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'CYP1A1', 'Loratadine']",0.5
14950,83791.0,Loratadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Loratadine']",0.5
14951,27326.0,Quinine,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Quinine']",0.5
14951,27326.0,Quinine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Quinine']",0.5
14951,27326.0,Quinine,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Quinine']",0.5
14951,27326.0,Quinine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Quinine']",0.5
14951,27626.0,Quinine,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'GP9', 'Quinine']",0.5
14951,32638.0,Quinine,babesiosis,disease-phenotype-protein-drug,off-label use,"['babesiosis', 'Hepatomegaly', 'CYP1A1', 'Quinine']",0.5
14951,32886.0,Quinine,typical hemolytic-uremic syndrome,disease-phenotype-protein-drug,contraindication,"['typical hemolytic-uremic syndrome', 'Thrombocytopenia', 'GP9', 'Quinine']",0.5
14951,33128.0,Quinine,malaria,disease-phenotype-protein-drug,indication,"['malaria', 'Thrombocytopenia', 'GP9', 'Quinine']",0.5
14951,33440.0,Quinine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Thrombocytopenia', 'GP9', 'Quinine']",0.5
14951,33618.0,Quinine,atrial fibrillation (disease),disease-protein-drug,contraindication,"['atrial fibrillation (disease)', 'CYP2C19', 'Quinine']",0.5
14951,33618.0,Quinine,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Quinine']",0.5
14951,35565.0,Quinine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Quinine']",0.5
14951,35565.0,Quinine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Quinine']",0.5
14951,36040.0,Quinine,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'CYP2C19', 'Quinine']",0.5
14951,36040.0,Quinine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Quinine']",0.5
14951,83751.0,Quinine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Quinine']",0.5
14951,83923.0,Quinine,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'CYP2C19', 'Quinine']",0.5
14951,83923.0,Quinine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Quinine']",0.5
14951,83924.0,Quinine,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'CYP2C19', 'Quinine']",0.5
14952,27326.0,Haloperidol,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Haloperidol']",0.5
14952,27326.0,Haloperidol,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Haloperidol']",0.5
14952,27326.0,Haloperidol,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Haloperidol']",0.5
14952,27326.0,Haloperidol,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Haloperidol']",0.5
14952,27645.0,Haloperidol,torsion dystonia,disease-phenotype-protein-drug,contraindication,"['torsion dystonia', 'Action tremor', 'CYP2D6', 'Haloperidol']",0.5
14952,27655.0,Haloperidol,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Haloperidol']",0.5
14952,27740.0,Haloperidol,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Haloperidol']",0.5
14952,28313.0,Haloperidol,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'MCHR1', 'Haloperidol']",0.5
14952,28313.0,Haloperidol,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Haloperidol']",0.5
14952,28547.0,Haloperidol,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Haloperidol']",0.5
14952,28547.0,Haloperidol,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Haloperidol']",0.5
14952,28547.0,Haloperidol,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Pesticides', 'CYP1A1', 'Haloperidol']",0.5
14952,28547.0,Haloperidol,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Haloperidol']",0.5
14952,28780.0,Haloperidol,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Haloperidol']",0.5
14952,28780.0,Haloperidol,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'DRD3', 'Haloperidol']",0.5
14952,28780.0,Haloperidol,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP1A1', 'Haloperidol']",0.5
14952,28780.0,Haloperidol,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Haloperidol']",0.5
14952,29352.0,Haloperidol,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Fever', 'HTR1A', 'Haloperidol']",0.5
14952,29494.0,Haloperidol,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A1', 'Haloperidol']",0.5
14952,30184.0,Haloperidol,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A1', 'Haloperidol']",0.5
14952,30879.0,Haloperidol,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'DRD1', 'Haloperidol']",0.5
14952,31283.0,Haloperidol,Tourette syndrome,disease-protein-drug,indication,"['Tourette syndrome', 'DRD3', 'Haloperidol']",0.5
14952,31732.0,Haloperidol,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'HTR6', 'Haloperidol']",0.5
14952,33449.0,Haloperidol,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Haloperidol']",0.5
14952,33454.0,Haloperidol,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Haloperidol']",0.5
14952,33605.0,Haloperidol,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Haloperidol']",0.5
14952,35565.0,Haloperidol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Haloperidol']",0.5
14952,35565.0,Haloperidol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Haloperidol']",0.5
14952,35641.0,Haloperidol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Haloperidol']",0.5
14952,35641.0,Haloperidol,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Haloperidol']",0.5
14952,35915.0,Haloperidol,mental disorder,disease-protein-drug,indication,"['mental disorder', 'HTR2A', 'Haloperidol']",0.5
14952,35915.0,Haloperidol,mental disorder,disease-exposure-bioprocess-gene-drug,indication,"['mental disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Haloperidol']",0.5
14952,36104.0,Haloperidol,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Haloperidol']",0.5
14952,36229.0,Haloperidol,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Haloperidol']",0.5
14952,36469.0,Haloperidol,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'DRD3', 'Haloperidol']",0.5
14952,37565.0,Haloperidol,delirium,disease-protein-drug,off-label use,"['delirium', 'DRD3', 'Haloperidol']",0.5
14952,37706.0,Haloperidol,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'SLC18A2', 'Haloperidol']",0.5
14952,38003.0,Haloperidol,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD3', 'Haloperidol']",0.5
14952,83751.0,Haloperidol,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Haloperidol']",0.5
14952,83778.0,Haloperidol,schizophreniform disorder,disease-protein-drug,indication,"['schizophreniform disorder', 'HTR2A', 'Haloperidol']",0.5
14952,83778.0,Haloperidol,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Haloperidol']",0.5
14952,83779.0,Haloperidol,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'HTR2A', 'Haloperidol']",0.5
14952,83779.0,Haloperidol,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Haloperidol']",0.5
14952,83998.0,Haloperidol,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Haloperidol']",0.5
14953,33577.0,Lercanidipine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Lercanidipine']",0.5
14953,33577.0,Lercanidipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Lercanidipine']",0.5
14953,36035.0,Lercanidipine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Lercanidipine']",0.5
14954,30494.0,Cyclophosphamide,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Cyclophosphamide']",0.5
14954,30990.0,Cyclophosphamide,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Hepatomegaly', 'NR1I2', 'Cyclophosphamide']",0.5
14954,35771.0,Cyclophosphamide,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'CYP3A4', 'Cyclophosphamide']",0.5
14954,35771.0,Cyclophosphamide,breast neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['breast neoplasm', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Cyclophosphamide']",0.5
14954,35771.0,Cyclophosphamide,breast neoplasm,disease-exposure-gene-drug,indication,"['breast neoplasm', 'Endocrine Disruptors', 'NR1I2', 'Cyclophosphamide']",0.5
14954,37334.0,Cyclophosphamide,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'CYP3A4', 'Cyclophosphamide']",0.5
14955,27476.0,Vincristine,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Vincristine']",0.5
14955,27476.0,Vincristine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Vincristine']",0.5
14955,27530.0,Vincristine,Charcot-Marie-Tooth disease,disease-phenotype-protein-drug,contraindication,"['Charcot-Marie-Tooth disease', 'Seizure', 'ABCC2', 'Vincristine']",0.5
14955,28830.0,Vincristine,"leukemia, lymphocytic, susceptibility to",disease-protein-drug,indication,"['leukemia, lymphocytic, susceptibility to', 'ABCB1', 'Vincristine']",0.5
14955,29173.0,Vincristine,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'positive regulation of inflammatory response', 'ABCC1', 'Vincristine']",0.5
14955,29993.0,Vincristine,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Hepatomegaly', 'ABCC3', 'Vincristine']",0.5
14955,30494.0,Vincristine,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,off-label use,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Vincristine']",0.5
14955,30654.0,Vincristine,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Vincristine']",0.5
14955,30990.0,Vincristine,mycosis fungoides and variants,disease-phenotype-protein-drug,off-label use,"['mycosis fungoides and variants', 'Hepatomegaly', 'ABCC3', 'Vincristine']",0.5
14955,31033.0,Vincristine,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'ABCC2', 'Vincristine']",0.5
14955,31033.0,Vincristine,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Hepatomegaly', 'ABCC3', 'Vincristine']",0.5
14955,32629.0,Vincristine,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'ABCC2', 'Vincristine']",0.5
14955,32629.0,Vincristine,familial intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'Hepatomegaly', 'ABCC3', 'Vincristine']",0.5
14955,33077.0,Vincristine,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'inflammatory response', 'ABCC2', 'Vincristine']",0.5
14955,33077.0,Vincristine,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'ABCC3', 'Vincristine']",0.5
14955,33188.0,Vincristine,neuroblastoma,disease-protein-drug,indication,"['neuroblastoma', 'ABCB1', 'Vincristine']",0.5
14955,33621.0,Vincristine,acute lymphoblastic leukemia (disease),disease-protein-drug,indication,"['acute lymphoblastic leukemia (disease)', 'ABCB1', 'Vincristine']",0.5
14955,33621.0,Vincristine,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Vincristine']",0.5
14955,35650.0,Vincristine,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Benzene', 'inflammatory response', 'ABCC2', 'Vincristine']",0.5
14955,35884.0,Vincristine,diffuse large B-cell lymphoma,disease-protein-drug,indication,"['diffuse large B-cell lymphoma', 'ABCB1', 'Vincristine']",0.5
14955,35884.0,Vincristine,diffuse large B-cell lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['diffuse large B-cell lymphoma', 'Polychlorinated Biphenyls', 'female pregnancy', 'ABCC2', 'Vincristine']",0.5
14955,36425.0,Vincristine,primary central nervous system lymphoma,disease-protein-drug,indication,"['primary central nervous system lymphoma', 'ABCB1', 'Vincristine']",0.5
14955,36645.0,Vincristine,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Vincristine']",0.5
14955,36983.0,Vincristine,astrocytoma (excluding glioblastoma),disease-exposure-bioprocess-gene-drug,off-label use,"['astrocytoma (excluding glioblastoma)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Vincristine']",0.5
14955,38059.0,Vincristine,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'ABCC2', 'Vincristine']",0.5
14955,38312.0,Vincristine,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Vincristine']",0.5
14955,83769.0,Vincristine,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Vincristine']",0.5
14955,83802.0,Vincristine,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Vincristine']",0.5
14955,83802.0,Vincristine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Vincristine']",0.5
14955,84154.0,Vincristine,"primary cutaneous diffuse large B-cell lymphoma, Leg type",disease-protein-drug,indication,"['primary cutaneous diffuse large B-cell lymphoma, Leg type', 'ABCB1', 'Vincristine']",0.5
14955,84155.0,Vincristine,Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly,disease-protein-drug,indication,"['Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly', 'ABCB1', 'Vincristine']",0.5
14955,84156.0,Vincristine,plasmablastic lymphoma,disease-protein-drug,indication,"['plasmablastic lymphoma', 'ABCB1', 'Vincristine']",0.5
14955,84157.0,Vincristine,diffuse large B-cell lymphoma of the central nervous system,disease-protein-drug,indication,"['diffuse large B-cell lymphoma of the central nervous system', 'ABCB1', 'Vincristine']",0.5
14955,84158.0,Vincristine,T-cell/histiocyte rich large B cell lymphoma,disease-protein-drug,indication,"['T-cell/histiocyte rich large B cell lymphoma', 'ABCB1', 'Vincristine']",0.5
14955,84159.0,Vincristine,ALK-positive large B-cell lymphoma,disease-protein-drug,indication,"['ALK-positive large B-cell lymphoma', 'ABCB1', 'Vincristine']",0.5
14955,84160.0,Vincristine,primary mediastinal large B-cell lymphoma,disease-protein-drug,indication,"['primary mediastinal large B-cell lymphoma', 'ABCB1', 'Vincristine']",0.5
14955,84161.0,Vincristine,intravascular large B-cell lymphoma,disease-protein-drug,indication,"['intravascular large B-cell lymphoma', 'ABCB1', 'Vincristine']",0.5
14956,27843.0,Carbamazepine,acute intermittent porphyria,disease-phenotype-protein-drug,contraindication,"['acute intermittent porphyria', 'Nausea', 'ABCB1', 'Carbamazepine']",0.5
14956,27921.0,Carbamazepine,attention deficit-hyperactivity disorder,disease-protein-drug,off-label use,"['attention deficit-hyperactivity disorder', 'CHRNA4', 'Carbamazepine']",0.5
14956,27933.0,Carbamazepine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Carbamazepine']",0.5
14956,27933.0,Carbamazepine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'SCN10A', 'Carbamazepine']",0.5
14956,28294.0,Carbamazepine,neurohypophyseal diabetes insipidus,disease-phenotype-protein-drug,off-label use,"['neurohypophyseal diabetes insipidus', 'Vomiting', 'ABCB1', 'Carbamazepine']",0.5
14956,28456.0,Carbamazepine,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'ABCC2', 'Carbamazepine']",0.5
14956,29494.0,Carbamazepine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NR1I2', 'Carbamazepine']",0.5
14956,29525.0,Carbamazepine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Carbamazepine']",0.5
14956,30184.0,Carbamazepine,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'NR1I2', 'Carbamazepine']",0.5
14956,30449.0,Carbamazepine,trigeminal neuralgia,disease-phenotype-protein-drug,indication,"['trigeminal neuralgia', 'Allodynia', 'SCN10A', 'Carbamazepine']",0.5
14956,30879.0,Carbamazepine,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'ABCC2', 'Carbamazepine']",0.5
14956,32456.0,Carbamazepine,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'SCN1A', 'Carbamazepine']",0.5
14956,32456.0,Carbamazepine,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'ABCC2', 'Carbamazepine']",0.5
14956,32772.0,Carbamazepine,central diabetes insipidus,disease-phenotype-protein-drug,off-label use,"['central diabetes insipidus', 'Seizure', 'ABCC2', 'Carbamazepine']",0.5
14956,33352.0,Carbamazepine,glossopharyngeal neuralgia,disease-phenotype-protein-drug,indication,"['glossopharyngeal neuralgia', 'Seizure', 'ABCC2', 'Carbamazepine']",0.5
14956,33577.0,Carbamazepine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Carbamazepine']",0.5
14956,33577.0,Carbamazepine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Carbamazepine']",0.5
14956,33632.0,Carbamazepine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Carbamazepine']",0.5
14956,35565.0,Carbamazepine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Carbamazepine']",0.5
14956,35641.0,Carbamazepine,epilepsy,disease-protein-drug,indication,"['epilepsy', 'ABCB1', 'Carbamazepine']",0.5
14956,35764.0,Carbamazepine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Carbamazepine']",0.5
14956,36035.0,Carbamazepine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Carbamazepine']",0.5
14956,36104.0,Carbamazepine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Carbamazepine']",0.5
14956,36187.0,Carbamazepine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'RALBP1', 'Carbamazepine']",0.5
14956,36187.0,Carbamazepine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Carbamazepine']",0.5
14956,36229.0,Carbamazepine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Carbamazepine']",0.5
14956,36743.0,Carbamazepine,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'ABCC2', 'Carbamazepine']",0.5
14956,37703.0,Carbamazepine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Carbamazepine']",0.5
14956,38242.0,Carbamazepine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'SCN2A', 'Carbamazepine']",0.5
14956,39815.0,Carbamazepine,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'ABCC2', 'Carbamazepine']",0.5
14956,83760.0,Carbamazepine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Carbamazepine']",0.5
14956,83763.0,Carbamazepine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'SCN2A', 'Carbamazepine']",0.5
14956,83928.0,Carbamazepine,partial motor epilepsy,disease-protein-drug,indication,"['partial motor epilepsy', 'ABCC2', 'Carbamazepine']",0.5
14956,84036.0,Carbamazepine,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'CHRNA4', 'Carbamazepine']",0.5
14956,84036.0,Carbamazepine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,off-label use,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Carbamazepine']",0.5
14957,28208.0,Fenfluramine,type 2 diabetes mellitus,disease-protein-drug,contraindication,"['type 2 diabetes mellitus', 'CYP1A2', 'Fenfluramine']",0.5
14957,28208.0,Fenfluramine,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Air Pollutants', 'memory', 'SLC6A4', 'Fenfluramine']",0.5
14957,28552.0,Fenfluramine,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'locomotory behavior', 'HTR2C', 'Fenfluramine']",0.5
14957,28651.0,Fenfluramine,monogenic obesity,disease-protein-drug,indication,"['monogenic obesity', 'HTR2A', 'Fenfluramine']",0.5
14957,30035.0,Fenfluramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A4', 'Fenfluramine']",0.5
14957,33575.0,Fenfluramine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Fenfluramine']",0.5
14957,33575.0,Fenfluramine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'memory', 'SLC6A4', 'Fenfluramine']",0.5
14957,33577.0,Fenfluramine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Fenfluramine']",0.5
14957,33577.0,Fenfluramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Fenfluramine']",0.5
14957,36035.0,Fenfluramine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Fenfluramine']",0.5
14958,27326.0,Cisapride,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Cisapride']",0.5
14958,27326.0,Cisapride,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'memory', 'HTR2A', 'Cisapride']",0.5
14958,27326.0,Cisapride,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'HTR4', 'Cisapride']",0.5
14958,27655.0,Cisapride,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Cisapride']",0.5
14958,35565.0,Cisapride,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HTR2A', 'Cisapride']",0.5
14958,35764.0,Cisapride,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HTR2A', 'Cisapride']",0.5
14958,36080.0,Cisapride,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of heart rate by cardiac conduction', 'KCNH2', 'Cisapride']",0.5
14958,36187.0,Cisapride,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'memory', 'HTR2A', 'Cisapride']",0.5
14958,37786.0,Cisapride,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'memory', 'HTR2A', 'Cisapride']",0.5
14959,33577.0,Nicardipine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Nicardipine']",0.5
14959,33577.0,Nicardipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Nicardipine']",0.5
14959,33577.0,Nicardipine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'CACNA2D1', 'Nicardipine']",0.5
14959,33605.0,Nicardipine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Nicardipine']",0.5
14959,35565.0,Nicardipine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Nicardipine']",0.5
14959,35909.0,Nicardipine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Nicardipine']",0.5
14959,35909.0,Nicardipine,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'CACNA2D1', 'Nicardipine']",0.5
14959,36035.0,Nicardipine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Nicardipine']",0.5
14959,83942.0,Nicardipine,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'cognition', 'CHRM1', 'Nicardipine']",0.5
14959,83942.0,Nicardipine,intracerebral hemorrhage,disease-exposure-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'CACNA2D1', 'Nicardipine']",0.5
14960,37888.0,Astemizole,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Astemizole']",0.5
14960,37888.0,Astemizole,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Astemizole']",0.5
14960,83791.0,Astemizole,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Astemizole']",0.5
14961,30035.0,Simvastatin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Simvastatin']",0.5
14961,33575.0,Simvastatin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Simvastatin']",0.5
14961,33598.0,Simvastatin,stroke disorder,disease-exposure-bioprocess-gene-drug,indication,"['stroke disorder', 'Pesticides', 'visual learning', 'HMGCR', 'Simvastatin']",0.5
14961,33612.0,Simvastatin,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Simvastatin']",0.5
14961,33695.0,Simvastatin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'HMGCR', 'Simvastatin']",0.5
14961,35565.0,Simvastatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Simvastatin']",0.5
14961,35909.0,Simvastatin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Simvastatin']",0.5
14961,35953.0,Simvastatin,atherosclerosis,disease-exposure-bioprocess-gene-drug,indication,"['atherosclerosis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Simvastatin']",0.5
14961,36187.0,Simvastatin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Simvastatin']",0.5
14961,37180.0,Simvastatin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Simvastatin']",0.5
14961,83898.0,Simvastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Simvastatin']",0.5
14962,27326.0,Trazodone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of cytokine production', 'ADRA2A', 'Trazodone']",0.5
14962,27326.0,Trazodone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'HTR1A', 'Trazodone']",0.5
14962,27655.0,Trazodone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'HTR1A', 'Trazodone']",0.5
14962,27933.0,Trazodone,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Trazodone']",0.5
14962,27933.0,Trazodone,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Trazodone']",0.5
14962,28396.0,Trazodone,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Trazodone']",0.5
14962,28456.0,Trazodone,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'HTR1A', 'Trazodone']",0.5
14962,35669.0,Trazodone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Trazodone']",0.5
14962,35761.0,Trazodone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Trazodone']",0.5
14962,38957.0,Trazodone,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Trazodone']",0.5
14962,38957.0,Trazodone,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'platelet activation', 'ADRA2A', 'Trazodone']",0.5
14962,83751.0,Trazodone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Trazodone']",0.5
14962,83840.0,Trazodone,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Trazodone']",0.5
14962,83841.0,Trazodone,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Trazodone']",0.5
14963,32033.0,Midazolam,insomnia (disease),disease-protein-drug,off-label use,"['insomnia (disease)', 'GABRB3', 'Midazolam']",0.5
14963,36040.0,Midazolam,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Midazolam']",0.5
14963,37617.0,Midazolam,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Midazolam']",0.5
14963,83923.0,Midazolam,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'brain development', 'GABRA5', 'Midazolam']",0.5
14964,29978.0,Mycophenolate mofetil,Lesch-Nyhan syndrome,disease-phenotype-protein-drug,contraindication,"['Lesch-Nyhan syndrome', 'Vomiting', 'ABCB1', 'Mycophenolate mofetil']",0.5
14964,32942.0,Mycophenolate mofetil,progressive multifocal leukoencephalopathy,disease-phenotype-protein-drug,contraindication,"['progressive multifocal leukoencephalopathy', 'Seizure', 'ABCC2', 'Mycophenolate mofetil']",0.5
14964,35565.0,Mycophenolate mofetil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CES1', 'Mycophenolate mofetil']",0.5
14964,36104.0,Mycophenolate mofetil,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Mycophenolate mofetil']",0.5
14964,36229.0,Mycophenolate mofetil,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Mycophenolate mofetil']",0.5
14964,36382.0,Mycophenolate mofetil,skin neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['skin neoplasm', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Mycophenolate mofetil']",0.5
14964,36425.0,Mycophenolate mofetil,primary central nervous system lymphoma,disease-protein-drug,contraindication,"['primary central nervous system lymphoma', 'ABCB1', 'Mycophenolate mofetil']",0.5
14965,33577.0,Eplerenone,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Eplerenone']",0.5
14965,33577.0,Eplerenone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP11B2', 'Eplerenone']",0.5
14965,35565.0,Eplerenone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP11B2', 'Eplerenone']",0.5
14965,36035.0,Eplerenone,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Eplerenone']",0.5
14966,33575.0,Amprenavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'positive regulation of inflammatory response', 'ABCC1', 'Amprenavir']",0.5
14966,33577.0,Amprenavir,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Amprenavir']",0.5
14966,33577.0,Amprenavir,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Amprenavir']",0.5
14966,33593.0,Amprenavir,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Amprenavir']",0.5
14966,33593.0,Amprenavir,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CYP2D6', 'Amprenavir']",0.5
14966,33695.0,Amprenavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Amprenavir']",0.5
14966,35565.0,Amprenavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Amprenavir']",0.5
14966,36035.0,Amprenavir,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Amprenavir']",0.5
14966,36187.0,Amprenavir,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'positive regulation of inflammatory response', 'ABCC1', 'Amprenavir']",0.5
14966,37180.0,Amprenavir,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'positive regulation of inflammatory response', 'ABCC1', 'Amprenavir']",0.5
14966,37743.0,Amprenavir,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Amprenavir']",0.5
14967,35565.0,Delavirdine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Delavirdine']",0.5
14968,27933.0,Modafinil,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Modafinil']",0.5
14968,27933.0,Modafinil,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Modafinil']",0.5
14968,28391.0,Modafinil,narcolepsy,disease-exposure-bioprocess-gene-drug,indication,"['narcolepsy', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Modafinil']",0.5
14968,30035.0,Modafinil,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2B6', 'Modafinil']",0.5
14968,30664.0,Modafinil,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'ADRA1B', 'Modafinil']",0.5
14968,33577.0,Modafinil,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Modafinil']",0.5
14968,33577.0,Modafinil,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Modafinil']",0.5
14968,35915.0,Modafinil,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Modafinil']",0.5
14968,36035.0,Modafinil,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Modafinil']",0.5
14968,36187.0,Modafinil,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Modafinil']",0.5
14968,37180.0,Modafinil,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Modafinil']",0.5
14968,37703.0,Modafinil,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Modafinil']",0.5
14968,37786.0,Modafinil,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Modafinil']",0.5
14968,83760.0,Modafinil,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Modafinil']",0.5
14968,83778.0,Modafinil,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Modafinil']",0.5
14968,83779.0,Modafinil,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Modafinil']",0.5
14969,32928.0,Clopidogrel,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Elevated hepatic transaminase', 'CYP1A2', 'Clopidogrel']",0.5
14971,30494.0,Tadalafil,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,contraindication,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Tadalafil']",0.5
14971,33598.0,Tadalafil,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Tadalafil']",0.5
14971,35909.0,Tadalafil,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Tadalafil']",0.5
14971,37180.0,Tadalafil,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Tadalafil']",0.5
14971,37604.0,Tadalafil,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,indication,"['erectile dysfunction (disease)', 'bisphenol A', 'metabolic process', 'PDE11A', 'Tadalafil']",0.5
14972,30035.0,Disulfiram,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'CYP2E1', 'Disulfiram']",0.5
14972,33575.0,Disulfiram,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'DBH', 'Disulfiram']",0.5
14972,33575.0,Disulfiram,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'CYP2E1', 'Disulfiram']",0.5
14972,35565.0,Disulfiram,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Disulfiram']",0.5
14972,35641.0,Disulfiram,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DBH', 'Disulfiram']",0.5
14972,35915.0,Disulfiram,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Disulfiram']",0.5
14972,35953.0,Disulfiram,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'glucose homeostasis', 'DBH', 'Disulfiram']",0.5
14972,36187.0,Disulfiram,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'DBH', 'Disulfiram']",0.5
14972,36469.0,Disulfiram,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'DBH', 'Disulfiram']",0.5
14972,83778.0,Disulfiram,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Disulfiram']",0.5
14972,83779.0,Disulfiram,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Disulfiram']",0.5
14973,27843.0,Mifepristone,acute intermittent porphyria,disease-phenotype-protein-drug,contraindication,"['acute intermittent porphyria', 'Nausea', 'ABCB1', 'Mifepristone']",0.5
14973,29134.0,Mifepristone,erythropoietic protoporphyria,disease-phenotype-protein-drug,contraindication,"['erythropoietic protoporphyria', 'Pruritus', 'ABCB11', 'Mifepristone']",0.5
14973,29457.0,Mifepristone,variegate porphyria,disease-phenotype-protein-drug,contraindication,"['variegate porphyria', 'Nausea', 'ABCB1', 'Mifepristone']",0.5
14973,30813.0,Mifepristone,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Mifepristone']",0.5
14973,32977.0,Mifepristone,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Pruritus', 'ABCB11', 'Mifepristone']",0.5
14973,33555.0,Mifepristone,autosomal erythropoietic protoporphyria,disease-phenotype-protein-drug,contraindication,"['autosomal erythropoietic protoporphyria', 'Pruritus', 'ABCB11', 'Mifepristone']",0.5
14974,30494.0,Vardenafil,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,contraindication,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Vardenafil']",0.5
14974,33598.0,Vardenafil,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Vardenafil']",0.5
14974,33635.0,Vardenafil,leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['leukemia (disease)', 'Cadmium', 'visual perception', 'PDE6H', 'Vardenafil']",0.5
14974,35909.0,Vardenafil,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Vardenafil']",0.5
14974,37180.0,Vardenafil,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Vardenafil']",0.5
14974,37604.0,Vardenafil,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,indication,"['erectile dysfunction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Vardenafil']",0.5
14975,27476.0,Sirolimus,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Sirolimus']",0.5
14975,28640.0,Sirolimus,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'MTOR', 'Sirolimus']",0.5
14975,29275.0,Sirolimus,lymphangioleiomyomatosis,disease-phenotype-protein-drug,indication,"['lymphangioleiomyomatosis', 'Seizure', 'FGF2', 'Sirolimus']",0.5
14975,32214.0,Sirolimus,glioblastoma (disease),disease-protein-drug,contraindication,"['glioblastoma (disease)', 'MTOR', 'Sirolimus']",0.5
14975,32214.0,Sirolimus,glioblastoma (disease),disease-phenotype-protein-drug,contraindication,"['glioblastoma (disease)', 'Seizure', 'FGF2', 'Sirolimus']",0.5
14975,32636.0,Sirolimus,peripheral primitive neuroectodermal tumor,disease-phenotype-protein-drug,contraindication,"['peripheral primitive neuroectodermal tumor', 'Seizure', 'FGF2', 'Sirolimus']",0.5
14975,32942.0,Sirolimus,progressive multifocal leukoencephalopathy,disease-phenotype-protein-drug,contraindication,"['progressive multifocal leukoencephalopathy', 'Seizure', 'FGF2', 'Sirolimus']",0.5
14975,33575.0,Sirolimus,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'FGF2', 'Sirolimus']",0.5
14975,33575.0,Sirolimus,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'FGF2', 'Sirolimus']",0.5
14975,33577.0,Sirolimus,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Sirolimus']",0.5
14975,33577.0,Sirolimus,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Sirolimus']",0.5
14975,33598.0,Sirolimus,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'visual learning', 'MTOR', 'Sirolimus']",0.5
14975,33695.0,Sirolimus,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Sirolimus']",0.5
14975,35565.0,Sirolimus,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Sirolimus']",0.5
14975,35764.0,Sirolimus,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Sirolimus']",0.5
14975,35909.0,Sirolimus,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Sirolimus']",0.5
14975,36035.0,Sirolimus,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Sirolimus']",0.5
14975,36382.0,Sirolimus,skin neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['skin neoplasm', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Sirolimus']",0.5
14975,36425.0,Sirolimus,primary central nervous system lymphoma,disease-protein-drug,contraindication,"['primary central nervous system lymphoma', 'ABCB1', 'Sirolimus']",0.5
14975,36492.0,Sirolimus,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'visual learning', 'MTOR', 'Sirolimus']",0.5
14975,36935.0,Sirolimus,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'MTOR', 'Sirolimus']",0.5
14975,36937.0,Sirolimus,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'MTOR', 'Sirolimus']",0.5
14975,37438.0,Sirolimus,ependymoblastoma,disease-exposure-bioprocess-gene-drug,contraindication,"['ependymoblastoma', 'Tetrachloroethylene', 'visual learning', 'MTOR', 'Sirolimus']",0.5
14975,38312.0,Sirolimus,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B1', 'Sirolimus']",0.5
14975,39299.0,Sirolimus,oligoastrocytoma,disease-protein-drug,contraindication,"['oligoastrocytoma', 'FGF2', 'Sirolimus']",0.5
14975,83764.0,Sirolimus,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'social behavior', 'MTOR', 'Sirolimus']",0.5
14975,83796.0,Sirolimus,lymphosarcoma,disease-protein-drug,contraindication,"['lymphosarcoma', 'MTOR', 'Sirolimus']",0.5
14975,84143.0,Sirolimus,giant cell glioblastoma,disease-protein-drug,contraindication,"['giant cell glioblastoma', 'MTOR', 'Sirolimus']",0.5
14976,27933.0,Triazolam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Triazolam']",0.5
14976,27933.0,Triazolam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Triazolam']",0.5
14976,30035.0,Triazolam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Triazolam']",0.5
14976,31618.0,Triazolam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Triazolam']",0.5
14976,31650.0,Triazolam,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'GABRA5', 'Triazolam']",0.5
14976,32313.0,Triazolam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Triazolam']",0.5
14976,35565.0,Triazolam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Triazolam']",0.5
14976,35764.0,Triazolam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Triazolam']",0.5
14976,35915.0,Triazolam,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Triazolam']",0.5
14976,37703.0,Triazolam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Triazolam']",0.5
14976,83760.0,Triazolam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Triazolam']",0.5
14976,83778.0,Triazolam,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Triazolam']",0.5
14976,83779.0,Triazolam,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Triazolam']",0.5
14977,27326.0,Ondansetron,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ondansetron']",0.5
14977,27326.0,Ondansetron,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'HTR4', 'Ondansetron']",0.5
14977,27655.0,Ondansetron,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'HTR1B', 'Ondansetron']",0.5
14977,35641.0,Ondansetron,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Ondansetron']",0.5
14977,38003.0,Ondansetron,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'CYP2D6', 'Ondansetron']",0.5
14977,83751.0,Ondansetron,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Ondansetron']",0.5
14978,35565.0,Bimatoprost,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Bimatoprost']",0.5
14979,27933.0,Zonisamide,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'MAOB', 'Zonisamide']",0.5
14979,27933.0,Zonisamide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'positive regulation of heart rate', 'SCN3B', 'Zonisamide']",0.5
14979,27933.0,Zonisamide,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CA5A', 'Zonisamide']",0.5
14979,29494.0,Zonisamide,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'CA9', 'Zonisamide']",0.5
14979,33594.0,Zonisamide,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of heart rate', 'SCN5A', 'Zonisamide']",0.5
14979,35565.0,Zonisamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SCN2A', 'Zonisamide']",0.5
14979,35764.0,Zonisamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN5A', 'Zonisamide']",0.5
14979,35915.0,Zonisamide,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Zonisamide']",0.5
14979,36104.0,Zonisamide,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Zonisamide']",0.5
14979,36229.0,Zonisamide,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Zonisamide']",0.5
14979,37703.0,Zonisamide,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'MAOB', 'Zonisamide']",0.5
14979,83760.0,Zonisamide,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'MAOB', 'Zonisamide']",0.5
14979,83778.0,Zonisamide,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Zonisamide']",0.5
14979,83779.0,Zonisamide,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Zonisamide']",0.5
14980,28158.0,Metronidazole,inflammatory bowel disease,disease-protein-drug,off-label use,"['inflammatory bowel disease', 'ABCB1', 'Metronidazole']",0.5
14980,28158.0,Metronidazole,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,off-label use,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Metronidazole']",0.5
14980,28158.0,Metronidazole,inflammatory bowel disease,disease-phenotype-protein-drug,off-label use,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Metronidazole']",0.5
14980,30035.0,Metronidazole,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Metronidazole']",0.5
14980,33575.0,Metronidazole,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Metronidazole']",0.5
14980,35565.0,Metronidazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Metronidazole']",0.5
14980,35641.0,Metronidazole,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Metronidazole']",0.5
14980,35764.0,Metronidazole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Metronidazole']",0.5
14980,36104.0,Metronidazole,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Metronidazole']",0.5
14980,36229.0,Metronidazole,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Metronidazole']",0.5
14981,27326.0,Buprenorphine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Buprenorphine']",0.5
14981,27326.0,Buprenorphine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Buprenorphine']",0.5
14981,27655.0,Buprenorphine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'OPRM1', 'Buprenorphine']",0.5
14981,28149.0,Buprenorphine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Buprenorphine']",0.5
14981,28396.0,Buprenorphine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Buprenorphine']",0.5
14981,30035.0,Buprenorphine,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'ABCB1', 'Buprenorphine']",0.5
14981,30813.0,Buprenorphine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Buprenorphine']",0.5
14981,31072.0,Buprenorphine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Buprenorphine']",0.5
14981,32719.0,Buprenorphine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Buprenorphine']",0.5
14981,35565.0,Buprenorphine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Buprenorphine']",0.5
14981,36080.0,Buprenorphine,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Buprenorphine']",0.5
14981,36469.0,Buprenorphine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Buprenorphine']",0.5
14981,36693.0,Buprenorphine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Buprenorphine']",0.5
14981,37617.0,Buprenorphine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Buprenorphine']",0.5
14981,37743.0,Buprenorphine,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Buprenorphine']",0.5
14981,37753.0,Buprenorphine,opiate dependence,disease-protein-drug,indication,"['opiate dependence', 'OPRM1', 'Buprenorphine']",0.5
14981,83751.0,Buprenorphine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Buprenorphine']",0.5
14981,83910.0,Buprenorphine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Buprenorphine']",0.5
14981,84242.0,Buprenorphine,morphine dependence,disease-protein-drug,indication,"['morphine dependence', 'OPRM1', 'Buprenorphine']",0.5
14982,27933.0,Zaleplon,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Zaleplon']",0.5
14983,35764.0,Azelastine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Azelastine']",0.5
14983,35764.0,Azelastine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Azelastine']",0.5
14983,36091.0,Azelastine,atopic conjunctivitis,disease-phenotype-protein-drug,indication,"['atopic conjunctivitis', 'Allergy', 'CYP1A1', 'Azelastine']",0.5
14983,37888.0,Azelastine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Azelastine']",0.5
14983,37888.0,Azelastine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Azelastine']",0.5
14983,37888.0,Azelastine,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Azelastine']",0.5
14983,37888.0,Azelastine,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'CYP1A1', 'Azelastine']",0.5
14983,83791.0,Azelastine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Azelastine']",0.5
14984,28052.0,Felodipine,hypertrophic cardiomyopathy,disease-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'CACNA1C', 'Felodipine']",0.5
14984,28052.0,Felodipine,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Sudden cardiac death', 'CACNA1C', 'Felodipine']",0.5
14984,28231.0,Felodipine,supravalvular aortic stenosis (disease),disease-phenotype-protein-drug,contraindication,"['supravalvular aortic stenosis (disease)', 'Arrhythmia', 'CACNA1C', 'Felodipine']",0.5
14984,28441.0,Felodipine,hereditary angioedema with C1Inh deficiency,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema with C1Inh deficiency', 'Vomiting', 'ABCB1', 'Felodipine']",0.5
14984,29854.0,Felodipine,hereditary angioedema,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Felodipine']",0.5
14984,33577.0,Felodipine,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'CYP3A5', 'Felodipine']",0.5
14984,33577.0,Felodipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Felodipine']",0.5
14984,33577.0,Felodipine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'CACNA2D1', 'Felodipine']",0.5
14984,35565.0,Felodipine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Felodipine']",0.5
14984,35764.0,Felodipine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Felodipine']",0.5
14984,35953.0,Felodipine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'regulation of heart rate', 'CALM1', 'Felodipine']",0.5
14984,35953.0,Felodipine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'CACNA2D1', 'Felodipine']",0.5
14984,35958.0,Felodipine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'CACNA1H', 'Felodipine']",0.5
14984,36035.0,Felodipine,hypertension,disease-protein-drug,indication,"['hypertension', 'CYP3A5', 'Felodipine']",0.5
14984,36104.0,Felodipine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Felodipine']",0.5
14984,36187.0,Felodipine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of heart rate', 'CALM1', 'Felodipine']",0.5
14984,36187.0,Felodipine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CACNA2D1', 'Felodipine']",0.5
14984,36229.0,Felodipine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Felodipine']",0.5
14984,37180.0,Felodipine,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'NR3C2', 'Felodipine']",0.5
14984,37180.0,Felodipine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of heart rate', 'CALM1', 'Felodipine']",0.5
14984,37180.0,Felodipine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CACNA2D1', 'Felodipine']",0.5
14984,83823.0,Felodipine,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'NR3C2', 'Felodipine']",0.5
14984,83824.0,Felodipine,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'NR3C2', 'Felodipine']",0.5
14986,35565.0,Praziquantel,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Praziquantel']",0.5
14986,35669.0,Praziquantel,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Praziquantel']",0.5
14986,35761.0,Praziquantel,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Praziquantel']",0.5
14987,30035.0,Fluvastatin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'HDAC2', 'Fluvastatin']",0.5
14987,33598.0,Fluvastatin,stroke disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['stroke disorder', 'Pesticides', 'visual learning', 'HMGCR', 'Fluvastatin']",0.5
14987,33598.0,Fluvastatin,stroke disorder,disease-exposure-gene-drug,off-label use,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Fluvastatin']",0.5
14987,33612.0,Fluvastatin,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Fluvastatin']",0.5
14987,35565.0,Fluvastatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Fluvastatin']",0.5
14987,35565.0,Fluvastatin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Fluvastatin']",0.5
14987,35909.0,Fluvastatin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Fluvastatin']",0.5
14987,35953.0,Fluvastatin,atherosclerosis,disease-exposure-bioprocess-gene-drug,indication,"['atherosclerosis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Fluvastatin']",0.5
14987,35953.0,Fluvastatin,atherosclerosis,disease-exposure-gene-drug,indication,"['atherosclerosis', 'Arsenic', 'CYP1A1', 'Fluvastatin']",0.5
14987,83898.0,Fluvastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Fluvastatin']",0.5
14988,27326.0,Pimozide,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CALM1', 'Pimozide']",0.5
14988,27326.0,Pimozide,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Pimozide']",0.5
14988,27326.0,Pimozide,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Pimozide']",0.5
14988,27655.0,Pimozide,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Pimozide']",0.5
14988,27655.0,Pimozide,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD3', 'Pimozide']",0.5
14988,28375.0,Pimozide,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Pimozide']",0.5
14988,28547.0,Pimozide,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Pimozide']",0.5
14988,28547.0,Pimozide,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'regulation of heart rate', 'CALM1', 'Pimozide']",0.5
14988,28547.0,Pimozide,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Pimozide']",0.5
14988,28780.0,Pimozide,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CALM1', 'Pimozide']",0.5
14988,28780.0,Pimozide,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'DRD3', 'Pimozide']",0.5
14988,28780.0,Pimozide,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD3', 'Pimozide']",0.5
14988,29494.0,Pimozide,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A2', 'Pimozide']",0.5
14988,29525.0,Pimozide,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'KCNH2', 'Pimozide']",0.5
14988,30184.0,Pimozide,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A2', 'Pimozide']",0.5
14988,30879.0,Pimozide,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'DRD3', 'Pimozide']",0.5
14988,31283.0,Pimozide,Tourette syndrome,disease-protein-drug,indication,"['Tourette syndrome', 'DRD3', 'Pimozide']",0.5
14988,33454.0,Pimozide,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Pimozide']",0.5
14988,35565.0,Pimozide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Pimozide']",0.5
14988,35641.0,Pimozide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Pimozide']",0.5
14988,35641.0,Pimozide,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Pimozide']",0.5
14988,35764.0,Pimozide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'CALM1', 'Pimozide']",0.5
14988,36104.0,Pimozide,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Pimozide']",0.5
14988,36229.0,Pimozide,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Pimozide']",0.5
14988,37706.0,Pimozide,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Pimozide']",0.5
14988,39081.0,Pimozide,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Pimozide']",0.5
14988,83751.0,Pimozide,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Pimozide']",0.5
14988,83998.0,Pimozide,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Pimozide']",0.5
14988,84023.0,Pimozide,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Pimozide']",0.5
14990,27361.0,Chlorpheniramine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,27933.0,Chlorpheniramine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,27933.0,Chlorpheniramine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,28158.0,Chlorpheniramine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Chlorpheniramine']",0.5
14990,28473.0,Chlorpheniramine,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Chlorpheniramine']",0.5
14990,28780.0,Chlorpheniramine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Chlorpheniramine']",0.5
14990,28780.0,Chlorpheniramine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,28780.0,Chlorpheniramine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,28899.0,Chlorpheniramine,obsessive-compulsive disorder,disease-protein-drug,contraindication,"['obsessive-compulsive disorder', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,28899.0,Chlorpheniramine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,30035.0,Chlorpheniramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,30813.0,Chlorpheniramine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,31650.0,Chlorpheniramine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,31732.0,Chlorpheniramine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'SLC6A3', 'Chlorpheniramine']",0.5
14990,32384.0,Chlorpheniramine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,32737.0,Chlorpheniramine,hypocomplementemic urticarial vasculitis,disease-phenotype-protein-drug,contraindication,"['hypocomplementemic urticarial vasculitis', 'Seizure', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,33306.0,Chlorpheniramine,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'CYP2D6', 'Chlorpheniramine']",0.5
14990,33410.0,Chlorpheniramine,dermatitis herpetiformis,disease-phenotype-protein-drug,contraindication,"['dermatitis herpetiformis', 'Pruritus', 'HRH1', 'Chlorpheniramine']",0.5
14990,33440.0,Chlorpheniramine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Coma', 'CYP2D6', 'Chlorpheniramine']",0.5
14990,33575.0,Chlorpheniramine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,33577.0,Chlorpheniramine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Chlorpheniramine']",0.5
14990,33577.0,Chlorpheniramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,33603.0,Chlorpheniramine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Chlorpheniramine']",0.5
14990,33605.0,Chlorpheniramine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Chlorpheniramine']",0.5
14990,33632.0,Chlorpheniramine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Chlorpheniramine']",0.5
14990,33675.0,Chlorpheniramine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,35565.0,Chlorpheniramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,35641.0,Chlorpheniramine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Chlorpheniramine']",0.5
14990,35641.0,Chlorpheniramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Chlorpheniramine']",0.5
14990,35669.0,Chlorpheniramine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,35761.0,Chlorpheniramine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,35764.0,Chlorpheniramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,35897.0,Chlorpheniramine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,35915.0,Chlorpheniramine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,35953.0,Chlorpheniramine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Chlorpheniramine']",0.5
14990,35953.0,Chlorpheniramine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,36034.0,Chlorpheniramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,36035.0,Chlorpheniramine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Chlorpheniramine']",0.5
14990,36080.0,Chlorpheniramine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,36187.0,Chlorpheniramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,36252.0,Chlorpheniramine,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,36274.0,Chlorpheniramine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,36469.0,Chlorpheniramine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,36492.0,Chlorpheniramine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,36693.0,Chlorpheniramine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,36693.0,Chlorpheniramine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Chlorpheniramine']",0.5
14990,37180.0,Chlorpheniramine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,37617.0,Chlorpheniramine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,37785.0,Chlorpheniramine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Chlorpheniramine']",0.5
14990,37786.0,Chlorpheniramine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,37830.0,Chlorpheniramine,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,37888.0,Chlorpheniramine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Chlorpheniramine']",0.5
14990,37888.0,Chlorpheniramine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Chlorpheniramine']",0.5
14990,38575.0,Chlorpheniramine,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Chlorpheniramine']",0.5
14990,83778.0,Chlorpheniramine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,83779.0,Chlorpheniramine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Chlorpheniramine']",0.5
14990,83791.0,Chlorpheniramine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Chlorpheniramine']",0.5
14990,83910.0,Chlorpheniramine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'SLC6A3', 'Chlorpheniramine']",0.5
14990,83911.0,Chlorpheniramine,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Chlorpheniramine']",0.5
14991,35565.0,Cilostazol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Cilostazol']",0.5
14991,35764.0,Cilostazol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Cilostazol']",0.5
14992,27326.0,Itraconazole,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Itraconazole']",0.5
14992,27326.0,Itraconazole,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Itraconazole']",0.5
14992,27326.0,Itraconazole,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Itraconazole']",0.5
14992,27326.0,Itraconazole,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Itraconazole']",0.5
14992,28052.0,Itraconazole,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Hepatomegaly', 'CYP1A1', 'Itraconazole']",0.5
14992,30374.0,Itraconazole,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'CYP1A1', 'Itraconazole']",0.5
14992,35565.0,Itraconazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CYP51A1', 'Itraconazole']",0.5
14992,35565.0,Itraconazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Itraconazole']",0.5
14992,35670.0,Itraconazole,heart valve disease,disease-exposure-gene-drug,contraindication,"['heart valve disease', 'Agent Orange', 'CYP1A1', 'Itraconazole']",0.5
14992,35751.0,Itraconazole,peripheral nervous system disease,disease-exposure-gene-drug,contraindication,"['peripheral nervous system disease', 'Agent Orange', 'CYP1A1', 'Itraconazole']",0.5
14992,35764.0,Itraconazole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Itraconazole']",0.5
14992,35764.0,Itraconazole,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Itraconazole']",0.5
14992,36187.0,Itraconazole,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Itraconazole']",0.5
14992,36187.0,Itraconazole,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Itraconazole']",0.5
14992,36544.0,Itraconazole,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP2E1', 'Itraconazole']",0.5
14992,36544.0,Itraconazole,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CYP51A1', 'Itraconazole']",0.5
14992,37617.0,Itraconazole,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A1', 'Itraconazole']",0.5
14992,37617.0,Itraconazole,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Itraconazole']",0.5
14992,37617.0,Itraconazole,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'CYP1A1', 'Itraconazole']",0.5
14992,37659.0,Itraconazole,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Itraconazole']",0.5
14992,37786.0,Itraconazole,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Itraconazole']",0.5
14992,37786.0,Itraconazole,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Agent Orange', 'CYP1A1', 'Itraconazole']",0.5
14992,83751.0,Itraconazole,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Itraconazole']",0.5
14993,27361.0,Phenobarbital,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,27476.0,Phenobarbital,Gilbert syndrome,disease-protein-drug,off-label use,"['Gilbert syndrome', 'ABCC2', 'Phenobarbital']",0.5
14993,27476.0,Phenobarbital,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,off-label use,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Phenobarbital']",0.5
14993,27933.0,Phenobarbital,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Phenobarbital']",0.5
14993,27933.0,Phenobarbital,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenobarbital']",0.5
14993,27933.0,Phenobarbital,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,28017.0,Phenobarbital,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Phenobarbital']",0.5
14993,28158.0,Phenobarbital,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Phenobarbital']",0.5
14993,28158.0,Phenobarbital,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Phenobarbital']",0.5
14993,28158.0,Phenobarbital,inflammatory bowel disease,disease-exposure-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'CYP1A1', 'Phenobarbital']",0.5
14993,28158.0,Phenobarbital,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Phenobarbital']",0.5
14993,28473.0,Phenobarbital,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CHRNA7', 'Phenobarbital']",0.5
14993,28714.0,Phenobarbital,cystic fibrosis,disease-phenotype-protein-drug,contraindication,"['cystic fibrosis', 'Male infertility', 'CYP1A1', 'Phenobarbital']",0.5
14993,28780.0,Phenobarbital,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CHRNA7', 'Phenobarbital']",0.5
14993,28780.0,Phenobarbital,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRNA4', 'Phenobarbital']",0.5
14993,28780.0,Phenobarbital,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP2E1', 'Phenobarbital']",0.5
14993,28780.0,Phenobarbital,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,28899.0,Phenobarbital,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Asbestos', 'inflammatory response', 'ABCC2', 'Phenobarbital']",0.5
14993,28899.0,Phenobarbital,obsessive-compulsive disorder,disease-exposure-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Tobacco Smoke Pollution', 'CYP1A1', 'Phenobarbital']",0.5
14993,29182.0,Phenobarbital,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Phenobarbital']",0.5
14993,29182.0,Phenobarbital,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,29494.0,Phenobarbital,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NR1I2', 'Phenobarbital']",0.5
14993,29614.0,Phenobarbital,osteoporosis,disease-exposure-bioprocess-gene-drug,off-label use,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Phenobarbital']",0.5
14993,29865.0,Phenobarbital,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Focal-onset seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,30035.0,Phenobarbital,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Phenobarbital']",0.5
14993,30184.0,Phenobarbital,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'NR1I2', 'Phenobarbital']",0.5
14993,30879.0,Phenobarbital,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,31395.0,Phenobarbital,benign prostatic hyperplasia (disease),disease-exposure-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'CYP1A1', 'Phenobarbital']",0.5
14993,31618.0,Phenobarbital,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,31650.0,Phenobarbital,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,31732.0,Phenobarbital,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'CHRNA7', 'Phenobarbital']",0.5
14993,32313.0,Phenobarbital,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,32456.0,Phenobarbital,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,32719.0,Phenobarbital,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Prolonged neonatal jaundice', 'NR1I2', 'Phenobarbital']",0.5
14993,32737.0,Phenobarbital,hypocomplementemic urticarial vasculitis,disease-phenotype-protein-drug,contraindication,"['hypocomplementemic urticarial vasculitis', 'Hepatomegaly', 'NR1I2', 'Phenobarbital']",0.5
14993,32797.0,Phenobarbital,IgG4-related retroperitoneal fibrosis,disease-phenotype-protein-drug,contraindication,"['IgG4-related retroperitoneal fibrosis', 'Pain', 'GRIN1', 'Phenobarbital']",0.5
14993,32967.0,Phenobarbital,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'NR1I2', 'Phenobarbital']",0.5
14993,32977.0,Phenobarbital,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Phenobarbital']",0.5
14993,32977.0,Phenobarbital,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,33306.0,Phenobarbital,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'CYP1A1', 'Phenobarbital']",0.5
14993,33410.0,Phenobarbital,dermatitis herpetiformis,disease-phenotype-protein-drug,contraindication,"['dermatitis herpetiformis', 'Pruritus', 'ABCB11', 'Phenobarbital']",0.5
14993,33440.0,Phenobarbital,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,33534.0,Phenobarbital,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'ABCC2', 'Phenobarbital']",0.5
14993,33575.0,Phenobarbital,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Phenobarbital']",0.5
14993,33575.0,Phenobarbital,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Phenobarbital']",0.5
14993,33575.0,Phenobarbital,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Phenobarbital']",0.5
14993,33577.0,Phenobarbital,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Phenobarbital']",0.5
14993,33577.0,Phenobarbital,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Phenobarbital']",0.5
14993,33577.0,Phenobarbital,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Phenobarbital']",0.5
14993,33594.0,Phenobarbital,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Phenobarbital']",0.5
14993,33594.0,Phenobarbital,diarrheal disease,disease-exposure-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,33605.0,Phenobarbital,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Phenobarbital']",0.5
14993,33632.0,Phenobarbital,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Phenobarbital']",0.5
14993,33675.0,Phenobarbital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,33675.0,Phenobarbital,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,35471.0,Phenobarbital,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'inflammatory response', 'ABCC2', 'Phenobarbital']",0.5
14993,35565.0,Phenobarbital,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Phenobarbital']",0.5
14993,35565.0,Phenobarbital,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Phenobarbital']",0.5
14993,35641.0,Phenobarbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'ABCB1', 'Phenobarbital']",0.5
14993,35641.0,Phenobarbital,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Phenobarbital']",0.5
14993,35669.0,Phenobarbital,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,35669.0,Phenobarbital,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,35761.0,Phenobarbital,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Phenobarbital']",0.5
14993,35761.0,Phenobarbital,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,35764.0,Phenobarbital,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Phenobarbital']",0.5
14993,35764.0,Phenobarbital,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,35915.0,Phenobarbital,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'GRIN1', 'Phenobarbital']",0.5
14993,35915.0,Phenobarbital,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cognition', 'CHRNA4', 'Phenobarbital']",0.5
14993,36034.0,Phenobarbital,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'GRIN2B', 'Phenobarbital']",0.5
14993,36035.0,Phenobarbital,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Phenobarbital']",0.5
14993,36080.0,Phenobarbital,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Phenobarbital']",0.5
14993,36104.0,Phenobarbital,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Phenobarbital']",0.5
14993,36187.0,Phenobarbital,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,36187.0,Phenobarbital,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,36229.0,Phenobarbital,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Phenobarbital']",0.5
14993,36252.0,Phenobarbital,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Phenobarbital']",0.5
14993,36252.0,Phenobarbital,thyroid gland disease,disease-exposure-gene-drug,contraindication,"['thyroid gland disease', 'Pesticides', 'CYP2E1', 'Phenobarbital']",0.5
14993,36266.0,Phenobarbital,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRA1', 'Phenobarbital']",0.5
14993,36274.0,Phenobarbital,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRNA4', 'Phenobarbital']",0.5
14993,36312.0,Phenobarbital,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Phenobarbital']",0.5
14993,36469.0,Phenobarbital,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'GRIN2B', 'Phenobarbital']",0.5
14993,36645.0,Phenobarbital,hyperbilirubinemia,disease-protein-drug,off-label use,"['hyperbilirubinemia', 'ABCC2', 'Phenobarbital']",0.5
14993,36693.0,Phenobarbital,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'GRIK2', 'Phenobarbital']",0.5
14993,36693.0,Phenobarbital,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Phenobarbital']",0.5
14993,36743.0,Phenobarbital,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'ABCC2', 'Phenobarbital']",0.5
14993,37180.0,Phenobarbital,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,37180.0,Phenobarbital,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,37617.0,Phenobarbital,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A1', 'Phenobarbital']",0.5
14993,37617.0,Phenobarbital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,37617.0,Phenobarbital,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,37703.0,Phenobarbital,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Phenobarbital']",0.5
14993,37718.0,Phenobarbital,brain ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,37785.0,Phenobarbital,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Phenobarbital']",0.5
14993,37785.0,Phenobarbital,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRNA4', 'Phenobarbital']",0.5
14993,37786.0,Phenobarbital,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,37786.0,Phenobarbital,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Agent Orange', 'CYP1A1', 'Phenobarbital']",0.5
14993,37830.0,Phenobarbital,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,37830.0,Phenobarbital,bronchitis,disease-exposure-gene-drug,contraindication,"['bronchitis', 'Tobacco Smoke Pollution', 'CYP1A1', 'Phenobarbital']",0.5
14993,38242.0,Phenobarbital,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'GRIN1', 'Phenobarbital']",0.5
14993,38242.0,Phenobarbital,bipolar disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Phenobarbital']",0.5
14993,38312.0,Phenobarbital,hereditary hyperbilirubinemia,disease-protein-drug,off-label use,"['hereditary hyperbilirubinemia', 'ABCC2', 'Phenobarbital']",0.5
14993,38575.0,Phenobarbital,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CHRNA7', 'Phenobarbital']",0.5
14993,39798.0,Phenobarbital,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Phenobarbital']",0.5
14993,39798.0,Phenobarbital,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'CYP1A1', 'Phenobarbital']",0.5
14993,39815.0,Phenobarbital,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'ABCC2', 'Phenobarbital']",0.5
14993,83760.0,Phenobarbital,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Phenobarbital']",0.5
14993,83764.0,Phenobarbital,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'learning or memory', 'GRIN2B', 'Phenobarbital']",0.5
14993,83778.0,Phenobarbital,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'GRIN1', 'Phenobarbital']",0.5
14993,83778.0,Phenobarbital,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cognition', 'CHRNA4', 'Phenobarbital']",0.5
14993,83779.0,Phenobarbital,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'GRIN1', 'Phenobarbital']",0.5
14993,83779.0,Phenobarbital,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cognition', 'CHRNA4', 'Phenobarbital']",0.5
14993,83805.0,Phenobarbital,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRA1', 'Phenobarbital']",0.5
14993,83906.0,Phenobarbital,status epilepticus,disease-protein-drug,off-label use,"['status epilepticus', 'GRIA2', 'Phenobarbital']",0.5
14993,83911.0,Phenobarbital,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CHRNA7', 'Phenobarbital']",0.5
14994,27326.0,Domperidone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Domperidone']",0.5
14994,27326.0,Domperidone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Domperidone']",0.5
14994,27655.0,Domperidone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD3', 'Domperidone']",0.5
14994,35565.0,Domperidone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Domperidone']",0.5
14994,83751.0,Domperidone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Domperidone']",0.5
14995,27326.0,Clarithromycin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Clarithromycin']",0.5
14995,27326.0,Clarithromycin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of ventricular cardiac muscle cell membrane repolarization', 'KCNH2', 'Clarithromycin']",0.5
14995,29614.0,Clarithromycin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Clarithromycin']",0.5
14995,31033.0,Clarithromycin,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'ABCB11', 'Clarithromycin']",0.5
14995,31033.0,Clarithromycin,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Pruritus', 'ABCB11', 'Clarithromycin']",0.5
14995,32629.0,Clarithromycin,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'ABCB11', 'Clarithromycin']",0.5
14995,32710.0,Clarithromycin,inhalational anthrax,disease-phenotype-protein-drug,off-label use,"['inhalational anthrax', 'Vomiting', 'ABCB1', 'Clarithromycin']",0.5
14995,32950.0,Clarithromycin,Lyme disease,disease-phenotype-protein-drug,off-label use,"['Lyme disease', 'Arrhythmia', 'KCNH2', 'Clarithromycin']",0.5
14995,32977.0,Clarithromycin,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Pruritus', 'ABCB11', 'Clarithromycin']",0.5
14995,33543.0,Clarithromycin,boutonneuse fever,disease-phenotype-protein-drug,off-label use,"['boutonneuse fever', 'Nausea', 'ABCB1', 'Clarithromycin']",0.5
14995,35565.0,Clarithromycin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Clarithromycin']",0.5
14995,35764.0,Clarithromycin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Clarithromycin']",0.5
14995,38059.0,Clarithromycin,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'ABCB11', 'Clarithromycin']",0.5
14995,83751.0,Clarithromycin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Clarithromycin']",0.5
14996,31395.0,Finasteride,benign prostatic hyperplasia (disease),disease-protein-drug,indication,"['benign prostatic hyperplasia (disease)', 'SRD5A2', 'Finasteride']",0.5
14996,31395.0,Finasteride,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,indication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'testosterone biosynthetic process', 'SRD5A2', 'Finasteride']",0.5
14996,35565.0,Finasteride,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Finasteride']",0.5
14997,32617.0,Anastrozole,hereditary breast ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Anastrozole']",0.5
14997,36187.0,Anastrozole,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Anastrozole']",0.5
14997,37786.0,Anastrozole,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Anastrozole']",0.5
14998,27326.0,Halofantrine,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Halofantrine']",0.5
14998,27326.0,Halofantrine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of ventricular cardiac muscle cell membrane repolarization', 'KCNH2', 'Halofantrine']",0.5
14998,27326.0,Halofantrine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Halofantrine']",0.5
14998,35764.0,Halofantrine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Halofantrine']",0.5
14999,27326.0,Quetiapine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Quetiapine']",0.5
14999,27326.0,Quetiapine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Quetiapine']",0.5
14999,27645.0,Quetiapine,torsion dystonia,disease-phenotype-protein-drug,contraindication,"['torsion dystonia', 'Action tremor', 'CHRM4', 'Quetiapine']",0.5
14999,27655.0,Quetiapine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'HTR1B', 'Quetiapine']",0.5
14999,27740.0,Quetiapine,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Quetiapine']",0.5
14999,28149.0,Quetiapine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Quetiapine']",0.5
14999,28249.0,Quetiapine,major affective disorder,disease-protein-drug,indication,"['major affective disorder', 'DRD5', 'Quetiapine']",0.5
14999,28313.0,Quetiapine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Quetiapine']",0.5
14999,28313.0,Quetiapine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Quetiapine']",0.5
14999,28375.0,Quetiapine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Quetiapine']",0.5
14999,28396.0,Quetiapine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Quetiapine']",0.5
14999,28651.0,Quetiapine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2A', 'Quetiapine']",0.5
14999,28780.0,Quetiapine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Quetiapine']",0.5
14999,28780.0,Quetiapine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Quetiapine']",0.5
14999,28780.0,Quetiapine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Quetiapine']",0.5
14999,29352.0,Quetiapine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Fever', 'HTR1A', 'Quetiapine']",0.5
14999,29637.0,Quetiapine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Quetiapine']",0.5
14999,29637.0,Quetiapine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'HTR1B', 'Quetiapine']",0.5
14999,30324.0,Quetiapine,blepharospasm,disease-protein-drug,contraindication,"['blepharospasm', 'DRD5', 'Quetiapine']",0.5
14999,30879.0,Quetiapine,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'HTR1B', 'Quetiapine']",0.5
14999,31393.0,Quetiapine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Quetiapine']",0.5
14999,31393.0,Quetiapine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Quetiapine']",0.5
14999,31732.0,Quetiapine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'HTR6', 'Quetiapine']",0.5
14999,33449.0,Quetiapine,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Quetiapine']",0.5
14999,33454.0,Quetiapine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Quetiapine']",0.5
14999,33575.0,Quetiapine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Quetiapine']",0.5
14999,33577.0,Quetiapine,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Quetiapine']",0.5
14999,33577.0,Quetiapine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Quetiapine']",0.5
14999,33593.0,Quetiapine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2A', 'Quetiapine']",0.5
14999,33593.0,Quetiapine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Quetiapine']",0.5
14999,33593.0,Quetiapine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Quetiapine']",0.5
14999,33632.0,Quetiapine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Quetiapine']",0.5
14999,33695.0,Quetiapine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Quetiapine']",0.5
14999,35565.0,Quetiapine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Quetiapine']",0.5
14999,35641.0,Quetiapine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Quetiapine']",0.5
14999,35641.0,Quetiapine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Quetiapine']",0.5
14999,35909.0,Quetiapine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Quetiapine']",0.5
14999,36035.0,Quetiapine,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Quetiapine']",0.5
14999,36104.0,Quetiapine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Quetiapine']",0.5
14999,36187.0,Quetiapine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Quetiapine']",0.5
14999,36229.0,Quetiapine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Quetiapine']",0.5
14999,36469.0,Quetiapine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'DRD3', 'Quetiapine']",0.5
14999,37180.0,Quetiapine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Quetiapine']",0.5
14999,37786.0,Quetiapine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'CHRM1', 'Quetiapine']",0.5
14999,38003.0,Quetiapine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD3', 'Quetiapine']",0.5
14999,38242.0,Quetiapine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'DRD5', 'Quetiapine']",0.5
14999,38242.0,Quetiapine,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Quetiapine']",0.5
14999,38928.0,Quetiapine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Quetiapine']",0.5
14999,83751.0,Quetiapine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Quetiapine']",0.5
14999,83752.0,Quetiapine,focal hand dystonia,disease-protein-drug,contraindication,"['focal hand dystonia', 'DRD5', 'Quetiapine']",0.5
14999,83763.0,Quetiapine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'DRD5', 'Quetiapine']",0.5
14999,83764.0,Quetiapine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Quetiapine']",0.5
14999,83998.0,Quetiapine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Quetiapine']",0.5
14999,84023.0,Quetiapine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Quetiapine']",0.5
15000,27326.0,Lapatinib,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'response to cobalamin', 'EGFR', 'Lapatinib']",0.5
15000,36544.0,Lapatinib,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ABCB1', 'Lapatinib']",0.5
15000,36544.0,Lapatinib,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Lapatinib']",0.5
15000,37659.0,Lapatinib,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'learning or memory', 'EGFR', 'Lapatinib']",0.5
15000,83751.0,Lapatinib,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Lapatinib']",0.5
15001,27326.0,Paliperidone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Paliperidone']",0.5
15001,27326.0,Paliperidone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Paliperidone']",0.5
15001,27645.0,Paliperidone,torsion dystonia,disease-phenotype-protein-drug,contraindication,"['torsion dystonia', 'Action tremor', 'CYP2D6', 'Paliperidone']",0.5
15001,27655.0,Paliperidone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Paliperidone']",0.5
15001,27740.0,Paliperidone,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Paliperidone']",0.5
15001,28149.0,Paliperidone,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Paliperidone']",0.5
15001,28158.0,Paliperidone,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Paliperidone']",0.5
15001,28158.0,Paliperidone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Paliperidone']",0.5
15001,28158.0,Paliperidone,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Paliperidone']",0.5
15001,28313.0,Paliperidone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Paliperidone']",0.5
15001,28313.0,Paliperidone,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Paliperidone']",0.5
15001,28375.0,Paliperidone,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Paliperidone']",0.5
15001,28547.0,Paliperidone,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Paliperidone']",0.5
15001,28547.0,Paliperidone,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Paliperidone']",0.5
15001,28547.0,Paliperidone,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Paliperidone']",0.5
15001,28651.0,Paliperidone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2A', 'Paliperidone']",0.5
15001,28780.0,Paliperidone,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Paliperidone']",0.5
15001,28780.0,Paliperidone,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'DRD3', 'Paliperidone']",0.5
15001,28780.0,Paliperidone,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Paliperidone']",0.5
15001,29637.0,Paliperidone,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Paliperidone']",0.5
15001,29637.0,Paliperidone,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD1', 'Paliperidone']",0.5
15001,30035.0,Paliperidone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Paliperidone']",0.5
15001,30879.0,Paliperidone,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'DRD1', 'Paliperidone']",0.5
15001,31393.0,Paliperidone,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Paliperidone']",0.5
15001,31393.0,Paliperidone,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Paliperidone']",0.5
15001,31912.0,Paliperidone,autism susceptibility 1,disease-protein-drug,off-label use,"['autism susceptibility 1', 'DRD3', 'Paliperidone']",0.5
15001,31912.0,Paliperidone,autism susceptibility 1,disease-phenotype-protein-drug,off-label use,"['autism susceptibility 1', 'Seizure', 'DRD1', 'Paliperidone']",0.5
15001,33449.0,Paliperidone,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Paliperidone']",0.5
15001,33454.0,Paliperidone,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Paliperidone']",0.5
15001,33575.0,Paliperidone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Paliperidone']",0.5
15001,33593.0,Paliperidone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2A', 'Paliperidone']",0.5
15001,33593.0,Paliperidone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Paliperidone']",0.5
15001,33593.0,Paliperidone,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Paliperidone']",0.5
15001,33605.0,Paliperidone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HTR1D', 'Paliperidone']",0.5
15001,35641.0,Paliperidone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Paliperidone']",0.5
15001,35641.0,Paliperidone,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Paliperidone']",0.5
15001,35909.0,Paliperidone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'HRH1', 'Paliperidone']",0.5
15001,35915.0,Paliperidone,mental disorder,disease-protein-drug,indication,"['mental disorder', 'HTR2A', 'Paliperidone']",0.5
15001,35915.0,Paliperidone,mental disorder,disease-exposure-bioprocess-gene-drug,indication,"['mental disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Paliperidone']",0.5
15001,36104.0,Paliperidone,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Paliperidone']",0.5
15001,36229.0,Paliperidone,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Paliperidone']",0.5
15001,36693.0,Paliperidone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'DRD2', 'Paliperidone']",0.5
15001,36693.0,Paliperidone,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Paliperidone']",0.5
15001,37180.0,Paliperidone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Paliperidone']",0.5
15001,37706.0,Paliperidone,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Paliperidone']",0.5
15001,37717.0,Paliperidone,autism spectrum disorder,disease-protein-drug,off-label use,"['autism spectrum disorder', 'DRD3', 'Paliperidone']",0.5
15001,38003.0,Paliperidone,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD3', 'Paliperidone']",0.5
15001,38242.0,Paliperidone,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'DRD2', 'Paliperidone']",0.5
15001,38242.0,Paliperidone,bipolar disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Paliperidone']",0.5
15001,38928.0,Paliperidone,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Paliperidone']",0.5
15001,39081.0,Paliperidone,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Paliperidone']",0.5
15001,83751.0,Paliperidone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Paliperidone']",0.5
15001,83763.0,Paliperidone,manic bipolar affective disorder,disease-protein-drug,off-label use,"['manic bipolar affective disorder', 'HTR2A', 'Paliperidone']",0.5
15001,83764.0,Paliperidone,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Paliperidone']",0.5
15001,83778.0,Paliperidone,schizophreniform disorder,disease-protein-drug,indication,"['schizophreniform disorder', 'HTR2A', 'Paliperidone']",0.5
15001,83778.0,Paliperidone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Paliperidone']",0.5
15001,83779.0,Paliperidone,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'HTR2A', 'Paliperidone']",0.5
15001,83779.0,Paliperidone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Paliperidone']",0.5
15001,83998.0,Paliperidone,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Paliperidone']",0.5
15001,84023.0,Paliperidone,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Paliperidone']",0.5
15001,84310.0,Paliperidone,autism (disease),disease-protein-drug,off-label use,"['autism (disease)', 'DRD3', 'Paliperidone']",0.5
15001,84310.0,Paliperidone,autism (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['autism (disease)', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Paliperidone']",0.5
15002,27326.0,Sunitinib,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'KIT', 'Sunitinib']",0.5
15002,27476.0,Sunitinib,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Sunitinib']",0.5
15002,27476.0,Sunitinib,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Sunitinib']",0.5
15002,27626.0,Sunitinib,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'KIT', 'Sunitinib']",0.5
15002,27655.0,Sunitinib,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Sunitinib']",0.5
15002,29194.0,Sunitinib,gastrointestinal stromal tumor,disease-protein-drug,indication,"['gastrointestinal stromal tumor', 'PDGFRA', 'Sunitinib']",0.5
15002,30813.0,Sunitinib,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'ABCC2', 'Sunitinib']",0.5
15002,33632.0,Sunitinib,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Petroleum', 'respiratory system process', 'FLT4', 'Sunitinib']",0.5
15002,33643.0,Sunitinib,renal cell carcinoma (disease),disease-protein-drug,indication,"['renal cell carcinoma (disease)', 'FLT4', 'Sunitinib']",0.5
15002,33643.0,Sunitinib,renal cell carcinoma (disease),disease-exposure-bioprocess-gene-drug,indication,"['renal cell carcinoma (disease)', 'Arsenic', 'pigmentation', 'KIT', 'Sunitinib']",0.5
15002,35565.0,Sunitinib,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'KIT', 'Sunitinib']",0.5
15002,35641.0,Sunitinib,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Sunitinib']",0.5
15002,35641.0,Sunitinib,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'KIT', 'Sunitinib']",0.5
15002,36034.0,Sunitinib,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Petroleum', 'respiratory system process', 'FLT4', 'Sunitinib']",0.5
15002,36432.0,Sunitinib,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'PDGFRA', 'Sunitinib']",0.5
15002,36469.0,Sunitinib,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Petroleum', 'respiratory system process', 'FLT4', 'Sunitinib']",0.5
15002,36544.0,Sunitinib,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ABCB1', 'Sunitinib']",0.5
15002,36544.0,Sunitinib,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'KIT', 'Sunitinib']",0.5
15002,36645.0,Sunitinib,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Sunitinib']",0.5
15002,36935.0,Sunitinib,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'FLT1', 'Sunitinib']",0.5
15002,36937.0,Sunitinib,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'FLT4', 'Sunitinib']",0.5
15002,37659.0,Sunitinib,heart failure,disease-protein-drug,contraindication,"['heart failure', 'PDGFRA', 'Sunitinib']",0.5
15002,37659.0,Sunitinib,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'respiratory system process', 'FLT4', 'Sunitinib']",0.5
15002,38312.0,Sunitinib,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'ABCC2', 'Sunitinib']",0.5
15002,83751.0,Sunitinib,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Sunitinib']",0.5
15003,28478.0,Cortisone acetate,autoimmune disease,disease-exposure-bioprocess-gene-drug,indication,"['autoimmune disease', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Cortisone acetate']",0.5
15003,29078.0,Cortisone acetate,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,29614.0,Cortisone acetate,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,30494.0,Cortisone acetate,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,off-label use,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,33077.0,Cortisone acetate,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,33575.0,Cortisone acetate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Cortisone acetate']",0.5
15003,33577.0,Cortisone acetate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Cortisone acetate']",0.5
15003,33577.0,Cortisone acetate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,33581.0,Cortisone acetate,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Cortisone acetate']",0.5
15003,33621.0,Cortisone acetate,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Cortisone acetate']",0.5
15003,33649.0,Cortisone acetate,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Cortisone acetate']",0.5
15003,33675.0,Cortisone acetate,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Cortisone acetate']",0.5
15003,33679.0,Cortisone acetate,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Cortisone acetate']",0.5
15003,35565.0,Cortisone acetate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,35650.0,Cortisone acetate,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,35669.0,Cortisone acetate,heart disease,disease-exposure-bioprocess-gene-drug,off-label use,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Cortisone acetate']",0.5
15003,35764.0,Cortisone acetate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,35823.0,Cortisone acetate,eye disease,disease-exposure-bioprocess-gene-drug,indication,"['eye disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,35915.0,Cortisone acetate,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Cortisone acetate']",0.5
15003,35915.0,Cortisone acetate,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,36034.0,Cortisone acetate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,36035.0,Cortisone acetate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Cortisone acetate']",0.5
15003,36080.0,Cortisone acetate,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Cortisone acetate']",0.5
15003,36129.0,Cortisone acetate,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,36469.0,Cortisone acetate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,36644.0,Cortisone acetate,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,37617.0,Cortisone acetate,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Cortisone acetate']",0.5
15003,37722.0,Cortisone acetate,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,37785.0,Cortisone acetate,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,indication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,37830.0,Cortisone acetate,bronchitis,disease-exposure-bioprocess-gene-drug,off-label use,"['bronchitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Cortisone acetate']",0.5
15003,37888.0,Cortisone acetate,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Cortisone acetate']",0.5
15003,39798.0,Cortisone acetate,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Cortisone acetate']",0.5
15003,83778.0,Cortisone acetate,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Cortisone acetate']",0.5
15003,83778.0,Cortisone acetate,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,83779.0,Cortisone acetate,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Cortisone acetate']",0.5
15003,83779.0,Cortisone acetate,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Cortisone acetate']",0.5
15003,83830.0,Cortisone acetate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Cortisone acetate']",0.5
15006,27326.0,Iloperidone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Iloperidone']",0.5
15006,27326.0,Iloperidone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Iloperidone']",0.5
15006,27655.0,Iloperidone,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Iloperidone']",0.5
15006,28313.0,Iloperidone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'CYP2E1', 'Iloperidone']",0.5
15006,28313.0,Iloperidone,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Iloperidone']",0.5
15006,28375.0,Iloperidone,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Iloperidone']",0.5
15006,28396.0,Iloperidone,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Iloperidone']",0.5
15006,28651.0,Iloperidone,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'CYP2E1', 'Iloperidone']",0.5
15006,28780.0,Iloperidone,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Iloperidone']",0.5
15006,28780.0,Iloperidone,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Iloperidone']",0.5
15006,28780.0,Iloperidone,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP2E1', 'Iloperidone']",0.5
15006,28780.0,Iloperidone,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Iloperidone']",0.5
15006,29637.0,Iloperidone,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Iloperidone']",0.5
15006,29637.0,Iloperidone,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD1', 'Iloperidone']",0.5
15006,33454.0,Iloperidone,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Iloperidone']",0.5
15006,33575.0,Iloperidone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Iloperidone']",0.5
15006,33575.0,Iloperidone,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'CYP2E1', 'Iloperidone']",0.5
15006,33593.0,Iloperidone,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'CYP2E1', 'Iloperidone']",0.5
15006,33593.0,Iloperidone,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Organophosphorus Compounds', 'learning or memory', 'DRD3', 'Iloperidone']",0.5
15006,33593.0,Iloperidone,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'DRD2', 'Iloperidone']",0.5
15006,35565.0,Iloperidone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Iloperidone']",0.5
15006,35641.0,Iloperidone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD1', 'Iloperidone']",0.5
15006,35641.0,Iloperidone,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Iloperidone']",0.5
15006,37180.0,Iloperidone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Iloperidone']",0.5
15006,37180.0,Iloperidone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'CYP2E1', 'Iloperidone']",0.5
15006,39081.0,Iloperidone,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Iloperidone']",0.5
15006,83751.0,Iloperidone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Iloperidone']",0.5
15006,83764.0,Iloperidone,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'learning or memory', 'DRD3', 'Iloperidone']",0.5
15006,83998.0,Iloperidone,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Iloperidone']",0.5
15006,84023.0,Iloperidone,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Iloperidone']",0.5
15009,27326.0,Romidepsin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Romidepsin']",0.5
15009,27326.0,Romidepsin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'HDAC1', 'Romidepsin']",0.5
15009,27326.0,Romidepsin,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Romidepsin']",0.5
15009,27326.0,Romidepsin,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Romidepsin']",0.5
15009,33632.0,Romidepsin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Romidepsin']",0.5
15009,35565.0,Romidepsin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Romidepsin']",0.5
15009,35565.0,Romidepsin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Romidepsin']",0.5
15009,36040.0,Romidepsin,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'CYP2C19', 'Romidepsin']",0.5
15009,36040.0,Romidepsin,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Romidepsin']",0.5
15009,36104.0,Romidepsin,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Romidepsin']",0.5
15009,36229.0,Romidepsin,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Romidepsin']",0.5
15009,83923.0,Romidepsin,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'CYP2C19', 'Romidepsin']",0.5
15009,83923.0,Romidepsin,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Romidepsin']",0.5
15009,83924.0,Romidepsin,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'CYP2C19', 'Romidepsin']",0.5
15010,35565.0,Rivaroxaban,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Rivaroxaban']",0.5
15010,35764.0,Rivaroxaban,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Rivaroxaban']",0.5
15011,37604.0,Udenafil,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,indication,"['erectile dysfunction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Udenafil']",0.5
15012,27476.0,Temsirolimus,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Temsirolimus']",0.5
15012,28640.0,Temsirolimus,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'MTOR', 'Temsirolimus']",0.5
15012,32214.0,Temsirolimus,glioblastoma (disease),disease-protein-drug,contraindication,"['glioblastoma (disease)', 'MTOR', 'Temsirolimus']",0.5
15012,32531.0,Temsirolimus,mantle cell lymphoma,disease-protein-drug,indication,"['mantle cell lymphoma', 'MTOR', 'Temsirolimus']",0.5
15012,33575.0,Temsirolimus,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Temsirolimus']",0.5
15012,33598.0,Temsirolimus,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'visual learning', 'MTOR', 'Temsirolimus']",0.5
15012,35565.0,Temsirolimus,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Temsirolimus']",0.5
15012,35651.0,Temsirolimus,B-cell neoplasm,disease-protein-drug,indication,"['B-cell neoplasm', 'MTOR', 'Temsirolimus']",0.5
15012,35764.0,Temsirolimus,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Temsirolimus']",0.5
15012,35909.0,Temsirolimus,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Temsirolimus']",0.5
15012,36492.0,Temsirolimus,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'visual learning', 'MTOR', 'Temsirolimus']",0.5
15012,36935.0,Temsirolimus,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'MTOR', 'Temsirolimus']",0.5
15012,36937.0,Temsirolimus,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'MTOR', 'Temsirolimus']",0.5
15012,37438.0,Temsirolimus,ependymoblastoma,disease-exposure-bioprocess-gene-drug,contraindication,"['ependymoblastoma', 'Tetrachloroethylene', 'visual learning', 'MTOR', 'Temsirolimus']",0.5
15012,83764.0,Temsirolimus,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'social behavior', 'MTOR', 'Temsirolimus']",0.5
15012,83796.0,Temsirolimus,lymphosarcoma,disease-protein-drug,indication,"['lymphosarcoma', 'MTOR', 'Temsirolimus']",0.5
15012,84143.0,Temsirolimus,giant cell glioblastoma,disease-protein-drug,contraindication,"['giant cell glioblastoma', 'MTOR', 'Temsirolimus']",0.5
15013,28208.0,Saxagliptin,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Saxagliptin']",0.5
15013,35565.0,Saxagliptin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SLCO4C1', 'Saxagliptin']",0.5
15013,35764.0,Saxagliptin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Saxagliptin']",0.5
15013,36040.0,Saxagliptin,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Saxagliptin']",0.5
15013,37180.0,Saxagliptin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Saxagliptin']",0.5
15014,27684.0,Ambrisentan,pulmonary venoocclusive disease,disease-phenotype-protein-drug,contraindication,"['pulmonary venoocclusive disease', 'Pulmonary arterial hypertension', 'EDNRB', 'Ambrisentan']",0.5
15014,33632.0,Ambrisentan,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Ambrisentan']",0.5
15014,36432.0,Ambrisentan,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'EDNRB', 'Ambrisentan']",0.5
15015,27933.0,Armodafinil,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Armodafinil']",0.5
15015,27933.0,Armodafinil,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Armodafinil']",0.5
15015,28391.0,Armodafinil,narcolepsy,disease-exposure-bioprocess-gene-drug,indication,"['narcolepsy', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Armodafinil']",0.5
15015,30664.0,Armodafinil,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'SLC6A3', 'Armodafinil']",0.5
15015,33577.0,Armodafinil,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Armodafinil']",0.5
15015,33577.0,Armodafinil,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Armodafinil']",0.5
15015,35915.0,Armodafinil,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Armodafinil']",0.5
15015,36035.0,Armodafinil,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Armodafinil']",0.5
15015,37703.0,Armodafinil,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Armodafinil']",0.5
15015,83760.0,Armodafinil,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Armodafinil']",0.5
15015,83778.0,Armodafinil,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Armodafinil']",0.5
15015,83779.0,Armodafinil,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Armodafinil']",0.5
15018,28520.0,Midostaurin,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'KIT', 'Midostaurin']",0.5
15018,28520.0,Midostaurin,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'spermatogenesis', 'KIT', 'Midostaurin']",0.5
15018,28520.0,Midostaurin,myeloid leukemia,disease-exposure-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'CYP2E1', 'Midostaurin']",0.5
15018,28542.0,Midostaurin,mastocytosis,disease-protein-drug,indication,"['mastocytosis', 'KIT', 'Midostaurin']",0.5
15018,28542.0,Midostaurin,mastocytosis,disease-phenotype-protein-drug,indication,"['mastocytosis', 'Hepatomegaly', 'CYP1A2', 'Midostaurin']",0.5
15018,32834.0,Midostaurin,aggressive systemic mastocytosis,disease-protein-drug,indication,"['aggressive systemic mastocytosis', 'KIT', 'Midostaurin']",0.5
15018,32834.0,Midostaurin,aggressive systemic mastocytosis,disease-phenotype-protein-drug,indication,"['aggressive systemic mastocytosis', 'Hepatomegaly', 'CYP1A2', 'Midostaurin']",0.5
15018,37714.0,Midostaurin,unclassified acute myeloid leukemia,disease-protein-drug,indication,"['unclassified acute myeloid leukemia', 'KIT', 'Midostaurin']",0.5
15018,38274.0,Midostaurin,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'KIT', 'Midostaurin']",0.5
15018,39124.0,Midostaurin,therapy related acute myeloid leukemia and myelodysplastic syndrome,disease-protein-drug,indication,"['therapy related acute myeloid leukemia and myelodysplastic syndrome', 'KIT', 'Midostaurin']",0.5
15018,39171.0,Midostaurin,mast cell leukemia,disease-protein-drug,indication,"['mast cell leukemia', 'KIT', 'Midostaurin']",0.5
15018,39498.0,Midostaurin,systemic mastocytosis,disease-protein-drug,indication,"['systemic mastocytosis', 'KIT', 'Midostaurin']",0.5
15018,83852.0,Midostaurin,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'KIT', 'Midostaurin']",0.5
15018,83853.0,Midostaurin,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'KIT', 'Midostaurin']",0.5
15018,83854.0,Midostaurin,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'KIT', 'Midostaurin']",0.5
15018,83855.0,Midostaurin,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'KIT', 'Midostaurin']",0.5
15018,83856.0,Midostaurin,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'KIT', 'Midostaurin']",0.5
15018,83857.0,Midostaurin,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'KIT', 'Midostaurin']",0.5
15018,83858.0,Midostaurin,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'KIT', 'Midostaurin']",0.5
15018,83859.0,Midostaurin,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'KIT', 'Midostaurin']",0.5
15018,83860.0,Midostaurin,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'KIT', 'Midostaurin']",0.5
15018,83861.0,Midostaurin,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'KIT', 'Midostaurin']",0.5
15018,83862.0,Midostaurin,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'KIT', 'Midostaurin']",0.5
15018,84326.0,Midostaurin,obsolete classic mast cell leukemia,disease-protein-drug,indication,"['obsolete classic mast cell leukemia', 'KIT', 'Midostaurin']",0.5
15018,84327.0,Midostaurin,aleukemic mast cell leukemia,disease-protein-drug,indication,"['aleukemic mast cell leukemia', 'KIT', 'Midostaurin']",0.5
15020,28640.0,Axitinib,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'FLT4', 'Axitinib']",0.5
15020,33643.0,Axitinib,renal cell carcinoma (disease),disease-protein-drug,indication,"['renal cell carcinoma (disease)', 'FLT4', 'Axitinib']",0.5
15020,33643.0,Axitinib,renal cell carcinoma (disease),disease-exposure-bioprocess-gene-drug,indication,"['renal cell carcinoma (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Axitinib']",0.5
15020,36935.0,Axitinib,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'FLT1', 'Axitinib']",0.5
15020,36937.0,Axitinib,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'FLT4', 'Axitinib']",0.5
15022,27326.0,Artemether,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Artemether']",0.5
15022,83751.0,Artemether,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Artemether']",0.5
15025,27476.0,Cabazitaxel,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Cabazitaxel']",0.5
15025,33632.0,Cabazitaxel,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Cabazitaxel']",0.5
15025,35565.0,Cabazitaxel,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Cabazitaxel']",0.5
15025,35764.0,Cabazitaxel,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Cabazitaxel']",0.5
15025,36104.0,Cabazitaxel,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Cabazitaxel']",0.5
15025,36229.0,Cabazitaxel,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Cabazitaxel']",0.5
15025,38312.0,Cabazitaxel,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Cabazitaxel']",0.5
15026,27933.0,Hydroxyprogesterone caproate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Hydroxyprogesterone caproate']",0.5
15026,27933.0,Hydroxyprogesterone caproate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,27933.0,Hydroxyprogesterone caproate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,29646.0,Hydroxyprogesterone caproate,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,29646.0,Hydroxyprogesterone caproate,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,30827.0,Hydroxyprogesterone caproate,endometrial cancer,disease-protein-drug,off-label use,"['endometrial cancer', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,33512.0,Hydroxyprogesterone caproate,preeclampsia,disease-exposure-bioprocess-gene-drug,contraindication,"['preeclampsia', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,33575.0,Hydroxyprogesterone caproate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,33575.0,Hydroxyprogesterone caproate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,33577.0,Hydroxyprogesterone caproate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Hydroxyprogesterone caproate']",0.5
15026,33577.0,Hydroxyprogesterone caproate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,33577.0,Hydroxyprogesterone caproate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,33675.0,Hydroxyprogesterone caproate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,33675.0,Hydroxyprogesterone caproate,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,35565.0,Hydroxyprogesterone caproate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,35738.0,Hydroxyprogesterone caproate,endometrial carcinoma (disease),disease-protein-drug,off-label use,"['endometrial carcinoma (disease)', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,35739.0,Hydroxyprogesterone caproate,uterine corpus cancer,disease-protein-drug,off-label use,"['uterine corpus cancer', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,35764.0,Hydroxyprogesterone caproate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,35764.0,Hydroxyprogesterone caproate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,36035.0,Hydroxyprogesterone caproate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Hydroxyprogesterone caproate']",0.5
15026,36634.0,Hydroxyprogesterone caproate,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,36634.0,Hydroxyprogesterone caproate,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,37038.0,Hydroxyprogesterone caproate,endometrium neoplasm,disease-protein-drug,off-label use,"['endometrium neoplasm', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,37703.0,Hydroxyprogesterone caproate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Hydroxyprogesterone caproate']",0.5
15026,83760.0,Hydroxyprogesterone caproate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Hydroxyprogesterone caproate']",0.5
15026,84172.0,Hydroxyprogesterone caproate,glucose intolerance,disease-exposure-bioprocess-gene-drug,contraindication,"['glucose intolerance', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15026,84172.0,Hydroxyprogesterone caproate,glucose intolerance,disease-exposure-gene-drug,contraindication,"['glucose intolerance', 'Arsenic', 'PGR', 'Hydroxyprogesterone caproate']",0.5
15026,84173.0,Hydroxyprogesterone caproate,prediabetes syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['prediabetes syndrome', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Hydroxyprogesterone caproate']",0.5
15027,31116.0,Crizotinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Crizotinib']",0.5
15027,33688.0,Crizotinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Crizotinib']",0.5
15028,33632.0,Boceprevir,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Boceprevir']",0.5
15028,36104.0,Boceprevir,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Boceprevir']",0.5
15028,36229.0,Boceprevir,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Boceprevir']",0.5
15028,37743.0,Boceprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Boceprevir']",0.5
15030,30039.0,Ponatinib,"chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['chronic myelogenous leukemia, BCR-ABL1 positive', 'ABL1', 'Ponatinib']",0.5
15030,30039.0,Ponatinib,"chronic myelogenous leukemia, BCR-ABL1 positive",disease-phenotype-protein-drug,indication,"['chronic myelogenous leukemia, BCR-ABL1 positive', 'Leukocytosis', 'FLT3', 'Ponatinib']",0.5
15033,30654.0,Idelalisib,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Idelalisib']",0.5
15035,27933.0,Vortioxetine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'CYP2C19', 'Vortioxetine']",0.5
15035,27933.0,Vortioxetine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1B', 'Vortioxetine']",0.5
15035,38957.0,Vortioxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'HTR1B', 'Vortioxetine']",0.5
15035,38957.0,Vortioxetine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Vortioxetine']",0.5
15035,83840.0,Vortioxetine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'CYP2C19', 'Vortioxetine']",0.5
15035,83841.0,Vortioxetine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'HTR1B', 'Vortioxetine']",0.5
15036,31477.0,Olaparib,ovarian cancer,disease-exposure-bioprocess-gene-drug,indication,"['ovarian cancer', 'Cadmium', 'cellular response to oxidative stress', 'PARP1', 'Olaparib']",0.5
15036,32617.0,Olaparib,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Olaparib']",0.5
15038,37743.0,Daclatasvir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Daclatasvir']",0.5
15040,37743.0,Paritaprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Paritaprevir']",0.5
15042,37743.0,Elbasvir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Elbasvir']",0.5
15043,37743.0,Asunaprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP2A6', 'Asunaprevir']",0.5
15045,28714.0,Tezacaftor,cystic fibrosis,disease-protein-drug,indication,"['cystic fibrosis', 'CFTR', 'Tezacaftor']",0.5
15045,28714.0,Tezacaftor,cystic fibrosis,disease-phenotype-protein-drug,indication,"['cystic fibrosis', 'Male infertility', 'CFTR', 'Tezacaftor']",0.5
15046,31116.0,Icotinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'EGFR', 'Icotinib']",0.5
15046,33688.0,Icotinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'EGFR', 'Icotinib']",0.5
15052,28391.0,Lemborexant,narcolepsy,disease-protein-drug,contraindication,"['narcolepsy', 'HCRTR2', 'Lemborexant']",0.5
15052,28391.0,Lemborexant,narcolepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['narcolepsy', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Lemborexant']",0.5
15052,30664.0,Lemborexant,X-linked adrenoleukodystrophy,disease-protein-drug,contraindication,"['X-linked adrenoleukodystrophy', 'HCRTR2', 'Lemborexant']",0.5
15052,33324.0,Lemborexant,narcolepsy-cataplexy syndrome,disease-protein-drug,contraindication,"['narcolepsy-cataplexy syndrome', 'HCRTR2', 'Lemborexant']",0.5
15052,35742.0,Lemborexant,central nervous system disease,disease-protein-drug,contraindication,"['central nervous system disease', 'HCRTR2', 'Lemborexant']",0.5
15052,84092.0,Lemborexant,Balo concentric sclerosis,disease-protein-drug,contraindication,"['Balo concentric sclerosis', 'HCRTR2', 'Lemborexant']",0.5
15054,33688.0,Lorlatinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ALK', 'Lorlatinib']",0.5
15055,29652.0,Deutetrabenazine,Huntington disease-like,disease-phenotype-protein-drug,indication,"['Huntington disease-like', 'Action tremor', 'CYP2D6', 'Deutetrabenazine']",0.5
15055,31245.0,Deutetrabenazine,Huntington disease,disease-phenotype-protein-drug,indication,"['Huntington disease', 'Rigidity', 'CYP2D6', 'Deutetrabenazine']",0.5
15055,32740.0,Deutetrabenazine,Huntington disease-like syndrome due to C9ORF72 expansions,disease-phenotype-protein-drug,indication,"['Huntington disease-like syndrome due to C9ORF72 expansions', 'Rigidity', 'CYP2D6', 'Deutetrabenazine']",0.5
15055,33341.0,Deutetrabenazine,juvenile Huntington disease,disease-phenotype-protein-drug,indication,"['juvenile Huntington disease', 'Rigidity', 'CYP2D6', 'Deutetrabenazine']",0.5
15057,31477.0,Rucaparib,ovarian cancer,disease-exposure-bioprocess-gene-drug,indication,"['ovarian cancer', 'Cadmium', 'cellular response to oxidative stress', 'PARP1', 'Rucaparib']",0.5
15057,32617.0,Rucaparib,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Rucaparib']",0.5
15059,33675.0,Troleandomycin,asthma,disease-exposure-bioprocess-gene-drug,off-label use,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Troleandomycin']",0.5
15064,27326.0,Mometasone furoate,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR3C1', 'Mometasone furoate']",0.5
15064,27326.0,Mometasone furoate,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'PGR', 'Mometasone furoate']",0.5
15064,29614.0,Mometasone furoate,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Mometasone furoate']",0.5
15064,33577.0,Mometasone furoate,hypertensive disorder,disease-protein-drug,contraindication,"['hypertensive disorder', 'CYP3A5', 'Mometasone furoate']",0.5
15064,33577.0,Mometasone furoate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Mometasone furoate']",0.5
15064,33577.0,Mometasone furoate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Mometasone furoate']",0.5
15064,33649.0,Mometasone furoate,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Mometasone furoate']",0.5
15064,33675.0,Mometasone furoate,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Mometasone furoate']",0.5
15064,33675.0,Mometasone furoate,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Arsenic', 'PGR', 'Mometasone furoate']",0.5
15064,33679.0,Mometasone furoate,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Mometasone furoate']",0.5
15064,35565.0,Mometasone furoate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Mometasone furoate']",0.5
15064,36034.0,Mometasone furoate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Mometasone furoate']",0.5
15064,36035.0,Mometasone furoate,hypertension,disease-protein-drug,contraindication,"['hypertension', 'CYP3A5', 'Mometasone furoate']",0.5
15064,36129.0,Mometasone furoate,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Mometasone furoate']",0.5
15064,36187.0,Mometasone furoate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Mometasone furoate']",0.5
15064,36187.0,Mometasone furoate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Mometasone furoate']",0.5
15064,37888.0,Mometasone furoate,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Mometasone furoate']",0.5
15064,39798.0,Mometasone furoate,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Mometasone furoate']",0.5
15064,39798.0,Mometasone furoate,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'PGR', 'Mometasone furoate']",0.5
15064,83830.0,Mometasone furoate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Mometasone furoate']",0.5
15073,27933.0,Fluvoxamine,anxiety disorder,disease-protein-drug,off-label use,"['anxiety disorder', 'ABCB1', 'Fluvoxamine']",0.5
15073,27933.0,Fluvoxamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Fluvoxamine']",0.5
15073,27933.0,Fluvoxamine,anxiety disorder,disease-exposure-gene-drug,off-label use,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Fluvoxamine']",0.5
15073,28249.0,Fluvoxamine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A4', 'Fluvoxamine']",0.5
15073,33091.0,Fluvoxamine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Nausea', 'ABCB1', 'Fluvoxamine']",0.5
15073,33454.0,Fluvoxamine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Elevated hepatic transaminase', 'CYP1A2', 'Fluvoxamine']",0.5
15073,35565.0,Fluvoxamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Fluvoxamine']",0.5
15073,35565.0,Fluvoxamine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Fluvoxamine']",0.5
15073,35641.0,Fluvoxamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Fluvoxamine']",0.5
15073,36105.0,Fluvoxamine,phobic disorder,disease-protein-drug,indication,"['phobic disorder', 'SLC6A4', 'Fluvoxamine']",0.5
15073,37703.0,Fluvoxamine,neurotic disorder,disease-protein-drug,off-label use,"['neurotic disorder', 'SLC6A4', 'Fluvoxamine']",0.5
15073,38242.0,Fluvoxamine,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'SLC6A4', 'Fluvoxamine']",0.5
15073,83760.0,Fluvoxamine,dysthymic disorder,disease-protein-drug,off-label use,"['dysthymic disorder', 'SLC6A4', 'Fluvoxamine']",0.5
15074,27921.0,Amphetamine,attention deficit-hyperactivity disorder,disease-protein-drug,indication,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Amphetamine']",0.5
15074,27933.0,Amphetamine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'MAOB', 'Amphetamine']",0.5
15074,27933.0,Amphetamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Amphetamine']",0.5
15074,28052.0,Amphetamine,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Arrhythmia', 'SLC22A5', 'Amphetamine']",0.5
15074,28249.0,Amphetamine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'MAOB', 'Amphetamine']",0.5
15074,28391.0,Amphetamine,narcolepsy,disease-exposure-bioprocess-gene-drug,indication,"['narcolepsy', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Amphetamine']",0.5
15074,28651.0,Amphetamine,monogenic obesity,disease-protein-drug,indication,"['monogenic obesity', 'ADRB1', 'Amphetamine']",0.5
15074,29113.0,Amphetamine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Amphetamine']",0.5
15074,29175.0,Amphetamine,thyrotoxicosis,disease-protein-drug,contraindication,"['thyrotoxicosis', 'CARTPT', 'Amphetamine']",0.5
15074,29525.0,Amphetamine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Amphetamine']",0.5
15074,30035.0,Amphetamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Amphetamine']",0.5
15074,31618.0,Amphetamine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'ADRA1B', 'Amphetamine']",0.5
15074,32313.0,Amphetamine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'ADRA1B', 'Amphetamine']",0.5
15074,32977.0,Amphetamine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ADRA1B', 'Amphetamine']",0.5
15074,33575.0,Amphetamine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Amphetamine']",0.5
15074,33575.0,Amphetamine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,33577.0,Amphetamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,33598.0,Amphetamine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Amphetamine']",0.5
15074,33632.0,Amphetamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'social behavior', 'SLC6A4', 'Amphetamine']",0.5
15074,33675.0,Amphetamine,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Amphetamine']",0.5
15074,33675.0,Amphetamine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,35565.0,Amphetamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A4', 'Amphetamine']",0.5
15074,35641.0,Amphetamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADRA1B', 'Amphetamine']",0.5
15074,35641.0,Amphetamine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Amphetamine']",0.5
15074,35669.0,Amphetamine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Amphetamine']",0.5
15074,35669.0,Amphetamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,35761.0,Amphetamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,35764.0,Amphetamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,35909.0,Amphetamine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Amphetamine']",0.5
15074,35915.0,Amphetamine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Amphetamine']",0.5
15074,35953.0,Amphetamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,36009.0,Amphetamine,tic disorder,disease-protein-drug,contraindication,"['tic disorder', 'SLC6A3', 'Amphetamine']",0.5
15074,36034.0,Amphetamine,hyperthyroidism,disease-protein-drug,contraindication,"['hyperthyroidism', 'CARTPT', 'Amphetamine']",0.5
15074,36034.0,Amphetamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Amphetamine']",0.5
15074,36080.0,Amphetamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of heart rate', 'DRD2', 'Amphetamine']",0.5
15074,36187.0,Amphetamine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Amphetamine']",0.5
15074,36187.0,Amphetamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,36266.0,Amphetamine,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'MAOB', 'Amphetamine']",0.5
15074,36693.0,Amphetamine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC6A4', 'Amphetamine']",0.5
15074,36693.0,Amphetamine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Amphetamine']",0.5
15074,37180.0,Amphetamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,37617.0,Amphetamine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,37703.0,Amphetamine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'MAOB', 'Amphetamine']",0.5
15074,37786.0,Amphetamine,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB1', 'Amphetamine']",0.5
15074,37786.0,Amphetamine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15074,38242.0,Amphetamine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'MAOB', 'Amphetamine']",0.5
15074,38242.0,Amphetamine,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Amphetamine']",0.5
15074,38784.0,Amphetamine,Graves disease,disease-protein-drug,contraindication,"['Graves disease', 'CARTPT', 'Amphetamine']",0.5
15074,83760.0,Amphetamine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'MAOB', 'Amphetamine']",0.5
15074,83778.0,Amphetamine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Amphetamine']",0.5
15074,83779.0,Amphetamine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Amphetamine']",0.5
15074,83805.0,Amphetamine,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'MAOB', 'Amphetamine']",0.5
15074,84036.0,Amphetamine,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'SLC6A3', 'Amphetamine']",0.5
15074,84036.0,Amphetamine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Amphetamine']",0.5
15075,27700.0,Cevimeline,sclerosing cholangitis,disease-exposure-bioprocess-gene-drug,contraindication,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Cevimeline']",0.5
15075,27700.0,Cevimeline,sclerosing cholangitis,disease-phenotype-protein-drug,contraindication,"['sclerosing cholangitis', 'Ascites', 'CHRM3', 'Cevimeline']",0.5
15075,33675.0,Cevimeline,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRM1', 'Cevimeline']",0.5
15075,37180.0,Cevimeline,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Cevimeline']",0.5
15075,37830.0,Cevimeline,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'cognition', 'CHRM1', 'Cevimeline']",0.5
15076,33575.0,Esmolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Esmolol']",0.5
15076,33675.0,Esmolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Esmolol']",0.5
15076,35764.0,Esmolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Esmolol']",0.5
15077,27326.0,Bortezomib,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Bortezomib']",0.5
15077,27326.0,Bortezomib,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Bortezomib']",0.5
15077,28149.0,Bortezomib,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Bortezomib']",0.5
15077,28396.0,Bortezomib,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Bortezomib']",0.5
15077,30494.0,Bortezomib,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Bortezomib']",0.5
15077,30494.0,Bortezomib,plasma cell myeloma,disease-phenotype-protein-drug,indication,"['plasma cell myeloma', 'Splenomegaly', 'CYP1A2', 'Bortezomib']",0.5
15077,30892.0,Bortezomib,newborn respiratory distress syndrome,disease-phenotype-protein-drug,contraindication,"['newborn respiratory distress syndrome', 'Bradycardia', 'CYP2D6', 'Bortezomib']",0.5
15077,32531.0,Bortezomib,mantle cell lymphoma,disease-phenotype-protein-drug,indication,"['mantle cell lymphoma', 'Splenomegaly', 'CYP1A2', 'Bortezomib']",0.5
15077,33063.0,Bortezomib,adult acute respiratory distress syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['adult acute respiratory distress syndrome', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Bortezomib']",0.5
15077,33575.0,Bortezomib,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Bortezomib']",0.5
15077,33575.0,Bortezomib,diabetes mellitus (disease),disease-exposure-cellcomp-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Particulate Matter', 'proteasome complex', 'PSMB1', 'Bortezomib']",0.5
15077,33575.0,Bortezomib,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PSMB5', 'Bortezomib']",0.5
15077,35552.0,Bortezomib,pneumonia,disease-exposure-cellcomp-gene-drug,contraindication,"['pneumonia', 'Particulate Matter', 'proteasome complex', 'PSMB1', 'Bortezomib']",0.5
15077,35552.0,Bortezomib,pneumonia,disease-exposure-bioprocess-gene-drug,contraindication,"['pneumonia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Bortezomib']",0.5
15077,35565.0,Bortezomib,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Bortezomib']",0.5
15077,35669.0,Bortezomib,heart disease,disease-exposure-cellcomp-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'proteasome complex', 'PSMB1', 'Bortezomib']",0.5
15077,35669.0,Bortezomib,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'response to oxidative stress', 'PSMB5', 'Bortezomib']",0.5
15077,35761.0,Bortezomib,cardiovascular disease,disease-exposure-cellcomp-gene-drug,contraindication,"['cardiovascular disease', 'Particulate Matter', 'proteasome complex', 'PSMB1', 'Bortezomib']",0.5
15077,35761.0,Bortezomib,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PSMB5', 'Bortezomib']",0.5
15077,36104.0,Bortezomib,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Bortezomib']",0.5
15077,36229.0,Bortezomib,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Bortezomib']",0.5
15078,27933.0,Tramadol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'SLC6A2', 'Tramadol']",0.5
15078,27933.0,Tramadol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Tramadol']",0.5
15078,27933.0,Tramadol,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'GRIN2B', 'Tramadol']",0.5
15078,30035.0,Tramadol,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Tramadol']",0.5
15078,30715.0,Tramadol,Wernicke-Korsakoff syndrome,disease-phenotype-protein-drug,contraindication,"['Wernicke-Korsakoff syndrome', 'Memory impairment', 'SLC6A4', 'Tramadol']",0.5
15078,31072.0,Tramadol,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Tramadol']",0.5
15078,33091.0,Tramadol,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Nausea', 'OPRM1', 'Tramadol']",0.5
15078,33575.0,Tramadol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'triglyceride homeostasis', 'ADORA1', 'Tramadol']",0.5
15078,33575.0,Tramadol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'GRIN2B', 'Tramadol']",0.5
15078,33577.0,Tramadol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Tramadol']",0.5
15078,33577.0,Tramadol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'GRIN2B', 'Tramadol']",0.5
15078,35565.0,Tramadol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'ADORA1', 'Tramadol']",0.5
15078,35641.0,Tramadol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Tramadol']",0.5
15078,35641.0,Tramadol,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Tramadol']",0.5
15078,36080.0,Tramadol,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Tramadol']",0.5
15078,36080.0,Tramadol,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'ADORA1', 'Tramadol']",0.5
15078,36693.0,Tramadol,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Tramadol']",0.5
15078,36693.0,Tramadol,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Tramadol']",0.5
15078,37703.0,Tramadol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'OPRM1', 'Tramadol']",0.5
15078,37761.0,Tramadol,substance withdrawal syndrome,disease-protein-drug,contraindication,"['substance withdrawal syndrome', 'ADORA1', 'Tramadol']",0.5
15078,37765.0,Tramadol,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'CHRM3', 'Tramadol']",0.5
15078,83760.0,Tramadol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'OPRM1', 'Tramadol']",0.5
15079,27933.0,Betaxolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ADRB1', 'Betaxolol']",0.5
15079,27933.0,Betaxolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Betaxolol']",0.5
15079,29113.0,Betaxolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Betaxolol']",0.5
15079,33575.0,Betaxolol,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Betaxolol']",0.5
15079,33575.0,Betaxolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Betaxolol']",0.5
15079,33577.0,Betaxolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Betaxolol']",0.5
15079,33675.0,Betaxolol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Betaxolol']",0.5
15079,33675.0,Betaxolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Betaxolol']",0.5
15079,35565.0,Betaxolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Betaxolol']",0.5
15079,35764.0,Betaxolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Betaxolol']",0.5
15079,35897.0,Betaxolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'methylation', 'CYP1A2', 'Betaxolol']",0.5
15079,37703.0,Betaxolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Betaxolol']",0.5
15079,39773.0,Betaxolol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ADRB2', 'Betaxolol']",0.5
15079,83760.0,Betaxolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Betaxolol']",0.5
15079,83781.0,Betaxolol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ADRB2', 'Betaxolol']",0.5
15081,36034.0,Midodrine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Midodrine']",0.5
15082,27326.0,Citalopram,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Citalopram']",0.5
15082,27326.0,Citalopram,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Citalopram']",0.5
15082,27933.0,Citalopram,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Citalopram']",0.5
15082,27933.0,Citalopram,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Citalopram']",0.5
15082,28249.0,Citalopram,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A4', 'Citalopram']",0.5
15082,28899.0,Citalopram,obsessive-compulsive disorder,disease-protein-drug,off-label use,"['obsessive-compulsive disorder', 'SLC6A4', 'Citalopram']",0.5
15082,28899.0,Citalopram,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['obsessive-compulsive disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Citalopram']",0.5
15082,33091.0,Citalopram,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Nausea', 'ABCB1', 'Citalopram']",0.5
15082,33454.0,Citalopram,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Elevated hepatic transaminase', 'CYP1A2', 'Citalopram']",0.5
15082,35565.0,Citalopram,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Citalopram']",0.5
15082,35641.0,Citalopram,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Citalopram']",0.5
15082,35641.0,Citalopram,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Citalopram']",0.5
15082,35669.0,Citalopram,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Citalopram']",0.5
15082,35761.0,Citalopram,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Citalopram']",0.5
15082,37703.0,Citalopram,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A4', 'Citalopram']",0.5
15082,38242.0,Citalopram,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A4', 'Citalopram']",0.5
15082,38242.0,Citalopram,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Citalopram']",0.5
15082,38957.0,Citalopram,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Citalopram']",0.5
15082,38957.0,Citalopram,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Citalopram']",0.5
15082,83751.0,Citalopram,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Citalopram']",0.5
15082,83760.0,Citalopram,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Citalopram']",0.5
15082,83840.0,Citalopram,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Citalopram']",0.5
15082,83841.0,Citalopram,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Citalopram']",0.5
15082,83903.0,Citalopram,post-traumatic stress disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['post-traumatic stress disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Citalopram']",0.5
15083,27933.0,Reboxetine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Reboxetine']",0.5
15083,27933.0,Reboxetine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Reboxetine']",0.5
15083,38957.0,Reboxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'ABCB1', 'Reboxetine']",0.5
15083,38957.0,Reboxetine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Reboxetine']",0.5
15083,83840.0,Reboxetine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Reboxetine']",0.5
15083,83841.0,Reboxetine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'ABCB1', 'Reboxetine']",0.5
15084,30813.0,Clotrimazole,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Clotrimazole']",0.5
15084,39798.0,Clotrimazole,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Clotrimazole']",0.5
15085,27286.0,Sulfanilamide,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'CYP2D6', 'Sulfanilamide']",0.5
15085,27292.0,Sulfanilamide,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Cardiomegaly', 'CYP2E1', 'Sulfanilamide']",0.5
15085,35565.0,Sulfanilamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Sulfanilamide']",0.5
15085,35764.0,Sulfanilamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Sulfanilamide']",0.5
15086,33577.0,Clemastine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Clemastine']",0.5
15086,36034.0,Clemastine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Clemastine']",0.5
15086,37888.0,Clemastine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Clemastine']",0.5
15086,37888.0,Clemastine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Clemastine']",0.5
15086,83791.0,Clemastine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Clemastine']",0.5
15087,27326.0,Venlafaxine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'memory', 'SLC6A4', 'Venlafaxine']",0.5
15087,27326.0,Venlafaxine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Venlafaxine']",0.5
15087,27655.0,Venlafaxine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'SLC6A2', 'Venlafaxine']",0.5
15087,27933.0,Venlafaxine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Venlafaxine']",0.5
15087,27933.0,Venlafaxine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Venlafaxine']",0.5
15087,28249.0,Venlafaxine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Venlafaxine']",0.5
15087,28456.0,Venlafaxine,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'SLC6A2', 'Venlafaxine']",0.5
15087,30035.0,Venlafaxine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Venlafaxine']",0.5
15087,33091.0,Venlafaxine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Nausea', 'ABCB1', 'Venlafaxine']",0.5
15087,33454.0,Venlafaxine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Nausea', 'ABCB1', 'Venlafaxine']",0.5
15087,33577.0,Venlafaxine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Venlafaxine']",0.5
15087,33695.0,Venlafaxine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'memory', 'SLC6A4', 'Venlafaxine']",0.5
15087,35565.0,Venlafaxine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A4', 'Venlafaxine']",0.5
15087,35641.0,Venlafaxine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Venlafaxine']",0.5
15087,35669.0,Venlafaxine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Venlafaxine']",0.5
15087,35761.0,Venlafaxine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Venlafaxine']",0.5
15087,35909.0,Venlafaxine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Venlafaxine']",0.5
15087,36034.0,Venlafaxine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Venlafaxine']",0.5
15087,36105.0,Venlafaxine,phobic disorder,disease-protein-drug,indication,"['phobic disorder', 'SLC6A3', 'Venlafaxine']",0.5
15087,36693.0,Venlafaxine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC6A4', 'Venlafaxine']",0.5
15087,38242.0,Venlafaxine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Venlafaxine']",0.5
15087,38957.0,Venlafaxine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Venlafaxine']",0.5
15087,38957.0,Venlafaxine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Venlafaxine']",0.5
15087,83840.0,Venlafaxine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Venlafaxine']",0.5
15087,83841.0,Venlafaxine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Venlafaxine']",0.5
15088,27559.0,Bupivacaine,dilated cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['dilated cardiomyopathy', 'Sudden death', 'SCN10A', 'Bupivacaine']",0.5
15088,28158.0,Bupivacaine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Bupivacaine']",0.5
15088,28547.0,Bupivacaine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'CYP2D6', 'Bupivacaine']",0.5
15088,28547.0,Bupivacaine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,28547.0,Bupivacaine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Bupivacaine']",0.5
15088,29525.0,Bupivacaine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Bupivacaine']",0.5
15088,30035.0,Bupivacaine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2D6', 'Bupivacaine']",0.5
15088,33577.0,Bupivacaine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Bupivacaine']",0.5
15088,33618.0,Bupivacaine,atrial fibrillation (disease),disease-protein-drug,contraindication,"['atrial fibrillation (disease)', 'SCN10A', 'Bupivacaine']",0.5
15088,33618.0,Bupivacaine,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,33675.0,Bupivacaine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,35565.0,Bupivacaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Bupivacaine']",0.5
15088,35669.0,Bupivacaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,35761.0,Bupivacaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,35764.0,Bupivacaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Bupivacaine']",0.5
15088,35897.0,Bupivacaine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,36034.0,Bupivacaine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Bupivacaine']",0.5
15088,36080.0,Bupivacaine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,36187.0,Bupivacaine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,36469.0,Bupivacaine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Bupivacaine']",0.5
15088,36492.0,Bupivacaine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Bupivacaine']",0.5
15088,36693.0,Bupivacaine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Bupivacaine']",0.5
15088,37180.0,Bupivacaine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,37617.0,Bupivacaine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Bupivacaine']",0.5
15088,37785.0,Bupivacaine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Bupivacaine']",0.5
15089,27361.0,Codeine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,27476.0,Codeine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,27503.0,Codeine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,27626.0,Codeine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'OPRD1', 'Codeine']",0.5
15089,27843.0,Codeine,acute intermittent porphyria,disease-phenotype-protein-drug,contraindication,"['acute intermittent porphyria', 'Respiratory insufficiency', 'OPRM1', 'Codeine']",0.5
15089,27933.0,Codeine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'OPRM1', 'Codeine']",0.5
15089,27933.0,Codeine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,28158.0,Codeine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,28473.0,Codeine,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Codeine']",0.5
15089,28780.0,Codeine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Codeine']",0.5
15089,28780.0,Codeine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,28780.0,Codeine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,28899.0,Codeine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,29525.0,Codeine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Codeine']",0.5
15089,30035.0,Codeine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Codeine']",0.5
15089,30664.0,Codeine,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,contraindication,"['X-linked adrenoleukodystrophy', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,30813.0,Codeine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,31072.0,Codeine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Codeine']",0.5
15089,31618.0,Codeine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Respiratory insufficiency', 'OPRM1', 'Codeine']",0.5
15089,32313.0,Codeine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,32384.0,Codeine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,32719.0,Codeine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Codeine']",0.5
15089,32737.0,Codeine,hypocomplementemic urticarial vasculitis,disease-phenotype-protein-drug,contraindication,"['hypocomplementemic urticarial vasculitis', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,32977.0,Codeine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'OPRM1', 'Codeine']",0.5
15089,33306.0,Codeine,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'CYP2D6', 'Codeine']",0.5
15089,33410.0,Codeine,dermatitis herpetiformis,disease-phenotype-protein-drug,contraindication,"['dermatitis herpetiformis', 'Pruritus', 'OPRM1', 'Codeine']",0.5
15089,33440.0,Codeine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Arrhythmia', 'OPRK1', 'Codeine']",0.5
15089,33454.0,Codeine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Arrhythmia', 'OPRK1', 'Codeine']",0.5
15089,33575.0,Codeine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,33577.0,Codeine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,33594.0,Codeine,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,33632.0,Codeine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,33675.0,Codeine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,33677.0,Codeine,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Codeine']",0.5
15089,35565.0,Codeine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Codeine']",0.5
15089,35641.0,Codeine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Codeine']",0.5
15089,35669.0,Codeine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,35761.0,Codeine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,35764.0,Codeine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,35897.0,Codeine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Codeine']",0.5
15089,35915.0,Codeine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,35953.0,Codeine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,36034.0,Codeine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,36080.0,Codeine,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Codeine']",0.5
15089,36187.0,Codeine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,36252.0,Codeine,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Codeine']",0.5
15089,36266.0,Codeine,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'OPRM1', 'Codeine']",0.5
15089,36469.0,Codeine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,36478.0,Codeine,nervous system disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['nervous system disorder', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,36492.0,Codeine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,36693.0,Codeine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Codeine']",0.5
15089,37180.0,Codeine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,37617.0,Codeine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,37703.0,Codeine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'OPRM1', 'Codeine']",0.5
15089,37785.0,Codeine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,37786.0,Codeine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,37811.0,Codeine,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,37830.0,Codeine,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Codeine']",0.5
15089,37888.0,Codeine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Codeine']",0.5
15089,38575.0,Codeine,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Codeine']",0.5
15089,83760.0,Codeine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'OPRM1', 'Codeine']",0.5
15089,83778.0,Codeine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,83779.0,Codeine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Codeine']",0.5
15089,83805.0,Codeine,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'OPRM1', 'Codeine']",0.5
15089,83910.0,Codeine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Codeine']",0.5
15089,83911.0,Codeine,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Codeine']",0.5
15090,29865.0,Clobazam,Lennox-Gastaut syndrome,disease-protein-drug,indication,"['Lennox-Gastaut syndrome', 'GABRB3', 'Clobazam']",0.5
15090,29865.0,Clobazam,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Focal-onset seizure', 'GABRA5', 'Clobazam']",0.5
15090,32456.0,Clobazam,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'GABRB3', 'Clobazam']",0.5
15090,32456.0,Clobazam,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'GABRA5', 'Clobazam']",0.5
15091,30035.0,Chlorzoxazone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Chlorzoxazone']",0.5
15091,35565.0,Chlorzoxazone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Chlorzoxazone']",0.5
15091,35565.0,Chlorzoxazone,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Chlorzoxazone']",0.5
15091,36544.0,Chlorzoxazone,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP2E1', 'Chlorzoxazone']",0.5
15091,36544.0,Chlorzoxazone,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Chlorzoxazone']",0.5
15092,29173.0,Vinorelbine,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Vinorelbine']",0.5
15092,35833.0,Vinorelbine,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Vinorelbine']",0.5
15093,27559.0,Clozapine,dilated cardiomyopathy,disease-exposure-bioprocess-gene-drug,contraindication,"['dilated cardiomyopathy', 'bisphenol A', 'social behavior', 'DRD3', 'Clozapine']",0.5
15093,27740.0,Clozapine,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Clozapine']",0.5
15093,28149.0,Clozapine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Clozapine']",0.5
15093,28396.0,Clozapine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Clozapine']",0.5
15093,28651.0,Clozapine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2A', 'Clozapine']",0.5
15093,28780.0,Clozapine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Clozapine']",0.5
15093,28780.0,Clozapine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Clozapine']",0.5
15093,28780.0,Clozapine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP1A1', 'Clozapine']",0.5
15093,28780.0,Clozapine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Clozapine']",0.5
15093,28780.0,Clozapine,Alzheimer disease,disease-exposure-molfunc-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'glutathione transferase activity', 'GSTP1', 'Clozapine']",0.5
15093,29113.0,Clozapine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Clozapine']",0.5
15093,29352.0,Clozapine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Fever', 'HTR1A', 'Clozapine']",0.5
15093,29494.0,Clozapine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A1', 'Clozapine']",0.5
15093,30184.0,Clozapine,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A1', 'Clozapine']",0.5
15093,30879.0,Clozapine,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'HTR1B', 'Clozapine']",0.5
15093,31393.0,Clozapine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Clozapine']",0.5
15093,31393.0,Clozapine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Clozapine']",0.5
15093,31393.0,Clozapine,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Pesticides', 'CYP1A1', 'Clozapine']",0.5
15093,31393.0,Clozapine,metabolic syndrome X,disease-exposure-molfunc-gene-drug,contraindication,"['metabolic syndrome X', 'Pesticides', 'glutathione transferase activity', 'GSTP1', 'Clozapine']",0.5
15093,33449.0,Clozapine,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Clozapine']",0.5
15093,33454.0,Clozapine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Clozapine']",0.5
15093,33593.0,Clozapine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2A', 'Clozapine']",0.5
15093,33593.0,Clozapine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Clozapine']",0.5
15093,33593.0,Clozapine,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'CYP1A1', 'Clozapine']",0.5
15093,33593.0,Clozapine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Clozapine']",0.5
15093,33598.0,Clozapine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'CHRM1', 'Clozapine']",0.5
15093,33598.0,Clozapine,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP1A1', 'Clozapine']",0.5
15093,33598.0,Clozapine,stroke disorder,disease-exposure-molfunc-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'glutathione transferase activity', 'GSTP1', 'Clozapine']",0.5
15093,33605.0,Clozapine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HTR1D', 'Clozapine']",0.5
15093,33699.0,Clozapine,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Clozapine']",0.5
15093,35565.0,Clozapine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Clozapine']",0.5
15093,35565.0,Clozapine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Clozapine']",0.5
15093,35641.0,Clozapine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Clozapine']",0.5
15093,35641.0,Clozapine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Clozapine']",0.5
15093,35909.0,Clozapine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Clozapine']",0.5
15093,36080.0,Clozapine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Clozapine']",0.5
15093,36104.0,Clozapine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Clozapine']",0.5
15093,36187.0,Clozapine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'GSTP1', 'Clozapine']",0.5
15093,36187.0,Clozapine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Clozapine']",0.5
15093,36187.0,Clozapine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Clozapine']",0.5
15093,36229.0,Clozapine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Clozapine']",0.5
15093,38928.0,Clozapine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Clozapine']",0.5
15093,83763.0,Clozapine,manic bipolar affective disorder,disease-protein-drug,off-label use,"['manic bipolar affective disorder', 'HTR2A', 'Clozapine']",0.5
15093,83764.0,Clozapine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Clozapine']",0.5
15093,83998.0,Clozapine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Clozapine']",0.5
15094,27933.0,Mirtazapine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ADRA2A', 'Mirtazapine']",0.5
15094,27933.0,Mirtazapine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Mirtazapine']",0.5
15094,28396.0,Mirtazapine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Mirtazapine']",0.5
15094,28651.0,Mirtazapine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2A', 'Mirtazapine']",0.5
15094,33091.0,Mirtazapine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Fever', 'HTR2A', 'Mirtazapine']",0.5
15094,33593.0,Mirtazapine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2A', 'Mirtazapine']",0.5
15094,33593.0,Mirtazapine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Mirtazapine']",0.5
15094,33593.0,Mirtazapine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Mirtazapine']",0.5
15094,33598.0,Mirtazapine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Mirtazapine']",0.5
15094,33605.0,Mirtazapine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Mirtazapine']",0.5
15094,33695.0,Mirtazapine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Mirtazapine']",0.5
15094,35565.0,Mirtazapine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Mirtazapine']",0.5
15094,35641.0,Mirtazapine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADRA1B', 'Mirtazapine']",0.5
15094,35641.0,Mirtazapine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Mirtazapine']",0.5
15094,35909.0,Mirtazapine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Mirtazapine']",0.5
15094,37180.0,Mirtazapine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Mirtazapine']",0.5
15094,38957.0,Mirtazapine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Mirtazapine']",0.5
15094,38957.0,Mirtazapine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Mirtazapine']",0.5
15094,83763.0,Mirtazapine,manic bipolar affective disorder,disease-protein-drug,contraindication,"['manic bipolar affective disorder', 'SLC6A4', 'Mirtazapine']",0.5
15094,83840.0,Mirtazapine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ADRA2A', 'Mirtazapine']",0.5
15094,83841.0,Mirtazapine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Mirtazapine']",0.5
15094,83903.0,Mirtazapine,post-traumatic stress disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['post-traumatic stress disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Mirtazapine']",0.5
15095,27933.0,Timolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Timolol']",0.5
15095,27933.0,Timolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Timolol']",0.5
15095,28149.0,Timolol,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Timolol']",0.5
15095,28396.0,Timolol,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Timolol']",0.5
15095,29113.0,Timolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Timolol']",0.5
15095,29182.0,Timolol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Timolol']",0.5
15095,33534.0,Timolol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Vomiting', 'ABCB1', 'Timolol']",0.5
15095,33575.0,Timolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Timolol']",0.5
15095,33577.0,Timolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Timolol']",0.5
15095,33679.0,Timolol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Timolol']",0.5
15095,35565.0,Timolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Timolol']",0.5
15095,35764.0,Timolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Timolol']",0.5
15095,35897.0,Timolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Timolol']",0.5
15095,35909.0,Timolol,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2D6', 'Timolol']",0.5
15095,36034.0,Timolol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Timolol']",0.5
15095,36432.0,Timolol,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRB1', 'Timolol']",0.5
15095,37659.0,Timolol,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ADRB1', 'Timolol']",0.5
15095,37659.0,Timolol,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Cadmium', 'bone resorption', 'ADRB2', 'Timolol']",0.5
15095,37703.0,Timolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Timolol']",0.5
15095,83760.0,Timolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Timolol']",0.5
15095,83802.0,Timolol,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Timolol']",0.5
15097,35565.0,Mexiletine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'AHR', 'Mexiletine']",0.5
15097,37180.0,Mexiletine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'blood vessel development', 'AHR', 'Mexiletine']",0.5
15097,37180.0,Mexiletine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'AHR', 'Mexiletine']",0.5
15097,38396.0,Mexiletine,familial sick sinus syndrome,disease-protein-drug,contraindication,"['familial sick sinus syndrome', 'SCN5A', 'Mexiletine']",0.5
15097,38958.0,Mexiletine,sick sinus syndrome,disease-protein-drug,contraindication,"['sick sinus syndrome', 'SCN5A', 'Mexiletine']",0.5
15098,27326.0,Promazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Promazine']",0.5
15098,27326.0,Promazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Promazine']",0.5
15098,27655.0,Promazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD2', 'Promazine']",0.5
15098,27843.0,Promazine,acute intermittent porphyria,disease-phenotype-protein-drug,indication,"['acute intermittent porphyria', 'Tachycardia', 'DRD2', 'Promazine']",0.5
15098,28313.0,Promazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HRH1', 'Promazine']",0.5
15098,28313.0,Promazine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,28375.0,Promazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Promazine']",0.5
15098,28396.0,Promazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Promazine']",0.5
15098,28547.0,Promazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'DRD2', 'Promazine']",0.5
15098,28547.0,Promazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,28547.0,Promazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Promazine']",0.5
15098,28651.0,Promazine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2A', 'Promazine']",0.5
15098,28780.0,Promazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Promazine']",0.5
15098,28780.0,Promazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,28780.0,Promazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD2', 'Promazine']",0.5
15098,29637.0,Promazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Promazine']",0.5
15098,29637.0,Promazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD2', 'Promazine']",0.5
15098,30035.0,Promazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'DRD2', 'Promazine']",0.5
15098,31393.0,Promazine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Promazine']",0.5
15098,31393.0,Promazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'inflammatory response', 'HRH1', 'Promazine']",0.5
15098,33454.0,Promazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Promazine']",0.5
15098,33593.0,Promazine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2A', 'Promazine']",0.5
15098,33593.0,Promazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,33593.0,Promazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Promazine']",0.5
15098,33632.0,Promazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Promazine']",0.5
15098,35565.0,Promazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,35641.0,Promazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD2', 'Promazine']",0.5
15098,35641.0,Promazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Promazine']",0.5
15098,35915.0,Promazine,mental disorder,disease-protein-drug,indication,"['mental disorder', 'HTR2A', 'Promazine']",0.5
15098,35915.0,Promazine,mental disorder,disease-exposure-bioprocess-gene-drug,indication,"['mental disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,36187.0,Promazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,37180.0,Promazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,37706.0,Promazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Promazine']",0.5
15098,37786.0,Promazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,38003.0,Promazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD2', 'Promazine']",0.5
15098,38928.0,Promazine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Promazine']",0.5
15098,39081.0,Promazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Promazine']",0.5
15098,83751.0,Promazine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Promazine']",0.5
15098,83763.0,Promazine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'HTR2A', 'Promazine']",0.5
15098,83778.0,Promazine,schizophreniform disorder,disease-protein-drug,indication,"['schizophreniform disorder', 'HTR2A', 'Promazine']",0.5
15098,83778.0,Promazine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizophreniform disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,83779.0,Promazine,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'HTR2A', 'Promazine']",0.5
15098,83779.0,Promazine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizoaffective disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Promazine']",0.5
15098,83791.0,Promazine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Promazine']",0.5
15098,83998.0,Promazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Promazine']",0.5
15098,84023.0,Promazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Promazine']",0.5
15099,27933.0,Zolpidem,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Zolpidem']",0.5
15099,27933.0,Zolpidem,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Zolpidem']",0.5
15099,30035.0,Zolpidem,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRG2', 'Zolpidem']",0.5
15099,35565.0,Zolpidem,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Zolpidem']",0.5
15099,36693.0,Zolpidem,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Zolpidem']",0.5
15099,37703.0,Zolpidem,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Zolpidem']",0.5
15099,83760.0,Zolpidem,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Zolpidem']",0.5
15099,84036.0,Zolpidem,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,contraindication,"['attention deficit hyperactivity disorder, inattentive type', 'perfluorohexanesulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Zolpidem']",0.5
15100,27326.0,Prochlorperazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Prochlorperazine']",0.5
15100,27326.0,Prochlorperazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Prochlorperazine']",0.5
15100,27655.0,Prochlorperazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ADRA1B', 'Prochlorperazine']",0.5
15100,28158.0,Prochlorperazine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Prochlorperazine']",0.5
15100,28313.0,Prochlorperazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HRH1', 'Prochlorperazine']",0.5
15100,28313.0,Prochlorperazine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Prochlorperazine']",0.5
15100,28375.0,Prochlorperazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Prochlorperazine']",0.5
15100,28396.0,Prochlorperazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Prochlorperazine']",0.5
15100,28547.0,Prochlorperazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'DRD2', 'Prochlorperazine']",0.5
15100,28547.0,Prochlorperazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Prochlorperazine']",0.5
15100,28547.0,Prochlorperazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Prochlorperazine']",0.5
15100,28780.0,Prochlorperazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Prochlorperazine']",0.5
15100,28780.0,Prochlorperazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'HRH1', 'Prochlorperazine']",0.5
15100,28780.0,Prochlorperazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ADRA1B', 'Prochlorperazine']",0.5
15100,29637.0,Prochlorperazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Prochlorperazine']",0.5
15100,29637.0,Prochlorperazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'ADRA1B', 'Prochlorperazine']",0.5
15100,30035.0,Prochlorperazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'DRD2', 'Prochlorperazine']",0.5
15100,31393.0,Prochlorperazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Prochlorperazine']",0.5
15100,31650.0,Prochlorperazine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ADRA1B', 'Prochlorperazine']",0.5
15100,33454.0,Prochlorperazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Prochlorperazine']",0.5
15100,33593.0,Prochlorperazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Prochlorperazine']",0.5
15100,33593.0,Prochlorperazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'DRD2', 'Prochlorperazine']",0.5
15100,33632.0,Prochlorperazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'memory', 'HRH1', 'Prochlorperazine']",0.5
15100,35565.0,Prochlorperazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Prochlorperazine']",0.5
15100,35641.0,Prochlorperazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADRA1B', 'Prochlorperazine']",0.5
15100,35641.0,Prochlorperazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Prochlorperazine']",0.5
15100,35764.0,Prochlorperazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Prochlorperazine']",0.5
15100,36034.0,Prochlorperazine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Prochlorperazine']",0.5
15100,36187.0,Prochlorperazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Prochlorperazine']",0.5
15100,36274.0,Prochlorperazine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'HRH1', 'Prochlorperazine']",0.5
15100,37180.0,Prochlorperazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Prochlorperazine']",0.5
15100,37706.0,Prochlorperazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Prochlorperazine']",0.5
15100,37785.0,Prochlorperazine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'HRH1', 'Prochlorperazine']",0.5
15100,37786.0,Prochlorperazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Prochlorperazine']",0.5
15100,38003.0,Prochlorperazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD2', 'Prochlorperazine']",0.5
15100,39081.0,Prochlorperazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Prochlorperazine']",0.5
15100,83764.0,Prochlorperazine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Prochlorperazine']",0.5
15100,83998.0,Prochlorperazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Prochlorperazine']",0.5
15100,84023.0,Prochlorperazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Prochlorperazine']",0.5
15101,27366.0,Celecoxib,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Celecoxib']",0.5
15101,29078.0,Celecoxib,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Celecoxib']",0.5
15101,29078.0,Celecoxib,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Celecoxib']",0.5
15101,29078.0,Celecoxib,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15101,29078.0,Celecoxib,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Celecoxib']",0.5
15101,30035.0,Celecoxib,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Celecoxib']",0.5
15101,32325.0,Celecoxib,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Fever', 'PTGS2', 'Celecoxib']",0.5
15101,33577.0,Celecoxib,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Celecoxib']",0.5
15101,33577.0,Celecoxib,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15101,33598.0,Celecoxib,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Celecoxib']",0.5
15101,33598.0,Celecoxib,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Celecoxib']",0.5
15101,33598.0,Celecoxib,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15101,33632.0,Celecoxib,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Celecoxib']",0.5
15101,33632.0,Celecoxib,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15101,33675.0,Celecoxib,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of blood pressure', 'PTGS2', 'Celecoxib']",0.5
15101,33675.0,Celecoxib,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15101,35565.0,Celecoxib,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Celecoxib']",0.5
15101,35669.0,Celecoxib,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS2', 'Celecoxib']",0.5
15101,35669.0,Celecoxib,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15101,35761.0,Celecoxib,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS2', 'Celecoxib']",0.5
15101,35761.0,Celecoxib,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15101,35764.0,Celecoxib,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Celecoxib']",0.5
15101,35764.0,Celecoxib,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Celecoxib']",0.5
15101,35909.0,Celecoxib,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Celecoxib']",0.5
15101,35909.0,Celecoxib,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15101,36432.0,Celecoxib,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'PDPK1', 'Celecoxib']",0.5
15101,37180.0,Celecoxib,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS2', 'Celecoxib']",0.5
15101,37180.0,Celecoxib,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS2', 'Celecoxib']",0.5
15102,27326.0,Sotalol,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Sotalol']",0.5
15102,27326.0,Sotalol,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of ventricular cardiac muscle cell membrane repolarization', 'KCNH2', 'Sotalol']",0.5
15102,27326.0,Sotalol,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Sotalol']",0.5
15102,27655.0,Sotalol,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Sotalol']",0.5
15102,29113.0,Sotalol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Sotalol']",0.5
15102,33575.0,Sotalol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'KCNH2', 'Sotalol']",0.5
15102,33618.0,Sotalol,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'KCNH2', 'Sotalol']",0.5
15102,33618.0,Sotalol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Sotalol']",0.5
15102,33675.0,Sotalol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Sotalol']",0.5
15102,33675.0,Sotalol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'KCNH2', 'Sotalol']",0.5
15102,33679.0,Sotalol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Sotalol']",0.5
15102,39773.0,Sotalol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ADRB2', 'Sotalol']",0.5
15102,83751.0,Sotalol,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'KCNH2', 'Sotalol']",0.5
15102,83781.0,Sotalol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ADRB2', 'Sotalol']",0.5
15103,28158.0,Darifenacin,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Darifenacin']",0.5
15103,31650.0,Darifenacin,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Darifenacin']",0.5
15103,35565.0,Darifenacin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Darifenacin']",0.5
15103,37785.0,Darifenacin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Darifenacin']",0.5
15104,27286.0,Dextromethorphan,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'CYP2D6', 'Dextromethorphan']",0.5
15104,27292.0,Dextromethorphan,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Areflexia', 'CHRNB2', 'Dextromethorphan']",0.5
15104,27326.0,Dextromethorphan,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'DNA repair', 'CHRNA4', 'Dextromethorphan']",0.5
15104,27326.0,Dextromethorphan,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Dextromethorphan']",0.5
15104,27476.0,Dextromethorphan,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cognition', 'CHRNA4', 'Dextromethorphan']",0.5
15104,27503.0,Dextromethorphan,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'OPRM1', 'Dextromethorphan']",0.5
15104,27626.0,Dextromethorphan,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'OPRD1', 'Dextromethorphan']",0.5
15104,27655.0,Dextromethorphan,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'OPRM1', 'Dextromethorphan']",0.5
15104,28042.0,Dextromethorphan,hyperkalemic periodic paralysis,disease-phenotype-protein-drug,contraindication,"['hyperkalemic periodic paralysis', 'Respiratory insufficiency', 'OPRM1', 'Dextromethorphan']",0.5
15104,28158.0,Dextromethorphan,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'NCF4', 'Dextromethorphan']",0.5
15104,28158.0,Dextromethorphan,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Dextromethorphan']",0.5
15104,29525.0,Dextromethorphan,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Dextromethorphan']",0.5
15104,30035.0,Dextromethorphan,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRNB4', 'Dextromethorphan']",0.5
15104,30664.0,Dextromethorphan,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,contraindication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'CHRNB2', 'Dextromethorphan']",0.5
15104,31072.0,Dextromethorphan,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Dextromethorphan']",0.5
15104,31168.0,Dextromethorphan,pyruvate dehydrogenase E3 deficiency,disease-phenotype-protein-drug,contraindication,"['pyruvate dehydrogenase E3 deficiency', 'Hepatomegaly', 'CYBA', 'Dextromethorphan']",0.5
15104,31618.0,Dextromethorphan,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Respiratory insufficiency', 'OPRM1', 'Dextromethorphan']",0.5
15104,31650.0,Dextromethorphan,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'OPRM1', 'Dextromethorphan']",0.5
15104,31732.0,Dextromethorphan,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'SLC6A4', 'Dextromethorphan']",0.5
15104,32313.0,Dextromethorphan,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'OPRM1', 'Dextromethorphan']",0.5
15104,32737.0,Dextromethorphan,hypocomplementemic urticarial vasculitis,disease-phenotype-protein-drug,contraindication,"['hypocomplementemic urticarial vasculitis', 'Hepatomegaly', 'CYBA', 'Dextromethorphan']",0.5
15104,33410.0,Dextromethorphan,dermatitis herpetiformis,disease-phenotype-protein-drug,contraindication,"['dermatitis herpetiformis', 'Pruritus', 'OPRM1', 'Dextromethorphan']",0.5
15104,33454.0,Dextromethorphan,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Elevated hepatic transaminase', 'RAC1', 'Dextromethorphan']",0.5
15104,33575.0,Dextromethorphan,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYBA', 'Dextromethorphan']",0.5
15104,33575.0,Dextromethorphan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Dextromethorphan']",0.5
15104,33577.0,Dextromethorphan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Dextromethorphan']",0.5
15104,33603.0,Dextromethorphan,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'CYBA', 'Dextromethorphan']",0.5
15104,35565.0,Dextromethorphan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Dextromethorphan']",0.5
15104,35641.0,Dextromethorphan,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Dextromethorphan']",0.5
15104,35641.0,Dextromethorphan,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Dextromethorphan']",0.5
15104,35669.0,Dextromethorphan,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'CYBA', 'Dextromethorphan']",0.5
15104,35761.0,Dextromethorphan,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Dextromethorphan']",0.5
15104,35764.0,Dextromethorphan,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'SLC6A4', 'Dextromethorphan']",0.5
15104,35897.0,Dextromethorphan,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cell population proliferation', 'RAC1', 'Dextromethorphan']",0.5
15104,35953.0,Dextromethorphan,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'CYBA', 'Dextromethorphan']",0.5
15104,35953.0,Dextromethorphan,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'CYBA', 'Dextromethorphan']",0.5
15104,36034.0,Dextromethorphan,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'CHRNA7', 'Dextromethorphan']",0.5
15104,36080.0,Dextromethorphan,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Dextromethorphan']",0.5
15104,36080.0,Dextromethorphan,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRNA4', 'Dextromethorphan']",0.5
15104,36187.0,Dextromethorphan,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'CYBA', 'Dextromethorphan']",0.5
15104,36252.0,Dextromethorphan,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'cell population proliferation', 'RAC1', 'Dextromethorphan']",0.5
15104,36274.0,Dextromethorphan,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'bone resorption', 'RAC1', 'Dextromethorphan']",0.5
15104,36469.0,Dextromethorphan,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'CHRNA7', 'Dextromethorphan']",0.5
15104,36478.0,Dextromethorphan,nervous system disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['nervous system disorder', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2C9', 'Dextromethorphan']",0.5
15104,36492.0,Dextromethorphan,brain cancer,disease-protein-drug,contraindication,"['brain cancer', 'CYP2C9', 'Dextromethorphan']",0.5
15104,36492.0,Dextromethorphan,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Dextromethorphan']",0.5
15104,36693.0,Dextromethorphan,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Dextromethorphan']",0.5
15104,36693.0,Dextromethorphan,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Dextromethorphan']",0.5
15104,37180.0,Dextromethorphan,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'CYBA', 'Dextromethorphan']",0.5
15104,37617.0,Dextromethorphan,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'CYBA', 'Dextromethorphan']",0.5
15104,37659.0,Dextromethorphan,heart failure,disease-protein-drug,contraindication,"['heart failure', 'RAC1', 'Dextromethorphan']",0.5
15104,37659.0,Dextromethorphan,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'CYBA', 'Dextromethorphan']",0.5
15104,37785.0,Dextromethorphan,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRNA4', 'Dextromethorphan']",0.5
15104,37811.0,Dextromethorphan,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'CYBA', 'Dextromethorphan']",0.5
15104,37830.0,Dextromethorphan,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'CYBA', 'Dextromethorphan']",0.5
15104,37888.0,Dextromethorphan,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Dextromethorphan']",0.5
15104,83751.0,Dextromethorphan,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Dextromethorphan']",0.5
15104,83910.0,Dextromethorphan,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Dextromethorphan']",0.5
15105,29113.0,Carteolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Carteolol']",0.5
15105,33575.0,Carteolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Carteolol']",0.5
15105,33577.0,Carteolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Carteolol']",0.5
15105,33675.0,Carteolol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Carteolol']",0.5
15105,33675.0,Carteolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Carteolol']",0.5
15105,35897.0,Carteolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Carteolol']",0.5
15105,36432.0,Carteolol,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRB1', 'Carteolol']",0.5
15105,37659.0,Carteolol,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ADRB1', 'Carteolol']",0.5
15105,37659.0,Carteolol,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Cadmium', 'bone resorption', 'ADRB2', 'Carteolol']",0.5
15105,37830.0,Carteolol,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Carteolol']",0.5
15105,39773.0,Carteolol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ADRB2', 'Carteolol']",0.5
15105,83781.0,Carteolol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ADRB2', 'Carteolol']",0.5
15107,27476.0,Vinblastine,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'ABCC2', 'Vinblastine']",0.5
15107,27476.0,Vinblastine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'female pregnancy', 'ABCC2', 'Vinblastine']",0.5
15107,27933.0,Vinblastine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Vinblastine']",0.5
15107,27933.0,Vinblastine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of inflammatory response', 'ABCC1', 'Vinblastine']",0.5
15107,29993.0,Vinblastine,classic Hodgkin lymphoma,disease-phenotype-protein-drug,indication,"['classic Hodgkin lymphoma', 'Pruritus', 'ABCB11', 'Vinblastine']",0.5
15107,30990.0,Vinblastine,mycosis fungoides and variants,disease-phenotype-protein-drug,indication,"['mycosis fungoides and variants', 'Pruritus', 'ABCB11', 'Vinblastine']",0.5
15107,31116.0,Vinblastine,lung cancer,disease-protein-drug,off-label use,"['lung cancer', 'ABCB1', 'Vinblastine']",0.5
15107,31756.0,Vinblastine,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder cancer', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Vinblastine']",0.5
15107,33077.0,Vinblastine,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'inflammatory response', 'ABCC2', 'Vinblastine']",0.5
15107,33077.0,Vinblastine,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Pruritus', 'ABCB11', 'Vinblastine']",0.5
15107,33188.0,Vinblastine,neuroblastoma,disease-protein-drug,off-label use,"['neuroblastoma', 'ABCB1', 'Vinblastine']",0.5
15107,33642.0,Vinblastine,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Vinblastine']",0.5
15107,33688.0,Vinblastine,non-small cell lung carcinoma (disease),disease-protein-drug,off-label use,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Vinblastine']",0.5
15107,35616.0,Vinblastine,testicular cancer,disease-exposure-bioprocess-gene-drug,indication,"['testicular cancer', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Vinblastine']",0.5
15107,35624.0,Vinblastine,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Vinblastine']",0.5
15107,35650.0,Vinblastine,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Benzene', 'inflammatory response', 'ABCC2', 'Vinblastine']",0.5
15107,35833.0,Vinblastine,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'JUN', 'Vinblastine']",0.5
15107,36104.0,Vinblastine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Vinblastine']",0.5
15107,36187.0,Vinblastine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'TUBA1A', 'Vinblastine']",0.5
15107,36187.0,Vinblastine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'JUN', 'Vinblastine']",0.5
15107,36229.0,Vinblastine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Vinblastine']",0.5
15107,36645.0,Vinblastine,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'ABCC2', 'Vinblastine']",0.5
15107,37703.0,Vinblastine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Vinblastine']",0.5
15107,37786.0,Vinblastine,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'TUBA1A', 'Vinblastine']",0.5
15107,37786.0,Vinblastine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'JUN', 'Vinblastine']",0.5
15107,38312.0,Vinblastine,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'ABCC2', 'Vinblastine']",0.5
15107,83760.0,Vinblastine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Vinblastine']",0.5
15107,83802.0,Vinblastine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Vinblastine']",0.5
15108,28149.0,Doxazosin,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Doxazosin']",0.5
15108,28396.0,Doxazosin,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Doxazosin']",0.5
15108,33577.0,Doxazosin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Doxazosin']",0.5
15108,33605.0,Doxazosin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Doxazosin']",0.5
15108,35565.0,Doxazosin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Doxazosin']",0.5
15109,35565.0,Piperazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Piperazine']",0.5
15109,35641.0,Piperazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRB3', 'Piperazine']",0.5
15109,35764.0,Piperazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Piperazine']",0.5
15110,27326.0,Fluphenazine,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CALM1', 'Fluphenazine']",0.5
15110,27326.0,Fluphenazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Fluphenazine']",0.5
15110,27326.0,Fluphenazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Fluphenazine']",0.5
15110,27626.0,Fluphenazine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'AR', 'Fluphenazine']",0.5
15110,27655.0,Fluphenazine,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'CALM1', 'Fluphenazine']",0.5
15110,27655.0,Fluphenazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Fluphenazine']",0.5
15110,28149.0,Fluphenazine,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Fluphenazine']",0.5
15110,28313.0,Fluphenazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'CYP2E1', 'Fluphenazine']",0.5
15110,28313.0,Fluphenazine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Fluphenazine']",0.5
15110,28375.0,Fluphenazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Fluphenazine']",0.5
15110,28396.0,Fluphenazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Fluphenazine']",0.5
15110,28547.0,Fluphenazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'CYP2E1', 'Fluphenazine']",0.5
15110,28547.0,Fluphenazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluphenazine']",0.5
15110,28547.0,Fluphenazine,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Pesticides', 'CYP2E1', 'Fluphenazine']",0.5
15110,28547.0,Fluphenazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Fluphenazine']",0.5
15110,28651.0,Fluphenazine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'CYP2E1', 'Fluphenazine']",0.5
15110,28780.0,Fluphenazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CALM1', 'Fluphenazine']",0.5
15110,28780.0,Fluphenazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'spermatogenesis', 'AR', 'Fluphenazine']",0.5
15110,28780.0,Fluphenazine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP2E1', 'Fluphenazine']",0.5
15110,28780.0,Fluphenazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Fluphenazine']",0.5
15110,29637.0,Fluphenazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Fluphenazine']",0.5
15110,29637.0,Fluphenazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD1', 'Fluphenazine']",0.5
15110,30035.0,Fluphenazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Fluphenazine']",0.5
15110,31393.0,Fluphenazine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Fluphenazine']",0.5
15110,31393.0,Fluphenazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Lead', 'regulation of systemic arterial blood pressure', 'AR', 'Fluphenazine']",0.5
15110,31393.0,Fluphenazine,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Pesticides', 'CYP2E1', 'Fluphenazine']",0.5
15110,31395.0,Fluphenazine,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Fluphenazine']",0.5
15110,33454.0,Fluphenazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Fluphenazine']",0.5
15110,33593.0,Fluphenazine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'CYP2E1', 'Fluphenazine']",0.5
15110,33593.0,Fluphenazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'spermatogenesis', 'AR', 'Fluphenazine']",0.5
15110,33593.0,Fluphenazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CALM1', 'Fluphenazine']",0.5
15110,33632.0,Fluphenazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of systemic arterial blood pressure', 'AR', 'Fluphenazine']",0.5
15110,35565.0,Fluphenazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Fluphenazine']",0.5
15110,35641.0,Fluphenazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Fluphenazine']",0.5
15110,35641.0,Fluphenazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Fluphenazine']",0.5
15110,35915.0,Fluphenazine,mental disorder,disease-protein-drug,indication,"['mental disorder', 'HTR2A', 'Fluphenazine']",0.5
15110,35915.0,Fluphenazine,mental disorder,disease-exposure-bioprocess-gene-drug,indication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Fluphenazine']",0.5
15110,36104.0,Fluphenazine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Fluphenazine']",0.5
15110,36187.0,Fluphenazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluphenazine']",0.5
15110,36229.0,Fluphenazine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Fluphenazine']",0.5
15110,37180.0,Fluphenazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluphenazine']",0.5
15110,37180.0,Fluphenazine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'CYP2E1', 'Fluphenazine']",0.5
15110,37706.0,Fluphenazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Fluphenazine']",0.5
15110,37786.0,Fluphenazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Fluphenazine']",0.5
15110,38003.0,Fluphenazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD2', 'Fluphenazine']",0.5
15110,38928.0,Fluphenazine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Fluphenazine']",0.5
15110,39081.0,Fluphenazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Fluphenazine']",0.5
15110,83778.0,Fluphenazine,schizophreniform disorder,disease-protein-drug,indication,"['schizophreniform disorder', 'HTR2A', 'Fluphenazine']",0.5
15110,83778.0,Fluphenazine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Fluphenazine']",0.5
15110,83779.0,Fluphenazine,schizoaffective disorder,disease-protein-drug,indication,"['schizoaffective disorder', 'HTR2A', 'Fluphenazine']",0.5
15110,83779.0,Fluphenazine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,indication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Fluphenazine']",0.5
15110,83998.0,Fluphenazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Fluphenazine']",0.5
15110,84023.0,Fluphenazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Fluphenazine']",0.5
15111,33575.0,Dexmedetomidine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Dexmedetomidine']",0.5
15111,33575.0,Dexmedetomidine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Dexmedetomidine']",0.5
15111,33575.0,Dexmedetomidine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Dexmedetomidine']",0.5
15111,33577.0,Dexmedetomidine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Dexmedetomidine']",0.5
15111,33577.0,Dexmedetomidine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Dexmedetomidine']",0.5
15111,33605.0,Dexmedetomidine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA2A', 'Dexmedetomidine']",0.5
15111,35565.0,Dexmedetomidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Dexmedetomidine']",0.5
15111,35565.0,Dexmedetomidine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Dexmedetomidine']",0.5
15111,35764.0,Dexmedetomidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Dexmedetomidine']",0.5
15111,35764.0,Dexmedetomidine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Dexmedetomidine']",0.5
15112,27361.0,Dextropropoxyphene,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,27626.0,Dextropropoxyphene,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'OPRD1', 'Dextropropoxyphene']",0.5
15112,27655.0,Dextropropoxyphene,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,27933.0,Dextropropoxyphene,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,27933.0,Dextropropoxyphene,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dextropropoxyphene']",0.5
15112,28149.0,Dextropropoxyphene,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'OPRD1', 'Dextropropoxyphene']",0.5
15112,28396.0,Dextropropoxyphene,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Dextropropoxyphene']",0.5
15112,28473.0,Dextropropoxyphene,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Dextropropoxyphene']",0.5
15112,28780.0,Dextropropoxyphene,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Dextropropoxyphene']",0.5
15112,28780.0,Dextropropoxyphene,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Dextropropoxyphene']",0.5
15112,28780.0,Dextropropoxyphene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,28899.0,Dextropropoxyphene,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Dextropropoxyphene']",0.5
15112,29525.0,Dextropropoxyphene,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Dextropropoxyphene']",0.5
15112,30035.0,Dextropropoxyphene,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CES1', 'Dextropropoxyphene']",0.5
15112,33306.0,Dextropropoxyphene,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'CYP2D6', 'Dextropropoxyphene']",0.5
15112,33440.0,Dextropropoxyphene,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Arrhythmia', 'OPRK1', 'Dextropropoxyphene']",0.5
15112,33577.0,Dextropropoxyphene,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Dextropropoxyphene']",0.5
15112,33632.0,Dextropropoxyphene,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Dextropropoxyphene']",0.5
15112,33675.0,Dextropropoxyphene,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dextropropoxyphene']",0.5
15112,35565.0,Dextropropoxyphene,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CES1', 'Dextropropoxyphene']",0.5
15112,35641.0,Dextropropoxyphene,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,35764.0,Dextropropoxyphene,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Dextropropoxyphene']",0.5
15112,36080.0,Dextropropoxyphene,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,36080.0,Dextropropoxyphene,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cholesterol biosynthetic process', 'CES1', 'Dextropropoxyphene']",0.5
15112,36187.0,Dextropropoxyphene,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dextropropoxyphene']",0.5
15112,36693.0,Dextropropoxyphene,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,37617.0,Dextropropoxyphene,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dextropropoxyphene']",0.5
15112,37703.0,Dextropropoxyphene,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,37786.0,Dextropropoxyphene,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dextropropoxyphene']",0.5
15112,38575.0,Dextropropoxyphene,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Dextropropoxyphene']",0.5
15112,83760.0,Dextropropoxyphene,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'OPRM1', 'Dextropropoxyphene']",0.5
15112,83911.0,Dextropropoxyphene,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Dextropropoxyphene']",0.5
15113,27655.0,Galantamine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'CHRNA7', 'Galantamine']",0.5
15113,28473.0,Galantamine,Pick disease,disease-protein-drug,indication,"['Pick disease', 'CHRNA7', 'Galantamine']",0.5
15113,28780.0,Galantamine,Alzheimer disease,disease-protein-drug,indication,"['Alzheimer disease', 'CHRNA7', 'Galantamine']",0.5
15113,28780.0,Galantamine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRNA7', 'Galantamine']",0.5
15113,28780.0,Galantamine,Alzheimer disease,disease-exposure-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'BCHE', 'Galantamine']",0.5
15113,28780.0,Galantamine,Alzheimer disease,disease-phenotype-protein-drug,indication,"['Alzheimer disease', 'Seizure', 'CHRNA7', 'Galantamine']",0.5
15113,28780.0,Galantamine,Alzheimer disease,disease-exposure-molfunc-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Galantamine']",0.5
15113,35565.0,Galantamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA7', 'Galantamine']",0.5
15113,35641.0,Galantamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Galantamine']",0.5
15113,35641.0,Galantamine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Galantamine']",0.5
15113,35764.0,Galantamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Galantamine']",0.5
15113,35764.0,Galantamine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Galantamine']",0.5
15113,37617.0,Galantamine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRNA7', 'Galantamine']",0.5
15113,37617.0,Galantamine,chronic obstructive pulmonary disease,disease-exposure-molfunc-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Galantamine']",0.5
15113,38575.0,Galantamine,cerebellar degeneration,disease-protein-drug,indication,"['cerebellar degeneration', 'CHRNA7', 'Galantamine']",0.5
15113,83911.0,Galantamine,Reye syndrome,disease-protein-drug,indication,"['Reye syndrome', 'CHRNA7', 'Galantamine']",0.5
15113,83960.0,Galantamine,Alzheimer disease without neurofibrillary tangles,disease-protein-drug,indication,"['Alzheimer disease without neurofibrillary tangles', 'CHRNA7', 'Galantamine']",0.5
15114,27326.0,Thioridazine,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Thioridazine']",0.5
15114,27326.0,Thioridazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Thioridazine']",0.5
15114,27326.0,Thioridazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Thioridazine']",0.5
15114,27655.0,Thioridazine,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Thioridazine']",0.5
15114,27655.0,Thioridazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Thioridazine']",0.5
15114,28396.0,Thioridazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Thioridazine']",0.5
15114,28780.0,Thioridazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Thioridazine']",0.5
15114,28780.0,Thioridazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Thioridazine']",0.5
15114,28780.0,Thioridazine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP2E1', 'Thioridazine']",0.5
15114,28780.0,Thioridazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Thioridazine']",0.5
15114,33454.0,Thioridazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Thioridazine']",0.5
15114,35641.0,Thioridazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD1', 'Thioridazine']",0.5
15114,35641.0,Thioridazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Thioridazine']",0.5
15114,83998.0,Thioridazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Thioridazine']",0.5
15116,27933.0,Paroxetine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Paroxetine']",0.5
15116,27933.0,Paroxetine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Paroxetine']",0.5
15116,28249.0,Paroxetine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'DRD5', 'Paroxetine']",0.5
15116,28456.0,Paroxetine,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'HTR1B', 'Paroxetine']",0.5
15116,28899.0,Paroxetine,obsessive-compulsive disorder,disease-protein-drug,indication,"['obsessive-compulsive disorder', 'HTR2A', 'Paroxetine']",0.5
15116,28899.0,Paroxetine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,indication,"['obsessive-compulsive disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Paroxetine']",0.5
15116,33091.0,Paroxetine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Tachycardia', 'DRD2', 'Paroxetine']",0.5
15116,33454.0,Paroxetine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Paroxetine']",0.5
15116,35565.0,Paroxetine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Paroxetine']",0.5
15116,35641.0,Paroxetine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Paroxetine']",0.5
15116,35641.0,Paroxetine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Paroxetine']",0.5
15116,36105.0,Paroxetine,phobic disorder,disease-protein-drug,indication,"['phobic disorder', 'SLC6A4', 'Paroxetine']",0.5
15116,36105.0,Paroxetine,phobic disorder,disease-exposure-bioprocess-gene-drug,indication,"['phobic disorder', 'Asbestos', 'inflammatory response', 'HRH1', 'Paroxetine']",0.5
15116,37703.0,Paroxetine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'HTR1B', 'Paroxetine']",0.5
15116,38242.0,Paroxetine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'DRD5', 'Paroxetine']",0.5
15116,38242.0,Paroxetine,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Paroxetine']",0.5
15116,38957.0,Paroxetine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'HTR1B', 'Paroxetine']",0.5
15116,38957.0,Paroxetine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Paroxetine']",0.5
15116,83760.0,Paroxetine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'HTR1B', 'Paroxetine']",0.5
15116,83840.0,Paroxetine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Paroxetine']",0.5
15116,83841.0,Paroxetine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'HTR1B', 'Paroxetine']",0.5
15116,83903.0,Paroxetine,post-traumatic stress disorder,disease-exposure-bioprocess-gene-drug,indication,"['post-traumatic stress disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Paroxetine']",0.5
15117,28249.0,Trimipramine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'DRD5', 'Trimipramine']",0.5
15117,28313.0,Trimipramine,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'ABCB1', 'Trimipramine']",0.5
15117,28313.0,Trimipramine,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'social behavior', 'SLC6A4', 'Trimipramine']",0.5
15117,30035.0,Trimipramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Trimipramine']",0.5
15117,33598.0,Trimipramine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Trimipramine']",0.5
15117,35565.0,Trimipramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Trimipramine']",0.5
15117,35641.0,Trimipramine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Trimipramine']",0.5
15117,35641.0,Trimipramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Trimipramine']",0.5
15117,35669.0,Trimipramine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Trimipramine']",0.5
15117,35761.0,Trimipramine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Trimipramine']",0.5
15117,35764.0,Trimipramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Trimipramine']",0.5
15117,35909.0,Trimipramine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Trimipramine']",0.5
15117,36034.0,Trimipramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Trimipramine']",0.5
15117,36104.0,Trimipramine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Trimipramine']",0.5
15117,36187.0,Trimipramine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Trimipramine']",0.5
15117,36187.0,Trimipramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Trimipramine']",0.5
15117,36229.0,Trimipramine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Trimipramine']",0.5
15117,37703.0,Trimipramine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'ADRB1', 'Trimipramine']",0.5
15117,38242.0,Trimipramine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'DRD5', 'Trimipramine']",0.5
15117,38242.0,Trimipramine,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Trimipramine']",0.5
15117,83760.0,Trimipramine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'ADRB1', 'Trimipramine']",0.5
15119,27933.0,Tranylcypromine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Tranylcypromine']",0.5
15119,27933.0,Tranylcypromine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Tranylcypromine']",0.5
15119,27933.0,Tranylcypromine,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Tranylcypromine']",0.5
15119,28249.0,Tranylcypromine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'MAOB', 'Tranylcypromine']",0.5
15119,28313.0,Tranylcypromine,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'MAOB', 'Tranylcypromine']",0.5
15119,28313.0,Tranylcypromine,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Tranylcypromine']",0.5
15119,28396.0,Tranylcypromine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Tranylcypromine']",0.5
15119,31122.0,Tranylcypromine,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'MAOB', 'Tranylcypromine']",0.5
15119,33575.0,Tranylcypromine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Tranylcypromine']",0.5
15119,33575.0,Tranylcypromine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Tranylcypromine']",0.5
15119,33575.0,Tranylcypromine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'CYP2E1', 'Tranylcypromine']",0.5
15119,33577.0,Tranylcypromine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Tranylcypromine']",0.5
15119,33605.0,Tranylcypromine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'MAOB', 'Tranylcypromine']",0.5
15119,35565.0,Tranylcypromine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Tranylcypromine']",0.5
15119,35669.0,Tranylcypromine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Tranylcypromine']",0.5
15119,35735.0,Tranylcypromine,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'MAOB', 'Tranylcypromine']",0.5
15119,35761.0,Tranylcypromine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Tranylcypromine']",0.5
15119,35761.0,Tranylcypromine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'CYP2E1', 'Tranylcypromine']",0.5
15119,35764.0,Tranylcypromine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Tranylcypromine']",0.5
15119,35894.0,Tranylcypromine,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'MAOB', 'Tranylcypromine']",0.5
15119,35895.0,Tranylcypromine,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'MAOB', 'Tranylcypromine']",0.5
15119,35909.0,Tranylcypromine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Tranylcypromine']",0.5
15119,36034.0,Tranylcypromine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2C9', 'Tranylcypromine']",0.5
15119,36149.0,Tranylcypromine,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'MAOB', 'Tranylcypromine']",0.5
15119,36187.0,Tranylcypromine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Tranylcypromine']",0.5
15119,36860.0,Tranylcypromine,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'MAOB', 'Tranylcypromine']",0.5
15119,37919.0,Tranylcypromine,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'MAOB', 'Tranylcypromine']",0.5
15119,38242.0,Tranylcypromine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'MAOB', 'Tranylcypromine']",0.5
15119,38957.0,Tranylcypromine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'MAOB', 'Tranylcypromine']",0.5
15119,38957.0,Tranylcypromine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Tranylcypromine']",0.5
15119,83840.0,Tranylcypromine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'MAOB', 'Tranylcypromine']",0.5
15119,83841.0,Tranylcypromine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'MAOB', 'Tranylcypromine']",0.5
15120,27326.0,Dolasetron,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Dolasetron']",0.5
15120,27326.0,Dolasetron,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Dolasetron']",0.5
15120,35764.0,Dolasetron,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Dolasetron']",0.5
15120,83751.0,Dolasetron,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Dolasetron']",0.5
15121,29494.0,Methimazole,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A2', 'Methimazole']",0.5
15121,30184.0,Methimazole,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A2', 'Methimazole']",0.5
15121,31732.0,Methimazole,myxedema,disease-protein-drug,contraindication,"['myxedema', 'TPO', 'Methimazole']",0.5
15121,32719.0,Methimazole,congenital hypothyroidism,disease-protein-drug,contraindication,"['congenital hypothyroidism', 'TPO', 'Methimazole']",0.5
15121,36034.0,Methimazole,hyperthyroidism,disease-exposure-bioprocess-gene-drug,indication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Methimazole']",0.5
15121,36469.0,Methimazole,hypothyroidism,disease-protein-drug,contraindication,"['hypothyroidism', 'TPO', 'Methimazole']",0.5
15121,36469.0,Methimazole,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Methimazole']",0.5
15121,36544.0,Methimazole,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP2E1', 'Methimazole']",0.5
15121,36544.0,Methimazole,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Methimazole']",0.5
15122,33577.0,Tripelennamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Tripelennamine']",0.5
15122,36034.0,Tripelennamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Tripelennamine']",0.5
15122,37888.0,Tripelennamine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Tripelennamine']",0.5
15122,37888.0,Tripelennamine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Tripelennamine']",0.5
15122,83791.0,Tripelennamine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Tripelennamine']",0.5
15124,28158.0,Biperiden,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Biperiden']",0.5
15124,28547.0,Biperiden,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'CYP2D6', 'Biperiden']",0.5
15124,28547.0,Biperiden,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Biperiden']",0.5
15124,28547.0,Biperiden,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5
15124,28801.0,Biperiden,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'CYP2D6', 'Biperiden']",0.5
15124,28801.0,Biperiden,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CYP2D6', 'Biperiden']",0.5
15124,28974.0,Biperiden,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'CYP2D6', 'Biperiden']",0.5
15124,28974.0,Biperiden,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5
15124,30093.0,Biperiden,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'CYP2D6', 'Biperiden']",0.5
15124,30093.0,Biperiden,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'CYP2D6', 'Biperiden']",0.5
15124,31408.0,Biperiden,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'CYP2D6', 'Biperiden']",0.5
15124,31408.0,Biperiden,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5
15124,31650.0,Biperiden,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Biperiden']",0.5
15124,32468.0,Biperiden,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5
15124,32759.0,Biperiden,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'CYP2D6', 'Biperiden']",0.5
15124,32759.0,Biperiden,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CYP2D6', 'Biperiden']",0.5
15124,32974.0,Biperiden,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'CYP2D6', 'Biperiden']",0.5
15124,32974.0,Biperiden,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5
15124,33241.0,Biperiden,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'CYP2D6', 'Biperiden']",0.5
15124,33241.0,Biperiden,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CYP2D6', 'Biperiden']",0.5
15124,33577.0,Biperiden,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Biperiden']",0.5
15124,33594.0,Biperiden,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Biperiden']",0.5
15124,35565.0,Biperiden,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Biperiden']",0.5
15124,35764.0,Biperiden,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Biperiden']",0.5
15124,36034.0,Biperiden,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Biperiden']",0.5
15124,36187.0,Biperiden,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Biperiden']",0.5
15124,37617.0,Biperiden,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Biperiden']",0.5
15124,37785.0,Biperiden,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Biperiden']",0.5
15124,38003.0,Biperiden,basal ganglia disease,disease-protein-drug,indication,"['basal ganglia disease', 'CYP2D6', 'Biperiden']",0.5
15125,33594.0,Loperamide,diarrheal disease,disease-exposure-bioprocess-gene-drug,indication,"['diarrheal disease', 'Arsenic', 'regulation of heart rate', 'CALM1', 'Loperamide']",0.5
15125,35565.0,Loperamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Loperamide']",0.5
15126,28473.0,Donepezil,Pick disease,disease-protein-drug,indication,"['Pick disease', 'BCHE', 'Donepezil']",0.5
15126,28780.0,Donepezil,Alzheimer disease,disease-protein-drug,indication,"['Alzheimer disease', 'BCHE', 'Donepezil']",0.5
15126,28780.0,Donepezil,Alzheimer disease,disease-exposure-bioprocess-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'GRIN1', 'Donepezil']",0.5
15126,28780.0,Donepezil,Alzheimer disease,disease-exposure-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'BCHE', 'Donepezil']",0.5
15126,28780.0,Donepezil,Alzheimer disease,disease-phenotype-protein-drug,indication,"['Alzheimer disease', 'Seizure', 'NOS1', 'Donepezil']",0.5
15126,28780.0,Donepezil,Alzheimer disease,disease-exposure-molfunc-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Donepezil']",0.5
15126,33675.0,Donepezil,asthma,disease-protein-drug,contraindication,"['asthma', 'IL1B', 'Donepezil']",0.5
15126,33675.0,Donepezil,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of interleukin-6 production', 'IL1B', 'Donepezil']",0.5
15126,33675.0,Donepezil,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'IL1B', 'Donepezil']",0.5
15126,33675.0,Donepezil,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Donepezil']",0.5
15126,35641.0,Donepezil,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'NOS1', 'Donepezil']",0.5
15126,35641.0,Donepezil,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Donepezil']",0.5
15126,38575.0,Donepezil,cerebellar degeneration,disease-protein-drug,indication,"['cerebellar degeneration', 'BCHE', 'Donepezil']",0.5
15126,39773.0,Donepezil,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'IL1B', 'Donepezil']",0.5
15126,83781.0,Donepezil,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'IL1B', 'Donepezil']",0.5
15126,83911.0,Donepezil,Reye syndrome,disease-protein-drug,indication,"['Reye syndrome', 'BCHE', 'Donepezil']",0.5
15126,83960.0,Donepezil,Alzheimer disease without neurofibrillary tangles,disease-protein-drug,indication,"['Alzheimer disease without neurofibrillary tangles', 'BCHE', 'Donepezil']",0.5
15127,27326.0,Perphenazine,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CALM1', 'Perphenazine']",0.5
15127,27326.0,Perphenazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Perphenazine']",0.5
15127,27326.0,Perphenazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Perphenazine']",0.5
15127,27655.0,Perphenazine,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'CALM1', 'Perphenazine']",0.5
15127,27655.0,Perphenazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Perphenazine']",0.5
15127,28375.0,Perphenazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Perphenazine']",0.5
15127,28396.0,Perphenazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Perphenazine']",0.5
15127,28547.0,Perphenazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'DRD1', 'Perphenazine']",0.5
15127,28547.0,Perphenazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'regulation of heart rate', 'CALM1', 'Perphenazine']",0.5
15127,28547.0,Perphenazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Perphenazine']",0.5
15127,28780.0,Perphenazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CALM1', 'Perphenazine']",0.5
15127,28780.0,Perphenazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'DRD2', 'Perphenazine']",0.5
15127,28780.0,Perphenazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Perphenazine']",0.5
15127,29637.0,Perphenazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Perphenazine']",0.5
15127,29637.0,Perphenazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD1', 'Perphenazine']",0.5
15127,30035.0,Perphenazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CALM1', 'Perphenazine']",0.5
15127,31393.0,Perphenazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Perphenazine']",0.5
15127,33454.0,Perphenazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Perphenazine']",0.5
15127,33593.0,Perphenazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'perfluorohexanesulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Perphenazine']",0.5
15127,33593.0,Perphenazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'CALM1', 'Perphenazine']",0.5
15127,33632.0,Perphenazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Perphenazine']",0.5
15127,35565.0,Perphenazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Perphenazine']",0.5
15127,35641.0,Perphenazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD1', 'Perphenazine']",0.5
15127,35641.0,Perphenazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Perphenazine']",0.5
15127,36034.0,Perphenazine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Perphenazine']",0.5
15127,36187.0,Perphenazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of heart rate', 'CALM1', 'Perphenazine']",0.5
15127,37180.0,Perphenazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of heart rate', 'CALM1', 'Perphenazine']",0.5
15127,37706.0,Perphenazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Perphenazine']",0.5
15127,37786.0,Perphenazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of heart rate', 'CALM1', 'Perphenazine']",0.5
15127,38003.0,Perphenazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD2', 'Perphenazine']",0.5
15127,39081.0,Perphenazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Perphenazine']",0.5
15127,83751.0,Perphenazine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Perphenazine']",0.5
15127,83763.0,Perphenazine,manic bipolar affective disorder,disease-protein-drug,contraindication,"['manic bipolar affective disorder', 'DRD1', 'Perphenazine']",0.5
15127,83998.0,Perphenazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Perphenazine']",0.5
15127,84023.0,Perphenazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Perphenazine']",0.5
15130,27476.0,Tipranavir,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'UGT1A1', 'Tipranavir']",0.5
15130,27476.0,Tipranavir,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Tipranavir']",0.5
15130,33575.0,Tipranavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Tipranavir']",0.5
15130,33695.0,Tipranavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Tipranavir']",0.5
15130,35565.0,Tipranavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Tipranavir']",0.5
15130,36492.0,Tipranavir,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Tipranavir']",0.5
15130,36645.0,Tipranavir,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'UGT1A1', 'Tipranavir']",0.5
15130,37743.0,Tipranavir,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Tipranavir']",0.5
15130,38312.0,Tipranavir,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B3', 'Tipranavir']",0.5
15131,27326.0,Mesoridazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Mesoridazine']",0.5
15131,27326.0,Mesoridazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Mesoridazine']",0.5
15131,27655.0,Mesoridazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD2', 'Mesoridazine']",0.5
15131,27740.0,Mesoridazine,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR2A', 'Mesoridazine']",0.5
15131,28313.0,Mesoridazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Mesoridazine']",0.5
15131,28313.0,Mesoridazine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Mesoridazine']",0.5
15131,28396.0,Mesoridazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Mesoridazine']",0.5
15131,29352.0,Mesoridazine,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Fever', 'HTR2A', 'Mesoridazine']",0.5
15131,33449.0,Mesoridazine,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR2A', 'Mesoridazine']",0.5
15131,33454.0,Mesoridazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Mesoridazine']",0.5
15131,35641.0,Mesoridazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD2', 'Mesoridazine']",0.5
15131,35641.0,Mesoridazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Mesoridazine']",0.5
15131,83998.0,Mesoridazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Mesoridazine']",0.5
15132,27361.0,Hydrocodone,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'OPRM1', 'Hydrocodone']",0.5
15132,27503.0,Hydrocodone,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'OPRM1', 'Hydrocodone']",0.5
15132,27626.0,Hydrocodone,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'OPRD1', 'Hydrocodone']",0.5
15132,28158.0,Hydrocodone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,28473.0,Hydrocodone,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Hydrocodone']",0.5
15132,28780.0,Hydrocodone,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Hydrocodone']",0.5
15132,28780.0,Hydrocodone,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,28780.0,Hydrocodone,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'OPRM1', 'Hydrocodone']",0.5
15132,30035.0,Hydrocodone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Hydrocodone']",0.5
15132,30813.0,Hydrocodone,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Hydrocodone']",0.5
15132,31072.0,Hydrocodone,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Hydrocodone']",0.5
15132,31650.0,Hydrocodone,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'OPRM1', 'Hydrocodone']",0.5
15132,31732.0,Hydrocodone,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'SIGMAR1', 'Hydrocodone']",0.5
15132,32384.0,Hydrocodone,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Hydrocodone']",0.5
15132,33440.0,Hydrocodone,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Coma', 'CYP2D6', 'Hydrocodone']",0.5
15132,33575.0,Hydrocodone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,33577.0,Hydrocodone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,33632.0,Hydrocodone,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,33677.0,Hydrocodone,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Hydrocodone']",0.5
15132,35565.0,Hydrocodone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Hydrocodone']",0.5
15132,35641.0,Hydrocodone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Hydrocodone']",0.5
15132,35764.0,Hydrocodone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,35897.0,Hydrocodone,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Hydrocodone']",0.5
15132,35953.0,Hydrocodone,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,36034.0,Hydrocodone,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,36080.0,Hydrocodone,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Hydrocodone']",0.5
15132,36187.0,Hydrocodone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,36469.0,Hydrocodone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,36492.0,Hydrocodone,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,36693.0,Hydrocodone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Hydrocodone']",0.5
15132,37180.0,Hydrocodone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,37617.0,Hydrocodone,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,37785.0,Hydrocodone,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,37811.0,Hydrocodone,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Hydrocodone']",0.5
15132,37888.0,Hydrocodone,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Hydrocodone']",0.5
15132,38575.0,Hydrocodone,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Hydrocodone']",0.5
15132,83910.0,Hydrocodone,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Hydrocodone']",0.5
15132,83911.0,Hydrocodone,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Hydrocodone']",0.5
15133,27933.0,Pindolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'HTR1B', 'Pindolol']",0.5
15133,27933.0,Pindolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1B', 'Pindolol']",0.5
15133,29113.0,Pindolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Pindolol']",0.5
15133,33575.0,Pindolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Pindolol']",0.5
15133,33577.0,Pindolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Pindolol']",0.5
15133,35565.0,Pindolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Pindolol']",0.5
15133,35764.0,Pindolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Pindolol']",0.5
15133,35897.0,Pindolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Pindolol']",0.5
15133,36432.0,Pindolol,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'ADRB1', 'Pindolol']",0.5
15133,37659.0,Pindolol,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ADRB1', 'Pindolol']",0.5
15133,37659.0,Pindolol,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Cadmium', 'bone resorption', 'ADRB2', 'Pindolol']",0.5
15133,37703.0,Pindolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'HTR1B', 'Pindolol']",0.5
15133,83760.0,Pindolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'HTR1B', 'Pindolol']",0.5
15134,32617.0,Hydroxyurea,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'CYP2D6', 'Hydroxyurea']",0.5
15134,33653.0,Hydroxyurea,melanoma,disease-exposure-bioprocess-gene-drug,indication,"['melanoma', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Hydroxyurea']",0.5
15134,35764.0,Hydroxyurea,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Hydroxyurea']",0.5
15135,33656.0,Cinacalcet,hypercalcemia disease,disease-protein-drug,contraindication,"['hypercalcemia disease', 'CASR', 'Cinacalcet']",0.5
15135,35565.0,Cinacalcet,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Cinacalcet']",0.5
15135,35583.0,Cinacalcet,phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'CASR', 'Cinacalcet']",0.5
15135,38682.0,Cinacalcet,nephrocalcinosis,disease-protein-drug,contraindication,"['nephrocalcinosis', 'CASR', 'Cinacalcet']",0.5
15137,27326.0,Tolterodine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Tolterodine']",0.5
15137,27326.0,Tolterodine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Tolterodine']",0.5
15137,27655.0,Tolterodine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'CHRM1', 'Tolterodine']",0.5
15137,31650.0,Tolterodine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Tolterodine']",0.5
15137,36274.0,Tolterodine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Tolterodine']",0.5
15137,37573.0,Tolterodine,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Tolterodine']",0.5
15137,83751.0,Tolterodine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Tolterodine']",0.5
15138,27933.0,Selegiline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Selegiline']",0.5
15138,27933.0,Selegiline,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Selegiline']",0.5
15138,27933.0,Selegiline,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Selegiline']",0.5
15138,28149.0,Selegiline,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Selegiline']",0.5
15138,28249.0,Selegiline,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'MAOB', 'Selegiline']",0.5
15138,28396.0,Selegiline,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Selegiline']",0.5
15138,28801.0,Selegiline,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'MAOB', 'Selegiline']",0.5
15138,28801.0,Selegiline,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CYP2D6', 'Selegiline']",0.5
15138,30093.0,Selegiline,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'MAOB', 'Selegiline']",0.5
15138,30093.0,Selegiline,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'CYP2D6', 'Selegiline']",0.5
15138,31122.0,Selegiline,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'MAOB', 'Selegiline']",0.5
15138,31408.0,Selegiline,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'MAOB', 'Selegiline']",0.5
15138,31408.0,Selegiline,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CYP2D6', 'Selegiline']",0.5
15138,32974.0,Selegiline,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'MAOB', 'Selegiline']",0.5
15138,32974.0,Selegiline,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CYP2D6', 'Selegiline']",0.5
15138,33241.0,Selegiline,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'MAOB', 'Selegiline']",0.5
15138,33241.0,Selegiline,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CYP2D6', 'Selegiline']",0.5
15138,35565.0,Selegiline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Selegiline']",0.5
15138,35735.0,Selegiline,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'MAOB', 'Selegiline']",0.5
15138,35764.0,Selegiline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Selegiline']",0.5
15138,35894.0,Selegiline,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'MAOB', 'Selegiline']",0.5
15138,35895.0,Selegiline,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'MAOB', 'Selegiline']",0.5
15138,35915.0,Selegiline,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Selegiline']",0.5
15138,36149.0,Selegiline,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'MAOB', 'Selegiline']",0.5
15138,36860.0,Selegiline,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'MAOB', 'Selegiline']",0.5
15138,37919.0,Selegiline,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'MAOB', 'Selegiline']",0.5
15138,38242.0,Selegiline,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'MAOB', 'Selegiline']",0.5
15138,38957.0,Selegiline,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'MAOB', 'Selegiline']",0.5
15138,38957.0,Selegiline,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Selegiline']",0.5
15138,83778.0,Selegiline,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Selegiline']",0.5
15138,83779.0,Selegiline,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Selegiline']",0.5
15138,83840.0,Selegiline,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'MAOB', 'Selegiline']",0.5
15138,83841.0,Selegiline,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'MAOB', 'Selegiline']",0.5
15141,33594.0,Tegaserod,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Tegaserod']",0.5
15141,33598.0,Tegaserod,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'HTR4', 'Tegaserod']",0.5
15141,33598.0,Tegaserod,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Tegaserod']",0.5
15141,33598.0,Tegaserod,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'CYP2E1', 'Tegaserod']",0.5
15141,35565.0,Tegaserod,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Tegaserod']",0.5
15141,35909.0,Tegaserod,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Tegaserod']",0.5
15141,37180.0,Tegaserod,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'memory', 'SLC6A4', 'Tegaserod']",0.5
15141,37180.0,Tegaserod,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'CYP2E1', 'Tegaserod']",0.5
15143,29113.0,Bicalutamide,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Bicalutamide']",0.5
15143,33575.0,Bicalutamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Bicalutamide']",0.5
15143,33575.0,Bicalutamide,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Bicalutamide']",0.5
15143,33632.0,Bicalutamide,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of systemic arterial blood pressure', 'AR', 'Bicalutamide']",0.5
15143,35565.0,Bicalutamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Bicalutamide']",0.5
15143,36544.0,Bicalutamide,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ABCB1', 'Bicalutamide']",0.5
15143,36544.0,Bicalutamide,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Bicalutamide']",0.5
15144,28426.0,Rabeprazole,multiple endocrine neoplasia,disease-phenotype-protein-drug,indication,"['multiple endocrine neoplasia', 'Coma', 'CYP2D6', 'Rabeprazole']",0.5
15144,28542.0,Rabeprazole,mastocytosis,disease-phenotype-protein-drug,indication,"['mastocytosis', 'Hepatomegaly', 'CYP1A1', 'Rabeprazole']",0.5
15144,29614.0,Rabeprazole,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Rabeprazole']",0.5
15144,35565.0,Rabeprazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Rabeprazole']",0.5
15144,35565.0,Rabeprazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Rabeprazole']",0.5
15145,35565.0,Proguanil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Proguanil']",0.5
15146,27933.0,Nefazodone,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Nefazodone']",0.5
15146,27933.0,Nefazodone,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Nefazodone']",0.5
15146,30035.0,Nefazodone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Nefazodone']",0.5
15146,33598.0,Nefazodone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Nefazodone']",0.5
15146,33605.0,Nefazodone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Nefazodone']",0.5
15146,35565.0,Nefazodone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Nefazodone']",0.5
15146,35641.0,Nefazodone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Nefazodone']",0.5
15146,35669.0,Nefazodone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Nefazodone']",0.5
15146,35761.0,Nefazodone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Nefazodone']",0.5
15146,35909.0,Nefazodone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Nefazodone']",0.5
15146,36693.0,Nefazodone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC6A4', 'Nefazodone']",0.5
15146,37180.0,Nefazodone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Nefazodone']",0.5
15146,38242.0,Nefazodone,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'SLC6A2', 'Nefazodone']",0.5
15146,38957.0,Nefazodone,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Nefazodone']",0.5
15146,38957.0,Nefazodone,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'platelet activation', 'ADRA2A', 'Nefazodone']",0.5
15146,83840.0,Nefazodone,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Nefazodone']",0.5
15146,83841.0,Nefazodone,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Nefazodone']",0.5
15147,27361.0,Orphenadrine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'SLC6A2', 'Orphenadrine']",0.5
15147,27933.0,Orphenadrine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'SLC6A2', 'Orphenadrine']",0.5
15147,27933.0,Orphenadrine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'SCN10A', 'Orphenadrine']",0.5
15147,27933.0,Orphenadrine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Orphenadrine']",0.5
15147,28473.0,Orphenadrine,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Orphenadrine']",0.5
15147,28780.0,Orphenadrine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Orphenadrine']",0.5
15147,28780.0,Orphenadrine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'triglyceride metabolic process', 'CYP2E1', 'Orphenadrine']",0.5
15147,28780.0,Orphenadrine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP2E1', 'Orphenadrine']",0.5
15147,28780.0,Orphenadrine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'SLC6A2', 'Orphenadrine']",0.5
15147,28899.0,Orphenadrine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Nicotine', 'regulation of heart rate', 'SCN10A', 'Orphenadrine']",0.5
15147,29525.0,Orphenadrine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Orphenadrine']",0.5
15147,30035.0,Orphenadrine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Orphenadrine']",0.5
15147,31650.0,Orphenadrine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'SLC6A2', 'Orphenadrine']",0.5
15147,33306.0,Orphenadrine,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'CYP2D6', 'Orphenadrine']",0.5
15147,33440.0,Orphenadrine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Coma', 'CYP2D6', 'Orphenadrine']",0.5
15147,33577.0,Orphenadrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Orphenadrine']",0.5
15147,33632.0,Orphenadrine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Orphenadrine']",0.5
15147,35565.0,Orphenadrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Orphenadrine']",0.5
15147,35641.0,Orphenadrine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Orphenadrine']",0.5
15147,35641.0,Orphenadrine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Orphenadrine']",0.5
15147,35764.0,Orphenadrine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Orphenadrine']",0.5
15147,36187.0,Orphenadrine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Orphenadrine']",0.5
15147,36274.0,Orphenadrine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'calcium ion homeostasis', 'GRIN1', 'Orphenadrine']",0.5
15147,37786.0,Orphenadrine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Orphenadrine']",0.5
15147,38575.0,Orphenadrine,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Orphenadrine']",0.5
15147,83911.0,Orphenadrine,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Orphenadrine']",0.5
15148,27933.0,Escitalopram,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Escitalopram']",0.5
15148,27933.0,Escitalopram,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Escitalopram']",0.5
15148,28249.0,Escitalopram,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'MAOB', 'Escitalopram']",0.5
15148,28456.0,Escitalopram,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'ADRA1B', 'Escitalopram']",0.5
15148,28899.0,Escitalopram,obsessive-compulsive disorder,disease-protein-drug,off-label use,"['obsessive-compulsive disorder', 'HTR2A', 'Escitalopram']",0.5
15148,28899.0,Escitalopram,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['obsessive-compulsive disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Escitalopram']",0.5
15148,33091.0,Escitalopram,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Tachycardia', 'DRD2', 'Escitalopram']",0.5
15148,33454.0,Escitalopram,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Escitalopram']",0.5
15148,35565.0,Escitalopram,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Escitalopram']",0.5
15148,35641.0,Escitalopram,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Escitalopram']",0.5
15148,35641.0,Escitalopram,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Escitalopram']",0.5
15148,35669.0,Escitalopram,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Escitalopram']",0.5
15148,35761.0,Escitalopram,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Escitalopram']",0.5
15148,38242.0,Escitalopram,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'MAOB', 'Escitalopram']",0.5
15148,38242.0,Escitalopram,bipolar disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Escitalopram']",0.5
15148,38957.0,Escitalopram,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'MAOB', 'Escitalopram']",0.5
15148,38957.0,Escitalopram,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Escitalopram']",0.5
15148,83840.0,Escitalopram,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'MAOB', 'Escitalopram']",0.5
15148,83841.0,Escitalopram,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'MAOB', 'Escitalopram']",0.5
15148,83903.0,Escitalopram,post-traumatic stress disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['post-traumatic stress disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Escitalopram']",0.5
15149,28520.0,Idarubicin,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Idarubicin']",0.5
15149,33632.0,Idarubicin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'urea metabolic process', 'CYP2C9', 'Idarubicin']",0.5
15149,35565.0,Idarubicin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Idarubicin']",0.5
15149,35764.0,Idarubicin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Idarubicin']",0.5
15150,27326.0,Propafenone,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'SCN5A', 'Propafenone']",0.5
15150,27326.0,Propafenone,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Propafenone']",0.5
15150,27326.0,Propafenone,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Propafenone']",0.5
15150,27655.0,Propafenone,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Propafenone']",0.5
15150,28103.0,Propafenone,progressive familial heart block,disease-protein-drug,contraindication,"['progressive familial heart block', 'SCN5A', 'Propafenone']",0.5
15150,28103.0,Propafenone,progressive familial heart block,disease-phenotype-protein-drug,contraindication,"['progressive familial heart block', 'Arrhythmia', 'KCNH2', 'Propafenone']",0.5
15150,29494.0,Propafenone,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A2', 'Propafenone']",0.5
15150,30184.0,Propafenone,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A2', 'Propafenone']",0.5
15150,33586.0,Propafenone,atrioventricular block (disease),disease-protein-drug,contraindication,"['atrioventricular block (disease)', 'SCN5A', 'Propafenone']",0.5
15150,33618.0,Propafenone,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'SCN5A', 'Propafenone']",0.5
15150,33618.0,Propafenone,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Propafenone']",0.5
15150,33679.0,Propafenone,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Propafenone']",0.5
15150,35565.0,Propafenone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Propafenone']",0.5
15150,35764.0,Propafenone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN5A', 'Propafenone']",0.5
15150,35953.0,Propafenone,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Propafenone']",0.5
15150,36104.0,Propafenone,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Propafenone']",0.5
15150,36187.0,Propafenone,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Propafenone']",0.5
15150,36187.0,Propafenone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of heart rate', 'SCN5A', 'Propafenone']",0.5
15150,36229.0,Propafenone,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Propafenone']",0.5
15150,37180.0,Propafenone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of heart rate', 'SCN5A', 'Propafenone']",0.5
15150,37769.0,Propafenone,ventricular tachycardia,disease-protein-drug,indication,"['ventricular tachycardia', 'SCN5A', 'Propafenone']",0.5
15150,38396.0,Propafenone,familial sick sinus syndrome,disease-protein-drug,contraindication,"['familial sick sinus syndrome', 'SCN5A', 'Propafenone']",0.5
15150,38958.0,Propafenone,sick sinus syndrome,disease-protein-drug,contraindication,"['sick sinus syndrome', 'SCN5A', 'Propafenone']",0.5
15150,83751.0,Propafenone,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'SCN5A', 'Propafenone']",0.5
15150,84197.0,Propafenone,obsolete bundle branch block,disease-protein-drug,contraindication,"['obsolete bundle branch block', 'SCN5A', 'Propafenone']",0.5
15151,28208.0,Dexfenfluramine,type 2 diabetes mellitus,disease-protein-drug,contraindication,"['type 2 diabetes mellitus', 'CYP1A2', 'Dexfenfluramine']",0.5
15151,28208.0,Dexfenfluramine,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Air Pollutants', 'memory', 'SLC6A4', 'Dexfenfluramine']",0.5
15151,28552.0,Dexfenfluramine,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'locomotory behavior', 'HTR2C', 'Dexfenfluramine']",0.5
15151,30035.0,Dexfenfluramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Dexfenfluramine']",0.5
15151,33575.0,Dexfenfluramine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Dexfenfluramine']",0.5
15151,33575.0,Dexfenfluramine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'memory', 'SLC6A4', 'Dexfenfluramine']",0.5
15151,33575.0,Dexfenfluramine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'CYP2E1', 'Dexfenfluramine']",0.5
15151,33577.0,Dexfenfluramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Dexfenfluramine']",0.5
15151,33593.0,Dexfenfluramine,obesity disorder,disease-protein-drug,indication,"['obesity disorder', 'CYP2E1', 'Dexfenfluramine']",0.5
15151,33593.0,Dexfenfluramine,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Organophosphorus Compounds', 'social behavior', 'SLC6A4', 'Dexfenfluramine']",0.5
15151,33593.0,Dexfenfluramine,obesity disorder,disease-phenotype-protein-drug,indication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Dexfenfluramine']",0.5
15152,28158.0,Oxymorphone,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Oxymorphone']",0.5
15152,30035.0,Oxymorphone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Oxymorphone']",0.5
15152,30813.0,Oxymorphone,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Oxymorphone']",0.5
15152,31072.0,Oxymorphone,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Oxymorphone']",0.5
15152,32384.0,Oxymorphone,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Oxymorphone']",0.5
15152,33677.0,Oxymorphone,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Oxymorphone']",0.5
15152,35565.0,Oxymorphone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Oxymorphone']",0.5
15152,35641.0,Oxymorphone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Oxymorphone']",0.5
15152,35764.0,Oxymorphone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Oxymorphone']",0.5
15152,35897.0,Oxymorphone,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Oxymorphone']",0.5
15152,36080.0,Oxymorphone,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Oxymorphone']",0.5
15152,36469.0,Oxymorphone,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Oxymorphone']",0.5
15152,36492.0,Oxymorphone,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Oxymorphone']",0.5
15152,36693.0,Oxymorphone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Oxymorphone']",0.5
15152,37785.0,Oxymorphone,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Oxymorphone']",0.5
15152,83910.0,Oxymorphone,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Oxymorphone']",0.5
15153,27933.0,Acebutolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Acebutolol']",0.5
15153,27933.0,Acebutolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Acebutolol']",0.5
15153,29113.0,Acebutolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Acebutolol']",0.5
15153,33575.0,Acebutolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Acebutolol']",0.5
15153,33577.0,Acebutolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Acebutolol']",0.5
15153,33675.0,Acebutolol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Acebutolol']",0.5
15153,33675.0,Acebutolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Acebutolol']",0.5
15153,35565.0,Acebutolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Acebutolol']",0.5
15153,35764.0,Acebutolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Acebutolol']",0.5
15153,35897.0,Acebutolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Acebutolol']",0.5
15153,36034.0,Acebutolol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,off-label use,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Acebutolol']",0.5
15153,37703.0,Acebutolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Acebutolol']",0.5
15153,39773.0,Acebutolol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ADRB2', 'Acebutolol']",0.5
15153,39798.0,Acebutolol,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Acebutolol']",0.5
15153,83760.0,Acebutolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Acebutolol']",0.5
15153,83781.0,Acebutolol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ADRB2', 'Acebutolol']",0.5
15154,27476.0,Lomustine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Lomustine']",0.5
15154,33077.0,Lomustine,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Lomustine']",0.5
15154,35764.0,Lomustine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Lomustine']",0.5
15154,36492.0,Lomustine,brain cancer,disease-exposure-bioprocess-gene-drug,indication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Lomustine']",0.5
15154,36544.0,Lomustine,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP3A4', 'Lomustine']",0.5
15154,36544.0,Lomustine,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Lomustine']",0.5
15155,29113.0,Levobunolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Levobunolol']",0.5
15155,33575.0,Levobunolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Levobunolol']",0.5
15155,33675.0,Levobunolol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Levobunolol']",0.5
15155,33675.0,Levobunolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Levobunolol']",0.5
15155,35897.0,Levobunolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Levobunolol']",0.5
15155,39773.0,Levobunolol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ADRB2', 'Levobunolol']",0.5
15155,83781.0,Levobunolol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ADRB2', 'Levobunolol']",0.5
15156,29113.0,Metipranolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Metipranolol']",0.5
15156,33575.0,Metipranolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Metipranolol']",0.5
15156,33675.0,Metipranolol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Metipranolol']",0.5
15156,33675.0,Metipranolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Metipranolol']",0.5
15156,35897.0,Metipranolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Metipranolol']",0.5
15156,36034.0,Metipranolol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Metipranolol']",0.5
15156,37617.0,Metipranolol,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Metipranolol']",0.5
15156,37830.0,Metipranolol,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Metipranolol']",0.5
15156,39773.0,Metipranolol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ADRB2', 'Metipranolol']",0.5
15156,83781.0,Metipranolol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ADRB2', 'Metipranolol']",0.5
15159,28391.0,Lisdexamfetamine,narcolepsy,disease-exposure-bioprocess-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,30035.0,Lisdexamfetamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,33577.0,Lisdexamfetamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,33598.0,Lisdexamfetamine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,35909.0,Lisdexamfetamine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,35915.0,Lisdexamfetamine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,35953.0,Lisdexamfetamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,36034.0,Lisdexamfetamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,36187.0,Lisdexamfetamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,36693.0,Lisdexamfetamine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,37180.0,Lisdexamfetamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,83778.0,Lisdexamfetamine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,83779.0,Lisdexamfetamine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15159,84036.0,Lisdexamfetamine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'perfluorohexanesulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Lisdexamfetamine']",0.5
15160,35897.0,Arformoterol,pulmonary emphysema,disease-protein-drug,indication,"['pulmonary emphysema', 'CYP2A6', 'Arformoterol']",0.5
15160,35897.0,Arformoterol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Arformoterol']",0.5
15160,37617.0,Arformoterol,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,indication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Arformoterol']",0.5
15160,37830.0,Arformoterol,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Arformoterol']",0.5
15164,27933.0,Yohimbine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'DRD2', 'Yohimbine']",0.5
15164,27933.0,Yohimbine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Yohimbine']",0.5
15164,33605.0,Yohimbine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HTR1D', 'Yohimbine']",0.5
15164,35565.0,Yohimbine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HTR2A', 'Yohimbine']",0.5
15164,35669.0,Yohimbine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Yohimbine']",0.5
15164,35761.0,Yohimbine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose metabolic process', 'KCNJ11', 'Yohimbine']",0.5
15164,35764.0,Yohimbine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Yohimbine']",0.5
15164,37604.0,Yohimbine,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['erectile dysfunction (disease)', 'bisphenol A', 'social behavior', 'DRD3', 'Yohimbine']",0.5
15164,37703.0,Yohimbine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'HTR1B', 'Yohimbine']",0.5
15164,83760.0,Yohimbine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'HTR1B', 'Yohimbine']",0.5
15164,83995.0,Yohimbine,psychologic dyspareunia,disease-protein-drug,off-label use,"['psychologic dyspareunia', 'CYP2D6', 'Yohimbine']",0.5
15164,83996.0,Yohimbine,premature ejaculation (disease),disease-protein-drug,off-label use,"['premature ejaculation (disease)', 'CYP2D6', 'Yohimbine']",0.5
15165,27326.0,Methotrimeprazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Methotrimeprazine']",0.5
15165,27326.0,Methotrimeprazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Methotrimeprazine']",0.5
15165,27655.0,Methotrimeprazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD1', 'Methotrimeprazine']",0.5
15165,28375.0,Methotrimeprazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Methotrimeprazine']",0.5
15165,28396.0,Methotrimeprazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Methotrimeprazine']",0.5
15165,28547.0,Methotrimeprazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'CYP2E1', 'Methotrimeprazine']",0.5
15165,28547.0,Methotrimeprazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Methotrimeprazine']",0.5
15165,28547.0,Methotrimeprazine,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Pesticides', 'CYP2E1', 'Methotrimeprazine']",0.5
15165,28547.0,Methotrimeprazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Methotrimeprazine']",0.5
15165,28651.0,Methotrimeprazine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'CYP2E1', 'Methotrimeprazine']",0.5
15165,28780.0,Methotrimeprazine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Methotrimeprazine']",0.5
15165,28780.0,Methotrimeprazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Methotrimeprazine']",0.5
15165,28780.0,Methotrimeprazine,Alzheimer disease,disease-exposure-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'CYP2E1', 'Methotrimeprazine']",0.5
15165,28780.0,Methotrimeprazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD1', 'Methotrimeprazine']",0.5
15165,29637.0,Methotrimeprazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Methotrimeprazine']",0.5
15165,29637.0,Methotrimeprazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD1', 'Methotrimeprazine']",0.5
15165,30035.0,Methotrimeprazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Methotrimeprazine']",0.5
15165,30324.0,Methotrimeprazine,blepharospasm,disease-protein-drug,contraindication,"['blepharospasm', 'DRD5', 'Methotrimeprazine']",0.5
15165,31393.0,Methotrimeprazine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Methotrimeprazine']",0.5
15165,31393.0,Methotrimeprazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Methotrimeprazine']",0.5
15165,31393.0,Methotrimeprazine,metabolic syndrome X,disease-exposure-gene-drug,contraindication,"['metabolic syndrome X', 'Pesticides', 'CYP2E1', 'Methotrimeprazine']",0.5
15165,33454.0,Methotrimeprazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Methotrimeprazine']",0.5
15165,33593.0,Methotrimeprazine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'CYP2E1', 'Methotrimeprazine']",0.5
15165,33593.0,Methotrimeprazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Methotrimeprazine']",0.5
15165,33593.0,Methotrimeprazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Methotrimeprazine']",0.5
15165,33632.0,Methotrimeprazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'CHRM1', 'Methotrimeprazine']",0.5
15165,35565.0,Methotrimeprazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Methotrimeprazine']",0.5
15165,35641.0,Methotrimeprazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD1', 'Methotrimeprazine']",0.5
15165,35641.0,Methotrimeprazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Methotrimeprazine']",0.5
15165,36187.0,Methotrimeprazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Methotrimeprazine']",0.5
15165,37180.0,Methotrimeprazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Methotrimeprazine']",0.5
15165,37180.0,Methotrimeprazine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'CYP2E1', 'Methotrimeprazine']",0.5
15165,37706.0,Methotrimeprazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Methotrimeprazine']",0.5
15165,37786.0,Methotrimeprazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'CHRM1', 'Methotrimeprazine']",0.5
15165,38003.0,Methotrimeprazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD3', 'Methotrimeprazine']",0.5
15165,38928.0,Methotrimeprazine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Methotrimeprazine']",0.5
15165,39081.0,Methotrimeprazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Methotrimeprazine']",0.5
15165,83752.0,Methotrimeprazine,focal hand dystonia,disease-protein-drug,contraindication,"['focal hand dystonia', 'DRD5', 'Methotrimeprazine']",0.5
15165,83764.0,Methotrimeprazine,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Methotrimeprazine']",0.5
15165,83998.0,Methotrimeprazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Methotrimeprazine']",0.5
15165,84023.0,Methotrimeprazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Methotrimeprazine']",0.5
15166,33675.0,Tiotropium,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'cognition', 'CHRM1', 'Tiotropium']",0.5
15166,35897.0,Tiotropium,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'cognition', 'CHRM1', 'Tiotropium']",0.5
15166,37830.0,Tiotropium,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'cognition', 'CHRM1', 'Tiotropium']",0.5
15167,29525.0,Antipyrine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'PTGS2', 'Antipyrine']",0.5
15167,30035.0,Antipyrine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Antipyrine']",0.5
15167,31395.0,Antipyrine,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Antipyrine']",0.5
15167,32977.0,Antipyrine,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Antipyrine']",0.5
15167,32977.0,Antipyrine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Fever', 'PTGS2', 'Antipyrine']",0.5
15167,33575.0,Antipyrine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Antipyrine']",0.5
15167,33575.0,Antipyrine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Antipyrine']",0.5
15167,33575.0,Antipyrine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Antipyrine']",0.5
15167,33603.0,Antipyrine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'PTGS2', 'Antipyrine']",0.5
15167,35565.0,Antipyrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Antipyrine']",0.5
15167,35669.0,Antipyrine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Antipyrine']",0.5
15167,35669.0,Antipyrine,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Antipyrine']",0.5
15167,35761.0,Antipyrine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Antipyrine']",0.5
15167,35761.0,Antipyrine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Antipyrine']",0.5
15167,35953.0,Antipyrine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'PTGS2', 'Antipyrine']",0.5
15167,35953.0,Antipyrine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Antipyrine']",0.5
15167,35953.0,Antipyrine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'PTGS1', 'Antipyrine']",0.5
15167,36034.0,Antipyrine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Antipyrine']",0.5
15167,36187.0,Antipyrine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PTGS2', 'Antipyrine']",0.5
15167,36187.0,Antipyrine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Antipyrine']",0.5
15167,36187.0,Antipyrine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Antipyrine']",0.5
15167,39798.0,Antipyrine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Antipyrine']",0.5
15167,39798.0,Antipyrine,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'PTGS1', 'Antipyrine']",0.5
15171,27503.0,Dihydrocodeine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Bradycardia', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,27933.0,Dihydrocodeine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,27933.0,Dihydrocodeine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,28158.0,Dihydrocodeine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,28473.0,Dihydrocodeine,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,28780.0,Dihydrocodeine,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,28780.0,Dihydrocodeine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,28899.0,Dihydrocodeine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,30035.0,Dihydrocodeine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,33306.0,Dihydrocodeine,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,33440.0,Dihydrocodeine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Coma', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,33575.0,Dihydrocodeine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,33577.0,Dihydrocodeine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,33632.0,Dihydrocodeine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,35565.0,Dihydrocodeine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,35764.0,Dihydrocodeine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,35953.0,Dihydrocodeine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,36034.0,Dihydrocodeine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,36187.0,Dihydrocodeine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,36469.0,Dihydrocodeine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,36492.0,Dihydrocodeine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,36693.0,Dihydrocodeine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,37180.0,Dihydrocodeine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,37617.0,Dihydrocodeine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,37785.0,Dihydrocodeine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,37786.0,Dihydrocodeine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,37811.0,Dihydrocodeine,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Dihydrocodeine']",0.5
15171,38575.0,Dihydrocodeine,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Dihydrocodeine']",0.5
15171,83911.0,Dihydrocodeine,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Dihydrocodeine']",0.5
15173,27921.0,Dextroamphetamine,attention deficit-hyperactivity disorder,disease-protein-drug,indication,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Dextroamphetamine']",0.5
15173,28052.0,Dextroamphetamine,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Cardiomegaly', 'ADRA2C', 'Dextroamphetamine']",0.5
15173,28249.0,Dextroamphetamine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Dextroamphetamine']",0.5
15173,28391.0,Dextroamphetamine,narcolepsy,disease-exposure-bioprocess-gene-drug,indication,"['narcolepsy', 'Pesticides', 'cholesterol metabolic process', 'CYP2D6', 'Dextroamphetamine']",0.5
15173,30035.0,Dextroamphetamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Dextroamphetamine']",0.5
15173,30664.0,Dextroamphetamine,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'ADRA1B', 'Dextroamphetamine']",0.5
15173,33577.0,Dextroamphetamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Dextroamphetamine']",0.5
15173,33598.0,Dextroamphetamine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2D6', 'Dextroamphetamine']",0.5
15173,35641.0,Dextroamphetamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADRA1B', 'Dextroamphetamine']",0.5
15173,35669.0,Dextroamphetamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Dextroamphetamine']",0.5
15173,35761.0,Dextroamphetamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Dextroamphetamine']",0.5
15173,35909.0,Dextroamphetamine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Dextroamphetamine']",0.5
15173,35915.0,Dextroamphetamine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Dextroamphetamine']",0.5
15173,35953.0,Dextroamphetamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Dextroamphetamine']",0.5
15173,36009.0,Dextroamphetamine,tic disorder,disease-protein-drug,contraindication,"['tic disorder', 'SLC6A3', 'Dextroamphetamine']",0.5
15173,36034.0,Dextroamphetamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Dextroamphetamine']",0.5
15173,36187.0,Dextroamphetamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Dextroamphetamine']",0.5
15173,36693.0,Dextroamphetamine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Dextroamphetamine']",0.5
15173,37180.0,Dextroamphetamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Dextroamphetamine']",0.5
15173,38242.0,Dextroamphetamine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Dextroamphetamine']",0.5
15173,83778.0,Dextroamphetamine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Dextroamphetamine']",0.5
15173,83779.0,Dextroamphetamine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2D6', 'Dextroamphetamine']",0.5
15173,84036.0,Dextroamphetamine,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'SLC6A3', 'Dextroamphetamine']",0.5
15173,84036.0,Dextroamphetamine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Dextroamphetamine']",0.5
15174,27921.0,Metamfetamine,attention deficit-hyperactivity disorder,disease-protein-drug,indication,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Metamfetamine']",0.5
15174,27933.0,Metamfetamine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'MAOB', 'Metamfetamine']",0.5
15174,27933.0,Metamfetamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Metamfetamine']",0.5
15174,28052.0,Metamfetamine,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Arrhythmia', 'SLC22A5', 'Metamfetamine']",0.5
15174,29525.0,Metamfetamine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Metamfetamine']",0.5
15174,30035.0,Metamfetamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Metamfetamine']",0.5
15174,31618.0,Metamfetamine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'SLC6A2', 'Metamfetamine']",0.5
15174,32313.0,Metamfetamine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'SLC6A2', 'Metamfetamine']",0.5
15174,32977.0,Metamfetamine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'SLC6A2', 'Metamfetamine']",0.5
15174,33577.0,Metamfetamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,33598.0,Metamfetamine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Metamfetamine']",0.5
15174,33632.0,Metamfetamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'social behavior', 'SLC6A4', 'Metamfetamine']",0.5
15174,33675.0,Metamfetamine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,35565.0,Metamfetamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A4', 'Metamfetamine']",0.5
15174,35641.0,Metamfetamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Metamfetamine']",0.5
15174,35669.0,Metamfetamine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Metamfetamine']",0.5
15174,35669.0,Metamfetamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,35761.0,Metamfetamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,35764.0,Metamfetamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,35909.0,Metamfetamine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Metamfetamine']",0.5
15174,35915.0,Metamfetamine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Metamfetamine']",0.5
15174,35953.0,Metamfetamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,36009.0,Metamfetamine,tic disorder,disease-protein-drug,contraindication,"['tic disorder', 'SLC6A3', 'Metamfetamine']",0.5
15174,36034.0,Metamfetamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Metamfetamine']",0.5
15174,36080.0,Metamfetamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'positive regulation of blood pressure', 'ADRA2B', 'Metamfetamine']",0.5
15174,36187.0,Metamfetamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,36266.0,Metamfetamine,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'MAOB', 'Metamfetamine']",0.5
15174,36693.0,Metamfetamine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC6A4', 'Metamfetamine']",0.5
15174,37180.0,Metamfetamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,37617.0,Metamfetamine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15174,37703.0,Metamfetamine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'MAOB', 'Metamfetamine']",0.5
15174,38242.0,Metamfetamine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'MAOB', 'Metamfetamine']",0.5
15174,83760.0,Metamfetamine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'MAOB', 'Metamfetamine']",0.5
15174,83778.0,Metamfetamine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Metamfetamine']",0.5
15174,83779.0,Metamfetamine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Metamfetamine']",0.5
15174,83805.0,Metamfetamine,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'MAOB', 'Metamfetamine']",0.5
15174,84036.0,Metamfetamine,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'SLC6A3', 'Metamfetamine']",0.5
15174,84036.0,Metamfetamine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Metamfetamine']",0.5
15175,33577.0,Oxprenolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Oxprenolol']",0.5
15176,32886.0,Everolimus,typical hemolytic-uremic syndrome,disease-phenotype-protein-drug,contraindication,"['typical hemolytic-uremic syndrome', 'Coma', 'CYP2D6', 'Everolimus']",0.5
15176,33575.0,Everolimus,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Everolimus']",0.5
15176,33632.0,Everolimus,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Everolimus']",0.5
15176,33695.0,Everolimus,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Everolimus']",0.5
15176,35565.0,Everolimus,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Everolimus']",0.5
15176,35764.0,Everolimus,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Everolimus']",0.5
15176,35771.0,Everolimus,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'ABCB1', 'Everolimus']",0.5
15176,35771.0,Everolimus,breast neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['breast neoplasm', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Everolimus']",0.5
15176,36104.0,Everolimus,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Everolimus']",0.5
15176,36229.0,Everolimus,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Everolimus']",0.5
15176,36425.0,Everolimus,primary central nervous system lymphoma,disease-protein-drug,contraindication,"['primary central nervous system lymphoma', 'ABCB1', 'Everolimus']",0.5
15176,36935.0,Everolimus,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'MTOR', 'Everolimus']",0.5
15176,36937.0,Everolimus,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'MTOR', 'Everolimus']",0.5
15176,37334.0,Everolimus,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'ABCB1', 'Everolimus']",0.5
15176,83764.0,Everolimus,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Organophosphorus Compounds', 'social behavior', 'MTOR', 'Everolimus']",0.5
15176,83796.0,Everolimus,lymphosarcoma,disease-protein-drug,contraindication,"['lymphosarcoma', 'MTOR', 'Everolimus']",0.5
15177,28313.0,Zuclopenthixol,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD5', 'Zuclopenthixol']",0.5
15177,28313.0,Zuclopenthixol,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Zuclopenthixol']",0.5
15179,28921.0,Nicotinamide,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Cardiomegaly', 'CYP2E1', 'Nicotinamide']",0.5
15179,31502.0,Nicotinamide,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Increased body weight', 'CYP2D6', 'Nicotinamide']",0.5
15179,33575.0,Nicotinamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'mitochondrial DNA metabolic process', 'PARP1', 'Nicotinamide']",0.5
15179,33575.0,Nicotinamide,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'CYP2E1', 'Nicotinamide']",0.5
15179,35565.0,Nicotinamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Nicotinamide']",0.5
15179,35764.0,Nicotinamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Nicotinamide']",0.5
15179,36252.0,Nicotinamide,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'regulation of inflammatory response', 'BST1', 'Nicotinamide']",0.5
15179,36252.0,Nicotinamide,thyroid gland disease,disease-exposure-gene-drug,contraindication,"['thyroid gland disease', 'Pesticides', 'CYP2E1', 'Nicotinamide']",0.5
15179,37830.0,Nicotinamide,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'mitochondrial DNA metabolic process', 'PARP1', 'Nicotinamide']",0.5
15180,27700.0,Fusidic acid,sclerosing cholangitis,disease-exposure-bioprocess-gene-drug,indication,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Fusidic acid']",0.5
15180,27700.0,Fusidic acid,sclerosing cholangitis,disease-phenotype-protein-drug,indication,"['sclerosing cholangitis', 'Pruritus', 'ABCB11', 'Fusidic acid']",0.5
15180,28547.0,Fusidic acid,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'CYP2D6', 'Fusidic acid']",0.5
15180,28547.0,Fusidic acid,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Fusidic acid']",0.5
15180,28547.0,Fusidic acid,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Fusidic acid']",0.5
15180,31650.0,Fusidic acid,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ABCC2', 'Fusidic acid']",0.5
15180,32626.0,Fusidic acid,cholera,disease-phenotype-protein-drug,indication,"['cholera', 'Seizure', 'ABCC2', 'Fusidic acid']",0.5
15180,32918.0,Fusidic acid,vernal keratoconjunctivitis,disease-phenotype-protein-drug,indication,"['vernal keratoconjunctivitis', 'Pruritus', 'ABCB11', 'Fusidic acid']",0.5
15180,33193.0,Fusidic acid,plague,disease-phenotype-protein-drug,off-label use,"['plague', 'Coma', 'CYP2D6', 'Fusidic acid']",0.5
15180,33297.0,Fusidic acid,listeriosis,disease-phenotype-protein-drug,indication,"['listeriosis', 'Tremor', 'CYP2D6', 'Fusidic acid']",0.5
15180,33306.0,Fusidic acid,necrotizing enterocolitis,disease-phenotype-protein-drug,off-label use,"['necrotizing enterocolitis', 'Bradycardia', 'CYP2D6', 'Fusidic acid']",0.5
15180,33542.0,Fusidic acid,scrub typhus,disease-phenotype-protein-drug,indication,"['scrub typhus', 'Tremor', 'CYP2D6', 'Fusidic acid']",0.5
15180,33575.0,Fusidic acid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Fusidic acid']",0.5
15180,33581.0,Fusidic acid,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'inflammatory response', 'ABCC2', 'Fusidic acid']",0.5
15180,33594.0,Fusidic acid,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Fusidic acid']",0.5
15180,33618.0,Fusidic acid,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'inflammatory response', 'ABCC2', 'Fusidic acid']",0.5
15180,35552.0,Fusidic acid,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Fusidic acid']",0.5
15180,35565.0,Fusidic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Fusidic acid']",0.5
15180,35749.0,Fusidic acid,digestive system disease,disease-protein-drug,contraindication,"['digestive system disease', 'ABCC2', 'Fusidic acid']",0.5
15180,35749.0,Fusidic acid,digestive system disease,disease-exposure-bioprocess-gene-drug,contraindication,"['digestive system disease', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP3A4', 'Fusidic acid']",0.5
15180,35764.0,Fusidic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Fusidic acid']",0.5
15180,36080.0,Fusidic acid,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'ABCC2', 'Fusidic acid']",0.5
15180,37830.0,Fusidic acid,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Fusidic acid']",0.5
15181,27933.0,Phenacetin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Phenacetin']",0.5
15181,27933.0,Phenacetin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Phenacetin']",0.5
15181,27933.0,Phenacetin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Phenacetin']",0.5
15181,28473.0,Phenacetin,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CYP2D6', 'Phenacetin']",0.5
15181,28899.0,Phenacetin,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Nicotine', 'regulation of blood pressure', 'PTGS1', 'Phenacetin']",0.5
15181,28899.0,Phenacetin,obsessive-compulsive disorder,disease-exposure-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Tobacco Smoke Pollution', 'CYP1A1', 'Phenacetin']",0.5
15181,30035.0,Phenacetin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Phenacetin']",0.5
15181,30374.0,Phenacetin,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'CYP1A1', 'Phenacetin']",0.5
15181,32977.0,Phenacetin,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Phenacetin']",0.5
15181,33306.0,Phenacetin,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'CYP1A1', 'Phenacetin']",0.5
15181,33440.0,Phenacetin,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Coma', 'CYP2D6', 'Phenacetin']",0.5
15181,33577.0,Phenacetin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Phenacetin']",0.5
15181,33577.0,Phenacetin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Phenacetin']",0.5
15181,33632.0,Phenacetin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Phenacetin']",0.5
15181,33632.0,Phenacetin,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Phenacetin']",0.5
15181,33675.0,Phenacetin,asthma,disease-protein-drug,contraindication,"['asthma', 'PTGS1', 'Phenacetin']",0.5
15181,33675.0,Phenacetin,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Phenacetin']",0.5
15181,33675.0,Phenacetin,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'PTGS1', 'Phenacetin']",0.5
15181,35565.0,Phenacetin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Phenacetin']",0.5
15181,35565.0,Phenacetin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Phenacetin']",0.5
15181,35764.0,Phenacetin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Phenacetin']",0.5
15181,35764.0,Phenacetin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Phenacetin']",0.5
15181,36080.0,Phenacetin,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Phenacetin']",0.5
15181,36080.0,Phenacetin,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'PTGS1', 'Phenacetin']",0.5
15181,36187.0,Phenacetin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Phenacetin']",0.5
15181,36187.0,Phenacetin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Phenacetin']",0.5
15181,36693.0,Phenacetin,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Phenacetin']",0.5
15181,37617.0,Phenacetin,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A1', 'Phenacetin']",0.5
15181,37617.0,Phenacetin,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Phenacetin']",0.5
15181,37617.0,Phenacetin,chronic obstructive pulmonary disease,disease-exposure-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'PTGS1', 'Phenacetin']",0.5
15181,37703.0,Phenacetin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Phenacetin']",0.5
15181,37786.0,Phenacetin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Phenacetin']",0.5
15181,37786.0,Phenacetin,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Agent Orange', 'CYP1A1', 'Phenacetin']",0.5
15181,38575.0,Phenacetin,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CYP2D6', 'Phenacetin']",0.5
15181,83760.0,Phenacetin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Phenacetin']",0.5
15181,83911.0,Phenacetin,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CYP2D6', 'Phenacetin']",0.5
15185,27326.0,Tetrabenazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Tetrabenazine']",0.5
15185,27326.0,Tetrabenazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Tetrabenazine']",0.5
15185,27655.0,Tetrabenazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD2', 'Tetrabenazine']",0.5
15185,27933.0,Tetrabenazine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'DRD2', 'Tetrabenazine']",0.5
15185,27933.0,Tetrabenazine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'DRD2', 'Tetrabenazine']",0.5
15185,28375.0,Tetrabenazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Tetrabenazine']",0.5
15185,28396.0,Tetrabenazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Tetrabenazine']",0.5
15185,28547.0,Tetrabenazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'SLC18A2', 'Tetrabenazine']",0.5
15185,28547.0,Tetrabenazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'regulation of heart rate', 'DRD2', 'Tetrabenazine']",0.5
15185,28547.0,Tetrabenazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Tetrabenazine']",0.5
15185,29637.0,Tetrabenazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Tetrabenazine']",0.5
15185,29637.0,Tetrabenazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD2', 'Tetrabenazine']",0.5
15185,29652.0,Tetrabenazine,Huntington disease-like,disease-phenotype-protein-drug,indication,"['Huntington disease-like', 'Action tremor', 'CYP2D6', 'Tetrabenazine']",0.5
15185,31245.0,Tetrabenazine,Huntington disease,disease-phenotype-protein-drug,indication,"['Huntington disease', 'Rigidity', 'CYP2D6', 'Tetrabenazine']",0.5
15185,32740.0,Tetrabenazine,Huntington disease-like syndrome due to C9ORF72 expansions,disease-phenotype-protein-drug,indication,"['Huntington disease-like syndrome due to C9ORF72 expansions', 'Rigidity', 'CYP2D6', 'Tetrabenazine']",0.5
15185,33341.0,Tetrabenazine,juvenile Huntington disease,disease-phenotype-protein-drug,indication,"['juvenile Huntington disease', 'Rigidity', 'CYP2D6', 'Tetrabenazine']",0.5
15185,33605.0,Tetrabenazine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'DRD2', 'Tetrabenazine']",0.5
15185,35565.0,Tetrabenazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Tetrabenazine']",0.5
15185,37703.0,Tetrabenazine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'SLC18A2', 'Tetrabenazine']",0.5
15185,37706.0,Tetrabenazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'SLC18A2', 'Tetrabenazine']",0.5
15185,39081.0,Tetrabenazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Tetrabenazine']",0.5
15185,83760.0,Tetrabenazine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'SLC18A2', 'Tetrabenazine']",0.5
15185,83998.0,Tetrabenazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Tetrabenazine']",0.5
15185,84023.0,Tetrabenazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Tetrabenazine']",0.5
15186,33577.0,Celiprolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Celiprolol']",0.5
15187,27326.0,Nilotinib,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of transcription, DNA-templated', 'ABL1', 'Nilotinib']",0.5
15187,27326.0,Nilotinib,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Nilotinib']",0.5
15187,27476.0,Nilotinib,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'UGT1A1', 'Nilotinib']",0.5
15187,27476.0,Nilotinib,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Nilotinib']",0.5
15187,27626.0,Nilotinib,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'KIT', 'Nilotinib']",0.5
15187,30039.0,Nilotinib,"chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['chronic myelogenous leukemia, BCR-ABL1 positive', 'ABL1', 'Nilotinib']",0.5
15187,33575.0,Nilotinib,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABL1', 'Nilotinib']",0.5
15187,33577.0,Nilotinib,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Nilotinib']",0.5
15187,33632.0,Nilotinib,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Nilotinib']",0.5
15187,35565.0,Nilotinib,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'KIT', 'Nilotinib']",0.5
15187,36104.0,Nilotinib,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Nilotinib']",0.5
15187,36229.0,Nilotinib,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Nilotinib']",0.5
15187,36645.0,Nilotinib,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'UGT1A1', 'Nilotinib']",0.5
15187,38312.0,Nilotinib,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B1', 'Nilotinib']",0.5
15187,83751.0,Nilotinib,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Nilotinib']",0.5
15188,28651.0,Lorcaserin,monogenic obesity,disease-protein-drug,indication,"['monogenic obesity', 'HTR2C', 'Lorcaserin']",0.5
15188,33593.0,Lorcaserin,obesity disorder,disease-protein-drug,indication,"['obesity disorder', 'HTR2C', 'Lorcaserin']",0.5
15188,33593.0,Lorcaserin,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'beta-hexachlorocyclohexane', 'DNA methylation', 'CYP1A1', 'Lorcaserin']",0.5
15188,33593.0,Lorcaserin,obesity disorder,disease-exposure-gene-drug,indication,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'CYP1A1', 'Lorcaserin']",0.5
15188,33593.0,Lorcaserin,obesity disorder,disease-phenotype-protein-drug,indication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Lorcaserin']",0.5
15189,83995.0,Dapoxetine,psychologic dyspareunia,disease-protein-drug,indication,"['psychologic dyspareunia', 'CYP2D6', 'Dapoxetine']",0.5
15189,83996.0,Dapoxetine,premature ejaculation (disease),disease-protein-drug,indication,"['premature ejaculation (disease)', 'CYP2D6', 'Dapoxetine']",0.5
15191,83995.0,Ospemifene,psychologic dyspareunia,disease-protein-drug,indication,"['psychologic dyspareunia', 'CYP2D6', 'Ospemifene']",0.5
15193,28396.0,Rotigotine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,28547.0,Rotigotine,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD1', 'Rotigotine']",0.5
15193,28547.0,Rotigotine,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'regulation of heart rate', 'DRD2', 'Rotigotine']",0.5
15193,28547.0,Rotigotine,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,28801.0,Rotigotine,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD1', 'Rotigotine']",0.5
15193,28801.0,Rotigotine,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,28974.0,Rotigotine,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DRD1', 'Rotigotine']",0.5
15193,28974.0,Rotigotine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,30093.0,Rotigotine,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DRD1', 'Rotigotine']",0.5
15193,30093.0,Rotigotine,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,31408.0,Rotigotine,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DRD1', 'Rotigotine']",0.5
15193,31408.0,Rotigotine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,32759.0,Rotigotine,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DRD1', 'Rotigotine']",0.5
15193,32759.0,Rotigotine,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,32974.0,Rotigotine,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DRD1', 'Rotigotine']",0.5
15193,32974.0,Rotigotine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,33241.0,Rotigotine,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DRD1', 'Rotigotine']",0.5
15193,33241.0,Rotigotine,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CYP2D6', 'Rotigotine']",0.5
15193,33577.0,Rotigotine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'DRD2', 'Rotigotine']",0.5
15193,83749.0,Rotigotine,drug-induced dyskinesia,disease-protein-drug,contraindication,"['drug-induced dyskinesia', 'DRD3', 'Rotigotine']",0.5
15194,28313.0,Cariprazine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HRH1', 'Cariprazine']",0.5
15194,28313.0,Cariprazine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Cariprazine']",0.5
15194,38242.0,Cariprazine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'DRD2', 'Cariprazine']",0.5
15194,38242.0,Cariprazine,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Cariprazine']",0.5
15194,83763.0,Cariprazine,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'HTR2A', 'Cariprazine']",0.5
15196,28313.0,Sertindole,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Sertindole']",0.5
15196,28313.0,Sertindole,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Sertindole']",0.5
15197,27933.0,Mianserin,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'DRD5', 'Mianserin']",0.5
15197,27933.0,Mianserin,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR7', 'Mianserin']",0.5
15197,38957.0,Mianserin,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Mianserin']",0.5
15197,38957.0,Mianserin,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Mianserin']",0.5
15197,83840.0,Mianserin,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'DRD5', 'Mianserin']",0.5
15197,83841.0,Mianserin,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Mianserin']",0.5
15198,28208.0,Alogliptin,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Alogliptin']",0.5
15198,33575.0,Alogliptin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Alogliptin']",0.5
15200,33618.0,Vernakalant,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'KCND3', 'Vernakalant']",0.5
15200,33618.0,Vernakalant,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of heart rate', 'SCN5A', 'Vernakalant']",0.5
15201,33575.0,Dapagliflozin,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'CYP1A2', 'Dapagliflozin']",0.5
15201,33575.0,Dapagliflozin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Dapagliflozin']",0.5
15201,33575.0,Dapagliflozin,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Dapagliflozin']",0.5
15205,27326.0,Pazopanib,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Pazopanib']",0.5
15205,27326.0,Pazopanib,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Pazopanib']",0.5
15205,27476.0,Pazopanib,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'UGT1A1', 'Pazopanib']",0.5
15205,27476.0,Pazopanib,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'respiratory system process', 'FLT4', 'Pazopanib']",0.5
15205,28640.0,Pazopanib,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'FLT4', 'Pazopanib']",0.5
15205,32719.0,Pazopanib,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Hearing impairment', 'FGFR3', 'Pazopanib']",0.5
15205,33577.0,Pazopanib,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Pazopanib']",0.5
15205,33594.0,Pazopanib,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Pazopanib']",0.5
15205,33643.0,Pazopanib,renal cell carcinoma (disease),disease-protein-drug,indication,"['renal cell carcinoma (disease)', 'FLT4', 'Pazopanib']",0.5
15205,33643.0,Pazopanib,renal cell carcinoma (disease),disease-exposure-bioprocess-gene-drug,indication,"['renal cell carcinoma (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Pazopanib']",0.5
15205,35958.0,Pazopanib,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'SH2B3', 'Pazopanib']",0.5
15205,36469.0,Pazopanib,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Petroleum', 'respiratory system process', 'FLT4', 'Pazopanib']",0.5
15205,36540.0,Pazopanib,sarcoma,disease-exposure-bioprocess-gene-drug,indication,"['sarcoma', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'KIT', 'Pazopanib']",0.5
15205,36544.0,Pazopanib,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ABCB1', 'Pazopanib']",0.5
15205,36544.0,Pazopanib,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'KIT', 'Pazopanib']",0.5
15205,36645.0,Pazopanib,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'UGT1A1', 'Pazopanib']",0.5
15205,36935.0,Pazopanib,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'FLT1', 'Pazopanib']",0.5
15205,36937.0,Pazopanib,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'FLT4', 'Pazopanib']",0.5
15205,37175.0,Pazopanib,proteinuria,disease-exposure-bioprocess-gene-drug,contraindication,"['proteinuria', 'Cadmium', 'inflammatory response', 'KIT', 'Pazopanib']",0.5
15205,37180.0,Pazopanib,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'SH2B3', 'Pazopanib']",0.5
15205,37180.0,Pazopanib,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'respiratory system process', 'FLT4', 'Pazopanib']",0.5
15205,38312.0,Pazopanib,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B1', 'Pazopanib']",0.5
15205,83751.0,Pazopanib,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Pazopanib']",0.5
15205,83823.0,Pazopanib,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'SH2B3', 'Pazopanib']",0.5
15205,83824.0,Pazopanib,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'SH2B3', 'Pazopanib']",0.5
15205,83942.0,Pazopanib,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'respiratory system process', 'FLT4', 'Pazopanib']",0.5
15206,30494.0,Panobinostat,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Panobinostat']",0.5
15209,27933.0,Vilazodone,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'CYP2C19', 'Vilazodone']",0.5
15209,27933.0,Vilazodone,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Vilazodone']",0.5
15209,28249.0,Vilazodone,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A4', 'Vilazodone']",0.5
15209,28456.0,Vilazodone,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'HTR1A', 'Vilazodone']",0.5
15209,33091.0,Vilazodone,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Fever', 'HTR1A', 'Vilazodone']",0.5
15209,33454.0,Vilazodone,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Fever', 'HTR1A', 'Vilazodone']",0.5
15209,35641.0,Vilazodone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1A', 'Vilazodone']",0.5
15209,38242.0,Vilazodone,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A4', 'Vilazodone']",0.5
15209,38957.0,Vilazodone,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Vilazodone']",0.5
15209,38957.0,Vilazodone,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Vilazodone']",0.5
15209,83840.0,Vilazodone,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'CYP2C19', 'Vilazodone']",0.5
15209,83841.0,Vilazodone,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Vilazodone']",0.5
15210,27503.0,Mepyramine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Bradycardia', 'CYP2D6', 'Mepyramine']",0.5
15210,27933.0,Mepyramine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2D6', 'Mepyramine']",0.5
15210,27933.0,Mepyramine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'memory', 'HRH1', 'Mepyramine']",0.5
15210,28158.0,Mepyramine,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'SLC22A4', 'Mepyramine']",0.5
15210,28158.0,Mepyramine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,28899.0,Mepyramine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Asbestos', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,29525.0,Mepyramine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Mepyramine']",0.5
15210,30035.0,Mepyramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2D6', 'Mepyramine']",0.5
15210,32719.0,Mepyramine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'SLC22A5', 'Mepyramine']",0.5
15210,33306.0,Mepyramine,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'CYP2D6', 'Mepyramine']",0.5
15210,33575.0,Mepyramine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,33577.0,Mepyramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Mepyramine']",0.5
15210,33603.0,Mepyramine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Mepyramine']",0.5
15210,33605.0,Mepyramine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Mepyramine']",0.5
15210,33675.0,Mepyramine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,35565.0,Mepyramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Mepyramine']",0.5
15210,35641.0,Mepyramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Mepyramine']",0.5
15210,35669.0,Mepyramine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A4', 'Mepyramine']",0.5
15210,35669.0,Mepyramine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,35761.0,Mepyramine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,35764.0,Mepyramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Mepyramine']",0.5
15210,35897.0,Mepyramine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,35953.0,Mepyramine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Mepyramine']",0.5
15210,35953.0,Mepyramine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,36034.0,Mepyramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Mepyramine']",0.5
15210,36080.0,Mepyramine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,36187.0,Mepyramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,36469.0,Mepyramine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Mepyramine']",0.5
15210,36492.0,Mepyramine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'triglyceride metabolic process', 'SLC22A4', 'Mepyramine']",0.5
15210,36693.0,Mepyramine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Mepyramine']",0.5
15210,36693.0,Mepyramine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Mepyramine']",0.5
15210,37180.0,Mepyramine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,37617.0,Mepyramine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,37785.0,Mepyramine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'triglyceride metabolic process', 'SLC22A4', 'Mepyramine']",0.5
15210,37786.0,Mepyramine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,37888.0,Mepyramine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Mepyramine']",0.5
15210,37888.0,Mepyramine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Mepyramine']",0.5
15210,83791.0,Mepyramine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Mepyramine']",0.5
15211,27933.0,Desvenlafaxine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'SLC6A2', 'Desvenlafaxine']",0.5
15211,27933.0,Desvenlafaxine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Desvenlafaxine']",0.5
15211,28249.0,Desvenlafaxine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Desvenlafaxine']",0.5
15211,28456.0,Desvenlafaxine,nephrogenic syndrome of inappropriate antidiuresis,disease-phenotype-protein-drug,contraindication,"['nephrogenic syndrome of inappropriate antidiuresis', 'Seizure', 'SLC6A2', 'Desvenlafaxine']",0.5
15211,33091.0,Desvenlafaxine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Tremor', 'CYP2D6', 'Desvenlafaxine']",0.5
15211,33454.0,Desvenlafaxine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tremor', 'CYP2D6', 'Desvenlafaxine']",0.5
15211,33577.0,Desvenlafaxine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Desvenlafaxine']",0.5
15211,33695.0,Desvenlafaxine,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'memory', 'SLC6A4', 'Desvenlafaxine']",0.5
15211,35565.0,Desvenlafaxine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A4', 'Desvenlafaxine']",0.5
15211,35641.0,Desvenlafaxine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Desvenlafaxine']",0.5
15211,35669.0,Desvenlafaxine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Desvenlafaxine']",0.5
15211,35761.0,Desvenlafaxine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Desvenlafaxine']",0.5
15211,35909.0,Desvenlafaxine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Desvenlafaxine']",0.5
15211,36105.0,Desvenlafaxine,phobic disorder,disease-protein-drug,off-label use,"['phobic disorder', 'SLC6A3', 'Desvenlafaxine']",0.5
15211,38242.0,Desvenlafaxine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Desvenlafaxine']",0.5
15211,38957.0,Desvenlafaxine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Desvenlafaxine']",0.5
15211,38957.0,Desvenlafaxine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Desvenlafaxine']",0.5
15211,83840.0,Desvenlafaxine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'SLC6A2', 'Desvenlafaxine']",0.5
15211,83841.0,Desvenlafaxine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Desvenlafaxine']",0.5
15212,31650.0,Fesoterodine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Fesoterodine']",0.5
15213,27326.0,Lumefantrine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Lumefantrine']",0.5
15213,27326.0,Lumefantrine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Lumefantrine']",0.5
15213,83751.0,Lumefantrine,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Lumefantrine']",0.5
15218,28466.0,Phenylbutyric acid,isovaleric acidemia,disease-phenotype-protein-drug,off-label use,"['isovaleric acidemia', 'Coma', 'CYP2D6', 'Phenylbutyric acid']",0.5
15218,29034.0,Phenylbutyric acid,hyperammonemia due to N-acetylglutamate synthase deficiency,disease-phenotype-protein-drug,indication,"['hyperammonemia due to N-acetylglutamate synthase deficiency', 'Coma', 'CYP2D6', 'Phenylbutyric acid']",0.5
15218,29186.0,Phenylbutyric acid,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,indication,"['carbamoyl phosphate synthetase I deficiency disease', 'Coma', 'CYP2D6', 'Phenylbutyric acid']",0.5
15218,30829.0,Phenylbutyric acid,argininosuccinic aciduria,disease-phenotype-protein-drug,indication,"['argininosuccinic aciduria', 'Coma', 'CYP2D6', 'Phenylbutyric acid']",0.5
15218,32132.0,Phenylbutyric acid,citrullinemia,disease-phenotype-protein-drug,indication,"['citrullinemia', 'Tremor', 'CYP2D6', 'Phenylbutyric acid']",0.5
15218,35565.0,Phenylbutyric acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Phenylbutyric acid']",0.5
15218,35764.0,Phenylbutyric acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Phenylbutyric acid']",0.5
15221,33577.0,Bupranolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Bupranolol']",0.5
15222,27933.0,Levomilnacipran,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Levomilnacipran']",0.5
15222,27933.0,Levomilnacipran,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Levomilnacipran']",0.5
15222,38957.0,Levomilnacipran,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Levomilnacipran']",0.5
15222,38957.0,Levomilnacipran,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Levomilnacipran']",0.5
15222,83840.0,Levomilnacipran,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'ABCB1', 'Levomilnacipran']",0.5
15222,83841.0,Levomilnacipran,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Levomilnacipran']",0.5
15223,28313.0,Perospirone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HRH1', 'Perospirone']",0.5
15223,28313.0,Perospirone,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD4', 'Perospirone']",0.5
15226,28772.0,Eliglustat,Gaucher disease,disease-phenotype-protein-drug,indication,"['Gaucher disease', 'Tremor', 'CYP2D6', 'Eliglustat']",0.5
15230,28455.0,Lenvatinib,papillary renal cell carcinoma,disease-protein-drug,indication,"['papillary renal cell carcinoma', 'FLT1', 'Lenvatinib']",0.5
15230,28640.0,Lenvatinib,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'FLT4', 'Lenvatinib']",0.5
15230,29339.0,Lenvatinib,"thyroid cancer, nonmedullary",disease-protein-drug,indication,"['thyroid cancer, nonmedullary', 'RET', 'Lenvatinib']",0.5
15230,30749.0,Lenvatinib,thyroid gland carcinoma,disease-protein-drug,indication,"['thyroid gland carcinoma', 'FLT1', 'Lenvatinib']",0.5
15230,30749.0,Lenvatinib,thyroid gland carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['thyroid gland carcinoma', 'perfluorooctanoic acid', 'respiratory system process', 'FLT4', 'Lenvatinib']",0.5
15230,33643.0,Lenvatinib,renal cell carcinoma (disease),disease-protein-drug,indication,"['renal cell carcinoma (disease)', 'FLT4', 'Lenvatinib']",0.5
15230,33643.0,Lenvatinib,renal cell carcinoma (disease),disease-exposure-bioprocess-gene-drug,indication,"['renal cell carcinoma (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Lenvatinib']",0.5
15230,36935.0,Lenvatinib,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'FLT1', 'Lenvatinib']",0.5
15230,36937.0,Lenvatinib,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'FLT4', 'Lenvatinib']",0.5
15230,37130.0,Lenvatinib,papillary adenocarcinoma,disease-protein-drug,indication,"['papillary adenocarcinoma', 'FLT1', 'Lenvatinib']",0.5
15231,28005.0,Stiripentol,developmental and epileptic encephalopathy,disease-protein-drug,indication,"['developmental and epileptic encephalopathy', 'GABRG2', 'Stiripentol']",0.5
15231,28005.0,Stiripentol,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,indication,"['developmental and epileptic encephalopathy', 'Decreased liver function', 'CYP1A2', 'Stiripentol']",0.5
15231,33125.0,Stiripentol,early myoclonic encephalopathy,disease-protein-drug,indication,"['early myoclonic encephalopathy', 'GABRG2', 'Stiripentol']",0.5
15231,84256.0,Stiripentol,Dravet syndrome,disease-protein-drug,indication,"['Dravet syndrome', 'GABRG2', 'Stiripentol']",0.5
15232,27933.0,Brexpiprazole,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'DRD2', 'Brexpiprazole']",0.5
15232,27933.0,Brexpiprazole,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'DRD2', 'Brexpiprazole']",0.5
15232,28313.0,Brexpiprazole,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Brexpiprazole']",0.5
15232,28313.0,Brexpiprazole,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Brexpiprazole']",0.5
15232,38957.0,Brexpiprazole,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'HTR2A', 'Brexpiprazole']",0.5
15232,38957.0,Brexpiprazole,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'platelet activation', 'ADRA2C', 'Brexpiprazole']",0.5
15232,83840.0,Brexpiprazole,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'DRD2', 'Brexpiprazole']",0.5
15232,83841.0,Brexpiprazole,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'HTR2A', 'Brexpiprazole']",0.5
15233,27933.0,Dosulepin,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'CYP2C19', 'Dosulepin']",0.5
15233,27933.0,Dosulepin,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Dosulepin']",0.5
15233,38957.0,Dosulepin,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'SLC6A4', 'Dosulepin']",0.5
15233,38957.0,Dosulepin,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Dosulepin']",0.5
15233,83840.0,Dosulepin,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'CYP2C19', 'Dosulepin']",0.5
15233,83841.0,Dosulepin,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'SLC6A4', 'Dosulepin']",0.5
15235,37743.0,Dasabuvir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Dasabuvir']",0.5
15240,30494.0,Ixazomib,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Ixazomib']",0.5
15240,30494.0,Ixazomib,plasma cell myeloma,disease-phenotype-protein-drug,indication,"['plasma cell myeloma', 'Splenomegaly', 'CYP1A2', 'Ixazomib']",0.5
15241,37888.0,Rupatadine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Rupatadine']",0.5
15241,37888.0,Rupatadine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'PTAFR', 'Rupatadine']",0.5
15241,83791.0,Rupatadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Rupatadine']",0.5
15242,33128.0,Artenimol,malaria,disease-protein-drug,indication,"['malaria', 'G6PD', 'Artenimol']",0.5
15242,33128.0,Artenimol,malaria,disease-phenotype-protein-drug,indication,"['malaria', 'Thrombocytopenia', 'CYCS', 'Artenimol']",0.5
15245,33577.0,Talinolol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Talinolol']",0.5
15247,29614.0,Elagolix,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Elagolix']",0.5
15250,27610.0,Fedratinib,primary myelofibrosis,disease-protein-drug,indication,"['primary myelofibrosis', 'JAK2', 'Fedratinib']",0.5
15250,27610.0,Fedratinib,primary myelofibrosis,disease-phenotype-protein-drug,indication,"['primary myelofibrosis', 'Venous thrombosis', 'JAK2', 'Fedratinib']",0.5
15250,83871.0,Fedratinib,myelofibrosis,disease-protein-drug,indication,"['myelofibrosis', 'JAK2', 'Fedratinib']",0.5
15254,27326.0,Levosalbutamol,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Levosalbutamol']",0.5
15254,27326.0,Levosalbutamol,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP2D6', 'Levosalbutamol']",0.5
15254,29113.0,Levosalbutamol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Levosalbutamol']",0.5
15254,33575.0,Levosalbutamol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Levosalbutamol']",0.5
15254,33577.0,Levosalbutamol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Levosalbutamol']",0.5
15254,33675.0,Levosalbutamol,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Levosalbutamol']",0.5
15254,33675.0,Levosalbutamol,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Levosalbutamol']",0.5
15254,33679.0,Levosalbutamol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Levosalbutamol']",0.5
15254,36034.0,Levosalbutamol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Levosalbutamol']",0.5
15254,36187.0,Levosalbutamol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB2', 'Levosalbutamol']",0.5
15254,36187.0,Levosalbutamol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Levosalbutamol']",0.5
15260,27503.0,Dexchlorpheniramine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Bradycardia', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,28158.0,Dexchlorpheniramine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,30035.0,Dexchlorpheniramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,33575.0,Dexchlorpheniramine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,33577.0,Dexchlorpheniramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,33675.0,Dexchlorpheniramine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,35565.0,Dexchlorpheniramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,35669.0,Dexchlorpheniramine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,35761.0,Dexchlorpheniramine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,35764.0,Dexchlorpheniramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,35953.0,Dexchlorpheniramine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,36034.0,Dexchlorpheniramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,36187.0,Dexchlorpheniramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,36469.0,Dexchlorpheniramine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,36492.0,Dexchlorpheniramine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,36693.0,Dexchlorpheniramine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,37180.0,Dexchlorpheniramine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15260,37785.0,Dexchlorpheniramine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2D6', 'Dexchlorpheniramine']",0.5
15263,28520.0,Enasidenib,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'IDH2', 'Enasidenib']",0.5
15263,28520.0,Enasidenib,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Enasidenib']",0.5
15263,37714.0,Enasidenib,unclassified acute myeloid leukemia,disease-protein-drug,indication,"['unclassified acute myeloid leukemia', 'IDH2', 'Enasidenib']",0.5
15263,38274.0,Enasidenib,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'IDH2', 'Enasidenib']",0.5
15263,39124.0,Enasidenib,therapy related acute myeloid leukemia and myelodysplastic syndrome,disease-protein-drug,indication,"['therapy related acute myeloid leukemia and myelodysplastic syndrome', 'IDH2', 'Enasidenib']",0.5
15263,83852.0,Enasidenib,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'IDH2', 'Enasidenib']",0.5
15263,83853.0,Enasidenib,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'IDH2', 'Enasidenib']",0.5
15263,83854.0,Enasidenib,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'IDH2', 'Enasidenib']",0.5
15263,83855.0,Enasidenib,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'IDH2', 'Enasidenib']",0.5
15263,83856.0,Enasidenib,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'IDH2', 'Enasidenib']",0.5
15263,83857.0,Enasidenib,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'IDH2', 'Enasidenib']",0.5
15263,83858.0,Enasidenib,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'IDH2', 'Enasidenib']",0.5
15263,83859.0,Enasidenib,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'IDH2', 'Enasidenib']",0.5
15263,83860.0,Enasidenib,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'IDH2', 'Enasidenib']",0.5
15263,83861.0,Enasidenib,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'IDH2', 'Enasidenib']",0.5
15263,83862.0,Enasidenib,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'IDH2', 'Enasidenib']",0.5
15269,29078.0,Upadacitinib,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Upadacitinib']",0.5
15269,29078.0,Upadacitinib,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Upadacitinib']",0.5
15271,31756.0,Mitomycin,urinary bladder cancer,disease-protein-drug,off-label use,"['urinary bladder cancer', 'POR', 'Mitomycin']",0.5
15271,33464.0,Mitomycin,urinary bladder small cell neuroendocrine carcinoma,disease-protein-drug,off-label use,"['urinary bladder small cell neuroendocrine carcinoma', 'POR', 'Mitomycin']",0.5
15271,33642.0,Mitomycin,urinary bladder carcinoma,disease-protein-drug,off-label use,"['urinary bladder carcinoma', 'POR', 'Mitomycin']",0.5
15271,35624.0,Mitomycin,urinary bladder neoplasm,disease-protein-drug,off-label use,"['urinary bladder neoplasm', 'POR', 'Mitomycin']",0.5
15271,83866.0,Mitomycin,non-papillary transitional cell carcinoma of the bladder,disease-protein-drug,off-label use,"['non-papillary transitional cell carcinoma of the bladder', 'POR', 'Mitomycin']",0.5
15272,35833.0,Nilutamide,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Nilutamide']",0.5
15272,36080.0,Nilutamide,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Nilutamide']",0.5
15273,27286.0,Nitrofurantoin,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ABCC2', 'Nitrofurantoin']",0.5
15273,27292.0,Nitrofurantoin,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Seizure', 'ABCC2', 'Nitrofurantoin']",0.5
15273,33575.0,Nitrofurantoin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Nitrofurantoin']",0.5
15273,35471.0,Nitrofurantoin,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'inflammatory response', 'ABCC2', 'Nitrofurantoin']",0.5
15273,36544.0,Nitrofurantoin,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ABCB1', 'Nitrofurantoin']",0.5
15273,36544.0,Nitrofurantoin,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Nitrofurantoin']",0.5
15274,28249.0,Benzphetamine,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC18A2', 'Benzphetamine']",0.5
15274,30035.0,Benzphetamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ADRA2A', 'Benzphetamine']",0.5
15274,33575.0,Benzphetamine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Benzphetamine']",0.5
15274,33577.0,Benzphetamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Benzphetamine']",0.5
15274,33593.0,Benzphetamine,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Benzphetamine']",0.5
15274,35669.0,Benzphetamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Benzphetamine']",0.5
15274,35761.0,Benzphetamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Benzphetamine']",0.5
15274,35915.0,Benzphetamine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Benzphetamine']",0.5
15274,35953.0,Benzphetamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Benzphetamine']",0.5
15274,36034.0,Benzphetamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Benzphetamine']",0.5
15274,38242.0,Benzphetamine,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC18A2', 'Benzphetamine']",0.5
15274,83778.0,Benzphetamine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Benzphetamine']",0.5
15274,83779.0,Benzphetamine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Benzphetamine']",0.5
15282,28208.0,Insulin lispro,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'CYP1A2', 'Insulin lispro']",0.5
15282,28208.0,Insulin lispro,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose homeostasis', 'IGF1R', 'Insulin lispro']",0.5
15282,28208.0,Insulin lispro,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'INSR', 'Insulin lispro']",0.5
15282,28552.0,Insulin lispro,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'immune response', 'IGF1R', 'Insulin lispro']",0.5
15282,29113.0,Insulin lispro,diabetic ketoacidosis,disease-phenotype-protein-drug,indication,"['diabetic ketoacidosis', 'Insulin resistance', 'INSR', 'Insulin lispro']",0.5
15282,33575.0,Insulin lispro,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'CYP1A2', 'Insulin lispro']",0.5
15282,33575.0,Insulin lispro,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'IGF1R', 'Insulin lispro']",0.5
15283,28552.0,Insulin glargine,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'immune response', 'IGF1R', 'Insulin glargine']",0.5
15283,33575.0,Insulin glargine,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'CYP1A2', 'Insulin glargine']",0.5
15283,33575.0,Insulin glargine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'IGF1R', 'Insulin glargine']",0.5
15288,33294.0,Interferon alfa-2b,follicular lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['follicular lymphoma', 'Polychlorinated Biphenyls', 'methylation', 'CYP1A2', 'Interferon alfa-2b']",0.5
15288,33294.0,Interferon alfa-2b,follicular lymphoma,disease-phenotype-protein-drug,indication,"['follicular lymphoma', 'Splenomegaly', 'CYP1A2', 'Interferon alfa-2b']",0.5
15288,33653.0,Interferon alfa-2b,melanoma,disease-exposure-bioprocess-gene-drug,indication,"['melanoma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Interferon alfa-2b']",0.5
15289,27326.0,Moxifloxacin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Moxifloxacin']",0.5
15289,33193.0,Moxifloxacin,plague,disease-phenotype-protein-drug,indication,"['plague', 'Hepatomegaly', 'CYP1A2', 'Moxifloxacin']",0.5
15289,36187.0,Moxifloxacin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cellular response to DNA damage stimulus', 'TOP2A', 'Moxifloxacin']",0.5
15289,36544.0,Moxifloxacin,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP1A2', 'Moxifloxacin']",0.5
15289,36544.0,Moxifloxacin,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Moxifloxacin']",0.5
15289,37765.0,Moxifloxacin,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'CYP1A2', 'Moxifloxacin']",0.5
15289,37786.0,Moxifloxacin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cellular response to DNA damage stimulus', 'TOP2A', 'Moxifloxacin']",0.5
15289,39696.0,Moxifloxacin,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,off-label use,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Moxifloxacin']",0.5
15290,28536.0,Anagrelide,thrombocythemia,disease-phenotype-protein-drug,indication,"['thrombocythemia', 'Splenomegaly', 'CYP1A2', 'Anagrelide']",0.5
15290,32293.0,Anagrelide,familial thrombocytosis,disease-phenotype-protein-drug,indication,"['familial thrombocytosis', 'Splenomegaly', 'CYP1A2', 'Anagrelide']",0.5
15290,33632.0,Anagrelide,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'PDE3A', 'Anagrelide']",0.5
15290,35565.0,Anagrelide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Anagrelide']",0.5
15290,35669.0,Anagrelide,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Anagrelide']",0.5
15290,35761.0,Anagrelide,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Anagrelide']",0.5
15290,35764.0,Anagrelide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Anagrelide']",0.5
15291,28396.0,Ropinirole,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Neurodegeneration', 'ADRA1B', 'Ropinirole']",0.5
15291,28547.0,Ropinirole,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD2', 'Ropinirole']",0.5
15291,28547.0,Ropinirole,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Ropinirole']",0.5
15291,28801.0,Ropinirole,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD2', 'Ropinirole']",0.5
15291,28801.0,Ropinirole,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Seizure', 'DRD3', 'Ropinirole']",0.5
15291,28974.0,Ropinirole,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DRD2', 'Ropinirole']",0.5
15291,28974.0,Ropinirole,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Seizure', 'DRD3', 'Ropinirole']",0.5
15291,30093.0,Ropinirole,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DRD2', 'Ropinirole']",0.5
15291,31408.0,Ropinirole,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DRD2', 'Ropinirole']",0.5
15291,31408.0,Ropinirole,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Seizure', 'DRD3', 'Ropinirole']",0.5
15291,32974.0,Ropinirole,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DRD2', 'Ropinirole']",0.5
15291,32974.0,Ropinirole,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Seizure', 'DRD3', 'Ropinirole']",0.5
15291,33605.0,Ropinirole,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Ropinirole']",0.5
15291,35915.0,Ropinirole,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Ropinirole']",0.5
15291,83749.0,Ropinirole,drug-induced dyskinesia,disease-protein-drug,contraindication,"['drug-induced dyskinesia', 'DRD3', 'Ropinirole']",0.5
15291,83778.0,Ropinirole,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Ropinirole']",0.5
15291,83779.0,Ropinirole,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Ropinirole']",0.5
15292,28158.0,Ropivacaine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Ropivacaine']",0.5
15292,30035.0,Ropivacaine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2B6', 'Ropivacaine']",0.5
15292,30374.0,Ropivacaine,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'CYP1A2', 'Ropivacaine']",0.5
15292,33675.0,Ropivacaine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Ropivacaine']",0.5
15292,35565.0,Ropivacaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Ropivacaine']",0.5
15292,35669.0,Ropivacaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Ropivacaine']",0.5
15292,35761.0,Ropivacaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Ropivacaine']",0.5
15292,35764.0,Ropivacaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Ropivacaine']",0.5
15292,36080.0,Ropivacaine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Ropivacaine']",0.5
15292,37617.0,Ropivacaine,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A2', 'Ropivacaine']",0.5
15292,37617.0,Ropivacaine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Ropivacaine']",0.5
15294,27476.0,Tacrine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol biosynthetic process', 'CES1', 'Tacrine']",0.5
15294,28473.0,Tacrine,Pick disease,disease-protein-drug,indication,"['Pick disease', 'BCHE', 'Tacrine']",0.5
15294,28780.0,Tacrine,Alzheimer disease,disease-protein-drug,indication,"['Alzheimer disease', 'BCHE', 'Tacrine']",0.5
15294,28780.0,Tacrine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'cholesterol metabolic process', 'CYP1A2', 'Tacrine']",0.5
15294,28780.0,Tacrine,Alzheimer disease,disease-exposure-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'BCHE', 'Tacrine']",0.5
15294,28780.0,Tacrine,Alzheimer disease,disease-phenotype-protein-drug,indication,"['Alzheimer disease', 'Seizure', 'BCHE', 'Tacrine']",0.5
15294,28780.0,Tacrine,Alzheimer disease,disease-exposure-molfunc-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Tacrine']",0.5
15294,33594.0,Tacrine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Tacrine']",0.5
15294,33594.0,Tacrine,diarrheal disease,disease-exposure-molfunc-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Tacrine']",0.5
15294,33675.0,Tacrine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Tacrine']",0.5
15294,33675.0,Tacrine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'glyphosate', 'BCHE', 'Tacrine']",0.5
15294,33675.0,Tacrine,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Tacrine']",0.5
15294,35565.0,Tacrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Tacrine']",0.5
15294,35641.0,Tacrine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Tacrine']",0.5
15294,38575.0,Tacrine,cerebellar degeneration,disease-protein-drug,indication,"['cerebellar degeneration', 'BCHE', 'Tacrine']",0.5
15294,83911.0,Tacrine,Reye syndrome,disease-protein-drug,indication,"['Reye syndrome', 'BCHE', 'Tacrine']",0.5
15294,83960.0,Tacrine,Alzheimer disease without neurofibrillary tangles,disease-protein-drug,indication,"['Alzheimer disease without neurofibrillary tangles', 'BCHE', 'Tacrine']",0.5
15295,28208.0,Triamterene,type 2 diabetes mellitus,disease-protein-drug,contraindication,"['type 2 diabetes mellitus', 'CYP1A2', 'Triamterene']",0.5
15295,28208.0,Triamterene,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Zinc', 'gene expression', 'SCNN1B', 'Triamterene']",0.5
15295,28552.0,Triamterene,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'gene expression', 'SCNN1B', 'Triamterene']",0.5
15295,29182.0,Triamterene,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'gene expression', 'SCNN1B', 'Triamterene']",0.5
15295,33534.0,Triamterene,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'SCNN1A', 'Triamterene']",0.5
15295,33575.0,Triamterene,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Triamterene']",0.5
15295,33575.0,Triamterene,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'gene expression', 'SCNN1B', 'Triamterene']",0.5
15295,33577.0,Triamterene,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'gene expression', 'SCNN1B', 'Triamterene']",0.5
15295,35565.0,Triamterene,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'gene expression', 'SCNN1B', 'Triamterene']",0.5
15295,35764.0,Triamterene,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'gene expression', 'SCNN1B', 'Triamterene']",0.5
15295,83802.0,Triamterene,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'gene expression', 'SCNN1B', 'Triamterene']",0.5
15296,29182.0,Griseofulvin,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Griseofulvin']",0.5
15296,29494.0,Griseofulvin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A2', 'Griseofulvin']",0.5
15296,30184.0,Griseofulvin,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A2', 'Griseofulvin']",0.5
15296,32977.0,Griseofulvin,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Griseofulvin']",0.5
15297,27933.0,Secobarbital,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Secobarbital']",0.5
15297,27933.0,Secobarbital,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Secobarbital']",0.5
15297,27933.0,Secobarbital,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'GRIN2B', 'Secobarbital']",0.5
15297,30035.0,Secobarbital,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GRIN1', 'Secobarbital']",0.5
15297,30374.0,Secobarbital,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'CYP1A2', 'Secobarbital']",0.5
15297,31618.0,Secobarbital,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GRIA2', 'Secobarbital']",0.5
15297,32313.0,Secobarbital,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GRIA2', 'Secobarbital']",0.5
15297,32977.0,Secobarbital,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Secobarbital']",0.5
15297,32977.0,Secobarbital,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GRIA2', 'Secobarbital']",0.5
15297,33577.0,Secobarbital,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'CHRNA7', 'Secobarbital']",0.5
15297,33577.0,Secobarbital,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'GRIN2B', 'Secobarbital']",0.5
15297,33605.0,Secobarbital,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Secobarbital']",0.5
15297,33632.0,Secobarbital,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GRIN2C', 'Secobarbital']",0.5
15297,33675.0,Secobarbital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRNA4', 'Secobarbital']",0.5
15297,33675.0,Secobarbital,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'bisphenol A', 'GRIN2B', 'Secobarbital']",0.5
15297,35552.0,Secobarbital,pneumonia,disease-exposure-bioprocess-gene-drug,contraindication,"['pneumonia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Secobarbital']",0.5
15297,35565.0,Secobarbital,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Secobarbital']",0.5
15297,35641.0,Secobarbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'CHRNA7', 'Secobarbital']",0.5
15297,35641.0,Secobarbital,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Secobarbital']",0.5
15297,35669.0,Secobarbital,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Secobarbital']",0.5
15297,35669.0,Secobarbital,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'GRIN2B', 'Secobarbital']",0.5
15297,35761.0,Secobarbital,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Secobarbital']",0.5
15297,35761.0,Secobarbital,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'GRIN2B', 'Secobarbital']",0.5
15297,35764.0,Secobarbital,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Secobarbital']",0.5
15297,35833.0,Secobarbital,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Secobarbital']",0.5
15297,36080.0,Secobarbital,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'CYP1A2', 'Secobarbital']",0.5
15297,36266.0,Secobarbital,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRA1', 'Secobarbital']",0.5
15297,36693.0,Secobarbital,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'GRIK2', 'Secobarbital']",0.5
15297,36693.0,Secobarbital,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Secobarbital']",0.5
15297,37617.0,Secobarbital,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'CYP1A2', 'Secobarbital']",0.5
15297,37617.0,Secobarbital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Secobarbital']",0.5
15297,37703.0,Secobarbital,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Secobarbital']",0.5
15297,83760.0,Secobarbital,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Secobarbital']",0.5
15297,83805.0,Secobarbital,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRA1', 'Secobarbital']",0.5
15297,83906.0,Secobarbital,status epilepticus,disease-protein-drug,indication,"['status epilepticus', 'GRIA2', 'Secobarbital']",0.5
15298,33104.0,Streptozocin,carcinoid syndrome,disease-phenotype-protein-drug,off-label use,"['carcinoid syndrome', 'Elevated hepatic transaminase', 'CYP1A2', 'Streptozocin']",0.5
15298,33575.0,Streptozocin,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC2A2', 'Streptozocin']",0.5
15298,33575.0,Streptozocin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Streptozocin']",0.5
15298,33575.0,Streptozocin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Streptozocin']",0.5
15298,33632.0,Streptozocin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Streptozocin']",0.5
15298,35565.0,Streptozocin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Streptozocin']",0.5
15298,35565.0,Streptozocin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Streptozocin']",0.5
15298,35764.0,Streptozocin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Streptozocin']",0.5
15298,35764.0,Streptozocin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Streptozocin']",0.5
15299,27286.0,Trimethoprim,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CYP1A2', 'Trimethoprim']",0.5
15299,27292.0,Trimethoprim,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'CYP1A2', 'Trimethoprim']",0.5
15299,32626.0,Trimethoprim,cholera,disease-phenotype-protein-drug,off-label use,"['cholera', 'Vomiting', 'ABCB1', 'Trimethoprim']",0.5
15299,32932.0,Trimethoprim,brucellosis,disease-phenotype-protein-drug,off-label use,"['brucellosis', 'Hepatomegaly', 'CYP1A2', 'Trimethoprim']",0.5
15299,32977.0,Trimethoprim,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Trimethoprim']",0.5
15299,32999.0,Trimethoprim,shigellosis,disease-phenotype-protein-drug,indication,"['shigellosis', 'Nausea', 'ABCB1', 'Trimethoprim']",0.5
15299,33314.0,Trimethoprim,leptospirosis,disease-phenotype-protein-drug,off-label use,"['leptospirosis', 'Hepatomegaly', 'CYP1A2', 'Trimethoprim']",0.5
15299,33334.0,Trimethoprim,nocardiosis,disease-phenotype-protein-drug,off-label use,"['nocardiosis', 'Vomiting', 'ABCB1', 'Trimethoprim']",0.5
15299,33359.0,Trimethoprim,Whipple disease,disease-phenotype-protein-drug,off-label use,"['Whipple disease', 'Hepatomegaly', 'CYP1A2', 'Trimethoprim']",0.5
15299,33474.0,Trimethoprim,typhoid fever,disease-phenotype-protein-drug,off-label use,"['typhoid fever', 'Hepatomegaly', 'CYP1A2', 'Trimethoprim']",0.5
15299,35565.0,Trimethoprim,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Trimethoprim']",0.5
15299,35764.0,Trimethoprim,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Trimethoprim']",0.5
15299,36104.0,Trimethoprim,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Trimethoprim']",0.5
15299,36229.0,Trimethoprim,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Trimethoprim']",0.5
15300,33314.0,Enoxacin,leptospirosis,disease-phenotype-protein-drug,off-label use,"['leptospirosis', 'Hepatomegaly', 'CYP1A2', 'Enoxacin']",0.5
15302,33482.0,Albendazole,cystic echinococcosis,disease-phenotype-protein-drug,indication,"['cystic echinococcosis', 'Hepatomegaly', 'CYP1A1', 'Albendazole']",0.5
15302,33632.0,Albendazole,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Albendazole']",0.5
15302,35565.0,Albendazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Albendazole']",0.5
15302,35565.0,Albendazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Albendazole']",0.5
15302,36104.0,Albendazole,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Albendazole']",0.5
15302,36229.0,Albendazole,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Albendazole']",0.5
15303,27286.0,Methoxsalen,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CYP1A1', 'Methoxsalen']",0.5
15303,27292.0,Methoxsalen,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'CYP1A2', 'Methoxsalen']",0.5
15303,27450.0,Methoxsalen,peroxisome biogenesis disorder,disease-phenotype-protein-drug,contraindication,"['peroxisome biogenesis disorder', 'Splenomegaly', 'CYP1A2', 'Methoxsalen']",0.5
15303,27582.0,Methoxsalen,Griscelli syndrome,disease-phenotype-protein-drug,contraindication,"['Griscelli syndrome', 'Hepatomegaly', 'CYP1A1', 'Methoxsalen']",0.5
15303,27618.0,Methoxsalen,Hermansky-Pudlak syndrome,disease-phenotype-protein-drug,contraindication,"['Hermansky-Pudlak syndrome', 'Splenomegaly', 'CYP1A2', 'Methoxsalen']",0.5
15303,28985.0,Methoxsalen,familial porphyria cutanea tarda,disease-protein-drug,contraindication,"['familial porphyria cutanea tarda', 'CYP1A2', 'Methoxsalen']",0.5
15303,29182.0,Methoxsalen,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'cell population proliferation', 'CYP1A1', 'Methoxsalen']",0.5
15303,29375.0,Methoxsalen,squamous cell carcinoma,disease-protein-drug,contraindication,"['squamous cell carcinoma', 'CYP1A2', 'Methoxsalen']",0.5
15303,29375.0,Methoxsalen,squamous cell carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['squamous cell carcinoma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Methoxsalen']",0.5
15303,29375.0,Methoxsalen,squamous cell carcinoma,disease-exposure-gene-drug,contraindication,"['squamous cell carcinoma', 'Arsenic', 'CYP1A1', 'Methoxsalen']",0.5
15303,29392.0,Methoxsalen,Chediak-Higashi syndrome,disease-phenotype-protein-drug,contraindication,"['Chediak-Higashi syndrome', 'Splenomegaly', 'CYP1A2', 'Methoxsalen']",0.5
15303,29457.0,Methoxsalen,variegate porphyria,disease-phenotype-protein-drug,contraindication,"['variegate porphyria', 'Elevated hepatic transaminase', 'CYP1A2', 'Methoxsalen']",0.5
15303,30961.0,Methoxsalen,sporadic porphyria cutanea tarda,disease-protein-drug,contraindication,"['sporadic porphyria cutanea tarda', 'CYP1A2', 'Methoxsalen']",0.5
15303,30990.0,Methoxsalen,mycosis fungoides and variants,disease-phenotype-protein-drug,off-label use,"['mycosis fungoides and variants', 'Hepatomegaly', 'CYP1A1', 'Methoxsalen']",0.5
15303,32977.0,Methoxsalen,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Methoxsalen']",0.5
15303,33179.0,Methoxsalen,porphyria cutanea tarda,disease-protein-drug,contraindication,"['porphyria cutanea tarda', 'CYP1A2', 'Methoxsalen']",0.5
15303,33555.0,Methoxsalen,autosomal erythropoietic protoporphyria,disease-phenotype-protein-drug,contraindication,"['autosomal erythropoietic protoporphyria', 'Decreased liver function', 'CYP1A2', 'Methoxsalen']",0.5
15303,33653.0,Methoxsalen,melanoma,disease-exposure-bioprocess-gene-drug,contraindication,"['melanoma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Methoxsalen']",0.5
15303,33653.0,Methoxsalen,melanoma,disease-exposure-gene-drug,contraindication,"['melanoma', 'Arsenic', 'CYP1A1', 'Methoxsalen']",0.5
15303,35565.0,Methoxsalen,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Methoxsalen']",0.5
15303,35565.0,Methoxsalen,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Methoxsalen']",0.5
15303,37738.0,Methoxsalen,basal cell carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['basal cell carcinoma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Methoxsalen']",0.5
15303,37738.0,Methoxsalen,basal cell carcinoma,disease-exposure-gene-drug,contraindication,"['basal cell carcinoma', 'Arsenic', 'CYP1A1', 'Methoxsalen']",0.5
15303,39052.0,Methoxsalen,inborn disorder of porphyrin metabolism,disease-protein-drug,contraindication,"['inborn disorder of porphyrin metabolism', 'CYP1A2', 'Methoxsalen']",0.5
15304,35565.0,Guanabenz,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Guanabenz']",0.5
15304,35764.0,Guanabenz,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Guanabenz']",0.5
15304,35909.0,Guanabenz,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Guanabenz']",0.5
15304,35953.0,Guanabenz,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'CYP1A2', 'Guanabenz']",0.5
15304,36187.0,Guanabenz,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Guanabenz']",0.5
15306,33605.0,Tizanidine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Tizanidine']",0.5
15306,35764.0,Tizanidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Tizanidine']",0.5
15306,35915.0,Tizanidine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP1A2', 'Tizanidine']",0.5
15306,83778.0,Tizanidine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP1A2', 'Tizanidine']",0.5
15306,83779.0,Tizanidine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP1A2', 'Tizanidine']",0.5
15307,35764.0,Thiabendazole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Thiabendazole']",0.5
15307,35764.0,Thiabendazole,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Thiabendazole']",0.5
15308,27248.0,Riluzole,amyotrophic lateral sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['amyotrophic lateral sclerosis', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Riluzole']",0.5
15308,27248.0,Riluzole,amyotrophic lateral sclerosis,disease-exposure-gene-drug,indication,"['amyotrophic lateral sclerosis', 'Agent Orange', 'CYP1A1', 'Riluzole']",0.5
15308,27476.0,Riluzole,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP1A2', 'Riluzole']",0.5
15308,36544.0,Riluzole,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP1A2', 'Riluzole']",0.5
15308,36544.0,Riluzole,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Riluzole']",0.5
15310,27286.0,Nalidixic acid,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Hepatomegaly', 'CYP1A2', 'Nalidixic acid']",0.5
15310,27292.0,Nalidixic acid,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'CYP1A2', 'Nalidixic acid']",0.5
15310,32977.0,Nalidixic acid,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Nalidixic acid']",0.5
15310,35565.0,Nalidixic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Nalidixic acid']",0.5
15310,36478.0,Nalidixic acid,nervous system disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['nervous system disorder', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP1A2', 'Nalidixic acid']",0.5
15311,27933.0,Primidone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Primidone']",0.5
15311,27933.0,Primidone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Primidone']",0.5
15311,27933.0,Primidone,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Primidone']",0.5
15311,29494.0,Primidone,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A2', 'Primidone']",0.5
15311,29865.0,Primidone,Lennox-Gastaut syndrome,disease-protein-drug,indication,"['Lennox-Gastaut syndrome', 'GABRB3', 'Primidone']",0.5
15311,29865.0,Primidone,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Focal-onset seizure', 'GRIA2', 'Primidone']",0.5
15311,30035.0,Primidone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Primidone']",0.5
15311,30184.0,Primidone,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A2', 'Primidone']",0.5
15311,30543.0,Primidone,Shwachman-Diamond syndrome,disease-phenotype-protein-drug,contraindication,"['Shwachman-Diamond syndrome', 'Hepatomegaly', 'CYP1A2', 'Primidone']",0.5
15311,30879.0,Primidone,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'TRPM3', 'Primidone']",0.5
15311,31519.0,Primidone,ataxia-pancytopenia syndrome,disease-phenotype-protein-drug,contraindication,"['ataxia-pancytopenia syndrome', 'Splenomegaly', 'CYP1A2', 'Primidone']",0.5
15311,31618.0,Primidone,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'TRPM3', 'Primidone']",0.5
15311,32313.0,Primidone,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'TRPM3', 'Primidone']",0.5
15311,32456.0,Primidone,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'GABRB3', 'Primidone']",0.5
15311,32456.0,Primidone,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'TRPM3', 'Primidone']",0.5
15311,32977.0,Primidone,inherited porphyria,disease-protein-drug,contraindication,"['inherited porphyria', 'CYP1A2', 'Primidone']",0.5
15311,32977.0,Primidone,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'TRPM3', 'Primidone']",0.5
15311,32994.0,Primidone,autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome,disease-phenotype-protein-drug,contraindication,"['autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome', 'Splenomegaly', 'CYP1A2', 'Primidone']",0.5
15311,33632.0,Primidone,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Primidone']",0.5
15311,35565.0,Primidone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Primidone']",0.5
15311,35641.0,Primidone,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Primidone']",0.5
15311,35641.0,Primidone,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Primidone']",0.5
15311,35764.0,Primidone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Primidone']",0.5
15311,36104.0,Primidone,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Primidone']",0.5
15311,36229.0,Primidone,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Primidone']",0.5
15311,36743.0,Primidone,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'CHRNA7', 'Primidone']",0.5
15311,37703.0,Primidone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Primidone']",0.5
15311,38242.0,Primidone,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'GABRB3', 'Primidone']",0.5
15311,38242.0,Primidone,bipolar disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['bipolar disorder', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Primidone']",0.5
15311,39815.0,Primidone,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'GRIA2', 'Primidone']",0.5
15311,83760.0,Primidone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Primidone']",0.5
15311,83928.0,Primidone,partial motor epilepsy,disease-protein-drug,indication,"['partial motor epilepsy', 'CHRNA7', 'Primidone']",0.5
15312,35764.0,Pentoxifylline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of glomerular filtration', 'ADORA1', 'Pentoxifylline']",0.5
15312,39798.0,Pentoxifylline,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,indication,"['peripheral arterial disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Pentoxifylline']",0.5
15315,31637.0,Dacarbazine,Budd-Chiari syndrome,disease-phenotype-protein-drug,contraindication,"['Budd-Chiari syndrome', 'Hepatomegaly', 'CYP1A1', 'Dacarbazine']",0.5
15315,33077.0,Dacarbazine,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Benzene', 'methylation', 'CYP1A2', 'Dacarbazine']",0.5
15315,33077.0,Dacarbazine,Hodgkins lymphoma,disease-exposure-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'CYP2E1', 'Dacarbazine']",0.5
15315,33077.0,Dacarbazine,Hodgkins lymphoma,disease-phenotype-protein-drug,indication,"['Hodgkins lymphoma', 'Hepatomegaly', 'CYP1A1', 'Dacarbazine']",0.5
15315,33632.0,Dacarbazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Dacarbazine']",0.5
15315,35565.0,Dacarbazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Dacarbazine']",0.5
15315,35565.0,Dacarbazine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Dacarbazine']",0.5
15315,35764.0,Dacarbazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Dacarbazine']",0.5
15315,35764.0,Dacarbazine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Dacarbazine']",0.5
15316,32967.0,Famotidine,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'CYP1A2', 'Famotidine']",0.5
15316,33594.0,Famotidine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Famotidine']",0.5
15316,35565.0,Famotidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Famotidine']",0.5
15316,35764.0,Famotidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Famotidine']",0.5
15317,28158.0,Alosetron,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Alosetron']",0.5
15317,35565.0,Alosetron,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Alosetron']",0.5
15317,37785.0,Alosetron,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Alosetron']",0.5
15318,37830.0,Lomefloxacin,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Lomefloxacin']",0.5
15319,27933.0,Ramelteon,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Ramelteon']",0.5
15319,27933.0,Ramelteon,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ramelteon']",0.5
15319,35565.0,Ramelteon,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Ramelteon']",0.5
15319,37703.0,Ramelteon,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Ramelteon']",0.5
15319,83760.0,Ramelteon,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Ramelteon']",0.5
15320,33091.0,Frovatriptan,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Seizure', 'HTR1B', 'Frovatriptan']",0.5
15320,33575.0,Frovatriptan,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Frovatriptan']",0.5
15320,33575.0,Frovatriptan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Frovatriptan']",0.5
15320,33577.0,Frovatriptan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Frovatriptan']",0.5
15320,33593.0,Frovatriptan,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'bone remodeling', 'HTR1B', 'Frovatriptan']",0.5
15320,33598.0,Frovatriptan,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP1A2', 'Frovatriptan']",0.5
15320,35909.0,Frovatriptan,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of gene expression', 'CYP1A2', 'Frovatriptan']",0.5
15320,36187.0,Frovatriptan,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Frovatriptan']",0.5
15320,36312.0,Frovatriptan,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'methylation', 'CYP1A2', 'Frovatriptan']",0.5
15320,37786.0,Frovatriptan,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Frovatriptan']",0.5
15320,39798.0,Frovatriptan,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Frovatriptan']",0.5
15321,35565.0,Levobupivacaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Levobupivacaine']",0.5
15321,35669.0,Levobupivacaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Levobupivacaine']",0.5
15321,35761.0,Levobupivacaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Levobupivacaine']",0.5
15321,35764.0,Levobupivacaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Levobupivacaine']",0.5
15322,27326.0,Norfloxacin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Norfloxacin']",0.5
15322,27326.0,Norfloxacin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Norfloxacin']",0.5
15322,27326.0,Norfloxacin,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Norfloxacin']",0.5
15322,27326.0,Norfloxacin,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Norfloxacin']",0.5
15322,27933.0,Norfloxacin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Norfloxacin']",0.5
15322,27933.0,Norfloxacin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CYP1A1', 'Norfloxacin']",0.5
15322,29494.0,Norfloxacin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A1', 'Norfloxacin']",0.5
15322,29525.0,Norfloxacin,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Norfloxacin']",0.5
15322,32729.0,Norfloxacin,botulism,disease-phenotype-protein-drug,indication,"['botulism', 'Arrhythmia', 'SLC22A5', 'Norfloxacin']",0.5
15322,33314.0,Norfloxacin,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'CYP1A1', 'Norfloxacin']",0.5
15322,33474.0,Norfloxacin,typhoid fever,disease-phenotype-protein-drug,indication,"['typhoid fever', 'Hepatomegaly', 'CYP1A1', 'Norfloxacin']",0.5
15322,33575.0,Norfloxacin,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Norfloxacin']",0.5
15322,33575.0,Norfloxacin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Norfloxacin']",0.5
15322,33575.0,Norfloxacin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Norfloxacin']",0.5
15322,33594.0,Norfloxacin,diarrheal disease,disease-exposure-bioprocess-gene-drug,indication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Norfloxacin']",0.5
15322,33594.0,Norfloxacin,diarrheal disease,disease-exposure-gene-drug,indication,"['diarrheal disease', 'Arsenic', 'CYP1A1', 'Norfloxacin']",0.5
15322,33632.0,Norfloxacin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Norfloxacin']",0.5
15322,35552.0,Norfloxacin,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Norfloxacin']",0.5
15322,35552.0,Norfloxacin,pneumonia,disease-exposure-gene-drug,indication,"['pneumonia', 'Arsenic', 'CYP1A1', 'Norfloxacin']",0.5
15322,35565.0,Norfloxacin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Norfloxacin']",0.5
15322,35565.0,Norfloxacin,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Norfloxacin']",0.5
15322,35751.0,Norfloxacin,peripheral nervous system disease,disease-exposure-gene-drug,contraindication,"['peripheral nervous system disease', 'Agent Orange', 'CYP1A1', 'Norfloxacin']",0.5
15322,35764.0,Norfloxacin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Norfloxacin']",0.5
15322,35764.0,Norfloxacin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CYP1A1', 'Norfloxacin']",0.5
15322,35915.0,Norfloxacin,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Norfloxacin']",0.5
15322,36187.0,Norfloxacin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Norfloxacin']",0.5
15322,36187.0,Norfloxacin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'CYP1A1', 'Norfloxacin']",0.5
15322,36544.0,Norfloxacin,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP3A4', 'Norfloxacin']",0.5
15322,36544.0,Norfloxacin,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Norfloxacin']",0.5
15322,37765.0,Norfloxacin,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'CYP1A2', 'Norfloxacin']",0.5
15322,37786.0,Norfloxacin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Norfloxacin']",0.5
15322,37786.0,Norfloxacin,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Agent Orange', 'CYP1A1', 'Norfloxacin']",0.5
15322,37830.0,Norfloxacin,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'DNA methylation', 'CYP1A1', 'Norfloxacin']",0.5
15322,37830.0,Norfloxacin,bronchitis,disease-exposure-gene-drug,indication,"['bronchitis', 'Tobacco Smoke Pollution', 'CYP1A1', 'Norfloxacin']",0.5
15322,39696.0,Norfloxacin,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,off-label use,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Norfloxacin']",0.5
15322,39696.0,Norfloxacin,pulmonary tuberculosis,disease-exposure-gene-drug,off-label use,"['pulmonary tuberculosis', 'Arsenic', 'CYP1A1', 'Norfloxacin']",0.5
15322,83751.0,Norfloxacin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Norfloxacin']",0.5
15322,83778.0,Norfloxacin,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Norfloxacin']",0.5
15322,83779.0,Norfloxacin,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Norfloxacin']",0.5
15324,29078.0,Leflunomide,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'AHR', 'Leflunomide']",0.5
15324,29078.0,Leflunomide,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Leflunomide']",0.5
15324,29078.0,Leflunomide,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'AHR', 'Leflunomide']",0.5
15324,29494.0,Leflunomide,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'AHR', 'Leflunomide']",0.5
15324,33632.0,Leflunomide,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'urea metabolic process', 'CYP2C9', 'Leflunomide']",0.5
15324,33632.0,Leflunomide,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'AHR', 'Leflunomide']",0.5
15324,35565.0,Leflunomide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'AHR', 'Leflunomide']",0.5
15324,35764.0,Leflunomide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Leflunomide']",0.5
15324,35764.0,Leflunomide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'AHR', 'Leflunomide']",0.5
15325,27326.0,Gemifloxacin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Gemifloxacin']",0.5
15325,27933.0,Gemifloxacin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Gemifloxacin']",0.5
15326,27326.0,Ofloxacin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ofloxacin']",0.5
15326,27655.0,Ofloxacin,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Ofloxacin']",0.5
15326,29494.0,Ofloxacin,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A2', 'Ofloxacin']",0.5
15326,30184.0,Ofloxacin,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A2', 'Ofloxacin']",0.5
15326,30879.0,Ofloxacin,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'ABCC2', 'Ofloxacin']",0.5
15326,31650.0,Ofloxacin,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ABCC2', 'Ofloxacin']",0.5
15326,32729.0,Ofloxacin,botulism,disease-phenotype-protein-drug,indication,"['botulism', 'Arrhythmia', 'SLC22A5', 'Ofloxacin']",0.5
15326,33314.0,Ofloxacin,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'CYP1A2', 'Ofloxacin']",0.5
15326,33474.0,Ofloxacin,typhoid fever,disease-phenotype-protein-drug,indication,"['typhoid fever', 'Hepatomegaly', 'CYP1A2', 'Ofloxacin']",0.5
15326,33575.0,Ofloxacin,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CYP1A2', 'Ofloxacin']",0.5
15326,33575.0,Ofloxacin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Ofloxacin']",0.5
15326,33594.0,Ofloxacin,diarrheal disease,disease-exposure-bioprocess-gene-drug,indication,"['diarrheal disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ofloxacin']",0.5
15326,33632.0,Ofloxacin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'response to oxidative stress', 'ABCC2', 'Ofloxacin']",0.5
15326,35552.0,Ofloxacin,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Ofloxacin']",0.5
15326,35565.0,Ofloxacin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Ofloxacin']",0.5
15326,35641.0,Ofloxacin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCC2', 'Ofloxacin']",0.5
15326,35764.0,Ofloxacin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Ofloxacin']",0.5
15326,36187.0,Ofloxacin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Ofloxacin']",0.5
15326,36544.0,Ofloxacin,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'ABCC2', 'Ofloxacin']",0.5
15326,36544.0,Ofloxacin,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Ofloxacin']",0.5
15326,37786.0,Ofloxacin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Ofloxacin']",0.5
15326,37830.0,Ofloxacin,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'inflammatory response', 'ABCC2', 'Ofloxacin']",0.5
15326,39696.0,Ofloxacin,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,off-label use,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'regulation of gene expression', 'CYP1A2', 'Ofloxacin']",0.5
15327,35552.0,Sparfloxacin,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Sparfloxacin']",0.5
15331,29113.0,Insulin aspart,diabetic ketoacidosis,disease-phenotype-protein-drug,indication,"['diabetic ketoacidosis', 'Insulin resistance', 'INSR', 'Insulin aspart']",0.5
15332,29113.0,Insulin glulisine,diabetic ketoacidosis,disease-phenotype-protein-drug,indication,"['diabetic ketoacidosis', 'Insulin resistance', 'INSR', 'Insulin glulisine']",0.5
15333,28249.0,Rasagiline,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'MAOB', 'Rasagiline']",0.5
15333,28396.0,Rasagiline,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Neurodegeneration', 'BCL2', 'Rasagiline']",0.5
15333,28547.0,Rasagiline,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'MAOB', 'Rasagiline']",0.5
15333,28547.0,Rasagiline,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'cellular response to DNA damage stimulus', 'BCL2', 'Rasagiline']",0.5
15333,28801.0,Rasagiline,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'MAOB', 'Rasagiline']",0.5
15333,28974.0,Rasagiline,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'MAOB', 'Rasagiline']",0.5
15333,30093.0,Rasagiline,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'MAOB', 'Rasagiline']",0.5
15333,31122.0,Rasagiline,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'MAOB', 'Rasagiline']",0.5
15333,31122.0,Rasagiline,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Cerebral hemorrhage', 'BCL2', 'Rasagiline']",0.5
15333,31408.0,Rasagiline,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'MAOB', 'Rasagiline']",0.5
15333,32759.0,Rasagiline,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'MAOB', 'Rasagiline']",0.5
15333,32974.0,Rasagiline,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'MAOB', 'Rasagiline']",0.5
15333,33241.0,Rasagiline,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'MAOB', 'Rasagiline']",0.5
15333,33577.0,Rasagiline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Rasagiline']",0.5
15333,33577.0,Rasagiline,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'BCL2', 'Rasagiline']",0.5
15333,33653.0,Rasagiline,melanoma,disease-exposure-bioprocess-gene-drug,contraindication,"['melanoma', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Rasagiline']",0.5
15333,33653.0,Rasagiline,melanoma,disease-exposure-gene-drug,contraindication,"['melanoma', 'Arsenic', 'BCL2', 'Rasagiline']",0.5
15333,35565.0,Rasagiline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Rasagiline']",0.5
15333,35735.0,Rasagiline,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'MAOB', 'Rasagiline']",0.5
15333,35894.0,Rasagiline,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'MAOB', 'Rasagiline']",0.5
15333,35895.0,Rasagiline,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'MAOB', 'Rasagiline']",0.5
15333,36149.0,Rasagiline,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'MAOB', 'Rasagiline']",0.5
15333,36860.0,Rasagiline,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'MAOB', 'Rasagiline']",0.5
15333,37919.0,Rasagiline,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'MAOB', 'Rasagiline']",0.5
15333,38242.0,Rasagiline,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'MAOB', 'Rasagiline']",0.5
15338,27476.0,Deferasirox,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'UGT1A1', 'Deferasirox']",0.5
15338,27476.0,Deferasirox,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Deferasirox']",0.5
15338,29494.0,Deferasirox,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'CYP1A2', 'Deferasirox']",0.5
15338,30184.0,Deferasirox,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'CYP1A2', 'Deferasirox']",0.5
15338,33003.0,Deferasirox,beta thalassemia,disease-phenotype-protein-drug,indication,"['beta thalassemia', 'Hepatomegaly', 'CYP1A2', 'Deferasirox']",0.5
15338,33434.0,Deferasirox,beta-thalassemia intermedia,disease-phenotype-protein-drug,indication,"['beta-thalassemia intermedia', 'Hepatomegaly', 'CYP1A2', 'Deferasirox']",0.5
15338,33632.0,Deferasirox,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Deferasirox']",0.5
15338,35565.0,Deferasirox,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Deferasirox']",0.5
15338,35764.0,Deferasirox,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Deferasirox']",0.5
15338,36104.0,Deferasirox,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Deferasirox']",0.5
15338,36229.0,Deferasirox,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Deferasirox']",0.5
15338,36645.0,Deferasirox,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'UGT1A1', 'Deferasirox']",0.5
15338,37765.0,Deferasirox,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'CYP1A2', 'Deferasirox']",0.5
15338,38312.0,Deferasirox,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'UGT1A1', 'Deferasirox']",0.5
15354,27476.0,Eltrombopag,Gilbert syndrome,disease-protein-drug,contraindication,"['Gilbert syndrome', 'UGT1A1', 'Eltrombopag']",0.5
15354,27476.0,Eltrombopag,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP1A2', 'Eltrombopag']",0.5
15354,31637.0,Eltrombopag,Budd-Chiari syndrome,disease-phenotype-protein-drug,contraindication,"['Budd-Chiari syndrome', 'Hepatomegaly', 'CYP1A2', 'Eltrombopag']",0.5
15354,32928.0,Eltrombopag,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Elevated hepatic transaminase', 'CYP1A2', 'Eltrombopag']",0.5
15354,33632.0,Eltrombopag,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'platelet aggregation', 'MPL', 'Eltrombopag']",0.5
15354,35565.0,Eltrombopag,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Eltrombopag']",0.5
15354,35764.0,Eltrombopag,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Eltrombopag']",0.5
15354,36645.0,Eltrombopag,hyperbilirubinemia,disease-protein-drug,contraindication,"['hyperbilirubinemia', 'UGT1A1', 'Eltrombopag']",0.5
15354,38312.0,Eltrombopag,hereditary hyperbilirubinemia,disease-protein-drug,contraindication,"['hereditary hyperbilirubinemia', 'SLCO1B1', 'Eltrombopag']",0.5
15354,38469.0,Eltrombopag,thrombocytosis disease,disease-protein-drug,contraindication,"['thrombocytosis disease', 'MPL', 'Eltrombopag']",0.5
15360,27933.0,Agomelatine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'HTR2C', 'Agomelatine']",0.5
15360,27933.0,Agomelatine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Agomelatine']",0.5
15360,38957.0,Agomelatine,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'CYP2C9', 'Agomelatine']",0.5
15360,38957.0,Agomelatine,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'methylation', 'CYP1A2', 'Agomelatine']",0.5
15360,83840.0,Agomelatine,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'HTR2C', 'Agomelatine']",0.5
15360,83841.0,Agomelatine,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'CYP2C9', 'Agomelatine']",0.5
15363,32531.0,Bendamustine,mantle cell lymphoma,disease-phenotype-protein-drug,off-label use,"['mantle cell lymphoma', 'Splenomegaly', 'CYP1A2', 'Bendamustine']",0.5
15363,33294.0,Bendamustine,follicular lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['follicular lymphoma', 'Polychlorinated Biphenyls', 'methylation', 'CYP1A2', 'Bendamustine']",0.5
15363,33294.0,Bendamustine,follicular lymphoma,disease-phenotype-protein-drug,indication,"['follicular lymphoma', 'Splenomegaly', 'CYP1A2', 'Bendamustine']",0.5
15363,35565.0,Bendamustine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Bendamustine']",0.5
15363,35764.0,Bendamustine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Bendamustine']",0.5
15366,37722.0,Teriflunomide,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Teriflunomide']",0.5
15367,30494.0,Pomalidomide,plasma cell myeloma,disease-protein-drug,indication,"['plasma cell myeloma', 'CRBN', 'Pomalidomide']",0.5
15367,30494.0,Pomalidomide,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Pomalidomide']",0.5
15367,30494.0,Pomalidomide,plasma cell myeloma,disease-phenotype-protein-drug,indication,"['plasma cell myeloma', 'Splenomegaly', 'CYP1A2', 'Pomalidomide']",0.5
15372,28391.0,Viloxazine,narcolepsy,disease-exposure-bioprocess-gene-drug,indication,"['narcolepsy', 'Pesticides', 'cholesterol metabolic process', 'CYP1A2', 'Viloxazine']",0.5
15373,28208.0,Lobeglitazone,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'CYP1A2', 'Lobeglitazone']",0.5
15373,28208.0,Lobeglitazone,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose homeostasis', 'PPARG', 'Lobeglitazone']",0.5
15373,28208.0,Lobeglitazone,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'PPARG', 'Lobeglitazone']",0.5
15373,28208.0,Lobeglitazone,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'PPARG', 'Lobeglitazone']",0.5
15373,33575.0,Lobeglitazone,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'CYP1A2', 'Lobeglitazone']",0.5
15373,33575.0,Lobeglitazone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'PPARG', 'Lobeglitazone']",0.5
15373,33575.0,Lobeglitazone,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PPARG', 'Lobeglitazone']",0.5
15392,37743.0,Voxilaprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Voxilaprevir']",0.5
15399,35669.0,Acefylline,heart disease,disease-exposure-bioprocess-gene-drug,indication,"['heart disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Acefylline']",0.5
15399,35761.0,Acefylline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,indication,"['cardiovascular disease', 'Arsenic', 'regulation of gene expression', 'CYP1A2', 'Acefylline']",0.5
15399,37830.0,Acefylline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants, Occupational', 'regulation of gene expression', 'CYP1A2', 'Acefylline']",0.5
15406,33577.0,Bromotheophylline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP1A2', 'Bromotheophylline']",0.5
15406,35565.0,Bromotheophylline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'CYP1A2', 'Bromotheophylline']",0.5
15406,36034.0,Bromotheophylline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP1A2', 'Bromotheophylline']",0.5
15409,29118.0,Ropeginterferon alfa-2b,acquired polycythemia vera,disease-phenotype-protein-drug,indication,"['acquired polycythemia vera', 'Hepatomegaly', 'CYP1A2', 'Ropeginterferon alfa-2b']",0.5
15412,28520.0,Histamine,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'cognition', 'HRH3', 'Histamine']",0.5
15412,28552.0,Histamine,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'locomotory behavior', 'SLC18A2', 'Histamine']",0.5
15412,29525.0,Histamine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'SLC22A5', 'Histamine']",0.5
15412,30035.0,Histamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'HNMT', 'Histamine']",0.5
15412,33512.0,Histamine,preeclampsia,disease-exposure-bioprocess-gene-drug,contraindication,"['preeclampsia', 'perfluorononanoic acid', 'cognition', 'HRH3', 'Histamine']",0.5
15412,33575.0,Histamine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC22A3', 'Histamine']",0.5
15412,33575.0,Histamine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Histamine']",0.5
15412,33577.0,Histamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Histamine']",0.5
15412,33603.0,Histamine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Histamine']",0.5
15412,33605.0,Histamine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Histamine']",0.5
15412,33675.0,Histamine,asthma,disease-protein-drug,contraindication,"['asthma', 'HNMT', 'Histamine']",0.5
15412,33675.0,Histamine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'HRH3', 'Histamine']",0.5
15412,35669.0,Histamine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A3', 'Histamine']",0.5
15412,35669.0,Histamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'HRH3', 'Histamine']",0.5
15412,35761.0,Histamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Histamine']",0.5
15412,35915.0,Histamine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cognition', 'HRH3', 'Histamine']",0.5
15412,35953.0,Histamine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Histamine']",0.5
15412,35953.0,Histamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Sulfur', 'methylation', 'HNMT', 'Histamine']",0.5
15412,36034.0,Histamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'HRH3', 'Histamine']",0.5
15412,36080.0,Histamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'methylation', 'HNMT', 'Histamine']",0.5
15412,36187.0,Histamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'HRH3', 'Histamine']",0.5
15412,36693.0,Histamine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC22A3', 'Histamine']",0.5
15412,36693.0,Histamine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Histamine']",0.5
15412,39773.0,Histamine,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'HNMT', 'Histamine']",0.5
15412,83778.0,Histamine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cognition', 'HRH3', 'Histamine']",0.5
15412,83779.0,Histamine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cognition', 'HRH3', 'Histamine']",0.5
15412,83781.0,Histamine,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'HNMT', 'Histamine']",0.5
15413,29173.0,Gemcitabine,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['small cell lung carcinoma', 'Arsenic', 'response to folic acid', 'TYMS', 'Gemcitabine']",0.5
15413,31116.0,Gemcitabine,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Gemcitabine']",0.5
15413,31477.0,Gemcitabine,ovarian cancer,disease-protein-drug,indication,"['ovarian cancer', 'TYMS', 'Gemcitabine']",0.5
15413,31756.0,Gemcitabine,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder cancer', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Gemcitabine']",0.5
15413,32617.0,Gemcitabine,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Gemcitabine']",0.5
15413,32886.0,Gemcitabine,typical hemolytic-uremic syndrome,disease-phenotype-protein-drug,contraindication,"['typical hemolytic-uremic syndrome', 'Vomiting', 'ABCB1', 'Gemcitabine']",0.5
15413,33623.0,Gemcitabine,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'TYMS', 'Gemcitabine']",0.5
15413,33632.0,Gemcitabine,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'TYMS', 'Gemcitabine']",0.5
15413,33642.0,Gemcitabine,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Gemcitabine']",0.5
15413,33688.0,Gemcitabine,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Gemcitabine']",0.5
15413,35565.0,Gemcitabine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Gemcitabine']",0.5
15413,35616.0,Gemcitabine,testicular cancer,disease-exposure-bioprocess-gene-drug,off-label use,"['testicular cancer', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Gemcitabine']",0.5
15413,35624.0,Gemcitabine,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,off-label use,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'developmental growth', 'TYMS', 'Gemcitabine']",0.5
15413,35764.0,Gemcitabine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to folic acid', 'TYMS', 'Gemcitabine']",0.5
15413,36050.0,Gemcitabine,head and neck cancer,disease-protein-drug,off-label use,"['head and neck cancer', 'TYMS', 'Gemcitabine']",0.5
15413,36527.0,Gemcitabine,yolk sac tumor,disease-protein-drug,indication,"['yolk sac tumor', 'TYMS', 'Gemcitabine']",0.5
15413,36792.0,Gemcitabine,ovarian mucinous adenocarcinoma,disease-protein-drug,indication,"['ovarian mucinous adenocarcinoma', 'TYMS', 'Gemcitabine']",0.5
15413,36794.0,Gemcitabine,ovarian adenocarcinoma,disease-protein-drug,indication,"['ovarian adenocarcinoma', 'TYMS', 'Gemcitabine']",0.5
15413,37047.0,Gemcitabine,immature ovarian teratoma,disease-protein-drug,indication,"['immature ovarian teratoma', 'TYMS', 'Gemcitabine']",0.5
15413,37082.0,Gemcitabine,malignant germ cell tumor of ovary,disease-protein-drug,indication,"['malignant germ cell tumor of ovary', 'TYMS', 'Gemcitabine']",0.5
15413,37150.0,Gemcitabine,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'TYMS', 'Gemcitabine']",0.5
15413,37152.0,Gemcitabine,familial ovarian cancer,disease-protein-drug,indication,"['familial ovarian cancer', 'TYMS', 'Gemcitabine']",0.5
15413,37423.0,Gemcitabine,ovarian clear cell adenocarcinoma,disease-protein-drug,indication,"['ovarian clear cell adenocarcinoma', 'TYMS', 'Gemcitabine']",0.5
15413,37466.0,Gemcitabine,ovarian small cell carcinoma,disease-protein-drug,indication,"['ovarian small cell carcinoma', 'TYMS', 'Gemcitabine']",0.5
15413,37967.0,Gemcitabine,ovarian endometrioid adenocarcinoma,disease-protein-drug,indication,"['ovarian endometrioid adenocarcinoma', 'TYMS', 'Gemcitabine']",0.5
15413,39603.0,Gemcitabine,malignant sex cord stromal tumor of ovary,disease-protein-drug,indication,"['malignant sex cord stromal tumor of ovary', 'TYMS', 'Gemcitabine']",0.5
15413,39615.0,Gemcitabine,borderline epithelial tumor of ovary,disease-protein-drug,indication,"['borderline epithelial tumor of ovary', 'TYMS', 'Gemcitabine']",0.5
15413,83816.0,Gemcitabine,ovarian carcinosarcoma,disease-protein-drug,indication,"['ovarian carcinosarcoma', 'TYMS', 'Gemcitabine']",0.5
15413,83817.0,Gemcitabine,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary site-specific ovarian cancer syndrome', 'TYMS', 'Gemcitabine']",0.5
15413,83818.0,Gemcitabine,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,indication,"['primary non-gestational choriocarcinoma of ovary', 'TYMS', 'Gemcitabine']",0.5
15413,83819.0,Gemcitabine,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,indication,"['malignant dysgerminomatous germ cell tumor of ovary', 'TYMS', 'Gemcitabine']",0.5
15413,83820.0,Gemcitabine,maligant granulosa cell tumor of ovary,disease-protein-drug,indication,"['maligant granulosa cell tumor of ovary', 'TYMS', 'Gemcitabine']",0.5
15413,83821.0,Gemcitabine,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,indication,"['malignant Sertoli-Leydig cell tumor of ovary', 'TYMS', 'Gemcitabine']",0.5
15413,83822.0,Gemcitabine,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,indication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'TYMS', 'Gemcitabine']",0.5
15413,83865.0,Gemcitabine,upper aerodigestive tract neoplasm,disease-protein-drug,off-label use,"['upper aerodigestive tract neoplasm', 'TYMS', 'Gemcitabine']",0.5
15414,35764.0,Azacitidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'DNA methylation involved in embryo development', 'DNMT1', 'Azacitidine']",0.5
15416,27933.0,Lorazepam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Lorazepam']",0.5
15416,27933.0,Lorazepam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Lorazepam']",0.5
15416,29865.0,Lorazepam,Lennox-Gastaut syndrome,disease-protein-drug,indication,"['Lennox-Gastaut syndrome', 'GABRB3', 'Lorazepam']",0.5
15416,29865.0,Lorazepam,Lennox-Gastaut syndrome,disease-phenotype-protein-drug,indication,"['Lennox-Gastaut syndrome', 'Focal-onset seizure', 'GABRA5', 'Lorazepam']",0.5
15416,30035.0,Lorazepam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Lorazepam']",0.5
15416,30715.0,Lorazepam,Wernicke-Korsakoff syndrome,disease-phenotype-protein-drug,off-label use,"['Wernicke-Korsakoff syndrome', 'Memory impairment', 'GABRA5', 'Lorazepam']",0.5
15416,31618.0,Lorazepam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Lorazepam']",0.5
15416,32033.0,Lorazepam,insomnia (disease),disease-protein-drug,off-label use,"['insomnia (disease)', 'GABRB3', 'Lorazepam']",0.5
15416,32313.0,Lorazepam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Lorazepam']",0.5
15416,32456.0,Lorazepam,cutis verticis gyrata,disease-protein-drug,indication,"['cutis verticis gyrata', 'GABRB3', 'Lorazepam']",0.5
15416,32456.0,Lorazepam,cutis verticis gyrata,disease-phenotype-protein-drug,indication,"['cutis verticis gyrata', 'Seizure', 'GABRA5', 'Lorazepam']",0.5
15416,32977.0,Lorazepam,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GABRA5', 'Lorazepam']",0.5
15416,33115.0,Lorazepam,absence epilepsy,disease-protein-drug,indication,"['absence epilepsy', 'GABRG2', 'Lorazepam']",0.5
15416,33125.0,Lorazepam,early myoclonic encephalopathy,disease-protein-drug,indication,"['early myoclonic encephalopathy', 'GABRG2', 'Lorazepam']",0.5
15416,35565.0,Lorazepam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Lorazepam']",0.5
15416,35641.0,Lorazepam,epilepsy,disease-protein-drug,off-label use,"['epilepsy', 'GABRG2', 'Lorazepam']",0.5
15416,35764.0,Lorazepam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Lorazepam']",0.5
15416,36266.0,Lorazepam,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRG2', 'Lorazepam']",0.5
15416,37703.0,Lorazepam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Lorazepam']",0.5
15416,39815.0,Lorazepam,visual epilepsy,disease-protein-drug,indication,"['visual epilepsy', 'GABRA5', 'Lorazepam']",0.5
15416,83760.0,Lorazepam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Lorazepam']",0.5
15416,83805.0,Lorazepam,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRG2', 'Lorazepam']",0.5
15417,28552.0,Phentermine,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'SLC6A3', 'Phentermine']",0.5
15417,29175.0,Phentermine,thyrotoxicosis,disease-phenotype-protein-drug,contraindication,"['thyrotoxicosis', 'Weight loss', 'NPY', 'Phentermine']",0.5
15417,30035.0,Phentermine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Phentermine']",0.5
15417,33512.0,Phentermine,preeclampsia,disease-exposure-bioprocess-gene-drug,contraindication,"['preeclampsia', 'perfluorononanoic acid', 'memory', 'SLC6A4', 'Phentermine']",0.5
15417,33577.0,Phentermine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'NPY', 'Phentermine']",0.5
15417,33593.0,Phentermine,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Organophosphorus Compounds', 'social behavior', 'SLC6A4', 'Phentermine']",0.5
15417,33605.0,Phentermine,hypotensive disorder,disease-protein-drug,indication,"['hypotensive disorder', 'MAOB', 'Phentermine']",0.5
15417,35669.0,Phentermine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'NPY', 'Phentermine']",0.5
15417,35761.0,Phentermine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of blood pressure', 'NPY', 'Phentermine']",0.5
15417,35915.0,Phentermine,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NPY', 'Phentermine']",0.5
15417,35915.0,Phentermine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Phentermine']",0.5
15417,36034.0,Phentermine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Phentermine']",0.5
15417,36693.0,Phentermine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC6A4', 'Phentermine']",0.5
15417,83778.0,Phentermine,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NPY', 'Phentermine']",0.5
15417,83778.0,Phentermine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Phentermine']",0.5
15417,83779.0,Phentermine,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NPY', 'Phentermine']",0.5
15417,83779.0,Phentermine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Phentermine']",0.5
15418,27326.0,Dofetilide,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Dofetilide']",0.5
15418,27326.0,Dofetilide,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'memory', 'KCNK2', 'Dofetilide']",0.5
15418,27655.0,Dofetilide,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Dofetilide']",0.5
15418,33618.0,Dofetilide,atrial fibrillation (disease),disease-protein-drug,indication,"['atrial fibrillation (disease)', 'KCNH2', 'Dofetilide']",0.5
15418,33618.0,Dofetilide,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'memory', 'KCNK2', 'Dofetilide']",0.5
15418,35565.0,Dofetilide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'KCNK2', 'Dofetilide']",0.5
15418,35764.0,Dofetilide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'KCNK2', 'Dofetilide']",0.5
15418,83751.0,Dofetilide,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Dofetilide']",0.5
15419,27326.0,Azithromycin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'innate immune response', 'PADI4', 'Azithromycin']",0.5
15419,27655.0,Azithromycin,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Azithromycin']",0.5
15419,31650.0,Azithromycin,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'ABCC2', 'Azithromycin']",0.5
15419,33543.0,Azithromycin,boutonneuse fever,disease-phenotype-protein-drug,off-label use,"['boutonneuse fever', 'Nausea', 'ABCB1', 'Azithromycin']",0.5
15419,33594.0,Azithromycin,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'innate immune response', 'PADI4', 'Azithromycin']",0.5
15419,35565.0,Azithromycin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Azithromycin']",0.5
15419,83751.0,Azithromycin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Azithromycin']",0.5
15420,28426.0,Pantoprazole,multiple endocrine neoplasia,disease-phenotype-protein-drug,indication,"['multiple endocrine neoplasia', 'Vomiting', 'ABCB1', 'Pantoprazole']",0.5
15420,29614.0,Pantoprazole,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Pantoprazole']",0.5
15420,32875.0,Pantoprazole,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Pantoprazole']",0.5
15421,27933.0,Temazepam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Temazepam']",0.5
15421,27933.0,Temazepam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Temazepam']",0.5
15421,30035.0,Temazepam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Temazepam']",0.5
15421,31618.0,Temazepam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Temazepam']",0.5
15421,32033.0,Temazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Temazepam']",0.5
15421,32313.0,Temazepam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Temazepam']",0.5
15421,35565.0,Temazepam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Temazepam']",0.5
15421,35764.0,Temazepam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Temazepam']",0.5
15421,37703.0,Temazepam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Temazepam']",0.5
15421,83760.0,Temazepam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Temazepam']",0.5
15424,28375.0,Cabergoline,familial hyperprolactinemia,disease-protein-drug,indication,"['familial hyperprolactinemia', 'DRD2', 'Cabergoline']",0.5
15424,29637.0,Cabergoline,prolactin producing pituitary gland tumor,disease-protein-drug,indication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Cabergoline']",0.5
15424,29637.0,Cabergoline,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,indication,"['prolactin producing pituitary gland tumor', 'Seizure', 'HTR1B', 'Cabergoline']",0.5
15424,32797.0,Cabergoline,IgG4-related retroperitoneal fibrosis,disease-phenotype-protein-drug,contraindication,"['IgG4-related retroperitoneal fibrosis', 'Fever', 'HTR1A', 'Cabergoline']",0.5
15424,33512.0,Cabergoline,preeclampsia,disease-exposure-bioprocess-gene-drug,contraindication,"['preeclampsia', 'perfluorononanoic acid', 'female pregnancy', 'ADRA2B', 'Cabergoline']",0.5
15424,35565.0,Cabergoline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HTR2A', 'Cabergoline']",0.5
15424,39081.0,Cabergoline,hyperprolactinemia (disease),disease-protein-drug,indication,"['hyperprolactinemia (disease)', 'DRD2', 'Cabergoline']",0.5
15424,84023.0,Cabergoline,acquired hyperprolactinemia,disease-protein-drug,indication,"['acquired hyperprolactinemia', 'DRD2', 'Cabergoline']",0.5
15425,33594.0,Doxycycline,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Doxycycline']",0.5
15425,37830.0,Doxycycline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Doxycycline']",0.5
15426,33577.0,Isradipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Isradipine']",0.5
15426,33577.0,Isradipine,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'CACNA2D1', 'Isradipine']",0.5
15426,35565.0,Isradipine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Isradipine']",0.5
15426,35953.0,Isradipine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'regulation of heart contraction', 'CACNA1H', 'Isradipine']",0.5
15426,35953.0,Isradipine,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'CACNA2D1', 'Isradipine']",0.5
15426,35958.0,Isradipine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'CACNA1H', 'Isradipine']",0.5
15426,36187.0,Isradipine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of heart contraction', 'CACNA1H', 'Isradipine']",0.5
15426,36187.0,Isradipine,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'CACNA2D1', 'Isradipine']",0.5
15426,37180.0,Isradipine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of heart contraction', 'CACNA1H', 'Isradipine']",0.5
15426,37180.0,Isradipine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'CACNA2D1', 'Isradipine']",0.5
15428,33575.0,Bexarotene,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'RXRB', 'Bexarotene']",0.5
15428,35565.0,Bexarotene,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Bexarotene']",0.5
15428,36469.0,Bexarotene,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Bexarotene']",0.5
15429,33621.0,Vindesine,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['acute lymphoblastic leukemia (disease)', 'Triazines', 'lipid metabolic process', 'CYP3A4', 'Vindesine']",0.5
15429,33653.0,Vindesine,melanoma,disease-exposure-bioprocess-gene-drug,indication,"['melanoma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Vindesine']",0.5
15429,36812.0,Vindesine,lung neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['lung neoplasm', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Vindesine']",0.5
15430,27933.0,Pentobarbital,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Pentobarbital']",0.5
15430,27933.0,Pentobarbital,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR1I2', 'Pentobarbital']",0.5
15430,27933.0,Pentobarbital,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'GRIN2B', 'Pentobarbital']",0.5
15430,30035.0,Pentobarbital,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Pentobarbital']",0.5
15430,31618.0,Pentobarbital,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GRIA2', 'Pentobarbital']",0.5
15430,32033.0,Pentobarbital,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Pentobarbital']",0.5
15430,32313.0,Pentobarbital,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GRIA2', 'Pentobarbital']",0.5
15430,32977.0,Pentobarbital,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GRIA2', 'Pentobarbital']",0.5
15430,33577.0,Pentobarbital,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'CHRNA7', 'Pentobarbital']",0.5
15430,33577.0,Pentobarbital,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'GRIN2B', 'Pentobarbital']",0.5
15430,33605.0,Pentobarbital,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Pentobarbital']",0.5
15430,33675.0,Pentobarbital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Pentobarbital']",0.5
15430,33675.0,Pentobarbital,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'bisphenol A', 'GRIN2B', 'Pentobarbital']",0.5
15430,35552.0,Pentobarbital,pneumonia,disease-exposure-bioprocess-gene-drug,contraindication,"['pneumonia', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR1I2', 'Pentobarbital']",0.5
15430,35565.0,Pentobarbital,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Pentobarbital']",0.5
15430,35641.0,Pentobarbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Pentobarbital']",0.5
15430,35641.0,Pentobarbital,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Pentobarbital']",0.5
15430,35669.0,Pentobarbital,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Pentobarbital']",0.5
15430,35669.0,Pentobarbital,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'GRIN2B', 'Pentobarbital']",0.5
15430,35761.0,Pentobarbital,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Pentobarbital']",0.5
15430,35761.0,Pentobarbital,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'GRIN2B', 'Pentobarbital']",0.5
15430,35764.0,Pentobarbital,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Pentobarbital']",0.5
15430,35833.0,Pentobarbital,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Pentobarbital']",0.5
15430,36080.0,Pentobarbital,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRNA4', 'Pentobarbital']",0.5
15430,36266.0,Pentobarbital,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRG2', 'Pentobarbital']",0.5
15430,36312.0,Pentobarbital,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,indication,"['transient ischemic attack (disease)', 'Particulate Matter', 'brain development', 'GRIN2C', 'Pentobarbital']",0.5
15430,36693.0,Pentobarbital,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'GRIK2', 'Pentobarbital']",0.5
15430,36693.0,Pentobarbital,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Pentobarbital']",0.5
15430,37617.0,Pentobarbital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Pentobarbital']",0.5
15430,37703.0,Pentobarbital,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Pentobarbital']",0.5
15430,37718.0,Pentobarbital,brain ischemia,disease-exposure-bioprocess-gene-drug,indication,"['brain ischemia', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Pentobarbital']",0.5
15430,83760.0,Pentobarbital,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Pentobarbital']",0.5
15430,83805.0,Pentobarbital,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRG2', 'Pentobarbital']",0.5
15430,83906.0,Pentobarbital,status epilepticus,disease-protein-drug,indication,"['status epilepticus', 'GRIA2', 'Pentobarbital']",0.5
15431,28017.0,Dihydroergotamine,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Dihydroergotamine']",0.5
15431,32977.0,Dihydroergotamine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'HTR1B', 'Dihydroergotamine']",0.5
15431,33577.0,Dihydroergotamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Dihydroergotamine']",0.5
15431,36187.0,Dihydroergotamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Dihydroergotamine']",0.5
15431,39798.0,Dihydroergotamine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Dihydroergotamine']",0.5
15432,36129.0,Pimecrolimus,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Pimecrolimus']",0.5
15433,27326.0,Alfuzosin,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'KCNH2', 'Alfuzosin']",0.5
15433,27326.0,Alfuzosin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of ventricular cardiac muscle cell membrane repolarization', 'KCNH2', 'Alfuzosin']",0.5
15433,27655.0,Alfuzosin,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Alfuzosin']",0.5
15433,27655.0,Alfuzosin,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ADRA1B', 'Alfuzosin']",0.5
15433,28396.0,Alfuzosin,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Skeletal muscle atrophy', 'KCNH2', 'Alfuzosin']",0.5
15433,33605.0,Alfuzosin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Alfuzosin']",0.5
15433,35565.0,Alfuzosin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Alfuzosin']",0.5
15433,83751.0,Alfuzosin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Alfuzosin']",0.5
15434,35565.0,Trimethadione,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Trimethadione']",0.5
15434,35764.0,Trimethadione,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Trimethadione']",0.5
15435,30813.0,Megestrol acetate,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Megestrol acetate']",0.5
15435,32617.0,Megestrol acetate,hereditary breast ovarian cancer syndrome,disease-protein-drug,off-label use,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Megestrol acetate']",0.5
15435,33575.0,Megestrol acetate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Megestrol acetate']",0.5
15435,33575.0,Megestrol acetate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Megestrol acetate']",0.5
15435,33577.0,Megestrol acetate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Megestrol acetate']",0.5
15435,33577.0,Megestrol acetate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Megestrol acetate']",0.5
15435,35565.0,Megestrol acetate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Megestrol acetate']",0.5
15435,35738.0,Megestrol acetate,endometrial carcinoma (disease),disease-protein-drug,indication,"['endometrial carcinoma (disease)', 'PGR', 'Megestrol acetate']",0.5
15435,35739.0,Megestrol acetate,uterine corpus cancer,disease-protein-drug,indication,"['uterine corpus cancer', 'PGR', 'Megestrol acetate']",0.5
15435,35764.0,Megestrol acetate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Megestrol acetate']",0.5
15435,35764.0,Megestrol acetate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Megestrol acetate']",0.5
15435,37038.0,Megestrol acetate,endometrium neoplasm,disease-protein-drug,indication,"['endometrium neoplasm', 'PGR', 'Megestrol acetate']",0.5
15436,30274.0,Methylergometrine,HELLP syndrome,disease-phenotype-protein-drug,contraindication,"['HELLP syndrome', 'Seizure', 'DRD1', 'Methylergometrine']",0.5
15436,33577.0,Methylergometrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Methylergometrine']",0.5
15436,33598.0,Methylergometrine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'visual learning', 'DRD1', 'Methylergometrine']",0.5
15436,35565.0,Methylergometrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Methylergometrine']",0.5
15436,35641.0,Methylergometrine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD1', 'Methylergometrine']",0.5
15436,35641.0,Methylergometrine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD1', 'Methylergometrine']",0.5
15436,35764.0,Methylergometrine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Methylergometrine']",0.5
15436,35909.0,Methylergometrine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Methylergometrine']",0.5
15437,27476.0,Aminoglutethimide,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Aminoglutethimide']",0.5
15437,35565.0,Aminoglutethimide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Aminoglutethimide']",0.5
15437,36469.0,Aminoglutethimide,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Aminoglutethimide']",0.5
15438,29078.0,Sulfadiazine,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,off-label use,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Sulfadiazine']",0.5
15438,33632.0,Sulfadiazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Sulfadiazine']",0.5
15438,33675.0,Sulfadiazine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Sulfadiazine']",0.5
15438,35565.0,Sulfadiazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Sulfadiazine']",0.5
15438,35764.0,Sulfadiazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Sulfadiazine']",0.5
15440,32930.0,Nimodipine,acquired aneurysmal subarachnoid hemorrhage,disease-phenotype-protein-drug,indication,"['acquired aneurysmal subarachnoid hemorrhage', 'Syncope', 'CACNA1C', 'Nimodipine']",0.5
15440,35565.0,Nimodipine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'regulation of gene expression', 'AHR', 'Nimodipine']",0.5
15441,27933.0,Eszopiclone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Eszopiclone']",0.5
15441,27933.0,Eszopiclone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Eszopiclone']",0.5
15441,32033.0,Eszopiclone,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Eszopiclone']",0.5
15441,37703.0,Eszopiclone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Eszopiclone']",0.5
15441,83760.0,Eszopiclone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Eszopiclone']",0.5
15442,35764.0,Dicloxacillin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Dicloxacillin']",0.5
15443,35565.0,Caspofungin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Caspofungin']",0.5
15444,27326.0,Toremifene,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Toremifene']",0.5
15444,27326.0,Toremifene,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Toremifene']",0.5
15444,27326.0,Toremifene,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Toremifene']",0.5
15444,27326.0,Toremifene,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Toremifene']",0.5
15444,83751.0,Toremifene,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Toremifene']",0.5
15446,27684.0,Bosentan,pulmonary venoocclusive disease,disease-phenotype-protein-drug,contraindication,"['pulmonary venoocclusive disease', 'Pulmonary arterial hypertension', 'EDNRB', 'Bosentan']",0.5
15446,33027.0,Bosentan,scleroderma (disease),disease-phenotype-protein-drug,indication,"['scleroderma (disease)', 'Pruritus', 'ABCB11', 'Bosentan']",0.5
15446,33225.0,Bosentan,systemic sclerosis,disease-phenotype-protein-drug,indication,"['systemic sclerosis', 'Pruritus', 'ABCB11', 'Bosentan']",0.5
15446,33632.0,Bosentan,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Bosentan']",0.5
15446,35565.0,Bosentan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Bosentan']",0.5
15446,36432.0,Bosentan,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'EDNRB', 'Bosentan']",0.5
15446,36544.0,Bosentan,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP3A4', 'Bosentan']",0.5
15446,36544.0,Bosentan,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Bosentan']",0.5
15447,29078.0,Valdecoxib,rheumatoid arthritis,disease-protein-drug,off-label use,"['rheumatoid arthritis', 'PTGS2', 'Valdecoxib']",0.5
15447,29078.0,Valdecoxib,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,off-label use,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Valdecoxib']",0.5
15447,29078.0,Valdecoxib,rheumatoid arthritis,disease-exposure-gene-drug,off-label use,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS2', 'Valdecoxib']",0.5
15447,29078.0,Valdecoxib,rheumatoid arthritis,disease-phenotype-protein-drug,off-label use,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Valdecoxib']",0.5
15448,37768.0,Lisuride,migraine disorder,disease-protein-drug,indication,"['migraine disorder', 'HTR2A', 'Lisuride']",0.5
15449,27933.0,Ethosuximide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Ethosuximide']",0.5
15449,27933.0,Ethosuximide,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Ethosuximide']",0.5
15449,29182.0,Ethosuximide,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of heart rate by cardiac conduction', 'CACNA1G', 'Ethosuximide']",0.5
15449,35565.0,Ethosuximide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Ethosuximide']",0.5
15449,35764.0,Ethosuximide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Ethosuximide']",0.5
15451,27933.0,Bisoprolol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Bisoprolol']",0.5
15451,27933.0,Bisoprolol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Bisoprolol']",0.5
15451,29182.0,Bisoprolol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Bisoprolol']",0.5
15451,33534.0,Bisoprolol,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Vomiting', 'ABCB1', 'Bisoprolol']",0.5
15451,33575.0,Bisoprolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Bisoprolol']",0.5
15451,33618.0,Bisoprolol,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Bisoprolol']",0.5
15451,33675.0,Bisoprolol,asthma,disease-protein-drug,contraindication,"['asthma', 'ADRB2', 'Bisoprolol']",0.5
15451,33675.0,Bisoprolol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Bisoprolol']",0.5
15451,33679.0,Bisoprolol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Bisoprolol']",0.5
15451,35565.0,Bisoprolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Bisoprolol']",0.5
15451,35764.0,Bisoprolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Bisoprolol']",0.5
15451,35897.0,Bisoprolol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Bisoprolol']",0.5
15451,37703.0,Bisoprolol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRB1', 'Bisoprolol']",0.5
15451,39773.0,Bisoprolol,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ADRB2', 'Bisoprolol']",0.5
15451,39798.0,Bisoprolol,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Bisoprolol']",0.5
15451,83760.0,Bisoprolol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRB1', 'Bisoprolol']",0.5
15451,83781.0,Bisoprolol,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ADRB2', 'Bisoprolol']",0.5
15451,83802.0,Bisoprolol,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Bisoprolol']",0.5
15452,36104.0,Rifabutin,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Rifabutin']",0.5
15452,36229.0,Rifabutin,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Rifabutin']",0.5
15452,39696.0,Rifabutin,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,off-label use,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'HSP90B1', 'Rifabutin']",0.5
15452,39696.0,Rifabutin,pulmonary tuberculosis,disease-exposure-gene-drug,off-label use,"['pulmonary tuberculosis', 'Nitrogen Dioxide', 'HSP90AA1', 'Rifabutin']",0.5
15456,27700.0,Amphotericin B,sclerosing cholangitis,disease-exposure-bioprocess-gene-drug,off-label use,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Amphotericin B']",0.5
15456,35552.0,Amphotericin B,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Amphotericin B']",0.5
15456,35565.0,Amphotericin B,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Amphotericin B']",0.5
15456,35764.0,Amphotericin B,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Amphotericin B']",0.5
15456,37830.0,Amphotericin B,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Amphotericin B']",0.5
15457,27933.0,Flurazepam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Flurazepam']",0.5
15457,27933.0,Flurazepam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Flurazepam']",0.5
15457,27933.0,Flurazepam,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CYP2E1', 'Flurazepam']",0.5
15457,30035.0,Flurazepam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Flurazepam']",0.5
15457,31618.0,Flurazepam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Flurazepam']",0.5
15457,32033.0,Flurazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Flurazepam']",0.5
15457,32313.0,Flurazepam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Flurazepam']",0.5
15457,32977.0,Flurazepam,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GABRA5', 'Flurazepam']",0.5
15457,35565.0,Flurazepam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Flurazepam']",0.5
15457,35764.0,Flurazepam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Flurazepam']",0.5
15457,35833.0,Flurazepam,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Flurazepam']",0.5
15457,35915.0,Flurazepam,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Flurazepam']",0.5
15457,37703.0,Flurazepam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Flurazepam']",0.5
15457,83760.0,Flurazepam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Flurazepam']",0.5
15457,83778.0,Flurazepam,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Flurazepam']",0.5
15457,83779.0,Flurazepam,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Flurazepam']",0.5
15458,28017.0,Ergotamine,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Ergotamine']",0.5
15458,28158.0,Ergotamine,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Ergotamine']",0.5
15458,28158.0,Ergotamine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Ergotamine']",0.5
15458,28158.0,Ergotamine,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Ergotamine']",0.5
15458,28899.0,Ergotamine,obsessive-compulsive disorder,disease-protein-drug,contraindication,"['obsessive-compulsive disorder', 'HTR2A', 'Ergotamine']",0.5
15458,28899.0,Ergotamine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Ergotamine']",0.5
15458,30374.0,Ergotamine,"COPD, severe early onset",disease-protein-drug,contraindication,"['COPD, severe early onset', 'HTR2A', 'Ergotamine']",0.5
15458,31618.0,Ergotamine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'HTR1B', 'Ergotamine']",0.5
15458,31650.0,Ergotamine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'HTR1B', 'Ergotamine']",0.5
15458,32313.0,Ergotamine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'HTR1B', 'Ergotamine']",0.5
15458,32797.0,Ergotamine,IgG4-related retroperitoneal fibrosis,disease-phenotype-protein-drug,contraindication,"['IgG4-related retroperitoneal fibrosis', 'Fever', 'HTR1A', 'Ergotamine']",0.5
15458,32977.0,Ergotamine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Fever', 'HTR1A', 'Ergotamine']",0.5
15458,33306.0,Ergotamine,necrotizing enterocolitis,disease-phenotype-protein-drug,contraindication,"['necrotizing enterocolitis', 'Bradycardia', 'HTR1A', 'Ergotamine']",0.5
15458,33577.0,Ergotamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,33594.0,Ergotamine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'pigmentation', 'DRD2', 'Ergotamine']",0.5
15458,33632.0,Ergotamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Ergotamine']",0.5
15458,33664.0,Ergotamine,sleep apnea syndrome,disease-phenotype-protein-drug,contraindication,"['sleep apnea syndrome', 'Apnea', 'HTR1A', 'Ergotamine']",0.5
15458,33675.0,Ergotamine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,35565.0,Ergotamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HTR2A', 'Ergotamine']",0.5
15458,35641.0,Ergotamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Ergotamine']",0.5
15458,35641.0,Ergotamine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Ergotamine']",0.5
15458,35764.0,Ergotamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,36034.0,Ergotamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HTR2A', 'Ergotamine']",0.5
15458,36080.0,Ergotamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of heart rate', 'DRD2', 'Ergotamine']",0.5
15458,36104.0,Ergotamine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Ergotamine']",0.5
15458,36187.0,Ergotamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,36229.0,Ergotamine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Ergotamine']",0.5
15458,36274.0,Ergotamine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,36312.0,Ergotamine,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'reactive oxygen species metabolic process', 'DRD5', 'Ergotamine']",0.5
15458,36693.0,Ergotamine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'DRD2', 'Ergotamine']",0.5
15458,36693.0,Ergotamine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Ergotamine']",0.5
15458,37617.0,Ergotamine,chronic obstructive pulmonary disease,disease-protein-drug,contraindication,"['chronic obstructive pulmonary disease', 'HTR2A', 'Ergotamine']",0.5
15458,37617.0,Ergotamine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,37703.0,Ergotamine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'HTR1B', 'Ergotamine']",0.5
15458,37718.0,Ergotamine,brain ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['brain ischemia', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,37768.0,Ergotamine,migraine disorder,disease-protein-drug,indication,"['migraine disorder', 'HTR2A', 'Ergotamine']",0.5
15458,37785.0,Ergotamine,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Ergotamine']",0.5
15458,37785.0,Ergotamine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'HTR2A', 'Ergotamine']",0.5
15458,37786.0,Ergotamine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,39798.0,Ergotamine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Ergotamine']",0.5
15458,83760.0,Ergotamine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'HTR1B', 'Ergotamine']",0.5
15459,35565.0,Sufentanil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Sufentanil']",0.5
15459,35764.0,Sufentanil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Sufentanil']",0.5
15460,33575.0,Azatadine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Azatadine']",0.5
15460,33577.0,Azatadine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Azatadine']",0.5
15460,33603.0,Azatadine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Azatadine']",0.5
15460,35953.0,Azatadine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Azatadine']",0.5
15460,35953.0,Azatadine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Azatadine']",0.5
15460,36034.0,Azatadine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Azatadine']",0.5
15460,36187.0,Azatadine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Azatadine']",0.5
15460,37888.0,Azatadine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Azatadine']",0.5
15460,37888.0,Azatadine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Azatadine']",0.5
15460,83791.0,Azatadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Azatadine']",0.5
15461,28478.0,Imiquimod,autoimmune disease,disease-exposure-bioprocess-gene-drug,contraindication,"['autoimmune disease', 'Particulate Matter', 'immune response', 'TLR7', 'Imiquimod']",0.5
15461,36644.0,Imiquimod,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Imiquimod']",0.5
15461,83754.0,Imiquimod,common wart,disease-exposure-bioprocess-gene-drug,indication,"['common wart', 'Zinc', 'inflammatory response', 'TLR7', 'Imiquimod']",0.5
15462,29614.0,Esomeprazole,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Esomeprazole']",0.5
15462,32875.0,Esomeprazole,Zollinger-Ellison syndrome,disease-phenotype-protein-drug,indication,"['Zollinger-Ellison syndrome', 'Nausea', 'ABCB1', 'Esomeprazole']",0.5
15466,27478.0,Acetazolamide,renal tubular acidosis,disease-protein-drug,contraindication,"['renal tubular acidosis', 'CA2', 'Acetazolamide']",0.5
15466,28208.0,Acetazolamide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Zinc', 'response to oxidative stress', 'CA3', 'Acetazolamide']",0.5
15466,28552.0,Acetazolamide,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'response to oxidative stress', 'CA3', 'Acetazolamide']",0.5
15466,33575.0,Acetazolamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CA3', 'Acetazolamide']",0.5
15466,35565.0,Acetazolamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Acetazolamide']",0.5
15466,35764.0,Acetazolamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Acetazolamide']",0.5
15466,36080.0,Acetazolamide,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'response to oxidative stress', 'CA3', 'Acetazolamide']",0.5
15467,27933.0,Ethynodiol diacetate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,27933.0,Ethynodiol diacetate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,27933.0,Ethynodiol diacetate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'PGR', 'Ethynodiol diacetate']",0.5
15467,28651.0,Ethynodiol diacetate,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,29646.0,Ethynodiol diacetate,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,29646.0,Ethynodiol diacetate,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,29646.0,Ethynodiol diacetate,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'PGR', 'Ethynodiol diacetate']",0.5
15467,30827.0,Ethynodiol diacetate,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Ethynodiol diacetate']",0.5
15467,31107.0,Ethynodiol diacetate,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,33575.0,Ethynodiol diacetate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,33575.0,Ethynodiol diacetate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Ethynodiol diacetate']",0.5
15467,33577.0,Ethynodiol diacetate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Ethynodiol diacetate']",0.5
15467,33577.0,Ethynodiol diacetate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Ethynodiol diacetate']",0.5
15467,33598.0,Ethynodiol diacetate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Ethynodiol diacetate']",0.5
15467,33598.0,Ethynodiol diacetate,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Arsenic', 'PGR', 'Ethynodiol diacetate']",0.5
15467,33695.0,Ethynodiol diacetate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Ethynodiol diacetate']",0.5
15467,33699.0,Ethynodiol diacetate,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,35565.0,Ethynodiol diacetate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Ethynodiol diacetate']",0.5
15467,35738.0,Ethynodiol diacetate,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Ethynodiol diacetate']",0.5
15467,35739.0,Ethynodiol diacetate,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,35909.0,Ethynodiol diacetate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Ethynodiol diacetate']",0.5
15467,35958.0,Ethynodiol diacetate,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,36187.0,Ethynodiol diacetate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,36187.0,Ethynodiol diacetate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,36187.0,Ethynodiol diacetate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Ethynodiol diacetate']",0.5
15467,36634.0,Ethynodiol diacetate,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,36634.0,Ethynodiol diacetate,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Ethynodiol diacetate']",0.5
15467,36634.0,Ethynodiol diacetate,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'PGR', 'Ethynodiol diacetate']",0.5
15467,37038.0,Ethynodiol diacetate,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Ethynodiol diacetate']",0.5
15467,37180.0,Ethynodiol diacetate,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,37180.0,Ethynodiol diacetate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,37180.0,Ethynodiol diacetate,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'PGR', 'Ethynodiol diacetate']",0.5
15467,37703.0,Ethynodiol diacetate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,37768.0,Ethynodiol diacetate,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,83760.0,Ethynodiol diacetate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,83823.0,Ethynodiol diacetate,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Ethynodiol diacetate']",0.5
15467,83824.0,Ethynodiol diacetate,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Ethynodiol diacetate']",0.5
15471,27326.0,Granisetron,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CYP1A1', 'Granisetron']",0.5
15471,27326.0,Granisetron,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Granisetron']",0.5
15471,27326.0,Granisetron,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'CYP1A1', 'Granisetron']",0.5
15471,27326.0,Granisetron,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Bradycardia', 'CYP1A1', 'Granisetron']",0.5
15472,27933.0,Tiagabine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'SLC6A1', 'Tiagabine']",0.5
15472,27933.0,Tiagabine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'memory', 'SLC6A1', 'Tiagabine']",0.5
15472,35565.0,Tiagabine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A1', 'Tiagabine']",0.5
15472,36743.0,Tiagabine,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'SLC6A1', 'Tiagabine']",0.5
15472,37703.0,Tiagabine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'SLC6A1', 'Tiagabine']",0.5
15472,83760.0,Tiagabine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'SLC6A1', 'Tiagabine']",0.5
15474,35565.0,Fulvestrant,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Fulvestrant']",0.5
15475,27326.0,Felbamate,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'memory', 'GRIN2A', 'Felbamate']",0.5
15475,27933.0,Felbamate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Felbamate']",0.5
15475,27933.0,Felbamate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'memory', 'GRIN2A', 'Felbamate']",0.5
15475,27933.0,Felbamate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'GRIN2B', 'Felbamate']",0.5
15475,35565.0,Felbamate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'GRIN2A', 'Felbamate']",0.5
15475,35641.0,Felbamate,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GRIN2A', 'Felbamate']",0.5
15475,35641.0,Felbamate,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN2A', 'Felbamate']",0.5
15475,35764.0,Felbamate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'GRIN2A', 'Felbamate']",0.5
15475,37703.0,Felbamate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Felbamate']",0.5
15475,83751.0,Felbamate,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Felbamate']",0.5
15475,83760.0,Felbamate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Felbamate']",0.5
15476,35552.0,Dirithromycin,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Dirithromycin']",0.5
15476,35565.0,Dirithromycin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Dirithromycin']",0.5
15476,37830.0,Dirithromycin,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Dirithromycin']",0.5
15477,30035.0,Ezetimibe,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Ezetimibe']",0.5
15477,33612.0,Ezetimibe,rhabdomyolysis (disease),disease-protein-drug,contraindication,"['rhabdomyolysis (disease)', 'CYP2C8', 'Ezetimibe']",0.5
15477,35565.0,Ezetimibe,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'NPC1L1', 'Ezetimibe']",0.5
15478,27326.0,Telithromycin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Telithromycin']",0.5
15478,33594.0,Telithromycin,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Telithromycin']",0.5
15478,35565.0,Telithromycin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Telithromycin']",0.5
15478,36544.0,Telithromycin,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP3A4', 'Telithromycin']",0.5
15478,36544.0,Telithromycin,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Telithromycin']",0.5
15478,83751.0,Telithromycin,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'CYP3A4', 'Telithromycin']",0.5
15479,27326.0,Salbutamol,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Salbutamol']",0.5
15479,29113.0,Salbutamol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Salbutamol']",0.5
15479,33575.0,Salbutamol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Salbutamol']",0.5
15479,33577.0,Salbutamol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Salbutamol']",0.5
15479,33675.0,Salbutamol,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Salbutamol']",0.5
15479,33675.0,Salbutamol,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Salbutamol']",0.5
15479,33679.0,Salbutamol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Salbutamol']",0.5
15479,36034.0,Salbutamol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Salbutamol']",0.5
15479,36187.0,Salbutamol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Salbutamol']",0.5
15479,36187.0,Salbutamol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Salbutamol']",0.5
15479,37617.0,Salbutamol,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,off-label use,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Salbutamol']",0.5
15479,37786.0,Salbutamol,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB1', 'Salbutamol']",0.5
15479,37786.0,Salbutamol,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Salbutamol']",0.5
15480,27933.0,Guanfacine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Guanfacine']",0.5
15480,27933.0,Guanfacine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of cytokine production', 'ADRA2A', 'Guanfacine']",0.5
15480,33605.0,Guanfacine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA2A', 'Guanfacine']",0.5
15480,35565.0,Guanfacine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Guanfacine']",0.5
15480,35909.0,Guanfacine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Guanfacine']",0.5
15480,36040.0,Guanfacine,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'CYP2C19', 'Guanfacine']",0.5
15480,36040.0,Guanfacine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Guanfacine']",0.5
15480,36187.0,Guanfacine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Guanfacine']",0.5
15480,37180.0,Guanfacine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Guanfacine']",0.5
15480,37703.0,Guanfacine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Guanfacine']",0.5
15480,83760.0,Guanfacine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Guanfacine']",0.5
15480,83923.0,Guanfacine,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'CYP2C19', 'Guanfacine']",0.5
15480,83923.0,Guanfacine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'platelet activation', 'ADRA2B', 'Guanfacine']",0.5
15480,83924.0,Guanfacine,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'CYP2C19', 'Guanfacine']",0.5
15480,84036.0,Guanfacine,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Guanfacine']",0.5
15481,29173.0,Topotecan,small cell lung carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['small cell lung carcinoma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Topotecan']",0.5
15481,32617.0,Topotecan,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'ABCB1', 'Topotecan']",0.5
15481,33594.0,Topotecan,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Topotecan']",0.5
15481,33632.0,Topotecan,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Topotecan']",0.5
15481,36104.0,Topotecan,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Topotecan']",0.5
15481,36229.0,Topotecan,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Topotecan']",0.5
15482,37573.0,Ergoloid mesylate,dementia (disease),disease-exposure-bioprocess-gene-drug,indication,"['dementia (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Ergoloid mesylate']",0.5
15483,33675.0,Pilocarpine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRM1', 'Pilocarpine']",0.5
15483,37617.0,Pilocarpine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Pilocarpine']",0.5
15484,33091.0,Sibutramine,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Seizure', 'SLC6A2', 'Sibutramine']",0.5
15484,33575.0,Sibutramine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,33577.0,Sibutramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,33598.0,Sibutramine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Sibutramine']",0.5
15484,35641.0,Sibutramine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Sibutramine']",0.5
15484,35669.0,Sibutramine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,35761.0,Sibutramine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,35764.0,Sibutramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,35909.0,Sibutramine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Sibutramine']",0.5
15484,36040.0,Sibutramine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,36187.0,Sibutramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,36312.0,Sibutramine,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Sibutramine']",0.5
15484,37180.0,Sibutramine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,39798.0,Sibutramine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Sibutramine']",0.5
15484,83923.0,Sibutramine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'brain morphogenesis', 'SLC6A4', 'Sibutramine']",0.5
15485,35565.0,Atovaquone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Atovaquone']",0.5
15486,33649.0,Prednicarbate,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Prednicarbate']",0.5
15486,36129.0,Prednicarbate,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Prednicarbate']",0.5
15486,39798.0,Prednicarbate,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Prednicarbate']",0.5
15490,28396.0,Pergolide,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'HTR1A', 'Pergolide']",0.5
15490,28547.0,Pergolide,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD1', 'Pergolide']",0.5
15490,28547.0,Pergolide,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Pergolide']",0.5
15490,28547.0,Pergolide,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'HTR1A', 'Pergolide']",0.5
15490,32797.0,Pergolide,IgG4-related retroperitoneal fibrosis,disease-phenotype-protein-drug,contraindication,"['IgG4-related retroperitoneal fibrosis', 'Fever', 'HTR1A', 'Pergolide']",0.5
15490,35764.0,Pergolide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Pergolide']",0.5
15490,37706.0,Pergolide,parkinsonian disorder,disease-protein-drug,indication,"['parkinsonian disorder', 'DRD2', 'Pergolide']",0.5
15492,27476.0,Estramustine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,28017.0,Estramustine,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,contraindication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Estramustine']",0.5
15492,33575.0,Estramustine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,33577.0,Estramustine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,35565.0,Estramustine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,35641.0,Estramustine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Estramustine']",0.5
15492,35764.0,Estramustine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,35909.0,Estramustine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,35958.0,Estramustine,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Estramustine']",0.5
15492,35963.0,Estramustine,prostate carcinoma,disease-protein-drug,indication,"['prostate carcinoma', 'ESR1', 'Estramustine']",0.5
15492,35966.0,Estramustine,prostate cancer,disease-protein-drug,indication,"['prostate cancer', 'ESR1', 'Estramustine']",0.5
15492,35966.0,Estramustine,prostate cancer,disease-exposure-bioprocess-gene-drug,indication,"['prostate cancer', 'Chlorpyrifos', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,36187.0,Estramustine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR2', 'Estramustine']",0.5
15492,36187.0,Estramustine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,37180.0,Estramustine,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Estramustine']",0.5
15492,37180.0,Estramustine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'memory', 'MAP1A', 'Estramustine']",0.5
15492,37604.0,Estramustine,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['erectile dysfunction (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR2', 'Estramustine']",0.5
15492,37768.0,Estramustine,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Estramustine']",0.5
15492,83823.0,Estramustine,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Estramustine']",0.5
15492,83824.0,Estramustine,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Estramustine']",0.5
15493,28375.0,Bromocriptine,familial hyperprolactinemia,disease-protein-drug,indication,"['familial hyperprolactinemia', 'DRD2', 'Bromocriptine']",0.5
15493,28547.0,Bromocriptine,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'ABCB1', 'Bromocriptine']",0.5
15493,28547.0,Bromocriptine,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Bromocriptine']",0.5
15493,28547.0,Bromocriptine,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5
15493,28974.0,Bromocriptine,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'ABCB1', 'Bromocriptine']",0.5
15493,28974.0,Bromocriptine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5
15493,30093.0,Bromocriptine,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'ABCB1', 'Bromocriptine']",0.5
15493,30093.0,Bromocriptine,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'HTR1A', 'Bromocriptine']",0.5
15493,30274.0,Bromocriptine,HELLP syndrome,disease-phenotype-protein-drug,contraindication,"['HELLP syndrome', 'Increased body weight', 'HTR2C', 'Bromocriptine']",0.5
15493,31408.0,Bromocriptine,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'ABCB1', 'Bromocriptine']",0.5
15493,31408.0,Bromocriptine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5
15493,32468.0,Bromocriptine,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5
15493,32759.0,Bromocriptine,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'ABCB1', 'Bromocriptine']",0.5
15493,32759.0,Bromocriptine,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'HTR1A', 'Bromocriptine']",0.5
15493,32974.0,Bromocriptine,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'ABCB1', 'Bromocriptine']",0.5
15493,32974.0,Bromocriptine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5
15493,33241.0,Bromocriptine,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'ABCB1', 'Bromocriptine']",0.5
15493,33241.0,Bromocriptine,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'HTR1A', 'Bromocriptine']",0.5
15493,33454.0,Bromocriptine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,off-label use,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Bromocriptine']",0.5
15493,33512.0,Bromocriptine,preeclampsia,disease-exposure-bioprocess-gene-drug,contraindication,"['preeclampsia', 'perfluorononanoic acid', 'female pregnancy', 'ADRA2B', 'Bromocriptine']",0.5
15493,33577.0,Bromocriptine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Bromocriptine']",0.5
15493,33598.0,Bromocriptine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'visual learning', 'DRD3', 'Bromocriptine']",0.5
15493,35565.0,Bromocriptine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HTR2A', 'Bromocriptine']",0.5
15493,35909.0,Bromocriptine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'HTR2A', 'Bromocriptine']",0.5
15493,36187.0,Bromocriptine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Bromocriptine']",0.5
15493,39081.0,Bromocriptine,hyperprolactinemia (disease),disease-protein-drug,indication,"['hyperprolactinemia (disease)', 'DRD2', 'Bromocriptine']",0.5
15493,84023.0,Bromocriptine,acquired hyperprolactinemia,disease-protein-drug,indication,"['acquired hyperprolactinemia', 'DRD2', 'Bromocriptine']",0.5
15494,27476.0,Rifapentine,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Rifapentine']",0.5
15494,30035.0,Rifapentine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2B6', 'Rifapentine']",0.5
15494,35565.0,Rifapentine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Rifapentine']",0.5
15494,39696.0,Rifapentine,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary tuberculosis', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Rifapentine']",0.5
15495,27933.0,Estazolam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Estazolam']",0.5
15495,27933.0,Estazolam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Estazolam']",0.5
15495,30035.0,Estazolam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Estazolam']",0.5
15495,31618.0,Estazolam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Estazolam']",0.5
15495,31650.0,Estazolam,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'GABRA5', 'Estazolam']",0.5
15495,32313.0,Estazolam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Estazolam']",0.5
15495,35565.0,Estazolam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Estazolam']",0.5
15495,35764.0,Estazolam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Estazolam']",0.5
15495,35915.0,Estazolam,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Estazolam']",0.5
15495,37703.0,Estazolam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Estazolam']",0.5
15495,83760.0,Estazolam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Estazolam']",0.5
15495,83778.0,Estazolam,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Estazolam']",0.5
15495,83779.0,Estazolam,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Estazolam']",0.5
15496,33594.0,Rifaximin,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR1I2', 'Rifaximin']",0.5
15497,30035.0,Levacetylmethadol,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'CHRNB4', 'Levacetylmethadol']",0.5
15497,37753.0,Levacetylmethadol,opiate dependence,disease-protein-drug,indication,"['opiate dependence', 'OPRM1', 'Levacetylmethadol']",0.5
15497,84242.0,Levacetylmethadol,morphine dependence,disease-protein-drug,indication,"['morphine dependence', 'OPRM1', 'Levacetylmethadol']",0.5
15498,30274.0,Ergometrine,HELLP syndrome,disease-phenotype-protein-drug,contraindication,"['HELLP syndrome', 'Nausea', 'ABCB1', 'Ergometrine']",0.5
15498,33577.0,Ergometrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Ergometrine']",0.5
15498,33598.0,Ergometrine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Ergometrine']",0.5
15498,35565.0,Ergometrine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Ergometrine']",0.5
15498,35641.0,Ergometrine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Ergometrine']",0.5
15498,35764.0,Ergometrine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Ergometrine']",0.5
15498,35909.0,Ergometrine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Ergometrine']",0.5
15500,29614.0,Desonide,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Desonide']",0.5
15500,33575.0,Desonide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Desonide']",0.5
15500,33577.0,Desonide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Desonide']",0.5
15500,33649.0,Desonide,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Desonide']",0.5
15500,33675.0,Desonide,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Desonide']",0.5
15500,33679.0,Desonide,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'NR3C1', 'Desonide']",0.5
15500,35565.0,Desonide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Desonide']",0.5
15500,35915.0,Desonide,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'NR3C1', 'Desonide']",0.5
15500,35915.0,Desonide,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Desonide']",0.5
15500,36129.0,Desonide,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Desonide']",0.5
15500,36469.0,Desonide,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Desonide']",0.5
15500,37888.0,Desonide,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Desonide']",0.5
15500,39696.0,Desonide,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary tuberculosis', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR3C1', 'Desonide']",0.5
15500,39798.0,Desonide,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Desonide']",0.5
15500,83778.0,Desonide,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'NR3C1', 'Desonide']",0.5
15500,83778.0,Desonide,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Desonide']",0.5
15500,83779.0,Desonide,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'NR3C1', 'Desonide']",0.5
15500,83779.0,Desonide,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Desonide']",0.5
15500,83830.0,Desonide,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Desonide']",0.5
15501,28208.0,Sitagliptin,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Sitagliptin']",0.5
15501,30035.0,Sitagliptin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Sitagliptin']",0.5
15501,30813.0,Sitagliptin,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Vomiting', 'ABCB1', 'Sitagliptin']",0.5
15501,32905.0,Sitagliptin,Sheehan syndrome,disease-phenotype-protein-drug,contraindication,"['Sheehan syndrome', 'Nausea', 'ABCB1', 'Sitagliptin']",0.5
15501,33575.0,Sitagliptin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Sitagliptin']",0.5
15501,35565.0,Sitagliptin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Sitagliptin']",0.5
15501,35764.0,Sitagliptin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Sitagliptin']",0.5
15501,37180.0,Sitagliptin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Sitagliptin']",0.5
15503,33575.0,Fosamprenavir,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Fosamprenavir']",0.5
15503,33577.0,Fosamprenavir,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Fosamprenavir']",0.5
15503,33695.0,Fosamprenavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Fosamprenavir']",0.5
15503,35565.0,Fosamprenavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Fosamprenavir']",0.5
15503,36187.0,Fosamprenavir,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Fosamprenavir']",0.5
15503,37180.0,Fosamprenavir,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Fosamprenavir']",0.5
15503,37743.0,Fosamprenavir,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Fosamprenavir']",0.5
15504,35552.0,Cefradine,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'innate immune response', 'SLC15A2', 'Cefradine']",0.5
15504,35831.0,Cefradine,respiratory tract infectious disease,disease-exposure-bioprocess-gene-drug,indication,"['respiratory tract infectious disease', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP3A4', 'Cefradine']",0.5
15505,33577.0,Tasosartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Tasosartan']",0.5
15505,33577.0,Tasosartan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'AGTR2', 'Tasosartan']",0.5
15505,36035.0,Tasosartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Tasosartan']",0.5
15507,27933.0,Mestranol,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ESR1', 'Mestranol']",0.5
15507,27933.0,Mestranol,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Mestranol']",0.5
15507,28651.0,Mestranol,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ESR1', 'Mestranol']",0.5
15507,30827.0,Mestranol,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'ESR1', 'Mestranol']",0.5
15507,31107.0,Mestranol,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Mestranol']",0.5
15507,33575.0,Mestranol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Mestranol']",0.5
15507,33577.0,Mestranol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Mestranol']",0.5
15507,33593.0,Mestranol,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Mestranol']",0.5
15507,33593.0,Mestranol,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Mestranol']",0.5
15507,33598.0,Mestranol,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Mestranol']",0.5
15507,33695.0,Mestranol,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Mestranol']",0.5
15507,33699.0,Mestranol,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Mestranol']",0.5
15507,35565.0,Mestranol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Mestranol']",0.5
15507,35738.0,Mestranol,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR1', 'Mestranol']",0.5
15507,35739.0,Mestranol,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Mestranol']",0.5
15507,35909.0,Mestranol,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Mestranol']",0.5
15507,35958.0,Mestranol,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Mestranol']",0.5
15507,36187.0,Mestranol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Mestranol']",0.5
15507,36187.0,Mestranol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Mestranol']",0.5
15507,36634.0,Mestranol,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'ESR1', 'Mestranol']",0.5
15507,36634.0,Mestranol,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP2C9', 'Mestranol']",0.5
15507,37038.0,Mestranol,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR1', 'Mestranol']",0.5
15507,37180.0,Mestranol,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Mestranol']",0.5
15507,37180.0,Mestranol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Mestranol']",0.5
15507,37703.0,Mestranol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ESR1', 'Mestranol']",0.5
15507,37768.0,Mestranol,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Mestranol']",0.5
15507,83760.0,Mestranol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ESR1', 'Mestranol']",0.5
15507,83823.0,Mestranol,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Mestranol']",0.5
15507,83824.0,Mestranol,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Mestranol']",0.5
15508,27476.0,Quinupristin,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Quinupristin']",0.5
15508,35565.0,Quinupristin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Quinupristin']",0.5
15510,33658.0,Bezafibrate,hyperlipidemia,disease-protein-drug,indication,"['hyperlipidemia', 'PPARA', 'Bezafibrate']",0.5
15510,36040.0,Bezafibrate,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'PPARA', 'Bezafibrate']",0.5
15510,36040.0,Bezafibrate,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'glucose homeostasis', 'PPARG', 'Bezafibrate']",0.5
15510,37764.0,Bezafibrate,familial hyperlipidemia,disease-protein-drug,indication,"['familial hyperlipidemia', 'PPARA', 'Bezafibrate']",0.5
15510,83923.0,Bezafibrate,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'PPARA', 'Bezafibrate']",0.5
15510,83923.0,Bezafibrate,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cell population proliferation', 'PPARD', 'Bezafibrate']",0.5
15510,83924.0,Bezafibrate,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'PPARA', 'Bezafibrate']",0.5
15511,33675.0,Pranlukast,asthma,disease-protein-drug,indication,"['asthma', 'RNASE3', 'Pranlukast']",0.5
15511,33675.0,Pranlukast,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Pranlukast']",0.5
15511,33675.0,Pranlukast,asthma,disease-exposure-gene-drug,indication,"['asthma', 'Air Pollutants', 'IL5', 'Pranlukast']",0.5
15511,37888.0,Pranlukast,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'IL5', 'Pranlukast']",0.5
15511,37888.0,Pranlukast,allergic rhinitis,disease-exposure-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'IL5', 'Pranlukast']",0.5
15511,37888.0,Pranlukast,allergic rhinitis,disease-phenotype-protein-drug,indication,"['allergic rhinitis', 'Allergy', 'TNF', 'Pranlukast']",0.5
15511,39773.0,Pranlukast,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'RNASE3', 'Pranlukast']",0.5
15511,83781.0,Pranlukast,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'RNASE3', 'Pranlukast']",0.5
15517,27933.0,Prazepam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Prazepam']",0.5
15517,27933.0,Prazepam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Prazepam']",0.5
15517,30035.0,Prazepam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Prazepam']",0.5
15517,32033.0,Prazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Prazepam']",0.5
15517,32313.0,Prazepam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Prazepam']",0.5
15517,32977.0,Prazepam,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GABRA5', 'Prazepam']",0.5
15517,35565.0,Prazepam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Prazepam']",0.5
15517,35764.0,Prazepam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Prazepam']",0.5
15517,35833.0,Prazepam,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Prazepam']",0.5
15517,35915.0,Prazepam,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Prazepam']",0.5
15517,37703.0,Prazepam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Prazepam']",0.5
15517,83760.0,Prazepam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Prazepam']",0.5
15517,83778.0,Prazepam,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Prazepam']",0.5
15517,83779.0,Prazepam,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Prazepam']",0.5
15518,27933.0,Quazepam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Quazepam']",0.5
15518,27933.0,Quazepam,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Quazepam']",0.5
15518,30035.0,Quazepam,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Quazepam']",0.5
15518,31618.0,Quazepam,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Quazepam']",0.5
15518,32033.0,Quazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Quazepam']",0.5
15518,32313.0,Quazepam,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Quazepam']",0.5
15518,32977.0,Quazepam,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GABRA5', 'Quazepam']",0.5
15518,35565.0,Quazepam,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Quazepam']",0.5
15518,35764.0,Quazepam,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Quazepam']",0.5
15518,35833.0,Quazepam,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Quazepam']",0.5
15518,37703.0,Quazepam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Quazepam']",0.5
15518,83760.0,Quazepam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Quazepam']",0.5
15519,32033.0,Nitrazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Nitrazepam']",0.5
15520,27933.0,Roflumilast,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'PDE4A', 'Roflumilast']",0.5
15520,27933.0,Roflumilast,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'PDE4D', 'Roflumilast']",0.5
15520,37703.0,Roflumilast,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'PDE4A', 'Roflumilast']",0.5
15520,83760.0,Roflumilast,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'PDE4A', 'Roflumilast']",0.5
15522,27476.0,Dalfopristin,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Dalfopristin']",0.5
15522,35565.0,Dalfopristin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Dalfopristin']",0.5
15536,35565.0,Maraviroc,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'CCR5', 'Maraviroc']",0.5
15536,35764.0,Maraviroc,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Maraviroc']",0.5
15536,36040.0,Maraviroc,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Maraviroc']",0.5
15536,36187.0,Maraviroc,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'CCR5', 'Maraviroc']",0.5
15536,36544.0,Maraviroc,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP3A4', 'Maraviroc']",0.5
15536,36544.0,Maraviroc,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'immune response', 'CCR5', 'Maraviroc']",0.5
15536,37180.0,Maraviroc,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'CCR5', 'Maraviroc']",0.5
15536,37743.0,Maraviroc,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Maraviroc']",0.5
15536,37786.0,Maraviroc,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'CCR5', 'Maraviroc']",0.5
15536,83923.0,Maraviroc,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'CCR5', 'Maraviroc']",0.5
15538,28313.0,Fluspirilene,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Fluspirilene']",0.5
15538,28313.0,Fluspirilene,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Fluspirilene']",0.5
15539,27476.0,Ixabepilone,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15539,33575.0,Ixabepilone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15539,33632.0,Ixabepilone,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15539,35565.0,Ixabepilone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15539,35669.0,Ixabepilone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15539,35761.0,Ixabepilone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15539,35771.0,Ixabepilone,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'ABCB1', 'Ixabepilone']",0.5
15539,35771.0,Ixabepilone,breast neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['breast neoplasm', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15539,36104.0,Ixabepilone,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Ixabepilone']",0.5
15539,36187.0,Ixabepilone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15539,36229.0,Ixabepilone,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Ixabepilone']",0.5
15539,37334.0,Ixabepilone,breast carcinoma,disease-protein-drug,indication,"['breast carcinoma', 'ABCB1', 'Ixabepilone']",0.5
15539,37786.0,Ixabepilone,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Ixabepilone']",0.5
15542,30035.0,Milnacipran,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Milnacipran']",0.5
15542,33091.0,Milnacipran,serotonin syndrome,disease-phenotype-protein-drug,contraindication,"['serotonin syndrome', 'Seizure', 'SLC6A2', 'Milnacipran']",0.5
15542,33577.0,Milnacipran,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Milnacipran']",0.5
15542,33577.0,Milnacipran,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'GRIN2B', 'Milnacipran']",0.5
15542,35565.0,Milnacipran,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A4', 'Milnacipran']",0.5
15542,35641.0,Milnacipran,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Milnacipran']",0.5
15542,35641.0,Milnacipran,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Milnacipran']",0.5
15542,35669.0,Milnacipran,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Milnacipran']",0.5
15542,35669.0,Milnacipran,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'GRIN2B', 'Milnacipran']",0.5
15542,35761.0,Milnacipran,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Milnacipran']",0.5
15542,35761.0,Milnacipran,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'GRIN2B', 'Milnacipran']",0.5
15546,27326.0,Indacaterol,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Indacaterol']",0.5
15546,29113.0,Indacaterol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Indacaterol']",0.5
15546,33575.0,Indacaterol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Indacaterol']",0.5
15546,33577.0,Indacaterol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Indacaterol']",0.5
15546,33679.0,Indacaterol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Indacaterol']",0.5
15546,35641.0,Indacaterol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Indacaterol']",0.5
15546,36034.0,Indacaterol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Indacaterol']",0.5
15546,36187.0,Indacaterol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB2', 'Indacaterol']",0.5
15546,36187.0,Indacaterol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Indacaterol']",0.5
15549,29614.0,Dexlansoprazole,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Dexlansoprazole']",0.5
15549,35565.0,Dexlansoprazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Dexlansoprazole']",0.5
15551,36743.0,Brivaracetam,partial epilepsy,disease-protein-drug,indication,"['partial epilepsy', 'SCN3A', 'Brivaracetam']",0.5
15551,83928.0,Brivaracetam,partial motor epilepsy,disease-protein-drug,indication,"['partial motor epilepsy', 'SCN3A', 'Brivaracetam']",0.5
15555,28651.0,Rimonabant,monogenic obesity,disease-protein-drug,indication,"['monogenic obesity', 'CNR1', 'Rimonabant']",0.5
15556,30035.0,Noscapine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SIGMAR1', 'Noscapine']",0.5
15556,31732.0,Noscapine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'SIGMAR1', 'Noscapine']",0.5
15556,33575.0,Noscapine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Noscapine']",0.5
15556,33577.0,Noscapine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Noscapine']",0.5
15556,35565.0,Noscapine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Noscapine']",0.5
15556,35641.0,Noscapine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SIGMAR1', 'Noscapine']",0.5
15556,36034.0,Noscapine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Noscapine']",0.5
15556,36469.0,Noscapine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Noscapine']",0.5
15556,37180.0,Noscapine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Noscapine']",0.5
15557,28396.0,Silodosin,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Neurodegeneration', 'ADRA1B', 'Silodosin']",0.5
15557,35764.0,Silodosin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Silodosin']",0.5
15558,28262.0,Tolvaptan,polycystic kidney disease,disease-phenotype-protein-drug,indication,"['polycystic kidney disease', 'Oliguria', 'AVPR2', 'Tolvaptan']",0.5
15558,28456.0,Tolvaptan,nephrogenic syndrome of inappropriate antidiuresis,disease-protein-drug,indication,"['nephrogenic syndrome of inappropriate antidiuresis', 'AVPR2', 'Tolvaptan']",0.5
15558,30035.0,Tolvaptan,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Tolvaptan']",0.5
15559,35565.0,Lacosamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Lacosamide']",0.5
15559,36187.0,Lacosamide,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Lacosamide']",0.5
15559,37786.0,Lacosamide,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Lacosamide']",0.5
15559,38958.0,Lacosamide,sick sinus syndrome,disease-protein-drug,contraindication,"['sick sinus syndrome', 'SCN10A', 'Lacosamide']",0.5
15561,37604.0,Avanafil,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,indication,"['erectile dysfunction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Avanafil']",0.5
15566,37743.0,Etravirine,hepatitis C virus infection,disease-protein-drug,contraindication,"['hepatitis C virus infection', 'CYP3A4', 'Etravirine']",0.5
15572,84261.0,Bosutinib,"blast phase chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['blast phase chronic myelogenous leukemia, BCR-ABL1 positive', 'BCR', 'Bosutinib']",0.5
15573,32249.0,Isavuconazonium,Zygomycosis,disease-phenotype-protein-drug,indication,"['Zygomycosis', 'Nausea', 'ABCB1', 'Isavuconazonium']",0.5
15580,33577.0,Pinacidil,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Pinacidil']",0.5
15582,83830.0,Difluprednate,ocular hypertension,disease-protein-drug,contraindication,"['ocular hypertension', 'NR3C1', 'Difluprednate']",0.5
15583,28208.0,Halcinonide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Halcinonide']",0.5
15583,33575.0,Halcinonide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Halcinonide']",0.5
15583,36129.0,Halcinonide,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Halcinonide']",0.5
15583,39798.0,Halcinonide,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Halcinonide']",0.5
15584,33577.0,Lanreotide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'SSTR5', 'Lanreotide']",0.5
15584,35565.0,Lanreotide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SSTR2', 'Lanreotide']",0.5
15584,36469.0,Lanreotide,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Lanreotide']",0.5
15584,83764.0,Lanreotide,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'SSTR5', 'Lanreotide']",0.5
15586,33675.0,Tranilast,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Tranilast']",0.5
15586,33675.0,Tranilast,asthma,disease-exposure-molfunc-gene-drug,indication,"['asthma', 'Pesticides', 'glutathione transferase activity', 'HPGDS', 'Tranilast']",0.5
15586,36129.0,Tranilast,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Tranilast']",0.5
15590,28313.0,Lurasidone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Lurasidone']",0.5
15590,28313.0,Lurasidone,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP3A4', 'Lurasidone']",0.5
15590,28375.0,Lurasidone,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Lurasidone']",0.5
15590,28396.0,Lurasidone,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'HTR1A', 'Lurasidone']",0.5
15590,29637.0,Lurasidone,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Lurasidone']",0.5
15590,29637.0,Lurasidone,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD2', 'Lurasidone']",0.5
15590,33454.0,Lurasidone,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Lurasidone']",0.5
15590,33575.0,Lurasidone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Lurasidone']",0.5
15590,33598.0,Lurasidone,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'visual learning', 'DRD2', 'Lurasidone']",0.5
15590,35565.0,Lurasidone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HTR2A', 'Lurasidone']",0.5
15590,35641.0,Lurasidone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD2', 'Lurasidone']",0.5
15590,35641.0,Lurasidone,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Lurasidone']",0.5
15590,35909.0,Lurasidone,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'HTR2A', 'Lurasidone']",0.5
15590,36312.0,Lurasidone,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'platelet activation', 'ADRA2C', 'Lurasidone']",0.5
15590,38242.0,Lurasidone,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'DRD2', 'Lurasidone']",0.5
15590,38242.0,Lurasidone,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Lurasidone']",0.5
15590,39081.0,Lurasidone,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Lurasidone']",0.5
15590,83764.0,Lurasidone,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Lurasidone']",0.5
15590,83998.0,Lurasidone,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Lurasidone']",0.5
15590,84023.0,Lurasidone,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Lurasidone']",0.5
15594,29993.0,Brentuximab vedotin,classic Hodgkin lymphoma,disease-protein-drug,indication,"['classic Hodgkin lymphoma', 'TNFRSF8', 'Brentuximab vedotin']",0.5
15594,33077.0,Brentuximab vedotin,Hodgkins lymphoma,disease-protein-drug,indication,"['Hodgkins lymphoma', 'TNFRSF8', 'Brentuximab vedotin']",0.5
15594,33077.0,Brentuximab vedotin,Hodgkins lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Brentuximab vedotin']",0.5
15594,83792.0,Brentuximab vedotin,obsolete Hodgkin's granuloma,disease-protein-drug,indication,"[""obsolete Hodgkin's granuloma"", 'TNFRSF8', 'Brentuximab vedotin']",0.5
15594,83793.0,Brentuximab vedotin,Hodgkin's paragranuloma,disease-protein-drug,indication,"[""Hodgkin's paragranuloma"", 'TNFRSF8', 'Brentuximab vedotin']",0.5
15594,83794.0,Brentuximab vedotin,"classic Hodgkin lymphoma, lymphocyte-rich type",disease-protein-drug,indication,"['classic Hodgkin lymphoma, lymphocyte-rich type', 'TNFRSF8', 'Brentuximab vedotin']",0.5
15596,28640.0,Cabozantinib,nonpapillary renal cell carcinoma,disease-protein-drug,indication,"['nonpapillary renal cell carcinoma', 'MET', 'Cabozantinib']",0.5
15596,32909.0,Cabozantinib,medullary thyroid gland carcinoma,disease-protein-drug,indication,"['medullary thyroid gland carcinoma', 'RET', 'Cabozantinib']",0.5
15596,36935.0,Cabozantinib,renal cell adenocarcinoma,disease-protein-drug,indication,"['renal cell adenocarcinoma', 'MET', 'Cabozantinib']",0.5
15596,36937.0,Cabozantinib,clear cell renal carcinoma,disease-protein-drug,indication,"['clear cell renal carcinoma', 'MET', 'Cabozantinib']",0.5
15597,27610.0,Ruxolitinib,primary myelofibrosis,disease-protein-drug,indication,"['primary myelofibrosis', 'JAK2', 'Ruxolitinib']",0.5
15597,27610.0,Ruxolitinib,primary myelofibrosis,disease-phenotype-protein-drug,indication,"['primary myelofibrosis', 'Venous thrombosis', 'JAK2', 'Ruxolitinib']",0.5
15597,29118.0,Ruxolitinib,acquired polycythemia vera,disease-protein-drug,indication,"['acquired polycythemia vera', 'JAK1', 'Ruxolitinib']",0.5
15597,29118.0,Ruxolitinib,acquired polycythemia vera,disease-phenotype-protein-drug,indication,"['acquired polycythemia vera', 'Venous thrombosis', 'JAK2', 'Ruxolitinib']",0.5
15597,33590.0,Ruxolitinib,polycythemia (disease),disease-protein-drug,indication,"['polycythemia (disease)', 'JAK1', 'Ruxolitinib']",0.5
15597,36825.0,Ruxolitinib,plasmacytoma,disease-protein-drug,indication,"['plasmacytoma', 'JAK1', 'Ruxolitinib']",0.5
15597,83871.0,Ruxolitinib,myelofibrosis,disease-protein-drug,indication,"['myelofibrosis', 'JAK2', 'Ruxolitinib']",0.5
15598,33575.0,Linagliptin,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'SLC22A3', 'Linagliptin']",0.5
15598,33575.0,Linagliptin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Linagliptin']",0.5
15599,29194.0,Regorafenib,gastrointestinal stromal tumor,disease-protein-drug,indication,"['gastrointestinal stromal tumor', 'PDGFRA', 'Regorafenib']",0.5
15599,29646.0,Regorafenib,hepatocellular carcinoma,disease-protein-drug,indication,"['hepatocellular carcinoma', 'ABCB1', 'Regorafenib']",0.5
15599,29646.0,Regorafenib,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['hepatocellular carcinoma', 'Air Pollutants', 'respiratory system process', 'FLT4', 'Regorafenib']",0.5
15599,32621.0,Regorafenib,pediatric hepatocellular carcinoma,disease-protein-drug,indication,"['pediatric hepatocellular carcinoma', 'ABCB1', 'Regorafenib']",0.5
15599,32621.0,Regorafenib,pediatric hepatocellular carcinoma,disease-phenotype-protein-drug,indication,"['pediatric hepatocellular carcinoma', 'Vomiting', 'ABCB1', 'Regorafenib']",0.5
15599,36634.0,Regorafenib,liver cancer,disease-protein-drug,indication,"['liver cancer', 'ABCB1', 'Regorafenib']",0.5
15599,36634.0,Regorafenib,liver cancer,disease-exposure-bioprocess-gene-drug,indication,"['liver cancer', 'perfluorooctanoic acid', 'respiratory system process', 'FLT4', 'Regorafenib']",0.5
15599,36999.0,Regorafenib,adenocarcinoma of liver and intrahepatic biliary tract,disease-protein-drug,indication,"['adenocarcinoma of liver and intrahepatic biliary tract', 'ABCB1', 'Regorafenib']",0.5
15599,37115.0,Regorafenib,squamous cell carcinoma of liver and intrahepatic biliary tract,disease-protein-drug,indication,"['squamous cell carcinoma of liver and intrahepatic biliary tract', 'ABCB1', 'Regorafenib']",0.5
15599,83869.0,Regorafenib,fibrolamellar hepatocellular carcinoma,disease-protein-drug,indication,"['fibrolamellar hepatocellular carcinoma', 'ABCB1', 'Regorafenib']",0.5
15599,83870.0,Regorafenib,undifferentiated carcinoma of liver and intrahepatic biliary tract,disease-protein-drug,indication,"['undifferentiated carcinoma of liver and intrahepatic biliary tract', 'ABCB1', 'Regorafenib']",0.5
15600,39696.0,Bedaquiline,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary tuberculosis', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Bedaquiline']",0.5
15603,35727.0,Dabrafenib,metastatic melanoma,disease-protein-drug,indication,"['metastatic melanoma', 'SIK1', 'Dabrafenib']",0.5
15606,36187.0,Fendiline,coronary artery disease,disease-exposure-bioprocess-gene-drug,indication,"['coronary artery disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Fendiline']",0.5
15606,37786.0,Fendiline,myocardial ischemia,disease-exposure-bioprocess-gene-drug,indication,"['myocardial ischemia', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Fendiline']",0.5
15609,29182.0,Aliskiren,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'REN', 'Aliskiren']",0.5
15609,29854.0,Aliskiren,hereditary angioedema,disease-phenotype-protein-drug,contraindication,"['hereditary angioedema', 'Nausea', 'ABCB1', 'Aliskiren']",0.5
15609,33534.0,Aliskiren,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'REN', 'Aliskiren']",0.5
15609,33605.0,Aliskiren,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'REN', 'Aliskiren']",0.5
15609,35565.0,Aliskiren,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Aliskiren']",0.5
15609,36104.0,Aliskiren,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Aliskiren']",0.5
15609,36229.0,Aliskiren,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Aliskiren']",0.5
15609,83802.0,Aliskiren,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Aliskiren']",0.5
15610,33598.0,Vorapaxar,stroke disorder,disease-exposure-bioprocess-gene-drug,indication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Vorapaxar']",0.5
15610,35909.0,Vorapaxar,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Vorapaxar']",0.5
15610,36312.0,Vorapaxar,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'platelet activation', 'F2R', 'Vorapaxar']",0.5
15610,83942.0,Vorapaxar,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'positive regulation of interleukin-6 production', 'F2R', 'Vorapaxar']",0.5
15611,28391.0,Suvorexant,narcolepsy,disease-protein-drug,contraindication,"['narcolepsy', 'HCRTR2', 'Suvorexant']",0.5
15611,28391.0,Suvorexant,narcolepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['narcolepsy', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Suvorexant']",0.5
15611,30664.0,Suvorexant,X-linked adrenoleukodystrophy,disease-protein-drug,contraindication,"['X-linked adrenoleukodystrophy', 'HCRTR2', 'Suvorexant']",0.5
15611,33324.0,Suvorexant,narcolepsy-cataplexy syndrome,disease-protein-drug,contraindication,"['narcolepsy-cataplexy syndrome', 'HCRTR2', 'Suvorexant']",0.5
15611,35742.0,Suvorexant,central nervous system disease,disease-protein-drug,contraindication,"['central nervous system disease', 'HCRTR2', 'Suvorexant']",0.5
15611,84092.0,Suvorexant,Balo concentric sclerosis,disease-protein-drug,contraindication,"['Balo concentric sclerosis', 'HCRTR2', 'Suvorexant']",0.5
15612,32631.0,Siltuximab,Castleman disease,disease-protein-drug,indication,"['Castleman disease', 'IL6', 'Siltuximab']",0.5
15612,32631.0,Siltuximab,Castleman disease,disease-phenotype-protein-drug,indication,"['Castleman disease', 'Anasarca', 'IL6', 'Siltuximab']",0.5
15612,33450.0,Siltuximab,Kimura disease,disease-protein-drug,indication,"['Kimura disease', 'IL6', 'Siltuximab']",0.5
15613,31116.0,Ceritinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Ceritinib']",0.5
15613,33688.0,Ceritinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Ceritinib']",0.5
15614,35897.0,Vilanterol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Vilanterol']",0.5
15614,37617.0,Vilanterol,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,indication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Vilanterol']",0.5
15614,37830.0,Vilanterol,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Vilanterol']",0.5
15614,39773.0,Vilanterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Vilanterol']",0.5
15614,83781.0,Vilanterol,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Vilanterol']",0.5
15621,29061.0,Dienogest,endometriosis of uterus,disease-protein-drug,contraindication,"['endometriosis of uterus', 'PGR', 'Dienogest']",0.5
15621,29113.0,Dienogest,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Dienogest']",0.5
15621,30827.0,Dienogest,endometrial cancer,disease-protein-drug,contraindication,"['endometrial cancer', 'PGR', 'Dienogest']",0.5
15621,32617.0,Dienogest,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'AR', 'Dienogest']",0.5
15621,33575.0,Dienogest,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Dienogest']",0.5
15621,33575.0,Dienogest,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'PGR', 'Dienogest']",0.5
15621,33575.0,Dienogest,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Dienogest']",0.5
15621,33577.0,Dienogest,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Dienogest']",0.5
15621,33577.0,Dienogest,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'PGR', 'Dienogest']",0.5
15621,33593.0,Dienogest,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'spermatogenesis', 'AR', 'Dienogest']",0.5
15621,33598.0,Dienogest,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'spermatogenesis', 'AR', 'Dienogest']",0.5
15621,33598.0,Dienogest,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Arsenic', 'PGR', 'Dienogest']",0.5
15621,33675.0,Dienogest,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Dienogest']",0.5
15621,33675.0,Dienogest,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'PGR', 'Dienogest']",0.5
15621,33680.0,Dienogest,endometriosis (disease),disease-protein-drug,contraindication,"['endometriosis (disease)', 'PGR', 'Dienogest']",0.5
15621,33680.0,Dienogest,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Dienogest']",0.5
15621,33695.0,Dienogest,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Dienogest']",0.5
15621,33699.0,Dienogest,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Dienogest']",0.5
15621,35565.0,Dienogest,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Dienogest']",0.5
15621,35738.0,Dienogest,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'PGR', 'Dienogest']",0.5
15621,35739.0,Dienogest,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'PGR', 'Dienogest']",0.5
15621,35764.0,Dienogest,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Dienogest']",0.5
15621,35764.0,Dienogest,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PGR', 'Dienogest']",0.5
15621,35909.0,Dienogest,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Dienogest']",0.5
15621,36187.0,Dienogest,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Dienogest']",0.5
15621,36187.0,Dienogest,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'PGR', 'Dienogest']",0.5
15621,36469.0,Dienogest,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'glyphosate', 'lipid metabolic process', 'CYP3A4', 'Dienogest']",0.5
15621,37038.0,Dienogest,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'PGR', 'Dienogest']",0.5
15621,37180.0,Dienogest,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Dienogest']",0.5
15621,37180.0,Dienogest,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'PGR', 'Dienogest']",0.5
15621,37573.0,Dienogest,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Dienogest']",0.5
15621,37703.0,Dienogest,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'AR', 'Dienogest']",0.5
15621,83760.0,Dienogest,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'AR', 'Dienogest']",0.5
15622,33707.0,Sonidegib,skin carcinoma,disease-protein-drug,indication,"['skin carcinoma', 'SMO', 'Sonidegib']",0.5
15622,36240.0,Sonidegib,carcinoma,disease-protein-drug,indication,"['carcinoma', 'SMO', 'Sonidegib']",0.5
15622,37009.0,Sonidegib,sweat gland cancer,disease-protein-drug,indication,"['sweat gland cancer', 'SMO', 'Sonidegib']",0.5
15622,37166.0,Sonidegib,sebaceous adenocarcinoma,disease-protein-drug,indication,"['sebaceous adenocarcinoma', 'SMO', 'Sonidegib']",0.5
15622,37738.0,Sonidegib,basal cell carcinoma,disease-protein-drug,indication,"['basal cell carcinoma', 'SMO', 'Sonidegib']",0.5
15622,37738.0,Sonidegib,basal cell carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['basal cell carcinoma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Sonidegib']",0.5
15629,33577.0,Azelnidipine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP3A4', 'Azelnidipine']",0.5
15638,33680.0,Norethynodrel,endometriosis (disease),disease-exposure-bioprocess-gene-drug,indication,"['endometriosis (disease)', 'bisphenol A', 'spermatogenesis', 'AR', 'Norethynodrel']",0.5
15638,33680.0,Norethynodrel,endometriosis (disease),disease-exposure-gene-drug,indication,"['endometriosis (disease)', 'mono(2-ethyl-5-hydroxyhexyl) phthalate', 'SHBG', 'Norethynodrel']",0.5
15640,37573.0,Dihydroergocornine,dementia (disease),disease-exposure-bioprocess-gene-drug,indication,"['dementia (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Dihydroergocornine']",0.5
15646,33675.0,Oleandomycin,asthma,disease-exposure-bioprocess-gene-drug,off-label use,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Oleandomycin']",0.5
15653,83802.0,Lesinurad,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Lesinurad']",0.5
15654,30654.0,Venetoclax,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Venetoclax']",0.5
15654,83868.0,Venetoclax,Richter syndrome,disease-protein-drug,indication,"['Richter syndrome', 'BCL2', 'Venetoclax']",0.5
15655,37743.0,Velpatasvir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Velpatasvir']",0.5
15662,29078.0,Sarilumab,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'IL6R', 'Sarilumab']",0.5
15662,29078.0,Sarilumab,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Sarilumab']",0.5
15666,29078.0,Baricitinib,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Baricitinib']",0.5
15666,29078.0,Baricitinib,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Baricitinib']",0.5
15667,27933.0,Esketamine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'CYP2C19', 'Esketamine']",0.5
15667,27933.0,Esketamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Arsenic', 'response to folic acid', 'EEF2', 'Esketamine']",0.5
15667,27933.0,Esketamine,anxiety disorder,disease-exposure-gene-drug,indication,"['anxiety disorder', 'bisphenol A', 'GRIN2B', 'Esketamine']",0.5
15667,35671.0,Esketamine,vascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['vascular disease', 'Arsenic', 'response to folic acid', 'EEF2', 'Esketamine']",0.5
15667,37703.0,Esketamine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'CYP2C19', 'Esketamine']",0.5
15667,83760.0,Esketamine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'CYP2C19', 'Esketamine']",0.5
15668,35963.0,Apalutamide,prostate carcinoma,disease-protein-drug,indication,"['prostate carcinoma', 'CYP2C19', 'Apalutamide']",0.5
15668,35966.0,Apalutamide,prostate cancer,disease-protein-drug,indication,"['prostate cancer', 'CYP2C19', 'Apalutamide']",0.5
15668,35966.0,Apalutamide,prostate cancer,disease-exposure-bioprocess-gene-drug,indication,"['prostate cancer', 'Dimethoate', 'lipid metabolic process', 'CYP3A4', 'Apalutamide']",0.5
15671,30654.0,Duvelisib,acute lymphoblastic/lymphocytic leukemia,disease-protein-drug,indication,"['acute lymphoblastic/lymphocytic leukemia', 'ABCG2', 'Duvelisib']",0.5
15679,37573.0,Vinpocetine,dementia (disease),disease-exposure-bioprocess-gene-drug,indication,"['dementia (disease)', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'CYP3A4', 'Vinpocetine']",0.5
15683,31116.0,Brigatinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'MET', 'Brigatinib']",0.5
15683,33688.0,Brigatinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'MET', 'Brigatinib']",0.5
15712,35909.0,Bencyclane,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol metabolic process', 'CYP3A4', 'Bencyclane']",0.5
15725,37743.0,Glecaprevir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Glecaprevir']",0.5
15739,28520.0,Ivosidenib,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'IDH1', 'Ivosidenib']",0.5
15739,28520.0,Ivosidenib,myeloid leukemia,disease-exposure-bioprocess-gene-drug,indication,"['myeloid leukemia', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Ivosidenib']",0.5
15739,37714.0,Ivosidenib,unclassified acute myeloid leukemia,disease-protein-drug,indication,"['unclassified acute myeloid leukemia', 'IDH1', 'Ivosidenib']",0.5
15739,38274.0,Ivosidenib,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'IDH1', 'Ivosidenib']",0.5
15739,39124.0,Ivosidenib,therapy related acute myeloid leukemia and myelodysplastic syndrome,disease-protein-drug,indication,"['therapy related acute myeloid leukemia and myelodysplastic syndrome', 'IDH1', 'Ivosidenib']",0.5
15739,83852.0,Ivosidenib,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'IDH1', 'Ivosidenib']",0.5
15739,83853.0,Ivosidenib,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'IDH1', 'Ivosidenib']",0.5
15739,83854.0,Ivosidenib,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'IDH1', 'Ivosidenib']",0.5
15739,83855.0,Ivosidenib,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'IDH1', 'Ivosidenib']",0.5
15739,83856.0,Ivosidenib,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'IDH1', 'Ivosidenib']",0.5
15739,83857.0,Ivosidenib,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'IDH1', 'Ivosidenib']",0.5
15739,83858.0,Ivosidenib,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'IDH1', 'Ivosidenib']",0.5
15739,83859.0,Ivosidenib,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'IDH1', 'Ivosidenib']",0.5
15739,83860.0,Ivosidenib,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'IDH1', 'Ivosidenib']",0.5
15739,83861.0,Ivosidenib,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'IDH1', 'Ivosidenib']",0.5
15739,83862.0,Ivosidenib,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'IDH1', 'Ivosidenib']",0.5
15747,83813.0,Voxelotor,hereditary persistence of fetal hemoglobin,disease-protein-drug,indication,"['hereditary persistence of fetal hemoglobin', 'HBA2', 'Voxelotor']",0.5
15753,33575.0,Miglitol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'GAA', 'Miglitol']",0.5
15753,35764.0,Miglitol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'glucose metabolic process', 'GAA', 'Miglitol']",0.5
15761,37766.0,Oseltamivir,influenza,disease-protein-drug,indication,"['influenza', 'SLC22A8', 'Oseltamivir']",0.5
15761,84255.0,Oseltamivir,"influenza, severe, susceptibility to",disease-protein-drug,indication,"['influenza, severe, susceptibility to', 'SLC22A8', 'Oseltamivir']",0.5
15762,27503.0,Trandolapril,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Sudden death', 'ACE', 'Trandolapril']",0.5
15762,28052.0,Trandolapril,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Sudden death', 'ACE', 'Trandolapril']",0.5
15762,28231.0,Trandolapril,supravalvular aortic stenosis (disease),disease-phenotype-protein-drug,contraindication,"['supravalvular aortic stenosis (disease)', 'Arrhythmia', 'ACE', 'Trandolapril']",0.5
15762,30669.0,Trandolapril,Becker muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['Becker muscular dystrophy', 'Arrhythmia', 'ACE', 'Trandolapril']",0.5
15762,32149.0,Trandolapril,Duchenne muscular dystrophy,disease-phenotype-protein-drug,contraindication,"['Duchenne muscular dystrophy', 'Arrhythmia', 'ACE', 'Trandolapril']",0.5
15762,33025.0,Trandolapril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Pulmonary arterial hypertension', 'ACE', 'Trandolapril']",0.5
15762,33577.0,Trandolapril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Trandolapril']",0.5
15762,33577.0,Trandolapril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Trandolapril']",0.5
15762,33605.0,Trandolapril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ACE', 'Trandolapril']",0.5
15762,33618.0,Trandolapril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Trandolapril']",0.5
15762,33618.0,Trandolapril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Trandolapril']",0.5
15762,33618.0,Trandolapril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Trandolapril']",0.5
15762,35565.0,Trandolapril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Trandolapril']",0.5
15762,35764.0,Trandolapril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Trandolapril']",0.5
15762,36286.0,Trandolapril,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'ACE', 'Trandolapril']",0.5
15762,37659.0,Trandolapril,heart failure,disease-protein-drug,contraindication,"['heart failure', 'ACE', 'Trandolapril']",0.5
15762,37659.0,Trandolapril,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Trandolapril']",0.5
15763,27286.0,Benzocaine,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Vomiting', 'ABCB1', 'Benzocaine']",0.5
15763,27933.0,Benzocaine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Benzocaine']",0.5
15763,27933.0,Benzocaine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'SCN10A', 'Benzocaine']",0.5
15763,29525.0,Benzocaine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Benzocaine']",0.5
15763,29614.0,Benzocaine,osteoporosis,disease-exposure-bioprocess-gene-drug,off-label use,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol biosynthetic process', 'CES1', 'Benzocaine']",0.5
15763,30035.0,Benzocaine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Benzocaine']",0.5
15763,31168.0,Benzocaine,pyruvate dehydrogenase E3 deficiency,disease-phenotype-protein-drug,contraindication,"['pyruvate dehydrogenase E3 deficiency', 'Vomiting', 'ABCB1', 'Benzocaine']",0.5
15763,33575.0,Benzocaine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Benzocaine']",0.5
15763,33594.0,Benzocaine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of heart rate', 'SCN10A', 'Benzocaine']",0.5
15763,33632.0,Benzocaine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of heart rate', 'SCN10A', 'Benzocaine']",0.5
15763,33649.0,Benzocaine,exanthem (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['exanthem (disease)', 'Particulate Matter', 'cholesterol biosynthetic process', 'CES1', 'Benzocaine']",0.5
15763,35565.0,Benzocaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CES1', 'Benzocaine']",0.5
15763,35641.0,Benzocaine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Benzocaine']",0.5
15763,35669.0,Benzocaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Benzocaine']",0.5
15763,35761.0,Benzocaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Benzocaine']",0.5
15763,35764.0,Benzocaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Benzocaine']",0.5
15763,36034.0,Benzocaine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CES1', 'Benzocaine']",0.5
15763,36080.0,Benzocaine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cholesterol biosynthetic process', 'CES1', 'Benzocaine']",0.5
15763,36104.0,Benzocaine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Benzocaine']",0.5
15763,36229.0,Benzocaine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Benzocaine']",0.5
15763,36644.0,Benzocaine,skin disease,disease-exposure-bioprocess-gene-drug,contraindication,"['skin disease', 'Pesticides', 'cholesterol metabolic process', 'CES1', 'Benzocaine']",0.5
15763,37703.0,Benzocaine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Benzocaine']",0.5
15763,83760.0,Benzocaine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Benzocaine']",0.5
15765,35565.0,Phenylacetic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'CES1', 'Phenylacetic acid']",0.5
15765,35764.0,Phenylacetic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Phenylacetic acid']",0.5
15767,27933.0,Homatropine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CHRM2', 'Homatropine']",0.5
15767,27933.0,Homatropine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'transmission of nerve impulse', 'CHRM5', 'Homatropine']",0.5
15767,28158.0,Homatropine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,30035.0,Homatropine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRM2', 'Homatropine']",0.5
15767,30813.0,Homatropine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'CHRM1', 'Homatropine']",0.5
15767,31618.0,Homatropine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CHRM1', 'Homatropine']",0.5
15767,31650.0,Homatropine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Homatropine']",0.5
15767,31732.0,Homatropine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'CHRM1', 'Homatropine']",0.5
15767,32313.0,Homatropine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRM1', 'Homatropine']",0.5
15767,32384.0,Homatropine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CHRM1', 'Homatropine']",0.5
15767,32977.0,Homatropine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CHRM1', 'Homatropine']",0.5
15767,33577.0,Homatropine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Homatropine']",0.5
15767,33632.0,Homatropine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,35565.0,Homatropine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,35641.0,Homatropine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CHRM2', 'Homatropine']",0.5
15767,35764.0,Homatropine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Homatropine']",0.5
15767,35897.0,Homatropine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,36034.0,Homatropine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,36080.0,Homatropine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,36187.0,Homatropine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,36274.0,Homatropine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,36469.0,Homatropine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,36492.0,Homatropine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,36693.0,Homatropine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CHRM2', 'Homatropine']",0.5
15767,37703.0,Homatropine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CHRM2', 'Homatropine']",0.5
15767,37785.0,Homatropine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Homatropine']",0.5
15767,83760.0,Homatropine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CHRM2', 'Homatropine']",0.5
15769,29182.0,Valsartan,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'AGTR1', 'Valsartan']",0.5
15769,29182.0,Valsartan,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'ABCC2', 'Valsartan']",0.5
15769,31033.0,Valsartan,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'ABCC2', 'Valsartan']",0.5
15769,32629.0,Valsartan,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'ABCC2', 'Valsartan']",0.5
15769,33534.0,Valsartan,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'AGTR1', 'Valsartan']",0.5
15769,33575.0,Valsartan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Valsartan']",0.5
15769,33577.0,Valsartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Valsartan']",0.5
15769,33577.0,Valsartan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Valsartan']",0.5
15769,33618.0,Valsartan,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'AGTR1', 'Valsartan']",0.5
15769,35565.0,Valsartan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Valsartan']",0.5
15769,36035.0,Valsartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Valsartan']",0.5
15769,38059.0,Valsartan,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'ABCC2', 'Valsartan']",0.5
15769,83802.0,Valsartan,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Valsartan']",0.5
15770,27219.0,Glimepiride,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'KCNJ11', 'Glimepiride']",0.5
15770,27292.0,Glimepiride,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Seizure', 'KCNJ11', 'Glimepiride']",0.5
15770,27741.0,Glimepiride,pituitary deficiency due to empty sella turcica syndrome,disease-phenotype-protein-drug,contraindication,"['pituitary deficiency due to empty sella turcica syndrome', 'Seizure', 'KCNJ11', 'Glimepiride']",0.5
15770,28208.0,Glimepiride,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'KCNJ11', 'Glimepiride']",0.5
15770,28208.0,Glimepiride,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose metabolic process', 'KCNJ11', 'Glimepiride']",0.5
15770,28208.0,Glimepiride,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'KCNJ11', 'Glimepiride']",0.5
15770,29614.0,Glimepiride,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'female pregnancy', 'ABCC8', 'Glimepiride']",0.5
15770,30813.0,Glimepiride,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'KCNJ11', 'Glimepiride']",0.5
15770,31756.0,Glimepiride,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder cancer', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Glimepiride']",0.5
15770,32337.0,Glimepiride,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'Seizure', 'KCNJ11', 'Glimepiride']",0.5
15770,32384.0,Glimepiride,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'KCNJ11', 'Glimepiride']",0.5
15770,33453.0,Glimepiride,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Seizure', 'KCNJ11', 'Glimepiride']",0.5
15770,33575.0,Glimepiride,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'KCNJ11', 'Glimepiride']",0.5
15770,33575.0,Glimepiride,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'KCNJ11', 'Glimepiride']",0.5
15770,33598.0,Glimepiride,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'visual learning', 'ABCC8', 'Glimepiride']",0.5
15770,33642.0,Glimepiride,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder carcinoma', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Glimepiride']",0.5
15770,35565.0,Glimepiride,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Glimepiride']",0.5
15770,35624.0,Glimepiride,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder neoplasm', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Glimepiride']",0.5
15770,35764.0,Glimepiride,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Glimepiride']",0.5
15770,35909.0,Glimepiride,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'ABCB11', 'Glimepiride']",0.5
15770,36187.0,Glimepiride,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Glimepiride']",0.5
15770,36544.0,Glimepiride,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'CYP2C9', 'Glimepiride']",0.5
15770,36544.0,Glimepiride,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Glimepiride']",0.5
15770,37180.0,Glimepiride,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Glimepiride']",0.5
15770,37786.0,Glimepiride,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Glimepiride']",0.5
15771,27326.0,Sulfisoxazole,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Sulfisoxazole']",0.5
15771,33675.0,Sulfisoxazole,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Sulfisoxazole']",0.5
15771,35565.0,Sulfisoxazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Sulfisoxazole']",0.5
15771,35764.0,Sulfisoxazole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Sulfisoxazole']",0.5
15772,28547.0,Tolcapone,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Organophosphorus Compounds', 'developmental process', 'COMT', 'Tolcapone']",0.5
15772,33653.0,Tolcapone,melanoma,disease-exposure-bioprocess-gene-drug,contraindication,"['melanoma', 'Arsenic', 'methylation', 'COMT', 'Tolcapone']",0.5
15772,35565.0,Tolcapone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP2C9', 'Tolcapone']",0.5
15773,35565.0,Treprostinil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'adipose tissue development', 'PPARD', 'Treprostinil']",0.5
15773,35764.0,Treprostinil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'adipose tissue development', 'PPARD', 'Treprostinil']",0.5
15773,35833.0,Treprostinil,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARD', 'Treprostinil']",0.5
15774,27361.0,Ketorolac,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'PTGS2', 'Ketorolac']",0.5
15774,33575.0,Ketorolac,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Ketorolac']",0.5
15774,33575.0,Ketorolac,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,33577.0,Ketorolac,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Ketorolac']",0.5
15774,33577.0,Ketorolac,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,33598.0,Ketorolac,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'PTGS2', 'Ketorolac']",0.5
15774,33598.0,Ketorolac,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cholesterol metabolic process', 'CYP2C9', 'Ketorolac']",0.5
15774,33598.0,Ketorolac,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,33632.0,Ketorolac,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'UGT2B7', 'Ketorolac']",0.5
15774,33632.0,Ketorolac,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,33675.0,Ketorolac,asthma,disease-protein-drug,contraindication,"['asthma', 'PTGS1', 'Ketorolac']",0.5
15774,33675.0,Ketorolac,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketorolac']",0.5
15774,33675.0,Ketorolac,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,35565.0,Ketorolac,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Ketorolac']",0.5
15774,35669.0,Ketorolac,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketorolac']",0.5
15774,35669.0,Ketorolac,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,35761.0,Ketorolac,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Ketorolac']",0.5
15774,35761.0,Ketorolac,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,35909.0,Ketorolac,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'PTGS2', 'Ketorolac']",0.5
15774,35909.0,Ketorolac,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,35916.0,Ketorolac,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Ketorolac']",0.5
15774,37180.0,Ketorolac,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketorolac']",0.5
15774,37180.0,Ketorolac,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,37564.0,Ketorolac,gastric ulcer (disease),disease-protein-drug,contraindication,"['gastric ulcer (disease)', 'PTGS1', 'Ketorolac']",0.5
15774,83942.0,Ketorolac,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Ketorolac']",0.5
15774,83942.0,Ketorolac,intracerebral hemorrhage,disease-exposure-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'PTGS1', 'Ketorolac']",0.5
15774,83961.0,Ketorolac,duodenal ulcer (disease),disease-protein-drug,contraindication,"['duodenal ulcer (disease)', 'PTGS2', 'Ketorolac']",0.5
15776,28313.0,Nabilone,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'CYP2E1', 'Nabilone']",0.5
15776,28313.0,Nabilone,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Nabilone']",0.5
15776,30035.0,Nabilone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CYP2E1', 'Nabilone']",0.5
15776,33577.0,Nabilone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'CNR1', 'Nabilone']",0.5
15776,33605.0,Nabilone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'CNR1', 'Nabilone']",0.5
15776,35915.0,Nabilone,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Nabilone']",0.5
15776,36187.0,Nabilone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'CNR2', 'Nabilone']",0.5
15776,36693.0,Nabilone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CNR1', 'Nabilone']",0.5
15776,37703.0,Nabilone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CNR2', 'Nabilone']",0.5
15776,83760.0,Nabilone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CNR2', 'Nabilone']",0.5
15776,83778.0,Nabilone,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Nabilone']",0.5
15776,83779.0,Nabilone,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cholesterol metabolic process', 'CYP2C9', 'Nabilone']",0.5
15777,31395.0,Oxandrolone,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Oxandrolone']",0.5
15777,32635.0,Oxandrolone,monosomy X,disease-phenotype-protein-drug,off-label use,"['monosomy X', 'Female infertility', 'AR', 'Oxandrolone']",0.5
15777,32829.0,Oxandrolone,Turner syndrome,disease-phenotype-protein-drug,off-label use,"['Turner syndrome', 'Female infertility', 'AR', 'Oxandrolone']",0.5
15777,35565.0,Oxandrolone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Oxandrolone']",0.5
15777,35764.0,Oxandrolone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Oxandrolone']",0.5
15777,35953.0,Oxandrolone,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Diethylhexyl Phthalate', 'Leydig cell differentiation', 'AR', 'Oxandrolone']",0.5
15777,35963.0,Oxandrolone,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'AR', 'Oxandrolone']",0.5
15777,35966.0,Oxandrolone,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'AR', 'Oxandrolone']",0.5
15777,35966.0,Oxandrolone,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Oxandrolone']",0.5
15777,36187.0,Oxandrolone,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Oxandrolone']",0.5
15777,36634.0,Oxandrolone,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'AR', 'Oxandrolone']",0.5
15777,36634.0,Oxandrolone,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Oxandrolone']",0.5
15777,37659.0,Oxandrolone,heart failure,disease-exposure-bioprocess-gene-drug,contraindication,"['heart failure', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Oxandrolone']",0.5
15778,27219.0,Tolazamide,hypogonadotropic hypogonadism with or without anosmia,disease-phenotype-protein-drug,contraindication,"['hypogonadotropic hypogonadism with or without anosmia', 'Seizure', 'KCNJ11', 'Tolazamide']",0.5
15778,27741.0,Tolazamide,pituitary deficiency due to empty sella turcica syndrome,disease-phenotype-protein-drug,contraindication,"['pituitary deficiency due to empty sella turcica syndrome', 'Seizure', 'KCNJ11', 'Tolazamide']",0.5
15778,30813.0,Tolazamide,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'KCNJ11', 'Tolazamide']",0.5
15778,32337.0,Tolazamide,"combined pituitary hormone deficiencies, genetic form",disease-phenotype-protein-drug,contraindication,"['combined pituitary hormone deficiencies, genetic form', 'Seizure', 'KCNJ11', 'Tolazamide']",0.5
15778,32384.0,Tolazamide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'KCNJ11', 'Tolazamide']",0.5
15778,33453.0,Tolazamide,Kallmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kallmann syndrome', 'Seizure', 'KCNJ11', 'Tolazamide']",0.5
15778,33575.0,Tolazamide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'KCNJ11', 'Tolazamide']",0.5
15778,33575.0,Tolazamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'KCNJ11', 'Tolazamide']",0.5
15778,35565.0,Tolazamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'ABCC8', 'Tolazamide']",0.5
15778,35764.0,Tolazamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'ABCC8', 'Tolazamide']",0.5
15779,33575.0,Dorzolamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CA3', 'Dorzolamide']",0.5
15779,33575.0,Dorzolamide,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'CYP2E1', 'Dorzolamide']",0.5
15779,35897.0,Dorzolamide,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'response to oxidative stress', 'CA3', 'Dorzolamide']",0.5
15779,36034.0,Dorzolamide,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP2C9', 'Dorzolamide']",0.5
15781,28017.0,Acetylsalicylic acid,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,indication,"['migraine with or without aura, susceptibility to', 'Vomiting', 'ABCB1', 'Acetylsalicylic acid']",0.5
15781,29078.0,Acetylsalicylic acid,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ABCB1', 'Acetylsalicylic acid']",0.5
15781,29078.0,Acetylsalicylic acid,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'spermatogenesis', 'PRKAG1', 'Acetylsalicylic acid']",0.5
15781,29078.0,Acetylsalicylic acid,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'CASP3', 'Acetylsalicylic acid']",0.5
15781,29078.0,Acetylsalicylic acid,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Acetylsalicylic acid']",0.5
15781,29273.0,Acetylsalicylic acid,osteoarthritis susceptibility,disease-protein-drug,indication,"['osteoarthritis susceptibility', 'AKR1C1', 'Acetylsalicylic acid']",0.5
15781,33609.0,Acetylsalicylic acid,osteoarthritis,disease-protein-drug,indication,"['osteoarthritis', 'AKR1C1', 'Acetylsalicylic acid']",0.5
15781,35958.0,Acetylsalicylic acid,hemoglobinopathy,disease-protein-drug,indication,"['hemoglobinopathy', 'HSPA5', 'Acetylsalicylic acid']",0.5
15781,36209.0,Acetylsalicylic acid,arthropathy,disease-protein-drug,indication,"['arthropathy', 'AKR1C1', 'Acetylsalicylic acid']",0.5
15781,83823.0,Acetylsalicylic acid,coronary thrombosis,disease-protein-drug,indication,"['coronary thrombosis', 'HSPA5', 'Acetylsalicylic acid']",0.5
15781,83824.0,Acetylsalicylic acid,myocardial infarction,disease-protein-drug,indication,"['myocardial infarction', 'HSPA5', 'Acetylsalicylic acid']",0.5
15782,28005.0,Vigabatrin,developmental and epileptic encephalopathy,disease-phenotype-protein-drug,indication,"['developmental and epileptic encephalopathy', 'Seizure', 'ABAT', 'Vigabatrin']",0.5
15782,33632.0,Vigabatrin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'urea metabolic process', 'CYP2C9', 'Vigabatrin']",0.5
15782,35764.0,Vigabatrin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Vigabatrin']",0.5
15783,28158.0,Cyclizine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Cyclizine']",0.5
15783,33603.0,Cyclizine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Cyclizine']",0.5
15783,33605.0,Cyclizine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Cyclizine']",0.5
15783,33675.0,Cyclizine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Cyclizine']",0.5
15783,35565.0,Cyclizine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Cyclizine']",0.5
15783,35641.0,Cyclizine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Cyclizine']",0.5
15783,35764.0,Cyclizine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Cyclizine']",0.5
15783,35953.0,Cyclizine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Cyclizine']",0.5
15783,35953.0,Cyclizine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Cyclizine']",0.5
15783,36034.0,Cyclizine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Cyclizine']",0.5
15783,36080.0,Cyclizine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Cyclizine']",0.5
15783,36187.0,Cyclizine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Cyclizine']",0.5
15783,36469.0,Cyclizine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Cyclizine']",0.5
15783,36693.0,Cyclizine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Cyclizine']",0.5
15783,37180.0,Cyclizine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Cyclizine']",0.5
15783,39798.0,Cyclizine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Cyclizine']",0.5
15783,83791.0,Cyclizine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Cyclizine']",0.5
15784,28208.0,Gliquidone,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Gliquidone']",0.5
15784,28208.0,Gliquidone,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Gliquidone']",0.5
15784,33575.0,Gliquidone,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Gliquidone']",0.5
15784,33575.0,Gliquidone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ABCC8', 'Gliquidone']",0.5
15785,28208.0,Glisoxepide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Glisoxepide']",0.5
15785,33575.0,Glisoxepide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Glisoxepide']",0.5
15791,36129.0,Crisaborole,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'regulation of heart rate', 'PDE4D', 'Crisaborole']",0.5
15794,27366.0,Aceclofenac,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Aceclofenac']",0.5
15796,33575.0,Glibornuride,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Glibornuride']",0.5
15797,37617.0,Olodaterol,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,indication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Olodaterol']",0.5
15798,35916.0,Lifitegrast,dry eye syndrome,disease-exposure-bioprocess-gene-drug,indication,"['dry eye syndrome', 'Mercury', 'cholesterol metabolic process', 'CYP2C9', 'Lifitegrast']",0.5
15801,28208.0,Carbutamide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Carbutamide']",0.5
15801,33575.0,Carbutamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP2C9', 'Carbutamide']",0.5
15804,27626.0,Cladribine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'PNP', 'Cladribine']",0.5
15804,33632.0,Cladribine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'response to oxidative stress', 'RRM2B', 'Cladribine']",0.5
15804,35764.0,Cladribine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'PNP', 'Cladribine']",0.5
15804,35764.0,Cladribine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PNP', 'Cladribine']",0.5
15804,83802.0,Cladribine,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Cladribine']",0.5
15804,83802.0,Cladribine,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'immune response', 'PNP', 'Cladribine']",0.5
15805,83769.0,Clofarabine,precursor T-cell acute lymphoblastic leukemia,disease-protein-drug,indication,"['precursor T-cell acute lymphoblastic leukemia', 'ABCG2', 'Clofarabine']",0.5
15808,27286.0,Pyrimethamine,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'HEXB', 'Pyrimethamine']",0.5
15808,27292.0,Pyrimethamine,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Seizure', 'HEXB', 'Pyrimethamine']",0.5
15808,32977.0,Pyrimethamine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'HEXB', 'Pyrimethamine']",0.5
15808,33632.0,Pyrimethamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'sensory perception of sound', 'HEXB', 'Pyrimethamine']",0.5
15808,33632.0,Pyrimethamine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'HEXB', 'Pyrimethamine']",0.5
15808,35565.0,Pyrimethamine,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'HEXB', 'Pyrimethamine']",0.5
15808,35764.0,Pyrimethamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'sensory perception of sound', 'HEXB', 'Pyrimethamine']",0.5
15808,35764.0,Pyrimethamine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'HEXB', 'Pyrimethamine']",0.5
15812,28547.0,Opicapone,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Organophosphorus Compounds', 'developmental process', 'COMT', 'Opicapone']",0.5
15816,29078.0,Loxoprofen,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Loxoprofen']",0.5
15816,29078.0,Loxoprofen,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cholesterol metabolic process', 'CYP3A4', 'Loxoprofen']",0.5
15816,29078.0,Loxoprofen,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Loxoprofen']",0.5
15816,29078.0,Loxoprofen,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Loxoprofen']",0.5
15817,28651.0,Adefovir dipivoxil,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'SLC22A3', 'Adefovir dipivoxil']",0.5
15817,33593.0,Adefovir dipivoxil,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'SLC22A3', 'Adefovir dipivoxil']",0.5
15817,33593.0,Adefovir dipivoxil,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'cellular response to oxidative stress', 'NME2', 'Adefovir dipivoxil']",0.5
15817,35764.0,Adefovir dipivoxil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cellular response to oxidative stress', 'NME2', 'Adefovir dipivoxil']",0.5
15817,36242.0,Adefovir dipivoxil,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Arsenic', 'cellular response to oxidative stress', 'NME2', 'Adefovir dipivoxil']",0.5
15818,35565.0,Memantine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'GRIN2A', 'Memantine']",0.5
15819,35565.0,Fomepizole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CAT', 'Fomepizole']",0.5
15819,35764.0,Fomepizole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'CAT', 'Fomepizole']",0.5
15821,28052.0,Isosorbide dinitrate,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Cardiomegaly', 'CYP2E1', 'Isosorbide dinitrate']",0.5
15821,33632.0,Isosorbide dinitrate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'NPR1', 'Isosorbide dinitrate']",0.5
15821,35909.0,Isosorbide dinitrate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'triglyceride metabolic process', 'CYP2E1', 'Isosorbide dinitrate']",0.5
15821,36034.0,Isosorbide dinitrate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Hydrocarbons, Chlorinated', 'triglyceride metabolic process', 'CYP2E1', 'Isosorbide dinitrate']",0.5
15821,36187.0,Isosorbide dinitrate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'NPR1', 'Isosorbide dinitrate']",0.5
15821,37180.0,Isosorbide dinitrate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'NPR1', 'Isosorbide dinitrate']",0.5
15821,37180.0,Isosorbide dinitrate,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'CYP2E1', 'Isosorbide dinitrate']",0.5
15821,83942.0,Isosorbide dinitrate,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'regulation of blood pressure', 'NPR1', 'Isosorbide dinitrate']",0.5
15822,29955.0,Ursodeoxycholic acid,Reynolds syndrome,disease-protein-drug,indication,"['Reynolds syndrome', 'ABCC2', 'Ursodeoxycholic acid']",0.5
15822,29955.0,Ursodeoxycholic acid,Reynolds syndrome,disease-phenotype-protein-drug,indication,"['Reynolds syndrome', 'Hepatomegaly', 'NR1H4', 'Ursodeoxycholic acid']",0.5
15822,31144.0,Ursodeoxycholic acid,primary biliary cholangitis,disease-protein-drug,indication,"['primary biliary cholangitis', 'ABCC2', 'Ursodeoxycholic acid']",0.5
15822,31144.0,Ursodeoxycholic acid,primary biliary cholangitis,disease-phenotype-protein-drug,indication,"['primary biliary cholangitis', 'Pruritus', 'ABCB11', 'Ursodeoxycholic acid']",0.5
15826,35641.0,Dalfampridine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'KCNA2', 'Dalfampridine']",0.5
15826,37722.0,Dalfampridine,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'glucose homeostasis', 'KCNB1', 'Dalfampridine']",0.5
15829,33575.0,Fingolimod,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SLC1A2', 'Fingolimod']",0.5
15829,33575.0,Fingolimod,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'SPHK1', 'Fingolimod']",0.5
15829,33575.0,Fingolimod,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Pesticides', 'CYP2E1', 'Fingolimod']",0.5
15829,35764.0,Fingolimod,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'CYP4F2', 'Fingolimod']",0.5
15829,35833.0,Fingolimod,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'blood vessel development', 'SPHK1', 'Fingolimod']",0.5
15832,27361.0,Carisoprodol,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'GABRA5', 'Carisoprodol']",0.5
15832,27843.0,Carisoprodol,acute intermittent porphyria,disease-phenotype-protein-drug,contraindication,"['acute intermittent porphyria', 'Seizure', 'GABRA5', 'Carisoprodol']",0.5
15832,28780.0,Carisoprodol,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Particulate Matter', 'brain development', 'GABRA5', 'Carisoprodol']",0.5
15832,28780.0,Carisoprodol,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GABRA5', 'Carisoprodol']",0.5
15832,30035.0,Carisoprodol,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRG2', 'Carisoprodol']",0.5
15832,30813.0,Carisoprodol,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'GABRA5', 'Carisoprodol']",0.5
15832,31732.0,Carisoprodol,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'GABRA5', 'Carisoprodol']",0.5
15832,32384.0,Carisoprodol,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GABRA5', 'Carisoprodol']",0.5
15832,33440.0,Carisoprodol,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Seizure', 'GABRA5', 'Carisoprodol']",0.5
15832,33632.0,Carisoprodol,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GABRA5', 'Carisoprodol']",0.5
15832,35565.0,Carisoprodol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'brain development', 'GABRA5', 'Carisoprodol']",0.5
15832,35641.0,Carisoprodol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Carisoprodol']",0.5
15832,35764.0,Carisoprodol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'brain development', 'GABRA5', 'Carisoprodol']",0.5
15832,36469.0,Carisoprodol,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'methyl bromide', 'nervous system process', 'GABRG2', 'Carisoprodol']",0.5
15833,33675.0,Methohexital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Particulate Matter', 'nervous system process', 'GABRA1', 'Methohexital']",0.5
15833,37617.0,Methohexital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Particulate Matter', 'nervous system process', 'GABRA1', 'Methohexital']",0.5
15834,27843.0,Thiopental,acute intermittent porphyria,disease-phenotype-protein-drug,contraindication,"['acute intermittent porphyria', 'Seizure', 'GRIA2', 'Thiopental']",0.5
15834,29457.0,Thiopental,variegate porphyria,disease-phenotype-protein-drug,contraindication,"['variegate porphyria', 'Seizure', 'GRIA2', 'Thiopental']",0.5
15834,30813.0,Thiopental,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'GRIA2', 'Thiopental']",0.5
15834,31650.0,Thiopental,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'GRIA2', 'Thiopental']",0.5
15834,31732.0,Thiopental,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'GABRA5', 'Thiopental']",0.5
15834,32384.0,Thiopental,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GRIA2', 'Thiopental']",0.5
15834,33632.0,Thiopental,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'CYP3A4', 'Thiopental']",0.5
15834,33675.0,Thiopental,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRNA4', 'Thiopental']",0.5
15834,35565.0,Thiopental,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Thiopental']",0.5
15834,35641.0,Thiopental,epilepsy,disease-protein-drug,indication,"['epilepsy', 'FAAH', 'Thiopental']",0.5
15834,35641.0,Thiopental,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Thiopental']",0.5
15834,35764.0,Thiopental,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Thiopental']",0.5
15834,36312.0,Thiopental,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['transient ischemic attack (disease)', 'Particulate Matter', 'brain development', 'GABRA5', 'Thiopental']",0.5
15834,36469.0,Thiopental,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'CHRNA7', 'Thiopental']",0.5
15834,37718.0,Thiopental,brain ischemia,disease-exposure-bioprocess-gene-drug,off-label use,"['brain ischemia', 'Air Pollutants', 'cognition', 'CHRNA4', 'Thiopental']",0.5
15835,27933.0,Methylphenobarbital,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Methylphenobarbital']",0.5
15835,27933.0,Methylphenobarbital,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of transcription, DNA-templated', 'NR1I2', 'Methylphenobarbital']",0.5
15835,31618.0,Methylphenobarbital,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GRIA2', 'Methylphenobarbital']",0.5
15835,32313.0,Methylphenobarbital,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GRIA2', 'Methylphenobarbital']",0.5
15835,32977.0,Methylphenobarbital,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GRIA2', 'Methylphenobarbital']",0.5
15835,33632.0,Methylphenobarbital,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GABRA5', 'Methylphenobarbital']",0.5
15835,33675.0,Methylphenobarbital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Methylphenobarbital']",0.5
15835,35565.0,Methylphenobarbital,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Methylphenobarbital']",0.5
15835,35641.0,Methylphenobarbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'CHRNA7', 'Methylphenobarbital']",0.5
15835,35641.0,Methylphenobarbital,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Methylphenobarbital']",0.5
15835,35764.0,Methylphenobarbital,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Methylphenobarbital']",0.5
15835,36080.0,Methylphenobarbital,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRNA4', 'Methylphenobarbital']",0.5
15835,36266.0,Methylphenobarbital,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRA1', 'Methylphenobarbital']",0.5
15835,36693.0,Methylphenobarbital,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'GRIK2', 'Methylphenobarbital']",0.5
15835,36693.0,Methylphenobarbital,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Methylphenobarbital']",0.5
15835,37617.0,Methylphenobarbital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR1I2', 'Methylphenobarbital']",0.5
15835,37703.0,Methylphenobarbital,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Methylphenobarbital']",0.5
15835,83760.0,Methylphenobarbital,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Methylphenobarbital']",0.5
15835,83805.0,Methylphenobarbital,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRA1', 'Methylphenobarbital']",0.5
15836,29113.0,Telmisartan,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'PPARG', 'Telmisartan']",0.5
15836,29182.0,Telmisartan,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'PPARG', 'Telmisartan']",0.5
15836,29182.0,Telmisartan,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'ABCC2', 'Telmisartan']",0.5
15836,31033.0,Telmisartan,benign recurrent intrahepatic cholestasis,disease-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'ABCC2', 'Telmisartan']",0.5
15836,31033.0,Telmisartan,benign recurrent intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['benign recurrent intrahepatic cholestasis', 'Pruritus', 'ABCB11', 'Telmisartan']",0.5
15836,32629.0,Telmisartan,familial intrahepatic cholestasis,disease-protein-drug,contraindication,"['familial intrahepatic cholestasis', 'ABCC2', 'Telmisartan']",0.5
15836,33534.0,Telmisartan,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'AGTR1', 'Telmisartan']",0.5
15836,33575.0,Telmisartan,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'PPARG', 'Telmisartan']",0.5
15836,33575.0,Telmisartan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Telmisartan']",0.5
15836,33575.0,Telmisartan,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PPARG', 'Telmisartan']",0.5
15836,33577.0,Telmisartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Telmisartan']",0.5
15836,33577.0,Telmisartan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Telmisartan']",0.5
15836,33577.0,Telmisartan,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'PPARG', 'Telmisartan']",0.5
15836,33618.0,Telmisartan,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'CYP2C19', 'Telmisartan']",0.5
15836,33618.0,Telmisartan,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'PPARG', 'Telmisartan']",0.5
15836,33618.0,Telmisartan,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Air Pollutants', 'PPARG', 'Telmisartan']",0.5
15836,35565.0,Telmisartan,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Telmisartan']",0.5
15836,35764.0,Telmisartan,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Telmisartan']",0.5
15836,35764.0,Telmisartan,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PPARG', 'Telmisartan']",0.5
15836,35909.0,Telmisartan,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'PPARG', 'Telmisartan']",0.5
15836,35909.0,Telmisartan,cerebrovascular disorder,disease-exposure-gene-drug,indication,"['cerebrovascular disorder', 'Air Pollutants', 'PPARG', 'Telmisartan']",0.5
15836,36035.0,Telmisartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Telmisartan']",0.5
15836,36286.0,Telmisartan,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'PPARG', 'Telmisartan']",0.5
15836,38059.0,Telmisartan,cholestasis,disease-protein-drug,contraindication,"['cholestasis', 'ABCC2', 'Telmisartan']",0.5
15836,83790.0,Telmisartan,gout,disease-protein-drug,contraindication,"['gout', 'ABCG2', 'Telmisartan']",0.5
15836,83802.0,Telmisartan,obsolete hyperuricemia (disease),disease-protein-drug,contraindication,"['obsolete hyperuricemia (disease)', 'ABCG2', 'Telmisartan']",0.5
15836,83802.0,Telmisartan,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Telmisartan']",0.5
15837,27933.0,Methsuximide,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CYP2C19', 'Methsuximide']",0.5
15837,27933.0,Methsuximide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Particulate Matter', 'regulation of heart rate by cardiac conduction', 'CACNA1G', 'Methsuximide']",0.5
15837,29182.0,Methsuximide,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of heart rate by cardiac conduction', 'CACNA1G', 'Methsuximide']",0.5
15837,37703.0,Methsuximide,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CYP2C19', 'Methsuximide']",0.5
15837,83760.0,Methsuximide,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CYP2C19', 'Methsuximide']",0.5
15838,83802.0,Benzbromarone,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Benzbromarone']",0.5
15840,33618.0,Digoxin,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ATP1A1', 'Digoxin']",0.5
15840,35764.0,Digoxin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Digoxin']",0.5
15840,35958.0,Digoxin,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ATP1A1', 'Digoxin']",0.5
15840,36469.0,Digoxin,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP11A1', 'Digoxin']",0.5
15840,37180.0,Digoxin,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ATP1A1', 'Digoxin']",0.5
15840,37180.0,Digoxin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'ATP1A1', 'Digoxin']",0.5
15840,83823.0,Digoxin,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ATP1A1', 'Digoxin']",0.5
15840,83824.0,Digoxin,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ATP1A1', 'Digoxin']",0.5
15841,27476.0,Glutethimide,Gilbert syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['Gilbert syndrome', 'perfluorononanoic acid', 'cholesterol metabolic process', 'CYP11A1', 'Glutethimide']",0.5
15841,31732.0,Glutethimide,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'GABRA5', 'Glutethimide']",0.5
15841,32033.0,Glutethimide,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Glutethimide']",0.5
15841,35565.0,Glutethimide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP11A1', 'Glutethimide']",0.5
15841,36469.0,Glutethimide,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Hydrocarbons, Chlorinated', 'cholesterol metabolic process', 'CYP11A1', 'Glutethimide']",0.5
15847,28208.0,Empagliflozin,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Copper', 'lipid metabolic process', 'UGT2B7', 'Empagliflozin']",0.5
15847,33575.0,Empagliflozin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Copper', 'lipid metabolic process', 'UGT2B7', 'Empagliflozin']",0.5
15849,27933.0,Brimonidine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ADRA2A', 'Brimonidine']",0.5
15849,27933.0,Brimonidine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'positive regulation of cytokine production', 'ADRA2A', 'Brimonidine']",0.5
15849,33575.0,Brimonidine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Brimonidine']",0.5
15849,35897.0,Brimonidine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'platelet activation', 'ADRA2B', 'Brimonidine']",0.5
15849,35909.0,Brimonidine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'female pregnancy', 'ADRA2B', 'Brimonidine']",0.5
15849,37703.0,Brimonidine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ADRA2A', 'Brimonidine']",0.5
15849,83760.0,Brimonidine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ADRA2A', 'Brimonidine']",0.5
15850,35764.0,Aminocaproic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'lipid metabolic process', 'LPA', 'Aminocaproic acid']",0.5
15850,35766.0,Aminocaproic acid,thrombotic disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombotic disease', 'Particulate Matter', 'platelet degranulation', 'PLG', 'Aminocaproic acid']",0.5
15853,28745.0,Abacavir,dermatomyositis,disease-protein-drug,contraindication,"['dermatomyositis', 'HLA-B', 'Abacavir']",0.5
15853,33593.0,Abacavir,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'immune response', 'HLA-B', 'Abacavir']",0.5
15853,33695.0,Abacavir,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'immune response', 'HLA-B', 'Abacavir']",0.5
15853,35565.0,Abacavir,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'HLA-B', 'Abacavir']",0.5
15853,35764.0,Abacavir,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'HLA-B', 'Abacavir']",0.5
15853,36104.0,Abacavir,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'UGT1A1', 'Abacavir']",0.5
15853,36229.0,Abacavir,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'UGT1A1', 'Abacavir']",0.5
15853,36242.0,Abacavir,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'immune response', 'HLA-B', 'Abacavir']",0.5
15853,37805.0,Abacavir,HIV infectious disease,disease-protein-drug,indication,"['HIV infectious disease', 'HLA-B', 'Abacavir']",0.5
15855,31122.0,Minoxidil,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Proteinuria', 'REN', 'Minoxidil']",0.5
15855,33577.0,Minoxidil,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'REN', 'Minoxidil']",0.5
15855,33577.0,Minoxidil,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Minoxidil']",0.5
15855,33598.0,Minoxidil,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'regulation of blood pressure', 'REN', 'Minoxidil']",0.5
15855,33598.0,Minoxidil,stroke disorder,disease-exposure-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'PTGS1', 'Minoxidil']",0.5
15855,35669.0,Minoxidil,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'REN', 'Minoxidil']",0.5
15855,35669.0,Minoxidil,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Minoxidil']",0.5
15855,35761.0,Minoxidil,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Minoxidil']",0.5
15855,35761.0,Minoxidil,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Minoxidil']",0.5
15855,35764.0,Minoxidil,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'REN', 'Minoxidil']",0.5
15855,35764.0,Minoxidil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'REN', 'Minoxidil']",0.5
15855,35909.0,Minoxidil,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'regulation of blood pressure', 'REN', 'Minoxidil']",0.5
15855,35909.0,Minoxidil,cerebrovascular disorder,disease-exposure-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'PTGS1', 'Minoxidil']",0.5
15855,35958.0,Minoxidil,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'REN', 'Minoxidil']",0.5
15855,37180.0,Minoxidil,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'REN', 'Minoxidil']",0.5
15855,37180.0,Minoxidil,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'REN', 'Minoxidil']",0.5
15855,37180.0,Minoxidil,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Minoxidil']",0.5
15855,83823.0,Minoxidil,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'REN', 'Minoxidil']",0.5
15855,83824.0,Minoxidil,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'REN', 'Minoxidil']",0.5
15856,27933.0,Naltrexone,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'OPRM1', 'Naltrexone']",0.5
15856,27933.0,Naltrexone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'OPRK1', 'Naltrexone']",0.5
15856,28610.0,Naltrexone,Mowat-Wilson syndrome,disease-phenotype-protein-drug,contraindication,"['Mowat-Wilson syndrome', 'Seizure', 'OPRM1', 'Naltrexone']",0.5
15856,29014.0,Naltrexone,Hirschsprung disease-ganglioneuroblastoma syndrome,disease-phenotype-protein-drug,contraindication,"['Hirschsprung disease-ganglioneuroblastoma syndrome', 'Arrhythmia', 'OPRK1', 'Naltrexone']",0.5
15856,30035.0,Naltrexone,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Naltrexone']",0.5
15856,30813.0,Naltrexone,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Naltrexone']",0.5
15856,31072.0,Naltrexone,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Naltrexone']",0.5
15856,32384.0,Naltrexone,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Naltrexone']",0.5
15856,32708.0,Naltrexone,Mowat-Wilson syndrome due to a ZEB2 point mutation,disease-phenotype-protein-drug,contraindication,"['Mowat-Wilson syndrome due to a ZEB2 point mutation', 'Focal-onset seizure', 'OPRM1', 'Naltrexone']",0.5
15856,32714.0,Naltrexone,Mowat-Wilson syndrome due to monosomy 2q22,disease-phenotype-protein-drug,contraindication,"['Mowat-Wilson syndrome due to monosomy 2q22', 'Focal-onset seizure', 'OPRM1', 'Naltrexone']",0.5
15856,32719.0,Naltrexone,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Naltrexone']",0.5
15856,32928.0,Naltrexone,acute liver failure,disease-phenotype-protein-drug,contraindication,"['acute liver failure', 'Nausea', 'OPRM1', 'Naltrexone']",0.5
15856,33206.0,Naltrexone,eosinophilic pneumonia,disease-phenotype-protein-drug,contraindication,"['eosinophilic pneumonia', 'Respiratory insufficiency', 'OPRM1', 'Naltrexone']",0.5
15856,33675.0,Naltrexone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Dust', 'immune response', 'OPRD1', 'Naltrexone']",0.5
15856,35565.0,Naltrexone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Naltrexone']",0.5
15856,35641.0,Naltrexone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Naltrexone']",0.5
15856,36080.0,Naltrexone,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Naltrexone']",0.5
15856,36693.0,Naltrexone,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Naltrexone']",0.5
15856,37617.0,Naltrexone,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Naltrexone']",0.5
15856,37703.0,Naltrexone,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'OPRM1', 'Naltrexone']",0.5
15856,37753.0,Naltrexone,opiate dependence,disease-protein-drug,contraindication,"['opiate dependence', 'OPRM1', 'Naltrexone']",0.5
15856,83760.0,Naltrexone,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'OPRM1', 'Naltrexone']",0.5
15856,83910.0,Naltrexone,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Naltrexone']",0.5
15856,84242.0,Naltrexone,morphine dependence,disease-protein-drug,contraindication,"['morphine dependence', 'OPRM1', 'Naltrexone']",0.5
15858,30905.0,Migalastat,chylomicron retention disease,disease-protein-drug,indication,"['chylomicron retention disease', 'GLA', 'Migalastat']",0.5
15858,31384.0,Migalastat,Fabry disease,disease-protein-drug,indication,"['Fabry disease', 'GLA', 'Migalastat']",0.5
15858,35475.0,Migalastat,lysosomal lipid storage disorder,disease-protein-drug,indication,"['lysosomal lipid storage disorder', 'GLA', 'Migalastat']",0.5
15864,37743.0,Pibrentasvir,hepatitis C virus infection,disease-protein-drug,indication,"['hepatitis C virus infection', 'CYP3A4', 'Pibrentasvir']",0.5
15867,33482.0,Mebendazole,cystic echinococcosis,disease-phenotype-protein-drug,off-label use,"['cystic echinococcosis', 'Hepatomegaly', 'CYP1A1', 'Mebendazole']",0.5
15867,35565.0,Mebendazole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol metabolic process', 'CYP3A4', 'Mebendazole']",0.5
15867,35565.0,Mebendazole,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Agent Orange', 'CYP1A1', 'Mebendazole']",0.5
15868,29113.0,Isoprenaline,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'PIK3R1', 'Isoprenaline']",0.5
15868,29175.0,Isoprenaline,thyrotoxicosis,disease-protein-drug,contraindication,"['thyrotoxicosis', 'SOD1', 'Isoprenaline']",0.5
15868,29175.0,Isoprenaline,thyrotoxicosis,disease-phenotype-protein-drug,contraindication,"['thyrotoxicosis', 'Weight loss', 'SOD1', 'Isoprenaline']",0.5
15868,33575.0,Isoprenaline,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'SOD1', 'Isoprenaline']",0.5
15868,33575.0,Isoprenaline,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'PIK3R1', 'Isoprenaline']",0.5
15868,33575.0,Isoprenaline,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Agent Orange', 'CYP1A1', 'Isoprenaline']",0.5
15868,33575.0,Isoprenaline,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Tobacco Smoke Pollution', 'superoxide dismutase activity', 'SOD1', 'Isoprenaline']",0.5
15868,33577.0,Isoprenaline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'SOD1', 'Isoprenaline']",0.5
15868,33577.0,Isoprenaline,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Agent Orange', 'CYP1A1', 'Isoprenaline']",0.5
15868,35958.0,Isoprenaline,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'SOD1', 'Isoprenaline']",0.5
15868,36034.0,Isoprenaline,hyperthyroidism,disease-protein-drug,contraindication,"['hyperthyroidism', 'SOD1', 'Isoprenaline']",0.5
15868,36034.0,Isoprenaline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'MAPK1', 'Isoprenaline']",0.5
15868,36187.0,Isoprenaline,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Isoprenaline']",0.5
15868,36187.0,Isoprenaline,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'PIK3R1', 'Isoprenaline']",0.5
15868,36187.0,Isoprenaline,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'SOD1', 'Isoprenaline']",0.5
15868,36187.0,Isoprenaline,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Tobacco Smoke Pollution', 'superoxide dismutase activity', 'SOD1', 'Isoprenaline']",0.5
15868,37180.0,Isoprenaline,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'SOD1', 'Isoprenaline']",0.5
15868,37180.0,Isoprenaline,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'PIK3R1', 'Isoprenaline']",0.5
15868,37180.0,Isoprenaline,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'SOD1', 'Isoprenaline']",0.5
15868,37180.0,Isoprenaline,myocardial infarction (disease),disease-exposure-molfunc-gene-drug,contraindication,"['myocardial infarction (disease)', 'Pesticides', 'superoxide dismutase activity', 'SOD1', 'Isoprenaline']",0.5
15868,38784.0,Isoprenaline,Graves disease,disease-protein-drug,contraindication,"['Graves disease', 'SOD1', 'Isoprenaline']",0.5
15868,83823.0,Isoprenaline,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'SOD1', 'Isoprenaline']",0.5
15868,83824.0,Isoprenaline,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'SOD1', 'Isoprenaline']",0.5
15870,33598.0,Amifostine,stroke disorder,disease-exposure-molfunc-gene-drug,contraindication,"['stroke disorder', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Amifostine']",0.5
15870,36187.0,Amifostine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'developmental process involved in reproduction', 'ALPL', 'Amifostine']",0.5
15870,36187.0,Amifostine,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Amifostine']",0.5
15870,37786.0,Amifostine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Lead', 'developmental process involved in reproduction', 'ALPL', 'Amifostine']",0.5
15870,37786.0,Amifostine,myocardial ischemia,disease-exposure-molfunc-gene-drug,contraindication,"['myocardial ischemia', 'Arsenic', 'alkaline phosphatase activity', 'ALPG', 'Amifostine']",0.5
15874,33512.0,Ritodrine,preeclampsia,disease-exposure-bioprocess-gene-drug,contraindication,"['preeclampsia', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Ritodrine']",0.5
15874,33577.0,Ritodrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'bone resorption', 'ADRB2', 'Ritodrine']",0.5
15874,84167.0,Ritodrine,gestational diabetes,disease-exposure-bioprocess-gene-drug,contraindication,"['gestational diabetes', 'Cadmium', 'bone resorption', 'ADRB2', 'Ritodrine']",0.5
15874,84282.0,Ritodrine,chorioamnionitis,disease-exposure-bioprocess-gene-drug,contraindication,"['chorioamnionitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Ritodrine']",0.5
15876,28158.0,Mesalazine,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'MPO', 'Mesalazine']",0.5
15876,28158.0,Mesalazine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'PPARG', 'Mesalazine']",0.5
15876,33632.0,Mesalazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'PPARG', 'Mesalazine']",0.5
15876,33632.0,Mesalazine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Mesalazine']",0.5
15876,35565.0,Mesalazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'CHUK', 'Mesalazine']",0.5
15876,35764.0,Mesalazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ALOX5', 'Mesalazine']",0.5
15876,35764.0,Mesalazine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Mesalazine']",0.5
15876,36274.0,Mesalazine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'regulation of blood pressure', 'PTGS1', 'Mesalazine']",0.5
15876,37784.0,Mesalazine,Crohn disease,disease-protein-drug,off-label use,"['Crohn disease', 'PPARG', 'Mesalazine']",0.5
15876,37785.0,Mesalazine,ulcerative colitis (disease),disease-protein-drug,indication,"['ulcerative colitis (disease)', 'MPO', 'Mesalazine']",0.5
15876,37785.0,Mesalazine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,indication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'PPARG', 'Mesalazine']",0.5
15876,83770.0,Mesalazine,Crohn's colitis,disease-protein-drug,off-label use,"[""Crohn's colitis"", 'PPARG', 'Mesalazine']",0.5
15877,33091.0,Cyproheptadine,serotonin syndrome,disease-phenotype-protein-drug,off-label use,"['serotonin syndrome', 'Fever', 'HTR2A', 'Cyproheptadine']",0.5
15877,33577.0,Cyproheptadine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Cyproheptadine']",0.5
15877,36034.0,Cyproheptadine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Cyproheptadine']",0.5
15877,37888.0,Cyproheptadine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Cyproheptadine']",0.5
15877,37888.0,Cyproheptadine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cognition', 'CHRM1', 'Cyproheptadine']",0.5
15877,83791.0,Cyproheptadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Cyproheptadine']",0.5
15878,28208.0,Mitiglinide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'ABCC8', 'Mitiglinide']",0.5
15878,28208.0,Mitiglinide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose homeostasis', 'PPARG', 'Mitiglinide']",0.5
15878,28208.0,Mitiglinide,type 2 diabetes mellitus,disease-exposure-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'PPARG', 'Mitiglinide']",0.5
15878,28208.0,Mitiglinide,type 2 diabetes mellitus,disease-phenotype-protein-drug,indication,"['type 2 diabetes mellitus', 'Insulin resistance', 'PPARG', 'Mitiglinide']",0.5
15878,33575.0,Mitiglinide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'ABCC8', 'Mitiglinide']",0.5
15878,33575.0,Mitiglinide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'PPARG', 'Mitiglinide']",0.5
15878,33575.0,Mitiglinide,diabetes mellitus (disease),disease-exposure-gene-drug,indication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PPARG', 'Mitiglinide']",0.5
15879,30035.0,Nalmefene,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'OPRM1', 'Nalmefene']",0.5
15882,27366.0,Acemetacin,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,indication,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Acemetacin']",0.5
15885,33575.0,Inositol nicotinate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'regulation of cholesterol metabolic process', 'DGAT2', 'Inositol nicotinate']",0.5
15885,33598.0,Inositol nicotinate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'triglyceride biosynthetic process', 'DGAT2', 'Inositol nicotinate']",0.5
15885,35565.0,Inositol nicotinate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'DGAT2', 'Inositol nicotinate']",0.5
15885,35909.0,Inositol nicotinate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol homeostasis', 'DGAT2', 'Inositol nicotinate']",0.5
15885,36187.0,Inositol nicotinate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'regulation of cholesterol metabolic process', 'DGAT2', 'Inositol nicotinate']",0.5
15885,37180.0,Inositol nicotinate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'regulation of cholesterol metabolic process', 'DGAT2', 'Inositol nicotinate']",0.5
15887,28158.0,Certolizumab pegol,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'TNF', 'Certolizumab pegol']",0.5
15887,28158.0,Certolizumab pegol,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'TNF', 'Certolizumab pegol']",0.5
15887,28158.0,Certolizumab pegol,inflammatory bowel disease,disease-exposure-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'TNF', 'Certolizumab pegol']",0.5
15887,29078.0,Certolizumab pegol,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'TNF', 'Certolizumab pegol']",0.5
15887,29078.0,Certolizumab pegol,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cognition', 'TNF', 'Certolizumab pegol']",0.5
15887,29078.0,Certolizumab pegol,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'TNF', 'Certolizumab pegol']",0.5
15887,29078.0,Certolizumab pegol,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'TNF', 'Certolizumab pegol']",0.5
15887,37784.0,Certolizumab pegol,Crohn disease,disease-protein-drug,indication,"['Crohn disease', 'TNF', 'Certolizumab pegol']",0.5
15887,39524.0,Certolizumab pegol,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'TNF', 'Certolizumab pegol']",0.5
15887,83770.0,Certolizumab pegol,Crohn's colitis,disease-protein-drug,indication,"[""Crohn's colitis"", 'TNF', 'Certolizumab pegol']",0.5
15889,27326.0,Tenofovir disoproxil,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'cellular response to oxidative stress', 'NME2', 'Tenofovir disoproxil']",0.5
15889,27655.0,Tenofovir disoproxil,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'ABCC2', 'Tenofovir disoproxil']",0.5
15889,27933.0,Tenofovir disoproxil,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Tenofovir disoproxil']",0.5
15889,27933.0,Tenofovir disoproxil,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cellular response to oxidative stress', 'NME2', 'Tenofovir disoproxil']",0.5
15889,33593.0,Tenofovir disoproxil,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'cellular response to oxidative stress', 'NME2', 'Tenofovir disoproxil']",0.5
15889,33695.0,Tenofovir disoproxil,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Cadmium', 'cellular response to oxidative stress', 'NME2', 'Tenofovir disoproxil']",0.5
15889,35565.0,Tenofovir disoproxil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'female pregnancy', 'ABCC2', 'Tenofovir disoproxil']",0.5
15889,35641.0,Tenofovir disoproxil,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Tenofovir disoproxil']",0.5
15889,35764.0,Tenofovir disoproxil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cellular response to oxidative stress', 'NME2', 'Tenofovir disoproxil']",0.5
15889,36242.0,Tenofovir disoproxil,fatty liver disease,disease-protein-drug,contraindication,"['fatty liver disease', 'ABCC2', 'Tenofovir disoproxil']",0.5
15889,36242.0,Tenofovir disoproxil,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Polychlorinated Biphenyls', 'female pregnancy', 'ABCC2', 'Tenofovir disoproxil']",0.5
15889,37703.0,Tenofovir disoproxil,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Tenofovir disoproxil']",0.5
15889,83760.0,Tenofovir disoproxil,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Tenofovir disoproxil']",0.5
15889,84131.0,Tenofovir disoproxil,non-alcoholic steatohepatitis,disease-protein-drug,contraindication,"['non-alcoholic steatohepatitis', 'ABCC2', 'Tenofovir disoproxil']",0.5
15892,31502.0,Ferric maltol,Wilson disease,disease-protein-drug,contraindication,"['Wilson disease', 'SLC11A2', 'Ferric maltol']",0.5
15892,31502.0,Ferric maltol,Wilson disease,disease-phenotype-protein-drug,contraindication,"['Wilson disease', 'Thrombocytopenia', 'ITGB3', 'Ferric maltol']",0.5
15892,33589.0,Ferric maltol,hypochromic anemia,disease-protein-drug,indication,"['hypochromic anemia', 'SLC11A2', 'Ferric maltol']",0.5
15892,33622.0,Ferric maltol,microcytic anemia,disease-protein-drug,indication,"['microcytic anemia', 'SLC11A2', 'Ferric maltol']",0.5
15892,36172.0,Ferric maltol,hemosiderosis,disease-protein-drug,contraindication,"['hemosiderosis', 'SLC11A2', 'Ferric maltol']",0.5
15892,36214.0,Ferric maltol,iron metabolism disease,disease-protein-drug,contraindication,"['iron metabolism disease', 'SLC11A2', 'Ferric maltol']",0.5
15892,36315.0,Ferric maltol,deficiency anemia,disease-protein-drug,indication,"['deficiency anemia', 'SLC11A2', 'Ferric maltol']",0.5
15892,38641.0,Ferric maltol,hereditary hemochromatosis,disease-protein-drug,contraindication,"['hereditary hemochromatosis', 'SLC11A2', 'Ferric maltol']",0.5
15892,84087.0,Ferric maltol,iron deficiency anemia,disease-protein-drug,indication,"['iron deficiency anemia', 'SLC11A2', 'Ferric maltol']",0.5
15893,29375.0,Bleomycin,squamous cell carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['squamous cell carcinoma', 'Arsenic', 'DNA repair', 'LIG1', 'Bleomycin']",0.5
15895,37604.0,Mirodenafil,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,indication,"['erectile dysfunction (disease)', 'Arsenic', 'cholesterol metabolic process', 'CYP3A4', 'Mirodenafil']",0.5
15902,27581.0,Vonicog Alfa,von Willebrand disease,disease-phenotype-protein-drug,indication,"['von Willebrand disease', 'Abnormal bleeding', 'COL1A1', 'Vonicog Alfa']",0.5
15903,27581.0,Von Willebrand Factor Human,von Willebrand disease,disease-phenotype-protein-drug,indication,"['von Willebrand disease', 'Abnormal bleeding', 'COL1A1', 'Von Willebrand Factor Human']",0.5
15907,32967.0,Histidine,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'HDC', 'Histidine']",0.5
15907,35669.0,Histidine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'brain development', 'SLC38A3', 'Histidine']",0.5
15907,35761.0,Histidine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Lead', 'brain development', 'SLC38A3', 'Histidine']",0.5
15907,35764.0,Histidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'brain development', 'SLC38A3', 'Histidine']",0.5
15907,36040.0,Histidine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'perfluorooctanoic acid', 'female pregnancy', 'SLC38A3', 'Histidine']",0.5
15907,83923.0,Histidine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'brain development', 'SLC38A3', 'Histidine']",0.5
15908,31918.0,Glutamic acid,phenylketonuria,disease-phenotype-protein-drug,contraindication,"['phenylketonuria', 'Intrauterine growth retardation', 'GLUD1', 'Glutamic acid']",0.5
15908,32967.0,Glutamic acid,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Decreased liver function', 'GPT', 'Glutamic acid']",0.5
15908,35669.0,Glutamic acid,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'gene expression', 'SLC1A1', 'Glutamic acid']",0.5
15908,35669.0,Glutamic acid,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Arsenic', 'SLC7A11', 'Glutamic acid']",0.5
15908,35669.0,Glutamic acid,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'transaminase activity', 'AADAT', 'Glutamic acid']",0.5
15908,35761.0,Glutamic acid,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'gene expression', 'SLC1A1', 'Glutamic acid']",0.5
15908,35761.0,Glutamic acid,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'SLC7A11', 'Glutamic acid']",0.5
15908,35761.0,Glutamic acid,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'transaminase activity', 'AADAT', 'Glutamic acid']",0.5
15908,35764.0,Glutamic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'gene expression', 'SLC1A1', 'Glutamic acid']",0.5
15908,35764.0,Glutamic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'SLC7A11', 'Glutamic acid']",0.5
15908,35764.0,Glutamic acid,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'transaminase activity', 'AADAT', 'Glutamic acid']",0.5
15908,36040.0,Glutamic acid,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'gene expression', 'SLC1A1', 'Glutamic acid']",0.5
15908,36040.0,Glutamic acid,chronic kidney disease,disease-exposure-gene-drug,contraindication,"['chronic kidney disease', 'perfluorooctanoic acid', 'GPT', 'Glutamic acid']",0.5
15908,36040.0,Glutamic acid,chronic kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['chronic kidney disease', 'perfluorooctanoic acid', 'L-alanine:2-oxoglutarate aminotransferase activity', 'GPT2', 'Glutamic acid']",0.5
15908,83923.0,Glutamic acid,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'gene expression', 'SLC1A1', 'Glutamic acid']",0.5
15908,83923.0,Glutamic acid,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Cadmium', 'GPT', 'Glutamic acid']",0.5
15912,28921.0,Arginine,sickle cell anemia,disease-phenotype-protein-drug,contraindication,"['sickle cell anemia', 'Hepatomegaly', 'NOS3', 'Arginine']",0.5
15912,31918.0,Arginine,phenylketonuria,disease-phenotype-protein-drug,contraindication,"['phenylketonuria', 'Intrauterine growth retardation', 'NOS3', 'Arginine']",0.5
15912,32967.0,Arginine,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hepatomegaly', 'NOS3', 'Arginine']",0.5
15912,35669.0,Arginine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A4', 'Arginine']",0.5
15912,35669.0,Arginine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'NOS3', 'Arginine']",0.5
15912,35669.0,Arginine,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'NOS2', 'Arginine']",0.5
15912,35761.0,Arginine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'NOS2', 'Arginine']",0.5
15912,35761.0,Arginine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'NOS2', 'Arginine']",0.5
15912,35764.0,Arginine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'NOS3', 'Arginine']",0.5
15912,36040.0,Arginine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'regulation of blood pressure', 'NOS3', 'Arginine']",0.5
15912,83923.0,Arginine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'NOS2', 'Arginine']",0.5
15912,83923.0,Arginine,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'NOS2', 'Arginine']",0.5
15913,29186.0,Citrulline,carbamoyl phosphate synthetase I deficiency disease,disease-phenotype-protein-drug,off-label use,"['carbamoyl phosphate synthetase I deficiency disease', 'Hyperammonemia', 'OTC', 'Citrulline']",0.5
15913,29832.0,Citrulline,hyperargininemia,disease-phenotype-protein-drug,off-label use,"['hyperargininemia', 'Hepatomegaly', 'NOS3', 'Citrulline']",0.5
15913,29923.0,Citrulline,lysinuric protein intolerance,disease-phenotype-protein-drug,off-label use,"['lysinuric protein intolerance', 'Hepatomegaly', 'NOS3', 'Citrulline']",0.5
15914,27700.0,Minocycline,sclerosing cholangitis,disease-protein-drug,off-label use,"['sclerosing cholangitis', 'NOS2', 'Minocycline']",0.5
15914,27700.0,Minocycline,sclerosing cholangitis,disease-exposure-bioprocess-gene-drug,off-label use,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'immune response', 'IL1B', 'Minocycline']",0.5
15914,27700.0,Minocycline,sclerosing cholangitis,disease-exposure-gene-drug,off-label use,"['sclerosing cholangitis', 'Tobacco Smoke Pollution', 'IL1B', 'Minocycline']",0.5
15914,27700.0,Minocycline,sclerosing cholangitis,disease-phenotype-protein-drug,off-label use,"['sclerosing cholangitis', 'Hepatomegaly', 'MAPK14', 'Minocycline']",0.5
15914,29078.0,Minocycline,rheumatoid arthritis,disease-protein-drug,off-label use,"['rheumatoid arthritis', 'ALOX5', 'Minocycline']",0.5
15914,29078.0,Minocycline,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,off-label use,"['rheumatoid arthritis', 'Pesticides', 'learning or memory', 'CASP3', 'Minocycline']",0.5
15914,29078.0,Minocycline,rheumatoid arthritis,disease-exposure-gene-drug,off-label use,"['rheumatoid arthritis', 'Pesticides', 'IL1B', 'Minocycline']",0.5
15914,29078.0,Minocycline,rheumatoid arthritis,disease-phenotype-protein-drug,off-label use,"['rheumatoid arthritis', 'Fever', 'IL1B', 'Minocycline']",0.5
15914,31072.0,Minocycline,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Allergy', 'CASP1', 'Minocycline']",0.5
15914,32626.0,Minocycline,cholera,disease-phenotype-protein-drug,indication,"['cholera', 'Fever', 'IL1B', 'Minocycline']",0.5
15914,32949.0,Minocycline,relapsing fever,disease-phenotype-protein-drug,indication,"['relapsing fever', 'Leukocytosis', 'IL1B', 'Minocycline']",0.5
15914,33193.0,Minocycline,plague,disease-phenotype-protein-drug,indication,"['plague', 'Hepatomegaly', 'MAPK14', 'Minocycline']",0.5
15914,33297.0,Minocycline,listeriosis,disease-phenotype-protein-drug,indication,"['listeriosis', 'Fever', 'IL1B', 'Minocycline']",0.5
15914,33314.0,Minocycline,leptospirosis,disease-phenotype-protein-drug,indication,"['leptospirosis', 'Hepatomegaly', 'MAPK14', 'Minocycline']",0.5
15914,33332.0,Minocycline,tularemia,disease-phenotype-protein-drug,indication,"['tularemia', 'Leukocytosis', 'IL1B', 'Minocycline']",0.5
15914,33334.0,Minocycline,nocardiosis,disease-phenotype-protein-drug,off-label use,"['nocardiosis', 'Fever', 'IL1B', 'Minocycline']",0.5
15914,35552.0,Minocycline,pneumonia,disease-protein-drug,indication,"['pneumonia', 'CASP1', 'Minocycline']",0.5
15914,35552.0,Minocycline,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'cellular response to oxidative stress', 'CYCS', 'Minocycline']",0.5
15914,35552.0,Minocycline,pneumonia,disease-exposure-gene-drug,indication,"['pneumonia', 'Arsenic', 'MMP9', 'Minocycline']",0.5
15914,35565.0,Minocycline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'IL1B', 'Minocycline']",0.5
15914,35565.0,Minocycline,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Manganese', 'NOS2', 'Minocycline']",0.5
15914,35764.0,Minocycline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ALOX5', 'Minocycline']",0.5
15914,35764.0,Minocycline,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'MMP9', 'Minocycline']",0.5
15914,35985.0,Minocycline,periodontitis,disease-protein-drug,indication,"['periodontitis', 'MMP9', 'Minocycline']",0.5
15914,37830.0,Minocycline,bronchitis,disease-protein-drug,indication,"['bronchitis', 'VEGFA', 'Minocycline']",0.5
15914,37830.0,Minocycline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'positive regulation of interleukin-6 production', 'MAPK13', 'Minocycline']",0.5
15914,37830.0,Minocycline,bronchitis,disease-exposure-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'CASP3', 'Minocycline']",0.5
15956,27933.0,Dyphylline,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ADORA2A', 'Dyphylline']",0.5
15956,27933.0,Dyphylline,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'regulation of heart rate', 'PDE4D', 'Dyphylline']",0.5
15956,29175.0,Dyphylline,thyrotoxicosis,disease-phenotype-protein-drug,contraindication,"['thyrotoxicosis', 'Weight loss', 'ADORA2A', 'Dyphylline']",0.5
15956,30035.0,Dyphylline,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'PDE4B', 'Dyphylline']",0.5
15956,31618.0,Dyphylline,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'ADORA2A', 'Dyphylline']",0.5
15956,32313.0,Dyphylline,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'ADORA2A', 'Dyphylline']",0.5
15956,32977.0,Dyphylline,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'ADORA2A', 'Dyphylline']",0.5
15956,33575.0,Dyphylline,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'triglyceride homeostasis', 'ADORA1', 'Dyphylline']",0.5
15956,33577.0,Dyphylline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'PDE4D', 'Dyphylline']",0.5
15956,33632.0,Dyphylline,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,33675.0,Dyphylline,asthma,disease-protein-drug,indication,"['asthma', 'PDE4D', 'Dyphylline']",0.5
15956,33675.0,Dyphylline,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,35565.0,Dyphylline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,35669.0,Dyphylline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,35761.0,Dyphylline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'triglyceride homeostasis', 'ADORA1', 'Dyphylline']",0.5
15956,35764.0,Dyphylline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'PDE4D', 'Dyphylline']",0.5
15956,35897.0,Dyphylline,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'apoptotic process', 'ADORA2A', 'Dyphylline']",0.5
15956,35915.0,Dyphylline,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,35958.0,Dyphylline,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ADORA1', 'Dyphylline']",0.5
15956,36034.0,Dyphylline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,36187.0,Dyphylline,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PDE4B', 'Dyphylline']",0.5
15956,36187.0,Dyphylline,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,37180.0,Dyphylline,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ADORA1', 'Dyphylline']",0.5
15956,37180.0,Dyphylline,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,37703.0,Dyphylline,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'PDE4A', 'Dyphylline']",0.5
15956,37786.0,Dyphylline,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'PDE4B', 'Dyphylline']",0.5
15956,37786.0,Dyphylline,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,37830.0,Dyphylline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,39773.0,Dyphylline,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'PDE4D', 'Dyphylline']",0.5
15956,83760.0,Dyphylline,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'PDE4A', 'Dyphylline']",0.5
15956,83778.0,Dyphylline,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,83779.0,Dyphylline,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cognition', 'ADORA1', 'Dyphylline']",0.5
15956,83781.0,Dyphylline,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'PDE4D', 'Dyphylline']",0.5
15956,83823.0,Dyphylline,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ADORA1', 'Dyphylline']",0.5
15956,83824.0,Dyphylline,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ADORA1', 'Dyphylline']",0.5
15970,30039.0,Radotinib,"chronic myelogenous leukemia, BCR-ABL1 positive",disease-protein-drug,indication,"['chronic myelogenous leukemia, BCR-ABL1 positive', 'ABL1', 'Radotinib']",0.5
15975,27361.0,Coagulation Factor IX (Recombinant),hemophilia,disease-protein-drug,indication,"['hemophilia', 'F8', 'Coagulation Factor IX (Recombinant)']",0.5
15975,27361.0,Coagulation Factor IX (Recombinant),hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Thromboembolism', 'F7', 'Coagulation Factor IX (Recombinant)']",0.5
15975,32354.0,Coagulation Factor IX (Recombinant),symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F8', 'Coagulation Factor IX (Recombinant)']",0.5
15979,27361.0,Coagulation Factor IX Human,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F8', 'Coagulation Factor IX Human']",0.5
15979,27361.0,Coagulation Factor IX Human,hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Thromboembolism', 'F7', 'Coagulation Factor IX Human']",0.5
15979,32354.0,Coagulation Factor IX Human,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F8', 'Coagulation Factor IX Human']",0.5
15982,27286.0,Sulfasalazine,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'ABCC2', 'Sulfasalazine']",0.5
15982,27292.0,Sulfasalazine,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Arrhythmia', 'PTGS2', 'Sulfasalazine']",0.5
15982,28158.0,Sulfasalazine,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'PPARG', 'Sulfasalazine']",0.5
15982,28158.0,Sulfasalazine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'PPARG', 'Sulfasalazine']",0.5
15982,29078.0,Sulfasalazine,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'ALOX5', 'Sulfasalazine']",0.5
15982,29078.0,Sulfasalazine,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'visual learning', 'SLC7A11', 'Sulfasalazine']",0.5
15982,29078.0,Sulfasalazine,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Sulfasalazine']",0.5
15982,29078.0,Sulfasalazine,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Sulfasalazine']",0.5
15982,32325.0,Sulfasalazine,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Fever', 'PTGS2', 'Sulfasalazine']",0.5
15982,32977.0,Sulfasalazine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Fever', 'PTGS2', 'Sulfasalazine']",0.5
15982,33027.0,Sulfasalazine,scleroderma (disease),disease-phenotype-protein-drug,off-label use,"['scleroderma (disease)', 'Seizure', 'ABCC2', 'Sulfasalazine']",0.5
15982,33225.0,Sulfasalazine,systemic sclerosis,disease-phenotype-protein-drug,off-label use,"['systemic sclerosis', 'Albuminuria', 'PTGS2', 'Sulfasalazine']",0.5
15982,33228.0,Sulfasalazine,localized scleroderma,disease-phenotype-protein-drug,off-label use,"['localized scleroderma', 'Arrhythmia', 'PTGS2', 'Sulfasalazine']",0.5
15982,33675.0,Sulfasalazine,asthma,disease-protein-drug,contraindication,"['asthma', 'ALOX5', 'Sulfasalazine']",0.5
15982,33675.0,Sulfasalazine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'PPARG', 'Sulfasalazine']",0.5
15982,33675.0,Sulfasalazine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'PTGS1', 'Sulfasalazine']",0.5
15982,35565.0,Sulfasalazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'CHUK', 'Sulfasalazine']",0.5
15982,35764.0,Sulfasalazine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ALOX5', 'Sulfasalazine']",0.5
15982,35764.0,Sulfasalazine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'SLC7A11', 'Sulfasalazine']",0.5
15982,37784.0,Sulfasalazine,Crohn disease,disease-protein-drug,off-label use,"['Crohn disease', 'PPARG', 'Sulfasalazine']",0.5
15982,37785.0,Sulfasalazine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,indication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'PPARG', 'Sulfasalazine']",0.5
15982,39773.0,Sulfasalazine,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'ALOX5', 'Sulfasalazine']",0.5
15982,83770.0,Sulfasalazine,Crohn's colitis,disease-protein-drug,off-label use,"[""Crohn's colitis"", 'PPARG', 'Sulfasalazine']",0.5
15982,83781.0,Sulfasalazine,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'ALOX5', 'Sulfasalazine']",0.5
15984,27366.0,Oxaprozin,"spondyloarthropathy, susceptibility to",disease-phenotype-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'Arrhythmia', 'PTGS2', 'Oxaprozin']",0.5
15984,29078.0,Oxaprozin,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Oxaprozin']",0.5
15984,29078.0,Oxaprozin,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Oxaprozin']",0.5
15984,29078.0,Oxaprozin,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Oxaprozin']",0.5
15984,29078.0,Oxaprozin,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Oxaprozin']",0.5
15984,33577.0,Oxaprozin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Oxaprozin']",0.5
15984,33577.0,Oxaprozin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Oxaprozin']",0.5
15984,35669.0,Oxaprozin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Oxaprozin']",0.5
15984,35669.0,Oxaprozin,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Oxaprozin']",0.5
15984,35761.0,Oxaprozin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Oxaprozin']",0.5
15984,35761.0,Oxaprozin,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Oxaprozin']",0.5
15984,35764.0,Oxaprozin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Oxaprozin']",0.5
15984,35764.0,Oxaprozin,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Oxaprozin']",0.5
15984,37180.0,Oxaprozin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Oxaprozin']",0.5
15984,37180.0,Oxaprozin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'PTGS1', 'Oxaprozin']",0.5
15985,28158.0,Balsalazide,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'PPARG', 'Balsalazide']",0.5
15985,28158.0,Balsalazide,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'lipid metabolic process', 'PPARG', 'Balsalazide']",0.5
15985,35764.0,Balsalazide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ALOX5', 'Balsalazide']",0.5
15985,35764.0,Balsalazide,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Balsalazide']",0.5
15985,36274.0,Balsalazide,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'regulation of blood pressure', 'PTGS1', 'Balsalazide']",0.5
15985,37785.0,Balsalazide,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,indication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'PPARG', 'Balsalazide']",0.5
15986,27361.0,Salsalate,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'PTGS2', 'Salsalate']",0.5
15986,28374.0,Salsalate,gastroesophageal reflux disease,disease-protein-drug,contraindication,"['gastroesophageal reflux disease', 'PTGS2', 'Salsalate']",0.5
15986,33440.0,Salsalate,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Fever', 'PTGS2', 'Salsalate']",0.5
15986,33575.0,Salsalate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Salsalate']",0.5
15986,33575.0,Salsalate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Salsalate']",0.5
15986,33632.0,Salsalate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'PTGS1', 'Salsalate']",0.5
15986,33632.0,Salsalate,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Salsalate']",0.5
15986,33714.0,Salsalate,esophagitis (disease),disease-protein-drug,contraindication,"['esophagitis (disease)', 'PTGS2', 'Salsalate']",0.5
15986,35565.0,Salsalate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Salsalate']",0.5
15986,35669.0,Salsalate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Salsalate']",0.5
15986,35669.0,Salsalate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Salsalate']",0.5
15986,35761.0,Salsalate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Salsalate']",0.5
15986,35761.0,Salsalate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Salsalate']",0.5
15986,35764.0,Salsalate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Salsalate']",0.5
15986,35764.0,Salsalate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Salsalate']",0.5
15986,36034.0,Salsalate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Salsalate']",0.5
15986,83878.0,Salsalate,peptic esophagitis,disease-protein-drug,contraindication,"['peptic esophagitis', 'PTGS2', 'Salsalate']",0.5
15987,27361.0,Choline magnesium trisalicylate,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,28374.0,Choline magnesium trisalicylate,gastroesophageal reflux disease,disease-protein-drug,contraindication,"['gastroesophageal reflux disease', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,29078.0,Choline magnesium trisalicylate,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,29078.0,Choline magnesium trisalicylate,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,29078.0,Choline magnesium trisalicylate,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,29078.0,Choline magnesium trisalicylate,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,33440.0,Choline magnesium trisalicylate,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Fever', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,33632.0,Choline magnesium trisalicylate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,33632.0,Choline magnesium trisalicylate,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,33714.0,Choline magnesium trisalicylate,esophagitis (disease),disease-protein-drug,contraindication,"['esophagitis (disease)', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,35565.0,Choline magnesium trisalicylate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,35669.0,Choline magnesium trisalicylate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,35669.0,Choline magnesium trisalicylate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,35761.0,Choline magnesium trisalicylate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,35761.0,Choline magnesium trisalicylate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,35764.0,Choline magnesium trisalicylate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,35764.0,Choline magnesium trisalicylate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,36034.0,Choline magnesium trisalicylate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,36040.0,Choline magnesium trisalicylate,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,36040.0,Choline magnesium trisalicylate,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,83878.0,Choline magnesium trisalicylate,peptic esophagitis,disease-protein-drug,contraindication,"['peptic esophagitis', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,83923.0,Choline magnesium trisalicylate,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15987,83923.0,Choline magnesium trisalicylate,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PTGS2', 'Choline magnesium trisalicylate']",0.5
15987,83924.0,Choline magnesium trisalicylate,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'PTGS1', 'Choline magnesium trisalicylate']",0.5
15989,29078.0,Tiaprofenic acid,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS1', 'Tiaprofenic acid']",0.5
15989,29078.0,Tiaprofenic acid,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Tiaprofenic acid']",0.5
15989,29078.0,Tiaprofenic acid,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Tiaprofenic acid']",0.5
15989,29078.0,Tiaprofenic acid,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Tiaprofenic acid']",0.5
15999,29078.0,Nepafenac,rheumatoid arthritis,disease-protein-drug,contraindication,"['rheumatoid arthritis', 'PTGS1', 'Nepafenac']",0.5
15999,29078.0,Nepafenac,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,contraindication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Nepafenac']",0.5
15999,29078.0,Nepafenac,rheumatoid arthritis,disease-exposure-gene-drug,contraindication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS1', 'Nepafenac']",0.5
15999,29078.0,Nepafenac,rheumatoid arthritis,disease-phenotype-protein-drug,contraindication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Nepafenac']",0.5
15999,33575.0,Nepafenac,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Nepafenac']",0.5
15999,33575.0,Nepafenac,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Nepafenac']",0.5
15999,35916.0,Nepafenac,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Nepafenac']",0.5
16004,27286.0,Phenyl salicylate,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'PTGS2', 'Phenyl salicylate']",0.5
16004,27292.0,Phenyl salicylate,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Arrhythmia', 'PTGS2', 'Phenyl salicylate']",0.5
16004,27361.0,Phenyl salicylate,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'PTGS2', 'Phenyl salicylate']",0.5
16004,28374.0,Phenyl salicylate,gastroesophageal reflux disease,disease-protein-drug,contraindication,"['gastroesophageal reflux disease', 'PTGS2', 'Phenyl salicylate']",0.5
16004,29525.0,Phenyl salicylate,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'PTGS2', 'Phenyl salicylate']",0.5
16004,31395.0,Phenyl salicylate,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Phenyl salicylate']",0.5
16004,31650.0,Phenyl salicylate,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'PTGS2', 'Phenyl salicylate']",0.5
16004,33440.0,Phenyl salicylate,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Fever', 'PTGS2', 'Phenyl salicylate']",0.5
16004,33575.0,Phenyl salicylate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Phenyl salicylate']",0.5
16004,33575.0,Phenyl salicylate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PTGS1', 'Phenyl salicylate']",0.5
16004,33577.0,Phenyl salicylate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Phenyl salicylate']",0.5
16004,33577.0,Phenyl salicylate,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'PTGS1', 'Phenyl salicylate']",0.5
16004,33632.0,Phenyl salicylate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of blood pressure', 'PTGS1', 'Phenyl salicylate']",0.5
16004,33632.0,Phenyl salicylate,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PTGS1', 'Phenyl salicylate']",0.5
16004,33714.0,Phenyl salicylate,esophagitis (disease),disease-protein-drug,contraindication,"['esophagitis (disease)', 'PTGS2', 'Phenyl salicylate']",0.5
16004,35565.0,Phenyl salicylate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'PTGS2', 'Phenyl salicylate']",0.5
16004,35669.0,Phenyl salicylate,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Phenyl salicylate']",0.5
16004,35669.0,Phenyl salicylate,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'PTGS1', 'Phenyl salicylate']",0.5
16004,35761.0,Phenyl salicylate,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'PTGS1', 'Phenyl salicylate']",0.5
16004,35761.0,Phenyl salicylate,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'PTGS1', 'Phenyl salicylate']",0.5
16004,35764.0,Phenyl salicylate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'PTGS1', 'Phenyl salicylate']",0.5
16004,35764.0,Phenyl salicylate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTGS2', 'Phenyl salicylate']",0.5
16004,36034.0,Phenyl salicylate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'PTGS2', 'Phenyl salicylate']",0.5
16004,36187.0,Phenyl salicylate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PTGS2', 'Phenyl salicylate']",0.5
16004,36187.0,Phenyl salicylate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'PTGS1', 'Phenyl salicylate']",0.5
16004,36187.0,Phenyl salicylate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'PTGS1', 'Phenyl salicylate']",0.5
16004,36274.0,Phenyl salicylate,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'regulation of blood pressure', 'PTGS1', 'Phenyl salicylate']",0.5
16004,36432.0,Phenyl salicylate,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'PTGS1', 'Phenyl salicylate']",0.5
16004,83875.0,Phenyl salicylate,bladder neck obstruction,disease-protein-drug,contraindication,"['bladder neck obstruction', 'PTGS2', 'Phenyl salicylate']",0.5
16004,83878.0,Phenyl salicylate,peptic esophagitis,disease-protein-drug,contraindication,"['peptic esophagitis', 'PTGS2', 'Phenyl salicylate']",0.5
16011,28249.0,Loxapine,major affective disorder,disease-protein-drug,indication,"['major affective disorder', 'HTR5A', 'Loxapine']",0.5
16011,28313.0,Loxapine,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'HTR5A', 'Loxapine']",0.5
16011,28313.0,Loxapine,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Loxapine']",0.5
16011,28375.0,Loxapine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Loxapine']",0.5
16011,28780.0,Loxapine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Loxapine']",0.5
16011,28780.0,Loxapine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Loxapine']",0.5
16011,29637.0,Loxapine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Loxapine']",0.5
16011,29637.0,Loxapine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'HTR1B', 'Loxapine']",0.5
16011,30035.0,Loxapine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Loxapine']",0.5
16011,33454.0,Loxapine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Loxapine']",0.5
16011,35641.0,Loxapine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Loxapine']",0.5
16011,35641.0,Loxapine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Loxapine']",0.5
16011,35669.0,Loxapine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Loxapine']",0.5
16011,35761.0,Loxapine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Loxapine']",0.5
16011,38242.0,Loxapine,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'HTR5A', 'Loxapine']",0.5
16011,38242.0,Loxapine,bipolar disorder,disease-exposure-bioprocess-gene-drug,indication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Loxapine']",0.5
16011,39081.0,Loxapine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Loxapine']",0.5
16011,83998.0,Loxapine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Loxapine']",0.5
16011,84023.0,Loxapine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Loxapine']",0.5
16014,27740.0,Chlorprothixene,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Chlorprothixene']",0.5
16014,28313.0,Chlorprothixene,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'ABCB1', 'Chlorprothixene']",0.5
16014,28313.0,Chlorprothixene,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'social behavior', 'DRD3', 'Chlorprothixene']",0.5
16014,28547.0,Chlorprothixene,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'ABCB1', 'Chlorprothixene']",0.5
16014,28547.0,Chlorprothixene,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Chlorprothixene']",0.5
16014,28547.0,Chlorprothixene,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Chlorprothixene']",0.5
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Chlorprothixene']",0.5
16014,28780.0,Chlorprothixene,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'HTR1B', 'Chlorprothixene']",0.5
16014,29352.0,Chlorprothixene,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Fever', 'HTR1A', 'Chlorprothixene']",0.5
16014,29494.0,Chlorprothixene,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Pulmonary arterial hypertension', 'HTR2B', 'Chlorprothixene']",0.5
16014,30715.0,Chlorprothixene,Wernicke-Korsakoff syndrome,disease-phenotype-protein-drug,contraindication,"['Wernicke-Korsakoff syndrome', 'Memory impairment', 'HTR6', 'Chlorprothixene']",0.5
16014,30879.0,Chlorprothixene,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'HTR1B', 'Chlorprothixene']",0.5
16014,33449.0,Chlorprothixene,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Chlorprothixene']",0.5
16014,33454.0,Chlorprothixene,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Chlorprothixene']",0.5
16014,35641.0,Chlorprothixene,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'HTR1B', 'Chlorprothixene']",0.5
16014,35641.0,Chlorprothixene,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD3', 'Chlorprothixene']",0.5
16014,35669.0,Chlorprothixene,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Chlorprothixene']",0.5
16014,35761.0,Chlorprothixene,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Chlorprothixene']",0.5
16014,36104.0,Chlorprothixene,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Chlorprothixene']",0.5
16014,36229.0,Chlorprothixene,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Chlorprothixene']",0.5
16014,37706.0,Chlorprothixene,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Chlorprothixene']",0.5
16014,83998.0,Chlorprothixene,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Chlorprothixene']",0.5
16028,27326.0,Eribulin,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'regulation of gene expression', 'BCL2', 'Eribulin']",0.5
16028,27326.0,Eribulin,long QT syndrome,disease-exposure-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'BCL2', 'Eribulin']",0.5
16031,31918.0,Phenylalanine,phenylketonuria,disease-protein-drug,contraindication,"['phenylketonuria', 'PAH', 'Phenylalanine']",0.5
16031,31918.0,Phenylalanine,phenylketonuria,disease-phenotype-protein-drug,contraindication,"['phenylketonuria', 'Cerebral calcification', 'FARSB', 'Phenylalanine']",0.5
16031,35669.0,Phenylalanine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'TH', 'Phenylalanine']",0.5
16031,35761.0,Phenylalanine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'TAT', 'Phenylalanine']",0.5
16031,35761.0,Phenylalanine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Tobacco Smoke Pollution', 'SLC7A8', 'Phenylalanine']",0.5
16031,35764.0,Phenylalanine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'TH', 'Phenylalanine']",0.5
16031,36040.0,Phenylalanine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'memory', 'TH', 'Phenylalanine']",0.5
16031,38741.0,Phenylalanine,disorder of phenylalanine metabolism,disease-protein-drug,contraindication,"['disorder of phenylalanine metabolism', 'PAH', 'Phenylalanine']",0.5
16031,83923.0,Phenylalanine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'leukocyte migration', 'SLC7A8', 'Phenylalanine']",0.5
16036,33605.0,Acetylcysteine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Acetylcysteine']",0.5
16036,33675.0,Acetylcysteine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'CHUK', 'Acetylcysteine']",0.5
16036,33675.0,Acetylcysteine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'SLC7A11', 'Acetylcysteine']",0.5
16036,36080.0,Acetylcysteine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'CHUK', 'Acetylcysteine']",0.5
16036,37830.0,Acetylcysteine,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'inflammatory response', 'CHUK', 'Acetylcysteine']",0.5
16041,33350.0,Mecasermin rinfabate,growth hormone insensitivity syndrome,disease-phenotype-protein-drug,indication,"['growth hormone insensitivity syndrome', 'Insulin resistance', 'INSR', 'Mecasermin rinfabate']",0.5
16054,28158.0,Trihexyphenidyl,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Trihexyphenidyl']",0.5
16054,28547.0,Trihexyphenidyl,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Trihexyphenidyl']",0.5
16054,28547.0,Trihexyphenidyl,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Trihexyphenidyl']",0.5
16054,28801.0,Trihexyphenidyl,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CHRM4', 'Trihexyphenidyl']",0.5
16054,31408.0,Trihexyphenidyl,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CHRM4', 'Trihexyphenidyl']",0.5
16054,31650.0,Trihexyphenidyl,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Trihexyphenidyl']",0.5
16054,32468.0,Trihexyphenidyl,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Resting tremor', 'CHRM4', 'Trihexyphenidyl']",0.5
16054,32759.0,Trihexyphenidyl,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CHRM4', 'Trihexyphenidyl']",0.5
16054,32974.0,Trihexyphenidyl,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CHRM4', 'Trihexyphenidyl']",0.5
16054,33241.0,Trihexyphenidyl,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CHRM4', 'Trihexyphenidyl']",0.5
16054,33577.0,Trihexyphenidyl,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Trihexyphenidyl']",0.5
16054,33594.0,Trihexyphenidyl,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Trihexyphenidyl']",0.5
16054,35565.0,Trihexyphenidyl,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Trihexyphenidyl']",0.5
16054,35764.0,Trihexyphenidyl,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Trihexyphenidyl']",0.5
16054,36034.0,Trihexyphenidyl,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Trihexyphenidyl']",0.5
16054,36187.0,Trihexyphenidyl,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Trihexyphenidyl']",0.5
16054,37617.0,Trihexyphenidyl,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Trihexyphenidyl']",0.5
16054,37785.0,Trihexyphenidyl,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Trihexyphenidyl']",0.5
16055,27933.0,Oxyphencyclimine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CHRM2', 'Oxyphencyclimine']",0.5
16055,27933.0,Oxyphencyclimine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Oxyphencyclimine']",0.5
16055,30035.0,Oxyphencyclimine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRM2', 'Oxyphencyclimine']",0.5
16055,31618.0,Oxyphencyclimine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CHRM1', 'Oxyphencyclimine']",0.5
16055,32313.0,Oxyphencyclimine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRM1', 'Oxyphencyclimine']",0.5
16055,32977.0,Oxyphencyclimine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CHRM1', 'Oxyphencyclimine']",0.5
16055,33632.0,Oxyphencyclimine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'CHRM1', 'Oxyphencyclimine']",0.5
16055,35565.0,Oxyphencyclimine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Oxyphencyclimine']",0.5
16055,36693.0,Oxyphencyclimine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CHRM2', 'Oxyphencyclimine']",0.5
16055,37703.0,Oxyphencyclimine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CHRM2', 'Oxyphencyclimine']",0.5
16055,83760.0,Oxyphencyclimine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CHRM2', 'Oxyphencyclimine']",0.5
16056,28547.0,Procyclidine,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Procyclidine']",0.5
16056,28547.0,Procyclidine,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5
16056,28801.0,Procyclidine,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CHRM4', 'Procyclidine']",0.5
16056,28974.0,Procyclidine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5
16056,30093.0,Procyclidine,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'CHRM4', 'Procyclidine']",0.5
16056,31408.0,Procyclidine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5
16056,31650.0,Procyclidine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Procyclidine']",0.5
16056,32468.0,Procyclidine,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5
16056,32759.0,Procyclidine,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CHRM4', 'Procyclidine']",0.5
16056,32974.0,Procyclidine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'CHRM4', 'Procyclidine']",0.5
16056,33577.0,Procyclidine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Procyclidine']",0.5
16056,35565.0,Procyclidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Procyclidine']",0.5
16056,35764.0,Procyclidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Procyclidine']",0.5
16056,36034.0,Procyclidine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Procyclidine']",0.5
16056,36187.0,Procyclidine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Procyclidine']",0.5
16056,36274.0,Procyclidine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Procyclidine']",0.5
16056,37785.0,Procyclidine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Procyclidine']",0.5
16057,27286.0,Hyoscyamine,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Action tremor', 'CHRM4', 'Hyoscyamine']",0.5
16057,27292.0,Hyoscyamine,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Seizure', 'CHRM1', 'Hyoscyamine']",0.5
16057,27361.0,Hyoscyamine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'CHRM1', 'Hyoscyamine']",0.5
16057,27933.0,Hyoscyamine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CHRM2', 'Hyoscyamine']",0.5
16057,27933.0,Hyoscyamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Hyoscyamine']",0.5
16057,28158.0,Hyoscyamine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,29113.0,Hyoscyamine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Hyoscyamine']",0.5
16057,30035.0,Hyoscyamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRM2', 'Hyoscyamine']",0.5
16057,31618.0,Hyoscyamine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CHRM1', 'Hyoscyamine']",0.5
16057,31650.0,Hyoscyamine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Hyoscyamine']",0.5
16057,32313.0,Hyoscyamine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRM1', 'Hyoscyamine']",0.5
16057,32977.0,Hyoscyamine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CHRM1', 'Hyoscyamine']",0.5
16057,33440.0,Hyoscyamine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Seizure', 'CHRM1', 'Hyoscyamine']",0.5
16057,33575.0,Hyoscyamine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,33577.0,Hyoscyamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,33594.0,Hyoscyamine,diarrheal disease,disease-exposure-bioprocess-gene-drug,off-label use,"['diarrheal disease', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Hyoscyamine']",0.5
16057,33632.0,Hyoscyamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,33675.0,Hyoscyamine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,35565.0,Hyoscyamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,35669.0,Hyoscyamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,35761.0,Hyoscyamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,35764.0,Hyoscyamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Hyoscyamine']",0.5
16057,35953.0,Hyoscyamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,36034.0,Hyoscyamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,36080.0,Hyoscyamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,36187.0,Hyoscyamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,36274.0,Hyoscyamine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,36693.0,Hyoscyamine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CHRM2', 'Hyoscyamine']",0.5
16057,37617.0,Hyoscyamine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,37703.0,Hyoscyamine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CHRM2', 'Hyoscyamine']",0.5
16057,37765.0,Hyoscyamine,cirrhosis of liver,disease-protein-drug,contraindication,"['cirrhosis of liver', 'CHRM3', 'Hyoscyamine']",0.5
16057,37785.0,Hyoscyamine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Hyoscyamine']",0.5
16057,39622.0,Hyoscyamine,cauda equina syndrome,disease-protein-drug,off-label use,"['cauda equina syndrome', 'CHRM2', 'Hyoscyamine']",0.5
16057,83760.0,Hyoscyamine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CHRM2', 'Hyoscyamine']",0.5
16057,84212.0,Hyoscyamine,obsolete neurogenic bladder (disease),disease-protein-drug,off-label use,"['obsolete neurogenic bladder (disease)', 'CHRM2', 'Hyoscyamine']",0.5
16059,27843.0,Tridihexethyl,acute intermittent porphyria,disease-phenotype-protein-drug,contraindication,"['acute intermittent porphyria', 'Seizure', 'CHRM1', 'Tridihexethyl']",0.5
16059,30035.0,Tridihexethyl,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRM2', 'Tridihexethyl']",0.5
16059,35565.0,Tridihexethyl,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Tridihexethyl']",0.5
16059,35641.0,Tridihexethyl,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CHRM2', 'Tridihexethyl']",0.5
16059,35764.0,Tridihexethyl,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Tridihexethyl']",0.5
16059,36693.0,Tridihexethyl,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CHRM2', 'Tridihexethyl']",0.5
16062,28158.0,Homatropine methylbromide,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,30035.0,Homatropine methylbromide,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRM2', 'Homatropine methylbromide']",0.5
16062,30813.0,Homatropine methylbromide,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,31650.0,Homatropine methylbromide,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,31732.0,Homatropine methylbromide,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,32384.0,Homatropine methylbromide,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,33577.0,Homatropine methylbromide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,35565.0,Homatropine methylbromide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,35641.0,Homatropine methylbromide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CHRM2', 'Homatropine methylbromide']",0.5
16062,35764.0,Homatropine methylbromide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Homatropine methylbromide']",0.5
16062,35897.0,Homatropine methylbromide,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,36034.0,Homatropine methylbromide,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,36080.0,Homatropine methylbromide,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,36187.0,Homatropine methylbromide,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,36274.0,Homatropine methylbromide,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,36469.0,Homatropine methylbromide,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,36492.0,Homatropine methylbromide,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16062,36693.0,Homatropine methylbromide,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CHRM2', 'Homatropine methylbromide']",0.5
16062,37785.0,Homatropine methylbromide,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Homatropine methylbromide']",0.5
16063,27503.0,Scopolamine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'CHRM1', 'Scopolamine']",0.5
16063,27933.0,Scopolamine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Scopolamine']",0.5
16063,27933.0,Scopolamine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Nicotine', 'transmission of nerve impulse', 'CHRM5', 'Scopolamine']",0.5
16063,28158.0,Scopolamine,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Scopolamine']",0.5
16063,28158.0,Scopolamine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,28158.0,Scopolamine,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Scopolamine']",0.5
16063,29113.0,Scopolamine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Scopolamine']",0.5
16063,30035.0,Scopolamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Scopolamine']",0.5
16063,31618.0,Scopolamine,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CHRM1', 'Scopolamine']",0.5
16063,31650.0,Scopolamine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Scopolamine']",0.5
16063,32313.0,Scopolamine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRM1', 'Scopolamine']",0.5
16063,32977.0,Scopolamine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CHRM1', 'Scopolamine']",0.5
16063,33577.0,Scopolamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'CHRNB2', 'Scopolamine']",0.5
16063,33632.0,Scopolamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,35565.0,Scopolamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,35641.0,Scopolamine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Scopolamine']",0.5
16063,35641.0,Scopolamine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Scopolamine']",0.5
16063,35669.0,Scopolamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,35761.0,Scopolamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Scopolamine']",0.5
16063,35764.0,Scopolamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNB2', 'Scopolamine']",0.5
16063,35833.0,Scopolamine,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,35915.0,Scopolamine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'CHRNB2', 'Scopolamine']",0.5
16063,35953.0,Scopolamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,36034.0,Scopolamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,36104.0,Scopolamine,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Scopolamine']",0.5
16063,36187.0,Scopolamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,36229.0,Scopolamine,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Scopolamine']",0.5
16063,36274.0,Scopolamine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,36693.0,Scopolamine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CHRM2', 'Scopolamine']",0.5
16063,36693.0,Scopolamine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Scopolamine']",0.5
16063,37180.0,Scopolamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,37617.0,Scopolamine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,37703.0,Scopolamine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Scopolamine']",0.5
16063,37785.0,Scopolamine,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Scopolamine']",0.5
16063,37785.0,Scopolamine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,37811.0,Scopolamine,rhinitis,disease-exposure-bioprocess-gene-drug,off-label use,"['rhinitis', 'Air Pollutants', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,37888.0,Scopolamine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cognition', 'CHRNA4', 'Scopolamine']",0.5
16063,83760.0,Scopolamine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Scopolamine']",0.5
16063,83778.0,Scopolamine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'CHRNB2', 'Scopolamine']",0.5
16063,83779.0,Scopolamine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'CHRNB2', 'Scopolamine']",0.5
16065,29113.0,Tropicamide,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Tropicamide']",0.5
16065,33575.0,Tropicamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Tropicamide']",0.5
16065,33577.0,Tropicamide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Tropicamide']",0.5
16065,36034.0,Tropicamide,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Tropicamide']",0.5
16065,36187.0,Tropicamide,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Tropicamide']",0.5
16065,37786.0,Tropicamide,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'CHRM1', 'Tropicamide']",0.5
16066,27503.0,Brompheniramine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'CHRM1', 'Brompheniramine']",0.5
16066,28158.0,Brompheniramine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,29113.0,Brompheniramine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Brompheniramine']",0.5
16066,30035.0,Brompheniramine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRM2', 'Brompheniramine']",0.5
16066,30813.0,Brompheniramine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'CHRM1', 'Brompheniramine']",0.5
16066,31650.0,Brompheniramine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Brompheniramine']",0.5
16066,31732.0,Brompheniramine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'CHRM1', 'Brompheniramine']",0.5
16066,32384.0,Brompheniramine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'CHRM1', 'Brompheniramine']",0.5
16066,33575.0,Brompheniramine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Brompheniramine']",0.5
16066,33577.0,Brompheniramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Brompheniramine']",0.5
16066,33603.0,Brompheniramine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Brompheniramine']",0.5
16066,33605.0,Brompheniramine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Brompheniramine']",0.5
16066,33675.0,Brompheniramine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,35565.0,Brompheniramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,35641.0,Brompheniramine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CHRM2', 'Brompheniramine']",0.5
16066,35641.0,Brompheniramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Brompheniramine']",0.5
16066,35669.0,Brompheniramine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,35761.0,Brompheniramine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Brompheniramine']",0.5
16066,35764.0,Brompheniramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Brompheniramine']",0.5
16066,35897.0,Brompheniramine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,35953.0,Brompheniramine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Brompheniramine']",0.5
16066,35953.0,Brompheniramine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,36034.0,Brompheniramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,36080.0,Brompheniramine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,36187.0,Brompheniramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,36274.0,Brompheniramine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,36469.0,Brompheniramine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,36492.0,Brompheniramine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,36693.0,Brompheniramine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CHRM2', 'Brompheniramine']",0.5
16066,36693.0,Brompheniramine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Brompheniramine']",0.5
16066,37180.0,Brompheniramine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,37617.0,Brompheniramine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,37785.0,Brompheniramine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,37888.0,Brompheniramine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Brompheniramine']",0.5
16066,37888.0,Brompheniramine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cognition', 'CHRM1', 'Brompheniramine']",0.5
16066,83791.0,Brompheniramine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Brompheniramine']",0.5
16068,28158.0,Bethanechol,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Bethanechol']",0.5
16068,28396.0,Bethanechol,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Bethanechol']",0.5
16068,28547.0,Bethanechol,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Bethanechol']",0.5
16068,28547.0,Bethanechol,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Bethanechol']",0.5
16068,28801.0,Bethanechol,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,contraindication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'CHRM4', 'Bethanechol']",0.5
16068,28974.0,Bethanechol,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,contraindication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'CHRM4', 'Bethanechol']",0.5
16068,30093.0,Bethanechol,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,contraindication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'CHRM4', 'Bethanechol']",0.5
16068,31408.0,Bethanechol,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,contraindication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'CHRM4', 'Bethanechol']",0.5
16068,32759.0,Bethanechol,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,contraindication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'CHRM4', 'Bethanechol']",0.5
16068,33241.0,Bethanechol,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,contraindication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'CHRM4', 'Bethanechol']",0.5
16068,33577.0,Bethanechol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Bethanechol']",0.5
16068,33675.0,Bethanechol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRM1', 'Bethanechol']",0.5
16068,35641.0,Bethanechol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'CHRM2', 'Bethanechol']",0.5
16068,36034.0,Bethanechol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Bethanechol']",0.5
16068,36187.0,Bethanechol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Bethanechol']",0.5
16069,30056.0,Mivacurium,butyrylcholinesterase deficiency,disease-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'BCHE', 'Mivacurium']",0.5
16069,30056.0,Mivacurium,butyrylcholinesterase deficiency,disease-phenotype-protein-drug,contraindication,"['butyrylcholinesterase deficiency', 'Apnea', 'BCHE', 'Mivacurium']",0.5
16069,31650.0,Mivacurium,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Mivacurium']",0.5
16069,35565.0,Mivacurium,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'learning', 'BCHE', 'Mivacurium']",0.5
16069,35669.0,Mivacurium,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart contraction', 'CHRM2', 'Mivacurium']",0.5
16069,35669.0,Mivacurium,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Mivacurium']",0.5
16069,35761.0,Mivacurium,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart contraction', 'CHRM2', 'Mivacurium']",0.5
16069,35761.0,Mivacurium,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'BCHE', 'Mivacurium']",0.5
16069,35761.0,Mivacurium,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Mivacurium']",0.5
16069,36040.0,Mivacurium,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Lead', 'choline metabolic process', 'BCHE', 'Mivacurium']",0.5
16069,83923.0,Mivacurium,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'nervous system process', 'CHRNA2', 'Mivacurium']",0.5
16071,28396.0,Isopropamide,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Isopropamide']",0.5
16071,28547.0,Isopropamide,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Isopropamide']",0.5
16071,33454.0,Isopropamide,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tremor', 'CHRM4', 'Isopropamide']",0.5
16074,28158.0,Mepenzolate,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Mepenzolate']",0.5
16074,33577.0,Mepenzolate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Mepenzolate']",0.5
16074,35565.0,Mepenzolate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Mepenzolate']",0.5
16074,35764.0,Mepenzolate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cognition', 'CHRM1', 'Mepenzolate']",0.5
16074,36034.0,Mepenzolate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Mepenzolate']",0.5
16074,36187.0,Mepenzolate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Mepenzolate']",0.5
16074,37785.0,Mepenzolate,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Mepenzolate']",0.5
16085,27503.0,Potassium chloride,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'SLC12A5', 'Potassium chloride']",0.5
16085,30813.0,Potassium chloride,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'SLC12A5', 'Potassium chloride']",0.5
16085,31650.0,Potassium chloride,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'SLC12A5', 'Potassium chloride']",0.5
16085,32384.0,Potassium chloride,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'SLC12A5', 'Potassium chloride']",0.5
16085,35565.0,Potassium chloride,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'learning', 'SLC12A5', 'Potassium chloride']",0.5
16085,35641.0,Potassium chloride,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC12A5', 'Potassium chloride']",0.5
16086,30382.0,Lepirudin,obsolete susceptibility to ischemic stroke,disease-protein-drug,contraindication,"['obsolete susceptibility to ischemic stroke', 'F2', 'Lepirudin']",0.5
16086,33598.0,Lepirudin,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'F2', 'Lepirudin']",0.5
16086,33598.0,Lepirudin,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Particulate Matter', 'platelet activation', 'F2', 'Lepirudin']",0.5
16086,35764.0,Lepirudin,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'F2', 'Lepirudin']",0.5
16086,35909.0,Lepirudin,cerebrovascular disorder,disease-protein-drug,contraindication,"['cerebrovascular disorder', 'F2', 'Lepirudin']",0.5
16086,35909.0,Lepirudin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Particulate Matter', 'platelet activation', 'F2', 'Lepirudin']",0.5
16086,38040.0,Lepirudin,cerebral infarction,disease-protein-drug,contraindication,"['cerebral infarction', 'F2', 'Lepirudin']",0.5
16179,27361.0,Turoctocog alfa,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F9', 'Turoctocog alfa']",0.5
16179,27361.0,Turoctocog alfa,hemophilia,disease-phenotype-protein-drug,indication,"['hemophilia', 'Thromboembolism', 'F2', 'Turoctocog alfa']",0.5
16179,32354.0,Turoctocog alfa,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F9', 'Turoctocog alfa']",0.5
16180,29854.0,Conestat alfa,hereditary angioedema,disease-protein-drug,indication,"['hereditary angioedema', 'F12', 'Conestat alfa']",0.5
16183,36644.0,Aminolevulinic acid,skin disease,disease-exposure-bioprocess-gene-drug,indication,"['skin disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Aminolevulinic acid']",0.5
16192,31918.0,L-Lysine,phenylketonuria,disease-phenotype-protein-drug,contraindication,"['phenylketonuria', 'Seizure', 'KARS1', 'L-Lysine']",0.5
16192,35669.0,L-Lysine,heart disease,disease-protein-drug,contraindication,"['heart disease', 'SLC22A4', 'L-Lysine']",0.5
16192,35669.0,L-Lysine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'KARS1', 'L-Lysine']",0.5
16192,35761.0,L-Lysine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'KARS1', 'L-Lysine']",0.5
16192,36040.0,L-Lysine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'perfluorooctanoic acid', 'triglyceride metabolic process', 'SLC22A4', 'L-Lysine']",0.5
16193,30035.0,Lindane,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRR1', 'Lindane']",0.5
16193,35641.0,Lindane,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRB3', 'Lindane']",0.5
16193,36129.0,Lindane,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Mercury', 'visual perception', 'GLRB', 'Lindane']",0.5
16193,36644.0,Lindane,skin disease,disease-exposure-bioprocess-gene-drug,contraindication,"['skin disease', 'Arsenic', 'regulation of transcription, DNA-templated', 'ESR1', 'Lindane']",0.5
16193,36644.0,Lindane,skin disease,disease-exposure-gene-drug,contraindication,"['skin disease', 'Arsenic', 'PGR', 'Lindane']",0.5
16195,29113.0,Glucosamine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'TNF', 'Glucosamine']",0.5
16195,29113.0,Glucosamine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'TNF', 'Glucosamine']",0.5
16195,32967.0,Glucosamine,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Hypothermia', 'TNF', 'Glucosamine']",0.5
16195,33575.0,Glucosamine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'TNF', 'Glucosamine']",0.5
16195,33575.0,Glucosamine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'TNF', 'Glucosamine']",0.5
16195,33575.0,Glucosamine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'TNF', 'Glucosamine']",0.5
16195,33577.0,Glucosamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'rhythmic process', 'NFKB2', 'Glucosamine']",0.5
16195,33577.0,Glucosamine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'IFNG', 'Glucosamine']",0.5
16195,33656.0,Glucosamine,hypercalcemia disease,disease-protein-drug,contraindication,"['hypercalcemia disease', 'TNF', 'Glucosamine']",0.5
16195,35583.0,Glucosamine,phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'TNF', 'Glucosamine']",0.5
16195,35764.0,Glucosamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'rhythmic process', 'NFKB2', 'Glucosamine']",0.5
16195,35764.0,Glucosamine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'MMP9', 'Glucosamine']",0.5
16195,38682.0,Glucosamine,nephrocalcinosis,disease-protein-drug,contraindication,"['nephrocalcinosis', 'TNF', 'Glucosamine']",0.5
16210,29182.0,Eprosartan,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'AGTR1', 'Eprosartan']",0.5
16210,29182.0,Eprosartan,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'ABCC2', 'Eprosartan']",0.5
16210,33534.0,Eprosartan,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'AGTR1', 'Eprosartan']",0.5
16210,33575.0,Eprosartan,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ABCC2', 'Eprosartan']",0.5
16210,33577.0,Eprosartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Eprosartan']",0.5
16210,33577.0,Eprosartan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'perfluorooctanoic acid', 'female pregnancy', 'ABCC2', 'Eprosartan']",0.5
16210,33618.0,Eprosartan,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'AGTR1', 'Eprosartan']",0.5
16210,36035.0,Eprosartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Eprosartan']",0.5
16210,83802.0,Eprosartan,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'female pregnancy', 'ABCC2', 'Eprosartan']",0.5
16214,33577.0,Azilsartan medoxomil,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Azilsartan medoxomil']",0.5
16214,33577.0,Azilsartan medoxomil,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'inflammatory response', 'AGTR1', 'Azilsartan medoxomil']",0.5
16214,36035.0,Azilsartan medoxomil,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Azilsartan medoxomil']",0.5
16215,33577.0,Fimasartan,hypertensive disorder,disease-protein-drug,indication,"['hypertensive disorder', 'AGTR1', 'Fimasartan']",0.5
16215,33577.0,Fimasartan,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Air Pollutants', 'inflammatory response', 'AGTR1', 'Fimasartan']",0.5
16215,36035.0,Fimasartan,hypertension,disease-protein-drug,indication,"['hypertension', 'AGTR1', 'Fimasartan']",0.5
16217,27933.0,Serine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'adipose tissue development', 'SPTLC2', 'Serine']",0.5
16217,27933.0,Serine,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'CBS', 'Serine']",0.5
16217,27933.0,Serine,anxiety disorder,disease-exposure-molfunc-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'transaminase activity', 'AGXT', 'Serine']",0.5
16217,33575.0,Serine,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'CBS', 'Serine']",0.5
16217,33575.0,Serine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'adipose tissue development', 'SPTLC2', 'Serine']",0.5
16217,33575.0,Serine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'CBS', 'Serine']",0.5
16217,33575.0,Serine,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'transaminase activity', 'AGXT', 'Serine']",0.5
16217,35669.0,Serine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'adipose tissue development', 'SPTLC2', 'Serine']",0.5
16217,35669.0,Serine,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'Arsenic', 'CBS', 'Serine']",0.5
16217,35669.0,Serine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'transaminase activity', 'AGXT', 'Serine']",0.5
16217,35761.0,Serine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'adipose tissue development', 'SPTLC2', 'Serine']",0.5
16217,35761.0,Serine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'CBS', 'Serine']",0.5
16217,35761.0,Serine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'transaminase activity', 'AGXT', 'Serine']",0.5
16217,35764.0,Serine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'adipose tissue development', 'SPTLC2', 'Serine']",0.5
16217,35764.0,Serine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'CBS', 'Serine']",0.5
16217,35764.0,Serine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'transaminase activity', 'AGXT', 'Serine']",0.5
16217,36040.0,Serine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'adipose tissue development', 'SPTLC2', 'Serine']",0.5
16217,39696.0,Serine,pulmonary tuberculosis,disease-exposure-gene-drug,indication,"['pulmonary tuberculosis', 'Arsenic', 'CBS', 'Serine']",0.5
16217,39696.0,Serine,pulmonary tuberculosis,disease-exposure-molfunc-gene-drug,indication,"['pulmonary tuberculosis', 'Arsenic', 'transaminase activity', 'AGXT', 'Serine']",0.5
16217,83923.0,Serine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'brain development', 'SRR', 'Serine']",0.5
16219,27857.0,Alprostadil,tetralogy of fallot,disease-exposure-bioprocess-gene-drug,indication,"['tetralogy of fallot', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Alprostadil']",0.5
16219,28520.0,Alprostadil,myeloid leukemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myeloid leukemia', 'Tobacco Smoke Pollution', 'immune response', 'PTGDR2', 'Alprostadil']",0.5
16219,33621.0,Alprostadil,acute lymphoblastic leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['acute lymphoblastic leukemia (disease)', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Alprostadil']",0.5
16219,33635.0,Alprostadil,leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['leukemia (disease)', 'Benzene', 'inflammatory response', 'PTGER1', 'Alprostadil']",0.5
16219,35833.0,Alprostadil,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Alprostadil']",0.5
16219,36274.0,Alprostadil,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'PTGER1', 'Alprostadil']",0.5
16219,39798.0,Alprostadil,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,off-label use,"['peripheral arterial disease', 'Air Pollutants', 'inflammatory response', 'PTGER1', 'Alprostadil']",0.5
16220,33575.0,Dinoprostone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'PTGER3', 'Dinoprostone']",0.5
16220,33577.0,Dinoprostone,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'immune response', 'PTGDR2', 'Dinoprostone']",0.5
16220,33632.0,Dinoprostone,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'transport', 'SLC51A', 'Dinoprostone']",0.5
16220,33675.0,Dinoprostone,asthma,disease-protein-drug,contraindication,"['asthma', 'PTGDR2', 'Dinoprostone']",0.5
16220,33675.0,Dinoprostone,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'PTGER3', 'Dinoprostone']",0.5
16220,35565.0,Dinoprostone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'PTGDR2', 'Dinoprostone']",0.5
16220,35669.0,Dinoprostone,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'PTGER3', 'Dinoprostone']",0.5
16220,35761.0,Dinoprostone,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'PTGER3', 'Dinoprostone']",0.5
16220,35764.0,Dinoprostone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'PTGDR2', 'Dinoprostone']",0.5
16220,35833.0,Dinoprostone,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'inflammatory response', 'PTGER3', 'Dinoprostone']",0.5
16220,39773.0,Dinoprostone,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'PTGDR2', 'Dinoprostone']",0.5
16220,83781.0,Dinoprostone,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'PTGDR2', 'Dinoprostone']",0.5
16221,27366.0,Misoprostol,"spondyloarthropathy, susceptibility to",disease-protein-drug,off-label use,"['spondyloarthropathy, susceptibility to', 'PTGER4', 'Misoprostol']",0.5
16221,28158.0,Misoprostol,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'PTGER4', 'Misoprostol']",0.5
16221,33598.0,Misoprostol,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Dioxins', 'immune response', 'PTGER4', 'Misoprostol']",0.5
16221,33632.0,Misoprostol,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'inflammatory response', 'PTGER3', 'Misoprostol']",0.5
16221,33675.0,Misoprostol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'PTGER3', 'Misoprostol']",0.5
16221,35565.0,Misoprostol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'PTGER4', 'Misoprostol']",0.5
16221,35669.0,Misoprostol,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'PTGER3', 'Misoprostol']",0.5
16221,35761.0,Misoprostol,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'PTGER3', 'Misoprostol']",0.5
16221,35909.0,Misoprostol,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'inflammatory response', 'PTGER3', 'Misoprostol']",0.5
16221,36544.0,Misoprostol,drug-induced liver injury,disease-exposure-bioprocess-gene-drug,contraindication,"['drug-induced liver injury', 'perfluorooctane sulfonic acid', 'immune response', 'PTGER4', 'Misoprostol']",0.5
16221,37180.0,Misoprostol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'PTGER3', 'Misoprostol']",0.5
16221,39820.0,Misoprostol,ankylosing spondylitis,disease-protein-drug,off-label use,"['ankylosing spondylitis', 'PTGER4', 'Misoprostol']",0.5
16222,33605.0,Iloprost,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'PLAT', 'Iloprost']",0.5
16222,37617.0,Iloprost,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'inflammatory response', 'PTGIR', 'Iloprost']",0.5
16226,35650.0,Rituximab,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Benzene', 'B cell differentiation', 'MS4A1', 'Rituximab']",0.5
16227,33294.0,Ibritumomab tiuxetan,follicular lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['follicular lymphoma', 'Polychlorinated Biphenyls', 'humoral immune response', 'MS4A1', 'Ibritumomab tiuxetan']",0.5
16268,29113.0,Fenofibric acid,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'PPARG', 'Fenofibric acid']",0.5
16268,29494.0,Fenofibric acid,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hepatomegaly', 'NR1I2', 'Fenofibric acid']",0.5
16268,29955.0,Fenofibric acid,Reynolds syndrome,disease-phenotype-protein-drug,contraindication,"['Reynolds syndrome', 'Hepatomegaly', 'NR1I2', 'Fenofibric acid']",0.5
16268,30184.0,Fenofibric acid,congenital neutropenia-myelofibrosis-nephromegaly syndrome,disease-phenotype-protein-drug,contraindication,"['congenital neutropenia-myelofibrosis-nephromegaly syndrome', 'Hepatomegaly', 'NR1I2', 'Fenofibric acid']",0.5
16268,33575.0,Fenofibric acid,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'PPARA', 'Fenofibric acid']",0.5
16268,33575.0,Fenofibric acid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'PPARD', 'Fenofibric acid']",0.5
16268,33575.0,Fenofibric acid,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'PPARG', 'Fenofibric acid']",0.5
16268,33632.0,Fenofibric acid,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'PPARD', 'Fenofibric acid']",0.5
16268,33632.0,Fenofibric acid,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'PPARG', 'Fenofibric acid']",0.5
16268,33658.0,Fenofibric acid,hyperlipidemia,disease-protein-drug,indication,"['hyperlipidemia', 'PPARA', 'Fenofibric acid']",0.5
16268,33695.0,Fenofibric acid,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'glucose homeostasis', 'PPARG', 'Fenofibric acid']",0.5
16268,35565.0,Fenofibric acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'adipose tissue development', 'PPARD', 'Fenofibric acid']",0.5
16268,36040.0,Fenofibric acid,chronic kidney disease,disease-protein-drug,contraindication,"['chronic kidney disease', 'PPARA', 'Fenofibric acid']",0.5
16268,36040.0,Fenofibric acid,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'glucose homeostasis', 'PPARG', 'Fenofibric acid']",0.5
16268,36469.0,Fenofibric acid,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', '2,4-Dichlorophenoxyacetic Acid', 'glucose metabolic process', 'PPARD', 'Fenofibric acid']",0.5
16268,37764.0,Fenofibric acid,familial hyperlipidemia,disease-protein-drug,indication,"['familial hyperlipidemia', 'PPARA', 'Fenofibric acid']",0.5
16268,83923.0,Fenofibric acid,chronic renal failure syndrome,disease-protein-drug,contraindication,"['chronic renal failure syndrome', 'PPARA', 'Fenofibric acid']",0.5
16268,83923.0,Fenofibric acid,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cell population proliferation', 'PPARD', 'Fenofibric acid']",0.5
16268,83924.0,Fenofibric acid,end stage renal failure,disease-protein-drug,contraindication,"['end stage renal failure', 'PPARA', 'Fenofibric acid']",0.5
16281,31918.0,Cysteine,phenylketonuria,disease-phenotype-protein-drug,contraindication,"['phenylketonuria', 'Intrauterine growth retardation', 'CTH', 'Cysteine']",0.5
16281,33675.0,Cysteine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'GCLC', 'Cysteine']",0.5
16281,33675.0,Cysteine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Arsenic', 'CBS', 'Cysteine']",0.5
16281,36080.0,Cysteine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'CDO1', 'Cysteine']",0.5
16281,37830.0,Cysteine,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'GCLC', 'Cysteine']",0.5
16281,37830.0,Cysteine,bronchitis,disease-exposure-gene-drug,indication,"['bronchitis', 'Air Pollutants, Occupational', 'GOT1', 'Cysteine']",0.5
16302,27326.0,Ibutilide,long QT syndrome,disease-protein-drug,contraindication,"['long QT syndrome', 'CACNA1C', 'Ibutilide']",0.5
16302,27326.0,Ibutilide,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'glucose metabolic process', 'KCNJ11', 'Ibutilide']",0.5
16302,27326.0,Ibutilide,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Sudden cardiac death', 'CACNA1C', 'Ibutilide']",0.5
16302,27655.0,Ibutilide,familial long QT syndrome,disease-protein-drug,contraindication,"['familial long QT syndrome', 'KCNH2', 'Ibutilide']",0.5
16302,27655.0,Ibutilide,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Syncope', 'CACNA1C', 'Ibutilide']",0.5
16302,83751.0,Ibutilide,torsades de pointes,disease-protein-drug,contraindication,"['torsades de pointes', 'KCNH2', 'Ibutilide']",0.5
16303,28149.0,Terazosin,orthostatic hypotension,disease-protein-drug,contraindication,"['orthostatic hypotension', 'ABCB1', 'Terazosin']",0.5
16303,28396.0,Terazosin,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Skeletal muscle atrophy', 'KCNH2', 'Terazosin']",0.5
16306,27503.0,Pentoxyverine,catecholaminergic polymorphic ventricular tachycardia,disease-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'SCN5A', 'Pentoxyverine']",0.5
16306,27503.0,Pentoxyverine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Sudden death', 'SCN10A', 'Pentoxyverine']",0.5
16306,27703.0,Pentoxyverine,incessant infant ventricular tachycardia,disease-protein-drug,contraindication,"['incessant infant ventricular tachycardia', 'SCN5A', 'Pentoxyverine']",0.5
16306,29525.0,Pentoxyverine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Pentoxyverine']",0.5
16306,30813.0,Pentoxyverine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Pentoxyverine']",0.5
16306,32384.0,Pentoxyverine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Pentoxyverine']",0.5
16306,33575.0,Pentoxyverine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,33577.0,Pentoxyverine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Pentoxyverine']",0.5
16306,35669.0,Pentoxyverine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,35761.0,Pentoxyverine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,35915.0,Pentoxyverine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Asbestos', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,35953.0,Pentoxyverine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,36034.0,Pentoxyverine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SCN2A', 'Pentoxyverine']",0.5
16306,36187.0,Pentoxyverine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,37180.0,Pentoxyverine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,37617.0,Pentoxyverine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,37769.0,Pentoxyverine,ventricular tachycardia,disease-protein-drug,contraindication,"['ventricular tachycardia', 'SCN5A', 'Pentoxyverine']",0.5
16306,37786.0,Pentoxyverine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,37811.0,Pentoxyverine,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,37888.0,Pentoxyverine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Pentoxyverine']",0.5
16306,83778.0,Pentoxyverine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Asbestos', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16306,83779.0,Pentoxyverine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Asbestos', 'inflammatory response', 'SCN9A', 'Pentoxyverine']",0.5
16312,27933.0,Clidinium,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,28158.0,Clidinium,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,31618.0,Clidinium,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CHRM1', 'Clidinium']",0.5
16312,31650.0,Clidinium,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Clidinium']",0.5
16312,32313.0,Clidinium,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRM1', 'Clidinium']",0.5
16312,32977.0,Clidinium,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CHRM1', 'Clidinium']",0.5
16312,33577.0,Clidinium,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,35565.0,Clidinium,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,35764.0,Clidinium,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,35833.0,Clidinium,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,35915.0,Clidinium,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,36034.0,Clidinium,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,36187.0,Clidinium,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,36274.0,Clidinium,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,37785.0,Clidinium,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,83778.0,Clidinium,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Clidinium']",0.5
16312,83779.0,Clidinium,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'cognition', 'CHRM1', 'Clidinium']",0.5
16313,28158.0,Propantheline,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Propantheline']",0.5
16313,31650.0,Propantheline,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Propantheline']",0.5
16313,33577.0,Propantheline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Propantheline']",0.5
16313,35565.0,Propantheline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Propantheline']",0.5
16313,35764.0,Propantheline,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cognition', 'CHRM1', 'Propantheline']",0.5
16313,36034.0,Propantheline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Propantheline']",0.5
16313,36187.0,Propantheline,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Propantheline']",0.5
16313,36274.0,Propantheline,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Propantheline']",0.5
16313,37785.0,Propantheline,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Propantheline']",0.5
16314,27933.0,Dicyclomine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CHRM2', 'Dicyclomine']",0.5
16314,27933.0,Dicyclomine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Dicyclomine']",0.5
16314,28158.0,Dicyclomine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRM1', 'Dicyclomine']",0.5
16314,30035.0,Dicyclomine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRM2', 'Dicyclomine']",0.5
16314,31650.0,Dicyclomine,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'CHRM1', 'Dicyclomine']",0.5
16314,32313.0,Dicyclomine,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CHRM1', 'Dicyclomine']",0.5
16314,32977.0,Dicyclomine,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CHRM1', 'Dicyclomine']",0.5
16314,33577.0,Dicyclomine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'CHRM1', 'Dicyclomine']",0.5
16314,33632.0,Dicyclomine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'CHRM1', 'Dicyclomine']",0.5
16314,35565.0,Dicyclomine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Dicyclomine']",0.5
16314,35764.0,Dicyclomine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of heart contraction', 'CHRM2', 'Dicyclomine']",0.5
16314,36034.0,Dicyclomine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Dicyclomine']",0.5
16314,36187.0,Dicyclomine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Dicyclomine']",0.5
16314,36693.0,Dicyclomine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'CHRM2', 'Dicyclomine']",0.5
16314,37703.0,Dicyclomine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CHRM2', 'Dicyclomine']",0.5
16314,37785.0,Dicyclomine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'CHRM1', 'Dicyclomine']",0.5
16314,83760.0,Dicyclomine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CHRM2', 'Dicyclomine']",0.5
16315,28547.0,Cycrimine,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Cycrimine']",0.5
16315,28801.0,Cycrimine,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Seizure', 'CHRM1', 'Cycrimine']",0.5
16315,28974.0,Cycrimine,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Seizure', 'CHRM1', 'Cycrimine']",0.5
16315,31408.0,Cycrimine,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Seizure', 'CHRM1', 'Cycrimine']",0.5
16315,32974.0,Cycrimine,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Seizure', 'CHRM1', 'Cycrimine']",0.5
16316,36274.0,Flavoxate,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'cognition', 'CHRM1', 'Flavoxate']",0.5
16317,27740.0,Molindone,adult idiopathic neutropenia,disease-phenotype-protein-drug,contraindication,"['adult idiopathic neutropenia', 'Fever', 'HTR1A', 'Molindone']",0.5
16317,28313.0,Molindone,schizophrenia,disease-protein-drug,indication,"['schizophrenia', 'DRD2', 'Molindone']",0.5
16317,28313.0,Molindone,schizophrenia,disease-exposure-bioprocess-gene-drug,indication,"['schizophrenia', 'Vitamin D', 'cognition', 'CHRM1', 'Molindone']",0.5
16317,28375.0,Molindone,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Molindone']",0.5
16317,28547.0,Molindone,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'DRD2', 'Molindone']",0.5
16317,28547.0,Molindone,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Molindone']",0.5
16317,28547.0,Molindone,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'HTR1A', 'Molindone']",0.5
16317,28780.0,Molindone,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Molindone']",0.5
16317,28780.0,Molindone,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD2', 'Molindone']",0.5
16317,29352.0,Molindone,cyclic hematopoiesis,disease-phenotype-protein-drug,contraindication,"['cyclic hematopoiesis', 'Fever', 'HTR1A', 'Molindone']",0.5
16317,29637.0,Molindone,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Molindone']",0.5
16317,29637.0,Molindone,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD2', 'Molindone']",0.5
16317,30879.0,Molindone,Kostmann syndrome,disease-phenotype-protein-drug,contraindication,"['Kostmann syndrome', 'Seizure', 'DRD2', 'Molindone']",0.5
16317,33449.0,Molindone,severe congenital neutropenia,disease-phenotype-protein-drug,contraindication,"['severe congenital neutropenia', 'Fever', 'HTR1A', 'Molindone']",0.5
16317,33454.0,Molindone,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Molindone']",0.5
16317,35565.0,Molindone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Molindone']",0.5
16317,35641.0,Molindone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD2', 'Molindone']",0.5
16317,35641.0,Molindone,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Molindone']",0.5
16317,36492.0,Molindone,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'cognition', 'CHRM1', 'Molindone']",0.5
16317,37706.0,Molindone,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Molindone']",0.5
16317,39081.0,Molindone,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Molindone']",0.5
16317,83998.0,Molindone,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Molindone']",0.5
16317,84023.0,Molindone,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Molindone']",0.5
16321,29614.0,Lasofoxifene,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'Cadmium', 'inflammatory response', 'CNR2', 'Lasofoxifene']",0.5
16322,35565.0,Levocarnitine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'SLC22A16', 'Levocarnitine']",0.5
16322,35764.0,Levocarnitine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'CES1', 'Levocarnitine']",0.5
16328,31918.0,Alanine,phenylketonuria,disease-phenotype-protein-drug,contraindication,"['phenylketonuria', 'Seizure', 'ABAT', 'Alanine']",0.5
16328,32967.0,Alanine,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Decreased liver function', 'GPT', 'Alanine']",0.5
16328,35669.0,Alanine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'SLC1A4', 'Alanine']",0.5
16328,35669.0,Alanine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'transaminase activity', 'PHYKPL', 'Alanine']",0.5
16328,35761.0,Alanine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'cognition', 'SLC1A4', 'Alanine']",0.5
16328,35761.0,Alanine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'GPT', 'Alanine']",0.5
16328,35761.0,Alanine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'transaminase activity', 'PHYKPL', 'Alanine']",0.5
16328,35764.0,Alanine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cognition', 'SLC1A4', 'Alanine']",0.5
16328,35764.0,Alanine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'GPT', 'Alanine']",0.5
16328,35764.0,Alanine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'transaminase activity', 'PHYKPL', 'Alanine']",0.5
16328,36040.0,Alanine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'perfluorooctanoic acid', 'cognition', 'SLC1A4', 'Alanine']",0.5
16328,36040.0,Alanine,chronic kidney disease,disease-exposure-gene-drug,contraindication,"['chronic kidney disease', 'perfluorooctanoic acid', 'GPT', 'Alanine']",0.5
16328,36040.0,Alanine,chronic kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['chronic kidney disease', 'perfluorooctanoic acid', 'L-alanine:2-oxoglutarate aminotransferase activity', 'GPT2', 'Alanine']",0.5
16328,83923.0,Alanine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cognition', 'SLC1A4', 'Alanine']",0.5
16328,83923.0,Alanine,chronic renal failure syndrome,disease-exposure-gene-drug,contraindication,"['chronic renal failure syndrome', 'Cadmium', 'GPT', 'Alanine']",0.5
16331,37811.0,Epoprostenol,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'inflammatory response', 'PTGIR', 'Epoprostenol']",0.5
16337,33605.0,Tolazoline,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Tolazoline']",0.5
16337,35671.0,Tolazoline,vascular disease,disease-exposure-bioprocess-gene-drug,indication,"['vascular disease', 'Arsenic', 'positive regulation of cytokine production', 'ADRA2A', 'Tolazoline']",0.5
16337,35909.0,Tolazoline,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'HRH1', 'Tolazoline']",0.5
16341,28158.0,Iron,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'FTH1', 'Iron']",0.5
16341,28158.0,Iron,inflammatory bowel disease,disease-exposure-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'FTH1', 'Iron']",0.5
16341,31502.0,Iron,Wilson disease,disease-protein-drug,contraindication,"['Wilson disease', 'CP', 'Iron']",0.5
16341,33589.0,Iron,hypochromic anemia,disease-protein-drug,indication,"['hypochromic anemia', 'TF', 'Iron']",0.5
16341,33622.0,Iron,microcytic anemia,disease-protein-drug,indication,"['microcytic anemia', 'TFRC', 'Iron']",0.5
16341,36172.0,Iron,hemosiderosis,disease-protein-drug,contraindication,"['hemosiderosis', 'TF', 'Iron']",0.5
16341,36214.0,Iron,iron metabolism disease,disease-protein-drug,contraindication,"['iron metabolism disease', 'CP', 'Iron']",0.5
16341,36315.0,Iron,deficiency anemia,disease-protein-drug,indication,"['deficiency anemia', 'TFRC', 'Iron']",0.5
16341,37785.0,Iron,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'FEN1', 'Iron']",0.5
16341,38641.0,Iron,hereditary hemochromatosis,disease-protein-drug,contraindication,"['hereditary hemochromatosis', 'CP', 'Iron']",0.5
16341,84087.0,Iron,iron deficiency anemia,disease-protein-drug,indication,"['iron deficiency anemia', 'TFRC', 'Iron']",0.5
16344,28158.0,Ferrous gluconate,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'FTH1', 'Ferrous gluconate']",0.5
16344,28158.0,Ferrous gluconate,inflammatory bowel disease,disease-exposure-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'FTH1', 'Ferrous gluconate']",0.5
16344,31502.0,Ferrous gluconate,Wilson disease,disease-protein-drug,contraindication,"['Wilson disease', 'CP', 'Ferrous gluconate']",0.5
16344,33589.0,Ferrous gluconate,hypochromic anemia,disease-protein-drug,indication,"['hypochromic anemia', 'TF', 'Ferrous gluconate']",0.5
16344,33622.0,Ferrous gluconate,microcytic anemia,disease-protein-drug,indication,"['microcytic anemia', 'TFRC', 'Ferrous gluconate']",0.5
16344,36172.0,Ferrous gluconate,hemosiderosis,disease-protein-drug,contraindication,"['hemosiderosis', 'TF', 'Ferrous gluconate']",0.5
16344,36214.0,Ferrous gluconate,iron metabolism disease,disease-protein-drug,contraindication,"['iron metabolism disease', 'CP', 'Ferrous gluconate']",0.5
16344,36315.0,Ferrous gluconate,deficiency anemia,disease-protein-drug,indication,"['deficiency anemia', 'TFRC', 'Ferrous gluconate']",0.5
16344,37785.0,Ferrous gluconate,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'FEN1', 'Ferrous gluconate']",0.5
16344,38641.0,Ferrous gluconate,hereditary hemochromatosis,disease-protein-drug,contraindication,"['hereditary hemochromatosis', 'CP', 'Ferrous gluconate']",0.5
16344,84087.0,Ferrous gluconate,iron deficiency anemia,disease-protein-drug,indication,"['iron deficiency anemia', 'TFRC', 'Ferrous gluconate']",0.5
16347,27746.0,Ferrous fumarate,intrahepatic cholestasis,disease-phenotype-protein-drug,contraindication,"['intrahepatic cholestasis', 'Preeclampsia', 'CP', 'Ferrous fumarate']",0.5
16347,27933.0,Ferrous fumarate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'FTH1', 'Ferrous fumarate']",0.5
16347,27933.0,Ferrous fumarate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'DNA repair', 'POLB', 'Ferrous fumarate']",0.5
16347,27933.0,Ferrous fumarate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Tobacco Smoke Pollution', 'FTH1', 'Ferrous fumarate']",0.5
16347,28158.0,Ferrous fumarate,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'FTH1', 'Ferrous fumarate']",0.5
16347,28158.0,Ferrous fumarate,inflammatory bowel disease,disease-exposure-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'FTH1', 'Ferrous fumarate']",0.5
16347,28651.0,Ferrous fumarate,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'TFRC', 'Ferrous fumarate']",0.5
16347,29113.0,Ferrous fumarate,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CP', 'Ferrous fumarate']",0.5
16347,29113.0,Ferrous fumarate,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'NEIL1', 'Ferrous fumarate']",0.5
16347,29646.0,Ferrous fumarate,hepatocellular carcinoma,disease-protein-drug,contraindication,"['hepatocellular carcinoma', 'CP', 'Ferrous fumarate']",0.5
16347,29646.0,Ferrous fumarate,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Air Pollutants', 'inflammatory response', 'POLB', 'Ferrous fumarate']",0.5
16347,30756.0,Ferrous fumarate,polycystic ovary syndrome,disease-protein-drug,off-label use,"['polycystic ovary syndrome', 'TFRC', 'Ferrous fumarate']",0.5
16347,31107.0,Ferrous fumarate,cervical cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['cervical cancer', 'Vehicle Emissions', 'inflammatory response', 'POLB', 'Ferrous fumarate']",0.5
16347,31502.0,Ferrous fumarate,Wilson disease,disease-protein-drug,contraindication,"['Wilson disease', 'CP', 'Ferrous fumarate']",0.5
16347,33575.0,Ferrous fumarate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'NEIL1', 'Ferrous fumarate']",0.5
16347,33575.0,Ferrous fumarate,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Manganese', 'TF', 'Ferrous fumarate']",0.5
16347,33577.0,Ferrous fumarate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'FEN1', 'Ferrous fumarate']",0.5
16347,33589.0,Ferrous fumarate,hypochromic anemia,disease-protein-drug,indication,"['hypochromic anemia', 'TF', 'Ferrous fumarate']",0.5
16347,33593.0,Ferrous fumarate,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'TFRC', 'Ferrous fumarate']",0.5
16347,33593.0,Ferrous fumarate,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'inflammatory response', 'POLB', 'Ferrous fumarate']",0.5
16347,33593.0,Ferrous fumarate,obesity disorder,disease-exposure-gene-drug,contraindication,"['obesity disorder', 'Manganese', 'TF', 'Ferrous fumarate']",0.5
16347,33598.0,Ferrous fumarate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Dioxins', 'regulation of telomere maintenance', 'HDAC8', 'Ferrous fumarate']",0.5
16347,33622.0,Ferrous fumarate,microcytic anemia,disease-protein-drug,indication,"['microcytic anemia', 'TFRC', 'Ferrous fumarate']",0.5
16347,33658.0,Ferrous fumarate,hyperlipidemia,disease-protein-drug,contraindication,"['hyperlipidemia', 'NEIL1', 'Ferrous fumarate']",0.5
16347,33695.0,Ferrous fumarate,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['hypertriglyceridemia (disease)', 'Mercury', 'memory', 'FEN1', 'Ferrous fumarate']",0.5
16347,33699.0,Ferrous fumarate,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'inflammatory response', 'POLB', 'Ferrous fumarate']",0.5
16347,35565.0,Ferrous fumarate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'FTH1', 'Ferrous fumarate']",0.5
16347,35565.0,Ferrous fumarate,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Manganese', 'TF', 'Ferrous fumarate']",0.5
16347,35764.0,Ferrous fumarate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'FEN1', 'Ferrous fumarate']",0.5
16347,35909.0,Ferrous fumarate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'memory', 'FEN1', 'Ferrous fumarate']",0.5
16347,35958.0,Ferrous fumarate,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'HBA2', 'Ferrous fumarate']",0.5
16347,36172.0,Ferrous fumarate,hemosiderosis,disease-protein-drug,contraindication,"['hemosiderosis', 'TF', 'Ferrous fumarate']",0.5
16347,36187.0,Ferrous fumarate,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'TFRC', 'Ferrous fumarate']",0.5
16347,36187.0,Ferrous fumarate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'POLB', 'Ferrous fumarate']",0.5
16347,36187.0,Ferrous fumarate,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Tobacco Smoke Pollution', 'FTH1', 'Ferrous fumarate']",0.5
16347,36214.0,Ferrous fumarate,iron metabolism disease,disease-protein-drug,contraindication,"['iron metabolism disease', 'CP', 'Ferrous fumarate']",0.5
16347,36315.0,Ferrous fumarate,deficiency anemia,disease-protein-drug,indication,"['deficiency anemia', 'TFRC', 'Ferrous fumarate']",0.5
16347,36634.0,Ferrous fumarate,liver cancer,disease-protein-drug,contraindication,"['liver cancer', 'CP', 'Ferrous fumarate']",0.5
16347,36634.0,Ferrous fumarate,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'perfluorooctanoic acid', 'memory', 'FEN1', 'Ferrous fumarate']",0.5
16347,37180.0,Ferrous fumarate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'POLB', 'Ferrous fumarate']",0.5
16347,37703.0,Ferrous fumarate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'FTH1', 'Ferrous fumarate']",0.5
16347,37764.0,Ferrous fumarate,familial hyperlipidemia,disease-protein-drug,contraindication,"['familial hyperlipidemia', 'NEIL1', 'Ferrous fumarate']",0.5
16347,37785.0,Ferrous fumarate,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'FEN1', 'Ferrous fumarate']",0.5
16347,38641.0,Ferrous fumarate,hereditary hemochromatosis,disease-protein-drug,contraindication,"['hereditary hemochromatosis', 'CP', 'Ferrous fumarate']",0.5
16347,83760.0,Ferrous fumarate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'FTH1', 'Ferrous fumarate']",0.5
16347,83813.0,Ferrous fumarate,hereditary persistence of fetal hemoglobin,disease-protein-drug,contraindication,"['hereditary persistence of fetal hemoglobin', 'HBA2', 'Ferrous fumarate']",0.5
16347,84087.0,Ferrous fumarate,iron deficiency anemia,disease-protein-drug,indication,"['iron deficiency anemia', 'TFRC', 'Ferrous fumarate']",0.5
16350,27292.0,Citric acid,glycogen storage disease,disease-phenotype-protein-drug,off-label use,"['glycogen storage disease', 'Cardiomegaly', 'SRC', 'Citric acid']",0.5
16350,27581.0,Citric acid,von Willebrand disease,disease-phenotype-protein-drug,contraindication,"['von Willebrand disease', 'Thrombocytopenia', 'ITPA', 'Citric acid']",0.5
16350,27626.0,Citric acid,thrombocytopenia,disease-protein-drug,contraindication,"['thrombocytopenia', 'SRC', 'Citric acid']",0.5
16350,27626.0,Citric acid,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'PLEKHA1', 'Citric acid']",0.5
16350,27626.0,Citric acid,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ITPA', 'Citric acid']",0.5
16350,28780.0,Citric acid,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'spermatogenesis', 'PLEKHA1', 'Citric acid']",0.5
16350,33440.0,Citric acid,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Thrombocytopenia', 'ITPA', 'Citric acid']",0.5
16350,33577.0,Citric acid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'lactation', 'APRT', 'Citric acid']",0.5
16350,33632.0,Citric acid,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'tissue homeostasis', 'AKR1B1', 'Citric acid']",0.5
16350,35565.0,Citric acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'PLEKHA1', 'Citric acid']",0.5
16350,35764.0,Citric acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'tissue homeostasis', 'AKR1B1', 'Citric acid']",0.5
16350,36432.0,Citric acid,congestive heart failure,disease-protein-drug,contraindication,"['congestive heart failure', 'CS', 'Citric acid']",0.5
16352,33577.0,Norepinephrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Norepinephrine']",0.5
16352,33605.0,Norepinephrine,hypotensive disorder,disease-protein-drug,indication,"['hypotensive disorder', 'ADRA1B', 'Norepinephrine']",0.5
16352,33675.0,Norepinephrine,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Norepinephrine']",0.5
16352,33675.0,Norepinephrine,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Norepinephrine']",0.5
16352,35766.0,Norepinephrine,thrombotic disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombotic disease', 'Particulate Matter', 'platelet activation', 'ADRA2B', 'Norepinephrine']",0.5
16352,35897.0,Norepinephrine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'platelet activation', 'ADRA2B', 'Norepinephrine']",0.5
16352,37830.0,Norepinephrine,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Norepinephrine']",0.5
16352,39773.0,Norepinephrine,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Norepinephrine']",0.5
16352,83781.0,Norepinephrine,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Norepinephrine']",0.5
16353,33593.0,Mazindol,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Organophosphorus Compounds', 'social behavior', 'SLC6A4', 'Mazindol']",0.5
16354,33575.0,Deserpidine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'SLC18A2', 'Deserpidine']",0.5
16357,27933.0,Isometheptene,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'SLC18A2', 'Isometheptene']",0.5
16357,27933.0,Isometheptene,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'SLC18A2', 'Isometheptene']",0.5
16357,30035.0,Isometheptene,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC18A2', 'Isometheptene']",0.5
16357,33577.0,Isometheptene,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Isometheptene']",0.5
16357,36187.0,Isometheptene,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Isometheptene']",0.5
16357,37786.0,Isometheptene,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Nitrogen Oxides', 'aging', 'ADRA1A', 'Isometheptene']",0.5
16376,28651.0,Quinestrol,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'ESR1', 'Quinestrol']",0.5
16376,29182.0,Quinestrol,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of inflammatory response', 'ESR1', 'Quinestrol']",0.5
16376,31477.0,Quinestrol,ovarian cancer,disease-protein-drug,contraindication,"['ovarian cancer', 'ESR1', 'Quinestrol']",0.5
16376,31596.0,Quinestrol,uterine corpus leiomyoma,disease-protein-drug,contraindication,"['uterine corpus leiomyoma', 'ESR1', 'Quinestrol']",0.5
16376,32617.0,Quinestrol,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'ESR1', 'Quinestrol']",0.5
16376,33575.0,Quinestrol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,33577.0,Quinestrol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,33593.0,Quinestrol,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'ESR1', 'Quinestrol']",0.5
16376,33593.0,Quinestrol,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Quinestrol']",0.5
16376,33598.0,Quinestrol,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,33675.0,Quinestrol,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,33680.0,Quinestrol,endometriosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['endometriosis (disease)', 'bisphenol A', 'intracellular estrogen receptor signaling pathway', 'ESR1', 'Quinestrol']",0.5
16376,33699.0,Quinestrol,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,35738.0,Quinestrol,endometrial carcinoma (disease),disease-protein-drug,contraindication,"['endometrial carcinoma (disease)', 'ESR1', 'Quinestrol']",0.5
16376,35739.0,Quinestrol,uterine corpus cancer,disease-protein-drug,contraindication,"['uterine corpus cancer', 'ESR1', 'Quinestrol']",0.5
16376,35901.0,Quinestrol,leiomyoma,disease-protein-drug,contraindication,"['leiomyoma', 'ESR1', 'Quinestrol']",0.5
16376,35909.0,Quinestrol,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,35958.0,Quinestrol,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'ESR1', 'Quinestrol']",0.5
16376,36187.0,Quinestrol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ESR1', 'Quinestrol']",0.5
16376,36187.0,Quinestrol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,36527.0,Quinestrol,yolk sac tumor,disease-protein-drug,contraindication,"['yolk sac tumor', 'ESR1', 'Quinestrol']",0.5
16376,36792.0,Quinestrol,ovarian mucinous adenocarcinoma,disease-protein-drug,contraindication,"['ovarian mucinous adenocarcinoma', 'ESR1', 'Quinestrol']",0.5
16376,36794.0,Quinestrol,ovarian adenocarcinoma,disease-protein-drug,contraindication,"['ovarian adenocarcinoma', 'ESR1', 'Quinestrol']",0.5
16376,37038.0,Quinestrol,endometrium neoplasm,disease-protein-drug,contraindication,"['endometrium neoplasm', 'ESR1', 'Quinestrol']",0.5
16376,37047.0,Quinestrol,immature ovarian teratoma,disease-protein-drug,contraindication,"['immature ovarian teratoma', 'ESR1', 'Quinestrol']",0.5
16376,37082.0,Quinestrol,malignant germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant germ cell tumor of ovary', 'ESR1', 'Quinestrol']",0.5
16376,37150.0,Quinestrol,malignant non-dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant non-dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Quinestrol']",0.5
16376,37152.0,Quinestrol,familial ovarian cancer,disease-protein-drug,contraindication,"['familial ovarian cancer', 'ESR1', 'Quinestrol']",0.5
16376,37180.0,Quinestrol,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'ESR1', 'Quinestrol']",0.5
16376,37180.0,Quinestrol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,37423.0,Quinestrol,ovarian clear cell adenocarcinoma,disease-protein-drug,contraindication,"['ovarian clear cell adenocarcinoma', 'ESR1', 'Quinestrol']",0.5
16376,37466.0,Quinestrol,ovarian small cell carcinoma,disease-protein-drug,contraindication,"['ovarian small cell carcinoma', 'ESR1', 'Quinestrol']",0.5
16376,37573.0,Quinestrol,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'positive regulation of transcription, DNA-templated', 'ESR1', 'Quinestrol']",0.5
16376,37768.0,Quinestrol,migraine disorder,disease-protein-drug,contraindication,"['migraine disorder', 'ESR1', 'Quinestrol']",0.5
16376,37967.0,Quinestrol,ovarian endometrioid adenocarcinoma,disease-protein-drug,contraindication,"['ovarian endometrioid adenocarcinoma', 'ESR1', 'Quinestrol']",0.5
16376,39603.0,Quinestrol,malignant sex cord stromal tumor of ovary,disease-protein-drug,contraindication,"['malignant sex cord stromal tumor of ovary', 'ESR1', 'Quinestrol']",0.5
16376,39615.0,Quinestrol,borderline epithelial tumor of ovary,disease-protein-drug,contraindication,"['borderline epithelial tumor of ovary', 'ESR1', 'Quinestrol']",0.5
16376,83816.0,Quinestrol,ovarian carcinosarcoma,disease-protein-drug,contraindication,"['ovarian carcinosarcoma', 'ESR1', 'Quinestrol']",0.5
16376,83817.0,Quinestrol,hereditary site-specific ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary site-specific ovarian cancer syndrome', 'ESR1', 'Quinestrol']",0.5
16376,83818.0,Quinestrol,primary non-gestational choriocarcinoma of ovary,disease-protein-drug,contraindication,"['primary non-gestational choriocarcinoma of ovary', 'ESR1', 'Quinestrol']",0.5
16376,83819.0,Quinestrol,malignant dysgerminomatous germ cell tumor of ovary,disease-protein-drug,contraindication,"['malignant dysgerminomatous germ cell tumor of ovary', 'ESR1', 'Quinestrol']",0.5
16376,83820.0,Quinestrol,maligant granulosa cell tumor of ovary,disease-protein-drug,contraindication,"['maligant granulosa cell tumor of ovary', 'ESR1', 'Quinestrol']",0.5
16376,83821.0,Quinestrol,malignant Sertoli-Leydig cell tumor of ovary,disease-protein-drug,contraindication,"['malignant Sertoli-Leydig cell tumor of ovary', 'ESR1', 'Quinestrol']",0.5
16376,83822.0,Quinestrol,"theca steroid-producing cell malignant tumor of ovary, not further specified",disease-protein-drug,contraindication,"['theca steroid-producing cell malignant tumor of ovary, not further specified', 'ESR1', 'Quinestrol']",0.5
16376,83823.0,Quinestrol,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'ESR1', 'Quinestrol']",0.5
16376,83824.0,Quinestrol,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'ESR1', 'Quinestrol']",0.5
16434,27326.0,Acetophenazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Acetophenazine']",0.5
16434,27326.0,Acetophenazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Acetophenazine']",0.5
16434,27626.0,Acetophenazine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'AR', 'Acetophenazine']",0.5
16434,27655.0,Acetophenazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD2', 'Acetophenazine']",0.5
16434,28375.0,Acetophenazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Acetophenazine']",0.5
16434,28547.0,Acetophenazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'DRD2', 'Acetophenazine']",0.5
16434,28547.0,Acetophenazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Acetophenazine']",0.5
16434,28780.0,Acetophenazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'spermatogenesis', 'AR', 'Acetophenazine']",0.5
16434,28780.0,Acetophenazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD2', 'Acetophenazine']",0.5
16434,29637.0,Acetophenazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Acetophenazine']",0.5
16434,29637.0,Acetophenazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD2', 'Acetophenazine']",0.5
16434,30035.0,Acetophenazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'DRD2', 'Acetophenazine']",0.5
16434,31393.0,Acetophenazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Lead', 'regulation of systemic arterial blood pressure', 'AR', 'Acetophenazine']",0.5
16434,31395.0,Acetophenazine,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Acetophenazine']",0.5
16434,33454.0,Acetophenazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Acetophenazine']",0.5
16434,33593.0,Acetophenazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'bisphenol A', 'spermatogenesis', 'AR', 'Acetophenazine']",0.5
16434,33593.0,Acetophenazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'DRD2', 'Acetophenazine']",0.5
16434,33632.0,Acetophenazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'regulation of systemic arterial blood pressure', 'AR', 'Acetophenazine']",0.5
16434,35565.0,Acetophenazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Acetophenazine']",0.5
16434,35641.0,Acetophenazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD2', 'Acetophenazine']",0.5
16434,35641.0,Acetophenazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Acetophenazine']",0.5
16434,36187.0,Acetophenazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Acetophenazine']",0.5
16434,37180.0,Acetophenazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Acetophenazine']",0.5
16434,37706.0,Acetophenazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Acetophenazine']",0.5
16434,37786.0,Acetophenazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Acetophenazine']",0.5
16434,38003.0,Acetophenazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD2', 'Acetophenazine']",0.5
16434,39081.0,Acetophenazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Acetophenazine']",0.5
16434,83998.0,Acetophenazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Acetophenazine']",0.5
16434,84023.0,Acetophenazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Acetophenazine']",0.5
16443,29113.0,Stanozolol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'AR', 'Stanozolol']",0.5
16443,31395.0,Stanozolol,benign prostatic hyperplasia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['benign prostatic hyperplasia (disease)', 'Tetrachlorodibenzodioxin', 'spermatogenesis', 'AR', 'Stanozolol']",0.5
16443,33575.0,Stanozolol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanozolol']",0.5
16443,33575.0,Stanozolol,diabetes mellitus (disease),disease-phenotype-protein-drug,contraindication,"['diabetes mellitus (disease)', 'Maternal diabetes', 'AR', 'Stanozolol']",0.5
16443,35565.0,Stanozolol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'AR', 'Stanozolol']",0.5
16443,35669.0,Stanozolol,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanozolol']",0.5
16443,35761.0,Stanozolol,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanozolol']",0.5
16443,35764.0,Stanozolol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of systemic arterial blood pressure', 'AR', 'Stanozolol']",0.5
16443,35963.0,Stanozolol,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'AR', 'Stanozolol']",0.5
16443,35966.0,Stanozolol,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'AR', 'Stanozolol']",0.5
16443,35966.0,Stanozolol,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'perfluorooctanoic acid', 'spermatogenesis', 'AR', 'Stanozolol']",0.5
16443,36187.0,Stanozolol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of systemic arterial blood pressure', 'AR', 'Stanozolol']",0.5
16459,36080.0,Triclosan,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of blood pressure', 'PPARG', 'Triclosan']",0.5
16459,36080.0,Triclosan,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'TPO', 'Triclosan']",0.5
16465,27626.0,Guanidine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'spermatogenesis', 'GAMT', 'Guanidine']",0.5
16465,33632.0,Guanidine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'creatine metabolic process', 'GAMT', 'Guanidine']",0.5
16468,33575.0,Goserelin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'cognition', 'LHCGR', 'Goserelin']",0.5
16468,33577.0,Goserelin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Methylmercury Compounds', 'cognition', 'LHCGR', 'Goserelin']",0.5
16468,33593.0,Goserelin,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'cognition', 'LHCGR', 'Goserelin']",0.5
16475,35641.0,Phenacemide,epilepsy,disease-protein-drug,indication,"['epilepsy', 'SCN1A', 'Phenacemide']",0.5
16490,27933.0,Pheniramine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'memory', 'HRH1', 'Pheniramine']",0.5
16490,28158.0,Pheniramine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,28780.0,Pheniramine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'HRH1', 'Pheniramine']",0.5
16490,28899.0,Pheniramine,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Asbestos', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,33410.0,Pheniramine,dermatitis herpetiformis,disease-phenotype-protein-drug,contraindication,"['dermatitis herpetiformis', 'Pruritus', 'HRH1', 'Pheniramine']",0.5
16490,33577.0,Pheniramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Pheniramine']",0.5
16490,33581.0,Pheniramine,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,33605.0,Pheniramine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Pheniramine']",0.5
16490,33632.0,Pheniramine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'memory', 'HRH1', 'Pheniramine']",0.5
16490,33675.0,Pheniramine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,35565.0,Pheniramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Pheniramine']",0.5
16490,35641.0,Pheniramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Pheniramine']",0.5
16490,35669.0,Pheniramine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,35761.0,Pheniramine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,35764.0,Pheniramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Pheniramine']",0.5
16490,35897.0,Pheniramine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,35915.0,Pheniramine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Asbestos', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,35953.0,Pheniramine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Pheniramine']",0.5
16490,35953.0,Pheniramine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,36034.0,Pheniramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Pheniramine']",0.5
16490,36080.0,Pheniramine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,36187.0,Pheniramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,36252.0,Pheniramine,thyroid gland disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thyroid gland disease', 'Particulate Matter', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,36274.0,Pheniramine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,36469.0,Pheniramine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Pheniramine']",0.5
16490,36492.0,Pheniramine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'visual learning', 'HRH1', 'Pheniramine']",0.5
16490,36693.0,Pheniramine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Pheniramine']",0.5
16490,37180.0,Pheniramine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,37617.0,Pheniramine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,37785.0,Pheniramine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'HRH1', 'Pheniramine']",0.5
16490,37786.0,Pheniramine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,37830.0,Pheniramine,bronchitis,disease-exposure-bioprocess-gene-drug,contraindication,"['bronchitis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,37888.0,Pheniramine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Pheniramine']",0.5
16490,37888.0,Pheniramine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,83778.0,Pheniramine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Asbestos', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,83779.0,Pheniramine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Asbestos', 'inflammatory response', 'HRH1', 'Pheniramine']",0.5
16490,83791.0,Pheniramine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Pheniramine']",0.5
16495,28520.0,Quizartinib,myeloid leukemia,disease-protein-drug,indication,"['myeloid leukemia', 'FLT3', 'Quizartinib']",0.5
16495,37714.0,Quizartinib,unclassified acute myeloid leukemia,disease-protein-drug,indication,"['unclassified acute myeloid leukemia', 'FLT3', 'Quizartinib']",0.5
16495,38274.0,Quizartinib,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'FLT3', 'Quizartinib']",0.5
16495,39124.0,Quizartinib,therapy related acute myeloid leukemia and myelodysplastic syndrome,disease-protein-drug,indication,"['therapy related acute myeloid leukemia and myelodysplastic syndrome', 'FLT3', 'Quizartinib']",0.5
16495,83852.0,Quizartinib,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'FLT3', 'Quizartinib']",0.5
16495,83853.0,Quizartinib,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'FLT3', 'Quizartinib']",0.5
16495,83854.0,Quizartinib,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'FLT3', 'Quizartinib']",0.5
16495,83855.0,Quizartinib,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'FLT3', 'Quizartinib']",0.5
16495,83856.0,Quizartinib,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'FLT3', 'Quizartinib']",0.5
16495,83857.0,Quizartinib,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'FLT3', 'Quizartinib']",0.5
16495,83858.0,Quizartinib,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'FLT3', 'Quizartinib']",0.5
16495,83859.0,Quizartinib,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'FLT3', 'Quizartinib']",0.5
16495,83860.0,Quizartinib,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'FLT3', 'Quizartinib']",0.5
16495,83861.0,Quizartinib,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'FLT3', 'Quizartinib']",0.5
16495,83862.0,Quizartinib,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'FLT3', 'Quizartinib']",0.5
16506,27361.0,Pentazocine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'OPRM1', 'Pentazocine']",0.5
16506,27626.0,Pentazocine,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'OPRK1', 'Pentazocine']",0.5
16506,27648.0,Pentazocine,familial glucocorticoid deficiency,disease-phenotype-protein-drug,contraindication,"['familial glucocorticoid deficiency', 'Vomiting', 'ABCB1', 'Pentazocine']",0.5
16506,28158.0,Pentazocine,inflammatory bowel disease,disease-protein-drug,contraindication,"['inflammatory bowel disease', 'ABCB1', 'Pentazocine']",0.5
16506,28158.0,Pentazocine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'OPRK1', 'Pentazocine']",0.5
16506,28158.0,Pentazocine,inflammatory bowel disease,disease-phenotype-protein-drug,contraindication,"['inflammatory bowel disease', 'Vomiting', 'ABCB1', 'Pentazocine']",0.5
16506,28780.0,Pentazocine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Pentazocine']",0.5
16506,28780.0,Pentazocine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'OPRM1', 'Pentazocine']",0.5
16506,29525.0,Pentazocine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Pentazocine']",0.5
16506,30035.0,Pentazocine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Pentazocine']",0.5
16506,30813.0,Pentazocine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Pentazocine']",0.5
16506,31072.0,Pentazocine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Pentazocine']",0.5
16506,31732.0,Pentazocine,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'SIGMAR1', 'Pentazocine']",0.5
16506,32384.0,Pentazocine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Pentazocine']",0.5
16506,32584.0,Pentazocine,inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,disease-phenotype-protein-drug,contraindication,"['inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 'Vomiting', 'ABCB1', 'Pentazocine']",0.5
16506,32719.0,Pentazocine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Pentazocine']",0.5
16506,33440.0,Pentazocine,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Arrhythmia', 'OPRK1', 'Pentazocine']",0.5
16506,33677.0,Pentazocine,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Pentazocine']",0.5
16506,35565.0,Pentazocine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRK1', 'Pentazocine']",0.5
16506,35641.0,Pentazocine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Pentazocine']",0.5
16506,35764.0,Pentazocine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'OPRK1', 'Pentazocine']",0.5
16506,35897.0,Pentazocine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Pentazocine']",0.5
16506,36080.0,Pentazocine,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Pentazocine']",0.5
16506,36693.0,Pentazocine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Pentazocine']",0.5
16506,37753.0,Pentazocine,opiate dependence,disease-protein-drug,contraindication,"['opiate dependence', 'OPRM1', 'Pentazocine']",0.5
16506,37785.0,Pentazocine,ulcerative colitis (disease),disease-protein-drug,contraindication,"['ulcerative colitis (disease)', 'ABCB1', 'Pentazocine']",0.5
16506,83910.0,Pentazocine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Pentazocine']",0.5
16506,84242.0,Pentazocine,morphine dependence,disease-protein-drug,contraindication,"['morphine dependence', 'OPRM1', 'Pentazocine']",0.5
16508,27933.0,Captodiame,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'DRD3', 'Captodiame']",0.5
16508,27933.0,Captodiame,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Parathion', 'learning or memory', 'DRD3', 'Captodiame']",0.5
16510,31107.0,Bevacizumab,cervical cancer,disease-protein-drug,indication,"['cervical cancer', 'VEGFA', 'Bevacizumab']",0.5
16510,31107.0,Bevacizumab,cervical cancer,disease-exposure-bioprocess-gene-drug,indication,"['cervical cancer', 'Vehicle Emissions', 'inflammatory response', 'FCGR2B', 'Bevacizumab']",0.5
16510,32214.0,Bevacizumab,glioblastoma (disease),disease-protein-drug,indication,"['glioblastoma (disease)', 'VEGFA', 'Bevacizumab']",0.5
16510,32214.0,Bevacizumab,glioblastoma (disease),disease-phenotype-protein-drug,indication,"['glioblastoma (disease)', 'Memory impairment', 'VEGFA', 'Bevacizumab']",0.5
16510,32617.0,Bevacizumab,hereditary breast ovarian cancer syndrome,disease-protein-drug,indication,"['hereditary breast ovarian cancer syndrome', 'C1QB', 'Bevacizumab']",0.5
16510,35741.0,Bevacizumab,cervical adenocarcinoma,disease-protein-drug,indication,"['cervical adenocarcinoma', 'VEGFA', 'Bevacizumab']",0.5
16510,35741.0,Bevacizumab,cervical adenocarcinoma,disease-exposure-bioprocess-gene-drug,indication,"['cervical adenocarcinoma', 'Vehicle Emissions', 'inflammatory response', 'FCGR2B', 'Bevacizumab']",0.5
16510,35771.0,Bevacizumab,breast neoplasm,disease-protein-drug,indication,"['breast neoplasm', 'C1QB', 'Bevacizumab']",0.5
16510,35771.0,Bevacizumab,breast neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['breast neoplasm', 'Air Pollutants', 'inflammatory response', 'FCGR2B', 'Bevacizumab']",0.5
16510,35771.0,Bevacizumab,breast neoplasm,disease-exposure-gene-drug,indication,"['breast neoplasm', 'Nitrogen Dioxide', 'VEGFA', 'Bevacizumab']",0.5
16510,36691.0,Bevacizumab,breast cancer,disease-protein-drug,indication,"['breast cancer', 'C1QB', 'Bevacizumab']",0.5
16510,84243.0,Bevacizumab,squamous cell carcinoma of the corpus uteri,disease-protein-drug,indication,"['squamous cell carcinoma of the corpus uteri', 'C1QB', 'Bevacizumab']",0.5
16510,84244.0,Bevacizumab,undifferentiated carcinoma of the corpus uteri,disease-protein-drug,indication,"['undifferentiated carcinoma of the corpus uteri', 'C1QB', 'Bevacizumab']",0.5
16511,33064.0,Ranibizumab,retinal artery occlusion,disease-protein-drug,indication,"['retinal artery occlusion', 'VEGFA', 'Ranibizumab']",0.5
16511,33581.0,Ranibizumab,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'VEGFA', 'Ranibizumab']",0.5
16511,33581.0,Ranibizumab,conjunctivitis (disease),disease-exposure-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'VEGFA', 'Ranibizumab']",0.5
16511,36325.0,Ranibizumab,diabetic retinopathy,disease-protein-drug,indication,"['diabetic retinopathy', 'VEGFA', 'Ranibizumab']",0.5
16511,83940.0,Ranibizumab,diabetic cataract,disease-protein-drug,indication,"['diabetic cataract', 'VEGFA', 'Ranibizumab']",0.5
16512,28869.0,Pegaptanib,macular degeneration,disease-protein-drug,indication,"['macular degeneration', 'VEGFA', 'Pegaptanib']",0.5
16517,28869.0,Aflibercept,macular degeneration,disease-protein-drug,indication,"['macular degeneration', 'VEGFA', 'Aflibercept']",0.5
16517,33064.0,Aflibercept,retinal artery occlusion,disease-protein-drug,indication,"['retinal artery occlusion', 'VEGFA', 'Aflibercept']",0.5
16519,28869.0,Brolucizumab,macular degeneration,disease-protein-drug,indication,"['macular degeneration', 'VEGFA', 'Brolucizumab']",0.5
16519,33581.0,Brolucizumab,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'VEGFA', 'Brolucizumab']",0.5
16519,33581.0,Brolucizumab,conjunctivitis (disease),disease-exposure-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'VEGFA', 'Brolucizumab']",0.5
16530,28052.0,Arbutamine,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Endocardial fibrosis', 'ADRB1', 'Arbutamine']",0.5
16532,29113.0,Pirbuterol,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Pirbuterol']",0.5
16532,33575.0,Pirbuterol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'bone resorption', 'ADRB2', 'Pirbuterol']",0.5
16532,33577.0,Pirbuterol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'bone resorption', 'ADRB2', 'Pirbuterol']",0.5
16532,33675.0,Pirbuterol,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Pirbuterol']",0.5
16532,33675.0,Pirbuterol,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Pirbuterol']",0.5
16532,33679.0,Pirbuterol,potassium deficiency disease,disease-protein-drug,contraindication,"['potassium deficiency disease', 'ADRB2', 'Pirbuterol']",0.5
16532,35833.0,Pirbuterol,lung disease,disease-exposure-bioprocess-gene-drug,indication,"['lung disease', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Pirbuterol']",0.5
16532,35897.0,Pirbuterol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Pirbuterol']",0.5
16532,36187.0,Pirbuterol,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Pirbuterol']",0.5
16532,36187.0,Pirbuterol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'bone resorption', 'ADRB2', 'Pirbuterol']",0.5
16532,37830.0,Pirbuterol,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Pirbuterol']",0.5
16532,39773.0,Pirbuterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Pirbuterol']",0.5
16532,83781.0,Pirbuterol,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Pirbuterol']",0.5
16536,29113.0,Racepinephrine,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Racepinephrine']",0.5
16536,33575.0,Racepinephrine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Racepinephrine']",0.5
16536,33577.0,Racepinephrine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Racepinephrine']",0.5
16536,36187.0,Racepinephrine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB1', 'Racepinephrine']",0.5
16536,36187.0,Racepinephrine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Racepinephrine']",0.5
16536,39798.0,Racepinephrine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Racepinephrine']",0.5
16543,29525.0,Hexylcaine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Hexylcaine']",0.5
16543,36080.0,Hexylcaine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of heart rate', 'SCN10A', 'Hexylcaine']",0.5
16544,29525.0,Dyclonine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Dyclonine']",0.5
16544,36080.0,Dyclonine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of heart rate', 'SCN10A', 'Dyclonine']",0.5
16545,33581.0,Proparacaine,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Soot', 'regulation of heart rate', 'SCN10A', 'Proparacaine']",0.5
16545,35669.0,Proparacaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Proparacaine']",0.5
16545,35761.0,Proparacaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Proparacaine']",0.5
16546,35669.0,Mepivacaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Mepivacaine']",0.5
16546,35761.0,Mepivacaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart rate', 'SCN10A', 'Mepivacaine']",0.5
16546,35764.0,Mepivacaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Mepivacaine']",0.5
16550,28780.0,Dipyridamole,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Nitrogen Oxides', 'aging', 'ADA', 'Dipyridamole']",0.5
16550,30035.0,Dipyridamole,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Dipyridamole']",0.5
16550,33618.0,Dipyridamole,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'platelet degranulation', 'ORM1', 'Dipyridamole']",0.5
16550,33632.0,Dipyridamole,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'response to oxidative stress', 'RCAN1', 'Dipyridamole']",0.5
16550,35565.0,Dipyridamole,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol homeostasis', 'ABCB11', 'Dipyridamole']",0.5
16550,35764.0,Dipyridamole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'ABCB11', 'Dipyridamole']",0.5
16550,36312.0,Dipyridamole,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['transient ischemic attack (disease)', 'Particulate Matter', 'platelet degranulation', 'ORM1', 'Dipyridamole']",0.5
16550,37180.0,Dipyridamole,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'ORM1', 'Dipyridamole']",0.5
16570,27559.0,Prilocaine,dilated cardiomyopathy,disease-protein-drug,contraindication,"['dilated cardiomyopathy', 'SCN5A', 'Prilocaine']",0.5
16570,27669.0,Prilocaine,familial dilated cardiomyopathy,disease-protein-drug,contraindication,"['familial dilated cardiomyopathy', 'SCN5A', 'Prilocaine']",0.5
16570,28547.0,Prilocaine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16570,33575.0,Prilocaine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16570,33577.0,Prilocaine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16570,33586.0,Prilocaine,atrioventricular block (disease),disease-protein-drug,contraindication,"['atrioventricular block (disease)', 'SCN5A', 'Prilocaine']",0.5
16570,35669.0,Prilocaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16570,35761.0,Prilocaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16570,35764.0,Prilocaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16570,36080.0,Prilocaine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16570,36187.0,Prilocaine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16570,37180.0,Prilocaine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of heart rate', 'SCN5A', 'Prilocaine']",0.5
16571,33649.0,Ornithine,exanthem (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['exanthem (disease)', 'Particulate Matter', 'learning or memory', 'GATM', 'Ornithine']",0.5
16582,35669.0,Leucine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of glucose metabolic process', 'LCMT1', 'Leucine']",0.5
16582,35761.0,Leucine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of glucose metabolic process', 'LCMT1', 'Leucine']",0.5
16582,35764.0,Leucine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'thyroid hormone metabolic process', 'SLC16A2', 'Leucine']",0.5
16582,36040.0,Leucine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'thyroid hormone metabolic process', 'SLC16A2', 'Leucine']",0.5
16582,83923.0,Leucine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'regulation of glucose metabolic process', 'LCMT1', 'Leucine']",0.5
16588,28208.0,Metformin,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'SLC22A3', 'Metformin']",0.5
16588,28208.0,Metformin,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,29614.0,Metformin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'Cadmium', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,30035.0,Metformin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC22A3', 'Metformin']",0.5
16588,31756.0,Metformin,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder cancer', 'Arsenic', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,33575.0,Metformin,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'SLC22A3', 'Metformin']",0.5
16588,33575.0,Metformin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,33598.0,Metformin,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,33642.0,Metformin,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder carcinoma', 'Arsenic', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,35565.0,Metformin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,35624.0,Metformin,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,contraindication,"['urinary bladder neoplasm', 'Arsenic', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,35764.0,Metformin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,35909.0,Metformin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,36040.0,Metformin,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Cadmium', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,36187.0,Metformin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,36544.0,Metformin,drug-induced liver injury,disease-protein-drug,contraindication,"['drug-induced liver injury', 'GPD1', 'Metformin']",0.5
16588,37180.0,Metformin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,37786.0,Metformin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16588,83923.0,Metformin,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'respiratory electron transport chain', 'ETFDH', 'Metformin']",0.5
16588,84167.0,Metformin,gestational diabetes,disease-exposure-bioprocess-gene-drug,off-label use,"['gestational diabetes', 'Arsenic', 'response to oxidative stress', 'ETFDH', 'Metformin']",0.5
16589,33598.0,Alteplase,stroke disorder,disease-protein-drug,indication,"['stroke disorder', 'FGA', 'Alteplase']",0.5
16589,33598.0,Alteplase,stroke disorder,disease-exposure-bioprocess-gene-drug,indication,"['stroke disorder', 'Air Pollutants', 'platelet aggregation', 'FGA', 'Alteplase']",0.5
16589,33598.0,Alteplase,stroke disorder,disease-exposure-gene-drug,indication,"['stroke disorder', 'Pesticides', 'SERPINE1', 'Alteplase']",0.5
16589,33699.0,Alteplase,pulmonary embolism (disease),disease-protein-drug,indication,"['pulmonary embolism (disease)', 'FGA', 'Alteplase']",0.5
16589,33699.0,Alteplase,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,indication,"['pulmonary embolism (disease)', 'Air Pollutants', 'platelet aggregation', 'FGA', 'Alteplase']",0.5
16589,37180.0,Alteplase,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,indication,"['myocardial infarction (disease)', 'Air Pollutants', 'platelet aggregation', 'FGA', 'Alteplase']",0.5
16589,37180.0,Alteplase,myocardial infarction (disease),disease-exposure-gene-drug,indication,"['myocardial infarction (disease)', 'Particulate Matter', 'SERPINE1', 'Alteplase']",0.5
16593,27933.0,Tranexamic acid,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'PLG', 'Tranexamic acid']",0.5
16593,27933.0,Tranexamic acid,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'innate immune response', 'SLC15A2', 'Tranexamic acid']",0.5
16593,28591.0,Tranexamic acid,hypoplasminogenemia,disease-protein-drug,contraindication,"['hypoplasminogenemia', 'PLG', 'Tranexamic acid']",0.5
16593,28591.0,Tranexamic acid,hypoplasminogenemia,disease-phenotype-protein-drug,contraindication,"['hypoplasminogenemia', 'Decreased level of plasminogen', 'PLG', 'Tranexamic acid']",0.5
16593,29646.0,Tranexamic acid,hepatocellular carcinoma,disease-exposure-bioprocess-gene-drug,contraindication,"['hepatocellular carcinoma', 'Arsenic', 'innate immune response', 'SLC15A2', 'Tranexamic acid']",0.5
16593,29646.0,Tranexamic acid,hepatocellular carcinoma,disease-exposure-gene-drug,contraindication,"['hepatocellular carcinoma', 'Benzene', 'PLG', 'Tranexamic acid']",0.5
16593,33575.0,Tranexamic acid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'innate immune response', 'SLC15A2', 'Tranexamic acid']",0.5
16593,33577.0,Tranexamic acid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'innate immune response', 'SLC15A2', 'Tranexamic acid']",0.5
16593,33593.0,Tranexamic acid,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Particulate Matter', 'platelet degranulation', 'PLG', 'Tranexamic acid']",0.5
16593,33598.0,Tranexamic acid,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Arsenic', 'innate immune response', 'SLC15A2', 'Tranexamic acid']",0.5
16593,35766.0,Tranexamic acid,thrombotic disease,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombotic disease', 'Particulate Matter', 'platelet degranulation', 'PLG', 'Tranexamic acid']",0.5
16593,35909.0,Tranexamic acid,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Particulate Matter', 'platelet degranulation', 'PLG', 'Tranexamic acid']",0.5
16593,36187.0,Tranexamic acid,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Tranexamic acid']",0.5
16593,36634.0,Tranexamic acid,liver cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['liver cancer', 'Arsenic', 'innate immune response', 'SLC15A2', 'Tranexamic acid']",0.5
16593,36634.0,Tranexamic acid,liver cancer,disease-exposure-gene-drug,contraindication,"['liver cancer', 'Benzene', 'PLG', 'Tranexamic acid']",0.5
16593,37180.0,Tranexamic acid,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'innate immune response', 'SLC15A2', 'Tranexamic acid']",0.5
16593,84328.0,Tranexamic acid,ligneous conjunctivitis,disease-protein-drug,contraindication,"['ligneous conjunctivitis', 'PLG', 'Tranexamic acid']",0.5
16634,28673.0,Coagulation factor VIIa Recombinant Human,congenital factor VII deficiency,disease-protein-drug,indication,"['congenital factor VII deficiency', 'F7', 'Coagulation factor VIIa Recombinant Human']",0.5
16634,38622.0,Coagulation factor VIIa Recombinant Human,factor VII deficiency,disease-protein-drug,indication,"['factor VII deficiency', 'F7', 'Coagulation factor VIIa Recombinant Human']",0.5
16635,31511.0,Fondaparinux,autoimmune thrombocytopenic,disease-phenotype-protein-drug,contraindication,"['autoimmune thrombocytopenic', 'Cerebral hemorrhage', 'SERPINC1', 'Fondaparinux']",0.5
16635,32563.0,Fondaparinux,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,contraindication,"['heparin-induced thrombocytopenia (disease)', 'Venous thrombosis', 'SERPINC1', 'Fondaparinux']",0.5
16635,83812.0,Fondaparinux,acute coronary syndrome,disease-protein-drug,off-label use,"['acute coronary syndrome', 'SERPINC1', 'Fondaparinux']",0.5
16671,27361.0,Emicizumab,hemophilia,disease-protein-drug,indication,"['hemophilia', 'F9', 'Emicizumab']",0.5
16671,32354.0,Emicizumab,symptomatic form of hemophilia in female carriers,disease-protein-drug,indication,"['symptomatic form of hemophilia in female carriers', 'F9', 'Emicizumab']",0.5
16672,28313.0,Baclofen,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'GABBR1', 'Baclofen']",0.5
16687,28052.0,Fosinopril,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Sudden death', 'ACE', 'Fosinopril']",0.5
16687,28231.0,Fosinopril,supravalvular aortic stenosis (disease),disease-phenotype-protein-drug,contraindication,"['supravalvular aortic stenosis (disease)', 'Arrhythmia', 'ACE', 'Fosinopril']",0.5
16687,29182.0,Fosinopril,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Fosinopril']",0.5
16687,29182.0,Fosinopril,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'ACE', 'Fosinopril']",0.5
16687,33025.0,Fosinopril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Pulmonary arterial hypertension', 'ACE', 'Fosinopril']",0.5
16687,33575.0,Fosinopril,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Fosinopril']",0.5
16687,33575.0,Fosinopril,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Particulate Matter', 'ACE', 'Fosinopril']",0.5
16687,33577.0,Fosinopril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Fosinopril']",0.5
16687,33577.0,Fosinopril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Fosinopril']",0.5
16687,33605.0,Fosinopril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ACE', 'Fosinopril']",0.5
16687,33618.0,Fosinopril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Fosinopril']",0.5
16687,33618.0,Fosinopril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Fosinopril']",0.5
16687,33618.0,Fosinopril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Fosinopril']",0.5
16687,35565.0,Fosinopril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Fosinopril']",0.5
16687,35764.0,Fosinopril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ACE', 'Fosinopril']",0.5
16687,36286.0,Fosinopril,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'ACE', 'Fosinopril']",0.5
16687,83802.0,Fosinopril,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Fosinopril']",0.5
16689,28231.0,Moexipril,supravalvular aortic stenosis (disease),disease-phenotype-protein-drug,contraindication,"['supravalvular aortic stenosis (disease)', 'Arrhythmia', 'ACE', 'Moexipril']",0.5
16689,29182.0,Moexipril,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Moexipril']",0.5
16689,29182.0,Moexipril,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'ACE', 'Moexipril']",0.5
16689,33025.0,Moexipril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Pulmonary arterial hypertension', 'ACE', 'Moexipril']",0.5
16689,33575.0,Moexipril,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Moexipril']",0.5
16689,33575.0,Moexipril,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Particulate Matter', 'ACE', 'Moexipril']",0.5
16689,33605.0,Moexipril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ACE', 'Moexipril']",0.5
16689,33618.0,Moexipril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Moexipril']",0.5
16689,33618.0,Moexipril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ACE', 'Moexipril']",0.5
16689,33618.0,Moexipril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Moexipril']",0.5
16689,35565.0,Moexipril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Moexipril']",0.5
16689,35764.0,Moexipril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ACE', 'Moexipril']",0.5
16689,36187.0,Moexipril,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ACE', 'Moexipril']",0.5
16689,36187.0,Moexipril,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Moexipril']",0.5
16689,36187.0,Moexipril,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Particulate Matter', 'ACE', 'Moexipril']",0.5
16689,36286.0,Moexipril,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'ACE', 'Moexipril']",0.5
16689,37786.0,Moexipril,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Moexipril']",0.5
16689,37786.0,Moexipril,myocardial ischemia,disease-exposure-gene-drug,contraindication,"['myocardial ischemia', 'Particulate Matter', 'ACE', 'Moexipril']",0.5
16689,83802.0,Moexipril,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Moexipril']",0.5
16690,28052.0,Lisinopril,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Sudden death', 'ACE', 'Lisinopril']",0.5
16690,29182.0,Lisinopril,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'regulation of blood pressure', 'REN', 'Lisinopril']",0.5
16690,29182.0,Lisinopril,systemic lupus erythematosus (disease),disease-exposure-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'ACE', 'Lisinopril']",0.5
16690,33025.0,Lisinopril,connective tissue disease,disease-phenotype-protein-drug,contraindication,"['connective tissue disease', 'Pulmonary arterial hypertension', 'ACE', 'Lisinopril']",0.5
16690,33534.0,Lisinopril,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Proteinuria', 'REN', 'Lisinopril']",0.5
16690,33575.0,Lisinopril,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'regulation of blood pressure', 'REN', 'Lisinopril']",0.5
16690,33575.0,Lisinopril,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Particulate Matter', 'ACE', 'Lisinopril']",0.5
16690,33577.0,Lisinopril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'REN', 'Lisinopril']",0.5
16690,33577.0,Lisinopril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Lisinopril']",0.5
16690,33605.0,Lisinopril,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'REN', 'Lisinopril']",0.5
16690,33618.0,Lisinopril,atrial fibrillation (disease),disease-protein-drug,off-label use,"['atrial fibrillation (disease)', 'ACE', 'Lisinopril']",0.5
16690,33618.0,Lisinopril,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'REN', 'Lisinopril']",0.5
16690,33618.0,Lisinopril,atrial fibrillation (disease),disease-exposure-gene-drug,off-label use,"['atrial fibrillation (disease)', 'Particulate Matter', 'ACE', 'Lisinopril']",0.5
16690,35565.0,Lisinopril,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Lisinopril']",0.5
16690,35764.0,Lisinopril,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'REN', 'Lisinopril']",0.5
16690,35764.0,Lisinopril,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'REN', 'Lisinopril']",0.5
16690,35958.0,Lisinopril,hemoglobinopathy,disease-protein-drug,indication,"['hemoglobinopathy', 'ACE', 'Lisinopril']",0.5
16690,36286.0,Lisinopril,diabetic nephropathy,disease-protein-drug,off-label use,"['diabetic nephropathy', 'ACE', 'Lisinopril']",0.5
16690,37180.0,Lisinopril,myocardial infarction (disease),disease-protein-drug,indication,"['myocardial infarction (disease)', 'ACE', 'Lisinopril']",0.5
16690,37180.0,Lisinopril,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,indication,"['myocardial infarction (disease)', 'Air Pollutants', 'regulation of blood pressure', 'REN', 'Lisinopril']",0.5
16690,37180.0,Lisinopril,myocardial infarction (disease),disease-exposure-gene-drug,indication,"['myocardial infarction (disease)', 'Particulate Matter', 'ACE', 'Lisinopril']",0.5
16690,83802.0,Lisinopril,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['obsolete hyperuricemia (disease)', 'perfluorooctane sulfonic acid', 'spermatogenesis', 'ACE', 'Lisinopril']",0.5
16690,83823.0,Lisinopril,coronary thrombosis,disease-protein-drug,indication,"['coronary thrombosis', 'ACE', 'Lisinopril']",0.5
16690,83824.0,Lisinopril,myocardial infarction,disease-protein-drug,indication,"['myocardial infarction', 'ACE', 'Lisinopril']",0.5
16693,33577.0,Cilazapril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Cilazapril']",0.5
16693,33577.0,Cilazapril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Cilazapril']",0.5
16694,33577.0,Spirapril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Spirapril']",0.5
16694,33577.0,Spirapril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Spirapril']",0.5
16697,33577.0,Temocapril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Temocapril']",0.5
16697,33577.0,Temocapril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Temocapril']",0.5
16698,33577.0,Enalaprilat,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Enalaprilat']",0.5
16698,33577.0,Enalaprilat,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Enalaprilat']",0.5
16698,36432.0,Enalaprilat,congestive heart failure,disease-protein-drug,indication,"['congestive heart failure', 'ACE', 'Enalaprilat']",0.5
16698,37659.0,Enalaprilat,heart failure,disease-protein-drug,indication,"['heart failure', 'ACE', 'Enalaprilat']",0.5
16698,37659.0,Enalaprilat,heart failure,disease-exposure-bioprocess-gene-drug,indication,"['heart failure', 'Air Pollutants', 'regulation of blood pressure', 'ACE', 'Enalaprilat']",0.5
16699,33577.0,Zofenopril,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'ACE', 'Zofenopril']",0.5
16699,33577.0,Zofenopril,hypertensive disorder,disease-exposure-gene-drug,indication,"['hypertensive disorder', 'Particulate Matter', 'ACE', 'Zofenopril']",0.5
16741,31502.0,Azelaic acid,Wilson disease,disease-protein-drug,contraindication,"['Wilson disease', 'AKR1D1', 'Azelaic acid']",0.5
16741,36214.0,Azelaic acid,iron metabolism disease,disease-protein-drug,contraindication,"['iron metabolism disease', 'AKR1D1', 'Azelaic acid']",0.5
16741,38641.0,Azelaic acid,hereditary hemochromatosis,disease-protein-drug,contraindication,"['hereditary hemochromatosis', 'AKR1D1', 'Azelaic acid']",0.5
16753,27626.0,Lenalidomide,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'TNFSF11', 'Lenalidomide']",0.5
16753,30494.0,Lenalidomide,plasma cell myeloma,disease-protein-drug,indication,"['plasma cell myeloma', 'CRBN', 'Lenalidomide']",0.5
16753,30494.0,Lenalidomide,plasma cell myeloma,disease-exposure-bioprocess-gene-drug,indication,"['plasma cell myeloma', 'Tetrachlorodibenzodioxin', 'ovulation', 'PTGS2', 'Lenalidomide']",0.5
16753,32531.0,Lenalidomide,mantle cell lymphoma,disease-phenotype-protein-drug,indication,"['mantle cell lymphoma', 'Fever', 'PTGS2', 'Lenalidomide']",0.5
16753,33699.0,Lenalidomide,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'regulation of blood pressure', 'PTGS2', 'Lenalidomide']",0.5
16753,33699.0,Lenalidomide,pulmonary embolism (disease),disease-exposure-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'PTGS2', 'Lenalidomide']",0.5
16753,36104.0,Lenalidomide,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Lenalidomide']",0.5
16753,36229.0,Lenalidomide,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Lenalidomide']",0.5
16758,29078.0,Alclofenac,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'PTGS2', 'Alclofenac']",0.5
16758,29078.0,Alclofenac,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'regulation of blood pressure', 'PTGS2', 'Alclofenac']",0.5
16758,29078.0,Alclofenac,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'PTGS2', 'Alclofenac']",0.5
16758,29078.0,Alclofenac,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'PTGS2', 'Alclofenac']",0.5
16788,27933.0,Methyclothiazide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Polychlorinated Biphenyls', 'response to steroid hormone', 'CA2', 'Methyclothiazide']",0.5
16788,33575.0,Methyclothiazide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Polychlorinated Biphenyls', 'response to steroid hormone', 'CA2', 'Methyclothiazide']",0.5
16791,27933.0,Benzthiazide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'response to oxidative stress', 'CA3', 'Benzthiazide']",0.5
16791,27933.0,Benzthiazide,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'Pesticides', 'CA5A', 'Benzthiazide']",0.5
16791,35764.0,Benzthiazide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to oxidative stress', 'CA3', 'Benzthiazide']",0.5
16792,27478.0,Methazolamide,renal tubular acidosis,disease-protein-drug,contraindication,"['renal tubular acidosis', 'CA2', 'Methazolamide']",0.5
16792,28208.0,Methazolamide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Zinc', 'response to oxidative stress', 'CA3', 'Methazolamide']",0.5
16792,28552.0,Methazolamide,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'response to oxidative stress', 'CA3', 'Methazolamide']",0.5
16792,33575.0,Methazolamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CA3', 'Methazolamide']",0.5
16792,35565.0,Methazolamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'response to oxidative stress', 'CA3', 'Methazolamide']",0.5
16792,35764.0,Methazolamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to oxidative stress', 'CA3', 'Methazolamide']",0.5
16792,36080.0,Methazolamide,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'response to oxidative stress', 'CA3', 'Methazolamide']",0.5
16793,27933.0,Chlorothiazide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Polychlorinated Biphenyls', 'response to steroid hormone', 'CA2', 'Chlorothiazide']",0.5
16793,28208.0,Chlorothiazide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Polychlorinated Biphenyls', 'response to steroid hormone', 'CA2', 'Chlorothiazide']",0.5
16793,33575.0,Chlorothiazide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Polychlorinated Biphenyls', 'response to steroid hormone', 'CA2', 'Chlorothiazide']",0.5
16793,33598.0,Chlorothiazide,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Polychlorinated Biphenyls', 'response to steroid hormone', 'CA2', 'Chlorothiazide']",0.5
16795,27478.0,Diclofenamide,renal tubular acidosis,disease-protein-drug,contraindication,"['renal tubular acidosis', 'CA2', 'Diclofenamide']",0.5
16795,28208.0,Diclofenamide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Zinc', 'response to oxidative stress', 'CA3', 'Diclofenamide']",0.5
16795,28552.0,Diclofenamide,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'response to oxidative stress', 'CA3', 'Diclofenamide']",0.5
16795,33575.0,Diclofenamide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CA3', 'Diclofenamide']",0.5
16795,35565.0,Diclofenamide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'response to oxidative stress', 'CA3', 'Diclofenamide']",0.5
16795,35764.0,Diclofenamide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to oxidative stress', 'CA3', 'Diclofenamide']",0.5
16795,36080.0,Diclofenamide,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'response to oxidative stress', 'CA3', 'Diclofenamide']",0.5
16796,27933.0,Quinethazone,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Polychlorinated Biphenyls', 'response to steroid hormone', 'CA2', 'Quinethazone']",0.5
16796,35641.0,Quinethazone,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC12A2', 'Quinethazone']",0.5
16802,29078.0,Aurothioglucose,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Particulate Matter', 'brain development', 'ADCY1', 'Aurothioglucose']",0.5
16802,29182.0,Aurothioglucose,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'brain development', 'ADCY1', 'Aurothioglucose']",0.5
16802,33575.0,Aurothioglucose,diabetes mellitus (disease),disease-protein-drug,contraindication,"['diabetes mellitus (disease)', 'ADCY5', 'Aurothioglucose']",0.5
16802,33575.0,Aurothioglucose,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'ADCY5', 'Aurothioglucose']",0.5
16802,33577.0,Aurothioglucose,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of insulin secretion involved in cellular response to glucose stimulus', 'ADCY5', 'Aurothioglucose']",0.5
16802,33649.0,Aurothioglucose,exanthem (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['exanthem (disease)', 'Particulate Matter', 'brain development', 'ADCY1', 'Aurothioglucose']",0.5
16802,35565.0,Aurothioglucose,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'brain development', 'ADCY1', 'Aurothioglucose']",0.5
16802,35764.0,Aurothioglucose,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of insulin secretion involved in cellular response to glucose stimulus', 'ADCY5', 'Aurothioglucose']",0.5
16802,35916.0,Aurothioglucose,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Mercury', 'regulation of insulin secretion involved in cellular response to glucose stimulus', 'ADCY5', 'Aurothioglucose']",0.5
16802,36129.0,Aurothioglucose,atopic eczema,disease-exposure-bioprocess-gene-drug,contraindication,"['atopic eczema', 'Mercury', 'regulation of insulin secretion involved in cellular response to glucose stimulus', 'ADCY5', 'Aurothioglucose']",0.5
16825,29614.0,Ardeparin,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorooctanoic acid', 'lactation', 'SERPINC1', 'Ardeparin']",0.5
16825,30094.0,Ardeparin,antithrombin III deficiency,disease-protein-drug,contraindication,"['antithrombin III deficiency', 'SERPINC1', 'Ardeparin']",0.5
16825,32296.0,Ardeparin,acquired purpura fulminans,disease-protein-drug,indication,"['acquired purpura fulminans', 'SERPINC1', 'Ardeparin']",0.5
16825,32563.0,Ardeparin,heparin-induced thrombocytopenia (disease),disease-phenotype-protein-drug,contraindication,"['heparin-induced thrombocytopenia (disease)', 'Venous thrombosis', 'SERPINC1', 'Ardeparin']",0.5
16825,35849.0,Ardeparin,disseminated intravascular coagulation,disease-protein-drug,indication,"['disseminated intravascular coagulation', 'SERPINC1', 'Ardeparin']",0.5
16825,37785.0,Ardeparin,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'lactation', 'SERPINC1', 'Ardeparin']",0.5
16825,39484.0,Ardeparin,purpura fulminans,disease-protein-drug,indication,"['purpura fulminans', 'SERPINC1', 'Ardeparin']",0.5
16825,83812.0,Ardeparin,acute coronary syndrome,disease-protein-drug,off-label use,"['acute coronary syndrome', 'SERPINC1', 'Ardeparin']",0.5
16837,33563.0,Urea,otitis media (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['otitis media (disease)', 'Particulate Matter', 'bone resorption', 'CTNNB1', 'Urea']",0.5
16837,33649.0,Urea,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'bone resorption', 'CTNNB1', 'Urea']",0.5
16837,36129.0,Urea,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'CTNNB1', 'Urea']",0.5
16842,28391.0,Pramipexole,narcolepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['narcolepsy', 'Pesticides', 'visual learning', 'DRD3', 'Pramipexole']",0.5
16842,28396.0,Pramipexole,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'HTR1A', 'Pramipexole']",0.5
16842,28547.0,Pramipexole,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD2', 'Pramipexole']",0.5
16842,28547.0,Pramipexole,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Pramipexole']",0.5
16842,28547.0,Pramipexole,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'HTR1A', 'Pramipexole']",0.5
16842,28801.0,Pramipexole,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD2', 'Pramipexole']",0.5
16842,28801.0,Pramipexole,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Tremor', 'HTR1A', 'Pramipexole']",0.5
16842,28974.0,Pramipexole,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DRD2', 'Pramipexole']",0.5
16842,28974.0,Pramipexole,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Resting tremor', 'HTR1A', 'Pramipexole']",0.5
16842,30093.0,Pramipexole,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DRD2', 'Pramipexole']",0.5
16842,30093.0,Pramipexole,parkinsonian-pyramidal syndrome,disease-phenotype-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'Tremor', 'HTR1A', 'Pramipexole']",0.5
16842,30664.0,Pramipexole,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,contraindication,"['X-linked adrenoleukodystrophy', 'Memory impairment', 'HTR1A', 'Pramipexole']",0.5
16842,31408.0,Pramipexole,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DRD2', 'Pramipexole']",0.5
16842,31408.0,Pramipexole,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Resting tremor', 'HTR1A', 'Pramipexole']",0.5
16842,31618.0,Pramipexole,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'DRD3', 'Pramipexole']",0.5
16842,32313.0,Pramipexole,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'DRD3', 'Pramipexole']",0.5
16842,32759.0,Pramipexole,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DRD2', 'Pramipexole']",0.5
16842,32759.0,Pramipexole,hemiparkinsonism-hemiatrophy syndrome,disease-phenotype-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'Tremor', 'HTR1A', 'Pramipexole']",0.5
16842,32974.0,Pramipexole,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DRD2', 'Pramipexole']",0.5
16842,32974.0,Pramipexole,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Resting tremor', 'HTR1A', 'Pramipexole']",0.5
16842,33241.0,Pramipexole,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DRD2', 'Pramipexole']",0.5
16842,33241.0,Pramipexole,hereditary late onset Parkinson disease,disease-phenotype-protein-drug,indication,"['hereditary late onset Parkinson disease', 'Resting tremor', 'HTR1A', 'Pramipexole']",0.5
16842,33653.0,Pramipexole,melanoma,disease-exposure-bioprocess-gene-drug,contraindication,"['melanoma', 'mancozeb', 'social behavior', 'DRD3', 'Pramipexole']",0.5
16842,33664.0,Pramipexole,sleep apnea syndrome,disease-phenotype-protein-drug,contraindication,"['sleep apnea syndrome', 'Apnea', 'HTR1A', 'Pramipexole']",0.5
16842,35764.0,Pramipexole,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Pramipexole']",0.5
16842,35915.0,Pramipexole,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Pramipexole']",0.5
16842,83749.0,Pramipexole,drug-induced dyskinesia,disease-protein-drug,contraindication,"['drug-induced dyskinesia', 'DRD3', 'Pramipexole']",0.5
16842,83778.0,Pramipexole,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Pramipexole']",0.5
16842,83779.0,Pramipexole,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'DRD3', 'Pramipexole']",0.5
16844,33605.0,Phentolamine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADRA1B', 'Phentolamine']",0.5
16844,35565.0,Phentolamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'glucose homeostasis', 'ADRA2A', 'Phentolamine']",0.5
16844,36187.0,Phentolamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phentolamine']",0.5
16844,36312.0,Phentolamine,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,indication,"['transient ischemic attack (disease)', 'Particulate Matter', 'platelet activation', 'ADRA2A', 'Phentolamine']",0.5
16844,37180.0,Phentolamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phentolamine']",0.5
16844,37604.0,Phentolamine,erectile dysfunction (disease),disease-exposure-bioprocess-gene-drug,off-label use,"['erectile dysfunction (disease)', 'Arsenic', 'positive regulation of cytokine production', 'ADRA2A', 'Phentolamine']",0.5
16844,37718.0,Phentolamine,brain ischemia,disease-exposure-bioprocess-gene-drug,indication,"['brain ischemia', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phentolamine']",0.5
16844,39798.0,Phentolamine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,indication,"['peripheral arterial disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phentolamine']",0.5
16845,35764.0,Phenoxybenzamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Phenoxybenzamine']",0.5
16845,36187.0,Phenoxybenzamine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB2', 'Phenoxybenzamine']",0.5
16845,36187.0,Phenoxybenzamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Phenoxybenzamine']",0.5
16846,33575.0,Oxymetazoline,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Oxymetazoline']",0.5
16846,33577.0,Oxymetazoline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Oxymetazoline']",0.5
16846,33581.0,Oxymetazoline,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'glucose homeostasis', 'ADRA2A', 'Oxymetazoline']",0.5
16846,35669.0,Oxymetazoline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Oxymetazoline']",0.5
16846,35761.0,Oxymetazoline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Oxymetazoline']",0.5
16846,35953.0,Oxymetazoline,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Oxymetazoline']",0.5
16846,36187.0,Oxymetazoline,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Oxymetazoline']",0.5
16847,33577.0,Apraclonidine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Apraclonidine']",0.5
16847,33635.0,Apraclonidine,leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['leukemia (disease)', 'Cobalt', 'glucose homeostasis', 'ADRA2A', 'Apraclonidine']",0.5
16847,83942.0,Apraclonidine,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Apraclonidine']",0.5
16851,33577.0,Xylometazoline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Xylometazoline']",0.5
16851,35669.0,Xylometazoline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Xylometazoline']",0.5
16851,35761.0,Xylometazoline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Xylometazoline']",0.5
16852,33577.0,Naphazoline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Naphazoline']",0.5
16852,33581.0,Naphazoline,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'glucose homeostasis', 'ADRA2A', 'Naphazoline']",0.5
16852,35669.0,Naphazoline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'ADRA2A', 'Naphazoline']",0.5
16852,35761.0,Naphazoline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'ADRA2A', 'Naphazoline']",0.5
16852,83764.0,Naphazoline,hyperglycemia,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperglycemia', 'Nickel', 'glucose homeostasis', 'ADRA2A', 'Naphazoline']",0.5
16853,33577.0,Moxonidine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'ADRA2A', 'Moxonidine']",0.5
16855,27921.0,Methylphenidate,attention deficit-hyperactivity disorder,disease-protein-drug,indication,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Methylphenidate']",0.5
16855,27933.0,Methylphenidate,anxiety disorder,disease-protein-drug,off-label use,"['anxiety disorder', 'SLC6A2', 'Methylphenidate']",0.5
16855,27933.0,Methylphenidate,anxiety disorder,disease-exposure-bioprocess-gene-drug,off-label use,"['anxiety disorder', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'SLC6A3', 'Methylphenidate']",0.5
16855,28249.0,Methylphenidate,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Methylphenidate']",0.5
16855,30035.0,Methylphenidate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Methylphenidate']",0.5
16855,30664.0,Methylphenidate,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'SLC6A3', 'Methylphenidate']",0.5
16855,33577.0,Methylphenidate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Methylphenidate']",0.5
16855,33632.0,Methylphenidate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'positive regulation of multicellular organism growth', 'SLC6A3', 'Methylphenidate']",0.5
16855,35641.0,Methylphenidate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Methylphenidate']",0.5
16855,35909.0,Methylphenidate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Methylphenidate']",0.5
16855,36009.0,Methylphenidate,tic disorder,disease-protein-drug,contraindication,"['tic disorder', 'SLC6A3', 'Methylphenidate']",0.5
16855,36187.0,Methylphenidate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'positive regulation of multicellular organism growth', 'SLC6A3', 'Methylphenidate']",0.5
16855,37180.0,Methylphenidate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Lead', 'positive regulation of multicellular organism growth', 'SLC6A3', 'Methylphenidate']",0.5
16855,37703.0,Methylphenidate,neurotic disorder,disease-protein-drug,off-label use,"['neurotic disorder', 'SLC6A2', 'Methylphenidate']",0.5
16855,38242.0,Methylphenidate,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Methylphenidate']",0.5
16855,83760.0,Methylphenidate,dysthymic disorder,disease-protein-drug,off-label use,"['dysthymic disorder', 'SLC6A2', 'Methylphenidate']",0.5
16855,84036.0,Methylphenidate,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'SLC6A3', 'Methylphenidate']",0.5
16855,84036.0,Methylphenidate,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Lead', 'positive regulation of multicellular organism growth', 'SLC6A3', 'Methylphenidate']",0.5
16867,28456.0,Demeclocycline,nephrogenic syndrome of inappropriate antidiuresis,disease-protein-drug,off-label use,"['nephrogenic syndrome of inappropriate antidiuresis', 'AVPR2', 'Demeclocycline']",0.5
16892,33675.0,Secretin human,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Organophosphates', 'brain development', 'SCTR', 'Secretin human']",0.5
16892,35565.0,Secretin human,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'brain development', 'SCTR', 'Secretin human']",0.5
16892,36242.0,Secretin human,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Lead', 'brain development', 'SCTR', 'Secretin human']",0.5
16975,27361.0,Pentosan polysulfate,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'FGF2', 'Pentosan polysulfate']",0.5
17023,27710.0,Tafamidis,AL amyloidosis,disease-protein-drug,indication,"['AL amyloidosis', 'TTR', 'Tafamidis']",0.5
17023,33591.0,Tafamidis,amyloidosis (disease),disease-protein-drug,indication,"['amyloidosis (disease)', 'TTR', 'Tafamidis']",0.5
17023,84174.0,Tafamidis,AH amyloidosis,disease-protein-drug,indication,"['AH amyloidosis', 'TTR', 'Tafamidis']",0.5
17023,84193.0,Tafamidis,ATTRV122I amyloidosis,disease-protein-drug,indication,"['ATTRV122I amyloidosis', 'TTR', 'Tafamidis']",0.5
17030,31116.0,Alectinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'ABCB1', 'Alectinib']",0.5
17030,33688.0,Alectinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'ABCB1', 'Alectinib']",0.5
17042,31116.0,Ramucirumab,lung cancer,disease-protein-drug,indication,"['lung cancer', 'KDR', 'Ramucirumab']",0.5
17042,33688.0,Ramucirumab,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'KDR', 'Ramucirumab']",0.5
17060,33672.0,Sodium tetradecyl sulfate,neoplasm (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['neoplasm (disease)', 'Air Pollutants', 'negative regulation of inflammatory response', 'PROC', 'Sodium tetradecyl sulfate']",0.5
17060,35953.0,Sodium tetradecyl sulfate,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'negative regulation of inflammatory response', 'PROC', 'Sodium tetradecyl sulfate']",0.5
17062,27361.0,Butalbital,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'GRIA2', 'Butalbital']",0.5
17062,27933.0,Butalbital,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Butalbital']",0.5
17062,27933.0,Butalbital,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'DNA repair', 'CHRNA4', 'Butalbital']",0.5
17062,28158.0,Butalbital,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,28473.0,Butalbital,Pick disease,disease-protein-drug,contraindication,"['Pick disease', 'CHRNA7', 'Butalbital']",0.5
17062,28780.0,Butalbital,Alzheimer disease,disease-protein-drug,contraindication,"['Alzheimer disease', 'CHRNA7', 'Butalbital']",0.5
17062,28780.0,Butalbital,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,28780.0,Butalbital,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GRIA2', 'Butalbital']",0.5
17062,28899.0,Butalbital,obsessive-compulsive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obsessive-compulsive disorder', 'Tobacco Smoke Pollution', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,30035.0,Butalbital,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Butalbital']",0.5
17062,30813.0,Butalbital,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'GRIA2', 'Butalbital']",0.5
17062,31618.0,Butalbital,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GRIA2', 'Butalbital']",0.5
17062,31732.0,Butalbital,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'GABRA5', 'Butalbital']",0.5
17062,32033.0,Butalbital,insomnia (disease),disease-protein-drug,contraindication,"['insomnia (disease)', 'GABRB3', 'Butalbital']",0.5
17062,32313.0,Butalbital,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GRIA2', 'Butalbital']",0.5
17062,32384.0,Butalbital,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'GRIA2', 'Butalbital']",0.5
17062,32977.0,Butalbital,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GRIA2', 'Butalbital']",0.5
17062,33440.0,Butalbital,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Seizure', 'GRIA2', 'Butalbital']",0.5
17062,33577.0,Butalbital,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'CHRNA7', 'Butalbital']",0.5
17062,33632.0,Butalbital,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GABRA5', 'Butalbital']",0.5
17062,33675.0,Butalbital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,35565.0,Butalbital,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,35641.0,Butalbital,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Butalbital']",0.5
17062,35641.0,Butalbital,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Butalbital']",0.5
17062,35764.0,Butalbital,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Butalbital']",0.5
17062,36080.0,Butalbital,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,36187.0,Butalbital,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,36266.0,Butalbital,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRG2', 'Butalbital']",0.5
17062,36469.0,Butalbital,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'CHRNA7', 'Butalbital']",0.5
17062,36693.0,Butalbital,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'GRIK2', 'Butalbital']",0.5
17062,36693.0,Butalbital,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Butalbital']",0.5
17062,37617.0,Butalbital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,37703.0,Butalbital,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Butalbital']",0.5
17062,37786.0,Butalbital,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butalbital']",0.5
17062,38575.0,Butalbital,cerebellar degeneration,disease-protein-drug,contraindication,"['cerebellar degeneration', 'CHRNA7', 'Butalbital']",0.5
17062,83760.0,Butalbital,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Butalbital']",0.5
17062,83805.0,Butalbital,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRG2', 'Butalbital']",0.5
17062,83911.0,Butalbital,Reye syndrome,disease-protein-drug,contraindication,"['Reye syndrome', 'CHRNA7', 'Butalbital']",0.5
17063,32033.0,Talbutal,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Talbutal']",0.5
17064,27361.0,Meprobamate,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'GABRA5', 'Meprobamate']",0.5
17064,27843.0,Meprobamate,acute intermittent porphyria,disease-phenotype-protein-drug,contraindication,"['acute intermittent porphyria', 'Seizure', 'GABRA5', 'Meprobamate']",0.5
17064,28780.0,Meprobamate,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Particulate Matter', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,28780.0,Meprobamate,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'GABRA5', 'Meprobamate']",0.5
17064,29182.0,Meprobamate,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,29182.0,Meprobamate,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'GABRA5', 'Meprobamate']",0.5
17064,30035.0,Meprobamate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Meprobamate']",0.5
17064,31732.0,Meprobamate,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'GABRA5', 'Meprobamate']",0.5
17064,32617.0,Meprobamate,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'GABRP', 'Meprobamate']",0.5
17064,33440.0,Meprobamate,thrombocytopenic purpura,disease-phenotype-protein-drug,contraindication,"['thrombocytopenic purpura', 'Seizure', 'GABRA5', 'Meprobamate']",0.5
17064,33534.0,Meprobamate,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'GABRA5', 'Meprobamate']",0.5
17064,33575.0,Meprobamate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Lead', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,33577.0,Meprobamate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Particulate Matter', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,33593.0,Meprobamate,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Lead', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,33598.0,Meprobamate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Particulate Matter', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,33632.0,Meprobamate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,33675.0,Meprobamate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Organophosphates', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,35565.0,Meprobamate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,35641.0,Meprobamate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Meprobamate']",0.5
17064,35764.0,Meprobamate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,35909.0,Meprobamate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Particulate Matter', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,36187.0,Meprobamate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,36469.0,Meprobamate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'methyl bromide', 'nervous system process', 'GABRQ', 'Meprobamate']",0.5
17064,37180.0,Meprobamate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Lead', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17064,37573.0,Meprobamate,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Particulate Matter', 'brain development', 'GABRA5', 'Meprobamate']",0.5
17065,35641.0,Metharbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'GABRG2', 'Metharbital']",0.5
17065,35641.0,Metharbital,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Metharbital']",0.5
17066,27933.0,Amobarbital,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRA3', 'Amobarbital']",0.5
17066,27933.0,Amobarbital,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'DNA repair', 'CHRNA4', 'Amobarbital']",0.5
17066,30035.0,Amobarbital,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRA1', 'Amobarbital']",0.5
17066,31618.0,Amobarbital,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GRIA2', 'Amobarbital']",0.5
17066,32313.0,Amobarbital,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GRIA2', 'Amobarbital']",0.5
17066,32977.0,Amobarbital,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GRIA2', 'Amobarbital']",0.5
17066,33577.0,Amobarbital,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'CHRNA7', 'Amobarbital']",0.5
17066,33632.0,Amobarbital,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GABRA5', 'Amobarbital']",0.5
17066,33675.0,Amobarbital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRNA4', 'Amobarbital']",0.5
17066,35552.0,Amobarbital,pneumonia,disease-exposure-bioprocess-gene-drug,contraindication,"['pneumonia', 'Arsenic', 'DNA repair', 'CHRNA4', 'Amobarbital']",0.5
17066,35565.0,Amobarbital,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Amobarbital']",0.5
17066,35641.0,Amobarbital,epilepsy,disease-protein-drug,indication,"['epilepsy', 'CHRNA7', 'Amobarbital']",0.5
17066,35641.0,Amobarbital,epilepsy,disease-exposure-bioprocess-gene-drug,indication,"['epilepsy', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Amobarbital']",0.5
17066,35669.0,Amobarbital,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Amobarbital']",0.5
17066,35761.0,Amobarbital,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Amobarbital']",0.5
17066,35764.0,Amobarbital,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Amobarbital']",0.5
17066,35833.0,Amobarbital,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Amobarbital']",0.5
17066,36080.0,Amobarbital,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRNA4', 'Amobarbital']",0.5
17066,36266.0,Amobarbital,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRA1', 'Amobarbital']",0.5
17066,36693.0,Amobarbital,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'GRIK2', 'Amobarbital']",0.5
17066,36693.0,Amobarbital,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Amobarbital']",0.5
17066,37617.0,Amobarbital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Amobarbital']",0.5
17066,37703.0,Amobarbital,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRA6', 'Amobarbital']",0.5
17066,83760.0,Amobarbital,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRA6', 'Amobarbital']",0.5
17066,83805.0,Amobarbital,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRA1', 'Amobarbital']",0.5
17066,83906.0,Amobarbital,status epilepticus,disease-protein-drug,indication,"['status epilepticus', 'GRIA2', 'Amobarbital']",0.5
17067,27933.0,Butobarbital,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRA3', 'Butobarbital']",0.5
17067,27933.0,Butobarbital,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'DNA repair', 'CHRNA4', 'Butobarbital']",0.5
17067,30035.0,Butobarbital,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRA1', 'Butobarbital']",0.5
17067,31618.0,Butobarbital,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GRIA2', 'Butobarbital']",0.5
17067,32313.0,Butobarbital,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GRIA2', 'Butobarbital']",0.5
17067,32977.0,Butobarbital,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GRIA2', 'Butobarbital']",0.5
17067,33632.0,Butobarbital,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GABRA5', 'Butobarbital']",0.5
17067,33675.0,Butobarbital,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butobarbital']",0.5
17067,35565.0,Butobarbital,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRNA4', 'Butobarbital']",0.5
17067,35764.0,Butobarbital,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'CHRNA7', 'Butobarbital']",0.5
17067,36080.0,Butobarbital,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'CHRNA4', 'Butobarbital']",0.5
17067,36266.0,Butobarbital,hepatic encephalopathy,disease-protein-drug,contraindication,"['hepatic encephalopathy', 'GABRA1', 'Butobarbital']",0.5
17067,36693.0,Butobarbital,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'GRIK2', 'Butobarbital']",0.5
17067,36693.0,Butobarbital,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'learning or memory', 'CHRNA7', 'Butobarbital']",0.5
17067,37617.0,Butobarbital,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Butobarbital']",0.5
17067,37703.0,Butobarbital,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRA6', 'Butobarbital']",0.5
17067,83760.0,Butobarbital,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRA6', 'Butobarbital']",0.5
17067,83805.0,Butobarbital,hepatic coma,disease-protein-drug,contraindication,"['hepatic coma', 'GABRA1', 'Butobarbital']",0.5
17112,29352.0,Filgrastim,cyclic hematopoiesis,disease-protein-drug,indication,"['cyclic hematopoiesis', 'ELANE', 'Filgrastim']",0.5
17112,33449.0,Filgrastim,severe congenital neutropenia,disease-protein-drug,indication,"['severe congenital neutropenia', 'ELANE', 'Filgrastim']",0.5
17112,38392.0,Filgrastim,constitutional neutropenia,disease-protein-drug,indication,"['constitutional neutropenia', 'ELANE', 'Filgrastim']",0.5
17124,29614.0,Phylloquinone,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'bone mineralization', 'BGLAP', 'Phylloquinone']",0.5
17124,33575.0,Phylloquinone,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'bone mineralization', 'BGLAP', 'Phylloquinone']",0.5
17124,35764.0,Phylloquinone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'bone mineralization', 'BGLAP', 'Phylloquinone']",0.5
17124,35963.0,Phylloquinone,prostate carcinoma,disease-protein-drug,contraindication,"['prostate carcinoma', 'BGLAP', 'Phylloquinone']",0.5
17124,35966.0,Phylloquinone,prostate cancer,disease-protein-drug,contraindication,"['prostate cancer', 'BGLAP', 'Phylloquinone']",0.5
17124,35966.0,Phylloquinone,prostate cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['prostate cancer', 'perfluorooctanoic acid', 'bone mineralization', 'BGLAP', 'Phylloquinone']",0.5
17149,28017.0,Butorphanol,"migraine with or without aura, susceptibility to",disease-phenotype-protein-drug,off-label use,"['migraine with or without aura, susceptibility to', 'Nausea', 'OPRM1', 'Butorphanol']",0.5
17149,30035.0,Butorphanol,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Butorphanol']",0.5
17149,31072.0,Butorphanol,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Butorphanol']",0.5
17149,35565.0,Butorphanol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Butorphanol']",0.5
17149,36080.0,Butorphanol,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Butorphanol']",0.5
17149,36187.0,Butorphanol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Mercury', 'immune response', 'OPRD1', 'Butorphanol']",0.5
17149,36693.0,Butorphanol,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Butorphanol']",0.5
17149,37180.0,Butorphanol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Butorphanol']",0.5
17149,37753.0,Butorphanol,opiate dependence,disease-protein-drug,contraindication,"['opiate dependence', 'OPRM1', 'Butorphanol']",0.5
17149,84242.0,Butorphanol,morphine dependence,disease-protein-drug,contraindication,"['morphine dependence', 'OPRM1', 'Butorphanol']",0.5
17150,28158.0,Nalbuphine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'OPRD1', 'Nalbuphine']",0.5
17150,29525.0,Nalbuphine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Nalbuphine']",0.5
17150,30035.0,Nalbuphine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Nalbuphine']",0.5
17150,30813.0,Nalbuphine,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Nalbuphine']",0.5
17150,31072.0,Nalbuphine,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Nalbuphine']",0.5
17150,32384.0,Nalbuphine,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Nalbuphine']",0.5
17150,32719.0,Nalbuphine,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Nalbuphine']",0.5
17150,33677.0,Nalbuphine,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Nalbuphine']",0.5
17150,35565.0,Nalbuphine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Nalbuphine']",0.5
17150,35641.0,Nalbuphine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Nalbuphine']",0.5
17150,35764.0,Nalbuphine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'OPRD1', 'Nalbuphine']",0.5
17150,35897.0,Nalbuphine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Nalbuphine']",0.5
17150,36080.0,Nalbuphine,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Nalbuphine']",0.5
17150,36693.0,Nalbuphine,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Nalbuphine']",0.5
17150,83910.0,Nalbuphine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Nalbuphine']",0.5
17151,28158.0,Levorphanol,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'OPRD1', 'Levorphanol']",0.5
17151,29525.0,Levorphanol,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Arrhythmia', 'OPRK1', 'Levorphanol']",0.5
17151,30035.0,Levorphanol,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Levorphanol']",0.5
17151,30813.0,Levorphanol,Addison disease,disease-phenotype-protein-drug,contraindication,"['Addison disease', 'Seizure', 'OPRM1', 'Levorphanol']",0.5
17151,31072.0,Levorphanol,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Levorphanol']",0.5
17151,32384.0,Levorphanol,adrenal insufficiency,disease-phenotype-protein-drug,contraindication,"['adrenal insufficiency', 'Seizure', 'OPRM1', 'Levorphanol']",0.5
17151,32719.0,Levorphanol,congenital hypothyroidism,disease-phenotype-protein-drug,contraindication,"['congenital hypothyroidism', 'Arrhythmia', 'OPRK1', 'Levorphanol']",0.5
17151,33677.0,Levorphanol,constipation disorder,disease-protein-drug,contraindication,"['constipation disorder', 'OPRM1', 'Levorphanol']",0.5
17151,35565.0,Levorphanol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Levorphanol']",0.5
17151,35641.0,Levorphanol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'OPRM1', 'Levorphanol']",0.5
17151,35764.0,Levorphanol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'OPRD1', 'Levorphanol']",0.5
17151,35897.0,Levorphanol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Levorphanol']",0.5
17151,36080.0,Levorphanol,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Levorphanol']",0.5
17151,36693.0,Levorphanol,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'OPRM1', 'Levorphanol']",0.5
17151,83910.0,Levorphanol,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'OPRM1', 'Levorphanol']",0.5
17152,36080.0,Remifentanil,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Remifentanil']",0.5
17153,30035.0,Diphenoxylate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'OPRM1', 'Diphenoxylate']",0.5
17153,32999.0,Diphenoxylate,shigellosis,disease-phenotype-protein-drug,contraindication,"['shigellosis', 'Nausea', 'OPRM1', 'Diphenoxylate']",0.5
17153,35565.0,Diphenoxylate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'OPRD1', 'Diphenoxylate']",0.5
17153,35764.0,Diphenoxylate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'OPRD1', 'Diphenoxylate']",0.5
17162,36040.0,Alvimopan,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'immune response', 'OPRD1', 'Alvimopan']",0.5
17162,37180.0,Alvimopan,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Alvimopan']",0.5
17162,83923.0,Alvimopan,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'OPRM1', 'Alvimopan']",0.5
17170,31650.0,Pyridostigmine,myasthenia gravis,disease-phenotype-protein-drug,indication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Pyridostigmine']",0.5
17170,33675.0,Pyridostigmine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'response to folic acid', 'BCHE', 'Pyridostigmine']",0.5
17170,33675.0,Pyridostigmine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'glyphosate', 'BCHE', 'Pyridostigmine']",0.5
17170,33675.0,Pyridostigmine,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Pyridostigmine']",0.5
17170,35764.0,Pyridostigmine,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Pyridostigmine']",0.5
17170,35764.0,Pyridostigmine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Pyridostigmine']",0.5
17170,35764.0,Pyridostigmine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Pyridostigmine']",0.5
17170,35764.0,Pyridostigmine,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Pyridostigmine']",0.5
17173,28547.0,Physostigmine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Physostigmine']",0.5
17173,28547.0,Physostigmine,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Chlorpyrifos', 'ACHE', 'Physostigmine']",0.5
17173,28547.0,Physostigmine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'ACHE', 'Physostigmine']",0.5
17173,28547.0,Physostigmine,Parkinson disease,disease-exposure-molfunc-gene-drug,contraindication,"['Parkinson disease', 'Organophosphates', 'cholinesterase activity', 'ACHE', 'Physostigmine']",0.5
17173,33575.0,Physostigmine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Physostigmine']",0.5
17173,33575.0,Physostigmine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Chlorpyrifos', 'ACHE', 'Physostigmine']",0.5
17173,33575.0,Physostigmine,diabetes mellitus (disease),disease-exposure-molfunc-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Arsenic', 'cholinesterase activity', 'ACHE', 'Physostigmine']",0.5
17173,33675.0,Physostigmine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'cognition', 'CHRNA4', 'Physostigmine']",0.5
17173,33675.0,Physostigmine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'Pesticides', 'ACHE', 'Physostigmine']",0.5
17173,33675.0,Physostigmine,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'ACHE', 'Physostigmine']",0.5
17173,35641.0,Physostigmine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ACHE', 'Physostigmine']",0.5
17173,35641.0,Physostigmine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Physostigmine']",0.5
17173,35669.0,Physostigmine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Physostigmine']",0.5
17173,35669.0,Physostigmine,heart disease,disease-exposure-molfunc-gene-drug,contraindication,"['heart disease', 'Arsenic', 'cholinesterase activity', 'ACHE', 'Physostigmine']",0.5
17173,35761.0,Physostigmine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'CHRNA4', 'Physostigmine']",0.5
17173,35761.0,Physostigmine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Pesticides', 'ACHE', 'Physostigmine']",0.5
17173,35761.0,Physostigmine,cardiovascular disease,disease-exposure-molfunc-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'cholinesterase activity', 'ACHE', 'Physostigmine']",0.5
17174,28473.0,Rivastigmine,Pick disease,disease-protein-drug,indication,"['Pick disease', 'BCHE', 'Rivastigmine']",0.5
17174,28547.0,Rivastigmine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'BCHE', 'Rivastigmine']",0.5
17174,28547.0,Rivastigmine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Lead', 'choline metabolic process', 'BCHE', 'Rivastigmine']",0.5
17174,28547.0,Rivastigmine,Parkinson disease,disease-exposure-gene-drug,contraindication,"['Parkinson disease', 'Chlorpyrifos', 'BCHE', 'Rivastigmine']",0.5
17174,28547.0,Rivastigmine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'ACHE', 'Rivastigmine']",0.5
17174,28547.0,Rivastigmine,Parkinson disease,disease-exposure-molfunc-gene-drug,contraindication,"['Parkinson disease', 'Organophosphates', 'cholinesterase activity', 'BCHE', 'Rivastigmine']",0.5
17174,28780.0,Rivastigmine,Alzheimer disease,disease-protein-drug,indication,"['Alzheimer disease', 'BCHE', 'Rivastigmine']",0.5
17174,28780.0,Rivastigmine,Alzheimer disease,disease-exposure-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'BCHE', 'Rivastigmine']",0.5
17174,28780.0,Rivastigmine,Alzheimer disease,disease-phenotype-protein-drug,indication,"['Alzheimer disease', 'Seizure', 'BCHE', 'Rivastigmine']",0.5
17174,28780.0,Rivastigmine,Alzheimer disease,disease-exposure-molfunc-gene-drug,indication,"['Alzheimer disease', 'Pesticides', 'cholinesterase activity', 'BCHE', 'Rivastigmine']",0.5
17174,33594.0,Rivastigmine,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Rivastigmine']",0.5
17174,33594.0,Rivastigmine,diarrheal disease,disease-exposure-molfunc-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Rivastigmine']",0.5
17174,33675.0,Rivastigmine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'response to folic acid', 'BCHE', 'Rivastigmine']",0.5
17174,33675.0,Rivastigmine,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'glyphosate', 'BCHE', 'Rivastigmine']",0.5
17174,33675.0,Rivastigmine,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Rivastigmine']",0.5
17174,35641.0,Rivastigmine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'BCHE', 'Rivastigmine']",0.5
17174,37617.0,Rivastigmine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Rivastigmine']",0.5
17174,37617.0,Rivastigmine,chronic obstructive pulmonary disease,disease-exposure-molfunc-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Rivastigmine']",0.5
17174,38575.0,Rivastigmine,cerebellar degeneration,disease-protein-drug,indication,"['cerebellar degeneration', 'BCHE', 'Rivastigmine']",0.5
17174,83911.0,Rivastigmine,Reye syndrome,disease-protein-drug,indication,"['Reye syndrome', 'BCHE', 'Rivastigmine']",0.5
17174,83960.0,Rivastigmine,Alzheimer disease without neurofibrillary tangles,disease-protein-drug,indication,"['Alzheimer disease without neurofibrillary tangles', 'BCHE', 'Rivastigmine']",0.5
17175,31650.0,Edrophonium,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'BCHE', 'Edrophonium']",0.5
17175,33577.0,Edrophonium,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'response to folic acid', 'BCHE', 'Edrophonium']",0.5
17175,33577.0,Edrophonium,hypertensive disorder,disease-exposure-molfunc-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Edrophonium']",0.5
17175,33675.0,Edrophonium,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Arsenic', 'response to folic acid', 'BCHE', 'Edrophonium']",0.5
17175,33675.0,Edrophonium,asthma,disease-exposure-gene-drug,contraindication,"['asthma', 'glyphosate', 'BCHE', 'Edrophonium']",0.5
17175,33675.0,Edrophonium,asthma,disease-exposure-molfunc-gene-drug,contraindication,"['asthma', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Edrophonium']",0.5
17175,35565.0,Edrophonium,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'learning', 'BCHE', 'Edrophonium']",0.5
17175,35764.0,Edrophonium,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Edrophonium']",0.5
17175,35764.0,Edrophonium,kidney disease,disease-exposure-molfunc-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Edrophonium']",0.5
17175,36034.0,Edrophonium,hyperthyroidism,disease-exposure-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'BCHE', 'Edrophonium']",0.5
17175,36034.0,Edrophonium,hyperthyroidism,disease-exposure-molfunc-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'cholinesterase activity', 'BCHE', 'Edrophonium']",0.5
17175,36187.0,Edrophonium,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'response to folic acid', 'BCHE', 'Edrophonium']",0.5
17175,36187.0,Edrophonium,coronary artery disease,disease-exposure-molfunc-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'cholinesterase activity', 'BCHE', 'Edrophonium']",0.5
17215,29614.0,Salmon calcitonin,osteoporosis,disease-protein-drug,indication,"['osteoporosis', 'CALCR', 'Salmon calcitonin']",0.5
17215,29614.0,Salmon calcitonin,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', ""2,3,3',4,4'-pentachlorobiphenyl"", 'positive regulation of cell death', 'CALCR', 'Salmon calcitonin']",0.5
17215,33656.0,Salmon calcitonin,hypercalcemia disease,disease-protein-drug,contraindication,"['hypercalcemia disease', 'CALCR', 'Salmon calcitonin']",0.5
17215,35583.0,Salmon calcitonin,phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'CALCR', 'Salmon calcitonin']",0.5
17215,38682.0,Salmon calcitonin,nephrocalcinosis,disease-protein-drug,contraindication,"['nephrocalcinosis', 'CALCR', 'Salmon calcitonin']",0.5
17215,83776.0,Salmon calcitonin,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'CALCR', 'Salmon calcitonin']",0.5
17220,35764.0,Milrinone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'lipid metabolic process', 'PDE3A', 'Milrinone']",0.5
17220,35958.0,Milrinone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'PDE3A', 'Milrinone']",0.5
17220,37180.0,Milrinone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'PDE3A', 'Milrinone']",0.5
17220,37180.0,Milrinone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Lead', 'lipid metabolic process', 'PDE3A', 'Milrinone']",0.5
17220,83823.0,Milrinone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'PDE3A', 'Milrinone']",0.5
17220,83824.0,Milrinone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'PDE3A', 'Milrinone']",0.5
17221,37659.0,Levosimendan,heart failure,disease-exposure-bioprocess-gene-drug,indication,"['heart failure', 'Nitrogen Dioxide', 'glucose metabolic process', 'KCNJ11', 'Levosimendan']",0.5
17222,28052.0,Amrinone,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Pulmonary edema', 'TNF', 'Amrinone']",0.5
17222,33605.0,Amrinone,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'TNF', 'Amrinone']",0.5
17222,35565.0,Amrinone,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'TNF', 'Amrinone']",0.5
17222,35764.0,Amrinone,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'PDE4D', 'Amrinone']",0.5
17222,35958.0,Amrinone,hemoglobinopathy,disease-protein-drug,contraindication,"['hemoglobinopathy', 'PDE3A', 'Amrinone']",0.5
17222,37180.0,Amrinone,myocardial infarction (disease),disease-protein-drug,contraindication,"['myocardial infarction (disease)', 'PDE3A', 'Amrinone']",0.5
17222,37180.0,Amrinone,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'TNF', 'Amrinone']",0.5
17222,37180.0,Amrinone,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'TNF', 'Amrinone']",0.5
17222,83823.0,Amrinone,coronary thrombosis,disease-protein-drug,contraindication,"['coronary thrombosis', 'PDE3A', 'Amrinone']",0.5
17222,83824.0,Amrinone,myocardial infarction,disease-protein-drug,contraindication,"['myocardial infarction', 'PDE3A', 'Amrinone']",0.5
17224,39773.0,Ibudilast,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'PDE4D', 'Ibudilast']",0.5
17224,83781.0,Ibudilast,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'PDE4D', 'Ibudilast']",0.5
17226,27626.0,Tirofiban,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ITGB3', 'Tirofiban']",0.5
17226,33598.0,Tirofiban,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'ITGB3', 'Tirofiban']",0.5
17226,33598.0,Tirofiban,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Air Pollutants', 'platelet aggregation', 'ITGB3', 'Tirofiban']",0.5
17226,35909.0,Tirofiban,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Air Pollutants', 'platelet aggregation', 'ITGB3', 'Tirofiban']",0.5
17226,36492.0,Tirofiban,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Air Pollutants', 'platelet aggregation', 'ITGB3', 'Tirofiban']",0.5
17226,83812.0,Tirofiban,acute coronary syndrome,disease-protein-drug,indication,"['acute coronary syndrome', 'ITGB3', 'Tirofiban']",0.5
17229,29709.0,Cetirizine,"dermatitis, atopic",disease-phenotype-protein-drug,off-label use,"['dermatitis, atopic', 'Pruritus', 'HRH1', 'Cetirizine']",0.5
17229,33575.0,Cetirizine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Cetirizine']",0.5
17229,33577.0,Cetirizine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Cetirizine']",0.5
17229,33603.0,Cetirizine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Cetirizine']",0.5
17229,35565.0,Cetirizine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Cetirizine']",0.5
17229,35764.0,Cetirizine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Cetirizine']",0.5
17229,35953.0,Cetirizine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Cetirizine']",0.5
17229,35953.0,Cetirizine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Cetirizine']",0.5
17229,36034.0,Cetirizine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Cetirizine']",0.5
17229,36040.0,Cetirizine,chronic kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic kidney disease', 'Mercury', 'memory', 'HRH1', 'Cetirizine']",0.5
17229,36129.0,Cetirizine,atopic eczema,disease-exposure-bioprocess-gene-drug,off-label use,"['atopic eczema', 'Mercury', 'memory', 'HRH1', 'Cetirizine']",0.5
17229,36187.0,Cetirizine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Cetirizine']",0.5
17229,37888.0,Cetirizine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Cetirizine']",0.5
17229,37888.0,Cetirizine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Cetirizine']",0.5
17229,83791.0,Cetirizine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Cetirizine']",0.5
17229,83923.0,Cetirizine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'inflammatory response', 'HRH1', 'Cetirizine']",0.5
17230,27503.0,Doxylamine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'CHRM1', 'Doxylamine']",0.5
17230,29113.0,Doxylamine,diabetic ketoacidosis,disease-protein-drug,contraindication,"['diabetic ketoacidosis', 'CHRM2', 'Doxylamine']",0.5
17230,30035.0,Doxylamine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRM2', 'Doxylamine']",0.5
17230,33575.0,Doxylamine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Doxylamine']",0.5
17230,33577.0,Doxylamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Doxylamine']",0.5
17230,33603.0,Doxylamine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Doxylamine']",0.5
17230,35565.0,Doxylamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Doxylamine']",0.5
17230,35953.0,Doxylamine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Doxylamine']",0.5
17230,35953.0,Doxylamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'cognition', 'CHRM1', 'Doxylamine']",0.5
17230,36034.0,Doxylamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'cognition', 'CHRM1', 'Doxylamine']",0.5
17230,36187.0,Doxylamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Doxylamine']",0.5
17230,37180.0,Doxylamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Doxylamine']",0.5
17230,37888.0,Doxylamine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Doxylamine']",0.5
17230,37888.0,Doxylamine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'cognition', 'CHRM1', 'Doxylamine']",0.5
17230,83791.0,Doxylamine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Doxylamine']",0.5
17231,28158.0,Dexbrompheniramine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Dexbrompheniramine']",0.5
17231,33575.0,Dexbrompheniramine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Dexbrompheniramine']",0.5
17231,33577.0,Dexbrompheniramine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Dexbrompheniramine']",0.5
17231,33603.0,Dexbrompheniramine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Dexbrompheniramine']",0.5
17231,33605.0,Dexbrompheniramine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Dexbrompheniramine']",0.5
17231,35565.0,Dexbrompheniramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Dexbrompheniramine']",0.5
17231,35641.0,Dexbrompheniramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Dexbrompheniramine']",0.5
17231,35764.0,Dexbrompheniramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Dexbrompheniramine']",0.5
17231,35897.0,Dexbrompheniramine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'inflammatory response', 'HRH1', 'Dexbrompheniramine']",0.5
17231,35953.0,Dexbrompheniramine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Dexbrompheniramine']",0.5
17231,35953.0,Dexbrompheniramine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Dexbrompheniramine']",0.5
17231,36034.0,Dexbrompheniramine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Dexbrompheniramine']",0.5
17231,36080.0,Dexbrompheniramine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Dexbrompheniramine']",0.5
17231,36187.0,Dexbrompheniramine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Dexbrompheniramine']",0.5
17231,36469.0,Dexbrompheniramine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Dexbrompheniramine']",0.5
17231,36492.0,Dexbrompheniramine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'visual learning', 'HRH1', 'Dexbrompheniramine']",0.5
17231,36693.0,Dexbrompheniramine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Dexbrompheniramine']",0.5
17231,37180.0,Dexbrompheniramine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Dexbrompheniramine']",0.5
17231,37785.0,Dexbrompheniramine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'HRH1', 'Dexbrompheniramine']",0.5
17231,37888.0,Dexbrompheniramine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Dexbrompheniramine']",0.5
17231,37888.0,Dexbrompheniramine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Dexbrompheniramine']",0.5
17231,83791.0,Dexbrompheniramine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Dexbrompheniramine']",0.5
17232,28158.0,Triprolidine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Triprolidine']",0.5
17232,33575.0,Triprolidine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Triprolidine']",0.5
17232,33577.0,Triprolidine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Triprolidine']",0.5
17232,33603.0,Triprolidine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Triprolidine']",0.5
17232,33605.0,Triprolidine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Triprolidine']",0.5
17232,33675.0,Triprolidine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Triprolidine']",0.5
17232,35565.0,Triprolidine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Triprolidine']",0.5
17232,35641.0,Triprolidine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Triprolidine']",0.5
17232,35764.0,Triprolidine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Triprolidine']",0.5
17232,35953.0,Triprolidine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Triprolidine']",0.5
17232,35953.0,Triprolidine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Triprolidine']",0.5
17232,36034.0,Triprolidine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Triprolidine']",0.5
17232,36080.0,Triprolidine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Triprolidine']",0.5
17232,36187.0,Triprolidine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Triprolidine']",0.5
17232,36469.0,Triprolidine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Triprolidine']",0.5
17232,36693.0,Triprolidine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Triprolidine']",0.5
17232,37180.0,Triprolidine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Triprolidine']",0.5
17232,37888.0,Triprolidine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Triprolidine']",0.5
17232,37888.0,Triprolidine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Triprolidine']",0.5
17232,83791.0,Triprolidine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Triprolidine']",0.5
17233,28158.0,Carbinoxamine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,33575.0,Carbinoxamine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,33577.0,Carbinoxamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Carbinoxamine']",0.5
17233,33603.0,Carbinoxamine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Carbinoxamine']",0.5
17233,33605.0,Carbinoxamine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Carbinoxamine']",0.5
17233,35565.0,Carbinoxamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Carbinoxamine']",0.5
17233,35641.0,Carbinoxamine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Carbinoxamine']",0.5
17233,35669.0,Carbinoxamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,35761.0,Carbinoxamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,35764.0,Carbinoxamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Carbinoxamine']",0.5
17233,35897.0,Carbinoxamine,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,35953.0,Carbinoxamine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Carbinoxamine']",0.5
17233,35953.0,Carbinoxamine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,36034.0,Carbinoxamine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Carbinoxamine']",0.5
17233,36080.0,Carbinoxamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,36187.0,Carbinoxamine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,36274.0,Carbinoxamine,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,36469.0,Carbinoxamine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Carbinoxamine']",0.5
17233,36492.0,Carbinoxamine,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'visual learning', 'HRH1', 'Carbinoxamine']",0.5
17233,36693.0,Carbinoxamine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Carbinoxamine']",0.5
17233,37180.0,Carbinoxamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,37785.0,Carbinoxamine,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'memory', 'HRH1', 'Carbinoxamine']",0.5
17233,37888.0,Carbinoxamine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Carbinoxamine']",0.5
17233,37888.0,Carbinoxamine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Carbinoxamine']",0.5
17233,83791.0,Carbinoxamine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Carbinoxamine']",0.5
17234,27326.0,Propiomazine,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Propiomazine']",0.5
17234,27326.0,Propiomazine,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Propiomazine']",0.5
17234,27655.0,Propiomazine,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD2', 'Propiomazine']",0.5
17234,28375.0,Propiomazine,familial hyperprolactinemia,disease-protein-drug,contraindication,"['familial hyperprolactinemia', 'DRD2', 'Propiomazine']",0.5
17234,28396.0,Propiomazine,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Resting tremor', 'CHRM4', 'Propiomazine']",0.5
17234,28547.0,Propiomazine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'DRD2', 'Propiomazine']",0.5
17234,28547.0,Propiomazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Propiomazine']",0.5
17234,28547.0,Propiomazine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Propiomazine']",0.5
17234,28651.0,Propiomazine,monogenic obesity,disease-protein-drug,contraindication,"['monogenic obesity', 'HTR2A', 'Propiomazine']",0.5
17234,28780.0,Propiomazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'cognition', 'CHRM1', 'Propiomazine']",0.5
17234,28780.0,Propiomazine,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'DRD2', 'Propiomazine']",0.5
17234,29637.0,Propiomazine,prolactin producing pituitary gland tumor,disease-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'DRD2', 'Propiomazine']",0.5
17234,29637.0,Propiomazine,prolactin producing pituitary gland tumor,disease-phenotype-protein-drug,contraindication,"['prolactin producing pituitary gland tumor', 'Seizure', 'DRD2', 'Propiomazine']",0.5
17234,30035.0,Propiomazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'DRD2', 'Propiomazine']",0.5
17234,31393.0,Propiomazine,metabolic syndrome X,disease-protein-drug,contraindication,"['metabolic syndrome X', 'HTR2C', 'Propiomazine']",0.5
17234,31393.0,Propiomazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'inflammatory response', 'HRH1', 'Propiomazine']",0.5
17234,33454.0,Propiomazine,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Propiomazine']",0.5
17234,33593.0,Propiomazine,obesity disorder,disease-protein-drug,contraindication,"['obesity disorder', 'HTR2A', 'Propiomazine']",0.5
17234,33593.0,Propiomazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'cognition', 'CHRM1', 'Propiomazine']",0.5
17234,33593.0,Propiomazine,obesity disorder,disease-phenotype-protein-drug,contraindication,"['obesity disorder', 'Increased body weight', 'HTR2C', 'Propiomazine']",0.5
17234,33632.0,Propiomazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'CHRM1', 'Propiomazine']",0.5
17234,35565.0,Propiomazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'CHRM1', 'Propiomazine']",0.5
17234,35641.0,Propiomazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'DRD2', 'Propiomazine']",0.5
17234,35641.0,Propiomazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Propiomazine']",0.5
17234,36187.0,Propiomazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Propiomazine']",0.5
17234,37180.0,Propiomazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'cognition', 'CHRM1', 'Propiomazine']",0.5
17234,37706.0,Propiomazine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'DRD2', 'Propiomazine']",0.5
17234,37786.0,Propiomazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'cognition', 'CHRM1', 'Propiomazine']",0.5
17234,38003.0,Propiomazine,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD2', 'Propiomazine']",0.5
17234,38928.0,Propiomazine,metabolic syndrome,disease-protein-drug,contraindication,"['metabolic syndrome', 'HTR2C', 'Propiomazine']",0.5
17234,39081.0,Propiomazine,hyperprolactinemia (disease),disease-protein-drug,contraindication,"['hyperprolactinemia (disease)', 'DRD2', 'Propiomazine']",0.5
17234,83998.0,Propiomazine,lingual-facial-buccal dyskinesia,disease-protein-drug,contraindication,"['lingual-facial-buccal dyskinesia', 'DRD2', 'Propiomazine']",0.5
17234,84023.0,Propiomazine,acquired hyperprolactinemia,disease-protein-drug,contraindication,"['acquired hyperprolactinemia', 'DRD2', 'Propiomazine']",0.5
17235,37888.0,Methdilazine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Methdilazine']",0.5
17235,37888.0,Methdilazine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Methdilazine']",0.5
17235,83791.0,Methdilazine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Methdilazine']",0.5
17237,33575.0,Desloratadine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Desloratadine']",0.5
17237,33577.0,Desloratadine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Desloratadine']",0.5
17237,33603.0,Desloratadine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Desloratadine']",0.5
17237,35565.0,Desloratadine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Desloratadine']",0.5
17237,35764.0,Desloratadine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Desloratadine']",0.5
17237,35953.0,Desloratadine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Desloratadine']",0.5
17237,35953.0,Desloratadine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Desloratadine']",0.5
17237,36034.0,Desloratadine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Desloratadine']",0.5
17237,36187.0,Desloratadine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Desloratadine']",0.5
17237,37888.0,Desloratadine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Desloratadine']",0.5
17237,37888.0,Desloratadine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Desloratadine']",0.5
17237,83791.0,Desloratadine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Desloratadine']",0.5
17238,33575.0,Dimenhydrinate,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Dimenhydrinate']",0.5
17238,33577.0,Dimenhydrinate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Dimenhydrinate']",0.5
17238,33605.0,Dimenhydrinate,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Dimenhydrinate']",0.5
17238,35565.0,Dimenhydrinate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Dimenhydrinate']",0.5
17238,36034.0,Dimenhydrinate,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Dimenhydrinate']",0.5
17238,36187.0,Dimenhydrinate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Dimenhydrinate']",0.5
17238,36274.0,Dimenhydrinate,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'inflammatory response', 'HRH1', 'Dimenhydrinate']",0.5
17238,37180.0,Dimenhydrinate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Dimenhydrinate']",0.5
17241,33577.0,Diphenylpyraline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Diphenylpyraline']",0.5
17241,36034.0,Diphenylpyraline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Diphenylpyraline']",0.5
17241,37888.0,Diphenylpyraline,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Diphenylpyraline']",0.5
17241,37888.0,Diphenylpyraline,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Diphenylpyraline']",0.5
17241,83791.0,Diphenylpyraline,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Diphenylpyraline']",0.5
17242,28158.0,Bromodiphenhydramine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Bromodiphenhydramine']",0.5
17242,33605.0,Bromodiphenhydramine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Bromodiphenhydramine']",0.5
17242,33675.0,Bromodiphenhydramine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Bromodiphenhydramine']",0.5
17242,35565.0,Bromodiphenhydramine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Bromodiphenhydramine']",0.5
17242,35641.0,Bromodiphenhydramine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Bromodiphenhydramine']",0.5
17242,35764.0,Bromodiphenhydramine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Bromodiphenhydramine']",0.5
17242,36080.0,Bromodiphenhydramine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Bromodiphenhydramine']",0.5
17242,36469.0,Bromodiphenhydramine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Bromodiphenhydramine']",0.5
17242,36693.0,Bromodiphenhydramine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Bromodiphenhydramine']",0.5
17243,28547.0,Alimemazine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Alimemazine']",0.5
17243,28780.0,Alimemazine,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'HRH1', 'Alimemazine']",0.5
17243,31393.0,Alimemazine,metabolic syndrome X,disease-exposure-bioprocess-gene-drug,contraindication,"['metabolic syndrome X', 'Zinc', 'inflammatory response', 'HRH1', 'Alimemazine']",0.5
17243,33593.0,Alimemazine,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Cadmium', 'inflammatory response', 'HRH1', 'Alimemazine']",0.5
17243,33632.0,Alimemazine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'memory', 'HRH1', 'Alimemazine']",0.5
17243,35565.0,Alimemazine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Alimemazine']",0.5
17243,35641.0,Alimemazine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Alimemazine']",0.5
17243,36187.0,Alimemazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Alimemazine']",0.5
17243,37180.0,Alimemazine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Alimemazine']",0.5
17243,37786.0,Alimemazine,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Alimemazine']",0.5
17243,83791.0,Alimemazine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Alimemazine']",0.5
17245,37888.0,Phenindamine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Phenindamine']",0.5
17245,37888.0,Phenindamine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Phenindamine']",0.5
17245,83791.0,Phenindamine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Phenindamine']",0.5
17246,33575.0,Clofedanol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Clofedanol']",0.5
17246,33577.0,Clofedanol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Clofedanol']",0.5
17246,33603.0,Clofedanol,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Clofedanol']",0.5
17246,35953.0,Clofedanol,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Clofedanol']",0.5
17246,35953.0,Clofedanol,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Clofedanol']",0.5
17246,36034.0,Clofedanol,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Clofedanol']",0.5
17246,36187.0,Clofedanol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Clofedanol']",0.5
17246,37180.0,Clofedanol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Clofedanol']",0.5
17246,37811.0,Clofedanol,rhinitis,disease-protein-drug,indication,"['rhinitis', 'HRH1', 'Clofedanol']",0.5
17246,37811.0,Clofedanol,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Clofedanol']",0.5
17246,37888.0,Clofedanol,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Clofedanol']",0.5
17246,37888.0,Clofedanol,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Clofedanol']",0.5
17246,83791.0,Clofedanol,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Clofedanol']",0.5
17252,33577.0,Antazoline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Antazoline']",0.5
17252,33581.0,Antazoline,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Antazoline']",0.5
17252,35669.0,Antazoline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Antazoline']",0.5
17252,35761.0,Antazoline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'HRH1', 'Antazoline']",0.5
17252,36034.0,Antazoline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Antazoline']",0.5
17252,37888.0,Antazoline,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Antazoline']",0.5
17252,37888.0,Antazoline,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Antazoline']",0.5
17252,83791.0,Antazoline,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Antazoline']",0.5
17256,28158.0,Chlorcyclizine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,33575.0,Chlorcyclizine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,33577.0,Chlorcyclizine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Chlorcyclizine']",0.5
17256,33605.0,Chlorcyclizine,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'HRH1', 'Chlorcyclizine']",0.5
17256,33675.0,Chlorcyclizine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,35565.0,Chlorcyclizine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'HRH1', 'Chlorcyclizine']",0.5
17256,35641.0,Chlorcyclizine,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Chlorcyclizine']",0.5
17256,35764.0,Chlorcyclizine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'HRH1', 'Chlorcyclizine']",0.5
17256,35953.0,Chlorcyclizine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Chlorcyclizine']",0.5
17256,35953.0,Chlorcyclizine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,36034.0,Chlorcyclizine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Chlorcyclizine']",0.5
17256,36080.0,Chlorcyclizine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,36187.0,Chlorcyclizine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,36469.0,Chlorcyclizine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Chlorcyclizine']",0.5
17256,36693.0,Chlorcyclizine,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'HRH1', 'Chlorcyclizine']",0.5
17256,37180.0,Chlorcyclizine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,37888.0,Chlorcyclizine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Chlorcyclizine']",0.5
17256,37888.0,Chlorcyclizine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,39798.0,Chlorcyclizine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Chlorcyclizine']",0.5
17256,83791.0,Chlorcyclizine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Chlorcyclizine']",0.5
17257,27933.0,Butriptyline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'SLC6A4', 'Butriptyline']",0.5
17257,27933.0,Butriptyline,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Butriptyline']",0.5
17257,37703.0,Butriptyline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A4', 'Butriptyline']",0.5
17257,83760.0,Butriptyline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Butriptyline']",0.5
17258,33575.0,Acrivastine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'HRH1', 'Acrivastine']",0.5
17258,33577.0,Acrivastine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'HRH1', 'Acrivastine']",0.5
17258,33603.0,Acrivastine,arteriosclerosis disorder,disease-protein-drug,contraindication,"['arteriosclerosis disorder', 'HRH1', 'Acrivastine']",0.5
17258,35953.0,Acrivastine,atherosclerosis,disease-protein-drug,contraindication,"['atherosclerosis', 'HRH1', 'Acrivastine']",0.5
17258,35953.0,Acrivastine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Acrivastine']",0.5
17258,36034.0,Acrivastine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'HRH1', 'Acrivastine']",0.5
17258,36187.0,Acrivastine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'HRH1', 'Acrivastine']",0.5
17258,37888.0,Acrivastine,allergic rhinitis,disease-protein-drug,indication,"['allergic rhinitis', 'HRH1', 'Acrivastine']",0.5
17258,37888.0,Acrivastine,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Nitrogen Dioxide', 'inflammatory response', 'HRH1', 'Acrivastine']",0.5
17258,83791.0,Acrivastine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Acrivastine']",0.5
17259,83791.0,Bilastine,vasomotor rhinitis,disease-protein-drug,indication,"['vasomotor rhinitis', 'HRH1', 'Bilastine']",0.5
17270,28547.0,Pimavanserin,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD2', 'Pimavanserin']",0.5
17270,28547.0,Pimavanserin,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'memory', 'HTR2A', 'Pimavanserin']",0.5
17270,28801.0,Pimavanserin,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DRD2', 'Pimavanserin']",0.5
17270,28801.0,Pimavanserin,juvenile onset Parkinson disease 19A,disease-phenotype-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'Seizure', 'DRD2', 'Pimavanserin']",0.5
17270,28974.0,Pimavanserin,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DRD2', 'Pimavanserin']",0.5
17270,28974.0,Pimavanserin,early-onset parkinsonism-intellectual disability syndrome,disease-phenotype-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'Seizure', 'DRD2', 'Pimavanserin']",0.5
17270,30093.0,Pimavanserin,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DRD2', 'Pimavanserin']",0.5
17270,31408.0,Pimavanserin,X-linked parkinsonism-spasticity syndrome,disease-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'DRD2', 'Pimavanserin']",0.5
17270,31408.0,Pimavanserin,X-linked parkinsonism-spasticity syndrome,disease-phenotype-protein-drug,indication,"['X-linked parkinsonism-spasticity syndrome', 'Seizure', 'DRD2', 'Pimavanserin']",0.5
17270,32759.0,Pimavanserin,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DRD2', 'Pimavanserin']",0.5
17270,32974.0,Pimavanserin,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DRD2', 'Pimavanserin']",0.5
17270,32974.0,Pimavanserin,atypical juvenile parkinsonism,disease-phenotype-protein-drug,indication,"['atypical juvenile parkinsonism', 'Seizure', 'DRD2', 'Pimavanserin']",0.5
17270,33241.0,Pimavanserin,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DRD2', 'Pimavanserin']",0.5
17273,37703.0,Amisulpride,neurotic disorder,disease-protein-drug,off-label use,"['neurotic disorder', 'DRD3', 'Amisulpride']",0.5
17273,83760.0,Amisulpride,dysthymic disorder,disease-protein-drug,off-label use,"['dysthymic disorder', 'DRD3', 'Amisulpride']",0.5
17278,33577.0,Ketanserin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'memory', 'HTR2A', 'Ketanserin']",0.5
17286,27446.0,Nitisinone,tyrosinemia,disease-protein-drug,contraindication,"['tyrosinemia', 'HPD', 'Nitisinone']",0.5
17301,27933.0,Flumazenil,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Flumazenil']",0.5
17301,27933.0,Flumazenil,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Lead', 'brain development', 'GABRA5', 'Flumazenil']",0.5
17301,35565.0,Flumazenil,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'brain development', 'GABRA5', 'Flumazenil']",0.5
17301,35641.0,Flumazenil,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Flumazenil']",0.5
17301,35669.0,Flumazenil,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'brain development', 'GABRA5', 'Flumazenil']",0.5
17301,35761.0,Flumazenil,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Lead', 'brain development', 'GABRA5', 'Flumazenil']",0.5
17305,27933.0,Protriptyline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ABCB1', 'Protriptyline']",0.5
17305,27933.0,Protriptyline,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Protriptyline']",0.5
17305,28249.0,Protriptyline,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Protriptyline']",0.5
17305,28313.0,Protriptyline,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'ABCB1', 'Protriptyline']",0.5
17305,28313.0,Protriptyline,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'social behavior', 'SLC6A4', 'Protriptyline']",0.5
17305,28391.0,Protriptyline,narcolepsy,disease-exposure-bioprocess-gene-drug,off-label use,"['narcolepsy', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Protriptyline']",0.5
17305,30035.0,Protriptyline,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Protriptyline']",0.5
17305,33675.0,Protriptyline,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'memory', 'SLC6A4', 'Protriptyline']",0.5
17305,35565.0,Protriptyline,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SLC6A4', 'Protriptyline']",0.5
17305,35641.0,Protriptyline,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Protriptyline']",0.5
17305,36034.0,Protriptyline,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SLC6A4', 'Protriptyline']",0.5
17305,37573.0,Protriptyline,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Air Pollutants', 'memory', 'SLC6A4', 'Protriptyline']",0.5
17305,37703.0,Protriptyline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A4', 'Protriptyline']",0.5
17305,38242.0,Protriptyline,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Protriptyline']",0.5
17305,83760.0,Protriptyline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Protriptyline']",0.5
17306,28208.0,Phenmetrazine,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'SLC6A3', 'Phenmetrazine']",0.5
17306,28552.0,Phenmetrazine,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'SLC6A3', 'Phenmetrazine']",0.5
17306,30035.0,Phenmetrazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Phenmetrazine']",0.5
17306,33575.0,Phenmetrazine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'SLC6A3', 'Phenmetrazine']",0.5
17306,33577.0,Phenmetrazine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Phenmetrazine']",0.5
17306,33593.0,Phenmetrazine,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'SLC6A3', 'Phenmetrazine']",0.5
17306,35641.0,Phenmetrazine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Phenmetrazine']",0.5
17306,35953.0,Phenmetrazine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Lead', 'positive regulation of multicellular organism growth', 'SLC6A3', 'Phenmetrazine']",0.5
17306,36187.0,Phenmetrazine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'positive regulation of multicellular organism growth', 'SLC6A3', 'Phenmetrazine']",0.5
17306,83910.0,Phenmetrazine,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'SLC6A3', 'Phenmetrazine']",0.5
17307,28208.0,Diethylpropion,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 2 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'SLC6A3', 'Diethylpropion']",0.5
17307,28552.0,Diethylpropion,type 1 diabetes mellitus,disease-exposure-bioprocess-gene-drug,contraindication,"['type 1 diabetes mellitus', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'SLC6A3', 'Diethylpropion']",0.5
17307,30035.0,Diethylpropion,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Diethylpropion']",0.5
17307,33575.0,Diethylpropion,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'locomotory behavior', 'SLC6A3', 'Diethylpropion']",0.5
17307,33577.0,Diethylpropion,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Diethylpropion']",0.5
17307,33593.0,Diethylpropion,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Dichlorodiphenyl Dichloroethylene', 'lactation', 'SLC6A3', 'Diethylpropion']",0.5
17307,35641.0,Diethylpropion,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Diethylpropion']",0.5
17307,35953.0,Diethylpropion,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Lead', 'positive regulation of multicellular organism growth', 'SLC6A3', 'Diethylpropion']",0.5
17307,36187.0,Diethylpropion,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'positive regulation of multicellular organism growth', 'SLC6A3', 'Diethylpropion']",0.5
17307,83910.0,Diethylpropion,drug psychosis,disease-protein-drug,contraindication,"['drug psychosis', 'SLC6A3', 'Diethylpropion']",0.5
17308,29182.0,Guanethidine,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'SLC6A2', 'Guanethidine']",0.5
17308,33534.0,Guanethidine,pediatric systemic lupus erythematosus,disease-phenotype-protein-drug,contraindication,"['pediatric systemic lupus erythematosus', 'Seizure', 'SLC6A2', 'Guanethidine']",0.5
17309,30035.0,Phendimetrazine,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Phendimetrazine']",0.5
17309,33512.0,Phendimetrazine,preeclampsia,disease-exposure-bioprocess-gene-drug,contraindication,"['preeclampsia', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Phendimetrazine']",0.5
17309,33577.0,Phendimetrazine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Phendimetrazine']",0.5
17309,33593.0,Phendimetrazine,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Nitrogen Oxides', 'aging', 'ADRA1A', 'Phendimetrazine']",0.5
17309,35669.0,Phendimetrazine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Phendimetrazine']",0.5
17309,35761.0,Phendimetrazine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Phendimetrazine']",0.5
17309,35953.0,Phendimetrazine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Phendimetrazine']",0.5
17310,27933.0,Amineptine,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'SLC6A2', 'Amineptine']",0.5
17310,27933.0,Amineptine,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'SLC6A4', 'Amineptine']",0.5
17310,37703.0,Amineptine,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'SLC6A4', 'Amineptine']",0.5
17310,83760.0,Amineptine,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'SLC6A4', 'Amineptine']",0.5
17315,27921.0,Dexmethylphenidate,attention deficit-hyperactivity disorder,disease-protein-drug,indication,"['attention deficit-hyperactivity disorder', 'SLC6A3', 'Dexmethylphenidate']",0.5
17315,28249.0,Dexmethylphenidate,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'SLC6A2', 'Dexmethylphenidate']",0.5
17315,30035.0,Dexmethylphenidate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'SLC6A2', 'Dexmethylphenidate']",0.5
17315,33577.0,Dexmethylphenidate,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,33598.0,Dexmethylphenidate,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'brain morphogenesis', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,33632.0,Dexmethylphenidate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'social behavior', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,35641.0,Dexmethylphenidate,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SLC6A2', 'Dexmethylphenidate']",0.5
17315,35909.0,Dexmethylphenidate,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'SLC6A3', 'Dexmethylphenidate']",0.5
17315,35915.0,Dexmethylphenidate,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,36009.0,Dexmethylphenidate,tic disorder,disease-protein-drug,contraindication,"['tic disorder', 'SLC6A3', 'Dexmethylphenidate']",0.5
17315,36187.0,Dexmethylphenidate,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'memory', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,36693.0,Dexmethylphenidate,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,37180.0,Dexmethylphenidate,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'memory', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,38242.0,Dexmethylphenidate,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'SLC6A2', 'Dexmethylphenidate']",0.5
17315,83778.0,Dexmethylphenidate,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,83779.0,Dexmethylphenidate,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'social behavior', 'SLC6A4', 'Dexmethylphenidate']",0.5
17315,84036.0,Dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",disease-protein-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'SLC6A3', 'Dexmethylphenidate']",0.5
17315,84036.0,Dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",disease-exposure-bioprocess-gene-drug,indication,"['attention deficit hyperactivity disorder, inattentive type', 'Air Pollutants', 'memory', 'SLC6A4', 'Dexmethylphenidate']",0.5
17318,28391.0,Solriamfetol,narcolepsy,disease-exposure-bioprocess-gene-drug,indication,"['narcolepsy', 'Pesticides', 'triglyceride metabolic process', 'SLC22A4', 'Solriamfetol']",0.5
17318,30664.0,Solriamfetol,X-linked adrenoleukodystrophy,disease-phenotype-protein-drug,indication,"['X-linked adrenoleukodystrophy', 'Neurodegeneration', 'SLC6A3', 'Solriamfetol']",0.5
17319,36187.0,Papaverine,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'PDE4B', 'Papaverine']",0.5
17319,36187.0,Papaverine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'positive regulation of interferon-gamma production', 'PDE4B', 'Papaverine']",0.5
17319,37180.0,Papaverine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'positive regulation of interferon-gamma production', 'PDE4B', 'Papaverine']",0.5
17319,39798.0,Papaverine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,indication,"['peripheral arterial disease', 'Arsenic', 'positive regulation of interferon-gamma production', 'PDE4B', 'Papaverine']",0.5
17333,35669.0,Isoleucine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'mitochondrial translation', 'IARS2', 'Isoleucine']",0.5
17333,35761.0,Isoleucine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Nitrates', 'thyroid-stimulating hormone secretion', 'SLC16A10', 'Isoleucine']",0.5
17333,83923.0,Isoleucine,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'mitochondrial translation', 'IARS2', 'Isoleucine']",0.5
17335,35565.0,Porfimer sodium,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'FCGR1A', 'Porfimer sodium']",0.5
17335,35764.0,Porfimer sodium,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'LDLR', 'Porfimer sodium']",0.5
17337,27326.0,Droperidol,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'pigmentation', 'DRD2', 'Droperidol']",0.5
17337,27326.0,Droperidol,long QT syndrome,disease-phenotype-protein-drug,contraindication,"['long QT syndrome', 'Tachycardia', 'DRD2', 'Droperidol']",0.5
17337,27655.0,Droperidol,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'DRD2', 'Droperidol']",0.5
17337,30035.0,Droperidol,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'DRD2', 'Droperidol']",0.5
17337,31122.0,Droperidol,phaeochromocytoma,disease-phenotype-protein-drug,contraindication,"['phaeochromocytoma', 'Tachycardia', 'DRD2', 'Droperidol']",0.5
17337,33454.0,Droperidol,neuroleptic malignant syndrome,disease-phenotype-protein-drug,contraindication,"['neuroleptic malignant syndrome', 'Tachycardia', 'DRD2', 'Droperidol']",0.5
17337,33577.0,Droperidol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of heart rate', 'DRD2', 'Droperidol']",0.5
17337,35565.0,Droperidol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'sensory perception of smell', 'DRD2', 'Droperidol']",0.5
17337,35764.0,Droperidol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'DRD2', 'Droperidol']",0.5
17337,36080.0,Droperidol,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'regulation of heart rate', 'DRD2', 'Droperidol']",0.5
17337,36693.0,Droperidol,substance-related disorder,disease-protein-drug,contraindication,"['substance-related disorder', 'DRD2', 'Droperidol']",0.5
17337,36693.0,Droperidol,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'DRD2', 'Droperidol']",0.5
17337,37617.0,Droperidol,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'regulation of heart rate', 'DRD2', 'Droperidol']",0.5
17337,37703.0,Droperidol,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'DRD2', 'Droperidol']",0.5
17337,38003.0,Droperidol,basal ganglia disease,disease-protein-drug,contraindication,"['basal ganglia disease', 'DRD2', 'Droperidol']",0.5
17337,83760.0,Droperidol,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'DRD2', 'Droperidol']",0.5
17339,33605.0,Methoxamine,hypotensive disorder,disease-protein-drug,indication,"['hypotensive disorder', 'ADRA1B', 'Methoxamine']",0.5
17341,33575.0,Tetryzoline,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Tetryzoline']",0.5
17341,35669.0,Tetryzoline,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Tetryzoline']",0.5
17341,35761.0,Tetryzoline,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Tetryzoline']",0.5
17345,33575.0,Resorcinol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'TPO', 'Resorcinol']",0.5
17345,33575.0,Resorcinol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'TPO', 'Resorcinol']",0.5
17345,33649.0,Resorcinol,exanthem (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['exanthem (disease)', 'Particulate Matter', 'response to oxidative stress', 'TPO', 'Resorcinol']",0.5
17345,33649.0,Resorcinol,exanthem (disease),disease-exposure-gene-drug,contraindication,"['exanthem (disease)', 'Vehicle Emissions', 'TPO', 'Resorcinol']",0.5
17345,35764.0,Resorcinol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'response to oxidative stress', 'TPO', 'Resorcinol']",0.5
17345,36080.0,Resorcinol,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'response to oxidative stress', 'TPO', 'Resorcinol']",0.5
17345,36080.0,Resorcinol,respiratory failure,disease-exposure-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'TPO', 'Resorcinol']",0.5
17345,39798.0,Resorcinol,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'response to oxidative stress', 'TPO', 'Resorcinol']",0.5
17345,39798.0,Resorcinol,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'TPO', 'Resorcinol']",0.5
17345,83754.0,Resorcinol,common wart,disease-exposure-bioprocess-gene-drug,contraindication,"['common wart', 'Zinc', 'response to oxidative stress', 'TPO', 'Resorcinol']",0.5
17350,29387.0,Etelcalcetide,hyperparathyroidism,disease-protein-drug,indication,"['hyperparathyroidism', 'CASR', 'Etelcalcetide']",0.5
17376,33193.0,Cefotaxime,plague,disease-phenotype-protein-drug,off-label use,"['plague', 'Hepatomegaly', 'ALB', 'Cefotaxime']",0.5
17376,83845.0,Cefotaxime,viral meningitis,disease-protein-drug,indication,"['viral meningitis', 'ALB', 'Cefotaxime']",0.5
17377,27452.0,Phenol,Diamond-Blackfan anemia,disease-phenotype-protein-drug,contraindication,"['Diamond-Blackfan anemia', 'Thrombocytopenia', 'ALB', 'Phenol']",0.5
17377,27460.0,Phenol,WT limb-blood syndrome,disease-phenotype-protein-drug,contraindication,"['WT limb-blood syndrome', 'Thrombocytopenia', 'ALB', 'Phenol']",0.5
17377,27664.0,Phenol,idiopathic aplastic anemia,disease-phenotype-protein-drug,contraindication,"['idiopathic aplastic anemia', 'Thrombocytopenia', 'ALB', 'Phenol']",0.5
17377,30222.0,Phenol,congenital amegakaryocytic thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['congenital amegakaryocytic thrombocytopenia', 'Thrombocytopenia', 'ALB', 'Phenol']",0.5
17377,30543.0,Phenol,Shwachman-Diamond syndrome,disease-phenotype-protein-drug,contraindication,"['Shwachman-Diamond syndrome', 'Hepatomegaly', 'ALB', 'Phenol']",0.5
17377,31313.0,Phenol,pancytopenia-developmental delay syndrome,disease-phenotype-protein-drug,contraindication,"['pancytopenia-developmental delay syndrome', 'Thrombocytopenia', 'ALB', 'Phenol']",0.5
17377,31519.0,Phenol,ataxia-pancytopenia syndrome,disease-phenotype-protein-drug,contraindication,"['ataxia-pancytopenia syndrome', 'Thrombocytopenia', 'ALB', 'Phenol']",0.5
17377,32319.0,Phenol,Fanconi anemia,disease-phenotype-protein-drug,contraindication,"['Fanconi anemia', 'Thrombocytopenia', 'ALB', 'Phenol']",0.5
17377,32562.0,Phenol,Hoyeraal-Hreidarsson syndrome,disease-phenotype-protein-drug,contraindication,"['Hoyeraal-Hreidarsson syndrome', 'Thrombocytopenia', 'ALB', 'Phenol']",0.5
17377,33575.0,Phenol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Phenol']",0.5
17377,33575.0,Phenol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Phenol']",0.5
17377,35565.0,Phenol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Phenol']",0.5
17377,35641.0,Phenol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Phenol']",0.5
17377,39798.0,Phenol,peripheral arterial disease,disease-exposure-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'ALB', 'Phenol']",0.5
17378,31493.0,Guaiacol,pancreatitis,disease-protein-drug,contraindication,"['pancreatitis', 'ALB', 'Guaiacol']",0.5
17378,33575.0,Guaiacol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Dichlorodiphenyl Dichloroethylene', 'heme biosynthetic process', 'ALB', 'Guaiacol']",0.5
17378,33575.0,Guaiacol,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Cadmium', 'ALB', 'Guaiacol']",0.5
17378,33577.0,Guaiacol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Guaiacol']",0.5
17378,33577.0,Guaiacol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'ALB', 'Guaiacol']",0.5
17378,33605.0,Guaiacol,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ALB', 'Guaiacol']",0.5
17378,35565.0,Guaiacol,liver disease,disease-exposure-gene-drug,contraindication,"['liver disease', 'Cadmium', 'ALB', 'Guaiacol']",0.5
17378,35641.0,Guaiacol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ALB', 'Guaiacol']",0.5
17378,35669.0,Guaiacol,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Guaiacol']",0.5
17378,35761.0,Guaiacol,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Lead', 'transport', 'ALB', 'Guaiacol']",0.5
17378,35761.0,Guaiacol,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Cadmium', 'ALB', 'Guaiacol']",0.5
17378,35764.0,Guaiacol,kidney disease,disease-protein-drug,contraindication,"['kidney disease', 'ALB', 'Guaiacol']",0.5
17378,35764.0,Guaiacol,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'transport', 'ALB', 'Guaiacol']",0.5
17378,35764.0,Guaiacol,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'ALB', 'Guaiacol']",0.5
17378,35897.0,Guaiacol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Guaiacol']",0.5
17378,35953.0,Guaiacol,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Guaiacol']",0.5
17378,35953.0,Guaiacol,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'Lead', 'ALB', 'Guaiacol']",0.5
17378,36187.0,Guaiacol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'transport', 'ALB', 'Guaiacol']",0.5
17378,36187.0,Guaiacol,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'ALB', 'Guaiacol']",0.5
17378,36492.0,Guaiacol,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Lead', 'transport', 'ALB', 'Guaiacol']",0.5
17378,36492.0,Guaiacol,brain cancer,disease-exposure-gene-drug,contraindication,"['brain cancer', 'Lead', 'ALB', 'Guaiacol']",0.5
17378,37180.0,Guaiacol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Lead', 'transport', 'ALB', 'Guaiacol']",0.5
17378,37180.0,Guaiacol,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Cadmium', 'ALB', 'Guaiacol']",0.5
17378,37811.0,Guaiacol,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Particulate Matter', 'platelet degranulation', 'ALB', 'Guaiacol']",0.5
17390,28052.0,Nesiritide,hypertrophic cardiomyopathy,disease-phenotype-protein-drug,contraindication,"['hypertrophic cardiomyopathy', 'Cardiomegaly', 'NPR1', 'Nesiritide']",0.5
17398,29078.0,Anakinra,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Air Pollutants', 'inflammatory response', 'IL1R1', 'Anakinra']",0.5
17407,27361.0,Pravastatin,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'ABCC2', 'Pravastatin']",0.5
17407,28780.0,Pravastatin,Alzheimer disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Alzheimer disease', 'Pesticides', 'visual learning', 'HMGCR', 'Pravastatin']",0.5
17407,28780.0,Pravastatin,Alzheimer disease,disease-phenotype-protein-drug,contraindication,"['Alzheimer disease', 'Seizure', 'ABCC2', 'Pravastatin']",0.5
17407,30035.0,Pravastatin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'ABCB1', 'Pravastatin']",0.5
17407,33594.0,Pravastatin,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Pravastatin']",0.5
17407,33632.0,Pravastatin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'SLC16A1', 'Pravastatin']",0.5
17407,33695.0,Pravastatin,hypertriglyceridemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['hypertriglyceridemia (disease)', 'Mercury', 'cholesterol homeostasis', 'HMGCR', 'Pravastatin']",0.5
17407,35565.0,Pravastatin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Pravastatin']",0.5
17407,35764.0,Pravastatin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol homeostasis', 'HMGCR', 'Pravastatin']",0.5
17407,35909.0,Pravastatin,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,indication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cholesterol biosynthetic process', 'HMGCR', 'Pravastatin']",0.5
17407,35953.0,Pravastatin,atherosclerosis,disease-exposure-bioprocess-gene-drug,indication,"['atherosclerosis', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC2', 'Pravastatin']",0.5
17407,83790.0,Pravastatin,gout,disease-protein-drug,contraindication,"['gout', 'ABCG2', 'Pravastatin']",0.5
17407,83898.0,Pravastatin,obsolete familial combined hyperlipidemia,disease-protein-drug,indication,"['obsolete familial combined hyperlipidemia', 'HMGCR', 'Pravastatin']",0.5
17414,28547.0,Piribedil,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DRD2', 'Piribedil']",0.5
17414,28547.0,Piribedil,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'regulation of heart rate', 'DRD2', 'Piribedil']",0.5
17414,37706.0,Piribedil,parkinsonian disorder,disease-protein-drug,indication,"['parkinsonian disorder', 'DRD2', 'Piribedil']",0.5
17417,28158.0,Natalizumab,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'ICAM1', 'Natalizumab']",0.5
17417,28158.0,Natalizumab,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'immune response', 'FCGR1A', 'Natalizumab']",0.5
17417,37722.0,Natalizumab,multiple sclerosis,disease-protein-drug,indication,"['multiple sclerosis', 'ICAM1', 'Natalizumab']",0.5
17417,37722.0,Natalizumab,multiple sclerosis,disease-exposure-bioprocess-gene-drug,indication,"['multiple sclerosis', 'Mercury', 'immune response', 'FCGR1A', 'Natalizumab']",0.5
17417,37722.0,Natalizumab,multiple sclerosis,disease-exposure-gene-drug,indication,"['multiple sclerosis', 'Lead', 'ICAM1', 'Natalizumab']",0.5
17428,33675.0,Etidronic acid,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Particulate Matter', 'apoptotic process', 'SLC25A6', 'Etidronic acid']",0.5
17435,33581.0,Latanoprost,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'inflammatory response', 'PTGFR', 'Latanoprost']",0.5
17437,27933.0,Metyrosine,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'TH', 'Metyrosine']",0.5
17437,27933.0,Metyrosine,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'pigmentation', 'TH', 'Metyrosine']",0.5
17437,28547.0,Metyrosine,Parkinson disease,disease-protein-drug,contraindication,"['Parkinson disease', 'TH', 'Metyrosine']",0.5
17437,28547.0,Metyrosine,Parkinson disease,disease-exposure-bioprocess-gene-drug,contraindication,"['Parkinson disease', 'Air Pollutants', 'memory', 'TH', 'Metyrosine']",0.5
17437,28547.0,Metyrosine,Parkinson disease,disease-phenotype-protein-drug,contraindication,"['Parkinson disease', 'Limb dystonia', 'TH', 'Metyrosine']",0.5
17437,35565.0,Metyrosine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'TH', 'Metyrosine']",0.5
17437,35735.0,Metyrosine,sympathetic paraganglioma,disease-protein-drug,indication,"['sympathetic paraganglioma', 'TH', 'Metyrosine']",0.5
17437,35764.0,Metyrosine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'TH', 'Metyrosine']",0.5
17437,35894.0,Metyrosine,duodenum cancer,disease-protein-drug,indication,"['duodenum cancer', 'TH', 'Metyrosine']",0.5
17437,35895.0,Metyrosine,small intestine cancer,disease-protein-drug,indication,"['small intestine cancer', 'TH', 'Metyrosine']",0.5
17437,36149.0,Metyrosine,heart cancer,disease-protein-drug,indication,"['heart cancer', 'TH', 'Metyrosine']",0.5
17437,36860.0,Metyrosine,adrenal gland cancer,disease-protein-drug,indication,"['adrenal gland cancer', 'TH', 'Metyrosine']",0.5
17437,37703.0,Metyrosine,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'TH', 'Metyrosine']",0.5
17437,37706.0,Metyrosine,parkinsonian disorder,disease-protein-drug,contraindication,"['parkinsonian disorder', 'TH', 'Metyrosine']",0.5
17437,37919.0,Metyrosine,adrenal gland pheochromocytoma,disease-protein-drug,indication,"['adrenal gland pheochromocytoma', 'TH', 'Metyrosine']",0.5
17437,83760.0,Metyrosine,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'TH', 'Metyrosine']",0.5
17494,27249.0,Tesamorelin,isolated growth hormone deficiency,disease-protein-drug,contraindication,"['isolated growth hormone deficiency', 'GHRHR', 'Tesamorelin']",0.5
17494,33166.0,Tesamorelin,isolated congenital growth hormone deficiency,disease-protein-drug,contraindication,"['isolated congenital growth hormone deficiency', 'GHRHR', 'Tesamorelin']",0.5
17494,33575.0,Tesamorelin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'hormone metabolic process', 'GHRHR', 'Tesamorelin']",0.5
17524,30990.0,Carmustine,mycosis fungoides and variants,disease-phenotype-protein-drug,off-label use,"['mycosis fungoides and variants', 'Edema', 'GSR', 'Carmustine']",0.5
17524,33077.0,Carmustine,Hodgkins lymphoma,disease-exposure-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'GSR', 'Carmustine']",0.5
17524,33077.0,Carmustine,Hodgkins lymphoma,disease-exposure-molfunc-gene-drug,indication,"['Hodgkins lymphoma', 'Pesticides', 'glutathione-disulfide reductase (NADPH) activity', 'GSR', 'Carmustine']",0.5
17524,33623.0,Carmustine,macrocytic anemia (disease),disease-protein-drug,contraindication,"['macrocytic anemia (disease)', 'GSR', 'Carmustine']",0.5
17524,33632.0,Carmustine,anemia (disease),disease-protein-drug,contraindication,"['anemia (disease)', 'GSR', 'Carmustine']",0.5
17524,35471.0,Carmustine,pulmonary fibrosis,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary fibrosis', 'Asbestos', 'cellular response to oxidative stress', 'GSR', 'Carmustine']",0.5
17524,35565.0,Carmustine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'cellular response to oxidative stress', 'GSR', 'Carmustine']",0.5
17524,35650.0,Carmustine,non-Hodgkin lymphoma,disease-exposure-bioprocess-gene-drug,indication,"['non-Hodgkin lymphoma', 'Cadmium', 'cellular response to oxidative stress', 'GSR', 'Carmustine']",0.5
17524,35650.0,Carmustine,non-Hodgkin lymphoma,disease-exposure-gene-drug,indication,"['non-Hodgkin lymphoma', 'Pesticides', 'GSR', 'Carmustine']",0.5
17524,35650.0,Carmustine,non-Hodgkin lymphoma,disease-exposure-molfunc-gene-drug,indication,"['non-Hodgkin lymphoma', 'Pesticides', 'glutathione-disulfide reductase (NADPH) activity', 'GSR', 'Carmustine']",0.5
17524,35764.0,Carmustine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cellular response to oxidative stress', 'GSR', 'Carmustine']",0.5
17524,35786.0,Carmustine,glioma,disease-exposure-gene-drug,indication,"['glioma', 'Pesticides', 'GSR', 'Carmustine']",0.5
17524,35786.0,Carmustine,glioma,disease-exposure-molfunc-gene-drug,indication,"['glioma', 'Pesticides', 'glutathione-disulfide reductase (NADPH) activity', 'GSR', 'Carmustine']",0.5
17524,35833.0,Carmustine,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Particulate Matter', 'electron transport chain', 'GSR', 'Carmustine']",0.5
17524,36492.0,Carmustine,brain cancer,disease-exposure-gene-drug,indication,"['brain cancer', 'Pesticides', 'GSR', 'Carmustine']",0.5
17524,36492.0,Carmustine,brain cancer,disease-exposure-molfunc-gene-drug,indication,"['brain cancer', 'Pesticides', 'glutathione-disulfide reductase (NADPH) activity', 'GSR', 'Carmustine']",0.5
17533,39208.0,Denileukin diftitox,primary cutaneous T-cell lymphoma,disease-protein-drug,indication,"['primary cutaneous T-cell lymphoma', 'IL2RG', 'Denileukin diftitox']",0.5
17536,33577.0,Darbepoetin alfa,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Particulate Matter', 'brain development', 'EPOR', 'Darbepoetin alfa']",0.5
17545,37714.0,Gemtuzumab ozogamicin,unclassified acute myeloid leukemia,disease-protein-drug,indication,"['unclassified acute myeloid leukemia', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,38274.0,Gemtuzumab ozogamicin,inherited acute myeloid leukemia,disease-protein-drug,indication,"['inherited acute myeloid leukemia', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,39124.0,Gemtuzumab ozogamicin,therapy related acute myeloid leukemia and myelodysplastic syndrome,disease-protein-drug,indication,"['therapy related acute myeloid leukemia and myelodysplastic syndrome', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83852.0,Gemtuzumab ozogamicin,acute myeloid leukemia with minimal differentiation,disease-protein-drug,indication,"['acute myeloid leukemia with minimal differentiation', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83853.0,Gemtuzumab ozogamicin,acute myeloblastic leukemia without maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia without maturation', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83854.0,Gemtuzumab ozogamicin,acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor,disease-protein-drug,indication,"['acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83855.0,Gemtuzumab ozogamicin,acute myeloid leukemia with t(8;21)(q22;q22) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;21)(q22;q22) translocation', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83856.0,Gemtuzumab ozogamicin,acute myeloid leukemia with CEBPA somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with CEBPA somatic mutations', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83857.0,Gemtuzumab ozogamicin,acute myeloid leukemia with t(8;16)(p11;p13) translocation,disease-protein-drug,indication,"['acute myeloid leukemia with t(8;16)(p11;p13) translocation', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83858.0,Gemtuzumab ozogamicin,acute myeloid leukemia with t(6;9)(p23;q34),disease-protein-drug,indication,"['acute myeloid leukemia with t(6;9)(p23;q34)', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83859.0,Gemtuzumab ozogamicin,acute myeloid leukemia with t(9;11)(p22;q23),disease-protein-drug,indication,"['acute myeloid leukemia with t(9;11)(p22;q23)', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83860.0,Gemtuzumab ozogamicin,acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2),disease-protein-drug,indication,"['acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83861.0,Gemtuzumab ozogamicin,acute myeloid leukemia with NPM1 somatic mutations,disease-protein-drug,indication,"['acute myeloid leukemia with NPM1 somatic mutations', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17545,83862.0,Gemtuzumab ozogamicin,acute myeloblastic leukemia with maturation,disease-protein-drug,indication,"['acute myeloblastic leukemia with maturation', 'CD33', 'Gemtuzumab ozogamicin']",0.5
17548,33593.0,Cetilistat,obesity disorder,disease-exposure-bioprocess-gene-drug,indication,"['obesity disorder', 'Lead', 'lipid metabolic process', 'PNLIP', 'Cetilistat']",0.5
17558,27626.0,Pregabalin,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'gene expression', 'SLC1A1', 'Pregabalin']",0.5
17558,37703.0,Pregabalin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'SLC1A1', 'Pregabalin']",0.5
17558,83760.0,Pregabalin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'SLC1A1', 'Pregabalin']",0.5
17559,27933.0,Gabapentin enacarbil,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'regulation of ventricular cardiac muscle cell membrane repolarization', 'CACNA2D1', 'Gabapentin enacarbil']",0.5
17559,35764.0,Gabapentin enacarbil,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'regulation of ventricular cardiac muscle cell membrane repolarization', 'CACNA2D1', 'Gabapentin enacarbil']",0.5
17560,29113.0,Orciprenaline,diabetic ketoacidosis,disease-phenotype-protein-drug,contraindication,"['diabetic ketoacidosis', 'Insulin resistance', 'ADRB2', 'Orciprenaline']",0.5
17560,33577.0,Orciprenaline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Cadmium', 'bone resorption', 'ADRB2', 'Orciprenaline']",0.5
17560,33675.0,Orciprenaline,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Orciprenaline']",0.5
17560,33675.0,Orciprenaline,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Orciprenaline']",0.5
17560,35897.0,Orciprenaline,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Orciprenaline']",0.5
17560,36187.0,Orciprenaline,coronary artery disease,disease-protein-drug,contraindication,"['coronary artery disease', 'ADRB2', 'Orciprenaline']",0.5
17560,36187.0,Orciprenaline,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Cadmium', 'bone resorption', 'ADRB2', 'Orciprenaline']",0.5
17560,37786.0,Orciprenaline,myocardial ischemia,disease-protein-drug,contraindication,"['myocardial ischemia', 'ADRB2', 'Orciprenaline']",0.5
17560,37786.0,Orciprenaline,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Cadmium', 'bone resorption', 'ADRB2', 'Orciprenaline']",0.5
17560,37830.0,Orciprenaline,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Orciprenaline']",0.5
17560,39773.0,Orciprenaline,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Orciprenaline']",0.5
17560,83781.0,Orciprenaline,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Orciprenaline']",0.5
17561,33675.0,Bitolterol,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Bitolterol']",0.5
17561,33675.0,Bitolterol,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Bitolterol']",0.5
17561,35897.0,Bitolterol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Bitolterol']",0.5
17561,37830.0,Bitolterol,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Bitolterol']",0.5
17561,39773.0,Bitolterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Bitolterol']",0.5
17561,83781.0,Bitolterol,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Bitolterol']",0.5
17568,33675.0,Tulobuterol,asthma,disease-protein-drug,indication,"['asthma', 'ADRB2', 'Tulobuterol']",0.5
17568,33675.0,Tulobuterol,asthma,disease-exposure-bioprocess-gene-drug,indication,"['asthma', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Tulobuterol']",0.5
17568,35897.0,Tulobuterol,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary emphysema', 'Particulate Matter', 'bone resorption', 'ADRB2', 'Tulobuterol']",0.5
17568,39773.0,Tulobuterol,allergic asthma,disease-protein-drug,indication,"['allergic asthma', 'ADRB2', 'Tulobuterol']",0.5
17568,83781.0,Tulobuterol,intrinsic asthma,disease-protein-drug,indication,"['intrinsic asthma', 'ADRB2', 'Tulobuterol']",0.5
17583,29078.0,Etanercept,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'TNF', 'Etanercept']",0.5
17583,29078.0,Etanercept,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cognition', 'TNF', 'Etanercept']",0.5
17583,29078.0,Etanercept,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'TNF', 'Etanercept']",0.5
17583,29078.0,Etanercept,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'TNF', 'Etanercept']",0.5
17583,30800.0,Etanercept,juvenile arthritis due to defect in LACC1,disease-protein-drug,indication,"['juvenile arthritis due to defect in LACC1', 'FCGR1A', 'Etanercept']",0.5
17583,32325.0,Etanercept,juvenile idiopathic arthritis,disease-protein-drug,indication,"['juvenile idiopathic arthritis', 'FCGR1A', 'Etanercept']",0.5
17583,32325.0,Etanercept,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Fever', 'TNF', 'Etanercept']",0.5
17583,36265.0,Etanercept,spondyloarthropathy,disease-protein-drug,indication,"['spondyloarthropathy', 'FCGR1A', 'Etanercept']",0.5
17583,39524.0,Etanercept,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'LTA', 'Etanercept']",0.5
17584,29078.0,Adalimumab,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'TNF', 'Adalimumab']",0.5
17584,29078.0,Adalimumab,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cognition', 'TNF', 'Adalimumab']",0.5
17584,29078.0,Adalimumab,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'TNF', 'Adalimumab']",0.5
17584,29078.0,Adalimumab,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'TNF', 'Adalimumab']",0.5
17584,32325.0,Adalimumab,juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['juvenile idiopathic arthritis', 'Fever', 'TNF', 'Adalimumab']",0.5
17584,37784.0,Adalimumab,Crohn disease,disease-protein-drug,indication,"['Crohn disease', 'TNF', 'Adalimumab']",0.5
17584,37785.0,Adalimumab,ulcerative colitis (disease),disease-protein-drug,indication,"['ulcerative colitis (disease)', 'TNF', 'Adalimumab']",0.5
17584,37785.0,Adalimumab,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,indication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'TNF', 'Adalimumab']",0.5
17584,39524.0,Adalimumab,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'TNF', 'Adalimumab']",0.5
17584,83770.0,Adalimumab,Crohn's colitis,disease-protein-drug,indication,"[""Crohn's colitis"", 'TNF', 'Adalimumab']",0.5
17585,28158.0,Infliximab,inflammatory bowel disease,disease-protein-drug,indication,"['inflammatory bowel disease', 'TNF', 'Infliximab']",0.5
17585,28158.0,Infliximab,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'TNF', 'Infliximab']",0.5
17585,28158.0,Infliximab,inflammatory bowel disease,disease-exposure-gene-drug,indication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'TNF', 'Infliximab']",0.5
17585,37784.0,Infliximab,Crohn disease,disease-protein-drug,indication,"['Crohn disease', 'TNF', 'Infliximab']",0.5
17585,37785.0,Infliximab,ulcerative colitis (disease),disease-protein-drug,indication,"['ulcerative colitis (disease)', 'TNF', 'Infliximab']",0.5
17585,37785.0,Infliximab,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,indication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'TNF', 'Infliximab']",0.5
17585,39524.0,Infliximab,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'TNF', 'Infliximab']",0.5
17585,83770.0,Infliximab,Crohn's colitis,disease-protein-drug,indication,"[""Crohn's colitis"", 'TNF', 'Infliximab']",0.5
17601,29078.0,Golimumab,rheumatoid arthritis,disease-protein-drug,indication,"['rheumatoid arthritis', 'TNF', 'Golimumab']",0.5
17601,29078.0,Golimumab,rheumatoid arthritis,disease-exposure-bioprocess-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'cognition', 'TNF', 'Golimumab']",0.5
17601,29078.0,Golimumab,rheumatoid arthritis,disease-exposure-gene-drug,indication,"['rheumatoid arthritis', 'Pesticides', 'TNF', 'Golimumab']",0.5
17601,29078.0,Golimumab,rheumatoid arthritis,disease-phenotype-protein-drug,indication,"['rheumatoid arthritis', 'Fever', 'TNF', 'Golimumab']",0.5
17601,37785.0,Golimumab,ulcerative colitis (disease),disease-protein-drug,indication,"['ulcerative colitis (disease)', 'TNF', 'Golimumab']",0.5
17601,37785.0,Golimumab,ulcerative colitis (disease),disease-exposure-bioprocess-gene-drug,indication,"['ulcerative colitis (disease)', 'perfluorooctanoic acid', 'cognition', 'TNF', 'Golimumab']",0.5
17601,39524.0,Golimumab,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'TNF', 'Golimumab']",0.5
17605,28849.0,Cetuximab,colorectal cancer,disease-protein-drug,indication,"['colorectal cancer', 'EGFR', 'Cetuximab']",0.5
17605,29375.0,Cetuximab,squamous cell carcinoma,disease-protein-drug,indication,"['squamous cell carcinoma', 'EGFR', 'Cetuximab']",0.5
17605,29375.0,Cetuximab,squamous cell carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['squamous cell carcinoma', 'Arsenic', 'response to cobalamin', 'EGFR', 'Cetuximab']",0.5
17605,36223.0,Cetuximab,malignant colon neoplasm,disease-protein-drug,indication,"['malignant colon neoplasm', 'EGFR', 'Cetuximab']",0.5
17605,36581.0,Cetuximab,colonic neoplasm,disease-protein-drug,indication,"['colonic neoplasm', 'EGFR', 'Cetuximab']",0.5
17605,36581.0,Cetuximab,colonic neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['colonic neoplasm', 'Chlorpyrifos', 'learning or memory', 'EGFR', 'Cetuximab']",0.5
17605,37144.0,Cetuximab,squamous cell carcinoma of colon,disease-protein-drug,indication,"['squamous cell carcinoma of colon', 'EGFR', 'Cetuximab']",0.5
17624,33618.0,Acetyldigitoxin,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,indication,"['atrial fibrillation (disease)', 'Particulate Matter', 'regulation of blood pressure', 'ATP1A1', 'Acetyldigitoxin']",0.5
17624,37659.0,Acetyldigitoxin,heart failure,disease-exposure-bioprocess-gene-drug,indication,"['heart failure', 'Air Pollutants', 'regulation of blood pressure', 'ATP1A1', 'Acetyldigitoxin']",0.5
17631,37617.0,Almitrine,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,indication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'regulation of blood pressure', 'ATP1A1', 'Almitrine']",0.5
17638,33594.0,Magnesium lactate,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'regulation of blood pressure', 'ATP1A1', 'Magnesium lactate']",0.5
17638,35764.0,Magnesium lactate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of blood pressure', 'ATP1A1', 'Magnesium lactate']",0.5
17647,33577.0,Mecamylamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Mercury', 'memory', 'CHRNB2', 'Mecamylamine']",0.5
17652,29525.0,Tetracaine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Tetracaine']",0.5
17652,33581.0,Tetracaine,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Nitrogen Dioxide', 'inflammatory response', 'SCN9A', 'Tetracaine']",0.5
17652,35565.0,Tetracaine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'SCN2A', 'Tetracaine']",0.5
17652,35641.0,Tetracaine,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'SCN9A', 'Tetracaine']",0.5
17652,35669.0,Tetracaine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Tetracaine']",0.5
17652,35761.0,Tetracaine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'inflammatory response', 'SCN9A', 'Tetracaine']",0.5
17652,35764.0,Tetracaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Tetracaine']",0.5
17652,36034.0,Tetracaine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SCN2A', 'Tetracaine']",0.5
17652,36080.0,Tetracaine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'inflammatory response', 'SCN9A', 'Tetracaine']",0.5
17654,31756.0,Valrubicin,urinary bladder cancer,disease-exposure-bioprocess-gene-drug,indication,"['urinary bladder cancer', 'Arsenic', 'cellular response to DNA damage stimulus', 'TOP2A', 'Valrubicin']",0.5
17654,33642.0,Valrubicin,urinary bladder carcinoma,disease-exposure-bioprocess-gene-drug,indication,"['urinary bladder carcinoma', 'Arsenic', 'cellular response to DNA damage stimulus', 'TOP2A', 'Valrubicin']",0.5
17654,35624.0,Valrubicin,urinary bladder neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['urinary bladder neoplasm', 'Arsenic', 'cellular response to DNA damage stimulus', 'TOP2A', 'Valrubicin']",0.5
17718,31116.0,Necitumumab,lung cancer,disease-protein-drug,indication,"['lung cancer', 'EGFR', 'Necitumumab']",0.5
17720,31116.0,Olmutinib,lung cancer,disease-protein-drug,indication,"['lung cancer', 'EGFR', 'Olmutinib']",0.5
17720,33688.0,Olmutinib,non-small cell lung carcinoma (disease),disease-protein-drug,indication,"['non-small cell lung carcinoma (disease)', 'EGFR', 'Olmutinib']",0.5
17724,30035.0,Methadyl acetate,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'OPRM1', 'Methadyl acetate']",0.5
17724,31072.0,Methadyl acetate,pseudotumor cerebri,disease-phenotype-protein-drug,contraindication,"['pseudotumor cerebri', 'Nausea', 'OPRM1', 'Methadyl acetate']",0.5
17724,33675.0,Methadyl acetate,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'OPRM1', 'Methadyl acetate']",0.5
17724,36080.0,Methadyl acetate,respiratory failure,disease-protein-drug,contraindication,"['respiratory failure', 'OPRM1', 'Methadyl acetate']",0.5
17724,37753.0,Methadyl acetate,opiate dependence,disease-protein-drug,indication,"['opiate dependence', 'OPRM1', 'Methadyl acetate']",0.5
17724,84242.0,Methadyl acetate,morphine dependence,disease-protein-drug,indication,"['morphine dependence', 'OPRM1', 'Methadyl acetate']",0.5
17727,35764.0,Pamidronic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'cellular response to DNA damage stimulus', 'CASP3', 'Pamidronic acid']",0.5
17728,29614.0,Zoledronic acid,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol biosynthetic process', 'FDPS', 'Zoledronic acid']",0.5
17729,33618.0,Alendronic acid,atrial fibrillation (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['atrial fibrillation (disease)', 'Particulate Matter', 'cholesterol biosynthetic process', 'FDPS', 'Alendronic acid']",0.5
17729,35764.0,Alendronic acid,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'PTPRE', 'Alendronic acid']",0.5
17730,29614.0,Ibandronate,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol biosynthetic process', 'FDPS', 'Ibandronate']",0.5
17735,29614.0,Incadronic acid,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol biosynthetic process', 'FDPS', 'Incadronic acid']",0.5
17736,29614.0,Minodronic acid,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'cholesterol biosynthetic process', 'FDPS', 'Minodronic acid']",0.5
17739,39444.0,Dihydrotachysterol,osteomalacia (disease),disease-protein-drug,indication,"['osteomalacia (disease)', 'VDR', 'Dihydrotachysterol']",0.5
17746,29614.0,Eldecalcitol,osteoporosis,disease-protein-drug,indication,"['osteoporosis', 'VDR', 'Eldecalcitol']",0.5
17746,29614.0,Eldecalcitol,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorooctanoic acid', 'lactation', 'VDR', 'Eldecalcitol']",0.5
17746,83776.0,Eldecalcitol,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'VDR', 'Eldecalcitol']",0.5
17776,33649.0,Desoximetasone,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Particulate Matter', 'apoptotic process', 'NR3C1', 'Desoximetasone']",0.5
17776,36129.0,Desoximetasone,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Desoximetasone']",0.5
17776,39798.0,Desoximetasone,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'negative regulation of transcription, DNA-templated', 'NR3C1', 'Desoximetasone']",0.5
17829,28249.0,Lithium citrate,major affective disorder,disease-protein-drug,indication,"['major affective disorder', 'GSK3B', 'Lithium citrate']",0.5
17829,32772.0,Lithium citrate,central diabetes insipidus,disease-phenotype-protein-drug,contraindication,"['central diabetes insipidus', 'Seizure', 'IMPA1', 'Lithium citrate']",0.5
17829,35764.0,Lithium citrate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'inositol metabolic process', 'IMPA1', 'Lithium citrate']",0.5
17829,35764.0,Lithium citrate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'GSK3B', 'Lithium citrate']",0.5
17829,38242.0,Lithium citrate,bipolar disorder,disease-protein-drug,off-label use,"['bipolar disorder', 'GSK3B', 'Lithium citrate']",0.5
17829,83763.0,Lithium citrate,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'GSK3B', 'Lithium citrate']",0.5
17831,28249.0,Lithium carbonate,major affective disorder,disease-protein-drug,indication,"['major affective disorder', 'GSK3B', 'Lithium carbonate']",0.5
17831,32772.0,Lithium carbonate,central diabetes insipidus,disease-phenotype-protein-drug,contraindication,"['central diabetes insipidus', 'Seizure', 'IMPA1', 'Lithium carbonate']",0.5
17831,35764.0,Lithium carbonate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'gene expression', 'SCNN1B', 'Lithium carbonate']",0.5
17831,35764.0,Lithium carbonate,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'GSK3B', 'Lithium carbonate']",0.5
17831,36063.0,Lithium carbonate,cognitive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cognitive disorder', 'Pesticides', 'gene expression', 'SCNN1B', 'Lithium carbonate']",0.5
17831,36469.0,Lithium carbonate,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'DDT', 'gene expression', 'SCNN1B', 'Lithium carbonate']",0.5
17831,38242.0,Lithium carbonate,bipolar disorder,disease-protein-drug,indication,"['bipolar disorder', 'GSK3B', 'Lithium carbonate']",0.5
17831,83763.0,Lithium carbonate,manic bipolar affective disorder,disease-protein-drug,indication,"['manic bipolar affective disorder', 'GSK3B', 'Lithium carbonate']",0.5
17832,28208.0,Acarbose,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Zinc', 'glucose metabolic process', 'GAA', 'Acarbose']",0.5
17832,33575.0,Acarbose,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,indication,"['diabetes mellitus (disease)', 'Zinc', 'glucose metabolic process', 'GAA', 'Acarbose']",0.5
17832,35565.0,Acarbose,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'glucose metabolic process', 'GAA', 'Acarbose']",0.5
17832,35764.0,Acarbose,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'glucose metabolic process', 'GAA', 'Acarbose']",0.5
17888,33577.0,Bremelanotide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'regulation of blood pressure', 'MC3R', 'Bremelanotide']",0.5
17888,35669.0,Bremelanotide,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'regulation of blood pressure', 'MC3R', 'Bremelanotide']",0.5
17888,35761.0,Bremelanotide,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'regulation of blood pressure', 'MC3R', 'Bremelanotide']",0.5
17889,27933.0,Varenicline,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'CHRNB2', 'Varenicline']",0.5
17889,27933.0,Varenicline,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'DNA repair', 'CHRNA4', 'Varenicline']",0.5
17889,28249.0,Varenicline,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'CHRNA6', 'Varenicline']",0.5
17889,28313.0,Varenicline,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'CHRNB2', 'Varenicline']",0.5
17889,28313.0,Varenicline,schizophrenia,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophrenia', 'Vitamin D', 'social behavior', 'CHRNB2', 'Varenicline']",0.5
17889,30035.0,Varenicline,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'CHRNA3', 'Varenicline']",0.5
17889,37703.0,Varenicline,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'CHRNA6', 'Varenicline']",0.5
17889,38242.0,Varenicline,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'CHRNA6', 'Varenicline']",0.5
17889,38242.0,Varenicline,bipolar disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['bipolar disorder', 'Tetrachloroethylene', 'visual learning', 'CHRNB2', 'Varenicline']",0.5
17889,39798.0,Varenicline,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'cognition', 'CHRNA4', 'Varenicline']",0.5
17889,83760.0,Varenicline,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'CHRNA6', 'Varenicline']",0.5
17903,28208.0,Vildagliptin,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Air Pollutants', 'psychomotor behavior', 'DPP4', 'Vildagliptin']",0.5
17949,28208.0,Albiglutide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'GLP1R', 'Albiglutide']",0.5
17949,28208.0,Albiglutide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Vehicle Emissions', 'positive regulation of blood pressure', 'GLP1R', 'Albiglutide']",0.5
17950,33575.0,Dulaglutide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'GLP1R', 'Dulaglutide']",0.5
17951,28208.0,Lixisenatide,type 2 diabetes mellitus,disease-protein-drug,indication,"['type 2 diabetes mellitus', 'GLP1R', 'Lixisenatide']",0.5
17951,28208.0,Lixisenatide,type 2 diabetes mellitus,disease-exposure-bioprocess-gene-drug,indication,"['type 2 diabetes mellitus', 'Vehicle Emissions', 'positive regulation of blood pressure', 'GLP1R', 'Lixisenatide']",0.5
17951,33575.0,Lixisenatide,diabetes mellitus (disease),disease-protein-drug,indication,"['diabetes mellitus (disease)', 'GLP1R', 'Lixisenatide']",0.5
17987,33577.0,Calcium chloride,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Arsenic', 'positive regulation of cytokine production', 'S100A13', 'Calcium chloride']",0.5
17987,35669.0,Calcium chloride,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Arsenic', 'positive regulation of cytokine production', 'S100A13', 'Calcium chloride']",0.5
17987,35761.0,Calcium chloride,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Arsenic', 'positive regulation of cytokine production', 'S100A13', 'Calcium chloride']",0.5
17987,35764.0,Calcium chloride,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'positive regulation of cytokine production', 'S100A13', 'Calcium chloride']",0.5
17987,35953.0,Calcium chloride,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Arsenic', 'positive regulation of cytokine production', 'S100A13', 'Calcium chloride']",0.5
17987,36187.0,Calcium chloride,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Arsenic', 'positive regulation of cytokine production', 'S100A13', 'Calcium chloride']",0.5
17987,37180.0,Calcium chloride,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Arsenic', 'positive regulation of cytokine production', 'S100A13', 'Calcium chloride']",0.5
17987,37617.0,Calcium chloride,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Arsenic', 'positive regulation of cytokine production', 'S100A13', 'Calcium chloride']",0.5
17999,29494.0,Flucytosine,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,disease-phenotype-protein-drug,contraindication,"['autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 'Hearing impairment', 'DNMT1', 'Flucytosine']",0.5
17999,35565.0,Flucytosine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'DNA methylation involved in embryo development', 'DNMT1', 'Flucytosine']",0.5
17999,35764.0,Flucytosine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'DNA methylation involved in embryo development', 'DNMT1', 'Flucytosine']",0.5
18036,33575.0,Bacitracin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'insulin metabolic process', 'IDE', 'Bacitracin']",0.5
18036,33581.0,Bacitracin,conjunctivitis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['conjunctivitis (disease)', 'Particulate Matter', 'platelet degranulation', 'A2M', 'Bacitracin']",0.5
18036,35565.0,Bacitracin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'insulin metabolic process', 'IDE', 'Bacitracin']",0.5
18036,35764.0,Bacitracin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'insulin metabolic process', 'IDE', 'Bacitracin']",0.5
18036,39798.0,Bacitracin,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Cadmium', 'insulin metabolic process', 'IDE', 'Bacitracin']",0.5
18102,27626.0,Plerixafor,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'immune response', 'CXCR4', 'Plerixafor']",0.5
18102,33635.0,Plerixafor,leukemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['leukemia (disease)', 'Benzene', 'inflammatory response', 'CXCR4', 'Plerixafor']",0.5
18123,33577.0,Regadenoson,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Air Pollutants', 'inflammatory response', 'ADORA2A', 'Regadenoson']",0.5
18123,33605.0,Regadenoson,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'ADORA2A', 'Regadenoson']",0.5
18123,33675.0,Regadenoson,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'inflammatory response', 'ADORA2A', 'Regadenoson']",0.5
18123,35641.0,Regadenoson,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ADORA2A', 'Regadenoson']",0.5
18123,36187.0,Regadenoson,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'ADORA2A', 'Regadenoson']",0.5
18123,36312.0,Regadenoson,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['transient ischemic attack (disease)', 'Particulate Matter', 'apoptotic process', 'ADORA2A', 'Regadenoson']",0.5
18123,37617.0,Regadenoson,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'inflammatory response', 'ADORA2A', 'Regadenoson']",0.5
18160,29161.0,Emapalumab,hemophagocytic lymphohistiocytosis,disease-phenotype-protein-drug,indication,"['hemophagocytic lymphohistiocytosis', 'Hyponatremia', 'IFNG', 'Emapalumab']",0.5
18179,28374.0,Sucralfate,gastroesophageal reflux disease,disease-protein-drug,off-label use,"['gastroesophageal reflux disease', 'PGA5', 'Sucralfate']",0.5
18179,33714.0,Sucralfate,esophagitis (disease),disease-protein-drug,off-label use,"['esophagitis (disease)', 'PGA5', 'Sucralfate']",0.5
18179,37564.0,Sucralfate,gastric ulcer (disease),disease-protein-drug,off-label use,"['gastric ulcer (disease)', 'EGF', 'Sucralfate']",0.5
18179,83878.0,Sucralfate,peptic esophagitis,disease-protein-drug,off-label use,"['peptic esophagitis', 'PGA5', 'Sucralfate']",0.5
18179,83923.0,Sucralfate,chronic renal failure syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic renal failure syndrome', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'FGF2', 'Sucralfate']",0.5
18195,29945.0,Gimeracil,gastric cancer,disease-protein-drug,indication,"['gastric cancer', 'DPYD', 'Gimeracil']",0.5
18195,31380.0,Gimeracil,diffuse gastric adenocarcinoma,disease-protein-drug,indication,"['diffuse gastric adenocarcinoma', 'DPYD', 'Gimeracil']",0.5
18195,36000.0,Gimeracil,gastric neoplasm,disease-protein-drug,indication,"['gastric neoplasm', 'DPYD', 'Gimeracil']",0.5
18195,37273.0,Gimeracil,gastric carcinoma,disease-protein-drug,indication,"['gastric carcinoma', 'DPYD', 'Gimeracil']",0.5
18195,83899.0,Gimeracil,gastric linitis plastica,disease-protein-drug,indication,"['gastric linitis plastica', 'DPYD', 'Gimeracil']",0.5
18226,28772.0,Velaglucerase alfa,Gaucher disease,disease-protein-drug,indication,"['Gaucher disease', 'GBA', 'Velaglucerase alfa']",0.5
18226,28772.0,Velaglucerase alfa,Gaucher disease,disease-phenotype-protein-drug,indication,"['Gaucher disease', 'Seizure', 'GBA', 'Velaglucerase alfa']",0.5
18230,38024.0,Ustekinumab,psoriasis,disease-protein-drug,indication,"['psoriasis', 'IL23A', 'Ustekinumab']",0.5
18230,39524.0,Ustekinumab,psoriatic arthritis,disease-protein-drug,indication,"['psoriatic arthritis', 'IL12B', 'Ustekinumab']",0.5
18230,39728.0,Ustekinumab,parapsoriasis,disease-protein-drug,indication,"['parapsoriasis', 'IL23A', 'Ustekinumab']",0.5
18277,27933.0,Levetiracetam,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'ABCB1', 'Levetiracetam']",0.5
18277,36104.0,Levetiracetam,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Levetiracetam']",0.5
18277,36229.0,Levetiracetam,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Levetiracetam']",0.5
18277,37703.0,Levetiracetam,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'ABCB1', 'Levetiracetam']",0.5
18277,83760.0,Levetiracetam,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'ABCB1', 'Levetiracetam']",0.5
18283,29182.0,Belimumab,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,indication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'immune response', 'TNFSF13B', 'Belimumab']",0.5
18309,36312.0,Fasudil,transient ischemic attack (disease),disease-exposure-bioprocess-gene-drug,indication,"['transient ischemic attack (disease)', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'PRKACA', 'Fasudil']",0.5
18309,37718.0,Fasudil,brain ischemia,disease-exposure-bioprocess-gene-drug,indication,"['brain ischemia', 'Air Pollutants', 'regulation of heart rate', 'PRKACA', 'Fasudil']",0.5
18313,35764.0,Oxacillin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Oxacillin']",0.5
18314,33575.0,Benzoic acid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'glucose homeostasis', 'SLC16A1', 'Benzoic acid']",0.5
18314,33577.0,Benzoic acid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'glucose homeostasis', 'SLC16A1', 'Benzoic acid']",0.5
18314,33632.0,Benzoic acid,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'SLC16A1', 'Benzoic acid']",0.5
18314,35565.0,Benzoic acid,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'glucose homeostasis', 'SLC16A1', 'Benzoic acid']",0.5
18314,35669.0,Benzoic acid,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'glucose homeostasis', 'SLC16A1', 'Benzoic acid']",0.5
18314,35761.0,Benzoic acid,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'glucose homeostasis', 'SLC16A1', 'Benzoic acid']",0.5
18314,35764.0,Benzoic acid,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'SLC16A1', 'Benzoic acid']",0.5
18314,36034.0,Benzoic acid,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'glyphosate', 'lipid metabolic process', 'SLC16A1', 'Benzoic acid']",0.5
18314,36187.0,Benzoic acid,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'glucose homeostasis', 'SLC16A1', 'Benzoic acid']",0.5
18314,36274.0,Benzoic acid,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'glucose homeostasis', 'SLC16A1', 'Benzoic acid']",0.5
18416,30773.0,Canakinumab,autosomal recessive familial Mediterranean fever,disease-phenotype-protein-drug,indication,"['autosomal recessive familial Mediterranean fever', 'Leukocytosis', 'IL1B', 'Canakinumab']",0.5
18416,30937.0,Canakinumab,autosomal dominant familial periodic fever,disease-phenotype-protein-drug,indication,"['autosomal dominant familial periodic fever', 'Leukocytosis', 'IL1B', 'Canakinumab']",0.5
18416,31768.0,Canakinumab,mevalonic aciduria,disease-phenotype-protein-drug,indication,"['mevalonic aciduria', 'Leukocytosis', 'IL1B', 'Canakinumab']",0.5
18416,32202.0,Canakinumab,familial Mediterranean fever,disease-phenotype-protein-drug,indication,"['familial Mediterranean fever', 'Fever', 'IL1B', 'Canakinumab']",0.5
18416,32692.0,Canakinumab,systemic-onset juvenile idiopathic arthritis,disease-phenotype-protein-drug,indication,"['systemic-onset juvenile idiopathic arthritis', 'Fever', 'IL1B', 'Canakinumab']",0.5
18416,83790.0,Canakinumab,gout,disease-protein-drug,indication,"['gout', 'IL1B', 'Canakinumab']",0.5
18590,35764.0,Streptomycin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'PADI4', 'Streptomycin']",0.5
18590,39696.0,Streptomycin,pulmonary tuberculosis,disease-exposure-bioprocess-gene-drug,indication,"['pulmonary tuberculosis', 'Arsenic', 'innate immune response', 'PADI4', 'Streptomycin']",0.5
18611,31116.0,Lonidamine,lung cancer,disease-protein-drug,indication,"['lung cancer', 'HK1', 'Lonidamine']",0.5
18611,36812.0,Lonidamine,lung neoplasm,disease-exposure-bioprocess-gene-drug,indication,"['lung neoplasm', 'Air Pollutants', 'inflammatory response', 'HK1', 'Lonidamine']",0.5
18687,35764.0,Cilastatin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Cadmium', 'inflammatory response', 'DPEP1', 'Cilastatin']",0.5
18687,36209.0,Cilastatin,arthropathy,disease-protein-drug,indication,"['arthropathy', 'DPEP1', 'Cilastatin']",0.5
18695,27626.0,Eptifibatide,thrombocytopenia,disease-phenotype-protein-drug,contraindication,"['thrombocytopenia', 'Thrombocytopenia', 'ITGB3', 'Eptifibatide']",0.5
18695,83812.0,Eptifibatide,acute coronary syndrome,disease-protein-drug,indication,"['acute coronary syndrome', 'ITGB3', 'Eptifibatide']",0.5
18756,30035.0,Acamprosate,substance abuse/dependence,disease-protein-drug,indication,"['substance abuse/dependence', 'GABRB3', 'Acamprosate']",0.5
18959,27326.0,Vorinostat,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'HDAC1', 'Vorinostat']",0.5
18959,27626.0,Vorinostat,thrombocytopenia,disease-exposure-bioprocess-gene-drug,contraindication,"['thrombocytopenia', 'Dioxins', 'regulation of telomere maintenance', 'HDAC8', 'Vorinostat']",0.5
18959,33575.0,Vorinostat,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC1', 'Vorinostat']",0.5
18959,33594.0,Vorinostat,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'positive regulation of tumor necrosis factor production', 'HDAC1', 'Vorinostat']",0.5
18959,33632.0,Vorinostat,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC1', 'Vorinostat']",0.5
18959,33699.0,Vorinostat,pulmonary embolism (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary embolism (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'HDAC1', 'Vorinostat']",0.5
18959,35565.0,Vorinostat,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctanoic acid', 'regulation of lipid metabolic process', 'HDAC3', 'Vorinostat']",0.5
19207,27933.0,Carbidopa,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'DDC', 'Carbidopa']",0.5
19207,28396.0,Carbidopa,multiple system atrophy,disease-phenotype-protein-drug,contraindication,"['multiple system atrophy', 'Neurodegeneration', 'DDC', 'Carbidopa']",0.5
19207,28547.0,Carbidopa,Parkinson disease,disease-protein-drug,indication,"['Parkinson disease', 'DDC', 'Carbidopa']",0.5
19207,28801.0,Carbidopa,juvenile onset Parkinson disease 19A,disease-protein-drug,indication,"['juvenile onset Parkinson disease 19A', 'DDC', 'Carbidopa']",0.5
19207,28974.0,Carbidopa,early-onset parkinsonism-intellectual disability syndrome,disease-protein-drug,indication,"['early-onset parkinsonism-intellectual disability syndrome', 'DDC', 'Carbidopa']",0.5
19207,30093.0,Carbidopa,parkinsonian-pyramidal syndrome,disease-protein-drug,indication,"['parkinsonian-pyramidal syndrome', 'DDC', 'Carbidopa']",0.5
19207,32468.0,Carbidopa,postencephalitic Parkinson disease,disease-phenotype-protein-drug,indication,"['postencephalitic Parkinson disease', 'Oculogyric crisis', 'DDC', 'Carbidopa']",0.5
19207,32759.0,Carbidopa,hemiparkinsonism-hemiatrophy syndrome,disease-protein-drug,indication,"['hemiparkinsonism-hemiatrophy syndrome', 'DDC', 'Carbidopa']",0.5
19207,32974.0,Carbidopa,atypical juvenile parkinsonism,disease-protein-drug,indication,"['atypical juvenile parkinsonism', 'DDC', 'Carbidopa']",0.5
19207,33241.0,Carbidopa,hereditary late onset Parkinson disease,disease-protein-drug,indication,"['hereditary late onset Parkinson disease', 'DDC', 'Carbidopa']",0.5
19207,37706.0,Carbidopa,parkinsonian disorder,disease-protein-drug,indication,"['parkinsonian disorder', 'DDC', 'Carbidopa']",0.5
19217,28849.0,Tipiracil,colorectal cancer,disease-protein-drug,indication,"['colorectal cancer', 'TYMP', 'Tipiracil']",0.5
19217,36223.0,Tipiracil,malignant colon neoplasm,disease-protein-drug,indication,"['malignant colon neoplasm', 'TYMP', 'Tipiracil']",0.5
19217,36581.0,Tipiracil,colonic neoplasm,disease-protein-drug,indication,"['colonic neoplasm', 'TYMP', 'Tipiracil']",0.5
19217,37144.0,Tipiracil,squamous cell carcinoma of colon,disease-protein-drug,indication,"['squamous cell carcinoma of colon', 'TYMP', 'Tipiracil']",0.5
19222,27933.0,Isocarboxazid,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'MAOB', 'Isocarboxazid']",0.5
19222,27933.0,Isocarboxazid,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Isocarboxazid']",0.5
19222,28249.0,Isocarboxazid,major affective disorder,disease-protein-drug,contraindication,"['major affective disorder', 'MAOB', 'Isocarboxazid']",0.5
19222,28313.0,Isocarboxazid,schizophrenia,disease-protein-drug,contraindication,"['schizophrenia', 'MAOB', 'Isocarboxazid']",0.5
19222,30035.0,Isocarboxazid,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'MAOB', 'Isocarboxazid']",0.5
19222,31122.0,Isocarboxazid,phaeochromocytoma,disease-protein-drug,contraindication,"['phaeochromocytoma', 'MAOB', 'Isocarboxazid']",0.5
19222,33575.0,Isocarboxazid,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Isocarboxazid']",0.5
19222,33577.0,Isocarboxazid,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Isocarboxazid']",0.5
19222,33605.0,Isocarboxazid,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'MAOB', 'Isocarboxazid']",0.5
19222,35669.0,Isocarboxazid,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Isocarboxazid']",0.5
19222,35735.0,Isocarboxazid,sympathetic paraganglioma,disease-protein-drug,contraindication,"['sympathetic paraganglioma', 'MAOB', 'Isocarboxazid']",0.5
19222,35761.0,Isocarboxazid,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Isocarboxazid']",0.5
19222,35894.0,Isocarboxazid,duodenum cancer,disease-protein-drug,contraindication,"['duodenum cancer', 'MAOB', 'Isocarboxazid']",0.5
19222,35895.0,Isocarboxazid,small intestine cancer,disease-protein-drug,contraindication,"['small intestine cancer', 'MAOB', 'Isocarboxazid']",0.5
19222,35909.0,Isocarboxazid,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Isocarboxazid']",0.5
19222,36149.0,Isocarboxazid,heart cancer,disease-protein-drug,contraindication,"['heart cancer', 'MAOB', 'Isocarboxazid']",0.5
19222,36187.0,Isocarboxazid,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Isocarboxazid']",0.5
19222,36860.0,Isocarboxazid,adrenal gland cancer,disease-protein-drug,contraindication,"['adrenal gland cancer', 'MAOB', 'Isocarboxazid']",0.5
19222,37919.0,Isocarboxazid,adrenal gland pheochromocytoma,disease-protein-drug,contraindication,"['adrenal gland pheochromocytoma', 'MAOB', 'Isocarboxazid']",0.5
19222,38242.0,Isocarboxazid,bipolar disorder,disease-protein-drug,contraindication,"['bipolar disorder', 'MAOB', 'Isocarboxazid']",0.5
19222,38957.0,Isocarboxazid,major depressive disorder,disease-protein-drug,indication,"['major depressive disorder', 'MAOB', 'Isocarboxazid']",0.5
19222,38957.0,Isocarboxazid,major depressive disorder,disease-exposure-bioprocess-gene-drug,indication,"['major depressive disorder', 'Particulate Matter', 'cytokine-mediated signaling pathway', 'MAOA', 'Isocarboxazid']",0.5
19222,83840.0,Isocarboxazid,unipolar depression,disease-protein-drug,indication,"['unipolar depression', 'MAOB', 'Isocarboxazid']",0.5
19222,83841.0,Isocarboxazid,endogenous depression,disease-protein-drug,indication,"['endogenous depression', 'MAOB', 'Isocarboxazid']",0.5
19223,33577.0,Pargyline,hypertensive disorder,disease-exposure-bioprocess-gene-drug,indication,"['hypertensive disorder', 'Nitrogen Dioxide', 'cytokine-mediated signaling pathway', 'MAOA', 'Pargyline']",0.5
19245,35909.0,Febuxostat,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Febuxostat']",0.5
19245,83802.0,Febuxostat,obsolete hyperuricemia (disease),disease-protein-drug,indication,"['obsolete hyperuricemia (disease)', 'XDH', 'Febuxostat']",0.5
19245,83802.0,Febuxostat,obsolete hyperuricemia (disease),disease-exposure-bioprocess-gene-drug,indication,"['obsolete hyperuricemia (disease)', 'perfluorooctanoic acid', 'lactation', 'XDH', 'Febuxostat']",0.5
19250,33632.0,Pentostatin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Air Pollutants', 'negative regulation of inflammatory response', 'ADA', 'Pentostatin']",0.5
19250,35764.0,Pentostatin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'placenta development', 'ADA', 'Pentostatin']",0.5
19330,36129.0,Dupilumab,atopic eczema,disease-exposure-bioprocess-gene-drug,indication,"['atopic eczema', 'Mercury', 'immune response', 'IL4R', 'Dupilumab']",0.5
19504,28482.0,Metreleptin,congenital generalized lipodystrophy,disease-phenotype-protein-drug,indication,"['congenital generalized lipodystrophy', 'Hepatomegaly', 'LEPR', 'Metreleptin']",0.5
19504,31864.0,Metreleptin,lipodystrophy,disease-phenotype-protein-drug,indication,"['lipodystrophy', 'Hepatomegaly', 'LEPR', 'Metreleptin']",0.5
19504,33327.0,Metreleptin,Berardinelli-Seip congenital lipodystrophy,disease-phenotype-protein-drug,indication,"['Berardinelli-Seip congenital lipodystrophy', 'Hepatomegaly', 'LEPR', 'Metreleptin']",0.5
19551,27361.0,Tromethamine,hemophilia,disease-phenotype-protein-drug,contraindication,"['hemophilia', 'Seizure', 'APP', 'Tromethamine']",0.5
19551,28158.0,Tromethamine,inflammatory bowel disease,disease-exposure-bioprocess-gene-drug,contraindication,"['inflammatory bowel disease', 'Tobacco Smoke Pollution', 'cognition', 'APP', 'Tromethamine']",0.5
19551,30382.0,Tromethamine,obsolete susceptibility to ischemic stroke,disease-protein-drug,contraindication,"['obsolete susceptibility to ischemic stroke', 'APP', 'Tromethamine']",0.5
19551,33575.0,Tromethamine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'response to oxidative stress', 'APP', 'Tromethamine']",0.5
19551,33575.0,Tromethamine,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Lead', 'APP', 'Tromethamine']",0.5
19551,33577.0,Tromethamine,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'APP', 'Tromethamine']",0.5
19551,33577.0,Tromethamine,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Lead', 'APP', 'Tromethamine']",0.5
19551,33598.0,Tromethamine,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'APP', 'Tromethamine']",0.5
19551,33598.0,Tromethamine,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Pesticides', 'cognition', 'APP', 'Tromethamine']",0.5
19551,33632.0,Tromethamine,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'cognition', 'APP', 'Tromethamine']",0.5
19551,33632.0,Tromethamine,anemia (disease),disease-exposure-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'APP', 'Tromethamine']",0.5
19551,33675.0,Tromethamine,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'APP', 'Tromethamine']",0.5
19551,35565.0,Tromethamine,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'APP', 'Tromethamine']",0.5
19551,35669.0,Tromethamine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'APP', 'Tromethamine']",0.5
19551,35761.0,Tromethamine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Zinc', 'response to oxidative stress', 'APP', 'Tromethamine']",0.5
19551,35761.0,Tromethamine,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'Lead', 'APP', 'Tromethamine']",0.5
19551,35764.0,Tromethamine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'cholesterol metabolic process', 'APP', 'Tromethamine']",0.5
19551,35764.0,Tromethamine,kidney disease,disease-exposure-gene-drug,contraindication,"['kidney disease', 'Lead', 'APP', 'Tromethamine']",0.5
19551,35909.0,Tromethamine,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'perfluorooctanoic acid', 'cognition', 'APP', 'Tromethamine']",0.5
19551,35916.0,Tromethamine,dry eye syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['dry eye syndrome', 'Mercury', 'cholesterol metabolic process', 'APP', 'Tromethamine']",0.5
19551,35916.0,Tromethamine,dry eye syndrome,disease-exposure-gene-drug,contraindication,"['dry eye syndrome', 'Lead', 'APP', 'Tromethamine']",0.5
19551,36080.0,Tromethamine,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Soot', 'cognition', 'APP', 'Tromethamine']",0.5
19551,37180.0,Tromethamine,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'APP', 'Tromethamine']",0.5
19551,37180.0,Tromethamine,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'Lead', 'APP', 'Tromethamine']",0.5
19551,83942.0,Tromethamine,intracerebral hemorrhage,disease-exposure-bioprocess-gene-drug,contraindication,"['intracerebral hemorrhage', 'Air Pollutants', 'positive regulation of tumor necrosis factor production', 'APP', 'Tromethamine']",0.5
19556,27286.0,Dimercaprol,galactosemia,disease-phenotype-protein-drug,contraindication,"['galactosemia', 'Seizure', 'APP', 'Dimercaprol']",0.5
19556,27292.0,Dimercaprol,glycogen storage disease,disease-phenotype-protein-drug,contraindication,"['glycogen storage disease', 'Splenomegaly', 'APP', 'Dimercaprol']",0.5
19556,33577.0,Dimercaprol,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'cholesterol metabolic process', 'APP', 'Dimercaprol']",0.5
19556,33577.0,Dimercaprol,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'Lead', 'APP', 'Dimercaprol']",0.5
19556,35565.0,Dimercaprol,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'cognition', 'APP', 'Dimercaprol']",0.5
19663,29387.0,Teriparatide,hyperparathyroidism,disease-protein-drug,contraindication,"['hyperparathyroidism', 'PTH1R', 'Teriparatide']",0.5
19663,29614.0,Teriparatide,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'perfluorononanoic acid', 'bone mineralization', 'PTH1R', 'Teriparatide']",0.5
19663,33626.0,Teriparatide,rickets (disease),disease-protein-drug,contraindication,"['rickets (disease)', 'PTH1R', 'Teriparatide']",0.5
19663,39444.0,Teriparatide,osteomalacia (disease),disease-protein-drug,contraindication,"['osteomalacia (disease)', 'PTH1R', 'Teriparatide']",0.5
19663,83804.0,Teriparatide,osteitis fibrosa,disease-protein-drug,contraindication,"['osteitis fibrosa', 'PTH1R', 'Teriparatide']",0.5
19671,29614.0,Denosumab,osteoporosis,disease-protein-drug,indication,"['osteoporosis', 'TNFSF11', 'Denosumab']",0.5
19671,29614.0,Denosumab,osteoporosis,disease-exposure-bioprocess-gene-drug,indication,"['osteoporosis', 'Cadmium', 'bone resorption', 'TNFSF11', 'Denosumab']",0.5
19671,83776.0,Denosumab,postmenopausal osteoporosis,disease-protein-drug,indication,"['postmenopausal osteoporosis', 'TNFSF11', 'Denosumab']",0.5
19699,27933.0,Dinoprost,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,33575.0,Dinoprost,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', ""2,4,5,2',4',5'-hexachlorobiphenyl"", 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,33577.0,Dinoprost,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,33675.0,Dinoprost,asthma,disease-protein-drug,contraindication,"['asthma', 'PTGDR2', 'Dinoprost']",0.5
19699,33675.0,Dinoprost,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Dust', 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,35565.0,Dinoprost,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,35669.0,Dinoprost,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,35761.0,Dinoprost,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Mercury', 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,35764.0,Dinoprost,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,35833.0,Dinoprost,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Tobacco Smoke Pollution', 'immune response', 'PTGDR2', 'Dinoprost']",0.5
19699,39773.0,Dinoprost,allergic asthma,disease-protein-drug,contraindication,"['allergic asthma', 'PTGDR2', 'Dinoprost']",0.5
19699,83781.0,Dinoprost,intrinsic asthma,disease-protein-drug,contraindication,"['intrinsic asthma', 'PTGDR2', 'Dinoprost']",0.5
19712,33598.0,Doxapram,stroke disorder,disease-protein-drug,contraindication,"['stroke disorder', 'KCNK3', 'Doxapram']",0.5
19712,33598.0,Doxapram,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Particulate Matter', 'brain development', 'KCNK3', 'Doxapram']",0.5
19712,33675.0,Doxapram,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Organophosphates', 'brain development', 'KCNK3', 'Doxapram']",0.5
19712,35565.0,Doxapram,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'brain development', 'KCNK3', 'Doxapram']",0.5
19712,35764.0,Doxapram,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'brain development', 'KCNK3', 'Doxapram']",0.5
19712,35909.0,Doxapram,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Particulate Matter', 'brain development', 'KCNK3', 'Doxapram']",0.5
19712,35953.0,Doxapram,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Particulate Matter', 'brain development', 'KCNK3', 'Doxapram']",0.5
19712,36187.0,Doxapram,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'brain development', 'KCNK3', 'Doxapram']",0.5
19712,37617.0,Doxapram,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Particulate Matter', 'brain development', 'KCNK3', 'Doxapram']",0.5
20128,32033.0,Ethchlorvynol,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Ethchlorvynol']",0.5
20129,27655.0,Chlordiazepoxide,familial long QT syndrome,disease-phenotype-protein-drug,contraindication,"['familial long QT syndrome', 'Seizure', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,27933.0,Chlordiazepoxide,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GABRB3', 'Chlordiazepoxide']",0.5
20129,27933.0,Chlordiazepoxide,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Lead', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,29182.0,Chlordiazepoxide,systemic lupus erythematosus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Particulate Matter', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,29182.0,Chlordiazepoxide,systemic lupus erythematosus (disease),disease-phenotype-protein-drug,contraindication,"['systemic lupus erythematosus (disease)', 'Seizure', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,30035.0,Chlordiazepoxide,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GABRB3', 'Chlordiazepoxide']",0.5
20129,31618.0,Chlordiazepoxide,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,31650.0,Chlordiazepoxide,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,31732.0,Chlordiazepoxide,myxedema,disease-phenotype-protein-drug,contraindication,"['myxedema', 'Memory impairment', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,32313.0,Chlordiazepoxide,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,32617.0,Chlordiazepoxide,hereditary breast ovarian cancer syndrome,disease-protein-drug,contraindication,"['hereditary breast ovarian cancer syndrome', 'GABRP', 'Chlordiazepoxide']",0.5
20129,32977.0,Chlordiazepoxide,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,33575.0,Chlordiazepoxide,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Lead', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,33577.0,Chlordiazepoxide,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Particulate Matter', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,33593.0,Chlordiazepoxide,obesity disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['obesity disorder', 'Lead', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,33598.0,Chlordiazepoxide,stroke disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['stroke disorder', 'Particulate Matter', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,33675.0,Chlordiazepoxide,asthma,disease-exposure-bioprocess-gene-drug,contraindication,"['asthma', 'Organophosphates', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,35565.0,Chlordiazepoxide,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Manganese', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,35641.0,Chlordiazepoxide,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GABRG2', 'Chlordiazepoxide']",0.5
20129,35764.0,Chlordiazepoxide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,35833.0,Chlordiazepoxide,lung disease,disease-exposure-bioprocess-gene-drug,contraindication,"['lung disease', 'Particulate Matter', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,35909.0,Chlordiazepoxide,cerebrovascular disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['cerebrovascular disorder', 'Particulate Matter', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,36187.0,Chlordiazepoxide,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,36469.0,Chlordiazepoxide,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'methyl bromide', 'nervous system process', 'GABRQ', 'Chlordiazepoxide']",0.5
20129,37180.0,Chlordiazepoxide,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Lead', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,37573.0,Chlordiazepoxide,dementia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['dementia (disease)', 'Particulate Matter', 'brain development', 'GABRA5', 'Chlordiazepoxide']",0.5
20129,37703.0,Chlordiazepoxide,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GABRB3', 'Chlordiazepoxide']",0.5
20129,83760.0,Chlordiazepoxide,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GABRB3', 'Chlordiazepoxide']",0.5
20133,27933.0,Ethyl loflazepate,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'GABRB3', 'Ethyl loflazepate']",0.5
20133,27933.0,Ethyl loflazepate,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Lead', 'brain development', 'GABRA5', 'Ethyl loflazepate']",0.5
20133,31650.0,Ethyl loflazepate,myasthenia gravis,disease-phenotype-protein-drug,contraindication,"['myasthenia gravis', 'Seizure', 'GABRA5', 'Ethyl loflazepate']",0.5
20133,37703.0,Ethyl loflazepate,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'GABRB3', 'Ethyl loflazepate']",0.5
20133,83760.0,Ethyl loflazepate,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'GABRB3', 'Ethyl loflazepate']",0.5
20139,32033.0,Doxefazepam,insomnia (disease),disease-protein-drug,indication,"['insomnia (disease)', 'GABRB3', 'Doxefazepam']",0.5
20146,27933.0,Magnesium carbonate,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GRIN2B', 'Magnesium carbonate']",0.5
20146,27933.0,Magnesium carbonate,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'memory', 'GRIN2A', 'Magnesium carbonate']",0.5
20146,27933.0,Magnesium carbonate,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'GRIN2B', 'Magnesium carbonate']",0.5
20146,28542.0,Magnesium carbonate,mastocytosis,disease-phenotype-protein-drug,off-label use,"['mastocytosis', 'Arrhythmia', 'CNNM2', 'Magnesium carbonate']",0.5
20146,29307.0,Magnesium carbonate,nephrolithiasis susceptibility caused by SLC26A1,disease-protein-drug,contraindication,"['nephrolithiasis susceptibility caused by SLC26A1', 'TRPM7', 'Magnesium carbonate']",0.5
20146,29614.0,Magnesium carbonate,osteoporosis,disease-exposure-bioprocess-gene-drug,off-label use,"['osteoporosis', 'perfluorononanoic acid', 'memory', 'GRIN2A', 'Magnesium carbonate']",0.5
20146,30035.0,Magnesium carbonate,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GRIN1', 'Magnesium carbonate']",0.5
20146,31618.0,Magnesium carbonate,congenital central hypoventilation syndrome,disease-phenotype-protein-drug,contraindication,"['congenital central hypoventilation syndrome', 'Seizure', 'CNNM2', 'Magnesium carbonate']",0.5
20146,32313.0,Magnesium carbonate,Haddad syndrome,disease-phenotype-protein-drug,contraindication,"['Haddad syndrome', 'Seizure', 'CNNM2', 'Magnesium carbonate']",0.5
20146,32967.0,Magnesium carbonate,sarcoidosis,disease-phenotype-protein-drug,contraindication,"['sarcoidosis', 'Arrhythmia', 'CNNM2', 'Magnesium carbonate']",0.5
20146,32977.0,Magnesium carbonate,inherited porphyria,disease-phenotype-protein-drug,contraindication,"['inherited porphyria', 'Seizure', 'CNNM2', 'Magnesium carbonate']",0.5
20146,33594.0,Magnesium carbonate,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'memory', 'GRIN2A', 'Magnesium carbonate']",0.5
20146,33632.0,Magnesium carbonate,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GRIN2C', 'Magnesium carbonate']",0.5
20146,35565.0,Magnesium carbonate,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'GRIN2A', 'Magnesium carbonate']",0.5
20146,35764.0,Magnesium carbonate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'GRIN2A', 'Magnesium carbonate']",0.5
20146,36693.0,Magnesium carbonate,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Magnesium carbonate']",0.5
20146,37171.0,Magnesium carbonate,nephrolithiasis,disease-protein-drug,contraindication,"['nephrolithiasis', 'TRPM7', 'Magnesium carbonate']",0.5
20146,37703.0,Magnesium carbonate,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GRIN2A', 'Magnesium carbonate']",0.5
20146,83760.0,Magnesium carbonate,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GRIN2A', 'Magnesium carbonate']",0.5
20146,83831.0,Magnesium carbonate,acute urate nephropathy,disease-protein-drug,contraindication,"['acute urate nephropathy', 'TRPM7', 'Magnesium carbonate']",0.5
20147,27933.0,Setiptiline,anxiety disorder,disease-protein-drug,indication,"['anxiety disorder', 'ADRA2A', 'Setiptiline']",0.5
20147,27933.0,Setiptiline,anxiety disorder,disease-exposure-bioprocess-gene-drug,indication,"['anxiety disorder', 'Nicotine', 'vasoconstriction', 'HTR1D', 'Setiptiline']",0.5
20147,37703.0,Setiptiline,neurotic disorder,disease-protein-drug,indication,"['neurotic disorder', 'HTR1B', 'Setiptiline']",0.5
20147,83760.0,Setiptiline,dysthymic disorder,disease-protein-drug,indication,"['dysthymic disorder', 'HTR1B', 'Setiptiline']",0.5
20148,27503.0,Synephrine,catecholaminergic polymorphic ventricular tachycardia,disease-phenotype-protein-drug,contraindication,"['catecholaminergic polymorphic ventricular tachycardia', 'Seizure', 'ADRA1B', 'Synephrine']",0.5
20148,33575.0,Synephrine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Synephrine']",0.5
20148,33605.0,Synephrine,hypotensive disorder,disease-protein-drug,off-label use,"['hypotensive disorder', 'ADRA1B', 'Synephrine']",0.5
20148,35669.0,Synephrine,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Synephrine']",0.5
20148,35761.0,Synephrine,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Synephrine']",0.5
20148,35953.0,Synephrine,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Synephrine']",0.5
20148,36187.0,Synephrine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Particulate Matter', 'apoptotic process', 'ADRA1A', 'Synephrine']",0.5
20151,33605.0,Mephentermine,hypotensive disorder,disease-protein-drug,indication,"['hypotensive disorder', 'ADRA1B', 'Mephentermine']",0.5
20153,28547.0,Metixene,Parkinson disease,disease-exposure-bioprocess-gene-drug,indication,"['Parkinson disease', 'Air Pollutants', 'cognition', 'CHRM1', 'Metixene']",0.5
20153,28547.0,Metixene,Parkinson disease,disease-phenotype-protein-drug,indication,"['Parkinson disease', 'Resting tremor', 'CHRM4', 'Metixene']",0.5
20156,33632.0,Dactinomycin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'visual perception', 'ABCC6', 'Dactinomycin']",0.5
20156,35565.0,Dactinomycin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'Cadmium', 'visual perception', 'ABCC6', 'Dactinomycin']",0.5
20156,35616.0,Dactinomycin,testicular cancer,disease-exposure-bioprocess-gene-drug,indication,"['testicular cancer', 'Hexachlorobenzene', 'heme biosynthetic process', 'ABCG2', 'Dactinomycin']",0.5
20156,36104.0,Dactinomycin,neutropenia,disease-protein-drug,contraindication,"['neutropenia', 'ABCB1', 'Dactinomycin']",0.5
20156,36229.0,Dactinomycin,agranulocytosis,disease-protein-drug,contraindication,"['agranulocytosis', 'ABCB1', 'Dactinomycin']",0.5
20157,27933.0,Guaifenesin,anxiety disorder,disease-protein-drug,contraindication,"['anxiety disorder', 'GRIN2B', 'Guaifenesin']",0.5
20157,27933.0,Guaifenesin,anxiety disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['anxiety disorder', 'Arsenic', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,27933.0,Guaifenesin,anxiety disorder,disease-exposure-gene-drug,contraindication,"['anxiety disorder', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,30035.0,Guaifenesin,substance abuse/dependence,disease-protein-drug,contraindication,"['substance abuse/dependence', 'GRIN1', 'Guaifenesin']",0.5
20157,33575.0,Guaifenesin,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,33575.0,Guaifenesin,diabetes mellitus (disease),disease-exposure-gene-drug,contraindication,"['diabetes mellitus (disease)', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,33577.0,Guaifenesin,hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Mercury', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,33577.0,Guaifenesin,hypertensive disorder,disease-exposure-gene-drug,contraindication,"['hypertensive disorder', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,33605.0,Guaifenesin,hypotensive disorder,disease-protein-drug,contraindication,"['hypotensive disorder', 'GRIN2B', 'Guaifenesin']",0.5
20157,33632.0,Guaifenesin,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'brain development', 'GRIN2C', 'Guaifenesin']",0.5
20157,33675.0,Guaifenesin,asthma,disease-exposure-bioprocess-gene-drug,off-label use,"['asthma', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,33675.0,Guaifenesin,asthma,disease-exposure-gene-drug,off-label use,"['asthma', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,35565.0,Guaifenesin,liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['liver disease', 'perfluorooctane sulfonic acid', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,35641.0,Guaifenesin,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'GRIN2A', 'Guaifenesin']",0.5
20157,35641.0,Guaifenesin,epilepsy,disease-exposure-bioprocess-gene-drug,contraindication,"['epilepsy', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Guaifenesin']",0.5
20157,35669.0,Guaifenesin,heart disease,disease-exposure-bioprocess-gene-drug,contraindication,"['heart disease', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,35669.0,Guaifenesin,heart disease,disease-exposure-gene-drug,contraindication,"['heart disease', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,35761.0,Guaifenesin,cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,35761.0,Guaifenesin,cardiovascular disease,disease-exposure-gene-drug,contraindication,"['cardiovascular disease', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,35764.0,Guaifenesin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,35897.0,Guaifenesin,pulmonary emphysema,disease-exposure-bioprocess-gene-drug,contraindication,"['pulmonary emphysema', 'Particulate Matter', 'brain development', 'GRIN2C', 'Guaifenesin']",0.5
20157,35915.0,Guaifenesin,mental disorder,disease-protein-drug,contraindication,"['mental disorder', 'GRIN1', 'Guaifenesin']",0.5
20157,35915.0,Guaifenesin,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Vitamin D', 'sleep', 'GRIN2A', 'Guaifenesin']",0.5
20157,35953.0,Guaifenesin,atherosclerosis,disease-exposure-bioprocess-gene-drug,contraindication,"['atherosclerosis', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,35953.0,Guaifenesin,atherosclerosis,disease-exposure-gene-drug,contraindication,"['atherosclerosis', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,36034.0,Guaifenesin,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Parathion', 'learning or memory', 'GRIN2B', 'Guaifenesin']",0.5
20157,36080.0,Guaifenesin,respiratory failure,disease-exposure-bioprocess-gene-drug,contraindication,"['respiratory failure', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,36187.0,Guaifenesin,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,36187.0,Guaifenesin,coronary artery disease,disease-exposure-gene-drug,contraindication,"['coronary artery disease', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,36242.0,Guaifenesin,fatty liver disease,disease-exposure-bioprocess-gene-drug,contraindication,"['fatty liver disease', 'Mercury', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,36274.0,Guaifenesin,pyloric stenosis (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['pyloric stenosis (disease)', 'Cadmium', 'calcium ion homeostasis', 'GRIN1', 'Guaifenesin']",0.5
20157,36469.0,Guaifenesin,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Parathion', 'learning or memory', 'GRIN2B', 'Guaifenesin']",0.5
20157,36492.0,Guaifenesin,brain cancer,disease-exposure-bioprocess-gene-drug,contraindication,"['brain cancer', 'Pesticides', 'visual learning', 'GRIN1', 'Guaifenesin']",0.5
20157,36693.0,Guaifenesin,substance-related disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['substance-related disorder', 'Tetrachloroethylene', 'visual learning', 'GRIN1', 'Guaifenesin']",0.5
20157,37180.0,Guaifenesin,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,37180.0,Guaifenesin,myocardial infarction (disease),disease-exposure-gene-drug,contraindication,"['myocardial infarction (disease)', 'bisphenol A', 'GRIN2B', 'Guaifenesin']",0.5
20157,37617.0,Guaifenesin,chronic obstructive pulmonary disease,disease-exposure-bioprocess-gene-drug,contraindication,"['chronic obstructive pulmonary disease', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,37703.0,Guaifenesin,neurotic disorder,disease-protein-drug,contraindication,"['neurotic disorder', 'GRIN2A', 'Guaifenesin']",0.5
20157,37786.0,Guaifenesin,myocardial ischemia,disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial ischemia', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,37811.0,Guaifenesin,rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['rhinitis', 'Air Pollutants', 'memory', 'GRIN2A', 'Guaifenesin']",0.5
20157,37888.0,Guaifenesin,allergic rhinitis,disease-exposure-bioprocess-gene-drug,indication,"['allergic rhinitis', 'Particulate Matter', 'brain development', 'GRIN2C', 'Guaifenesin']",0.5
20157,83760.0,Guaifenesin,dysthymic disorder,disease-protein-drug,contraindication,"['dysthymic disorder', 'GRIN2A', 'Guaifenesin']",0.5
20157,83778.0,Guaifenesin,schizophreniform disorder,disease-protein-drug,contraindication,"['schizophreniform disorder', 'GRIN1', 'Guaifenesin']",0.5
20157,83778.0,Guaifenesin,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Vitamin D', 'sleep', 'GRIN2A', 'Guaifenesin']",0.5
20157,83779.0,Guaifenesin,schizoaffective disorder,disease-protein-drug,contraindication,"['schizoaffective disorder', 'GRIN1', 'Guaifenesin']",0.5
20157,83779.0,Guaifenesin,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Vitamin D', 'sleep', 'GRIN2A', 'Guaifenesin']",0.5
20162,33603.0,Alirocumab,arteriosclerosis disorder,disease-protein-drug,indication,"['arteriosclerosis disorder', 'PCSK9', 'Alirocumab']",0.5
20162,35953.0,Alirocumab,atherosclerosis,disease-protein-drug,indication,"['atherosclerosis', 'PCSK9', 'Alirocumab']",0.5
20162,35953.0,Alirocumab,atherosclerosis,disease-exposure-bioprocess-gene-drug,indication,"['atherosclerosis', 'Arsenic', 'cholesterol metabolic process', 'PCSK9', 'Alirocumab']",0.5
20166,38024.0,Risankizumab,psoriasis,disease-protein-drug,indication,"['psoriasis', 'IL23A', 'Risankizumab']",0.5
20166,39728.0,Risankizumab,parapsoriasis,disease-protein-drug,indication,"['parapsoriasis', 'IL23A', 'Risankizumab']",0.5
20169,33512.0,Magnesium sulfate,preeclampsia,disease-exposure-bioprocess-gene-drug,indication,"['preeclampsia', 'Particulate Matter', 'regulation of heart rate by cardiac conduction', 'CACNA1C', 'Magnesium sulfate']",0.5
20169,33647.0,Magnesium sulfate,periodic paralysis (disease),disease-protein-drug,contraindication,"['periodic paralysis (disease)', 'CACNA1S', 'Magnesium sulfate']",0.5
20169,35764.0,Magnesium sulfate,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'visual perception', 'CACNA1F', 'Magnesium sulfate']",0.5
20172,33594.0,Silicon dioxide,diarrheal disease,disease-exposure-bioprocess-gene-drug,contraindication,"['diarrheal disease', 'Arsenic', 'innate immune response', 'MARCO', 'Silicon dioxide']",0.5
20172,35764.0,Silicon dioxide,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'MARCO', 'Silicon dioxide']",0.5
20178,27869.0,Catridecacog,"factor XIII, A subunit, deficiency",disease-protein-drug,indication,"['factor XIII, A subunit, deficiency', 'F13B', 'Catridecacog']",0.5
20193,29525.0,Pramocaine,sudden cardiac arrest,disease-phenotype-protein-drug,contraindication,"['sudden cardiac arrest', 'Sudden death', 'SCN10A', 'Pramocaine']",0.5
20193,29614.0,Pramocaine,osteoporosis,disease-exposure-bioprocess-gene-drug,contraindication,"['osteoporosis', 'perfluorononanoic acid', 'memory', 'SCN2A', 'Pramocaine']",0.5
20193,33575.0,Pramocaine,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Zinc', 'inflammatory response', 'SCN9A', 'Pramocaine']",0.5
20193,33649.0,Pramocaine,exanthem (disease),disease-exposure-bioprocess-gene-drug,indication,"['exanthem (disease)', 'Ozone', 'regulation of heart rate by cardiac conduction', 'SCN5A', 'Pramocaine']",0.5
20193,35764.0,Pramocaine,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'regulation of heart rate', 'SCN10A', 'Pramocaine']",0.5
20193,35915.0,Pramocaine,mental disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['mental disorder', 'Asbestos', 'inflammatory response', 'SCN9A', 'Pramocaine']",0.5
20193,36034.0,Pramocaine,hyperthyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hyperthyroidism', 'Chlorpyrifos', 'memory', 'SCN2A', 'Pramocaine']",0.5
20193,36187.0,Pramocaine,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pramocaine']",0.5
20193,36469.0,Pramocaine,hypothyroidism,disease-exposure-bioprocess-gene-drug,contraindication,"['hypothyroidism', 'Chlorpyrifos', 'memory', 'SCN2A', 'Pramocaine']",0.5
20193,39798.0,Pramocaine,peripheral arterial disease,disease-exposure-bioprocess-gene-drug,contraindication,"['peripheral arterial disease', 'Air Pollutants', 'inflammatory response', 'SCN9A', 'Pramocaine']",0.5
20193,83778.0,Pramocaine,schizophreniform disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizophreniform disorder', 'Asbestos', 'inflammatory response', 'SCN9A', 'Pramocaine']",0.5
20193,83779.0,Pramocaine,schizoaffective disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['schizoaffective disorder', 'Asbestos', 'inflammatory response', 'SCN9A', 'Pramocaine']",0.5
20194,39208.0,Mogamulizumab,primary cutaneous T-cell lymphoma,disease-protein-drug,indication,"['primary cutaneous T-cell lymphoma', 'CCR4', 'Mogamulizumab']",0.5
20196,31181.0,Golodirsen,muscular dystrophy,disease-protein-drug,indication,"['muscular dystrophy', 'DMD', 'Golodirsen']",0.5
20203,33193.0,Ceftazidime,plague,disease-phenotype-protein-drug,off-label use,"['plague', 'Arrhythmia', 'SLC22A5', 'Ceftazidime']",0.5
20203,35764.0,Ceftazidime,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Ceftazidime']",0.5
20204,37830.0,Cefixime,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Endotoxins', 'innate immune response', 'SLC15A2', 'Cefixime']",0.5
20206,35764.0,Cyclacillin,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Cyclacillin']",0.5
20206,37830.0,Cyclacillin,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Endotoxins', 'innate immune response', 'SLC15A2', 'Cyclacillin']",0.5
20212,35764.0,Melphalan,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'positive regulation of interferon-gamma production', 'SLC7A5', 'Melphalan']",0.5
20227,27326.0,Foscarnet,long QT syndrome,disease-exposure-bioprocess-gene-drug,contraindication,"['long QT syndrome', 'Arsenic', 'glucose homeostasis', 'SLC16A1', 'Foscarnet']",0.5
20227,33632.0,Foscarnet,anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'lipid metabolic process', 'SLC16A1', 'Foscarnet']",0.5
20227,35764.0,Foscarnet,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Mercury', 'glucose homeostasis', 'SLC16A1', 'Foscarnet']",0.5
20248,35552.0,Loracarbef,pneumonia,disease-exposure-bioprocess-gene-drug,indication,"['pneumonia', 'Arsenic', 'innate immune response', 'SLC15A2', 'Loracarbef']",0.5
20248,37830.0,Loracarbef,bronchitis,disease-exposure-bioprocess-gene-drug,indication,"['bronchitis', 'Endotoxins', 'innate immune response', 'SLC15A2', 'Loracarbef']",0.5
20249,35764.0,Cefuroxime,kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Arsenic', 'innate immune response', 'SLC15A2', 'Cefuroxime']",0.5
20254,35641.0,Polyethylene glycol,epilepsy,disease-protein-drug,contraindication,"['epilepsy', 'ABCB1', 'Polyethylene glycol']",0.5
20290,33575.0,"Sodium phosphate, monobasic",diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Lead', 'response to lead ion', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,33577.0,"Sodium phosphate, monobasic",hypertensive disorder,disease-exposure-bioprocess-gene-drug,contraindication,"['hypertensive disorder', 'Lead', 'response to lead ion', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,33625.0,"Sodium phosphate, monobasic",hypophosphatemia (disease),disease-protein-drug,indication,"['hypophosphatemia (disease)', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,33632.0,"Sodium phosphate, monobasic",anemia (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['anemia (disease)', 'Lead', 'response to lead ion', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,33656.0,"Sodium phosphate, monobasic",hypercalcemia disease,disease-protein-drug,contraindication,"['hypercalcemia disease', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,33656.0,"Sodium phosphate, monobasic",hypercalcemia disease,disease-phenotype-protein-drug,contraindication,"['hypercalcemia disease', 'Infantile hypercalcemia', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,35583.0,"Sodium phosphate, monobasic",phosphorus metabolism disease,disease-protein-drug,contraindication,"['phosphorus metabolism disease', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,35761.0,"Sodium phosphate, monobasic",cardiovascular disease,disease-exposure-bioprocess-gene-drug,contraindication,"['cardiovascular disease', 'Lead', 'response to lead ion', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,35764.0,"Sodium phosphate, monobasic",kidney disease,disease-exposure-bioprocess-gene-drug,contraindication,"['kidney disease', 'Lead', 'response to lead ion', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,36187.0,"Sodium phosphate, monobasic",coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'response to lead ion', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20290,36279.0,"Sodium phosphate, monobasic",calcinosis,disease-protein-drug,contraindication,"['calcinosis', 'SLC20A2', 'Sodium phosphate, monobasic']",0.5
20290,38682.0,"Sodium phosphate, monobasic",nephrocalcinosis,disease-protein-drug,contraindication,"['nephrocalcinosis', 'SLC34A1', 'Sodium phosphate, monobasic']",0.5
20293,33575.0,Inositol,diabetes mellitus (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['diabetes mellitus (disease)', 'Lead', 'inositol metabolic process', 'SLC5A3', 'Inositol']",0.5
20293,36187.0,Inositol,coronary artery disease,disease-exposure-bioprocess-gene-drug,contraindication,"['coronary artery disease', 'Lead', 'inositol metabolic process', 'SLC5A3', 'Inositol']",0.5
20293,37180.0,Inositol,myocardial infarction (disease),disease-exposure-bioprocess-gene-drug,contraindication,"['myocardial infarction (disease)', 'Lead', 'inositol metabolic process', 'SLC5A3', 'Inositol']",0.5
